PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	von der Ecken, J; Muller, M; Lehman, W; Manstein, DJ; Penczek, PA; Raunser, S				von der Ecken, Julian; Mueller, Mirco; Lehman, William; Manstein, Dietmar J.; Penczek, Pawel A.; Raunser, Stefan			Structure of the F-actin-tropomyosin complex	NATURE			English	Article							NEMALINE MYOPATHY; GENE ACTA1; ELECTRON-MICROSCOPY; MUSCLE ACTIN; CRYO-EM; CRYSTAL-STRUCTURE; GESTALT-BINDING; ATOMIC MODEL; MUTATIONS; FILAMENT	Filamentous actin (F-actin) is the major protein of muscle thin filaments, and actin microfilaments are the main component of the eukaryotic cytoskeleton. Mutations in different actin isoforms lead to early-onset autosomal dominant non-syndromic hearing loss(1), familial thoracic aortic aneurysms and dissections(2), and multiple variations of myopathies(3). In striated muscle fibres, the binding of myosin motors to actin filaments is mainly regulated by tropomyosin and troponin(4,5). Tropomyosin also binds to F-actin in smooth muscle and in non-muscle cells and stabilizes and regulates the filaments there in the absence of troponin(6). Although crystal structures for monomeric actin (G-actin) are available(7), a high-resolution structure of F-actin is still missing, hampering our understanding of how disease-causing mutations affect the function of thin muscle filaments and microfilaments. Here we report the three-dimensional structure of F-actin at a resolution of 3.7 angstrom in complex with tropomyo sin at a resolution of 6.5 angstrom, determined by electron cryomicroscopy. The structure reveals that the D-loop is ordered and acts as a central region for hydrophobic and electrostatic interactions that stabilize the F-actin filament. We clearly identify map density corresponding to ADP and Mg2+ and explain the possible effect of prominent disease-causing mutants. A comparison of F-actin with G-actin reveals the conformational changes during filament formation and identifies the D-loop as their key mediator. We also confirm that negatively charged tropomyosin interacts with a positively charged groove on F-actin. Comparison of the position of tropomyosin in F-actin-tropomyosin with its position in our previously determined F-actin-tropomyosin-myosin structure(8) reveals a myosin-induced transition of tropomyosin. Our results allow us to understand the role of individual mutations in the genesis of actin- and tropomyosin-related diseases and will serve as a strong foundation for the targeted development of drugs.	[von der Ecken, Julian; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Mueller, Mirco; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Lehman, William] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Penczek, Pawel A.] Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Max Planck Society; Hannover Medical School; Boston University; University of Texas System; University of Texas Health Science Center Houston	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Raunser, Stefan/AHE-1573-2022; Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019	Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147; Raunser, Stefan/0000-0001-9373-3016; von der Ecken, Julian/0000-0001-8526-2656	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [175.010.2009.001]; European Union's Regional Development Fund through 'Kansen voor West' [21Z.014]; Behrens-Weise foundation; NIH [U54 094598, R01 60635]; DFG [MA1081/19-1, R37HL036153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, U54GM094598] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); European Union's Regional Development Fund through 'Kansen voor West'; Behrens-Weise foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Hofnagel for excellent assistance in cryo sample preparation and electron microscopy, R. S. Goody for continuous support and for comments on the manuscript and I. Vetter for assistance in data processing. We gratefully acknowledge R. Matadeen and S. de Carlo (FEI Company) for image acquisition at the National Center for Electron Nanoscopy in Leiden (NeCEN), which is co-financed by grants from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (project 175.010.2009.001) and by the European Union's Regional Development Fund through 'Kansen voor West' (project 21Z.014). J.v.d.E. is a fellow of Studienstiftung des deutschen Volkes. This work was supported by the Behrens-Weise foundation (to S.R.), NIH U54 094598 and R01 60635 (to P.A.P.), DFG MA1081/19-1 (to D.J.M.) and R37HL036153 (to W.L.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bathe FS, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-2; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; D'Amico A, 2006, NEUROMUSCULAR DISORD, V16, P548, DOI 10.1016/j.nmd.2006.07.005; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Durer ZAO, 2010, J MOL BIOL, V395, P544, DOI 10.1016/j.jmb.2009.11.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Graziano C, 2004, INT J MOL MED, V13, P805; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Jain RK, 2012, NEUROLOGY, V78, P1100, DOI 10.1212/WNL.0b013e31824e8ebe; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Koy A, 2007, NEUROPEDIATRICS, V38, P282, DOI 10.1055/s-2008-1065356; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lehman W, 2014, ARCH BIOCHEM BIOPHYS, V552, P68, DOI 10.1016/j.abb.2013.09.011; Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0; Li XE, 2014, BIOCHEM BIOPH RES CO, V446, P304, DOI 10.1016/j.bbrc.2014.02.097; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Ohlsson M, 2004, NEUROMUSCULAR DISORD, V14, P471, DOI 10.1016/j.nmd.2004.05.016; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Penczek PA, 2010, METHOD ENZYMOL, V482, P73, DOI 10.1016/S0076-6879(10)82003-8; Perkins KZ, 2011, NEUROMUSCULAR DISORD, V21, P696, DOI 10.1016/j.nmd.2011.06.942; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; PITTENGER MF, 1994, CURR OPIN CELL BIOL, V6, P96, DOI 10.1016/0955-0674(94)90122-8; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sousa DR, 2013, J MOL BIOL, V425, P4544, DOI 10.1016/j.jmb.2013.08.020; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stenzel W, 2010, NEUROMUSCULAR DISORD, V20, P531, DOI 10.1016/j.nmd.2010.06.008; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; Sudo Akira, 2013, No To Hattatsu, V45, P452; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wang Z, 2012, BIOPOLYMERS, V97, P687, DOI 10.1002/bip.22046; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443	66	241	242	5	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					114	U272		10.1038/nature14033	http://dx.doi.org/10.1038/nature14033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25470062	Green Accepted			2022-12-01	WOS:000350304000047
J	Rutz, S; Kayagaki, N; Phung, QT; Eidenschenk, C; Noubade, R; Wang, XT; Lesch, J; Lu, RZ; Newton, K; Huang, OW; Cochran, AG; Vasser, M; Fauber, BP; DeVoss, J; Webster, J; Diehl, L; Modrusan, Z; Kirkpatrick, DS; Lill, JR; Ouyang, WJ; Dixit, VM				Rutz, Sascha; Kayagaki, Nobuhiko; Phung, Qui T.; Eidenschenk, Celine; Noubade, Rajkumar; Wang, Xiaoting; Lesch, Justin; Lu, Rongze; Newton, Kim; Huang, Oscar W.; Cochran, Andrea G.; Vasser, Mark; Fauber, Benjamin P.; DeVoss, Jason; Webster, Joshua; Diehl, Lauri; Modrusan, Zora; Kirkpatrick, Donald S.; Lill, Jennie R.; Ouyang, Wenjun; Dixit, Vishva M.			Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells	NATURE			English	Article							T(H)17 CELLS; MULTIPLE-SCLEROSIS; REGULATORY NETWORK; EXPRESSION; IDENTIFICATION; INFLAMMATION; CYTOKINE; PROTEIN; IL-17; MICE	helper type 17 (T(H)17) cells that produce the cytokines interleukin-17A (IL-17A) and IL-17F are implicated in the pathogenesis of several autoimmune diseases(1,2). The differentiation of T(H)17 cells is regulated by transcription factors such as ROR gamma t(3,4), but post-translational mechanisms preventing the rampant production of pro-inflammatory IL-17A have received less attention. Here we show that the deubiquitylating enzyme DUBA is a negative regulator of IL-17A production in T cells. Mice with DUBA-deficient T cells developed exacerbated inflammation in the small intestine after challenge with anti-CD3 antibodies. DUBA interacted with the ubiquitin ligase UBR5, which suppressed DUBA abundance in naive T cells. DUBA accumulated in activated T cells and stabilized UBR5, which then ubiquitylated ROR gamma t inresponse toTGF-beta signalling. Our data identify DUBA as a cell-intrinsic suppressor of IL-17 production.	[Rutz, Sascha; Eidenschenk, Celine; Noubade, Rajkumar; Wang, Xiaoting; Lesch, Justin; Lu, Rongze; DeVoss, Jason; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kayagaki, Nobuhiko; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Phung, Qui T.; Vasser, Mark; Kirkpatrick, Donald S.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Huang, Oscar W.; Cochran, Andrea G.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Fauber, Benjamin P.] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA; [Webster, Joshua; Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	ouyang@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Ouyang, Wenjun/ABA-8763-2020; Lu, Rongze/R-2149-2016	dixit, vishva m/0000-0001-6983-0326; Kirkpatrick, Donald/0000-0003-3091-2804; Ouyang, Wenjun/0000-0002-1811-5864; Cochran, Andrea/0000-0001-6469-795X				Anania VG, 2014, MOL CELL PROTEOMICS, V13, P145, DOI 10.1074/mcp.M113.031062; [Anonymous], 2008, EUR J IMMUNOL, V38, P2616; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkpatrick DS, 2013, P NATL ACAD SCI USA, V110, P19426, DOI 10.1073/pnas.1309473110; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Ma C, 2011, SCAND J IMMUNOL, V74, P47, DOI 10.1111/j.1365-3083.2011.02539.x; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sterling JA, 2006, ANTICANCER RES, V26, P1893; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	37	77	78	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					417	421		10.1038/nature13979	http://dx.doi.org/10.1038/nature13979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470037				2022-12-01	WOS:000349547400046
J	Izawa, D; Pines, J				Izawa, Daisuke; Pines, Jonathon			The mitotic checkpoint complex binds a second CDC20 to inhibit active APC/C	NATURE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; BUBR1; MAD2; MITOSIS; DESTRUCTION; APC(CDC20); MECHANISM; TURNOVER; SUPPORTS; ARREST	The spindle assembly checkpoint (SAC) maintains genomic stability by delaying chromosome segregation until the last chromosome has attached to the mitotic spindle. The SAC prevents the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase from recognizing cyclin B and securin by catalysing the incorporation of the APC/C co-activator, CDC20, into a complex called the mitotic checkpoint complex (MCC). The SAC works through unattached kinetochores generating a diffusible 'wait anaphase' signal(1,2) that inhibits the APC/C in the cytoplasm, but the nature of this signal remains a key unsolved problem. Moreover, the SAC and the APC/C are highly responsive to each other: the APC/C quickly targets cyclin B and securin once all the chromosomes attach in metaphase, but is rapidly inhibited should kinetochore attachment be perturbed(3,4). How this is achieved is also unknown. Here, we show that the MCC can inhibit a second CDC20 that has already bound and activated the APC/C. We show how the MCC inhibits active APC/C and that this is essential for the SAC. Moreover, this mechanism can prevent anaphase in the absence of kinetochore signalling. Thus, we propose that the diffusible 'wait anaphase' signal could be the MCC itself, and explain how reactivating the SAC can rapidly inhibit active APC/C.	[Izawa, Daisuke; Pines, Jonathon] Gurdon Inst, Cambridge CB2 1QN, England; [Izawa, Daisuke; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England		Pines, J (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk		Pines, Jonathon/0000-0002-5227-6004	Cancer Research UK; Wellcome Trust; CR UK; Cancer Research UK [13959, 13678] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); CR UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We are grateful to T. Matsusaka for developing infrared-dye-conjugated ubiquitylation substrates, to A. Musacchio, W. Earnshaw, T. Kiyomitsu and M. Yanagida for reagents, and to A. Musacchio and members of our laboratory for critical discussions. This work was supported by a project and a programme grant from Cancer Research UK to J.P. J.P. acknowledges core funding to the Gurdon Institute from the Wellcome Trust and CR UK.	Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Izawa D, 2012, J CELL BIOL, V199, P27, DOI 10.1083/jcb.201205170; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Lau DTC, 2012, CURR BIOL, V22, P180, DOI 10.1016/j.cub.2011.12.029; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mariani L., 2012, CURR BIOL; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 1997, P NATL ACAD SCI USA, V94, P5107, DOI 10.1073/pnas.94.10.5107; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286	29	122	127	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					631	U245		10.1038/nature13911	http://dx.doi.org/10.1038/nature13911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383541	Green Accepted			2022-12-01	WOS:000348775000047
J	Baldridge, MT; Nice, TJ; McCune, BT; Yokoyama, CC; Kambal, A; Wheadon, M; Diamond, MS; Ivanova, Y; Artyomov, M; Virgin, HW				Baldridge, Megan T.; Nice, Timothy J.; McCune, Broc T.; Yokoyama, Christine C.; Kambal, Amal; Wheadon, Michael; Diamond, Michael S.; Ivanova, Yulia; Artyomov, Maxim; Virgin, Herbert W.			Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection	SCIENCE			English	Article							III INTERFERON; REPLICATION; SUSCEPTIBILITY; TRANSMISSION; SUFFICIENT; AUTOPHAGY; IMMUNITY; ATG16L1	The capacity of human norovirus (NoV), which causes >90% of global epidemic nonbacterial gastroenteritis, to infect a subset of people persistently may contribute to its spread. How such enteric viruses establish persistent infections is not well understood. We found that antibiotics prevented persistent murine norovirus (MNoV) infection, an effect that was reversed by replenishment of the bacterial microbiota. Antibiotics did not prevent tissue infection or affect systemic viral replication but acted specifically in the intestine. The receptor for the antiviral cytokine interferon-lambda, Ifnlr1, as well as the transcription factors Stat1 and Irf3, were required for antibiotics to prevent viral persistence. Thus, the bacterial microbiome fosters enteric viral persistence in a manner counteracted by specific	[Baldridge, Megan T.; Nice, Timothy J.; McCune, Broc T.; Yokoyama, Christine C.; Kambal, Amal; Wheadon, Michael; Diamond, Michael S.; Ivanova, Yulia; Artyomov, Maxim; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Nice, Timothy/X-9114-2019; Diamond, Michael/AAH-1733-2019; Baldridge, Megan/T-7274-2019	Nice, Timothy/0000-0002-4471-7666; Diamond, Michael/0000-0002-8791-3165; Baldridge, Megan/0000-0002-7030-6131; Virgin, Herbert/0000-0001-8580-7628; Wheadon, Michael/0000-0002-2579-3786	NIH [R01 AI084887, U19 AI109725, 5T32CA009547, 5T32AI007163, 1F31CA177194, U19 AI083019, U19 AI106772]; Crohn's and Colitis Foundation Genetics Initiative [274415]; Broad Foundation [IBD-0357]; W. M. Keck Fellowship from Washington University; Cancer Research Institute; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA113275, T32CA009547, F31CA177194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106772, U19AI083019, R01AI084887, T32AI007163, U19AI109725] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation Genetics Initiative; Broad Foundation; W. M. Keck Fellowship from Washington University; Cancer Research Institute; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Liu for technical assistance, H. Lazear for discussions, D. Kreamalmeyer for animal care and breeding, members of the Virgin laboratory for manuscript review and discussion, and S. Doyle and Bristol-Myers Squibb for providing Ifnlr1<SUP>-/-</SUP> mice. The mouse norovirus strains used in this paper are available from Washington University under a material transfer agreement. Ifnlr1<SUP>-/-</SUP> mice were made available from ZymoGenetics Inc. (Bristol-Myers Squibb) under a material transfer agreement with Washington University School of Medicine. H.W.V. is a co-inventor on a patent filed by Washington University School of Medicine related to the use of murine norovirus. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Sequencing data have been uploaded to the European Nucleotide Archive (accession no. PRJEB7745). Supported by NIH grants R01 AI084887 and U19 AI109725, Crohn's and Colitis Foundation Genetics Initiative grant 274415, and Broad Foundation grant IBD-0357 (H.W.V.); NIH training grant 5T32CA009547 and the W. M. Keck Fellowship from Washington University (M.T.B.); NIH training grant 5T32AI007163 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society (T.J.N.); NIH grant 1F31CA177194 (B.T.M.); NIH training grant 5T32AI007163 (C.C.Y.); and NIH grants U19 AI083019 and U19 AI106772 (M. S. D.). Washington University and H.W.V. receive income based on licenses for MNoV technology.	Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chachu KA, 2008, J VIROL, V82, P6610, DOI 10.1128/JVI.00141-08; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim YG, 2011, CELL HOST MICROBE, V9, P496, DOI 10.1016/j.chom.2011.05.006; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	34	276	289	4	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					266	269		10.1126/science.1258025	http://dx.doi.org/10.1126/science.1258025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25431490	Green Accepted			2022-12-01	WOS:000347915300034
J	Suga, M; Akita, F; Hirata, K; Ueno, G; Murakami, H; Nakajima, Y; Shimizu, T; Yamashita, K; Yamamoto, M; Ago, H; Shen, JR				Suga, Michihiro; Akita, Fusamichi; Hirata, Kunio; Ueno, Go; Murakami, Hironori; Nakajima, Yoshiki; Shimizu, Tetsuya; Yamashita, Keitaro; Yamamoto, Masaki; Ago, Hideo; Shen, Jian-Ren			Native structure of photosystem II at 1.95 angstrom resolution viewed by femtosecond X-ray pulses	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; CRYSTAL-STRUCTURE; MANGANESE COMPLEX; WATER; DIFFRACTION; MODELS; DAMAGE; CLUSTER; STATES; EXAFS	Photosynthesis converts light energy into biologically useful chemical energy vital to life on Earth. The initial reaction of photosynthesis takes place in photosystem II (PSII), a 700-kilodalton homodimeric membrane protein complex that catalyses photo-oxidation of water into dioxygen through an S-state cycle of the oxygen evolving complex (OEC). The structure of PSII has been solved by X-ray diffraction (XRD) at 1.9 angstrom resolution, which revealed that the OEC is a Mn4CaO5-cluster coordinated by a well defined protein environment(1). However, extended X-ray absorption fine structure (EXAFS) studies showed that the manganese cations in the OEC are easily reduced by X-ray irradiation(2), and slight differences were found in the Mn-Mn distances determined by XRD1, EXAFS(3-7) and theoretical studies(8-14). Here we report a 'radiation-damage-free' structure of PSII from Thermosynechococcus vulcanus in the S-1 state at a resolution of 1.95 angstroms using femtosecond X-ray pulses of the SPring-8 angstrom compact free-electron laser (SACLA) and hundreds of large, highly isomorphous PSII crystals. Compared with the structure from XRD, the OEC in the X-ray free electron laser structure has Mn-Mn distances that are shorter by 0.1-0.2 angstroms. The valences of each manganese atom were tentatively assigned as Mn1D(III), Mn2C(IV), Mn3B(IV) and Mn4A(III), based on the average Mn-ligand distances and analysis of the Jahn-Teller axis on Mn(III). One of the oxo-bridged oxygens, O5, has significantly longer distances to Mn than do the other oxo-oxygen atoms, suggesting that O5 is a hydroxide ion instead of a normal oxygen dianion and therefore may serve as one of the substrate oxygen atoms. These findings provide a structural basis for the mechanism of oxygen evolution, and we expect that this structure will provide a blueprint for the design of artificial catalysts for water oxidation.	[Suga, Michihiro; Akita, Fusamichi; Nakajima, Yoshiki; Shimizu, Tetsuya; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan; [Hirata, Kunio; Ueno, Go; Murakami, Hironori; Yamashita, Keitaro; Yamamoto, Masaki; Ago, Hideo] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Hirata, Kunio] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan	Okayama University; RIKEN; Japan Science & Technology Agency (JST)	Ago, H (corresponding author), RIKEN, SPring Ctr 8, 1-1-1 Kouto Sayo, Mikazuki, Hyogo 6795148, Japan.	yamamoto@riken.jp; ago@spring8.or.jp; shen@cc.okayama-u.ac.jp	Akita, Fusamichi/C-2034-2015; Yamamoto, Masaki/B-7844-2015; Suga, Michi/C-2870-2015; Shen, Jian-Ren/B-2558-2011	Akita, Fusamichi/0000-0003-0537-6157; Yamamoto, Masaki/0000-0002-1311-1768; Nakajima, Yoshiki/0000-0002-0529-8075; Yamashita, Keitaro/0000-0002-5442-7582; Ago, Hideo/0000-0002-9040-488X	The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT; JST/CREST; Japan Synchrotron Radiation Research Institute (JASRI) [2012A8011, 2012B8040, 2013A8047, 2013B8052, 2014A8036]	The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Synchrotron Radiation Research Institute (JASRI)	We thank T. Ishikawa, M. Yabashi, K. Tono and Y. Inubushi for help in using the SACLA beamline, T. Tsukihara and S. Yoshikawa for suggestions and comments on the experiments, F. Seno for assistance with sample preparation, and K. Kawakami and Y. Umena for suggestions in the initial stage of the project. F. H. M. Koua participated in the initial stage of this work. This work was supported by an X-ray Free Electron Laser Priority Strategy Program (The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT) (H. A. and J.-R. S.), a JST/CREST grant (K. H.), a grant-in-aid for Specially Promoted Research no. 24000018 (J.-R. S.) and KAKENHI grant no. 26840023 (M. S.) from JSPS, MEXT, Japan. The XFEL experiments were performed at beamline 3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal nos 2012A8011, 2012B8040, 2013A8047, 2013B8052 and 2014A8036), and we thank staff at SACLA for their help.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Galstyan A, 2012, J AM CHEM SOC, V134, P7442, DOI 10.1021/ja300254n; Glockner C, 2013, J BIOL CHEM, V288, P22607, DOI 10.1074/jbc.M113.476622; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/nmeth.2962, 10.1038/NMETH.2962]; Holton JM, 2010, ACTA CRYSTALLOGR D, V66, P393, DOI 10.1107/S0907444910007262; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shoji M., MOL PHYS; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	35	830	843	26	749	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					99	U265		10.1038/nature13991	http://dx.doi.org/10.1038/nature13991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470056	Green Submitted			2022-12-01	WOS:000347178400043
J	Rohatgi, A; Khera, A; Berry, JD; Givens, EG; Ayers, CR; Wedin, KE; Neeland, IJ; Yuhanna, IS; Rader, DR; de Lemos, JA; Shaul, PW				Rohatgi, Anand; Khera, Amit; Berry, Jarett D.; Givens, Edward G.; Ayers, Colby R.; Wedin, Kyle E.; Neeland, Ian J.; Yuhanna, Ivan S.; Rader, Daniel R.; de Lemos, James A.; Shaul, Philip W.			HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ATHEROSCLEROSIS; ABILITY	BACKGROUND It is unclear whether high-density lipoprotein (HDL) cholesterol concentration plays a causal role in atherosclerosis. A more important factor may be HDL cholesterol efflux capacity, the ability of HDL to accept cholesterol from macrophages, which is a key step in reverse cholesterol transport. We investigated the epidemiology of cholesterol efflux capacity and its association with incident atherosclerotic cardiovascular disease outcomes in a large, multiethnic population cohort. METHODS We measured HDL cholesterol level, HDL particle concentration, and cholesterol efflux capacity at baseline in 2924 adults free from cardiovascular disease who were participants in the Dallas Heart Study, a probability-based population sample. The primary end point was atherosclerotic cardiovascular disease, defined as a first nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization or death from cardiovascular causes. The median follow-up period was 9.4 years. RESULTS In contrast to HDL cholesterol level, which was associated with multiple traditional risk factors and metabolic variables, cholesterol efflux capacity had minimal association with these factors. Baseline HDL cholesterol level was not associated with cardiovascular events in an adjusted analysis (hazard ratio, 1.08; 95% confidence interval [CI], 0.59 to 1.99). In a fully adjusted model that included traditional risk factors, HDL cholesterol level, and HDL particle concentration, there was a 67% reduction in cardiovascular risk in the highest quartile of cholesterol efflux capacity versus the lowest quartile (hazard ratio, 0.33; 95% CI, 0.19 to 0.55). Adding cholesterol efflux capacity to traditional risk factors was associated with improvement in discrimination and reclassification indexes. CONCLUSIONS Cholesterol efflux capacity, a new biomarker that characterizes a key step in reverse cholesterol transport, was inversely associated with the incidence of cardiovascular events in a population-based cohort.	[Rohatgi, Anand; Khera, Amit; Berry, Jarett D.; Givens, Edward G.; Ayers, Colby R.; Neeland, Ian J.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Yuhanna, Ivan S.; Shaul, Philip W.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX 75390 USA; [Wedin, Kyle E.] Emory Univ, Dept Internal Med, Atlanta, GA 30322 USA; [Rader, Daniel R.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Rader, Daniel R.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Rohatgi, A (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	rohatgi@utsouthwestern.edu	de Lemos, James/ABD-6669-2021		Donald W. Reynolds Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL118131] Funding Source: NIH RePORTER	Donald W. Reynolds Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Donald W. Reynolds Foundation and others.	Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI200523858; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boden WE, 2012, NEW ENGL J MED, V367, P189; Calkin AC, 2009, CIRCULATION, V120, P2095, DOI 10.1161/CIRCULATIONAHA.109.870709; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Jain T, 2004, J AM COLL CARDIOL, V44, P1011, DOI 10.1016/j.jacc.2004.05.069; Khera AV, 2013, ARTERIOSCL THROM VAS, V33, P1449, DOI 10.1161/ATVBAHA.113.301519; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Maroules CD, 2013, RADIOLOGY, V269, P84, DOI 10.1148/radiol.13122707; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Saddar S, 2013, CIRC RES, V112, P140, DOI 10.1161/CIRCRESAHA.112.280081; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Voight BF, 2012, LANCET, V380, P564; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	29	910	935	7	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2383	2393		10.1056/NEJMoa1409065	http://dx.doi.org/10.1056/NEJMoa1409065			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25404125	Bronze, Green Accepted			2022-12-01	WOS:000346425800007
J	Gorbunova, V; Boeke, JD; Helfand, SL; Sedivy, JM				Gorbunova, Vera; Boeke, Jef D.; Helfand, Stephen L.; Sedivy, John M.			Sleeping dogs of the genome	SCIENCE			English	Editorial Material							TRANSPOSABLE ELEMENTS; RETROTRANSPOSITION; MOBILE		[Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10016 USA; [Helfand, Stephen L.; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	University of Rochester; New York University; NYU Langone Medical Center; Brown University	Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	john_sedivy@brown.edu		Gorbunova, Vera/0000-0001-8979-0333	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410, P50GM107632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027237, T32AG041688, R01AG024353, R37AG016694, R37AG016667, P01AG047200] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG047200, R37 AG016694, R01 AG024353, R01AG027237, R37AG016667, P01 AG047200, RF1 AG024353, R01AG024353, T32AG041688, R01 AG027237, R37AG016694, R37 AG016667, T32 AG041688] Funding Source: Medline; NIGMS NIH HHS [P50GM107632, P30 GM103410, P30GM103410, P50 GM107632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Dawkins R., 1976, SELFISH GENE; De Cecco M, 2013, AGING-US, V5, P867, DOI 10.18632/aging.100621; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Faulkner GJ, 2011, FEBS LETT, V585, P1589, DOI 10.1016/j.febslet.2011.03.061; Guo HS, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms6276, 10.1038/ncomms5986]; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368; Maxwell PH, 2011, P NATL ACAD SCI USA, V108, P20376, DOI 10.1073/pnas.1100271108; Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Solyom S, 2012, GENOME MED, V4, DOI 10.1186/gm311; Van Meter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6011	14	29	31	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1187	1188		10.1126/science.aaa3177	http://dx.doi.org/10.1126/science.aaa3177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477445	Green Accepted			2022-12-01	WOS:000346189000045
J	Bercsenyi, K; Schmieg, N; Bryson, JB; Wallace, M; Caccin, P; Golding, M; Zanotti, G; Greensmith, L; Nischt, R; Schiavo, G				Bercsenyi, Kinga; Schmieg, Nathalie; Bryson, J. Barney; Wallace, Martin; Caccin, Paola; Golding, Matthew; Zanotti, Giuseppe; Greensmith, Linda; Nischt, Roswitha; Schiavo, Giampietro			Nidogens are therapeutic targets for the prevention of tetanus	SCIENCE			English	Article							BOTULINUM NEUROTOXIN-B; PROTEIN-RECEPTOR; BINDING-SITE; MATRIX; AFFINITY; DEFECTS; COMPLEX; LAMININ	T cell responses are initiated by antigen and promoted by a range of costimulatory signals. Understanding how T cells integrate alternative signal combinations and make decisions affecting immune response strength or tolerance poses a considerable theoretical challenge. Here, we report that T cell receptor (TCR) and costimulatory signals imprint an early, cell-intrinsic, division fate, whereby cells effectively count through generations before returning automatically to a quiescent state. This autonomous program can be extended by cytokines. Signals from the TCR, costimulatory receptors, and cytokines add together using a linear division calculus, allowing the strength of a T cell response to be predicted from the sum of the underlying signal components. These data resolve a long-standing costimulation paradox and provide a quantitative paradigm for therapeutically manipulating immune response strength.	[Bercsenyi, Kinga; Schmieg, Nathalie; Wallace, Martin; Golding, Matthew] Canc Res UK London Res Inst, Mol Neuropathobiol Lab, London WC2A 3LY, England; [Bercsenyi, Kinga; Schmieg, Nathalie; Bryson, J. Barney; Wallace, Martin; Greensmith, Linda; Schiavo, Giampietro] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Caccin, Paola; Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Nischt, Roswitha] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany	Cancer Research UK; University of London; University College London; University of Padua; University of Cologne	Schiavo, G (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England.	giampietro.schiavo@ucl.ac.uk	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Bercsenyi, Kinga/0000-0001-5730-9752; Bryson, J. Barney/0000-0001-5486-0258	Cancer Research UK; Medical Research Council; University of Padua; Deutsche Forschungsgemeinschaft through the Collaborative Research Center at the University of Cologne [SFB 829]; "Koln Fortune Programm"; Brain Research Trust; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Padua; Deutsche Forschungsgemeinschaft through the Collaborative Research Center at the University of Cologne; "Koln Fortune Programm"; Brain Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Kjaer (Cancer Research UK London Research Institute) for help with the Octet RED96 system and K<INF>d</INF> determination. N. O'Reilly and members of the Protein and Peptide Chemistry Laboratory (Cancer Research UK London Research Institute) for peptide synthesis, purification, and analysis; F. Giribaldi (Cancer Research UK London Research Institute) for help with footprint analyses; K. Deinhardt (University of Southampton) for mass spec analysis of axonal signaling endosomes; S. Swaminathan (Brookhaven National Laboratory) for experiments aiming at the crystallization of the N1 peptide-H<INF>C</INF>T complex; A. Rummel and T. Binz (Medizinische Hochschule Hannover) and N. Fairweather (Imperial College London) for providing access to published H<INF>C</INF>T mutants; I. Koxholt (University of Cologne) for help with nidogen-1 and -2 KO mice; and J. N. Sleigh (University College London) for help with statistical analyses. We also thank C. Montecucco (University of Padua) and S. Novoselov (University College London) for constructive comments. This work was supported by Cancer Research UK (K. B., N. S., M. G., M. W., and G. S.), by the Medical Research Council (M. W.), by the University of Padua (P. C. and G.Z.), and by the Deutsche Forschungsgemeinschaft (SFB 829) through the Collaborative Research Center at the University of Cologne and the "Koln Fortune Programm" (R. N.). L. G. is the Graham Watts Senior Research Fellow, supported by the Brain Research Trust. The data presented in this manuscript are found in the main paper and the supplementary data and materials and methods. The authors declare that they have no conflict of interest.	Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Benoit RM, 2014, NATURE, V505, P108, DOI 10.1038/nature12732; Berntsson RPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3058; Berntsson RPA, 2013, STRUCTURE, V21, P1602, DOI 10.1016/j.str.2013.06.026; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dong LJ, 2002, LAB INVEST, V82, P1617, DOI 10.1097/01.LAB.0000042240.52093.0F; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Fox MA, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-24; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; MATSUDA M, 1982, BIOCHEM BIOPH RES CO, V104, P799, DOI 10.1016/0006-291X(82)90708-2; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Montecucco C., 1995, CURR TOP MICROBIOL I, V195, P278; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Suwan-apichou O, 2006, INVEST OPHTH VIS SCI, V47, P133, DOI 10.1167/iovs.05-0380; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	30	50	52	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1118	1123		10.1126/science.1258138	http://dx.doi.org/10.1126/science.1258138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430769	Green Submitted			2022-12-01	WOS:000345763400044
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Spearman's rank correlation coefficient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LINEAR-REGRESSION		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Hall WD, 2003, BRIT MED J, V326, P1008, DOI 10.1136/bmj.326.7397.1008; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2686; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2340; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4483; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1753	7	91	92	8	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2014	349								g7327	10.1136/bmj.g7327	http://dx.doi.org/10.1136/bmj.g7327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KH	25432873	Green Published			2022-12-01	WOS:000346115900007
J	Gammon, K				Gammon, Katharine			Joint effort	NATURE			English	Editorial Material							HEMOPHILIA											Ceponis A, 2013, HAEMOPHILIA, V19, P790, DOI 10.1111/hae.12175; Greene WB, 1997, CLIN ORTHOP RELAT R, P19; Hakobyan N, 2014, J THROMB HAEMOST, V12, P1	3	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S170	S171		10.1038/515S170a	http://dx.doi.org/10.1038/515S170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427210	Bronze			2022-12-01	WOS:000346247600012
J	Endo, M; Shimizu, H; Nohales, MA; Araki, T; Kay, SA				Endo, Motomu; Shimizu, Hanako; Nohales, Maria A.; Araki, Takashi; Kay, Steve A.			Tissue-specific clocks in Arabidopsis show asymmetric coupling	NATURE			English	Article							CIRCADIAN CLOCK; EXPRESSION; PROMOTER; NETWORK; ROLES; TIME	Many organisms rely on a circadian clock system to adapt to daily and seasonal environmental changes. The mammalian circadian clock consists of a central clock in the suprachiasmatic nucleus that has tightly coupled neurons and synchronizes other clocks in peripheral tissues(1,2). Plants also have a circadian clock, but plant circadian clock function has long been assumed to be uncoupled(3). Only a few studies have been able to show weak, local coupling among cells'. Here, by implementing two novel techniques, we have performed a comprehensive tissue-specific analysis of leaf tissues, and show that the vasculature and mesophyll clocks asymmetrically regulate each other in Arabidopsis. The circadian clock in the vasculature has characteristics distinct from other tissues, cycles robustly without environmental cues, and affects circadian clock regulation in other tissues. Furthermore, we found that vasculature-enriched genes that are rhythmically expressed are preferentially expressed in the evening, whereas rhythmic mesophyll-enriched genes tend to be expressed in the morning. Our results set the stage for a deeper understanding of how the vasculature circadian clock in plants regulates key physiological responses such as flowering time.	[Endo, Motomu; Shimizu, Hanako; Araki, Takashi] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068501, Japan; [Endo, Motomu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Nohales, Maria A.; Kay, Steve A.] Univ So Calif Mol & Computat Biol, Dept Biol, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	Kyoto University; Japan Science & Technology Agency (JST)	Endo, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068501, Japan.	moendo@lif.kyoto-u.ac.jp	Kay, Steve A/F-6025-2011; Nohales, Maria A./AAA-8319-2019; Araki, Takashi/G-1760-2013	Kay, Steve A/0000-0002-0402-2878; Araki, Takashi/0000-0002-3616-1493; Nohales, Maria A./0000-0002-7874-4021	HFSP long-term Fellowship [LT00017/2008-L]; JST PRESTO [11103346]; JSPS KAKENHI [22770036, 25650097]; Sumitomo Foundation; Nakatani Foundation; National Institutes of Health (NIH) [R01 GM056006, GM067837];  [19060012];  [19060016]; Grants-in-Aid for Scientific Research [25113005] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056006, R01GM067837] Funding Source: NIH RePORTER	HFSP long-term Fellowship; JST PRESTO(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Nakatani Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Fukuda and Y. Sugisawa for processing raw microarray data; S. Yonehara for providing c-Jun and A-Fos plasmids; G. Breton, K. Hitomi, T. Oyama, T. Muranaka and Y. Kondo for advice; T. Koto, K. Katayama and B. Y. Chow for technical assistance; J. A. Hejna and T. R. Endo for English proofreading. This work was supported by an HFSP long-term Fellowship LT00017/2008-L (to M.E.), a JST PRESTO 11103346 (to M.E), JSPS KAKENHI grants 22770036 and 25650097 (to M.E.), a Sumitomo Foundation and Nakatani Foundation (to M.E.), Grants-in-Aid for Scientific Research on Priority Areas 19060012 and 19060016 (to T.A.), and National Institutes of Health (NIH) Grants R01 GM056006 and GM067837 (to S.A.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barclay JL, 2012, PROG BRAIN RES, V199, P163, DOI 10.1016/B978-0-444-59427-3.00030-7; Cano-Delgado A, 2010, ANNU REV CELL DEV BI, V26, P605, DOI 10.1146/annurev-cellbio-100109-104107; Endo M, 2005, PLANT CELL, V17, P1941, DOI 10.1105/tpc.105.032342; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Fukuda H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098102; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Herrero E, 2012, PLANT CELL, V24, P428, DOI 10.1105/tpc.111.093807; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Khan JA, 2007, PLANT PHYSIOL, V143, P1576, DOI 10.1104/pp.106.092296; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Nishimura T, 2003, PLANT CELL PHYSIOL, V44, P1131, DOI 10.1093/pcp/pcg158; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Pokhilko A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-23; Ranjan A, 2011, DEVELOPMENT, V138, P1851, DOI 10.1242/dev.061036; Sawchuk MG, 2008, PLANT PHYSIOL, V148, P1908, DOI 10.1104/pp.108.126946; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Thain SC, 2000, CURR BIOL, V10, P951, DOI 10.1016/S0960-9822(00)00630-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wenden B, 2012, P NATL ACAD SCI USA, V109, P6757, DOI 10.1073/pnas.1118814109; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	36	162	165	4	105	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					419	+		10.1038/nature13919	http://dx.doi.org/10.1038/nature13919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25363766	Green Accepted, Green Published			2022-12-01	WOS:000345770600047
J	Gupta, S				Gupta, Sujata			No hiding in the dark	NATURE			English	Editorial Material							SKIN-CANCER RISK; MELANOMA; COLOR; GENES											Abe Y, 2013, J DERMATOL SCI, V69, P167, DOI 10.1016/j.jdermsci.2012.10.016; Agbai ON, 2014, J AM ACAD DERMATOL, V70, P748, DOI 10.1016/j.jaad.2013.11.038; ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Brose MS, 2002, CANCER RES, V62, P6997; Hu SS, 2006, ARCH DERMATOL, V142, P704, DOI 10.1001/archderm.142.6.704; Kabigting Filamer D, 2009, Dermatol Online J, V15, P3; Lange JR, 2007, J CLIN ONCOL, V25, P1363, DOI 10.1200/JCO.2006.08.8310; Lee HY, 2012, ANN ACAD MED SINGAP, V41, P17; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Wu SW, 2014, CANCER EPIDEM BIOMAR, V23, P1080, DOI 10.1158/1055-9965.EPI-13-0821; Yoshizawa J, 2014, J DERMATOL, V41, P296, DOI 10.1111/1346-8138.12432	11	5	5	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S121	S123		10.1038/515S121a	http://dx.doi.org/10.1038/515S121a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407710	Bronze			2022-12-01	WOS:000345770600006
J	Farzadfard, F; Lu, TK				Farzadfard, Fahim; Lu, Timothy K.			Genomically encoded analog memory with precise in vivo DNA writing in living cell populations	SCIENCE			English	Article							SINGLE-STRANDED-DNA; REVERSE-TRANSCRIPTASE; INFORMATION-STORAGE; ESCHERICHIA-COLI; RECOMBINATION; LOGIC; REPLICATION; EFFICIENT; SYSTEM; INVOLVEMENT	Cellular memory is crucial to many natural biological processes and sophisticated synthetic biology applications. Existing cellular memories rely on epigenetic switches or recombinases, which are limited in scalability and recording capacity. In this work, we use the DNA of living cell populations as genomic "tape recorders" for the analog and distributed recording of long-term event histories. We describe a platform for generating single-stranded DNA (ssDNA) in vivo in response to arbitrary transcriptional signals. When coexpressed with a recombinase, these intracellularly expressed ssDNAs target specific genomic DNA addresses, resulting in precise mutations that accumulate in cell populations as a function of the magnitude and duration of the inputs. This platform could enable long-term cellular recorders for environmental and biomedical applications, biological state machines, and enhanced genome engineering strategies.	[Farzadfard, Fahim; Lu, Timothy K.] MIT, Synthet Biol Grp, Elect Res Lab, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT Synthet Biol Ctr, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT Microbiol Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, Synthet Biol Grp, Elect Res Lab, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		/0000-0003-1389-8203	NIH New Innovator Award [1DP2OD008435]; NIH National Centers for Systems Biology [1P50GM098792]; U.S. Office of Naval Research [N000141310424]; Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Centers for Systems Biology; U.S. Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH New Innovator Award (1DP2OD008435), NIH National Centers for Systems Biology (1P50GM098792), the U.S. Office of Naval Research (N000141310424), and the Defense Advanced Research Projects Agency. Sequencing data have been deposited in GenBank with accession numbers KM923743 to KM923754.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; BEBENEK K, 1993, J BIOL CHEM, V268, P10324; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Brakmann S, 2001, CHEMBIOCHEM, V2, P212, DOI 10.1002/1439-7633(20010302)2:3<212::AID-CBIC212>3.3.CO;2-I; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Chirieleison SM, 2013, NAT CHEM, V5, P1000, DOI [10.1038/nchem.1764, 10.1038/NCHEM.1764]; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Inniss MC, 2013, CURR BIOL, V23, pR812, DOI 10.1016/j.cub.2013.06.047; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lampson BC, 2005, CYTOGENET GENOME RES, V110, P491, DOI 10.1159/000084982; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MAO JR, 1995, J BIOL CHEM, V270, P19684, DOI 10.1074/jbc.270.34.19684; MIROCHNITCHENKO O, 1994, J BIOL CHEM, V269, P2380; MIYATA S, 1992, P NATL ACAD SCI USA, V89, P5735, DOI 10.1073/pnas.89.13.5735; Mosberg JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044638; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Poteete AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067440; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sharma Prem L., 2005, Antiviral Chemistry & Chemotherapy, V16, P169; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; YEE T, 1984, CELL, V38, P203, DOI 10.1016/0092-8674(84)90541-5; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	51	179	206	1	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					825	+	1256272	10.1126/science.1256272	http://dx.doi.org/10.1126/science.1256272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XZ	25395541	Green Submitted, Green Accepted			2022-12-01	WOS:000349771600001
J	Simon, A				Simon, Anna			Cholesterol Metabolism and Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							25-HYDROXYCHOLESTEROL; INTERFERON		Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Simon, A (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.		Simon, Anna/D-3757-2009	Simon, Anna/0000-0002-6141-7921				Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681	5	33	34	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1933	1935		10.1056/NEJMcibr1412016	http://dx.doi.org/10.1056/NEJMcibr1412016			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390746	Green Published			2022-12-01	WOS:000344709800017
J	van der Meer, AJ; Wedemeyer, H; Feld, JJ; Dufour, JF; Zeuzem, S; Hansen, BE; Janssen, HLA				van der Meer, Adriaan J.; Wedemeyer, Heiner; Feld, Jordan J.; Dufour, Jean-Francois; Zeuzem, Stefan; Hansen, Bettina E.; Janssen, Harry L. A.			Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHRONIC HEPATITIS-C; VIRUS-INFECTION; MORTALITY		[van der Meer, Adriaan J.; Hansen, Bettina E.; Janssen, Harry L. A.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Feld, Jordan J.] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Dufour, Jean-Francois] Univ Bern, Dept Clin Res, Bern, Switzerland; [Zeuzem, Stefan] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Frankfurt, Germany	Erasmus University Rotterdam; Erasmus MC; Hannover Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Bern; Goethe University Frankfurt; Goethe University Frankfurt Hospital	van der Meer, AJ (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	a.vandermeer@erasmusmc.nl	Hansen, Bettina E/P-5468-2014; Feld, Jordan/AAH-5628-2020; Dufour, Jean Francois Jacques/AAL-9866-2020; Zeuzem, Stefan/AAE-7435-2019	Hansen, Bettina E/0000-0001-8307-3341; Feld, Jordan/0000-0003-2640-2211; Dufour, Jean Francois Jacques/0000-0002-8062-1346; 				Akamatsu M, 2006, LIVER INT, V26, P536, DOI 10.1111/j.1478-3231.2006.01260.x; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; van der Meer AJ, 2014, J HEPATOL, V60, P191, DOI 10.1016/j.jhep.2013.07.043; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878	6	72	74	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1927	1928		10.1001/jama.2014.12627	http://dx.doi.org/10.1001/jama.2014.12627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25387192	Bronze			2022-12-01	WOS:000344532600024
J	Li, ZY; Liu, J; Zheng, MH; Xu, XZS				Li, Zhaoyu; Liu, Jie; Zheng, Maohua; Xu, X. Z. Shawn			Encoding of Both Analog- and Digital-like Behavioral Outputs by One C. elegans Interneuron	CELL			English	Article							CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; ALLOSTERIC MODULATION; NEURAL CIRCUITS; NEURONS; RECEPTOR; IDENTIFICATION; SENSITIVITY; CONNECTOME; FAMILY	Model organisms usually possess a small nervous system but nevertheless execute a large array of complex behaviors, suggesting that some neurons are likely multifunctional and may encode multiple behavioral outputs. Here, we show that the C. elegans interneuron AIY regulates two distinct behavioral outputs: locomotion speed and direction-switch by recruiting two different circuits. The "speed" circuit is excitatory with a wide dynamic range, which is well suited to encode speed, an analog-like output. The "direction-switch" circuit is inhibitory with a narrow dynamic range, which is ideal for encoding direction-switch, a digital-like output. Both circuits employ the neurotransmitter ACh but utilize distinct postsynaptic ACh receptors, whose distinct biophysical properties contribute to the distinct dynamic ranges of the two circuits. This mechanism enables graded C. elegans synapses to encode both analog- and digital-like outputs. Our studies illustrate how an interneuron in a simple organism encodes multiple behavioral outputs at the circuit, synaptic, and molecular levels.	[Li, Zhaoyu; Liu, Jie; Zheng, Maohua; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Li, Zhaoyu; Liu, Jie; Zheng, Maohua; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu		liu, jie/0000-0002-1215-5814; Li, Zhaoyu/0000-0002-5222-6832	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bing Ye for technical assistance and helpful discussions, and Liz Ronan and Bing Ye for critically reading the manuscript. Some strains were obtained from the Caenorhabditis Genetics Center (CGC) and Knockout Consortiums in the United States and Japan. This work was supported by grants from the NIH (X.Z.S.X.).	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; [Anonymous], 1996, ELEMENTS ARTIFICIAL, DOI DOI 10.7551/MITPRESS/2687.001.0001; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Berkowitz A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00036; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chang YH, 2001, J PHYSIOL-LONDON, V536, P471, DOI 10.1111/j.1469-7793.2001.0471c.xd; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Kocabas A, 2012, NATURE, V490, P273, DOI 10.1038/nature11431; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; McLaughlin James T., 2009, BMC Pharmacology, V9, P1, DOI 10.1186/1471-2210-9-1; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Rammes G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006715; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Schiller PH, 1996, BEHAV BRAIN RES, V76, P21, DOI 10.1016/0166-4328(95)00186-7; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Sherlekar AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060597; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	43	69	71	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					751	765		10.1016/j.cell.2014.09.056	http://dx.doi.org/10.1016/j.cell.2014.09.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417153	Green Accepted, Bronze			2022-12-01	WOS:000344522000009
J	Harper, S				Harper, Sarah			Economic and social implications of aging societies	SCIENCE			English	Review							HEALTH-CARE EXPENDITURE; POPULATION; FERTILITY; TRENDS; COMPRESSION; PARENTHOOD; DISABILITY; MORBIDITY; MORTALITY; REASONS	The challenge of global population aging has been brought into sharper focus by the financial crisis of 2008. In particular, growing national debt has drawn government attention to two apparently conflicting priorities: the need to sustain public spending on pensions and health care versus the need to reduce budget deficits. A number of countries are consequently reconsidering their pension and health care provisions, which account for up to 40% of all government spending in advanced economies. Yet population aging is a global phenomenon that will continue to affect all regions of the world. By 2050 there will be the same number of old as young in the world, with 2 billion people aged 60 or over and another 2 billion under age 15, each group accounting for 21% of the world's population.	Univ Oxford, Oxford Inst Populat Ageing, Oxford OX2 6PR, England	University of Oxford	Harper, S (corresponding author), Univ Oxford, Oxford Inst Populat Ageing, Oxford OX2 6PR, England.	sarah.harper@ageing.ox.ac.uk		Harper, Sarah/0000-0001-8248-7016				Basten S, 2013, DEMOGR RES, V28, P1145, DOI 10.4054/DemRes.2013.28.39; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Bloom D. E., 2011, PROGRAM ON THE GLOBA; Bloom DE, 2010, OXFORD REV ECON POL, V26, P583, DOI 10.1093/oxrep/grq038; Blossfeld HP, 2006, ROUTL ADV SOCIOL, P1; Breyer F, 2010, OXFORD REV ECON POL, V26, P674, DOI 10.1093/oxrep/grq032; Brucker H., 2002, CAN INTERNATIONAL MI; CALDWELL JC, 1980, POPUL DEV REV, V6, P225, DOI 10.2307/1972729; Chesnais J. C., 1998, REV POPULATION SOCIA, V7, P83; D'Addio A. C., 2005, TRENDS AND DETERMINA; D'Addio A.C., 2005, POLICIES INSTITUTION; Dustmann C, 2010, FISC STUD, V31, P1, DOI 10.1111/j.1475-5890.2010.00106.x; Eurostat, 2013, PROJECTED OLD AGE DE; Eurostat, 2013, TOTAL FERTILITY RATE; Fehr H., 2004, NBER WORKING PAPER 1; Fina-Sanglas L., 2000, EUROPES POPULATION A, V33, P43; FRIES JF, 1989, MILBANK Q, V67, P208, DOI 10.2307/3350138; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Haberkern K, 2010, AGEING SOC, V30, P299, DOI 10.1017/S0144686X09990316; Harper S., 2014, INTERNATIONAL HANDBO; Harper S., 2006, AGEING SOCIETIES MYT; Harper S., 2012, PEOPLE AND THE PLANE; Harper S., 2004, FAMILIES IN AGEING S; Harper S, 2010, INT SOC SECUR REV, V63, P177, DOI 10.1111/j.1468-246X.2010.01374.x; Howse K., 2011, ENHANCING HUMAN CAPA; Howse K., 2010, IARU WORKING PAPER; Howse K, 2012, PERSPECT PUBLIC HEAL, V132, P171, DOI 10.1177/1757913912444805; Iacovou M, 2011, POPUL DEV REV, V37, P89, DOI 10.1111/j.1728-4457.2011.00391.x; Jagger C, 2009, AGE AGEING, V38, P319, DOI 10.1093/ageing/afp016; Jenkner E., 2010, HEALTH CARE SPENDING; Kreyenfeld M, 2010, EUR SOCIOL REV, V26, P351, DOI 10.1093/esr/jcp026; Lee R, 2011, POPULATION AGING AND THE GENERATIONAL ECONOMY: A GLOBAL PERSPECTIVE, P1; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Leeson G. W., 2004, WORKING PAPER WP204; Lutz Wolfgang, 2006, VIENNA YB POPULATION, V4, P167, DOI DOI 10.1553/POPULATIONYEARBOOK2006S167; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Morgan SP, 2010, POPUL DEV REV, V36, P91, DOI 10.1111/j.1728-4457.2010.00319.x; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; OECD, 2007, BABIES AND BOSSES RE; Olshansky SJ, 1991, J AGING HEALTH, V312, P194, DOI DOI 10.1177/089826439100300205; Robine J. M., 2005, AGEING HORIZONS, V3, P14; Robine JM, 2003, EXP GERONTOL, V38, P735, DOI 10.1016/S0531-5565(03)00100-1; Seshamani M, 2004, AGE AGEING, V33, P556, DOI 10.1093/ageing/afh187; Seshamani Meena, 2003, Appl Health Econ Health Policy, V2, P9; Smith S, 2009, HEALTH AFFAIR, V28, P1276, DOI 10.1377/hlthaff.28.5.1276; Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; United Nations, 2013, WORLD POPULATION PRO; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Yong V, 2009, DEMOGR RES, V20, P467, DOI 10.4054/DemRes.2009.20.19; Zweifel P, 2004, GENEVA PAP R I-ISS P, V29, P652, DOI 10.1111/j.1468-0440.2004.00308.x; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	56	274	281	41	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		587	591		10.1126/science.1254405	http://dx.doi.org/10.1126/science.1254405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359967				2022-12-01	WOS:000343799700038
J	Hepburn, L; Prajsnar, TK; Klapholz, C; Moreno, P; Loynes, CA; Ogryzko, NV; Brown, K; Schiebler, M; Hegyi, K; Antrobus, R; Hammond, KL; Connolly, J; Ochoa, B; Bryant, C; Otto, M; Surewaard, B; Seneviratne, SL; Grogono, DM; Cachat, J; Ny, T; Kaser, A; Torok, ME; Peacock, SJ; Holden, M; Blundell, T; Wang, LH; Ligoxygakis, P; Minichiello, L; Woods, CG; Foster, SJ; Renshaw, SA; Floto, RA				Hepburn, Lucy; Prajsnar, Tomasz K.; Klapholz, Catherine; Moreno, Pablo; Loynes, Catherine A.; Ogryzko, Nikolay V.; Brown, Karen; Schiebler, Mark; Hegyi, Krisztina; Antrobus, Robin; Hammond, Katherine L.; Connolly, John; Ochoa, Bernardo; Bryant, Clare; Otto, Michael; Surewaard, Bas; Seneviratne, Suranjith L.; Grogono, Dorothy M.; Cachat, Julien; Ny, Tor; Kaser, Arthur; Toeroek, M. Estee; Peacock, Sharon J.; Holden, Matthew; Blundell, Tom; Wang, Lihui; Ligoxygakis, Petros; Minichiello, Liliana; Woods, C. Geoff; Foster, Simon J.; Renshaw, Stephen A.; Floto, R. Andres			A Spaetzle-like role for nerve growth factor beta in vertebrate immunity to Staphylococcus aureus	SCIENCE			English	Article							HOST-DEFENSE; TOLL; ACTIVATION; MECHANISM; MUTATION; RELEASE; SPATZLE; PAIN	Many key components of innate immunity to infection are shared between Drosophila and humans. However, the fly Toll ligandSpaetzle is not thought to have a vertebrate equivalent. We have found that the structurally related cystine-knot protein, nerve growth factor beta (NGF beta), plays an unexpected Spaetzle-like role in immunity to Staphylococcus aureus infection in chordates. Deleterious mutations of either human NGF beta or its high-affinity receptor tropomyosin-related kinase receptor A (TRKA) were associated with severe S. aureus infections. NGF beta was released by macrophages in response to S. aureus exoproteins through activation of the NOD-like receptors NLRP3 and NLRP4 and enhanced phagocytosis and superoxide-dependent killing, stimulated proinflammatory cytokine production, and promoted calcium-dependent neutrophil recruitment. TrkA knockdown in zebrafish increased susceptibility to S. aureus infection, confirming an evolutionarily conserved role for NGF beta-TRKA signaling in pathogen-specific host immunity.	[Hepburn, Lucy; Klapholz, Catherine; Moreno, Pablo; Brown, Karen; Schiebler, Mark; Hegyi, Krisztina; Antrobus, Robin; Woods, C. Geoff; Floto, R. Andres] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1TN, England; [Hepburn, Lucy; Klapholz, Catherine; Brown, Karen; Schiebler, Mark; Hegyi, Krisztina; Grogono, Dorothy M.; Kaser, Arthur; Toeroek, M. Estee; Peacock, Sharon J.; Floto, R. Andres] Univ Cambridge, Dept Med, Cambridge CB2 1TN, England; [Prajsnar, Tomasz K.; Connolly, John; Foster, Simon J.; Renshaw, Stephen A.] Univ Sheffield, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England; [Prajsnar, Tomasz K.; Connolly, John; Foster, Simon J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Prajsnar, Tomasz K.; Loynes, Catherine A.; Ogryzko, Nikolay V.; Hammond, Katherine L.; Renshaw, Stephen A.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; [Loynes, Catherine A.; Hammond, Katherine L.; Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Sheffield S10 2TN, S Yorkshire, England; [Brown, Karen; Grogono, Dorothy M.; Floto, R. Andres] Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge CB3 8RE, England; [Ochoa, Bernardo; Blundell, Tom] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England; [Bryant, Clare] Univ Cambridge, Dept Vet Med, Cambridge CB2 1TN, England; [Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Surewaard, Bas] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Seneviratne, Suranjith L.] Royal Free Hosp London, Dept Clin Immunol, London, England; [Cachat, Julien] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Ny, Tor] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Peacock, Sharon J.; Holden, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Holden, Matthew] Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland; [Wang, Lihui; Ligoxygakis, Petros] Univ Oxford, Biochem Dept, Oxford OX1 2JD, England; [Minichiello, Liliana] Univ Oxford, Pharmacol Dept, Oxford OX1 2JD, England; [Woods, C. Geoff] Univ Cambridge, Dept Med Genet, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Papworth Hospital; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utrecht University; Utrecht University Medical Center; University of Geneva; Umea University; Wellcome Trust Sanger Institute; University of St Andrews; University of Oxford; University of Oxford; University of Cambridge	Renshaw, SA (corresponding author), Univ Sheffield, Krebs Inst, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	s.a.renshaw@sheffield.ac.uk; arf27@cam.ac.uk	Grogono, Dorothy/Y-3306-2019; Renshaw, Steve/E-6192-2010; Schiebler, Mark/V-5201-2019; Holden, Matthew TG/K-6449-2014; Moreno, Pablo/AAC-7057-2020; Ogryzko, Nikolay/K-2478-2019; Peacock, Sharon J/ABE-6331-2020; Minichiello, Liliana/AAA-7190-2022	Renshaw, Steve/0000-0003-1790-1641; Holden, Matthew TG/0000-0002-4958-2166; Moreno, Pablo/0000-0002-9856-1679; Ogryzko, Nikolay/0000-0003-0199-5567; Otto, Michael/0000-0002-2222-4115; Torok, Mili Estee/0000-0001-9098-8590; Peacock, Sharon/0000-0002-1718-2782; Connolly, John/0000-0002-9232-7929; Grogono, Dorothy/0000-0002-3423-3158; Prajsnar, Tomasz/0000-0001-6562-8630	Wellcome Trust [084953, 089981]; Wellcome Trust [Medical Research Council, UK] [G0700091, G0701932]; Papworth Hospital; National Institute for Health Research Cambridge Biomedical Research Centre; NIAID, NIH; BBSRC [BB/K006436/1] Funding Source: UKRI; MRC [G0300170, G0701932, G108/595, MR/K006312/1, MR/M004864/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF4-Torok] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/K006436/1] Funding Source: researchfish; Medical Research Council [MR/M004864/1, MR/K006312/1, G0700091B, G108/595, G0701932, G0300170] Funding Source: researchfish; National Centre for the Replacement [NC/K500392/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust [Medical Research Council, UK](UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Papworth Hospital; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Clegg and E. Henderson for help with patient samples, R. Mifsud and D. Cusens for initial phylogenetic and functional analysis, A. Segal for provision of Nod2<SUP>-/-</SUP> mouse bone marrow, and the aquarium staff of the Bateson Centre, University of Sheffield for zebrafish husbandry. This work was supported by The Wellcome Trust [Senior Clinical Research Fellowship to R. A. F. (084953), project grant to S.J.F./S.A.R. (089981), The Medical Research Council, UK (Research center grant (G0700091), Senior Clinical Fellowship to S.A.R. (G0701932)], Papworth Hospital and the National Institute for Health Research Cambridge Biomedical Research Centre, and the Intramural Research Program of NIAID, NIH.	ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; BISCHOFF SC, 1992, BLOOD, V79, P2662; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; COHEN S, 1956, P NATL ACAD SCI USA, V42, P571, DOI 10.1073/pnas.42.9.571; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rotthier A, 2012, NAT REV NEUROL, V8, P73, DOI 10.1038/nrneurol.2011.227; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	30	50	51	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		641	646		10.1126/science.1258705	http://dx.doi.org/10.1126/science.1258705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359976	Green Accepted, Green Submitted			2022-12-01	WOS:000343799700052
J	Mann, J; McLean, R; Skeaff, M; Morenga, LT				Mann, Jim; McLean, Rachael; Skeaff, Murray; Morenga, Lisa Te			Low carbohydrate diets: going against the grain	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; WEIGHT-LOSS; FAT; RISK; DISEASE		[Mann, Jim] Univ Otago, Dept Human Nutr, Dunedin 9054, New Zealand; Univ Otago, Edgar Ctr Diabet & Obes Res, Dunedin 9054, New Zealand	University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, POB 56, Dunedin 9054, New Zealand.	jim.mann@otago.ac.nz	McLean, Rachael/AAF-7596-2019; Te Morenga, Lisa/C-4459-2011	McLean, Rachael/0000-0002-0005-328X; Te Morenga, Lisa/0000-0003-3526-0091				Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Hooper L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7666; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Nordic Council of Ministers, 2014, NORD NUTR REC 2012 I; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Scientific Advisory Committee on Nutrition, 2014, CARB HLTH R IN PRESS; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; US Department of Agriculture and US Department of Health and Human Services, 2020, DIET GUID AM 2020 20; USDA, 2014, SER SYST REV REL DIE; WHO, 2014, GUID FREE S IN PRESS	19	14	14	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2014	384	9953					1479	1480		10.1016/S0140-6736(14)61413-6	http://dx.doi.org/10.1016/S0140-6736(14)61413-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9MO	25390561				2022-12-01	WOS:000343899600004
J	Arie, S				Arie, Sophie			EBOLA Only the military can get the Ebola epidemic under control: MSF head	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Hussain M., 2014, MSF CALLS MILITARY M; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6094; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5866; *MSF, 2014, UN SPEC BRIEF EB; undp, HUM DEV IND; World Health Organization, 2014, EB RESP ROADM SIT RE	6	2	2	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2014	349								g6151	10.1136/bmj.g6151	http://dx.doi.org/10.1136/bmj.g6151			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LQ	25304485	Green Published, Bronze			2022-12-01	WOS:000342999100004
J	Magnusson, JP; Goritz, C; Tatarishvili, J; Dias, DO; Smith, EMK; Lindvall, O; Kokaia, Z; Frisen, J				Magnusson, Jens P.; Goritz, Christian; Tatarishvili, Jemal; Dias, David O.; Smith, Emma M. K.; Lindvall, Olle; Kokaia, Zaal; Frisen, Jonas			A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse	SCIENCE			English	Article							INJURED BRAIN; SELF-RENEWAL; ADULT BRAIN; IN-VIVO; CELLS; STROKE; DIFFERENTIATION; REPLACEMENT; GENERATION; STRIATUM	Neurogenesis is restricted in the adult mammalian brain; most neurons are neither exchanged during normal life nor replaced in pathological situations. We report that stroke elicits a latent neurogenic program in striatal astrocytes in mice. Notch1 signaling is reduced in astrocytes after stroke, and attenuated Notch1 signaling is necessary for neurogenesis by striatal astrocytes. Blocking Notch signaling triggers astrocytes in the striatum and the medial cortex to enter a neurogenic program, even in the absence of stroke, resulting in 850 +/- 210 (mean +/- SEM) new neurons in a mouse striatum. Thus, under Notch signaling regulation, astrocytes in the adult mouse brain parenchyma carry a latent neurogenic program that may potentially be useful for neuronal replacement strategies.	[Magnusson, Jens P.; Goritz, Christian; Dias, David O.; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Tatarishvili, Jemal; Lindvall, Olle; Kokaia, Zaal] Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden; [Smith, Emma M. K.] Lund Univ, Div Translat Canc Res, SE-22363 Lund, Sweden	Karolinska Institutet; Lund University; Skane University Hospital; Lund University	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021; Kokaia, Zaal/AAL-6009-2020	Göritz, Christian/0000-0003-0799-766X; Kokaia, Zaal/0000-0003-2296-2449; Magnusson, Jens/0000-0002-3928-8959; Smith, Emma/0000-0003-0609-4864; Oliveira Dias, David/0000-0002-2144-6621	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; The Swedish Heart and Lung Foundation; StratRegen; StemTherapy; European Union [279017]; Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse; Portuguese government [SFRH/BD/63164/2009]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; The Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); StratRegen; StemTherapy; European Union(European Commission); Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Portuguese government(Portuguese Foundation for Science and Technology)	We thank E. Andersson, E.-B. Braune, J. Dias, S.-B. Jin, and U. Lendahl for valuable discussions. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, The Swedish Heart and Lung Foundation, StratRegen, StemTherapy, European Union project TargetBraIn (279017), Torsten Soderbergs Stiftelse, and Knut och Alice Wallenbergs Stiftelse. D.O.D. was supported by the Portuguese government (SFRH/BD/63164/2009). C. G. is a Hallsten Academy and Wallenberg Academy fellow. We thank F. W. Pfrieger for providing Cx30 and GLAST transgenic mice through a material transfer agreement with the Institut Genetique Biologie Moleculaire Cellulaire (Strasbourg, France). Requests for mice should be directed to F. W. Pfrieger (CNRS, France). We declare no conflicts of interest. The supplementary materials contain additional data.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Smith E, 2012, GENESIS, V50, P700, DOI 10.1002/dvg.22030; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x	20	268	289	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					237	241		10.1126/science.346.6206.237	http://dx.doi.org/10.1126/science.346.6206.237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301628				2022-12-01	WOS:000342721500048
J	Krivanek, OL; Lovejoy, TC; Dellby, N; Aoki, T; Carpenter, RW; Rez, P; Soignard, E; Zhu, JT; Batson, PE; Lagos, MJ; Egerton, RF; Crozier, PA				Krivanek, Ondrej L.; Lovejoy, Tracy C.; Dellby, Niklas; Aoki, Toshihiro; Carpenter, R. W.; Rez, Peter; Soignard, Emmanuel; Zhu, Jiangtao; Batson, Philip E.; Lagos, Maureen J.; Egerton, Ray F.; Crozier, Peter A.			Vibrational spectroscopy in the electron microscope	NATURE			English	Article							ENERGY-LOSS SPECTROSCOPY; ABERRATION; EXCITATIONS; INTERFACES; FILMS	Vibrational spectroscopies using infrared radiation(1,2), Raman scattering(3), neutrons(4), low-energy electrons(5) and inelastic electron tunnelling(6) are powerful techniques that can analyse bonding arrangements, identify chemical compounds and probe many other important properties of materials. The spatial resolution of these spectroscopies is typically one micrometre or more, although it can reach a few tens of nanometres or even a few a angstroms when enhanced by the presence of a sharp metallic tip(6,7). If vibrational spectroscopy could be combined with the spatial resolution and flexibility of the transmission electron microscope, it would open up the study of vibrational modes in many different types of nanostructures. Unfortunately, the energy resolution of electron energy loss spectroscopy performed in the electron microscope has until now been too poor to allow such a combination. Recent developments that have improved the attainable energy resolution of electron energy loss spectroscopy in a scanning transmission electron microscope to around ten millielectronvolts now allow vibrational spectroscopy to be carried out in the electron microscope. Here we describe the innovations responsible for the progress, and present examples of applications in inorganic and organic materials, including the detection of hydrogen. We also demonstrate that the vibrational signal has both high-and low-spatial-resolution components, that the first component can be used to map vibrational features at nanometre-level resolution, and that the second component can be used for analysis carried out with the beam positioned just outside the sample-that is, for 'aloof' spectroscopy that largely avoids radiation damage.	[Krivanek, Ondrej L.; Lovejoy, Tracy C.; Dellby, Niklas] Nion Co, Kirkland, WA 98033 USA; [Krivanek, Ondrej L.; Rez, Peter] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Aoki, Toshihiro; Soignard, Emmanuel; Zhu, Jiangtao] Arizona State Univ, LeRoy Eyring Ctr Solid State Sci, Tempe, AZ 85287 USA; [Carpenter, R. W.; Soignard, Emmanuel] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Batson, Philip E.; Lagos, Maureen J.] Rutgers State Univ, Inst Adv Mat Devices & Nanotechnol, Piscataway, NJ 08854 USA; [Batson, Philip E.; Lagos, Maureen J.] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Batson, Philip E.; Lagos, Maureen J.] Rutgers State Univ, Dept Mat Sci, Piscataway, NJ 08854 USA; [Egerton, Ray F.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Crozier, Peter A.] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Alberta; Arizona State University; Arizona State University-Tempe	Krivanek, OL (corresponding author), Nion Co, 1102 Eighth St, Kirkland, WA 98033 USA.	krivanek@nion.com; crozier@asu.edu	Aoki, Toshihiro/I-4852-2015	Lagos, Maureen Joel/0000-0002-1452-5196; Crozier, Peter A./0000-0002-1837-2481	National Science Foundation [DMR MRI 0821796, DMR MRI-R2 959905]; Department of Energy [DE-SC0004954, DE-SC0005132, DE-SC0007694]; Natural Sciences and Engineering Council of Canada; UK Engineering and Physical Research Council (capital equipment grant) [EP/J021156/1]; Arizona State University; Rutgers University; Nion Co.	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); UK Engineering and Physical Research Council (capital equipment grant); Arizona State University; Rutgers University; Nion Co.	We thank A. Howie and J.-C. Idrobo for discussions, W. J. Bowman, J. Bruley, J. H. Butler, V. Domnich, R. A. Haber, Y. Ikuhara, M. R. Libera, D. S. Lowry and V. Nicolosi for provision of samples, J. Mardinly for help with running the instruments, our co-workers at Nion, especially N. J. Bacon, G. J. Corbin, P. J. Cramer, Z. Dellby, R. W. Hayner, P. Hrncirik, P. Phoungphidok, M. C. Sarahan, G. S. Skone, Z. Szilagyi and T. Yoo for help with the construction of the hardware, electronics and software for HERMES, and C. Trevor of Gatan Inc. for an instability-analysing script. We also acknowledge the use of facilities within the LeRoy Eyring Center for Solid State Science at Arizona State University. Financial support for the purchase of the microscopes was provided by National Science Foundation grants DMR MRI 0821796 (Arizona State University) and DMR MRI-R2 959905(Rutgers University). Department of Energy grant DE-SC0004954 provided support for P.A.C. and microscopy performed at Arizona State University, and Department of Energy grant DE-SC0005132 provided support for P. E. B., M. J. L. and microscopy performed at Rutgers University. Additional support was provided by the Department of Energy (grant DE-SC0007694), the Natural Sciences and Engineering Council of Canada, the UK Engineering and Physical Research Council (capital equipment grant EP/J021156/1), Arizona State University, Rutgers University and Nion Co.	BASHKIN IO, 1993, Z PHYS CHEM, V179, P335, DOI 10.1524/zpch.1993.179.Part_1_2.335; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Bock J., 1970, Journal of the American Ceramic Society, V53, P69, DOI 10.1111/j.1151-2916.1970.tb12012.x; BOERSCH H, 1966, PHYS REV LETT, V17, P379, DOI 10.1103/PhysRevLett.17.379; Cohen H, 1998, PHYS REV LETT, V80, P782, DOI 10.1103/PhysRevLett.80.782; Cueva P, 2013, MICROSC MICROANAL, V19, P1130; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; de Abajo FJG, 1999, INST PHYS CONF SER, P327; Dwyer C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054103; Egerton R. F., 2011, ELECT ENERGY LOSS SP; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; Griffiths O.R., 2007, FOURIER TRANSFORM IN; Gubbens A, 2010, ULTRAMICROSCOPY, V110, P962, DOI 10.1016/j.ultramic.2010.01.009; HAIDER M, 1995, OPTIK, V99, P167; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; HOWIE A, 1985, ULTRAMICROSCOPY, V18, P427, DOI 10.1016/0304-3991(85)90161-5; Ibach H., 1982, ELECT ENERGY LOSS SP; Krivanek OL, 2008, ULTRAMICROSCOPY, V108, P179, DOI 10.1016/j.ultramic.2007.07.010; Krivanek O L, 2011, SCANNING TRANSMISSIO, P613; KRIVANEK OL, 1992, MICROSC MICROANAL M, V3, P187, DOI 10.1051/mmm:0199200302-3018700; Krivanek OL, 1997, INST PHYS CONF SER, P35; Krivanek OL, 2014, J PHYS CONF SER, V522, DOI 10.1088/1742-6596/522/1/012023; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; LI JP, 1993, APPL PHYS LETT, V62, P3135, DOI 10.1063/1.109106; Lovejoy T. C., 2014, MICROSC MICROANAL S3, V20, P558; McCreery R.L., 2005, RAMAN SPECTROSCOPY C; Mitchell P.C.H., 2005, VIBRATIONAL SPECTROS; Oshima C, 1997, J PHYS-CONDENS MAT, V9, P1, DOI 10.1088/0953-8984/9/1/004; Pennycook S J, 2011, SCANNING TRANSMISSIO; Ramasse QM, 2013, NANO LETT, V13, P4989, DOI 10.1021/nl304187e; Rez P, 2014, MICROSC MICROANAL, V20, P671, DOI 10.1017/S1431927614000129; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stuart B. H., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Suenaga K, 2010, NATURE, V468, P1088, DOI 10.1038/nature09664; Terauchi M, 1999, J MICROSC-OXFORD, V194, P203, DOI 10.1046/j.1365-2818.1999.00450.x; Tiemeijer P. C., 2012, MICROSC MICROANAL S2, V8, P70; WALLS MG, 1989, ULTRAMICROSCOPY, V28, P40, DOI 10.1016/0304-3991(89)90266-0; Wang ZL, 1996, MICRON, V27, P265, DOI 10.1016/0968-4328(96)00011-X; Zhou W, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.206803	42	350	356	18	465	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					209	+		10.1038/nature13870	http://dx.doi.org/10.1038/nature13870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25297434				2022-12-01	WOS:000342663100038
J	Morgan, DJ; Kaye, KS; Diekema, DJ				Morgan, Daniel J.; Kaye, Keith S.; Diekema, Daniel J.			Reconsidering Isolation Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTACT PRECAUTIONS; INTENSIVE-CARE; TRANSMISSION; ACQUISITION; BACTERIA		[Morgan, Daniel J.] Univ Maryland, Sch Med, VA Maryland Healthcare Syst, Baltimore, MD 21201 USA; [Kaye, Keith S.] Detroit Med Ctr, Detroit, MI USA; [Kaye, Keith S.] Wayne State Univ, Detroit, MI USA; [Kaye, Keith S.] Univ Hlth Ctr, Detroit, MI USA; [Diekema, Daniel J.] Univ Iowa, Dept Internal Med, Div Infect Dis, Coll Med, Iowa City, IA 52242 USA	University System of Maryland; University of Maryland Baltimore; Detroit Medical Center; Wayne State University; University of Iowa	Morgan, DJ (corresponding author), Univ Maryland, Sch Med, VA Maryland Healthcare Syst, 10 S Pine St,MSTF 334, Baltimore, MD 21201 USA.	dmorgan@epi.umaryland.edu	Kaye, Keith/AAF-1048-2019	Diekema, Daniel/0000-0003-1273-0724				Dhar S, 2014, INFECT CONT HOSP EP, V35, P213, DOI 10.1086/675294; Haessler S, 2014, SUCCESS STORIES MRSA; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Siegel JD, 2006, MANAGEMENT MULTIDRUG	8	24	25	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1395	1396		10.1001/jama.2014.10142	http://dx.doi.org/10.1001/jama.2014.10142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291571				2022-12-01	WOS:000342630200010
J	Lang, BT; Cregg, JM; DePaul, MA; Tran, AP; Xu, K; Dyck, SM; Madalena, KM; Brown, BP; Weng, YL; Li, SX; Karimi-Abdolrezaee, S; Busch, SA; Shen, YJ; Silver, J				Lang, Bradley T.; Cregg, Jared M.; DePaul, Marc A.; Tran, Amanda P.; Xu, Kui; Dyck, Scott M.; Madalena, Kathryn M.; Brown, Benjamin P.; Weng, Yi-Lan; Li, Shuxin; Karimi-Abdolrezaee, Soheila; Busch, Sarah A.; Shen, Yingjie; Silver, Jerry			Modulation of the proteoglycan receptor PTP sigma promotes recovery after spinal cord injury	NATURE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CHONDROITIN SULFATE PROTEOGLYCAN; FUNCTIONAL RECOVERY; BLADDER FUNCTION; GROWTH CONE; REGENERATION; PLASTICITY; BARRIER; DOMAIN; MODEL	Contusive spinal cord injury leads to a variety of disabilities owing to limited neuronal regeneration and functional plasticity. It is well established that an upregulation of glial-derived chondroitin sulphate proteoglycans (CSPGs) within the glial scar and perineuronal net creates a barrier to axonal regrowth and sprouting(1-5). Protein tyrosine phosphatase sigma (PTP sigma), along with its sister phosphatase leukocyte common antigen-related (LAR) and the nogo receptors 1 and 3 (NgR), have recently been identified as receptors for the inhibitory glycosylated side chains of CSPGs(6-8). Here we find in rats that PTP sigma has a critical role in converting growth cones into a dystrophic state by tightly stabilizing them within CSPG-rich substrates. We generated a membrane-permeable peptide mimetic of the PTP sigma wedge domain that binds to PTP sigma and relieves CSPG-mediated inhibition. Systemic delivery of this peptide over weeks restored substantial serotonergic innervation to the spinal cord below the level of injury and facilitated functional recovery of both locomotor and urinary systems. Our results add a new layer of understanding to the critical role of PTP sigma in mediating the growth-inhibited state of neurons due to CSPGs within the injured adult spinal cord.	[Lang, Bradley T.; Cregg, Jared M.; DePaul, Marc A.; Tran, Amanda P.; Madalena, Kathryn M.; Busch, Sarah A.; Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Xu, Kui; Shen, Yingjie] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Dyck, Scott M.; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Regenerat Med Program, Winnipeg, MB R3E 0J9, Canada; [Dyck, Scott M.; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Dept Physiol, Winnipeg, MB R3E 0J9, Canada; [Brown, Benjamin P.] Baldwin Wallace Univ, Berea, OH 44017 USA; [Weng, Yi-Lan] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Li, Shuxin] Temple Univ, Sch Med, Ctr Neural Repair & Rehabil, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19140 USA	Case Western Reserve University; University System of Ohio; Ohio State University; University of Manitoba; University of Manitoba; Baldwin Wallace University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Silver, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	JXS10@case.edu	DePaul, Marc/H-9010-2017; Cregg, Jared/CAG-8414-2022	DePaul, Marc/0000-0002-3249-9550; Cregg, Jared/0000-0002-0027-9748; Brown, Benjamin/0000-0001-5296-087X; Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663; Tran, Amanda/0000-0002-8393-6124	National Institute of Neurological Disorders and Stroke [NS025713]; Case Western Reserve University Council; Unite to Fight Paralysis; Brumagin Memorial Fund; Spinal Cord Injury Sucks; United Paralysis Foundation; Kaneko Family Fund; NATIONAL EYE INSTITUTE [R01EY024575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025713, R37NS025713, R01NS079432] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Case Western Reserve University Council; Unite to Fight Paralysis; Brumagin Memorial Fund; Spinal Cord Injury Sucks; United Paralysis Foundation; Kaneko Family Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke grant NS025713 (J.S.); the Case Western Reserve University Council to Advance Human Health; P. Jing, R. Senior and S. Poon; Unite to Fight Paralysis; The Brumagin Memorial Fund; Spinal Cord Injury Sucks; United Paralysis Foundation; and The Kaneko Family Fund. The authors thank J. Flanagan, M. Blackmore, A. Filous, S. Brady-Kalnay, R. Gardner and B. Habecker for their valuable discussion and input into the project.	Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Cheng CL, 2004, EXP NEUROL, V187, P445, DOI 10.1016/j.expneurol.2004.02.014; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; DEGROAT WC, 1990, J AUTONOM NERV SYST, V30, pS71, DOI 10.1016/0165-1838(90)90105-R; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Jakeman L. B., 2012, ANIMAL MODELS ACUTE, P417; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Pikov V, 2001, J NEUROSCI, V21, P559, DOI 10.1523/JNEUROSCI.21-02-00559.2001; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Ramon y Cajal S, 1928, DEGENERATION REGENER; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Xie YM, 2006, J BIOL CHEM, V281, P16482, DOI 10.1074/jbc.M603131200; Xu B, 2015, NEUROBIOL DIS, V73, P36, DOI 10.1016/j.nbd.2014.08.030	35	288	298	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					404	408		10.1038/nature13974	http://dx.doi.org/10.1038/nature13974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470046	Green Accepted			2022-12-01	WOS:000349547400043
J	Buffie, CG; Bucci, V; Stein, RR; McKenney, PT; Ling, LL; Gobourne, A; No, D; Liu, H; Kinnebrew, M; Viale, A; Littmann, E; van den Brink, MRM; Jenq, RR; Taur, Y; Sander, C; Cross, JR; Toussaint, NC; Xavier, JB; Pamer, EG				Buffie, Charlie G.; Bucci, Vanni; Stein, Richard R.; McKenney, Peter T.; Ling, Lilan; Gobourne, Asia; No, Daniel; Liu, Hui; Kinnebrew, Melissa; Viale, Agnes; Littmann, Eric; van den Brink, Marcel R. M.; Jenq, Robert R.; Taur, Ying; Sander, Chris; Cross, Justin R.; Toussaint, Nora C.; Xavier, Joao B.; Pamer, Eric G.			Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile	NATURE			English	Article							INTESTINAL MICROBIOTA; METABOLISM; DOMINATION; PHYLOGENY; SCINDENS; PROPOSAL; SALTS; MICE	The gastrointestinal tracts of mammals are colonized by hundreds of microbial species that contribute to health, including colonization resistance against intestinal pathogens(1). Many antibiotics destroy intestinal microbial communities and increase susceptibility to intestinal pathogens(2). Among these, Clostridium difficile, a major cause of antibiotic-induced diarrhoea, greatly increases morbidity and mortality in hospitalized patients(3). Which intestinal bacteria provide resistance to C. difficile infection and their in vivo inhibitory mechanisms remain unclear. Here we correlate loss of specific bacterial taxa with development of infection, by treating mice with different antibiotics that result in distinct microbiota changes and lead to varied susceptibility to C. difficile. Mathematical modelling augmented by analyses of the microbiota of hospitalized patients identifies resistance-associated bacteria common to mice and humans. Using these platforms, we determine that Clostridium scindens, a bile acid 7 alpha-dehydroxylating intestinal bacterium, is associated with resistance to C. difficile infection and, upon administration, enhances resistance to infection in a secondary bile acid dependent fashion. Using a workflow involving mouse models, clinical studies, metagenomic analyses, and mathematical modelling, we identify a probiotic candidate that corrects a clinically relevant microbiome deficiency. These findings have implications for the rational design of targeted antimicrobials as well as microbiome-based diagnostics and therapeutics for individuals at risk of C. difficile infection.	[Buffie, Charlie G.; McKenney, Peter T.; Kinnebrew, Melissa; Taur, Ying; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Buffie, Charlie G.; McKenney, Peter T.; Ling, Lilan; Gobourne, Asia; No, Daniel; Kinnebrew, Melissa; Littmann, Eric; Taur, Ying; Toussaint, Nora C.; Xavier, Joao B.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10065 USA; [Bucci, Vanni; Stein, Richard R.; Sander, Chris; Toussaint, Nora C.; Xavier, Joao B.] Sloan Kettering Inst, Computat Biol Program, New York, NY 10065 USA; [Bucci, Vanni] Univ Massachusetts Dartmouth, Dept Biol, N Dartmouth, MA 02747 USA; [Liu, Hui; Cross, Justin R.] Sloan Kettering Inst, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Lab, New York, NY 10065 USA; [van den Brink, Marcel R. M.; Jenq, Robert R.] Mem Sloan Kettering Canc Ctr, Dept Med, Bone Marrow Transplant Serv, New York, NY 10065 USA; [van den Brink, Marcel R. M.; Pamer, Eric G.] Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University Massachusetts Dartmouth; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	pamere@mskcc.org	Xavier, Joao/H-5471-2011; Bucci, Vanni/B-4558-2011	Xavier, Joao/0000-0003-3592-1689; Ling, Lilan/0000-0001-6961-7787; Bucci, Vanni/0000-0002-3257-2922; Taur, Ying/0000-0002-6601-8284; Stein, Richard/0000-0002-5110-6863; Toussaint, Nora/0000-0001-7911-7647; Cross, Justin/0000-0002-6356-057X	US National Institutes of Health (NIH) [RO1 AI42135, AI95706]; Tow Foundation; NIH Office of the Director [DP2OD008440]; NCI [U54 CA148967]; Lucille Castori Center for Microbes, Inflammation, and Cancer; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH [T32GM07739]; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA148967, P01CA023766, T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095398, R01AI095706, R01AI042135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tow Foundation; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lucille Castori Center for Microbes, Inflammation, and Cancer; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	E.G.P. received funding from US National Institutes of Health (NIH) grants RO1 AI42135 and AI95706, and from the Tow Foundation. J.B.X. received funding from the NIH Office of the Director (DP2OD008440), NCI (U54 CA148967), and from a seed grant from the Lucille Castori Center for Microbes, Inflammation, and Cancer. C.G.B. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH (award number T32GM07739, awarded to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program).	Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Cohen J., 2013, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008; Kinnebrew MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090158; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000; Wells JE, 2003, CLIN CHIM ACTA, V331, P127, DOI 10.1016/S0009-8981(03)00115-3; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	40	1040	1126	16	410	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					205	U207		10.1038/nature13828	http://dx.doi.org/10.1038/nature13828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25337874	Green Accepted			2022-12-01	WOS:000347477600037
J	DaRosa, PA; Wang, ZZ; Jiang, XM; Pruneda, JN; Cong, F; Klevit, RE; Xu, WQ				DaRosa, Paul A.; Wang, Zhizhi; Jiang, Xiaomo; Pruneda, Jonathan N.; Cong, Feng; Klevit, Rachel E.; Xu, Wenqing			Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal	NATURE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX REVEALS; E3 LIGASE; RECOGNITION; MECHANISM; AXIN; PROTEINS; INSIGHTS; SYSTEM	Protein poly(ADP-ribosyl)ation (PARylation) has a role in diverse cellular processes such as DNA repair, transcription, Wnt signalling, andcell death(1-6). Recent studies have shown that PARylation can serve as a signal for the polyubiquitination and degradation of several crucial regulatory proteins, including Axin and 3BP2 (refs 7-9). The RING-type E3 ubiquitin ligase RNF146 (also known as Iduna) is responsible for PARylation-dependent ubiquitination (PARdU)(10-12). Here we provide a structural basis for RNF146-catalysed PARdU and how PARdU specificity is achieved. First, we show that iso-ADP-ribose (iso-ADPr), the smallest internal poly(ADP-ribose) (PAR) structural unit, binds between the WWE and RING domains of RNF146 and functions as an allosteric signal that switches the RING domain from a catalytically inactive state to an active one. In the absence of PAR, the RING domain is unable to bind and activate a ubiquitin-conjugating enzyme (E2) efficiently. Binding of PAR or iso-ADPr induces a major conformational change that creates a functional RING structure. Thus, RNF146 represents a new mechanistic class of RING E3 ligases, the activities of which are regulated by non-covalent ligand binding, and that may provide a template for designing inducible protein-degradation systems. Second, we find that RNF146 directly interacts with the PAR polymerase tankyrase (TNKS). Disruption of the RNF146-TNKS interaction inhibits turnover of the substrate Axin in cells. Thus, both substrate PARylation and PARdU are catalysed by enzymes within the same protein complex, and PARdU substrate specificity may be primarily determined by the substrate-TNKS interaction. We propose that the maintenance of unliganded RNF146 in an inactive state may serve to maintain the stability of the RNF146-TNKS complex, which in turn regulates the homeostasis of PARdU activity in the cell.	[DaRosa, Paul A.; Pruneda, Jonathan N.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [DaRosa, Paul A.; Wang, Zhizhi; Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Jiang, Xiaomo; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Novartis	Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	klevit@uw.edu; wxu@uw.edu	Wang, Zhizhi/K-3271-2016; Klevit, Rachel/AAI-7038-2021	Wang, Zhizhi/0000-0003-4948-925X; Klevit, Rachel/0000-0002-3476-969X; Da Rosa, Paul/0000-0001-7214-8758; Xu, Wenqing/0000-0002-2884-3101; Pruneda, Jonathan/0000-0002-0304-4418	National Institutes of Health (NIH) [R01 GM099766, T32 GM07270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM099766] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Brzovic and N. Zheng for discussions and editorial comments. We are grateful to the staff at Advanced Light Source (ALS) beamlines BL 8.2.1 and 8.2.2 for assistance with synchrotron data collection. This work was supported by National Institutes of Health (NIH) grant R01 GM099766 to W.X. and R.E.K. and NIH T32 GM07270 to P.A.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELANO WL, 1994, PROTEINS, V20, P105, DOI 10.1002/prot.340200202; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085377; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Virag L, 2013, MOL ASPECTS MED, V34, P1043, DOI 10.1016/j.mam.2013.05.002; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	38	124	132	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					223	U275		10.1038/nature13826	http://dx.doi.org/10.1038/nature13826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25327252	Green Accepted			2022-12-01	WOS:000347477600041
J	Fontaine, MC; Pease, JB; Steele, A; Waterhouse, RM; Neafsey, DE; Sharakhov, IV; Jiang, XF; Hall, AB; Catteruccia, F; Kakani, E; Mitchell, SN; Wu, YC; Smith, HA; Love, RR; Lawniczak, MK; Slotman, MA; Emrich, SJ; Hahn, MW; Besansky, NJ				Fontaine, Michael C.; Pease, James B.; Steele, Aaron; Waterhouse, Robert M.; Neafsey, Daniel E.; Sharakhov, Igor V.; Jiang, Xiaofang; Hall, Andrew B.; Catteruccia, Flaminia; Kakani, Evdoxia; Mitchell, Sara N.; Wu, Yi-Chieh; Smith, Hilary A.; Love, R. Rebecca; Lawniczak, Mara K.; Slotman, Michel A.; Emrich, Scott J.; Hahn, Matthew W.; Besansky, Nora J.			Extensive introgression in a malaria vector species complex revealed by phylogenomics	SCIENCE			English	Article							ANOPHELES-GAMBIAE COMPLEX; GENOME SEQUENCE; SPECIATION; HUMANS; POPULATIONS; RESISTANCE; DROSOPHILA; EVOLUTION; HYBRIDS	Introgressive hybridization is now recognized as a widespread phenomenon, but its role in evolution remains contested. Here, we use newly available reference genome assemblies to investigate phylogenetic relationships and introgression in a medically important group of Afrotropical mosquito sibling species. We have identified the correct species branching order to resolve a contentious phylogeny and show that lineages leading to the principal vectors of human malaria were among the first to split. Pervasive autosomal introgression between these malaria vectors means that only a small fraction of the genome, mainly on the X chromosome, has not crossed species boundaries. Our results suggest that traits enhancing vectorial capacity may be gained through interspecific gene flow, including between nonsister species.	[Fontaine, Michael C.; Smith, Hilary A.; Love, R. Rebecca; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Fontaine, Michael C.; Smith, Hilary A.; Love, R. Rebecca; Emrich, Scott J.; Besansky, Nora J.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Pease, James B.; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Steele, Aaron; Emrich, Scott J.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Waterhouse, Robert M.; Wu, Yi-Chieh] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Waterhouse, Robert M.; Neafsey, Daniel E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Waterhouse, Robert M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Sharakhov, Igor V.; Jiang, Xiaofang; Hall, Andrew B.] Virginia Polytech Inst & State Univ, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA 24061 USA; [Catteruccia, Flaminia; Kakani, Evdoxia; Mitchell, Sara N.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Catteruccia, Flaminia; Kakani, Evdoxia] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06100 Perugia, Italy; [Lawniczak, Mara K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Slotman, Michel A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University Bloomington; University of Notre Dame; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Geneva; Swiss Institute of Bioinformatics; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Imperial College London; Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington	Hahn, MW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mwh@indiana.edu; nbesansk@nd.edu	Mitchell, Sara/AAB-5536-2020; Sharakhov, Igor/B-1972-2008; Waterhouse, Robert M/A-1858-2010; Fontaine, Michael/G-5350-2011; Pease, James B./G-8358-2012; Mitchell, Sara/I-3104-2014	Sharakhov, Igor/0000-0003-0752-3747; Waterhouse, Robert M/0000-0003-4199-9052; Fontaine, Michael/0000-0003-1156-4154; Hahn, Matthew/0000-0002-5731-8808; Pease, James B./0000-0003-0125-9156; Jiang, Xiaofang/0000-0002-0955-8284; Mitchell, Sara/0000-0002-7926-1881; Catteruccia, Flaminia/0000-0003-3295-6683; Lawniczak, Mara/0000-0002-3006-2080	National Center for Biotechnology Information, NIH [PRJNA6751, PRJNA254046]; Broad Institute by National Human Genome Research Institute; NIH [R01AI076584, R21AI101459, R21AI094289, R21AI099528, R01AI104956, R01AI085079, HHSN272200900039C, T32GM007757]; Foundation for the National Institutes of Health through the Vector-based Control of Transmission Discovery Research program of the Grand Challenges in Global Health Initiative; Marie Curie International Outgoing Fellowship; Department of Education Graduate Assistance in Areas of National Need fellowship; Richard and Peggy Notebaert Premier Fellowship; Jack Kent Cooke Foundation Graduate Scholarship; Fralin Life Science Institute of Virginia Tech; U.K. Medical Research Council Career Development Award; European Research Council FP7 [260897]; MRC [G1100339] Funding Source: UKRI; Medical Research Council [G1100339] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508, R21AI094289, R21AI101459, R01AI104956, R01AI085079, R01AI076584, R21AI099528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757] Funding Source: NIH RePORTER	National Center for Biotechnology Information, NIH; Broad Institute by National Human Genome Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Vector-based Control of Transmission Discovery Research program of the Grand Challenges in Global Health Initiative; Marie Curie International Outgoing Fellowship(European Commission); Department of Education Graduate Assistance in Areas of National Need fellowship(US Department of Education); Richard and Peggy Notebaert Premier Fellowship; Jack Kent Cooke Foundation Graduate Scholarship; Fralin Life Science Institute of Virginia Tech; U.K. Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council FP7; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kern and B. J. White for early assistance with this project. Genome assemblies and sequence reads generated by the Broad and the BGI have been submitted to National Center for Biotechnology Information, NIH, under two umbrella BioProject IDs: PRJNA6751 and PRJNA254046. The mitochondrial genome alignments, VCF files of field individual samples, the Multiple Alignment Format Threaded Blockset Aligner (MAF TBA) genome alignment of reference assemblies, and the MAF genome alignment from high depth field samples are available on Dryad: doi: 10.5061/dryad.f4114. Sequencing was funded at the Broad Institute by a grant from the National Human Genome Research Institute. Individual laboratories were funded by the NIH [R01AI076584 (N. J. B., M.W.H.), R21AI101459 (N. J. B., H.A.S.), R21AI094289 and R21AI099528 (I.V.S.), R01AI104956 (F.C.), R01AI085079 (M.A.S.), HHSN272200900039C (S.J.E.), T32GM007757 (J.B.P.)], Foundation for the National Institutes of Health through the Vector-based Control of Transmission Discovery Research program of the Grand Challenges in Global Health Initiative (N. J. B., M.C.F.), Marie Curie International Outgoing Fellowship (R.M.W.), Department of Education Graduate Assistance in Areas of National Need fellowship (A.S.), Richard and Peggy Notebaert Premier Fellowship and Jack Kent Cooke Foundation Graduate Scholarship (R.R.L.), Fralin Life Science Institute of Virginia Tech (I.V.S.), U.K. Medical Research Council Career Development Award (M.K.L.), European Research Council FP7 (Starting Grant 260897 to F.C.). Author contributions: conceived project: N. J. B.; coordinated project: N. J. B., M.C.F.; supervised project at the Broad Institute: D.E.N.; genome alignments: R.M.W.; genomic data processing, read mapping, development of pipelines for variant calling and scripts for coordinate conversion, mtDNA genome reconstruction: A.S., M.C.F., S.J.E.; provided access to An. gambiae genomic sequences from Mali: R.R.L.; window-based phylogeny reconstruction, development and implementation of chromoplots, development and implementation of divergence-based method to infer species branching order; estimation of sequence-based divergence times: J.B.P., M.W.H.; introgression testing: J.B.P., M.C.F., M.W.H.; polymorphism and divergence analyses, phylogenomic analyses of nuclear and mtDNA genomes: M.C.F.; orthology predictions and gene-based phylogenetic reconstruction: R.M.W., Y.-C.W.; identification of inversion breakpoints, chromosomal inversion phylogeny, estimation of divergence time based on rates of rearrangement: I.V.S., A.B.H., X.J.; genomic library construction, H.A.S., M.C.F.; functional enrichment analyses: H.A.S., M.C.F., J.B.P.; ecdysteroid quantification: F.C., E.K., S.N.M.; molecular evolution: D.E.N., M.K.L., M. A.S.; wrote paper: N. J. B., M.C.F., M.W.H. with input from other authors.	Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; BRYAN JH, 1979, T ROY SOC TROP MED H, V73, P463, DOI 10.1016/0035-9203(79)90179-2; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Cheng CD, 2012, GENETICS, V190, P1417, DOI 10.1534/genetics.111.137794; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Cooke BA, 1999, MOL CELL ENDOCRINOL, V151, P25, DOI 10.1016/S0303-7207(98)00255-X; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Coyne J.A., 2004, SPECIATION; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAVIDSON G, 1962, NATURE, V196, P907, DOI 10.1038/196907a0; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; dellaTorre A, 1997, GENETICS, V146, P239; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; EERNISSE DJ, 1993, MOL BIOL EVOL, V10, P1170; Fouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034841; Gabrieli P, 2014, P NATL ACAD SCI USA, V111, P16353, DOI 10.1073/pnas.1410488111; Garcia BA, 1996, GENETICS, V143, P1313; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Giles G. M., 1902, HDB GNATS MOSQUITOES; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Maniere G, 2003, J ENDOCRINOL, V177, P35, DOI 10.1677/joe.0.1770035; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; O'Loughlin SM, 2014, MOL BIOL EVOL, V31, P889, DOI 10.1093/molbev/msu040; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pease J. B., 2014, BIORXIV, DOI [10.1101/004689, DOI 10.1101/004689]; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Shaw WR, 2014, P NATL ACAD SCI USA, V111, P5854, DOI 10.1073/pnas.1401715111; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Temu EA, 1997, ANN TROP MED PARASIT, V91, P963, DOI 10.1080/00034989760383; White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729	50	330	336	7	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217							1258524	10.1126/science.1258524	http://dx.doi.org/10.1126/science.1258524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25431491	Green Published, Green Accepted			2022-12-01	WOS:000347102300041
J	Margalida, A; Bogliani, G; Bowden, CGR; Donazar, JA; Genero, F; Gilbert, M; Karesh, WB; Kock, R; Lubroth, J; Manteca, X; Naidoo, V; Neimanis, A; Sanchez-Zapata, JA; Taggart, MA; Vaarten, J; Yon, L; Kuiken, T; Green, RE				Margalida, A.; Bogliani, G.; Bowden, C. G. R.; Donazar, J. A.; Genero, F.; Gilbert, M.; Karesh, W. B.; Kock, R.; Lubroth, J.; Manteca, X.; Naidoo, V.; Neimanis, A.; Sanchez-Zapata, J. A.; Taggart, M. A.; Vaarten, J.; Yon, L.; Kuiken, T.; Green, R. E.			One Health approach to use of veterinary pharmaceuticals	SCIENCE			English	Editorial Material							PROMOTING HUMAN HEALTH; TO-CRADLE STEWARDSHIP; ENVIRONMENTAL DISPOSITION; SOUTH-ASIA; DICLOFENAC; MEDICINES; DRUGS; DISPOSAL; VULTURES					t.kuiken@erasmusmc.nl	Karesh, William/AAU-9084-2020; Naidoo, Vinny/A-1508-2008; Sanchez-Zapata, Jose Antonio/H-1413-2015; Margalida, Antoni/AAG-5337-2020; Yon, Lisa K/G-4453-2011; Margalida, Antoni/A-2723-2011; Margalida, Antoni/A-2723-2011; Neimanis, Aleksija/E-4168-2016	Karesh, William/0000-0001-6042-2860; Naidoo, Vinny/0000-0003-2740-5983; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Yon, Lisa K/0000-0002-9765-3192; Margalida, Antoni/0000-0002-0576-3993; Bogliani, Giuseppe/0000-0001-9066-6540; Margalida, Antoni/0000-0002-3904-6212; Kuiken, Thijs/0000-0001-5501-9049; Margalida, Antoni/0000-0002-7383-671X; Donazar, Jose Antonio/0000-0002-9433-9755; Kock, Richard/0000-0002-6561-3209; Taggart, Mark/0000-0002-0649-8490; Gilbert, Martin/0000-0002-9930-4383; Neimanis, Aleksija/0000-0001-7747-2290				Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Agerstrand M, 2009, ENVIRON INT, V35, P778, DOI 10.1016/j.envint.2008.12.001; Baron M, 2012, WASTE BIOMASS VALORI, V3, P395, DOI 10.1007/s12649-012-9146-2; Beynon SA, 2012, VET PARASITOL, V189, P125, DOI 10.1016/j.vetpar.2012.03.041; Boxall ABA, 2010, HANDB EXP PHARMACOL, V199, P291, DOI 10.1007/978-3-642-10324-7_12; Bruinsma J, 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; Chaudhry MJI, 2012, BIRD CONSERV INT, V22, P389, DOI 10.1017/S0959270912000445; Committee for Medicinal Products for Veterinary Use, 2008, EMEACVMP4182822005RE; Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P757, DOI 10.1289/ehp.5947; Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P775, DOI 10.1289/ehp.5948; del Hoyo J., 1994, HDB BIRDS WORLD, V2; Friton GM, 2005, VET REC, V156, P809, DOI 10.1136/vr.156.25.809; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Kools Stefan A. E., 2008, Integrated Environmental Assessment and Management, V4, P399, DOI 10.1897/IEAM_2008-002.1; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; National Office of Animal Health, FACTS FIG UK AN MED; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Prakash V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049118; Sanchez-Zapata JA, 2010, BIRD STUDY, V57, P352, DOI 10.1080/00063651003674946; Sharma AK, 2014, BIRD CONSERV INT, V24, P282, DOI 10.1017/S0959270913000609; Tong AYC, 2011, ENVIRON INT, V37, P292, DOI 10.1016/j.envint.2010.10.002; Zorrilla I., 2014, CONSERV BIOL, DOI 10.1111/cobi.12417	24	59	60	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1296	1298		10.1126/science.1260260	http://dx.doi.org/10.1126/science.1260260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25477214	Green Submitted			2022-12-01	WOS:000346189600025
J	Gulamhusein, H; Yun, LS; Cheung, AM; Sutradhar, R; Paszat, L; Warde, P; Alibhai, SH				Gulamhusein, Husayn; Yun, Lingsong; Cheung, Angela M.; Sutradhar, Rinku; Paszat, Lawrence; Warde, Padraig; Alibhai, ShabbirM. H.			Bisphosphonate Prescriptions in Men With Androgen Deprivation Therapy Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							OSTEOPOROSIS		[Gulamhusein, Husayn; Cheung, Angela M.; Alibhai, ShabbirM. H.] Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada; [Yun, Lingsong; Sutradhar, Rinku; Paszat, Lawrence] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Warde, Padraig] Univ Hlth Network, Radiat Med Program, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Alibhai, SH (corresponding author), Univ Hlth Network, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	shabbir.alibhai@uhn.ca		Cheung, Angela M./0000-0001-8332-0744; Alibhai, Shabbir/0000-0001-7815-6046; Warde, Padraig/0000-0002-4236-0026	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alibhai SMH, 2012, JAMA-J AM MED ASSOC, V307, P255, DOI 10.1001/jama.2011.2022; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Cadarette SM, 2011, OSTEOPOROSIS INT, V22, P1335, DOI 10.1007/s00198-010-1329-8; Duncan Graeme G, 2006, Can J Urol, V13, P2962; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67	6	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2285	2286		10.1001/jama.2014.14038	http://dx.doi.org/10.1001/jama.2014.14038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25462000	Bronze			2022-12-01	WOS:000345684800025
J	Wang, R; Persky, NS; Yoo, B; Ouerfelli, O; Smogorzewska, A; Elledge, SJ; Pavletich, NP				Wang, Renjing; Persky, Nicole S.; Yoo, Barney; Ouerfelli, Ouathek; Smogorzewska, Agata; Elledge, Stephen J.; Pavletich, Nikola P.			Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1	SCIENCE			English	Article							KIAA1018/FAN1; CELLS; IDENTIFICATION; DAMAGE	DNA interstrand cross-links (ICLs) are highly toxic lesions associated with cancer and degenerative diseases. ICLs can be repaired by the Fanconi anemia (FA) pathway and through FA-independent processes involving the FAN1 nuclease. In this work, FAN1-DNA crystal structures and biochemical data reveal that human FAN1 cleaves DNA successively at every third nucleotide. In vitro, this exonuclease mechanism allows FAN1 to excise an ICL from one strand through flanking incisions. DNA access requires a 5 '-terminal phosphate anchor at a nick or a 1- or 2-nucleotide flap and is augmented by a 3 ' flap, suggesting that FAN1 action is coupled to DNA synthesis or recombination. FAN1 ' s mechanism of ICL excision is well suited for processing other localized DNA adducts as well.	[Wang, Renjing; Persky, Nicole S.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wang, Renjing; Persky, Nicole S.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Yoo, Barney; Ouerfelli, Ouathek] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pavletin@mskcc.org		Ouerfelli, Ouathek/0000-0002-7038-0219; Smogorzewska, Agata/0000-0001-6285-1562	Howard Hughes Medical Institute; NIH [R01HL120922]; Burroughs Wellcome Career Award; Doris Duke Clinical Scientist Development Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (N.P.P. and S.J.E.) and NIH grant R01HL120922 (A. S.). A. S. is a Rita Allen Foundation Scholar and the recipient of a Burroughs Wellcome Career Award and a Doris Duke Clinical Scientist Development Award. The Protein Data Bank accession codes are 4RI8 (5'pG<INF>1</INF>/3'T<INF>4</INF>), 4RI9 (5'pT<INF>1</INF>/3'T<INF>8</INF>), 4RIA (5'pNi), 4RIB (5'pT<INF>1</INF>), 4RIC (5'T<INF>2</INF>), and 4RID (apo-FAN1).	Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Fontebasso Y, 2013, DNA REPAIR, V12, P1011, DOI 10.1016/j.dnarep.2013.10.003; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Presolski SI, 2010, J AM CHEM SOC, V132, P14570, DOI 10.1021/ja105743g; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Trujillo JP, 2012, BLOOD, V120, P86, DOI 10.1182/blood-2012-04-420604; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Williams HL, 2013, TRENDS BIOCHEM SCI, V38, P386, DOI 10.1016/j.tibs.2013.05.004; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	20	43	44	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1127	1130		10.1126/science.1258973	http://dx.doi.org/10.1126/science.1258973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430771	Green Accepted			2022-12-01	WOS:000345763400046
J	Gubin, MM; Zhang, XL; Schuster, H; Caron, E; Ward, JP; Noguchi, T; Ivanova, Y; Hundal, J; Arthur, CD; Krebber, WJ; Mulder, GE; Toebes, M; Vesely, MD; Lam, SSK; Korman, AJ; Allison, JP; Freeman, GJ; Sharpe, AH; Pearce, EL; Schumacher, TN; Aebersold, R; Rammensee, HG; Melief, CJM; Mardis, ER; Gillanders, WE; Artyomov, MN; Schreiber, RD				Gubin, Matthew M.; Zhang, Xiuli; Schuster, Heiko; Caron, Etienne; Ward, Jeffrey P.; Noguchi, Takuro; Ivanova, Yulia; Hundal, Jasreet; Arthur, Cora D.; Krebber, Willem-Jan; Mulder, Gwenn E.; Toebes, Mireille; Vesely, Matthew D.; Lam, Samuel S. K.; Korman, Alan J.; Allison, James P.; Freeman, Gordon J.; Sharpe, Arlene H.; Pearce, Erika L.; Schumacher, Ton N.; Aebersold, Ruedi; Rammensee, Hans-Georg; Melief, Cornelis J. M.; Mardis, Elaine R.; Gillanders, William E.; Artyomov, Maxim N.; Schreiber, Robert D.			Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens	NATURE			English	Article							EXOME ANALYSIS REVEALS; QUANTITATIVE PROTEOMICS; T-CELLS; PD-1; INFLAMMATION; RESPONSES; EQUILIBRIUM; PREDICTIONS; IPILIMUMAB; TOLERANCE	The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates cellular transformation, promotes tumour growth and sculpts tumour cell immunogenicity(1-6), but also as an extrinsic tumour suppressor that either destroys developing tumours or restrains their expansion(1,2,7). Yet, clinically apparent cancers still arise in immunocompetent individuals in part as a consequence of cancer-induced immunosuppression. In many individuals, immunosuppression is mediated by cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and programmed death-1 (PD -1), two immunomodulatory receptors expressed on T cells(8,9). Monoclonal-antibody-based therapies targeting CTLA-4 and/or PD-1 (checkpoint blockade) have yielded significant clinical benefits including durable responses to patients with different malignancies(10-13). However, little is known about the identity of the tumour antigens that function as the targets of T cells activated by checkpoint blockade immunotherapy and whether these antigens can be used to generate vaccines that are highly tumour-specific. Here we use genomics and bioinformatics approaches to identify tumour-specific mutant proteins as a major class of T-cell rejection antigens following anti-PD-1 and/or anti-CTLA-4 therapy of mice bearing progressively growing sarcomas, and we show that therapeutic synthetic long-peptide vaccines incorporating these mutant epitopes induce tumour rejection comparably to checkpoint blockade immunotherapy. Although mutant tumour-antigen-specific T cells are present in progressively growing tumours, they are reactivated following treatment with anti-PD-1 and/or anti-CTLA-4 and display some overlapping but mostly treatment-specific transcriptional profiles, rendering them capable of mediating tumour rejection. These results reveal that tumour-specific mutant antigens are not only important targets of checkpoint blockade therapy, but they can also be used to develop personalized cancer-specific vaccines and to probe the mechanistic	[Gubin, Matthew M.; Ward, Jeffrey P.; Noguchi, Takuro; Ivanova, Yulia; Arthur, Cora D.; Vesely, Matthew D.; Lam, Samuel S. K.; Pearce, Erika L.; Artyomov, Maxim N.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhang, Xiuli; Gillanders, William E.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Schuster, Heiko; Rammensee, Hans-Georg] German Canc Res Ctr, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany; [Schuster, Heiko; Rammensee, Hans-Georg] German Canc Res Ctr, German Canc Consortium DKTK, D-72076 Tubingen, Germany; [Caron, Etienne; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Ward, Jeffrey P.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Hundal, Jasreet; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Krebber, Willem-Jan; Mulder, Gwenn E.; Melief, Cornelis J. M.] ISA Therapeut BV, NL-2333 CH Leiden, Netherlands; [Toebes, Mireille; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Korman, Alan J.] Bristol Myers Squibb Co, Redwood City, CA 94063 USA; [Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8093 Zurich, Switzerland; [Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Mardis, Elaine R.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich; Washington University (WUSTL); Washington University (WUSTL); Netherlands Cancer Institute; Bristol-Myers Squibb; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Freeman, Gordon/AAC-5380-2019; Vesely, Matthew/AFM-2324-2022; Vesely, Matthew/AAM-6813-2020; Schumacher, Ton/Y-2432-2019; Mardis, Elaine/W-2202-2019; Schreiber, Robert/Q-7550-2019; Noguchi, Takuro/AAW-9101-2020	Freeman, Gordon/0000-0002-7210-5616; Vesely, Matthew/0000-0001-9363-945X; Schumacher, Ton/0000-0003-0517-8804; Allison, James/0000-0001-8980-5697; Ward, Jeffrey/0000-0002-9707-895X; Schreiber, Robert/0000-0003-1590-2341; Lam, Siu Kit/0000-0003-1671-3999; Gubin, Matthew/0000-0001-7443-2752	National Cancer Institute [R01 CA043059, U01 CA141541, T32 CA00954729]; Cancer Research Institute; WWWW Foundation; Siteman Cancer Center/Barnes-Jewish Hospital (Cancer Frontier Fund); Susan G. Komen for the Cure (Promise grant); National Human Genome Research Institute; National Institute of Health [P50 CA101942, P01 A1054456]; Dutch Cancer Society (Queen Wilhelmina Research Award); Marie Curie Intra-European Fellowship within the Seventh Framework Programme of the European Community for Research; postdoctoral training grant(Irvington Postdoctoral Fellowship)from the Cancer Research Institute; NATIONAL CANCER INSTITUTE [P50CA101942, P30CA016672, R01CA190700, R01CA043059, P30CA091842, R37CA043059, U01CA141541, T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456, R01AI091965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; WWWW Foundation; Siteman Cancer Center/Barnes-Jewish Hospital (Cancer Frontier Fund); Susan G. Komen for the Cure (Promise grant); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society (Queen Wilhelmina Research Award); Marie Curie Intra-European Fellowship within the Seventh Framework Programme of the European Community for Research; postdoctoral training grant(Irvington Postdoctoral Fellowship)from the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to K. Murphy for the Batf3<SUP>-/-</SUP> mice, T. Hansen for providing MHC class I antibodies and the H-2K<SUP>b</SUP> construct, D. Fremont for the human beta 2m construct, and the National Institutes of Health (NIH) Tetramer Core Facility for producing MHC class I tetramers. We also thank R. Ahmed and M. Hashimoto for the multiplex staining strategy used to define functional and dysfunctional T cells. We thank A. Bensimon, O. Schubert and P. Kouvonen for instrument maintenance and for technical support with the mass spectrometry measurements and R. Vanganipuram, M. Selby and J. Valle for generating and supplying anti-PD-1 and anti-CTLA-4 in endotoxin-free sterile form. We also thank K. Sheehan, P. Allen, G. Dunn and R. Chan for constructive criticisms and comments, all members of the Schreiber laboratory for discussions, and the many members of The Genome Institute at Washington University School of Medicine. We would also like to thank W. Song for his assistance with the bioinformatics approaches, P. Kvistborg for assistance with tetramer combinatorial coding, and Christopher Nelson for advice with peptide-MHC monomer purification. This work was supported by grants to R.D.S. from the National Cancer Institute (R01 CA043059, U01 CA141541), the Cancer Research Institute and the WWWW Foundation; to R.D.S. and W.E.G. from The Siteman Cancer Center/Barnes-Jewish Hospital (Cancer Frontier Fund); to W.E.G. from Susan G. Komen for the Cure (Promise grant); to E.R.M. from the National Human Genome Research Institute; to G.J.F. from the National Institute of Health (P50 CA101942, P01 A1054456, P50 CA101942); to A.H.S. from the National Institute of Health (P50 CA101942); and to T.N.S. from the Dutch Cancer Society (Queen Wilhelmina Research Award). E.C. is supported by a Marie Curie Intra-European Fellowship within the Seventh Framework Programme of the European Community for Research. M.M.G. was supported by a postdoctoral training grant (T32 CA00954729) from the National Cancer Institute and is currently supported by a postdoctoral training grant(Irvington Postdoctoral Fellowship)from the Cancer Research Institute. Aspects of studies at Washington University were performed with assistance by the Immunomonitoring Laboratory of the Center for Human Immunology and Immunotherapy Programs and the Siteman Comprehensive Cancer Center.	Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Brunner MC, 1999, J IMMUNOL, V162, P5813; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kowalewski Daniel J, 2013, Methods Mol Biol, V960, P145, DOI 10.1007/978-1-62703-218-6_12; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thommen DS, 2012, J IMMUNOL, V188, P5283, DOI 10.4049/jimmunol.1101506; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	46	1344	1425	9	565	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					577	+		10.1038/nature13988	http://dx.doi.org/10.1038/nature13988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428507	Green Accepted, Green Submitted			2022-12-01	WOS:000346247600056
J	Chipumuro, E; Marco, E; Christensen, CL; Kwiatkowski, N; Zhang, TH; Hatheway, CM; Abraham, BJ; Sharma, B; Yeung, C; Altabef, A; Perez-Atayde, A; Wong, KK; Yuan, GC; Gray, NS; Young, RA; George, RE				Chipumuro, Edmond; Marco, Eugenio; Christensen, Camilla L.; Kwiatkowski, Nicholas; Zhang, Tinghu; Hatheway, Clark M.; Abraham, Brian J.; Sharma, Bandana; Yeung, Caleb; Altabef, Abigail; Perez-Atayde, Antonio; Wong, Kwok-Kin; Yuan, Guo-Cheng; Gray, Nathanael S.; Young, Richard A.; George, Rani E.			CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer	CELL			English	Article							BET BROMODOMAIN INHIBITION; RNA-POLYMERASE-II; N-MYC; C-MYC; ACTIVATING KINASE; THERAPEUTIC TARGETS; CELLULAR GROWTH; GENE-EXPRESSION; LYMPHOMA-CELLS; NEUROBLASTOMA	The MYC oncoproteins are thought to stimulate tumor cell growth and proliferation through amplification of gene transcription, a mechanism that has thwarted most efforts to inhibit MYC function as potential cancer therapy. Using a covalent inhibitor of cyclin-dependent kinase 7 (CDK7) to disrupt the transcription of amplified MYCN in neuroblastoma cells, we demonstrate downregulation of the oncoprotein with consequent massive suppression of MYCN-driven global transcriptional amplification. This response translated to significant tumor regression in a mouse model of high-risk neuroblastoma, without the introduction of systemic toxicity. The striking treatment selectivity of MYCN-overexpressing cells correlated with preferential downregulation of super-enhancer-associated genes, including MYCN and other known oncogenic drivers in neuroblastoma. These results indicate that CDK7 inhibition, by selectively targeting the mechanisms that promote global transcriptional amplification in tumor cells, may be useful therapy for cancers that are driven by MYC family oncoproteins.	[Chipumuro, Edmond; Hatheway, Clark M.; Sharma, Bandana; Yeung, Caleb; George, Rani E.] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA; [Chipumuro, Edmond; Hatheway, Clark M.; Sharma, Bandana; Yeung, Caleb; George, Rani E.] Boston Childrens Hosp, Boston, MA 02215 USA; [Chipumuro, Edmond; Yeung, Caleb; George, Rani E.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Christensen, Camilla L.; Altabef, Abigail; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kwiatkowski, Nicholas; Abraham, Brian J.; Young, Richard A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Kwiatkowski, Nicholas; Abraham, Brian J.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Zhang, Tinghu; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Perez-Atayde, Antonio] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	George, RE (corresponding author), Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA.	rani_george@dfci.harvard.edu	Marco, Eugenio/F-4583-2011; Abraham, Brian/C-2230-2019; Young, Richard A/F-6495-2012; George, Rani/AAG-7635-2019	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647; wong, kwok kin/0000-0001-6323-235X; Marco, Eugenio/0000-0002-3675-263X	NIH [R01CA148688, R01CA148688S1, R01CA179483-01, CA109901, HG002668, R21HG006778]; American Cancer Society [RSG-12-247-TBG]; Department of Defense [PR120741A]; Friends for Life Neuroblastoma Foundation; NATIONAL CANCER INSTITUTE [P01CA109901, R01CA148688, R01CA179483, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006778, R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); Friends for Life Neuroblastoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Ligon, D. Sabatini., W. Weiss, A. Kung, and the Children's Oncology Group for cell lines and plasmids and P. Baran for the dCA compound. We thank J.R. Gilbert and Takaomi Sanda for insightful discussions. This study was supported by NIH R01CA148688 (R. E. G.), R01CA148688S1 (E. C.), R01CA179483-01 (N.S.G. and T.H.Z.), CA109901, HG002668 (R. A. Y., N.K., B.A.), and R21HG006778 (G. C. Y.); American Cancer Society (RSG-12-247-TBG to R. E. G.); Department of Defense (PR120741A to R. E. G.); and Friends for Life Neuroblastoma Foundation (N.S.G. and R.E.G.). THZ1 has been licensed to Syros Pharmaceuticals for clinical development. N.S.G. and R.A.Y. are scientific founders of Syros Pharmaceuticals.	Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; COHN SL, 1990, ONCOGENE, V5, P1821; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Howard MJ, 2000, DEVELOPMENT, V127, P4073; KOHL NE, 1986, NATURE, V319, P73, DOI 10.1038/319073a0; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; Lam LT, 2001, GENOME BIOL, V2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Malynn BA, 2000, GENE DEV, V14, P1390; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; NISHIKURA K, 1985, P NATL ACAD SCI USA, V82, P2900, DOI 10.1073/pnas.82.9.2900; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schuhmacher M, 2013, TRANSCR-AUSTIN, V4, P192, DOI 10.4161/trns.25907; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stanke M, 1999, DEVELOPMENT, V126, P4087; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; VERONESE ML, 1995, BLOOD, V85, P2132, DOI 10.1182/blood.V85.8.2132.bloodjournal8582132; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	380	394	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1126	1139		10.1016/j.cell.2014.10.024	http://dx.doi.org/10.1016/j.cell.2014.10.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416950	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000345506300023
J	Fernandez, F; Lu, D; Ha, P; Costacurta, P; Chavez, R; Heller, HC; Ruby, NF				Fernandez, Fabian; Lu, Derek; Ha, Phong; Costacurta, Patricia; Chavez, Renee; Heller, H. Craig; Ruby, Norman F.			Dysrhythmia in the suprachiasmatic nucleus inhibits memory processing	SCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CIRCADIAN SYSTEM; DEMENTIA; RHYTHMS; DISTURBANCES; PERFORMANCE; DEPENDS; GENES; RATS	Chronic circadian dysfunction impairs declarative memory in humans but has little effect in common rodent models of arrhythmia caused by clock gene knockouts or surgical ablation of the suprachiasmatic nucleus (SCN). An important problem overlooked in these translational models is that human dysrhythmia occurs while SCN circuitry is genetically and neurologically intact. Siberian hamsters (Phodopus sungorus) are particularly well suited for translational studies because they can be made arrhythmic by a one-time photic treatment that severely impairs spatial and recognition memory. We found that once animals are made arrhythmic, subsequent SCN ablation completely rescues memory processing. These data suggest that the inhibitory effects of a malfunctioning SCN on cognition require preservation of circuitry between the SCN and downstream targets that are lost when these connections are severed.	[Lu, Derek; Ha, Phong; Costacurta, Patricia; Chavez, Renee; Heller, H. Craig; Ruby, Norman F.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fernandez, Fabian] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ruby@stanford.edu		Fernandez, Fabian-Xose/0000-0002-4288-5383; Heller, H Craig/0000-0003-4479-5880	National Institute of Mental Health [MH095837]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095837] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institute of Mental Health (#MH095837).	Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Covell GES, 2012, NEUROLOGIST, V18, P426, DOI 10.1097/NRL.0b013e318272f7ef; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Deboer T, 2004, AM J PHYSIOL-REG I, V287, pR8, DOI 10.1152/ajpregu.00125.2004; Grone BP, 2011, J BIOL RHYTHM, V26, P78, DOI 10.1177/0748730410388404; Harper DG, 2008, BRAIN, V131, P1609, DOI 10.1093/brain/awn049; Ko CH, 2003, BIOL RHYTHM RES, V34, P177, DOI 10.1076/brhm.34.2.177.14493; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mulder C, 2013, J BIOL RHYTHM, V28, P367, DOI 10.1177/0748730413512958; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Rouch I, 2005, ERGONOMICS, V48, P1282, DOI 10.1080/00140130500241670; Ruby NF, 2002, J NEUROSCI, V22, P357, DOI 10.1523/JNEUROSCI.22-01-00357.2002; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Ruby NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072433; Smarr BL, 2014, BEHAV NEUROSCI, V128, P283, DOI 10.1037/a0035963; Steinlechner S, 2002, J BIOL RHYTHM, V17, P248, DOI 10.1177/07430402017003008; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Turek FW, 2008, AM J PHYSIOL-REG I, V294, pR1672, DOI 10.1152/ajpregu.00160.2008; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Wardlaw SM, 2014, LEARN MEMORY, V21, P417, DOI 10.1101/lm.035451.114; Winfree A.T., 2001, GEOMETRY BIOL TIME, DOI [10.1007/978-1-4757-3484-3, DOI 10.1007/978-1-4757-3484-3]; Wu YH, 2007, SLEEP MED, V8, P623, DOI 10.1016/j.sleep.2006.11.010; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323	26	63	66	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					854	857		10.1126/science.1259652	http://dx.doi.org/10.1126/science.1259652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395537	Green Accepted			2022-12-01	WOS:000344659900046
J	Rahimi, A; Ulbrich, A; Coon, JJ; Stahl, SS				Rahimi, Alireza; Ulbrich, Arne; Coon, Joshua J.; Stahl, Shannon S.			Formic-acid-induced depolymerization of oxidized lignin to aromatics	NATURE			English	Article							PINE WOOD; OXIDATION; VALORIZATION; BIOMASS; PHOTODEGRADATION; DEGRADATION; STRATEGY	Lignin is a heterogeneous aromatic biopolymer that accounts for nearly 30% of the organic carbon on Earth(1) and is one of the few renewable sources of aromatic chemicals(2). As the most recalcitrant of the three components of lignocellulosic biomass (cellulose, hemicellulose and lignin)(3), lignin has been treated as a waste product in the pulp and paper industry, where it is burned to supply energy and recover pulping chemicals in the operation of paper mills(4). Extraction of higher value from lignin is increasingly recognized as being crucial to the economic viability of integrated biorefineries(5,6). Depolymerization is an important starting point for many lignin valorization strategies, because it could generate valuable aromatic chemicals and/or provide a source of low-molecular-mass feedstocks suitable for downstream processing(7). Commercial precedents show that certain types of lignin(lignosulphonates) may be converted into vanillin and other marketable products(8,9), but new technologies are needed to enhance the lignin value chain. The complex, irregular structure of lignin complicates chemical conversion efforts, and known depolymerization methods typically afford ill-defined products in low yields (that is, less than 10-20wt%)(2,10,11). Here we describe a method for the depolymerization of oxidized lignin under mild conditions in aqueous formic acid that results in more than 60wt% yield of low-molecular-mass aromatics. We present the discovery of this facile C-O cleavage method, its application to aspen lignin depolymerization, and mechanistic insights into the reaction. The broader implications of these results for lignin conversion and biomass refining are also considered.	[Rahimi, Alireza; Ulbrich, Arne; Coon, Joshua J.; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu	Ulbrich, Arne/ABG-8048-2021		Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]	Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science)(United States Department of Energy (DOE))	We thank J. Ralph for numerous helpful discussions, H. Kim and A. Azarpira for assistance with the purification and NMR characterization of aspen lignin, and S. Chakraborty for assistance with gel-permeation chromatographic analysis of lignin samples. Financial support for this project was provided by the Great Lakes Bioenergy Research Center (Department of Energy Biological and Environmental Research Office of Science DE-FC02-07ER64494). The NMR facility was partly supported by the National Science Foundation (CHE-9208463) and the National Institutes of Health (S10 RR08389).	Argyropoulos DS, 1996, PHOTOCHEM PHOTOBIOL, V64, P510, DOI 10.1111/j.1751-1097.1996.tb03098.x; Bauer K., 1985, ULLMANNS ENCY IND CH, VA11, P199; Bjorsvik HR, 2002, ORG PROCESS RES DEV, V6, P279, DOI 10.1021/op010087o; Business Areas, 2014, BORREGAARD      0620; CHANG HM, 1975, HOLZFORSCHUNG, V29, P153, DOI 10.1515/hfsg.1975.29.5.153; Chatel G, 2014, ACS SUSTAIN CHEM ENG, V2, P322, DOI 10.1021/sc4004086; Collinson SR, 2010, COORDIN CHEM REV, V254, P1854, DOI 10.1016/j.ccr.2010.04.007; Crestini C, 1997, TETRAHEDRON, V53, P7877, DOI 10.1016/S0040-4020(97)00460-2; FOUAD FM, 1978, TETRAHEDRON LETT, P4735; FUKAGAWA N, 1991, J WOOD CHEM TECHNOL, V11, P263, DOI 10.1080/02773819108050275; GIERER J, 1982, HOLZFORSCHUNG, V36, P123, DOI 10.1515/hfsg.1982.36.3.123; Hocking MB, 1997, J CHEM EDUC, V74, P1055, DOI 10.1021/ed074p1055; Holladay J.E., 2007, TOP VALUE ADDED CHEM, DOI 10.2172/921839; Lin S. Y., 1985, ULLMANNS ENCY IND CH, VA15, P305; LJUNGGREN S, 1984, HOLZFORSCHUNG, V38, P91, DOI 10.1515/hfsg.1984.38.2.91; Luterbacher JS, 2014, SCIENCE, V343, P277, DOI 10.1126/science.1246748; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; Nguyen JD, 2014, J AM CHEM SOC, V136, P1218, DOI 10.1021/ja4113462; Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rahimi A, 2013, J AM CHEM SOC, V135, P6415, DOI 10.1021/ja401793n; Ralph J., 2007, ELS; Ralph J., 2010, LIGNIN LIGNANS ADV C, P137, DOI DOI 10.1201/EBK1574444865-C5; Sanderson K, 2011, NATURE, V474, pS12, DOI 10.1038/474S012a; Toledano A, 2013, CHEMSUSCHEM, V6, P529, DOI 10.1002/cssc.201200755; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; VANUCCI C, 1988, J PHOTOCH PHOTOBIO A, V41, P251, DOI 10.1016/1010-6030(88)80042-X; Wang H., 2013, J APPL CHEM, V2013, P1, DOI [10.1155/2013/838645, DOI 10.1155/2013/838645]; Xu WY, 2012, CHEMSUSCHEM, V5, P667, DOI 10.1002/cssc.201100695; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	30	765	792	50	1051	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					249	252		10.1038/nature13867	http://dx.doi.org/10.1038/nature13867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363781				2022-12-01	WOS:000344631400046
J	Moritz, MA; Batllori, E; Bradstock, RA; Gill, AM; Handmer, J; Hessburg, PF; Leonard, J; McCaffrey, S; Odion, DC; Schoennagel, T; Syphard, AD				Moritz, Max A.; Batllori, Enric; Bradstock, Ross A.; Gill, A. Malcolm; Handmer, John; Hessburg, Paul F.; Leonard, Justin; McCaffrey, Sarah; Odion, Dennis C.; Schoennagel, Tania; Syphard, Alexandra D.			Learning to coexist with wildfire	NATURE			English	Review							WILDLAND-URBAN INTERFACE; FIRE REGIMES; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; MEDITERRANEAN BASIN; RISK-MANAGEMENT; WESTERN US; FOREST; FUEL; FUTURE	The impacts of escalating wildfire in many regions - the lives and homes lost, the expense of suppression and the damage to ecosystem services - necessitate a more sustainable coexistence with wildfire. Climate change and continued development on fire-prone landscapes will only compound current problems. Emerging strategies for managing ecosystems and mitigating risks to human communities provide some hope, although greater recognition of their inherent variation and links is crucial. Without a more integrated framework, fire will never operate as a natural ecosystem process, and the impact on society will continue to grow. A more coordinated approach to risk management and land-use planning in these coupled systems is needed.	[Moritz, Max A.; Batllori, Enric] Univ Calif Berkeley, Div Ecosyst Sci, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Bradstock, Ross A.] Univ Wollongong, Wollongong, NSW 2522, Australia; [Gill, A. Malcolm] Australian Natl Univ, Canberra, ACT 0200, Australia; [Handmer, John] RMIT Univ, Melbourne, Vic 3000, Australia; [Hessburg, Paul F.; McCaffrey, Sarah] US Forest Serv, Washington, DC 20250 USA; [Leonard, Justin] CSIRO, Clayton, Vic 3169, Australia; [Odion, Dennis C.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Schoennagel, Tania] Univ Colorado, Boulder, CO 80309 USA; [Syphard, Alexandra D.] Conservat Biol Inst, Corvallis, OR 97333 USA	University of California System; University of California Berkeley; University of Wollongong; Australian National University; Royal Melbourne Institute of Technology (RMIT); United States Department of Agriculture (USDA); United States Forest Service; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder	Moritz, MA (corresponding author), Univ Calif Berkeley, Div Ecosyst Sci, Dept Environm Sci Policy & Management, 130 Mulford Hall, Berkeley, CA 94720 USA.	mmoritz@berkeley.edu	Batllori, Enric/A-5695-2018; leonard, justin/T-1057-2019	Batllori, Enric/0000-0002-2130-0489; Syphard, Alexandra/0000-0003-3070-0596	NSF [EF-0553768]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	We would like to thank V. Butsic, S. Cole Moritz, C. English and K. McLeod for comments on drafts of the manuscript, as well as P. Morgan for suggestions that greatly improved the final version. Some of this work was conducted while M. A. M. was a Center Fellow at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant # EF-0553768), the University of California, Santa Barbara, and the State of California.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Allen CD, 2002, ECOL APPL, V12, P1418; [Anonymous], ECOSPHERE; Attiwill PM, 2014, CONSERV LETT, V7, P341, DOI 10.1111/conl.12062; Baker W. L., 2008, Open Forest Science Journal, V1, P1, DOI 10.2174/1874398600801010001; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Bar-Massada A, 2014, BIOSCIENCE, V64, P429, DOI 10.1093/biosci/biu039; Berkes Fikret, 1998, LINKING SOCIAL ECOLO; Blanchi R., 2008, Community bushfire safety, P77; Bovio G, 1997, INT J WILDLAND FIRE, V7, P249, DOI 10.1071/WF9970249; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Bradstock RA, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P307; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Burby RJ, 2006, ANN AM ACAD POLIT SS, V604, P171, DOI 10.1177/0002716205284676; Buxton M, 2011, GEOGR RES-AUST, V49, P1, DOI 10.1111/j.1745-5871.2010.00670.x; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Castellnou M., 2010, BEST PRACTICES FIRE, P3; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Chapin FS, 2006, P NATL ACAD SCI USA, V103, P16637, DOI 10.1073/pnas.0606955103; Cohen JD, 2004, CAN J FOREST RES, V34, P1616, DOI 10.1139/X04-049; Cohen JD, 2000, J FOREST, V98, P15; Cook GD, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P293; Cova TJ, 2013, GEOJOURNAL, V78, P273, DOI 10.1007/s10708-011-9419-5; Cruz MG, 2010, INT J WILDLAND FIRE, V19, P377, DOI 10.1071/WF08132; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dillon GK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00271.1; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Dunlop M., 2012, IMPLICATIONS CLIMATE; FAO, 2006, FIR MAN VOL GUID PRI; Fernandes PM, 2013, LANDSCAPE URBAN PLAN, V110, P175, DOI 10.1016/j.landurbplan.2012.10.014; Foote E. I. D., 1991, P 11 C FIR FOR MET, P16; Forest Fire Management Group, 2012, NAT BUSHF MAN POL ST; Forests and Rangelands, 2014, NAT STRAT FIN PHAS D; Franklin S. E., 1996, AM FIRE J, V40, P20; Fuhlendorf SD, 2002, LANDSCAPE ECOL, V17, P617, DOI 10.1023/A:1021592817039; Galiana-Martin L, 2011, LANDSCAPE RES, V36, P151, DOI 10.1080/01426397.2010.549218; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; Gill A. M., 2005, Environmental Hazards, V6, P65, DOI 10.1016/j.hazards.2005.10.005; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; GrissinoMayer HD, 1997, HOLOCENE, V7, P235, DOI 10.1177/095968369700700212; Gude P, 2008, J FOREST, V106, P198; Handmer J., 2005, Environmental Hazards, V6, P65, DOI 10.1016/j.hazards.2005.10.006; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Jakes PJ, 2012, INT J WILDLAND FIRE, V21, P764, DOI 10.1071/WF11086; Keeley JE, 2009, ECOLOGICAL FDN FIRE; Koutsias N, 2012, AGR FOREST METEOROL, V156, P41, DOI 10.1016/j.agrformet.2011.12.006; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Lampin-Maillet C, 2010, J ENVIRON MANAGE, V91, P732, DOI 10.1016/j.jenvman.2009.10.001; Leonard J., 2009, BUILDING LAND USE PL; Lowell K, 2009, INT J WILDLAND FIRE, V18, P1010, DOI 10.1071/WF08077; Manzello SL, 2009, FIRE SAFETY J, V44, P894, DOI 10.1016/j.firesaf.2009.05.001; Mazzoleni S., 2004, RECENT DYNAMICS MEDI; McCaffrey S, 2004, SOC NATUR RESOUR, V17, P509, DOI 10.1080/08941920490452445; McCaffrey S.M., 2012, NRS104 USDA FOR SERV; McCaffrey S, 2013, INT J WILDLAND FIRE, V22, P15, DOI 10.1071/WF11115; Mcdonald RI, 2009, LANDSCAPE URBAN PLAN, V93, P63, DOI 10.1016/j.landurbplan.2009.06.002; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mooney S. D., 2012, FLAMMABLE AUSTR FIRE, P293; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moritz MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041735; Moritz MA, 2004, FRONT ECOL ENVIRON, V2, P67, DOI 10.1890/1540-9295(2004)002[0067:TABAOS]2.0.CO;2; Moritz MA, 2013, ANN NY ACAD SCI, V1286, P92, DOI 10.1111/nyas.12104; Moritz MA, 2011, ECOL STUD-ANAL SYNTH, V213, P51, DOI 10.1007/978-94-007-0301-8_3; Murphy BP, 2013, J BIOGEOGR, V40, P1048, DOI 10.1111/jbi.12065; Myers R. L., 2006, LIVING FIRE SUSTANIN; NAVEH Z, 1994, ROLE FIRE MEDITERRAN, P163, DOI DOI 10.1007/978-1-4613-8395-6_9; Nimmo DG, 2014, ECOGRAPHY, V37, P805, DOI 10.1111/ecog.00684; Noss RF, 2006, FRONT ECOL ENVIRON, V4, P481, DOI 10.1890/1540-9295(2006)4[481:MFFITW]2.0.CO;2; Odion DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087852; Olsen CS, 2013, INT J WILDLAND FIRE, V22, P822, DOI 10.1071/WF12086; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Pausas JG, 2007, GLOBAL ECOL BIOGEOGR, V16, P330, DOI 10.1111/j.1466-8238.2006.00283.x; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Paveglio TB, 2009, ENVIRON MANAGE, V43, P1085, DOI 10.1007/s00267-009-9282-z; Penman TD, 2013, INT J DISAST RISK RE, V6, P67, DOI 10.1016/j.ijdrr.2013.09.001; Penman TD, 2011, INT J WILDLAND FIRE, V20, P721, DOI 10.1071/WF09131; Perry DA, 2011, FOREST ECOL MANAG, V262, P703, DOI 10.1016/j.foreco.2011.05.004; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Russell-Smith J, 2007, INT J WILDLAND FIRE, V16, P361, DOI 10.1071/WF07018; San-Miguel-Ayanz J, 2013, FOREST ECOL MANAG, V294, P11, DOI 10.1016/j.foreco.2012.10.050; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schoennagel T, 2011, FRONT ECOL ENVIRON, V9, P271, DOI 10.1890/090199; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Silva J.S., 2010, INTEGRATED FIRE MANA; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Stockmann K, 2010, FOREST POLICY ECON, V12, P147, DOI 10.1016/j.forpol.2009.09.009; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Syphard A. D., 2012, PLOS ONE, V7; Syphard AD, 2014, INT J WILDLAND FIRE, V23, P1165, DOI 10.1071/WF13158; Syphard AD, 2011, FOREST ECOL MANAG, V261, P2038, DOI 10.1016/j.foreco.2011.02.030; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; Toman E, 2013, SOCIAL SCI WILDLAND; Trabaud L.V., 1993, FIRE ENV ITS ECOLOGI, P277; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; vanWilgen BW, 1996, BIOSCIENCE, V46, P184, DOI 10.2307/1312739; Viegas DX, 2009, EARTH OBSERVATION OF WILDLAND FIRES IN MEDITERRANEAN ECOSYSTEMS, P97, DOI 10.1007/978-3-642-01754-4_8; Whittaker J, 2013, INT J WILDLAND FIRE, V22, P841, DOI 10.1071/WF12010; Whittaker J, 2010, AUST J EMERG MANAG, V25, P7; ZEDLER PH, 1983, ECOLOGY, V64, P809, DOI 10.2307/1937204	103	536	542	31	424	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					58	66		10.1038/nature13946	http://dx.doi.org/10.1038/nature13946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373675				2022-12-01	WOS:000344187500029
J	Fralick, M; Macdonald, EM; Gomes, T; Antoniou, T; Hollands, S; Mamdani, MM; Juurlink, DN				Fralick, Michael; Macdonald, Erin M.; Gomes, Tara; Antoniou, Tony; Hollands, Simon; Mamdani, Muhammad M.; Juurlink, David N.		CDSERN	Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING ENZYME-INHIBITOR; INDUCED HYPERKALEMIA; ADMINISTRATIVE DATA; TRIMETHOPRIM; CIPROFLOXACIN; COMBINATION; MECHANISM; ONTARIO; RATES	Objective To determine whether the prescription of co-trimoxazole with an angiotensin converting enzyme inhibitor or angiotensin receptor blocker is associated with sudden death. Design Population based nested case-control study. Setting Ontario, Canada, from 1 April 1994 to 1 January 2012. Participants Ontario residents aged 66 years or older treated with an angiotensin converting enzyme inhibitor or angiotensin receptor blocker. Cases were those who died suddenly shortly after receiving an outpatient prescription for one of co-trimoxazole, amoxicillin, ciprofloxacin, norfloxacin, or nitrofurantoin. Each case was matched with up to four controls on age, sex, chronic kidney disease, and diabetes. Main outcome measure Odds ratio for the association between sudden death and exposure to each antibiotic relative to amoxicillin, after adjustment for predictors of sudden death according to a disease risk index. Results Of 39 879 sudden deaths, 1027 occurred within seven days of exposure to an antibiotic and were matched to 3733 controls. Relative to amoxicillin, co-trimoxazole was associated with an increased risk of sudden death (adjusted odds ratio 1.38, 95% confidence interval 1.09 to 1.76). The risk was marginally higher at 14 days (adjusted odds ratio 1.54, 1.29 to 1.84). This corresponds to approximately three sudden deaths within 14 days per 1000 co-trimoxazole prescriptions. Ciprofloxacin (a known cause of QT interval prolongation) was also associated with an increased risk of sudden death (adjusted odds ratio 1.29, 1.03 to 1.62), but no such risk was observed with nitrofurantoin or norfloxacin. Conclusions In older patients receiving angiotensin converting enzyme inhibitors or angiotensin receptor blockers, co-trimoxazole is associated with an increased risk of sudden death. Unrecognized severe hyperkalemia may underlie this finding. When appropriate, alternative antibiotics should be considered in such patients.	[Fralick, Michael] Univ Toronto, Dept Internal Med, Toronto, ON M5G 2C4, Canada; [Macdonald, Erin M.; Gomes, Tara; Antoniou, Tony; Hollands, Simon; Mamdani, Muhammad M.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON M5N 4M5, Canada; St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Antoniou, Tony; Mamdani, Muhammad M.; Juurlink, David N.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M7, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] King Saud Univ, Riyadh, Saudi Arabia; [Juurlink, David N.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave G106, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca		Gomes, Tara/0000-0002-1468-1965	Canadian Drug Safety and Effectiveness Research Network (CDSERN); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institute for Health Research; Ontario HIV Treatment Network	Canadian Drug Safety and Effectiveness Research Network (CDSERN); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network	This study was supported in part by a grant from the Canadian Drug Safety and Effectiveness Research Network (CDSERN) and by the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute sponsored by the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. TA is supported by a new investigator award from the Canadian Institute for Health Research and Ontario HIV Treatment Network.	Alappan R, 1999, AM J NEPHROL, V19, P389, DOI 10.1159/000013483; Antoniou T, 2010, ARCH INTERN MED, V170, P1045, DOI 10.1001/archinternmed.2010.142; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bugge JF, 1996, J INTERN MED, V240, P249, DOI 10.1046/j.1365-2796.1996.43869000.x; Canaday D, 2013, ARCH INTERN MED, V120, P437; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; EiamOng S, 1996, KIDNEY INT, V49, P1372, DOI 10.1038/ki.1996.193; Eschmann E, 2014, EUR J CLIN PHARMACOL, V70, P215, DOI 10.1007/s00228-013-1597-2; Flanagan MC, 2006, INT J CARDIOL, V113, P239, DOI 10.1016/j.ijcard.2005.08.048; Frothingham R, 2001, PHARMACOTHERAPY, V21, P1468, DOI 10.1592/phco.21.20.1468.34482; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/cir102, 10.1093/cid/ciq257]; Health and Social Care Information Centre, 2013, PRESCR DIS COMM ENGL; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Ibrahim M, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.09.039; IMS Institute for Healthcare Informatics, 2012, NAT PRESCR AUD, P46; Izzo JL, 2011, J CLIN HYPERTENS, V13, P667, DOI 10.1111/j.1751-7176.2011.00508.x; Jolobe OMP, 1997, J INTERN MED, V242, P88; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kang JS, 2001, MOL PHARMACOL, V59, P122, DOI 10.1124/mol.59.1.122; Knorr JP, 2008, AM J HEALTH-SYST PH, V65, P547, DOI 10.2146/ajhp070081; Lam N, 2011, AM J KIDNEY DIS, V57, P521, DOI 10.1053/j.ajkd.2010.11.006; Margassery S, 2001, J NEPHROL, V14, P410; Marinella MA, 1999, GERONTOLOGY, V45, P209, DOI 10.1159/000022089; Motiwala SS, 2006, CAN J AGING, V25, P363, DOI 10.1353/cja.2007.0019; National Health Services Business Association, 2009, ANT PRESCR EXCL TOP; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Prabhakar M, 2004, HEART RHYTHM, V1, P624, DOI 10.1016/j.hrthm.2004.06.020; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Schaefer TJ, 2005, EMERG MED CLIN N AM, V23, P723, DOI 10.1016/j.emc.2005.03.016; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; van Walraven C, 2013, CAN MED ASSOC J, V185, pE755, DOI 10.1503/cmaj.130875; VELAZQUEZ H, 1993, ANN INTERN MED, V119, P296, DOI 10.7326/0003-4819-119-4-199308150-00008; World Health Organization (WHO), 2013, WHO MOD LIST ESS MED; Wright AJ, 2011, CAN MED ASSOC J, V183, P303, DOI 10.1503/cmaj.100702	38	47	48	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2014	349								g6196	10.1136/bmj.g6196	http://dx.doi.org/10.1136/bmj.g6196			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3DI	25359996	Green Published, hybrid			2022-12-01	WOS:000344156100002
J	McGinty, RK; Henrici, RC; Tan, S				McGinty, Robert K.; Henrici, Ryan C.; Tan, Song			Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome	NATURE			English	Article							CENTROMERIC NUCLEOSOME; H2A UBIQUITYLATION; CORE PARTICLE; E3 LIGASE; COMPLEX; MECHANISMS; PROTEINS; REVEALS; SYSTEM; DOMAIN	The Polycomb group of epigenetic enzymes represses expression of developmentally regulated genes in many eukaryotes. This group includes the Polycomb repressive complex 1 (PRC1), which ubiquitylates nucleosomal histone H2A Lys 119 using its E3 ubiquitin ligase subunits, Ring1B and Bmi1, together with an E2 ubiquitin-conjugating enzyme, UbcH5c. However, the molecular mechanism of nucleosome substrate recognition by PRC1 or other chromatin enzymes is unclear. Here we present the crystal structure of the human Ring1B-Bmi1-UbcH5c E3-E2 complex (the PRC1 ubiquitylation module) bound to its nucleosome core particle substrate. The structure shows how a chromatin enzyme achieves substrate specificity by interacting with several nucleosome surfaces spatially distinct from the site of catalysis. Our structure further reveals an unexpected role for the ubiquitin E2 enzyme in substrate recognition, and provides insight into how the related histone H2A E3 ligase, BRCA1, interacts with and ubiquitylates the nucleosome.	[McGinty, Robert K.; Henrici, Ryan C.; Tan, Song] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Henrici, Ryan C.] Penn State Univ, Schreyer Honors Coll, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tan, S (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	sxt30@psu.edu			NIGMS [GM060489-09S1, GM088236, GM111651]; Damon Runyon Post-doctoral fellowship [DRG 2107-12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088236, R01GM060489, R01GM111651] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Post-doctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the staff of APS NE-CAT beamlines 24ID-E and 24ID-C for their assistance during synchrotron data collection; H. Yennawar, N. Yennawar and J. Fecko at the Penn State Huck Institute X-ray core facility; A. Minns, M. Moore and J. Malloy for reagent preparation; T. Girish and J. Huang for assistance with data collection; S. Wang for providing U2OS cDNA; R. Makde and members of the Tan laboratory and the Penn State Center for Eukaryotic Gene Regulation for discussions. This work was supported by NIGMS grants GM060489-09S1, GM088236 and GM111651 to S. T. R. K. M. is supported by a Damon Runyon Post-doctoral fellowship (DRG 2107-12).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Arnaudo N, 2013, NAT STRUCT MOL BIOL, V20, P1119, DOI 10.1038/nsmb.2641; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Crea F, 2012, CRIT REV ONCOL HEMAT, V83, P184, DOI 10.1016/j.critrevonc.2011.10.007; D'Arcy A, 2004, METHODS, V34, P323, DOI 10.1016/j.ymeth.2004.03.023; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shrodinger L. L. C, 2014, PYMOL MOL GRAPH SYST; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	54	200	201	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					591	+		10.1038/nature13890	http://dx.doi.org/10.1038/nature13890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355358	Green Accepted, Green Submitted			2022-12-01	WOS:000343801500040
J	Koschowitz, MC; Fischer, C; Sander, M				Koschowitz, Marie-Claire; Fischer, Christian; Sander, Martin			Beyond the rainbow	SCIENCE			English	Editorial Material							EVOLUTION; DINOSAUR; FEATHERS		[Koschowitz, Marie-Claire; Sander, Martin] Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, D-53115 Bonn, Germany; [Koschowitz, Marie-Claire; Fischer, Christian] Univ Gottingen, Zool Museum, Dept Morphol Systemat & Evolutionary Biol, Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Sander, Martin] Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	University of Bonn; University of Gottingen	Koschowitz, MC (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, Nussallee 8, D-53115 Bonn, Germany.	m.koschowitz@uni-bonn.de						Angielczyk KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1642; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Chang BSW, 2003, INTEGR COMP BIOL, V43, P500, DOI 10.1093/icb/43.4.500; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Clarke J, 2013, SCIENCE, V340, P690, DOI 10.1126/science.1235463; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Godefroit P, 2014, SCIENCE, V345, P451, DOI 10.1126/science.1253351; Hill G.E., 2006, BIRD COLORATION, V2; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; ROWE MP, 2000, PALAEONTOL ELECTRON, V3, P43; Wilts BD, 2014, P NATL ACAD SCI USA, V111, P4363, DOI 10.1073/pnas.1323611111; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	15	13	14	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					416	418		10.1126/science.1258957	http://dx.doi.org/10.1126/science.1258957			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342783				2022-12-01	WOS:000343822900017
J	Rademaker, K; Hodgins, G; Moore, K; Zarrillo, S; Miller, C; Bromley, GRM; Leach, P; Reid, DA; Alvarez, WY; Sandweiss, DH				Rademaker, Kurt; Hodgins, Gregory; Moore, Katherine; Zarrillo, Sonia; Miller, Christopher; Bromley, Gordon R. M.; Leach, Peter; Reid, David A.; Yepez Alvarez, Willy; Sandweiss, Daniel H.			Paleoindian settlement of the high-altitude Peruvian Andes	SCIENCE			English	Article							EARLY HUMAN OCCUPATION; C-14; CALIBRATION; ADAPTATION; CHILE	Study of human adaptation to extreme environments is important for understanding our cultural and genetic capacity for survival. The Pucuncho Basin in the southern Peruvian Andes contains the highest-altitude Pleistocene archaeological sites yet identified in the world, about 900 meters above confidently dated contemporary sites. The Pucuncho workshop site [4355 meters above sea level (masl)] includes two fishtail projectile points, which date to about 12.8 to 11.5 thousand years ago (ka). Cuncaicha rock shelter (4480 masl) has a robust, well-preserved, and well-dated occupation sequence spanning the past 12.4 thousand years (ky), with 21 dates older than 11.5 ka. Our results demonstrate that despite cold temperatures and low-oxygen conditions, hunter-gatherers colonized extremehigh-altitudeAndean environments in the Terminal Pleistocene, within about 2 ky of the initial entry of humans to South America.	[Rademaker, Kurt; Sandweiss, Daniel H.] Univ Maine, Dept Anthropol, Orono, ME 04469 USA; [Rademaker, Kurt] Schloss Hohentubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany; [Hodgins, Gregory] Univ Arizona, Dept Phys, Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA; [Hodgins, Gregory] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Moore, Katherine] Univ Penn Museum, Philadelphia, PA 19104 USA; [Zarrillo, Sonia] Dept Anthropol & Archaeol, Calgary, BC, Canada; [Miller, Christopher] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Miller, Christopher] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, D-72070 Tubingen, Germany; [Rademaker, Kurt; Bromley, Gordon R. M.; Sandweiss, Daniel H.] Univ Maine, Climate Change Inst, Bryand Global Sci Ctr, Orono, ME 04469 USA; [Leach, Peter] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA; [Reid, David A.] Univ Illinois, Dept Anthropol, Chicago, IL 60607 USA	University of Maine System; University of Maine Orono; Eberhard Karls University of Tubingen; University of Arizona; University of Arizona; University of Pennsylvania; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Maine System; University of Maine Orono; University of Connecticut; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rademaker, K (corresponding author), Univ Maine, Dept Anthropol, South Stevens Hall, Orono, ME 04469 USA.	kurt.rademaker@umit.maine.edu	Rademaker, Kurt/AAH-1075-2021; Sandweiss, Daniel/K-5808-2019; Hodgins, Gregory/GVT-3022-2022; Hodgins, Gregory/D-9730-2018	Rademaker, Kurt/0000-0001-5676-4884; 	National Science Foundation Dissertation Grant [1208748]	National Science Foundation Dissertation Grant	Field work was supported by the Churchill Exploration Fund, National Geographic Society Waitt Foundation, Foundation for Exploration and Research on Cultural Origins, American Philosophical Society, and Lambda Alpha. B. Robinson and B. Hall funded pilot AMS dates. National Science Foundation Dissertation Grant no. 1208748 funded the AMS chronology. Pucuncho Basin pastoralists graciously allowed field work on their lands. A. Chu, R. Hintz, C. Mauricio, A. Ramos, A. Saenz, and E. Zuniga provided invaluable logistical support. We thank field assistants W. Beckwith, K. Gardella, M. Koehler, T. Labanowski, O. McGlamery, E. Olson, and J. Wertheim and the staff of the Arizona AMS Laboratory. E. Cooper created Fig. 2. T. Koffman and P. Strand calibrated C-II <SUP>3</SUP>He ages for Fig. 3. Two anonymous reviewers provided helpful comments on the manuscript. Additional data are available in the supplementary materials. Artifact collections are curated at the Ministry of Culture in Arequipa, Peru.	Aldenderfer M, 2006, WORLD ARCHAEOL, V38, P357, DOI 10.1080/00438240600813285; Aldenderfer MS, 2005, ADV TITICACA BASIN A, P25; Baker PT, 1976, MAN ANDES MULTIDISCI; Bigham AW, 2013, AM J HUM BIOL, V25, P190, DOI 10.1002/ajhb.22358; Blard PH, 2011, QUATERNARY SCI REV, V30, P3973, DOI 10.1016/j.quascirev.2011.11.001; Brantingham PJ, 2013, GEOARCHAEOLOGY, V28, P413, DOI 10.1002/gea.21448; Bromley GRM, 2009, QUATERNARY SCI REV, V28, P2514, DOI 10.1016/j.quascirev.2009.05.012; deFrance SD, 2009, J FIELD ARCHAEOL, V34, P227, DOI 10.1179/009346909791070853; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Dornbusch U., 1998, ERDKUNDE, V52, P41, DOI [10.3112/erdkunde.1998.01.04, DOI 10.3112/ERDKUNDE.1998.01.04]; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; Franklin W. L., 1981, SPECIAL PUBLICATION, V6, P457; Frisancho AR, 2013, AM J HUM BIOL, V25, P151, DOI 10.1002/ajhb.22367; Grosjean M, 2005, J QUATERNARY SCI, V20, P643, DOI 10.1002/jqs.969; Hather J. G., 2000, ARCHAEOLOGICAL PAREN; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Jackson D, 2007, CURR ANTHROPOL, V48, P725, DOI 10.1086/520965; Jackson L., 2006, PALEOINDIAN ARCHAEOL, P105; Jolie EA, 2011, CURR ANTHROPOL, V52, P285, DOI 10.1086/659336; Lynch Thomas F., 1980, GUITARRERO CAVE EARL; MARRIOT BM, 1996, NUTR NEEDS COLD HIGH; Melgar CM, 2013, QUATERN INT, V301, P60, DOI 10.1016/j.quaint.2012.04.003; NUNEZ L., 1987, ANDEAN PAST, V1, P57; Perry L, 2006, NATURE, V440, P76, DOI 10.1038/nature04294; Prates L, 2013, QUATERN INT, V301, P104, DOI 10.1016/j.quaint.2013.03.011; Rademaker K., 2012, THESIS U MAINE ORONO; Rademaker K., 2012, LEAST COST ANAL SOCI, P32; Rademaker K, 2013, GEOLOGY, V41, P779, DOI 10.1130/G34313.1; Rademaker K, 2013, QUATERN INT, V301, P34, DOI 10.1016/j.quaint.2012.08.2052; Rick, 1980, PREHISTORIC HUNTERS; Rick J. W., 1999, B ARQUEOLOGIA PUCP, V3, P263; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Steele J, 2009, J ARCHAEOL SCI, V36, P419, DOI 10.1016/j.jas.2008.09.024; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Weiss KM, 2007, EVOL ANTHROPOL, V16, P164, DOI 10.1002/evan.20140; Zhou D, 2013, AM J HUM GENET, V93, P452, DOI 10.1016/j.ajhg.2013.07.011	38	126	134	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					466	469		10.1126/science.1258260	http://dx.doi.org/10.1126/science.1258260			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AR8KB	25342802				2022-12-01	WOS:000343822900042
J	Fokkens, WJ; Hoffmans, R; Thomas, M				Fokkens, Wytske J.; Hoffmans, Ruth; Thomas, Mike			CHANGE PAGE Avoid prescribing antibiotics in acute rhinosinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESPIRATORY-TRACT INFECTIONS; PRIMARY-CARE; COMPLICATIONS; RESISTANCE; SINUSITIS		[Fokkens, Wytske J.; Hoffmans, Ruth] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands; [Thomas, Mike] Univ Southampton, Dept Primary Care Res, Southampton SO9 5NH, Hants, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Southampton	Fokkens, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.j.fokkens@amc.nl	Fokkens, Wytske WJ/ABF-2185-2020					Ahovuo-Saloranta A, 2008, COCHRANE DB SYST REV, V16; Babar-Craig H, 2010, RHINOLOGY, V48, P344, DOI 10.4193/Rhino09.130; Brookes-Howell L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000796; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Desrosiers M, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-2; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hansen FS, 2012, FAM PRACT, V29, P147, DOI 10.1093/fampra/cmr062; HANSEN JG, 1995, BRIT MED J, V311, P233, DOI 10.1136/bmj.311.6999.233; Hoffmans R, 2011, PRIM CARE RESP J, V20, P64, DOI 10.4104/pcrj.2010.00064; Jorgensen LC, 2013, SCAND J PRIM HEALTH, V31, P101, DOI 10.3109/02813432.2013.788270; Lemiengre MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006089.pub4; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Sastre J, 2012, J INVEST ALLERG CLIN, V22, P1; Schafer T, 2011, RHINOLOGY, V49, P272, DOI [10.4193/Rhin10.170, 10.4193/Rhino10.170]; Shaikh N, 2010, COCHRANE DB SYST REV, V12; Shintani Smith S, 2014, LARYNGOSCOPE; Smith SS, 2013, J ALLERGY CLIN IMMUN, V132, P1230, DOI 10.1016/j.jaci.2013.07.009; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; Wang DY, 2011, RHINOLOGY, V49, P264, DOI 10.4193/Rhino10.169; WILLIAMS JW, 1992, ANN INTERN MED, V117, P705, DOI 10.7326/0003-4819-117-9-705; Wood F, 2013, J ANTIMICROB CHEMOTH, V68, P237, DOI 10.1093/jac/dks338; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X; Zalmanovici A, 2009, COCHRANE DB SYST REV, V4	24	11	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g5703	10.1136/bmj.g5703	http://dx.doi.org/10.1136/bmj.g5703			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25353368				2022-12-01	WOS:000343767700001
J	Yawar, A				Yawar, Athar			The art of medicine In praise of Muswell Hillbillies	LANCET			English	Editorial Material												athar.yawar@doctors.org.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1340	1341		10.1016/S0140-6736(14)61808-0	http://dx.doi.org/10.1016/S0140-6736(14)61808-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AQ7NH	25317446				2022-12-01	WOS:000343004000014
J	Nallamothu, BK; Normand, SLT; Wang, YF; Hofer, TP; Brush, JE; Messenger, JC; Bradley, EH; Rumsfeld, JS; Krumholz, HM				Nallamothu, Brahmajee K.; Normand, Sharon-Lise T.; Wang, Yongfei; Hofer, Timothy P.; Brush, John E., Jr.; Messenger, John C.; Bradley, Elizabeth H.; Rumsfeld, John S.; Krumholz, Harlan M.			Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR DATA REGISTRY; ST-ELEVATION; CARDIAC-CATHETERIZATION; PERFORMANCE-MEASURES; PRIMARY ANGIOPLASTY; PRIMARY PCI; REPERFUSION; OUTCOMES; TRENDS	Background Recent reductions in average door-to-balloon (D2B) times have not been associated with decreases in mortality at the population level. We investigated this seemingly paradoxical finding by assessing components of this association at the individual and population levels simultaneously. We postulated that the changing population of patients undergoing primary percutaneous coronary intervention (pPCI) contributed to secular trends toward an increasing mortality risk, despite consistently decreased mortality in individual patients with shorter D2B times. Methods This was a retrospective study of ST-elevation myocardial infarction (STEMI) patients who underwent pPCI between Jan 1, 2005, and Dec 31, 2011, in the National Cardiovascular Data Registry (NCDR) CathPCI Registry. We looked for catheterisation laboratory visits associated with STEMI. We excluded patients not undergoing pPCI, transfer patients for pPCI, patients with D2B times less than 15 min or more than 3 h, and patients at hospitals that did not consistently report data across the study period. We assessed in-hospital mortality in the entire cohort and 6-month mortality in elderly patients aged 65 years or older matched to data from the Centers for Medicare and Medicaid Services. We built multilevel models to assess the relation between D2B time and in-hospital and 6-month mortality, including both individual and population-level components of this association after adjusting for patient and procedural factors. Findings 423 hospitals reported data on 150 116 procedures with a 55% increase in the number of patients undergoing pPCI at these facilities over time, as well as many changes in patient and procedural factors. Annual D2B times decreased significantly from a median of 86 min (IQR 65-109) in 2005 to 63 min (IQR 47-80) in 2011 (p<0.0001) with a concurrent rise in risk-adjusted in-hospital mortality (from 4.7% to 5.3%; p=0.06) and risk-adjusted 6-month mortality (from 12.9% to 14.4%; p=0.001). In multilevel models, shorter patient-specific D2B times were consistently associated at the individual level with lower in-hospital mortality (adjusted OR for each 10 min decrease 0.92; 95% CI 0.91-0.93; p<0.0001) and 6-month mortality (adjusted OR for each 10 min decrease, 0.94; 95% CI 0.93-0.95; p<0.0001). By contrast, risk-adjusted in-hospital and 6-month mortality at the population level, independent of patient-specific D2B times, rose in the growing and changing population of patients undergoing pPCI during the study period. Interpretation Shorter patient-specific D2B times were consistently associated with lower mortality over time, whereas secular trends suggest increased mortality risk in the growing and changing pPCI population. The absence of association of annual D2B time and changes in mortality at the population level should not be interpreted as an indication of its individual-level relation in patients with STEMI undergoing primary PCI.	[Nallamothu, Brahmajee K.; Hofer, Timothy P.] Univ Michigan, Sch Med, Ann Arbor VA Med Ctr, Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Hofer, Timothy P.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Wang, Yongfei] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Wang, Yongfei] Yale New Haven Med Ctr, Ctr Outcome Res & Evaluat, New Haven, CT 06504 USA; [Brush, John E., Jr.] Eastern Virginia Med Sch, Div Cardiol, Norfolk, VA 23501 USA; [Brush, John E., Jr.] Sentara Cardiovasc Res Inst, Norfolk, VA USA; [Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Dept Med, Aurora, CO USA; [Bradley, Elizabeth H.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med & Robert Wood Johnson Fdn, Dept Internal Med,Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Yale University; Yale University; Eastern Virginia Medical School; Sentara Healthcare; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Yale University; Yale University	Nallamothu, BK (corresponding author), Univ Michigan, Ctr Cardiovasc, SPC 5869, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020; Hofer, Timothy Philip/AAC-9238-2022	Normand, Sharon-Lise/0000-0001-7027-4769; Hofer, Timothy/0000-0003-0434-8787	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Antoniucci D, 2002, AM J CARDIOL, V89, P1248, DOI 10.1016/S0002-9149(02)02320-2; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Boulton G, 2011, LANCET, V377, P1633, DOI 10.1016/S0140-6736(11)60647-8; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Brennan JM, 2012, CIRC-CARDIOVASC QUAL, V5, P134, DOI 10.1161/CIRCOUTCOMES.111.963280; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2003, AM HEART J, V145, P708, DOI 10.1067/mhj.2003.9; Byrne RA, 2013, NEW ENGL J MED, V369, P1649, DOI 10.1056/NEJMe1310361; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; CHRISTIAN TF, 1992, CIRCULATION, V86, P81, DOI 10.1161/01.CIR.86.1.81; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Finney JW, 2011, AM J PUBLIC HEALTH, V101, P1635, DOI 10.2105/AJPH.2011.300153; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Jauhar S, 2014, NEW YORK TIMES  0320; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Mehta SR, 2013, NEW ENGL J MED, V369, P2263, DOI 10.1056/NEJMe1312702; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; REIMER KA, 1993, AM J CARDIOL, V72, pG13, DOI 10.1016/0002-9149(93)90102-I; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Szabo L, 2013, USATODAYCOM     0409; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Wang TY, 2009, ARCH INTERN MED, V169, P1411, DOI 10.1001/archinternmed.2009.223; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	37	205	214	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1114	1122		10.1016/S0140-6736(14)61932-2	http://dx.doi.org/10.1016/S0140-6736(14)61932-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25467573	Green Accepted			2022-12-01	WOS:000351270400029
J	Banerjee, S				Banerjee, Sube			Multimorbidity-older adults need health care that can count past one	LANCET			English	Editorial Material							DEMENTIA; COMORBIDITY; DEPRESSION; SERTRALINE; DISEASE		[Banerjee, Sube] Ctr Dementia Studies, Brighton, E Sussex, England; [Banerjee, Sube] Univ Sussex, Sussex Med Sch, Brighton BN1 9RY, E Sussex, England	University of Brighton; University of Sussex	Banerjee, S (corresponding author), Ctr Dementia Studies, Brighton, E Sussex, England.	s.banerjee@bsms.ac.uk		Banerjee, Sube/0000-0002-8083-7649				Alzheimer's Disease International, 2013, GLOB IMP DEM 2013 20; Banerjee S., 2009, USE ANTIPSYCHOTIC ME; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; House of Commons Health Committee, 2011, WRITT EV BRIT GER SO; Imison C, 2012, OLDER PEOPLE EMERGEN; LARSON EB, 1984, ANN INTERN MED, V100, P417, DOI 10.7326/0003-4819-100-3-417; Mason B, 2014, BMJ SUPPORT PALLIAT; MCCORMICK WC, 1994, J AM GERIATR SOC, V42, P517, DOI 10.1111/j.1532-5415.1994.tb04974.x; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; United Nations, 2014, INTR PROP OP WORK GR; WHO, 2014, WHO STRAT PEOPL CTR; WHO, 2014, MON PROGR UN HLTH CO; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	17	139	140	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					587	589		10.1016/S0140-6736(14)61596-8	http://dx.doi.org/10.1016/S0140-6736(14)61596-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468155				2022-12-01	WOS:000349214000010
J	Efremov, RG; Leitner, A; Aebersold, R; Raunser, S				Efremov, Rouslan G.; Leitner, Alexander; Aebersold, Ruedi; Raunser, Stefan			Architecture and conformational switch mechanism of the ryanodine receptor	NATURE			English	Article							PROTEIN-STRUCTURE PREDICTION; CALCIUM-RELEASE CHANNEL; CROSS-LINKED PEPTIDES; SKELETAL-MUSCLE; TOPOLOGY; RESOLUTION; CALMODULIN; SYSTEM; MODEL; FORMS	Muscle contraction is initiated by the release of calcium (Ca2+) from the sarcoplasmic reticulum into the cytoplasm of myocytes through ryanodine receptors (RyRs). RyRs are homotetrameric channels with a molecular mass of more than 2.2 megadaltons that are regulated by several factors, including ions, small molecules and proteins. Numerous mutations in RyRs have been associated with human diseases. The molecular mechanism underlying the complex regulation of RyRs is poorly understood. Using electron cryomicroscopy, here we determine the architecture of rabbit RyR1 at a resolutionof 6.1 angstrom. We show that the cytoplasmic moiety of RyR1 contains two large alpha-solenoid domains and several smaller domains, with folds suggestive of participation in protein-protein interactions. The transmembrane domain represents a chimaera of voltage-gated sodium and pH-activated ion channels. We identify the calcium-binding EF-hand domain and show that it functions as a conformational switch allosterically gating the channel.	[Efremov, Rouslan G.; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Efremov, Rouslan G.] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Efremov, Rouslan G.] VUB, Struct Biol Brussels, B-1050 Brussels, Belgium; [Leitner, Alexander; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Max Planck Society; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Efremov, RG (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	rouslan.efremov@vib-vub.be; stefan.raunser@mpi-dortmund.mpg.de	Raunser, Stefan/AHE-1573-2022; Leitner, Alexander/U-1601-2019; Efremov, Rouslan/P-9085-2015	Leitner, Alexander/0000-0003-4126-0725; Efremov, Rouslan/0000-0001-7516-8658; Raunser, Stefan/0000-0001-9373-3016				Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON DG, 1984, J CELL BIOL, V99, P1735, DOI 10.1083/jcb.99.5.1735; Fessenden JD, 2004, J BIOL CHEM, V279, P53028, DOI 10.1074/jbc.M411136200; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gulbis JM, 2004, CURR OPIN STRUC BIOL, V14, P440, DOI 10.1016/j.sbi.2004.06.008; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HAWKES MJ, 1989, MEMBRANE BIOCHEM, V8, P133, DOI 10.3109/09687688909025827; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kimlicka L, 2011, SCI CHINA LIFE SCI, V54, P712, DOI 10.1007/s11427-011-4198-2; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; Mackrill JJ, 2010, BIOCHEM PHARMACOL, V79, P1535, DOI 10.1016/j.bcp.2010.01.014; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Parys JB, 2012, ADV EXP MED BIOL, V740, P255, DOI 10.1007/978-94-007-2888-2_11; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Penczek PA, 2011, STRUCTURE, V19, P1582, DOI 10.1016/j.str.2011.10.003; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie G, 2012, BIOPOLYMERS, V97, P742, DOI 10.1002/bip.22074; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; SITSAPESAN R, 1994, BIOPHYS J, V67, P1484, DOI 10.1016/S0006-3495(94)80622-8; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uysal S, 2011, P NATL ACAD SCI USA, V108, P11896, DOI 10.1073/pnas.1105112108; Van Petegem F., 2014, J MOL BIOL; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Yin CC, 2005, J MOL BIOL, V349, P538, DOI 10.1016/j.jmb.2005.04.002; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	69	224	228	5	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					39	U72		10.1038/nature13916	http://dx.doi.org/10.1038/nature13916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470059				2022-12-01	WOS:000347178400030
J	Li, XC; Roberti, R; Blobel, G				Li, Xiaochun; Roberti, Rita; Blobel, Guenter			Structure of an integral membrane sterol reductase from Methylomicrobium alcaliphilum	NATURE			English	Article							LAMIN-B-RECEPTOR; 3-BETA-HYDROXYSTEROL DELTA(14)-REDUCTASE; CRYSTAL-STRUCTURE; MUTATIONS; PROTEIN; STEROIDOGENESIS; EXPRESSION; DISORDERS; DYSPLASIA; TOPOLOGY	Sterols are essential biological molecules in the majority of life forms. Sterol reductases(1) including Delta(14)-sterol reductase (C14SR, also known as TM7SF2), 7-dehydrocholesterol reductase (DHCR7) and 24-dehydrocholesterol reductase (DHCR24) reduce specific carbon-carbon double bonds of the sterol moiety using a reducing cofactor during sterol biosynthesis. Lamin B receptor(2) (LBR), an integral inner nuclear membrane protein, also contains a functional C14SR domain. Here we report the crystal structure of a Delta(14)-sterol reductase (MaSR1) from the methanotrophic bacterium Methylomicro-bium alcaliphilum 20Z (a homologue of human C14SR, LBR and DHCR7) with the cofactor NADPH. The enzyme contains ten transmembrane segments (TM1-10). Its catalytic domain comprises the carboxy-terminal half (containing TM6-10) and envelops two interconnected pockets, one of which faces the cytoplasm and houses NADPH, while the other one is accessible from the lipid bilayer. Comparison with a soluble steroid 5 beta-reductase structure(3) suggests that the reducing end of NADPH meets the sterol substrate at the juncture of the two pockets. A sterol reductase activity assay proves that MaSR1 can reduce the double bond of a cholesterol biosynthetic intermediate, demonstrating functional conservation to human C14SR. Therefore, our structure as a prototype of integral membrane sterol reductases provides molecular insight into mutations in DHCR7 and LBR for inborn human diseases.	[Li, Xiaochun; Blobel, Guenter] Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY 10065 USA; [Roberti, Rita] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy	Howard Hughes Medical Institute; Rockefeller University; University of Perugia	Li, XC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY 10065 USA.	xli05@rockefeller.edu; blobel@rockefeller.edu		ROBERTI, Rita/0000-0003-4131-5933; Li, Xiaochun/0000-0002-0177-0803	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [P41 GM111244] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Bennati AM, 2006, BBA-MOL CELL BIOL L, V1761, P677, DOI 10.1016/j.bbalip.2006.05.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clayton P, 2010, NUCLEUS-PHILA, V1, P354, DOI 10.4161/nucl.1.4.12435; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HENNEKES H, 1994, J CELL SCI, V107, P1019; Herman GE, 2012, AM J MED GENET C, V160C, P301, DOI 10.1002/ajmg.c.31340; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAIK YK, 1984, J BIOL CHEM, V259, P3413; Porter FD, 2008, EUR J HUM GENET, V16, P535, DOI 10.1038/ejhg.2008.10; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Roberti R, 2002, EUR J BIOCHEM, V269, P283, DOI 10.1046/j.0014-2956.2001.02646.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shchukin VN, 2011, MICROBIOLOGY+, V80, P608, DOI 10.1134/S0026261711050122; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Zwart P.H., 2005, CCP4 NEWSLETTER PROT, V43, P27	36	36	39	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					104	U280		10.1038/nature13797	http://dx.doi.org/10.1038/nature13797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25307054	Green Accepted			2022-12-01	WOS:000347178400044
J	Gnad, T; Scheibler, S; von Kugelgen, I; Scheele, C; Kilic, A; Glode, A; Hoffmann, LS; Reverte-Salisa, L; Horn, P; Mutlu, S; El-Tayeb, A; Kranz, M; Deuther-Conrad, W; Brust, P; Lidell, ME; Betz, MJ; Enerback, S; Schrader, J; Yegutkin, GG; Muller, CE; Pfeifer, A				Gnad, Thorsten; Scheibler, Saskia; von Kuegelgen, Ivar; Scheele, Camilla; Kilic, Ana; Gloede, Anja; Hoffmann, Linda S.; Reverte-Salisa, Laia; Horn, Philipp; Mutlu, Samet; El-Tayeb, Ali; Kranz, Mathias; Deuther-Conrad, Winnie; Brust, Peter; Lidell, Martin E.; Betz, Matthias J.; Enerbaeck, Sven; Schrader, Juergen; Yegutkin, Gennady G.; Mueller, Christa E.; Pfeifer, Alexander			Adenosine activates brown adipose tissue and recruits beige adipocytes via A(2A) receptors	NATURE			English	Article							FAT; RESPIRATION; LIPOLYSIS; MOUSE; CELLS; ATP	Brown adipose tissue (BAT) is specialized in energy expenditure, making it a potential target for anti-obesity therapies(1-5). Following exposure to cold, BAT is activated by the sympathetic nervous system with concomitant release of catecholamines and activation of beta-adrenergic receptors(1-5). Because BAT therapies based on cold exposureor beta-adrenergic agonists are clinically not feasible, alternative strategies must be explored. Purinergic co-transmission might be involved in sympathetic control of BAT and previous studies reported inhibitory effects of the purinergic transmitter adenosine in BAT from hamster or rat(6-8). However, the role of adenosine in human BAT is unknown. Here we show that adenosine activates human and murine brown adipocytes at low nanomolar concentrations. Adenosine is released in BAT during stimulation of sympathetic nerves as well as from brown adipocytes. The adenosine A(2A) receptor is the most abundant adenosine receptor in human and murine BAT. Pharmacological blockade or genetic loss of A(2A) receptors in mice causes adecrease in BAT-dependent thermogenesis, whereas treatment with A(2A) agonists significantly increases energy expenditure. Moreover, pharmacological stimulation of A(2A) receptors or injection of lentiviral vectors expressing the A(2A) receptor into white fat induces brown-like cells-so-called beige adipocytes. Importantly, mice fed a high-fat diet and treated with an A(2A) agonist are leaner with improved glucose tolerance. Taken together, our results demonstrate that adenosine-A(2A) signalling plays an unexpected physiological role in sympathetic BAT activation and protects mice from diet-induced obesity. Those findings reveal new possibilities for developing novel obesity therapies.	[Gnad, Thorsten; Scheibler, Saskia; von Kuegelgen, Ivar; Kilic, Ana; Gloede, Anja; Hoffmann, Linda S.; Reverte-Salisa, Laia; Horn, Philipp; Mutlu, Samet; Pfeifer, Alexander] Univ Bonn, Univ Hosp, Inst Pharmacol & Toxicol, D-53127 Bonn, Germany; [Scheibler, Saskia; Reverte-Salisa, Laia] Univ Bonn, Res Training Grp 1873, D-53127 Bonn, Germany; [Scheele, Camilla] Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Scheele, Camilla] Rigshosp, Ctr Phys Activ Res, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [El-Tayeb, Ali; Mueller, Christa E.] Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany; [Kranz, Mathias; Deuther-Conrad, Winnie; Brust, Peter] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, D-04318 Leipzig, Germany; [Lidell, Martin E.; Betz, Matthias J.; Enerbaeck, Sven] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med & Clin Genet, S-41390 Gothenburg, Sweden; [Schrader, Juergen] Univ Dusseldorf, Dept Mol Cardiol, D-40225 Dusseldorf, Germany; [Yegutkin, Gennady G.] Univ Turku, Med Res Lab, FIN-20520 Turku, Finland; [Mueller, Christa E.; Pfeifer, Alexander] Univ Bonn, Pharma Ctr, D-53127 Bonn, Germany	University of Bonn; University of Bonn; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Bonn; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Gothenburg; Heinrich Heine University Dusseldorf; University of Turku; University of Bonn	Pfeifer, A (corresponding author), Univ Bonn, Univ Hosp, Inst Pharmacol & Toxicol, D-53127 Bonn, Germany.	alexander.pfeifer@uni-bonn.de	Müller, Christa Elisabeth/C-7748-2014; Deuther-Conrad, Winnie/B-7558-2015; von Kügelgen, Ivar/D-2989-2019; Scheele, Camilla/S-6401-2017; Scheele, Camilla/AAA-3599-2020; Yegutkin, Gennady G./K-3815-2014	Müller, Christa Elisabeth/0000-0002-0013-6624; von Kügelgen, Ivar/0000-0002-2021-4028; Scheele, Camilla/0000-0002-6055-9709; Scheele, Camilla/0000-0002-6055-9709; Yegutkin, Gennady G./0000-0001-6684-7982; , Peter/0000-0001-5555-7058; Reverte-Salisa, Laia/0000-0002-9216-682X; Deuther-Conrad, Winnie/0000-0003-3168-3062; Kranz, Mathias/0000-0002-5641-7396; Betz, Matthias Johannes/0000-0002-6946-1871	Deutsche Forschungsgemeinschaft (DFG); Lundbeck Foundation; Novo Nordisk A/S; Danish National Research Foundation [DNRF55]; Trygfonden; BONFOR; Bonn International Graduate School DrugS; Swedish Research Council [2013-4466, 2010-3281, 2012-1652]; Knut and Alice Wallenberg Foundation; Sahlgrenska's University Hospital (LUA-ALF); European Union [HEALTH-F2-2011-278373]; Inga Britt and Arne Lundgren Foundation; Soderberg Foundation; King Gustaf V and Queen Victoria Freemason Foundation; Federal Ministry of Education and research	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk A/S(Novo Nordisk); Danish National Research Foundation(Danmarks Grundforskningsfond); Trygfonden; BONFOR; Bonn International Graduate School DrugS; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska's University Hospital (LUA-ALF); European Union(European Commission); Inga Britt and Arne Lundgren Foundation; Soderberg Foundation; King Gustaf V and Queen Victoria Freemason Foundation; Federal Ministry of Education and research(Federal Ministry of Education & Research (BMBF))	We thank D. Hass, S. Kipschull, N. Galicki James, B. Steckel, J. Mulich, M. Schneider and G. Petersson for technical assistance. We thank M. Idzko for A2A<SUP>-/-</SUP> mice. A.P. was supported by the Deutsche Forschungsgemeinschaft (DFG); S. S. and L.R.-S. were supported by the DFG-funded Research Training Group 1873 "Pharmacology of 7TM-receptors and downstream signalling pathways''; C. S. was supported by the Lundbeck Foundation and Novo Nordisk A/S. CIM is supported by the Danish National Research Foundation (DNRF55) and CFAS is supported by Trygfonden. A.K. and L.S.H. were supported by BONFOR. A. G. was supported by the Bonn International Graduate School DrugS and the Federal Ministry of Education and research. M.E.L. was supported by the Swedish Research Council (2013-4466). S.E. was supported by the Swedish Research Council (2010-3281, 2012-1652), The Knut and Alice Wallenberg Foundation, Sahlgrenska's University Hospital (LUA-ALF), European Union grants (HEALTH-F2-2011-278373; DIABAT), the Inga Britt and Arne Lundgren Foundation, the Soderberg Foundation, and the King Gustaf V and Queen Victoria Freemason Foundation.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Betz MJ, 2013, J CLIN ENDOCR METAB, V98, P4097, DOI 10.1210/jc.2012-3535; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gourine AV, 2009, TRENDS NEUROSCI, V32, P241, DOI 10.1016/j.tins.2009.03.002; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Helenius M, 2012, BBA-MOL CELL RES, V1823, P1967, DOI 10.1016/j.bbamcr.2012.08.001; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; JohanssonA SM, 2008, EUR J PHARMACOL, V597, P92, DOI 10.1016/j.ejphar.2008.08.022; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; MCMAHON KK, 1982, LIFE SCI, V30, P1185, DOI 10.1016/0024-3205(82)90661-0; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; SCHIMMEL RJ, 1984, AM J PHYSIOL, V246, pC301, DOI 10.1152/ajpcell.1984.246.3.C301; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; SZILLAT D, 1983, AM J PHYSIOL, V245, pE555, DOI 10.1152/ajpendo.1983.245.6.E555; UNELIUS L, 1990, AM J PHYSIOL, V258, pC818, DOI 10.1152/ajpcell.1990.258.5.C818; VONKUGELGEN I, 1994, NEUROSCIENCE, V61, P199, DOI 10.1016/0306-4522(94)90223-2; WOODWARD JA, 1986, BIOCHEM J, V238, P395, DOI 10.1042/bj2380395; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	27	237	242	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					395	+		10.1038/nature13816	http://dx.doi.org/10.1038/nature13816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25317558				2022-12-01	WOS:000346484800047
J	Scudellari, M				Scudellari, Megan			DRUG DEVELOPMENT: Try and try again	NATURE			English	Editorial Material																		Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Finn RS, 2014, J HEPATOL, V60, P243, DOI 10.1016/j.jhep.2013.10.031; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089	3	33	35	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S4	S6		10.1038/516S4a	http://dx.doi.org/10.1038/516S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW5JD	25470198	Bronze			2022-12-01	WOS:000346310800001
J	Ma, ZJ; Melville, DS; Liu, JG; Chen, Y; Yang, HY; Ren, WW; Zhang, ZW; Piersma, T; Li, B				Ma, Zhijun; Melville, David S.; Liu, Jianguo; Chen, Ying; Yang, Hongyan; Ren, Wenwei; Zhang, Zhengwang; Piersma, Theunis; Li, Bo			ECOSYSTEMS MANAGEMENT Rethinking China's new great wall	SCIENCE			English	Editorial Material									[Ma, Zhijun; Chen, Ying; Li, Bo] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200438, Peoples R China; [Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, Dept Fisheries & Wildlife, E Lansing, MI 48823 USA; [Yang, Hongyan] Beijing Forestry Univ, Coll Nat Reserve, Beijing 100083, Peoples R China; [Yang, Hongyan; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Chair Global Flyway Ecol, NL-9700 CC Groningen, Netherlands; [Yang, Hongyan; Piersma, Theunis] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol, NL-1790 AB Den Burg, Texel, Netherlands; [Ren, Wenwei] World Wildlife Fund China Shanghai Off, Shanghai 200083, Peoples R China; [Zhang, Zhengwang] Beijing Normal Univ, Coll Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing 100875, Peoples R China	Fudan University; Michigan State University; Beijing Forestry University; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Beijing Normal University	Ma, ZJ (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200438, Peoples R China.	zhijunm@fudan.edu.cn	Ma, Zhijun/B-4650-2011; Li, Bo/AAA-8968-2020; Li, Bo/B-8016-2010; Liu, Jianguo/G-5211-2015	Li, Bo/0000-0002-7294-6888; Li, Bo/0000-0002-0439-5666; Liu, Jianguo/0000-0001-6344-0087; Piersma, Theunis/0000-0001-9668-466X				Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; [Anonymous], 2012, IUCN SITUATION ANAL; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Chen Z.X., 2000, CHINESE SCI BULL, V45, P17, DOI DOI 10.1007/BF02886190; China Council for International Cooperation on Environment and Development, 2010, ANN POL REP EC MAN G, P113; [Consultation Group of Academic Division of Earth Science of Chinese Academy of Sciences CAS], 2011, 2011 SCI DEV REP, P344; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Guan D. M., 2013, STUDY NATL MARINE FU; He GZ, 2013, SCIENCE, V341, P133, DOI 10.1126/science.1235000; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Lieberthal Kenneth., 1988, POLICY MAKING CHINA; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035	12	310	355	18	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					912	914		10.1126/science.1257258	http://dx.doi.org/10.1126/science.1257258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6EL	25414287				2022-12-01	WOS:000345696000015
J	Vierstra, J; Rynes, E; Sandstrom, R; Zhang, MH; Canfield, T; Hansen, RS; Stehling-Sun, S; Sabo, PJ; Byron, R; Humbert, R; Thurman, RE; Johnson, AK; Vong, S; Lee, K; Bates, D; Neri, F; Diegel, M; Giste, E; Haugen, E; Dunn, D; Wilken, MS; Josefowicz, S; Samstein, R; Chang, KH; Eichler, EE; De Bruijn, M; Reh, TA; Skoultchi, A; Rudensky, A; Orkin, SH; Papayannopoulou, T; Treuting, PM; Selleri, L; Kaul, R; Groudine, M; Bender, MA; Stamatoyannopoulos, JA				Vierstra, Jeff; Rynes, Eric; Sandstrom, Richard; Zhang, Miaohua; Canfield, Theresa; Hansen, R. Scott; Stehling-Sun, Sandra; Sabo, Peter J.; Byron, Rachel; Humbert, Richard; Thurman, Robert E.; Johnson, Audra K.; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Haugen, Eric; Dunn, Douglas; Wilken, Matthew S.; Josefowicz, Steven; Samstein, Robert; Chang, Kai-Hsin; Eichler, Evan E.; De Bruijn, Marella; Reh, Thomas A.; Skoultchi, Arthur; Rudensky, Alexander; Orkin, Stuart H.; Papayannopoulou, Thalia; Treuting, Piper M.; Selleri, Licia; Kaul, Rajinder; Groudine, Mark; Bender, M. A.; Stamatoyannopoulos, John A.			Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution	SCIENCE			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; GENOME; EXPANSION; LINEAGES; ELEMENTS; ENHANCER; REGIONS; SITES	To study the evolutionary dynamics of regulatory DNA, we mapped >1.3 million deoxyribonuclease I-hypersensitive sites (DHSs) in 45 mouse cell and tissue types, and systematically compared these with human DHS maps from orthologous compartments. We found that the mouse and human genomes have undergone extensive cis-regulatory rewiring that combines branch-specific evolutionary innovation and loss with widespread repurposing of conserved DHSs to alternative cell fates, and that this process is mediated by turnover of transcription factor (TF) recognition elements. Despite pervasive evolutionary remodeling of the location and content of individual cis-regulatory regions, within orthologous mouse and human cell types the global fraction of regulatory DNA bases encoding recognition sites for each TF has been strictly conserved. Our findings provide new insights into the evolutionary forces shaping mammalian regulatory DNA landscapes.	[Vierstra, Jeff; Rynes, Eric; Sandstrom, Richard; Canfield, Theresa; Stehling-Sun, Sandra; Sabo, Peter J.; Humbert, Richard; Thurman, Robert E.; Johnson, Audra K.; Vong, Shinny; Lee, Kristen; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Haugen, Eric; Dunn, Douglas; Eichler, Evan E.; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zhang, Miaohua; Byron, Rachel; Groudine, Mark; Bender, M. A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wilken, Matthew S.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Josefowicz, Steven; Samstein, Robert; Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Josefowicz, Steven; Samstein, Robert; Eichler, Evan E.; Rudensky, Alexander; Orkin, Stuart H.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Chang, Kai-Hsin; Papayannopoulou, Thalia] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [De Bruijn, Marella] John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Skoultchi, Arthur] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst,Dept Pediat Oncol, Boston, MA 02115 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Selleri, Licia] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Groudine, Mark] Univ Washington, Dept Radiat Oncol, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Washington; University of Washington Seattle; Cornell University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Vierstra, Jeff/0000-0001-6406-8563; josefowicz, steven/0000-0001-7453-779X; Kaul, Rajinder/0000-0002-7895-9284; Sandstrom, Richard/0000-0002-3356-1547; Samstein, Robert/0000-0001-6860-2401; Haugen, Eric/0000-0001-7444-8981	NIH grants [U54HG007010, 1RC2HG005654, R37DK44746, 2R01HD04399709]; NSF Graduate Research Fellowship [DGE-071824]; Medical Research Council [MC_UU_12009/2] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043997] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005654, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266, R37DK044746] Funding Source: NIH RePORTER; MRC [MC_UU_12009/2] Funding Source: UKRI	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by NIH grants U54HG007010 (J.A.S.), 1RC2HG005654 (J.A.S. and M.G.), R37DK44746 (M.G. and M.A.B.), and 2R01HD04399709 (L.S.) and by NSF Graduate Research Fellowship DGE-071824 (J.V.). E.E.E. is on the scientific advisory boards for Pacific Biosciences Inc., SynapDx Corp., and DNAnexus Inc. J.V. and J.A.S. designed the experiments and analysis; E.R., R.S., and R.E.T. aided in data analysis and management; all other authors participated in data generation and sample collection; and J.V. and J.A.S. wrote the manuscript with help from E.R. We thank H. Wang and E. K. Salinas for help with figures. All sequence data generated in this study can be accessed with GEO accession numbers found within tables S1 and S2.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; [Anonymous], 2014, NATURE, DOI [10.1038/nature13992, DOI 10.1038/NATURE13992]; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Garel S, 1999, DEVELOPMENT, V126, P5285; Guenet JL, 2005, GENOME RES, V15, P1729, DOI 10.1101/gr.3728305; Hardouin SN, 2000, CLIN GENET, V57, P237, DOI 10.1034/j.1399-0004.2000.570401.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Payne JL, 2014, SCIENCE, V343, P875, DOI 10.1126/science.1249046; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P11207, DOI 10.1073/pnas.90.23.11207; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Schachterle W, 2012, DEV BIOL, V361, P439, DOI 10.1016/j.ydbio.2011.10.023; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xiong Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-587	26	167	169	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1007	1012		10.1126/science.1246426	http://dx.doi.org/10.1126/science.1246426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25411453	Green Accepted, Green Submitted			2022-12-01	WOS:000345696000047
J	Majzoub, K; Hafirassou, ML; Meignin, C; Goto, A; Marzi, S; Fedorova, A; Verdier, Y; Vinh, J; Hoffmann, JA; Martin, F; Baumert, TF; Schuster, C; Imler, JL				Majzoub, Karim; Hafirassou, Mohamed Lamine; Meignin, Carine; Goto, Akira; Marzi, Stefano; Fedorova, Antonina; Verdier, Yann; Vinh, Joelle; Hoffmann, Jules A.; Martin, Franck; Baumert, Thomas F.; Schuster, Catherine; Imler, Jean-Luc			RACK1 Controls IRES-Mediated Translation of Viruses	CELL			English	Article							HEPATITIS-C-VIRUS; CRICKET PARALYSIS VIRUS; 40S RIBOSOMAL-SUBUNIT; INITIATION-FACTOR 3; EUKARYOTIC TRANSLATION; DEPENDENT TRANSLATION; VERSATILE SCAFFOLD; PROTEIN-SYNTHESIS; DECODING CENTER; 80S RIBOSOME	Fighting viral infections is hampered by the scarcity of viral targets and their variability, resulting in development of resistance. Viruses depend on cellular molecules-which are attractive alternative targets-for their life cycle, provided that they are dispensable for normal cell functions. Using the model organism Drosophila melanogaster, we identify the ribosomal protein RACK1 as a cellular factor required for infection by internal ribosome entry site (IRES)-containing viruses. We further show that RACK1 is an essential determinant for hepatitis C virus translation and infection, indicating that its function is conserved for distantly related human and fly viruses. Inhibition of RACK1 does not affect Drosophila or human cell viability and proliferation, and RACK1-silenced adult flies are viable, indicating that this protein is not essential for general translation. Our findings demonstrate a specific function for RACK1 in selective mRNA translation and uncover a target for the development of broad antiviral intervention.	[Majzoub, Karim; Meignin, Carine; Goto, Akira; Hoffmann, Jules A.; Imler, Jean-Luc] CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67000 Strasbourg, France; [Hafirassou, Mohamed Lamine; Meignin, Carine; Fedorova, Antonina; Hoffmann, Jules A.; Baumert, Thomas F.; Schuster, Catherine; Imler, Jean-Luc] Univ Strasbourg, F-67000 Strasbourg, France; [Hafirassou, Mohamed Lamine; Fedorova, Antonina; Baumert, Thomas F.; Schuster, Catherine] INSERM, UMR1110, Inst Rech Malad Virales & Hepat, F-67000 Strasbourg, France; [Marzi, Stefano; Martin, Franck] CNRS, UPR9002, Inst Biol Mol & Cellulaire, F-67000 Strasbourg, France; [Verdier, Yann; Vinh, Joelle] ESPCI ParisTech, USR3149, F-75005 Paris, France; [Hoffmann, Jules A.] Univ Strasbourg, Inst Etud Avancees, F-67000 Strasbourg, France; [Baumert, Thomas F.] Hop Univ Strasbourg, IHU, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schuster, C (corresponding author), Univ Strasbourg, F-67000 Strasbourg, France.	catherine.schuster@unistra.fr; jl.imler@unistra.fr	Baumert, Thomas/ABF-4718-2020; MARTIN, Franck/D-9042-2015; Schuster, Catherine/H-9355-2016; Imler, Jean-Luc/GXH-4323-2022; Marzi, Stefano/A-1810-2012; GOTO, Akira/V-7847-2017; Vinh, Joelle/K-1347-2015	Baumert, Thomas/0000-0002-8864-2168; MARTIN, Franck/0000-0001-9724-4025; Schuster, Catherine/0000-0001-7281-4511; Marzi, Stefano/0000-0003-0399-4613; GOTO, Akira/0000-0003-3395-484X; Vinh, Joelle/0000-0001-7184-2668; Meignin, Carine/0000-0002-6588-9045; Majzoub, Karim/0000-0001-7345-6840; Verdier, Yann/0000-0002-3319-0053	CNRS; Inserm; NIH [PO1 AI070167]; Investissement d'Avenir program (HepSys) [ANR-10-LAB-28]; Investissement d'Avenir program (NetRNA) [ANR-10-LABX-36]; Investissement d'Avenir program (I2MC) [ANR-11-EQPX-0022]; Investissement d'Avenir program (IDEX) [W13RATCS]; ANR [ANR-09-MIEN-006-01, ANR-11-SVSE802501]; ARC [IHU201301187]; ANRS [2010-307/2011-415]; FRM; TGE FT-ICR; ESPCI ParisTech; Fonds pour la Recherche et la Technologie of the French Ministry of Research for the LTQ FT acquisition; ANRS; CNRS/Region Alsace; IDEX program from the University of Strasbourg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investissement d'Avenir program (HepSys)(French National Research Agency (ANR)); Investissement d'Avenir program (NetRNA)(French National Research Agency (ANR)); Investissement d'Avenir program (I2MC)(French National Research Agency (ANR)); Investissement d'Avenir program (IDEX)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); ANRS(ANRSFrench National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); TGE FT-ICR; ESPCI ParisTech; Fonds pour la Recherche et la Technologie of the French Ministry of Research for the LTQ FT acquisition; ANRS(ANRSFrench National Research Agency (ANR)); CNRS/Region Alsace(Centre National de la Recherche Scientifique (CNRS)Region Grand-Est); IDEX program from the University of Strasbourg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CNRS, Inserm, and grants from NIH (PO1 AI070167 to J.A.H. and J.-L.I.); Investissement d'Avenir programs (HepSys ANR-10-LAB-28 to T. B. and NetRNA ANR-10-LABX-36; I2MC ANR-11-EQPX-0022, to J.-L.I. and S. M.; IDEX W13RATCS to C. S.); ANR (ANR-09-MIEN-006-01 to J.-L.I. and ANR-11-SVSE802501 to F. M.); ARC (IHU201301187 to T. B.); ANRS (2010-307/2011-415, to C. S.); and FRM (to C. M.). Financial support from the TGE FT-ICR, the ESPCI ParisTech, and the Fonds pour la Recherche et la Technologie of the French Ministry of Research for the LTQ FT acquisition are gratefully acknowledged. M. L. H., K. M., and A. F. were supported by fellowships from ANRS, CNRS/Region Alsace, and the IDEX program from the University of Strasbourg, respectively. We thank S. Pellegrino and M. Yusupov (IGBMC, Strasbourg) for advice and assistance in the preparation of translation competent cell free extracts; R. Bartenschlager (University of Heidelberg, Heidelberg, Germany) for providing Jc1 and Luc-Jc1 expression vectors; F. V. Chisari (TSRI, La Jolla) for Huh7.5.1 cells; M. Beckerle (University of Utah) for providing RACK1 antiserum; S. Thompson (Birmingham) for sharing the plasmid pSRT208; and the transgenic RNAi Project (TRiP) at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks. We also thank E. Santiago, N. Ftaich, and M. Parnot for technical assistance; B. Fischer and D. Dembele (siRNA screening and microarray platforms at IGBMC) for the InCell1000 and the transcriptomic analysis; and E. Westhof and W. Filipowicz for discussions and critical reading of the manuscript.	Belozerov VE, 2014, MOL CELL BIOL, V34, P474, DOI 10.1128/MCB.00824-13; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choudhuri A, 2013, P NATL ACAD SCI USA, V110, P9818, DOI 10.1073/pnas.1302934110; Chu YD, 2014, CELL CYCLE, V13, P1995, DOI 10.4161/cc.29017; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Gibson TJ, 2012, FEBS LETT, V586, P2787, DOI 10.1016/j.febslet.2012.04.048; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Koh CS, 2014, P NATL ACAD SCI USA, V111, P9139, DOI 10.1073/pnas.1406335111; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Otsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024359; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Speth C, 2013, PLANT J, V76, P433, DOI 10.1111/tpj.12308; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Topisirovic I, 2011, CELL, V145, P333, DOI 10.1016/j.cell.2011.04.006; Volta V, 2013, CELL MOL LIFE SCI, V70, P1439, DOI 10.1007/s00018-012-1215-y; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wakiyama M, 2006, BIOCHEM BIOPH RES CO, V343, P1067, DOI 10.1016/j.bbrc.2006.03.076; Walsh D, 2014, GENE DEV, V28, P835, DOI 10.1101/gad.236752.113; Xiao F., 2014, GUT; Xiao F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004128; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	64	115	119	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1086	1095		10.1016/j.cell.2014.10.041	http://dx.doi.org/10.1016/j.cell.2014.10.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416947	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000345506300020
J	Woodward, C; Shulmeister, J; Larsen, J; Jacobsen, GE; Zawadzki, A				Woodward, C.; Shulmeister, J.; Larsen, J.; Jacobsen, G. E.; Zawadzki, A.			The hydrological legacy of deforestation on global wetlands	SCIENCE			English	Article							WATER YIELD; NEW-ZEALAND; LATE-HOLOCENE; SOUTH ISLAND; VEGETATION CHANGES; ECOSYSTEMS; CATCHMENT; LAKE; AFFORESTATION; SETTLEMENT	Increased catchment erosion and nutrient loading are commonly recognized impacts of deforestation on global wetlands. In contrast, an increase in water availability in deforested catchments is well known in modern studies but is rarely considered when evaluating past human impacts. We used a Budyko water balance approach, a meta-analysis of global wetland response to deforestation, and paleoecological studies from Australasia to explore this issue. After complete deforestation, we demonstrated that water available to wetlands increases by up to 15% of annual precipitation. This can convert ephemeral swamps to permanent lakes or even create new wetlands. This effect is globally significant, with 9 to 12% of wetlands affected, including 20 to 40% of Ramsar wetlands, but is widely unrecognized because human impact studies rarely test for it.	[Woodward, C.; Shulmeister, J.; Larsen, J.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Jacobsen, G. E.; Zawadzki, A.] Australian Nucl Sci & Technol Org, Inst Environm Res, Kirrawee Dc, NSW 2232, Australia	University of Queensland; Australian Nuclear Science & Technology Organisation	Woodward, C (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Chamberlain Bldg,St Lucia Campus, Brisbane, Qld 4072, Australia.	c.woodward1@uq.edu.au	Shulmeister, James/J-2859-2015	Shulmeister, James/0000-0001-5863-9462; Larsen, Joshua/0000-0002-0650-7369; Woodward, Craig/0000-0003-1197-820X	Australian Research Council Discovery Project [DP 110103081]; Australian Institute for Nuclear Science and Engineering [ALNGRA11068, ALNGRA12071]	Australian Research Council Discovery Project(Australian Research Council); Australian Institute for Nuclear Science and Engineering	This research was part of an Australian Research Council Discovery Project (DP 110103081) and was also partly supported by the Australian Institute for Nuclear Science and Engineering (grants ALNGRA11068 and ALNGRA12071). The database used for the meta-analysis of Holocene records of catchment deforestation and wetland change can be downloaded from the Dryad Digital Repository at http://dx.doi.org/10.5061/dryad.m62gj.	Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Bruijnzeel L.A, 1988, J TROP FOR SCI, V1, P229; Budyko M.I., 1974, INT GEOPHYS SERIES, P18; Cubizolle H, 2012, QUATERN INT, V251, P77, DOI 10.1016/j.quaint.2011.07.001; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; GALE SJ, 1995, QUATERNARY SCI REV, V14, P395, DOI 10.1016/0277-3791(95)00033-X; Gergis J, 2012, CLIMATIC CHANGE, V111, P923, DOI 10.1007/s10584-011-0263-x; HORNBECK JW, 1993, J HYDROL, V150, P323, DOI 10.1016/0022-1694(93)90115-P; Macklin MG, 2012, GEOLOGY, V40, P775, DOI 10.1130/G33364.1; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; Page MJ, 2010, MAR GEOL, V270, P30, DOI 10.1016/j.margeo.2009.10.019; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Silberstein R., 2003, 0301 MON U COOP RES; Sondergaard M, 2007, J APPL ECOL, V44, P1089, DOI 10.1111/j.1365-2664.2007.01426.x; Sterling SM, 2013, NAT CLIM CHANGE, V3, P385, DOI [10.1038/nclimate1690, 10.1038/NCLIMATE1690]; Stubbs B. J., 1998, Environment and History, V4, P145, DOI 10.3197/096734098779555628; Szesztay K., 2010, HYDROL SCI B, V19, P73; Vance TR, 2013, J CLIMATE, V26, P710, DOI 10.1175/JCLI-D-12-00003.1; Williams PW, 2005, EARTH PLANET SC LETT, V230, P301, DOI 10.1016/j.epsl.2004.10.024; Woodward C, 2014, HOLOCENE, V24, P668, DOI 10.1177/0959683614526935; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	24	82	83	18	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					844	847		10.1126/science.1260510	http://dx.doi.org/10.1126/science.1260510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395535	Green Submitted			2022-12-01	WOS:000344659900043
J	Sun, W; Boulais, E; Hakobyan, Y; Wang, WL; Guan, A; Bathe, M; Yin, P				Sun, Wei; Boulais, Etienne; Hakobyan, Yera; Wang, Wei Li; Guan, Amy; Bathe, Mark; Yin, Peng			Casting inorganic structures with DNA molds	SCIENCE			English	Article							ENERGY-LOSS SPECTROSCOPY; SINGLE-STRANDED-DNA; NANOSCALE SHAPES; PLASMONIC NANOSTRUCTURES; NUCLEIC-ACID; FOLDING DNA; NANOPARTICLES; GOLD; ORIGAMI; GROWTH	We report a general strategy for designing and synthesizing inorganic nanostructures with arbitrarily prescribed three-dimensional shapes. Computationally designed DNA strands self-assemble into a stiff "nanomold" that contains a user-specified three-dimensional cavity and encloses a nucleating gold "seed." Under mild conditions, this seed grows into a larger cast structure that fills and thus replicates the cavity. We synthesized a variety of nanoparticles with 3-nanometer resolution: three distinct silver cuboids with three independently tunable dimensions, silver and gold nanoparticles with diverse cross sections, and composite structures with homo- and heterogeneous components. The designer equilateral silver triangular and spherical nanoparticles exhibited plasmonic properties consistent with electromagnetism-based simulations. Our framework is generalizable to more complex geometries and diverse inorganic materials, offering a range of applications in biosensing, photonics, and nanoelectronics.	[Sun, Wei; Wang, Wei Li; Guan, Amy; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Sun, Wei; Wang, Wei Li; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Boulais, Etienne; Hakobyan, Yera; Bathe, Mark] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	mark.bathe@mit.edu; py@hms.harvard.edu	Sun, Wei/I-4376-2014; Wang, Wei L/B-8061-2009	Wang, Wei L/0000-0002-5064-8097	Defense Advanced Research Projects Agency Young Faculty Award [N66001111413]; Office of Naval Research (ONR) Young Investigator Program Award [N000141110914]; ONR [N000141010827, N000141310593, N000141410610, DURIP N000141310664, N000141210621]; Army Research Office [W911NF1210238]; NIH Director's New Innovator Award [1DP2OD007292]; NSF Faculty Early Career Development Award [CCF1054898]; NSF Expedition in Computing Award [CCF1317291]; NSF [CCF1162459, CMMI1333215, CMMI1334109, CMMI1344915, ECS-0335765]; Wyss Institute; NSF-DMREF [CMMI1334109]; Natural Sciences and Engineering Research Council of Canada; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC0205CH11231]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1344915] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency Young Faculty Award; Office of Naval Research (ONR) Young Investigator Program Award(Office of Naval Research); ONR(Office of Naval Research); Army Research Office; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Faculty Early Career Development Award(National Science Foundation (NSF)); NSF Expedition in Computing Award; NSF(National Science Foundation (NSF)); Wyss Institute; NSF-DMREF(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Y. Ke, J. Shen, and B. Wei for discussion, and E. Haney, D. Pastuszak and E. Chen for assistance in draft preparation. Supported by Defense Advanced Research Projects Agency Young Faculty Award N66001111413, Office of Naval Research (ONR) Young Investigator Program Award N000141110914, ONR grants N000141010827, N000141310593, and N000141410610, Army Research Office grant W911NF1210238, NIH Director's New Innovator Award 1DP2OD007292, NSF Faculty Early Career Development Award CCF1054898, NSF Expedition in Computing Award CCF1317291, NSF grants CCF1162459, CMMI1333215, CMMI1334109, and CMMI1344915 and Wyss Institute funds (P. Y.); ONR grants DURIP N000141310664 and N000141210621 and NSF-DMREF grant CMMI1334109 (M. B., E. B., and Y. H.); and the Natural Sciences and Engineering Research Council of Canada (E. B.). This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765. CNS is part of Harvard University. The EELS of the Ag NPs was measured at National Center for Electron Microscopy, which is supported by the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy under contract DE-AC0205CH11231. Contributions: W. S. designed the system, conducted the experiments, and analyzed the data; E. B. designed and performed optical and EELS simulations, and analyzed the data; Y. H. designed and performed mechanical simulation, and analyzed the data; W. L. W. performed EELS experiments and analyzed the data; A. G. performed experiments and analyzed the data; M. B. designed and supervised the simulation study and interpreted the data; P. Y. conceived, designed, and supervised the study and interpreted the data; and all authors wrote the manuscript. All data described in this article are presented in the supplementary materials.	Bathe M, 2008, PROTEINS, V70, P1595, DOI 10.1002/prot.21708; Bealing CR, 2012, ACS NANO, V6, P2118, DOI 10.1021/nn3000466; Berti L, 2008, NAT NANOTECHNOL, V3, P81, DOI 10.1038/nnano.2007.460; Boulais E, 2013, J PHYS CHEM C, V117, P9386, DOI 10.1021/jp312475h; Boulais E, 2012, NANO LETT, V12, P4763, DOI 10.1021/nl302200w; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; BROOKS BR, 1995, J COMPUT CHEM, V16, P1522, DOI 10.1002/jcc.540161209; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chaudhuri RG, 2012, CHEM REV, V112, P2373, DOI 10.1021/cr100449n; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Fan FR, 2008, J AM CHEM SOC, V130, P6949, DOI 10.1021/ja801566d; Fischler M, 2007, SMALL, V3, P1049, DOI 10.1002/smll.200600534; Gao CB, 2011, J AM CHEM SOC, V133, P19706, DOI 10.1021/ja209647d; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hohenester U, 2014, COMPUT PHYS COMMUN, V185, P1177, DOI 10.1016/j.cpc.2013.12.010; Hohenester U, 2012, COMPUT PHYS COMMUN, V183, P370, DOI 10.1016/j.cpc.2011.09.009; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Jin Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2690; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Koh AL, 2011, NANO LETT, V11, P1323, DOI 10.1021/nl104410t; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Liu JF, 2011, ACS NANO, V5, P2240, DOI 10.1021/nn1035075; Lohse SE, 2012, J AM CHEM SOC, V134, P15607, DOI 10.1021/ja307589n; Ma N, 2009, NAT NANOTECHNOL, V4, P121, DOI [10.1038/NNANO.2008.373, 10.1038/nnano.2008.373]; Maurin-Pasturel G, 2014, ANGEW CHEM INT EDIT, V53, P3872, DOI 10.1002/anie.201310443; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Ming T, 2009, J AM CHEM SOC, V131, P16350, DOI 10.1021/ja907549n; Myroshnychenko V, 2012, NANO LETT, V12, P4172, DOI 10.1021/nl301742h; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Pilo-Pais M, 2011, NANO LETT, V11, P3489, DOI 10.1021/nl202066c; Pompa PP, 2006, NAT NANOTECHNOL, V1, P126, DOI 10.1038/nnano.2006.93; Puzder A, 2004, NANO LETT, V4, P2361, DOI 10.1021/nl0485861; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Ruan LY, 2013, NANO LETT, V13, P840, DOI 10.1021/nl400022g; Samano EC, 2011, SOFT MATTER, V7, P3240, DOI 10.1039/c0sm01318h; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Scholl JA, 2012, NATURE, V483, P421, DOI 10.1038/nature10904; Schreiber R, 2011, SMALL, V7, P1795, DOI 10.1002/smll.201100465; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Surwade SP, 2013, J AM CHEM SOC, V135, P6778, DOI 10.1021/ja401785h; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Wang F, 2013, J AM CHEM SOC, V135, P5588, DOI 10.1021/ja310501y; Wang F, 2011, J AM CHEM SOC, V133, P1106, DOI 10.1021/ja1095733; Wang ZD, 2012, ANGEW CHEM INT EDIT, V51, P9078, DOI 10.1002/anie.201203716; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yu J, 2010, SMALL, V6, P2242, DOI 10.1002/smll.201000889; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e; Zhang HL, 2012, CHEM COMMUN, V48, P6405, DOI 10.1039/c2cc32204h; Zhao Z, 2011, ANGEW CHEM INT EDIT, V50, P2041, DOI 10.1002/anie.201006818	67	219	223	7	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					717	+	1258361	10.1126/science.1258361	http://dx.doi.org/10.1126/science.1258361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25301973	Green Accepted, Green Submitted			2022-12-01	WOS:000344690100031
J	Bonapace, L; Coissieux, MM; Wyckoff, J; Mertz, KD; Varga, Z; Junt, T; Bentires-Alj, M				Bonapace, Laura; Coissieux, Marie-May; Wyckoff, Jeffrey; Mertz, Kirsten D.; Varga, Zsuzsanna; Junt, Tobias; Bentires-Alj, Mohamed			Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis	NATURE			English	Article							CHEMOATTRACTANT PROTEIN-1; CARCINOMA CELLS; EXPRESSION; INTERLEUKIN-6; MONOCYTES; GROWTH	Secretion of C-C chemokine ligand 2 (CCL2) by mammary tumours recruits CCR2-expressing inflammatory monocytes to primary tumours and metastatic sites, and CCL2 neutralization in mice inhibits metastasis-1 by retaining monocytes in the bone marrow. Here we report a paradoxical effect of CCL2 in four syngeneic mouse models of metastatic breast cancer. Surprisingly, interruption of CCL2 inhibition leads to an overshoot of metastases and accelerates death. This is the result of monocyte release from the bone marrow and enhancement of cancer cell mobilization from the primary tumour, as well as blood vessel formation and increased proliferation of metastatic cells in the lungs in an interleukin (IL)-6- and vascular endothelial growth factor (VEGF)-A-dependent manner. Notably, inhibition of CCL2 and IL-6 markedly reduced metastases and increased survival of the animals. CCL2 has been implicated in various neoplasias and adopted as a therapeutic target(1-3). However, our results call for caution when considering anti-CCL2 agents as monotherapy in metastatic disease and highlight the tumour microenvironment as a critical determinant of successful anti-metastatic therapy.	[Bonapace, Laura; Coissieux, Marie-May; Wyckoff, Jeffrey; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland; [Bonapace, Laura; Junt, Tobias] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Mertz, Kirsten D.; Varga, Zsuzsanna] Univ Zurich Hosp, Dept Pathol, CH-8006 Zurich, Switzerland; [Mertz, Kirsten D.] Cantonal Hosp Baselland, Inst Pathol Liestal, CH-4410 Liestal, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Zurich; University Zurich Hospital; Kantonsspital Baselland	Bonapace, L (corresponding author), Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland.	bentires@fmi.ch	Junt, Tobias/AAE-4389-2021; Mertz, Kirsten/AAY-1660-2020; Mohamed, Bentires-Alj/F-4484-2015	Mertz, Kirsten/0000-0002-3074-6925; Mohamed, Bentires-Alj/0000-0001-6344-1127; Coissieux, Marie-May/0000-0001-5017-5253	Novartis Research Foundation; European Research Council [243211-PTPsBDC]; Swiss Cancer League; Swiss National Foundation; Krebsliga Beider Basel; FP7 Marie Curie Fellowship	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss Cancer League; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Krebsliga Beider Basel; FP7 Marie Curie Fellowship	We thank R. L. Anderson, N. Hynes, and R. Cardiff for cell lines, R. Thierry and M. Kirschmann for scripts for immunohistochemistry and two-photon imaging analysis, M. Stadler and H.-R. Hotz for bioinformatics, H. Kohler for FACS and S. Bichet for technical support, H. Brinkhaus and P. Loetscher for helpful discussions, D. Dylan for the CSFR1 inhibitor, J. van Rheenen, J. Stein, J. Rietdorf, T. Oertner and S. Bundschuh for helping us set up the multiphoton intravital microscope, and the Bentires-Alj group for feedback. Research in the laboratory of M. B.-A. is supported by the Novartis Research Foundation, the European Research Council (243211-PTPsBDC), the Swiss Cancer League, the Swiss National Foundation, and the Krebsliga Beider Basel. M.-M.C. is supported by the FP7 Marie Curie Fellowship.	Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bonapace L, 2012, J MAMMARY GLAND BIOL, V17, P125, DOI 10.1007/s10911-012-9250-8; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Karnoub A. E., 2007, BREAST DIS, V26, P75, DOI DOI 10.3233/BD-2007-26107; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; PALANGIE T, 1994, EUR J CANCER, V30A, P921, DOI 10.1016/0959-8049(94)90115-5; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5; Wani AA, 2011, ONCOGENE, V30, P2778, DOI 10.1038/onc.2010.644; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1167, DOI 10.1101/pdb.top065904; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	30	428	448	8	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525								10.1038/nature13862	http://dx.doi.org/10.1038/nature13862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3RG	25337873				2022-12-01	WOS:000349545400001
J	De Strooper, B				De Strooper, Bart			Lessons from a Failed gamma-Secretase Alzheimer Trial	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; BETA-PEPTIDE; SYNAPTIC PLASTICITY; ASPARTIC PROTEASE; DISEASE; PRESENILIN; INHIBITOR; MICE; SEMAGACESTAT	gamma-Secretase proteases have been associated with pathology in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiological roles. A negative drug trial with a broad spectrum gamma-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing gamma-secretase research therapeutically. This pessimism is unwarranted: analysis of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.	[De Strooper, Bart] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [De Strooper, Bart] Univ Leuven, KU Leuven Ctr Human Genet, B-3000 Louvain, Belgium; [De Strooper, Bart] Univ Leuven, Leuven Inst Neurodegenerat disorders, B-3000 Louvain, Belgium; [De Strooper, Bart] UCL, UCL Inst Neurol, London WC1N 1PJ, England	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of London; University College London	De Strooper, B (corresponding author), VIB Ctr Biol Dis, B-3000 Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019		European Research Council (ERC); Stichting Alzheimer Onderzoek (SAO); Fonds voor Wetenschappelijk Onderzoek (FWO); KU Leuven and Leuven University fund; Vlaams Instituut voor Biotechnologie (VIB); KU Leuven/Flemish Government; IUAP P7/16 NEUROBRAINNET network; Vlaams initiatief voor dementia (VIND); Janssen Pharmaceutica	European Research Council (ERC)(European Research Council (ERC)); Stichting Alzheimer Onderzoek (SAO); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); KU Leuven and Leuven University fund; Vlaams Instituut voor Biotechnologie (VIB); KU Leuven/Flemish Government(KU Leuven); IUAP P7/16 NEUROBRAINNET network; Vlaams initiatief voor dementia (VIND); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The author thanks Profs Lucia Chavez-Gutierrez and Eric Karran for critical discussion and input and Gwen Aerts for help with the figure. Research is supported by the European Research Council (ERC), the Stichting Alzheimer Onderzoek (SAO), the Fonds voor Wetenschappelijk Onderzoek (FWO), KU Leuven and Leuven University fund, the Vlaams Instituut voor Biotechnologie (VIB), a Methusalem grant of the KU Leuven/Flemish Government, the IUAP P7/16 NEUROBRAINNET network, Vlaams initiatief voor dementia (VIND) and Janssen Pharmaceutica. B.D.S. is the Arthur Bax and Anna Vanluffelen Chair for Alzheimer Disease.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Borgegard T, 2012, J NEUROSCI, V32, P17297, DOI 10.1523/JNEUROSCI.1451-12.2012; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dolev I, 2013, NAT NEUROSCI, V16, P587, DOI 10.1038/nn.3376; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 1998, NATURE, V391, P339, DOI 10.1038/34800; Henley DB, 2014, CURR MED RES OPIN, V30, P2021, DOI 10.1185/03007995.2014.939167; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Karran E, 2014, ANN NEUROL, V76, P185, DOI 10.1002/ana.24188; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Li T, 2003, J NEUROSCI, V23, P3272; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Miyashita H, 2011, J BIOL CHEM, V286, P26188, DOI 10.1074/jbc.M111.260273; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Portelius E, 2012, J ALZHEIMERS DIS, V31, P335, DOI 10.3233/JAD-2012-120508; Probst G, 2013, J MED CHEM, V56, P5261, DOI 10.1021/jm301741t; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Yi P, 2010, DRUG METAB DISPOS, V38, P554, DOI 10.1124/dmd.109.030841; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang JB, 2013, J NEUROSCI, V33, P12825, DOI 10.1523/JNEUROSCI.0783-13.2013	46	200	200	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					721	726		10.1016/j.cell.2014.10.016	http://dx.doi.org/10.1016/j.cell.2014.10.016			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417150	Bronze			2022-12-01	WOS:000344522000006
J	Lonnroth, K; Migliori, GB; Raviglione, M				Loennroth, Knut; Migliori, Giovanni Battista; Raviglione, Mario			Toward Tuberculosis Elimination in Low-Incidence Countries: Reflections From a Global Consultation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Lonnroth, K (corresponding author), WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva, Switzerland.		Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017; Migliori, Giovanni Battista/AAB-8589-2020	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256; Migliori, Giovanni Battista/0000-0002-2597-574X; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; European Centre for Disease Prevention and Control, 2008, FRAM ACT PLAN FIGHT; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; World Health Organization, 2014, TUB EL LOW COUNTR FR; World Health Organization, 2014, A6711 WHO; World Health Organization, 2015, GLOBAL TUBERCULOSIS	10	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					670	U91		10.7326/M14-1888	http://dx.doi.org/10.7326/M14-1888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364889				2022-12-01	WOS:000347244100009
J	Hussain, T; Llacer, JL; Fernandez, IS; Munoz, A; Martin-Marcos, P; Savva, CG; Lorsch, JR; Hinnebusch, AG; Ramakrishnan, V				Hussain, Tanweer; Llacer, Jose L.; Fernandez, Israel S.; Munoz, Antonio; Martin-Marcos, Pilar; Savva, Christos G.; Lorsch, Jon R.; Hinnebusch, Alan G.; Ramakrishnan, V.			Structural Changes Enable Start Codon Recognition by the Eukaryotic Translation Initiation Complex	CELL			English	Article							40S RIBOSOMAL-SUBUNIT; C-TERMINAL DOMAIN; PREINITIATION COMPLEX; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTIONS; MESSENGER-RNA; FACTORS EIF1; SELECTION; BINDING; TRNA(MET)	During eukaryotic translation initiation, initiator tRNA does not insert fully into the P decoding site on the 40S ribosomal subunit. This conformation (POUT) is compatible with scanning mRNA for the AUG start codon. Base pairing with AUG is thought to promote isomerization to a more stable conformation (PIN) that arrests scanning and promotes dissociation of eIF1 from the 40S subunit. Here, we present a cryoEM reconstruction of a yeast preinitiation complex at 4.0 angstrom resolution with initiator tRNA in the PIN state, prior to eIF1 release. The structure reveals stabilization of the codon-anticodon duplex by the N-terminal tail of eIF1A, changes in the structure of eIF1 likely instrumental in its subsequent release, and changes in the conformation of eIF2. The mRNA traverses the entire mRNA cleft and makes connections to the regulatory domain of eIF2 alpha, eIF1A, and ribosomal elements that allow recognition of context nucleotides surrounding the AUG codon.	[Hussain, Tanweer; Llacer, Jose L.; Fernandez, Israel S.; Savva, Christos G.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Munoz, Antonio; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Martin-Marcos, Pilar; Hinnebusch, Alan G.] Eunice K Shriver Natl Inst Child Hlth & Human Dev, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Munoz, Antonio; Lorsch, Jon R.] Eunice K Shriver Natl Inst Child Hlth & Human Dev, Lab Mech & Regulat Prot Synth, NIH, Bethesda, MD 20892 USA	MRC Laboratory Molecular Biology; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Llacer, José Luis/K-4299-2017; Llácer, José Luis/AAB-8711-2022	Llacer, José Luis/0000-0001-5304-1795; Llácer, José Luis/0000-0001-5304-1795; Fernandez, Israel/0000-0001-7218-1603; Hussain, Tanweer/0000-0003-4735-2380; Lorsch, Jon/0000-0002-4521-4999; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [MC_U105184332]; Wellcome Trust Senior Investigator award [WT096570]; Agouron Institute; Jeantet Foundation; NIH [GM62128]; Human Frontiers in Science Program [RGP-0028/2009]; Intramural Research Program of the NIH; EMBO; FEBS; Medical Research Council [MC_U105184332] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008940, ZIAHD001004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062128] Funding Source: NIH RePORTER; MRC [MC_U105184332] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Investigator award(Wellcome Trust); Agouron Institute(Pfizer); Jeantet Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program(Human Frontier Science Program); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); FEBS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Shaoxia Chen and Greg McMullan for technical support with cryo-EM, Toby Darling and Jake Grimmett for help with computing, Xiao-Chen Bai and Sjors H.W. Scheres for help and advice with EM data processing, and Garib Murshudov and Alan Brown for help with refinement of the atomic coordinates. We also thank Fan Zhang for providing the purified Sui3-2 mutant of eIF2, Jinsheng Dong for sharing his genetic findings on the U31:A39 tRNA<INF>i</INF> variant prior to publication, Ann Kelley and Sarah Walker for providing reagents and advice, and Thomas Dever for his insightful suggestion to employ Sui<SUP>-</SUP> variants. T.H. and J.L.L. were, respectively, supported by postdoctoral fellowships from EMBO and FEBS. This work was funded by grants to V.R. from the UK Medical Research Council (MC_U105184332), Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute and the Jeantet Foundation, from the NIH (GM62128) previously to J.R.L., and from the Human Frontiers in Science Program (RGP-0028/2009) to A.G.H., J.R.L., and V.R., and by the Intramural Research Program of the NIH (A.G.H., P.M.-M., J.R.L., and A.M.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; Dong JS, 2014, GENE DEV, V28, P502, DOI 10.1101/gad.236547.113; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Martin-Marcos P, 2014, RNA, V20, P150, DOI 10.1261/rna.042069.113; Martin-Marcos P, 2013, J BIOL CHEM, V288, P27546, DOI 10.1074/jbc.M113.498642; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Qin D, 2007, RNA, V13, P2348, DOI 10.1261/rna.715307; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharifulin D, 2013, CHEMBIOCHEM, V14, P2136, DOI 10.1002/cbic.201300318; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Stolboushkina E, 2008, J MOL BIOL, V382, P680, DOI 10.1016/j.jmb.2008.07.039; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	54	133	133	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					597	607		10.1016/j.cell.2014.10.001	http://dx.doi.org/10.1016/j.cell.2014.10.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417110	Green Published, hybrid			2022-12-01	WOS:000344521700015
J	McCalley, CK; Woodcroft, BJ; Hodgkins, SB; Wehr, RA; Kim, EH; Mondav, R; Crill, PM; Chanton, JP; Rich, VI; Tyson, GW; Saleska, SR				McCalley, Carmody K.; Woodcroft, Ben J.; Hodgkins, Suzanne B.; Wehr, Richard A.; Kim, Eun-Hae; Mondav, Rhiannon; Crill, Patrick M.; Chanton, Jeffrey P.; Rich, Virginia I.; Tyson, Gene W.; Saleska, Scott R.			Methane dynamics regulated by microbial community response to permafrost thaw	NATURE			English	Article							GLOBAL WETLAND EXTENT; STABLE CARBON; PRESENT STATE; PEATLAND; CLIMATE; PATHWAYS; FLUXES; ENVIRONMENTS; OXIDATION	Permafrost contains about 50% of the global soil carbon(1). It is thought that the thawing of permafrost can lead to a loss of soil carbon in the form of methane and carbon dioxide emissions(2,3). The magnitude of the resulting positive climate feedback of such greenhouse gas emissions is still unknown(3) and may to a large extent depend on the poorly understood role of microbial community composition in regulating the metabolic processes that drive such ecosystem-scale greenhouse gas fluxes. Here we show that changes in vegetation and increasing methane emissions with permafrost thaw are associated with a switch from hydrogenotrophic to partly acetoclastic methanogenesis, resulting in a large shift in the delta C-13 signature (1015 parts per thousand) of emitted methane. We used a natural landscape gradient of permafrost thaw in northern Sweden(4,5) as a model to investigate the role of microbial communities in regulating methane cycling, and to test whether a knowledge of community dynamics could improve predictions of carbon emissions under loss of permafrost. Abundance of the methanogen Candidatus Methanoflorens stordalenmirensis(6) is a key predictor of the shifts in methane isotopes, which in turn predicts the proportions of carbon emitted as methane and as carbon dioxide, an important factor for simulating the climate feedback associated with permafrost thaw in global models(3,7). By showing that the abundance of key microbial lineages can be used to predict atmospherically relevant patterns in methane isotopes and the proportion of carbon metabolized to methane during permafrost thaw, we establish a basis for scaling changing microbial communities to ecosystem isotope dynamics. Our findings indicate that microbial ecology may be important in ecosystem-scale responses to global change.	[McCalley, Carmody K.; Wehr, Richard A.; Saleska, Scott R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Woodcroft, Ben J.; Mondav, Rhiannon; Tyson, Gene W.] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hodgkins, Suzanne B.; Chanton, Jeffrey P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Kim, Eun-Hae; Rich, Virginia I.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Crill, Patrick M.] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden	University of Arizona; University of Queensland; State University System of Florida; Florida State University; University of Arizona; Stockholm University	McCalley, CK (corresponding author), Univ New Hampshire, Earth Syst Res Ctr, Durham, NH 03824 USA.	carmody.mccalley@unh.edu; saleska@email.arizona.edu	Tyson, Gene W/C-6558-2013; Mondav, Rhiannon/M-1219-2017; Hodgkins, Suzanne/AAC-8580-2020; Crill, Patrick/ABC-1357-2021; Saleska, Scott R/K-1733-2016	Tyson, Gene W/0000-0001-8559-9427; Mondav, Rhiannon/0000-0002-5574-5531; Hodgkins, Suzanne/0000-0002-0489-9207; Saleska, Scott R/0000-0002-4974-3628; Woodcroft, Ben/0000-0003-0670-7480; Wehr, Richard/0000-0002-0806-9390; Crill, Patrick/0000-0003-1110-3059	US Department of Energy Office of Biological and Environmental Research [DE-SC0004632]; University of Arizona Technology and Research Initiative Fund, through the Water, Environmental and Energy Solutions Initiative; Australian Postgraduate Award Scholarship	US Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); University of Arizona Technology and Research Initiative Fund, through the Water, Environmental and Energy Solutions Initiative; Australian Postgraduate Award Scholarship	We thank the Abisko Scientific Research Station for infrastructure and logistical support; T. Logan and N. Rakos for their assistance in the field; and S. Wofsy and S. Frolking for feedback on a draft of this paper. This work was supported by the US Department of Energy Office of Biological and Environmental Research (award DE-SC0004632), and by the University of Arizona Technology and Research Initiative Fund, through the Water, Environmental and Energy Solutions Initiative. R.M. was supported by an Australian Postgraduate Award Scholarship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backstrand K, 2010, BIOGEOSCIENCES, V7, P95; Backstrand K, 2008, TELLUS B, V60, P226, DOI 10.1111/j.1600-0889.2007.00331.x; Backstrand K, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000703; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Bubier J, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001946; Camill P, 1998, AM NAT, V151, P207, DOI 10.1086/286112; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan JKC, 2005, WHO CLASSIFICATION T, P85, DOI DOI 10.1016/J.ORGGEOCHEM.2004.10.007; Chanton JP, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000134; Christensen TR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018680; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Corbett JE, 2013, BIOGEOCHEMISTRY, V114, P327, DOI 10.1007/s10533-012-9813-1; Dyke LD, 2010, ARCTIC, V63, P429; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; Hines ME, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002903; Hodgkins SB, 2014, P NATL ACAD SCI USA, V111, P5819, DOI 10.1073/pnas.1314641111; Hornibrook ERC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031231; Hornibrook ERC, 1997, GEOCHIM COSMOCHIM AC, V61, P745, DOI 10.1016/S0016-7037(96)00368-7; Johansson T, 2006, GLOBAL CHANGE BIOL, V12, P2352, DOI 10.1111/j.1365-2486.2006.01267.x; Jorgenson MT, 2001, CLIMATIC CHANGE, V48, P551, DOI 10.1023/A:1005667424292; Kai FM, 2011, NATURE, V476, P194, DOI 10.1038/nature10259; KEELING CD, 1961, GEOCHIM COSMOCHIM AC, V24, P277, DOI 10.1016/0016-7037(61)90023-0; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Lee H, 2012, GLOBAL CHANGE BIOL, V18, P515, DOI 10.1111/j.1365-2486.2011.02519.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Mondav R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4212; O'Donnell JA, 2012, ECOSYSTEMS, V15, P213, DOI 10.1007/s10021-011-9504-0; Olefeldt D, 2013, GLOBAL CHANGE BIOL, V19, P589, DOI 10.1111/gcb.12071; Pataki DE, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001850; Payette S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020358; Popp TJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P1063, DOI 10.1029/1999GB900060; Quinton WL, 2011, HYDROL PROCESS, V25, P152, DOI 10.1002/hyp.7894; R Development Core Team, 2012, LANG ENV STAT COMP; Riley WJ, 2011, BIOGEOSCIENCES, V8, P1925, DOI 10.5194/bg-8-1925-2011; Santoni GW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016960; Schuur EAG, 2013, CLIMATIC CHANGE, V119, P359, DOI 10.1007/s10584-013-0730-7; Tans PP, 1997, GLOBAL BIOGEOCHEM CY, V11, P77, DOI 10.1029/96GB03940; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Turetsky MR, 2002, SOIL BIOL BIOCHEM, V34, P907, DOI 10.1016/S0038-0717(02)00022-6; vanOldenborgh, 2013, CLIMATE CHANGE 2013, DOI [DOI 10.1017/CBO9781107415324.004, 10.1017/CBO9781107415324, DOI 10.1017/CBO9781107415324]; Vitt DH, 2000, CAN J FOREST RES, V30, P283, DOI 10.1139/x99-214; Wania R, 2013, GEOSCI MODEL DEV, V6, P617, DOI 10.5194/gmd-6-617-2013; WERLE P, 1993, APPL PHYS B-PHOTO, V57, P131, DOI 10.1007/BF00425997; WHITICAR MJ, 1986, ORG GEOCHEM, V10, P759, DOI 10.1016/S0146-6380(86)80013-4; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/NCLIMATE1951, 10.1038/nclimate1951]; ZOLTAI SC, 1993, ARCTIC ALPINE RES, V25, P240, DOI 10.2307/1551820	57	242	252	48	549	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					478	+		10.1038/nature13798	http://dx.doi.org/10.1038/nature13798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341787	Green Submitted			2022-12-01	WOS:000343775900037
J	Magill, SS; Edwards, JR; Beldavs, ZG; Dumyati, G; Janelle, SJ; Kainer, MA; Lynfield, R; Nadle, J; Neuhauser, MM; Ray, SM; Richards, K; Rodriguez, R; Thompson, DL; Fridkin, SK				Magill, Shelley S.; Edwards, Jonathan R.; Beldavs, Zintars G.; Dumyati, Ghinwa; Janelle, Sarah J.; Kainer, Marion A.; Lynfield, Ruth; Nadle, Joelle; Neuhauser, Melinda M.; Ray, Susan M.; Richards, Katherine; Rodriguez, Richard; Thompson, Deborah L.; Fridkin, Scott K.		Emerging Infect Program Healthcare; Associated Infect Antimicrobial Us	Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMMUNITY-ACQUIRED PNEUMONIA; ANTIBIOTIC USE; UNITED-STATES; GENERAL HOSPITALS; TRACT-INFECTIONS; RISK-FACTORS; THERAPY; ENTEROBACTERIACEAE; STEWARDSHIP	IMPORTANCE Inappropriate antimicrobial drug use is associated with adverse events in hospitalized patients and contributes to the emergence and spread of resistant pathogens. Targeting effective interventions to improve antimicrobial use in the acute care setting requires understanding hospital prescribing practices. OBJECTIVE To determine the prevalence of and describe the rationale for antimicrobial use in participating hospitals. DESIGN, SETTING, AND PARTICIPANTS One-day prevalence surveys were conducted in acute care hospitals in 10 states between May and September 2011. Patients were randomly selected from each hospital's morning census on the survey date. Data collectors reviewed medical records retrospectively to gather data on antimicrobial drugs administered to patients on the survey date and the day prior to the survey date, including reasons for administration, infection sites treated, and whether treated infections began in community or health care settings. MAIN OUTCOMES AND MEASURES Antimicrobial use prevalence, defined as the number of patients receiving antimicrobial drugs at the time of the survey divided by the total number of surveyed patients. RESULTS Of 11 282 patients in 183 hospitals, 5635 (49.9%; 95% CI, 49.0%-50.9%) were administered at least 1 antimicrobial drug; 77.5%(95% CI, 76.6%-78.3%) of antimicrobial drugs were used to treat infections, most commonly involving the lower respiratory tract, urinary tract, or skin and soft tissues, whereas 12.2%(95% CI, 11.5%-12.8%) were given for surgical and 5.9% (95% CI, 5.5%-6.4%) for medical prophylaxis. Of 7641 drugs to treat infections, the most common were parenteral vancomycin (1103, 14.4%; 95% CI, 13.7%-15.2%), ceftriaxone (825, 10.8%; 95% CI, 10.1%-11.5%), piperacillin-tazobactam (788, 10.3%; 95% CI, 9.6%-11.0%), and levofloxacin (694, 9.1%; 95% CI, 8.5%-9.7%). Most drugs administered to treat infections were given for community-onset infections (69.0%; 95% CI, 68.0%-70.1%) and to patients outside critical care units (81.6%; 95% CI, 80.4%-82.7%). The 4 most common treatment antimicrobial drugs overall were also the most common drugs used for both community-onset and health care facility-onset infections and for infections in patients in critical care and noncritical care locations. CONCLUSIONS AND RELEVANCE In this cross-sectional evaluation of antimicrobial use in US hospitals, use of broad-spectrum antimicrobial drugs such as piperacillin-tazobactam and drugs such as vancomycin for resistant pathogens was common, including for treatment of community-onset infections and among patients outside critical care units. Further work is needed to understand the settings and indications for which reducing antimicrobial use can be most effectively and safely accomplished.	[Magill, Shelley S.; Edwards, Jonathan R.; Neuhauser, Melinda M.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Beldavs, Zintars G.] Oregon Hlth Author, Oregon Publ Hlth Div, Portland, Dorset, England; [Dumyati, Ghinwa] New York Rochester Emerging Infect Program, Rochester, NY USA; [Dumyati, Ghinwa] Univ Rochester, Med Ctr, Rochester, NY 14627 USA; [Janelle, Sarah J.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Kainer, Marion A.] Tennessee Dept Hlth, Nashville, TN USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Nadle, Joelle] Calif Emerging Infect Program, Oakland, CA USA; [Neuhauser, Melinda M.] Pharm Benefits Management Serv, Dept Vet Affairs, Hines, IL USA; [Ray, Susan M.] Atlanta Vet Affairs Med Ctr, Georgia Emerging Infect Program, Decatur, GA USA; [Ray, Susan M.] Emory Univ, Sch Med, Georgia Emerging Infect Program, Atlanta, GA USA; [Richards, Katherine] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Rodriguez, Richard] Connecticut Dept Publ Hlth, Hartford, CT USA; [Thompson, Deborah L.] New Mexico Dept Hlth, Santa Fe, NM USA	Centers for Disease Control & Prevention - USA; University of Rochester; Colorado Department of Public Health & Environment; Tennessee Department Health; Minnesota Department of Health (MHD); California Emerging Infections Program; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Maryland Department of Health & Mental Hygiene; New Mexico Department of Health	Magill, SS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-24, Atlanta, GA 30333 USA.	smagill@cdc.gov		Ray, Susan/0000-0002-6327-088X; Kainer, Marion/0000-0001-7678-8744	Emerging Infections Program; CDC's Division of Healthcare Quality Promotion, Division of Preparedness and Emerging Infections; CDC's Office of Antimicrobial Resistance	Emerging Infections Program; CDC's Division of Healthcare Quality Promotion, Division of Preparedness and Emerging Infections; CDC's Office of Antimicrobial Resistance	The survey was supported through a cooperative agreement with the Emerging Infections Program. Funds to conduct the survey came from the CDC's Division of Healthcare Quality Promotion, Division of Preparedness and Emerging Infections, and Office of Antimicrobial Resistance.	[Anonymous], NAT STAT HEALTHC ASS; [Anonymous], AN THER CLASS STRUCT; Avdic E, 2012, CLIN INFECT DIS, V54, P1581, DOI 10.1093/cid/cis242; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berrios-Torres SI, 2014, INFECT CONT HOSP EP, V35, P231, DOI 10.1086/675289; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; CASTLE M, 1977, JAMA-J AM MED ASSOC, V237, P2819, DOI 10.1001/jama.237.26.2819; Centers for Disease Control and Prevention, COR EL HOSP ANT STEW; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Centers for Disease Control and Prevention (CDC), 2010, PREV PER GROUP B STR; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Dean AG, OPENEPI OPEN SOURVE; Fauci AS, 2014, JAMA-J AM MED ASSOC, V311, P1853, DOI 10.1001/jama.2014.2465; Fridkin S, 2014, MMWR-MORBID MORTAL W, V63, P194; Fridkin SK, 2014, CLIN INFECT DIS, V58, P401, DOI 10.1093/cid/cit710; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hawkins RB, 2013, AM J SURG, V206, P451, DOI 10.1016/j.amjsurg.2013.02.009; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Huttner B, 2013, J ANTIMICROB CHEMOTH, V68, P2393, DOI 10.1093/jac/dkt171; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Jinno S, 2012, AM J INFECT CONTROL, V40, P782, DOI 10.1016/j.ajic.2011.10.010; KASS EH, 1978, ANN INTERN MED, V89, P800, DOI 10.7326/0003-4819-89-5-800; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marchaim D, 2012, INFECT CONT HOSP EP, V33, P817, DOI 10.1086/666642; Pakyz AL, 2008, ARCH INTERN MED, V168, P2254, DOI 10.1001/archinte.168.20.2254; Polgreen PM, 2007, INFECT CONT HOSP EP, V28, P212, DOI 10.1086/512174; Schouten JA, 2007, CLIN INFECT DIS, V44, P931, DOI 10.1086/512193; SHAPIRO M, 1979, J INFECT DIS, V139, P698, DOI 10.1093/infdis/139.6.698; Shorr AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-268; Srigley JA, 2013, AM J INFECT CONTROL, V41, P1116, DOI 10.1016/j.ajic.2013.04.017; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; The Joint Commission, IMPR AM HOSP JOINT C; US Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Zilberberg MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-154	38	229	235	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1438	1446		10.1001/jama.2014.12923	http://dx.doi.org/10.1001/jama.2014.12923			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291579	Bronze			2022-12-01	WOS:000342630200020
J	Crystal, AS; Shaw, AT; Sequist, LV; Friboulet, L; Niederst, MJ; Lockerman, EL; Frias, RL; Gainor, JF; Amzallag, A; Greninger, P; Lee, D; Kalsy, A; Gomez-Caraballo, M; Elamine, L; Howe, E; Hur, W; Lifshits, E; Robinson, HE; Katayama, R; Faber, AC; Awad, MM; Ramaswamy, S; Mino-Kenudson, M; Iafrate, AJ; Benes, CH; Engelman, JA				Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Hur, Wooyoung; Lifshits, Eugene; Robinson, Hayley E.; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Mino-Kenudson, Mari; Iafrate, A. John; Benes, Cyril H.; Engelman, Jeffrey A.			Patient-derived models of acquired resistance can identify effective drug combinations for cancer	SCIENCE			English	Article							CELL LUNG-CANCER; KINASE INHIBITION; BYPASS MECHANISMS; ALK; CRIZOTINIB; MUTATIONS; GEFITINIB; CHEMOTHERAPY; ACTIVATION; CERITINIB	Targeted cancer therapies have produced substantial clinical responses, but most tumors develop resistance to these drugs. Here, we describe a pharmacogenomic platform that facilitates rapid discovery of drug combinations that can overcome resistance. We established cell culture models derived from biopsy samples of lung cancer patients whose disease had progressed while on treatment with epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors and then subjected these cells to genetic analyses and a pharmacological screen. Multiple effective drug combinations were identified. For example, the combination of ALK and MAPK kinase (MEK) inhibitors was active in an ALK-positive resistant tumor that had developed a MAP2K1 activating mutation, and the combination of EGFR and fibroblast growth factor receptor (FGFR) inhibitors was active in an EGFR mutant resistant cancer with a mutation in FGFR3. Combined ALK and SRC (pp60c-src) inhibition was effective in several ALK-driven patient-derived models, a result not predicted by genetic analysis alone. With further refinements, this strategy could help direct therapeutic choices for individual patients.	[Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Lifshits, Eugene; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Benes, Cyril H.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Lifshits, Eugene; Robinson, Hayley E.; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Mino-Kenudson, Mari; Iafrate, A. John; Benes, Cyril H.; Engelman, Jeffrey A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Robinson, Hayley E.; Mino-Kenudson, Mari; Iafrate, A. John] Massachusetts Gen Hosp, Ctr Canc, Dept Pathol, Boston, MA 02114 USA; [Hur, Wooyoung] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hur, Wooyoung] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hur, Wooyoung] Korea Inst Sci & Technol, Chem Kin Res Ctr, Seoul 136791, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Korea Institute of Science & Technology (KIST)	Engelman, JA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA.	cbenes@partners.org; jengelman@partners.org	friboulet, luc/N-7276-2015; Katayama, Ryohei/K-8537-2014; Frias, Rosa L./AAT-3133-2021; Gainor, Justin/T-5411-2019; Amzallag, Arnaud/Y-5802-2019	friboulet, luc/0000-0002-1129-4978; Katayama, Ryohei/0000-0001-7394-895X; Amzallag, Arnaud/0000-0001-7467-1227; Crystal, Adam/0000-0002-2302-2654	NIH [R01CA137008, R01CA164273, 1U54HG006097-01]; Wellcome Trust [086357, 102696]; National Cancer Institute Lung SPORE [P50CA090578]; Department of Defense; Conquer Cancer Foundation Young Investigator Award; Uniting Against Lung Cancer; Free to Breathe; Lungevity; National Foundation for Cancer Research; Be a Piece of the Solution; Novartis; Sanofi-Aventis; AstraZeneca; Chugai; Amgen; Genentech; GSK; Merck; Pfizer; Boehringer Ingelheim; Ariad; Roche; Ignyta; NATIONAL CANCER INSTITUTE [R01CA164273, P50CA090578, R01CA137008] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Cancer Institute Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Conquer Cancer Foundation Young Investigator Award; Uniting Against Lung Cancer; Free to Breathe; Lungevity; National Foundation for Cancer Research; Be a Piece of the Solution; Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Chugai; Amgen(Amgen); Genentech(Roche HoldingGenentech); GSK(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Ariad; Roche(Roche Holding); Ignyta; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. H. Park for direction, redirection, and support; S. R. Vora for continual critical discussion and support; W. Michaud for providing feeder cells and training for the development of patient-derived cell lines; and N. Gray for providing several kinase inhibitors. This study was funded by support from the NIH R01CA137008 (J.A.E.), R01CA164273 (A.T.S. and J.A.E.), 1U54HG006097-01 (C.H.B.), the Wellcome Trust (086357 and 102696, C.H.B.), the National Cancer Institute Lung SPORE P50CA090578 (A.S.C., A.J.I., and J.A.E.), the Department of Defense (L.V.S. and J.A.E.), Conquer Cancer Foundation Young Investigator Award (A.S.C.), Uniting Against Lung Cancer (A.S.C. and A.T.S.), Free to Breathe (A.S.C.), Lungevity (L.V.S. and J.A.E.), National Foundation for Cancer Research (A.T.S.), and Be a Piece of the Solution. J.A.E. is a paid consultant for Novartis, Sanofi-Aventis, AstraZeneca, Chugai, Amgen, Genentech, GSK, Merck, and Pfizer, and he holds equity in Gatekeeper Pharmaceuticals, which has a potential equity interest in T790M inhibitors. J.A.E. also receives research support from Novartis. J.F.G. is a paid consultant for Boehringer Ingelheim. A.T.S. is a paid consultant for Pfizer, Novartis, Ariad, Chugai, Genentech, Roche, and Ignyta. A.J.I. is a Senior Advisory Board member and holds equity in Enzymatics Inc. For gene expression analyses, the raw data are deposited in ArrayExpress (accession number is E-MTAB-783). The normalized data are available at www.cancerrxgene.org/downloads.	BAGRODIA S, 1991, NATURE, V349, P172, DOI 10.1038/349172a0; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Marsilje TH, 2013, J MED CHEM, V56, P5675, DOI 10.1021/jm400402q; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Yamaguchi N, 2014, LUNG CANCER, V83, P37, DOI 10.1016/j.lungcan.2013.09.019	27	505	527	2	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1480	1486		10.1126/science.1254721	http://dx.doi.org/10.1126/science.1254721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25394791	Green Accepted			2022-12-01	WOS:000346536500056
J	McCracken, KW; Cata, EM; Crawford, CM; Sinagoga, KL; Schumacher, M; Rockich, BE; Tsai, YH; Mayhew, CN; Spence, JR; Zavros, Y; Wells, JM				McCracken, Kyle W.; Cata, Emily M.; Crawford, Calyn M.; Sinagoga, Katie L.; Schumacher, Michael; Rockich, Briana E.; Tsai, Yu-Hwai; Mayhew, Christopher N.; Spence, Jason R.; Zavros, Yana; Wells, James M.			Modelling human development and disease in pluripotent stem-cell-derived gastric organoids	NATURE			English	Article							HELICOBACTER-PYLORI INFECTION; EPIDERMAL GROWTH-FACTOR; IN-VITRO; DEFINITIVE ENDODERM; DUODENAL-ULCER; SPECIFICATION; MORPHOGENESIS; INTEGRATION; EPITHELIUM; MESODERM	Gastric diseases, including peptic ulcer disease and gastric cancer, affect 10% of the world's population and are largely due to chronic Helicobacter pylori infection(1-3). Species differences in embryonic development and architecture of the adult stomach make animal models suboptimal for studying human stomach organogenesis and pathogenesis(4), and there is no experimental model of normal human gastric mucosa. Here we report the de novo generation of three-dimensional human gastric tissue in vitro through the directed differentiation of human pluripotent stem cells. We show that temporal manipulation of the FGF, WNT, BMP, retinoic acid and EGF signalling pathways and three-dimensional growth are sufficient to generate human gastric organoids (hGOs). Developing hGOs progressed through molecular and morphogenetic stages that were nearly identical to the developing antrum of the mouse stomach. Organoids formed primitive gastric gland-and pit-like domains, proliferative zones containing LGR5-expressing cells, surface and antral mucous cells, and a diversity of gastric endocrine cells. We used hGO cultures to identify novel signalling mechanisms that regulate early endoderm patterning and gastric endocrine cell differentiation upstream of the transcription factor NEUROG3. UsinghGOs to model pathogenesis of human disease, we found that H. pylori infection resulted in rapid association of the virulence factor CagA with the c-Met receptor, activation of signalling and induction of epithelial proliferation. Together, these studies describe a new and robust in vitro system for elucidating the mechanisms underlying human stomach development and disease.	[McCracken, Kyle W.; Cata, Emily M.; Crawford, Calyn M.; Sinagoga, Katie L.; Mayhew, Christopher N.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Schumacher, Michael; Zavros, Yana] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Rockich, Briana E.; Spence, Jason R.] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI 48109 USA; [Tsai, Yu-Hwai; Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	zavrosya@ucmail.uc.edu; james.wells@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	McCracken, Kyle/0000-0001-7650-5513; Mayhew, Chris/0000-0002-7408-1726; Schumacher, Michael/0000-0003-3353-0414	National Institutes of Health [R01DK080823, R01DK092456, K01DK091415]; NIGMS Medical Scientist Training Program [T32 GM063483]; American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer; Cincinnati Digestive Disease Center Award [P30 DK0789392]; Clinical Translational Science Award [U54 RR025216]; Michigan Gastrointestinal Peptide Research Center (MGPRC) [NIDDK 5P30DK034933]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083402, P30DK034933, R01DK080823, R01DK098350, K01DK091415, R01DK092456, P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072915, T32GM063483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Medical Scientist Training Program; American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer; Cincinnati Digestive Disease Center Award; Clinical Translational Science Award; Michigan Gastrointestinal Peptide Research Center (MGPRC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Zorn, J. Whitsett, N. Shroyer, the Pluripotent Stem Cell Facility and members of the Wells and Zorn laboratories for reagents and feedback. We also thank M. Kofron for assistance with confocal imaging and T. Westbrook for providing the pInducer20 vector. We thank R. Peek for assistance with analysing electron micrograph images. This work was supported by National Institutes of Health grants R01DK080823, R01DK092456 and K01DK091415, NIGMS Medical Scientist Training Program T32 GM063483, and the American Gastroenterological Association: Robert and Sally Funderburg Research Award in Gastric Cancer. We also acknowledge core support from the Cincinnati Digestive Disease Center Award (P30 DK0789392), Clinical Translational Science Award (U54 RR025216), the Michigan Gastrointestinal Peptide Research Center (MGPRC; NIDDK 5P30DK034933), and technical support from CCHMC Confocal Imaging Core, CCHMC Pathology Core, and CCHMC Viral Vector Core.	Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Choi E., 2014, GUT; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; JOHNSON LR, 1980, AM J PHYSIOL, V238, pG45, DOI 10.1152/ajpgi.1980.238.1.G45; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; MAJUMDAR APN, 1984, J PEDIATR GASTR NUTR, V3, P618, DOI 10.1097/00005176-198409000-00024; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Olbe L, 1996, GASTROENTEROLOGY, V110, P1386, DOI 10.1053/gast.1996.v110.pm8613042; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peek RM, 2008, DIS MODEL MECH, V1, P50, DOI 10.1242/dmm.000364; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Teo AKK, 2012, STEM CELLS, V30, P631, DOI 10.1002/stem.1022; Tiso N, 2002, MECH DEVELOP, V118, P29, DOI 10.1016/S0925-4773(02)00252-6; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Xia HHX, 2000, AM J GASTROENTEROL, V95, P114, DOI 10.1111/j.1572-0241.2000.01609.x; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yuan YH, 2006, NAT CLIN PRACT GASTR, V3, P80, DOI 10.1038/ncpgasthep0393	42	566	596	14	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					400	+		10.1038/nature13863	http://dx.doi.org/10.1038/nature13863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25363776	Green Accepted			2022-12-01	WOS:000346484800048
J	Kumar, RM; Cahan, P; Shalek, AK; Satija, R; DaleyKeyser, A; Li, H; Zhang, J; Pardee, K; Gennert, D; Trombetta, JJ; Ferrante, TC; Regev, A; Daley, GQ; Collins, JJ				Kumar, Roshan M.; Cahan, Patrick; Shalek, Alex K.; Satija, Rahul; DaleyKeyser, Ajay; Li, Hu; Zhang, Jin; Pardee, Keith; Gennert, David; Trombetta, John J.; Ferrante, Thomas C.; Regev, Aviv; Daley, George Q.; Collins, James J.			Deconstructing transcriptional heterogeneity in pluripotent stem cells	NATURE			English	Article							RNA-SEQ; GROUND-STATE; SELF-RENEWAL; MICRORNA; GENERATION; EXPRESSION; NOISE; DIFFERENTIATION; QUANTIFICATION; MAINTENANCE	Pluripotent stem cells (PSCs) are capable of dynamic interconversion between distinct substates; however, the regulatory circuits specifying these states and enabling transitions between them are not well understood. Here we set out to characterize transcriptional heterogeneity in mouse PSCs by single-cell expression profiling under different chemical and genetic perturbations. Signalling factors and developmental regulators show highly variable expression, with expression states for some variable genes heritable through multiple cell divisions. Expression variability and population heterogeneity can be influenced by perturbation of signalling pathways and chromatin regulators. Notably, either removal of mature microRNAs or pharmacological blockage of signalling pathways drives PSCs into a low-noise ground state characterized by a reconfigured pluripotency network, enhanced self-renewal and a distinct chromatin state, an effect mediated by opposing microRNA families acting on the Myc/Lin28/let-7 axis. These data provide insight into the nature of transcriptional heterogeneity in PSCs.	[Kumar, Roshan M.; DaleyKeyser, Ajay; Pardee, Keith; Ferrante, Thomas C.; Collins, James J.] Harvard Univ, Wyss lnst Biologically Inspired Engn, Boston, MA 02115 USA; [Kumar, Roshan M.; Pardee, Keith; Collins, James J.] Boston Univ, Ctr Synthet Biol, Dept Biomed Engn, Howard Hughes Inst, Boston, MA 02215 USA; [Cahan, Patrick; Zhang, Jin; Daley, George Q.] Boston Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA; [Cahan, Patrick; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dana Farber Canc Inst,Dept Biol Chem & Mol Pharma, Boston, MA 02115 USA; [Shalek, Alex K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Satija, Rahul; Gennert, David; Trombetta, John J.; Regev, Aviv] Harvard Univ, MIT, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Li, Hu] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Ctr Individualized Med, Rochester, MN 55905 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA	Harvard University; Boston University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Daley, GQ (corresponding author), Harvard Univ, Sch Med,Manton Ctr Orphan Dis Res, Harvard Stem Cell Inst,Howard Hughes Med Inst, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; jcollins@bu.edu	Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019	Shalek, Alex/0000-0001-5670-8778; Cahan, Patrick/0000-0003-3652-2540	NIH [R24DK092760, R01GM107536, P50HG005550]; HHMI; Broad Institute; Klarman Cell Observatory at the Broad Institute; NIH CEGS [1P50HG006193-01]; NIH Pioneer Award [DP1OD003958-01]; Wyss Institute; NIDDK [K01DK096013]; NHLBI [T32HL066987, T32HL007623]; Manton Center for Orphan Disease Research; NIH Postdoctoral Fellowship [1F32HD075541-01]; Mayo Clinic Center for Individualized Medicine;  [NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, T32HL007623] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096013, R24DK092760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107536] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Broad Institute; Klarman Cell Observatory at the Broad Institute; NIH CEGS; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Manton Center for Orphan Disease Research; NIH Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Collins and Daley laboratories for discussions. J.J.C. is supported by NIH grant R24DK092760 and the HHMI. G.Q.D. is supported by grants from the NIH (R01GM107536, R24DK092760, P50HG005550) and is an affiliate member of the Broad Institute and an investigator of the Manton Center for Orphan Disease Research and the Howard Hughes Medical Institute. A.R. is supported by the Broad Institute, the Klarman Cell Observatory at the Broad Institute, an NIH CEGS (1P50HG006193-01), an NIH Pioneer Award (DP1OD003958-01) and the HHMI. R.M.K. is supported by the Wyss Institute. P.C. is supported by NIDDK (K01DK096013) and received support from NHLBI (T32HL066987 and T32HL007623) and the Manton Center for Orphan Disease Research. R.S. was supported by an NIH Postdoctoral Fellowship (1F32HD075541-01). H.L. is supported by the Mayo Clinic Center for Individualized Medicine. Sequencing was performed by the Broad Institute Genomics Platform. Flow cytometry was performed in the Hematologic Neoplasia Flow Cytometry Facility at the Dana-Farber Cancer Institute and the BCH IDDRC Stem Cell Core Facility at Boston Children's Hospital supported by NIH-P30-HD18655. Single-cell qPCR experiments were performed at the BCH IDDRC Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P30-HD18655. Fludigm C<INF>1</INF> experiments were performed at the Broad Institute and the Biopolymers Facility at Harvard Medical School.	Arias A. M., 2011, CURR OPIN CELL BIOL, V23, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/nmeth.2930, 10.1038/NMETH.2930]; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HOLM S, 1979, SCAND J STAT, V6, P65; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	69	241	249	6	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					56	U112		10.1038/nature13920	http://dx.doi.org/10.1038/nature13920			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471879	Green Accepted, Green Submitted			2022-12-01	WOS:000346310800037
J	Frisch, S				Frisch, Suzy			Medical cannabis: US researchers battle for access to the plant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Abrams DI, 2007, CLIN PHARMACOL THER, V82, P572, DOI 10.1038/sj.clpt.6100200; Aggarwal Sunil K, 2009, J Opioid Manag, V5, P153; Borgelt LM, 2013, PHARMACOTHERAPY, V33, P195, DOI 10.1002/phar.1187; Charuvastra A, 2005, J ADDICT DIS, V24, P87, DOI 10.1300/J069v24n03_07; Drug Enforcement Administration, 2011, DEA POS MAR; Drug Enforcement Administration, DRUG SCHED; Drug Policy Alliance, DEA 4 DEC IMP REJ SC; FRISCH S, MED CANNABIS US RES; Grant I, 2010, REPORT LEGISLATURE G; Hotakeinen R, 2014, FEDS ACCUSED STEERIN; ProCon, 2014, SUMM CHART 23 STAT D; ProConorg, 2014, NUMB LEG MED MAR PAT; Rappold RS, 2014, WEBMD HLTH NEWS 0402	13	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2014	349								g6997	10.1136/bmj.g6997	http://dx.doi.org/10.1136/bmj.g6997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2KB	25416312				2022-12-01	WOS:000345446000003
J	Pope, BD; Ryba, T; Dileep, V; Yue, F; Wu, WS; Denas, O; Vera, DL; Wang, YL; Hansen, RS; Canfield, TK; Thurman, RE; Cheng, Y; Gulsoy, G; Dennis, JH; Snyder, MP; Stamatoyannopoulos, JA; Taylor, J; Hardison, RC; Kahveci, T; Ren, B; Gilbert, DM				Pope, Benjamin D.; Ryba, Tyrone; Dileep, Vishnu; Yue, Feng; Wu, Weisheng; Denas, Olgert; Vera, Daniel L.; Wang, Yanli; Hansen, R. Scott; Canfield, Theresa K.; Thurman, Robert E.; Cheng, Yong; Guelsoy, Guenhan; Dennis, Jonathan H.; Snyder, Michael P.; Stamatoyannopoulos, John A.; Taylor, James; Hardison, Ross C.; Kahveci, Tamer; Ren, Bing; Gilbert, David M.			Topologically associating domains are stable units of replication-timing regulation	NATURE			English	Article							H3 LYSINE 27; REVEALS; ORGANIZATION; METHYLATION; CHROMOSOME; DYNAMICS; GENOMES; SWITCH; EZH2	Eukaryotic chromosomes replicate in a temporal order known as the replication-timing program(1). In mammals, replication timing is cell-type-specific with at least half the genome switching replication timing during development, primarily in units of 400-800 kilobases (replication domains'), whose positions are preserved in different cell types, conserved between species, and appear to confine long-range effects of chromosome rearrangements(2-7). Early and late replication correlate, respectively, with open and closed three-dimensional chromatin compartments identified by high-resolution chromosome conformation capture (Hi-C), and, to a lesser extent, late replication correlates with lamina-associated domains (LADs)(4,5,8,9). Recent Hi-C mapping has unveiled substructure within chromatin compartments called topologically associating domains (TADs) that are largely conserved in their positions between cell types and are similar in size to replication domains(8,10). However, TADs can be further sub-stratified into smaller domains, challenging the significance of structures at any particular scale(11,12). Moreover, attempts to reconcile TADs and LADs to replication-timing data have not revealed a common, underlying domain structure(8,9,13). Here we localize boundaries of replication domains to the early-replicating border of replication-timing transitions and map their positions in 18 human and 13 mouse cell types. We demonstrate that, collectively, replication domain boundaries share a near one-to-one correlation with TAD boundaries, whereas within a cell type, adjacent TADs that replicate at similar times obscure replication domain boundaries, largely accounting for the previously reported lack of alignment. Moreover, cell-type-specific replication timing of TADs partitions the genome into two large-scale sub-nuclear compartments revealing that replication-timing transitions are indistinguishable from late-replicating regions in chromatin composition and lamina association and accounting for the reduced correlation of replication timing to LADs and heterochromatin. Our results reconcile cell-type-specific sub-nuclear compartmentalization and replication timing with developmentally stable structural domains and offer a unified model for large-scale chromosome structure and function.	[Pope, Benjamin D.; Dileep, Vishnu; Vera, Daniel L.; Dennis, Jonathan H.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Ryba, Tyrone] New Coll Florida, Div Nat Sci, Sarasota, FL 34243 USA; [Yue, Feng] Penn State Univ, Sch Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Yue, Feng; Wang, Yanli; Snyder, Michael P.] Penn State Univ, Huck Inst Life Sci, Bioinformat & Genom Program, University Pk, PA 16802 USA; [Wu, Weisheng; Hardison, Ross C.] Penn State Univ, Huck Inst Life Sci, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Denas, Olgert; Taylor, James] Emory Univ, O WayneRollins Res Ctr, Dept Biol, Atlanta, GA 30322 USA; [Denas, Olgert; Taylor, James] Emory Univ, O WayneRollins Res Ctr, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Hansen, R. Scott] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Canfield, Theresa K.; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cheng, Yong] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Guelsoy, Guenhan; Kahveci, Tamer] Univ Florida, Gainesville, FL 32611 USA; [Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	State University System of Florida; Florida State University; State University System of Florida; New College Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Emory University; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; State University System of Florida; University of Florida; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Gilbert, DM (corresponding author), Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.	gilbert@bio.fsu.edu	Taylor, James/F-1026-2011; Dileep, Vishnu/S-1328-2018; Pope, Ben/Y-4326-2019; cheng, yong/I-4270-2012; Hardison, Ross C/G-1142-2010	Taylor, James/0000-0001-5079-840X; Dileep, Vishnu/0000-0001-9181-2191; Pope, Ben/0000-0003-1847-9163; Hardison, Ross C/0000-0003-4084-7516; Snyder, Michael/0000-0003-0784-7987; Vera, Daniel/0000-0003-2202-7397	NIH [GM083337, GM085354, HG005602, HG005573, DK065806, HG003991]; National Cancer Institute of the National Institutes of Health [F31CA165863]; NATIONAL CANCER INSTITUTE [F31CA165863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991, RC2HG005602, U54HG006997, RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065806, R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, R01GM083337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Laugesen, G. Andersen and K. Helm for providing Suz12 control and knockout naive mESC lines. We thank F.Ay, M. Libbrecht,W. S. Noble, E. Besnard, J. M. LeMaitre, C. Cayrou, M. Mechali and J. Dekker for helpful discussions. This research was supported by NIH grants GM083337 and GM085354 to D.M.G., HG005602 to M.P.S., HG005573 and DK065806 to R.C.H., and HG003991 to B.R. B.D.P. is supported by the National Cancer Institute of the National Institutes of Health under award number F31CA165863.	Audit B, 2009, NUCLEIC ACIDS RES, V37, P6064, DOI 10.1093/nar/gkp631; Baker A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002443; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farkash-Amar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048986; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Julienne H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003233; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Lu JJ, 2010, J CELL BIOL, V189, P967, DOI 10.1083/jcb.201002002; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pope BD, 2012, HUM MOL GENET, V21, P4162, DOI 10.1093/hmg/dds232; Rhind N, 2010, CHROMOSOME RES, V18, P35, DOI 10.1007/s10577-009-9093-3; Ryba T, 2012, GENOME RES, V22, P1833, DOI 10.1101/gr.138511.112; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Takebayashi S, 2012, P NATL ACAD SCI USA, V109, P12574, DOI 10.1073/pnas.1207185109; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; Wright M. L., 2011, DNA REPLICATION CURR; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	36	502	520	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					402	+		10.1038/nature13986	http://dx.doi.org/10.1038/nature13986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409831	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000345770600043
J	Xing, Z; Lin, AF; Li, CL; Liang, K; Wang, SY; Liu, Y; Park, PK; Qin, L; Wei, YK; Hawke, DH; Hung, MC; Lin, CR; Yang, LQ				Xing, Zhen; Lin, Aifu; Li, Chunlai; Liang, Ke; Wang, Shouyu; Liu, Yang; Park, Peter K.; Qin, Li; Wei, Yongkun; Hawke, David H.; Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing			IncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals	CELL			English	Article							BREAST-CANCER METASTASIS; RNA-BINDING PROTEINS; NONCODING RNAS; POLYMERASE-II; CITRON KINASE; FHA DOMAIN; HEDGEHOG; MECHANISMS; GENES; SNIP1	IncRNAs are known to regulate a number of different developmental and tumorigenic processes. Here, we report a role for lncRNA BCAR4 in breast cancer metastasis that is mediated by chemokine-induced binding of BCAR4 to two transcription factors with extended regulatory consequences. BCAR4 binding of SNIP1 and PNUTS in response to CCL21 releases the SNIP1's inhibition of p300-dependent histone acetylation, which in turn enables the BCAR4-recruited PNUTS to bind H3K18ac and relieve inhibition of RNA Pol II via activation of the PP1 phosphatase. This mechanism activates a noncanonical Hedgehog/GLI2 transcriptional program that promotes cell migration. BCAR4 expression correlates with advanced breast cancers, and therapeutic delivery of locked nucleic acids (LNAs) targeting BCAR4 strongly suppresses breast cancer metastasis in mouse models. The findings reveal a disease-relevant lncRNA mechanism consisting of both direct coordinated protein recruitment and indirect regulation of transcription factors.	[Xing, Zhen; Lin, Aifu; Li, Chunlai; Liang, Ke; Wang, Shouyu; Liu, Yang; Park, Peter K.; Wei, Yongkun; Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing] Univ Texas, Grad Sch Biomed Sci, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing] Univ Texas, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX USA; [Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Qin, Li] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan	University of Texas System; University of Texas System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; China Medical University Taiwan; China Medical University Taiwan	Lin, CR (corresponding author), Univ Texas, Grad Sch Biomed Sci, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	clin2@mdanderson.org; lyang7@mdanderson.org	Li, Chunlai/AAI-8839-2021; Hung, Mien-Chie/ABD-5911-2021	Li, Chunlai/0000-0003-1897-9889; Hung, Mien-Chie/0000-0003-4317-4740; Qin, Li/0000-0003-0099-4992; Hawke, David/0000-0002-6102-7843	NIH [4R00DK094981-02, 5R00CA166527-03]; UT Startup grant; UT STARS grant; CPRIT award [R1218]; NATIONAL CANCER INSTITUTE [R00CA166527, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK094981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Startup grant; UT STARS grant; CPRIT award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr. Joan Massague and Dr. Jianming Xu for providing the MDA-MB-231 LM2 cell line and D. Aten for assistance with figure presentation. We thank the Small Animal Imaging Facility at the MD Anderson Cancer Center for assistance in mice imaging. This work was supported by an NIH K99/R00 award (4R00DK094981-02), UT Startup and UT STARS grants (to C. Lin.), and an NIH K99/R00 award (5R00CA166527-03), CPRIT award (R1218), and UT Startup and UT STARS grants (to L.Y.).	Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Ciurciu A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003885; Dias N, 2002, MOL CANCER THER, V1, P347; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Favoni RE, 2000, PHARMACOL REV, V52, P179; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Godinho M, 2011, J CELL PHYSIOL, V226, P1741, DOI 10.1002/jcp.22503; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hui M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3401; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kim RH, 2001, J BIOL CHEM, V276, P46297, DOI 10.1074/jbc.M103819200; Kim RH, 2000, GENE DEV, V14, P1605; Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Thelie A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-125; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105	38	333	346	4	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1110	1125		10.1016/j.cell.2014.10.013	http://dx.doi.org/10.1016/j.cell.2014.10.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416949	Green Accepted, Bronze			2022-12-01	WOS:000345506300022
J	Hodgkinson, JA; Tucker, KL; Crawford, C; Greenfield, SM; Heneghan, C; Hinton, L; Khan, K; Locock, L; Mackillop, L; McCourt, C; Selwood, M; McManus, RJ				Hodgkinson, James A.; Tucker, Katherine L.; Crawford, Carole; Greenfield, Sheila M.; Heneghan, Carl; Hinton, Lisa; Khan, Khalid; Locock, Louise; Mackillop, Lucy; McCourt, Christine; Selwood, Mary; McManus, Richard J.			Is self monitoring of blood pressure in pregnancy safe and effective?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PREECLAMPSIA; HOME; HYPERTENSION; WOMEN; OSCILLOMETRY; INFLATIONARY; VALIDATION; DIAGNOSIS; ECLAMPSIA	Guidelines encourage the use of self monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But Hodgkinson and colleagues explain that our enthusiasm may run ahead of the evidence and call for more research before it is routinely adopted	[Hodgkinson, James A.; Greenfield, Sheila M.] Univ Birmingham, Birmingham, W Midlands, England; [Tucker, Katherine L.; Crawford, Carole; Heneghan, Carl; Hinton, Lisa; Locock, Louise; Selwood, Mary; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX3 6GG, England; [Khan, Khalid] Blizard Inst, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit, London, England; [Locock, Louise] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Mackillop, Lucy] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Womens Ctr, Oxford, England; [McCourt, Christine] City Univ London, London EC1V 0HB, England	University of Birmingham; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; City University London	McManus, RJ (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX3 6GG, England.	richard.mcmanus@phc.ox.ac.uk	Khan, Khalid S/AAT-8824-2020; Hinton, Lisa/AAA-2266-2019; Hodgkinson, James/AAY-3410-2020	Khan, Khalid S/0000-0001-5084-7312; Hodgkinson, James/0000-0002-7583-5278; Mackillop, Lucy/0000-0002-1927-1594; Hinton, Lisa/0000-0002-6082-3151; Tucker, Katherine/0000-0001-6544-8066; McCourt, Christine/0000-0003-4765-5795	National Institute for Health Research [PB-PG-1207-15042, NIHR-RP-02-12-015, RP-PG-1209-10051, CDF/01/017] Funding Source: researchfish; Department of Health [CDF/01/017, NIHR-RP-02-12-015, PB-PG-1207-15042, RP-PG-1209-10051] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P72; American College of Obstetricians and gynecologists ibI, 2013, HYP PREGN IND PRACT; [Anonymous], 2004, 7 RPEP JOINT NAT COM; Ayala DE, 1997, HYPERTENSION, V30, P611, DOI 10.1161/01.HYP.30.3.611; Baral-Grant S, 2012, INT J HYPERTENS, V58, P2068; Bellomo G, 1999, JAMA-J AM MED ASSOC, V282, P1447, DOI 10.1001/jama.282.15.1447; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; CARTWRIGHT W, 1992, BRIT J OBSTET GYNAEC, V99, P182, DOI 10.1111/j.1471-0528.1992.tb14495.x; Cartwright W, 1993, PROFESSIONAL CARE MO, V3, P8; Chung Y, 2009, HYPERTENS PREGNANCY, V28, P348, DOI 10.1080/10641950802601286; De Greeff A, 2006, J HYPERTENS       S4, V24, pS279; de Greeff A, 2009, BLOOD PRESS MONIT, V14, P37, DOI 10.1097/MBP.0b013e32831e305d; Dehaeck U, 2010, J OBSTET GYNAECOL CA, V32, P328, DOI 10.1016/S1701-2163(16)34476-0; Denolle T, 2008, HYPERTENS PREGNANCY, V27, P305, DOI 10.1080/10641950802000950; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Golara M, 2002, BJOG-INT J OBSTET GY, V109, P1143; Hermida RC, 2005, BLOOD PRESS MONIT, V10, P33, DOI 10.1097/00126097-200502000-00007; Hermida RC, 1997, HYPERTENSION, V30, P1531, DOI 10.1161/01.HYP.30.6.1531; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kitagawa M, 2000, J Obstet Gynaecol Res, V26, P427; Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47; LINDHEIMER MD, 2000, HYPERTENSION COMPANI, P688; Magee LA, 2007, HYPERTENS PREGNANCY, V26, P371, DOI 10.1080/10641950701547549; Maternal and Child Health Research Consortium, 2001, CONF ENQ STILLB DEAT; Meads CA, 2008, HLTH TECHNOL ASSESS, V12; Naef R W 3rd, 1998, J Perinatol, V18, P226; Natarajan P, 1999, AM J OBSTET GYNECOL, V181, P1203, DOI 10.1016/S0002-9378(99)70109-2; National Collaborating Centre for Women's and Children's Health, 2008, ANT CAR ROUT CAR HLT; National Institute for Health and Care Excellence, 2008, NICE CLIN GUID CG62; National Institute for Health and Clinical Excellence, 2010, NIC CLIN GUID CG107; National Institutes of Health, 2000, WORK GROUP REP HIGH; NICE, 2011, NICE GUID CG127; Office for National Statistics, 2014, STAT B CONC ENGL WAL; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; RAYBURN WF, 1984, AM J OBSTET GYNECOL, V148, P159, DOI 10.1016/S0002-9378(84)80168-4; RAYBURN WF, 1985, CLIN EXP HYPERTENS B, V4, P63, DOI 10.3109/10641958509031656; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reinders A, 2003, BJOG-INT J OBSTET GY, V110, P134, DOI 10.1016/S1470-0328(02)02538-7; Reinders A, 2005, BJOG, V112, P1; Ross-McGill H, 2000, BRIT J OBSTET GYNAEC, V107, P217, DOI 10.1111/j.1471-0528.2000.tb11692.x; Schwartz WJ, 1996, J REPROD MED, V41, P581; Swindells HE, 1990, MIDWIFE HLTH VISITOR, V26, P88; Taylor RS, 2001, HYPERTENS PREGNANCY, V20, P25, DOI 10.1081/PRG-100104169; Thornton JG, 2000, BRIT J OBSTET GYNAEC, V107, P1181, DOI 10.1111/j.1471-0528.2000.tb11129.x; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Waugh J, 2003, HYPERTENS PREGNANCY, V22, P93, DOI 10.1081/PRG-120017007	51	23	24	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6616	10.1136/bmj.g6616	http://dx.doi.org/10.1136/bmj.g6616			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406132	Green Published, Green Accepted			2022-12-01	WOS:000345445600004
J	Venkatesh, A; Goodrich, K; Conway, PH				Venkatesh, Arjun; Goodrich, Kate; Conway, Patrick H.			Opportunities for Quality Measurement to Improve the Value of Care for Patients With Multiple Chronic Conditions	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH OUTCOMES; GUIDELINES	Quality measurement efforts have not historically focused on patients with multiple chronic conditions (MCCs), despite them comprising one quarter of the population and two thirds of health care spending. The Patient Protection and Affordable Care Act (ACA) creates several mechanisms for the Centers for Medicare & Medicaid Services (CMS) to transform quality measurement into an organized enterprise designed to support clinicians caring for this vulnerable population. This article highlights 3 emerging policy opportunities for CMS to guide public and private quality measurement efforts for patients with MCCs. First, it discusses infusing an MCC framework into measure development to promote patient-centered, as opposed to single-disease-specific, performance measurement. Second, it describes the importance of using common performance measures for individual clinicians, hospitals, and communities to accelerate meaningful improvement in the prevention and management of chronic conditions across local populations. Finally, the need for longitudinal measurement as a foundation for sustained quality improvement is presented. The ACA's expansion of insurance access and portability necessitates collaborative alignment of chronic condition quality measurement efforts between public and private programs to develop a high-value lifelong health system.	[Venkatesh, Arjun] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06519 USA; [Goodrich, Kate; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Ctr Clin Stand & Qual, Baltimore, MD 21244 USA; George Washington Univ, Sch Med, Washington, DC USA; Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Yale University; Centers for Medicare & Medicaid Services; George Washington University; Cincinnati Children's Hospital Medical Center	Venkatesh, A (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, 464 Congress St,Suite 260, New Haven, CT 06519 USA.	arjun.venkatesh@yale.edu			Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	By the Robert Wood Johnson Foundation Clinical Scholars Program (Dr. Venkatesh).	Agency for Healthcare Research and Quality, 2006, AHRQ QUAL IND PREV Q; Ashman JJ, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120308; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barr Victoria J, 2003, Hosp Q, V7, P73; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Chan CL, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-405; Conway PH, 2013, JAMA-J AM MED ASSOC, V309, P2215, DOI 10.1001/jama.2013.4929; Conway PH, 2013, EHEALTH ALIGNING QUA; Dunn L., 2011, BECKERS HOSP RE 1004; Eddy DM, 2012, HEALTH AFFAIR, V31, P2441, DOI 10.1377/hlthaff.2011.1274; Ford ES, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.120316, 10.5888/pcd10.130244, 10.5888/pcd10.120316e]; Goodman RA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120239; Halfon N, 2013, NEW ENGL J MED, V368, P1569, DOI 10.1056/NEJMp1215897; National Quality Forum, MEAS APPL PARTN; National Quality Forum, 2012, MCC MEAS FRAM FIN RE; Owens DK, 2013, ANN INTERN MED, V159, P223, DOI 10.7326/0003-4819-159-3-201308060-00014; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Robert Wood Johnson Foundation, 2010, CHRONIC CONDITIONS M; Taksler GB, 2013, ANN INTERN MED, V159, P161, DOI 10.7326/0003-4819-159-3-201308060-00005; Tinetti ME, 2011, J AM GERIATR SOC, V59, P1686, DOI 10.1111/j.1532-5415.2011.03573.x; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; US Department of Health and Human Services, 2011, 2011 REP C NAT STRAT; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Wagner E H, 1998, Eff Clin Pract, V1, P2; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203	26	15	15	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S76	S80		10.7326/M13-3014	http://dx.doi.org/10.7326/M13-3014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402407				2022-12-01	WOS:000364909900011
J	Watanabe, S; Trimbuch, T; Camacho-Perez, M; Rost, BR; Brokowski, B; Sohl-Kielczynski, B; Felies, A; Davis, MW; Rosenmund, C; Jorgensen, EM				Watanabe, Shigeki; Trimbuch, Thorsten; Camacho-Perez, Marcial; Rost, Benjamin R.; Brokowski, Bettina; Soehl-Kielczynski, Berit; Felies, Annegret; Davis, M. Wayne; Rosenmund, Christian; Jorgensen, Erik M.			Clathrin regenerates synaptic vesicles from endosomes	NATURE			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; MEDIATED ENDOCYTOSIS; PHYSIOLOGICAL TEMPERATURES; CAENORHABDITIS-ELEGANS; MEMBRANE RETRIEVAL; TERMINALS; RELEASE; DYNAMIN; TRAFFICKING	Ultrafast endocytosis can retrieve a single, large endocytic vesicle as fast as 50-100 ms after synaptic vesicle fusion. However, the fate of the large endocytic vesicles is not known. Here we demonstrate that these vesicles transition to a synaptic endosome about one second after stimulation. The endosome is resolved into coated vesicles after 3 s, which in turn become small-diameter synaptic vesicles 5-6 s after stimulation. We disrupted clathrin function using RNA interference (RNAi) and found that clathrin is not required for ultrafast endocytosis but is required to generate synaptic vesicles from the endosome. Ultrafast endocytosis fails when actin polymerization is disrupted, or when neurons are stimulated at room temperature instead of physiological temperature. In the absence of ultrafast endocytosis, synaptic vesicles are retrieved directly from the plasma membrane by clathrin-mediated endocytosis. These results may explain discrepancies among published experiments concerning the role of clathrin in synaptic vesicle endocytosis.	[Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Trimbuch, Thorsten; Camacho-Perez, Marcial; Rost, Benjamin R.; Brokowski, Bettina; Soehl-Kielczynski, Berit; Felies, Annegret; Rosenmund, Christian] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Brokowski, Bettina] German Ctr Neurodegenerat Dis DZNE, D-10117 Berlin, Germany	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	christian.rosenmund@charite.de; jorgensen@biology.utah.edu	Rosenmund, Christian/AAC-3596-2020; Rost, Benjamin/AHD-2242-2022	Rosenmund, Christian/0000-0002-3905-2444; Rost, Benjamin/0000-0003-1906-0081; Camacho Perez, Marcial/0000-0002-2367-1259; Watanabe, Shigeki/0000-0001-7580-8141; Davis, Mikel/0000-0003-1867-1593; Trimbuch, Thorsten/0000-0001-7512-8955	EMBO; US National Institutes of Health [NS034307]; European Research Council grant [249939 SYNVGLUT]; German Research Council grants [Neurocure EXC 257, SFB 665, SFB 958]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307, R01NS034307] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council grant(European Research Council (ERC)); German Research Council grants; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Lorenz and A. Muenster-Wandowski for providing access to electron microscopy, J. Iwasa for the original model figure, S. Jorgensen for image processing, and C. Garner for discussions. We thank EMBO for providing the travel funds (S.W.). The research was funded by the US National Institutes of Health (NS034307 EMJ), European Research Council grant (249939 SYNVGLUT CR), and German Research Council grants (Neurocure EXC 257 EMJ+CR, SFB 665 + SFB 958 CR). E.M.J. is an Investigator of the Howard Hughes Medical Institute and is an Alexander von Humboldt Scholar.	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gisselsson LL, 2005, J CEREBR BLOOD F MET, V25, P1346, DOI 10.1038/sj.jcbfm.9600131; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gu MY, 2013, ELIFE, V2, DOI 10.7554/eLife.00190; Hartmann-Petersen R, 2000, CYTOMETRY, V40, P260, DOI 10.1002/1097-0320(20000801)40:4<260::AID-CYTO2>3.0.CO;2-J; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Heuser J., 1979, 4 INTENSIVE STUDY PR, P573; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KANE RE, 1976, J CELL BIOL, V71, P704, DOI 10.1083/jcb.71.3.704; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kittelmann M, 2013, P NATL ACAD SCI USA, V110, pE3007, DOI 10.1073/pnas.1305679110; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Schikorski T, 2014, P NATL ACAD SCI USA, V111, P5415, DOI 10.1073/pnas.1321541111; SIK A, 1995, J NEUROSCI, V15, P6651; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Teng HB, 1999, J NEUROSCI, V19, P4855; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	50	177	177	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					228	U168		10.1038/nature13846	http://dx.doi.org/10.1038/nature13846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25296249	Green Accepted			2022-12-01	WOS:000344631400041
J	Ghosh, I; Ghosh, T; Bardagi, JI; Konig, B				Ghosh, Indrajit; Ghosh, Tamal; Bardagi, Javier I.; Koenig, Burkhard			Reduction of aryl halides by consecutive visible light-induced electron transfer processes	SCIENCE			English	Article							HOMOLYTIC AROMATIC-SUBSTITUTION; C-H-ARYLATION; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; DIAZONIUM SALTS; TRANSFORMATIONS; HETEROARENES; ACTIVATION; TRANSITION; ALDEHYDES	Biological photosynthesis uses the energy of several visible light photons for the challenging oxidation of water, whereas chemical photocatalysis typically involves only single-photon excitation. Perylene bisimide is reduced by visible light photoinduced electron transfer (PET) to its stable and colored radical anion. We report here that subsequent excitation of the radical anion accumulates sufficient energy for the reduction of stable aryl chlorides giving aryl radicals, which were trapped by hydrogen atom donors or used in carbon-carbon bond formation. This consecutive PET (conPET) overcomes the current energetic limitation of visible light photoredox catalysis and allows the photocatalytic conversion of less reactive chemical bonds in organic synthesis.	[Ghosh, Indrajit; Ghosh, Tamal; Bardagi, Javier I.; Koenig, Burkhard] Univ Regensburg, Inst Organ Chem, D-93040 Regensburg, Germany	University of Regensburg	Konig, B (corresponding author), Univ Regensburg, Inst Organ Chem, D-93040 Regensburg, Germany.	burkhard.koenig@ur.de	Koenig, Burkhard/GRX-2026-2022; Ghosh, Indrajit/Z-3421-2019; Ghosh, Indrajit/D-2302-2010; Koenig, Burkhard/O-8172-2019; Koenig, Burkhard/A-1362-2009	Koenig, Burkhard/0000-0002-6131-4850; Ghosh, Indrajit/0000-0002-5127-2271; Ghosh, Indrajit/0000-0002-5127-2271; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850	Deutsche Forschungsgemeinschaft [GRK 1626]; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank the Deutsche Forschungsgemeinschaft (GRK 1626) for financial support. J.I.B. thanks the Alexander von Humboldt Foundation for a scholarship. We thank R. Vasold for his assistance in GC-MS measurements.	Buden ME, 2013, ORG LETT, V15, P1174, DOI 10.1021/ol3034687; Cahard E, 2012, ANGEW CHEM INT EDIT, V51, P3673, DOI 10.1002/anie.201200084; CHAMI Z, 1991, J ORG CHEM, V56, P586, DOI 10.1021/jo00002a020; Cheng YN, 2013, ORG LETT, V15, P2664, DOI 10.1021/ol400946k; Concepcion JJ, 2012, P NATL ACAD SCI USA, V109, P15560, DOI 10.1073/pnas.1212254109; Costentin C, 2004, J AM CHEM SOC, V126, P16051, DOI 10.1021/ja045989u; Furst L, 2010, ORG LETT, V12, P3104, DOI 10.1021/ol101146f; Gosztola D, 2000, J PHYS CHEM A, V104, P6545, DOI 10.1021/jp000706f; Hari DP, 2014, ANGEW CHEM INT EDIT, V53, P725, DOI 10.1002/anie.201307051; Hari DP, 2013, ANGEW CHEM INT EDIT, V52, P4734, DOI 10.1002/anie.201210276; Hari DP, 2012, J AM CHEM SOC, V134, P2958, DOI 10.1021/ja212099r; Harkins SB, 2005, J AM CHEM SOC, V127, P2030, DOI 10.1021/ja043092r; Kim H, 2012, ANGEW CHEM INT EDIT, V51, P12303, DOI 10.1002/anie.201203599; Liu YX, 2013, SYNLETT, V24, P507, DOI 10.1055/s-0032-1318155; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Newcomb M., 2012, ENCY RADICALS CHEM B, P107; Nguyen JD, 2012, NAT CHEM, V4, P854, DOI 10.1038/NCHEM.1452; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Pause L, 1999, J AM CHEM SOC, V121, P7158, DOI 10.1021/ja991365q; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Ramanan C, 2012, J AM CHEM SOC, V134, P386, DOI 10.1021/ja2080482; Ravelli D, 2009, CHEM SOC REV, V38, P1999, DOI 10.1039/b714786b; REHM D, 1970, ISRAEL J CHEM, V8, P259; Rossi RA, 2003, CHEM REV, V103, P71, DOI 10.1021/cr960134o; Sasaki Y, 2013, J AM CHEM SOC, V135, P5441, DOI 10.1021/ja400238r; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Shirman E, 2008, J PHYS CHEM B, V112, P8855, DOI 10.1021/jp8029743; Tauber MJ, 2006, J AM CHEM SOC, V128, P1782, DOI 10.1021/ja057031k; Teply F, 2011, COLLECT CZECH CHEM C, V76, P859, DOI 10.1135/cccc2011078; Wurthner F, 2004, CHEM COMMUN, P1564, DOI 10.1039/b401630k; Xuan J, 2012, ANGEW CHEM INT EDIT, V51, P6828, DOI 10.1002/anie.201200223	32	602	604	32	689	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					725	728		10.1126/science.1258232	http://dx.doi.org/10.1126/science.1258232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378618				2022-12-01	WOS:000344690100034
J	Ulrich, CM				Ulrich, Connie M.			PERSONAL VIEW Ebola is causing moral distress among African healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHICAL CLIMATE; NURSES; STRESS		[Ulrich, Connie M.] Univ Penn, Sch Nursing, Dept Med Eth & Hlth Policy, Philadelphia, PA 19106 USA; [Ulrich, Connie M.] Univ Penn, New Courtland Ctr Transit & Hlth, Philadelphia, PA 19106 USA	University of Pennsylvania; University of Pennsylvania	Ulrich, CM (corresponding author), Univ Penn, Sch Nursing, Dept Med Eth & Hlth Policy, Philadelphia, PA 19106 USA.							Bradley I., 2009, CLIN CORRELATIO 0528; Camus A., 1991, PLAGUE; Hamric AB, 2007, CRIT CARE MED, V35, P422, DOI 10.1097/01.CCM.0000254722.50608.2D; Harrowing JN, 2010, INT J NURS STUD, V47, P723, DOI 10.1016/j.ijnurstu.2009.11.010; Jameton A., 1984, PRENTICE HALL, DOI [DOI 10.1097/NJH.000000000000010, 10.1002/chp.4760040110]; Malik K., 2014 HUM DEV REP SUS; Piers RD, 2011, JAMA-J AM MED ASSOC, V306, P2694, DOI 10.1001/jama.2011.1888; Ulrich C, 2007, SOC SCI MED, V65, P1708, DOI 10.1016/j.socscimed.2007.05.050; Ulrich CM, 2010, J ADV NURS, V66, P2510, DOI 10.1111/j.1365-2648.2010.05425.x; World Health Organization, 2014, EB RESP ROADM SIT RE	10	30	31	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2014	349								g6672	10.1136/bmj.g6672	http://dx.doi.org/10.1136/bmj.g6672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT0CF	25380700	Green Published, Bronze			2022-12-01	WOS:000344603900003
J	Green, AA; Silver, PA; Collins, JJ; Yin, P				Green, Alexander A.; Silver, Pamela A.; Collins, James J.; Yin, Peng			Toehold Switches: De-Novo-Designed Regulators of Gene Expression	CELL			English	Article							SYNTHETIC BIOLOGY APPLICATIONS; STRAND DISPLACEMENT CASCADES; ESCHERICHIA-COLI; LIVING CELLS; TRANSCRIPTIONAL REGULATORS; MESSENGER-RNAS; RIBOREGULATORS; COMPUTATION; LOGIC; DNA	Efforts to construct synthetic networks in living cells have been hindered by the limited number of regulatory components that provide wide dynamic range and low crosstalk. Here, we report a class of de-novo-designed prokaryotic riboregulators called toehold switches that activate gene expression in response to cognate RNAs with arbitrary sequences. Toehold switches provide a high level of orthogonality and can be forward engineered to provide average dynamic range above 400. We show that switches can be integrated into the genome to regulate endogenous genes and use them as sensors that respond to endogenous RNAs. We exploit the orthogonality of toehold switches to regulate 12 genes independently and to construct a genetic circuit that evaluates 4-input AND logic. Toehold switches, with their wide dynamic range, orthogonality, and programmability, represent a versatile and powerful platform for regulation of translation, offering diverse applications in molecular biology, synthetic biology, and biotechnology.	[Green, Alexander A.; Silver, Pamela A.; Collins, James J.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Silver, Pamela A.; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA	Harvard University; Harvard University; Harvard Medical School; Boston University; Howard Hughes Medical Institute; Boston University	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu	Green, Alexander A./X-7025-2019	Green, Alexander A./0000-0003-2058-1204	DARPA Living Foundries [HR001112C0061]; NIH Director's New Innovator Award [1DP2OD007292]; NIH Transformative Research Award [1R01EB018659]; Office of Naval Research (ONR) Young Investigator Program Award [N000141110914]; ONR [N000141010827, N000141310593, N000141410610]; National Science Foundation (NSF) Faculty Early Career Development Award [CCF1054898]; NSF Expedition in Computing Award [CCF1317291]; NSF [CCF1162459]; Wyss Institute funds; Defense Threat Reduction Agency [HDTRA1-14-1-0006]; ONR MURI [N000141110725]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	DARPA Living Foundries; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Transformative Research Award; Office of Naval Research (ONR) Young Investigator Program Award; ONR(Office of Naval Research); National Science Foundation (NSF) Faculty Early Career Development Award(National Science Foundation (NSF)); NSF Expedition in Computing Award; NSF(National Science Foundation (NSF)); Wyss Institute funds; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); ONR MURI(MURIOffice of Naval Research); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge J. Kim, C. Myhrvold, K. Pardee, and X. Chen for critical reading of the manuscript and helpful discussions and J.M.L. Ho for preliminary experiments, plasmid preparation, and helpful discussions. This work was supported by a DARPA Living Foundries grant (HR001112C0061) to P.A.S., P.Y., and J.J.C.; an NIH Director's New Innovator Award (1DP2OD007292); an NIH Transformative Research Award (1R01EB018659); an Office of Naval Research (ONR) Young Investigator Program Award (N000141110914); ONR grants (N000141010827, N000141310593, and N000141410610); a National Science Foundation (NSF) Faculty Early Career Development Award (CCF1054898); an NSF Expedition in Computing Award (CCF1317291); NSF grant (CCF1162459) and Wyss Institute funds to P.Y.; Defense Threat Reduction Agency grant HDTRA1-14-1-0006 to J.J.C.; ONR MURI grant N000141110725 to J.J.C. and P.A.S.; and the Howard Hughes Medical Institute (J.J.C.). A provisional patent based on this work has been filed.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gultyaev AP, 1997, J MOL BIOL, V273, P26, DOI 10.1006/jmbi.1997.1295; Gutell RR, 2000, J MOL BIOL, V300, P791, DOI 10.1006/jmbi.2000.3900; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Liu CC, 2012, NAT METHODS, V9, P1088, DOI [10.1038/NMETH.2184, 10.1038/nmeth.2184]; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi L, 2012, NUCLEIC ACIDS RES, V40, P5775, DOI 10.1093/nar/gks168; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rhodius VA, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.58; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Takahashi MK, 2013, NUCLEIC ACIDS RES, V41, P7577, DOI 10.1093/nar/gkt452; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	40	402	421	25	256	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					925	939		10.1016/j.cell.2014.10.002	http://dx.doi.org/10.1016/j.cell.2014.10.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417166	Bronze, Green Accepted			2022-12-01	WOS:000344522000022
J	Jutkowitz, E; Choi, HK; Pizzi, LT; Kuntz, KM				Jutkowitz, Eric; Choi, Hyon K.; Pizzi, Laura T.; Kuntz, Karen M.			Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM URATE; HYPERURICEMIA; HEALTH; CARE; RECOMMENDATIONS; RHEUMATOLOGY; POPULATION; FREQUENCY; EFFICACY; FLARES	Background: Gout is the most common inflammatory arthritis in the United States. Objective: To evaluate the cost-effectiveness of urate-lowering treatment strategies for the management of gout. Design: Markov model. Data Sources: Published literature and expert opinion. Target Population: Patients for whom allopurinol or febuxostat is a suitable initial urate-lowering treatment. Time Horizon: Lifetime. Perspective: Health care payer. Intervention: 5 urate-lowering treatment strategies were evaluated: no treatment; allopurinol-or febuxostat-only therapy; allopurinol-febuxostat sequential therapy; and febuxostat-allopurinol sequential therapy. Two dosing scenarios were investigated: fixed dose (80 mg of febuxostat daily, 0.80 success rate; 300 mg of allopurinol daily, 0.39 success rate) and dose escalation (<= 120 mg of febuxostat daily, 0.82 success rate; <= 800 mg of allopurinol daily, 0.78 success rate). Outcome Measures: Discounted costs, discounted quality-adjusted life-years, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: In both dosing scenarios, allopurinol-only therapy was cost-saving. Dose-escalation allopurinol-febuxostat sequential therapy was more costly but more effective than dose-escalation allopurinol therapy, with an incremental cost-effectiveness ratio of $39 400 per quality-adjusted life-year. Results of Sensitivity Analysis: The relative rankings of treatments did not change. Our results were relatively sensitive to several potential variations of model assumptions; however, the cost-effectiveness ratios of dose escalation with allopurinol-febuxostat sequential therapy remained lower than the willingness-to-pay threshold of $109 000 per quality-adjusted life-year. Limitation: Long-term outcome data for patients with gout, including medication adherence, are limited. Conclusion: Allopurinol single therapy is cost-saving compared with no treatment. Dose-escalation allopurinol-febuxostat sequential therapy is cost-effective compared with accepted willingness-to-pay thresholds.	Univ Minnesota, Minneapolis, MN 55455 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Jefferson Sch Pharm, Philadelphia, PA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Jutkowitz, E (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, MMC 729,420 Delaware St SE, Minneapolis, MN 55455 USA.	Jutko001@umn.edu			Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056291, R01AR065944, R21AR056042, P60AR047785] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Agency for Healthcare Research and Quality.	Sanchez JLA, 2007, ARCH SURG-CHICAGO, V142, P50, DOI 10.1001/archsurg.142.1.50; [Anonymous], 2010, 2010 RED BOOK PHARM; ARELLANO F, 1993, ANN PHARMACOTHER, V27, P337, DOI 10.1177/106002809302700317; Beard SM, 2014, EUR J HEALTH ECON, V15, P453, DOI 10.1007/s10198-013-0486-z; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Briggs A., 2006, DECISION MODELLING H; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Dong D, 2012, NEUROLOGY, V79, P1259, DOI 10.1212/WNL.0b013e31826aac73; FERRAZ MB, 1995, J RHEUMATOL, V22, P908; Gold MR., 1996, COST EFFECTIVENESS H; Hamburger M, 2011, PHYSICIAN SPORTSMED, V39, P98, DOI 10.3810/psm.2011.11.1946; Henry J. Kaiser Family Foundation, 2010, MED ENROLLMENT PERCE; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna PP, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-117; MCINNES GT, 1981, ANN RHEUM DIS, V40, P245, DOI 10.1136/ard.40.3.245; Meltzer Michele, 2012, Evid Based Med, V17, P105, DOI 10.1136/ebmed-2011-100065; Moreland LW, 2005, NEW ENGL J MED, V353, P2505, DOI 10.1056/NEJMe058247; National Institute for Health and Care Excellence, 2008, FEB MAN HYP PEOPL CO; Neogi T, 2006, J RHEUMATOL, V33, P104; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Reinders MK, 2010, CLIN INTERV AGING, V5, P7; Rothenbacher D, 2011, RHEUMATOLOGY, V50, P973, DOI 10.1093/rheumatology/keq363; RUNDLES RW, 1966, ANN INTERN MED, V64, P229, DOI 10.7326/0003-4819-64-2-229; Sarawate CA, 2006, MAYO CLIN PROC, V81, P925, DOI 10.4065/81.7.925; Sarawate CA, 2006, JCR-J CLIN RHEUMATOL, V12, P61, DOI 10.1097/01.rhu.0000209882.50228.9f; Schumacher HR, 2009, RHEUMATOLOGY, V48, P188, DOI 10.1093/rheumatology/ken457; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Sheils J., 2009, HARMONIZING OBAMA BA; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Stevenson M, 2011, PHARMACOECONOMICS, V29, P133, DOI 10.2165/11535770-000000000-00000; Wu EQ, 2008, J MANAGE CARE PHARM, V14, P164, DOI 10.18553/jmcp.2008.14.2.164; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	39	38	44	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2014	161	9					617	U112		10.7326/M14-0227	http://dx.doi.org/10.7326/M14-0227			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TE	25364883				2022-12-01	WOS:000347244100002
J	Hoffmann, KF; Brindley, PJ; Berriman, M				Hoffmann, Karl F.; Brindley, Paul J.; Berriman, Matthew			Halting harmful helminths	SCIENCE			English	Editorial Material							SCHISTOSOMA-MANSONI; DISEASE; BURDEN; CELLS; LINE		[Hoffmann, Karl F.] Aberystwyth Univ, IBERS, Aberystwyth SY23 3DA, Dyfed, Wales; [Brindley, Paul J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Brindley, Paul J.] George Washington Univ, Res Ctr Neglected Dis Poverty, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Berriman, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); George Washington University; George Washington University; Wellcome Trust Sanger Institute	Hoffmann, KF (corresponding author), Aberystwyth Univ, IBERS, Aberystwyth SY23 3DA, Dyfed, Wales.	krh@aber.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Brindley, Paul J./0000-0003-1765-0002; Hoffmann, Karl/0000-0002-3932-5502				Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Beckmann S, 2007, EXP PARASITOL, V117, P292, DOI 10.1016/j.exppara.2007.04.007; Bhardwaj R, 2011, METHODS MOL BIOL, V764, P223, DOI 10.1007/978-1-61779-188-8_15; Collins JJ, 2013, NATURE, V494, P476, DOI 10.1038/nature11924; Hahnel S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002336; Holtfreter M., 2014, EUROSURVEILLANCE, V19, P153; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Majoros G, 2008, EMERG INFECT DIS, V14, P1812, DOI 10.3201/eid1411.080479; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mann VH, 2014, TRANSGENIC RES, V23, P539, DOI 10.1007/s11248-013-9779-3; Albani CM, 2013, ACTA TROP, V128, P124, DOI 10.1016/j.actatropica.2013.07.001; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Ye Q, 2013, BIOTECHNOL ADV, V31, P1722, DOI 10.1016/j.biotechadv.2013.09.003	15	24	24	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					168	169		10.1126/science.1261139	http://dx.doi.org/10.1126/science.1261139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301604				2022-12-01	WOS:000342721500022
J	Dayer, MJ; Jones, S; Prendergast, B; Baddour, LM; Lockhart, PB; Thornhill, MH				Dayer, Mark J.; Jones, Simon; Prendergast, Bernard; Baddour, Larry M.; Lockhart, Peter B.; Thornhill, Martin H.			Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis	LANCET			English	Article							ANTIBIOTIC-PROPHYLAXIS; TEMPORAL TRENDS; NICE GUIDANCE; PREVENTION; IMPACT; GUIDELINES; RISK; BACTEREMIA; DIAGNOSIS; ADULTS	Background Antibiotic prophylaxis given before invasive dental procedures in patients at risk of developing infective endocarditis has historically been the focus of infective endocarditis prevention. Recent changes in antibiotic prophylaxis guidelines in the USA and Europe have substantially reduced the number of patients for whom antibiotic prophylaxis is recommended. In the UK, guidelines from the National Institute for Health and Clinical Excellence (NICE) recommended complete cessation of antibiotic prophylaxis for prevention of infective endocarditis in March, 2008. We aimed to investigate changes in the prescribing of antibiotic prophylaxis and the incidence of infective endocarditis since the introduction of these guidelines. Methods We did a retrospective secular trend study, analysed as an interrupted time series, to investigate the effect of antibiotic prophylaxis versus no prophylaxis on the incidence of infective endocarditis in England. We analysed data for the prescription of antibiotic prophylaxis from Jan 1, 2004, to March 31, 2013, and hospital discharge episode statistics for patients with a primary diagnosis of infective endocarditis from Jan 1, 2000, to March 31, 2013. We compared the incidence of infective endocarditis before and after the introduction of the NICE guidelines using segmented regression analysis of the interrupted time series. Findings Prescriptions of antibiotic prophylaxis for the prevention of infective endocarditis fell substantially after introduction of the NICE guidance (mean 10 900 prescriptions per month [Jan 1, 2004, to March 31, 2008] vs 2236 prescriptions per month [April 1, 2008, to March 31, 2013], p<0. 0001). Starting in March, 2008, the number of cases of infective endocarditis increased significantly above the projected historical trend, by 0.11 cases per 10 million people per month (95% CI 0.05-0.16, p<0.0001). By March, 2013, 35 more cases per month were reported than would have been expected had the previous trend continued. This increase in the incidence of infective endocarditis was significant for both individuals at high risk of infective endocarditis and those at lower risk. Interpretation Although our data do not establish a causal association, prescriptions of antibiotic prophylaxis have fallen substantially and the incidence of infective endocarditis has increased significantly in England since introduction of the 2008 NICE guidelines.	[Dayer, Mark J.] Taunton & Somerset NHS Trust, Dept Cardiol, Taunton, Somerset, England; [Jones, Simon] Univ Surrey, Integrated Care Res, Guildford GU2 5XH, Surrey, England; [Prendergast, Bernard] John Radcliffe Hosp, Cardiothorac Serv, Dept Cardiol, Oxford OX3 9DU, England; [Baddour, Larry M.] Mayo Clin, Div Infect Dis, Coll Med, Rochester, MN USA; [Lockhart, Peter B.; Thornhill, Martin H.] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA; [Thornhill, Martin H.] Univ Sheffield, Unit Oral & Maxillofacial Surg & Med, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England	University of Surrey; University of Oxford; Mayo Clinic; Carolinas Medical Center; University of Sheffield	Thornhill, MH (corresponding author), Univ Sheffield, Unit Oral & Maxillofacial Surg & Med, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England.	m.thornhill@sheffield.ac.uk	Dayer, Mark/AAE-4654-2020	Jones, Simon/0000-0002-8267-5647; Thornhill, Martin/0000-0003-0681-4083	Heart Research UK; Simplyhealth; US National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE023092] Funding Source: NIH RePORTER	Heart Research UK; Simplyhealth; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Heart Research UK, Simplyhealth, and US National Institutes of Health.	Aylin P, 2007, EUR J VASC ENDOVASC, V33, P461, DOI 10.1016/j.ejvs.2006.10.033; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bikdeli B, 2013, J AM COLL CARDIOL, V62, P2217, DOI 10.1016/j.jacc.2013.07.071; Chambers JB, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3531; Connaughton M, 2008, BRIT MED J, V336, P771, DOI 10.1136/bmj.39512.666412.AD; Dayer MJ, 2013, QJM-INT J MED, V106, P237, DOI 10.1093/qjmed/hcs235; DeSimone DC, 2012, CIRCULATION, V126, P60, DOI 10.1161/CIRCULATIONAHA.112.095281; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; FOX J, 2002, TIME SERIES REGRESSI; Gilg J, 2013, NEPHRON CLIN PRACT, V123, P1, DOI 10.1159/000353320; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Health & Social Care Information Centre, 2014, DIAB PREV; HINKLEY DV, 1970, BIOMETRIKA, V57, P1; HSCIC, 2014, NHS DENT STAT ENGL; HSCIC, HOSP EP STAT; HSCIC, 2014, METH CREAT CIP SPELL; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lockhart PB, 2004, CIRCULATION, V109, P2878, DOI 10.1161/01.CIR.0000129303.90488.29; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lockhart PB, 2007, J AM DENT ASSOC, V138, P458, DOI 10.14219/jada.archive.2007.0198; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; NICE, 2008, PROPH INF END; Office for National Statistics, 2012, CHANG OLD RES CAR HO; Pallasch Thomas J, 2003, Dent Clin North Am, V47, P665, DOI 10.1016/S0011-8532(03)00037-5; Pasquali SK, 2012, AM HEART J, V163, P894, DOI 10.1016/j.ahj.2012.03.002; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; R Core Development Team, 2008, R LANG ENV STAT COMP; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Rogers AM, 2008, J AM SOC ECHOCARDIOG, V21, P775, DOI 10.1016/j.echo.2008.04.001; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	38	330	344	6	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1219	1228		10.1016/S0140-6736(14)62007-9	http://dx.doi.org/10.1016/S0140-6736(14)62007-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25467569	Green Submitted, Green Accepted			2022-12-01	WOS:000351715100035
J	Xue, SF; Tian, SQ; Fujii, K; Kladwang, W; Das, R; Barna, M				Xue, Shifeng; Tian, Siqi; Fujii, Kotaro; Kladwang, Wipapat; Das, Rhiju; Barna, Maria			RNA regulons in Hox 5 ' UTRs confer ribosome specificity to gene regulation	NATURE			English	Article							LINKED DYSKERATOSIS-CONGENITA; CAP-DEPENDENT TRANSLATION; SECONDARY STRUCTURE; MESSENGER-RNAS; ENTRY SITE; CAPILLARY-ELECTROPHORESIS; SPECIALIZED RIBOSOMES; MEDIATED TRANSLATION; ROBUST ANALYSIS; AXIAL SKELETON	Emerging evidence suggests that the ribosome has a regulatory function in directing how the genome is translated in time and space. However, how this regulation is encoded in the messenger RNA sequence remains largely unknown. Here we uncover unique RNA regulons embedded in homeobox (Hox) 5' untranslated regions (UTRs) that confer ribosome-mediated control of gene expression. These structured RNA elements, resembling viral internal ribosome entry sites (IRESs), are found in subsets of Hox mRNAs. They facilitate ribosome recruitment and require the ribosomal protein RPL38 for their activity. Despite numerous layers of Hox gene regulation, these IRES elements are essential for converting Hox transcripts into proteins to pattern the mammalian body plan. This specialized mode of IRES-dependent translation is enabled by an additional regulatory element that we term the translation inhibitory element (TIE), which blocks cap-dependent translation of transcripts. Together, these data uncover a new paradigm for ribosome-mediated control of gene expression and organismal development.	[Xue, Shifeng; Fujii, Kotaro; Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Xue, Shifeng; Fujii, Kotaro; Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Xue, Shifeng] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Tian, Siqi; Kladwang, Wipapat; Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University	Barna, M (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	mbarna@stanford.edu		Das, Rhiju/0000-0001-7497-0972; Fujii, Kotaro/0000-0002-6028-4776; Xue, Shifeng/0000-0002-4668-5952	Agency of Science, Technology and Research of Singapore; Stanford Graduate Fellowship; Human Frontier Science Program Fellowship [NIH R01 GM102519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102519] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER	Agency of Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Stanford Graduate Fellowship(Stanford University); Human Frontier Science Program Fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank members of the Barna laboratory and D. Ruggero for discussion and critical reading of the manuscript. We thank E. Sarinay Cenik for advice with RNA pull- down experiments; and Y. Rim, A. Sapiro and A. Mateo for technical assistance. This work was supported by the Agency of Science, Technology and Research of Singapore (S. X.), Stanford Graduate Fellowship (S. T.), Human Frontier Science Program Fellowship (K. F.), NIH R01 GM102519 (R. D.), NIH Director's New InnovatorAward, 7DP2OD00850902(M. B.), Alfred P. SloanResearch Fellowship(M. B.) and Pew Scholars Award (M. B.).	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Boulet AM, 1996, DEV BIOL, V177, P232, DOI 10.1006/dbio.1996.0159; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Coulombe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010600; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dinman JD, 2009, J BIOL CHEM, V284, P11761, DOI 10.1074/jbc.R800074200; FLETCHER L, 1990, J BIOL CHEM, V265, P19582; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Harris D. A., 2003, CURR PROTOC NUCL ACI; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Johnston IA, 2006, J EXP BIOL, V209, P2249, DOI 10.1242/jeb.02153; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim H, 2013, NUCLEIC ACIDS RES, V41, pW492, DOI 10.1093/nar/gkt501; Kim J, 2009, BIOINFORMATICS, V25, P1137, DOI 10.1093/bioinformatics/btp110; Kladwang W., 2014, PREPRINT; Kladwang W, 2014, BIOCHEMISTRY-US, V53, P3063, DOI 10.1021/bi5003426; Kladwang W, 2011, NAT CHEM, V3, P954, DOI [10.1038/nchem.1176, 10.1038/NCHEM.1176]; Kladwang W, 2011, RNA, V17, P522, DOI 10.1261/rna.2516311; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Lukavsky PJ, 2003, NAT STRUCT BIOL, V10, P1033, DOI 10.1038/nsb1004; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Riley A, 2010, NUCLEIC ACIDS RES, V38, P4665, DOI 10.1093/nar/gkq241; Seetin MG, 2014, METHODS MOL BIOL, V1086, P95, DOI 10.1007/978-1-62703-667-2_6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Stupina VA, 2011, J VIROL, V85, P4638, DOI 10.1128/JVI.00005-11; Talkish J, 2014, RNA, V20, P713, DOI 10.1261/rna.042218.113; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Tian SQ, 2014, RNA, V20, P1815, DOI 10.1261/rna.044321.114; Ungureanu NH, 2006, J BIOL CHEM, V281, P15155, DOI 10.1074/jbc.M511319200; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004136; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277	59	190	192	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					33	U55		10.1038/nature14010	http://dx.doi.org/10.1038/nature14010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25409156	Green Accepted			2022-12-01	WOS:000347178400029
J	Gould, J				Gould, Julie			Genie in a vector	NATURE			English	Editorial Material							HEMOPHILIA; HEMOSTASIS											Du LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3773; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707	4	5	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S160	S161		10.1038/515S160a	http://dx.doi.org/10.1038/515S160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427205				2022-12-01	WOS:000346247600007
J	Maganga, GD; Kapetshi, J; Berthet, N; Ilunga, BK; Kabange, F; Kingebeni, PM; Mondonge, V; Muyembe, JJT; Bertherat, E; Briand, S; Cabore, J; Epelboin, A; Formenty, P; Kobinger, G; Gonzalez-Angulo, L; Labouba, I; Manuguerra, JC; Okwo-Bele, JM; Dye, C; Leroy, EM				Maganga, Gael D.; Kapetshi, Jimmy; Berthet, Nicolas; Ilunga, Benoit Kebela; Kabange, Felix; Kingebeni, Placide Mbala; Mondonge, Vital; Muyembe, Jean-Jacques T.; Bertherat, Eric; Briand, Sylvie; Cabore, Joseph; Epelboin, Alain; Formenty, Pierre; Kobinger, Gary; Gonzalez-Angulo, Lice; Labouba, Ingrid; Manuguerra, Jean-Claude; Okwo-Bele, Jean-Marie; Dye, Christopher; Leroy, Eric M.			Ebola Virus Disease in the Democratic Republic of Congo	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND The seventh reported outbreak of Ebola virus disease (EVD) in the equatorial African country of the Democratic Republic of Congo (DRC) began on July 26, 2014, as another large EVD epidemic continued to spread in West Africa. Simultaneous reports of EVD in equatorial and West Africa raised the question of whether the two outbreaks were linked. METHODS We obtained data from patients in the DRC, using the standard World Health Organization clinical-investigation form for viral hemorrhagic fevers. Patients were classified as having suspected, probable, or confirmed EVD or a non-EVD illness. Blood samples were obtained for polymerase-chain-reaction-based diagnosis, viral isolation, sequencing, and phylogenetic analysis. RESULTS The outbreak began in Inkanamongo village in the vicinity of Boende town in Equateur province and has been confined to that province. A total of 69 suspected, probable, or confirmed cases were reported between July 26 and October 7, 2014, including 8 cases among health care workers, with 49 deaths. As of October 7, there have been approximately six generations of cases of EVD since the outbreak began. The reported weekly case incidence peaked in the weeks of August 17 and 24 and has since fallen sharply. Genome sequencing revealed Ebola virus (EBOV, Zaire species) as the cause of this outbreak. A coding-complete genome sequence of EBOV that was isolated during this outbreak showed 99.2% identity with the most closely related variant from the 1995 outbreak in Kikwit in the DRC and 96.8% identity to EBOV variants that are currently circulating in West Africa. CONCLUSIONS The current EVD outbreak in the DRC has clinical and epidemiologic characteristics that are similar to those of previous EVD outbreaks in equatorial Africa. The causal agent is a local EBOV variant, and this outbreak has a zoonotic origin different from that in the 2014 epidemic in West Africa.	[Maganga, Gael D.; Berthet, Nicolas; Labouba, Ingrid; Leroy, Eric M.] World Hlth Org WHO Collaborating Ctr, Ctr Int Rech Med Franceville, Franceville, Gabon; [Ilunga, Benoit Kebela; Kabange, Felix] Minist Hlth, Kinshasa, DEM REP CONGO; [Kapetshi, Jimmy; Kingebeni, Placide Mbala; Muyembe, Jean-Jacques T.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mondonge, Vital; Cabore, Joseph] WHO, Kinshasa, DEM REP CONGO; [Berthet, Nicolas] CNRS, Unite Epidemiol & Physiopathol Virus Oncogenes, UMR3569, Paris, France; [Epelboin, Alain] CNRS, MNHN, UMR 7206, Paris, France; [Manuguerra, Jean-Claude] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infect, Paris, France; [Leroy, Eric M.] CNRS 5290, Inst Rech Dev, Unite Malad Infect & Vectuers Ecol Genet Evolut &, IRD 224,UM1,UM2, Montpellier, France; [Kobinger, Gary] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Bertherat, Eric; Briand, Sylvie; Formenty, Pierre; Gonzalez-Angulo, Lice; Okwo-Bele, Jean-Marie; Dye, Christopher] WHO, CH-1211 Geneva, Switzerland	World Health Organization; Institute Nacional de Recherche Biomedical; World Health Organization; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Public Health Agency of Canada; World Health Organization	Dye, C (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	dyec@who.int	CABORE, Joseph Waogodo/AAV-5998-2021; GONZÁLEZ-ANGULO, Lice/HDO-5359-2022; LEROY, Eric M/I-4347-2016; Dye, Christopher/AIC-4659-2022; Berthet, Nicolas/J-9373-2012	GONZÁLEZ-ANGULO, Lice/0000-0002-6934-0586; LEROY, Eric M/0000-0003-0022-0890; CABORE, Joseph Waogodo/0000-0003-4602-6110; Dye, Christopher/0000-0002-2957-1793	Centre International de Recherches Medicales de Franceville	Centre International de Recherches Medicales de Franceville	Funded by the Centre International de Recherches Medicales de Franceville and others.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Epelboin A., 2008, HUMANITARIAN STAKES, V1, P25; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212	10	155	162	0	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2083	2091		10.1056/NEJMoa1411099	http://dx.doi.org/10.1056/NEJMoa1411099			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25317743	Bronze, Green Published			2022-12-01	WOS:000345580000007
J	Stitziel, NO; Won, HH; Morrison, AC; Peloso, GM; Do, R; Lange, LA; Fontanillas, P; Gupta, N; Duga, S; Goel, A; Farrall, M; Saleheen, D; Ferrario, P; Konig, I; Asselta, R; Merlini, PA; Marziliano, N; Notarangelo, MF; Schick, U; Auer, P; Assimes, TL; Reilly, M; Wilensky, R; Rader, DJ; Hovingh, GK; Meitinger, T; Kessler, T; Kastrati, A; Laugwitz, KL; Siscovick, D; Rotter, JI; Hazen, SL; Tracy, R; Cresci, S; Spertus, J; Jackson, R; Schwartz, SM; Natarajan, P; Crosby, J; Muzny, D; Ballantyne, C; Rich, SS; O'Donnell, CJ; Abecasis, G; Sunyaev, S; Nickerson, DA; Buring, JE; Ridker, PM; Chasman, DI; Austin, E; Ye, Z; Kullo, IJ; Weeke, PE; Shaffer, CM; Bastarache, LA; Denny, JC; Roden, DM; Palmer, C; Deloukas, P; Lin, DY; Tang, ZZ; Erdmann, J; Schunkert, H; Danesh, J; Marrugat, J; Elosua, R; Ardissino, D; McPherson, R; Watkins, H; Reiner, AP; Wilson, JG; Altshuler, D; Gibbs, RA; Lander, ES; Boerwinkle, E; Gabriel, S; Kathiresan, S				Stitziel, Nathan O.; Won, Hong-Hee; Morrison, Alanna C.; Peloso, Gina M.; Do, Ron; Lange, Leslie A.; Fontanillas, Pierre; Gupta, Namrata; Duga, Stefano; Goel, Anuj; Farrall, Martin; Saleheen, Danish; Ferrario, Paola; Koenig, Inke; Asselta, Rosanna; Merlini, Piera A.; Marziliano, Nicola; Notarangelo, Maria Francesca; Schick, Ursula; Auer, Paul; Assimes, Themistocles L.; Reilly, Muredach; Wilensky, Robert; Rader, Daniel J.; Hovingh, G. Kees; Meitinger, Thomas; Kessler, Thorsten; Kastrati, Adnan; Laugwitz, Karl-Ludwig; Siscovick, David; Rotter, Jerome I.; Hazen, Stanley L.; Tracy, Russell; Cresci, Sharon; Spertus, John; Jackson, Rebecca; Schwartz, Stephen M.; Natarajan, Pradeep; Crosby, Jacy; Muzny, Donna; Ballantyne, Christie; Rich, Stephen S.; O'Donnell, Christopher J.; Abecasis, Goncalo; Sunyaev, Shamil; Nickerson, Deborah A.; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.; Austin, Erin; Ye, Zi; Kullo, Iftikhar J.; Weeke, Peter E.; Shaffer, Christian M.; Bastarache, Lisa A.; Denny, Joshua C.; Roden, Dan M.; Palmer, Colin; Deloukas, Panos; Lin, Dan-Yu; Tang, Zheng-zheng; Erdmann, Jeanette; Schunkert, Heribert; Danesh, John; Marrugat, Jaume; Elosua, Roberto; Ardissino, Diego; McPherson, Ruth; Watkins, Hugh; Reiner, Alex P.; Wilson, James G.; Altshuler, David; Gibbs, Richard A.; Lander, Eric S.; Boerwinkle, Eric; Gabriel, Stacey; Kathiresan, Sekar			Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENETIC-VARIANTS; CHOLESTEROL; EZETIMIBE; RISK; LDL; SIMVASTATIN; ABSORPTION; RATIONALE; EFFICACY; DESIGN	BACKGROUND Ezetimibe lowers plasma levels of low-density lipoprotein (LDL) cholesterol by inhibiting the activity of the Niemann-Pick C1-like 1 (NPC1L1) protein. However, whether such inhibition reduces the risk of coronary heart disease is not known. Human mutations that inactivate a gene encoding a drug target can mimic the action of an inhibitory drug and thus can be used to infer potential effects of that drug. METHODS We sequenced the exons of NPC1L1 in 7364 patients with coronary heart disease and in 14,728 controls without such disease who were of European, African, or South Asian ancestry. We identified carriers of inactivating mutations (nonsense, splice-site, or frameshift mutations). In addition, we genotyped a specific inactivating mutation (p.Arg406X) in 22,590 patients with coronary heart disease and in 68,412 controls. We tested the association between the presence of an inactivating mutation and both plasma lipid levels and the risk of coronary heart disease. RESULTS With sequencing, we identified 15 distinct NPC1L1 inactivating mutations; approximately 1 in every 650 persons was a heterozygous carrier for 1 of these mutations. Heterozygous carriers of NPC1L1 inactivating mutations had a mean LDL cholesterol level that was 12 mg per deciliter (0.31 mmol per liter) lower than that in noncarriers (P = 0.04). Carrier status was associated with a relative reduction of 53% in the risk of coronary heart disease (odds ratio for carriers, 0.47; 95% confidence interval, 0.25 to 0.87; P = 0.008). In total, only 11 of 29,954 patients with coronary heart disease had an inactivating mutation (carrier frequency, 0.04%) in contrast to 71 of 83,140 controls (carrier frequency, 0.09%). CONCLUSIONS Naturally occurring mutations that disrupt NPC1L1 function were found to be associated with reduced plasma LDL cholesterol levels and a reduced risk of coronary heart disease.	[Stitziel, Nathan O.; Cresci, Sharon] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63130 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63130 USA; [Cresci, Sharon] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Natarajan, Pradeep; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Natarajan, Pradeep; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [O'Donnell, Christopher J.; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Natarajan, Pradeep; O'Donnell, Christopher J.; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Sunyaev, Shamil] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Won, Hong-Hee; Peloso, Gina M.; Do, Ron; Fontanillas, Pierre; Gupta, Namrata; Natarajan, Pradeep; Sunyaev, Shamil; Altshuler, David; Lander, Eric S.; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Morrison, Alanna C.; Crosby, Jacy; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Muzny, Donna; Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ballantyne, Christie] Baylor Coll Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Duga, Stefano; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Merlini, Piera A.; Marziliano, Nicola; Notarangelo, Maria Francesca; Ardissino, Diego] Azienda Osped Univ Parma, Parma, Italy; [Merlini, Piera A.; Ardissino, Diego] Assoc Studio Trombosi Cardiol, Pavia, Italy; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Danesh, John] Univ Cambridge, Cambridge, England; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Palmer, Colin] Univ Dundee, Med Res Inst, Dundee, Scotland; [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Reilly, Muredach; Wilensky, Robert] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Ferrario, Paola; Koenig, Inke] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Buring, Julie E.] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23538 Lubeck, Germany; [Buring, Julie E.] DZHK German Res Ctr Cardiovasc Res Partner Site H, Lubeck, Germany; [Meitinger, Thomas] Helmholtz Zentrum, Inst Humangenet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, D-80290 Munich, Germany; [Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-80290 Munich, Germany; [Kessler, Thorsten; Kastrati, Adnan; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Meitinger, Thomas; Kastrati, Adnan; Laugwitz, Karl-Ludwig; Schunkert, Heribert] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Schick, Ursula; Schwartz, Stephen M.; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98195 USA; [Schwartz, Stephen M.; Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Auer, Paul] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Assimes, Themistocles L.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Assimes, Themistocles L.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Jackson, Rebecca] Ohio State Univ, Dept Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Spertus, John] Univ Missouri Kansas City, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Austin, Erin; Ye, Zi; Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Weeke, Peter E.; Shaffer, Christian M.; Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Bastarache, Lisa A.; Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Tang, Zheng-zheng] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Weeke, Peter E.] Rigshosp, Copenhagen Univ Hosp, Mol Cardiol Lab, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Marrugat, Jaume; Elosua, Roberto] Inst Hosp Mar Invest Med IMIM, Grp Epidemiol & Genet Cardiovasc, Barcelona, Spain; [McPherson, Ruth] Univ Ottawa Heart Inst, Div Cardiol, Ottawa, ON, Canada; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Milan; University of Parma; University Hospital of Parma; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Wellcome Trust Sanger Institute; University of Dundee; University of London; Queen Mary University London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Lubeck; University of Lubeck; German Centre for Cardiovascular Research; Helmholtz Association; Technical University of Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Amsterdam; Academic Medical Center Amsterdam; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; University of Vermont; University of Vermont; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Virginia; University of Michigan System; University of Michigan; Mayo Clinic; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Rigshospitalet; University of Copenhagen; King Abdulaziz University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Ottawa; University of Ottawa Heart Institute; University of Mississippi; University of Mississippi Medical Center	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Erdmann, Jeanette/A-4417-2009; Won, Hong-Hee/D-2672-2011; Ferrario, Paola G./AAR-8775-2020; Meitinger, Thomas/O-1318-2015; Spertus, John/ABD-3075-2021; Altshuler, David M/A-4476-2009; Ardissino, Diego/AAC-4041-2022; Ballantyne, Christie/A-6599-2008; Zi, Ye/GWM-3932-2022; Hazen, Stanley L/ABD-5845-2021; Erdmann, Jeanette/P-7513-2014; Asselta, Rosanna/AAC-2367-2019; Denny, Josh/AAL-3359-2021; Study, GoDARTS/K-9448-2016; Natarajan, Pradeep/H-9764-2019; Nicola, Marziliano/ABF-9518-2021; Roden, Dan/ABD-5412-2021; Auer, Paul/AAC-5060-2019; Duga, Stefano/F-8173-2014; , Kastrati/Y-2389-2019; Assimes, Themistocles Leonard/D-9696-2015; Deloukas, Panos/B-2922-2013; König, Inke R/A-4544-2009; Stitziel, Nathan/AAL-8413-2021; Rotter, Jerome/AAY-6598-2021; Palmer, Colin NA/C-7053-2008; Kessler, Thorsten/AAI-7292-2021; Kessler, Thorsten/O-7426-2015	Won, Hong-Hee/0000-0001-5719-0552; Ferrario, Paola G./0000-0003-1769-6799; Altshuler, David M/0000-0002-7250-4107; Erdmann, Jeanette/0000-0002-4486-6231; Asselta, Rosanna/0000-0001-5351-0619; Denny, Josh/0000-0002-3049-7332; Natarajan, Pradeep/0000-0001-8402-7435; Duga, Stefano/0000-0003-3457-1410; Assimes, Themistocles Leonard/0000-0003-2349-0009; Deloukas, Panos/0000-0001-9251-070X; König, Inke R/0000-0003-0504-6465; Stitziel, Nathan/0000-0002-4963-8211; Palmer, Colin NA/0000-0002-6415-6560; Kessler, Thorsten/0000-0003-3326-1621; ELOSUA, ROBERTO/0000-0001-8235-0095; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Goel, Anuj/0000-0003-2307-4021; Reilly, Muredach/0000-0002-3035-9386; Rich, Stephen/0000-0003-3872-7793; solinas, emilia/0000-0003-3532-1317; Morrison, Alanna/0000-0001-6381-4296; Watkins, Hugh/0000-0002-5287-9016; Meitinger, Thomas/0000-0002-8838-8403; Ballantyne, Christie/0000-0002-6432-1730; Marrugat, Jaume/0000-0003-3320-554X	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002, K08HL114642, T32HL007208, ZIAHL006175, R01HL107816, RC2HL102925, ZIAHL006173, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the National Institutes of Health and others.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2014, CELL METAB, V20, P387, DOI 10.1016/j.cmet.2014.08.007; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Do R, NATURE IN PRESS; Doney ASF, 2004, ARTERIOSCL THROM VAS, V24, P2403, DOI 10.1161/01.ATV.0000147897.57527.e4; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Ezzet F, 2001, J CLIN PHARMACOL, V41, P943, DOI 10.1177/00912700122010915; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Hegele Robert A, 2005, Lipids Health Dis, V4, P16, DOI 10.1186/1476-511X-4-16; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krumholz HM, 2010, CIRC-CARDIOVASC QUAL, V3, P565, DOI 10.1161/CIRCOUTCOMES.110.959577; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; Senti M, 2001, ARTERIOSCL THROM VAS, V21, P415, DOI 10.1161/01.ATV.21.3.415; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Taylor HA, 2005, ETHNIC DIS, V15, pS1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang J, 2005, CLIN GENET, V67, P175, DOI 10.1111/j.1399-0004.2004.00388.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Ye Zi, 2013, Glob Cardiol Sci Pract, V2013, P82, DOI 10.5339/gcsp.2013.10; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	38	293	298	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2072	2082		10.1056/NEJMoa1405386	http://dx.doi.org/10.1056/NEJMoa1405386			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25390462	Green Published, Green Submitted, Green Accepted			2022-12-01	WOS:000345580000006
J	Fang, B; Everett, LJ; Jager, J; Briggs, E; Armour, SM; Feng, D; Roy, A; Gerhart-Hines, Z; Sun, Z; Lazar, MA				Fang, Bin; Everett, Logan J.; Jager, Jennifer; Briggs, Erika; Armour, Sean M.; Feng, Dan; Roy, Ankur; Gerhart-Hines, Zachary; Sun, Zheng; Lazar, Mitchell A.			Circadian Enhancers Coordinate Multiple Phases of Rhythmic Gene Transcription In Vivo	CELL			English	Article							REV-ERB-ALPHA; NUCLEAR RECEPTORS; CLOCK; BINDING; EXPRESSION; MOUSE; LIVER; DBP; METABOLISM; ACTIVATION	Mammalian transcriptomes display complex circadian rhythms with multiple phases of gene expression that cannot be accounted for by current models of the molecular clock. We have determined the underlying mechanisms by measuring nascent RNA transcription around the clock in mouse liver. Unbiased examination of enhancer RNAs (eRNAs) that cluster in specific circadian phases identified functional enhancers driven by distinct transcription factors (TFs). We further identify on a global scale the components of the TF cistromes that function to orchestrate circadian gene expression. Integrated genomic analyses also revealed mechanisms by which a single circadian factor controls opposing transcriptional phases. These findings shed light on the diversity and specificity of TF function in the generation of multiple phases of circadian gene transcription in a mammalian organ.	[Fang, Bin; Everett, Logan J.; Jager, Jennifer; Briggs, Erika; Armour, Sean M.; Feng, Dan; Roy, Ankur; Gerhart-Hines, Zachary; Sun, Zheng; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Dept Genet, Philadelphia, PA 19104 USA; [Fang, Bin; Everett, Logan J.; Jager, Jennifer; Briggs, Erika; Armour, Sean M.; Feng, Dan; Roy, Ankur; Gerhart-Hines, Zachary; Sun, Zheng; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Everett, Logan/AAK-1523-2021; Lazar, Mitchell A/AAF-3738-2019	Jager, Jennifer/0000-0003-3740-9742; Feng, Dan/0000-0001-5926-8894	NIH [R01 DK45586, F32 DK095526, K99 DK099443, F32 DK095563]; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, F32DK095563, K99DK099443, R00DK099443, F32DK095526, P30DK019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Functional Genomics Core (J. Schug and K. Kaestner) and Viral Vector Core (J. Johnston and A. Sandhu) of the Penn Diabetes Research Center (P30 DK19525) for next-generation sequencing and AAV production, respectively. We also thank the Penn Microarray Core for microarray analysis. We thank Dr. Ken Zaret for critical reading of the manuscript. This work was supported by NIH grants R01 DK45586 (M. A. L.), F32 DK095526 (L. J. E.), K99 DK099443 (Z.S.), and F32 DK095563 (Z.G.H.), and the JPB Foundation.	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Anafi RC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001840; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Ciarleglio CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097412; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gilardi F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004155; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li SB, 2001, GENE, V263, P239, DOI 10.1016/S0378-1119(00)00565-5; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peek CB, 2012, TRENDS ENDOCRIN MET, V23, P312, DOI 10.1016/j.tem.2012.02.003; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2001, CURR OPIN CELL BIOL, V13, P357, DOI 10.1016/S0955-0674(00)00220-9; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhao X, 2014, EMBO REP, V15, P518, DOI 10.1002/embr.201338271	49	148	153	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1140	1152		10.1016/j.cell.2014.10.022	http://dx.doi.org/10.1016/j.cell.2014.10.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416951	Bronze, Green Accepted			2022-12-01	WOS:000345506300024
J	Schmale, J; Shindell, D; von Schneidemesser, E; Chabay, I; Lawrence, M				Schmale, Julia; Shindell, Drew; von Schneidemesser, Erika; Chabay, Ilan; Lawrence, Mark			Clean up our skies	NATURE			English	Editorial Material							CLIMATE-CHANGE; AIR		[Schmale, Julia; von Schneidemesser, Erika; Chabay, Ilan; Lawrence, Mark] Inst Adv Sustainabil Studies, Potsdam, Germany; [Shindell, Drew] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Schmale, J (corresponding author), Paul Scherrer Inst, Zurich, Switzerland.	julia.schmale@gmail.com	von Schneidemesser, Erika/AAL-8777-2021; Schmale, Julia/Q-3942-2019; Schmale, Julia/F-8851-2016; Shindell, Drew/D-4636-2012	Schmale, Julia/0000-0002-1048-7962; Schmale, Julia/0000-0002-1048-7962; Shindell, Drew/0000-0003-1552-4715; Chabay, Ilan/0000-0002-9776-8803; Lawrence, Mark/0000-0002-2178-4903; von Schneidemesser, Erika/0000-0003-1386-285X				Bowerman NHA, 2013, NAT CLIM CHANGE, V3, P1021, DOI [10.1038/nclimate2034, 10.1038/NCLIMATE2034]; Harlan SL, 2011, CURR OPIN ENV SUST, V3, P126, DOI 10.1016/j.cosust.2011.01.001; Hu AX, 2013, NAT CLIM CHANGE, V3, P730, DOI [10.1038/NCLIMATE1869, 10.1038/nclimate1869]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Pierrehumbert RT, 2014, ANNU REV EARTH PL SC, V42, P341, DOI 10.1146/annurev-earth-060313-054843; Schmale J, 2014, ATMOS ENVIRON, V90, P146, DOI 10.1016/j.atmosenv.2014.03.016; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; U. S. Environmental Protection Agency, 2012, RED BLACK CARB EM S; UNEP, 2011, INT ASS BLACK CARB T; Williams M, 2012, CARBON MANAG, V3, P511, DOI 10.4155/CMT.12.49	10	85	85	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					335	337		10.1038/515335a	http://dx.doi.org/10.1038/515335a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7HE	25409811	Bronze, Green Published			2022-12-01	WOS:000345770600019
J	Lee, TC; Frenette, C; Jayaraman, D; Green, L; Pilote, L				Lee, Todd C.; Frenette, Charles; Jayaraman, Dev; Green, Laurence; Pilote, Louise			Antibiotic Self-stewardship: Trainee-Led Structured Antibiotic Time-outs to Improve Antimicrobial Use	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; GUIDELINES; KNOWLEDGE; AMERICA	Background: Antibiotic use is an important quality improvement target. Nearly 50% of antibiotic use is unnecessary or inappropriate. To combat overuse, the Centers for Disease Control and Prevention (CDC) proposed "time-outs" to reevaluate antibiotics. Objective: To optimize antibiotic use through trainee-led time-outs. Design: Before-after study. Setting: Internal medicine (2 units, 46 beds) at a university hospital. Patients: Inpatients (n = 679). Intervention: From January 2012 until June 2013, while receiving monthly education on antimicrobial stewardship, resident physicians adjusted patients' antibiotic therapy through twice-weekly time-out audits using a structured electronic checklist. Measurements: Antibiotic costs were standardized and compared in the year before and after the audits. Use was measured as World Health Organization defined daily doses (DDDs) per 1000 patient-days. Total antibiotic use and the use of moxifloxacin, carbapenems, antipseudomonal penicillins, and vancomycin were compared by using interrupted time series. Rates of nosocomial Clostridium difficile infection were compared by using incidence rate ratios. Results: Total costs in the units decreased from $149 743CAD (January 2011 to January 2012) to $80 319 (January 2012 to January 2013), for a savings of $69 424 (46% reduction). Of the savings, $54 150 (78%) was related to carbapenems and $15 274 (22%) was due to other antibiotic classes. Adherence with the auditing process was 80%. In the time-series analyses, the only reliable and statistically significant change was a reduction in the rate of moxifloxicin use, by -1.9 DDDs per 1000 patient-days per month (95% CI, -3.8 to -0.02; P = 0.048). Rates of C. difficile infection decreased from 24.2 to 19.6 per 10 000 patient-days (incidence rate ratio, 0.8 [CI, 0.5 to 1.3]). Limitation: Other temporal factors may confound the findings. Conclusions: An antibiotic self-stewardship bundle to implement the CDC's suggested time-outs seems to have reduced overall costs and targeted antibiotic use.	McGill Univ, Ctr Hlth, Montreal, PQ, Canada; McGill Univ, McGill Ctr Qual Improvement, Montreal, PQ, Canada	McGill University; McGill University	Lee, TC (corresponding author), Royal Victoria Hosp, Div Internal Med, 687 Pine Ave West,Room A4-21, Montreal, PQ H3A 1A1, Canada.	todd.lee@mcgill.ca		Lee, Todd/0000-0002-2267-4239; Pilote, Louise/0000-0002-6159-0628	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This article is part of the Annals supplement "RWJF Clinical Scholars in Pursuit of the Value Proposition: Evaluations of Low-Cost Innovations for Prevention and Management of Conditions." The Robert Wood Johnson Foundation provided funding for publication of this supplement, which is only available online at www.annals.org. Carol M. Mangione, MD, MPH (co-director of the RWJF Clinical Scholars Program at the University of California, Los Angeles); Jaya K. Rao, MD, MHS (Annals Deputy Editor); and Christine Laine, MD, MPH (Annals Editor in Chief), served as editors for this supplement.	Abbo LM, 2013, CLIN INFECT DIS, V57, P631, DOI 10.1093/cid/cit370; Centers for Disease Control and Prevention, COR EL HOSP ANT STEW; Centers for Disease Control and Prevention (CDC), 2012, GET SMART HEALTHC; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Drew RH, 2009, PHARMACOTHERAPY, V29, P593, DOI 10.1592/phco.29.5.593; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Johannsson B, 2011, INFECT CONT HOSP EP, V32, P367, DOI 10.1086/658946; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Srinivasan A, 2004, ARCH INTERN MED, V164, P1451, DOI 10.1001/archinte.164.13.1451; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weiss CH, 2013, CRIT CARE MED, V41, P2563, DOI 10.1097/CCM.0b013e318298291a; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	15	60	61	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S53	S58		10.7326/M13-3016	http://dx.doi.org/10.7326/M13-3016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3RR	25402404				2022-12-01	WOS:000364909900008
J	Kumar, ME; Bogard, PE; Espinoza, FH; Menke, DB; Kingsley, DM; Krasnow, MA				Kumar, Maya E.; Bogard, Patrick E.; Espinoza, F. Hernan; Menke, Douglas B.; Kingsley, David M.; Krasnow, Mark A.			Defining a mesenchymal progenitor niche at single-cell resolution	SCIENCE			English	Article							SMOOTH-MUSCLE; STEM-CELLS; INTESTINAL CRYPT; LUNG DEVELOPMENT; SELF-RENEWAL; POPULATIONS; HOMEOSTASIS; CONTRIBUTE; PROGRAM; GENE	Most vertebrate organs are composed of epithelium surrounded by support and stromal tissues formed from mesenchyme cells, which are not generally thought to form organized progenitor pools. Here, we use clonal cell labeling with multicolor reporters to characterize individual mesenchymal progenitors in the developing mouse lung. We observe a diversity of mesenchymal progenitor populations with different locations, movements, and lineage boundaries. Airway smooth muscle (ASM) progenitors map exclusively to mesenchyme ahead of budding airways. Progenitors recruited from these tip pools differentiate into ASM around airway stalks; flanking stalk mesenchyme can be induced to form an ASM niche by a lateral bud or by an airway tip plus focal Wnt signal. Thus, mesenchymal progenitors can be organized into localized and carefully controlled domains that rival epithelial progenitor niches in regulatory sophistication.	[Kumar, Maya E.; Bogard, Patrick E.; Espinoza, F. Hernan; Menke, Douglas B.; Kingsley, David M.; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kumar, Maya E.; Bogard, Patrick E.; Espinoza, F. Hernan; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Menke, Douglas B.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Menke, Douglas B.; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Georgia; University of Georgia; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	krasnow@stanford.edu	Kumar, Maya/HDM-9018-2022	Espinoza, Francisco/0000-0002-1855-1914; Menke, Douglas/0000-0002-7109-1451; Bogard, Patrick/0000-0002-7137-7089	National Research Service Award (NRSA) [F32HL083645]; NIH [R01HL075769, U01HL099995]; Vera M. Wall Center for Pulmonary Vascular Disease at Stanford University; Damon Runyon and Parker B. Francis postdoctoral fellowships; NRSA postdoctoral fellowship [F32HD048006]; NIH Center of Excellence in Genomic Studies grant [5P50HG2568]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD048006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, U01HL099999, F32HL083645, R01HL075769] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vera M. Wall Center for Pulmonary Vascular Disease at Stanford University; Damon Runyon and Parker B. Francis postdoctoral fellowships; NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center of Excellence in Genomic Studies grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Research Service Award (NRSA) postdoctoral fellowship F32HL083645 (M.E.K.), NIH grants R01HL075769 and U01HL099995, and the Vera M. Wall Center for Pulmonary Vascular Disease at Stanford University (M.A.K.); Damon Runyon and Parker B. Francis postdoctoral fellowships (F.H.E.); NRSA postdoctoral fellowship F32HD048006 (D.B.M.); and NIH Center of Excellence in Genomic Studies grant 5P50HG2568 (D.M.K.). M.A.K. and D.M.K. are investigators of the Howard Hughes Medical Institute. M.E.K. and M.A.K. designed the experiments, performed data analysis, and wrote the manuscript. M.E.K. performed the experiments. M.E.K. and P.E.B. made the Tbx4LME transgenic mice. F.H.E. analyzed gene expression at branch tips. D.B.M. and D.M.K. isolated the Tbx4 enhancer element. The data reported in this paper are tabulated in the supplementary materials, and expression profiling data sets have been deposited to the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) (GSE62039). The authors thank D. Riordan for help with statistical analysis and L. Luo and I. Weissman for generously sharing mouse lines before publication.	Arey LB., 1965, TXB LAB MANUAL EMBRY, P350; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berair R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-145; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bogard P., 2012, THESIS; Cano E, 2013, AM J PHYSIOL-LUNG C, V305, pL322, DOI 10.1152/ajplung.00424.2012; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; CRICK FHC, 1975, SCIENCE, V189, P340, DOI 10.1126/science.806966; De Langhe SP, 2006, DEV BIOL, V299, P52, DOI 10.1016/j.ydbio.2006.07.001; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079; Flint JM, 1906, AM J ANAT, V6, P1; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Greif DM, 2012, DEV CELL, V23, P482, DOI 10.1016/j.devcel.2012.07.009; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; MacCord K., 2012, EMBRYO PROJECT ENCYC; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Menke DB, 2008, DEVELOPMENT, V135, P2543, DOI 10.1242/dev.017384; Metzger R., 2007, THESIS; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Prentiss C. W., 1915, LAB MANUAL TXB EMBRY; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SPOONER BS, 1970, J EXP ZOOL, V175, P445, DOI 10.1002/jez.1401750404; TADERERA JV, 1967, DEV BIOL, V16, P489, DOI 10.1016/0012-1606(67)90061-9; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	40	89	91	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					827	+	1258810	10.1126/science.1258810	http://dx.doi.org/10.1126/science.1258810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XZ	25395543	Green Accepted			2022-12-01	WOS:000349771600003
J	Woodard, SC; Rosenthal, Y; Miller, KG; Wright, JD; Chiu, BK; Lawrence, KT				Woodard, Stella C.; Rosenthal, Yair; Miller, Kenneth G.; Wright, James D.; Chiu, Beverly K.; Lawrence, Kira T.			Antarctic role in Northern Hemisphere glaciation	SCIENCE			English	Article							SOUTHERN-OCEAN; MID-PLIOCENE; BOTTOM-WATER; DEEP-WATER; CLIMATE TRANSITIONS; ISOTOPE RECORD; ICE-SHEET; ATLANTIC; TEMPERATURE; CIRCULATION	Earth's climate underwent a major transition from the warmth of the late Pliocene, when global surface temperatures were similar to 2 degrees to 3 degrees C higher than today, to extensive Northern Hemisphere glaciation (NHG) similar to 2.73 million years ago (Ma). We show that North Pacific deep waters were substantially colder (4 degrees C) and probably fresher than the North Atlantic Deep Water before the intensification of NHG. At similar to 2.73 Ma, the Atlantic-Pacific temperature gradient was reduced to < 1 degrees C, suggesting the initiation of stronger heat transfer from the North Atlantic to the deep Pacific. We posit that increased glaciation of Antarctica, deduced from the 21 +/- 10-meter sea-level fall from 3.15 to 2.75 Ma, and the development of a strong polar halocline fundamentally altered deep ocean circulation, which enhanced interhemispheric heat and salt transport, thereby contributing to NHG.	[Woodard, Stella C.; Rosenthal, Yair] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Yair; Miller, Kenneth G.; Wright, James D.; Chiu, Beverly K.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08845 USA; [Lawrence, Kira T.] Lafayette Coll, Dept Geol & Environm Geosci, Easton, PA 18042 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Lafayette College	Woodard, SC (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	woodard@marine.rutgers.edu	Wright, James/AAF-7180-2019	Wright, James/0000-0001-5212-9146	NSF [EAR-1052257, OCE-1334691]; Rutgers Aresty Undergraduate Research Fellowship	NSF(National Science Foundation (NSF)); Rutgers Aresty Undergraduate Research Fellowship	We thank N. Venti and K. Billups for providing samples and J. Crisicone, N. Abdul, and R. Mortlock for lab assistance. Funding was provided by NSF grants EAR-1052257 and OCE-1334691. B.K.C. thanks Rutgers Aresty Undergraduate Research Fellowship for its support.	Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Cronin TM, 2005, MAR MICROPALEONTOL, V54, P249, DOI 10.1016/j.marmicro.2004.12.003; Dowsett HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02013; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; Elderfield H, 2010, QUATERNARY SCI REV, V29, P160, DOI 10.1016/j.quascirev.2009.07.013; FAIRBANKS RG, 1978, QUATERNARY RES, V10, P181, DOI 10.1016/0033-5894(78)90100-X; Fantle MS, 2006, GEOCHIM COSMOCHIM AC, V70, P3883, DOI 10.1016/j.gca.2006.06.009; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; HILLENBRAND CD, 2001, P OCEAN DRILLING PRO, V0178; Hodell DA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001211; Jansen E, 2000, PALEOCEANOGRAPHY, V15, P709, DOI 10.1029/1999PA000435; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Knies J, 2014, EARTH PLANET SC LETT, V387, P132, DOI 10.1016/j.epsl.2013.11.007; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Maslin MA, 1996, GEOL RUNDSCH, V85, P452, DOI 10.1007/BF02369002; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Menviel L, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001892; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Passchier S, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002061; Ravelo AC, 2000, GEOPHYS RES LETT, V27, P1001, DOI 10.1029/1999GL007000; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; SHACKLETON NJ, 1983, EARTH PLANET SC LETT, V65, P233, DOI 10.1016/0012-821X(83)90162-0; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Steph S, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001092; Wright JD, 1996, PALEOCEANOGRAPHY, V11, P157, DOI 10.1029/95PA03696; Zhang ZS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2521	37	36	40	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					847	851		10.1126/science.1255586	http://dx.doi.org/10.1126/science.1255586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25342658				2022-12-01	WOS:000344659900044
J	Maric, M; Maculins, T; De Piccoli, G; Labib, K				Maric, Marija; Maculins, Timurs; De Piccoli, Giacomo; Labib, Karim			Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replication	SCIENCE			English	Article							EUKARYOTIC DNA; SACCHAROMYCES-CEREVISIAE; POLYMERASE ALPHA; DVC1 C1ORF124; YEAST GENES; AAA-ATPASE; COMPLEX; MCM2-7; GINS; SUMO	Chromosome replication is initiated by a universal mechanism in eukaryotic cells, involving the assembly and activation at replication origins of the CMG (Cdc45-MCM-GINS) DNA helicase, which is essential for the progression of replication forks. Disassembly of CMG is likely to be a key regulated step at the end of chromosome replication, but the mechanism was unknown until now. Here we show that the ubiquitin ligase known as SCFDia2 promotes ubiquitylation of CMG during the final stages of chromosome replication in Saccharomyces cerevisiae. The Cdc48/p97 segregase then associates with ubiquitylated CMG, leading rapidly to helicase disassembly. These findings indicate that the end of chromosome replication in eukaryotes is controlled in a similarly complex fashion to the much-better-characterized initiation step.	[Maric, Marija; Labib, Karim] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Coll Life Sci, Dundee DD1 5EH, Scotland; [Maric, Marija; Maculins, Timurs; De Piccoli, Giacomo] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	University of Dundee; Cancer Research UK; University of Manchester	Labib, K (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	kpmlabib@dundee.ac.uk		Maculins, Timurs/0000-0002-9333-301X	Cancer Research UK; Medical Research Council; Wellcome Trust [097945/B/11/Z, 102943/Z/13/Z]; Cancer Research UK [16326] Funding Source: researchfish; Medical Research Council [MC_UU_12016/13] Funding Source: researchfish; MRC [MC_UU_12016/13] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Cancer Research UK, the Medical Research Council, and the Wellcome Trust (references 097945/B/11/Z for flow cytometry and 102943/Z/13/Z for an award to K.L.) for funding our work. We are grateful to M. Foltman for assistance in the early stages of the project; H. Ulrich, M. Foltman, and S. Sengupta for plasmids; R. Deshaies, M. Kanemaki, H. Morohashi, K. Nasmyth, K. Nishimura, P. Zegerman, and S. Sengupta for providing strains; A. Gambus for helpful discussions; I. Hagan and C. Wilkinson for their support during the latter stages of this work; and all members of our group for helpful discussions.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Li Y, 2013, GENES CELLS, V18, P266, DOI 10.1111/gtc.12040; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/NCHEMBIO.1313, 10.1038/nchembio.1313]; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samson RY, 2013, MOL CELL, V50, P457, DOI 10.1016/j.molcel.2013.05.008; Sanchez-Diaz A., 2004, SCI STKE; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; SIKORSKI RS, 1989, GENETICS, V122, P19; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Takara TJ, 2009, CELL, V139, P652, DOI 10.1016/j.cell.2009.10.037; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	55	140	140	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					440	+	1253596	10.1126/science.1253596	http://dx.doi.org/10.1126/science.1253596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YT	25342810	Green Accepted, Green Submitted			2022-12-01	WOS:000349773700003
J	Dhillon, RS; Srikrishna, D; Sachs, J				Dhillon, Ranu S.; Srikrishna, Devabhaktuni; Sachs, Jeffrey			Controlling Ebola: next steps	LANCET			English	Editorial Material									[Dhillon, Ranu S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Srikrishna, Devabhaktuni] Patient Knowhow, San Mateo, CA USA; [Dhillon, Ranu S.; Sachs, Jeffrey] Columbia Univ, Earth Inst, New York, NY 10027 USA	Harvard University; Brigham & Women's Hospital; Columbia University	Sachs, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	sachs@ei.columbia.edu						Babcock C, 2012, ACAD MED, V87, P1609, DOI 10.1097/ACM.0b013e31826db6a2; Bulger C, 2014, VITAL LINK HLTH SERV; Clark P, 2014, WASHINGTON POST; Elsharkawi H., 2010, HUMANITARIAN EXCHANG, P46; European Mobile Laboratory Project, 2014, 3 UN EUR MOB LAB PRO; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Humanitarian Response, 2014, FACTS LAT S; Iyengar R, 2016, INFORM TECHNOL DEV, V22, P525, DOI 10.1080/02681102.2014.940267; Khan AS, 1999, J INFECT DIS; McKay B, 2014, WALL STREET J; Medecins Sans Frontieres, 2014, LIB MASS DISTR FAM P; Medecins Sans Frontieres, 2014, EB TREATM CTR INT EX; Mitman G, 2014, NEW ENGL J MED, V371, P1763, DOI 10.1056/NEJMp1411244; MULRINE ANNA, 2014, CHRISTIAN SCI MONITO; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; UK Government, 2014, BRIT SUPPL ARR FREET; US Agency for International Development Centers for Disease Control and Prevention, 2014, USG RESP EB OUTBR W; US Agency for International Development Maternal and Child Health Integrated Program, 2013, DEV STRENGTH COMM HL; Vogel G, 2014, SCIENCE, V345, P1549, DOI 10.1126/science.345.6204.1549; World Health Organization, 2014, EB RESP ROADM SIT RE; World Health Organization, 2013, ASS COMM HLTH WORK I	23	25	27	2	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2014	384	9952					1409	1411		10.1016/S0140-6736(14)61696-2	http://dx.doi.org/10.1016/S0140-6736(14)61696-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ8TV	25308287				2022-12-01	WOS:000343107000007
J	Mathers, CD; Stevens, GA; Boerma, T; White, RA; Tobias, MI				Mathers, Colin D.; Stevens, Gretchen A.; Boerma, Ties; White, Richard A.; Tobias, Martin I.			Causes of international increases in older age life expectancy	LANCET			English	Article							MORTALITY-RATES; VERBAL AUTOPSY; SOUTH-AFRICA; HEALTH; DEATH; TRENDS; ADULTS; SMOKING; POPULATION; DEMOGRAPHY	In high-income countries, life expectancy at age 60 years has increased in recent decades. Falling tobacco use (for men only) and cardiovascular disease mortality (for both men and women) are the main factors contributing to this rise. In high-income countries, avoidable male mortality has fallen since 1980 because of decreases in avoidable cardiovascular deaths. For men in Latin America, the Caribbean, Europe, and central Asia, and for women in all regions, avoidable mortality has changed little or increased since 1980. As yet, no evidence exists that the rate of improvement in older age mortality (60 years and older) is slowing down or that older age deaths are being compressed into a narrow age band as they approach a hypothesised upper limit to longevity.	[Mathers, Colin D.; Stevens, Gretchen A.; Boerma, Ties] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [White, Richard A.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway; [White, Richard A.] Norwegian Inst Publ Hlth, Dept Hlth Stat, Div Epidemiol, Oslo, Norway; [Tobias, Martin I.] Minist Hlth, Wellington, New Zealand	World Health Organization; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH)	Mathers, CD (corresponding author), WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.	mathersc@who.int		White, Richard Aubrey/0000-0002-6747-1726; Mathers, Colin/0000-0002-0617-6731	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Alam N, 2010, J HEALTH POPUL NUTR, V28, P520; [Anonymous], 2002, INT NETW CONT DEM EV; [Anonymous], WHO MORT DAT; Becher H, 2008, AM J TROP MED HYG, V78, P106, DOI 10.4269/ajtmh.2008.78.106; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; COALE AJ, 1991, DEMOGRAPHY, V28, P293, DOI 10.2307/2061281; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dechter A R, 1991, Popul Bull UN, P1; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gavrilova NS, 2000, POPUL RES POLICY REV, V19, P397, DOI 10.1023/A:1010621601409; Gay J, 2011, MORTALITY AMENABLE H; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; Glei DA, 2011, INT DIFFERENCES MORT; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Kannisto V., 2000, DEMOGR RES, V3, P6, DOI [10.4054/demres.2000.3.6, DOI 10.4054/DEMRES.2000.3.6]; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Mostafa G, 2000, SOC SCI MED, V50, P763, DOI 10.1016/S0277-9536(99)00295-6; *NAT I POP RES TRA, 2003, BANGL MAT HLTH SERV; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Nolte E, 2004, DOES HLTH CARE SAVE; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Office of the Registrar General of India, 2009, REP CAUS DEATH IND 2; Page A., 2006, AUSTR NZ ATLAS AVOID; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Sun E, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.6616; Tang KK, 2008, J HEALTH ECON, V27, P624, DOI 10.1016/j.jhealeco.2007.08.003; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; Tobias M, 2008, AUST NZ J PSYCHIAT, V42, P828, DOI 10.1080/00048670802277297; UK Department for International Development and Government of the United Republic of Tanzania, 1997, POL IMPL AD MORB MOR; United Nations, 2011, HIGH LEV M GEN ASS P; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wilmoth JR, 2000, EXP GERONTOL, V35, P1111, DOI 10.1016/S0531-5565(00)00194-7; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2003, FRAM CONV TOB CONTR; World Health Organization (WHO), 2014, WHO METH LIF EXP HLT	55	198	205	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					540	548		10.1016/S0140-6736(14)60569-9	http://dx.doi.org/10.1016/S0140-6736(14)60569-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468166				2022-12-01	WOS:000349213600033
J	Venkatanarayan, A; Raulji, P; Norton, W; Chakravarti, D; Coarfa, C; Su, XH; Sandur, SK; Ramirez, MS; Lee, J; Kingsley, CV; Sananikone, EF; Rajapakshe, K; Naff, K; Parker-Thornburg, J; Bankson, JA; Tsai, KY; Gunaratne, PH; Flores, ER				Venkatanarayan, Avinashnarayan; Raulji, Payal; Norton, William; Chakravarti, Deepavali; Coarfa, Cristian; Su, Xiaohua; Sandur, Santosh K.; Ramirez, Marc S.; Lee, Jaehuk; Kingsley, Charles V.; Sananikone, Eliot F.; Rajapakshe, Kimal; Naff, Katherine; Parker-Thornburg, Jan; Bankson, James A.; Tsai, Kenneth Y.; Gunaratne, Preethi H.; Flores, Elsa R.			IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo	NATURE			English	Article							P53-INDUCIBLE REGULATOR; P63; P73; ACTIVATION; MUTANT; TAP63; CHEMOTHERAPY; SUPPRESSION; INHIBITION; MUTATIONS	TP53 is commonly altered in human cancer, and Tp53 reactivation suppresses tumoursin vivo inmice(1,2) (TP53 and Tp53 are also known as p53). This strategy has proven difficult to implement therapeutically, and here we examine an alternative strategy by manipulating the p53 family members, Tp63 and Tp73 (also known as p63 and p73, respectively). The acidic transactivation-domain-bearing (TA) isoforms of p63 and p73 structurally and functionally resemble p53, whereas the Delta N isoforms (lacking the acidic transactivation domain) of p63 and p73 are frequently overexpressed in cancer and act primarily in a dominant-negative fashion against p53, TAp63 and TAp73 to inhibit their tumour-suppressive functions(3-8). The p53 family interacts extensively in cellular processes that promote tumour suppression, such as apoptosis and autophagy(9-14), thus a clear understanding of this interplay in cancer is needed to treat tumours with alterations in the p53 pathway. Here we show that deletion of the Delta N isoforms of p63 or p73 leads to metabolic reprogramming and regression of p53-deficient tumours through upregulation of IAPP, the gene that encodes amylin, a 37-amino-acid peptide co-secreted with insulin by the b cells of the pancreas. We found that IAPP is causally involved in this tumour regression and that amylin functions through the calcitonin receptor (CalcR) and receptor activity modifying protein 3 (RAMP3) to inhibit glycolysis and induce reactive oxygen species and apoptosis. Pramlintide, a synthetic analogue of amylin that is currently used to treat type 1 and type 2 diabetes, caused rapid tumour regression in p53-deficient thymic lymphomas, representing a novel strategy to target p53-deficient cancers.	[Venkatanarayan, Avinashnarayan; Raulji, Payal; Chakravarti, Deepavali; Su, Xiaohua; Sandur, Santosh K.; Sananikone, Eliot F.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Venkatanarayan, Avinashnarayan; Raulji, Payal; Chakravarti, Deepavali; Su, Xiaohua; Sandur, Santosh K.; Sananikone, Eliot F.; Tsai, Kenneth Y.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Venkatanarayan, Avinashnarayan; Chakravarti, Deepavali; Sananikone, Eliot F.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Venkatanarayan, Avinashnarayan; Chakravarti, Deepavali; Su, Xiaohua; Sandur, Santosh K.; Sananikone, Eliot F.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Houston, TX 77030 USA; [Norton, William; Naff, Katherine] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Coarfa, Cristian; Rajapakshe, Kimal] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sandur, Santosh K.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Mumbai 400085, Maharashtra, India; [Ramirez, Marc S.; Lee, Jaehuk; Kingsley, Charles V.; Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Parker-Thornburg, Jan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Tsai, Kenneth Y.] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Bhabha Atomic Research Center (BARC); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Flores, ER (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	elsaflores@mdanderson.org	Rajapakshe, Kimal/P-1592-2015; Bankson, James A./J-9798-2014	Bankson, James A./0000-0002-8574-154X; Tsai, Kenneth/0000-0001-5325-212X	NCI [R01CA160394, R01CA134796]; CPRIT [RP120124, RP101243-P5]; NCI-Cancer Center Core Grant [CA-16672]; Lymphoma SPORE [P50CA136411]; Hildegardo E. and Olga M. Flores Foundation; Mel Klein Foundation; NATIONAL CANCER INSTITUTE [R01CA134796, P30CA016672, P50CA136411, R01CA160394] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT; NCI-Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lymphoma SPORE; Hildegardo E. and Olga M. Flores Foundation; Mel Klein Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We than kA. Jain, V. Pant, J. Jackson, A. Marisetty, K. Michel and the Small Animal Imaging Facility (SAIF) for technical advice. This work was supported by grants to E.R.F. from NCI (R01CA160394) and (R01CA134796), CPRIT (RP120124), NCI-Cancer Center Core Grant (CA-16672) (University of Texas M.D. Anderson Cancer Center), a development award from the Lymphoma SPORE (P50CA136411), the Hildegardo E. and Olga M. Flores Foundation, and the Mel Klein Foundation and grant to J.A.B. from CPRIT(RP101243-P5). E.R.F. is a scholar of the Leukemia and Lymphoma Society, the Rita Allen Foundation and the V Foundation for Cancer Research. A.V. is a Schissler Scholar and D.C. is a CPRIT Scholar (RP101502).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Castle AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE531, DOI 10.1152/ajpendo.1998.275.3.E531; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarti D, 2014, P NATL ACAD SCI USA, V111, pE572, DOI 10.1073/pnas.1319743111; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Edelman S, 2008, BIODRUGS, V22, P375, DOI 10.2165/0063030-200822060-00004; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pillay K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826706; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vin H, 2013, ELIFE, V2, DOI 10.7554/eLife.00969; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	47	92	95	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					626	U229		10.1038/nature13910	http://dx.doi.org/10.1038/nature13910			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25409149	Green Accepted			2022-12-01	WOS:000348775000046
J	Zuo, W; Zhang, T; Wu, DZ; Guan, SP; Liew, AA; Yamamoto, Y; Wang, X; Lim, SJ; Vincent, M; Lessard, M; Crum, CP; Xian, W; McKeon, F				Zuo, Wei; Zhang, Ting; Wu, Daniel Zheng'An; Guan, Shou Ping; Liew, Audrey-Ann; Yamamoto, Yusuke; Wang, Xia; Lim, Siew Joo; Vincent, Matthew; Lessard, Mark; Crum, Christopher P.; Xian, Wa; McKeon, Frank			p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration	NATURE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED PULMONARY-FIBROSIS; MEDICAL PROGRESS; INFLUENZA-VIRUS; IN-VITRO; EXPRESSION; PNEUMONIA; INFECTION; CHILDREN; OUTCOMES	Lung diseases such as chronic obstructive pulmonary disease(1) and pulmonary fibrosis(2) involve the progressive and inexorable destruction of oxygen exchange surfaces and airways, and have emerged as a leading cause of death worldwide. Mitigating therapies, aside from impractical organ transplantation, remain limited and the possibility of regenerative medicine has lacked empirical support. However, it is clinically known that patients who survive sudden, massive loss of lung tissue from necrotizing pneumonia(3,4) or acute respiratory distress syndrome(5,6) often recover full pulmonary function within six months. Correspondingly, we recently demonstrated lung regeneration in mice following H1N1 influenza virus infection, and linked distal airway stem cells expressing Trp63 (p63) and keratin 5, called DASC(p63/Krt5), to this process(7). Here we show that pre-existing, intrinsically committed DASC(p63/Krt5) undergo a proliferative expansion in response to influenza-induced lung damage, and assemble into nascent alveoli at sites of interstitial lung inflammation. We also show that the selective ablation of DASC(p63/Krt5) in vivo prevents this regeneration, leading to pre-fibrotic lesions and deficient oxygen exchange. Finally, we demonstrate that single DASC(p63/Krt5)-derived pedigrees differentiate to type I and type II pneumocytes as well as bronchiolar secretory cells following transplantation to infected lung and also minimize the structural consequences of endogenous stem cell loss on this process. The ability to propagate these cells in culture while maintaining their intrinsic lineage commitment suggests their potential in stem cell-based therapies for acute and chronic lung diseases.	[Zuo, Wei; Zhang, Ting; Wu, Daniel Zheng'An; Guan, Shou Ping; Liew, Audrey-Ann; Lim, Siew Joo; Xian, Wa; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Yamamoto, Yusuke; Wang, Xia; Xian, Wa; McKeon, Frank] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Vincent, Matthew] Adv Cell Technol, Marlborough, MA 01752 USA; [Lessard, Mark] Jackson Lab, Bar Harbor, ME 04609 USA; [Crum, Christopher P.; Xian, Wa] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Xian, Wa; McKeon, Frank] Natl Univ Hlth Syst, Dept Med, Singapore 119228, Singapore; [Xian, Wa] Univ Connecticut, Dept Genet & Dev Biol, Ctr Hlth, Farmington, CT 06030 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Jackson Laboratory; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National University of Singapore; University of Connecticut	McKeon, F (corresponding author), ASTAR, Genome Inst Singapore, Singapore 138672, Singapore.	waxian@jax.org; mckeon.xian@gmail.com		Lessard, Mark/0000-0002-1927-2204	Joint Council Off ice of the Agency for Science Technology Research Agency (ASTAR), Singapore; Defense Advanced Research Projects Agency (DARPA) [N66001-09-1-2121]; Johnson & Johnson ASTAR Joint Program; Connecticut Innovations	Joint Council Off ice of the Agency for Science Technology Research Agency (ASTAR), Singapore; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Johnson & Johnson ASTAR Joint Program; Connecticut Innovations	This work was supported by grants from the Joint Council Off ice of the Agency for Science Technology Research Agency (ASTAR), Singapore (W.X., F.M.), Defense Advanced Research Projects Agency (DARPA, N66001-09-1-2121 to F.M.), the Johnson & Johnson ASTAR Joint Program (W.X., F.M.) and support from Connecticut Innovations (W.X., F.M.). We thank M. LaLande, B. Lane and H. Hui Ng for support, G. Wright, B. Tennent, B. Knowles and T. McLaughlin for comments on the manuscript, J. Hammer for artwork, P. Kraus for blastocyst injections, and H. Ahmad and K. L. Goh for technical assistance. We thank H. Green for advice and support.	Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BASKERVILLE A, 1974, BRIT J EXP PATHOL, V55, P130; Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P743, DOI 10.1101/pdb.prot076521; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; KEREM E, 1994, AM J RESP CRIT CARE, V149, P242, DOI 10.1164/ajrccm.149.1.8111589; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Li Y, 2009, ARCH DERMATOL RES, V301, P205, DOI 10.1007/s00403-008-0881-y; Matuschak George M, 2010, Mo Med, V107, P252; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sawicki GS, 2008, EUR RESPIR J, V31, P1285, DOI 10.1183/09031936.00099807; Schmidt D, 1996, TOXICOL LETT, V88, P75, DOI 10.1016/0378-4274(96)03720-4; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUGIHARA H, 1993, AM J PATHOL, V142, P783; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; VYALOV SL, 1993, AM J PATHOL, V143, P1754; Wilcox ME, 2013, CHEST, V143, P920, DOI 10.1378/chest.12-0685; Xian W, 2012, CELL CYCLE, V11, P887, DOI 10.4161/cc.11.5.19328	34	282	300	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					616	U194		10.1038/nature13903	http://dx.doi.org/10.1038/nature13903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383540	Green Published			2022-12-01	WOS:000348775000044
J	Mandl, KD				Mandl, Kenneth D.			Ebola in the United States EHRs as a Public Health Tool at the Point of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mandl, Kenneth D.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	kenneth_mandl@harvard.edu			NATIONAL LIBRARY OF MEDICINE [G08LM009778, R01LM007677] Funding Source: NIH RePORTER; NLM NIH HHS [G08 LM009778, R01 LM007677, 1G08LM009778] Funding Source: Medline; PHITPO CDC HHS [P01HK000088] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PHITPO CDC HHS		Bever L., 2014, WASHINGTON POST; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Kreda D, 2014, OPEN PLATFORM ARCHIT; Mandl KD, 2012, J AM MED INFORM ASSN, V19, P597, DOI 10.1136/amiajnl-2011-000622; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411; Middleton B, 2013, J AM MED INFORM ASSN, V20, pE2, DOI 10.1136/amiajnl-2012-001458; Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P901; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	8	7	7	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2499	2500		10.1001/jama.2014.15064	http://dx.doi.org/10.1001/jama.2014.15064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25329170	Bronze			2022-12-01	WOS:000346346900009
J	Crous-Bou, M; Fung, TT; Prescott, J; Julin, B; Du, M; Sun, Q; Rexrode, KM; Hu, FB; De Vivo, I				Crous-Bou, Marta; Fung, Teresa T.; Prescott, Jennifer; Julin, Bettina; Du, Mengmeng; Sun, Qi; Rexrode, Kathryn M.; Hu, Frank B.; De Vivo, Immaculata			Mediterranean diet and telomere length in Nurses' Health Study: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; OXIDATIVE STRESS; RISK-FACTORS; ASSOCIATION; MORTALITY; ADHERENCE; PATTERNS	Objective To examine whether adherence to the Mediterranean diet was associated with longer telomere length, a biomarker of aging. Design Population based cohort study. Setting Nurses' Health Study, an ongoing prospective cohort study of 121 700 nurses enrolled in 1976; in 1989-90 a subset of 32 825 women provided blood samples. Participants 4676 disease-free women from nested case-control studies within the Nurses' Health Study with telomere length measured who also completed food frequency questionnaires. Main outcome measure Association between relative telomere lengths in peripheral blood leukocytes measured by quantitative real time polymerase chain reaction and Alternate Mediterranean Diet score calculated from self reported dietary data. Results Greater adherence to the Mediterranean diet was associated with longer telomeres after adjustment for potential confounders. Least squares mean telomere length z scores were -0.038 (SE 0.035) for the lowest Mediterranean diet score groups and 0.072 (0.030) for the highest group (P for trend=0.004). Conclusion In this large study, greater adherence to the Mediterranean diet was associated with longer telomeres. These results further support the benefits of adherence to the Mediterranean diet for promoting health and longevity.	[Crous-Bou, Marta; Prescott, Jennifer; Julin, Bettina; Du, Mengmeng; Sun, Qi; Hu, Frank B.; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Crous-Bou, Marta; Prescott, Jennifer; Julin, Bettina; Du, Mengmeng; Sun, Qi; Rexrode, Kathryn M.; Hu, Frank B.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Crous-Bou, Marta; Julin, Bettina; Hu, Frank B.; De Vivo, Immaculata] Harvard Univ, Sch Med, Program Genet Epidemiol & Stat Genet, Dept Epidemiol, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Fung, Teresa T.; Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Du, Mengmeng] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Simmons University; Harvard University; Harvard T.H. Chan School of Public Health; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	De Vivo, I (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	nhidv@channing.harvard.edu	Rexrode, Kathryn M/I-1177-2018; Crous-Bou, Marta/A-9499-2019	Crous-Bou, Marta/0000-0003-1493-4288; Rexrode, Kathryn/0000-0003-3387-8429; De Vivo, Immaculata/0000-0002-7185-7402	National Cancer Institute, National Institutes of Health [1R01 CA134958, 2R01 CA082838, P01 CA087969, R01 CA49449, CA065725, CA132190, CA139586, CA140790, CA133914, CA132175, CA163451, HL088521, HL60712, U54 CA155626, R01 AR059073, HL34594]; Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute; National Cancer Institute [R25 CA94880]; NHLBI [R00HL098459]; NATIONAL CANCER INSTITUTE [R03CA139586, R01CA163451, U54CA155626, K07CA140790, R01CA065725, P01CA087969, R01CA134958, R03CA132190, R01CA049449, R01CA082838, R25CA094880, R03CA132175, R03CA133914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098459, R01HL088521, R01HL060712, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059073] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Nurses' Health Study is supported by the National Cancer Institute, National Institutes of Health (1R01 CA134958, 2R01 CA082838, P01 CA087969, R01 CA49449, CA065725, CA132190, CA139586, CA140790, CA133914, CA132175, CA163451, HL088521, HL60712, U54 CA155626, R01 AR059073, HL34594). MC-B is also supported by a Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute. MD is supported by grant R25 CA94880 from the National Cancer Institute. QS is supported by an NHLBI sponsored career development award (R00HL098459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2009, NATURE, V461, P706, DOI 10.1038/461706a; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, P43, DOI DOI 10.1126/SAGEKE.2004.51.PE43; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetou V, 2008, BRIT J CANCER, V99, P191, DOI 10.1038/sj.bjc.6604418; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boccardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062781; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Garcia-Calzon S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Krauss J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026983; Liang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023462; Lopez-Garcia E, 2014, AM J CLIN NUTR, V99, P172, DOI 10.3945/ajcn.113.068106; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Page JH, 2008, CLIN CHEM, V54, P1190, DOI 10.1373/clinchem.2007.099291; Prescott J, 2012, HUM REPROD, V27, P3622, DOI 10.1093/humrep/des314; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Samieri C, 2013, ANN INTERN MED, V159, P584, DOI 10.7326/0003-4819-159-9-201311050-00004; Scarmeas N, 2006, ARCH NEUROL-CHICAGO, V63, P1709, DOI 10.1001/archneur.63.12.noc60109; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038374; TRICHOPOULOU A, 1995, AM J CLIN NUTR, V61, p1346S, DOI 10.1093/ajcn/61.6.1346S; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trichopoulou Antonia, 2009, BMJ, V338, pb2337, DOI 10.1136/bmj.b2337; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2003, NAT BIOTECHNOL, V21, P229, DOI 10.1038/nbt0303-229b; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	69	148	150	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2014	349								g6674	10.1136/bmj.g6674	http://dx.doi.org/10.1136/bmj.g6674			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KK	25467028	Green Published, hybrid			2022-12-01	WOS:000346116300002
J	Kim, IN; Lee, K; Gruber, N; Karl, DM; Bullister, JL; Yang, S; Kim, TW				Kim, Il-Nam; Lee, Kitack; Gruber, Nicolas; Karl, David M.; Bullister, John L.; Yang, Simon; Kim, Tae-Wook			Increasing anthropogenic nitrogen in the North Pacific Ocean	SCIENCE			English	Article							ATMOSPHERIC DEPOSITION; ATLANTIC OCEAN; FIXATION; ASIA; EMISSIONS; PATTERNS; NITRATE; CARBON	The recent increase in anthropogenic emissions of reactive nitrogen from northeastern Asia and the subsequent enhanced deposition over the extensive regions of the North Pacific Ocean (NPO) have led to a detectable increase in the nitrate (N) concentration of the upper ocean. The rate of increase of excess N relative to phosphate (P) was found to be highest (similar to 0.24 micromoles per kilogram per year) in the vicinity of the Asian source continent, with rates decreasing eastward across the NPO, consistent with the magnitude and distribution of atmospheric nitrogen deposition. This anthropogenically driven increase in the N content of the upper NPO may enhance primary production in this N-limited region, potentially leading to a long-term change of the NPO from being N-limited to P-limited.	[Kim, Il-Nam; Lee, Kitack] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea; [Gruber, Nicolas; Yang, Simon] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, Zurich, Switzerland; [Karl, David M.] Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanog, Honolulu, HI 96822 USA; [Bullister, John L.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Kim, Tae-Wook] Korea Inst Ocean Sci & Technol, Ocean Circulat & Climate Res Div, Ansan 426744, South Korea	Pohang University of Science & Technology (POSTECH); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; Korea Institute of Ocean Science & Technology (KIOST)	Lee, K (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea.	ktl@postech.ac.kr	Lee, Kitack/G-7184-2015; Kim, Tae-Wook/E-9611-2011; Gruber, Nicolas/B-7013-2009; Karl, David/AFP-3837-2022	Kim, Tae-Wook/0000-0002-4236-0720; Gruber, Nicolas/0000-0002-2085-2310; Karl, David/0000-0002-6660-6721; Lee, Kitack/0000-0002-4226-2303	Mid-Career Researcher Program [2012R1A2A1A01004631]; National Research Foundation (NRF) of Ministry of Science, Information Communication Technology, and Future Planning, Science and Technology [2013K1A1A2A02078278]; "Management of marine organisms causing ecological disturbance and harmful effects" program - Ministry of Oceans and Fisheries; Basic Science Research Program through NRF [2012R1A6A3A0403883]; NSF [OCE09-26766, EF04-24599]; Gordon and Betty Moore Foundation; NOAA's Climate Program Office; ETH Zurich	Mid-Career Researcher Program; National Research Foundation (NRF) of Ministry of Science, Information Communication Technology, and Future Planning, Science and Technology; "Management of marine organisms causing ecological disturbance and harmful effects" program - Ministry of Oceans and Fisheries; Basic Science Research Program through NRF(National Research Foundation of Korea); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NOAA's Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); ETH Zurich(ETH Zurich)	We thank all scientists responsible for the CFC-12 and nutrient measurements in the GLODAP (http://cdiac.ornl.gov/oceans/glodap/) and PACIFICA (http://cdiac.ornl.gov/oceans/PACIFICA/) databases and the CREAMS II (http://sam.ucsd.edu) and HOT (http://hahana.soest.hawaii.edu/hot/) programs. This research was supported by the Mid-Career Researcher Program (no. 2012R1A2A1A01004631) and the Global Research Project funded by the National Research Foundation (NRF) of Ministry of Science, Information Communication Technology, and Future Planning, Science and Technology (no. 2013K1A1A2A02078278). Partial support was provided by the "Management of marine organisms causing ecological disturbance and harmful effects" program funded by the Ministry of Oceans and Fisheries. T.-W.K. was supported by the Basic Science Research Program through NRF (no. 2012R1A6A3A0403883). D. M. K was funded by the NSF (nos. OCE09-26766 and EF04-24599) and the Gordon and Betty Moore Foundation. J.L.B. was funded by NOAA's Climate Program Office. N.G. and S.Y. acknowledge the financial support from ETH Zurich. Author contributions: I.-N.K. and K. L. designed the study and wrote the manuscript with support from N.G., D. M. K., and J. L. B. I.-N.K. analyzed the data. N.G., D. M. K., J. L. B., S.Y., and T.-W.K. contributed to the manuscript with discussions and comments. S.Y. and N.G. performed NCAR Community Earth System Model simulations. The authors declare no competing financial interests.	AKIMOTO H, 1994, ATMOS ENVIRON, V28, P213, DOI 10.1016/1352-2310(94)90096-5; Carrillo JH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001892; Ciais P., 2013, CLIM CHANG 2013 PHYS; Dentener F.J., 2006, GLOBAL MAPS ATMOSPHE; DONEY SC, 1992, DEEP-SEA RES, V39, P1857, DOI 10.1016/0198-0149(92)90003-C; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Fine RA, 2011, ANNU REV MAR SCI, V3, P173, DOI 10.1146/annurev.marine.010908.163933; Galloway JN, 2000, NUTR CYCL AGROECOSYS, V57, P1, DOI 10.1023/A:1009832221034; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Jung JY, 2011, J ATMOS CHEM, V68, P157, DOI 10.1007/s10874-012-9218-5; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Lee K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014198; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/ngeo1757, 10.1038/NGEO1757]; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Okin GS, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003858; Prospero JM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001524; Singh A, 2013, DEEP-SEA RES PT II, V93, P148, DOI 10.1016/j.dsr2.2013.04.008; Suntharalingam P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050778	22	131	137	10	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1102	1106		10.1126/science.1258396	http://dx.doi.org/10.1126/science.1258396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430767				2022-12-01	WOS:000345763400040
J	Liu, ZY; Lu, ZY; Wen, XY; Otto-Bliesner, BL; Timmermann, A; Cobb, KM				Liu, Zhengyu; Lu, Zhengyao; Wen, Xinyu; Otto-Bliesner, B. L.; Timmermann, A.; Cobb, K. M.			Evolution and forcing mechanisms of El Nino over the past 21,000 years	NATURE			English	Article							TROPICAL PACIFIC; SOUTHERN-OSCILLATION; ANNUAL CYCLE; CLIMATE; VARIABILITY; HOLOCENE; MODEL; CIRCULATION; SUPPRESSION; VARIANCE	The El Nino Southern Oscillation (ENSO) is Earth's dominant source of interannual climate variability, but its response to global warming remains highly uncertain(1). To improve our understanding of ENSO's sensitivity to external climate forcing, it is paramount to determine its past behaviour by using palaeoclimate data and model simulations. Palaeoclimate records show that ENSO has varied considerably since the Last Glacial Maximum (21,000 years ago)(2-9), and some data sets suggest a gradual intensification of ENS 0 over the past 6,000 years(2'5'7'8). Previous attempts to simulate the transient evolution of ENSO have relied on simplified models(10) or snapshot(11-13) experiments. Here we analyse a series of transient Coupled General Circulation Model simulations forced by changes in greenhouse gasses, orbital forcing, the meltwater discharge and the ice-sheet history throughout the past 21,000 years. Consistent with most palaeo-ENSO reconstructions, our model simulates an orbitally induced strengthening of ENSO during the Holocene epoch, which is caused by increasing positive ocean-atmosphere feedbacks. During the early deglaciation, ENSO characteristics change drastically in response to meltwater discharges and the resulting changes in the Atlantic Meridional Overturning Circulation and equatorial annual cycle. Increasing deglacial atmospheric CO2 concentrations tend to weaken ENSO, whereas retreating glacial ice sheets intensify ENSO. The complex evolution of forcings and ENSO feedbacks and the uncertainties in the reconstruction further highlight the challenge and opportunity for constraining future ENSO responses.	[Liu, Zhengyu] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Liu, Zhengyu] Univ Wisconsin, Nelson Ctr Climat Res, Madison, WI 53706 USA; [Liu, Zhengyu; Lu, Zhengyao; Wen, Xinyu] Peking Univ, Sch Phys, Lab Climate Ocean & Atmosphere Studies, Beijing 100871, Peoples R China; [Otto-Bliesner, B. L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA; [Timmermann, A.] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Timmermann, A.] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Cobb, K. M.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Peking University; National Center Atmospheric Research (NCAR) - USA; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University System of Georgia; Georgia Institute of Technology	Liu, ZY (corresponding author), Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA.	zliu3@wisc.edu	Otto-Bliesner, Bette/AAY-7691-2020; Timmermann, Axel/F-4977-2011; Timmermann, Axel/Y-2799-2019	Timmermann, Axel/0000-0003-0657-2969; Timmermann, Axel/0000-0003-0657-2969; , Zhengyao/0000-0002-5911-7110; Cobb, Kim/0000-0002-2125-9164	US National Science Foundation (NSF)/P2C2 Program, Chinese [NSFC41130105]; US Department of Energy/Office of Science (BER), Chinese [MOST2012CB955200, NSF1049219, 1204011]; Directorate For Geosciences [1049219, 1049238] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1010869] Funding Source: National Science Foundation	US National Science Foundation (NSF)/P2C2 Program, Chinese(National Science Foundation (NSF)); US Department of Energy/Office of Science (BER), Chinese(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by the US National Science Foundation (NSF)/P2C2 Program, Chinese NSFC41130105, the US Department of Energy/Office of Science (BER), Chinese MOST2012CB955200, NSF1049219 and 1204011. The computation is carried out at Oak Ridge National Laboratory of the Department of Energy and the National Center for Atmospheric Research supercomputing facility.	BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Brown J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001512; Carre M, 2014, SCIENCE, V345, P1045, DOI 10.1126/science.1252220; Chiang JCH, 2009, J CLIMATE, V22, P923, DOI 10.1175/2008JCLI2644.1; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Deser C, 2006, J CLIMATE, V19, P2451, DOI 10.1175/JCLI3759.1; Felis T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1973; He F., 2011, THESIS U WISCONSIN M; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kim ST, 2011, CLIM DYNAM, V36, P1609, DOI [10.1007/s00382-010-0872-5, 10.1007/s00382-010-0796-0]; Koutavas A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002378; Liu Z, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000819; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Liu ZG, 2002, J CLIMATE, V15, P1088, DOI 10.1175/1520-0442(2002)015<1088:ASMSOE>2.0.CO;2; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; LIU ZY, 1994, J ATMOS SCI, V51, P3807, DOI 10.1175/1520-0469(1994)051<3807:EPOCAD>2.0.CO;2; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McGregor S, 2013, CLIM PAST, V9, P2269, DOI 10.5194/cp-9-2269-2013; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Meehl GA, 2006, CLIM DYNAM, V26, P549, DOI 10.1007/s00382-005-0098-0; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Otto-Bliesner B., 2003, GEOPHYS RES LETT, V30, DOI [10.1029/2003GL08553, DOI 10.1029/2003GL08553]; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; PENLAND C, 1995, J CLIMATE, V8, P1999, DOI 10.1175/1520-0442(1995)008<1999:TOGOTS>2.0.CO;2; Rein B, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001099; Riedinger MA, 2002, J PALEOLIMNOL, V27, P1, DOI 10.1023/A:1013514408468; Rittenour TM, 2000, SCIENCE, V288, P1039, DOI 10.1126/science.288.5468.1039; Roberts W. H., 2007, THESIS U WASHINGTON; Sadekov AY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3692; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1; Timmermann A, 2007, J CLIMATE, V20, P4147, DOI 10.1175/JCLI4240.1; Timmermann A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019442; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724	41	176	189	14	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					550	553		10.1038/nature13963	http://dx.doi.org/10.1038/nature13963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428502	Green Submitted			2022-12-01	WOS:000346247600051
J	Willyard, C				Willyard, Cassandra			Riddle of the rays	NATURE			English	Editorial Material							MALIGNANT-MELANOMA											BERAL V, 1981, BRIT J CANCER, V44, P886, DOI 10.1038/bjc.1981.288; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Elmwood J. M., 1985, INT J CANCER, V35, P427; Gallagher RP, 2011, INT J CANCER, V128, P1872, DOI 10.1002/ijc.25503; Li WQ, 2014, JAMA INTERN MED, V174, P964, DOI 10.1001/jamainternmed.2014.594; Meyskens FL, 2011, RECENT RESULTS CANC, V188, P65, DOI 10.1007/978-3-642-10858-7_5; VAGERO D, 1990, BRIT J IND MED, V47, P317; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806	8	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S112	S113		10.1038/515S112a	http://dx.doi.org/10.1038/515S112a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407706	Bronze			2022-12-01	WOS:000345770600002
J	Lamberts, M; Lip, GYH; Hansen, ML; Lindhardsen, J; Olesen, JB; Raunso, J; Olsen, AMS; Andersen, PK; Gerds, TA; Fosbol, EL; Torp-Pedersen, C; Gislason, GH				Lamberts, Morten; Lip, Gregory Y. H.; Hansen, Morten Lock; Lindhardsen, Jesper; Olesen, Jonas Bjerring; Raunso, Jakob; Olsen, Anne-Marie Schjerning; Andersen, Per Kragh; Gerds, Thomas Alexander; Fosbol, Emil L.; Torp-Pedersen, Christian; Gislason, Gunnar H.			Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CORONARY INTERVENTION; ORAL ANTICOAGULANTS; TRIPLE THERAPY; WARFARIN; ASPIRIN; STROKE; METAANALYSIS; DEATH; CLOPIDOGREL	Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are assumed to increase bleeding risk, but their actual relation to serious bleeding in patients with atrial fibrillation (AF) who are receiving antithrombotic medication is unknown. Objective: To investigate the risk for serious bleeding and thromboembolism associated with ongoing NSAID and antithrombotic therapy. Design: Observational cohort study. Setting: Nationwide registries. Patients: Danish patients with AF hospitalized between 1997 and 2011. Measurements: Absolute risk for serious bleeding and thromboembolism with ongoing NSAID and antithrombotic therapy, assessed by using Cox models. Results: Of 150 900 patients with AF (median age, 75 years [interquartile range, 65 to 83 years]; 47% female), 53 732 (35.6%) were prescribed an NSAID during a median follow-up of 6.2 years (interquartile range, 2.1 to 14.0 years). There were 17 187 (11.4%) and 19 561 (13.0%) occurrences of serious bleeding and thromboembolism, respectively. At 3 months, the absolute risk for serious bleeding within 14 days of NSAID exposure was 3.5 events per 1000 patients compared with 1.5 events per 1000 patients without NSAID exposure. The risk difference was 1.9 events per 1000 patients. In patients selected for oral anticoagulant therapy, the absolute risk difference was 2.5 events per 1000 patients. Use of NSAIDs was associated with increased absolute risks for serious bleeding and thromboembolism across all antithrombotic regimens and NSAID types. An NSAID dosage above the recommended minimum was associated with a substantially increased hazard ratio for bleeding. Limitation: Observational design and unmeasured confounders. Conclusion: Use of NSAIDs was associated with an independent risk for serious bleeding and thromboembolism in patients with AF. Short-term NSAID exposure was associated with increased bleeding risk. Physicians should exercise caution with NSAIDs in patients with AF.	Gentofte Univ Hosp, DK-2900 Hellerup, Denmark; Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Natl Inst Publ Hlth, DK-2100 Copenhagen, Denmark; Univ Southern Denmark, Copenhagen, Denmark; Aalborg Univ, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Birmingham; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Aalborg University	Lamberts, M (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Post 635,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	mortenlamberts@gmail.com	Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Fosbol, Emil/0000-0002-2048-4167; Gerds, Thomas Alexander/0000-0002-5955-816X; Lamberts, Morten/0000-0002-9827-440X	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Dr. Gislason is supported by an unrestricted research scholarship from the Novo Nordisk Foundation.	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Camm AJ, 2012, EUR HEART J, V33; Chang CH, 2010, STROKE, V41, P1884, DOI 10.1161/STROKEAHA.110.585828; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Davidson BL, 2014, JAMA INTERN MED, V174, P947, DOI 10.1001/jamainternmed.2014.946; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Fosbol EL, 2014, INT J STROKE, V9, P943, DOI 10.1111/j.1747-4949.2012.00863.x; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Galliard-Grigioni KS, 2009, EUR J PHARMACOL, V609, P96, DOI 10.1016/j.ejphar.2009.02.042; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hart RG, 1999, CEREBROVASC DIS, V9, P215, DOI 10.1159/000015958; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Husted S, 2014, THROMB HAEMOSTASIS, V111, P781, DOI 10.1160/TH14-03-0228; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lamberts M, 2013, INT J CARDIOL, V168, P832, DOI 10.1016/j.ijcard.2012.10.004; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Mason PK, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.09.030; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Olsen AMS, 2012, CIRCULATION, V126, P1955, DOI 10.1161/CIRCULATIONAHA.112.112607; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ruiz-Nodar JM, 2011, REV ESP CARDIOL, V64, P965, DOI [10.1016/j.rec.2011.04.013, 10.1016/j.recesp.2011.04.014]; Schaefer MG, 2003, AM J HEALTH-SYST PH, V60, P1319, DOI 10.1093/ajhp/60.13.1319; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	39	63	65	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					690	U136		10.7326/M13-1581	http://dx.doi.org/10.7326/M13-1581			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402512				2022-12-01	WOS:000347245600026
J	Pratto, F; Brick, K; Khil, P; Smagulova, F; Petukhova, GV; Camerini-Otero, RD				Pratto, Florencia; Brick, Kevin; Khil, Pavel; Smagulova, Fatima; Petukhova, Galina V.; Camerini-Otero, R. Daniel			Recombination initiation maps of individual human genomes	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; COPY NUMBER VARIATION; MEIOTIC RECOMBINATION; HOT-SPOT; SPERM CELLS; HOTSPOTS; PRDM9; MOUSE; INSTABILITY; RATES	DNA double-strand breaks (DSBs) are introduced in meiosis to initiate recombination and generate crossovers, the reciprocal exchanges of genetic material between parental chromosomes. Here, we present high-resolution maps of meiotic DSBs in individual human genomes. Comparing DSB maps between individuals shows that along with DNA binding by PRDM9, additional factors may dictate the efficiency of DSB formation. We find evidence for both GC-biased gene conversion and mutagenesis around meiotic DSB hotspots, while frequent colocalization of DSB hotspots with chromosome rearrangement breakpoints implicates the aberrant repair of meiotic DSBs in genomic disorders. Furthermore, our data indicate that DSB frequency is a major determinant of crossover rate. These maps provide new insights into the regulation of meiotic recombination and the impact of meiotic recombination on genome function.	[Pratto, Florencia; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel] NIDDK, NIH, Bethesda, MD 20892 USA; [Smagulova, Fatima; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA	Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	galina.petukhova@usuhs.edu; rdcamerini@mail.nih.gov	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Pratto, Florencia/0000-0002-9678-8044; Smagulova, Fatima/0000-0001-6883-1968	NIH from National Institute of General Medical Sciences [1R01GM084104-01A1]; March of Dimes [1-FY13-506]; NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	NIH from National Institute of General Medical Sciences; March of Dimes(March of Dimes); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Smith and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Genomics Core for sequencing assistance. We thank M. Lichten and P. Hsieh for critical feedback on the manuscript and also extend our gratitude to A. Jeffreys for providing details of human crossover rates. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD (http://biowulf.nih.gov). This research was supported by NIH grant 1R01GM084104-01A1 from National Institute of General Medical Sciences (G.V.P.), March of Dimes grant 1-FY13-506 (G.V.P.) and by the NIDDK Intramural Research Program (R.D.C.O.). The sequencing data reported in this paper are archived at the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) as accession no. GSE59836.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arbel-Eden A, 2013, G3-GENES GENOM GENET, V3, P633, DOI 10.1534/g3.113.005603; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bost B, 2014, BIOESSAYS, V36, P84, DOI 10.1002/bies.201300109; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Clement Y, 2013, MOL BIOL EVOL, V30, P2612, DOI 10.1093/molbev/mst154; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Dittwald P, 2013, HUM MUTAT, V34, P210, DOI 10.1002/humu.22217; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Fan QQ, 1997, GENETICS, V145, P661; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Khil PP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000831; KIMURA M, 1973, GENETICS, V75, P199; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Oliver-Bonet M, 2005, MOL HUM REPROD, V11, P517, DOI 10.1093/molehr/gah193; Page J, 2012, CHROMOSOMA, V121, P307, DOI 10.1007/s00412-012-0364-y; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rocco V, 1996, GENES CELLS, V1, P645, DOI 10.1046/j.1365-2443.1996.00256.x; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; WU TC, 1995, GENETICS, V140, P55; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	167	167	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					826	+	1256442	10.1126/science.1256442	http://dx.doi.org/10.1126/science.1256442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XZ	25395542	Green Accepted			2022-12-01	WOS:000349771600002
J	Alpern, JD; Stauffer, WM; Kesselheim, AS				Alpern, Jonathan D.; Stauffer, William M.; Kesselheim, Aaron S.			High-Cost Generic Drugs - Implications for Patients and Policymakers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alpern, Jonathan D.; Stauffer, William M.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Alpern, Jonathan D.; Stauffer, William M.] Reg Hosp, Dept Med, St Paul, MN USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Alpern, JD (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.		Liles, Nathan W/C-9819-2018; Kesselheim, Aaron/R-6793-2017	Liles, Nathan W/0000-0002-3710-7296; Kesselheim, Aaron/0000-0002-8867-2666				[Anonymous], MICR 2 0 EL VERS; Choudhry NK, 2009, HEALTH AFFAIR, V28, P827, DOI 10.1377/hlthaff.28.3.827; Colliver V, 2014, PRICES SOAR SOME GEN; Government Accountability Office, 2009, BRANDN PRESCR DRUG P	4	82	82	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1859	1862		10.1056/NEJMp1408376	http://dx.doi.org/10.1056/NEJMp1408376			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25390739	Bronze			2022-12-01	WOS:000344709800002
J	Lee, H; Deignan, JL; Dorrani, N; Strom, SP; Kantarci, S; Quintero-Rivera, F; Das, K; Toy, T; Harry, B; Yourshaw, M; Fox, M; Fogel, BL; Martinez-Agosto, JA; Wong, DA; Chang, VY; Shieh, PB; Palmer, CGS; Dipple, KM; Grody, WW; Vilain, E; Nelson, SF				Lee, Hane; Deignan, Joshua L.; Dorrani, Naghmeh; Strom, Samuel P.; Kantarci, Sibel; Quintero-Rivera, Fabiola; Das, Kingshuk; Toy, Traci; Harry, Bret; Yourshaw, Michael; Fox, Michelle; Fogel, Brent L.; Martinez-Agosto, Julian A.; Wong, Derek A.; Chang, Vivian Y.; Shieh, Perry B.; Palmer, Christina G. S.; Dipple, Katrina M.; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.			Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DE-NOVO MUTATIONS; ACMG RECOMMENDATIONS; INCIDENTAL FINDINGS; VARIANTS; GUIDELINES; STANDARDS; EPILEPSY; RETURN	IMPORTANCE Clinical exome sequencing (CES) is rapidly becoming a common molecular diagnostic test for individuals with rare genetic disorders. OBJECTIVE To report on initial clinical indications for CES referrals and molecular diagnostic rates for different indications and for different test types. DESIGN, SETTING, AND PARTICIPANTS Clinical exome sequencing was performed on 814 consecutive patients with undiagnosed, suspected genetic conditions at the University of California, Los Angeles, Clinical Genomics Center between January 2012 and August 2014. Clinical exome sequencing was conducted as trio-CES (both parents and their affected child sequenced simultaneously) to effectively detect de novo and compound heterozygous variants or as proband-CES (only the affected individual sequenced) when parental samples were not available. MAIN OUTCOMES AND MEASURES Clinical indications for CES requests, molecular diagnostic rates of CES overall and for phenotypic subgroups, and differences in molecular diagnostic rates between trio-CES and proband-CES. RESULTS Of the 814 cases, the overall molecular diagnosis rate was 26%(213 of 814; 95% CI, 23%-29%). The molecular diagnosis rate for trio-CES was 31% (127 of 410 cases; 95% CI, 27%-36%) and 22%(74 of 338 cases; 95% CI, 18%-27%) for proband-CES. In cases of developmental delay in children (< 5 years, n = 138), the molecular diagnosis rate was 41% (45 of 109; 95% CI, 32%-51%) for trio-CES cases and 9% (2 of 23, 95% CI, 1%-28%) for proband-CES cases. The significantly higher diagnostic yield (P value =.002; odds ratio, 7.4 [95% CI, 1.6-33.1]) of trio-CES was due to the identification of de novo and compound heterozygous variants. CONCLUSIONS AND RELEVANCE In this sample of patients with undiagnosed, suspected genetic conditions, trio-CES was associated with higher molecular diagnostic yield than proband-CES or traditional molecular diagnostic methods. Additional studies designed to validate these findings and to explore the effect of this approach on clinical and economic outcomes are warranted.	[Lee, Hane; Deignan, Joshua L.; Strom, Samuel P.; Kantarci, Sibel; Quintero-Rivera, Fabiola; Das, Kingshuk; Toy, Traci; Grody, Wayne W.; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lee, Hane; Deignan, Joshua L.; Dorrani, Naghmeh; Strom, Samuel P.; Kantarci, Sibel; Quintero-Rivera, Fabiola; Das, Kingshuk; Toy, Traci; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Clin Genom Ctr, Los Angeles, CA 90095 USA; [Dorrani, Naghmeh; Yourshaw, Michael; Fox, Michelle; Martinez-Agosto, Julian A.; Wong, Derek A.; Chang, Vivian Y.; Dipple, Katrina M.; Grody, Wayne W.; Vilain, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Harry, Bret] Univ Calif Los Angeles, Inst Digital Res & Educ, Los Angeles, CA 90095 USA; [Fogel, Brent L.; Shieh, Perry B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Martinez-Agosto, Julian A.; Palmer, Christina G. S.; Dipple, Katrina M.; Grody, Wayne W.; Vilain, Eric; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Palmer, Christina G. S.; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nelson, SF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Clin Genom Ctr, 695 Charles E Young Dr S,GONDA 5506A, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Nelson, Stanley F/D-4771-2009; Martinez-Agosto, Julian A/I-9435-2019; Yourshaw, Michael/F-9807-2015	Nelson, Stanley F/0000-0002-2082-3114; Martinez-Agosto, Julian A/0000-0001-6776-6949; Yourshaw, Michael/0000-0001-7612-0437; Wong, Derek/0000-0002-7762-2276	National Institutes of Health's National Center for Advancing Translational Science [UCLA CTSI UL1TR000124]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIH-P30-5P30AR057230]; California Institute of Regenerative Medicine [RT2-01985]; K12 Child Health Research Career Development Award [2K12HD034610-16]; Hyundai Hope on Wheels Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD034610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082094] Funding Source: NIH RePORTER	National Institutes of Health's National Center for Advancing Translational Science; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); K12 Child Health Research Career Development Award; Hyundai Hope on Wheels Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Part of the study was supported by the National Institutes of Health's National Center for Advancing Translational Science (UCLA CTSI UL1TR000124) and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-P30-5P30AR057230), the California Institute of Regenerative Medicine (RT2-01985), the K12 Child Health Research Career Development Award (2K12HD034610-16), and the Hyundai Hope on Wheels Scholar Award.	Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; American College of Medical Genetics and Genomics, ACMG UPD REC OPT OUT; Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; GraphPad Software, QUICKCALCS; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Griffin HR, J GENET, DOI [10.1038/gim.2014.66, DOI 10.1038/GIM.2014.66]; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Hutchon D. J. R., CALCULATOR CONFIDENC; Jacob HJ, 2013, NEW ENGL J MED, V369, P1557, DOI 10.1056/NEJMe1310846; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Papenhausen P, 2011, AM J MED GENET A, V155A, P757, DOI 10.1002/ajmg.a.33939; Rehder CW, 2013, GENET MED, V15, P150, DOI 10.1038/gim.2012.169; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Strom SP, 2014, GENET MED, V16, P510, DOI 10.1038/gim.2013.183; Strom SP, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-49; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yourshaw M, BRIEF BIOINFORM, DOI [10.1093/bib/bbu008, DOI 10.1093/BIB/BBU008]; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004	24	624	644	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1880	1887		10.1001/jama.2014.14604	http://dx.doi.org/10.1001/jama.2014.14604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS8ZE	25326637	Green Accepted, Bronze			2022-12-01	WOS:000344532600017
J	Sanyaolu, LN; Farmer, SEJ; Cuddihy, PJ				Sanyaolu, Leigh N.; Farmer, Sarah E. J.; Cuddihy, Patrick J.			Nasal septal haematoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; ABSCESS; DIAGNOSIS; CHILDREN		[Sanyaolu, Leigh N.; Farmer, Sarah E. J.; Cuddihy, Patrick J.] Royal Gwent Hosp, Dept Otolaryngol, Newport, Gwent, Wales	Royal Gwent Hospital	Sanyaolu, LN (corresponding author), Royal Gwent Hosp, Dept Otolaryngol, Newport, Gwent, Wales.	lnsanyaolu@doctors.org.uk		Sanyaolu, Leigh/0000-0002-6762-6986				Agrawal N, 2007, J EVAL CLIN PRACT, V13, P295, DOI 10.1111/j.1365-2753.2006.00700.x; Alshaikh N, 2011, INT J PEDIATR OTORHI, V75, P737, DOI 10.1016/j.ijporl.2011.03.010; Alvarez H, 2000, Auris Nasus Larynx, V27, P339, DOI 10.1016/S0385-8146(00)00071-7; Baring DEC, 2012, OTOLARYNG HEAD NECK, V146, P913, DOI 10.1177/0194599811435892; Canty PA, 1996, ARCH OTOLARYNGOL, V122, P1373; CHUKUEZI AB, 1992, J LARYNGOL OTOL, V106, P396, DOI 10.1017/S0022215100119656; Dispenza C, 2004, INT J PEDIATR OTORHI, V68, P1417, DOI 10.1016/j.ijporl.2004.05.014; Ferlito A, 2005, AM J OTOLARYNG, V26, P181, DOI 10.1016/j.amjoto.2004.11.006; Flint PW., 2010, CUMMINGS OTOLARYNGOL; Huang PH, 2006, OTOLARYNG HEAD NECK, V135, P335, DOI 10.1016/j.otohns.2005.09.015; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; MATSUBA HM, 1986, ANN PLAS SURG, V16, P161, DOI 10.1097/00000637-198602000-00015; OLSEN KD, 1980, ARCH OTOLARYNGOL, V106, P317; WILSON SW, 1994, INJURY, V25, P685, DOI 10.1016/0020-1383(94)90017-5; Wright RJ, 2011, FACIAL PLAST SURG, V27, P483, DOI 10.1055/s-0031-1288931	15	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2014	349								g6075	10.1136/bmj.g6075	http://dx.doi.org/10.1136/bmj.g6075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CC	25370844				2022-12-01	WOS:000344603600002
J	Marcus, G; Marblestone, A; Dean, T				Marcus, Gary; Marblestone, Adam; Dean, Thomas			The atoms of neural computation	SCIENCE			English	Editorial Material							PREFRONTAL CORTEX; BRAIN; SYNAPSES; MODEL		[Marcus, Gary] NYU, Dept Psychol, New York, NY 10003 USA; [Marcus, Gary] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Marblestone, Adam] MIT, Media Lab, Cambridge, MA 02139 USA; [Dean, Thomas] Google, Mountain View, CA 94043 USA	New York University; New York University; Massachusetts Institute of Technology (MIT); Google Incorporated	Marcus, G (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	gary.marcus@nyu.edu						Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Gallistel C., 2009, MEMORY COMPUTATIONAL, DOI 10.1002/9781444310498; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hayworth KJ, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00073; Kriete T, 2013, P NATL ACAD SCI USA, V110, P16390, DOI 10.1073/pnas.1303547110; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Marcus G., 2001, ALGEBRAIC MIND INTEG; O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; VONDERMALSBURG C, 1995, CURR OPIN NEUROBIOL, V5, P520, DOI 10.1016/0959-4388(95)80014-X	15	35	36	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		551	552		10.1126/science.1261661	http://dx.doi.org/10.1126/science.1261661			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359953	Green Submitted			2022-12-01	WOS:000343799700024
J	Zhou, CK; Slaughter, BD; Unruh, JR; Guo, FL; Yu, ZL; Mickey, K; Narkar, A; Ross, RT; McClain, M; Li, R				Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Guo, Fengli; Yu, Zulin; Mickey, Kristen; Narkar, Akshay; Ross, Rhonda Trimble; McClain, Melainia; Li, Rong			Organelle-Based Aggregation and Retention of Damaged Proteins in Asymmetrically Dividing Cells	CELL			English	Article							BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MISFOLDED PROTEINS; QUALITY-CONTROL; AGGRESOME FORMATION; HEAT-SHOCK; LIFE-SPAN; MITOCHONDRIA; STRESS; ER	Aggregation of damaged or misfolded proteins is a protective mechanism against proteotoxic stress, abnormalities of which underlie many aging-related diseases. Here, we show that in asymmetrically dividing yeast cells, aggregation of cytosolic misfolded proteins does not occur spontaneously but requires new polypeptide synthesis and is restricted to the surface of ER, which harbors the majority of active translation sites. Protein aggregates formed on ER are frequently also associated with or are later captured by mitochondria, greatly constraining aggregate mobility. During mitosis, aggregates are tethered to well-anchored maternal mitochondria, whereas mitochondria acquired by the bud are largely free of aggregates. Disruption of aggregate-mitochondria association resulted in increased mobility and leakage of mother-accumulated aggregates into the bud. Cells with advanced replicative age exhibit gradual decline of aggregates-mitochondria association, likely contributing to their diminished ability to rejuvenate through asymmetric cell division.	[Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Guo, Fengli; Yu, Zulin; Narkar, Akshay; Ross, Rhonda Trimble; McClain, Melainia; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Zhou, Chuankai; Narkar, Akshay; Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Mickey, Kristen] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	rli@stowers.org	Narkar, Akshay/AAD-2925-2022	Unruh, Jay/0000-0003-3077-4990	American Heart Association predoctoral fellowship [13PRE16750001]; NIH grant [RO1-GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	American Heart Association predoctoral fellowship(American Heart Association); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Parnell and B. Rubinstein for assistance with data analysis, J. Lange for assistance in microscopy, D. Bradford and S. McCroskey for assistance in strain construction, R. Parker, Y. Ohsumi, K. Weiss, J. Nunnari, D. Kaganovich, D. Gottschling, S. Jaspersen, and L. Pon for providing plasmids and strains, and R. Halfmann for comments on the manuscript. This work was supported by an American Heart Association predoctoral fellowship (13PRE16750001) (to C.Z.) and an NIH grant (RO1-GM057063) (to R.L.).	Altmann K, 2008, J CELL BIOL, V181, P119, DOI 10.1083/jcb.200709099; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bockler S, 2014, DEV CELL, V28, P450, DOI 10.1016/j.devcel.2014.01.012; Boldogh IR, 2004, MOL BIOL CELL, V15, P3994, DOI 10.1091/mbc.e04-01-0053; Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052; Camilleri A, 2013, BBA-BIOMEMBRANES, V1828, P2532, DOI 10.1016/j.bbamem.2013.06.026; Carpenter JF, 1999, METHOD ENZYMOL, V309, P236; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; PESTKA S, 1972, J BIOL CHEM, V247, P6895; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Rikhvanov EG, 2005, CURR GENET, V48, P44, DOI 10.1007/s00294-005-0587-z; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; SERRANO R, 1977, EUR J BIOCHEM, V80, P97, DOI 10.1111/j.1432-1033.1977.tb11861.x; Slaughter BD, 2010, MOL BIOL CELL, V21, P4306, DOI 10.1091/mbc.E10-05-0451; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Unruh JR, 2013, CURR BIOL, V23, pR74, DOI 10.1016/j.cub.2012.12.005; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	50	139	139	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					530	542		10.1016/j.cell.2014.09.026	http://dx.doi.org/10.1016/j.cell.2014.09.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417105	Green Accepted, Bronze			2022-12-01	WOS:000344521700010
J	Cohen, PA; Maller, G; DeSouza, R; Neal-Kababick, J				Cohen, Pieter A.; Maller, Gregory; DeSouza, Renan; Neal-Kababick, James			Presence of Banned Drugs in Dietary Supplements Following FDA Recalls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Cohen, Pieter A.] Harvard Univ, Sch Med, Boston, MA USA; [Maller, Gregory; DeSouza, Renan] Cornell Univ, Ithaca, NY USA; [Neal-Kababick, James] Flora Res Labs, Grants Pass, OR USA	Harvard University; Harvard Medical School; Cornell University	Cohen, PA (corresponding author), 236 Highland Ave, Somerville, MA 02143 USA.	pcohen@challiance.org						[Anonymous], TAINT SUPPL CDER; Cohen PA, 2012, J GEN INTERN MED, V27, P51, DOI 10.1007/s11606-011-1828-0; Harel Z, 2013, JAMA INTERN MED, V173, P926, DOI 10.1001/jamainternmed.2013.379; Mans DJ, 2013, J PHARMACEUT BIOMED, V83, P122, DOI 10.1016/j.jpba.2013.02.031; US Food and Drug Administration, REC HLTH FRAUD; US Food and Drug Administration, SAF REC MARK WITHDR	6	66	66	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1691	1693		10.1001/jama.2014.10308	http://dx.doi.org/10.1001/jama.2014.10308			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335153	Green Published, Bronze			2022-12-01	WOS:000343301400028
J	Lewis, B				Lewis, Barbara			ESSAY Joan's family bill of rights: an essay by Barbara Lewis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Joans Family Bill Rights, Los Angeles, CA 90077 USA		Lewis, B (corresponding author), Joans Family Bill Rights, 2934 Beverly Glen Circle,Suite 240, Los Angeles, CA 90077 USA.	BarbaraLewis@JoansFamilyBillOfRights.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6022	10.1136/bmj.g6022	http://dx.doi.org/10.1136/bmj.g6022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25353644				2022-12-01	WOS:000343767700002
J	Neuman, MD; Wirtalla, C; Werner, RM				Neuman, Mark D.; Wirtalla, Christopher; Werner, Rachel M.			Association Between Skilled Nursing Facility Quality Indicators and Hospital Readmissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POST-ACUTE CARE; OF-CARE; RACIAL DISPARITIES; MEDICAID PAYMENT; HOME QUALITY; FOR-PROFIT; REHOSPITALIZATION; RESIDENTS; COST	IMPORTANCE Hospital readmissions are common, costly, and potentially preventable. Little is known about the association between available skilled nursing facility (SNF) performance measures and the risk of hospital readmission. OBJECTIVE To measure the association between SNF performance measures and hospital readmissions among Medicare beneficiaries receiving postacute care at SNFs in the United States. DESIGN AND PARTICIPANTS Using national Medicare data on fee-for-service Medicare beneficiaries discharged to a SNF after an acute care hospitalization between September 1, 2009, and August 31, 2010, we examined the association between SNF performance on publicly available metrics (SNF staffing intensity, health deficiencies identified through site inspections, and the percentages of SNF patients with delirium, moderate to severe pain, and new or worsening pressure ulcers) and the risk of readmission or death 30 days after discharge to a SNF. Adjusted analyses controlled for patient case mix, SNF facility factors, and the discharging hospital. MAIN OUTCOMES AND MEASURES Readmission to an acute care hospital or death within 30 days of the index hospital discharge. RESULTS Of 1 530 824 patients discharged, 357 752 (23.3%; 99% CI, 23.3%-23.5%) were readmitted or died within 30 days; 72 472 died within 30 days (4.7%; 99% CI, 4.7%-4.8%), and 321 709 were readmitted (21.0%; 99% CI, 20.9%-21.1%). The unadjusted risk of readmission or death was lower at SNFs with better staffing ratings and better facility inspection ratings. [GRAPHICS] Adjustment for patient factors, SNF facility factors, and the discharging hospital attenuated these associations; we observed small differences in the adjusted risk of readmission or death according to SNF facility inspection ratings. Other measures did not predict clinically meaningful differences in the adjusted risk of readmission or death. CONCLUSIONS AND RELEVANCE Among fee-for-service Medicare beneficiaries discharged to a SNF after an acute care hospitalization, available performance measures were not consistently associated with differences in the adjusted risk of readmission or death. Copyright 2014 American Medical Association. All rights reserved.	[Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Werner, Rachel M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Wirtalla, Christopher; Werner, Rachel M.] Univ Penn, Div Gen Internal Med, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Neuman, MD (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, 423 Guardian Dr,1119A Blockley Hall, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221	National Institute on Aging [K08AG043548, R01 AG034182]; NATIONAL INSTITUTE ON AGING [K08AG043548, R01AG034182] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging (grant K08AG043548 to Dr Neuman; grant R01 AG034182 to Dr Werner).	Ackerly DC, 2014, NEW ENGL J MED, V370, P689, DOI 10.1056/NEJMp1315350; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Bostick JE, 2006, J AM MED DIR ASSOC, V7, P366, DOI 10.1016/j.jamda.2006.01.024; Centers for Medicare and Medicaid Services, 2012, DES NURS HOM COMP 5; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Diehr P, 2005, J CLIN EPIDEMIOL, V58, P1115, DOI 10.1016/j.jclinepi.2005.05.002; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Grabowski DC, 2004, HEALTH SERV RES, V39, P793, DOI 10.1111/j.1475-6773.2004.00258.x; Grabowski DC, 2004, HEALTH AFFAIR, V23, P243, DOI 10.1377/hlthaff.23.5.243; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2004, J HEALTH POLIT POLIC, V29, P43, DOI 10.1215/03616878-29-1-43; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Harrington C, 2012, HEALTH SERV RES, V47, P106, DOI 10.1111/j.1475-6773.2011.01311.x; Hillmer MP, 2005, MED CARE RES REV, V62, P139, DOI 10.1177/1077558704273769; Horwitz LI, 2013, MEASURE UPDATES SPEC; Hughes CM, 2000, MED CARE, V38, P1164, DOI 10.1097/00005650-200012000-00003; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kim H, 2009, GERONTOLOGIST, V49, P81, DOI 10.1093/geront/gnp014; Kim H, 2009, J GERONTOL B-PSYCHOL, V64, P269, DOI 10.1093/geronb/gbn019; Li Y, 2011, AM J PUBLIC HEALTH, V101, P875, DOI 10.2105/AJPH.2010.300055; Mechanic R, 2014, NEW ENGL J MED, V370, P692, DOI 10.1056/NEJMp1315607; Mechanic RE, 2011, NEW ENGL J MED, V365, P777, DOI 10.1056/NEJMp1105963; Mor V, 2004, MILBANK Q, V82, P227, DOI 10.1111/j.0887-378X.2004.00309.x; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Morris JN., 2003, VALIDATION LONG TERM; Ouslander JG, 2011, NEW ENGL J MED, V365, P1165, DOI 10.1056/NEJMp1105449; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Rantz MJ, 2004, GERONTOLOGIST, V44, P24, DOI 10.1093/geront/44.1.24; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Saliba D, 2005, DESIGN VALIDATION PO; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Unroe KT, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.04.020; US Department of Health and Human Services; Office of the Inspector General, 2013, MED NURS HOM RES HOS	36	99	99	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1542	1551		10.1001/jama.2014.13513	http://dx.doi.org/10.1001/jama.2014.13513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7HL	25321909	Green Accepted			2022-12-01	WOS:000342983200018
J	Marvi, H; Gong, CH; Gravish, N; Astley, H; Travers, M; Hatton, RL; Mendelson, JR; Choset, H; Hu, DL; Goldman, DI				Marvi, Hamidreza; Gong, Chaohui; Gravish, Nick; Astley, Henry; Travers, Matthew; Hatton, Ross L.; Mendelson, Joseph R., III; Choset, Howie; Hu, David L.; Goldman, Daniel I.			Sidewinding with minimal slip: Snake and robot ascent of sandy slopes	SCIENCE			English	Article							LEGGED LOCOMOTION; FLIGHT; MECHANICS; MODELS	Limbless organisms such as snakes can navigate nearly all terrain. In particular, desert-dwelling sidewinder rattlesnakes (Crotalus cerastes) operate effectively on inclined granular media (such as sand dunes) that induce failure in field-tested limbless robots through slipping and pitching. Our laboratory experiments reveal that as granular incline angle increases, sidewinder rattlesnakes increase the length of their body in contact with the sand. Implementing this strategy in a physical robot model of the snake enables the device to ascend sandy slopes close to the angle of maximum slope stability. Plate drag experiments demonstrate that granular yield stresses decrease with increasing incline angle. Together, these three approaches demonstrate how sidewinding with contact-length control mitigates failure on granular media.	[Marvi, Hamidreza; Hu, David L.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA; [Marvi, Hamidreza; Gravish, Nick; Astley, Henry; Hu, David L.; Goldman, Daniel I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Gong, Chaohui; Travers, Matthew; Choset, Howie] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Hatton, Ross L.] Oregon State Univ, Sch Mech Ind & Mfg Engn, Corvallis, OR 97331 USA; [Mendelson, Joseph R., III; Hu, David L.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Mendelson, Joseph R., III] Zoo Atlanta, Dept Herpetol, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Carnegie Mellon University; Oregon State University; University System of Georgia; Georgia Institute of Technology	Goldman, DI (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	daniel.goldman@physics.gatech.edu		Gravish, Nicholas/0000-0002-9391-2476	National Science Foundation (NSF) [CMMI-1000389, PHY-0848894, PHY-1205878, PHY-1150760]; Army Research Office [W911NF-11-1-0514, W911NF1310092]; Army Research Lab Micro Autonomous Systems and Technology Collaborative Technology Alliance [W911NF-08-2-0004]; Elizabeth Smithgall Watts endowment; Division Of Physics [1205878] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1426443] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Army Research Office; Army Research Lab Micro Autonomous Systems and Technology Collaborative Technology Alliance; Elizabeth Smithgall Watts endowment; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank M. Tesch, E. Cappo, J. Rembisz, and L. Li from Robotics Institute at Carnegie Mellon University for helping with the robot experiments; J. Brock, D. Brothers, R. Hill, L. Wyrwich, and B. Lock from Zoo Atlanta for helping with snake experiments; A. Young and K. Young for assistance with collecting snakes; D. Dimenichi, R. Chrystal, and J. Shieh from Georgia Institute of Technology for helping with construction and video analysis; T. Nowak and C. Hobbs for photography; V. Linevich for CAD drawings; P. Umbanhowar and A. Zangwill for helpful discussion; the National Science Foundation (NSF) (CMMI-1000389, PHY-0848894, PHY-1205878, and PHY-1150760); Army Research Office under grants W911NF-11-1-0514 and W911NF1310092; the Army Research Lab Micro Autonomous Systems and Technology Collaborative Technology Alliance under grant W911NF-08-2-0004; and the Elizabeth Smithgall Watts endowment, for financial support. D. I. G., H. C., and D. H. also acknowledge the Army Research Office and NSF Physics of Living Systems for supporting the Locomotion Systems Science Workshop in Arlington, Virginia, May 2012. The data collected for this study will be made available through the SMARTech data repository at Georgia Institute of Technology.	Albert R, 1999, PHYS REV LETT, V82, P205, DOI 10.1103/PhysRevLett.82.205; Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011; BURDICK JW, 1995, ADV ROBOTICS, V9, P195, DOI 10.1163/156855395X00166; Byrnes G, 2010, J EXP BIOL, V213, P4249, DOI 10.1242/jeb.047225; Clark JE, 2001, IEEE INT CONF ROBOT, P3643, DOI 10.1109/ROBOT.2001.933183; Costantino DJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011305; Costello M, 2008, P I MECH ENG G-J AER, V222, P1067, DOI 10.1243/09544100JAERO304; GRAY J, 1946, J EXP BIOL, V23, P101; Hatton RL, 2010, IEEE INT CONF ROBOT, P691, DOI 10.1109/ROBOT.2010.5509875; Henann DL, 2013, P NATL ACAD SCI USA, V110, P6730, DOI 10.1073/pnas.1219153110; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Hu DL, 2009, P NATL ACAD SCI USA, V106, P10081, DOI 10.1073/pnas.0812533106; JAYNE BC, 1985, COPEIA, P195, DOI 10.2307/1444809; JAYNE BC, 1988, J EXP BIOL, V140, P1; JAYNE BC, 1986, COPEIA, P915, DOI 10.2307/1445288; Katsuragi H, 2007, NAT PHYS, V3, P420, DOI 10.1038/nphys583; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2009, P NATL ACAD SCI USA, V106, P3029, DOI 10.1073/pnas.0809095106; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Maladen RD, 2009, SCIENCE, V325, P314, DOI 10.1126/science.1172490; Marvi H, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0188; Marvi H, 2012, J R SOC INTERFACE, V9, P3067, DOI 10.1098/rsif.2012.0132; Mazouchova N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026007; Mazouchova N, 2010, BIOL LETTERS, V6, P398, DOI 10.1098/rsbl.2009.1041; Mosauer W, 1930, AM NAT, V64, P179, DOI 10.1086/280308; NORRIS KS, 1966, COPEIA, P650; Playter R., 2006, P SOC PHOTO-OPT INS, V6230; SECOR SM, 1992, J EXP BIOL, V163, P1; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Socha JJ, 2002, NATURE, V418, P603, DOI 10.1038/418603a; Tesch M, 2009, ADV ROBOTICS, V23, P1131, DOI 10.1163/156855309X452566; Winter AG, 2012, J EXP BIOL, V215, P2072, DOI 10.1242/jeb.058172	32	147	151	15	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					224	229		10.1126/science.1255718	http://dx.doi.org/10.1126/science.1255718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301625	Green Submitted			2022-12-01	WOS:000342721500045
J	Rasmussen, SA; Jamieson, DJ				Rasmussen, Sonja A.; Jamieson, Denise J.			2009 H1N1 Influenza and Pregnancy-5 Years Later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rasmussen, Sonja A.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Rasmussen, Sonja/0000-0002-0574-4928; Jamieson, Denise/0000-0003-2597-1201				Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Rasmussen SA, 2012, CLIN OBSTET GYNECOL, V55, P487, DOI 10.1097/GRF.0b013e31824df23e; Uyeki TM, 2014, NEW ENGL J MED, V370, P789, DOI 10.1056/NEJMp1400034; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wollenhaupt M, 2014, PHARMACOEPIDEMIOL DR	5	20	20	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1373	1375		10.1056/NEJMp1403496	http://dx.doi.org/10.1056/NEJMp1403496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295498				2022-12-01	WOS:000342674800004
J	Meng, LY; Ward, AJ; Chun, S; Bennett, CF; Beaudet, AL; Rigo, F				Meng, Linyan; Ward, Amanda J.; Chun, Seung; Bennett, C. Frank; Beaudet, Arthur L.; Rigo, Frank			Towards a therapy for Angelman syndrome by targeting a long non-coding RNA	NATURE			English	Article							ANTISENSE OLIGONUCLEOTIDE; UBIQUITIN LIGASE; UBE3A; MODEL; PHARMACOLOGY; TRANSCRIPT; EXPRESSION; MUTATIONS; REPRESSES; DEFICITS	Angelman syndromeis a single-gene disorder characterized by intellectual disability, developmental delay, behavioural uniqueness, speech impairment, seizures and ataxia(1,2). It is caused by maternal deficiency of the imprinted gene UBE3A, encoding an E3 ubiquitin ligase(3-5). All patients carry at least one copy of paternal UBE3A, which is intact but silenced by a nuclear-localized long non-coding RNA, UBE3A antisense transcript (UBE3A-ATS)(6-8). Murine Ube3a-ATS reduction by either transcription termination or topoisomerase I inhibition has been shown to increase paternal Ube3a expression(9,10). Despite a clear understanding of the disease-causing event in Angelman syndrome and the potential to harness the intact paternal allele to correct the disease, no gene-specific treatment exists for patients. Here we developed a potential therapeutic intervention for Angelman syndrome by reducing Ube3a-ATS with antisense oligonucleotides (ASOs). ASO treatment achieved specific reduction of Ube3a-ATS and sustained unsilencing of paternal Ube3a in neurons in vitro and in vivo. Partial restoration of UBE3A protein in an Angelman syndrome mouse model ameliorated some cognitive deficits associated with the disease. Although additional studies of phenotypic correction are needed, we have developed a sequence-specific and clinically feasible method to activate expression of the paternal Ube3a allele.	[Meng, Linyan; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Meng, Linyan; Beaudet, Arthur L.] Texas Childrens Hosp, Houston, TX 77030 USA; [Ward, Amanda J.; Chun, Seung; Bennett, C. Frank; Rigo, Frank] ISIS Pharmaceut, Dept Core Antisense Res, Carlsbad, CA 92010 USA	Baylor College of Medicine; Baylor College of Medicine; Isis Pharmaceuticals Inc	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.edu; frigo@isisph.com		Whipple, Amanda/0000-0002-7000-2453	National Institutes of Health [R01 HD037283]; Angelman Syndrome Foundation; Baylor College of Medicine Intellectual and Developmental Disability Research Center [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092, R01HD037283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angelman Syndrome Foundation; Baylor College of Medicine Intellectual and Developmental Disability Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank T. Cooper for suggesting the collaboration between L.M., A.L.B. and Isis Pharmaceuticals. L.M. thanks D. Liu, X. Jun, H. Zheng, J. Rosen, C. Spencer and X. Zhai for technical support and reagent sharing, and M. Costa-Mattioli, J. Jankowsky and Y. Elgersma for discussions. This research was supported by funding from National Institutes of Health grant R01 HD037283 (A.L.B.), the Angelman Syndrome Foundation (A.L.B. and L.M.), and Baylor College of Medicine Intellectual and Developmental Disability Research Center grant P30HD024064.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Allensworth M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-7; Butler M, 1997, LAB INVEST, V77, P379; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Chiriboga C., 2013, 65 AM AC NEUR ANN M; Dagli A, 2011, MOL SYNDROMOL, V2, P100, DOI 10.1159/000328837; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Huang HS, 2013, BEHAV BRAIN RES, V243, P79, DOI 10.1016/j.bbr.2012.12.052; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meng LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004039; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Williams CA, 2010, GENET MED, V12, P385, DOI 10.1097/GIM.0b013e3181def138; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200	26	311	330	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					409	412		10.1038/nature13975	http://dx.doi.org/10.1038/nature13975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470045	Green Accepted			2022-12-01	WOS:000349547400044
J	Aboderin, IAG; Beard, JR				Aboderin, Isabella A. G.; Beard, John R.			Older people's health in sub- Saharan Africa	LANCET			English	Editorial Material							CHALLENGES; IBADAN; HIV		[Aboderin, Isabella A. G.] African Populat & Hlth Res Ctr, Nairobi 00100, Kenya; [Aboderin, Isabella A. G.] Univ Southampton, Ctr Res Ageing, Southampton, Hants, England; [Beard, John R.] WHO, Dept Ageing & Life Course, CH-1211 Geneva, Switzerland	African Population & Health Research Centre; University of Southampton; World Health Organization	Aboderin, IAG (corresponding author), African Populat & Hlth Res Ctr, POB 10787, Nairobi 00100, Kenya.	iaboderin@aphrc.org	Beard, John R/K-9621-2014; Beard, John/AAI-4592-2021	Beard, John R/0000-0002-8557-0242; Beard, John/0000-0002-8557-0242	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aboderin I., 2010, DIMENSIONS DETERMINA; Aboderin I, 2013, 20 INT ASS GER GER W; Bekibele CO, 2008, OPHTHAL EPIDEMIOL, V15, P250, DOI 10.1080/09286580802336583; Bloom D.E., 2012, GLOBAL POPULATION AG, P35; Clausen T, 2005, J NUTR HEALTH AGING, V9, P455; Gureje O, 2007, LANCET, V370, P957, DOI 10.1016/S0140-6736(07)61446-9; Gureje O, 2014, J AM GERIATR SOC, V62, P836, DOI 10.1111/jgs.12802; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Lowsky DJ, 2014, J GERONTOL A-BIOL, V69, P640, DOI 10.1093/gerona/glt162; Mathenge M.K., 2011, MARKET PARTICIPATION; McIntyre D., 2004, LIVING LONGER AGEING, P160; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Olukoya P., 2014, GHANA COUNTRY ASSESS; Payne CF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001435; Skovdal M, 2011, AIDS CARE, V23, P957, DOI 10.1080/09540121.2010.542298; United Nations Children's Fund (UNICEF), 2007, STAT WORLDS CHILDR D; United Nations Economic Commission for Africa, 2013, AFR REG CONS M SUST; United Nations Population Division, 2012, POP AG DEV 2012; United Nations Population Division, WORLD POP PROSP 2012; WHO, 2012, GOOD HLTH ADDS LIF Y	20	91	93	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					E9	E11		10.1016/S0140-6736(14)61602-0	http://dx.doi.org/10.1016/S0140-6736(14)61602-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468150				2022-12-01	WOS:000349214000002
J	Murray, CJL				Murray, Christopher J. L.			Maximizing Antiretroviral Therapy in Developing Countries The Dual Challenge of Efficiency and Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV		Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu						De Cock KM, 2014, CLIN INFECT DIS, V58, P1012, DOI 10.1093/cid/ciu026; IHME, 2014, HLTH SERVICE PROVISI; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; UNAIDS, 2014, GAP REP; World Health Organization, CONS GUID US ANT DRU	6	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					359	360		10.1001/jama.2014.16376	http://dx.doi.org/10.1001/jama.2014.16376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25436833				2022-12-01	WOS:000349072600014
J	Motani, R; Jiang, DY; Chen, GB; Tintori, A; Rieppel, O; Ji, C; Huang, JD				Motani, Ryosuke; Jiang, Da-Yong; Chen, Guan-Bao; Tintori, Andrea; Rieppel, Olivier; Ji, Cheng; Huang, Jian-Dong			A basal ichthyosauriform with a short snout from the Lower Triassic of China	NATURE			English	Article							LETHALLY HOT TEMPERATURES; GREENHOUSE; REPTILIA; AMNIOTES; CHAOHU	The incompleteness of the fossil record obscures the origin of many of the more derived clades of vertebrates. One such group is the Ichthyopterygia, a clade of obligatory marine reptiles that appeared in the Early Triassic epoch, without any known intermediates(1). Here we describe a basal ichthyosauriform from the upper Lower Triassic (about 248 million years ago) of China, whose primitive skeleton indicates possible amphibious habits. It is smaller than ichthyopterygians and had unusually large flippers that probably allowed limited terrestrial locomotion. It also retained characteristics of terrestrial diapsid reptiles, including a short snout and body trunk(2). Unlike more-derived ichthyosauriforms(3), it was probably a suction feeder. The new species supports the sister-group relationships between ichthyosauriforms and Hupehsuchia(4), the two forming the Ichthyosauromorpha. Basal ichthyosauromorphs are known exclusively from south China, suggesting that the clade originated in the region, which formed a warm(5,6) and humid(7) tropical archipelago(8) in the Early Triassic. The oldest unequivocal record of a sauropterygian is also from the same stratigraphic unit of the region(9).	[Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-Yong] Peking Univ, Minist Educ, Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Jiang, Da-Yong] Peking Univ, Dept Geol, Beijing 100871, Peoples R China; [Jiang, Da-Yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Jiang, Da-Yong] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Guan-Bao; Huang, Jian-Dong] Anhui Geol Museum, Dept Res, Hefei 230031, Anhui, Peoples R China; [Tintori, Andrea] Univ Milan, Dipartimento Sci Terra, I-20133 Milan, Italy; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL 60605 USA; [Ji, Cheng] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China	University of California System; University of California Davis; Peking University; Peking University; Peking University; Chinese Academy of Sciences; University of Milan; Field Museum of Natural History (Chicago); Chinese Academy of Sciences	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA.	rmotani@ucdavis.edu; djiang@pku.edu.cn	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	National Geographic Society Committee for Research and Exploration [8669-09]; National Natural Science Foundation of China [40920124002, 41372016]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123102]; Research Fund for the Doctoral Program of Higher Education [20120001110072]; Project of Protection for Geological Heritage from Department of Land and Resource of Anhui Province	National Geographic Society Committee for Research and Exploration(National Geographic Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Project of Protection for Geological Heritage from Department of Land and Resource of Anhui Province	We thank T. Sato for the excellent preparation of the holotype. The study was enabled by grants from the National Geographic Society Committee for Research and Exploration (8669-09) to R.M., Project 40920124002 and 41372016 from the National Natural Science Foundation of China to D.-Y.J., Project 123102 from State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) to D.-Y.J., Project 20120001110072 from the Research Fund for the Doctoral Program of Higher Education to D.-Y.J., and a Project of Protection for Geological Heritage from Department of Land and Resource of Anhui Province to G.-B.C.	Boettcher, 1990, STUTTGARTER BEITRA B, V164, P1; Caldwell Michael W., 1994, Journal of Vertebrate Paleontology, V14, p19A; CALLAWAY JM, 1989, CAN J EARTH SCI, V26, P1491, DOI 10.1139/e89-126; CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; CARROLL RL, 1985, SPEC PAP PALAEONTOL, P145; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; Goudemand N, 2013, SCIENCE, V339, DOI 10.1126/science.1232924; Harland W.B., 1997, GEOLOGICAL SOC MEMOI, V17, P1, DOI [DOI 10.1144/gsl.mem.1997.017.01.16, 10.1144/GSL.MEM.1997.017.01.26, DOI 10.1144/GSL.MEM.1997.017.01.26]; Hoffstetter R., 1969, P201; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Jiang DY, 2014, J VERTEBR PALEONTOL, V34, P1044, DOI 10.1080/02724634.2014.846264; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; Mazouchova N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026007; McGOWAN C., 2003, ICHTHYOPTERYGIA, V8; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani R., J VERTEBR P IN PRESS; Motani R., 2014, PLOS ONE, V9; Motani R., 1972, J VERTEBR P IN PRESS; Motani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066075; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nicholls Elizabeth L., 1995, P521; Peron S, 2005, GEODIN ACTA, V18, P431, DOI 10.3166/ga.18.431-446; RIEPPEL O, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P123; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Sun ZM, 2009, EARTH PLANET SC LETT, V279, P350, DOI 10.1016/j.epsl.2009.01.009; Talevi M, 2012, NATURWISSENSCHAFTEN, V99, P241, DOI 10.1007/s00114-012-0886-4; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Xiao WJ, 2005, GEOL SOC AM BULL, V117, P945, DOI 10.1130/B25417.1	29	77	85	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					485	+		10.1038/nature13866	http://dx.doi.org/10.1038/nature13866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25383536				2022-12-01	WOS:000348196500034
J	Wang, JC; Xie, GC; Singh, M; Ghanbarian, AT; Rasko, T; Szvetnik, A; Cai, HQ; Besser, D; Prigione, A; Fuchs, NV; Schumann, GG; Chen, W; Lorincz, MC; Ivics, Z; Hurst, LD; Izsvak, Z				Wang, Jichang; Xie, Gangcai; Singh, Manvendra; Ghanbarian, Avazeh T.; Rasko, Tamas; Szvetnik, Attila; Cai, Huiqiang; Besser, Daniel; Prigione, Alessandro; Fuchs, Nina V.; Schumann, Gerald G.; Chen, Wei; Lorincz, Matthew C.; Ivics, Zoltan; Hurst, Laurence D.; Izsvak, Zsuzsanna			Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells	NATURE			English	Article							SLEEPING-BEAUTY; RNA-SEQ; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; PLURIPOTENCY; CHROMATIN; INDUCTION; PROGRAM; NETWORK; DIFFERENTIATION	Naive embryonic stem cells hold great promise for research and therapeutics as they have broad and robust developmental potential. While such cells are readily derived from mouse blastocysts it has not been possible to isolate human equivalents easily(1,2), although human naive-like cells have been artificially generated (rather than extracted) by coercion of human primed embryonic stem cells by modifying culture conditions(2-4) or through transgenic modification(5). Here we show that a sub-population within cultures of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) manifests key properties of naive state cells. These naive-like cells can be genetically tagged, and are associated with elevated transcription of HERVH, a primate-specific endogenous retrovirus. HERVH elements provide functional binding sites for a combination of naive pluripotency transcription factors, including LBP9, recently recognized as relevant to naivety inmice(6). LBP9-HERVH drives hESC-specific alternative and chimaeric transcripts, including pluripotency-modulating long non-coding RNAs. Disruption of LBP9, HERVH and HERVH-derived transcripts compromises self-renewal. These observations define HERVH expression as a hallmark of naive-like hESCs, and establish novel primate-specific transcriptional circuitry regulating pluripotency.	[Wang, Jichang; Xie, Gangcai; Singh, Manvendra; Rasko, Tamas; Szvetnik, Attila; Cai, Huiqiang; Besser, Daniel; Prigione, Alessandro; Fuchs, Nina V.; Chen, Wei; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Xie, Gangcai] CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Ghanbarian, Avazeh T.; Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Fuchs, Nina V.; Schumann, Gerald G.; Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; University of Bath; Paul Ehrlich Institute; University of British Columbia	Izsvak, Z (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	l.d.hurst@bath.ac.uk; zizsvak@mdc-berlin.de	Besser, Daniel/A-8304-2012; Xie, Gangcai/AAN-9197-2021; Ghanbarian, Avazeh/H-7310-2019; Prigione, Alessandro/ABA-1584-2021; Chen, Wei/C-1273-2011; Alessandro, Prigione/B-2959-2013; Hurst, Laurence/F-9215-2010	Besser, Daniel/0000-0002-4958-9624; Xie, Gangcai/0000-0002-8286-2987; Ghanbarian, Avazeh/0000-0003-3920-5807; Izsvak, Zsuzsanna/0000-0002-2053-2384; Fuchs, Nina/0000-0003-4175-0740; Singh, Manvendra/0000-0002-8626-5418; Wang, Jichang/0000-0002-7027-0298; Alessandro, Prigione/0000-0001-9457-1952; Lorincz, Matthew/0000-0003-0885-0467; Hurst, Laurence/0000-0002-1002-1054	University of Bath; DFG [SCHU1014/8-1]; LOEWE Center for Cell and Gene Therapy Frankfurt/Hessian Ministry of Higher Education, Research and the Arts [III L 4-518/17.004];  [ERC-2011-AdG 294742]	University of Bath; DFG(German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy Frankfurt/Hessian Ministry of Higher Education, Research and the Arts; 	L.D.H. is Wolfson Royal Society Research Merit Award Holder. A.T.G. is funded by a scholarship from the University of Bath. Z.Iz. is funded by ERC-2011-AdG 294742. G.G.S. is funded by DFG grant SCHU1014/8-1 and LOEWE Center for Cell and Gene Therapy Frankfurt/Hessian Ministry of Higher Education, Research and the Arts (ref. number III L 4-518/17.004). We thank U. Martin and S. Merkert (Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover Medical School, Hannover, Germany) for providing the cell lines hCBEC, hCBiPS1, hCBiPS2 and hFF-iPS4. We thank G. Klein for the inspiration of working with ERVs and Z. Cseresnyes for his assistance in imaging.	Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Grabundzija I, 2013, NUCLEIC ACIDS RES, V41, P1829, DOI 10.1093/nar/gks1305; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Kaufman Christopher D, 2005, J RNAi Gene Silencing, V1, P97; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishiyama A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01390; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Theunissen T.W., 2014, CELL STEM CELL; To S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011702; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Volders P.-J., 2012, NUCLEIC ACIDS RES, V41, P246; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Welling M, 2013, TRENDS CELL BIOL, V23, P442, DOI 10.1016/j.tcb.2013.04.004; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000	56	255	270	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					405	+		10.1038/nature13804	http://dx.doi.org/10.1038/nature13804			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25317556	Green Accepted			2022-12-01	WOS:000346484800049
J	Humphries, C				Humphries, Courtney			SEX DIFFERENCES: Luck of the chromosomes	NATURE			English	Editorial Material							GENDER DISPARITY											Hartwell HJ, 2014, P NATL ACAD SCI USA, V111, P11455, DOI 10.1073/pnas.1404267111; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu WC, 2014, WORLD J GASTROENTERO, V20, P6252, DOI 10.3748/wjg.v20.i20.6252; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143	5	9	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S10	S11		10.1038/516S10a	http://dx.doi.org/10.1038/516S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470193	Bronze			2022-12-01	WOS:000346310800004
J	Seok, S; Fu, T; Choi, SE; Li, Y; Zhu, R; Kumar, S; Sun, XX; Yoon, G; Kang, Y; Zhong, WX; Ma, J; Kemper, B; Kemper, JK				Seok, Sunmi; Fu, Ting; Choi, Sung-E; Li, Yang; Zhu, Rong; Kumar, Subodh; Sun, Xiaoxiao; Yoon, Gyesoon; Kang, Yup; Zhong, Wenxuan; Ma, Jian; Kemper, Byron; Kemper, Jongsook Kim			Transcriptional regulation of autophagy by an FXR-CREB axis	NATURE			English	Article							FARNESOID X RECEPTOR; COACTIVATOR CRTC2; LIPID-METABOLISM; GENOMIC ANALYSIS; ER STRESS; PHOSPHORYLATION; DISEASE; BINDING; OBESITY; LIVER	Lysosomal degradation of cytoplasmic components by autophagy is essential for cellular survival and homeostasis under nutrient-deprived conditions(1-4). Acute regulation of autophagy by nutrient-sensing kinases is well defined(3,5-7), but longer-term transcriptional regulation is relatively unknown. Here we show that the fed-state sensing nuclear receptor farnesoid X receptor (FXR)(8,9) and the fasting transcriptional activator cAMP response element-binding protein (CREB)(10,11) coordinately regulate the hepatic autophagy gene network. Pharmacological activation of FXR repressed many autophagy genes and inhibited autophagy even in fasted mice, and feeding-mediated inhibition of macroautophagy was attenuated in FXR-knockout mice. From mouse liver chromatin immunoprecipitation and high-throughput sequencing data(12,15), FXR and CREB binding peaks were detected at 178 and 112 genes, respectively, out of 230 autophagy-related genes, and 78 genes showed shared binding, mostly in their promoter regions. CREB promoted autophagic degradation of lipids, or lipophagy(16), under nutrient-deprived conditions, and FXR inhibited this response. Mechanistically, CREB upregulated autophagy genes, including A tg7, Ulkl and Tfeb, by recruiting the coactivator CRTC2. After feeding or pharmacological activation, FXR trans-repressed these genes by disrupting the functional CREB-CRTC2 complex. This study identifies the new FXR-CREB axis as a key physiological switch regulating autophagy, resulting in sustained nutrient regulation of autophagy during feeding/fasting cycles.	[Seok, Sunmi; Fu, Ting; Choi, Sung-E; Kumar, Subodh; Kemper, Byron; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Choi, Sung-E; Yoon, Gyesoon; Kang, Yup] Ajou Univ, Sch Med, Inst Med Sci, Suwon 442749, South Korea; [Li, Yang; Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Li, Yang; Ma, Jian] Univ Illinois, Inst Genome Biol, Urbana, IL 61801 USA; [Zhu, Rong; Sun, Xiaoxiao; Zhong, Wenxuan] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University of Illinois System; University of Illinois Urbana-Champaign; Ajou University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; University of Georgia	Kemper, JK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	jongsook@illinois.edu	Ma, Jian/A-9838-2008; Fu, Shirley Ting/B-7632-2018; Li, Yang/F-4020-2012	Ma, Jian/0000-0002-4202-5834; Li, Yang/0000-0001-5464-4328	National Institutes of Health [DK62777, DK95842]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062777, R56DK062777, R01DK095842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Ryerson and D. Tkac for constructing the pGEX4T-FXR clones. We thank M. Montminy for providing Ad-CRTC2 and Ad-CRTC2(S171A), S.-H. Koo for the CREB and CRTC2 plasmids, G. Hotamisligil for Ad-GFP-LC3, and R. Puertollano for the Flag-TFEB plasmid. This study was supported by grants from the National Institutes of Health (DK62777 and DK95842) to J.K.K.	Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee J, 2012, HEPATOLOGY, V56, P108, DOI 10.1002/hep.25609; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sachdeva UM, 2008, AUTOPHAGY, V4, P581, DOI 10.4161/auto.6141; Seok S, 2013, J BIOL CHEM, V288, P23252, DOI 10.1074/jbc.M113.452037; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	26	278	289	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					108	U274		10.1038/nature13949	http://dx.doi.org/10.1038/nature13949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383523	Green Published, Green Accepted			2022-12-01	WOS:000346310800049
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Industry's interest in diagnosing more dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Alzheimer's Society, 2012, THE PATIENT JOURNEY; Alzheimer's Society, 2014, DEMENTIA UK UPDATE; Alzheimer's Society, 2013, WORRIED ABOUT YOUR M; [Anonymous], 2014, MEMBERS LILLY UK; Brunet M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6666; Burns A, 2013, TIMELY DIAGNOSIS OF; Hughes J, 2014, RAPID RESPONSE; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Ramesh R., 2013, GUARDIAN	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2014	349								g7480	10.1136/bmj.g7480	http://dx.doi.org/10.1136/bmj.g7480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KN	25471323	Green Published, hybrid			2022-12-01	WOS:000346116600013
J	Johansson, S; Villamor, E; Altman, M; Bonamy, AKE; Granath, F; Cnattingius, S				Johansson, Stefan; Villamor, Eduardo; Altman, Maria; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven			Maternal overweight and obesity in early pregnancy and risk of infant mortality: a population based cohort study in Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; WEIGHT; OUTCOMES; DEATH; STILLBIRTH; SMOKING; WOMEN; FAT	Objective To investigate associations between maternal overweight and obesity and infant mortality outcomes, including cause-specific mortality. Design Population based cohort study. Setting and participants 1 857 822 live single births in Sweden 1992-2010. Main outcome measures Associations between maternal body mass index (BMI) in early pregnancy and risks of infant, neonatal, and postneonatal mortality, overall and stratified by gestational length and by causes of infant death. Odds ratios were adjusted for maternal age, parity, smoking, education, height, country of birth, and year of delivery. Results Infant mortality rates increased from 2.4/1000 among normal weight women (BMI 18.5-24.9) to 5.8/1000 among women with obesity grade 3 (BMI >= 40.0). Compared with normal weight, overweight (BMI 25.0-29.9) and obesity grade 1 (BMI 30.0-34.9) were associated with modestly increased risks of infant mortality (adjusted odds ratios 1.25 (95% confidence interval 1.16 to 1.35) and 1.37 (1.22 to 1.53), respectively), and obesity grade 2 (BMI 35.0-39.9) and grade 3 were associated with more than doubled risks (adjusted odds ratios 2.11 (1.79 to 2.49) and 2.44 (1.88 to 3.17)). In analyses stratified by preterm and term births, maternal BMI was related to risks of infant mortality primarily in term births (>= 37 weeks), where risks of deaths due to birth asphyxia and other neonatal morbidities increased with maternal overweight and obesity. Obesity grade 2-3 was also associated with increased infant mortality due to congenital anomalies and sudden infant death syndrome. Conclusions Maternal overweight and obesity are associated with increased risks of infant mortality due to increased mortality risk in term births and an increased prevalence of preterm births. Maternal overweight and obesity may be an important preventable risk factor for infant mortality in many countries.	[Johansson, Stefan; Altman, Maria; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven] Dept Med, Clin Epidemiol Unit, Solna, Sweden; [Johansson, Stefan; Altman, Maria; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven] Karolinska Univ Hosp, Karolinska Inst, SE-17176 Stockholm, Sweden; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Karolinska Institutet; Karolinska University Hospital; University of Michigan System; University of Michigan	Johansson, S (corresponding author), Dept Med, Clin Epidemiol Unit, Solna, Sweden.	stefan.johansson@ki.se	Bonamy, Anna-Karin E/B-7106-2012	Bonamy, Anna-Karin E/0000-0003-4552-9912; Johansson, Stefan/0000-0001-8832-6918	Karolinska Institutet; Swedish Research Council for Health, Working Life and Welfare [2014-0073]	Karolinska Institutet(Karolinska Institutet); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	An unrestricted grant from Karolinska Institutet (Distinguished Professor Award to SC) and from the Swedish Research Council for Health, Working Life and Welfare (project No 2014-0073).	Altman M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001152; Ambalavanan N, 2012, PEDIATRICS, V130, pE115, DOI 10.1542/peds.2011-3693; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bahadue FL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001456.pub2; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Carpenter R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002299; Cawley J, 2004, J HEALTH ECON, V23, P293, DOI 10.1016/j.jhealeco.2003.12.003; Chapman DJ, 2013, PEDIATRICS, V131, pE162, DOI 10.1542/peds.2012-0688; Chen A, 2009, EPIDEMIOLOGY, V20, P74, DOI 10.1097/EDE.0b013e3181878645; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Eriksson Ulf J, 2012, Methods Mol Biol, V889, P425, DOI 10.1007/978-1-61779-867-2_26; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Hakansson S, 2008, ACTA PAEDIATR, V97, P1386, DOI 10.1111/j.1651-2227.2008.00940.x; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hutcheon JA, 2012, PAEDIATR PERINAT EP, V26, P109, DOI 10.1111/j.1365-3016.2011.01254.x; Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Lindsay CA, 1997, OBSTET GYNECOL, V89, P377, DOI 10.1016/S0029-7844(96)00517-0; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; MacDorman MF, 2010, INT J HEALTH SERV, V40, P577, DOI 10.2190/HS.40.4.a; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; National Board of Health and Welfare Centre for Epidemiology, 2003, SWED MED BIRTH REG S; National Board of Health and Welfare Sweden, NAT BOARD HLTH WELF, V2020-12-7089; Persson M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001648; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Robinson H, 2003, OBSTET GYNECOL, V101, P24, DOI 10.1016/S0029-7844(02)02448-1; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Salihu HM, 2008, OBSTET GYNECOL, V111, P1410, DOI 10.1097/AOG.0b013e318173ecd4; Sewell MF, 2007, J REPROD MED, V52, P907; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Statistics Sweden, 2010, TABL POP SWED 2009; Statistics Sweden, 2006, EV SWED REG ED; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Thompson DR, 2008, PUBLIC HEALTH REP, V123, P487, DOI 10.1177/003335490812300410; Villalbi JR, 2007, PAEDIATR PERINAT EP, V21, P441, DOI 10.1111/j.1365-3016.2007.00845.x; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organisation (WHO), GLOB DAT BOD MASS IN; Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161	43	100	101	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2014	349								g6572	10.1136/bmj.g6572	http://dx.doi.org/10.1136/bmj.g6572			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW2KK	25467170	Green Published, hybrid			2022-12-01	WOS:000346116300001
J	Pare, AC; Vichas, A; Fincher, CT; Mirman, Z; Farrell, DL; Mainieri, A; Zallen, JA				Pare, Adam C.; Vichas, Athea; Fincher, Christopher T.; Mirman, Zachary; Farrell, Dene L.; Mainieri, Avantika; Zallen, Jennifer A.			A positional Toll receptor code directs convergent extension in Drosophila	NATURE			English	Article							PLANAR CELL POLARITY; INNATE IMMUNE RECOGNITION; DORSAL-VENTRAL PATTERN; TISSUE MORPHOGENESIS; NEGATIVE REGULATOR; AXIS ELONGATION; EXPRESSION; FORCES; GENE; INTERCALATION	Elongation of the head-to-tail body axis by convergent extension is a conserved developmental process throughout metazoans. In Drosophila, patterns of transcription factor expression provide spatial cues that induce systematically oriented cell movements and promote tissue elongation. However, the mechanisms by which patterned transcriptional inputs control cell polarity and behaviour have long been elusive. We demonstrate that three Toll family receptors, Toll-2, Toll-6 and Toll-8, are expressed in overlapping transverse stripes along the anterior-posterior axis and act in combination to direct planar polarity and polarized cell rearrangements during convergent extension. Simultaneous disruption of all three receptors strongly reduces actomyosin -driven junctional remodelling and axis elongation, and an ectopic stripe of Toll receptor expression is sufficient to induce planar polarized actomyosin contractility. These results demonstrate that tissue-level patterns of Toll receptor expression provide spatial signals that link positional information from the anterior-posterior patterning system to the essential cell behaviours that drive convergent extension.	[Pare, Adam C.; Vichas, Athea; Fincher, Christopher T.; Mirman, Zachary; Farrell, Dene L.; Mainieri, Avantika; Zallen, Jennifer A.] Howard Hughes Med Inst, New York, NY 10065 USA; [Pare, Adam C.; Vichas, Athea; Fincher, Christopher T.; Mirman, Zachary; Farrell, Dene L.; Mainieri, Avantika; Zallen, Jennifer A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Zallen, JA (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	zallenj@mskcc.org		Vichas, Athea/0000-0001-6328-6200	NIH/NIGMS [GM079340, GM102803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079340, R01GM102803] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Anderson, K. Kasza, W. Razzell, G. Sabio, M. Shirasu-Hiza, A. Spencer, M. Tamada and R. Zallen for comments on the manuscript, B. Glick for the fast-folding YFP, M. Buszczak for pUASp-w-attB, and the BAC-Recombineering Core Facility at the University of Chicago for Toll-8-YFP. This work was funded by NIH/NIGMS grants GM079340 and GM102803 to JA.Z. J.A.Z. is an Early Career Scientist of the Howard Hughes Medical Institute.	Ballard SL, 2014, J CELL BIOL, V204, P1157, DOI 10.1083/jcb.201308115; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; CHIANG C, 1994, MECH DEVELOP, V47, P225; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; ELDON E, 1994, DEVELOPMENT, V120, P885; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; GERTTULA S, 1988, GENETICS, V119, P123; Grote K, 2011, THESCIENTIFICWORLDJO, V11, P981, DOI 10.1100/tsw.2011.92; Huebener P, 2013, BBA-MOL BASIS DIS, V1832, P1005, DOI 10.1016/j.bbadis.2012.11.017; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kasza KE, 2014, P NATL ACAD SCI USA, V111, P11732, DOI 10.1073/pnas.1400520111; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEITH FJ, 1990, EMBO J, V9, P4299, DOI 10.1002/j.1460-2075.1990.tb07878.x; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kim S, 2006, GENESIS, V44, P541, DOI 10.1002/dvg.20245; Kleve CD, 2006, DEV DYNAM, V235, P1953, DOI 10.1002/dvdy.20820; Kolesnikov T, 2007, DEV BIOL, V307, P53, DOI 10.1016/j.ydbio.2007.04.014; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Ludwig MZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002364; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Mahaffey JP, 2013, DEVELOPMENT, V140, P1262, DOI 10.1242/dev.085316; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; McIlroy G, 2013, NAT NEUROSCI, V16, P1248, DOI 10.1038/nn.3474; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Rose D, 1997, DEVELOPMENT, V124, P1561; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; STJOHNSTON D, 1992, CELL, V68, P201; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wieschaus E., 1992, GASTRULATION, P213; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	62	147	149	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					523	+		10.1038/nature13953	http://dx.doi.org/10.1038/nature13953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25363762	Green Accepted			2022-12-01	WOS:000346247600046
J	Hoag, H				Hoag, Hannah			A chance of survival	NATURE			English	Editorial Material							METASTATIC MELANOMA; CANCER; BRAF; VEMURAFENIB; RESISTANCE; IPILIMUMAB; ANTIBODY; SAFETY											Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lipson EJ, 2011, CLIN CANCER RES, V17, P6958, DOI 10.1158/1078-0432.CCR-11-1595; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888	14	5	5	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S118	S120		10.1038/515S118a	http://dx.doi.org/10.1038/515S118a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407709	Bronze			2022-12-01	WOS:000345770600005
J	Oda, T; Yanagisawa, H; Kamiya, R; Kikkawa, M				Oda, Toshiyuki; Yanagisawa, Haruaki; Kamiya, Ritsu; Kikkawa, Masahide			A molecular ruler determines the repeat length in eukaryotic cilia and flagella	SCIENCE			English	Article							DYNEIN REGULATORY COMPLEX; CHLAMYDOMONAS FLAGELLA; NEBULIN; MICROTUBULES; LINK	Existence of cellular structures with specific size raises a fundamental question in biology: How do cells measure length? One conceptual answer to this question is by a molecular ruler, but examples of such rulers in eukaryotes are lacking. In this work, we identified a molecular ruler in eukaryotic cilia and flagella. Using cryo-electron tomography, we found that FAP59 and FAP172 form a 96-nanometer (nm)-long complex in Chlamydomonas flagella and that the absence of the complex disrupted 96-nm repeats of axonemes. Furthermore, lengthening of the FAP59/172 complex by domain duplication resulted in extension of the repeats up to 128 nm, as well as duplication of specific axonemal components. Thus, the FAP59/172 complex is the molecular ruler that determines the 96-nm repeat length and arrangements of components in cilia and flagella.	[Oda, Toshiyuki; Yanagisawa, Haruaki; Kikkawa, Masahide] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kamiya, Ritsu] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kamiya, Ritsu] Gakushuin Univ, Dept Life Sci, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	University of Tokyo; University of Tokyo; Gakushuin University	Kikkawa, M (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mkikkawa@m.u-tokyo.ac.jp	Oda, Toshiyuki/GLR-2321-2022; Kikkawa, Masahide/A-6692-2010	Oda, Toshiyuki/0000-0001-8090-2159; Kikkawa, Masahide/0000-0001-7656-8194; Yanagisawa, Haruaki/0000-0003-0313-2343	CREST, Japan Science and Technology Agency; Takeda Science Foundation; Kazato Research Foundation; Japan Society for the Promotion of Science KAKENHI grant [20770119]	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kazato Research Foundation(Kazato Research Foundation); Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Hirono (University of Tokyo) and T. Yagi (Prefectural University of Hiroshima) for technical assistance and valuable advice. This work was supported by CREST, Japan Science and Technology Agency (to M. K.), the Takeda Science Foundation (to M. K. and T. O.), the Kazato Research Foundation (to T. O.), and Japan Society for the Promotion of Science KAKENHI grant 20770119 (to H.Y.). We declare no competing financial interests. The electron microscopy maps of averaged DMT are available in the EM Data Bank (www.emdatabank.org) under accession numbers EMD-6108 to EMD-6117.	Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Boesger Jens, 2012, Int J Plant Genomics, V2012, P581460, DOI 10.1155/2012/581460; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Cornelis GR, 2006, CURR OPIN MICROBIOL, V9, P201, DOI 10.1016/j.mib.2006.01.002; Fernandes I, 2014, J CELL BIOL, V206, P559, DOI 10.1083/jcb.201401094; Greaser ML, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00035; HAIMO LT, 1981, J CELL BIOL, V91, pS125, DOI 10.1083/jcb.91.3.125s; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; King SM, 2006, CELL MOTIL CYTOSKEL, V63, P245, DOI 10.1002/cm.20129; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merveille AC, 2014, J VET INTERN MED, V28, P771, DOI 10.1111/jvim.12336; Norrander JM, 1996, J MOL BIOL, V257, P385, DOI 10.1006/jmbi.1996.0170; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Oda T, 2013, J STRUCT BIOL, V183, P305, DOI 10.1016/j.jsb.2013.07.003; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; TRINICK J, 1994, TRENDS BIOCHEM SCI, V19, P405, DOI 10.1016/0968-0004(94)90088-4	24	96	98	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					857	860		10.1126/science.1260214	http://dx.doi.org/10.1126/science.1260214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395538				2022-12-01	WOS:000344659900047
J	Sanchez-Bayo, F				Sanchez-Bayo, Francisco			The trouble with neonicotinoids	SCIENCE			English	Editorial Material									Univ Sydney, Fac Agr & Environm, Eveleigh, NSW 2015, Australia	University of Sydney	Sanchez-Bayo, F (corresponding author), Univ Sydney, Fac Agr & Environm, Eveleigh, NSW 2015, Australia.	sanchezbayo@mac.com	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216				Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Decourtye A., 2009, INSECT NICOTINIC ACE, P85; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Nyman AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062472; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	15	120	125	12	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					806	807		10.1126/science.1259159	http://dx.doi.org/10.1126/science.1259159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395518				2022-12-01	WOS:000344659900017
J	Whitty, CJM; Farrar, J; Ferguson, N; Edmunds, WJ; Piot, P; Leach, M; Davies, SC				Whitty, Christopher J. M.; Farrar, Jeremy; Ferguson, Neil; Edmunds, W. John; Piot, Peter; Leach, Melissa; Davies, Sally C.			Tough choices to reduce Ebola transmission	NATURE			English	Editorial Material							VIRUS TRANSMISSION; HEMORRHAGIC-FEVER; OUTBREAK		[Whitty, Christopher J. M.] UK Dept Int Dev, London, England; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England; [Ferguson, Neil] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Edmunds, W. John; Piot, Peter] London Sch Hyg & Trop Med, London, England; [Leach, Melissa] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Davies, Sally C.] UK Dept Hlth, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Sussex	Whitty, CJM (corresponding author), UK Dept Int Dev, London, England.	c-whitty@dfid.gov.uk	Ferguson, Neil/B-8578-2008; Farrar, Jeremy J./HGA-7610-2022	Ferguson, Neil/0000-0002-1154-8093; Whitty, Christopher/0000-0002-6076-5027; Farrar, Jeremy/0000-0002-2700-623X	Medical Research Council [MR/K010174/1] Funding Source: Medline; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080, NF-SI-0513-10125, NF-SI-0508-10252] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Hewlett B S, 2005, Bull Soc Pathol Exot, V98, P230; Heymann DL, 2014, NATURE, V514, P299, DOI 10.1038/514299a; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; World Health Organization, 2014, EB RESP ROADM SIT RE	7	43	44	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					192	194		10.1038/515192a	http://dx.doi.org/10.1038/515192a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0MZ	25391946	Bronze			2022-12-01	WOS:000344631400024
J	Azim, E				Azim, Eiman			Shortcuts and checkpoints on the road to skilled movement	SCIENCE			English	Editorial Material							OPTIMAL FEEDBACK-CONTROL; MOTOR CONTROL; CIRCUITS		[Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA; [Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Biochem & Mol Biophys,Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Azim, E (corresponding author), Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA.			Azim, Eiman/0000-0002-1015-1772	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS088193] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [K99 NS088193] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Frank K, 1957, FED PROC, V16, P49; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Miri A, 2013, NEURON, V80, P827, DOI 10.1016/j.neuron.2013.10.049; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; STEIN RB, 1976, BIOL CYBERN, V22, P147, DOI 10.1007/BF00365525; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; WHISHAW IQ, 1992, BEHAV BRAIN RES, V47, P59, DOI 10.1016/S0166-4328(05)80252-9; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	17	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		554	555		10.1126/science.1260778	http://dx.doi.org/10.1126/science.1260778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359954				2022-12-01	WOS:000343799700025
J	Hall, JW; Grey, D; Garrick, D; Fung, F; Brown, C; Dadson, SJ; Sadoff, CW				Hall, J. W.; Grey, D.; Garrick, D.; Fung, F.; Brown, C.; Dadson, S. J.; Sadoff, C. W.			Coping with the curse of freshwater variability	SCIENCE			English	Editorial Material							CLIMATE-CHANGE		[Hall, J. W.; Grey, D.; Dadson, S. J.] Univ Oxford, Oxford OX1 3QY, England; [Garrick, D.] McMaster Univ, Dept Polit Sci, Hamilton, ON L8S 0A3, Canada; [Garrick, D.] McMaster Univ, Walter G Booth Sch Engn Practice, Hamilton, ON L8S 0A3, Canada; [Fung, F.] Environm Agcy, Bristol BS1 5AH, Avon, England; [Brown, C.] Univ Massachusetts, Dept Civil & Environm Engn, Amherst, MA 01003 USA; [Sadoff, C. W.] World Bank, Washington, DC 20433 USA	University of Oxford; McMaster University; McMaster University; University of Massachusetts System; University of Massachusetts Amherst; The World Bank	Hall, JW (corresponding author), Univ Oxford, S Parks Rd, Oxford OX1 3QY, England.	jim.hall@eci.ox.ac.uk	Dadson, Simon J/D-2370-2010; Hall, Jim W/ABF-1407-2020	Hall, Jim W/0000-0002-2024-9191; GARRICK, DUSTIN/0000-0001-6504-6550; Fung, Fai/0000-0003-4367-151X; Dadson, Simon/0000-0002-6144-4639; Sadoff, Claudia/0000-0002-7354-563X	Engineering and Physical Sciences Research Council [EP/I01344X/2] Funding Source: researchfish; Natural Environment Research Council [NE/L010364/1, NE/I01277X/2] Funding Source: researchfish; EPSRC [EP/I01344X/2] Funding Source: UKRI; NERC [NE/I01277X/2, NE/L010364/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2013, SEV WEATH AS PER RIS; Briscoe J., 2006, INDIAS WATER EC BRAC; Brown C, 2006, NAT RESOUR FORUM, V30, P306, DOI 10.1111/j.1477-8947.2006.00118.x; Flooding of Rojana Industrial Park Ayutthaya Thailand, 2011, DEFENSE VIDEO IMAGER; Gleick PH, 2014, WEATHER CLIM SOC, V6, P331, DOI 10.1175/WCAS-D-13-00059.1; Grafton RQ, 2013, NAT CLIM CHANGE, V3, P315, DOI [10.1038/NCLIMATE1746, 10.1038/nclimate1746]; Grey D., 2013, PHILOS T R SOC LONDO, V371, P1471; Hall JW, 2012, NAT CLIM CHANGE, V2, P833, DOI 10.1038/nclimate1749; IPCC, 2012, MAN RISKS CLIM EXTR; Janssen MA, 2007, SOC NATUR RESOUR, V20, P307, DOI 10.1080/08941920601161320; Lorenz C, 2012, J HYDROMETEOROL, V13, P1397, DOI 10.1175/JHM-D-11-088.1; Moody P, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012497; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; World Bank, 2006, ETH MAN WAT RES MAX	14	121	123	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					429	430		10.1126/science.1257890	http://dx.doi.org/10.1126/science.1257890			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342791				2022-12-01	WOS:000343822900025
J	Coombes, R; Arie, S				Coombes, Rebecca; Arie, Sophie			BRIEFING Ebola: How well is the UK prepared?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Center for Disease Control, DET HOSP CHECKL EB P; Mabey D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6202; Public Health England, ENH EB SCREEN PROC; Public Health England, 2014, EB Q A; Public Health England, 2014, VIR HAEM FEV RISK AS; Public Health England, 2014, EB ADV RISK ASS U FU; Public Health England, RET W AFR INF EB; The College of Emergency Medicine, 2014, EB GUID EM DEP	8	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6288	10.1136/bmj.g6288	http://dx.doi.org/10.1136/bmj.g6288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25354397	Bronze, Green Published			2022-12-01	WOS:000343767700009
J	Ma, ZQ; Wang, XL; Wang, X; Rodriguez, RA; Moore, CE; Gao, SH; Tan, XH; Ma, YY; Rheingold, AL; Baran, PS; Chen, C				Ma, Zhiqiang; Wang, Xiaolei; Wang, Xiao; Rodriguez, Rodrigo A.; Moore, Curtis E.; Gao, Shuanhu; Tan, Xianghui; Ma, Yuyong; Rheingold, Arnold L.; Baran, Phil S.; Chen, Chuo			Asymmetric syntheses of sceptrin and massadine and evidence for biosynthetic enantiodivergence	SCIENCE			English	Article							PYRROLE-IMIDAZOLE ALKALOIDS; VISIBLE-LIGHT PHOTOCATALYSIS; AGELAS-CONIFERA; ENERGY-TRANSFER; CORE SKELETONS; NAGELAMIDE-E; SPONGE; AGELIFERIN; PALAUAMINE; CYCLOADDITIONS	Cycloaddition is an essential tool in chemical synthesis. Instead of using light or heat as a driving force, marine sponges promote cycloaddition with a more versatile but poorly understood mechanism in producing pyrrole-imidazole alkaloids sceptrin, massadine, and ageliferin. Through de novo synthesis of sceptrin and massadine, we show that sponges may use single-electron oxidation as a central mechanism to promote three different types of cycloaddition. Additionally, we provide surprising evidence that, in contrast to previous reports, sceptrin, massadine, and ageliferin have mismatched chirality. Therefore, massadine cannot be an oxidative rearrangement product of sceptrin or ageliferin, as is commonly believed. Taken together, our results demonstrate unconventional chemical approaches to achieving cycloaddition reactions in synthesis and uncover enantiodivergence as a new biosynthetic paradigm for natural products.	[Ma, Zhiqiang; Wang, Xiaolei; Wang, Xiao; Gao, Shuanhu; Tan, Xianghui; Ma, Yuyong; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rodriguez, Rodrigo A.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Moore, Curtis E.; Rheingold, Arnold L.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; University of California System; University of California San Diego	Chen, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chuo.chen@utsouthwestern.edu	Rheingold, Arnold/U-4735-2019; Wang, Xiao/F-4535-2015; Ma, Yuyong/I-2678-2016; wang, xiaolei/K-6888-2014	Rheingold, Arnold/0000-0003-4472-8127; Ma, Yuyong/0000-0001-9591-6465; wang, xiaolei/0000-0002-8867-6528; Chen, Chuo/0000-0002-3118-4901	NIH [NIGMS R01-GM079554, R01-GM073949]; Welch Foundation [I-1596]; UT Southwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073949, R01GM079554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UT Southwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kock (Alfred Wegener Institute) for providing the natural samples of sceptrin and massadine, and J. Munoz (Alfred Wegener Institute) for providing a copy of the CD spectrum of natural sceptrin center dot TFA. We also thank V. Lynch (University of Texas at Austin), J. Clardy (Harvard University), and T. Molinski (University of California, San Diego) for helpful discussions. The CD experiments were performed by H. Shi [University of Texas (UT) Southwestern]. Financial support was provided by NIH (NIGMS R01-GM079554 and R01-GM073949), the Welch Foundation (I-1596), and UT Southwestern. Metrical parameters for the structures of natural sceptrin (1a) and 21 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-995387 (1a), 1014159 (21), and 1016848 (21).	Al-Mourabit A, 2011, NAT PROD REP, V28, P1229, DOI 10.1039/c0np00013b; Baran PS, 2006, ANGEW CHEM INT EDIT, V45, P249, DOI 10.1002/anie.200503374; Baran PS, 2004, ANGEW CHEM INT EDIT, V43, P2674, DOI 10.1002/anie.200453937; Baran PS, 2004, J AM CHEM SOC, V126, P3726, DOI 10.1021/ja049648s; BAULD NL, 1989, TETRAHEDRON, V45, P5307, DOI 10.1016/S0040-4020(01)89486-2; Birman VB, 2004, ORG LETT, V6, P2369, DOI 10.1021/ol049283g; Chen FC, 2003, J POLYM SCI POL PHYS, V41, P2681, DOI 10.1002/polb.10648; Dilley AS, 2001, ORG LETT, V3, P1535, DOI 10.1021/ol015864j; Ding H, 2013, CHEM SCI, V4, P303, DOI 10.1039/c2sc21651e; Finefield JM, 2012, ANGEW CHEM INT EDIT, V51, P4802, DOI 10.1002/anie.201107204; Gautschi JT, 2004, J NAT PROD, V67, P1256, DOI 10.1021/np0340495; Grube A, 2007, ANGEW CHEM INT EDIT, V46, P6721, DOI 10.1002/anie.200701935; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; KEIFER PA, 1991, J ORG CHEM, V56, P2965, DOI 10.1021/jo00009a008; Kinnel RB, 1998, J ORG CHEM, V63, P3281, DOI 10.1021/jo971987z; KOBAYASHI J, 1990, TETRAHEDRON, V46, P5579, DOI 10.1016/S0040-4020(01)87756-5; Kock M, 2007, ANGEW CHEM INT EDIT, V46, P6586, DOI 10.1002/anie.200701798; Lovely CJ, 2004, ORG LETT, V6, P735, DOI 10.1021/ol036403w; Lu Z, 2012, ANGEW CHEM INT EDIT, V51, P10329, DOI 10.1002/anie.201204835; Ma ZQ, 2011, CHEM COMMUN, V47, P427, DOI 10.1039/c0cc02214d; Munoz J, 2012, TETRAHEDRON LETT, V53, P5828, DOI 10.1016/j.tetlet.2012.07.110; Nishimura S, 2003, ORG LETT, V5, P2255, DOI 10.1021/ol034564u; Northrop BH, 2006, ANGEW CHEM INT EDIT, V45, P4126, DOI 10.1002/anie.200600514; O'Malley DP, 2008, ANGEW CHEM INT EDIT, V47, P3581, DOI 10.1002/anie.200801138; O'Malley DP, 2007, J AM CHEM SOC, V129, P4762, DOI 10.1021/ja069035a; Overman LE, 1997, J AM CHEM SOC, V119, P7159, DOI 10.1021/ja9712985; Seiple IB, 2011, J AM CHEM SOC, V133, P14710, DOI 10.1021/ja2047232; Seiple IB, 2010, ANGEW CHEM INT EDIT, V49, P1095, DOI 10.1002/anie.200907112; Starr JT, 2000, J AM CHEM SOC, V122, P8793, DOI 10.1021/ja0019575; Stout EP, 2012, ANGEW CHEM INT EDIT, V51, P4877, DOI 10.1002/anie.201108119; Su S, 2011, J AM CHEM SOC, V133, P13922, DOI 10.1021/ja206191g; Su S, 2008, J AM CHEM SOC, V130, P16490, DOI 10.1021/ja8074852; Tan XH, 2006, ANGEW CHEM INT EDIT, V45, P4345, DOI 10.1002/anie.200601208; VALENTINE D, 1972, J AM CHEM SOC, V94, P3449, DOI 10.1021/ja00765a032; WALKER RP, 1981, J AM CHEM SOC, V103, P6772, DOI 10.1021/ja00412a052; Wang X, 2012, J AM CHEM SOC, V134, P18834, DOI 10.1021/ja309172t; Wang X, 2011, J AM CHEM SOC, V133, P15350, DOI 10.1021/ja207386q; Yamaguchi J, 2008, ANGEW CHEM INT EDIT, V47, P3578, DOI 10.1002/anie.200705913; Yoon TP, 2013, ACS CATAL, V3, P895, DOI 10.1021/cs400088e	39	85	85	3	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					219	224		10.1126/science.1255677	http://dx.doi.org/10.1126/science.1255677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301624	Green Accepted			2022-12-01	WOS:000342721500044
J	Schmidt, H; Zalyte, R; Urnavicius, L; Carter, AP				Schmidt, Helgo; Zalyte, Ruta; Urnavicius, Linas; Carter, Andrew P.			Structure of human cytoplasmic dynein-2 primed for its power stroke	NATURE			English	Article							MICROTUBULE-BINDING DOMAIN; CRYSTAL-STRUCTURE; MOTOR DOMAIN; COILED-COIL; HEAVY-CHAIN; STALK; IMAGE; MECHANISM; PROTEINS; SEQUENCE	Members of the dynein family, consisting of cytoplasmic and axonemal isoforms, are motors that move towards the minus ends of microtubules. Cytoplasmic dynein-1 (dynein-1) plays roles in mitosis and cellular cargo transport(1), and is implicated in viral infections(2) and neurodegenerative diseases(3). Cytoplasmic dynein-2 (dynein-2) performs intraflagellar transport(4) and is associated with human skeletal ciliopathies(5). Dyneins share a conserved motor domain that couples cycles of ATP hydrolysis with conformational changes to produce movement(6-9). Here we present the crystal structure of the human cytoplasmic dynein-2 motor bound to the ATP-hydrolysis transition state analogue ADP. vanadate(10). The structure reveals a closure of the motor's ring of six AAA+ domains (ATPases associated with various cellular activites: AAA1-AAA6). This induces a steric clash with the linker, the key element for the generation of movement, driving it into a conformation that is primed to produce force. Ring closure also changes the interface between the stalk and buttress coiled-coil extensions of the motor domain. This drives helix sliding in the stalk which causes the microtubule binding domain at its tip to release from the microtubule. Our structure answers the key questions of how ATP hydrolysis leads to linker remodelling and microtubule affinity regulation.	[Schmidt, Helgo; Zalyte, Ruta; Urnavicius, Linas; Carter, Andrew P.] MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Carter, AP (corresponding author), MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk		Carter, Andrew/0000-0001-7292-5430	Medical Research Council, UK [MC_UP_A025_1011]; Wellcome Trust New Investigator Award [WT100387]; EMBO Young Investigator Award; MRC [MC_UP_A025_1011] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1011, 1274168, 1352465] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust New Investigator Award(Wellcome Trust); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, UK (MC_UP_A025_1011), a Wellcome Trust New Investigator Award (WT100387) and an EMBO Young Investigator Award. We thank M. Yu for in-house support with X-ray data collection and Diamond Light Source for access to beamline I02 (MX8547-70). We thank G. Dornan and M. Barczyk for assistance with insect cell culture. We also thank S. Bullock and D. Barford for their advice and comments on the manuscript.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Gleave ES, 2014, J STRUCT BIOL, V186, P367, DOI 10.1016/j.jsb.2014.03.019; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Liu Y, 2013, GENE DEV, V27, P1233, DOI 10.1101/gad.212381.112; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishikawa Y, 2014, J MOL BIOL, V426, P3232, DOI 10.1016/j.jmb.2014.06.023; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roberts AJ, 2012, STRUCTURE, V20, P1670, DOI 10.1016/j.str.2012.07.003; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014	43	97	97	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					435	438		10.1038/nature14023	http://dx.doi.org/10.1038/nature14023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470043	Green Accepted			2022-12-01	WOS:000349547400050
J	Westcott, PMK; Halliwill, KD; To, MD; Rashid, M; Rust, AG; Keane, TM; Delrosario, R; Jen, KY; Gurley, KE; Kemp, CJ; Fredlund, E; Quigley, DA; Adams, DJ; Balmain, A				Westcott, Peter M. K.; Halliwill, Kyle D.; To, Minh D.; Rashid, Mamunur; Rust, Alistair G.; Keane, Thomas M.; Delrosario, Reyno; Jen, Kuang-Yu; Gurley, Kay E.; Kemp, Christopher J.; Fredlund, Erik; Quigley, David A.; Adams, David J.; Balmain, Allan			The mutational landscapes of genetic and chemical models of Kras-driven lung cancer	NATURE			English	Article							SEQUENCING DATA; K-RAS; POINT MUTATIONS; EXPRESSION; GENOME; MOUSE; SIGNATURES; CARCINOMA; MTUS1; CELL	Next-generation sequencing of human tumours has refined our understanding of the mutational processes operative in cancer initiation and progression, yet major questions remain regarding the factors that induce driver mutations and the processes that shape mutation selection during tumorigenesis. Here we performed whole-exome sequencing on adenomas from three mouse models of non-small-cell lung cancer, which were induced either by exposure to carcinogens (methyl-nitrosourea (MNU) and urethane) or by genetic activation of Kras (Kras(LA2)). Although the MNU-induced tumours carried exactly the same initiating mutation in Kras as seen in the Kras(LA2) model (G12D), MNU tumours had an average of 192 non-synonymous, somatic single-nucleotide variants, compared with only six in tumours from the Kras(LA2) model. By contrast, the Kras(LA2) tumours exhibited a significantly higher level of aneuploidy and copy number alterations compared with the carcinogen-induced tumours, suggesting that carcinogen-induced and genetically engineered models lead to tumour development through different routes. The wild-type allele of Kras has been shown to act as a tumour suppressor inmouse models of non-small-cell lung cancer. We demonstrate that urethane-induced tumours from wild-type mice carry mostly (94%) Kras Q61R mutations, whereas those from Kras heterozygous animals carry mostly (92%) KrasQ61L mutations, indicating a major role for germ-line Kras status in mutation selection during initiation. The exome wide mutation spectra incarcinogen-induced tumours overwhelmingly display signatures of the initiating carcinogen, while adenocarcinomas acquire additional C > T mutations at CpG sites. These data provide a basis for understanding results from human tumour genome sequencing, which has identified two broad categories of tumours based on the relative frequency of single-nucleotide variations and copy number alterations(1), and underline the importance of carcinogen models for understanding the complex mutation spectra seen in human cancers.	[Westcott, Peter M. K.; Halliwill, Kyle D.; To, Minh D.; Delrosario, Reyno; Quigley, David A.; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Westcott, Peter M. K.; Halliwill, Kyle D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Rashid, Mamunur; Rust, Alistair G.; Keane, Thomas M.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Jen, Kuang-Yu] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Gurley, Kay E.; Kemp, Christopher J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Fredlund, Erik] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17121 Stockholm, Sweden; [Balmain, Allan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Karolinska Institutet; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	abalmain@cc.ucsf.edu	Jen, Kuang-Yu/AAM-5722-2020; Jen, Kuang-Yu/AAM-5429-2020	Rust, Alistair/0000-0001-7287-192X; Adams, David/0000-0001-9490-0306; Jen, Kuang-Yu/0000-0003-2815-5912; Keane, Thomas/0000-0001-7532-6898	National Cancer Institute (NCI) [R01 CA111834, U01 CA84244, U01 CA141455, U01 CA176287]; Bonnie Addario Foundation; National Institutes of Health (NIH) [T32 GM007175]; National Science Foundation GRFP award; NCI F31 NRSA award; NIH [T32 GM007175]; Cancer Research UK; Wellcome Trust; Cancer Research UK [13031] Funding Source: researchfish	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bonnie Addario Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation GRFP award; NCI F31 NRSA award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was supported by National Cancer Institute (NCI) grants R01 CA111834, U01 CA84244, U01 CA141455 and U01 CA176287 (to A.B.), and partly funded by the Bonnie Addario Foundation. P.M.K.W. was supported by the National Institutes of Health (NIH) training grant T32 GM007175 and a National Science Foundation GRFP award, and is currently supported by an NCI F31 NRSA award. K.D.H. was supported by the NIH training grant T32 GM007175, and is currently supported by an NCI F31 NRSA award. D.J.A. is supported by Cancer Research UK and the Wellcome Trust. We are appreciative of help and comments from our colleagues in refining this study and manuscript. We would also like to thank S. Busch for assistance with animal studies, and S. Green, T. Yuan and M. McMahon for providing the K493.1 cell line.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Berndt A, 2011, CANCER RES, V71, P5779, DOI 10.1158/0008-5472.CAN-11-1418; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Benedetto M, 2006, MOL CELL ENDOCRINOL, V252, P207, DOI 10.1016/j.mce.2006.03.014; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Fawdar S, 2013, P NATL ACAD SCI USA, V110, P12426, DOI 10.1073/pnas.1305207110; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forkert PG, 2010, DRUG METAB REV, V42, P355, DOI 10.3109/03602531003611915; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kurowska M, 2012, MUTAT RES-FUND MOL M, V738, P52, DOI 10.1016/j.mrfmmm.2012.08.008; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NUZUM EO, 1990, MOL CARCINOGEN, V3, P287, DOI 10.1002/mc.2940030509; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; To MD, 2011, MOL CANCER RES, V9, P1339, DOI 10.1158/1541-7786.MCR-11-0219; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xiao J, 2012, ONCOL LETT, V4, P113, DOI 10.3892/ol.2012.673; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zuern C, 2010, ONCOL REP, V23, P183, DOI 10.3892/or_00000621	42	223	228	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					489	+		10.1038/nature13898	http://dx.doi.org/10.1038/nature13898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363767	Green Submitted, Green Accepted			2022-12-01	WOS:000348196500035
J	Huang, YH; Zhu, C; Kondo, Y; Anderson, AC; Gandhi, A; Russell, A; Dougan, SK; Petersen, BS; Melum, E; Pertel, T; Clayton, KL; Raab, M; Chen, Q; Beauchemin, N; Yazaki, PJ; Pyzik, M; Ostrowski, MA; Glickman, JN; Rudd, CE; Ploegh, HL; Franke, A; Petsko, GA; Kuchroo, VK; Blumberg, RS				Huang, Yu-Hwa; Zhu, Chen; Kondo, Yasuyuki; Anderson, Ana C.; Gandhi, Amit; Russell, Andrew; Dougan, Stephanie K.; Petersen, Britt-Sabina; Melum, Espen; Pertel, Thomas; Clayton, Kiera L.; Raab, Monika; Chen, Qiang; Beauchemin, Nicole; Yazaki, Paul J.; Pyzik, Michal; Ostrowski, Mario A.; Glickman, Jonathan N.; Rudd, Christopher E.; Ploegh, Hidde L.; Franke, Andre; Petsko, Gregory A.; Kuchroo, Vijay K.; Blumberg, Richard S.			CEACAM1 regulates TIM-3-mediated tolerance and exhaustion	NATURE			English	Article							CD4(+) T-CELLS; CRYSTAL-STRUCTURE; MURINE; TIM-3; RECEPTOR; ADHESION; PROTEIN; ANTIGEN; BINDING; INDUCTION	T-cell immunoglobulin domain and mucin domain-3 (TIM-3, also known as HAVCR2) is an activation-induced inhibitory molecule involved in tolerance and shown to induce T-cell exhaustion in chronic viral infection and cancers'. Under some conditions, TIM-3 expression has also been shown to be stimulatory. Considering that TIM-3, like cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1), is being targeted for cancer immunotherapy, it is important to identify the circumstances under which TIM-3 can inhibit and activate T-cell responses. Here we show that TIM-3 is co-expressed and forms a heterodimer with carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), another well-known molecule expressed on activated T cells and involved in T-cell inhibition(6-10). Biochemical, biophysical and X-ray crystallography studies show that the membranedistal immunoglobulin-variable (IgV) -like amino-terminal domain of each is crucial to these interactions. The presence of CEACAM 1 endows TIM-3 with inhibitory function. CEACAM1 facilitates the maturation and cell surface expression of TIM-3 by forming a heterodimeric interaction in cis through the highly related membranedistal N-terminal domains of each molecule. CEACAM 1 and TIM-3 also bind in trans through their N-terminal domains. Both cis and trans interactions between CEACAM1 and TIM-3 determine the tolerance-inducing function of TIM-3. In a mouse adoptive transfer colitis model, CEACAM 1 -deficient T cells are hyper-inflammatory with reduced cell surface expression of TIM-3 and regulatory cytokines, and this is restored by T-cell-specific CEACAM 1 expression. During chronic viral infection and in a tumour environment, CEACAM1 and TIM-3 mark exhausted T cells. Co-blockade of CEACAM1 and TIM-3 leads to enhancement of anti-tumour immune responses with improved elimination of tumours in mouse colorectal cancer models. Thus, CEACAM 1 serves as a heterophilic ligand for TIM-3 that is required for its ability to mediate T-cell inhibition, and this interaction has a crucial role in regulating autoimmunity and anti-tumour immunity.	[Huang, Yu-Hwa; Kondo, Yasuyuki; Gandhi, Amit; Melum, Espen; Pyzik, Michal; Blumberg, Richard S.] Harvard Univ, Sch Med, Dept Med, Div Gastroenterol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Zhu, Chen; Anderson, Ana C.; Pertel, Thomas; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Zhu, Chen; Anderson, Ana C.; Pertel, Thomas; Kuchroo, Vijay K.] Brigham & Womens Hosp, Harvard Inst Med, Boston, MA 02115 USA; [Russell, Andrew; Petsko, Gregory A.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Dougan, Stephanie K.; Ploegh, Hidde L.] MIT, Whitehead Inst, Cambridge, MA 02142 USA; [Petersen, Britt-Sabina; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Melum, Espen] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Med Surg & Transplantat, N-0424 Oslo, Norway; [Clayton, Kiera L.; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Raab, Monika; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England; [Chen, Qiang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Beauchemin, Nicole] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Yazaki, Paul J.] City Hope Natl Med Ctr, Beckman Inst, Duarte, CA 91010 USA; [Ostrowski, Mario A.] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5S 1A8, Canada; [Glickman, Jonathan N.] Miraca Life Sci, GI Pathol, Newton, MA 02464 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brandeis University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Kiel; University of Oslo; University of Toronto; University of Cambridge; Sichuan University; McGill University; City of Hope; Beckman Research Institute of City of Hope; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Blumberg, RS (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Gastroenterol,Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	rblumberg@partners.org	Rudd, Christopher E/ABF-7259-2021; Anderson, Ana C/ABD-6829-2021; chen, qiang/M-1630-2016; Rudd, Christopher E/GOH-2021-2022; Löscher, Britt-Sabina/I-1671-2012; Franke, Andre/B-2151-2010; Petsko, Gregory/AAO-7962-2020; Pyzik, Michal/AAC-7220-2019	Anderson, Ana C/0000-0002-0877-2932; chen, qiang/0000-0002-2398-4482; Rudd, Christopher E/0000-0001-5295-9019; Löscher, Britt-Sabina/0000-0001-9022-9017; Franke, Andre/0000-0003-1530-5811; Pertel, Thomas/0000-0002-2286-6011; Pyzik, Michal/0000-0003-2591-6202	American Cancer Society [RSG-11-057-01-LIB]; Norwegian PSC research center; Unger Vetlesen Medical Fund; Crohn's & Colitis Foundation of America fellowship grant; Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' Award; Harvard Clinical Translational Science Center [UL1 TR001102]; National Basic Research Program of China [2010CB529906]; Canadian Institute of Health Research [MOP-93787]; AACR-Pancreatic Cancer Action Network; National Institutes of Health (NIH) [GM32415, AI073748, NS045937, AI039671, AI056299, DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center (HDDC) [DK0034854]; High Point Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, P01AI039671, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R56DK053056, R01DK051362, R01DK088199, R01DK044319, R01DK053056, R37DK044319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032415, R01GM026788, T32GM007122, P41GM111244, R37GM032415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Norwegian PSC research center; Unger Vetlesen Medical Fund; Crohn's & Colitis Foundation of America fellowship grant; Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' Award(German Research Foundation (DFG)); Harvard Clinical Translational Science Center; National Basic Research Program of China(National Basic Research Program of China); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); AACR-Pancreatic Cancer Action Network; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (HDDC); High Point Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Gallagher, M. Yoshida and K. Holmes for essential reagents, R. Gali for statistical assistance, C. Chen, T. Wesse, S. Sabet,S. Greve, T. Henke, D. Tan, K. Sakuishi and J. Sullivan for technical assistance, E. Greenfield and C. Bencsics for core services, and J. H. Wang, E. Reinherz, R. Grenha, H. lijima, J. Shively, A. Kaser, T. E. Adolph, K. Baker, D. Ringe and S. Zeissig for discussions. We thank the staff of the Dana Farber/Harvard Cancer Center monoclonal antibody core for purification of proteins used in X-ray crystallography and beam line X25 and X6A of the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory, USA. The NSLS is supported by the US Department of Energy. This work was supported by the American Cancer Society grant RSG-11-057-01-LIB (A.C.A); the Norwegian PSC research center and the Unger Vetlesen Medical Fund (EM.); Crohn's & Colitis Foundation of America fellowship grant (Y.-H.H.); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' Award (A.F. and B.-S.P.); Harvard Clinical Translational Science Center, UL1 TR001102 (R. Gali); the National Basic Research Program of China No. 2010CB529906 (Q.C.); Canadian Institute of Health Research (K.L.C. and N.B.); Canadian Institute of Health Research grant MOP-93787 (M.A.O.); AACR-Pancreatic Cancer Action Network (H.L.P. and S.K.D.); National Institutes of Health (NIH) grant GM32415 (GAP.); NIH grants AI073748, NS045937, AI039671 and AI056299 (V.K.K.); NIH grants DK044319, DK051362, DK053056, DK088199, the Harvard Digestive Diseases Center (HDDC) DK0034854 and High Point Foundation (R.S.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen LF, 2012, IMMUNITY, V37, P930, DOI 10.1016/j.immuni.2012.07.016; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gallagher TM, 1997, J VIROL, V71, P3129, DOI 10.1128/JVI.71.4.3129-3137.1997; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MIZUGUCHI K, 1995, CURR OPIN STRUC BIOL, V5, P377, DOI 10.1016/0959-440X(95)80100-6; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morales VM, 1999, J IMMUNOL, V163, P1363; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; SMITH AL, 1991, J INFECT DIS, V163, P879, DOI 10.1093/infdis/163.4.879; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Zhang XW, 2002, PROTEIN EXPRES PURIF, V25, P105, DOI 10.1006/prep.2002.1616; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	56	359	403	4	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					386	U566		10.1038/nature13848	http://dx.doi.org/10.1038/nature13848			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363763	Green Accepted, Green Submitted			2022-12-01	WOS:000347810300050
J	Finkelstein, A; Derdikman, D; Rubin, A; Foerster, JN; Las, L; Ulanovsky, N				Finkelstein, Arseny; Derdikman, Dori; Rubin, Alon; Foerster, Jakob N.; Las, Liora; Ulanovsky, Nachum			Three-dimensional head-direction coding in the bat brain	NATURE			English	Article							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL PLACE CELLS; FREELY MOVING RATS; GRID CELLS; SPATIAL REPRESENTATION; ECHOLOCATING BATS; PATH-INTEGRATION; VERTICAL PLANE; COGNITIVE MAP; DYNAMICS	Navigation requires a sense of direction ('compass'), which in mammals is thought to be provided by head-direction cells, neurons that discharge when the animal's head points to a specific azimuth. However, it remains unclear whether a three-dimensional (3D) compass exists in the brain. Here we conducted neural recordings in bats, mammals well-adapted to 3D spatial behaviours, and found head-direction cells tuned to azimuth, pitch or roll, or to conjunctive combinations of 3D angles, in both crawling and flying bats. Head-direction cells were organized along a functional-anatomical gradient in the presubiculum, transitioning from 2D to 3D representations. In inverted bats, the azimuth-tuning of neurons shifted by 180 degrees, suggesting that 3D head direction is represented in azimuth x pitch toroidal coordinates. Consistent with our toroidal model, pitch-cell tuning was unimodal, circular, and continuous within the available 360 degrees of pitch. Taken together, these results demonstrate a 3D head-direction mechanism in mammals, which could support navigation in 3D space.	[Finkelstein, Arseny; Derdikman, Dori; Rubin, Alon; Foerster, Jakob N.; Las, Liora; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Derdikman, Dori] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Derdikman, Dori] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	nachum.ulanovsky@weizmann.ac.il	LAS, LIORA/AGF-2249-2022; Finkelstein, Arseny/AAH-9250-2021	Finkelstein, Arseny/0000-0003-1480-5670; Ulanovsky, Nachum/0000-0001-8598-4667	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program [HFSP RGP0062/2009-C]; Israel Science Foundation [ISF 1017/08, ISF 1319/13]; Minerva Foundation; Clore predoctoral excellence fellowship; MIT-Israel (MISTI) student exchange internship	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Clore predoctoral excellence fellowship; MIT-Israel (MISTI) student exchange internship	We thank A. Treves, J.-M. Fellous, M. Okun, A. Wallach, M. Geva-Sagiv and M. M. Yartsev for comments on the manuscript; B. Pasmantirer and G. Ankaoua for mechanical designs; S. Kaufman for bat training, assistance in neural recordings, and illustrations; T. Eliav and T. Tamir for help in experiments; A. Tuval and M. Weinberg for veterinary oversight; G. Brodsky for graphics; R. Eilam and C. Ra'anan for histology; and M. P. Witter for advice on reconstruction of tetrode-track locations and anatomical delineations. This study was supported by research grants to N.U. from the European Research Council (ERC-NEUROBAT), the Human Frontiers Science Program (HFSP RGP0062/2009-C), the Israel Science Foundation (ISF 1017/08 and ISF 1319/13), and the Minerva Foundation; by a Clore predoctoral excellence fellowship to A.F.; and by an MIT-Israel (MISTI) student exchange internship to J.N.F. D.D. is the incumbent of the David and Inez Myers Career Advancement Chair in Life Sciences.	Altringham J.D., 1996, BATS BIOL BEHAV; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Bassett JP, 2001, J NEUROSCI, V21, P5740, DOI 10.1523/JNEUROSCI.21-15-05740.2001; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brandon MP, 2013, NAT NEUROSCI, V16, P739, DOI 10.1038/nn.3383; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Calton JL, 2005, J NEUROSCI, V25, P2420, DOI 10.1523/JNEUROSCI.3511-04.2005; Calton JL, 2003, J NEUROSCI, V23, P9719; Canto CB, 2012, J NEUROSCI, V32, P17620, DOI 10.1523/JNEUROSCI.3526-12.2012; Gallistel C.R., 1990, ORG LEARNING; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; Iriarte-Diaz J, 2008, J EXP BIOL, V211, P3478, DOI 10.1242/jeb.017590; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Jeffery KJ, 2013, BEHAV BRAIN SCI, V36, P523, DOI 10.1017/S0140525X12002476; Knierim JJ, 2000, NAT NEUROSCI, V3, P209, DOI 10.1038/72910; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Miller JF, 2013, SCIENCE, V342, P1111, DOI 10.1126/science.1244056; Neuweiler G., 2000, BIOL BATS; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Rubin A, 2014, J NEUROSCI, V34, P1067, DOI 10.1523/JNEUROSCI.5393-12.2014; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1996, CEREB CORTEX, V6, P238, DOI 10.1093/cercor/6.2.238; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stackman RW, 2000, J NEUROPHYSIOL, V83, P393, DOI 10.1152/jn.2000.83.1.393; Stackman RW, 1998, J NEUROSCI, V18, P9020; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 2013, J NEUROPHYSIOL, V109, P873, DOI 10.1152/jn.00239.2012; Taube JS, 2004, J NEUROPHYSIOL, V92, P2887, DOI 10.1152/jn.00887.2003; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Ulanoysky N, 2011, HIPPOCAMPUS, V21, P150, DOI 10.1002/hipo.20731; Valerio S, 2012, NAT NEUROSCI, V15, P1445, DOI 10.1038/nn.3215; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yovel Y, 2011, J COMP PHYSIOL A, V197, P515, DOI 10.1007/s00359-011-0639-4; Yovel Y, 2010, SCIENCE, V327, P701, DOI 10.1126/science.1183310; Zar, 2011, BIOSTAT ANAL; Zhang K, 1996, J NEUROSCI, V16, P2112; Zugaro MB, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-14-j0001.2001	59	133	135	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					159	U65		10.1038/nature14031	http://dx.doi.org/10.1038/nature14031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25470055				2022-12-01	WOS:000347477600027
J	Nelson-Sathi, S; Sousa, FL; Roettger, M; Lozada-Chavez, N; Thiergart, T; Janssen, A; Bryant, D; Landan, G; Schonheit, P; Siebers, B; McInerney, JO; Martin, WF				Nelson-Sathi, Shijulal; Sousa, Filipa L.; Roettger, Mayo; Lozada-Chavez, Nabor; Thiergart, Thorsten; Janssen, Arnold; Bryant, David; Landan, Giddy; Schoenheit, Peter; Siebers, Bettina; McInerney, James O.; Martin, William F.			Origins of major archaeal clades correspond to gene acquisitions from bacteria	NATURE			English	Article							CARBOHYDRATE-METABOLISM; MAXIMUM-LIKELIHOOD; PROTEIN FAMILIES; LIFE; TREE; EVOLUTION; GENOME; PHYLOGENY; DIVERSITY; ALGORITHM	The mechanisms that underlie the origin of major prokaryotic groups are poorly understood. In principle, the origin of both species and higher taxa among prokaryotes should entail similar mechanisms-ecological interactions with the environment paired with natural genetic variation involving lineage-specific gene innovations and lineage-specific gene acquisitions(1-4). To investigate the origin of higher taxa in archaea, we have determined gene distributions and gene phylogenies for the 267,568 protein-coding genes of 134 sequenced archaeal genomes in the context of their homologues from 1,847 reference bacterial genomes. Archaeal-specific gene families define 13 traditionally recognized archaeal higher taxa in our sample. Here we report that the origins of these 13 groups unexpectedly correspond to 2,264 group-specific gene acquisitions from bacteria. Interdomain gene transfer is highly asymmetric, transfers from bacteria to archaea are more than fivefold more frequent than vice versa. Gene transfers identified at major evolutionary transitions among prokaryotes specifically implicate gene acquisitions for metabolic functions from bacteria as key innovations in the origin of higher archaeal taxa.	[Nelson-Sathi, Shijulal; Sousa, Filipa L.; Roettger, Mayo; Lozada-Chavez, Nabor; Thiergart, Thorsten; Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Janssen, Arnold] Univ Dusseldorf, Math Inst, D-40225 Dusseldorf, Germany; [Bryant, David] Univ Otago, Dept Math & Stat, Dunedin 9054, New Zealand; [Landan, Giddy] Univ Kiel, Genom Microbiol Grp, Inst Microbiol, D-24118 Kiel, Germany; [Schoenheit, Peter] Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany; [Siebers, Bettina] Univ Duisburg Essen, Fac Chem, Biofilm Ctr, D-45117 Essen, Germany; [McInerney, James O.] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Martin, William F.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Otago; University of Kiel; University of Kiel; University of Duisburg Essen; Maynooth University; Universidade Nova de Lisboa	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany.	bill@hhu.de	Landan, Giddy/C-1086-2019; Mcinerney, James/AAF-7234-2020; Sousa, Filipa/ACC-2848-2022; Martin, William F./O-5446-2015; Sousa, Filipa L./H-6192-2012	Landan, Giddy/0000-0002-2502-8750; Sousa, Filipa/0000-0002-4084-1942; Martin, William F./0000-0003-1478-6449; Sousa, Filipa L./0000-0002-4075-1701; Nelson-Sathi, Shijulal/0000-0002-3346-0383; Siebers, Bettina/0000-0002-9905-541X	European Research Council (ERC) [232975, 281357]; graduate school E-Norm of the Heinrich-Heine University; DFG [Scho 316/11-1, SI 642/10-1]; BMBF [0316188A]	European Research Council (ERC)(European Research Council (ERC)European Commission); graduate school E-Norm of the Heinrich-Heine University; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	We gratefully acknowledge funding from European Research Council (ERC 232975 to W. F. M.), the graduate school E-Norm of the Heinrich-Heine University (W. F. M.), the DFG (Scho 316/11-1 to P. S.; SI 642/10-1 to B. S.), and BMBF (0316188A, B. S.). G. L. is supported by an ERC grant (281357 to Tal Dagan), D. B. thanks the Alexander von Humbold Foundation for a Fellowship. Computational support of the Zentrum fur Informations-und Medientechnologie (ZIM) at the Heinrich-Heine University is gratefully acknowledged.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hess WR, 2004, CURR OPIN BIOTECH, V15, P191, DOI 10.1016/j.copbio.2004.03.007; Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; Puigbo P, 2010, GENOME BIOL EVOL, V2, P745, DOI 10.1093/gbe/evq062; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Williams D, 2012, GENOME BIOL EVOL, V4, P1223, DOI 10.1093/gbe/evs098; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46	30	156	164	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					77	U185		10.1038/nature13805	http://dx.doi.org/10.1038/nature13805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25317564	Green Accepted			2022-12-01	WOS:000347178400038
J	Barrington-Trimis, JL; Samet, JM; McConnell, R				Barrington-Trimis, Jessica L.; Samet, Jonathan M.; McConnell, Rob			Flavorings in Electronic Cigarettes An Unrecognized Respiratory Health Hazard?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barrington-Trimis, Jessica L.; Samet, Jonathan M.; McConnell, Rob] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California	Barrington-Trimis, JL (corresponding author), Univ So Calif, Dept Prevent Med, 2001 N Soto St,230-D, Los Angeles, CA 90089 USA.	jtrimis@usc.edu	Barrington-Trimis, Jessica/ABE-7311-2020		NATIONAL CANCER INSTITUTE [P50CA180905] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA180905, P50 CA180905] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; [Anonymous], 2012, RESPIRATORY HEALTH A; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Farsalinos KE, 2015, NICOTINE TOB RES, V17, P168, DOI 10.1093/ntr/ntu176; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hallagan J., 2014, THE SAFETY ASSESSMEN; Kreiss K, 2014, AM J IND MED, V57, P129, DOI 10.1002/ajim.22282; Potera C, 2012, ENVIRON HEALTH PERSP, V120, pA457, DOI 10.1289/ehp.120-a457; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	9	154	156	0	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2493	2494		10.1001/jama.2014.14830	http://dx.doi.org/10.1001/jama.2014.14830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25383564	Green Accepted			2022-12-01	WOS:000346346900006
J	Tomas, NM; Beck, LH; Meyer-Schwesinger, C; Seitz-Polski, B; Ma, H; Zahner, G; Dolla, G; Hoxha, E; Helmchen, U; Dabert-Gay, AS; Debayle, D; Merchant, M; Klein, J; Salant, DJ; Stahl, RAK; Lambeau, G				Tomas, Nicola M.; Beck, Laurence H., Jr.; Meyer-Schwesinger, Catherine; Seitz-Polski, Barbara; Ma, Hong; Zahner, Gunther; Dolla, Guillaume; Hoxha, Elion; Helmchen, Udo; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Merchant, Michael; Klein, Jon; Salant, David J.; Stahl, Rolf A. K.; Lambeau, Gerard			Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHOSPHOLIPASE-A2 RECEPTOR; AUTOANTIBODIES; ANTIBODIES; DIAGNOSIS	BACKGROUND Idiopathic membranous nephropathy is an autoimmune disease. In approximately 70% of patients, it is associated with autoantibodies against the phospholipase A2 receptor 1 (PLA2R1). Antigenic targets in the remaining patients are unknown. METHODS Using Western blotting, we screened serum samples from patients with idiopathic membranous nephropathy, patients with other glomerular diseases, and healthy controls for antibodies against human native glomerular proteins. We partially purified a putative new antigen, identified this protein by means of mass spectrometry of digested peptides, and validated the results by analysis of recombinant protein expression, immunoprecipitation, and immunohistochemical analysis. RESULTS Serum samples from 6 of 44 patients in a European cohort and 9 of 110 patients in a Boston cohort with anti-PLA2R1-negative idiopathic membranous nephropathy recognized a glomerular protein that was 250 kD in size. None of the serum samples from the 74 patients with idiopathic membranous nephropathy who were seropositive for anti-PLA2R1 antibodies, from the 76 patients with other glomerular diseases, and from the 44 healthy controls reacted against this antigen. Although this newly identified antigen is clearly different from PLA2R1, it shares some biochemical features, such as N-glycosylation, membranous location, and reactivity with serum only under nonreducing conditions. Mass spectrometry identified this antigen as thrombospondin type-1 domain-containing 7A (THSD7A). All reactive serum samples recognized recombinant THSD7A and immunoprecipitated THSD7A from glomerular lysates. Moreover, immunohistochemical analyses of biopsy samples from patients revealed localization of THSD7A to podocytes, and IgG eluted from one of these samples was specific for THSD7A. CONCLUSIONS In our cohort, 15 of 154 patients with idiopathic membranous nephropathy had circulating autoantibodies to THSD7A but not to PLA2R1, a finding that suggests a distinct subgroup of patients with this condition.	[Tomas, Nicola M.; Seitz-Polski, Barbara; Dolla, Guillaume; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Lambeau, Gerard] CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France; [Tomas, Nicola M.; Seitz-Polski, Barbara; Dolla, Guillaume; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Lambeau, Gerard] Univ Nice Sophia Antipolis, Valbonne, France; [Tomas, Nicola M.; Meyer-Schwesinger, Catherine; Zahner, Gunther; Hoxha, Elion; Helmchen, Udo; Stahl, Rolf A. K.] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Beck, Laurence H., Jr.; Ma, Hong; Salant, David J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Merchant, Michael; Klein, Jon] Univ Louisville, Louisville, KY 40292 USA; [Klein, Jon] Robley Rex Vet Affairs Med Ctr, Louisville, KY USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; University of Louisville	Lambeau, G (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Rte Lucioles, F-06560 Valbonne, France.	lambeau@ipmc.cnrs.fr	Lambeau, Gerard/GRJ-5624-2022; Merchant, Michael/F-7109-2013; Hoxha, Elion/ABB-2981-2021; Seitz-Polski, Barbara/ADS-4852-2022; Merchant, Michael/N-7444-2013	Lambeau, Gerard/0000-0002-9239-518X; Seitz-Polski, Barbara/0000-0002-8913-5969; Merchant, Michael/0000-0003-4128-4057; Salant, David/0000-0002-3866-3120	French National Center for Scientific Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097053, T32DK007053, R01DK090029] Funding Source: NIH RePORTER	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the French National Center for Scientific Research and others.	Beck LH, 2010, SEMIN NEPHROL, V30, P635, DOI 10.1016/j.semnephrol.2010.09.011; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Dahnrich C, 2013, CLIN CHIM ACTA, V421, P213, DOI 10.1016/j.cca.2013.03.015; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Deegens JKJ, 2007, DRUG AGING, V24, P717, DOI 10.2165/00002512-200724090-00002; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Larsen C, 2013, FORTUNE, V167, P26; Seitz-Polski B, 2014, NEPHROL DIAL TRANSPL; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Wang CH, 2010, J CELL PHYSIOL, V222, P685, DOI 10.1002/jcp.21990	19	503	557	3	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2277	2287		10.1056/NEJMoa1409354	http://dx.doi.org/10.1056/NEJMoa1409354			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25394321	Green Accepted			2022-12-01	WOS:000346048800008
J	Gaudet, D; Brisson, D; Tremblay, K; Alexander, VJ; Singleton, W; Hughes, SG; Geary, RS; Baker, BF; Graham, MJ; Crooke, RM; Witztum, JL				Gaudet, Daniel; Brisson, Diane; Tremblay, Karine; Alexander, Veronica J.; Singleton, Walter; Hughes, Steven G.; Geary, Richard S.; Baker, Brenda F.; Graham, Mark J.; Crooke, Rosanne M.; Witztum, Joseph L.			Targeting APOC3 in the Familial Chylomicronemia Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-C-III; DENSITY-LIPOPROTEIN CHOLESTEROL; OF-FUNCTION MUTATIONS; CARDIOVASCULAR-DISEASE; SEVERE HYPERTRIGLYCERIDEMIA; PLASMA TRIGLYCERIDES; TRANSGENIC MICE; RISK; LIPASE; GENE	The familial chylomicronemia syndrome is a genetic disorder characterized by severe hypertriglyceridemia and recurrent pancreatitis due to a deficiency in lipoprotein lipase (LPL). Currently, there are no effective therapies except for extreme restriction in the consumption of dietary fat. Apolipoprotein C-III (APOC3) is known to inhibit LPL, although there is also evidence that APOC3 increases the level of plasma triglycerides through an LPL-independent mechanism. We administered an inhibitor of APOC3 messenger RNA (mRNA), called ISIS 304801, to treat three patients with the familial chylomicronemia syndrome and triglyceride levels ranging from 1406 to 2083 mg per deciliter (15.9 to 23.5 mmol per liter). After 13 weeks of study-drug administration, plasma APOC3 levels were reduced by 71 to 90% and triglyceride levels by 56 to 86%. During the study, all patients had a triglyceride level of less than 500 mg per deciliter (5.7 mmol per liter) with treatment. These data support the role of APOC3 as a key regulator of LPL-independent pathways of triglyceride metabolism.	[Gaudet, Daniel; Brisson, Diane; Tremblay, Karine] Chicoutimi Hosp, ECOGENE Clin Res Ctr 21, Chicoutimi, PQ, Canada; [Gaudet, Daniel; Brisson, Diane; Tremblay, Karine] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Alexander, Veronica J.; Singleton, Walter; Hughes, Steven G.; Geary, Richard S.; Baker, Brenda F.; Graham, Mark J.; Crooke, Rosanne M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, Sch Med, Div Endocrinol Metab, La Jolla, CA 92093 USA	Universite de Montreal; Isis Pharmaceuticals Inc; University of California System; University of California San Diego	Witztum, JL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	daniel.gaudet@umontreal.ca; jwitztum@ucsd.edu	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Baker, Brenda/0000-0001-8586-768X; Tremblay, Karine/0000-0002-2774-9738	Isis Pharmaceuticals	Isis Pharmaceuticals	Supported by Isis Pharmaceuticals.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Alexander V, 2014, J AM COLL CARDIOL S, V12, P63; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Brown WV, 2012, J CLIN LIPIDOL, V6, P397, DOI 10.1016/j.jacl.2012.08.002; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; Brunzell JD, 2000, METABOLIC MOL BASIS, P2789; CHAIT A, 1992, ADV INTERNAL MED, V37, P249; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Christian JB, 2011, J CARDIOVASC MED, V12, P714, DOI 10.2459/JCM.0b013e328349c4e5; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Lee R G, 2013, DIABETES S1A, V62, pLB14; Lee RG, 2013, J CARDIOVASC TRANSL, V6, P969, DOI 10.1007/s12265-013-9495-7; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; SCHONFELD G, 1979, METABOLISM, V28, P1001, DOI 10.1016/0026-0495(79)90004-0; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Tremblay K, 2011, J CLIN LIPIDOL, V5, P37, DOI 10.1016/j.jacl.2010.11.004; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70; Zheng CY, 2014, CURR OPIN LIPIDOL, V25, P35, DOI 10.1097/MOL.0000000000000040	31	304	319	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2200	2206		10.1056/NEJMoa1400284	http://dx.doi.org/10.1056/NEJMoa1400284			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25470695				2022-12-01	WOS:000345976700008
J	Keyhani, S; Myers, LJ; Cheng, E; Hebert, P; Williams, LS; Bravata, DM				Keyhani, Salomeh; Myers, Laura J.; Cheng, Eric; Hebert, Paul; Williams, Linda S.; Bravata, Dawn M.			Effect of Clinical and Social Risk Factors on Hospital Profiling for Stroke Readmission A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							30-DAY READMISSION; HEART-FAILURE; PREDICTION; MORTALITY; IDENTIFY; MODELS; CARE	Background: The Centers for Medicare & Medicaid Services (CMS) and Veterans Health Administration (VA) will report 30-day stroke readmission rates as a measure of hospital quality. A national debate on whether social risk factors should be included in models developed for hospital profiling is ongoing. Objective: To compare a CMS-based model of 30-day readmission with a more comprehensive model that includes measures of social risk (such as homelessness) or clinical factors (such as stroke severity and functional status). Design: Data from a retrospective cohort study were used to develop a CMS-based 30-day readmission model that included age and comorbid conditions based on codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (model 1). This model was then compared with one that included administrative social risk factors (model 2). Finally, the CMS model (model 1) was compared with a model that included social risk and clinical factors from chart review (model 3). These 3 models were used to rank hospitals by 30-day risk-standardized readmission rates and examine facility rankings among the models. Setting: Hospitals in the VA. Participants: Patients hospitalized with stroke in 2007. Measurements: 30-day readmission rates. Results: The 30-day readmission rate was 12.8%. The c-statistics for the 3 models were 0.636, 0.646, and 0.661, respectively. All hospitals were classified as performing "as expected" using all 3 models (that is, performance did not differ from the VA national average); therefore, the addition of detailed clinical information or social risk factors did not alter assessment of facility performance. Limitation: A predominantly male veteran cohort limits the generalizability of these findings. Conclusion: In the VA, more comprehensive models that included social risk and clinical factors did not affect hospital comparisons based on 30-day readmission rates.	[Keyhani, Salomeh] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Indiana Univ Sch Med, Vet Hlth Adm Hlth Serv Res & Dev, Stroke Qual Enhancement Res Initiat Program, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Ctr Excellence Implementing Evidence Based Practi, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Regenstrief Inst Hlth Care, Indianapolis, IN USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Washington, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Keyhani, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement,111A1, San Francisco, CA 94121 USA.	salomeh.keyhani@va.gov			Veterans Health Administration Office of Quality and Performance; Health Services Research and Development Service Quality Enhancement Research Initiative of the Department of Veterans Affairs [RRP 12-192]; National Heart, Lung, and Blood Institute, U. S. Department of Health and Human Services [1R01HL116522-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116522] Funding Source: NIH RePORTER	Veterans Health Administration Office of Quality and Performance; Health Services Research and Development Service Quality Enhancement Research Initiative of the Department of Veterans Affairs; National Heart, Lung, and Blood Institute, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Veterans Health Administration Office of Quality and Performance and Health Services Research and Development Service Quality Enhancement Research Initiative of the Department of Veterans Affairs (RRP 12-192) and the National Heart, Lung, and Blood Institute, U.S. Department of Health and Human Services (1R01HL116522-01A1).	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; [Anonymous], 2014, AM COMM SURV; [Anonymous], 2011, FED REGISTER, V76, P51476; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Arling G, 2012, CIRC-CARDIOVASC QUAL, V5, P44, DOI 10.1161/CIRCOUTCOMES.111.961474; Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443; Austin PC, 2002, MED DECIS MAKING, V22, P163, DOI 10.1177/02729890222063044; Bernheim S, 2010, HOSP 30 DAY READMISS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keyhani S, 2012, MED CARE, V50, P66, DOI 10.1097/MLR.0b013e3182294092; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Krumholz HM, 2011, RISK ADJUSTMENT MODE; Lichtman JH, 2010, STROKE, V41, P2525, DOI 10.1161/STROKEAHA.110.599159; Morse JM, 2002, AM J INFECT CONTROL, V30, P376, DOI 10.1067/mic.2002.125808; MORSE JM, 1989, SOC SCI MED, V28, P81, DOI 10.1016/0277-9536(89)90309-2; National Quality Forum, 2014, RISK ADJ SOC STAT OT; O'Connell B, 2002, J CLIN NURS, V11, P134, DOI 10.1046/j.1365-2702.2002.00578.x; Reker DM, 2005, J REHABIL RES DEV, V42, P77, DOI 10.1682/JRRD.2003.11.0164; U.S. Department of Health and Human Services, 2011, HOSP COMP; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858; Yale New Haven Health Services Corporation/Center for Outcomes Research and Evaluation, 2012, TEST HOSP LEV AC ISC; Yale New Haven Health Services Corporation/Center for Outcomes Research and Evaluation, 2012, RESP HOSP 30 DAY ISC	27	23	23	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					775	U51		10.7326/M14-0361	http://dx.doi.org/10.7326/M14-0361			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UJ	25437405				2022-12-01	WOS:000347247200006
J	Espin-Palazon, R; Stachura, DL; Campbell, CA; Garcia-Moreno, D; Del Cid, N; Kim, AD; Candel, S; Meseguer, J; Mulero, V; Traver, D				Espin-Palazon, Raquel; Stachura, David L.; Campbell, Clyde A.; Garcia-Moreno, Diana; Del Cid, Natasha; Kim, Albert D.; Candel, Sergio; Meseguer, Jose; Mulero, Victoriano; Traver, David			Proinflammatory Signaling Regulates Hematopoietic Stem Cell Emergence	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; EARLY MACROPHAGES; ZEBRAFISH EMBRYO; MOUSE EMBRYO; FACTOR-ALPHA; TNF-ALPHA	Hematopoietic stemcells (HSCs) underlie the production of blood and immune cells for the lifetime of an organism. In vertebrate embryos, HSCs arise from the unique transdifferentiation of hemogenic endothelium comprising the floor of the dorsal aorta during a brief developmental window. To date, this process has not been replicated in vitro from pluripotent precursors, partly because the full complement of required signaling inputs remains to be determined. Here, we show that TNFR2 via TNF alpha activates the Notch and NF-kappa B signaling pathways to establish HSC fate, indicating a requirement for inflammatory signaling in HSC generation. We determine that primitive neutrophils are the major source of TNF alpha, assigning a role for transient innate immune cells in establishing the HSC program. These results demonstrate that proinflammatory signaling, in the absence of infection, is utilized by the developing embryo to generate the lineal precursors of the adult hematopoietic system.	[Espin-Palazon, Raquel; Stachura, David L.; Campbell, Clyde A.; Del Cid, Natasha; Kim, Albert D.; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Espin-Palazon, Raquel; Garcia-Moreno, Diana; Candel, Sergio; Meseguer, Jose; Mulero, Victoriano] Univ Murcia, IMIB Arrixaca, Fac Biol, Dept Biol Celular & Histol, E-30100 Murcia, Spain; [Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of California System; University of California San Diego	Mulero, V (corresponding author), Univ Murcia, IMIB Arrixaca, Fac Biol, Dept Biol Celular & Histol, Campus Univ Espinardo, E-30100 Murcia, Spain.	vmulero@um.es; dtraver@ucsd.edu	Garcia-Moreno, Diana/ABG-2131-2020	Mulero, Victoriano/0000-0001-9527-0211; Candel Camacho, Sergio/0000-0001-7919-6584; Garcia, Diana/0000-0002-1521-2327	Spanish Ministry of Science and Innovation [BIO2011-23400, CSD2007-00002]; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia de la Region de Murcia [04538/GERM/06]; NIH [K01-DK087814-01A1, R01-DK074482]; CIRM New Faculty Award [RN1-00575-1]; AHA Innovative Science Award [12PILT12860010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482, K01DK087814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; AHA Innovative Science Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Spanish Ministry of Science and Innovation (grants BIO2011-23400, and CSD2007-00002 to V. M.), the Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia de la Region de Murcia (grant 04538/GERM/06 to V. M. and predoctoral and postdoctoral fellowships to R. E.-P.), the NIH (K01-DK087814-01A1; D. L. S.), a CIRM New Faculty Award RN1-00575-1 (D. T.), AHA Innovative Science Award 12PILT12860010 (D. T.), and NIH R01-DK074482 (D. T.). We thank Inmaculada Fuentes, Pedro Martinez, Efren Reyes, Chase Melick, and Karen Ong for technical assistance; Nadia Mercader for ideas and discussion; Francisco Juan Martinez-Navarro and Liangdao Li for help with WISH; and Kylie Price and SAI staff for flow cytometry.	Abbas S, 2003, J BIOL CHEM, V278, P20077, DOI 10.1074/jbc.M208619200; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2010, BLOOD, V115, P2777, DOI 10.1182/blood-2009-09-244590; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bigas A, 2013, BLOOD CELL MOL DIS, V51, P264, DOI 10.1016/j.bcmd.2013.07.005; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Espin R, 2013, DIS MODEL MECH, V6, P383, DOI 10.1242/dmm.010249; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Gerondakis S, 2012, IMMUNOL REV, V246, P272, DOI 10.1111/j.1600-065X.2011.01090.x; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Johnston DA, 2009, GENE, V435, P36, DOI 10.1016/j.gene.2009.01.003; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kim AD, 2014, EMBO J, V33, P2363, DOI 10.15252/embj.201488784; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kobayashi I, 2014, NATURE, V512, P319, DOI 10.1038/nature13623; KOHCHI C, 1994, INT J BIOCHEM, V26, P111, DOI 10.1016/0020-711X(94)90203-8; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kortschak RD, 2001, DEV GENES EVOL, V211, P350; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kyba M, 2003, EXP HEMATOL, V31, P994, DOI 10.1016/j.exphem.2003.08.002; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Mizrahi K, 2014, BLOOD, V124, P176, DOI 10.1182/blood-2014-03-559641; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Quillien A, 2014, DEVELOPMENT, V141, P1544, DOI 10.1242/dev.099986; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; SHALABY MR, 1990, J EXP MED, V172, P1517, DOI 10.1084/jem.172.5.1517; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; THISSE C, 1993, DEVELOPMENT, V119, P1203; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Wang H, 2013, J BIOL CHEM, V288, P16761, DOI 10.1074/jbc.M112.446633; Westerfield M., 1993, GUIDE LAB USE ZEBRAF; Wiens GD, 2011, DEV COMP IMMUNOL, V35, P1324, DOI 10.1016/j.dci.2011.03.031; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	67	194	197	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1070	1085		10.1016/j.cell.2014.10.031	http://dx.doi.org/10.1016/j.cell.2014.10.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416946	Green Accepted, Bronze			2022-12-01	WOS:000345506300019
J	Koren, A; Handsaker, RE; Kamitaki, N; Karlic, R; Ghosh, S; Polak, P; Eggan, K; McCarroll, SA				Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Karlic, Rosa; Ghosh, Sulagna; Polak, Paz; Eggan, Kevin; McCarroll, Steven A.			Genetic Variation in Human DNA Replication Timing	CELL			English	Article							JAK2 HAPLOTYPE; HUMAN MUTATION; INITIATION; CANCER; WAVES; DYNAMICS; SNP	Genomic DNA replicates in a choreographed temporal order that impacts the distribution of mutations along the genome. We show here that DNA replication timing is shaped by genetic polymorphisms that act in cis upon megabase-scale DNA segments. In genome sequences from proliferating cells, read depth along chromosomes reflected DNA replication activity in those cells. We used this relationship to analyze variation in replication timing among 161 individuals sequenced by the 1000 Genomes Project. Genome-wide association of replication timing with genetic variation identified 16 loci at which inherited alleles associate with replication timing. We call these "replication timing quantitative trait loci" (rtQTLs). rtQTLs involved the differential use of replication origins, exhibited allele-specific effects on replication timing, and associated with gene expression variation at megabase scales. Our results show replication timing to be shaped by genetic polymorphism and identify a means by which inherited polymorphism regulates the mutability of nearby sequences.	[Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; McCarroll, Steven A.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Koren, Amnon; Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; Polak, Paz; Eggan, Kevin; McCarroll, Steven A.] Harvard, Cambridge, MA 02142 USA; [Handsaker, Robert E.; Kamitaki, Nolan; Ghosh, Sulagna; Eggan, Kevin; McCarroll, Steven A.] MIT, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Karlic, Rosa] Univ Zagreb, Fac Sci, Div Biol, Bioinformat Grp, Zagreb 10000, Croatia; [Ghosh, Sulagna; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Polak, Paz] MIT, Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Polak, Paz] Harvard Univ, Sch Med, Dept Med, Ctr Canc, Boston, MA 02114 USA; [Polak, Paz] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Zagreb; University of Zagreb, School of Dental Medicine; Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021; Polak, Paz/AAH-9380-2020; Eggan, Kevin/P-7119-2018	Handsaker, Bob/0000-0002-3128-3547; Kamitaki, Nolan/0000-0003-0614-0189; McCarroll, Steven/0000-0002-6954-8184; Karlic, Rosa/0000-0002-1291-2897	National Human Genome Research Institute [R01 HG 006855]; Integra-Life Seventh Framework Programme [315997]; Stanley Center for Psychiatric Research; Howard Hughes Medical Institute; Harvard Stem Cell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Integra-Life Seventh Framework Programme; Stanley Center for Psychiatric Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Vanessa Van Doren for technical assistance and David Altshuler, Chris Patil, Giulio Genovese, Sam Rose, and Itamar Simon for discussions and comments on the manuscript. This work was supported by the National Human Genome Research Institute (R01 HG 006855 to S. A. M.), the Integra-Life Seventh Framework Programme (grant 315997 to R. K.), the Stanley Center for Psychiatric Research, the Howard Hughes Medical Institute, and the Harvard Stem Cell Institute.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimitriadou E, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-46; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hawkins M, 2013, CELL REP, V5, P1132, DOI 10.1016/j.celrep.2013.10.014; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lepretre F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1215; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Manukjan G, 2013, BIOTECHNIQUES, V55, P231, DOI 10.2144/000114097; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Mukhopadhyay R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004319; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pedersen BS, 2013, NUCLEIC ACIDS RES, V41, P7615, DOI 10.1093/nar/gkt552; Pope BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027413; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Ryba T, 2012, GENOME RES, V22, P1833, DOI 10.1101/gr.138511.112; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; SHARP PM, 1989, SCIENCE, V246, P808, DOI 10.1126/science.2683084; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; van de Wiel MA, 2009, BIOINFORMATICS, V25, P1099, DOI 10.1093/bioinformatics/btp132; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101	43	96	97	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1015	1026		10.1016/j.cell.2014.10.025	http://dx.doi.org/10.1016/j.cell.2014.10.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416942	Green Accepted, Bronze			2022-12-01	WOS:000345506300015
J	King, D				King, David			Marketing wearable home baby monitors: real peace of mind?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFANT-DEATH-SYNDROME; APNEA; SIDS		Univ Sheffield, Acad Unit Child Hlth, Sheffield S10 2TH, S Yorkshire, England	University of Sheffield	King, D (corresponding author), Univ Sheffield, Acad Unit Child Hlth, Sheffield S10 2TH, S Yorkshire, England.	d.a.king@sheffield.ac.uk						[Anonymous], 2014, TIME; Blackmon LR, 2003, PEDIATRICS, V111, P914; HODGMAN JE, 1988, ANN NY ACAD SCI, V533, P164, DOI 10.1111/j.1749-6632.1988.tb37246.x; Moon RY, 2011, PEDIATRICS, V128, pE1341, DOI 10.1542/peds.2011-2285; Owlet, INTRO OWLET SMART SO; Owlet Care, OWL VIT MON YOUR CHI; Peck S., 2014, TELEGRAPH; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Rest Devices, STAY CONN MIM BAB MO; Rollins Center for Entrepreneurship and Technology, 2013, IBMC 2013 TEAM OWL 1; Sproutling, SMART BAB MON; Startup Bootcamp, D MADDEN REST DEV; WARD SLD, 1986, PEDIATRICS, V77, P451	13	5	5	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6639	10.1136/bmj.g6639	http://dx.doi.org/10.1136/bmj.g6639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406191	Green Accepted			2022-12-01	WOS:000345445600005
J	Odame, I				Odame, Isaac			We need a global solution	NATURE			English	Editorial Material							SICKLE-CELL-DISEASE		[Odame, Isaac] Hosp Sick Children, Global Sickle Cell Dis Network, Toronto, ON M5G 1X8, Canada; [Odame, Isaac] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Odame, Isaac] Univ Toronto, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Odame, I (corresponding author), Hosp Sick Children, Global Sickle Cell Dis Network, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	isaac.odame@sickkids.ca						Aygun B, 2012, PEDIATR BLOOD CANCER, V59, P386, DOI 10.1002/pbc.24175; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Weatherall D, 2005, BLOOD, V105, P921, DOI 10.1182/blood-2004-06-2404	3	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S10	S10		10.1038/515S10a	http://dx.doi.org/10.1038/515S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390135	Bronze			2022-12-01	WOS:000344631400007
J	Bhabha, G; Cheng, HC; Zhang, N; Moeller, A; Liao, MF; Speir, JA; Cheng, YF; Vale, RD				Bhabha, Gira; Cheng, Hui-Chun; Zhang, Nan; Moeller, Arne; Liao, Maofu; Speir, Jeffrey A.; Cheng, Yifan; Vale, Ronald D.			Allosteric Communication in the Dynein Motor Domain	CELL			English	Article							EM STRUCTURE DETERMINATION; MICROTUBULE-BINDING; CYTOPLASMIC DYNEIN; CRYSTAL-STRUCTURE; FORCE GENERATION; ATP HYDROLYSIS; POWER STROKE; UCSF CHIMERA; COILED-COIL; AAA	Dyneins power microtubule motility using ring-shaped, AAA-containing motor domains. Here, we report X-ray and electron microscopy (EM) structures of yeast dynein bound to different ATP analogs, which collectively provide insight into the roles of dynein's two major ATPase sites, AAA1 and AAA3, in the conformational change mechanism. ATP binding to AAA1 triggers a cascade of conformational changes that propagate to all six AAA domains and cause a large movement of the ``linker,'' dynein's mechanical element. In contrast to the role of AAA1 in driving motility, nucleotide transitions in AAA3 gate the transmission of conformational changes between AAA1 and the linker, suggesting that AAA3 acts as a regulatory switch. Further structural and mutational studies also uncover a role for the linker in regulating the catalytic cycle of AAA1. Together, these results reveal how dynein's two major ATP-binding sites initiate and modulate conformational changes in the motor domain during motility.	[Bhabha, Gira; Cheng, Hui-Chun; Zhang, Nan; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Bhabha, Gira; Cheng, Hui-Chun; Zhang, Nan; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Moeller, Arne; Speir, Jeffrey A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Liao, Maofu; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute; University of California System; University of California San Francisco	Cheng, HC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan.	hccheng@life.nthu.edu.tw; ron.vale@ucsf.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Moeller, Arne/0000-0003-1101-5366; Cheng, Yifan/0000-0001-9535-0369	NIH [R01GM09731, S10RR026814, 9 P41 GM103310]; UCSF (Breakthrough Biomedical Research Award); American Heart Association [11POST7110022]; Merck fellowship of the Damon Runyon Cancer Research Foundation [DRG-2136-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R01GM097312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF (Breakthrough Biomedical Research Award); American Heart Association(American Heart Association); Merck fellowship of the Damon Runyon Cancer Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Bridget Carragher, Clint Potter, and their team (NRAMM, Scripps) and staff at ALS beamline 8.3.1 at the Lawrence Berkeley Laboratory for assistance with data collection.We thank Carol Cho (Stanford), Luke Rice (UT Southwestern Medical Center), and all members in the Vale and Cheng labs for helpful discussions. Funding was provided by NIH (R01GM09731, R.D.V.), NIH (S10RR026814; Y.C.), UCSF (Breakthrough Biomedical Research Award, Y.C.), the American Heart Association (11POST7110022, H.-C.C.), the Merck fellowship of the Damon Runyon Cancer Research Foundation (DRG-2136-12, G.B.), and NIH (9 P41 GM103310, to the National Resource for Automated Molecular Microscopy).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; GIBBONS BH, 1987, J BIOL CHEM, V262, P8354; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kull FJ, 2013, J CELL SCI, V126, P9, DOI 10.1242/jcs.103911; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Rayment I, 1996, ANNU REV PHYSIOL, V58, P671; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roberts AJ, 2012, STRUCTURE, V20, P1670, DOI 10.1016/j.str.2012.07.003; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110	46	62	62	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					857	868		10.1016/j.cell.2014.10.018	http://dx.doi.org/10.1016/j.cell.2014.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417161	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000344522000017
J	Corbett, A; Burns, A; Ballard, C				Corbett, Anne; Burns, Alistair; Ballard, Clive			Don't use antipsychotics routinely to treat agitation and aggression in people with dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO; RISPERIDONE; METAANALYSIS; PSYCHOSIS; SYMPTOMS; DISEASE; TRIAL; DRUGS		[Corbett, Anne; Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Burns, Alistair] Univ Manchester, Manchester M13 9NT, Lancs, England	University of London; King's College London; University of Manchester	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	clive.ballard@kcl.ac.uk	Corbett, Anne/B-3223-2014	Corbett, Anne/0000-0003-2015-0316; Ballard, Clive/0000-0003-0022-5632; Burns, Alistair/0000-0002-9837-0645				APA Work Group on Alzheimer's Disease and other Dementias, 2007, Am J Psychiatry, V164, P5; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard C, 2013, CURR OPIN PSYCHIATR, V26, P252, DOI 10.1097/YCO.0b013e32835f414b; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Barnes TRE, 2012, BRIT J PSYCHIAT, V201, P221, DOI 10.1192/bjp.bp.111.107631; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P134, DOI 10.4088/JCP.v64n0205; Corbett A, 2012, NAT REV NEUROL, V8, P264, DOI 10.1038/nrneurol.2012.53; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; Declercq T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007726.pub2; Devanand DP, 2011, INT J GERIATR PSYCH, V26, P937, DOI 10.1002/gps.2630; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; Medicines and Healthcare Regulatory Agency, ANT DRUGS; National Institute for Health and Care Excellence/ Social Care Institute of Excellence (NICE/ SCIE), 2006, DEM SUPP PEOPL DEM T; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Testad I, 2014, INT PSYCHOGERIATR, V26, P1083, DOI 10.1017/S1041610214000131; US Federal Drugs Agency, 2005, PUBL HLTH ADV DEATHS	22	51	51	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2014	349								g6420	10.1136/bmj.g6420	http://dx.doi.org/10.1136/bmj.g6420			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CB	25368388				2022-12-01	WOS:000344603500003
J	Hol, FJH; Dekker, C				Hol, Felix J. H.; Dekker, Cees			Zooming in to see the bigger picture: Microfluidic and nanofabrication tools to study bacteria	SCIENCE			English	Review							SINGLE-CELL; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ELECTRON-TRANSFER; GENETIC-ANALYSIS; HIGH-THROUGHPUT; QUORUM; MICROORGANISMS; PERSISTENCE; DIFFUSION	The spatial structure of natural habitats strongly affects bacterial life, ranging from nanoscale structural features that individual cells exploit for surface attachment, to micro-and millimeter-scale chemical gradients that drive population-level processes. Nanofabrication and microfluidics are ideally suited to manipulate the environment at those scales and have emerged as powerful tools with which to study bacteria. Here, we review the new scientific insights gained by using a diverse set of nanofabrication and microfluidic techniques to study individual bacteria and multispecies communities. This toolbox is beginning to elucidate disparate bacterial phenomena-including aging, electron transport, and quorum sensing-and enables the dissection of environmental communities through single-cell genomics. A more intimate integration of microfluidics, nanofabrication, and microbiology will enable further exploration of bacterial life at the smallest scales.	[Hol, Felix J. H.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	c.dekker@tudelft.nl	Hol, Felix/AAL-3588-2021	Hol, Felix/0000-0001-8061-0826; Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]; Netherlands Organisation for Scientific Research (NWO/OCW) part of the Frontiers of Nanoscience program	European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research (NWO/OCW) part of the Frontiers of Nanoscience program	We acknowledge invaluable discussions with J. Keymer, P. Galajda, J. Mannik, F. Wu, S. van Vliet, M. Voges, and B. Beaumont. F.J.H.H. acknowledges J. Keymer for sage advice and mentoring. This work was supported by the European Research Council Advanced Grant 247072 and the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Ahmed T, 2010, NANO LETT, V10, P3379, DOI 10.1021/nl101204e; Amir A, 2014, P NATL ACAD SCI USA, V111, P5778, DOI 10.1073/pnas.1317497111; Baca HK, 2006, SCIENCE, V313, P337, DOI 10.1126/science.1126590; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Berke AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038102; Bigger JW, 1944, LANCET, V2, P497; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Caspi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083775; Chen PP, 2014, SMALL, V10, P3018, DOI 10.1002/smll.201303724; Connell JL, 2013, P NATL ACAD SCI USA, V110, P18380, DOI 10.1073/pnas.1309729110; Connell JL, 2012, NAT CHEM BIOL, V8, P10, DOI 10.1038/nchembio.749; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Di Leonardo R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038101; Di Leonardo R, 2010, P NATL ACAD SCI USA, V107, P9541, DOI 10.1073/pnas.0910426107; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Fadeeva E, 2011, LANGMUIR, V27, P3012, DOI 10.1021/la104607g; Flickinger ST, 2011, J AM CHEM SOC, V133, P5966, DOI 10.1021/ja111131f; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Galajda P, 2007, J BACTERIOL, V189, P8704, DOI 10.1128/JB.01033-07; Galajda P, 2008, J MOD OPTIC, V55, P3413, DOI 10.1080/09500340802495826; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hiratsuka Y, 2006, P NATL ACAD SCI USA, V103, P13618, DOI 10.1073/pnas.0604122103; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Hol FJH, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0068-2; Hol FJH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077042; Hulme SE, 2008, LAB CHIP, V8, P1888, DOI 10.1039/b809892a; Ivanova EP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00165; Jeong HE, 2013, NANO LETT, V13, P2864, DOI 10.1021/nl401205b; Jiang XC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3751; Jiang XC, 2010, P NATL ACAD SCI USA, V107, P16806, DOI 10.1073/pnas.1011699107; Julou T, 2013, P NATL ACAD SCI USA, V110, P12577, DOI 10.1073/pnas.1301428110; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Koumakis N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3588; Leung K, 2012, P NATL ACAD SCI USA, V109, P7665, DOI 10.1073/pnas.1106752109; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Lovley DR, 2012, ANNU REV MICROBIOL, V66, P391, DOI 10.1146/annurev-micro-092611-150104; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/NNANO.2011.119, 10.1038/nnano.2011.119]; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Moolman MC, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-12; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Norman TM, 2013, NATURE, V503, P481, DOI 10.1038/nature12804; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Raynaud X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087217; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Renner LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084143; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Rusconi R, 2011, BIOPHYS J, V100, P1392, DOI 10.1016/j.bpj.2011.01.065; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Saragosti J, 2011, P NATL ACAD SCI USA, V108, P16235, DOI 10.1073/pnas.1101996108; Seymour JR, 2009, AM NAT, V173, pE15, DOI 10.1086/593004; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025029, 10.1371/journal.pone.0026803]; Smart AG, 2010, PHYS TODAY, V63, P18, DOI 10.1063/1.3529396; Sokolov A, 2010, P NATL ACAD SCI USA, V107, P969, DOI 10.1073/pnas.0913015107; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; van Vliet S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-116; Vigeant MAS, 2002, APPL ENVIRON MICROB, V68, P2794, DOI 10.1128/AEM.68.6.2794-2801.2002; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Weibel DB, 2005, P NATL ACAD SCI USA, V102, P11963, DOI 10.1073/pnas.0505481102; Weitz M, 2014, J AM CHEM SOC, V136, P72, DOI 10.1021/ja411132w; Wessel AK, 2013, NAT REV MICROBIOL, V11, P337, DOI 10.1038/nrmicro3010; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.11.010; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	112	135	138	8	401	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					438	+	1251821	10.1126/science.1251821	http://dx.doi.org/10.1126/science.1251821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YT	25342809				2022-12-01	WOS:000349773700001
J	Thomson, AR; Wood, CW; Burton, AJ; Bartlett, GJ; Sessions, RB; Brady, RL; Woolfson, DN				Thomson, Andrew R.; Wood, Christopher W.; Burton, Antony J.; Bartlett, Gail J.; Sessions, Richard B.; Brady, R. Leo; Woolfson, Derek N.			Computational design of water-soluble alpha-helical barrels	SCIENCE			English	Article							COILED-COIL STRUCTURES; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; REPEAT PROTEINS; SIDE-CHAINS; CHANNEL; ASSEMBLIES; PACKING	The design of protein sequences that fold into prescribed de novo structures is challenging. General solutions to this problem require geometric descriptions of protein folds and methods to fit sequences to these. The a-helical coiled coils present a promising class of protein for this and offer considerable scope for exploring hitherto unseen structures. For a-helical barrels, which have more than four helices and accessible central channels, many of the possible structures remain unobserved. Here, we combine geometrical considerations, knowledge-based scoring, and atomistic modeling to facilitate the design of new channel-containing a-helical barrels. X-ray crystal structures of the resulting designs match predicted in silico models. Furthermore, the observed channels are chemically defined and have diameters related to oligomer state, which present routes to design protein function.	[Thomson, Andrew R.; Wood, Christopher W.; Burton, Antony J.; Bartlett, Gail J.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Wood, Christopher W.; Sessions, Richard B.; Brady, R. Leo; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Thomson, AR (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	chzart@bristol.ac.uk; d.n.woolfson@bristol.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Bartlett, Gail/F-3064-2015	Sessions, Richard/0000-0003-0320-0895; Thomson, Andrew/0000-0002-1066-1369; Woolfson, Derek/0000-0002-0394-3202; Wood, Christopher/0000-0003-1243-3105	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) South West Doctoral Training Partnership; Engineering and Physical Sciences Research Council (EPSRC) Bristol Chemical Synthesis Centre for Doctoral Training; EPSRC [EP/J001430/1]; BBSRC [BB/J008990/1]; European Research Council [340764]; Royal Society Wolfson Research Merit Award; Diamond Light Source [MX8922]; Biotechnology and Biological Sciences Research Council [BB/L01386X/1, BB/J008990/1, 1228976] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J001430/1, 1115150, EP/K03927X/1] Funding Source: researchfish; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/K03927X/1] Funding Source: UKRI	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) South West Doctoral Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC) Bristol Chemical Synthesis Centre for Doctoral Training(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Diamond Light Source; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C.W.W. and A.J.B. are supported by the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) South West Doctoral Training Partnership and the Engineering and Physical Sciences Research Council (EPSRC) Bristol Chemical Synthesis Centre for Doctoral Training, respectively. The work was funded by grants from the EPSRC (EP/J001430/1; D.N.W.), BBSRC (BB/J008990/1; D.N.W. and R.L.B.) and the European Research Council (340764; D.N.W.). D.N.W. holds a Royal Society Wolfson Research Merit Award. We thank the Diamond Light Source for access to beamlines I0-3 and I0-4 (award MX8922). We thank N. Zaccai for advice on protein x-ray crystallography, and members of the Brady and Woolfson groups for general discussions. A.R.T. and D.N.W. conceived the research program and approach; A.R.T. designed the peptide sequences; A.R.T., C.W.W., and A.J.B. synthesized the peptides and performed solution-phase characterizations; C.W.W., A.J.B., and R.L.B. solved the x-ray crystal structures; A.R.T., C.W.W., G.J.B., and R.B.S. wrote the computational design and modeling algorithms; A.R.T. and D.N.W. wrote the paper. All authors analyzed the data, and reviewed and contributed to the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank with the accession codes: CC-Pent, 4pn8; CC-Hex2, 4pn9; CC-Hex3, 4pnb; CC-Hept, 4pna; CC-Pent-variant, 4pnd.	Burton AJ, 2013, J AM CHEM SOC, V135, P12524, DOI 10.1021/ja4053027; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kopec KO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077074; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; McIntosh-Smith S, 2012, COMPUT J, V55, P192, DOI 10.1093/comjnl/bxr091; Meusch D, 2014, NATURE, V508, P61, DOI 10.1038/nature13015; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; PABO C, 1983, NATURE, V301, P200, DOI 10.1038/301200a0; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Reichen C, 2014, J STRUCT BIOL, V185, P147, DOI 10.1016/j.jsb.2013.07.012; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wood CW, 2014, BIOINFORMATICS, V30, P3029, DOI 10.1093/bioinformatics/btu502; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/NCHEMBIO.692, 10.1038/nchembio.692]	32	235	244	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					485	488		10.1126/science.1257452	http://dx.doi.org/10.1126/science.1257452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342807	Green Submitted			2022-12-01	WOS:000343822900047
J	Jia, J; Arif, A; Terenzi, F; Willard, B; Plow, EF; Hazen, SL; Fox, PL				Jia, Jie; Arif, Abul; Terenzi, Fulvia; Willard, Belinda; Plow, Edward F.; Hazen, Stanley L.; Fox, Paul L.			Target-Selective Protein S-Nitrosylation by Sequence Motif Recognition	CELL			English	Article							NITRIC-OXIDE SYNTHASE; TRANSFER-RNA SYNTHETASE; NONCANONICAL FUNCTION; GENOME-WIDE; CELL-DEATH; BINDING; COMPLEX; GAPDH; IDENTIFICATION; EXPRESSION	S-nitrosylation is a ubiquitous protein modification emerging as a principal mechanism of nitric oxide (NO)-mediated signal transduction and cell function. S-nitrosylases can use NO synthase (NOS)-derived NO to modify selected cysteines in target proteins. Despite proteomic identification of over a thousand S-nitrosylated proteins, few S-nitrosylases have been identified. Moreover, mechanisms underlying site-selective S-nitrosylation and the potential role of specific sequence motifs remain largely unknown. Here, we describe a stimulus-inducible, heterotrimeric S-nitrosylase complex consisting of inducible NOS (iNOS), S100A8, and S100A9. S100A9 exhibits transnitrosylase activity, shuttling NO from iNOS to the target protein, whereas S100A8 and S100A9 coordinately direct site selection. A family of proteins S-nitrosylated by iNOS-S100A8/A9 were revealed by proteomic analysis. A conserved I/L-X-C-X-2-D/E motif was necessary and sufficient for iNOS-S100A8/A9-mediated S-nitrosylation. These results reveal an elusive parallel between protein S-nitrosylation and phosphorylation, namely, stimulus-dependent posttranslational modification of selected targets by primary sequence motif recognition.	[Jia, Jie; Arif, Abul; Terenzi, Fulvia; Hazen, Stanley L.; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	foxp@ccf.org	Hazen, Stanley L/ABD-5845-2021	Jia, Jie/0000-0002-9583-1055	NIH [P01 HL029582, P01 HL076491, R01 GM086430, S10 RR031537]; AHA, National Affiliate; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL029582, R01HL017964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA, National Affiliate; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants P01 HL029582, P01 HL076491, and R01 GM086430 (to P.L.F.). A.A. was supported by a Scientist Development Grant from the AHA, National Affiliate. Shared Instrument Grant, S10 RR031537 from the NIH (to B.W.) was used to purchase the Orbitrap mass spectrometer. A patent has been filed for the SunTag technology.	Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUBER R, 1992, J MOL BIOL, V223, P683, DOI 10.1016/0022-2836(92)90984-R; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Ismail SA, 2005, ACTA CRYSTALLOGR D, V61, P1508, DOI 10.1107/S0907444905026740; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Ma LP, 2012, INT J CARDIOL, V155, P26, DOI 10.1016/j.ijcard.2011.01.082; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nakamura T, 2013, ANTIOXID REDOX SIGN, V18, P239, DOI 10.1089/ars.2012.4703; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; PADGETT CM, 1995, AM J PHYSIOL-CELL PH, V269, pC739, DOI 10.1152/ajpcell.1995.269.3.C739; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Riva M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061832; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; van Tits LJH, 2000, FREE RADICAL BIO MED, V29, P747, DOI 10.1016/S0891-5849(00)00372-5; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zahid S, 2014, NEUROSCIENCE, V256, P126, DOI 10.1016/j.neuroscience.2013.10.026; Zareba-Koziol M, 2014, MOL CELL PROTEOMICS, V13, P2288, DOI 10.1074/mcp.M113.036079	61	111	122	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					623	634		10.1016/j.cell.2014.09.032	http://dx.doi.org/10.1016/j.cell.2014.09.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417112	Green Accepted, Bronze			2022-12-01	WOS:000344521700017
J	Li, YY; Wen, H; Xi, YX; Tanaka, K; Wang, HB; Peng, DN; Ren, YF; Jin, QH; Dent, SYR; Li, W; Li, HT; Shi, XB				Li, Yuanyuan; Wen, Hong; Xi, Yuanxin; Tanaka, Kaori; Wang, Haibo; Peng, Danni; Ren, Yongfeng; Jin, Qihuang; Dent, Sharon Y. R.; Li, Wei; Li, Haitao; Shi, Xiaobing			AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation	CELL			English	Article							ELONGATION COMPLEX SEC; TANDEM PHD FINGER; TRANSCRIPTION ELONGATION; HIV-1 TAT; CHROMATIN; MLL; ACETYLTRANSFERASE; BINDING; YAF9; RECOGNITION	The recognition of modified histones by "reader'' proteins constitutes a key mechanism regulating gene expression in the chromatin context. Compared with the great variety of readers for histone methylation, few protein modules that recognize histone acetylation are known. Here, we show that the AF9 YEATS domain binds strongly to histone H3K9 acetylation and, to a lesser extent, H3K27 and H3K18 acetylation. Crystal structural studies revealed that AF9 YEATS adopts an eight-stranded immunoglobin fold and utilizes a serine-lined aromatic "sandwiching'' cage for acetyllysine readout, representing a novel recognition mechanism that is distinct from that of known acetyllysine readers. ChIP-seq experiments revealed a strong colocalization of AF9 and H3K9 acetylation genome-wide, which is important for the chromatin recruitment of the H3K79 methyltransferase DOT1L. Together, our studies identified the evolutionarily conserved YEATS domain as a novel acetyllysine-binding module and established a direct link between histone acetylation and DOT1L-mediated H3K79 methylation in transcription control.	[Li, Yuanyuan; Wang, Haibo; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, MOE Key Lab Prot Sci, Ctr Struct Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan; Wang, Haibo; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Yuanyuan; Wang, Haibo; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Wen, Hong; Peng, Danni; Jin, Qihuang; Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Houston, TX 77030 USA; [Wen, Hong; Tanaka, Kaori; Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev & Program, Houston, TX 77030 USA; [Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas Houston, Mol Carcinogenesis Grad Program, Grad Sch Biomed Sci, Houston, TX 77030 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Li, HT (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, MOE Key Lab Prot Sci, Ctr Struct Biol,Sch Life Sci, Beijing 100084, Peoples R China.	lht@tsinghua.edu.cn; xbshi@mdanderson.org	Dent, Sharon YR/F-1746-2011; Li, Haitao/B-2668-2012	Dent, Sharon YR/0000-0002-4824-3269; Li, Haitao/0000-0001-6741-293X; Wang, Haibo/0000-0003-2416-9153; Wen, Hong/0000-0001-8739-4572; Li, Wei/0000-0001-9931-5990; Shi, Xiaobing/0000-0001-5242-8189	Welch [G1719]; American Cancer Society [RSG-13-290-01-TBE]; Major State Basic Research Development Program in China [2011CB965300]; Program for New Century Excellent Talents in University; NIH [R01HG007538, R01GM067718]; CPRIT [RP110471]; MDACC Institutional Research Grant; Center for Cancer Epigenetics pilot grant; China Postdoctoral Science Foundation [2014T70069]; Duncan Scholar Award; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067718] Funding Source: NIH RePORTER	Welch(The Welch Foundation); American Cancer Society(American Cancer Society); Major State Basic Research Development Program in China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; MDACC Institutional Research Grant; Center for Cancer Epigenetics pilot grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Duncan Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Bedford, J. Bradner, O. Gozani, J. Tyler, and B. Li for comments and reagents. We thank the staffs at beamline BL17U of the Shanghai Synchrotron Radiation Facility and Dr. S. Fan at Tsinghua Center for Structural Biology for their assistance in data collection and the China National Center for Protein Sciences Beijing for providing facility support. We thank the MD Anderson Sequencing and Microarray Facility and the Science Park Next-Generation Sequencing Facility for Solexa sequencing. We thank Joseph Munch for editing the manuscript. This work was supported in part by funds from Welch (G1719) and American Cancer Society (RSG-13-290-01-TBE) to X.S, the Major State Basic Research Development Program in China (2011CB965300) and Program for New Century Excellent Talents in University to H.L., NIH (R01HG007538 to W.L and R01GM067718 to S.Y.R.D), CPRIT (RP110471 to X.S., W.L., and S.Y.R.D), MDACC Institutional Research Grant and Center for Cancer Epigenetics pilot grant to H. Wen, and China Postdoctoral Science Foundation (2014T70069 to Y.L.). Y.L. is a Tsinghua-Peking Center for Life Sciences postdoctoral fellow. W.L. is a recipient of a Duncan Scholar Award. X.S. is a Kimmel Scholar and a R. Lee Clark Fellow.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Masson I, 2003, MOL CELL BIOL, V23, P6086, DOI 10.1128/MCB.23.17.6086-6102.2003; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nishio M., 1998, METH STEREO; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P384, DOI 10.1038/87531; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	220	226	7	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					558	571		10.1016/j.cell.2014.09.049	http://dx.doi.org/10.1016/j.cell.2014.09.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417107	Green Accepted, Bronze			2022-12-01	WOS:000344521700012
J	Barzel, A; Paulk, NK; Shi, Y; Huang, Y; Chu, K; Zhang, F; Valdmanis, PN; Spector, LP; Porteus, MH; Gaensler, KM; Kay, MA				Barzel, A.; Paulk, N. K.; Shi, Y.; Huang, Y.; Chu, K.; Zhang, F.; Valdmanis, P. N.; Spector, L. P.; Porteus, M. H.; Gaensler, K. M.; Kay, M. A.			Promoter less gene targeting without nucleases ameliorates haemophilia B in mice	NATURE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; IN-VIVO; LIVER TRANSDUCTION; MOUSE MODEL; THERAPY; INTEGRATION; VECTORS	Site-specific gene addition can allow stable transgene expression for gene therapy. When possible, this is preferred over the use of promiscuously integrating vectors, which are sometimes associated with clonal expansion(1) and oncogenesis(2). Site-specific endonudeases that can induce high rates of targeted genome editing are finding increasing applications in biological discovery and gene therapy(3). However, two safety concerns persist: endonudease-associated adverse effects, both on-target(4) and off-target(5,6); and oncogene activation caused by promoter integration, even without nucleases(7). Here we perform recombinant adeno-associated virus (rAAV)-mediated promoterless gene targeting without nucleases and demonstrate amelioration of the bleeding diathesis in haemophilia B mice. In particular, we target a promoterless human coagulation factor IX (F9) gene to the liver-expressed mouse albumin (Alb) locus. F9 is targeted, along with a preceding 2A-peptide coding sequence, to be integrated just upstream to the Alb stop codon. While F9 is fused to Alb at the DNA and RNA levels, two separate proteins are synthesized by way of ribosomal skipping. Thus, F9 expression is linked to robust hepatic albumin expression without disrupting it. We injected an AAV8-F9 vector into neonatal and adult mice and achieved on-target integration into similar to 0.5% of the albumin alleles in hepatocytes. We established that F9 was produced only from on-target integration, and ribosomal skipping was highly efficient. Stable F9 plasma levels at 7-20% of normal were obtained, and treated F9-deficient mice had normal coagulation times. In conclusion, transgene integration as a 2A-fusion to a highly expressed endogenous gene may obviate the requirement for nucleases and/or vector-borne promoters. This method may allow for safe and efficacious gene targeting in both infants and adults by greatly diminishing off-target effects while still providing therapeutic levels of expression from integration.	[Barzel, A.; Paulk, N. K.; Huang, Y.; Chu, K.; Zhang, F.; Valdmanis, P. N.; Spector, L. P.; Porteus, M. H.; Kay, M. A.] Dept Pediat, Stanford, CA 94305 USA; [Barzel, A.; Paulk, N. K.; Huang, Y.; Chu, K.; Zhang, F.; Valdmanis, P. N.; Spector, L. P.; Kay, M. A.] Dept Genet, Stanford, CA 94305 USA; [Shi, Y.; Gaensler, K. M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kay, MA (corresponding author), Dept Pediat, 269 Campus Dr,CCSR Bldg,Room 2105, Stanford, CA 94305 USA.	markay@stanford.edu	Barzel, Adi/ABD-2981-2021; Huang, ZhiXin/H-5123-2017; Wilson, Matthew H/K-3193-2013	Huang, ZhiXin/0000-0003-0705-1970; Paulk, Nicole/0000-0002-5557-6280; Valdmanis, Paul/0000-0001-8840-6969; Kay, Mark/0000-0002-2799-2615	National Heart Lung & Blood Institute [R01-HL064274, F32-HL119059]; Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA [UL1 TR001085]; Child Health Research Institute of Stanford University; American Liver Foundation; Stanford Dean's Fellowship; Laurie Krauss Lacob Faculty Scholar Fund in Pediatric Translational Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064274, F32HL119059] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	National Heart Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA; Child Health Research Institute of Stanford University; American Liver Foundation; Stanford Dean's Fellowship; Laurie Krauss Lacob Faculty Scholar Fund in Pediatric Translational Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant to M.A.K. from the National Heart Lung & Blood Institute (R01-HL064274). A.B. was supported by a fellowship from the Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA UL1 TR001085 and Child Health Research Institute of Stanford University. N.K.P. was supported by a fellowship from the National Heart Lung & Blood Institute (F32-HL119059), the Hans Popper Memorial Fellowship from the American Liver Foundation, and the Stanford Dean's Fellowship. M.H.P. was supported by the Laurie Krauss Lacob Faculty Scholar Fund in Pediatric Translational Medicine. The funding organizations played no role in experimental design, data analysis or manuscript preparation.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Anguela XM, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.720.720; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Li CW, 2012, J VIROL, V86, P7752, DOI 10.1128/JVI.00675-12; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Lisowski L, 2012, MOL THER, V20, P1912, DOI 10.1038/mt.2012.164; Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Paulk NK, 2012, HUM GENE THER, V23, P658, DOI 10.1089/hum.2012.038; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Rogers G. L., 2012, J GENET SYNDR GEN S1, P012; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Yew NS, 2013, PEDIATR ENDOCR REV P, V11, P99	35	156	175	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					360	U476		10.1038/nature13864	http://dx.doi.org/10.1038/nature13864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363772	Green Accepted			2022-12-01	WOS:000347810300044
J	Kurtova, AV; Xiao, J; Mo, QX; Pazhanisamy, S; Krasnow, R; Lerner, SP; Chen, FJ; Roh, TT; Lay, E; Ho, PL; Chan, KS				Kurtova, Antonina V.; Xiao, Jing; Mo, Qianxing; Pazhanisamy, Senthil; Krasnow, Ross; Lerner, Seth P.; Chen, Fengju; Roh, Terrence T.; Lay, Erica; Ho, Philip Levy; Chan, Keith Syson			Blocking PGE(2)-induced tumour repopulation abrogates bladder cancer chemoresistance	NATURE			English	Article							STEM-CELLS; CHEMOTHERAPY; NEOADJUVANT; HOMEOSTASIS; PROGRESSION; RENEWAL; GROWTH; REPAIR	Cytotoxic chemotherapy is effective in debulking tumour masses initially; however, in some patients tumours become progressively unresponsive after multiple treatment cycles. Previous studies have demonstrated that cancer stem cells (CSCs) are selectively enriched after chemotherapy through enhanced survival(1-3). Here we reveal a new mechanism by which bladder CSCs actively contribute to therapeutic resistance via an unexpected proliferative response to repopulate residual tumours between chemotherapy cycles, using human bladder cancer xenografts. Further analyses demonstrate the recruitment of a quiescent label-retaining pool of CSCs into cell division in response to chemotherapy-induced damages, similar to mobilization of normal stem cells during wound repair(4-7). While chemotherapy effectively induces apoptosis, associated prostaglandin E-2 (PGE(2)) release paradoxically promotes neighbouring CSC repopulation. This repopulation can be abrogated by a PGE(2)-neutralizing antibody and celecoxib drug-mediated blockade of PGE(2) signalling. In vivo administration of the cyclooxygenase-2 (COX2) inhibitor celecoxib effectively abolishes a PGE(2)- and COX2-mediated wound response gene signature, and attenuates progressive manifestation of chemoresistance in xenograft tumours, including primary xenografts derived from a patient who was resistant to chemotherapy. Collectively, these findings uncover a new underlying mechanism that models the progressive development of clinical chemoresistance, and implicate an adjunctive therapy to enhance chemotherapeutic response of bladder urothelial carcinomas by abrogating early tumour repopulation.	[Kurtova, Antonina V.; Xiao, Jing; Roh, Terrence T.; Chan, Keith Syson] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kurtova, Antonina V.; Chan, Keith Syson] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Mo, Qianxing; Chen, Fengju; Chan, Keith Syson] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Mo, Qianxing; Chen, Fengju; Chan, Keith Syson] Baylor Coll Med, Ctr Cell Gene & Therapy, Houston, TX 77030 USA; [Pazhanisamy, Senthil; Krasnow, Ross; Lerner, Seth P.; Lay, Erica; Ho, Philip Levy; Chan, Keith Syson] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Roh, Terrence T.] Baylor Coll Med, Summer Med & Res Training SMART Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Chan, KS (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	kc1@bcm.edu	Kurtova, Antonina/H-6546-2015	Lay, Erica/0000-0001-7568-2737; Krasnow, Ross/0000-0001-9773-9431; Roh, Terrence/0000-0001-6831-1153	National Cancer Institute [CA129640, CA175397]; V Scholar Award; Dan L Duncan Career Award; Bladder Cancer Partnership; CPRIT pre-doctoral fellowship [RP101499]; AUA Research Scholar Award; CPRIT training grant [RP140102]; NATIONAL CANCER INSTITUTE [R01CA175397, P30CA125123, R00CA129640] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Scholar Award; Dan L Duncan Career Award; Bladder Cancer Partnership; CPRIT pre-doctoral fellowship; AUA Research Scholar Award; CPRIT training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank S. Tsai, J. Rosen, L. Donehower, M. Brenner and B. Deneen for their editorial suggestions, and grant funding from the National Cancer Institute CA129640, CA175397, V Scholar Award, Dan L Duncan Career Award, and Bladder Cancer Partnership (K.S.C.), CPRIT pre-doctoral fellowship RP101499 (A.V.K.), AUA Research Scholar Award (P.L.H.) and CPRIT training grant RP140102 for SMART program (T.T.R.). This work is supported by the Genomic & RNA Profiling Core (L. White), Cytometry & Cell Sorting Core (NIAID AI036211, NCI CA125123 and RR024574; J. Sederstorm), and Human Tissue Acquisition & Pathology Core (NCI CA125123; M. Ittmann) at Baylor College of Medicine, the Texas Advanced Computing Center at UT Austin and Rice University for providing High Performance Computing resources. We dedicate this work to the memory of J. Pride (a patient with bladder cancer and friend of I. Weissman), who funded the original work of K.S.C., which served as an important foundation leading to the current study.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Flaig TW, 2012, NAT REV UROL, V9, P65, DOI 10.1038/nrurol.2011.220; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Green DR, 2011, IMMUNITY, V35, P441, DOI 10.1016/j.immuni.2011.10.003; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Knowles M. A., NATURE REV IN PRESS; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Meeks JJ, 2012, EUR UROL, V62, P523, DOI 10.1016/j.eururo.2012.05.048; Niegisch G, 2013, EUR UROL, V64, P355, DOI 10.1016/j.eururo.2013.06.002; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Sternberg CN, 2013, EUR UROL, V63, P58, DOI 10.1016/j.eururo.2012.08.010; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697	30	387	401	5	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					209	U224		10.1038/nature14034	http://dx.doi.org/10.1038/nature14034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25470039	Green Accepted			2022-12-01	WOS:000347477600038
J	Sheffield, MEJ; Dombeck, DA				Sheffield, Mark E. J.; Dombeck, Daniel A.			Calcium transient prevalence across the dendritic arbour predicts place field properties	NATURE			English	Article							NEURONS IN-VIVO; CA1 PYRAMIDAL NEURONS; CELLULAR RESOLUTION; BASAL DENDRITES; NEURAL ACTIVITY; VIRTUAL NAVIGATION; SPIKES; DYNAMICS; SPINES; CELLS	Establishing the hippocampal cellular ensemble that represents an animal's environment involves the emergence and disappearance of place fields in specific CA1 pyramidal neurons(1-4), and the acquisition of different spatial firing properties across the active population(5). While such firing flexibility and diversity have been linked to spatial memory, attention and task performance(6,7), the cellular and network origin of these place cell features is unknown. Basic integrate-and-fire models of place firing propose that such features result solely from varying inputs to place cells(8,9), but recent studies(3,10) suggest instead that place cells themselves may play an active role through regenerative dendritic events. However, owing to the difficulty of performing functional recordings from place cell dendrites, no direct evidence of regenerative dendritic events exists, leaving any possible connection to place coding unknown. Using multi-plane two-photon calcium imaging of CA1 place cell somata, axons and dendrites in mice navigating a virtual environment, here we show that regenerative dendritic events do exist in place cells of behaving mice, and, surprisingly, their prevalence throughout the arbour is highly spatiotemporally variable. Furthermore, we show that the prevalence of such events predicts the spatial precision and persistence or disappearance of place fields. This suggests that the dynamics of spiking throughout the dendritic arbour may play a key role in forming the hippocampal representation of space.	[Sheffield, Mark E. J.; Dombeck, Daniel A.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Dombeck, DA (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	d-dombeck@northwestern.edu		Dombeck, Daniel/0000-0003-2576-5918; Sheffield, Mark/0000-0003-0969-7820	Klingenstein Foundation; Whitehall Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Northwestern University; National Institutes of Health [1R01MH101297]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101297] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); Whitehall Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Northwestern University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to B. Mensh for discussions on data conceptualization, interpretation and presentation. We thank C. Harvey, B. Mensh, N. Spruston, C. Woolley, W. Kath and L. Looger for comments on the manuscript, E. Han and P. Boueri for technical assistance, and V. Jayaraman, R. Kerr, D. Kim, L. Looger, K. Svoboda from the GENIE Project (Janelia Farm, Howard Hughes Medical Institute) for GCaMP6. This work was supported by The Klingenstein Foundation, The Whitehall Foundation, The Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, Northwestern University, The National Institutes of Health (1R01MH101297), and M.S. is an Ellison Medical Foundation Fellow of the Life Sciences Research Foundation.	Ariav G, 2003, J NEUROSCI, V23, P7750; Barry C, 2007, HIPPOCAMPUS, V17, P786, DOI 10.1002/hipo.20324; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Hill DN, 2013, P NATL ACAD SCI USA, V110, P13618, DOI 10.1073/pnas.1312599110; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhou WL, 2008, EUR J NEUROSCI, V27, P923, DOI 10.1111/j.1460-9568.2008.06075.x; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	48	135	135	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					200	U191		10.1038/nature13871	http://dx.doi.org/10.1038/nature13871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25363782	Green Accepted			2022-12-01	WOS:000347477600036
J	Cox, E; Borio, L; Temple, R				Cox, Edward; Borio, Luciana; Temple, Robert			Evaluating Ebola Therapies - The Case for RCTs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EPIDEMIC		[Cox, Edward; Temple, Robert] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Borio, Luciana] US FDA, Off Commissioner, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Cox, E (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310	4	61	62	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2350	2351		10.1056/NEJMp1414145	http://dx.doi.org/10.1056/NEJMp1414145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25470568				2022-12-01	WOS:000346425800003
J	Duan, B; Cheng, LZ; Bourane, S; Britz, O; Padilla, C; Garcia-Campmany, L; Krashes, M; Knowlton, W; Velasquez, T; Ren, XY; Ross, SE; Lowell, BB; Wang, Y; Goulding, M; Ma, QF				Duan, Bo; Cheng, Longzhen; Bourane, Steeve; Britz, Olivier; Padilla, Christopher; Garcia-Campmany, Lidia; Krashes, Michael; Knowlton, Wendy; Velasquez, Tomoko; Ren, Xiangyu; Ross, Sarah E.; Lowell, Bradford B.; Wang, Yun; Goulding, Martyn; Ma, Qiufu			Identification of Spinal Circuits Transmitting and Gating Mechanical Pain	CELL			English	Article							SUBSTANTIA-GELATINOSA NEURONS; SUPERFICIAL DORSAL-HORN; MARGINAL ZONE; GABAERGIC NEURONS; THERMAL STIMULI; SENSORY NEURONS; CELLULAR BASIS; CORD; HYPERALGESIA; GATE	Pain information processing in the spinal cord has been postulated to rely on nociceptive transmission (T) neurons receiving inputs from nociceptors and A beta mechanoreceptors, with A beta inputs gated through feed-forward activation of spinal inhibitory neurons (INs). Here, we used intersectional genetic manipulations to identify these critical components of pain transduction. Marking and ablating six populations of spinal excitatory and inhibitory neurons, coupled with behavioral and electrophysiological analysis, showed that excitatory neurons expressing somatostatin (SOM) include T-type cells, whose ablation causes loss of mechanical pain. Inhibitory neurons marked by the expression of dynorphin (Dyn) represent INs, which are necessary to gate A beta fibers from activating SOM+ neurons to evoke pain. Therefore, peripheral mechanical nociceptors and A beta mechanoreceptors, together with spinal SOM+ excitatory and Dyn(+) inhibitory neurons, form a microcircuit that transmits and gates mechanical pain.	[Duan, Bo; Cheng, Longzhen; Knowlton, Wendy; Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Duan, Bo; Cheng, Longzhen; Knowlton, Wendy; Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bourane, Steeve; Britz, Olivier; Padilla, Christopher; Garcia-Campmany, Lidia; Velasquez, Tomoko; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Garcia-Campmany, Lidia; Krashes, Michael; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; [Garcia-Campmany, Lidia; Krashes, Michael; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Ross, Sarah E.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Ross, Sarah E.] Univ Pittsburgh, Pain Ctr, Pittsburgh, PA 15213 USA; [Cheng, Longzhen; Wang, Yun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Cheng, Longzhen; Wang, Yun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Fudan University	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu; Qiufu_Ma@dfci.harvard.edu	Cheng, Longzhen/ABF-7581-2021; Ren, Xiangyu/AAR-3691-2020; Krashes, Michael/P-7677-2019; Bourane, Steeve/AAI-6143-2020	Bourane, Steeve/0000-0002-9805-2196; Ren, Xiangyu/0000-0001-5497-5194	NIH [R01NS086372, NS047710, P01 NS072040, R01 NS 080586, P01 NS072031, R01 AR063772, R21 AR064445, R01 DK075632, R37 DK053477, R01 DK071051, R01 DK089044, R01 DK096010, P30 DK057521, P30 DK046200, F32 DK089710]; National Natural Science Foundation of China [81171224, 81100815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063772, R21AR064445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071051, P30DK057521, P30DK046200, R37DK053477, R01DK089044, F32DK089710, R01DK075632, R01DK096010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086372, P30NS072031, R01NS080586, R01NS047710, P01NS047572, P01NS072040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Z. Josh Huang and the Jackson laboratory for the SOM-IRES-Cre and Calb2-IRES-Cre mice, GENSAT and MMRRC at University of California, Davis, for the NPY-Cre mice, the Allen Brain Institute, and the Jackson Laboratory for the Rosa26<SUP>LSL-tdTomato</SUP> mice, and Dr. Susan Dymecki for the ROSA26<SUP>CAG-FRT-STOP-FRT-GFP</SUP> mice. We thank Drs. Yan Lu, Clifford Woolf, and Fu-Chia Yang for critical comments on the manuscript; Dr Yan Lu for his advice on spinal cord slice recording; and Dr. Enrique Jose Cobos for providing the scoring system in measuring dynamic allodynia. The Ma lab was supported by NIH grants (R01NS086372, NS047710, and P01 NS072040), the Goulding lab is supported by NIH grants (R01NS086372, R01 NS 080586, and P01 NS072031), the Ross lab is supported by NIH grants (R01 AR063772 and R21 AR064445), and the Lowell lab was supported by NIH grants (R01 DK075632, R37 DK053477, R01 DK071051, R01 DK089044, R01 DK096010, P30 DK057521, and P30 DK046200). M.K. was supported by F32 DK089710. L.C. and Y.W. were supported by grants from the National Natural Science Foundation of China (81171224 and 81100815).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Baba H, 2003, MOL CELL NEUROSCI, V24, P818, DOI 10.1016/S1044-7431(03)00236-7; BENNETT GJ, 1980, J COMP NEUROL, V194, P809, DOI 10.1002/cne.901940407; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BINI G, 1984, PAIN, V18, P239, DOI 10.1016/0304-3959(84)90819-4; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Bruno RM, 2011, CURR OPIN NEUROBIOL, V21, P701, DOI 10.1016/j.conb.2011.06.003; BURGESS PR, 1967, J PHYSIOL-LONDON, V190, P541, DOI 10.1113/jphysiol.1967.sp008227; Bushnell M.C., 2008, SENSES COMPREHENSIVE, P279, DOI 10.1016/b978-012370880-9.00163-8; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; CERVERO F, 1979, Q J EXP PHYSIOL CMS, V64, P297, DOI 10.1113/expphysiol.1979.sp002484; CERVERO F, 1976, PAIN, V2, P5, DOI 10.1016/0304-3959(76)90042-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; GOBEL S, 1978, J COMP NEUROL, V180, P395, DOI 10.1002/cne.901800213; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Head H, 1905, BRAIN, V28, P100; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Kosugi M, 2013, J PHYSIOL-LONDON, V591, P1935, DOI 10.1113/jphysiol.2012.244210; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; KUMAZAWA T, 1978, J COMP NEUROL, V177, P417, DOI 10.1002/cne.901770305; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lu Y, 2013, J CLIN INVEST, V123, P4050, DOI 10.1172/JCI70026; Ma QF, 2012, NEUROSCI BULL, V28, P91, DOI 10.1007/s12264-012-1201-2; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Mar L, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-3; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Melzack R., 1982, CHALLENGE PAIN; Mendell LM, 2014, PAIN, V155, P210, DOI 10.1016/j.pain.2013.12.010; Miraucourt LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001116; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; MOLONY V, 1981, Q J EXP PHYSIOL CMS, V66, P211, DOI 10.1113/expphysiol.1981.sp002551; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NOORDENBOS W, 1987, PAIN, V29, P141, DOI 10.1016/0304-3959(87)91031-1; Prescott SA, 2014, NAT NEUROSCI, V17, P183, DOI 10.1038/nn.3629; PRICE DD, 1979, J NEUROPHYSIOL, V42, P1590, DOI 10.1152/jn.1979.42.6.1590; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; SALTER MW, 1990, PAIN, V40, P311, DOI 10.1016/0304-3959(90)91128-6; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sardella TCP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-76; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; WALL PD, 1978, BRAIN, V101, P1, DOI 10.1093/brain/101.1.1; WALL PD, 1967, SCIENCE, V155, P108, DOI 10.1126/science.155.3758.108; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Willis WD, 2001, PAIN, V92, P267, DOI 10.1016/S0304-3959(01)00268-8; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Xu Y, 2013, J NEUROSCI, V33, P14738, DOI 10.1523/JNEUROSCI.5512-12.2013; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010	69	306	315	6	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1417	1432		10.1016/j.cell.2014.11.003	http://dx.doi.org/10.1016/j.cell.2014.11.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25467445	Green Accepted, Bronze			2022-12-01	WOS:000346652900019
J	Fine, C				Fine, Cordelia			NEUROSCIENCE His brain, her brain?	SCIENCE			English	Editorial Material							SEX-DIFFERENCES; GENDER; CONNECTOME		[Fine, Cordelia] Univ Melbourne, Melbourne Business Sch, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Fine, Cordelia] Univ Melbourne, Ctr Eth Leadership, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Fine, C (corresponding author), Univ Melbourne, Melbourne Business Sch, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	cfine@unimelb.edu.au						Fine C., 2010, DELUSIONS GENDER OUR; Fine C, 2013, NEUROETHICS-NETH, V6, P369, DOI 10.1007/s12152-012-9169-1; Halpern DF, 2011, SCIENCE, V333, P1706, DOI 10.1126/science.1205031; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Joel D, 2014, BRIT J PHARMACOL, V171, P4620, DOI 10.1111/bph.12732; Joel D, 2014, P NATL ACAD SCI USA, V111, pE637, DOI 10.1073/pnas.1323319111; Joel D, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-27; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; O'Connor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110830; Rippon G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00650; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; SPENCE JT, 1993, J PERS SOC PSYCHOL, V64, P624, DOI 10.1037/0022-3514.64.4.624	15	17	17	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					915	916		10.1126/science.1262061	http://dx.doi.org/10.1126/science.1262061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU6EL	25414288				2022-12-01	WOS:000345696000016
J	Baud, MGJ; Lin-Shiao, E; Cardote, T; Tallant, C; Pschibul, A; Chan, KH; Zengerle, M; Garcia, JR; Kwan, TTL; Ferguson, FM; Ciulli, A				Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T. -L.; Ferguson, Fleur M.; Ciulli, Alessio			A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes	SCIENCE			English	Article							INHIBITION; TARGET	Small molecules are useful tools for probing the biological function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins. The Bromo and Extra-Terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer. The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-molecule inhibitors, but these inhibitors lack selectivity for individual family members. We developed an ethyl derivative of an existing small-molecule inhibitor, I-BET/JQ1, and showed that it binds leucine/alanine mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains. Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BETprotein, Brd4, from chromatin. Expansion of this approach could help identify the individual roles of single BETproteins in human physiology and disease.	[Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Ciulli, Alessio] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, James Black Ctr, Dundee DD1 5EH, Scotland; [Baud, Matthias G. J.; Lin-Shiao, Enrique; Tallant, Cynthia; Kwan, Terence T. -L.; Ferguson, Fleur M.; Ciulli, Alessio] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Dundee; University of Cambridge	Ciulli, A (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, James Black Ctr, Dow St, Dundee DD1 5EH, Scotland.	a.ciulli@dundee.ac.uk	Ferguson, Fleur M/L-2639-2019	Ferguson, Fleur M/0000-0003-4091-7617; Lin Shiao, Enrique/0000-0001-5396-9614; Chan, Kwok Ho/0000-0002-6693-2682; Baud, Matthias/0000-0003-3714-4350	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J001201/1, BB/G023123/1]; European Commission; Wellcome Trust [097945/Z/11/Z, 100476/Z/12/Z]; Biotechnology and Biological Sciences Research Council [BB/J001201/1, 980607, BB/J001201/2, BB/G023123/2, BB/G023123/1] Funding Source: researchfish; BBSRC [BB/G023123/2, BB/J001201/2, BB/J001201/1, BB/G023123/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Knapp, O. Fedorov, and their team for constructs, assistance with BLI, and discussions; S. Swift for assistance with the Light Microscopy Facility; C. Conte, E. Griffis, V. Cowling, and M. Peggie for materials and discussions; and D. Chirgadze for assistance with the Crystallographic X-ray Facility. This work was supported by awards to A. C. from the UK Biotechnology and Biological Sciences Research Council (BBSRC, grant BB/J001201/1 and David Phillips Fellowship BB/G023123/1). E. L. S. and A. P. were supported by European Commission Erasmus work placement grants. Microscopy and biophysics were supported by Wellcome Trust strategic awards to the University of Dundee (097945/Z/11/Z and 100476/Z/12/Z, respectively). The University of Dundee and the authors have filed patent applications (GB1320994.5 and GB1401001.1) related to the use of the bump-and-hole BET bromodomain chemical probes and mutant pairs for examining the biological function of BET bromodomain proteins. Coordinates and structure factors have been deposited with the Protein Data Bank (PDB) under accession code 4QEU [Brd2(2)<INF>L383A</INF> apo], 4QEV (in complex with ME), and 4QEW (in complex with ET).	Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GlaxoSmithKline, STUD INV SAF PHARM P; Lamoureux F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4511; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	17	110	128	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		638	641		10.1126/science.1249830	http://dx.doi.org/10.1126/science.1249830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25323695	Green Accepted			2022-12-01	WOS:000343799700051
J	Banerjee, I; Miyake, Y; Nobs, SP; Schneider, C; Horvath, P; Kopf, M; Matthias, P; Helenius, A; Yamauchi, Y				Banerjee, Indranil; Miyake, Yasuyuki; Nobs, Samuel Philip; Schneider, Christoph; Horvath, Peter; Kopf, Manfred; Matthias, Patrick; Helenius, Ari; Yamauchi, Yohei			Influenza A virus uses the aggresome processing machinery for host cell entry	SCIENCE			English	Article							HISTONE DEACETYLASE-6; CYTOPLASMIC DYNEIN; NUCLEAR IMPORT; PROTEIN; TRANSPORT; HDAC6; RIBONUCLEOPROTEINS; INHIBITOR; STRESS	During cell entry, capsids of incoming influenza A viruses (IAVs) must be uncoated before viral ribonucleoproteins (vRNPs) can enter the nucleus for replication. After hemagglutinin-mediated membrane fusion in late endocytic vacuoles, the vRNPs and the matrix proteins dissociate from each other and disperse within the cytosol. Here, we found that for capsid disassembly, IAV takes advantage of the host cell's aggresome formation and disassembly machinery. The capsids mimicked misfolded protein aggregates by carrying unanchored ubiquitin chains that activated a histone deacetylase 6 (HDAC6)-dependent pathway. The ubiquitin-binding domain was essential for recruitment of HDAC6 to viral fusion sites and for efficient uncoating and infection. That other components of the aggresome processing machinery, including dynein, dynactin, and myosin II, were also required suggested that physical forces generated by microtubule-and actin-associated motors are essential for IAV entry.	[Banerjee, Indranil; Helenius, Ari; Yamauchi, Yohei] Eidgenoss Tech Hsch ETH Zurich, Inst Biochem, Zurich, Switzerland; [Miyake, Yasuyuki; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Nobs, Samuel Philip; Schneider, Christoph; Kopf, Manfred] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland; [Horvath, Peter] Biol Res Ctr, Synthet & Syst Biol Unit, H-6701 Szeged, Hungary; [Matthias, Patrick] Univ Basel, Fac Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Basel	Helenius, A (corresponding author), Eidgenoss Tech Hsch ETH Zurich, Inst Biochem, Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch; yohei.yamauchi@bc.biol.ethz.ch	Nobs, Samuel Philip/N-4819-2019; Kopf, Manfred/B-6907-2009; Miyake, Yasuyuki/AAS-1504-2021	Nobs, Samuel Philip/0000-0003-0627-892X; Kopf, Manfred/0000-0002-0628-7140; Miyake, Yasuyuki/0000-0001-6250-0260; Yamauchi, Yohei/0000-0002-8233-9133; Schneider, Christoph/0000-0002-0452-2960	ETH Zurich; European Research Council; Swiss National Science Foundation (SNSF); SNSF; NIH; Novartis Research Foundation	ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation	We thank many current and former members of the Helenius laboratory for helpful discussions, T. Heger for providing us the infection counter algorithm, and ScopeM of ETH Zurich for assistance in microscopy. This work was supported by grants to A.H. from ETH Zurich, the European Research Council, and the Swiss National Science Foundation (SNSF); to C.S. and M.K. from the SNSF and NIH; and to Y.M. and P.M. from the Novartis Research Foundation. The findings of this work are filed under patent no. 14172323.9-1464 "New treatment against influenza virus."	Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Myers KA, 2006, TRAFFIC, V7, P1333, DOI 10.1111/j.1600-0854.2006.00476.x; Noda T, 2012, P NATL ACAD SCI USA, V109, P8797, DOI 10.1073/pnas.1206736109; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Stauffer S, 2014, J VIROL; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	26	157	159	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					473	477		10.1126/science.1257037	http://dx.doi.org/10.1126/science.1257037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342804				2022-12-01	WOS:000343822900044
J	Liu, D; Gu, XW; Zhu, J; Zhang, XX; Han, Z; Yan, WJ; Cheng, Q; Hao, J; Fan, HM; Hou, RQ; Chen, ZQ; Chen, YL; Li, CYT				Liu, Ding; Gu, Xiaowei; Zhu, Jia; Zhang, Xiaoxing; Han, Zhe; Yan, Wenjun; Cheng, Qi; Hao, Jiang; Fan, Hongmei; Hou, Ruiqing; Chen, Zhaoqin; Chen, Yulei; Li, Chengyu T.			Medial prefrontal activity during delay period contributes to learning of a working memory task	SCIENCE			English	Article							SHORT-TERM-MEMORY; NEURAL MECHANISMS; CORTICAL ACTIVITY; CORTEX; DYNAMICS; DECISION; RAT; INFORMATION; ACQUISITION; LESIONS	Cognitive processes require working memory (WM) that involves a brief period of memory retention known as the delay period. Elevated delay-period activity in the medial prefrontal cortex (mPFC) has been observed, but its functional role in WM tasks remains unclear. We optogenetically suppressed or enhanced activity of pyramidal neurons in mouse mPFC during the delay period. Behavioral performance was impaired during the learning phase but not after the mice were well trained. Delay-period mPFC activity appeared to be more important in memory retention than in inhibitory control, decision-making, or motor selection. Furthermore, endogenous delay-period mPFC activity showed more prominent modulation that correlated with memory retention and behavioral performance. Thus, properly regulated mPFC delay-period activity is critical for information retention during learning of a WM task.	[Liu, Ding; Gu, Xiaowei; Zhu, Jia; Zhang, Xiaoxing; Han, Zhe; Yan, Wenjun; Cheng, Qi; Hao, Jiang; Fan, Hongmei; Hou, Ruiqing; Chen, Zhaoqin; Chen, Yulei; Li, Chengyu T.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Liu, Ding; Gu, Xiaowei; Zhu, Jia; Zhang, Xiaoxing; Han, Zhe; Yan, Wenjun; Cheng, Qi; Hao, Jiang; Fan, Hongmei; Hou, Ruiqing; Chen, Zhaoqin; Chen, Yulei; Li, Chengyu T.] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Primate Neurobiol, Shanghai 200031, Peoples R China; [Liu, Ding; Gu, Xiaowei; Zhu, Jia; Han, Zhe; Yan, Wenjun; Cheng, Qi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CYT (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	tonylicy@ion.ac.cn	Zhang, Xiaoxing/AAL-8549-2021	, Xiaowei/0000-0003-2906-6348; Zhu, Jia/0000-0003-2240-7007; Zhang, Xiaoxing/0000-0001-5229-6091	Chinese 973 Program [2011CBA00406]; State Key Laboratory of Neuroscience; Chinese Academy of Sciences Hundreds of Talents Program	Chinese 973 Program(National Basic Research Program of China); State Key Laboratory of Neuroscience; Chinese Academy of Sciences Hundreds of Talents Program(Chinese Academy of Sciences)	We thank M. P. Stryker for communication on head-fixed mice preparation; Z. F. Mainen and N. Uchida for communication on behavioral design; G. Laurent for communication on population analysis; L. P. Wang for help in optogenetics; L. N. Lin for help in tetrode drive manufacturing; H. L. Hu for help in electrophysiological recordings; Y. Dan and J. F. Erlich for communication on spike sorting; H. Y. Zoghbi for VGAT-Cre mice; B. L. Roth for DREADD vectors; Z. L. Qiu, H. L. Hu, and X. Yu for help on AAV virus packaging and transgenic mice; A. K. Guo for help in PID experiments; Q. Hu for help in imaging experiments; Y. G. Sun for histochemistry experiments; Y. F. Li for help in drawing diagrams; and M. M. Poo and R. Desimone for critical comments on the manuscript. The work was supported by Chinese 973 Program (2011CBA00406), the State Key Laboratory of Neuroscience, and Chinese Academy of Sciences Hundreds of Talents Program (to C.T.L.). All the behavioral, optogenetic, electrophysiological, and histochemical data are archived in Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Baddeley A.D., 1986, WORKING MEMORY; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; LU XCM, 1993, PHYSIOL BEHAV, V53, P795, DOI 10.1016/0031-9384(93)90191-H; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Meyers EM, 2012, P NATL ACAD SCI USA, V109, P4651, DOI 10.1073/pnas.1201022109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; Passingham RE., 2012, NEUROBIOLOGY PREFRON; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Sobotka S, 2005, J NEUROPHYSIOL, V93, P128, DOI 10.1152/jn.01002.2003; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009	30	122	127	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					458	463		10.1126/science.1256573	http://dx.doi.org/10.1126/science.1256573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342800				2022-12-01	WOS:000343822900040
J	Fu, QM; Li, H; Moorjani, P; Jay, F; Slepchenko, SM; Bondarev, AA; Johnson, PLF; Aximu-Petri, A; Prufer, K; de Filippo, C; Meyer, M; Zwyns, N; Salazar-Garcia, DC; Kuzmin, YV; Keates, SG; Kosintsev, PA; Razhev, DI; Richards, MP; Peristov, NV; Lachmann, M; Douka, K; Higham, TFG; Slatkin, M; Hublin, JJ; Reich, D; Kelso, J; Viola, TB; Paabo, S				Fu, Qiaomei; Li, Heng; Moorjani, Priya; Jay, Flora; Slepchenko, Sergey M.; Bondarev, Aleksei A.; Johnson, Philip L. F.; Aximu-Petri, Ayinuer; Pruefer, Kay; de Filippo, Cesare; Meyer, Matthias; Zwyns, Nicolas; Salazar-Garcia, Domingo C.; Kuzmin, Yaroslav V.; Keates, Susan G.; Kosintsev, Pavel A.; Razhev, Dmitry I.; Richards, Michael P.; Peristov, Nikolai V.; Lachmann, Michael; Douka, Katerina; Higham, Thomas F. G.; Slatkin, Montgomery; Hublin, Jean-Jacques; Reich, David; Kelso, Janet; Viola, T. Bence; Paeaebo, Svante			Genome sequence of a 45,000-year-old modern human from western Siberia	NATURE			English	Article							HUMAN-EVOLUTION; HUMAN DISPERSALS; HISTORY; ASIA; DIVERGENCE; ADMIXTURE; EUROPE	We present the high-quality genome sequence of a similar to 45,000-year-old modern human male from Siberia. This individual derives from a population that lived before-or simultaneously with-the separation of the populations in western and eastern Eurasia and carries a similar amount of Neanderthal ancestry as present-day Eurasians. However, the genomic segments of Neanderthal ancestry are substantially longer than those observed in present-day individuals, indicating that Neanderthal gene flow into the ancestors of this individual occurred 7,000-13,000 years before he lived. We estimate an autosomal mutation rate of 0.4 x 10(-9) to 0.6 x 10(-9) per site per year, a Y chromosomal mutation rate of 0.7 x 10(-9) to 0.9 x 10(-9) per site per year based on the additional substitutions that have occurred in present-day non-Africans compared to this genome, and a mitochondrial mutation rate of 1.8 x 10(-8) to 3.2 x 10(-8) per site per year based on the age of the bone.	[Fu, Qiaomei] Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Fu, Qiaomei; Aximu-Petri, Ayinuer; Pruefer, Kay; de Filippo, Cesare; Meyer, Matthias; Lachmann, Michael; Kelso, Janet; Viola, T. Bence; Paeaebo, Svante] Max Planck Inst Evolutionare Anthropol, Dept EvolutionaryGenet, D-04103 Leipzig, Germany; [Li, Heng; Moorjani, Priya; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Moorjani, Priya] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jay, Flora; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Slepchenko, Sergey M.; Razhev, Dmitry I.] Russian Acad Sci, Siberian Branch, Inst Problems Dev North, Tyumen 625026, Russia; [Bondarev, Aleksei A.] Minist Internal Affairs, Omsk Div, Expert Criminalist Ctr, Omsk 644007, Russia; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Zwyns, Nicolas; Salazar-Garcia, Domingo C.; Richards, Michael P.; Hublin, Jean-Jacques; Viola, T. Bence] Max Planck Inst Evolutionare Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Zwyns, Nicolas] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Salazar-Garcia, Domingo C.] Univ Cape Town, Dept Archaeol, ZA-7701 Cape Town, South Africa; [Salazar-Garcia, Domingo C.] Univ Valencia, Dept Prehist & Arqueol, Valencia 46010, Spain; [Salazar-Garcia, Domingo C.] Max Planck Inst Evolutionare Anthropol, Res Grp Plant Foods Hominin Dietary Ecol, D-04103 Leipzig, Germany; [Kuzmin, Yaroslav V.; Keates, Susan G.] Russian Acad Sci, Siberian Branch, Inst Geol & Mineral, Novosibirsk 630090, Russia; [Kosintsev, Pavel A.] Russian Acad Sci, Urals Branch, Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Lab Archaeol, Vancouver, BC V6T 1Z1, Canada; [Peristov, Nikolai V.] Siberian Cultural Ctr, Omsk 644010, Russia; [Lachmann, Michael] Santa Fe Inst, Santa Fe, NM 87501 USA; [Douka, Katerina; Higham, Thomas F. G.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QY, England; [Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Columbia University; University of California System; University of California Berkeley; Russian Academy of Sciences; Tyumen Scientific Center of the Russian Academy of Sciences; Emory University; Max Planck Society; University of California System; University of California Davis; University of Cape Town; University of Valencia; Max Planck Society; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of British Columbia; The Santa Fe Institute; University of Oxford; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Fu, QM (corresponding author), Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.	qiaomei_fu@eva.mpg.de; reich@genetics.med.harvard.edu; kelso@eva.mpg.de; bence_viola@eva.mpg.de	Douka, Katerina/L-3287-2014; Li, Heng/D-9344-2011; Slepchenko, Sergey/AAN-5737-2020; Richards, Michael/O-3717-2016; Kelso, Janet/N-1812-2019; Salazar-García, Domingo C./AAB-1115-2019; Yaroslav, Kuzmin/GVT-7991-2022; Razhev, Dmitry/AAD-3668-2019; Kuzmin, Yaroslav/A-5286-2014; Higham, Tom/Y-2707-2019; Slepchenko, Sergey M/H-3454-2017	Douka, Katerina/0000-0002-0558-0011; Li, Heng/0000-0003-4874-2874; Richards, Michael/0000-0001-5274-8887; Kelso, Janet/0000-0002-3618-322X; Higham, Tom/0000-0002-5949-598X; Slepchenko, Sergey M/0000-0002-9365-3849; jay, flora/0000-0001-5884-4730; Salazar-Garcia, Domingo C./0000-0002-8017-0194	Chinese Academy of Sciences [XDA05130202]; Ministry of Science and Technology of China [2007FY110200]; Urals Branch, Russian Academy of Sciences [12-C-4-1014]; Russian Foundation for Basic Sciences [12-06-00045]; National Institutes of Health of the USA [R01-GM40282]; NIH [K99-GM104158, GM100233]; ERC [324139]; National Science Foundation [1032255]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM115006, R01GM040282, K99GM104158, R01GM100233] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Urals Branch, Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Sciences; National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to P. Gunz, M. Kircher, A. I. Krivoshapkin, P. Nigst, M. Ongyerth, N. Patterson, G. Renaud, U. Stenzel, M. Stoneking and S. Talamo for valuable input, comments and help; T. Pfisterer and H. Temming for technical assistance. Q.F. is funded in part by the Chinese Academy of Sciences (XDA05130202) and the Ministry of Science and Technology of China (2007FY110200); P.A.K. by Urals Branch, Russian Academy of Sciences (12-C-4-1014) and Y.V.K. by the Russian Foundation for Basic Sciences (12-06-00045); F.J. and M.S. by the National Institutes of Health of the USA (R01-GM40282); P.J. by the NIH (K99-GM104158); and T.F.G.H. by ERC advanced grant 324139. D.R. is a Howard Hughes Medical Institute Investigator and supported by the National Science Foundation (1032255) and the NIH (GM100233). Major funding for this work was provided by the Presidential Innovation Fund of the Max Planck Society.	Brock F, 2012, RADIOCARBON, V54, P879, DOI 10.1017/S0033822200047524; Ellis N, 2002, GENOME RES, V12, P339; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; GOEBEL T, 1993, CURR ANTHROPOL, V34, P452, DOI 10.1086/204192; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kuhn S. L., 2014, QUAT INT; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McCown T, 1939, STONE AGE MOUNT CARM, V2; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Trinkaus E, 1999, J ARCHAEOL SCI, V26, P409, DOI 10.1006/jasc.1998.0343; Vandermeersch B., 1981, HOMMES FOSSILES QAFZ, V319; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	36	548	575	8	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					445	+		10.1038/nature13810	http://dx.doi.org/10.1038/nature13810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341783	Green Accepted, Green Published			2022-12-01	WOS:000343775900030
J	Gostin, LO; Friedman, EA				Gostin, Lawrence O.; Friedman, Eric A.			Ebola: a crisis in global health leadership	LANCET			English	Editorial Material									[Gostin, Lawrence O.; Friedman, Eric A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Gostin, Lawrence O.] WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, INT HLTH REG; Callimachi N, 2014, NY TIMES; CDC, 2014, BUDG REQ SUMM FISC Y; Cooper H., 2014, NY TIMES; Fink S., 2014, NY TIMES; Gostin Lawrence, 2014, GLOBAL HLTH LAW; Gostin LO, 2014, LANCET; McNeil D., 2014, NY TIMES; Medecins sans Frontieres, 2014, GLOB BIOD RESP URG N; Nossiter Adam, 2014, NY TIMES; Ooms G, 2014, FINANCING HLTH GLOBA; Painter K, 2014, US TODAY; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; United Nations, 2014, EB VIR DIS OUTBR OV; WHO, 2014, ANN FIN REP AUD FIN; WHO, GLOB HLTH OBS DAT RE; World Health Organisation, 1946, WHO CONST; World Health Organization, 2011, REP REV COMM FUNCT I; World Health Organization, 2013, PROP PROGR BUDG 2014; World Health Organization, 2014, EB VIR DIS OUTBR RES; World Health Organization, 2014, WHO STAT M INT HLTH	21	62	66	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1323	1325		10.1016/S0140-6736(14)61791-8	http://dx.doi.org/10.1016/S0140-6736(14)61791-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7NH	25306563	Green Submitted			2022-12-01	WOS:000343004000005
J	Gil, Y; Greaves, M; Hendler, J; Hirsh, H				Gil, Yolanda; Greaves, Mark; Hendler, James; Hirsh, Haym			Amplify scientific discovery with artificial intelligence	SCIENCE			English	Editorial Material									[Gil, Yolanda] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Greaves, Mark] Pacific NW Natl Lab, Richland, WA 99354 USA; [Hendler, James] Rensselaer Polytech Inst, Troy, NY 12203 USA; [Hirsh, Haym] Cornell Univ, Ithaca, NY 14850 USA	University of Southern California; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Rensselaer Polytechnic Institute; Cornell University	Gil, Y (corresponding author), Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA.	hendler@cs.rpi.edu		Hendler, James/0000-0003-3056-1960; Gil, Yolanda/0000-0001-8465-8341; Greaves, Mark/0000-0002-6239-9999				Aragon CR, 2008, J PHYS CONF SER, V125, P12091, DOI 10.1088/1742-6596/125/1/012091; Caetano C, 2011, INT J QUANTUM CHEM, V111, P2732, DOI 10.1002/qua.22572; DEEPA SN, 2011, INDIAN J SCI TECHNOL, V4, P1583; Gil Y, 2011, IEEE INTELL SYST, V26, P62, DOI 10.1109/MIS.2010.9; Hendler J, 2003, SCIENCE, V299, P520, DOI 10.1126/science.1078874; Kelly III John E., 2013, SMART MACHINES; Langley P., 1987, SCI DISCOVERY COMPUT; Leach SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000215; Lindsay R.K., 1980, APPL ARTIFICIAL INTE; Martialay M., CITIZEN SCI; Waltz D, 2009, SCIENCE, V324, P43, DOI 10.1126/science.1172781	11	66	74	9	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					171	172		10.1126/science.1259439	http://dx.doi.org/10.1126/science.1259439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301606				2022-12-01	WOS:000342721500024
J	Zhang, XQ; Bogunovic, D; Payelle-Brogard, B; Francois-Newton, V; Speer, SD; Yuan, C; Volpi, S; Li, Z; Sanal, O; Mansouri, D; Tezcan, I; Rice, GI; Chen, CY; Mansouri, N; Mahdaviani, SA; Itan, Y; Boisson, B; Okada, S; Zeng, L; Wang, X; Jiang, H; Liu, WQ; Han, TT; Liu, DL; Ma, T; Wang, B; Liu, MG; Liu, JY; Wang, QK; Yalnizoglu, D; Radoshevich, L; Uze, G; Gros, P; Rozenberg, F; Zhang, SY; Jouanguy, E; Bustamante, J; Garcia-Sastre, A; Abel, L; Lebon, P; Notarangelo, LD; Crow, YJ; Boisson-Dupuis, S; Casanova, JL; Pellegrini, S				Zhang, Xianqin; Bogunovic, Dusan; Payelle-Brogard, Beatrice; Francois-Newton, Veronique; Speer, Scott D.; Yuan, Chao; Volpi, Stefano; Li, Zhi; Sanal, Ozden; Mansouri, Davood; Tezcan, Ilhan; Rice, Gillian I.; Chen, Chunyuan; Mansouri, Nahal; Mahdaviani, Seyed Alireza; Itan, Yuval; Boisson, Bertrand; Okada, Satoshi; Zeng, Lu; Wang, Xing; Jiang, Hui; Liu, Wenqiang; Han, Tiantian; Liu, Delin; Ma, Tao; Wang, Bo; Liu, Mugen; Liu, Jing-Yu; Wang, Qing K.; Yalnizoglu, Dilek; Radoshevich, Lilliana; Uze, Gilles; Gros, Philippe; Rozenberg, Flore; Zhang, Shen-Ying; Jouanguy, Emmanuelle; Bustamante, Jacinta; Garcia-Sastre, Adolfo; Abel, Laurent; Lebon, Pierre; Notarangelo, Luigi D.; Crow, Yanick J.; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Pellegrini, Sandra			Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation	NATURE			English	Article							AICARDI-GOUTIERES SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BASAL GANGLIA CALCIFICATION; INTRACRANIAL CALCIFICATION; EXPRESSION SIGNATURE; GENE; MUTATIONS; IMMUNITY; AUTOIMMUNITY; PROTEOLYSIS	Intracellular ISG15 is an interferon (IFN)-alpha/beta-inducible ubiquitin-like modifier which can covalently bind other proteins in a process called ISGylation; it is an effector of IFN-alpha/beta-dependent antiviral immunity in mice(1-4). We previously published a study describing humans with inherited ISG15deficiency but without unusually severe viral diseases(5). We showed that these patients were prone to mycobacterial disease and that human ISG15 was non-redundant as an extracellular IFN-gamma-inducing molecule. We show here that ISG15-deficient patients also display unanticipated cellular, immunological and clinical signs of enhanced IFN-alpha/beta immunity, reminiscent of the Mendelian autoinflammatory interferonopathies Aicardi-Goutieres syndrome and spondyloenchondrodysplasia(6-9). We further show that an absence of intracellular ISG15 in the patients' cells prevents the accumulation of USP18(10,11), a potent negative regulator of IFN-alpha/beta signalling, resulting in the enhancement and amplification of IFN-alpha/beta responses. Human ISG15, therefore, is not only redundant for antiviral immunity, but is a key negative regulator of IFN-alpha/beta immunity. In humans, intracellular ISG15 is IFN-alpha/beta-inducible not to serve as a substrate for ISGylation-dependent antiviral immunity, but to ensure USP18-dependent regulation of IFN-alpha/beta and prevention of IFN-alpha/beta-dependent autoinflammation.	[Zhang, Xianqin; Yuan, Chao; Zeng, Lu; Wang, Xing; Liu, Wenqiang; Han, Tiantian; Ma, Tao; Liu, Mugen; Liu, Jing-Yu; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Bogunovic, Dusan; Itan, Yuval; Boisson, Bertrand; Okada, Satoshi; Zhang, Shen-Ying; Abel, Laurent; Boisson-Dupuis, Stephanie] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Bogunovic, Dusan; Speer, Scott D.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Payelle-Brogard, Beatrice; Francois-Newton, Veronique; Li, Zhi; Pellegrini, Sandra] Inst Pasteur, Cytokine Signaling Unit, CNRS URA 1961, F-75724 Paris, France; [Speer, Scott D.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Speer, Scott D.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Microbiol Training Area, New York, NY 10029 USA; [Volpi, Stefano; Notarangelo, Luigi D.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Volpi, Stefano] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy; [Sanal, Ozden; Tezcan, Ilhan; Yalnizoglu, Dilek] Hacettepe Univ, Childrens Hosp, Div Immunol, TR-06100 Ankara, Turkey; [Sanal, Ozden; Tezcan, Ilhan; Yalnizoglu, Dilek] Hacettepe Univ, Childrens Hosp, Pediat Neurol Dept, TR-06100 Ankara, Turkey; [Mansouri, Davood; Mansouri, Nahal; Mahdaviani, Seyed Alireza] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Pediat Resp Dis Res Ctr, Div Infect Dis & Clin Immunol, Tehran 4739, Iran; [Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Chen, Chunyuan] Cent S Univ, Xiangya Hosp 3, Dept Pediat, Changsha 410013, Hunan, Peoples R China; [Jiang, Hui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Liu, Delin] Sangzhi Cty Peoples Hosp, Sangzhi 427100, Peoples R China; [Wang, Bo] Hubei Maternal & Child Hlth Hosp, Genet Lab, Wuhan 430070, Peoples R China; [Wang, Qing K.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; [Radoshevich, Lilliana] Inst Pasteur, Bacteria Cell Interact Unit, F-75724 Paris, France; [Uze, Gilles] Univ Montpellier 2, CNRS UMR5235, F-34095 Montpellier, France; [Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ H3A 0G4, Canada; [Rozenberg, Flore; Lebon, Pierre] Paris Descartes Univ, F-75006 Paris, France; [Jouanguy, Emmanuelle; Bustamante, Jacinta; Abel, Laurent; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Jouanguy, Emmanuelle; Bustamante, Jacinta; Abel, Laurent; Crow, Yanick J.; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Bustamante, Jacinta] Necker Hosp Sick Children, Ctr Study Primary Immunodeficiencies, F-75015 Paris, France; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Crow, Yanick J.] Imagine Inst, Lab Neurogenet & Neuroinflammat, INSERM UMR 1163, F-75006 Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France	Huazhong University of Science & Technology; Rockefeller University; Icahn School of Medicine at Mount Sinai; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital; University of Genoa; Hacettepe University; Hacettepe University; Shahid Beheshti University Medical Sciences; University of Manchester; Central South University; Beijing Genomics Institute (BGI); Cleveland Clinic Foundation; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; McGill University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bogunovic, D (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	Dusan.Bogunovic@mssm.edu	Rice, Gillian I/G-3128-2015; Volpi, Stefano/O-3717-2014; Pellegrini, Sandra/Y-6351-2019; Rozenberg, Flore/O-8854-2017; Crow, Yanick J/N-6120-2014; Boisson-Dupuis, Stéphanie/I-2040-2017; Boisson, Bertrand/AAC-6058-2019; Notarangelo, Luigi D/F-9718-2016; Uzé, Gilles/O-6383-2019; Okada, Satoshi/B-8901-2011; Jouanguy, Emmanuelle/H-7901-2017; Casanova, Jean-Laurent/I-3418-2017; Zhang, Shen-Ying/I-2685-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Abel, Laurent/H-8888-2017; mahdaviani, alireza/G-3256-2017; Pellegrini, Sandra -/G-5546-2015; mansouri, davood/G-6471-2017; LI, Zhi/Q-4790-2018; Boisson, Bertrand/I-2485-2017; Bustamante, Jacinta/H-7877-2017	Rice, Gillian I/0000-0002-4223-0571; Volpi, Stefano/0000-0002-7129-868X; Pellegrini, Sandra/0000-0001-5837-7589; Crow, Yanick J/0000-0001-7211-7564; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Boisson, Bertrand/0000-0001-5240-3555; Notarangelo, Luigi D/0000-0002-8335-0262; Okada, Satoshi/0000-0002-4622-5657; Jouanguy, Emmanuelle/0000-0002-7358-9157; Zhang, Shen-Ying/0000-0002-9449-3672; Abel, Laurent/0000-0001-7016-6493; mahdaviani, alireza/0000-0001-6224-4797; Pellegrini, Sandra -/0000-0001-5837-7589; mansouri, davood/0000-0002-0564-8282; LI, Zhi/0000-0003-4422-4914; Boisson, Bertrand/0000-0001-5240-3555; Bustamante, Jacinta/0000-0002-3439-2482; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Casanova, Jean-Laurent/0000-0002-7782-4169; Uze, Gilles/0000-0002-4150-5772; Chao, Yuan/0000-0003-1315-0166; Radoshevich, Lilliana/0000-0003-0294-9300; Wang, Qing/0000-0002-5639-8519	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076210, R01AI035237, R37AI095983, R00AI106942, U19AI083025, P01AI090935] Funding Source: NIH RePORTER; European Research Council [309449] Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000043, 8UL1TR000043] Funding Source: Medline; NIAID NIH HHS [R00AI106942-02, P01 AI090935, P01AI090935, R01 AI035237, R00 AI106942, U19 AI083025, R37AI095983, P01 AI076210, 1P01AI076210-01A1, U19AI083025, R37 AI095983] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bogunovic D, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.36; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Broering R, 2010, GUT, V59, P1111, DOI 10.1136/gut.2009.195545; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chua PK, 2009, J GEN VIROL, V90, P2929, DOI 10.1099/vir.0.013128-0; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; KENDALL B, 1986, NEURORADIOLOGY, V28, P324, DOI 10.1007/BF00333438; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Livingston JH, 2013, DEV MED CHILD NEUROL, V55, P46, DOI 10.1111/j.1469-8749.2012.04437.x; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Raymond AA, 1996, LUPUS, V5, P123, DOI 10.1177/096120339600500207; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Tokarz S, 2004, J BIOL CHEM, V279, P46424, DOI 10.1074/jbc.M403189200; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	31	313	322	0	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					89	U229		10.1038/nature13801	http://dx.doi.org/10.1038/nature13801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25307056	Green Published, Green Accepted			2022-12-01	WOS:000347178400041
J	Tedersoo, L; Bahram, M; Polme, S; Koljalg, U; Yorou, NS; Wijesundera, R; Ruiz, LV; Vasco-Palacios, AM; Thu, PQ; Suija, A; Smith, ME; Sharp, C; Saluveer, E; Saitta, A; Rosas, M; Riit, T; Ratkowsky, D; Pritsch, K; Poldmaa, K; Piepenbring, M; Phosri, C; Peterson, M; Parts, K; Partel, K; Otsing, E; Nouhra, E; Njouonkou, AL; Nilsson, RH; Morgado, LN; Mayor, J; May, TW; Majuakim, L; Lodge, DJ; Lee, SS; Larsson, KH; Kohout, P; Hosaka, K; Hiiesalu, I; Henkel, TW; Harend, H; Guo, LD; Greslebin, A; Grelet, G; Geml, J; Gates, G; Dunstan, W; Dunk, C; Drenkhan, R; Dearnaley, J; De Kesel, A; Dang, T; Chen, X; Buegger, F; Brearley, FQ; Bonito, G; Anslan, S; Abell, S; Abarenkov, K				Tedersoo, Leho; Bahram, Mohammad; Polme, Sergei; Koljalg, Urmas; Yorou, Nourou S.; Wijesundera, Ravi; Villarreal Ruiz, Luis; Vasco-Palacios, Aida M.; Pham Quang Thu; Suija, Ave; Smith, Matthew E.; Sharp, Cathy; Saluveer, Erki; Saitta, Alessandro; Rosas, Miguel; Riit, Taavi; Ratkowsky, David; Pritsch, Karin; Poldmaa, Kadri; Piepenbring, Meike; Phosri, Cherdchai; Peterson, Marko; Parts, Kaarin; Paertel, Kadri; Otsing, Eveli; Nouhra, Eduardo; Njouonkou, Andre L.; Nilsson, R. Henrik; Morgado, Luis N.; Mayor, Jordan; May, Tom W.; Majuakim, Luiza; Lodge, D. Jean; Lee, Su See; Larsson, Karl-Henrik; Kohout, Petr; Hosaka, Kentaro; Hiiesalu, Indrek; Henkel, Terry W.; Harend, Helery; Guo, Liang-dong; Greslebin, Alina; Grelet, Gwen; Geml, Jozsef; Gates, Genevieve; Dunstan, William; Dunk, Chris; Drenkhan, Rein; Dearnaley, John; De Kesel, Andre; Tan Dang; Chen, Xin; Buegger, Franz; Brearley, Francis Q.; Bonito, Gregory; Anslan, Sten; Abell, Sandra; Abarenkov, Kessy			Global diversity and geography of soil fungi	SCIENCE			English	Article							ECTOMYCORRHIZAL FUNGI; COMMUNITY STRUCTURE; CLIMATE-CHANGE; PATTERNS; PLANT; BIOGEOGRAPHY; GRADIENT; ECOSYSTEMS; DISPERSAL; ABUNDANCE	Fungi play major roles in ecosystem processes, but the determinants of fungal diversity and biogeographic patterns remain poorly understood. Using DNA metabarcoding data from hundreds of globally distributed soil samples, we demonstrate that fungal richness is decoupled from plant diversity. The plant-to-fungus richness ratio declines exponentially toward the poles. Climatic factors, followed by edaphic and spatial variables, constitute the best predictors of fungal richness and community composition at the global scale. Fungi show similar latitudinal diversity gradients to other organisms, with several notable exceptions. These findings advance our understanding of global fungal diversity patterns and permit integration of fungi into a general macroecological framework.	[Tedersoo, Leho; Polme, Sergei; Abarenkov, Kessy] Univ Tartu, Nat Hist Museum, EE-50090 Tartu, Estonia; [Bahram, Mohammad; Koljalg, Urmas; Suija, Ave; Saluveer, Erki; Riit, Taavi; Poldmaa, Kadri; Peterson, Marko; Parts, Kaarin; Paertel, Kadri; Otsing, Eveli; Kohout, Petr; Hiiesalu, Indrek; Harend, Helery; Anslan, Sten] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Yorou, Nourou S.] Univ Parakou, Fac Agron, Parakou, Benin; [Wijesundera, Ravi] Univ Colombo, Dept Plant Sci, Colombo 3, Sri Lanka; [Villarreal Ruiz, Luis] Colegio Postgrad Lineas Prioritarias Invest 6, LARGEMBIO, Mexico City, DF, Mexico; [Vasco-Palacios, Aida M.] Royal Netherlands Acad Arts & Sci, Cent Bur Schimmelcultures, Fungal Biodivers Ctr, Utrecht, Netherlands; [Pham Quang Thu; Tan Dang] Vietnamese Acad Forest Sci, Hanoi, Vietnam; [Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Sharp, Cathy] Nat Hist Museum, Bulawayo, Zimbabwe; [Saitta, Alessandro] Univ Palermo, Dept Agr & Forest Sci, Palermo, Italy; [Rosas, Miguel; Piepenbring, Meike] Goethe Univ Frankfurt, Dept Mycol, D-60054 Frankfurt, Germany; [Ratkowsky, David; Gates, Genevieve] Tasmanian Inst Agr, Hobart, Tas, Australia; [Pritsch, Karin; Buegger, Franz] Helmholtz Zentrum Munchen, Inst Soil Ecol, Neuherberg, Germany; [Phosri, Cherdchai] Nakhon Phanom Univ, Dept Biol, Nakhon Phanom, Thailand; [Nouhra, Eduardo] Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Njouonkou, Andre L.] Univ Bamenda, Dept Biol Sci, Bambili, Cameroon; [Nilsson, R. Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Morgado, Luis N.; Geml, Jozsef] Naturalis Biodivers Ctr, Leiden, Netherlands; [Mayor, Jordan; Dunk, Chris] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [May, Tom W.; Bonito, Gregory] Royal Bot Gardens, Melbourne, Vic, Australia; [Majuakim, Luiza] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Sabah, Malaysia; [Lodge, D. Jean] US Forest Serv, Ctr Forest Mycol Res, USDA, Luquillo, PR USA; [Lee, Su See] Forest Res Inst Malaysia, Kepong, Selangor, Malaysia; [Larsson, Karl-Henrik] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Hosaka, Kentaro] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Henkel, Terry W.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Guo, Liang-dong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Greslebin, Alina] Univ Nacl Patagonia SJB, Fac Cs Nat, CONICET, Esquel, Chubut, Argentina; [Grelet, Gwen] Landcare Res, Ecosyst & Global Change Team, Lincoln, New Zealand; [Dunstan, William] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Drenkhan, Rein] Estonian Univ Life Sci, Inst Forestry & Rural Engn, Tartu, Estonia; [Dearnaley, John] Univ So Queensland, Fac Hlth Engn & Sci, Toowoomba, Qld 4350, Australia; [De Kesel, Andre] Bot Garden Meise, Meise, Belgium; [Chen, Xin] Zhejiag Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Brearley, Francis Q.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M15 6BH, Lancs, England; [Abell, Sandra] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia	University of Tartu; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Colombo; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); State University System of Florida; University of Florida; University of Palermo; Goethe University Frankfurt; University of Tasmania; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Nakhon Phanom University; University of Gothenburg; Naturalis Biodiversity Center; Swedish University of Agricultural Sciences; Universiti Malaysia Sabah; United States Department of Agriculture (USDA); United States Forest Service; Institute Penyelidikan Perhutanan Malaysia; University of Oslo; National Museum of Nature and Science; California State University System; California State Polytechnic University, Humboldt; Chinese Academy of Sciences; Institute of Microbiology, CAS; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Landcare Research - New Zealand; Murdoch University; Estonian University of Life Sciences; University of Southern Queensland; Manchester Metropolitan University; James Cook University	Tedersoo, L (corresponding author), Univ Tartu, Nat Hist Museum, Ulikooli 18, EE-50090 Tartu, Estonia.	leho.tedersoo@ut.ee	YOROU, Nourou S./AAE-2754-2022; Kohout, Petr/B-4975-2011; Põldmaa, Kadri/AAV-6439-2020; Vasco-Palacios, Aida/AAU-9075-2020; GUO, Liang-dong/C-1407-2015; Kõljalg, Urmas/AAM-7828-2020; Kõljalg, Urmas/H-6925-2015; Smith, Matthew E./ABC-3015-2020; Geml, Jozsef/AAW-9993-2020; Abarenkov, Kessy/H-9611-2015; Nilsson, R. Henrik/A-6062-2009; Bahram, Mohammad/A-9766-2010; Põldmaa, Kadri/AAB-8631-2019; Tedersoo, Leho/ABE-7452-2020; Smith, Matthew E/A-8115-2012; Abell-Davis, Sandra E/G-9637-2011; Geml, Jozsef/C-2223-2018; May, Tom/C-2460-2014	YOROU, Nourou S./0000-0001-6997-811X; Kohout, Petr/0000-0002-3985-2310; Põldmaa, Kadri/0000-0002-7936-2455; Vasco-Palacios, Aida/0000-0003-0539-9711; Kõljalg, Urmas/0000-0002-5171-1668; Smith, Matthew E./0000-0002-0878-0932; Abarenkov, Kessy/0000-0001-5526-4845; Nilsson, R. Henrik/0000-0002-8052-0107; Smith, Matthew E/0000-0002-0878-0932; Abell-Davis, Sandra E/0000-0001-8296-9867; Geml, Jozsef/0000-0001-8745-0423; De Kesel, Andre/0000-0002-5287-4637; May, Tom/0000-0003-2214-4972; SAITTA, Alessandro/0000-0002-5670-7780; Dang, Tan/0000-0002-2765-0084; Anslan, Sten/0000-0002-2299-454X; Dearnaley, John/0000-0001-9842-727X; Villarreal Ruiz, Luis/0000-0001-8472-4898; Otsing, Eveli/0000-0001-7416-257X; Phosri, Cherdchai/0000-0003-3963-752X	Estonian Science Foundation [9286, 171PUT, IUT20-30, EMP265]; Frontiers in Biodiversity Research; European Research Council; Direct For Biological Sciences [1239764] Funding Source: National Science Foundation	Estonian Science Foundation; Frontiers in Biodiversity Research; European Research Council(European Research Council (ERC)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The sequence data and metadata are deposited in the Short Read Archive (accession SRP043706) and UNITE databases. Data used for analyses are available as supplementary materials, data files S1 and S2. We thank A. Corrales, H. Mann, D. Sveshnikov, F. O. P. Stefani, A. Voitk, and Y. Wu for supplying single soil samples; R. Puusepp, M. Haugas, and M. Noukas for sample preparation; H. Kreft for providing interpolated plant diversity data; S. Juris for designing the printed figure; M. I. Bidartondo, K. G. Peay, and three anonymous reviewers for constructive comments on the manuscript; and relevant institutions of multiple countries for issuing permissions for sampling and delivery. The bulk of this project was funded from Estonian Science Foundation grants 9286, 171PUT, and IUT20-30; EMP265; Frontiers in Biodiversity Research; European Research Council; and in part by numerous funding sources that facilitated co-author efforts in collecting and preprocessing samples.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bahram M, 2014, FUNGAL ECOL, V7, P70, DOI 10.1016/j.funeco.2013.10.003; Bahram M, 2013, J ECOL, V101, P1335, DOI 10.1111/1365-2745.12120; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hiiesalu I, 2014, NEW PHYTOL, V203, P233, DOI 10.1111/nph.12765; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Peay KG, 2010, NEW PHYTOL, V185, P878, DOI 10.1111/j.1469-8137.2009.03158.x; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; R Core Team, 2014, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sato H, 2012, MOL ECOL, V21, P5599, DOI 10.1111/mec.12053; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Serna-Chavez HM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1162, DOI 10.1111/geb.12070; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2013, FUNGAL BIOL REV, V27, P83, DOI 10.1016/j.fbr.2013.09.001; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2012, NEW PHYTOL, V195, P832, DOI 10.1111/j.1469-8137.2012.04217.x; Timling I, 2014, MOL ECOL, V23, P3258, DOI 10.1111/mec.12743; Treseder KK, 2014, ECOL LETT, V17, P1086, DOI 10.1111/ele.12311; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029	53	1794	1909	190	2014	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1078	+	1256688	10.1126/science.1256688	http://dx.doi.org/10.1126/science.1256688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430773	Green Submitted, Green Accepted			2022-12-01	WOS:000345763400032
J	Jack, A				Jack, Andrew			INFLUENZA TREATMENT Will Tamiflu recommendations change this winter?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], 2010, WHO GUID PHARM MAN P; [Anonymous], 2013, WHO MOD LIST ESS MED WHO MOD LIST ESS MED; [Anonymous], 2021, HUM INF AV INFL AH5N; Cohen D, 2014, BMJ-BRIT MED J, V340, pc2912; European Centre for Disease Prevention and Control, 2014, NEW UPD EV NEUR INH; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Multiparty Group for Advice on Science, MULT EXP TEAM M; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; WHO, ESS MED SEL OS; World Health Organization (WHO), 2014, AV INFL A H7N9 VIR P	11	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g6742	10.1136/bmj.g6742	http://dx.doi.org/10.1136/bmj.g6742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KG	25430733				2022-12-01	WOS:000346115800002
J	Lonfat, N; Montavon, T; Darbellay, F; Gitto, S; Duboule, D				Lonfat, Nicolas; Montavon, Thomas; Darbellay, Fabrice; Gitto, Sandra; Duboule, Denis			Convergent evolution of complex regulatory landscapes and pleiotropy at Hox loci	SCIENCE			English	Article							EXTERNAL GENITALIA; TRANSGENIC ANALYSIS; GENE-REGULATION; DOMAINS; MORPHOGENESIS; EXPRESSION; APPENDAGE; ENHANCERS; CLUSTERS; HOXA-13	Hox genes are required during the morphogenesis of both vertebrate digits and external genitals. We investigated whether transcription in such distinct contexts involves a shared enhancer-containing landscape. We show that the same regulatory topology is used, yet with some tissue-specific enhancer-promoter interactions, suggesting the hijacking of a regulatory backbone from one context to the other. In addition, comparable organizations are observed at both HoxA and HoxD clusters, which separated through genome duplication in an ancestral invertebrate animal. We propose that this convergent regulatory evolution was triggered by the preexistence of some chromatin architecture, thus facilitating the subsequent recruitment of the appropriate transcription factors. Such regulatory topologies may have both favored and constrained the evolution of pleiotropic developmental loci in vertebrates.	[Lonfat, Nicolas; Montavon, Thomas; Darbellay, Fabrice; Duboule, Denis] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Gitto, Sandra; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Duboule, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	denis.duboule@epfl.ch		duboule, denis/0000-0001-9961-2960; Lonfat, Nicolas/0000-0001-7078-3301; Montavon, Thomas/0000-0001-8247-1399; Darbellay, Fabrice/0000-0001-6942-3325	Federal Institute of Technology (EPFL); University of Geneva; Swiss National Research Foundation [310030B_138662]; European Research Council [232790]	Federal Institute of Technology (EPFL); University of Geneva; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission)	We thank D. Noordermeer, P. Fabre, G. Andrey, A. Necsulea, and all colleagues from the Duboule laboratories for their help and for reagents and discussions. We thank M. Docquier and the Geneva Genomics Platform, S. Verp and S. Offner for help with transgenic animals, and M. Leleu from the Bioinformatics and Biostatistics Core Facility (BBCF) of the Ecole Polytechnique Federale (EPFL). Computations were performed at Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics, using tools developed by the BBCF. This work was supported by funds from the Federal Institute of Technology (EPFL), the University of Geneva, the Swiss National Research Foundation (no. 310030B_138662), and European Research Council grant SystemsHox.ch (no. 232790). Data sets presented in this study are available with accession no. GSE62269.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Cohn MJ, 2011, DEV DYNAM, V240, P1108, DOI 10.1002/dvdy.22631; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; Duboule D, 1998, TRENDS GENET, V14, P54, DOI 10.1016/S0168-9525(97)01358-9; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; HOLLAND PWH, 1994, DEVELOPMENT, P125; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Lehoczky JA, 2008, EVOL DEV, V10, P421, DOI 10.1111/j.1525-142X.2008.00253.x; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Ravi V, 2009, P NATL ACAD SCI USA, V106, P16327, DOI 10.1073/pnas.0907914106; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Suzuki K, 2003, DEVELOPMENT, V130, P6209, DOI 10.1242/dev.00846; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Warot X, 1997, DEVELOPMENT, V124, P4781; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773	27	92	93	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1004	1006		10.1126/science.1257493	http://dx.doi.org/10.1126/science.1257493			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414315				2022-12-01	WOS:000345696000046
J	Barouch, DH; Michael, NL				Barouch, Dan H.; Michael, Nelson L.			Accelerating HIV-1 Vaccine Efficacy Trials	CELL			English	Editorial Material							DOUBLE-BLIND; GAG/POL/NEF VACCINE; HVTN 503/PHAMBILI; RHESUS-MONKEYS; SOUTH-AFRICA; PHASE 2H; INFECTION; CHALLENGES		[Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Barouch, Dan H.] Harvard, Cambridge, MA 02139 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu; nmichael@hivresearch.org	Barouch, Dan/Y-3918-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096040, U19AI095985, R01AI084794, U19AI078526] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI095985, U19 AI096040, U19 AI078526, R01 AI084794] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baden LR, 2014, J INFECT DIS; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Reynolds MR, 2012, VACCINE, V30, P4465, DOI 10.1016/j.vaccine.2012.04.082; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519	13	15	15	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					969	972		10.1016/j.cell.2014.10.046	http://dx.doi.org/10.1016/j.cell.2014.10.046			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416935	Green Accepted, Bronze			2022-12-01	WOS:000345506300008
J	Joachimiak, LA; Walzthoeni, T; Liu, CW; Aebersold, R; Frydman, J				Joachimiak, Lukasz A.; Walzthoeni, Thomas; Liu, Corey W.; Aebersold, Ruedi; Frydman, Judith			The Structural Basis of Substrate Recognition by the Eukaryotic Chaperonin TRiC/CCT	CELL			English	Article							GROEL APICAL DOMAIN; CYTOSOLIC CHAPERONIN; BINDING-SITES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; COMPLEX; PROTEINS; SUBUNIT; PROTEOSTASIS	The eukaryotic chaperonin TRiC (also called CCT) is the obligate chaperone for many essential proteins. TRiC is hetero-oligomeric, comprising two stacked rings of eight different subunits each. Subunit diversification from simpler archaeal chaperonins appears linked to proteome expansion. Here, we integrate structural, biophysical, and modeling approaches to identify the hitherto unknown substrate-binding site in TRiC and uncover the basis of substrate recognition. NMR and modeling provided a structural model of a chaperonin-substrate complex. Mutagenesis and crosslinking-mass spectrometry validated the identified substrate-binding interface and demonstrate that TRiC contacts full-length substrates combinatorially in a subunit-specific manner. The binding site of each subunit has a distinct, evolutionarily conserved pattern of polar and hydrophobic residues specifying recognition of discrete substrate motifs. The combinatorial recognition of polypeptides broadens the specificity of TRiC and may direct the topology of bound polypeptides along a productive folding trajectory, contributing to TRiC's unique ability to fold obligate substrates.	[Joachimiak, Lukasz A.; Frydman, Judith] Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA; [Walzthoeni, Thomas; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Walzthoeni, Thomas] Univ Zurich, ETH Zurich, Ph D Program Mol Life Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Joachimiak, LA (corresponding author), Pacific Biosci, 1380 Willow St, Menlo Pk, CA 94025 USA.	lajoachi@gmail.com; jfrydman@stanford.edu		, judith/0000-0003-2302-6943	NIH fellowship; NIH grants; ERC grant [AdG-233226]; ETH Zurich; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098254, R01GM074074] Funding Source: NIH RePORTER	NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC grant; ETH Zurich(ETH Zurich); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. R. Andino, A. Joachimiak, D. Gestaut, and K. Dalton for comments on the manuscript and Drs. L. Gierasch and D. Agard for advice. We thank Dr. M. Eckart from the PAN facility for help with the SPR experiments. This work was supported by an NIH fellowship to L.A.J., NIH grants to J.F., ERC grant to R. A. (Proteomics v3.0; AdG-233226 to R. A.), and funds from ETH Zurich to R. A. and T. W.	Ashcroft AE, 2002, J BIOL CHEM, V277, P33115, DOI 10.1074/jbc.M203398200; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heller M, 2004, J MOL BIOL, V336, P717, DOI 10.1016/j.jmb.2003.12.035; Hong S, 2001, J VIROL, V75, P2526, DOI 10.1128/JVI.75.6.2526-2534.2001; Hua QX, 2001, J MOL BIOL, V306, P513, DOI 10.1006/jmbi.2000.4405; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; Inoue Y, 2011, VIROLOGY, V410, P38, DOI 10.1016/j.virol.2010.10.026; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kasembeli M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001844; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Mao BC, 2014, J AM CHEM SOC, V136, P1893, DOI 10.1021/ja409845w; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pappenberger G, 2002, J MOL BIOL, V318, P1367, DOI 10.1016/S0022-2836(02)00190-0; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Salgado GF, 2009, BIOCHEMISTRY-US, V48, P2355, DOI 10.1021/bi801794v; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; van der Schot G, 2013, J BIOMOL NMR, V57, P27, DOI 10.1007/s10858-013-9762-6; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; You L, 2004, J MOL BIOL, V341, P1343, DOI 10.1016/j.jmb.2004.06.081; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	53	95	95	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1042	1055		10.1016/j.cell.2014.10.042	http://dx.doi.org/10.1016/j.cell.2014.10.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416944	Green Accepted, Bronze			2022-12-01	WOS:000345506300017
J	Swetter, SM; Geller, AC				Swetter, Susan M.; Geller, Alan C.			Catch melanoma early	NATURE			English	Editorial Material									[Swetter, Susan M.] Stanford Univ, Med Ctr, Pigmented Lesion & Melanoma Program, Palo Alto, CA 94304 USA; [Swetter, Susan M.] Inst Canc Res, Palo Alto, CA USA; [Geller, Alan C.] Harvard Univ, Sch Publ Hlth, Boston, MA USA; [Geller, Alan C.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Swetter, SM (corresponding author), Stanford Univ, Med Ctr, Pigmented Lesion & Melanoma Program, Palo Alto, CA 94304 USA.	sswetter@stanford.edu; ageller@hsph.harvard.edu						Aitken JF, 2010, INT J CANCER, V126, P450, DOI 10.1002/ijc.24747; Katalinic A, 2012, CANCER-AM CANCER SOC, V118, P5395, DOI 10.1002/cncr.27566; Schneider JS, 2008, J AM ACAD DERMATOL, V58, P741, DOI 10.1016/j.jaad.2007.10.648; Swetter SM, 2012, CANCER-AM CANCER SOC, V118, P3725, DOI 10.1002/cncr.26707	4	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S117	S117		10.1038/515S117a	http://dx.doi.org/10.1038/515S117a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407708	Bronze			2022-12-01	WOS:000345770600004
J	Scott, AR				Scott, Andrew R.			Creating a cure-all	NATURE			English	Editorial Material							SICKLE-CELL-DISEASE; TRANSPLANTATION											Bolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; Kanter J, 2013, BLOOD REV, V27, P279, DOI 10.1016/j.blre.2013.09.001; Vrecenak J. D., 2014, BLOOD	4	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S14	S15		10.1038/515S14a	http://dx.doi.org/10.1038/515S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390137	Bronze			2022-12-01	WOS:000344631400009
J	von Gottberg, A; de Gouveia, L; Tempia, S; Quan, V; Meiring, S; von Mollendorf, C; Madhi, SA; Zell, ER; Verani, JR; O'Brien, KL; Whitney, CG; Klugman, KP; Cohen, C				von Gottberg, Anne; de Gouveia, Linda; Tempia, Stefano; Quan, Vanessa; Meiring, Susan; von Mollendorf, Claire; Madhi, Shabir A.; Zell, Elizabeth R.; Verani, Jennifer R.; O'Brien, Katherine L.; Whitney, Cynthia G.; Klugman, Keith P.; Cohen, Cheryl		GERMS-SA Investigators	Effects of Vaccination on Invasive Pneumococcal Disease in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV-INFECTED ADULTS; CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CHILDREN; ERA; IMMUNIZATION; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION; EFFICACY	BACKGROUND In South Africa, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 with a three-dose schedule for infants at 6, 14, and 36 weeks of age; a 13-valent vaccine (PCV13) replaced PCV7 in 2011. In 2012, it was estimated that 81% of 12-month-old children had received three doses of vaccine. We assessed the effect of vaccination on invasive pneumococcal disease. METHODS We conducted national, active, laboratory-based surveillance for invasive pneumococcal disease. We calculated the change in the incidence of the disease from a prevaccine (baseline) period (2005 through 2008) to postvaccine years 2011 and 2012, with a focus on high-risk age groups. RESULTS Surveillance identified 35,192 cases of invasive pneumococcal disease. The rates among children younger than 2 years of age declined from 54.8 to 17.0 cases per 100,000 person-years from the baseline period to 2012, including a decline from 32.1 to 3.4 cases per 100,000 person-years in disease caused by PCV7 serotypes (-89%; 95% confidence interval [CI], -92 to -86). Among children not infected with the human immunodeficiency virus (HIV), the estimated incidence of invasive pneumococcal disease caused by PCV7 serotypes decreased by 85% (95% CI, -89 to -79), whereas disease caused by nonvaccine serotypes increased by 33% (95% CI, 15 to 48). Among adults 25 to 44 years of age, the rate of PCV7-serotype disease declined by 57% (95% CI, -63 to -50), from 3.7 to 1.6 cases per 100,000 person-years. CONCLUSIONS Rates of invasive pneumococcal disease among children in South Africa fell substantially by 2012. Reductions in the rates of disease caused by PCV7 serotypes among both children and adults most likely reflect the direct and indirect effects of vaccination.	[von Gottberg, Anne; de Gouveia, Linda; Quan, Vanessa; Meiring, Susan; von Mollendorf, Claire; Madhi, Shabir A.; Cohen, Cheryl] Univ Witwatersrand, Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis NICD, Natl Hlth Lab Serv NHLS, Johannesburg, South Africa; [von Gottberg, Anne; de Gouveia, Linda; Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Zell, Elizabeth R.; Verani, Jennifer R.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [O'Brien, Katherine L.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	von Gottberg, A (corresponding author), Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Private Bag X4, ZA-2131 Johannesburg, Gauteng, South Africa.	annev@nicd.ac.za	Meiring, Susan/M-1463-2019; Moore, David/AAU-7186-2020; Mlisana, Koleka/N-6204-2013	Meiring, Susan/0000-0003-4508-5469; Moore, David/0000-0001-6091-1605; Mlisana, Koleka/0000-0002-8436-3268; O'Brien, Katherine/0000-0002-0164-4030; Malope-Kgokong, Babatyi/0000-0001-7446-7664; von Gottberg, Anne/0000-0002-0243-7455; Cohen, Cheryl/0000-0003-0376-2302	National Institute for Communicable Diseases of the National Health Laboratory Service; President's Emergency Plan for AIDS Relief; U.S. Agency for International Development's Antimicrobial Resistance Initiative; Centers for Disease Control and Prevention [U62/CCU022901, 5U2GPS001328, U60/CCU022088]; Pfizer; Global Alliance for Vaccines and Immunization through the Program for Appropriate Technology in Health; GlaxoSmithKline; Sanofi Pasteur; Novartis	National Institute for Communicable Diseases of the National Health Laboratory Service; President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development's Antimicrobial Resistance Initiative(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer(Pfizer); Global Alliance for Vaccines and Immunization through the Program for Appropriate Technology in Health; GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Novartis(Novartis)	Supported by the National Institute for Communicable Diseases of the National Health Laboratory Service, the President's Emergency Plan for AIDS Relief, the U.S. Agency for International Development's Antimicrobial Resistance Initiative, and the Centers for Disease Control and Prevention (cooperative agreements U62/CCU022901, 5U2GPS001328, and U60/CCU022088).; Dr. von Gottberg reports receiving grant support through her institution from Pfizer; Dr. von Mollendorf, receiving honoraria for presentations from Pfizer and salary support from the Global Alliance for Vaccines and Immunization through the Program for Appropriate Technology in Health; Dr. Madhi, receiving fees from GlaxoSmithKline and Pfizer for serving on advisory boards, lecture fees from GlaxoSmithKline, Pfizer, and Sanofi Pasteur, and grant support through his institution from GlaxoSmithKline, Pfizer, and Novartis; Dr. O'Brien, receiving grant support from GlaxoSmithKline and Pfizer; and Dr. Klugman, receiving fees from Pfizer and GlaxoSmithKline for serving on advisory boards and grant support from Pfizer. No other potential conflict of interest relevant to this article was reported.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; Cohen C, 2014, CLIN INFECT DIS, V59, P808, DOI 10.1093/cid/ciu431; Crowther-Gibson P, 2012, ANTIMICROB AGENTS CH, V56, P5088, DOI 10.1128/AAC.06463-11; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Department of Health, 2011 NAT ANT SENT HI; du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hamasuna R, 2008, AUSTRALIA; Hampton LM, 2012, J INFECT DIS, V205, P401, DOI 10.1093/infdis/jir755; Huebner RE, 1999, S AFR MED J, V89, P924; Johnson LF, 2012, S AFR J HIV MED, P22; Johnson LF, THEMBISA VERSION 1 0; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Knoll MD, 2014, PEDIATR INFECT DIS J, V33, pS119, DOI 10.1097/INF.0000000000000079; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Madhi SA, 2012, VACCINE, V30, pC21, DOI 10.1016/j.vaccine.2012.05.055; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Public Health England, 2014, RES AN PNEUM DIS CAS; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Statistics South Africa, 2013, STATSONLINE P0302 MI; Stephens DS, 2005, LANCET, V365, P855, DOI 10.1016/S0140-6736(05)71043-6; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; von Mollendorf C, 2014, ANTIMICROB AGENTS CH, V58, P3293, DOI 10.1128/AAC.02580-13; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, WHO UNICEF EST PCV3; World Health Organization, WHO VACC PREV DIS MO; World Health Organization, WHO PROGR IMM VACC B; World Health Organization/UNAIDS, 2001, AFR HEALTH SCI, V1, P30	41	243	246	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1889	1899		10.1056/NEJMoa1401914	http://dx.doi.org/10.1056/NEJMoa1401914			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25386897				2022-12-01	WOS:000344709800006
J	Corcoran, AJ; Conner, WE				Corcoran, Aaron J.; Conner, William E.			Bats jamming bats: Food competition through sonar interference	SCIENCE			English	Article							FREE-TAILED BAT; BIG BROWN BATS; CONSPECIFICS	Communication signals are susceptible to interference ("jamming") from conspecifics and other sources. Many active sensing animals, including bats and electric fish, alter the frequency of their emissions to avoid inadvertent jamming from conspecifics. We demonstrated that echolocating bats adaptively jam conspecifics during competitions for food. Three-dimensional flight path reconstructions and audio-video field recordings of foraging bats (Tadarida brasiliensis) revealed extended interactions in which bats emitted sinusoidal frequency-modulated ultrasonic signals that interfered with the echolocation of conspecifics attacking insect prey. Playbacks of the jamming call, but not of control sounds, caused bats to miss insect targets. This study demonstrates intraspecific food competition through active disruption of a competitor's sensing during food acquisition.	[Corcoran, Aaron J.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA; [Corcoran, Aaron J.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Wake Forest University; University System of Maryland; University of Maryland College Park	Corcoran, AJ (corresponding author), Wake Forest Univ, Dept Biol, 030 Winston Hall, Winston Salem, NC 27106 USA.	aaron.j.corcoran@gmail.com			Wake Forest University Summer Fellowship Program; American Museum of Natural History (Theodore Roosevelt Grant); National Institute of Deafness and Communicative Disorders of the National Institutes of Health [UMD T32 DC-00046]; National Science Foundation [IOS-1257248]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046] Funding Source: NIH RePORTER	Wake Forest University Summer Fellowship Program; American Museum of Natural History (Theodore Roosevelt Grant); National Institute of Deafness and Communicative Disorders of the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Z. Walker, K. Roman, D. Margius, N. Dowdy, and K. Irvin for field assistance; the Southwestern Research Station staff for coordination of activities; and C. Moss for thoughtful review of the manuscript. Funding was provided by the Wake Forest University Summer Fellowship Program, the American Museum of Natural History (Theodore Roosevelt Grant), an institutional training grant (UMD T32 DC-00046) from the National Institute of Deafness and Communicative Disorders of the National Institutes of Health, and the National Science Foundation (grant number IOS-1257248). Data are available in the supplementary materials.	Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; BATES DL, 1990, CAN J ZOOL, V68, P49, DOI 10.1139/z90-009; Betke M, 2008, J MAMMAL, V89, P18, DOI 10.1644/07-MAMM-A-011.1; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Corcoran AJ, 2011, J EXP BIOL, V214, P2416, DOI 10.1242/jeb.054783; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; Fuzessery ZM, 2006, J NEUROPHYSIOL, V96, P1320, DOI 10.1152/jn.00021.2006; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; Gillam Erin H, 2007, Proc Biol Sci, V274, P651, DOI 10.1098/rspb.2006.0047; Heiligenberg W., 1991, NEURAL NETS ELECT FI; Masters WM, 1996, J COMP PHYSIOL A, V179, P703, DOI 10.1007/BF00216134; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Ratcliffe JM, 2004, CAN J ZOOL, V82, P966, DOI 10.1139/Z04-074; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557; Wright GS, 2014, CURR BIOL, V24, P885, DOI 10.1016/j.cub.2014.02.058	16	45	46	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					745	747		10.1126/science.1259512	http://dx.doi.org/10.1126/science.1259512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378624				2022-12-01	WOS:000344690100040
J	Munro, JB; Gorman, J; Ma, XC; Zhou, Z; Arthos, J; Burton, DR; Koff, WC; Courter, JR; Smith, AB; Kwong, PD; Blanchard, SC; Mothes, W				Munro, James B.; Gorman, Jason; Ma, Xiaochu; Zhou, Zhou; Arthos, James; Burton, Dennis R.; Koff, Wayne C.; Courter, Joel R.; Smith, Amos B., III; Kwong, Peter D.; Blanchard, Scott C.; Mothes, Walther			Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions	SCIENCE			English	Article							NEUTRALIZING ANTIBODY PG9; RECEPTOR-BINDING; STRUCTURAL BASIS; CD4 RECEPTOR; GP120; GLYCOPROTEIN; RECOGNITION; VACCINE; FUSION; BROAD	The HIV-1 envelope (Env) mediates viral entry into host cells. To enable the direct imaging of conformational dynamics within Env, we introduced fluorophores into variable regions of the glycoprotein gp120 subunit and measured single-molecule fluorescence resonance energy transfer within the context of native trimers on the surface of HIV-1 virions. Our observations revealed unliganded HIV-1 Env to be intrinsically dynamic, transitioning between three distinct prefusion conformations, whose relative occupancies were remodeled by receptor CD4 and antibody binding. The distinct properties of neutralization-sensitive and neutralization-resistant HIV-1 isolates support a dynamics-based mechanism of immune evasion and ligand recognition.	[Munro, James B.; Ma, Xiaochu; Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Gorman, Jason; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Zhou, Zhou; Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Koff, Wayne C.] IAVI, New York, NY 10004 USA; [Courter, Joel R.; Smith, Amos B., III] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; University of Pennsylvania	Mothes, W (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	james.munro@tufts.edu; scb2005@med.cornell.edu; walther.mothes@yale.edu	Blanchard, Scott C./A-5804-2009; Gorman, Jason/AGG-9417-2022	Blanchard, Scott C./0000-0003-2717-9365; Gorman, Jason/0000-0002-3775-6560	NIH [R21 AI100696, P01 56550, R01 GM098859]; Cancer Research Institute; China Scholarship Council; International AIDS Vaccine Initiative's (IAVI) Neutralizing Antibody Consortium; NIH Intramural Research Program (Vaccine Research Center); Bill & Melinda Gates Foundation; U.S. Agency for International Development (USAID); American people through USAID; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100696, ZIAAI005023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098859, P01GM056550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; China Scholarship Council(China Scholarship Council); International AIDS Vaccine Initiative's (IAVI) Neutralizing Antibody Consortium; NIH Intramural Research Program (Vaccine Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); American people through USAID(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jin, L. Agosto, T. Wang, R. B. Altman, and M. R. Wasserman for assistance; C. Walsh, J. Binely, A. Trkola, and M. Krystal for reagents; and members of the Structural Biology Section, Vaccine Research Center, for critically reading the manuscript. We thank I. Wilson and J. Sodroski for encouraging us to extend our approach to a R5-tropic Env. The data presented in this paper are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants R21 AI100696 to W. M. and S. C. B; P01 56550 to W. M., S. C. B., and A. B. S.; and R01 GM098859 to S. C. B.; by the Irvington Fellows Program of the Cancer Research Institute to J. B. M; by a fellowship from the China Scholarship Council-Yale World Scholars to X. M.; by grants from the International AIDS Vaccine Initiative's (IAVI) Neutralizing Antibody Consortium to D. R. B., W. C. K., and P. D. K.; and by funding from the NIH Intramural Research Program (Vaccine Research Center) to P. D. K. IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation and the U.S. Agency for International Development (USAID). This study is made possible by the generous support of the American people through USAID. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. government. Reagents from the NIH are subject to nonrestrictive material transfer agreements. Patent applications pertaining to this work are the U.S. and World Application US2009/006049 and WO/2010/053583, Synthesis of JRC-II-191 (A. B. S., J.R.C.), U.S. Patent Application 13/202,351, Methods and Compositions for Altering Photopysical Properties of Fluorophores via Proximal Quenching (S. C. B., Z.Z.); U. S. Patent Application 14/373,402 Dye Compositions, Methods of Preparation, Conjugates Thereof, and Methods of Use (S. C. B., Z.Z.); and International and US Patent Application PCT/US13/42249 Reagents and Methods for Identifying Anti-HIV Compounds (S. C. B., J.B.M., W. M.). S. C. B. is a co-founder of Lumidyne Corporation.	Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; DeVico AL, 2007, CURR HIV RES, V5, P561, DOI 10.2174/157016207782418560; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Li ZF, 2013, ANTIMICROB AGENTS CH, V57, P4172, DOI 10.1128/AAC.00513-13; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; Mukherjee NG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065103; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	42	325	331	9	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					759	763		10.1126/science.1254426	http://dx.doi.org/10.1126/science.1254426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25298114	Green Accepted			2022-12-01	WOS:000344690100044
J	Tainaka, K; Kubota, SI; Suyama, TQ; Susaki, EA; Perrin, D; Ukai-Tadenuma, M; Ukai, H; Ueda, HR				Tainaka, Kazuki; Kubota, Shimpei I.; Suyama, Takeru Q.; Susaki, Etsuo A.; Perrin, Dimitri; Ukai-Tadenuma, Maki; Ukai, Hideki; Ueda, Hiroki R.			Whole-Body Imaging with Single-Cell Resolution by Tissue Decolorization	CELL			English	Article							LIGHT SHEET MICROSCOPY; MOUSE-BRAIN; FLUORESCENCE; SYSTEM; RECONSTRUCTION; HISTOLOGY; ORGANS; ACID; MICE; GFP	The development of whole-body imaging at single-cell resolution enables system-level approaches to studying cellular circuits in organisms. Previous clearing methods focused on homogenizing mismatched refractive indices of individual tissues, enabling reductions in opacity but falling short of achieving transparency. Here, we show that an aminoalcohol decolorizes blood by efficiently eluting the heme chromophore from hemoglobin. Direct transcardial perfusion of an aminoalcohol-containing cocktail that we previously termed CUBIC coupled with a 10 day to 2 week clearing protocol decolorized and rendered nearly transparent almost all organs of adult mice as well as the entire body of infant and adult mice. This CUBIC-perfusion protocol enables rapid whole-body and whole-organ imaging at single-cell resolution by using light-sheet fluorescent microscopy. The CUBIC protocol is also applicable to 3D pathology, anatomy, and immunohistochemistry of various organs. These results suggest that whole-body imaging of colorless tissues at high resolution will contribute to organism-level systems biology.	[Tainaka, Kazuki; Kubota, Shimpei I.; Suyama, Takeru Q.; Susaki, Etsuo A.; Ueda, Hiroki R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan; [Tainaka, Kazuki; Susaki, Etsuo A.; Perrin, Dimitri; Ukai-Tadenuma, Maki; Ukai, Hideki; Ueda, Hiroki R.] RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Tainaka, Kazuki; Susaki, Etsuo A.; Ueda, Hiroki R.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Ueda, HR (corresponding author), Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014; Perrin, Dimitri/H-8630-2013	Ueda, Hiroki R/0000-0001-8342-9176; Perrin, Dimitri/0000-0002-4007-5256; Tainaka, Kazuki/0000-0002-5943-8723; Susaki, Etsuo/0000-0001-5621-7311	Program for Innovative Cell Biology, Innovative Technology; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT/Japan Society for the Promotion of Science (JSPS) [25221004, 23115006, 26-1180]; strategic programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	Program for Innovative Cell Biology, Innovative Technology; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); strategic programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	We thank the lab members at RIKEN CDB, QBiC, and The University of Tokyo, in particular, H. Yukinaga, J. Hara, J. Yoshida, C. Imai, and Y. Niwa for their kind help in preparing the materials; A. Millius for reviewing and editing the manuscript; K. Matsumoto for helpful suggestions in developing the CB-Perfusion protocol; Y. Abe, T. Sengoku, and S. Kondo for their kind help in developing the CB-Perfusion protocol and transmittance evaluation; and S. Shoi for his kind help in statistical analysis. We also thank T. Abe and H. Kiyonari for providing materials for targeting vectors and R26-H2B EGFP mice; LARGE, RIKEN CDB for housing the mice; D. Asanuma and K. Hirose for their kind help in measuring visible spectra; H. Sekiya, K. Kanemaru, D. Ino, J. Suzuki, K. Miyazono, S. Ehata, K. Takahashi, H. Takayanagi, S. Sawa, G. Matteo, Y. Mori, and Y. Yoshioka for their kind comments and suggestions; and Media Cybernetics for supporting the usage of AutoQuant X3. This work was supported by the Program for Innovative Cell Biology by Innovative Technology and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research (S) (grant no. 25221004), a Grant-in-Aid for Scientific Research on Innovative Areas (grant no. 23115006), and a Grant-in-Aid JSPS Fellows (grant no. 26-1180) from MEXT/Japan Society for the Promotion of Science (JSPS), the strategic programs for R&D (President's discretionary fund) of RIKEN, an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center, a grant from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), a Grant-in-Aid from Japan Foundation for Applied Enzymology, a Grant-in-Aid from the Shimabara Science Promotion Foundation, and by the RIKEN Foreign Postdoctoral Researcher Program.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alnuami AA, 2008, INT J BIOL MACROMOL, V43, P182, DOI 10.1016/j.ijbiomac.2008.05.002; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Faber DJ, 2003, OPT LETT, V28, P1436, DOI 10.1364/OL.28.001436; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Keller PJ, 2012, CURR OPIN NEUROBIOL, V22, P138, DOI 10.1016/j.conb.2011.08.003; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kristinsson HG, 2004, J AGR FOOD CHEM, V52, P3633, DOI 10.1021/jf034563g; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Mack SA, 2014, METHODS MOL BIOL, V1130, P165, DOI 10.1007/978-1-62703-989-5_12; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Spalteholz W, 1914, DURCHSICHTIGMACHEN M; Steinke H, 2001, ANN ANAT, V183, P91, DOI 10.1016/S0940-9602(01)80020-0; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	30	312	332	4	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					911	924		10.1016/j.cell.2014.10.034	http://dx.doi.org/10.1016/j.cell.2014.10.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417165	Green Submitted, Bronze			2022-12-01	WOS:000344522000021
J	Gilbert, LA; Horlbeck, MA; Adamson, B; Villalta, JE; Chen, Y; Whitehead, EH; Guimaraes, C; Panning, B; Ploegh, HL; Bassik, MC; Qi, LS; Kampmann, M; Weissman, JS				Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Whitehead, Evan H.; Guimaraes, Carla; Panning, Barbara; Ploegh, Hidde L.; Bassik, Michael C.; Qi, Lei S.; Kampmann, Martin; Weissman, Jonathan S.			Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation	CELL			English	Article							HUMAN-CELLS; MAMMALIAN-CELLS; TRANSCRIPTION FACTORS; SHRNA LIBRARIES; CHOLERA-TOXIN; EXPRESSION; RNA; BINDING; SCREENS; DIFFERENTIATION	While the catalog of mammalian transcripts and their expression levels in different cell types and disease states is rapidly expanding, our understanding of transcript function lags behind. We present a robust technology enabling systematic investigation of the cellular consequences of repressing or inducing individual transcripts. We identify rules for specific targeting of transcriptional repressors (CRISPRi), typically achieving 90%-99% knockdown with minimal off-target effects, and activators (CRISPRa) to endogenous genes via endonuclease-deficient Cas9. Together they enable modulation of gene expression over a similar to 1,000-fold range. Using these rules, we construct genome-scale CRISPRi and CRISPRa libraries, each of which we validate with two pooled screens. Growth-based screens identify essential genes, tumor suppressors, and regulators of differentiation. Screens for sensitivity to a cholera-diphtheria toxin provide broad insights into the mechanisms of pathogen entry, retrotranslocation and toxicity. Our results establish CRISPRi and CRISPRa as powerful tools that provide rich and complementary information for mapping complex pathways.	[Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Whitehead, Evan H.; Bassik, Michael C.; Qi, Lei S.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Bassik, Michael C.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Whitehead, Evan H.; Bassik, Michael C.; Qi, Lei S.; Kampmann, Martin; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Horlbeck, Max A.; Adamson, Britt; Villalta, Jacqueline E.; Chen, Yuwen; Bassik, Michael C.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Whitehead, Evan H.; Qi, Lei S.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Guimaraes, Carla; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; [Guimaraes, Carla; Ploegh, Hidde L.] MIT, Cambridge, MA 02142 USA; [Panning, Barbara] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco	Kampmann, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	martin.kampmann@ucsf.edu; jonathan.weissman@ucsf.edu	Qi, Lei S/AAC-5088-2019; Gilbert, Luke/AAC-5300-2019	Qi, Lei S/0000-0002-3965-3223; Weissman, Jonathan/0000-0003-2445-670X; Whitehead, Evan/0000-0002-4132-2140; Gilbert, Luke/0000-0001-5854-0825; Kampmann, Martin/0000-0002-3819-7019	NIH [P50 GM102706, P50 GM081879, U01 CA168370, R01 DA036858]; Howard Hughes Medical Institute; UCSF Medical Scientist Training Program; NCI/NIH Pathway to Independence Award [K99CA181494];  [DRG-[2182-14]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD084069] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA168370, K99CA181494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706, T32GM008284, P50GM081879, R01GM100341, R01GM100518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); UCSF Medical Scientist Training Program; NCI/NIH Pathway to Independence Award; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank M. Tanenbaum, J. Tsai, K. Kostova, J. Zalatan, W. Lim, S. Weissman, J. Doudna, and R. Vale for unpublished reagents, technical advice and helpful discussion. L.S.Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology. This work was supported by NIH P50 GM102706 (J.S.W.), NIH P50 GM081879 (L.S.Q., E.H.W.), NIH U01 CA168370 and NIH R01 DA036858 (J.S.W.), as well as the Howard Hughes Medical Institute (J.E.V., Y.C., M.K., M.A.H., J.S.W.). B.A. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-[2182-14]). L.A.G. is a Fellow of the Leukemia and Lymphoma Society. M.A.H. is supported by the UCSF Medical Scientist Training Program. M.K. is supported by NCI/NIH Pathway to Independence Award K99CA181494.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Alberich-Jorda M, 2012, J CLIN INVEST, V122, P4490, DOI 10.1172/JCI65102; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; SMITH R, 2009, CONSUM REP, V74, P6; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; VANNESS BG, 1980, J BIOL CHEM, V255, P717; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang P, 2000, BLOOD, V96, P2641; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	49	1420	1522	37	436	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					647	661		10.1016/j.cell.2014.09.029	http://dx.doi.org/10.1016/j.cell.2014.09.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25307932	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000344521700019
J	Huang, H; Sabari, BR; Garcia, BA; Allis, CD; Zhao, YM				Huang, He; Sabari, Benjamin R.; Garcia, Benjamin A.; Allis, C. David; Zhao, Yingming			SnapShot: Histone Modifications	CELL			English	Editorial Material							POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN; CODE		[Huang, He; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Sabari, Benjamin R.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Chicago; Rockefeller University; University of Pennsylvania	Huang, H (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.				NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NCI NIH HHS [CA160036, U24 CA160036] Funding Source: Medline; NCRR NIH HHS [RR020839, U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [R01 GM105933, GM105933, R01 GM110174] Funding Source: Medline; NIH HHS [DP2 OD007447, DP2OD007447] Funding Source: Medline; NIMH NIH HHS [P50 MH096890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA160036] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174, R01GM105933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; Fierz B, 2012, NAT CHEM BIOL, V8, P417, DOI [10.1038/NCHEMBIO.938, 10.1038/nchembio.938]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Young NL, 2010, CELL MOL LIFE SCI, V67, P3983, DOI 10.1007/s00018-010-0475-7	9	273	282	8	94	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					458	+	458.e1	10.1016/j.cell.2014.09.037	http://dx.doi.org/10.1016/j.cell.2014.09.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303536	Green Accepted, Bronze			2022-12-01	WOS:000343095600025
J	Perdiguero, EG; Klapproth, K; Schulz, C; Busch, K; Azzoni, E; Crozet, L; Garner, H; Trouillet, C; de Bruijn, MF; Geissmann, F; Rodewald, HR				Perdiguero, Elisa Gomez; Klapproth, Kay; Schulz, Christian; Busch, Katrin; Azzoni, Emanuele; Crozet, Lucile; Garner, Hannah; Trouillet, Celine; de Bruijn, Marella F.; Geissmann, Frederic; Rodewald, Hans-Reimer			Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors	NATURE			English	Article							STEM-CELL DIFFERENTIATION; MICROGLIA DERIVE; MONOCYTES; ONTOGENY; HEMATOPOIESIS; MATURATION; REVEALS; EMBRYO; LIFE; MYB	Most haematopoietic cells renew from adult haematopoietic stem cells (HSCs)(1-3), however, macrophages in adult tissues can self-maintain independently of HSCO4-7. Progenitors with macrophage potential in vitro have been described in the yolk sac before emergence of HSCO8-3, and fetal macrophages(13-15) can develop independently of Myb(4), a transcription factor required for HSC16, and can persist in adult tissues(4.17,18). Nevertheless, the origin of adult macrophages and the qualitative and quantitative contributions of HSC and putative non-HSC-derived progenitors are still unclear'. Here we show in mice that the vast majority of adult tissue-resident macrophages in liver (Kupffer cells), brain '(microglia), epidermis (Langerhans cells) and lung (alveolar macrophages) originate from a Tie2(+) (also known as Tek) cellular pathway generating Csf1r(+) erythro-myeloid progenitors (EMPs) distinct from HSCs. EMPs develop in the yolk sac at embryonic day (E) 8.5, migrate and colonize the nascent fetal liver before E10.5, and give rise to fetal erythrocytes, macrophages, granulocytes and monocytes until at least E16.5. Subsequently, HSC-derived cells replace erythrocytes, granulocytes and monocytes. Kupffer cells, microglia and Langerhans cells are only marginally replaced in oneyear-old mice, whereas alveolar macrophages may be progressively replaced in ageing mice. Our fate-mapping experiments identify, in the fetal liver, a sequence of yolk sac EMP-derived and HSC-derived haematopoiesis, and identify yolk sac EMPs as a common origin for tissue macrophages.	[Perdiguero, Elisa Gomez; Schulz, Christian; Crozet, Lucile; Garner, Hannah; Trouillet, Celine; Geissmann, Frederic] Kings Coll London, CMCBI, London SE1 1UL, England; [Klapproth, Kay; Busch, Katrin; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Azzoni, Emanuele; de Bruijn, Marella F.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DS, England	University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Geissmann, F (corresponding author), Kings Coll London, CMCBI, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Schulz, Christian/J-8545-2012; Perdiguero, Elisa Gomez/U-2120-2018; Azzoni, Emanuele/AAE-8064-2022	Schulz, Christian/0000-0003-3878-7833; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Azzoni, Emanuele/0000-0002-4572-5692; geissmann, frederic/0000-0001-5029-2468	Wellcome Trust [WT101853MA]; ERC from European Research Council [2010-StG-261299]; ERC [233074, SFB 938, SFB 873]; Biotechnology and Biological Sciences Research Council [1168004] Funding Source: researchfish; Medical Research Council [MC_UU_12009/2] Funding Source: researchfish; MRC [MC_UU_12009/2] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ERC from European Research Council; ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are indebted to J. Pollard, University of Edinburgh for the Csf1r reporter strains, J. Frampton, University of Birmingham for the MA-deficient animals, and T. Boehm, Max Planck Institute, Freiburg for the Flt3<SUP>Cre</SUP> strain. The authors also thank A. McGuigan and the staff of the Biological Service Unit at King's College London, S. Heck and the Biomedical Research Centre at King's Health Partners, S. Woodcock and the staff of the Viapath haematology laboratory in Guy's hospital and S. Schafer and T. Arnsperger for technical assistance at the German Cancer Research Center. This work was supported by a Wellcome Trust Senior Investigator award (WT101853MA) and ERC Investigator award (2010-StG-261299) from the European Research Council to F.G. and an ERC Investigator award (Advanced Grant 233074), SFB 938 project L, and SFB 873 project B11 to H.-R.R.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/NMETH.1309, 10.1038/nmeth.1309]; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	27	1234	1254	12	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					547	551		10.1038/nature13989	http://dx.doi.org/10.1038/nature13989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25470051	Green Accepted			2022-12-01	WOS:000350097300049
J	Chaisson, MJP; Huddleston, J; Dennis, MY; Sudmant, PH; Malig, M; Hormozdiari, F; Antonacci, F; Surti, U; Sandstrom, R; Boitano, M; Landolin, JM; Stamatoyannopoulos, JA; Hunkapiller, MW; Korlach, J; Eichler, EE				Chaisson, Mark J. P.; Huddleston, John; Dennis, Megan Y.; Sudmant, Peter H.; Malig, Maika; Hormozdiari, Fereydoun; Antonacci, Francesca; Surti, Urvashi; Sandstrom, Richard; Boitano, Matthew; Landolin, Jane M.; Stamatoyannopoulos, John A.; Hunkapiller, Michael W.; Korlach, Jonas; Eichler, Evan E.			Resolving the complexity of the human genome using single-molecule sequencing	NATURE			English	Article							ALIGNMENT; PROGRAM; GAPS; MAP	The human genome is arguably the most complete mammalian reference assembly(1-3), yetmore than 160 euchromatic gaps remain(4-6) and aspects of its structural variation remain poorly understood ten years after its completion(7-9). To identify missing sequence and genetic variation, here we sequence and analyse ahaploid human genome (CHM1) using single-molecule, real-time DNA sequencing(10). We close or extend 55% of the remaining interstitial gaps in the human GRCh37 reference genome-78% of which carried long runs of degenerate short tandem repeats, often several kilobases in length, embedded within (G+C)-rich genomic regions. We resolve the complete sequence of 26,079 euchromatic structural variants at the base-pair level, including inversions, complex insertions and long tracts of tandem repeats. Most have not been previously reported, with the greatest increases in sensitivity occurring for events less than 5 kilobases in size. Compared to the human reference, we find a significant insertional bias (3: 1) in regions corresponding to complex insertions and long short tandem repeats. Our results suggest a greater complexity of the human genome in the form of variation of longer and more complex repetitive DNA that can now be largely resolved with the application of this longer-read sequencing technology.	[Chaisson, Mark J. P.; Huddleston, John; Dennis, Megan Y.; Sudmant, Peter H.; Malig, Maika; Hormozdiari, Fereydoun; Sandstrom, Richard; Stamatoyannopoulos, John A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Huddleston, John; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Antonacci, Francesca] Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy; [Surti, Urvashi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Boitano, Matthew; Landolin, Jane M.; Hunkapiller, Michael W.; Korlach, Jonas] Pacific Biosci Calif Inc, Menlo Pk, CA 94025 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Antonacci, Francesca/F-5457-2013	Antonacci, Francesca/0000-0002-5833-6186; Sandstrom, Richard/0000-0002-3356-1547; Hormozdiari, Fereydoun/0000-0003-2703-9274; Sudmant, Peter/0000-0002-9573-8248	US National Institutes of Health (NIH) [HG002385, HG007497]; US National Institute of Neurological Disorders and Stroke [K99NS083627]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007635, R01HG002385, U41HG007497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS083627] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Alexander, D. Church and A. Klammer for discussions, K. Mohajeri and L. Harsh man for technical assistance and T. Brown for assistance in manuscript preparation. This work was supported, in part, by US National Institutes of Health (NIH) grant HG002385 and HG007497 to E.E.E. M.Y.D. is supported by the US National Institute of Neurological Disorders and Stroke (award K99NS083627). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kimelman A, 2012, GENOME RES, V22, P802, DOI 10.1101/gr.133850.111; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kurahashi H, 2007, GENOME RES, V17, P461, DOI 10.1101/gr.5769507; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Smit A., 1996, REPEATMASKER OPEN 3; Steinberg KM, GENOME RES IN PRESS; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	27	445	463	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					608	U163		10.1038/nature13907	http://dx.doi.org/10.1038/nature13907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383537	Green Accepted, Green Submitted			2022-12-01	WOS:000348775000042
J	Yamin, D; Gertler, S; Ndeffo-Mbah, ML; Skrip, LA; Fallah, M; Nyenswah, TG; Altice, FL; Galvani, AP				Yamin, Dan; Gertler, Shai; Ndeffo-Mbah, Martial L.; Skrip, Laura A.; Fallah, Mosoka; Nyenswah, Tolbert G.; Altice, Frederick L.; Galvani, Alison P.			Effect of Ebola Progression on Transmission and Control in Liberia	ANNALS OF INTERNAL MEDICINE			English	Article							HEMORRHAGIC-FEVER; WEST-AFRICA; VIRAL LOAD; RESPONSES; DYNAMICS; OUTBREAK; CONGO; RISK	Background: The Ebola outbreak that is sweeping across West Africa is the largest, most volatile, and deadliest Ebola epidemic ever recorded. Liberia is the most profoundly affected country, with more than 3500 infections and 2000 deaths recorded in the past 3 months. Objective: To evaluate the contribution of disease progression and case fatality on transmission and to examine the potential for targeted interventions to eliminate the disease. Design: Stochastic transmission model that integrates epidemiologic and clinical data on incidence and case fatality, daily viral load among survivors and nonsurvivors evaluated on the basis of the 2000-2001 outbreak in Uganda, and primary data on contacts of patients with Ebola in Liberia. Setting: Montserrado County, Liberia, July to September 2014. Measurements: Ebola incidence and case-fatality records from 2014 Liberian Ministry of Health and Social Welfare. Results: The average number of secondary infections generated throughout the entire infectious period of a single infected case, R, was estimated as 1.73 (95% CI, 1.66 to 1.83). There was substantial stratification between survivors (R-Survivors), for whom the estimate was 0.66 (CI, 0.10 to 1.69), and nonsurvivors (R-Nonsurvivors), for whom the estimate was 2.36 (CI, 1.72 to 2.80). The nonsurvivors had the highest risk for transmitting the virus later in the course of disease progression. Consequently, the isolation of 75% of infected individuals in critical condition within 4 days from symptom onset has a high chance of eliminating the disease. Limitation: Projections are based on the initial dynamics of the epidemic, which may change as the outbreak and interventions evolve. Conclusion: These results underscore the importance of isolating the most severely ill patients with Ebola within the first few days of their symptomatic phase.	[Yamin, Dan; Gertler, Shai; Ndeffo-Mbah, Martial L.; Skrip, Laura A.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, New Haven, CT 06510 USA; [Fallah, Mosoka; Nyenswah, Tolbert G.] Minist Hlth & Social Welf, Monrovia 1000 10, Liberia; [Altice, Frederick L.] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06510 USA	Yale University; Yale University	Yamin, D (corresponding author), Yale Univ, Sch Publ Hlth, 135 Coll St,Suite 200, New Haven, CT 06510 USA.	dan.yamin@gmail.com	Gertler, Shai/AAD-2052-2019	Ndeffo Mbah, Martial/0000-0003-4158-7613; Altice, Frederick/0000-0002-7860-693X	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health.	Althaus C, 2014, PLOS CURR OUTBREAKS; ANDERSON R M, 1991; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Brauer F., 2005, ELECTRON J DIFFER EQ, V2005, P29; Centers for Disease Control and Prevention, 2014, EBOLA OUTBREAK IN WE; Cooper Helene, 2014, NEW YORK TIMES; Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Eichner Martin, 2011, Osong Public Health Res Perspect, V2, P3, DOI 10.1016/j.phrp.2011.04.001; Formenty P, 2008, CONTROL OF COMMUNICA; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Galvani AP, 2014, ANN INTERN MED, V161, P749, DOI 10.7326/M14-1904; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Liberia Institute of Statistics and Geo-Information Services, 2008, 2008 NATIONAL POPULA; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; Ministry of Health and Social Welfare Republic of Liberia., 2014, LIBERIA EBOLA SITREP; Ministry of Healthand Social Welfare Republic of Liberia, 2014, SITUATION REPORT ON; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Owers S, 2014, PLOS CURR OUTBREAKS; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; World Health Organization, 2014, WHY THE EBOLA OUTBRE; World Health Organization (WHO), 2014, EBOLA RESPONSE ROADM	32	60	61	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					11	U140		10.7326/M14-2255	http://dx.doi.org/10.7326/M14-2255			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25347321	Green Accepted			2022-12-01	WOS:000350103000002
J	Zalk, R; Clarke, OB; des Georges, A; Grassucci, RA; Reiken, S; Mancia, F; Hendrickson, WA; Frank, J; Marks, AR				Zalk, Ran; Clarke, Oliver B.; des Georges, Amedee; Grassucci, Robert A.; Reiken, Steven; Mancia, Filippo; Hendrickson, Wayne A.; Frank, Joachim; Marks, Andrew R.			Structure of a mammalian ryanodine receptor	NATURE			English	Article							CALCIUM-RELEASE CHANNEL; PARTICLE ELECTRON CRYOMICROSCOPY; EM STRUCTURE DETERMINATION; SKELETAL-MUSCLE; CRYO-EM; INTRACELLULAR CALCIUM; DEFECTIVE REGULATION; HEART-FAILURE; MICROSCOPY; DOMAIN	Ryanodine receptors (RyRs) mediate the rapid release of calcium (Ca2+) from intracellular stores into the cytosol, which is essential for numerous cellular functions including excitation-contraction coupling in muscle. Lack of sufficient structural detail has impeded understanding of RyR gating and regulation. Here we report the closed-state structure of the 2.3-megadalton complex of the rabbit skeletal muscle type 1 RyR (RyR1), solved by single-particle electron cryomicroscopy at an overall resolution of 4.8 angstrom. We fitted a polyalanine-level model to all 3,757 ordered residues in each protomer, defining the transmembrane pore in unprecedented detail and placing all cytosolic domains as tertiary folds. The cytosolic assembly is built on an extended alpha-solenoid scaffold connecting key regulatory domains to the pore. The RyR1 pore architecture places it in the six-transmembrane ion channel superfamily. A unique domain inserted between the second and third transmembrane helices interacts intimately with paired EF-hands originating from the alpha-solenoid scaffold, suggesting a mechanism for channel gating by Ca2+.	[Zalk, Ran; Reiken, Steven; Mancia, Filippo; Hendrickson, Wayne A.; Marks, Andrew R.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Clarke, Oliver B.; des Georges, Amedee; Grassucci, Robert A.; Hendrickson, Wayne A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Marks, Andrew R.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Marks, Andrew R.] Columbia Univ, Wu Ctr Mol Cardiol, Coll Phys & Surg, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	wayne@xtl.cumc.columbia.edu; jf2192@columbia.edu; arm42@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781; Mancia, Filippo/0000-0003-3293-2200	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083418, P01HL081172, R01HL061503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, R01GM029169] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL061503, P01 HL081172, R01HL061503, R01 HL083418] Funding Source: Medline; NIAMS NIH HHS [R01AR060037, R01 AR060037] Funding Source: Medline; NIGMS NIH HHS [U54GM095315, R01 GM029169, U54 GM095315, R01GM29169] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andersson Daniel C, 2010, Drug Discov Today Dis Mech, V7, pe151, DOI 10.1016/j.ddmec.2010.09.009; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langlois R, 2014, J STRUCT BIOL, V186, P1, DOI 10.1016/j.jsb.2014.03.001; Lau K., 2014, NATURE COMM, V5, P5937; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; MARKS AR, 1990, J BIOL CHEM, V265, P13143; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; Stern MD, 1997, J GEN PHYSIOL, V110, P415, DOI 10.1085/jgp.110.4.415; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Volkov AG, 1997, BIOELECTROCH BIOENER, V42, P153, DOI 10.1016/S0302-4598(96)05097-0; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; XIN HB, 1995, BIOCHEM BIOPH RES CO, V214, P263, DOI 10.1006/bbrc.1995.2283; Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092; Yin CC, 2005, J STRUCT BIOL, V149, P219, DOI 10.1016/j.jsb.2004.10.008; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237	54	275	279	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					44	U90		10.1038/nature13950	http://dx.doi.org/10.1038/nature13950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470061	Green Accepted			2022-12-01	WOS:000347178400031
J	Jaiswal, S; Fontanillas, P; Flannick, J; Manning, A; Grauman, PV; Mar, BG; Lindsley, RC; Mermel, CH; Burtt, N; Chavez, A; Higgins, JM; Moltchanov, V; Kuo, FC; Kluk, MJ; Henderson, B; Kinnunen, L; Koistinen, HA; Ladenvall, C; Getz, G; Correa, A; Banahan, BF; Gabriel, S; Kathiresan, S; Stringham, HM; McCarthy, MI; Boehnke, M; Tuomilehto, J; Haiman, C; Groop, L; Atzmon, G; Wilson, JG; Neuberg, D; Altshuler, D; Ebert, BL				Jaiswal, Siddhartha; Fontanillas, Pierre; Flannick, Jason; Manning, Alisa; Grauman, Peter V.; Mar, Brenton G.; Lindsley, R. Coleman; Mermel, Craig H.; Burtt, Noel; Chavez, Alejandro; Higgins, John M.; Moltchanov, Vladislav; Kuo, Frank C.; Kluk, Michael J.; Henderson, Brian; Kinnunen, Leena; Koistinen, Heikki A.; Ladenvall, Claes; Getz, Gad; Correa, Adolfo; Banahan, Benjamin F.; Gabriel, Stacey; Kathiresan, Sekar; Stringham, Heather M.; McCarthy, Mark I.; Boehnke, Michael; Tuomilehto, Jaakko; Haiman, Christopher; Groop, Leif; Atzmon, Gil; Wilson, James G.; Neuberg, Donna; Altshuler, David; Ebert, Benjamin L.			Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL DISTRIBUTION WIDTH; MYELOPROLIFERATIVE DISORDERS; DNMT3A MUTATIONS; POINT MUTATIONS; TET2 MUTATIONS; MOSAICISM; DISCOVERY; GENES; INFLAMMATION; MORTALITY	Background The incidence of hematologic cancers increases with age. These cancers are associated with recurrent somatic mutations in specific genes. We hypothesized that such mutations would be detectable in the blood of some persons who are not known to have hematologic disorders. Methods We analyzed whole-exome sequencing data from DNA in the peripheral-blood cells of 17,182 persons who were unselected for hematologic phenotypes. We looked for somatic mutations by identifying previously characterized single-nucleotide variants and small insertions or deletions in 160 genes that are recurrently mutated in hematologic cancers. The presence of mutations was analyzed for an association with hematologic phenotypes, survival, and cardiovascular events. Results Detectable somatic mutations were rare in persons younger than 40 years of age but rose appreciably in frequency with age. Among persons 70 to 79 years of age, 80 to 89 years of age, and 90 to 108 years of age, these clonal mutations were observed in 9.5% (219 of 2300 persons), 11.7% (37 of 317), and 18.4% (19 of 103), respectively. The majority of the variants occurred in three genes: DNMT3A, TET2, and ASXL1. The presence of a somatic mutation was associated with an increase in the risk of hematologic cancer (hazard ratio, 11.1; 95% confidence interval [CI], 3.9 to 32.6), an increase in all-cause mortality (hazard ratio, 1.4; 95% CI, 1.1 to 1.8), and increases in the risks of incident coronary heart disease (hazard ratio, 2.0; 95% CI, 1.2 to 3.4) and ischemic stroke (hazard ratio, 2.6; 95% CI, 1.4 to 4.8). Conclusions Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly due to an increased risk of cardiovascular disease.	[Jaiswal, Siddhartha; Grauman, Peter V.; Mar, Brenton G.; Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Lindsley, R. Coleman] Brigham & Womens Hosp, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA; [Kuo, Frank C.; Kluk, Michael J.] Brigham & Womens Hosp, Ctr Adv Mol Diagnost, Boston, MA 02115 USA; [Kuo, Frank C.; Kluk, Michael J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jaiswal, Siddhartha; Mermel, Craig H.; Chavez, Alejandro; Higgins, John M.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Higgins, John M.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Gabriel, Stacey; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Med, Div Endocrinol, Boston, MA 02114 USA; [Jaiswal, Siddhartha] Brigham & Womens Hosp, Boston Childrens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA; [Jaiswal, Siddhartha] Dana Farber Canc Inst, Boston, MA 02115 USA; [Mar, Brenton G.] Dept Pediat Oncol, Boston, MA USA; [Neuberg, Donna] Dept Biostat & Computat Biol, Boston, MA USA; [Higgins, John M.] Massachusetts Gen Hosp, Dana Farber Canc Inst, Boston, MA 02114 USA; [Higgins, John M.] Dept Syst Biol, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Dept Med, Boston, MA USA; [Ebert, Benjamin L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ebert, Benjamin L.] Harvard Stem Cell Inst, Boston, MA USA; [Fontanillas, Pierre; Flannick, Jason; Manning, Alisa; Burtt, Noel; Gabriel, Stacey; Kathiresan, Sekar; Altshuler, David] Broad Inst Massachusetts Inst Technol & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA USA; [Moltchanov, Vladislav] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Moltchanov, Vladislav] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Minerva Fdn Inst Med Res, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Dept Med, Div Endocrinol, Helsinki, Finland; [Kinnunen, Leena; Koistinen, Heikki A.; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Henderson, Brian; Haiman, Christopher] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Ladenvall, Claes; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci, Clin Res Ctr,Skane Univ Hosp, Lund, Sweden; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med, Oxford, MS USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Oxford, MS USA; [Banahan, Benjamin F.] Univ Mississippi, Ctr Pharmaceut Mkt & Management, Oxford, MS USA; [Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Atzmon, Gil] Albert Einstein Coll Med, Dept Med & Genet, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Southern California; Lund University; Skane University Hospital; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Michigan System; University of Michigan; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Danube University Krems; King Abdulaziz University; Yeshiva University	Ebert, BL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, 1 Blackfan Cir,Karp 5-210, Boston, MA 02115 USA.	bebert@partners.org	Altshuler, David M/A-4476-2009; Manning, Alisa Knodle/ABC-7711-2021; Lindsley, Coleman/AAA-3040-2021; Mermel, Craig/AAZ-7322-2020; Kinnunen, Leena/B-7059-2012; Koistinen, Heikki/J-7313-2016; McCarthy, Mark/M-3763-2015	Altshuler, David M/0000-0002-7250-4107; Mermel, Craig/0000-0002-0816-3395; Kinnunen, Leena/0000-0001-8739-4812; Lindsley, Coleman/0000-0001-9822-806X; Koistinen, Heikki/0000-0001-7870-070X; Mar, Brenton/0000-0002-3857-9324; McCarthy, Mark/0000-0002-4393-0510	National Institutes of Health (NIH) [R01HL082945]; Gabrielle's Angel Foundation; Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR); NIH [5T32HL066987, U01 DK085526, U01 DK085501, U01 DK085524, U01 DK085545, U01 DK085584, DK088389, P01AG021654, 1R01AG042188, P30AG038072]; Medical Research Council [G0601261]; Medical Research Council (High Throughput Genomics Hub) [G0900747 91070]; Wellcome Trust [090367, 090532, 098381, 083948, 085475]; Paul Glenn Foundation; National Heart, Lung, and Blood Institute [HSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C]; National Institute on Minority Health and Health Disparities; National Human Genome Research Institute (NHGRI) of the NIH [U54 HG003067]; MRC [G0601261] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P01CA066996, T32CA009216, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, T32HL066987] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085584, P30DK020572, DP2DK098087, U01DK085524, U01DK085545, U01DK085526, RC2DK088389, U01DK085501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021654, P30AG038072, R01AG042188] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (High Throughput Genomics Hub)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Paul Glenn Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Human Genome Research Institute (NHGRI) of the NIH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (NIH) (R01HL082945) and the Gabrielle's Angel Foundation, by Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR) Awards (to Dr. Ebert), and by an NIH Training Grant (5T32HL066987, to Dr. Jaiswal). The T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) consortium was supported by grants from the NIH (U01s DK085526, DK085501, DK085524, DK085545, and DK085584). The GoT2D (Genetics of Type 2 Diabetes) consortium is supported by grants from the Medical Research Council (G0601261 and High Throughput Genomics Hub grant G0900747 91070), the Wellcome Trust (090367, 090532, 098381, 083948, 085475), and the NIH (DK088389). The Longevity Genes Project is supported by grants from the NIH (P01AG021654, 1R01AG042188, P30AG038072), and by a Paul Glenn Foundation Grant. The Jackson Heart Study is supported by contracts (HSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C) from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities. Dr. McCarthy is a Wellcome Trust Senior Investigator and an NIH Research Senior Investigator. Exome sequencing in the Jackson Heart Study was funded by an award from the National Human Genome Research Institute (NHGRI) of the NIH (U54 HG003067, to Dr. Gabriel).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Asmar F, 2013, HAEMATOLOGICA, V98, P1912, DOI 10.3324/haematol.2013.088740; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; Busque L, 1996, BLOOD, V88, P59; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Champion KM, 1997, BRIT J HAEMATOL, V97, P920, DOI 10.1046/j.1365-2141.1997.1933010.x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Ley TJ, 2013, NEW ENGL J MED, V369, P98; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neumann M, 2013, BLOOD, V121, P4749, DOI 10.1182/blood-2012-11-465138; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Surveillance Epidemiology and End Results Program, 2014, US POP DAT 1969 2012; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	45	2341	2391	6	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2488	2498		10.1056/NEJMoa1408617	http://dx.doi.org/10.1056/NEJMoa1408617			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25426837	Green Published, Green Accepted			2022-12-01	WOS:000346920300008
J	Gonsalves, G; Staley, P				Gonsalves, Gregg; Staley, Peter			Panic, Paranoia, and Public Health - The AIDS Epidemic's Lessons for Ebola	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gonsalves, Gregg] Yale Univ, Sch Law, Yale Global Hlth Justice Partnership, New Haven, CT 06520 USA; [Gonsalves, Gregg] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University	Gonsalves, G (corresponding author), Yale Univ, Sch Law, Yale Global Hlth Justice Partnership, New Haven, CT 06520 USA.			Gonsalves, Gregg/0000-0002-5789-9841				Berrill K.T., 1990, J INTERPERS VIOLENCE, V5, P274; BRANDT AM, 1988, SCIENCE, V239, P375, DOI 10.1126/science.3276007; Center for HIV Law and Policy, 2010, POS JUST PROJ; Dorf MC, 2014, CONTAINING EBOLE QUA, DOI 10.1056/NEJMp1413425; GOSTIN L O, 1989, Journal of the American Medical Association, V261, P1621, DOI 10.1001/jama.261.11.1621; GOSTIN LO, 1990, JAMA-J AM MED ASSOC, V263, P950	6	54	55	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2348	2349		10.1056/NEJMp1413425	http://dx.doi.org/10.1056/NEJMp1413425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW7DX	25372947				2022-12-01	WOS:000346425800002
J	Fleurie, A; Lesterlin, C; Manuse, S; Zhao, C; Cluze, C; Lavergne, JP; Franz-Wachtel, M; Macek, B; Combet, C; Kuru, E; Van Nieuwenhze, MS; Bruns, YV; Sherratt, D; Grangeasse, C				Fleurie, Aurore; Lesterlin, Christian; Manuse, Sylvie; Zhao, Chao; Cluze, Caroline; Lavergne, Jean-Pierre; Franz-Wachtel, Mirita; Macek, Boris; Combet, Christophe; Kuru, Erkin; Van Nieuwenhze, Michael S.; Bruns, Yves V.; Sherratt, David; Grangeasse, Christophe			MapZ marks the division sites and positions FtsZ rings in Streptococcus pneumoniae	NATURE			English	Article							SER/THR PROTEIN-KINASE; CELL-DIVISION; MEMBRANE-PROTEIN; BINDING; GROWTH; STKP; IDENTIFICATION; MORPHOGENESIS; PEPTIDOGLYCAN; MAINTENANCE	In every living organism, cell division requires accurate identification of the division site and placement of the division machinery. In bacteria, this process is traditionally considered to begin with the polymerization of the highly conserved tubulin-like protein FtsZinto a ring that locates precisely at mid-cell(1). Over the past decades, several systems have been reported to regulate the spatiotemporal assembly and placement of the FtsZ ring(2-5). However, the human pathogen Streptococcus pneumoniae, in common with many other organisms, is devoid of these canonical systems and the mechanisms of positioning the division machinery remain unknown(4,6). Here we characterize a novel factor that locates at the division site before FtsZ and guides septum positioning in pneumococcus. Mid-cell-anchored protein Z (MapZ) forms ring structures at the cell equator and moves apart as the cell elongates, therefore behaving as a permanent beacon of division sites. MapZ then positions the FtsZ ring through direct protein-protein interactions. MapZ-mediated control differs from previously described systems mostly on the basis of negative regulation of FtsZ assembly. Furthermore, MapZ is an endogenous target of the Ser/Thr kinase StkP, which was recently shown to have a central role in cytokinesis and morphogenesis of S. pneumoniae(7-9). We show that both phosphorylated and non-phosphorylated forms of MapZ are required for proper Z-ring formation and dynamics. Altogether, this work uncovers a new mechanism for bacterial cell division that is regulated by phosphorylation and illustrates that nature has evolved a diversity of cell division mechanisms adapted to the different bacterial clades.	[Fleurie, Aurore; Manuse, Sylvie; Zhao, Chao; Lavergne, Jean-Pierre; Combet, Christophe; Grangeasse, Christophe] Univ Lyon 1, CNRS, UMR 5086, IBCP, F-69007 Lyon, France; [Lesterlin, Christian; Sherratt, David] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Cluze, Caroline] Univ Lyon 1, CNRS, UMR 5305, Lab Biol Tissulaire & Ingn Threrapeut,IBCP, F-69007 Lyon, France; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Kuru, Erkin; Van Nieuwenhze, Michael S.; Bruns, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kuru, Erkin; Van Nieuwenhze, Michael S.; Bruns, Yves V.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Eberhard Karls University of Tubingen; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Grangeasse, C (corresponding author), Univ Lyon 1, CNRS, UMR 5086, IBCP, F-69007 Lyon, France.	christian.lesterlin@bioch.ox.ac.uk; c.grangeasse@ibcp.fr	Macek, Boris/N-1442-2015; VanNieuwenhze, Michael/B-5120-2018; Zhao, Chao/AAG-4497-2020	Macek, Boris/0000-0002-1206-2458; VanNieuwenhze, Michael/0000-0001-6093-5949; Zhao, Chao/0000-0001-7349-306X; Cluzel, Caroline/0000-0001-8946-3439; Brun, Yves/0000-0002-9289-1909; COMBET, Christophe/0000-0002-7348-3520; Sherratt, David/0000-0002-2104-5430; Lesterlin, Christian/0000-0002-9108-0848; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; Universite Claude Bernard Lyon 1; FINOVI foundation; Agence National de la Recherche [ANR-12-BSV3-0008-01]; Region Rhone-Alpes [ARC1]; Wellcome Trust [WT083469MA, 091911]; National Institutes of Health [GM051986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051986] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; FINOVI foundation; Agence National de la Recherche(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the CNRS, the Universite Claude Bernard Lyon 1, the FINOVI foundation, the Agence National de la Recherche (ANR-12-BSV3-0008-01) and the Region Rhone-Alpes (ARC1 and financial support for A.F. (Cluster 10) and C.Z. (CMIRA)). C.L. was supported by a Wellcome Trust Programme Grant to D.S. (WT083469MA), advanced microscopy at Micron Oxford was supported by a Wellcome Trust Strategic Award (091911), and Y.V.B. was supported by a National Institutes of Health grant (GM051986). We acknowledge the contribution of the PLATIM and the Protein Science facilities of the SFR Biosciences Gerland-Lyon Sud (UMS344/US8) and the Centre Technologique des Microstructures de l'Universite Lyon 1. We thank C. Chamot for technical assistance in microscopy, S. Uphoff and J. Wiktor for providing help with Matlab and A.-M. Di Guilmi for providing us with the antibody against pneumococcal FtsZ. We thank N. Campo, N. Dubarry and J.-P. Claverys for stimulating discussions and critical reading of the manuscript. N. Campo is also thanked for her help with time-lapse microscopy.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Fleurie A, 2012, MOL MICROBIOL, V83, P746, DOI 10.1111/j.1365-2958.2011.07962.x; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIGGINS ML, 1970, J BACTERIOL, V101, P643, DOI 10.1128/JB.101.2.643-648.1970; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Krol E, 2013, JOVE-J VIS EXP, DOI 10.3791/50844; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Krzywinski M, 2013, NAT METHODS, V10, P1041, DOI 10.1038/nmeth.2698; Krzywinski M, 2013, NAT METHODS, V10, P809, DOI 10.1038/nmeth.2613; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lesterlin C, 2014, NATURE, V506, P249, DOI 10.1038/nature12868; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Monahan LG, 2013, MOL MICROBIOL, V87, P231, DOI 10.1111/mmi.12114; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Morlot C, 2013, MOL MICROBIOL, V90, P88, DOI 10.1111/mmi.12348; Novakova L, 2010, J BACTERIOL, V192, P3629, DOI 10.1128/JB.01564-09; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; TOMASZ A, 1964, J CELL BIOL, V22, P453, DOI 10.1083/jcb.22.2.453; Wheeler R, 2011, MOL MICROBIOL, V82, P1096, DOI 10.1111/j.1365-2958.2011.07871.x; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671	50	131	134	7	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					259	+		10.1038/nature13966	http://dx.doi.org/10.1038/nature13966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25470041	Green Accepted			2022-12-01	WOS:000346383500048
J	Chen, X; Grandont, L; Li, HJ; Hauschild, R; Paque, S; Abuzeineh, A; Ralcusova, H; Benkova, E; Perrot-Rechenmann, C; Friml, J				Chen, Xu; Grandont, Laurie; Li, Hongjiang; Hauschild, Robert; Paque, Sebastien; Abuzeineh, Anas; Ralcusova, Hana; Benkova, Eva; Perrot-Rechenmann, Catherine; Friml, Jiri			Inhibition of cell expansion by rapid ABP1-mediated auxin effect on microtubules	NATURE			English	Article							BINDING PROTEIN-1; EPIDERMAL-CELLS; ROOT-GROWTH; ARABIDOPSIS; ENDOCYTOSIS; GRAVITROPISM; PERCEPTION; NUCLEATION; REVEALS; ARRAYS	The prominent and evolutionarily ancient role of the plant hormone auxin is the regulation of cell expansion(1). Cell expansion requires ordered arrangement of the cytoskeleton(2) but molecular mechanisms underlying its regulation by signalling molecules including auxin are unknown. Here we show in the model plant Arabidopsis thaliana that in elongating cells exogenous application of auxin or redistribution of endogenous auxin induces very rapid microtubule re-orientation from transverse to longitudinal, coherent with the inhibition of cell expansion. This fast auxin effect requires auxin binding protein 1 (ABP1) and involves a contribution of downstream signalling components such as ROP6 GTPase, ROP-interactive protein RIC1 and the microtubule-severing protein katanin. These components are required for rapid auxin- and ABP I -mediated re-orientation of microtubules to regulate cell elongation in roots and dark-grown hypocotyls as well as asymmetric growth during gravitropic responses.	[Chen, Xu; Li, Hongjiang; Hauschild, Robert; Ralcusova, Hana; Benkova, Eva; Friml, Jiri] Inst Sci Technol Austria 1ST Austria, A-3400 Klosterneuburg, Austria; [Chen, Xu; Li, Hongjiang; Abuzeineh, Anas; Ralcusova, Hana; Benkova, Eva; Friml, Jiri] Univ Ghent, Vlaams Inst Biotechnol VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Chen, Xu; Li, Hongjiang; Abuzeineh, Anas; Ralcusova, Hana; Benkova, Eva; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Grandont, Laurie; Paque, Sebastien; Perrot-Rechenmann, Catherine] CNRS, Saclay Plant Sci LabEx, Inst Sci Vegetal, UPR2355, F-91198 Gif Sur Yvette, France	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Perrot-Rechenmann, C (corresponding author), CNRS, Saclay Plant Sci LabEx, Inst Sci Vegetal, UPR2355, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	Catherine.Rechenmann@isv.cnrs-gif.fr; jiri.friml@ist.ac.at	Friml, Jiri/D-9511-2012	Friml, Jiri/0000-0002-8302-7596; Chen, Xu/0000-0002-5166-083X; Li, Hongjiang/0000-0001-5039-9660	European Research Council [ERC-2011-StG-20101109-PSDP]; ANR blanc AuxiWall project [ANR-11-BSV5-0007]; Agency for Innovation by Science and Technology (IWT); Conseil General de l'Essonne	European Research Council(European Research Council (ERC)European Commission); ANR blanc AuxiWall project(French National Research Agency (ANR)); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Conseil General de l'Essonne	We thank R. Dixit for performing complementary experiments, D. W. Ehrhardt and T. Hashimoto for providing the seeds of TUB6 RFP and EB1b-GFP respectively, E. Zazimalova, J. Petrasek and M. Fendrych for discussing the manuscript and J. Leung for text optimization. This work was supported by the European Research Council (project ERC-2011-StG-20101109-PSDP, to J.F.), ANR blanc AuxiWall project (ANR-11-BSV5-0007, to C.P.-R. and L.G.) and the Agency for Innovation by Science and Technology (IWT) (to H.R.). This work benefited from the facilities and expertise of the Imagif Cell Biology platform (http://www.imagif.cnrs.fr), which is supported by the Conseil General de l'Essonne.	Blancaflor EB, 2002, J PLANT GROWTH REGUL, V21, P120, DOI 10.1007/s003440010041; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Chan J, 2007, NAT CELL BIOL, V9, P171, DOI 10.1038/ncb1533; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Lucas J, 2008, CURR OPIN PLANT BIOL, V11, P94, DOI 10.1016/j.pbi.2007.12.001; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Montagnac G, 2013, NATURE, V502, P567, DOI 10.1038/nature12571; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Sedbrook JC, 2008, TRENDS PLANT SCI, V13, P303, DOI 10.1016/j.tplants.2008.04.002; Shishova M, 2010, J PLANT PHYSIOL, V167, P417, DOI 10.1016/j.jplph.2009.12.014; Simon S, 2013, NEW PHYTOL, V200, P1034, DOI 10.1111/nph.12437; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ubeda-Tomas S, 2012, TRENDS PLANT SCI, V17, P326, DOI 10.1016/j.tplants.2012.02.002; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003	30	94	100	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					90	U206		10.1038/nature13889	http://dx.doi.org/10.1038/nature13889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25409144	Green Accepted			2022-12-01	WOS:000346310800045
J	Shang, Y; Ma, YS; Zhou, Y; Zhang, HM; Duan, LX; Chen, HM; Zeng, JG; Zhou, Q; Wang, SH; Gu, WJ; Liu, M; Ren, JW; Gu, XF; Zhang, SP; Wang, Y; Yasukawa, K; Bouwmeester, HJ; Qi, XQ; Zhang, ZH; Lucas, WJ; Huang, SW				Shang, Yi; Ma, Yongshuo; Zhou, Yuan; Zhang, Huimin; Duan, Lixin; Chen, Huiming; Zeng, Jianguo; Zhou, Qian; Wang, Shenhao; Gu, Wenjia; Liu, Min; Ren, Jinwei; Gu, Xingfang; Zhang, Shengping; Wang, Ye; Yasukawa, Ken; Bouwmeester, Harro J.; Qi, Xiaoquan; Zhang, Zhonghua; Lucas, William J.; Huang, Sanwen			Biosynthesis, regulation, and domestication of bitterness in cucumber	SCIENCE			English	Article							SPECIALIZED METABOLISM; BIOLOGICAL-ACTIVITIES; CUCURBITACIN-C; CANCER-CELLS; SATIVUS L; PLANTS; GENE; RESISTANCE; PATHWAY	Cucurbitacins are triterpenoids that confer a bitter taste in cucurbits such as cucumber, melon, watermelon, squash, and pumpkin. These compounds discourage most pests on the plant and have also been shown to have antitumor properties. With genomics and biochemistry, we identified nine cucumber genes in the pathway for biosynthesis of cucurbitacin C and elucidated four catalytic steps. We discovered transcription factors Bl (Bitter leaf) and Bt (Bitter fruit) that regulate this pathway in leaves and fruits, respectively. Traces in genomic signatures indicated that selection imposed on Bt during domestication led to derivation of nonbitter cucurbits from their bitter ancestors.	[Shang, Yi; Ma, Yongshuo; Zhou, Yuan; Zhang, Huimin; Zhou, Qian; Wang, Shenhao; Gu, Wenjia; Liu, Min; Gu, Xingfang; Zhang, Shengping; Wang, Ye; Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China; [Shang, Yi; Huang, Sanwen] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen 518124, Peoples R China; [Ma, Yongshuo; Zhang, Huimin; Liu, Min] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [Zhou, Yuan; Zeng, Jianguo] Hunan Agr Univ, Hort & Landscape Coll, Natl Chinese Med Herbs Technol Ctr, Changsha 410128, Hunan, Peoples R China; [Duan, Lixin; Qi, Xiaoquan] Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China; [Chen, Huiming] Hunan Acad Agr Sci, Hunan Vegetable Res Inst, Changsha 410125, Hunan, Peoples R China; [Gu, Wenjia] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ren, Jinwei] Chinese Acad Sci, Inst Microbiol, Beijing 100190, Peoples R China; [Yasukawa, Ken] Nihon Univ, Sch Pharm, Tokyo 1018308, Japan; [Bouwmeester, Harro J.] Wageningen Univ, Lab Plant Physiol, NL-6700 Wageningen, Netherlands; [Lucas, William J.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Nanjing Agricultural University; Hunan Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS; Hunan Academy of Agricultural Sciences; Wuhan University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Nihon University; Wageningen University & Research; University of California System; University of California Davis	Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China.	huangsanwen@caas.cn	Qi, Xiaoquan/G-1545-2010; Zhou, Yuan/J-6908-2017; Huang, Sanwen/ABE-9053-2020	Qi, Xiaoquan/0000-0001-7175-115X; Zhou, Yuan/0000-0003-2892-0100; Huang, Sanwen/0000-0002-8547-5309; zhang, zhonghua/0000-0002-1034-227X; Bouwmeester, Harro/0000-0003-0907-2732; Zhou, Qian/0000-0002-5269-8178; Shang, Yi/0000-0001-5795-1198; Lucas, William/0000-0003-4714-7491; Ma, Yongshuo/0000-0002-0748-2810	Spanish Consolider-Ingenio program [CPAN CSD2007-00042, MultiDark CSD2009-00064]; Academy of Finland [127740]; DFG Cluster of Excellence; Croatian Science Foundation (HrZZ) [09/176]; University of Rijeka [13.12.1.3.02]; DFG Collaborative Research Centers [SFB823/C4, SFB876/C3]; Polish MNiSzW grant [745/N-HESS-MAGIC/2010/0]; DFG [WI 1860/10-1]; ERDF; Spanish MINECO [FPA2012-39502, JCI-2011-10019, AYA2009-13036-C02-02, AYA2012-38491-C02-01]; Generalitat Valenciana [PROMETEO/2009/104]; COST [MP0905]; national research councils; European Commission [283393]	Spanish Consolider-Ingenio program(Spanish Government); Academy of Finland(Academy of Finland); DFG Cluster of Excellence(German Research Foundation (DFG)); Croatian Science Foundation (HrZZ); University of Rijeka; DFG Collaborative Research Centers(German Research Foundation (DFG)); Polish MNiSzW grant; DFG(German Research Foundation (DFG)); ERDF(European Commission); Spanish MINECO(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); COST(European Cooperation in Science and Technology (COST)); national research councils; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the Instituto de Astrofisica de Canarias for the excellent working conditions at the Observatorio del Roque de los Muchachos in La Palma. The support of the German BMBF and MPG, the Italian INFN, the Swiss National Fund SNF, and the Spanish MICINN is gratefully acknowledged. This work was also supported by the CPAN CSD2007-00042 and MultiDark CSD2009-00064 projects of the Spanish Consolider-Ingenio 2010 program, by grant 127740 of the Academy of Finland, by the DFG Cluster of Excellence "Origin and Structure of the Universe", by the Croatian Science Foundation (HrZZ) Projects 09/176, by the University of Rijeka Project 13.12.1.3.02, by the DFG Collaborative Research Centers SFB823/C4 and SFB876/C3, and by the Polish MNiSzW grant 745/N-HESS-MAGIC/2010/0. We thank also the support by DFG WI 1860/10-1. J. S. was supported by ERDF and the Spanish MINECO through FPA2012-39502 and JCI-2011-10019 grants. E. R. was partially supported by the Spanish MINECO projects AYA2009-13036-C02-02 and AYA2012-38491-C02-01 and by the Generalitat Valenciana project PROMETEO/2009/104, as well as by the COST MP0905 action 'Black Holes in a Violent Universe.' The European VLBI Network is a joint facility of European, Chinese, South African and other radio astronomy institutes funded by their national research councils. The research leading to these results has received funding from the European Commission Seventh Framework Programme (FP/2007-2013) under grant agreement No. 283393 (RadioNet3). The MAGIC data are archived in the data center at the Port dInformacio Cientfica (PIC) in Barcelona. The EVN data are available at the Data Archive at the Joint Institute for VLBI in Europe (JIVE).	Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; Blaskovich MA, 2003, CANCER RES, V63, P1270; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; DACOSTA CP, 1971, SCIENCE, V172, P1145, DOI 10.1126/science.172.3988.1145; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Dwivedi NK, 2010, GENET RESOUR CROP EV, V57, P443, DOI 10.1007/s10722-009-9484-5; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Horie H, 2007, JARQ-JPN AGR RES Q, V41, P65, DOI 10.6090/jarq.41.65; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; METCALF RL, 1980, P NATL ACAD SCI-BIOL, V77, P3769, DOI 10.1073/pnas.77.7.3769; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Shibuya M, 2004, TETRAHEDRON, V60, P6995, DOI 10.1016/j.tet.2004.04.088; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839	19	256	306	43	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1084	1088		10.1126/science.1259215	http://dx.doi.org/10.1126/science.1259215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430763				2022-12-01	WOS:000345763400035
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Stop playing politics with illegal drug use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Home Office, 2014, DRUGS INT COMP; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Johnson A., 2009, GUARDIAN; Light M, 2013, MINISTRY JUSTICE ANA; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; Nutt DJ, 2009, J PSYCHOPHARMACOL, V23, P3, DOI 10.1177/0269881108099672; Parliament.uk, 2013, 9 PARL UK	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g7273	10.1136/bmj.g7273	http://dx.doi.org/10.1136/bmj.g7273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KG	25430933	Green Published, hybrid			2022-12-01	WOS:000346115800010
J	Tilman, D; Clark, M				Tilman, David; Clark, Michael			Global diets link environmental sustainability and human health	NATURE			English	Article							MEDITERRANEAN DIET; NUTRITION TRANSITION; MEAT CONSUMPTION; VEGETARIAN DIETS; ADVENTIST HEALTH; CANCER INCIDENCE; HEART-DISEASE; LAND-USE; MORTALITY; SURVIVAL	Diets link environmental and human health. Rising incomes and urbanization are driving a global dietary transition in which traditional diets are replaced by diets higher in refined sugars, refined fats, oils and meats. By 2050 these dietary trends, if unchecked, would be a major contributor to an estimated 80 per cent increase in global agricultural greenhouse gas emissions from food production and to global land clearing. Moreover, these dietary shifts are greatly increasing the incidence of type II diabetes, coronary heart disease and other chronic non-communicable diseases that lower global life expectancies. Alternative diets that offer substantial health benefits could, if widely adopted, reduce global agricultural greenhouse gas emissions, reduce land clearing and resultant species extinctions, and help prevent such diet-related chronic non-communicable diseases. The implementation of dietary solutions to the tightly linked diet-environment-health trilemma is a global challenge, and opportunity, of great environmental and public health importance.	[Tilman, David; Clark, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021	Clark, Michael/0000-0001-7161-7751	LTER programme of the US National Science Foundation; University of Minnesota Foundation	LTER programme of the US National Science Foundation(National Science Foundation (NSF)); University of Minnesota Foundation(University of Minnesota System)	We thank M. Burgess, A. Clark and E. Hallstrom for their comments, K. Thompson for assistance with data collection, editing, and creating figures, and the LTER programme of the US National Science Foundation and the University of Minnesota Foundation for support.	Alexandratos N., 2012, ESA1203 FAO; [Anonymous], 2002, ETUDES TRAVAUX LASDE; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Bartley D., 2014, STATE WORLD FISHERIE, P199; Brunner EJ, 2008, AM J CLIN NUTR, V87, P1414, DOI 10.1093/ajcn/87.5.1414; Buckland G, 2012, AM J CLIN NUTR, V96, P142, DOI 10.3945/ajcn.111.024216; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Eisler MC, 2014, NATURE, V507, P32, DOI 10.1038/507032a; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; FAO, 2013, FISHSTAT; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Groningen Growth and Development Centre, 2013, TOT EC DAT; Gustavsson J., 2011, INT C SAV FOOD INT 2, DOI 10.1098/rstb.2010.0126; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hoevenaar-Blom MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045458; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang T, 2012, ANN NUTR METAB, V60, P233, DOI 10.1159/000337301; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Key TJ, 2009, BRIT J CANCER, V101, P192, DOI 10.1038/sj.bjc.6605098; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Key TJA, 1996, BMJ-BRIT MED J, V313, P775, DOI 10.1136/bmj.313.7060.775; Kuznets S, 1955, AM ECON REV, V45, P1; Lagiou P, 2006, BRIT J NUTR, V96, P384, DOI 10.1079/BJN20061824; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; Marlow HJ, 2009, AM J CLIN NUTR, V89, pS1699, DOI 10.3945/ajcn.2009.26736Z; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Mathlouthi N, 2002, CAN J ANIM SCI, V82, P193, DOI 10.4141/A01-047; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; O'Kiely P, 2011, IRISH J AGR FOOD RES, V50, P189; Orlich MJ, 2013, JAMA INTERN MED, V173, P1230, DOI 10.1001/jamainternmed.2013.6473; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Singh PN, 2003, AM J CLIN NUTR, V78, p526S, DOI 10.1093/ajcn/78.3.526S; Smil V., 2000, FEEDING WORLD CHALLE; Smith J., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0002; SNOWDON DA, 1984, PREV MED, V13, P490, DOI 10.1016/0091-7435(84)90017-3; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Sundrum A, 2011, NJAS-WAGEN J LIFE SC, V58, P163, DOI 10.1016/j.njas.2011.09.006; Tantamango-Bartley Y, 2013, CANCER EPIDEM BIOMAR, V22, P286, DOI 10.1158/1055-9965.EPI-12-1060; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tubielle F. N., 2014, AGR FORESTRY OTHER L; United States Department of Agriculture, 2013, CHOOS MY PLAT; United States Department of Agriculture, 2013, NAT NUTR DAT; Waite R., 2014, WORLDFISH, P1; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Willett Walter C., 1995, American Journal of Clinical Nutrition, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	74	1550	1583	84	1347	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					518	+		10.1038/nature13959	http://dx.doi.org/10.1038/nature13959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25383533				2022-12-01	WOS:000346247600045
J	Subramaniam, AR; Zid, BM; O'Shea, EK				Subramaniam, Arvind R.; Zid, Brian M.; O'Shea, Erin K.			An Integrated Approach Reveals Regulatory Controls on Bacterial Translation Elongation	CELL			English	Article							AMINO-ACID STARVATION; TRANSFER-RNA ISOACCEPTORS; ESCHERICHIA-COLI; RIBOSOME-RESCUE; MESSENGER-RNA; GENE-EXPRESSION; CODON USAGE; PROTEIN TRANSLATION; QUALITY-CONTROL; TMRNA SYSTEM	Ribosomes elongate at a nonuniform rate during translation. Theoretical models and experiments disagree on the in vivo determinants of elongation rate and the mechanism by which elongation rate affects protein levels. To resolve this conflict, we measured transcriptome-wide ribosome occupancy under multiple conditions and used it to formulate a whole-cell model of translation in E. coli. Our model predicts that elongation rates at most codons during nutrient-rich growth are not limited by the intracellular concentrations of aminoacyl-tRNAs. However, elongation pausing during starvation for single amino acids is highly sensitive to the kinetics of tRNA aminoacylation. We further show that translation abortion upon pausing accounts for the observed ribosome occupancy along mRNAs during starvation. Abortion reduces global protein synthesis, but it enhances the translation of a subset of mRNAs. These results suggest a regulatory role for aminoacylation and abortion during stress, and our study provides an experimentally constrained framework for modeling translation.	[Subramaniam, Arvind R.; Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Subramaniam, Arvind R.; Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Subramaniam, AR (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	asubram@fas.harvard.edu; erin_oshea@harvard.edu		Subramaniam, Arvind Rasi/0000-0001-6145-4303; Zid, Brian/0000-0003-1876-2479	NIH [GM107113]; Howard Hughes Medical Institute; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM107113, R00GM107113] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Calarco, P. Cluzel, V. Denic, A. Murray, and C. Shoemaker for discussions; G.W. Li and E. Oh for advice on ribosome profiling; G.L. Chew and A. Gutu for advice on northern blotting; H. Aiba for the XL001 strain; P. Shah for clarifications on the yeast model; and K. Amarnath, A. Buskirk, S. Chandrasekaran, A. Darnell, G. W. Li, W. Moebius, J. Moffitt, P. Shah, and E. Wallace for comments on the manuscript. The computations in this paper were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University. This research was supported by an NIH K99 Pathway to Independence Award GM107113 (A.R.S.) and by the Howard Hughes Medical Institute (E.K.O.).	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; [Anonymous], [No title captured]; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Fender A, 2004, BIOCHIMIE, V86, P21, DOI 10.1016/j.biochi.2003.11.011; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; HARRIS CL, 1980, NUCLEIC ACIDS RES, V8, P2023, DOI 10.1093/nar/8.9.2023; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanova N, 2005, J MOL BIOL, V350, P897, DOI 10.1016/j.jmb.2005.05.033; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; Keiler K.C., 2014, J BACTERIOL JB; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li X, 2008, MOL MICROBIOL, V68, P462, DOI 10.1111/j.1365-2958.2008.06167.x; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; MYERS G, 1971, J BIOL CHEM, V246, P4955; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Subramaniam AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01501; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Wallace EWJ, 2013, MOL BIOL EVOL, V30, P1438, DOI 10.1093/molbev/mst051; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; YEGIAN CD, 1966, P NATL ACAD SCI USA, V55, P839, DOI 10.1073/pnas.55.4.839; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196	58	91	92	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1200	1211		10.1016/j.cell.2014.10.043	http://dx.doi.org/10.1016/j.cell.2014.10.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416955	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000345506300028
J	Ali, MK; Bullard, KM; Gregg, EW; del Rio, C				Ali, Mohammed K.; Bullard, Kai McKeever; Gregg, Edward W.; del Rio, Carlos			A Cascade of Care for Diabetes in the United States: Visualizing the Gaps	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-GLUCOSE CONTROL; MULTIFACTORIAL INTERVENTION; COST-EFFECTIVENESS; RISK-FACTORS; HIV CARE; TYPE-2; MANAGEMENT; STRATEGIES; PATIENT; MORTALITY	Background: A "cascade-of-care" concept helped to address implementation gaps in HIV care. Objective: To develop a similar cascade for U.S. diabetes care to visualize gaps in awareness of diagnosis, engagement, and treatment. Design: Nationally representative cross-sectional surveys. Setting: 2007 to 2012 NHANES (National Health and Nutrition Examination Surveys). Participants: Nonpregnant civilians aged 18 years or older. Measurements: Standardized data collection and laboratory procedures. Diabetes care was benchmarked against recent diabetes and cardiovascular risk reduction guidelines. Results: In 2012, an estimated 28.4 million (11.8%) U.S. adults had diabetes, of whom 20.5 million (72.2%) were aware of their diagnosis. Among diagnosed adults, 95.3% had a usual care provider and 91.7% made 2 or more visits in the past year. In contrast, among undiagnosed adults, 84.5% had a usual care provider and 66.5% reported 2 or more visits in the past year. Among diagnosed adults, 63.7%, 65.5%, 56.6%, and 80.6% met individualized hemoglobin A(1c), blood pressure (BP <140/80 mmHg), lipid (low-density lipoprotein [LDL] cholesterol <2.6 mmol/L [<100 mg/dL]), and nonsmoking goals, respectively; 26.7% met combined ABC (hemoglobin A1c, BP, and LDL cholesterol) targets, and 21.3% met combined ABC targets and did not smoke. Among undiagnosed adults, 77.0%, 57.9%, 36.0%, and 77.9% met hemoglobin A1c, BP, lipid, and nonsmoking goals, respectively; 22.1% met combined ABC targets; and 18.8% met combined ABC targets and were nonsmokers. Limitation: Institutionalized and noncivilian persons are not surveyed in NHANES. Conclusion: Three of 10 adults with diabetes remain undiagnosed, which may be related to less access to care. Compared with diagnosed adults, undiagnosed adults have less elevated hemoglobin A1c levels, less lipid treatment and worse control, and similarly poor BP and combined ABC control regardless of smoking status. Addressing these care gaps in both groups would prevent long-term complications.	Emory Univ, Natl Ctr Chron Dis Prevent & Hlth Promot, Rollins Sch Publ Hlth, Ctr Dis Control & Prevent, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Emory University	Ali, MK (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, 4770 Buford Highway NE, Atlanta, GA 30341 USA.	mkali@emory.edu	del Rio, Carlos/B-3763-2012; Ali, Mohammed K/N-9833-2013	del Rio, Carlos/0000-0002-0153-3517; Ali, Mohammed/0000-0001-7266-2503; Gregg, Edward/0000-0003-2381-6822				Ahmann AJ, 2007, AM J MANAG CARE, V13, pS41; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; American Diabetes Association, 2014, AR YOU RISK AL; American Heart Association, 2012, KNOW YOUR HLTH NUM; [Anonymous], 1998, BMJ, V317, P720; Barr D, 2013, REVITALIZING US NATL; Bernstein J., 2010, DOES INSURANCE COVER; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP 20; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics National Health and Nutrition Examination Survey, 2012, UPD ADV NHANES HEM A; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Ettner SL, 2006, HEALTH SERV RES, V41, P1221, DOI 10.1111/j.1475-6773.2006.00533.x; Fryar Cheryl D, 2012, Natl Health Stat Report, P1; Gaede P, 2008, DIABETES CARE, V31, P1510, DOI 10.2337/dc07-2452; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; Gregg EW, 2010, MED CARE, V48, P31, DOI 10.1097/MLR.0b013e3181bd4783; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kelly E, 2010, J OCCUP ENVIRON MED, V52, P528, DOI 10.1097/JOM.0b013e3181dbe339; Martin SS, 2014, ANN INTERN MED, V160, P356, DOI 10.7326/M13-2805; MN Community Measurement, 2012, 2012 HLTH CAR QUAL R; Mohiuddin SM, 2007, CHEST, V131, P446, DOI 10.1378/chest.06-1587; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Ofri D, 2014, NY TIMES; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pogach L, 2011, JAMA-J AM MED ASSOC, V305, P709, DOI 10.1001/jama.2011.153; Ratner RE, 2011, DIABETES CARE, V34, P1054, DOI 10.2337/dc10-1987; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Rolando L, 2013, J OCCUP ENVIRON MED, V55, P410, DOI 10.1097/JOM.0b013e31827cbaec; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Srikanth S, 2005, CARDIOL CLIN, V23, P193, DOI 10.1016/j.ccl.2004.11.002; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thorpe KE, 2010, HEALTH AFFAIR, V29, P718, DOI 10.1377/hlthaff.2009.0474; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U.S. Census Bureau Population Division, 2010, METH US RES POP EST	55	98	102	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					681	689		10.7326/M14-0019	http://dx.doi.org/10.7326/M14-0019			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402511				2022-12-01	WOS:000347245600025
J	Jubelt, LE; Graham, J; Maeng, DD; Li, HL; Epstein, AJ; Metlay, JP				Jubelt, Lindsay E.; Graham, Jove; Maeng, Daniel D.; Li, Huilin; Epstein, Andrew J.; Metlay, Joshua P.			Patient Ratings of Case Managers in a Medical Home: Associations With Patient Satisfaction and Health Care Utilization	ANNALS OF INTERNAL MEDICINE			English	Article							VOLUNTARY DISENROLLMENT; REPORTED EXPERIENCE; COMMUNICATION; BENEFICIARIES; OUTCOMES; QUALITY; RISK; HOSPITALIZATION; PERCEPTIONS; PREDICTORS	Background: Case managers are employed in medical homes to coordinate care for clinically complex patients. Objective: To measure the association of patient perceptions of case manager performance with overall satisfaction and subsequent health care utilization. Design: Retrospective cohort study. Setting: Integrated health system in Pennsylvania. Patients: Members of the health system-owned health plan who 1) received primary care in the health system's clinics, 2) were exposed to clinic-embedded case managers, and 3) completed a survey of satisfaction with care. Measurements: Survey assessment of case manager performance and overall satisfaction with care and claims-based assessment of case manager performance and subsequent hospitalizations or emergency department visits. Survey measures were dichotomized into very good versus less than very good. Results: A total of 1755 patients (44%) completed the survey and 1415 met study criteria. Survey respondents who reported very good ratings of case manager performance across all items had a higher probability of reporting very good overall satisfaction with care (92.2% vs. 62.5%; P < 0.001) and had a lower incidence of subsequent emergency department visits (incidence rate ratio, 0.79 [95% CI, 0.64 to 0.98]; P = 0.029) but not hospitalizations (incidence rate ratio, 0.92 [CI, 0.75 to 1.11]; P = 0.37) up to 2 years after the survey compared with survey respondents who reported less-than-very good case manager performance on 1 or more questions on the survey. Limitations: Satisfaction data demonstrated substantial ceiling effects. Survey nonresponse may have introduced bias in the results. Conclusion: Patients' favorable perceptions of case managers are associated with higher overall satisfaction with care and may lower risk for future acute care use.	[Epstein, Andrew J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Li, Huilin] NYU, Langone Med Ctr, Dept Populat Hlth, New York, NY 10016 USA; [Graham, Jove] Geisinger Ctr Hlth Res, Danville, PA 17822 USA; [Maeng, Daniel D.] Geisinger Hlth Syst, Danville, PA 17822 USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; New York University; NYU Langone Medical Center; Geisinger Health System; Harvard University; Massachusetts General Hospital	Jubelt, LE (corresponding author), NYU, Sch Med, Dept Populat Hlth, 1 Pk Ave,10th Floor, New York, NY 10016 USA.	lindsay.jubelt@nyumc.org		Li, Huilin/0000-0002-8288-7068; Epstein, Andrew/0000-0001-5078-6564	Robert Wood Johnson Foundation; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI073957] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Robert Wood Johnson Foundation and the U.S. Department of Veterans Affairs.	Abramowitz S, 1987, QRB Qual Rev Bull, V13, P122; Agency for Healthcare Research and Quality R MD, CAHPS CLIN GROUP SUR; [Anonymous], 2011, EVALUATION CMS HCC R; Chang JT, 2006, ANN INTERN MED, V144, P665, DOI 10.7326/0003-4819-144-9-200605020-00010; Chen J., 2000, J OFFICIAL STAT, V16, P113; Devoe JE, 2008, J AM BOARD FAM MED, V21, P441, DOI 10.3122/jabfm.2008.05.080054; Elliott MN, 2009, MED CARE, V47, P842, DOI 10.1097/MLR.0b013e318197b22a; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Gray BM, 2012, HEALTH SERV RES, V47, P4, DOI 10.1111/j.1475-6773.2011.01302.x; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Hargraves JL, 2003, HEALTH SERV RES, V38, P1509; Heller A, 2009, MED CARE, V47, P850, DOI 10.1097/MLR.0b013e318197b661; Hutchinson A, 1999, QUAL HEALTH CARE, V8, P213, DOI 10.1136/qshc.8.4.213; Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Keenan PS, 2009, MED CARE, V47, P882, DOI 10.1097/MLR.0b013e3181a39415; Kellerman R, 2007, AM FAM PHYSICIAN, V76, P774; Kern LM, 2013, AM J MANAG CARE, V19, P403; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Larkins AS, 2013, EUR J GASTROEN HEPAT, V25, P44, DOI 10.1097/MEG.0b013e3283589f80; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lied TR, 2003, HEALTH CARE FINANC R, V25, P55; Lin PJ, 2010, AM J MANAG CARE, V16, P191; Maeng DD, 2013, POPUL HEALTH MANAG, V16, P157, DOI 10.1089/pop.2012.0048; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Mitchell SE, 2014, J GEN INTERN MED, V29, P349, DOI 10.1007/s11606-013-2647-2; O'Connor SJ, 2003, HEALTH CARE MANAGE R, V28, P21, DOI 10.1097/00004010-200301000-00003; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Ruiz-Moral R, 2006, PATIENT EDUC COUNS, V64, P242, DOI 10.1016/j.pec.2006.02.010; Safran DG, 2001, J FAM PRACTICE, V50, P130; Tallman Karen, 2007, Perm J, V11, P19; Williams S, 1998, FAM PRACT, V15, P480, DOI 10.1093/fampra/15.5.480; Wofford MM, 2004, ACAD MED, V79, P134, DOI 10.1097/00001888-200402000-00008; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	36	11	11	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S59	S65		10.7326/M13-3007	http://dx.doi.org/10.7326/M13-3007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402405				2022-12-01	WOS:000364909900009
J	Laskey, WK				Laskey, Warren K.			Drug-Eluting Stents: Boom or Bust?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY-ARTERY STENTS; OUTCOMES; THERAPY; HEALTH		[Laskey, Warren K.] Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Laskey, WK (corresponding author), Univ New Mexico, Dept Internal Med, Div Cardiol, MSC10-5550,1 Univ New Mexico, Albuquerque, NM 87131 USA.	wlaskey@salud.unm.edu						Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Groeneveld PW, 2011, ARCH INTERN MED, V171, P1289, DOI 10.1001/archinternmed.2011.141; Kandzari DE, 2005, AM J CARDIOL, V96, P750, DOI 10.1016/j.amjcard.2005.05.015; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816	9	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					740	U190		10.7326/M14-0874	http://dx.doi.org/10.7326/M14-0874			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402515				2022-12-01	WOS:000347245600031
J	DeBaun, MR				DeBaun, Michael R.			Thinking beyond survival	NATURE			English	Editorial Material							SICKLE; TRANSFUSIONS		Vanderbilt Univ, Med Ctr, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Nashville, TN 37235 USA	Meharry Medical College; Vanderbilt University	DeBaun, MR (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Nashville, TN 37235 USA.	m.debaun@vanderbilt.edu						Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; King AA, 2014, AM J HEMATOL, V89, P162, DOI 10.1002/ajh.23604; Yanni E, 2009, J PEDIATR-US, V154, P541, DOI 10.1016/j.jpeds.2008.09.052	4	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S16	S16		10.1038/515S16a	http://dx.doi.org/10.1038/515S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390138				2022-12-01	WOS:000344631400010
J	Humphries, C				Humphries, Courtney			A complicated path	NATURE			English	Editorial Material																		Abdulmalik O, 2005, BRIT J HAEMATOL, V128, P552, DOI 10.1111/j.1365-2141.2004.05332.x; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311	2	6	6	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S4	S5		10.1038/515S4a	http://dx.doi.org/10.1038/515S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390140	Bronze			2022-12-01	WOS:000344631400004
J	Kharbanda, EO; Vazquez-Benitez, G; Lipkind, HS; Klein, NP; Cheetham, TC; Naleway, A; Omer, SB; Hambidge, SJ; Lee, GM; Jackson, ML; McCarthy, NL; DeStefano, F; Nordin, JD				Kharbanda, Elyse O.; Vazquez-Benitez, Gabriela; Lipkind, Heather S.; Klein, Nicola P.; Cheetham, T. Craig; Naleway, Allison; Omer, Saad B.; Hambidge, Simon J.; Lee, Grace M.; Jackson, Michael L.; McCarthy, Natalie L.; DeStefano, Frank; Nordin, James D.			Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INACTIVATED INFLUENZA VACCINE; ADVISORY-COMMITTEE; TDAP IMMUNIZATION; VIRUS VACCINE; PREGNANCY; SAFETY; DIPHTHERIA; TETANUS; WOMEN; RECOMMENDATIONS	IMPORTANCE In 2010, due to a pertussis outbreak and neonatal deaths, the California Department of Health recommended that the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) be administered during pregnancy. Tdap is now recommended by the Advisory Committee on Immunization Practices for all pregnant women, preferably between 27 and 36 weeks' gestation. Limited data exist on Tdap safety during pregnancy. OBJECTIVE To evaluate whether maternal Tdap vaccination during pregnancy is associated with increased risks of adverse obstetric events or adverse birth outcomes. DESIGN AND SETTING Retrospective, observational cohort study using administrative health care databases from 2 California Vaccine Safety Datalink sites. PARTICIPANTS AND EXPOSURES Of 123 494 women with singleton pregnancies ending in a live birth between January 1, 2010, and November 15, 2012, 26 229 (21%) received Tdap during pregnancy and 97 265 did not. MAIN OUTCOMES AND MEASURES Risks of small-for-gestational-age (SGA) births (<10th percentile), chorioamnionitis, preterm birth (<37 weeks' gestation), and hypertensive disorders of pregnancy were evaluated. Relative risk (RR) estimates were adjusted for site, receipt of another vaccine during pregnancy, and propensity to receive Tdap during pregnancy. Cox regression was used for preterm delivery, and Poisson regression for other outcomes. RESULTS Vaccination was not associated with increased risks of adverse birth outcomes: crude estimates for preterm delivery were 6.3% of vaccinated and 7.8% of unvaccinated women (adjusted RR, 1.03; 95% CI, 0.97-1.09); 8.4% of vaccinated and 8.3% of unvaccinated had an SGA birth (adjusted RR, 1.00; 95% CI, 0.96-1.06). Receipt of Tdap before 20 weeks was not associated with hypertensive disorder of pregnancy (adjusted RR, 1.09; 95% CI, 0.99-1.20); chorioamnionitis was diagnosed in 6.1% of vaccinated and 5.5% of unvaccinated women (adjusted RR, 1.19; 95% CI, 1.13-1.26). CONCLUSIONS AND RELEVANCE In this cohort of women with singleton pregnancies that ended in live birth, receipt of Tdap during pregnancy was not associated with increased risk of hypertensive disorders of pregnancy or preterm or SGA birth, although a small but statistically significant increased risk of chorioamnionitis diagnosis was observed.	[Kharbanda, Elyse O.; Vazquez-Benitez, Gabriela; Nordin, James D.] HealthPartners Inst Educ & Res, Minneapolis, MN 55440 USA; [Lipkind, Heather S.] Yale Univ, New Haven, CT USA; [Klein, Nicola P.] Kaiser Permanente No Calif, Oakland, CA USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Naleway, Allison] Kaiser Permanente Northwest, Portland, OR USA; [Omer, Saad B.] Kaiser Permanente Georgia, Atlanta, GA USA; [Hambidge, Simon J.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Hambidge, Simon J.] Denver Hlth, Dept Ambulatory Care Serv, Denver, CO USA; [Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Lee, Grace M.] Harvard Univ, Sch Med, Boston, MA USA; [Jackson, Michael L.] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [McCarthy, Natalie L.; DeStefano, Frank] Ctr Dis Control & Prevent, Atlanta, GA USA	Yale University; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Denver Health Medical Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Group Health Cooperative; Centers for Disease Control & Prevention - USA	Kharbanda, EO (corresponding author), HealthPartners Inst Educ & Res, POB 1524,MS 21111R, Minneapolis, MN 55440 USA.	elyse.o.kharbanda@healthpartners.com		Kharbanda, Elyse/0000-0003-1806-6502; Nordin, James/0000-0002-3359-5843	CDC [200-2012-53526]; CDC Vaccine Safety Datalink infrastructure task order [200-2012-53581, 200-2012-53580]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC Vaccine Safety Datalink infrastructure task order	This study was funded through contract 200-2012-53526 from the CDC. Additional funding for chart reviews came from contracts 200-2012-53581 and 200-2012-53580 from the CDC Vaccine Safety Datalink infrastructure task order.	Abramovici A, 2014, AM J PERINAT, V31, P1009, DOI 10.1055/s-0034-1371357; Andrade SE, 2013, PHARMACOEPIDEM DR S, V22, P7, DOI 10.1002/pds.3319; [Anonymous], 2013, Obstet Gynecol, V121, P1411, DOI 10.1097/01.AOG.0000431054.33593.e3; Baggs J, 2011, PEDIATRICS, V127, pS45, DOI 10.1542/peds.2010-1722H; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P817; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P669; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Christian LM, 2013, AM J REPROD IMMUNOL, V70, P45, DOI 10.1111/aji.12117; Christian LM, 2011, VACCINE, V29, P8982, DOI 10.1016/j.vaccine.2011.09.039; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Donegan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4219; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Getahun D, 2013, J MED STAT INFORM, V1, P1, DOI DOI 10.7243/2053-7662-1-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Healy CM, 2013, CLIN INFECT DIS, V56, P539, DOI 10.1093/cid/cis923; Irving SA, 2013, OBSTET GYNECOL, V121, P159, DOI [10.1097/AOG.0b013e318279f56f, http://10.1097/AOG.0b013e318279f56f]; Jimenez-Truque N, 2014, JAMA-J AM MED ASSOC, V311, P1736, DOI 10.1001/jama.2014.3555; Kharbanda EO, 2014, PREV MED, V67, P316, DOI 10.1016/j.ypmed.2014.05.025; Kharbanda EO, 2012, AM J OBSTET GYNECOL, V207, pS47, DOI 10.1016/j.ajog.2012.06.073; Kharbanda EO, 2013, OBSTET GYNECOL, V122, P659, DOI 10.1097/AOG.0b013e3182a1118a; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Myatt L, 2013, BJOG-INT J OBSTET GY, V120, P1183, DOI 10.1111/1471-0528.12128; Naleway AL, 2013, VACCINE, V31, P2898, DOI 10.1016/j.vaccine.2013.03.069; Nordin JD, 2014, J PEDIATR-US, V164, P1051, DOI 10.1016/j.jpeds.2014.01.037; Nordin JD, 2013, OBSTET GYNECOL, V121, P519, DOI 10.1097/AOG.0b013e3182831b83; Nordin JD, 2014, J PEDIAT, V164, pe2; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pasternak Bjorn, 2012, BMJ, V344, pe2794, DOI 10.1136/bmj.e2794; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Shakib JH, 2013, J PEDIATR-US, V163, P1422, DOI 10.1016/j.jpeds.2013.06.021; Sheffield JS, 2012, OBSTET GYNECOL, V120, P532, DOI 10.1097/AOG.0b013e318263a278; Steinhoff MC, 2012, CAN MED ASSOC J, V184, P645, DOI 10.1503/cmaj.110754; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Zheteyeva YA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.006	45	142	144	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2014	312	18					1897	1904		10.1001/jama.2014.14825	http://dx.doi.org/10.1001/jama.2014.14825			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AS8ZE	25387187	Green Accepted, Bronze			2022-12-01	WOS:000344532600019
J	Burki, T				Burki, Talha			VECTOR BORNE DISEASE India's ambition to eliminate visceral leishmaniasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BIHAR					talhakburki@gmail.com						Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bhatia B, 2014, TIMES INDIA; Ross R., 1899, REPORT NATURE KALA A; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Sinha PK, 2014, LANCET GLOB HEALTH, V2, pE7, DOI 10.1016/S2214-109X(13)70151-7	6	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2014	349								g6671	10.1136/bmj.g6671	http://dx.doi.org/10.1136/bmj.g6671			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CF	25380595				2022-12-01	WOS:000344603900002
J	Williams, CC; Jan, CH; Weissman, JS				Williams, Christopher C.; Jan, Calvin H.; Weissman, Jonathan S.			Targeting and plasticity of mitochondrial proteins revealed by proximity-specific ribosome profiling	SCIENCE			English	Article							FUMARATE REDUCTASE; MESSENGER-RNAS; IMPORT; PROTEOME; DATABASE; SITES; GENE	Nearly all mitochondrial proteins are nuclear-encoded and are targeted to their mitochondrial destination from the cytosol. Here, we used proximity-specific ribosome profiling to comprehensively measure translation at the mitochondrial surface in yeast. Most inner-membrane proteins were cotranslationally targeted to mitochondria, reminiscent of proteins entering the endoplasmic reticulum (ER). Comparison between mitochondrial and ER localization demonstrated that the vast majority of proteins were targeted to a specific organelle. A prominent exception was the fumarate reductase Osm1, known to reside in mitochondria. We identified a conserved ER isoform of Osm1, which contributes to the oxidative protein-folding capacity of the organelle. This dual localization was enabled by alternative translation initiation sites encoding distinct targeting signals. These findings highlight the exquisite in vivo specificity of organellar targeting mechanisms.	[Williams, Christopher C.; Jan, Calvin H.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Center for RNA Systems Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Weissman and P. Walter labs for discussion and E. Costa and V. Okreglak for critical reading of the manuscript. The University of California, San Francisco, Center for Advanced Technology and Nikon Imaging Center provided technical support. We thank C. Policarpi for assistance in strain construction and pilot ribosome profiling experiments, G. Brar for sharing unpublished ribosome profiling data, P. Walter for use of the Su9-TagBFP plasmid, and J. Horst for assistance with anaerobic growth conditions and equipment. This research was supported by the Center for RNA Systems Biology and the Howard Hughes Medical Institute. C. C. W. is an NSF Graduate Research Fellow. C. H. J. is the Rebecca Ridley Kry Fellow of the Damon Runyon Cancer Research Foundation (DRG-2085-11). Data are deposited in Gene Expression Omnibus under accession nos. GSE61011 and GSE61012.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Enomoto K, 2002, FEMS MICROBIOL LETT, V215, P103; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Liu ZH, 2013, APPL ENVIRON MICROB, V79, P2962, DOI 10.1128/AEM.03207-12; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Muratsubaki H, 1998, ARCH BIOCHEM BIOPHYS, V352, P175, DOI 10.1006/abbi.1998.0583; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; SUISSA M, 1982, J BIOL CHEM, V257, P3048; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	27	212	215	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					748	751		10.1126/science.1257522	http://dx.doi.org/10.1126/science.1257522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378625	Green Accepted			2022-12-01	WOS:000344690100041
J	Buckley, CD; Tan, JY; Anderson, KL; Hanein, D; Volkmann, N; Weis, WI; Nelson, WJ; Dunn, AR				Buckley, Craig D.; Tan, Jiongyi; Anderson, Karen L.; Hanein, Dorit; Volkmann, Niels; Weis, William I.; Nelson, W. James; Dunn, Alexander R.			The minimal cadherin-catenin complex binds to actin filaments under force	SCIENCE			English	Article							CELL-ADHESION MOLECULES; ALPHA-E-CATENIN; BETA-CATENIN; CATCH BONDS; ADHERENS JUNCTIONS; F-ACTIN; SLIP BONDS; VINCULIN; PROTEIN; DISSOCIATION	Linkage between the adherens junction (AJ) and the actin cytoskeleton is required for tissue development and homeostasis. In vivo findings indicated that the AJ proteins E-cadherin, beta-catenin, and the filamentous (F)-actin binding protein alpha E-catenin form a minimal cadherin-catenin complex that binds directly to F-actin. Biochemical studies challenged this model because the purified cadherin-catenin complex does not bind F-actin in solution. Here, we reconciled this difference. Using an optical trap-based assay, we showed that the minimal cadherin-catenin complex formed stable bonds with an actin filament under force. Bond dissociation kinetics can be explained by a catch-bond model in which force shifts the bond from a weakly to a strongly bound state. These results may explain how the cadherin-catenin complex transduces mechanical forces at cell-cell junctions.	[Buckley, Craig D.; Dunn, Alexander R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Tan, Jiongyi; Weis, William I.; Dunn, Alexander R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Anderson, Karen L.; Hanein, Dorit; Volkmann, Niels] Sanford Burnham Med Res Inst, Bioinformat & Struct Syst Biol Program, La Jolla, CA 92037 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Weis, William I.; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Dunn, Alexander R.] Stanford Univ, Stanford Cardiovascular Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Stanford University; Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	bill.weis@stanford.edu; wjnelson@stanford.edu; alex.dunn@stanford.edu	Weis, William/G-1437-2011	Weis, William/0000-0002-5583-6150	NSF; Stanford Bio-X predoctoral fellowships; Burroughs Wellcome Career Award at the Scientific Interface; NSF [EFRI 1136790]; NIH [1DP2OD007078, GM35527, GM56169, P01GM098412, UO1GM094663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R01GM056169, T32GM008294, U01GM094663, P01GM098412, R37GM035527] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007078] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Stanford Bio-X predoctoral fellowships; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank S. Pokutta, J. Bianchini, and P. Miller for help with protein purification and biochemistry. C. D. B. thanks J. Sung and S. Nag for assistance with optical trapping instrumentation. D. H. and N.V. thank W. Ochoa, M. Rodriguez Lee, and C. Page for their contribution to the study, and H. Freeze and F. Levine for advice and discussion. The data reported in this paper are further detailed in the supplementary materials. This work was supported by NSF predoctoral fellowships (C. D. B. and J. T.), Stanford Bio-X predoctoral fellowships (C. D. B. and J. T.), a Burroughs Wellcome Career Award at the Scientific Interface (A. R. D.), the NSF (EFRI 1136790 to W. I. W., W.J.N., and A. R. D.), and the NIH (New Innovator Award 1DP2OD007078 to A. R. D., GM35527 to W.J.N., GM56169 to W. I. W., P01GM098412 to D. H. and N.V., and UO1GM094663 to W.J.N., W. I. W., D. H., and N.V.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; Bartolo D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051910; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Chakrabarti S, 2014, P NATL ACAD SCI USA, V111, P9048, DOI 10.1073/pnas.1405384111; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Clobes AM, 2014, J MUSCLE RES CELL M, V35, P143, DOI 10.1007/s10974-014-9375-z; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Janssens B, 2001, J CELL SCI, V114, P3177; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Manibog K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4941; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	52	354	356	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		600	+	1254211	10.1126/science.1254211	http://dx.doi.org/10.1126/science.1254211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359979	Green Accepted			2022-12-01	WOS:000343799700039
J	Xiong, FZ; Ma, WZ; Hiscock, TW; Mosaliganti, KR; Tentner, AR; Brakke, KA; Rannou, N; Gelas, A; Souhait, L; Swinburne, IA; Obholzer, ND; Megason, SG				Xiong, Fengzhu; Ma, Wenzhe; Hiscock, Tom W.; Mosaliganti, Kishore R.; Tentner, Andrea R.; Brakke, Kenneth A.; Rannou, Nicolas; Gelas, Arnaud; Souhait, Lydie; Swinburne, Ian A.; Obholzer, Nikolaus D.; Megason, Sean G.			Interplay of Cell Shape and Division Orientation Promotes Robust Morphogenesis of Developing Epithelia	CELL			English	Article							TISSUE MORPHOGENESIS; CLEAVAGE PLANE; EMBRYONIC-DEVELOPMENT; ENVELOPING LAYER; ZEBRAFISH; MICROSCOPY; DROSOPHILA; POLARITY; ADHESION; DOMAINS	Epithelial cells acquire functionally important shapes (e.g., squamous, cuboidal, columnar) during development. Here, we combine theory, quantitative imaging, and perturbations to analyze how tissue geometry, cell divisions, and mechanics interact to shape the presumptive enveloping layer (pre-EVL) on the zebrafish embryonic surface. We find that, under geometrical constraints, pre-EVL flattening is regulated by surface cell number changes following differentially oriented cell divisions. The division pattern is, in turn, determined by the cell shape distribution, which forms under geometrical constraints by cell-cell mechanical coupling. An integrated mathematical model of this shape-division feedback loop recapitulates empirical observations. Surprisingly, the model predicts that cell shape is robust to changes of tissue surface area, cell volume, and cell number, which we confirm in vivo. Further simulations and perturbations suggest the parameter linking cell shape and division orientation contributes to epithelial diversity. Together, our work identifies an evolvable design logic that enables robust cell-level regulation of tissue-level development.	[Xiong, Fengzhu; Ma, Wenzhe; Hiscock, Tom W.; Mosaliganti, Kishore R.; Tentner, Andrea R.; Rannou, Nicolas; Gelas, Arnaud; Souhait, Lydie; Swinburne, Ian A.; Obholzer, Nikolaus D.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Brakke, Kenneth A.] Susquehanna Univ, Dept Math, Selinsgrove, PA 17870 USA	Harvard University; Harvard Medical School; Susquehanna University	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	megason@hms.harvard.edu	Ma, Wenzhe/N-3320-2017; XIONG, FENGZHU/A-9590-2015	XIONG, FENGZHU/0000-0002-6153-0254; Hiscock, Tom/0000-0002-0319-8679	NIH [HG004071, DC010791, GM026875, 5F32HL097599]; Hearing Health Foundation Emerging Research Grant; Novartis Fellowship in Systems Biology; Biological Sciences in Dental Medicine at Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097599] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875, R37GM026875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation Emerging Research Grant; Novartis Fellowship in Systems Biology; Biological Sciences in Dental Medicine at Harvard University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. D'India for fish care. H. Otsuna, M. Wuhr, J. Zhang, K. Ishihara, M. Yajima, C. Heisenberg, P. Keller, N. Papalopulu, T. Mitchison, M. Kirschner, R. Ward, and the S. G. M. laboratory members for reagents, communications, and comments. This work is supported by NIH grants HG004071, DC010791, and GM026875. I. A. S. acknowledges NIH fellowship 5F32HL097599, a Hearing Health Foundation Emerging Research Grant, and a Novartis Fellowship in Systems Biology. F. X. is also supported by the graduate program of Biological Sciences in Dental Medicine at Harvard University.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brakke K., 1992, EXP MATH, V1, P141, DOI [DOI 10.1080/10586458.1992.10504253, 10.1080/10586458.1992.10504253]; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Deramaudt T, 2005, BBA-REV CANCER, V1756, P97, DOI 10.1016/j.bbcan.2005.08.003; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; FANKHAUSER G, 1945, J EXP ZOOL, V100, P445, DOI 10.1002/jez.1401000310; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Galli M, 2008, ANNU REV GENET, V42, P389, DOI 10.1146/annurev.genet.40.110405.090523; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Herbst E.C., 2002, THESIS U N CAROLINA; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; HO RK, 1992, DEVELOPMENT, P65; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KIMMEL CB, 1985, DEV BIOL, V108, P78, DOI 10.1016/0012-1606(85)90010-7; Kolega J., 1986, P103; Krens SFG, 2011, P NATL ACAD SCI USA, V108, pE9, DOI 10.1073/pnas.1010767108; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Megason SG, 2011, CURR OPIN GENET DEV, V21, P519, DOI 10.1016/j.gde.2011.09.012; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; Rebollo E, 2009, DEVELOPMENT, V136, P3393, DOI 10.1242/dev.041822; Sagerstrom CG, 2005, DEV DYNAM, V232, P85, DOI 10.1002/dvdy.20198; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOLPERT L, 1961, EXP CELL RES, V25, P374, DOI 10.1016/0014-4827(61)90287-7; Wray Gregory A., 1997, P309; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Zhang J, 2011, DEV GROWTH DIFFER, V53, P679, DOI 10.1111/j.1440-169X.2011.01275.x	64	73	73	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					415	427		10.1016/j.cell.2014.09.007	http://dx.doi.org/10.1016/j.cell.2014.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303534	Bronze, Green Accepted			2022-12-01	WOS:000343095600021
J	Suzman, R; Beard, JR; Boerma, T; Chatterji, S				Suzman, Richard; Beard, John R.; Boerma, Ties; Chatterji, Somnath			Health in an ageing world-what do we know?	LANCET			English	Editorial Material									[Suzman, Richard] NIA, Div Behav & Social Res, NIH, Bethesda, MD 20892 USA; [Beard, John R.] WHO, Dept Ageing & Life Course, CH-1211 Geneva, Switzerland; [Boerma, Ties; Chatterji, Somnath] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); World Health Organization; World Health Organization	Chatterji, S (corresponding author), WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.	chatterjis@who.int	CHATTERJI, Somnath/ABE-6832-2020; Beard, John/AAP-5388-2021; Beard, John/AAI-4592-2021	Beard, John/0000-0002-8557-0242	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Beard J.R., 2014, LANCET; Bloom DE, 2014, LANCET; Chatterji S, 2014, LANCET; Mathers C. D., 2014, LANCET; Miret M, BULL WHO IN PRESS; National Institute on Aging, 2013, PSYCH SCI BEH EC SER; National Research Council, 2013, SUBJECTIVE WELL BEIN; National Research Council, 2010, ACC HLTH HLTH CARE A; Prince MJ, 2014, LANCET; Steptoe A, 2014, LANCET; UN Department of Economic and Social Affairs Population Division., WORLD POP PROSP MED; WHO, 2014, WHO STUD GLOB AGEING; World Economic Forum World Health Organization, 2011, WORKING PAPER SERIES	13	167	171	3	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					484	+		10.1016/S0140-6736(14)61597-X	http://dx.doi.org/10.1016/S0140-6736(14)61597-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468156				2022-12-01	WOS:000349213600006
J	Freudenthal, BD; Beard, WA; Perera, L; Shock, DD; Kim, T; Schlick, T; Wilson, SH				Freudenthal, Bret D.; Beard, William A.; Perera, Lalith; Shock, David D.; Kim, Taejin; Schlick, Tamar; Wilson, Samuel H.			Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide	NATURE			English	Article							EMPIRICAL FORCE-FIELD; BASE EXCISION-REPAIR; MOLECULAR-DYNAMICS; OXIDATIVE STRESS; KINETIC-ANALYSIS; STRUCTURAL BASIS; NUCLEIC-ACIDS; DNA; BETA; TARGET	Oxidative stress promotes genomic instability and humandiseases(1). A common oxidized nucleoside is 8-oxo-7,8-dihydro-2'-deoxyguanosine, which is found both in DNA (8-oxo-G) and as a free nucleotide (8-oxo- dGTP)(2,3). Nucleotide pools are especially vulnerable to oxidative damage(4). Therefore cells encodeanenzyme(MutT/MTH1) that removes free oxidized nucleotides. This cleansing function is required for cancer cell survival(5,6) and to modulate Escherichia coli antibiotic sensitivity in a DNA polymerase (pol)-dependent manner(7). How polymerases discriminate between damaged and non-damaged nucleotides is not well understood. This analysis is essential given the role of oxidized nucleotides in mutagenesis, cancer therapeutics, and bacterial antibiotics(8). Even with cellular sanitizing activities, nucleotide pools contain enough 8-oxo-dGTP to promote mutagenesis(9,10). This arises from the dual coding potential where 8-oxo-dGTP(anti) base pairs with cytosine and 8-oxo-dGTP(syn) uses its Hoogsteen edge to base pair with adenine(11). Here we use time-lapse crystallography to follow 8-oxo-dGTP insertion opposite adenine or cytosine with human pol beta, to reveal that insertion is accommodated in either the syn-oranti-conformation, respectively. For 8-oxo-dGTP(anti) insertion, a novel divalent metal relieves repulsive interactions between the adducted guanine base and the triphosphate of the oxidized nucleotide. With either templating base, hydrogen-bonding interactions between the bases are lost as the enzyme reopens after catalysis, leading to a cytotoxic nicked DNA repair intermediate. Combining structural snapshots with kinetic and computational analysis reveals how 8-oxo-dGTP uses charge modulation during insertion that can lead to a blocked DNA repair intermediate.	[Freudenthal, Bret D.; Beard, William A.; Perera, Lalith; Shock, David D.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kim, Taejin; Schlick, Tamar] NYU, Dept Chem, New York, NY 10003 USA; [Kim, Taejin; Schlick, Tamar] NYU Shanghai, NYU ECNU Ctr Computat Chem, New York, NY 10003 USA; [Kim, Taejin; Schlick, Tamar] NYU, Courant Inst Math Sci, New York, NY 10012 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); New York University; New York University	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	perera, Lalith/B-6879-2012; Wilson, Samuel H/E-6644-2019; Perera, Lalith/ABB-9995-2021	perera, Lalith/0000-0003-0823-1631; Wilson, Samuel H/0000-0002-1702-5293; Schlick, Tamar/0000-0002-2392-2062	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-E5050158, Z01-ES050161, ZIC-ES043010]; National Institutes of Health [1U19CA105010]; Philip Morris USA Inc.; Philip Morris International; NATIONAL CANCER INSTITUTE [U19CA177547, U19CA105010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158, Z01ES050161, ZICES043010] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc.; Philip Morris International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the Collaborative Crystallography group at the National Institute of Environmental Health Sciences for help with data collection and analysis. We thank L. Pedersen for discussions. Use of the advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (project numbers Z01-E5050158 (to SW.), Z01-ES050161 (to S.W.), and ZIC-ES043010 (to L.P.)) and in association with National Institutes of Health grant 1U19CA105010. We are grateful for computational support for the molecular dynamics simulations from the HPC clusters at NYU as well as the Blue Gene at CCNI. Support from Philip Morris USA Inc. and Philip Morris International to T.S. is gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; [Anonymous], 2010, AXPYMOL MOL GRAPH PL, V1.0; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown JA, 2007, J MOL BIOL, V367, P1258, DOI 10.1016/j.jmb.2007.01.069; Cabelof DC, 2002, CARCINOGENESIS, V23, P1419, DOI 10.1093/carcin/23.9.1419; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Eckenroth BE, 2014, BIOCHEMISTRY-US, V53, P2075, DOI 10.1021/bi500270e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2013, NUCLEIC ACIDS RES, V41, P1848, DOI 10.1093/nar/gks1276; Frisch M. J., 2010, GAUSSIAN 09 REVISION; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Koag MC, 2014, J BIOL CHEM, V289, P6289, DOI 10.1074/jbc.M113.537803; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miller H, 2000, BIOCHEMISTRY-US, V39, P1029, DOI 10.1021/bi991789x; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Wang YL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-7; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906	48	111	111	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					635	U261		10.1038/nature13886	http://dx.doi.org/10.1038/nature13886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25409153	Green Accepted, Green Submitted			2022-12-01	WOS:000348775000048
J	Kortepeter, MG; Smith, PW; Hewlett, A; Cieslak, TJ				Kortepeter, Mark G.; Smith, Philip W.; Hewlett, Angela; Cieslak, Theodore J.			Caring for Patients With Ebola: A Challenge in Any Care Facility	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS; UNIT		[Kortepeter, Mark G.] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Smith, Philip W.; Hewlett, Angela] Univ Nebraska Med Ctr, Div Infect Dis, Biocontainment Unit, Omaha, NE USA; [Cieslak, Theodore J.] San Antonio Mil Med Ctr, Dept Pediat, Ft Sam Houston, TX USA	Uniformed Services University of the Health Sciences - USA; University of Nebraska System; University of Nebraska Medical Center; San Antonio Military Medical Center	Kortepeter, MG (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.							Armstrong LR, 1999, INFECT CONT HOSP EP, V20, P176, DOI 10.1086/501607; Centers for Disease Control and Prevention, 2014, INFECT PREV CONTR RE; Centers for Disease Control and Prevention; Assistant Secretary of Preparedness and Response, HLTH CAR PROV PREP C; Fischer WA, 2014, ANN INTERN MED, V161, P753, DOI 10.7326/M14-1953; Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Smith PW, 2006, BIOSECUR BIOTERROR, V4, P351, DOI 10.1089/bsp.2006.4.351	6	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					68	U112		10.7326/M14-2289	http://dx.doi.org/10.7326/M14-2289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25320965				2022-12-01	WOS:000350103000010
J	Mizuguchi, T; Fudenberg, G; Mehta, S; Belton, JM; Taneja, N; Folco, HD; FitzGerald, P; Dekker, J; Mirny, L; Barrowman, J; Grewal, SIS				Mizuguchi, Takeshi; Fudenberg, Geoffrey; Mehta, Sameet; Belton, Jon-Matthew; Taneja, Nitika; Folco, Hernan Diego; FitzGerald, Peter; Dekker, Job; Mirny, Leonid; Barrowman, Jemima; Grewal, Shiv I. S.			Cohesin-dependent globules and heterochromatin shape 3D genome architecture in S. pombe	NATURE			English	Article							FISSION YEAST CHROMOSOMES; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; CHROMATIN INTERACTIONS; DROSOPHILA GENOME; HI-C; ORGANIZATION; CENTROMERES; PRINCIPLES; DOMAINS	Eukaryotic genomes are folded into three-dimensional structures, such as self-associating topological domains, the borders of which are enriched in cohesin and CCCTC-binding factor (CTCF) required for long-range interactions(1-7). How local chromatin interactions govern higher-order folding of chromatin fibres and the function of cohesin in this process remain poorly understood. Here we perform genome-wide chromatin conformation capture (Hi-C) analysis(8) to explore the high-resolution organization of the Schizosaccharomyces pombe genome, which despite its small size exhibits fundamental features found in other eukaryotes(9). Our analyses of wild-type and mutant strains reveal key elements of chromosome architecture and genome organization. On chromosome arms, small regions of chromatin locally interact to form 'globules'. This feature requires a function of cohesin distinct from its role in sister chromatid cohesion. Cohesin is enriched at globule boundaries and its loss causes disruption of local globule structures and global chromosome territories. By contrast, heterochromatin, which loads cohesin at specific sites including pericentromeric and subtelomeric domains(9-11), is dispensable for globule formation but nevertheless affects genome organization. We show that heterochromatin mediates chromatin fibre compaction at centromeres and promotes prominent inter-arm interactions within centromere-proximal regions, providing structural constraints crucial for proper genome organization. Loss of heterochromatin relaxes constraints on chromosomes, causing an increase in intra-and inter-chromosomal interactions. Together, our analyses uncover fundamental genome folding principles that drive higher-order chromosome organization crucial for coordinating nuclear functions.	[Mizuguchi, Takeshi; Mehta, Sameet; Taneja, Nitika; Folco, Hernan Diego; Barrowman, Jemima; Grewal, Shiv I. S.] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA; [Fudenberg, Geoffrey; Mirny, Leonid] Harvard Univ, Grad Program Biophys, Boston, MA 02115 USA; [Fudenberg, Geoffrey; Mirny, Leonid] MIT, Dept Phys, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Belton, Jon-Matthew; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [FitzGerald, Peter] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	TANEJA, NITIKA/T-5633-2017; Mehta, Sameet/A-1936-2011; Mirny, Leonid/ABE-8083-2020; TANEJA, NITIKA/AAY-8446-2021	TANEJA, NITIKA/0000-0002-5513-5282; Mehta, Sameet/0000-0002-3029-3217; Mirny, Leonid/0000-0002-0785-5410; TANEJA, NITIKA/0000-0002-5513-5282; Fudenberg, Geoffrey/0000-0001-5905-6517; Grewal, Shiv/0000-0002-4552-9261	National Institutes of Health, National Cancer Institute; NHGRI [HG003143]; NCI Physical Sciences-Oncology Center at MIT [U54CA143874]; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523, U54CA143874] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI Physical Sciences-Oncology Center at MIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Y. Watanabe and M. Yanagida for strains, M. Zofall for contributions, and A. Kelly for comments. This study used the Helix Systems and the Biowulf Linux cluster at the National Institutes of Health. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and by a grant from NHGRI (HG003143) to J.D. The work of G.F. and L.M is supported by NCI Physical Sciences-Oncology Center at MIT (U54CA143874).	Alfredsson-Timmins J, 2007, J CELL SCI, V120, P1935, DOI 10.1242/jcs.03457; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Gard S, 2009, J CELL BIOL, V187, P455, DOI 10.1083/jcb.200906075; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Molnar M, 2008, GENETICS, V178, P99, DOI 10.1534/genetics.107.082826; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Renauld H, 1997, TRENDS CELL BIOL, V7, P201, DOI 10.1016/S0962-8924(97)01034-9; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	35	166	169	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					432	+		10.1038/nature13833	http://dx.doi.org/10.1038/nature13833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25307058	Green Accepted, Green Submitted			2022-12-01	WOS:000346484800055
J	Fonville, JM; Wilks, SH; James, SL; Fox, A; Ventresca, M; Aban, M; Xue, L; Jones, TC; Le, NMH; Pham, QT; Tran, ND; Wong, Y; Mosterin, A; Katzelnick, LC; Labonte, D; Le, TT; van der Net, G; Skepner, E; Russell, CA; Kaplan, TD; Rimmelzwaan, GF; Masurel, N; de Jong, JC; Palache, A; Beyer, WEP; Le, QM; Nguyen, TH; Wertheim, HFL; Hurt, AC; Osterhaus, ADME; Barr, IG; Fouchier, RAM; Horby, PW; Smith, DJ				Fonville, J. M.; Wilks, S. H.; James, S. L.; Fox, A.; Ventresca, M.; Aban, M.; Xue, L.; Jones, T. C.; Le, N. M. H.; Pham, Q. T.; Tran, N. D.; Wong, Y.; Mosterin, A.; Katzelnick, L. C.; Labonte, D.; Le, T. T.; van der Net, G.; Skepner, E.; Russell, C. A.; Kaplan, T. D.; Rimmelzwaan, G. F.; Masurel, N.; de Jong, J. C.; Palache, A.; Beyer, W. E. P.; Le, Q. M.; Nguyen, T. H.; Wertheim, H. F. L.; Hurt, A. C.; Osterhaus, A. D. M. E.; Barr, I. G.; Fouchier, R. A. M.; Horby, P. W.; Smith, D. J.			Antibody landscapes after influenza virus infection or vaccination	SCIENCE			English	Article							ORIGINAL ANTIGENIC SIN	We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.	[Fonville, J. M.; Wilks, S. H.; James, S. L.; Ventresca, M.; Jones, T. C.; Mosterin, A.; Katzelnick, L. C.; Skepner, E.; Smith, D. J.] Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge CB2 3EJ, England; [Fonville, J. M.; Wilks, S. H.; James, S. L.; Jones, T. C.; Mosterin, A.; Katzelnick, L. C.; Skepner, E.; Russell, C. A.; Smith, D. J.] World Hlth Org WHO Collaborating Ctr Modeling Evo, Cambridge CB2 3EJ, England; [Fonville, J. M.; van der Net, G.; Rimmelzwaan, G. F.; Masurel, N.; de Jong, J. C.; Beyer, W. E. P.; Osterhaus, A. D. M. E.; Fouchier, R. A. M.; Smith, D. J.] Erasmus MC, Dept Virosci, NL-3015 CE Rotterdam, Netherlands; [Fox, A.; Le, N. M. H.; Wertheim, H. F. L.; Horby, P. W.] Oxford Univ Clin Res Unit, Hanoi, Vietnam; [Fox, A.; Le, N. M. H.; Wertheim, H. F. L.; Horby, P. W.] Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Aban, M.; Xue, L.; Hurt, A. C.; Barr, I. G.] Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia; [Pham, Q. T.; Tran, N. D.; Le, T. T.; Le, Q. M.; Nguyen, T. H.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Wong, Y.] Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England; [Labonte, D.] Univ Cambridge, Dept Zool, Insect Biomech Grp, Cambridge CB2 3EJ, England; [Russell, C. A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Kaplan, T. D.] Bobblewire Com, St Louis, MO 63112 USA; [Palache, A.] Abbott Labs, NL-1380 DA Weesp, Netherlands; [Wertheim, H. F. L.; Horby, P. W.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Hurt, A. C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3010, Australia	University of Cambridge; World Health Organization; Erasmus University Rotterdam; Erasmus MC; Victorian Infectious Diseases Reference Laboratory; World Health Organization; National Institute of Hygiene & Epidemiology (NIHE); University of Oxford; University of Cambridge; University of Cambridge; University of Oxford; University of Melbourne	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Russell, Colin/ABE-7106-2020; Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014; Wertheim, Heiman FL/F-3338-2016	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Wertheim, Heiman FL/0000-0002-5003-5565; Fox, Annette/0000-0002-0565-7146; Horby, Peter/0000-0002-9822-1586; Labonte, David/0000-0002-1952-8732; Barr, Ian/0000-0002-7351-418X; Hurt, Aeron/0000-0003-1826-4314; Russell, Colin/0000-0002-2113-162X; James, Sarah/0000-0002-6969-1167; Wong, Yan/0000-0002-3536-6411	Medical Research Council Fellowship [MR/K021885/1]; Homerton College; Gates-Cambridge Scholarship; NIH Oxford-Cambridge Scholars program; Royal Society University Research Fellowship [RG55423]; National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts [HHSN266200700010C, HHSN272201400008C]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant [91896613]; European Union [223498, 278976]; Human Frontier Science Program grant [P0050/2008]; Wellcome Trust [WT087982MA]; NIH Director's Pioneer Award [DP1-OD000490-01]; Australian government Department of Health; MRC [MR/K021885/1] Funding Source: UKRI; Medical Research Council [MR/K021885/1] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	Medical Research Council Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Homerton College; Gates-Cambridge Scholarship; NIH Oxford-Cambridge Scholars program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research Fellowship(Royal Society of London); National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts; Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant; European Union(European Commission); Human Frontier Science Program grant(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian government Department of Health(Australian GovernmentDepartment of Health & Ageing); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Bodewes, J. Bryant, D. Burke, N. Lewis, E. Selkov, B. Muhlemann, G. de Mutsert, and F. Pistoor. We also thank the staff of the Ha Nam Provincial Preventive Medicine Centre, the Hamlet health workers, and the National Institute for Hygiene and Epidemiology, Vietnam, for their support in conducting the fieldwork. We are indebted to the cooperation of the Ha Nam cohort and vaccine study participants. J.M.F. is supported by a Medical Research Council Fellowship (MR/K021885/1) and a Junior Research Fellowship from Homerton College, L. C. K. by the Gates-Cambridge Scholarship and the NIH Oxford-Cambridge Scholars program, and C. A. R. by a Royal Society University Research Fellowship (RG55423). We acknowledge the National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts HHSN266200700010C and HHSN272201400008C, Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant 91896613, the European Union FP7 programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science Program grant P0050/2008, the Wellcome Trust (WT087982MA), and NIH Director's Pioneer Award DP1-OD000490-01. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian government Department of Health. A.D.M.E.O. (as Chief Scientific Officer of Viroclinics Biosciences BV) has advisory affiliations with GlaxoSmithKline, Novartis, and Roche. Sequences of the influenza viruses used in this study are available in GenBank with accession numbers: KM821278 to KM821358. Erasmus Medical Center (Rotterdam, the Netherlands) requires a materials transfer agreement for sharing viruses and antisera.	Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; DAVENPORT FM, 1955, LANCET, V2, P469; DAVENPORT FM, 1956, J EXP MED, V104, P85, DOI 10.1084/jem.104.1.85; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; FRANCIS T, 1947, AM J PUBLIC HEALTH, V37, P1013, DOI 10.2105/AJPH.37.8.1013; Francis T., 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; HENNESSY AV, 1955, J IMMUNOL, V75, P401; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Horsfall FL, 1941, J EXP MED, V74, P433, DOI 10.1084/jem.74.5.433; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; O'Donnell CD, 2014, CLIN VACCINE IMMUNOL, V21, P737, DOI 10.1128/CVI.00790-13; Pan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023910; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	25	241	244	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					996	1000		10.1126/science.1256427	http://dx.doi.org/10.1126/science.1256427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414313	Green Accepted, Green Submitted			2022-12-01	WOS:000345696000044
J	Saini, P; Loke, YK; Gamble, C; Altman, DG; Williamson, PR; Kirkham, JJ				Saini, Pooja; Loke, Yoon K.; Gamble, Carrol; Altman, Douglas G.; Williamson, Paula R.; Kirkham, Jamie J.			Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; IMPACT	Objective To determine the extent and nature of selective non-reporting of harm outcomes in clinical studies that were eligible for inclusion in a cohort of systematic reviews. Design Cohort study of systematic reviews from two databases. Setting Outcome reporting bias in trials for harm outcomes (ORBIT II) in systematic reviews from the Cochrane Library and a separate cohort of systematic reviews of adverse events. Participants 92 systematic reviews of randomised controlled trials and non-randomised studies published in the Cochrane Library between issue 9, 2012 and issue 2, 2013 (Cochrane cohort) and 230 systematic reviews published between 1 January 2007 and 31 December 2011 in other publications, synthesising data on harm outcomes (adverse event cohort). Methods A 13 point classification system for missing outcome data on harm was developed and applied to the studies. Results 86% (79/92) of reviews in the Cochrane cohort did not include full data from the main harm outcome of interest of each review for all of the eligible studies included within that review; 76% (173/230) for the adverse event cohort. Overall, the single primary harm outcome was inadequately reported in 76% (705/931) of the studies included in the 92 reviews from the Cochrane cohort and not reported in 47% (4159/8837) of the 230 reviews in the adverse event cohort. In a sample of primary studies not reporting on the single primary harm outcome in the review, scrutiny of the study publication revealed that outcome reporting bias was suspected in nearly two thirds (63%, 248/393). Conclusions The number of reviews suspected of outcome reporting bias as a result of missing or partially reported harm related outcomes from at least one eligible study is high. The declaration of important harms and the quality of the reporting of harm outcomes must be improved in both primary studies and systematic reviews.	[Saini, Pooja] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GA, Merseyside, England; [Loke, Yoon K.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Gamble, Carrol; Williamson, Paula R.; Kirkham, Jamie J.] Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Liverpool; University of East Anglia; University of Liverpool; University of Oxford	Kirkham, JJ (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3GA, Merseyside, England.	jjk@liv.ac.uk	Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016; Kirkham, Jamie/AAD-4490-2019	Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Kirkham, Jamie/0000-0003-2579-9325; Saini, Pooja/0000-0002-4981-7914	Medical Research Council [MR/J004855/1]; Cancer Research UL programme [C5529]; MRC [MR/J004855/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UL programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	The Outcome Reporting Bias In Trials (ORBIT II) project was funded by the Medical Research Council (grant No MR/J004855/1). DGA is supported by a Cancer Research UL programme grant (C5529). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Golder S, 2014, HEALTH INFO LIBR J, V31, P92, DOI 10.1111/hir.12041; Golder S, 2013, J CLIN EPIDEMIOL, V66, P253, DOI 10.1016/j.jclinepi.2012.09.013; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hodkinson A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003436; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zorzela L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7668	16	122	124	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 21	2014	349								g6501	10.1136/bmj.g6501	http://dx.doi.org/10.1136/bmj.g6501			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2KB	25416499	Green Published, hybrid			2022-12-01	WOS:000345446000001
J	Holmes, D				Holmes, David			THE CANCER THAT RISES WITH THE SUN	NATURE			English	Editorial Material																			0	30	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S110	S111		10.1038/515S110a	http://dx.doi.org/10.1038/515S110a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407705	Bronze			2022-12-01	WOS:000345770600001
J	Sczepanski, JT; Joyce, GF				Sczepanski, Jonathan T.; Joyce, Gerald F.			A cross-chiral RNA polymerase ribozyme	NATURE			English	Article							TEMPLATE; LIGATION; OLIGONUCLEOTIDES; POLYMERIZATION; EXTENSION; SELECTION; MODEL; ACID	Thirty years ago it was shown that the non-enzymatic, template-directed polymerization of activated mononudeotides proceeds readily in a homochiral system, but is severely inhibited by the presence of the opposing enantiomerl. This finding poses a severe challenge for the spontaneous emergence of RNA-based life, and has led to the suggestion that either RNA was preceded by some other genetic polymer that is not subject to chiral inhibition(2) or chiral symmetry was broken through chemical processes before the origin of RNA-based life(3,4). Once an RNA enzyme arose that could catalyse the polymerization of RNA, it would have been possible to distinguish among the two enantiomers, enabling RNA replication and RNA-based evolution to occur. It is commonly thought that the earliest RNA polymerase and its substrates would have been of the same handedness, but this is not necessarily the case. Replicating D- and L-RNA molecules may have emerged together, based on the ability of structured RNAs of one handedness to catalyse the templated polymerization of activated mononudeotides of the opposite handedness. Here we develop such a cross-chiral RNA polymerase, using in vitro evolution starting from a population of random-sequence RNAs. The El-RNA enzyme, consisting of 83 nucleotides, catalyses the joining of L-mono- or oligonudeotide substrates on a complementary L-RNA template, and similar behaviour occurs for the L-enzyme with El-substrates and a El-template. Chiral inhibition is avoided because the 10(6)-fold rate acceleration of the enzyme only pertains to cross-chiral substrates. The enzyme's activity is sufficient to generate full-length copies of its enantiomer through the templated joining of 11 component oligonudeotides.	[Sczepanski, Jonathan T.; Joyce, Gerald F.] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu	Sczepanski, Jonathan T/N-8719-2015; Sczepanski, Jonathan/AAC-8094-2021	Sczepanski, Jonathan T/0000-0002-9275-2597; Sczepanski, Jonathan/0000-0002-9275-2597	NASA [NNX10AQ91G]; Simons Foundation [287624]; National Institutes of Health [F32 GM101741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM101741] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); Simons Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant NNX10AQ91G from NASA and by grant 287624 from the Simons Foundation. J.T.S. was supported by Ruth L. Kirschstein National Research Service Award No. F32 GM101741 from the National Institutes of Health.	Adamala K, 2013, SCIENCE, V342, P1098, DOI 10.1126/science.1241888; ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; BOHLER C, 1995, NATURE, V376, P578, DOI 10.1038/376578a0; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Caton-Williams J., 2013, CURR PROTOC NUCL ACI, V52; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; Hein JE, 2011, NAT CHEM, V3, P704, DOI [10.1038/NCHEM.1108, 10.1038/nchem.1108]; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Klussmann M, 2006, NATURE, V441, P621, DOI 10.1038/nature04780; McGinness KE, 2002, CHEM BIOL, V9, P297, DOI 10.1016/S1074-5521(02)00110-2; Paul N, 2006, CHEM BIOL, V13, P329, DOI 10.1016/j.chembiol.2006.01.007; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	21	108	113	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					440	+		10.1038/nature13900	http://dx.doi.org/10.1038/nature13900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25363769	Green Accepted			2022-12-01	WOS:000345770600052
J	Lund, LH; Benson, L; Dahlstrom, U; Edner, M; Friberg, L				Lund, Lars H.; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus; Friberg, Leif			Association Between Use of beta-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYSTOLIC FUNCTION; PROPENSITY SCORE; CLINICAL EFFECTIVENESS; MORTALITY-RATES; OLDER PATIENTS; TASK-FORCE; HOSPITALIZATION; METAANALYSIS; CARVEDILOL	IMPORTANCE Heart failure with preserved ejection fraction (HFPEF) may be as common and may have similar mortality as heart failure with reduced ejection fraction (HFREF). beta-Blockers reduce mortality in HFREF but are inadequately studied in HFPEF. OBJECTIVE To test the hypothesis that beta-blockers are associated with reduced all-cause mortality in HFPEF. DESIGN Propensity score-matched cohort study using the Swedish Heart Failure Registry. Propensity scores for beta-blacker use were derived from 52 baseline clinical and socioeconomic variables. SETTING Nationwide registry of 67 hospitals with inpatient and outpatient units and 95 outpatient primary care clinics in Sweden with patients entered into the registry between July 1, 2005, and December 30, 2012, and followed up until December 31, 2012. PARTICIPANTS From a consecutive sample of 41 976 patients, 19 083 patients with HFPEF (mean [SD] age, 76 [12] years; 46% women). Of these, 8244 were matched 2:1 based on age and propensity score for beta-blocker use, yielding 5496 treated and 2748 untreated patients with HFPEF. Also we conducted a positive-control consistency analysis involving 22 893 patients with HFREF, of whom 6081 were matched yielding 4054 treated and 2027 untreated patients. EXPOSURES beta-Blockers prescribed at discharge from the hospital or during an outpatient visit, analyzed 2 ways: without consideration of crossover and per-protocol analysis with censoring at crossover, if applicable. MAIN OUTCOMES AND MEASURES The prespecified primary outcome was all-cause mortality and the secondary outcome was combined all-cause mortality or heart failure hospitalization. RESULTS Median follow-up in HFPEF was 755 days, overall; 709 days in the matched cohort; no patients were lost to follow-up. In the matched HFPEF cohort, 1-year survival was 80% vs 79% for treated vs untreated patients, and 5-year survival was 45% vs 42%, with 2279(41%) vs 1244(45%) total deaths and 177 vs 191 deaths per 1000 patient-years (hazard ratio [HR], 0.93; 95% Cl, 0.86-0.996; P =.04). beta-Blockers were not associated with reduced combined mortality or heart failure hospitalizations: 3368(61%) vs 1753(64%) total for first events, with 371 vs 378 first events per 1000 patient-years (HR, 0.98; 95% Cl, 0.92-1.04; P = .46). In the matched HFREF cohort, beta-blockers were associated with reduced mortality (HR, 0.89; 95% Cl, 0.82-0.97, P=.005) and also with reduced combined mortality or heart failure hospitalization (HR, 0.89; 95% Cl, 0.84-0.95; P =.001). CONCLUSIONS AND RELEVANCE In patients with HFPEF, use of beta-blockers was associated with lower all-cause mortality but not with combined all-cause mortality or heart failure hospitalization. beta-Blockers in HFPEF should be examined in a large randomized clinical trial.	[Lund, Lars H.; Edner, Magnus] Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden; [Lund, Lars H.] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden; [Benson, Lina] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Friberg, Leif] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Friberg, Leif] Danderyd Hosp, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Linkoping University; Linkoping University; Danderyds Hospital; Karolinska Institutet; Danderyds Hospital	Lund, LH (corresponding author), Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	Lars.Lund@alumni.duke.edu	Friberg, Leif/E-7941-2013	Friberg, Leif/0000-0002-7453-0157; Benson, Lina/0000-0002-5393-0055	Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation; Swedish Research Council [2013-23897-104604-23]; Swedish Heart Lung Foundation [20080409, 20100419]; Sockholm County Council [20090556, 20110120]	Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Sockholm County Council	The Swedish Heart Failure Registry is funded by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, and the Swedish Heart-Lung Foundation. This study was supported in part by grants 2013-23897-104604-23 from the Swedish Research Council, 20080409 and 20100419 from the Swedish Heart Lung Foundation, and 20090556 and 20110120 from the Sockholm County Council to Dr Lund's institution.	Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; Bergstrom A, 2004, EUR J HEART FAIL, V6, P453, DOI 10.1016/j.ejheart.2004.02.003; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chun S, 2012, CIRC-HEART FAIL, V5, P414, DOI 10.1161/CIRCHEARTFAILURE.111.964791; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dharmarajan K, 2013, JAMA INTERN MED, V173, P1547, DOI 10.1001/jamainternmed.2013.7717; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; El-Refai M, 2013, J CARD FAIL, V19, P73, DOI 10.1016/j.cardfail.2012.11.011; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090555; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lund LH, 2014, EUR J HEART FAIL, V16, P992, DOI 10.1002/ejhf.137; Lund LH, 2012, JAMA-J AM MED ASSOC, V308, P2108, DOI 10.1001/jama.2012.14785; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nevzorov R, 2012, EUR J INTERN MED, V23, P374, DOI 10.1016/j.ejim.2012.01.011; Patel K, 2014, INT J CARDIOL, V173, P393, DOI 10.1016/j.ijcard.2014.03.005; Patel K, 2012, EUR J HEART FAIL, V14, P1179, DOI 10.1093/eurjhf/hfs101; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Tavazzi L, 2013, CIRC-HEART FAIL, V6, P473, DOI 10.1161/CIRCHEARTFAILURE.112.000161; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Yamamoto K, 2013, EUR J HEART FAIL, V15, P110, DOI 10.1093/eurjhf/hfs141; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	37	106	108	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2008	2018		10.1001/jama.2014.15241	http://dx.doi.org/10.1001/jama.2014.15241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399276				2022-12-01	WOS:000345450500015
J	Choi, SH; Kim, YH; Hebisch, M; Sliwinski, C; Lee, S; D'Avanzo, C; Chen, HC; Hooli, B; Asselin, C; Muffat, J; Klee, JB; Zhang, C; Wainger, BJ; Peitz, M; Kovacs, DM; Woolf, CJ; Wagner, SL; Tanzi, RE; Kim, DY				Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias; Sliwinski, Christopher; Lee, Seungkyu; D'Avanzo, Carla; Chen, Hechao; Hooli, Basavaraj; Asselin, Caroline; Muffat, Julien; Klee, Justin B.; Zhang, Can; Wainger, Brian J.; Peitz, Michael; Kovacs, Dora M.; Woolf, Clifford J.; Wagner, Steven L.; Tanzi, Rudolph E.; Kim, Doo Yeon			A three-dimensional human neural cell culture model of Alzheimer's disease	NATURE			English	Article							TRANSGENIC MOUSE MODELS; AMYLOID HYPOTHESIS; A-BETA; TAU; PATHOLOGY; IPSCS	Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-beta plaques and neurofibrillary tangles(1). The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-beta peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau(2,3). However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-beta-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology(4,5). Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-beta species and phosphorylated tau but did not demonstrate amyloid-beta plaquesor neurofibrillary tangles(6-11). Here we report that FAD mutations in beta-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-beta, including amyloid-beta plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloidb beta generation with beta- or gamma-secretase inhibitors not only decreased amyloid-beta pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-beta-mediated tau phosphorylation. We have successfully recapitulated amyloid-beta and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.	[Choi, Se Hoon; Kim, Young Hye; Hebisch, Matthias; Sliwinski, Christopher; D'Avanzo, Carla; Chen, Hechao; Hooli, Basavaraj; Asselin, Caroline; Klee, Justin B.; Zhang, Can; Kovacs, Dora M.; Tanzi, Rudolph E.; Kim, Doo Yeon] Harvard Univ, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Genet & Aging Res Unit,Med Sch, Charlestown, MA 02129 USA; [Kim, Young Hye] Korea Basic Sci Inst, Div Mass Spectrometry Res, Cheongju 363883, Chungbuk, South Korea; [Hebisch, Matthias; Peitz, Michael] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Hebisch, Matthias; Peitz, Michael] Hertie Fdn, D-53127 Bonn, Germany; [Lee, Seungkyu; Wainger, Brian J.; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Lee, Seungkyu; Wainger, Brian J.; Woolf, Clifford J.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Muffat, Julien] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; Korea Basic Science Institute (KBSI); University of Bonn; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Diego	Kim, DY (corresponding author), Harvard Univ, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Genet & Aging Res Unit,Med Sch, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; dkim@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; Wainger, Brian/L-7553-2017; Peitz, Michael/AHB-0741-2022; Woolf, Clifford/A-9784-2010	Tanzi, Rudolph/0000-0002-7032-1454; Muffat, Julien/0000-0003-1889-7023; Lee, Seungkyu/0000-0002-1929-3320	Cure Alzheimer's fund; national Institute of Health grants [5P01AG15379, 5R37MH060009]; NIH/NINDS [P30NS04776]; IBDG Grant [DK43351]; BADERC Award [DK57521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776, R01NS045860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015379, P01AG004953, P50AG005134, RF1AG048080, R01AG014713, R21AG031483] Funding Source: NIH RePORTER	Cure Alzheimer's fund; national Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); IBDG Grant; BADERC Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the grants from the Cure Alzheimer's fund (D.Y.K., S.H.C. and R.E.T.) and national Institute of Health grants 5P01AG15379 (R.E.T.) and 5R37MH060009 (R.E.T.). We thank T. L. Spires, M. Polydoro and S. Wegmann for revising the manuscript, and M. L. McKee for the electron microscopy assistance. We also appreciate B. T. Hyman, O. Berezovska, J. Hardy and P. Davies for providing cDNAs and antibodies. We acknowledge Ragon Institute's Imaging Core facility (part of the Harvard CFAR Immunology Core), Massachusetts General Hospital (MGH) Viral Vector Core (supported by NIH/NINDS P30NS04776), MGH Microscopy Core of the Center for Systems Biology for immunoelectron microscopy (partially supported by an IBDG Grant DK43351 and a BADERC Award DK57521), MGH Confocal Microscope Core and MGH Pathology Core for technical and instrument support.	Chin J, 2011, METHODS MOL BIOL, V670, P169, DOI 10.1007/978-1-60761-744-0_13; Choi SH, 2012, CELL STEM CELL, V10, P235, DOI 10.1016/j.stem.2012.02.011; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; CRAS P, 1990, AM J PATHOL, V137, P241; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Duff K, 2001, BIOCHEM SOC SYMP, V67, P195; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jaworski T., 2003, NATURE, V423, P435; Julien C, 2012, METHODS MOL BIOL, V849, P473, DOI 10.1007/978-1-61779-551-0_32; Kirby LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039329; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee V. M.-Y., 2002, NEUROPSYCHOPHARMACOL, P1339; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Tang-Schomer M. D., 2014, P NATL ACAD SCI US; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Trojanowski JQ, 2002, MED CLIN N AM, V86, P615, DOI 10.1016/S0025-7125(02)00002-0; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	30	689	709	17	461	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					274	U293		10.1038/nature13800	http://dx.doi.org/10.1038/nature13800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25307057	Green Accepted, Green Submitted			2022-12-01	WOS:000344631400052
J	Lui, JH; Nowakowski, TJ; Pollen, AA; Javaherian, A; Kriegstein, AR; Oldham, MC				Lui, Jan H.; Nowakowski, Tomasz J.; Pollen, Alex A.; Javaherian, Ashkan; Kriegstein, Arnold R.; Oldham, Michael C.			Radial glia require PDGFD-PDGFR beta signalling in human but not mouse neocortex	NATURE			English	Article							RECEPTOR-BETA; EVOLUTION; TRANSCRIPTOME; GENE; BRAIN; ZONES	Evolutionary expansion of the human neocortex underlies many of our unique mental abilities. This expansion has been attributed to the increased proliferative potential(1,2) of radial glia (RG; neural stem cells) and their subventricular dispersion from the periventricular niche(3-5) during neocortical development. Such adaptations may have evolved through gene expression changes in RG. However, whether or how RG gene expression varies between humans and other species is unknown. Here we show that the transcriptional profiles of human and mouse neocortical RG are broadly conserved during neurogenesis, yet diverge for specific signalling pathways. By analysing differential gene co-expression relationships between the species, we demonstrate that the growth factor PDGFD is specifically expressed by RG inhuman, but not mouse, corticogenesis. We also show that the expression domain of PDGFR beta, the cognate receptor(6,7) for PDGFD, is evolutionarily divergent, with high expression in the germinal region of dorsal human neocortex but not in the mouse. Pharmacological inhibition of PDGFD-PDGFR beta signalling in slice culture prevents normal cell cycle progression of neocortical RG in human, but not mouse. Conversely, injection of recombinant PDGFD or ectopic expression of constitutively active PDGFR beta in developing mouse neocortex increases the proportion of RG and their subventricular dispersion. These findings highlight the requirement of PDGFD-PDGFR beta signalling for human neocortical development and suggest that local production of growth factors by RG supports the expanded germinal region and progenitor heterogeneity of species with large brains.	[Lui, Jan H.; Nowakowski, Tomasz J.; Pollen, Alex A.; Javaherian, Ashkan; Kriegstein, Arnold R.; Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lui, Jan H.; Nowakowski, Tomasz J.; Pollen, Alex A.; Javaherian, Ashkan; Kriegstein, Arnold R.; Oldham, Michael C.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Oldham, MC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	kriegsteina@stemcell.ucsf.edu; oldhamm@stemcell.ucsf.edu	Nowakowski, Tomasz/P-7731-2014	Nowakowski, Tomasz/0000-0003-2345-4964	NIH, NINDS; Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01153]; Damon Runyon Foundation Postdoctoral Fellowship [DRG-2013]; University of California San Francisco Program for Breakthrough Biomedical Research - Sandler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072630, R01NS021223, R01NS075998] Funding Source: NIH RePORTER	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship; Damon Runyon Foundation Postdoctoral Fellowship; University of California San Francisco Program for Breakthrough Biomedical Research - Sandler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at San Francisco General Hospital Women's Options Center for their consideration in allowing access to donated human prenatal tissue. We thank J. DeYoung and the staff at the Southern California Genotyping Consortium at the University of California Los Angeles for microarray data generation. We are grateful to A. Holloway for her critical reading of the manuscript, and also thank W. Walantus, S. Wang, Y. Wang and other University of California San Francisco personnel for technical and administrative support. We thank C. Stiles and D. Rowitch for the TEL-PDGFR beta construct. This work was supported by grants from the NIH, NINDS (A.R.K.), the Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship for J.H.L. (TG2-01153), a Damon Runyon Foundation Postdoctoral Fellowship for A.A.P. (DRG-2013), and the University of California San Francisco Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation (M.C.O.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the California Institute for Regenerative Medicine or any other agency of the State of California.	Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Magnusson PU, 2007, ARTERIOSCL THROM VAS, V27, P2142, DOI 10.1161/01.ATV.0000282198.60701.94; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Oldham MC, 2014, OMICS APPL NEUROSCIE, P85; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Roberts WG, 2005, CANCER RES, V65, P957; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	29	108	110	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					264	U258		10.1038/nature13973	http://dx.doi.org/10.1038/nature13973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391964	Green Accepted, Green Submitted			2022-12-01	WOS:000344631400050
J	Hawkes, N; Arie, S				Hawkes, Nigel; Arie, Sophie			EBOLA Is the United Nations catching up with Ebola at last?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2014, BBC; Chan M, 2014, COMMUNICATION   0808; Clarke Toni, 2014, REUTERS; Fink S., 2014, NY TIMES; Fortner R, 2014, WHAT OTHER GLOBAL HL; Masters S, 2014, INDEPENDENT SUN 1019; UN, 2014, TRUST FUND FACTSH; UN Office for the Coordination of Humanitarian Affairs, 2014, EB VIR DIS OUTBR OV; United Nations Mission for Ebola Emergency Response [UNMEER], 2014, EXT SIT REP; WHO, 2014, EB RESP ROAD MAP SIT; World Health Organization, 2014, WHO STAT M INT HLTH	11	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2014	349								g6576	10.1136/bmj.g6576	http://dx.doi.org/10.1136/bmj.g6576			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT0CD	25378433	Green Published, Bronze			2022-12-01	WOS:000344603700004
J	Smith, JG; Luk, K; Schulz, CA; Engert, JC; Do, R; Hindy, G; Rukh, G; Dufresne, L; Almgren, P; Owens, DS; Harris, TB; Peloso, GM; Kerr, KF; Wong, Q; Smith, AV; Budoff, MJ; Rotter, JI; Cupples, LA; Rich, S; Kathiresan, S; Orho-Melander, M; Gudnason, V; O'Donnell, CJ; Post, WS; Thanassoulis, G				Smith, J. Gustav; Luk, Kevin; Schulz, Christina-Alexandra; Engert, James C.; Do, Ron; Hindy, George; Rukh, Gull; Dufresne, Line; Almgren, Peter; Owens, David S.; Harris, Tamara B.; Peloso, Gina M.; Kerr, Kathleen F.; Wong, Quenna; Smith, Albert V.; Budoff, Matthew J.; Rotter, Jerome I.; Cupples, L. Adrienne; Rich, Stephen; Kathiresan, Sekar; Orho-Melander, Marju; Gudnason, Vilmundur; O'Donnell, Christopher J.; Post, Wendy S.; Thanassoulis, George		CHARGE Extracoronary	Association of Low-Density Lipoprotein Cholesterol-Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENDELIAN RANDOMIZATION; HEART-DISEASE; EARLY LESION; PROGRESSION; RISK; CALCIFICATION; DESIGN; LOCI	IMPORTANCE Plasma low-density lipoprotein cholesterol (LDL-C) has been associated with aortic stenosis in observational studies; however, randomized trials with cholesterol-lowering therapies in individuals with established valve disease have failed to demonstrate reduced disease progression. OBJECTIVE To evaluate whether genetic data are consistent with an association between LDL-C, high-density lipoprotein cholesterol (HDL-C), or triglycerides (TG) and aortic valve disease. DESIGN, SETTING, AND PARTICIPANTS Using a Mendelian randomization study design, we evaluated whether weighted genetic risk scores (GRSs), a measure of the genetic predisposition to elevations in plasma lipids, constructed using single-nucleotide polymorphisms identified in genome-wide association studies for plasma lipids, were associated with aortic valve disease. We included community-based cohorts participating in the CHARGE consortium (n = 6942), including the Framingham Heart Study (cohort inception to last follow-up: 1971-2013; n = 1295), Multi-Ethnic Study of Atherosclerosis (2000-2012; n = 2527), Age Gene/Environment Study-Reykjavik (2000-2012; n = 3120), and the Malmo Diet and Cancer Study (MDCS, 1991-2010; n = 28 461). MAIN OUTCOMES AND MEASURES Aortic valve calcium quantified by computed tomography in CHARGE and incident aortic stenosis in the MDCS. RESULTS The prevalence of aortic valve calcium across the 3 CHARGE cohorts was 32% (n = 2245). In the MDCS, over a median follow-up time of 16.1 years, aortic stenosis developed in 17 per 1000 participants (n = 473) and aortic valve replacement for aortic stenosis occurred in 7 per 1000 (n = 205). Plasma LDL-C, but not HDL-C or TG, was significantly associated with incident aortic stenosis (hazard ratio [HR] per mmol/L, 1.28; 95% CI, 1.04-1.57; P = .02; aortic stenosis incidence: 1.3% and 2.4% in lowest and highest LDL-C quartiles, respectively). The LDL-C GRS, but not HDL-C or TG GRS, was significantly associated with presence of aortic valve calcium in CHARGE (odds ratio [OR] per GRS increment, 1.38; 95% CI, 1.09-1.74; P = .007) and with incident aortic stenosis in MDCS (HR per GRS increment, 2.78; 95% CI, 1.22-6.37; P = .02; aortic stenosis incidence: 1.9% and 2.6% in lowest and highest GRS quartiles, respectively). In sensitivity analyses excluding variants weakly associated with HDL-C or TG, the LDL-C GRS remained associated with aortic valve calcium (P = .03) and aortic stenosis (P = .009). In instrumental variable analysis, LDL-C was associated with an increase in the risk of incident aortic stenosis (HR per mmol/L, 1.51; 95% CI, 1.07-2.14; P = .02). CONCLUSIONS AND RELEVANCE Genetic predisposition to elevated LDL-C was associated with presence of aortic valve calcium and incidence of aortic stenosis, providing evidence supportive of a causal association between LDL-C and aortic valve disease. Whether earlier intervention to reduce LDL-C could prevent aortic valve disease merits further investigation. Copyright 2014 American Medical Association. All rights reserved.	[Smith, J. Gustav] Lund Univ, Dept Cardiol, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Dept Heart Failure & Valvular Dis, Lund, Sweden; [Smith, J. Gustav; Schulz, Christina-Alexandra; Hindy, George; Rukh, Gull; Almgren, Peter; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Smith, J. Gustav; Peloso, Gina M.; Kathiresan, Sekar] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Luk, Kevin; Engert, James C.; Dufresne, Line; Thanassoulis, George] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Engert, James C.; Thanassoulis, George] Res Inst, Dept Med, Montreal, PQ H3A 1A1, Canada; [Smith, J. Gustav; Do, Ron; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Smith, J. Gustav; Do, Ron; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA USA; [Owens, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Harris, Tamara B.] NIA, Bethesda, MD 20892 USA; [Kerr, Kathleen F.; Wong, Quenna] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Budoff, Matthew J.; Rotter, Jerome I.] Harbor UCLA, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Cupples, L. Adrienne; O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Rich, Stephen] Univ Virginia, Charlottesville, VA USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Donnell, Christopher J.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Bethesda, MD 20892 USA; [Post, Wendy S.] Johns Hopkins Univ, Dept Internal Med, Div Cardiol, Baltimore, MD USA	Lund University; Lund University; Skane University Hospital; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Boston University; Framingham Heart Study; University of Virginia; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Thanassoulis, G (corresponding author), McGill Univ, Ctr Hlth, 687 Pine Ave W H4-55, Montreal, PQ H3A 1A1, Canada.	george.thanassoulis@mcgill.ca	Kerr, Kathleen F./A-2893-2013; Gudnason, Vilmundur/K-6885-2015; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Budoff, Matthew/ABD-5175-2021	Kerr, Kathleen F./0000-0002-6438-9583; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Budoff, Matthew/0000-0002-9616-1946; Rich, Stephen/0000-0003-3872-7793; Hindy, George/0000-0002-7257-9299; Owens, David/0000-0002-7293-9688; Cupples, L. Adrienne/0000-0003-0273-7965; Engert, James/0000-0001-8411-4790	Swedish Cancer Society; Swedish Medical Research Council; Swedish Dairy Association; Albert Pahlsson Foundation; Gunnar Nilsson Foundation; Malmo city council; Swedish Heart-Lung Foundation; Swedish National Health Service; Crafoord Foundation; Skane University Hospital; Thorsten Westerstrom Foundation; National Institute on Aging [N01-AG-12100]; National Eye Institute; National Institute on Deafness and Other Communication Disorders; National Heart, Lung, and Blood Institute (NHLBI); National Institute on Aging Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (Icelandic parliament); NHLBI [N02-HL-64278, UL1 RR024156, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259, N01-HC-25195]; American College of Cardiology Foundation/Merck Adult Cardiology Research Fellowship Award; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease Young Investigator Award; Clinician-Scientist Salary Award from the Fonds de la Recherche du Quebec-Sante; RI-MUHC/Merck Research Competition; Canadian Institutes of Health Research [MOP-119380, MOP-126033];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169];  [N01-HC-65226];  [R01 HL071739]; Novo Nordisk Fonden [NNF14OC0011049] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095166, N01HC095161, N01HC095163, N01HC095160, N01HC095164, N01HC095167, N01HC095169, N01HC095162, N01HC095165, N01HC095168, N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071259, R01HL065226, R01HL071252, R01HL064278, R01HL071250, T32HL007208, R01HL071739, ZIAHL006175, R01HL071251, ZIAHL006002, R01HL071051, R01HL071205, ZIAHL006173, R01HL071258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Dairy Association; Albert Pahlsson Foundation; Gunnar Nilsson Foundation; Malmo city council; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish National Health Service; Crafoord Foundation; Skane University Hospital; Thorsten Westerstrom Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (Icelandic parliament); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American College of Cardiology Foundation/Merck Adult Cardiology Research Fellowship Award; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease Young Investigator Award; Clinician-Scientist Salary Award from the Fonds de la Recherche du Quebec-Sante; RI-MUHC/Merck Research Competition; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; ; ; ; ; ; ; ; ; ; ; ; Novo Nordisk Fonden(Novo Nordisk Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Malmo Diet and Cancer study was supported by the Swedish Cancer Society, the Swedish Medical Research Council, the Swedish Dairy Association, the Albert Pahlsson and Gunnar Nilsson Foundations, and the Malmo city council. Dr J. G. Smith was supported by the Swedish Heart-Lung Foundation, governmental funding of clinical research within the Swedish National Health Service, the Crafoord Foundation, Skane University Hospital, and the Thorsten Westerstrom Foundation. The Age, Gene/Environment Susceptibility-Reykjavik Study was supported by a grant from the National Institute on Aging (N01-AG-12100) and by the National Eye Institute, the National Institute on Deafness and Other Communication Disorders, the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (Icelandic parliament). The MESA, MESA CARe, and the MESA SHARe project were supported by contracts N01-HC-95159 through 95169, N01-HC-65226, and N02-HL-64278 and grants from the NHLBI (UL1 RR024156, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259). Computed tomographic measures in MESA were supported by a grant to Dr Budoff (R01 HL071739). The Framingham Heart Study was supported by contracts from the NHLBI (N01-HC-25195, N02-HL-64278) with Affymetrix for genotyping services. Dr Kathiresan was supported by the American College of Cardiology Foundation/Merck Adult Cardiology Research Fellowship Award and the GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease Young Investigator Award. Dr Thanassoulis was supported by a Clinician-Scientist Salary Award from the Fonds de la Recherche du Quebec-Sante and operating grants from the RI-MUHC/Merck Research Competition and the Canadian Institutes of Health Research (MOP-119380 and MOP-126033).	Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HIRSCH D, 1993, CALCIFIED TISSUE INT, V52, P94, DOI 10.1007/BF00308315; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Owens DS, 2008, ARCH INTERN MED, V168, P1200, DOI 10.1001/archinte.168.11.1200; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rajamannan NM, 2003, NEW ENGL J MED, V349, P717, DOI 10.1056/NEJMc031360; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Thanassoulis G, 2010, J AM COLL CARDIOL, V55, P2491, DOI 10.1016/j.jacc.2010.03.019; Tikkanen E, 2011, CIRC-CARDIOVASC GENE, V4, P673, DOI 10.1161/CIRCGENETICS.111.960369; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	30	146	155	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1764	1771		10.1001/jama.2014.13959	http://dx.doi.org/10.1001/jama.2014.13959			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25344734	Green Accepted, Bronze			2022-12-01	WOS:000344194500014
J	Friedman, A				Friedman, Allyson			Jump-starting natural resilience reverses stress susceptibility	SCIENCE			English	Editorial Material							DOPAMINE NEURONS; REWARD CIRCUIT; SOCIAL DEFEAT; I-H; DEPRESSION; MIDBRAIN; TRAUMA; RISK		Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Friedman, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.				NIMH NIH HHS [F32 MH096464] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096464] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2010, REPORT NATL ADVISORY; Arencibia-Albite F, 2007, NEUROSCIENCE, V149, P303, DOI 10.1016/j.neuroscience.2007.08.009; Atkinson PA, 2009, J PSYCHIATR MENT HLT, V16, P137, DOI 10.1111/j.1365-2850.2008.01341.x; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Culpepper L, 2010, J CLIN PSYCHIAT, V71, P4, DOI 10.4088/JCP.9104su1c.01; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lam RW, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810372979; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Vythilingam M, 2009, PSYCHIAT RES-NEUROIM, V172, P75, DOI 10.1016/j.pscychresns.2008.06.008; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; WHO, 2009, WHO IN DEPR PUBL HLT; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028	22	11	12	4	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209								10.1126/science.1260781	http://dx.doi.org/10.1126/science.1260781			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7VH	25359955				2022-12-01	WOS:000349836100001
J	Joo, W; Hippenmeyer, S; Luo, LQ				Joo, William; Hippenmeyer, Simon; Luo, Liqun			Dendrite morphogenesis depends on relative levels of NT-3/TrkC signaling	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; NERVOUS-SYSTEM; NEURONAL DEVELOPMENT; MOSAIC ANALYSIS; DOUBLE MARKERS; IN-VIVO; TRKC; RECEPTORS; NEUROTROPHIN-3; GROWTH	Neurotrophins regulate diverse aspects of neuronal development and plasticity, but their precise in vivo functions during neural circuit assembly in the central brain remain unclear. We show that the neurotrophin receptor tropomyosin-related kinase C (TrkC) is required for dendritic growth and branching of mouse cerebellar Purkinje cells. Sparse TrkC knockout reduced dendrite complexity, but global Purkinje cell knockout had no effect. Removal of the TrkC ligand neurotrophin-3 (NT-3) from cerebellar granule cells, which provide major afferent input to developing Purkinje cell dendrites, rescued the dendrite defects caused by sparse TrkC disruption in Purkinje cells. Our data demonstrate that NT-3 from presynaptic neurons (granule cells) is required for TrkC-dependent competitive dendrite morphogenesis in postsynaptic neurons (Purkinje cells)-a previously unknown mechanism of neural circuit development.	[Joo, William; Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Joo, William; Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Joo, William; Luo, Liqun] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu		Hippenmeyer, Simon/0000-0003-2279-1061; Luo, Liqun/0000-0001-5467-9264	Stanford Neurosciences Graduate Program; Lorraine Kendall Predoctoral Fellowship Fund; NIH National Research Service Award Predoctoral Fellowship [5 F31 NS071697]; NIH [R01-NS050835]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835, F31NS071697] Funding Source: NIH RePORTER	Stanford Neurosciences Graduate Program; Lorraine Kendall Predoctoral Fellowship Fund; NIH National Research Service Award Predoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty, L. Tessarollo, and D. Rowitch for mouse lines; the Stanford Gene Vector and Virus Core for AAV production; P. Mehlen and S. Tauszig-Delamasure for advice on cell culture experiments; B. Weissbourd for assistance with in situ hybridization; and T. Clandinin and members of the Luo Lab for helpful discussions and comments on the manuscript. W.J. was supported by the Stanford Neurosciences Graduate Program, the Lorraine Kendall Predoctoral Fellowship Fund, and an NIH National Research Service Award Predoctoral Fellowship (5 F31 NS071697). This research was also supported by an NIH grant (R01-NS050835). L. L. is an investigator of the Howard Hughes Medical Institute. The supplementary materials contain additional data. Stanford University holds a patent on the MADM technology (U. S. Patent 7,282,621) that is described in this paper. The MADM mice are available at the Jackson Laboratory. There is no restriction on sharing all materials with nonprofit organizations. Commercial use of the mice requires a license from Stanford. Please contact Kirsten Leute at kirsten.leute@stanford.edu for more information.	Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; English CN, 2012, P NATL ACAD SCI USA, V109, P19456, DOI 10.1073/pnas.1206492109; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Hippenmeyer S, 2013, CELL REP, V3, P960, DOI 10.1016/j.celrep.2013.02.002; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	31	64	64	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		626	629		10.1126/science.1258996	http://dx.doi.org/10.1126/science.1258996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359972	Green Accepted			2022-12-01	WOS:000343799700047
J	Lee, FS; Heimer, H; Giedd, JN; Lein, ES; Sestan, N; Weinberger, DR; Casey, BJ				Lee, Francis S.; Heimer, Hakon; Giedd, Jay N.; Lein, Edward S.; Sestan, Nenad; Weinberger, Daniel R.; Casey, B. J.			Adolescent mental health-Opportunity and obligation	SCIENCE			English	Editorial Material							DISORDERS; BRAIN; FEAR		[Lee, Francis S.; Casey, B. J.] Weill Cornell Med Coll, Dept Psychiat, Sackler Inst, New York, NY 10065 USA; [Heimer, Hakon] Brain & Behav Res Fdn, Schizophrenia Res Forum, Providence, RI 02906 USA; [Heimer, Hakon] Cold Spring Harbor Lab, Banbury Ctr, Cold Spring Harbor, NY 11724 USA; [Giedd, Jay N.] Univ Calif San Diego, Div Child & Adolescent Psychiat, San Diego, CA 92123 USA; [Lein, Edward S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol & Psychiat, New Haven, CT 06510 USA; [Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Casey, B. J.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 20215 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Inst Genom Med, Baltimore, MD 20215 USA	Cornell University; Cold Spring Harbor Laboratory; University of California System; University of California San Diego; Allen Institute for Brain Science; Yale University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Lee, FS (corresponding author), Weill Cornell Med Coll, Dept Psychiat, Sackler Inst, New York, NY 10065 USA.	bjc2002@med.cornell.edu	Giedd, Jay/J-9644-2015	Giedd, Jay/0000-0003-2002-8978; Heimer, Hakon/0000-0001-6827-7549	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079513, ZIAMH002794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052819] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH079513] Funding Source: Medline; NINDS NIH HHS [R01 NS052819] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Beecham J, 2014, J CHILD PSYCHOL PSYC, V55, P714, DOI 10.1111/jcpp.12216; Bloom D., 2011, GLOBAL EC BURDEN NON; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Drysdale AT, 2014, BIOL PSYCHIAT, V75, pE19, DOI 10.1016/j.biopsych.2013.08.015; Dunton GF, 2014, HEALTH PSYCHOL, V33, P255, DOI 10.1037/a0032640; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Spear L., 2010, BEHAV NEUROSCIENCE A; Tebbenkamp ATN, 2014, CURR OPIN NEUROL, V27, P149, DOI 10.1097/WCO.0000000000000069; WHO, 2007, EC ASP MENT HLTH CHI	17	245	251	12	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		547	549		10.1126/science.1260497	http://dx.doi.org/10.1126/science.1260497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359951	Green Accepted			2022-12-01	WOS:000343799700022
J	Fortunato, SAV; Adamski, M; Ramos, OM; Leininger, S; Liu, J; Ferrier, DEK; Adamska, M				Fortunato, Sofia A. V.; Adamski, Marcin; Ramos, Olivia Mendivil; Leininger, Sven; Liu, Jing; Ferrier, David E. K.; Adamska, Maja			Calcisponges have a ParaHox gene and dynamic expression of dispersed NK homeobox genes	NATURE			English	Article							RNA-SEQ DATA; EVOLUTION; HOX; GENOME; SPONGE; AMPHIOXUS; EXPANSION; SELECTION	Sponges are simple animals with few cell types, but their genomes paradoxically contain a wide variety of developmental transcription factors(1-4), including homeobox genes belonging to the Antennapedia (ANTP) class(5,6), which in bilaterians encompass Hox, ParaHox and NK genes. In the genome of the demosponge Amphimedon queens-landica, no Hox or ParaHox genes are present, but NK genes are linked in a tight cluster similar to the NK clusters of bilaterians(5). It has been proposed that Hox and ParaHox genes originated from NK cluster genes after divergence of sponges from the lineage leading to cnidarians and bilaterians(5,7). On the other hand, synteny analysis lends support to the notion that the absence of Hox and ParaHox genes in Amphimedon is a result of secondary loss (the ghost locus hypothesis)(8). Here we analysed complete suites of ANTP-class homeoboxes in two calcareous sponges, Sycon ciliatum and Leucosolenia complicata. Our phylogenetic analyses demonstrate that these calcisponges possess orthologues of bilaterian NK genes (Hex, Hmx and Msx), a varying number of additional NK genes and one ParaHox gene, Cdx. Despite the generation of scaffolds spanning multiple genes, we find no evidence of clustering of Sycon NK genes. All Sycon ANTP-class genes are developmentally expressed, with patterns suggesting their involvement in cell type specification in embryos and adults, metamorphosis and body plan patterning. These results demonstrate that ParaHox genes predate the origin of sponges, thus confirming the ghost locus hypothesis(8), and highlight the need to analyse the genomes of multiple sponge lineages to obtain a complete picture of the ancestral composition of the first animal genome.	[Fortunato, Sofia A. V.; Adamski, Marcin; Leininger, Sven; Liu, Jing; Adamska, Maja] Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; [Fortunato, Sofia A. V.] Univ Bergen, Dept Biol, N-5008 Bergen, Norway; [Ramos, Olivia Mendivil; Ferrier, David E. K.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland	University of Bergen; University of Bergen; University of St Andrews	Adamska, M (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	maja.adamska@sars.uib.no	Ferrier, David E.K./D-7595-2013; Adamska, Maja/L-3306-2015	Ferrier, David E.K./0000-0003-3247-6233; Adamska, Maja/0000-0002-4223-8450	Sars Centre core budget; Norwegian Research Council; BBSRC; School of Biology, University of St Andrews	Sars Centre core budget; Norwegian Research Council(Research Council of NorwayEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Biology, University of St Andrews	This study was funded by the Sars Centre core budget to M. Adamska. Sequencing was performed at the Norwegian High Throughput Sequencing Centre funded by the Norwegian Research Council. O.M.R. and D. E. K. F. acknowledge support from the BBSRC and the School of Biology, University of St Andrews. We thank B. Bergum for collecting samples in the 2011 season and R. Holdhus from the Genomics Core Facility at the University of Bergen for help with DNA shearing.	AMANO S, 1993, INVERTEBR REPROD DEV, V24, P13, DOI 10.1080/07924259.1993.9672327; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Fahey B, 2008, BIOL BULL-US, V214, P205, DOI 10.2307/25470664; Ferrier DEK, 2010, ADV EXP MED BIOL, V689, P91; Fortunato S, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-14; Fortunato SAV, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-23; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hui JHL, 2008, EVOL DEV, V10, P725, DOI 10.1111/j.1525-142X.2008.00286.x; Hui JHL, 2012, MOL BIOL EVOL, V29, P157, DOI 10.1093/molbev/msr175; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Leininger S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4905; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Peterson KJ, 2007, EVOL DEV, V9, P405, DOI 10.1111/j.1525-142X.2007.00179.x; Ramos OM, 2012, CURR BIOL, V22, P1951, DOI 10.1016/j.cub.2012.08.023; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Takatori N, 2008, DEV GENES EVOL, V218, P579, DOI 10.1007/s00427-008-0245-9; Voigt C., BMC EVOL BI IN PRESS; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	30	70	71	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					620	+		10.1038/nature13881	http://dx.doi.org/10.1038/nature13881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355364	Green Accepted			2022-12-01	WOS:000343801500047
J	Libby, E; Ratcliff, WC				Libby, Eric; Ratcliff, William C.			Ratcheting the evolution of multicellularity	SCIENCE			English	Editorial Material							INDIVIDUALITY; TRANSITION		[Libby, Eric] Santa Fe Inst, Santa Fe, NM 87501 USA; [Ratcliff, William C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	The Santa Fe Institute; University System of Georgia; Georgia Institute of Technology	Libby, E (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	elibby@santafe.edu						CRESPI BJ, 1995, BEHAV ECOL, V6, P109, DOI 10.1093/beheco/6.1.109; Folse HJ, 2010, Q REV BIOL, V85, P447, DOI 10.1086/656905; Godfrey-Smith P., 2009, DARWINIAN POPULATION; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; KARAKASHIAN STEPHEN J., 1963, PHYSIOL ZOOL, V36, P52; Libby E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003803; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Michod RE, 2007, P NATL ACAD SCI USA, V104, P8613, DOI 10.1073/pnas.0701489104; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Rainey PB, 2010, BIOESSAYS, V32, P872, DOI 10.1002/bies.201000039; Ratcliff WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3742; Ratcliff WC, 2012, P NATL ACAD SCI USA, V109, P1595, DOI 10.1073/pnas.1115323109; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Williams G. C., 1966, P307	15	31	32	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					426	427		10.1126/science.1262053	http://dx.doi.org/10.1126/science.1262053			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8KB	25342789				2022-12-01	WOS:000343822900023
J	Birkhad, K				Birkhad, Kim			Stormy outlook for long-term ecology studies	NATURE			English	Editorial Material									Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Birkhad, K (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	t.r.birkhead@sheffield.ac.uk							0	30	31	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					405	405		10.1038/514405a	http://dx.doi.org/10.1038/514405a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341754	Bronze			2022-12-01	WOS:000343775900008
J	Kopfer, DA; Song, C; Gruene, T; Sheldrick, GM; Zachariae, U; de Groot, BL				Koepfer, David A.; Song, Chen; Gruene, Tim; Sheldrick, George M.; Zachariae, Ulrich; de Groot, Bert L.			Ion permeation in K+ channels occurs by direct Coulomb knock-on	SCIENCE			English	Article							MOLECULAR-DYNAMICS; POTASSIUM CHANNEL; STRUCTURAL BASIS; CONDUCTION; SELECTIVITY; MECHANISM; WATER; FILTER; KCSA; INACTIVATION	Potassium channels selectively conduct K+ ions across cellular membranes with extraordinary efficiency. Their selectivity filter exhibits four binding sites with approximately equal electron density in crystal structures with high K+ concentrations, previously thought to reflect a superposition of alternating ion-and water-occupied states. Consequently, cotranslocation of ions with water has become a widely accepted ion conduction mechanism for potassium channels. By analyzing more than 1300 permeation events from molecular dynamics simulations at physiological voltages, we observed instead that permeation occurs via ion-ion contacts between neighboring K+ ions. Coulomb repulsion between adjacent ions is found to be the key to high-efficiency K+ conduction. Crystallographic data are consistent with directly neighboring K+ ions in the selectivity filter, and our model offers an intuitive explanation for the high throughput rates of K+ channels.	[Koepfer, David A.; de Groot, Bert L.] Max Planck Inst Biophys Chem, Biomol Dynam Grp, D-37077 Gottingen, Germany; [Song, Chen] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Gruene, Tim; Sheldrick, George M.] Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany; [Zachariae, Ulrich] Univ Dundee, Sch Engn Phys & Math, Dundee DD1 4HN, Scotland; [Zachariae, Ulrich] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	Max Planck Society; University of Oxford; University of Gottingen; University of Dundee; University of Dundee	Song, C (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	sc3210@gmail.com; u.zachariae@dundee.ac.uk; bgroot@gwdg.de		Gruene, Tim/0000-0002-8873-4978; Zachariae, Ulrich/0000-0003-3287-8494	International Max Planck Research School for Biology and Complex Systems; Marie Curie Intra European Fellowship within European Community; Volkswagen Stiftung; Scottish Universities' Physics Alliance; German research foundation DFG [SFB803]	International Max Planck Research School for Biology and Complex Systems; Marie Curie Intra European Fellowship within European Community; Volkswagen Stiftung(Volkswagen); Scottish Universities' Physics Alliance; German research foundation DFG(German Research Foundation (DFG))	We thank H. Sun and S. Wacker tor simulations of K<INF>v</INF>1.2, R. Sknepnek for assistance with HOOMD-blue, and H. Grubmuller, M.S.P. Sansom, P. Pohl, T. Graen, and K. Zeth for helpful discussions. Supported by the International Max Planck Research School for Biology and Complex Systems (D.A.K.), a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (C.S.), the Volkswagen Stiftung (via the Niedersachsenprofessur awarded to G.M.S.) (T.G.), the Scottish Universities' Physics Alliance (U.Z.), and the German research foundation DFG through SFB803 (B.L.d.G.).	Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Ceccarini L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049017; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Domene C, 2003, BIOPHYS J, V85, P2787, DOI 10.1016/S0006-3495(03)74702-X; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fowler PW, 2013, J CHEM THEORY COMPUT, V9, P5176, DOI 10.1021/ct4005933; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; Hille B., 2001, ION CHANNELS EXCITAB, V3; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Hubschle CB, 2011, J APPL CRYSTALLOGR, V44, P1281, DOI 10.1107/S0021889811043202; HUMMER G, 1994, MOL PHYS, V81, P1155, DOI 10.1080/00268979400100771; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Kasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056342; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Miller C, 2001, NATURE, V414, P23, DOI 10.1038/35102126; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Saparov SM, 2004, P NATL ACAD SCI USA, V101, P4805, DOI 10.1073/pnas.0308309101; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; Sumikama T, 2006, J PHYS CHEM B, V110, P20671, DOI 10.1021/jp062547r; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	36	197	198	7	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					352	355		10.1126/science.1254840	http://dx.doi.org/10.1126/science.1254840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324389	Green Published			2022-12-01	WOS:000343041100045
J	Dzau, VJ; Pizzo, PA				Dzau, Victor J.; Pizzo, Philip A.			Relieving Pain in America Insights From an Institute of Medicine Committee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dzau, Victor J.] Inst Med, Washington, DC 20001 USA; [Pizzo, Philip A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Dzau, VJ (corresponding author), Inst Med, 500 Fifth St NW, Washington, DC 20001 USA.	vdzau@nas.edu						Fauber J., CHRONIC PAIN STAT CA; Institute of Medicine website, REL PAIN AM BLUEPR T; National Academies, POL PROC COMM COMP B; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005	4	59	59	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2014	312	15					1507	1508		10.1001/jama.2014.12986	http://dx.doi.org/10.1001/jama.2014.12986			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7HL	25321905				2022-12-01	WOS:000342983200009
J	Payne, KAP; Quezada, CP; Fisher, K; Dunstan, MS; Collins, FA; Sjuts, H; Levy, C; Hay, S; Rigby, SEJ; Leys, D				Payne, Karl A. P.; Quezada, Carolina P.; Fisher, Karl; Dunstan, Mark S.; Collins, Fraser A.; Sjuts, Hanno; Levy, Colin; Hay, Sam; Rigby, Stephen E. J.; Leys, David			Reductive dehalogenase structure suggests a mechanism for B12-dependent dehalogenation	NATURE			English	Article							MOLECULAR CHARACTERIZATION; HALORESPIRATION; COB(II)ALAMIN; ENZYME	Organohalide chemistry underpins many industrial and agricultural processes, and a large proportion of environmental pollutants are organohalides(1). Nevertheless, organohalide chemistry is not exclusively of anthropogenic origin, with natural abiotic and biological processes contributing to the global halide cycle(2,3). Reductive dehalogenases are responsible for biological dehalogenation in organohalide respiring bacteria(4,5), with substrates including polychlorinated biphenyls or dioxins(6,7). Reductive dehalogenases form a distinct subfamily of cobalamin (B12)-dependent enzymes that are usuallymembrane associated and oxygen sensitive, hindering detailed studies(8-12). Here we report the characterization of a soluble, oxygen-tolerant reductive dehalogenase and, by combining structure determination with EPR (electron paramagnetic resonance) spectroscopy and simulation, show that a direct interaction between the cobalamin cobalt and the substrate halogen underpins catalysis. In contrast to the carbon-cobalt bond chemistry catalysed by the other cobalamin-dependent subfamilies(13), we propose that reductive dehalogenases achieve reduction of the organohalide substrate via halogen-cobalt bond formation. This presents a new model in both organohalide and cobalamin (bio) chemistry that will guide future exploitation of these enzymes in bioremediation or biocatalysis.	[Payne, Karl A. P.; Quezada, Carolina P.; Fisher, Karl; Dunstan, Mark S.; Collins, Fraser A.; Sjuts, Hanno; Levy, Colin; Hay, Sam; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Quezada, Carolina Paz/AAG-1981-2019; Hay, Sam/D-5974-2012; Fisher, Karl/A-5956-2013	Quezada, Carolina Paz/0000-0002-0260-5754; Hay, Sam/0000-0003-3274-0938; Fisher, Karl/0000-0003-3539-8939; payne, karl/0000-0002-6331-6374; Dunstan, Mark/0000-0002-9416-5505	ERC grant [DEHALORES206080]; CONICYT Chile; Biotechnology and Biological Sciences Research Council [1626769, BB/E013007/1, BB/H021523/1, 1338042, BB/C00521X/1] Funding Source: researchfish; BBSRC [BB/E013007/1, BB/H021523/1] Funding Source: UKRI	ERC grant; CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an ERC grant (DEHALORES206080) to D.L. S.H. is a BBSRC David Phillips research fellow. C.P.Q. is supported by CONICYT Chile. We thank Diamond Light Source for access to beamline IO4 (proposal number MX8997) that contributed to the results presented here; R. Biedendieck (Technische Universitat Braunschweig, Germany), S. Moore and M. Warren (University of Kent, UK) for providing plasmids and assistance with B. megaterium molecular biology; the assistance given by IT Services and the use of the Computational Shared Facility at The University of Manchester; and A. Munro (University of Manchester) for critical comments and discussion.	Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BAYSTON JH, 1970, BIOCHEMISTRY-US, V9, P2164, DOI 10.1021/bi00812a020; Bommer M., 2014, SCIENCE; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Chen K, 2013, MOL MICROBIOL, V89, P1121, DOI 10.1111/mmi.12332; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Frisch M. J., 2010, GAUSSIAN 09; Gamer M, 2009, APPL MICROBIOL BIOT, V82, P1195, DOI 10.1007/s00253-009-1952-5; Gribble GW, 2012, ALKALOIDS-CHEM BIOL, V71, P1, DOI 10.1016/B978-0-12-398282-7.00001-1; Grostern A, 2009, APPL ENVIRON MICROB, V75, P2684, DOI 10.1128/AEM.02037-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Krasotkina J, 2001, J BIOL CHEM, V276, P40991, DOI 10.1074/jbc.M106217200; Lai QL, 2012, J BACTERIOL, V194, P6958, DOI 10.1128/JB.01905-12; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leys D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0316; Maillard J, 2003, APPL ENVIRON MICROB, V69, P4628, DOI 10.1128/AEM.69.8.4628-4638.2003; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14906, DOI 10.1073/pnas.1308098110; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neumann A, 2002, ARCH MICROBIOL, V177, P420, DOI 10.1007/s00203-002-0409-3; Oberg G, 2002, APPL MICROBIOL BIOT, V58, P565, DOI 10.1007/s00253-001-0895-2; Ren Z, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00018; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Stringer R, 2001, CHLORINE ENV OVERVIE; Stroupe M. E., 2005, TETRAPYRROLES THEIR, P373; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van de Pas BA, 1999, J BIOL CHEM, V274, P20287, DOI 10.1074/jbc.274.29.20287; Van Doorslaer S, 2003, J AM CHEM SOC, V125, P5915, DOI 10.1021/ja021218j; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlfarth G, 1997, CURR OPIN BIOTECH, V8, P290, DOI 10.1016/S0958-1669(97)80006-7	34	173	174	19	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					513	+		10.1038/nature13901	http://dx.doi.org/10.1038/nature13901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25327251	Green Accepted			2022-12-01	WOS:000348196500041
J	Wu, HM; Fairley, JK; Steinberg, J; Kozarsky, P				Wu, Henry M.; Fairley, Jessica K.; Steinberg, James; Kozarsky, Phyllis			The Potential Ebola-Infected Patient in the Ambulatory Care Setting: Preparing for the Worst Without Compromising Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Wu, HM (corresponding author), 550 Peachtree St NE,Med Off Tower 7, Atlanta, GA 30308 USA.	hmwu@emory.edu	Fairley, Jessica K/W-2777-2019					[Anonymous], 2014, CAS DEF EB VIR DIS E; Center for Disease Control, 2014, 2014 EB OUTBR W AFR; Centers for Disease Control and Prevention, 2014, CAS EB DIAGN US; Centers for Disease Control and Prevention, 2014, INT GUID ENV INF CON; Centers for Disease Control and Prevention, 2014, GUID PERS PROT EQ BE; Centers for Disease Control and Prevention, 2014, INT GUID SPEC COLL T; Isakov A, 2014, ANN INTERN MED, V161, P829, DOI 10.7326/M14-2084; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007	9	10	10	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					66	U109		10.7326/M14-2312	http://dx.doi.org/10.7326/M14-2312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25329137				2022-12-01	WOS:000350103000009
J	Genovese, G; Kahler, AK; Handsaker, RE; Lindberg, J; Rose, SA; Bakhoum, SF; Chambert, K; Mick, E; Neale, BM; Fromer, M; Purcell, SM; Svantesson, O; Landen, M; Hoglund, M; Lehmann, S; Gabriel, SB; Moran, JL; Lander, ES; Sullivan, PF; Sklar, P; Gronberg, H; Hultman, CM; McCarroll, SA				Genovese, Giulio; Kaehler, Anna K.; Handsaker, Robert E.; Lindberg, Johan; Rose, Samuel A.; Bakhoum, Samuel F.; Chambert, Kimberly; Mick, Eran; Neale, Benjamin M.; Fromer, Menachem; Purcell, Shaun M.; Svantesson, Oscar; Landen, Mikael; Hoeglund, Martin; Lehmann, Soeren; Gabriel, Stacey B.; Moran, Jennifer L.; Lander, Eric S.; Sullivan, Patrick F.; Sklar, Pamela; Groenberg, Henrik; Hultman, Christina M.; McCarroll, Steven A.			Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELLS; EPIGENETIC REGULATORS; PPM1D MUTATIONS; MOSAICISM; GENOME; EVOLUTION; DNMT3A; ASXL1; JAK2; TET2	Background Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent. Methods We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380 persons, unselected for cancer or hematologic phenotypes. We identified somatic mutations on the basis of unusual allelic fractions. We used data from Swedish national patient registers to follow health outcomes for 2 to 7 years after DNA sampling. Results Clonal hematopoiesis with somatic mutations was observed in 10% of persons older than 65 years of age but in only 1% of those younger than 50 years of age. Detectable clonal expansions most frequently involved somatic mutations in three genes (DNMT3A, ASXL1, and TET2) that have previously been implicated in hematologic cancers. Clonal hematopoiesis was a strong risk factor for subsequent hematologic cancer (hazard ratio, 12.9; 95% confidence interval, 5.8 to 28.7). Approximately 42% of hematologic cancers in this cohort arose in persons who had clonality at the time of DNA sampling, more than 6 months before a first diagnosis of cancer. Analysis of bone marrow-biopsy specimens obtained from two patients at the time of diagnosis of acute myeloid leukemia revealed that their cancers arose from the earlier clones. Conclusions Clonal hematopoiesis with somatic mutations is readily detected by means of DNA sequencing, is increasingly common as people age, and is associated with increased risks of hematologic cancer and death. A subset of the genes that are mutated in patients with myeloid cancers is frequently mutated in apparently healthy persons; these mutations may represent characteristic early events in the development of hematologic cancers.	[Genovese, Giulio; Handsaker, Robert E.; Rose, Samuel A.; Chambert, Kimberly; Neale, Benjamin M.; Moran, Jennifer L.; McCarroll, Steven A.] Stanley Ctr Psychiat Res, Cambridge, MA USA; [Genovese, Giulio; Handsaker, Robert E.; McCarroll, Steven A.] Program Med & Populat Genet, Cambridge, MA USA; [Gabriel, Stacey B.; Lander, Eric S.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Genovese, Giulio; Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Mick, Eran] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Kaehler, Anna K.; Lindberg, Johan; Svantesson, Oscar; Sullivan, Patrick F.; Groenberg, Henrik; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lindberg, Johan] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Lehmann, Soeren] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Lehmann, Soeren] Karolinska Univ Hosp, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Landen, Mikael] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hoeglund, Martin] Univ Hosp, Dept Med Sci, Uppsala, Sweden; [Hoeglund, Martin] Univ Hosp, Div Hematol, Uppsala, Sweden; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Fromer, Menachem; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Fromer, Menachem; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	giulio.genovese@gmail.com; mccarroll@genetics.med.harvard.edu	Landen, Mikael/AAD-7917-2020; Handsaker, Bob/AAX-9095-2021	Handsaker, Bob/0000-0002-3128-3547; Lindberg, Johan/0000-0003-3610-6774; McCarroll, Steven/0000-0002-6954-8184; Rose, Samuel/0000-0001-9701-0050; Genovese, Giulio/0000-0003-3066-5575; Bakhoum, Samuel/0000-0002-4779-8422; Moran, Jennifer/0000-0002-5664-4716; Hoglund, Martin/0000-0003-2468-0226	National Human Genome Research Institute [U54 HG003067, R01 HG006855]; Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; National Institute of Mental Health [R01 MH077139, RC2 MH089905]; Sylvan C. Herman Foundation; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG006855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, RC2MH089905] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sylvan C. Herman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the National Human Genome Research Institute (U54 HG003067 and R01 HG006855), the Stanley Center for Psychiatric Research, the Alexander and Margaret Stewart Trust, the National Institute of Mental Health (R01 MH077139 and RC2 MH089905), and the Sylvan C. Herman Foundation.	Akbari MR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt323; Busque L, 1996, BLOOD, V88, P59; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen TC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.74; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fasan A, 2014, LEUKEMIA, V28, P794, DOI 10.1038/leu.2013.273; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2014, CANCER CELL, V25, P713, DOI 10.1016/j.ccr.2014.06.001; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kulasekararaj AG, 2013, BRIT J HAEMATOL, V160, P660, DOI 10.1111/bjh.12203; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ley TJ, 2013, NEW ENGL J MED, V369, P98; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Martelli MP, 2013, BLOOD REV, V27, P13, DOI 10.1016/j.blre.2012.11.001; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Potter NE, 2014, NATURE, V506, P300, DOI 10.1038/nature13056; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Schick UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059823; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Vasanthakumar A, 2014, CELL STEM CELL, V14, P421, DOI 10.1016/j.stem.2014.03.008; Zhang LW, 2014, NAT GENET, V46, P726, DOI 10.1038/ng.2995	41	1841	1882	5	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2477	2487		10.1056/NEJMoa1409405	http://dx.doi.org/10.1056/NEJMoa1409405			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25426838	Green Accepted, Green Published, Green Submitted			2022-12-01	WOS:000346920300007
J	Trivellin, G; Daly, AF; Faucz, FR; Yuan, B; Rostomyan, L; Larco, DO; Schernthaner-Reiter, MH; Szarek, E; Leal, LF; Caberg, JH; Castermans, E; Villa, C; Dimopoulos, A; Chittiboina, P; Xekouki, P; Shah, N; Metzger, D; Lysy, PA; Ferrante, E; Strebkova, N; Mazerkina, N; Zatelli, MC; Lodish, M; Horvath, A; de Alexandre, RB; Manning, AD; Levy, I; Keil, MF; Sierra, MD; Palmeira, L; Coppieters, W; Georges, M; Naves, LA; Jamar, M; Bours, V; Wu, TJ; Choong, CS; Bertherat, J; Chanson, P; Kamenicky, P; Farrell, WE; Barlier, A; Quezado, M; Bjelobaba, I; Stojilkovic, SS; Wess, J; Costanzi, S; Liu, P; Lupski, JR; Beckers, A; Stratakis, CA				Trivellin, G.; Daly, A. F.; Faucz, F. R.; Yuan, B.; Rostomyan, L.; Larco, D. O.; Schernthaner-Reiter, M. H.; Szarek, E.; Leal, L. F.; Caberg, J. -H.; Castermans, E.; Villa, C.; Dimopoulos, A.; Chittiboina, P.; Xekouki, P.; Shah, N.; Metzger, D.; Lysy, P. A.; Ferrante, E.; Strebkova, N.; Mazerkina, N.; Zatelli, M. C.; Lodish, M.; Horvath, A.; de Alexandre, R. Bertollo; Manning, A. D.; Levy, I.; Keil, M. F.; Sierra, M. de la Luz; Palmeira, L.; Coppieters, W.; Georges, M.; Naves, L. A.; Jamar, M.; Bours, V.; Wu, T. J.; Choong, C. S.; Bertherat, J.; Chanson, P.; Kamenicky, P.; Farrell, W. E.; Barlier, A.; Quezado, M.; Bjelobaba, I.; Stojilkovic, S. S.; Wess, J.; Costanzi, S.; Liu, P.; Lupski, J. R.; Beckers, A.; Stratakis, C. A.			Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-COUPLED RECEPTOR; ISOLATED PITUITARY-ADENOMAS; SHORT STATURE; EXPRESSION; GENE; DUPLICATION; MESSENGER; AIP	BACKGROUND Increased secretion of growth hormone leads to gigantism in children and acromegaly in adults; the genetic causes of gigantism and acromegaly are poorly understood. METHODS We performed clinical and genetic studies of samples obtained from 43 patients with gigantism and then sequenced an implicated gene in samples from 248 patients with acromegaly. RESULTS We observed microduplication on chromosome Xq26.3 in samples from 13 patients with gigantism; of these samples, 4 were obtained from members of two unrelated kindreds, and 9 were from patients with sporadic cases. All the patients had disease onset during early childhood. Of the patients with gigantism who did not carry an Xq26.3 microduplication, none presented before the age of 5 years. Genomic characterization of the Xq26.3 region suggests that the microduplications are generated during chromosome replication and that they contain four protein-coding genes. Only one of these genes, GPR101, which encodes a G-protein-coupled receptor, was overexpressed in patients' pituitary lesions. We identified a recurrent GPR101 mutation (p.E308D) in 11 of 248 patients with acromegaly, with the mutation found mostly in tumors. When the mutation was transfected into rat GH3 cells, it led to increased release of growth hormone and proliferation of growth hormone-producing cells. CONCLUSIONS We describe a pediatric disorder (which we have termed X-linked acrogigantism [X-LAG]) that is caused by an Xq26.3 genomic duplication and is characterized by early-onset gigantism resulting from an excess of growth hormone. Duplication of GPR101 probably causes X-LAG. We also found a recurrent mutation in GPR101 in some adults with acromegaly.	[Trivellin, G.; Faucz, F. R.; Schernthaner-Reiter, M. H.; Szarek, E.; Leal, L. F.; Dimopoulos, A.; Xekouki, P.; Lodish, M.; Horvath, A.; de Alexandre, R. Bertollo; Manning, A. D.; Levy, I.; Keil, M. F.; Sierra, M. de la Luz; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Trivellin, G.; Faucz, F. R.; Schernthaner-Reiter, M. H.; Szarek, E.; Leal, L. F.; Dimopoulos, A.; Xekouki, P.; Lodish, M.; Horvath, A.; de Alexandre, R. Bertollo; Manning, A. D.; Levy, I.; Keil, M. F.; Sierra, M. de la Luz; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Endocrinol Interinst Training Program, NIH, Bethesda, MD USA; [Bjelobaba, I.; Stojilkovic, S. S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Signaling, Program Dev Neurosci, NIH, Bethesda, MD USA; [Chittiboina, P.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Quezado, M.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Wess, J.] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD USA; [Larco, D. O.; Wu, T. J.] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20814 USA; [Daly, A. F.; Rostomyan, L.; Villa, C.; Beckers, A.] Univ Liege, Ctr Hosp Univ Liege, Dept Endocrinol, Liege, Belgium; [Caberg, J. -H.; Castermans, E.; Jamar, M.; Bours, V.] Univ Liege, Ctr Hosp Univ Liege, Dept Clin Genet, Liege, Belgium; [Palmeira, L.; Coppieters, W.; Georges, M.] Domaine Univ Sart Tilman, Grp Interdisciplinaire Genoprote Appl GIGA Genom, Liege, Belgium; [Lysy, P. A.] Catholic Univ Louvain, Clin Univ St Luc, Dept Pediat, Pediat Endocrinol Unit, Louvain, Belgium; [Faucz, F. R.; de Alexandre, R. Bertollo] Pontificia Univ Catolica Parana, Sch Hlth & Biosci, Curitiba, Parana, Brazil; [Naves, L. A.] Univ Brasilia, Fac Med, Dept Endocrinol, Brasilia, DF, Brazil; [Yuan, B.; Liu, P.; Lupski, J. R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, J. R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, J. R.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Villa, C.] Hop Foch, Dept Anat & Cytol Pathol, Suresnes, France; [Villa, C.; Bertherat, J.] Univ Paris 05, Inst Cochin, Hop Cochin, INSERM,U1016,Serv Endocrinol, Paris, France; [Chanson, P.; Kamenicky, P.] Hop Univ Paris Sud, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Chanson, P.; Kamenicky, P.] Ctr Reference Malad Endocriniennes Rares Croissan, Le Kremlin Bicetre, France; [Chanson, P.; Kamenicky, P.] Univ Paris 11, Fac Med, UMR S693, Le Kremlin Bicetre, France; [Barlier, A.] Aix Marseille Univ, CNRS, UMR 7286, Ctr Rech Neurobiol & Neurophysiol Marseille, Marseille, France; [Shah, N.] King Edward Mem Hosp, Dept Endocrinol, Mumbai, Maharashtra, India; [Metzger, D.] BC Childrens Hosp, Endocrinol & Diabet Unit, Vancouver, BC, Canada; [Levy, I.] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Ferrante, E.] Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Endocrinol & Diabetol Unit, Milan, Italy; [Zatelli, M. C.] Univ Ferrara, Dept Med Sci, Endocrinol Sect, I-44100 Ferrara, Italy; [Strebkova, N.] Inst Pediat Endocrinol, Endocrinol Res Ctr, Moscow, Russia; [Mazerkina, N.] NN Burdenko Inst Neurosurg, Moscow, Russia; [Horvath, A.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Costanzi, S.] Amer Univ, Dept Chem, Washington, DC 20016 USA; [Costanzi, S.] Amer Univ, Ctr Behav Neurosci, Washington, DC 20016 USA; [Choong, C. S.] Princess Margaret Hosp Children, Dept Paediat Endocrinol, Perth, WA, Australia; [Choong, C. S.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia; [Farrell, W. E.] Keele Univ, Guy Hilton Res Ctr, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA; University of Liege; University of Liege; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Pontificia Universidade Catolica do Parana; Universidade de Brasilia; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; BC Childrens Hospital; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Ferrara; Russian Academy of Medical Sciences; Endocrinology Research Centre; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; George Washington University; American University; American University; University of Western Australia; Keele University	Stratakis, CA (corresponding author), NIH, Clin Res Ctr, 10 Ctr Dr,Bldg 10,Rm 1-3330,MSC1103, Bethesda, MD 20892 USA.	albert.beckers@chu.ulg.ac.be; stratakc@mail.nih.gov	Liu, Pengfei/U-9743-2019; Ferrante, Emanuele/O-2500-2015; Faucz, Fabio R/C-1607-2009; Bjelobaba, Ivana/ABA-1538-2020; Naves, Luciana A/I-1111-2012; Choong, Catherine/J-4646-2014; Lodish, Maya/HCH-4078-2022; Barlier, Anne/G-2398-2015; Stratakis, Constantine A./AAP-4745-2020; Chittiboina, Prashant/AAE-3799-2020; Zatelli, Maria Chiara/Y-1160-2019; Xekouki, Paraskevi/AAM-2485-2021; Chittiboina, Prashant/T-7177-2017; choong, catherine S/D-4051-2012; Leal, Leticia Ferro/F-1053-2015; Sierra, Maria/GYU-1134-2022; Trivellin, Giampaolo/J-6583-2016; Rostomyan, Liliya/ABB-1961-2021; Wu, John/ABI-3578-2020; Daly, Adrian F/E-2178-2011; Trivellin, Giampaolo/ABF-9857-2020; Kamenicky, Peter/S-4554-2018; de Alexandre, Rodrigo/H-9489-2013; Chanson, Philippe/F-8511-2013; Zatelli, Maria Chiara/U-2649-2018	Liu, Pengfei/0000-0002-4177-709X; Ferrante, Emanuele/0000-0002-0556-7650; Bjelobaba, Ivana/0000-0002-7649-0304; Naves, Luciana A/0000-0002-3363-3803; Choong, Catherine/0000-0002-3982-271X; Chittiboina, Prashant/0000-0001-9349-4756; Chittiboina, Prashant/0000-0001-9349-4756; choong, catherine S/0000-0002-3982-271X; Trivellin, Giampaolo/0000-0003-2384-4153; Rostomyan, Liliya/0000-0003-3784-2132; Daly, Adrian F/0000-0001-6130-2975; Trivellin, Giampaolo/0000-0003-2384-4153; Wu, Tao-Yiao/0000-0002-8274-0226; Faucz, Fabio/0000-0001-7959-9842; Barlier, Anne/0000-0002-3740-6173; Costanzi, Stefano/0000-0003-3183-7332; Schernthaner-Reiter, Marie Helene/0000-0002-7972-7610; BERTHERAT, Jerome/0000-0003-2551-3008; de Alexandre, Rodrigo/0000-0002-1253-7716; Savateev, Aleksandr/0000-0001-6433-1202; Metzger, Daniel/0000-0002-1715-4319; Mazerkina, Nadia/0000-0002-0428-0498; Beckers, Albert/0000-0001-6351-1367; Chanson, Philippe/0000-0001-5096-5722; Zatelli, Maria Chiara/0000-0001-8408-7796; KAMENICKY, Peter/0000-0002-1994-4226; Georges, Michel/0000-0003-4124-2375; Lodish, Maya/0000-0002-7701-9290	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920, ZIAHD000195, U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.	Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Behrens LH, 1932, ENDOCRINOLOGY, V16, P120, DOI 10.1210/endo-16-2-120; Bergamaschi S, 2010, HORM RES PAEDIAT, V73, P74, DOI 10.1159/000271919; Cho-Clark M, 2014, MOL ENDOCRINOL, V28, P80, DOI 10.1210/me.2013-1203; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P3316, DOI 10.1210/jc.2005-2671; de Herder WW, 2009, PITUITARY, V12, P236, DOI 10.1007/s11102-008-0138-y; ESPINER EA, 1981, J ENDOCRINOL INVEST, V4, P445, DOI 10.1007/BF03348309; Glasker S, 2011, J CLIN ENDOCR METAB, V96, pE2078, DOI 10.1210/jc.2011-1401; Gurrieri F, 2011, AM J MED GENET A, V155A, P145, DOI 10.1002/ajmg.a.33586; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Lowell BB, 2011, Patents: novel gpr101 transgenic mice and methods of use thereof, Patent No. 20110173706; Madrigal I, 2010, J HUM GENET, V55, P822, DOI 10.1038/jhg.2010.119; Moller RS, 2014, HUM GENET, V133, P625, DOI 10.1007/s00439-013-1403-3; Nilaweera KN, 2007, J NEUROENDOCRINOL, V19, P34, DOI 10.1111/j.1365-2826.2006.01502.x; Nord KH, 2014, NAT GENET, V46, P474, DOI 10.1038/ng.2927; Peverelli E, 2014, J MOL ENDOCRINOL, V52, pR67, DOI 10.1530/JME-13-0172; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Stankiewicz P, 2005, AM J MED GENET A, V138A, P11, DOI 10.1002/ajmg.a.30910; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Tatton-Brown K, 2007, EUR J HUM GENET, V15, P264, DOI 10.1038/sj.ejhg.5201686; Veldhuis JD, 2012, HANDBOOK OF NEUROENDOCRINOLOGY, P237, DOI 10.1016/B978-0-12-375097-6.10010-1; Vissers LELM, 2012, METHODS MOL BIOL, V838, P29, DOI 10.1007/978-1-61779-507-7_2; Xekouki P, 2010, EXPERT REV ENDOCRINO, V5, P697, DOI 10.1586/EEM.10.47; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	28	186	194	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2363	2374		10.1056/NEJMoa1408028	http://dx.doi.org/10.1056/NEJMoa1408028			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25470569	Green Accepted, Green Published			2022-12-01	WOS:000346425800005
J	Dickson, VK; Pedi, L; Long, SB				Dickson, Veronica Kane; Pedi, Leanne; Long, Stephen B.			Structure and insights into the function of a Ca2+-activated Cl- channel	NATURE			English	Article							VITELLIFORM MACULAR DYSTROPHY; CHLORIDE CHANNEL; CRYSTAL-STRUCTURE; MOUSE BESTROPHIN-2; AROMATIC RINGS; FAMILY; PROTEIN; GENE; MUTATIONS; RELEASE	Bestrophin calcium-activated chloride channels (CaCCs) regulate the flow of chloride and other monovalent anions across cellular membranes in response to intracellular calcium (Ca2+) levels. Mutations in bestrophin 1 (BEST1) cause certain eye diseases. Here we present X-ray structures of chicken BEST1-Fab complexes, at 2.85 angstrom resolution, with permeant anions and Ca2+. Representing, to our knowledge, the first structure of a CaCC, the eukaryotic BEST1 channel, which recapitulates CaCC function in liposomes, is formed from a pentameric assembly of subunits. Ca2+ binds to the channel's large cytosolic region. A single ion pore, approximately 95 angstrom in length, is located along the central axis and contains at least 15 binding sites for anions. A hydrophobic neck within the pore probably forms the gate. Phenylalanine residues within it may coordinate permeating anions via anion-pi interactions. Conformational changes observed near the 'Ca2+ clasp' hint at the mechanism of Ca2+-dependent gating. Disease-causing mutations are prevalent within the gating apparatus.	[Dickson, Veronica Kane; Pedi, Leanne; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	Longs@mskcc.org		Long, Stephen/0000-0002-8144-1398; Kane Dickson, Veronica/0000-0002-8649-8094	Burroughs Wellcome Career Award in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110396, P41GM111244] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the staff at beamlines X25 and X29 of the National Synchrotron Light Source, beamline 24-ID-C of the Advanced Photon Source, and F. Weis-Garcia and the Monoclonal Antibody Facility at MSKCC. We thank C. Lima, M. Long, N. Pavletich, V. Ruta and members of the laboratory for discussions. S.B.L. is a recipient of a Burroughs Wellcome Career Award in the Biomedical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bharill S, 2014, P NATL ACAD SCI USA, V111, P6491, DOI 10.1073/pnas.1400248111; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gomez NM, 2013, PFLUG ARCH EUR J PHY, V465, P481, DOI 10.1007/s00424-012-1181-0; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hille B., 1992, IONIC CHANNELS EXCIT; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Jackson MR, 2007, J PHYS CHEM B, V111, P8242, DOI 10.1021/jp0661995; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kinnick TR, 2011, RETINA-J RET VIT DIS, V31, P581, DOI 10.1097/IAE.0b013e318203ee60; Konecny Robert, 2012, Computational Science and Discovery, V5, DOI 10.1088/1749-4699/5/1/015005; Kranjc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004672; Kunzelmann K, 2011, BIOL CHEM, V392, P125, DOI 10.1515/BC.2011.010; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marchant D, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044511; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; THOMAS KA, 1982, P NATL ACAD SCI-BIOL, V79, P4843, DOI 10.1073/pnas.79.16.4843; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wittstrom E, 2011, OPHTHALMIC GENET, V32, P217, DOI 10.3109/13816810.2011.567884; Woo DH, 2012, CELL, V151, P25, DOI 10.1016/j.cell.2012.09.005; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Yu K, 2006, INVEST OPHTH VIS SCI, V47, P4956, DOI 10.1167/iovs.06-0524; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670	62	144	146	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					213	+		10.1038/nature13913	http://dx.doi.org/10.1038/nature13913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25337878	Green Accepted			2022-12-01	WOS:000346383500037
J	Weintraub, K				Weintraub, Karen			VACCINES: Taking a shot at protection	NATURE			English	Editorial Material							VACCINATION; PROGRAM											Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Chiang CJ, 2013, JAMA-J AM MED ASSOC, V310, P974, DOI 10.1001/jama.2013.276701; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Wu TW, 2013, HEPATOLOGY, V57, P38, DOI 10.1002/hep.25988	4	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S12	S13		10.1038/516S12a	http://dx.doi.org/10.1038/516S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470194	Bronze			2022-12-01	WOS:000346310800005
J	Volerman, A; Cifu, AS				Volerman, Anna; Cifu, Adam S.			Cervical Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; LIQUID-BASED CYTOLOGY; SERVICES TASK-FORCE; CONVENTIONAL CYTOLOGY; HUMAN-PAPILLOMAVIRUS		[Volerman, Anna; Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						American College of Obstetricians and Gynecologists (ACOG), 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.0B013E318277C92A; [Anonymous], CERV CANC; [Anonymous], SCREEN CERV CANC WOM; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kulasingam SL, 2011, 1105157EF1 AHRQ; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Whitlock EP, 2011, ANN INTERN MED, V155, P687; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376	11	5	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2279	2280		10.1001/jama.2014.14992	http://dx.doi.org/10.1001/jama.2014.14992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461998				2022-12-01	WOS:000345684800023
J	Kind, AJH; Jencks, S; Brock, J; Yu, MG; Bartels, C; Ehlenbach, W; Greenberg, C; Smith, M				Kind, Amy J. H.; Jencks, Steve; Brock, Jane; Yu, Menggang; Bartels, Christie; Ehlenbach, William; Greenberg, Caprice; Smith, Maureen			Neighborhood Socioeconomic Disadvantage and 30-Day Rehospitalization	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL READMISSION; ALL-CAUSE; MORTALITY; DISPARITIES; HEALTH; RISK; CARE; INEQUALITIES; COMMUNITIES; COMORBIDITY	Background: Measures of socioeconomic disadvantage may enable improved targeting of programs to prevent rehospitalizations, but obtaining such information directly from patients can be difficult. Measures of U.S. neighborhood socioeconomic disadvantage are more readily available but are rarely used clinically. Objective: To evaluate the association between neighborhood socioeconomic disadvantage at the census block group level, as measured by the Singh validated area deprivation index (ADI), and 30-day rehospitalization. Design: Retrospective cohort study. Setting: United States. Patients: Random 5% national sample of Medicare patients discharged with congestive heart failure, pneumonia, or myocardial infarction between 2004 and 2009 (n = 255 744). Measurements: Medicare data were linked to 2000 census data to construct an ADI for each patient's census block group, which were then sorted into percentiles by increasing ADI. Relationships between neighborhood ADI grouping and 30-day rehospitalization were evaluated using multivariate logistic regression models, controlling for patient sociodemographic characteristics, comorbid conditions and severity, and index hospital characteristics. Results: The 30-day rehospitalization rate did not vary significantly across the least disadvantaged 85% of neighborhoods, which had an average rehospitalization rate of 21%. However, within the most disadvantaged 15% of neighborhoods, rehospitalization rates increased from 22% to 27% with worsening ADI. This relationship persisted after full adjustment, with the most disadvantaged neighborhoods having a rehospitalization risk (adjusted risk ratio, 1.09 [95% CI, 1.05 to 1.12]) similar to that of chronic pulmonary disease (adjusted risk ratio, 1.06 [CI, 1.04 to 1.08]) and greater than that of uncomplicated diabetes (adjusted risk ratio, 0.95 [CI, 0.94 to 0.97]). Limitation: No direct markers of care quality or access. Conclusion: Residence within a disadvantaged U.S. neighborhood is a rehospitalization predictor of magnitude similar to chronic pulmonary disease. Measures of neighborhood disadvantage, such as the ADI, could potentially be used to inform policy and care after hospital discharge.	Univ Wisconsin, Sch Med & Publ Hlth, Geriatr Res Educ & Clin Ctr, William S Middleton Vet Affairs Hosp, Madison, WI 53706 USA; Univ Wisconsin, Sch Nursing, Madison, WI USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; Telligen, Englewood, CO USA	Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kind, AJH (corresponding author), William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	ajk@medicine.wisc.edu	Ehlenbach, William J./R-5784-2019; Bartels, Christie Michels/ABG-4072-2020	Ehlenbach, William J./0000-0002-2864-5543; Bartels, Christie Michels/0000-0001-6523-0374; Kind, Amy/0000-0002-7183-610X	National Institute on Aging; University of Wisconsin School of Medicine and Public Health's Institute for Clinical and Translational Research and Health Innovation Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034551, K23AG038352] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Wisconsin School of Medicine and Public Health's Institute for Clinical and Translational Research and Health Innovation Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging and University of Wisconsin School of Medicine and Public Health's Institute for Clinical and Translational Research and Health Innovation Program.	Acevedo-Garcia D, 2008, HEALTH AFFAIR, V27, P321, DOI 10.1377/hlthaff.27.2.321; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Berenson Julia, 2012, Issue Brief (Commonw Fund), V34, P1; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Breslow NE., 1980, IARC SCI PUBL, P5; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Bureau U.S. Census, 2012, CART BOUND FIL DESCR; Cederberg M., 2009, THEMATIC REPORT SOCI; Centers for Medicare & Medicaid Services, 2009, CHRON COND DAT WAR; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Federal Reserve System Brookings Institution, 2008, END CHALL CONC POV A; Fleegler EW, 2007, PEDIATRICS, V119, pE1332, DOI 10.1542/peds.2006-1505; Foraker RE, 2011, CIRC-HEART FAIL, V4, P308, DOI 10.1161/CIRCHEARTFAILURE.110.959031; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; Gordon D., 1997, BREADLINE BRITAIN 19; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; HOUSE JS, 1990, MILBANK Q, V68, P383, DOI 10.2307/3350111; Hsieh C.-C., 1993, CRIMINAL JUSTICE REV, V18, P182, DOI [10.1177/073401689301800203, DOI 10.1177/073401689301800203]; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2008, HOSP 30 DAY ACUTE MY; Krumholz HM., 2008, HOSP 30 DAY PNEUMONI; Krumholz HNS, 2008, HOSP 30 DAY HEART FA; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; National Quality Forum, 2012, PAT OUTC ALL CAUS RE; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Raphael S., 2011, METROPOLITAN OPPORTU; Rau J., 2012, KAISER HLTH NEW 0813; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Singh GK, 2004, CANCER, V101, P1051, DOI 10.1002/cncr.20467; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Singh GK, 2002, JNCI-J NATL CANCER I, V94, P916, DOI 10.1093/jnci/94.12.916; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Singh GK, 2013, J URBAN HEALTH, V90, P388, DOI 10.1007/s11524-012-9744-0; Singh GK, 2011, J CANCER EPIDEMIOL, V2011, DOI 10.1155/2011/107497; Spicker P., 2000, WELFARE STATE GEN TH; Sundquist K, 2003, J EPIDEMIOL COMMUN H, V57, P347, DOI 10.1136/jech.57.5.347; U.S. Census Bureau, POV DEF; U.S. Department of Agriculture Economic Research Service, RUR CLASS OV; US Department of Housing & Urban Development, 1996, 1 BIENNIAL REPORT C; van Walraven C, 2013, J HOSP MED, V8, P261, DOI 10.1002/jhm.2025; Washington State Department of Health, 2009, GUID US RUR URB CLAS	59	495	495	1	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					765	U36		10.7326/M13-2946	http://dx.doi.org/10.7326/M13-2946			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UJ	25437404	Green Accepted			2022-12-01	WOS:000347247200005
J	Zhelezinskaia, I; Kaufman, AJ; Farquhar, J; Cliff, J				Zhelezinskaia, Iadviga; Kaufman, Alan J.; Farquhar, James; Cliff, John			Large sulfur isotope fractionations associated with Neoarchean microbial sulfate reduction	SCIENCE			English	Article							WESTERN-AUSTRALIA; HAMERSLEY BASIN; KAAPVAAL CRATON; ATMOSPHERE; EVOLUTION; SEDIMENTS; RECORD; SYSTEMATICS; RESERVOIR; INSIGHTS	The minor extent of sulfur isotope fractionation preserved in many Neoarchean sedimentary successions suggests that sulfate-reducing microorganisms played an insignificant role in ancient marine environments, despite evidence that these organisms evolved much earlier. We present bulk, microdrilled, and ion probe sulfur isotope data from carbonate-associated pyrite in the similar to 2.5-billion-year-old Batatal Formation of Brazil, revealing large mass-dependent fractionations (approaching 50 per mil) associated with microbial sulfate reduction, as well as consistently negative Delta S-33 values (similar to -2 per mil) indicative of atmospheric photochemical reactions. Persistent S-33 depletion through similar to 60 meters of shallow marine carbonate implies long-term stability of seawater sulfate abundance and isotope composition. In contrast, a negative Delta S-33 excursion in lower Batatal strata indicates a response time of similar to 40,000 to 150,000 years, suggesting Neoarchean sulfate concentrations between similar to 1 and 10 mu M.	[Zhelezinskaia, Iadviga; Kaufman, Alan J.; Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Zhelezinskaia, Iadviga; Kaufman, Alan J.; Farquhar, James] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Cliff, John] Univ Western Australia, ARC Ctr Excellence Core Crust Fluid Syst, Ctr Microscopy Characterizat & Anal, Crawley, WA 6009, Australia	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Western Australia	Zhelezinskaia, I (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	zhelezka@umd.edu	Cliff, John B/C-7696-2011; Zhelezinskaia, Iadviga/ABH-8456-2020	Cliff, John B/0000-0002-7395-5604; Zhelezinskaia, Iadviga/0000-0002-7677-0488	Fulbright Program [15110620]; NASA Astrobiology Institute [NNA09DA81A]; NSF Frontiers of Earth Surface Dynamics program [432129]; Directorate For Geosciences [1338810] Funding Source: National Science Foundation	Fulbright Program; NASA Astrobiology Institute; NSF Frontiers of Earth Surface Dynamics program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Noce, N. Geboy, and A. Shrestha, as well as the facilities and the scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterization and Analysis at the University of Western Australia, a facility funded by the University, State, and Commonwealth governments. Supported by the Fulbright Program (grantee ID 15110620, I.Z.), NASA Astrobiology Institute grant NNA09DA81A (J.F.), and NSF Frontiers of Earth Surface Dynamics program grant 432129 (A.J.K.). All data are provided in the supplementary materials.	Altermann W, 1998, SEDIMENT GEOL, V120, P225, DOI 10.1016/S0037-0738(98)00034-7; Bontognali TRR, 2012, P NATL ACAD SCI USA, V109, P15146, DOI 10.1073/pnas.1207491109; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Cheney ES, 1996, PRECAMBRIAN RES, V79, P3, DOI 10.1016/0301-9268(95)00085-2; Condie KC, 2001, PRECAMBRIAN RES, V106, P239, DOI 10.1016/S0301-9268(00)00097-8; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2013, P NATL ACAD SCI USA, V110, P17638, DOI 10.1073/pnas.1218851110; Fischer WW, 2009, PRECAMBRIAN RES, V169, P15, DOI 10.1016/j.precamres.2008.10.010; Gomes ML, 2013, GEOLOGY, V41, P663, DOI 10.1130/G34187.1; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halevy I, 2013, P NATL ACAD SCI USA, V110, P17644, DOI 10.1073/pnas.1213148110; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Jamieson JW, 2013, NAT GEOSCI, V6, P61, DOI [10.1038/NGEO1647, 10.1038/ngeo1647]; Johnston DT, 2007, GEOCHIM COSMOCHIM AC, V71, P3929, DOI 10.1016/j.gca.2007.05.008; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Ono SH, 2009, PRECAMBRIAN RES, V169, P58, DOI 10.1016/j.precamres.2008.10.013; Paris G., 2012, MINERAL MAG, V76, P2204; Partridge MA, 2008, EARTH PLANET SC LETT, V272, P41, DOI 10.1016/j.epsl.2008.03.051; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Reinhard CT, 2013, NATURE, V497, P100, DOI 10.1038/nature12021; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Shen YN, 2009, EARTH PLANET SC LETT, V279, P383, DOI 10.1016/j.epsl.2009.01.018; SIMONSON BM, 1993, PRECAMBRIAN RES, V60, P287, DOI 10.1016/0301-9268(93)90052-4; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238	30	66	66	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					742	744		10.1126/science.1256211	http://dx.doi.org/10.1126/science.1256211			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378623				2022-12-01	WOS:000344690100039
J	Sarma, K; Cifuentes-Rojas, C; Ergun, A; del Rosario, A; Jeon, Y; White, F; Sadreyev, R; Lee, JT				Sarma, Kavitha; Cifuentes-Rojas, Catherine; Ergun, Ayla; del Rosario, Amanda; Jeon, Yesu; White, Forest; Sadreyev, Ruslan; Lee, Jeannie T.			ATRX Directs Binding of PRC2 to Xist RNA and Polycomb Targets	CELL			English	Article							X-CHROMOSOME INACTIVATION; REPRESSIVE COMPLEX 2; LONG NONCODING RNAS; SYNDROME PROTEIN; STEM-CELLS; CHROMATIN; GENE; DOMAIN; REPEAT; LOCALIZATION	X chromosome inactivation (XCI) depends on the long noncoding RNA Xist and its recruitment of Polycomb Repressive Complex 2 (PRC2). PRC2 is also targeted to other sites throughout the genome to effect transcriptional repression. Using XCI as a model, we apply an unbiased proteomics approach to isolate Xist and PRC2 regulators and identified ATRX. ATRX unexpectedly functions as a high-affinity RNA-binding protein that directly interacts with RepA/Xist RNA to promote loading of PRC2 in vivo. Without ATRX, PRC2 cannot load onto Xist RNA nor spread in cis along the X chromosome. Moreover, epigenomic profiling reveals that genomewide targeting of PRC2 depends on ATRX, as loss of ATRX leads to spatial redistribution of PRC2 and derepression of Polycomb responsive genes. Thus, ATRX is a required specificity determinant for PRC2 targeting and function.	[Sarma, Kavitha; Cifuentes-Rojas, Catherine; Jeon, Yesu; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Sarma, Kavitha; Cifuentes-Rojas, Catherine; Ergun, Ayla; Jeon, Yesu; Sadreyev, Ruslan; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Sarma, Kavitha; Cifuentes-Rojas, Catherine; Ergun, Ayla; Jeon, Yesu; Sadreyev, Ruslan; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Sadreyev, Ruslan; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sadreyev, Ruslan; Lee, Jeannie T.] Harvard Univ, Sch Med, Boston, MA USA; [del Rosario, Amanda] MIT, Dept Bioengn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu		White, Forest/0000-0002-1545-1651	National Institutes of Health Grants [F32-GM090765, F32-GM101828, RO1-GM090278]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM101828, R01GM090278, F32GM090765] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ulandt Kim for next generation sequencing, all lab members for helpful advice, and Drs.David Picketts (Ottawa Hospital Research Institute) and Xiaolu Yang (University of Pennsylvania) for the kind gift of ATRX plasmids. This work was supported by National Institutes of Health Grants F32-GM090765 (to K.S.), F32-GM101828 (to CCR), and RO1-GM090278 (to J.T.L.).J.T.L.is an Investigator of the Howard Hughes Medical Institute.	Baumann C, 2009, CHROMOSOMA, V118, P209, DOI 10.1007/s00412-008-0189-x; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clynes D, 2013, TRENDS BIOCHEM SCI, V38, P461, DOI 10.1016/j.tibs.2013.06.011; Curran TG, 2013, METHODS, V61, P219, DOI 10.1016/j.ymeth.2013.03.004; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Johnson H, 2012, MOL CELL PROTEOMICS, V11, P1724, DOI 10.1074/mcp.M112.019984; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Nusinow DA, 2007, J BIOL CHEM, V282, P12851, DOI 10.1074/jbc.M610502200; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Ratnakumar K, 2013, EPIGENETICS-US, V8, P3, DOI 10.4161/epi.23271; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	57	144	153	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					869	883		10.1016/j.cell.2014.10.019	http://dx.doi.org/10.1016/j.cell.2014.10.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417162	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000344522000018
J	Thome, JJC; Yudanin, N; Ohmura, Y; Kubota, M; Grinshpun, B; Sathaliyawala, T; Kato, T; Lerner, H; Shen, YF; Farber, DL				Thome, Joseph J. C.; Yudanin, Naomi; Ohmura, Yoshiaki; Kubota, Masaru; Grinshpun, Boris; Sathaliyawala, Taheri; Kato, Tomoaki; Lerner, Harvey; Shen, Yufeng; Farber, Donna L.			Spatial Map of Human T Cell Compartmentalization and Maintenance over Decades of Life	CELL			English	Article							EFFECTOR-MEMORY; RHEUMATOID-ARTHRITIS; LYMPHOID ORGANS; DOWN-REGULATION; EXPRESSION; RESIDENT; CD4(+); SUBSETS; CCR7; DIFFERENTIATION	Mechanisms for human memory T cell differentiation and maintenance have largely been inferred from studies of peripheral blood, though the majority of T cells are found in lymphoid and mucosal sites. We present here a multidimensional, quantitative analysis of human T cell compartmentalization and maintenance over six decades of life in blood, lymphoid, and mucosal tissues obtained from 56 individual organ donors. Our results reveal that the distribution and tissue residence of naive, central, and effector memory, and terminal effector subsets is contingent on both their differentiation state and tissue localization. Moreover, T cell homeostasis driven by cytokine or TCR-mediated signals is different in CD4+ or CD8+ T cell lineages, varies with their differentiation stage and tissue localization, and cannot be inferred from blood. Our data provide an unprecedented spatial and temporal map of human T cell compartmentalization and maintenance, supporting distinct pathways for human T cell fate determination and homeostasis.	[Thome, Joseph J. C.; Yudanin, Naomi; Sathaliyawala, Taheri; Farber, Donna L.] Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY 10032 USA; [Ohmura, Yoshiaki; Kubota, Masaru; Kato, Tomoaki; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Thome, Joseph J. C.; Yudanin, Naomi; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Grinshpun, Boris; Shen, Yufeng] Columbia Univ, Dept Syst Biol & Biomed Informat, New York, NY 10032 USA; [Grinshpun, Boris; Shen, Yufeng] Columbia Univ, JP Sulzberger Columbia Genome Ctr, New York, NY 10032 USA; [Lerner, Harvey] New York Organ Donor Network, New York, NY 10001 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Farber, DL (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY 10032 USA.	df2396@cumc.columbia.edu	Yudanin, Naomi/U-2757-2019	Yudanin, Naomi/0000-0002-5019-2851; Grinshpun, Boris/0000-0001-7699-7554; Farber, Donna/0000-0001-8236-9183	NIH [P01AI06697, F31AG047003]; BD Bioscience Immunology Research Grant; S10 Shared Instrumentation Grant [1S10RR027050]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086164, P01AI106697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BD Bioscience Immunology Research Grant; S10 Shared Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH P01AI06697 awarded to D.L.F. J.J.T is supported by NIH F31AG047003 and a BD Bioscience Immunology Research Grant. These studies were performed in the CCTI Flow Cytometry Core funded in part through an S10 Shared Instrumentation Grant, 1S10RR027050. We wish to gratefully acknowledge the generosity of the donor families and the outstanding efforts of the NYODN transplant coordinators and staff for making this study possible. We also wish to thank Dr. Claire Gordon and Mr. Sam Mickel for assistance with tissue processing, and Drs. Uri Hershberg and Claire Gordon for critical reading of this manuscript.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Kiazyk SAK, 2008, TRENDS MICROBIOL, V16, P567, DOI 10.1016/j.tim.2008.08.011; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Schon MP, 1999, J IMMUNOL, V162, P6641; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Strauch UG, 2001, J IMMUNOL, V166, P3506, DOI 10.4049/jimmunol.166.5.3506; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Turner DL, 2014, IMMUNOL REV, V258, P150, DOI 10.1111/imr.12149; Vallejo AN, 1999, J IMMUNOL, V162, P6572; Vander Lugt B, 2013, J IMMUNOL, V191, P3119, DOI 10.4049/jimmunol.1200938; Walch JM, 2013, J CLIN INVEST, V123, P2663, DOI 10.1172/JCI66722; Wang DH, 2004, J IMMUNOL, V172, P214, DOI 10.4049/jimmunol.172.1.214; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Warrington KJ, 2003, BLOOD, V101, P3543, DOI 10.1182/blood-2002-08-2574	42	346	353	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					814	828		10.1016/j.cell.2014.10.026	http://dx.doi.org/10.1016/j.cell.2014.10.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417158	Bronze, Green Accepted			2022-12-01	WOS:000344522000014
J	Zuppinger-Dingley, D; Schmid, B; Petermann, JS; Yadav, V; De Deyn, GB; Flynn, DFB				Zuppinger-Dingley, Debra; Schmid, Bernhard; Petermann, Jana S.; Yadav, Varuna; De Deyn, Gerlinde B.; Flynn, Dan F. B.			Selection for niche differentiation in plant communities increases biodiversity effects	NATURE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIPS; GRASSLAND EXPERIMENT; SPECIES-DIVERSITY; EVOLUTION; GENOTYPES; RICHNESS	In experimental plant communities, relationships between biodiversity and ecosystem functioning have been found to strengthen over time(1,2), a fact often attributed to increased resource complementarity between species in mixtures(3) and negative plant-soil feedbacks in monocultures(4). Here we show that selection for niche differentiation between species can drive this increasing biodiversity effect. Growing 12 grassland species in test monocultures and mixtures, we found character displacement between species and increased biodiversity effects when plants had been selected over 8 years in species mixtures rather than in monocultures. When grown in mixtures, relative differences in height and specific leaf area between plant species selected in mixtures (mixture types) were greater than between species selected inmonocultures (monoculture types). Furthermore, net biodiversity and complementarity effects(1,2) were greater in mixtures of mixture types than inmixtures of monoculture types. Our study demonstrates a novel mechanism for the increase in biodiversity effects: selection for increased niche differentiation through character displacement. Selection in diverse mixtures may therefore increase species coexistence and ecosystem functioning in natural communities and may also allow increased mixture yields in agriculture or forestry. However, loss of biodiversity and prolonged selection of crops in monoculture may compromise this potential for selection in the longer term.	[Zuppinger-Dingley, Debra; Schmid, Bernhard; Yadav, Varuna; Flynn, Dan F. B.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Zuppinger-Dingley, Debra; Schmid, Bernhard; Yadav, Varuna; Flynn, Dan F. B.] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland; [Petermann, Jana S.] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Petermann, Jana S.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [De Deyn, Gerlinde B.] Wageningen Univ, NL-6708 PB Wageningen, Netherlands; [Flynn, Dan F. B.] Harvard Univ, Arnold Arboretum, Boston, MA 02131 USA	University of Zurich; University of Zurich; Free University of Berlin; Wageningen University & Research; Harvard University	Schmid, B (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernhard.schmid@ieu.uzh.ch; dan.flynn@ieu.uzh.ch	Petermann, Jana/E-2130-2013; De Deyn, Gerlinde/F-7080-2017; Schmid, Bernhard/C-8625-2009; Zuppinger-Dingley, Debra/N-7022-2013; De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/AFI-8702-2022; Flynn, Dan/AAT-7028-2020; Petermann, Jana/AAK-9787-2020; Flynn, Dan/A-4200-2008	Petermann, Jana/0000-0002-3898-5656; De Deyn, Gerlinde/0000-0003-4823-6912; Schmid, Bernhard/0000-0002-8430-3214; De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; Flynn, Dan/0000-0002-2978-5257; Petermann, Jana/0000-0002-3898-5656; Flynn, Dan/0000-0002-2978-5257; Zuppinger-Dingley, Debra/0000-0002-4573-0563	Swiss National Science Foundation [130720]; University Research Priority Program Global Change and Biodiversity of the University of Zurich; NWO-ALW VIDI grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University Research Priority Program Global Change and Biodiversity of the University of Zurich; NWO-ALW VIDI grant	This study was supported by the Swiss National Science Foundation (grant number 130720 to B. S.) and the University Research Priority Program Global Change and Biodiversity of the University of Zurich. Thanks to D. Trujillo Villegas, L. Oesch, T. Zwimpfer, M. Furler, R. Husi, the gardeners of the Jena Experiment and student helpers for technical assistance. G. B. D. D. acknowledges the NWO-ALW VIDI grant scheme for financial support.	Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CONNELL J H, 1971, P298; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kulmatiski A, 2012, P ROY SOC B-BIOL SCI, V279, P3020, DOI 10.1098/rspb.2012.0285; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Roscher C, 2013, PERSPECT PLANT ECOL, V15, P139, DOI 10.1016/j.ppees.2013.02.004; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Strauss SY, 2008, ECOL LETT, V11, P199, DOI 10.1111/j.1461-0248.2007.01128.x; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TURKINGTON R, 1979, J ECOL, V67, P219, DOI 10.2307/2259346; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wacker L, 2009, J PLANT ECOL-UK, V2, P95, DOI 10.1093/jpe/rtp010; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Zeller SL, 2012, ECOL APPL, V22, P1817, DOI 10.1890/11-0876.1	30	208	214	20	429	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					108	+		10.1038/nature13869	http://dx.doi.org/10.1038/nature13869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25317555				2022-12-01	WOS:000344187500039
J	Ianchulev, T; Minckler, DS; Hoskins, HD; Packer, M; Stamper, R; Pamnani, RD; Koo, EY				Ianchulev, Tsontcho; Minckler, Donald S.; Hoskins, H. Dunbar; Packer, Mark; Stamper, Robert; Pamnani, Ravinder D.; Koo, Edward Y.			Wearable Technology With Head-Mounted Displays and Visual Function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ianchulev, Tsontcho; Hoskins, H. Dunbar; Stamper, Robert; Koo, Edward Y.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94109 USA; [Minckler, Donald S.] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA USA; [Packer, Mark] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Pamnani, Ravinder D.] Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California Irvine; Oregon Health & Science University; Stanford University	Ianchulev, T (corresponding author), Univ Calif San Francisco, 909 Hyde St,Ste 530, San Francisco, CA 94109 USA.	sean@ianchulev.com	Packer, Mark/P-8600-2019	Packer, Mark/0000-0003-2681-6641				Steel SE, 1996, OPHTHAL PHYSL OPT, V16, P95, DOI 10.1016/0275-5408(95)00026-7	1	9	9	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1799	1801		10.1001/jama.2014.13754	http://dx.doi.org/10.1001/jama.2014.13754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369493	Green Submitted			2022-12-01	WOS:000344194500020
J	Whitson, HE; Lin, FR				Whitson, Heather E.; Lin, Frank R.			Hearing and Vision Care for Older Adults Sensing a Need to Update Medicare Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEMENTIA		[Whitson, Heather E.] Duke Univ, Med Ctr, Dept Med Geriatr, Durham, NC 27710 USA; [Whitson, Heather E.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Whitson, Heather E.] Duke Ctr Study Aging & Human Dev, Durham, NC USA; [Whitson, Heather E.] Durham VA Geriatr Res Educ & Clin Ctr GRECC, Durham, NC USA; [Lin, Frank R.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Sch Med, Dept Med Geriatr, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lin, Frank R.] Johns Hopkins Ctr Hlth & Aging, Baltimore, MD USA	Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Whitson, HE (corresponding author), Duke Univ, Med Ctr, POB 3003, Durham, NC 27710 USA.	heather.whitson@duke.edu	Whitson, Heather/K-8941-2019	Whitson, Heather/0000-0002-8417-4846	NATIONAL INSTITUTE ON AGING [R01AG043438, P30AG028716, R24AG045050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011279] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG028716, R01AG043438, R24AG045050, R01 AG043438, R24 AG045050, P30AG028716] Funding Source: Medline; NIDCD NIH HHS [K23DC011279, K23 DC011279] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Hudson HL, 2006, OPHTHALMOLOGY, V113, P1987, DOI 10.1016/j.ophtha.2006.07.010; International Federation on Ageing, 2013, HIGH COST LOW VIS EV; IOM (Institute of Medicine) and NRC (National Research Council), 2014, HEAR LOSS HLTH AG WO; Lin FR, 2014, AGING MENT HEALTH, V18, P671, DOI 10.1080/13607863.2014.915924; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; National Eye Institute (NEI), LOW VIS; NIH Research Portfolio Online Reporting Tools (RePORT), HEARING AIDS; Rogers MAM, 2010, AM J EPIDEMIOL, V171, P728, DOI 10.1093/aje/kwp453; USPSTF, US PREV SERV TASK FO	9	26	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2014	312	17					1739	1740		10.1001/jama.2014.13535	http://dx.doi.org/10.1001/jama.2014.13535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3QX	25369486	Green Accepted			2022-12-01	WOS:000344194500009
J	Schirle, NT; Sheu-Gruttadauria, J; MacRae, IJ				Schirle, Nicole T.; Sheu-Gruttadauria, Jessica; MacRae, Ian J.			Structural basis for microRNA targeting	SCIENCE			English	Article							POSTTRANSCRIPTIONAL REGULATION; PASSENGER-STRAND; GUIDE STRAND; C-ELEGANS; ARGONAUTE; RNA; SIRNA; CLEAVAGE; RISC; COMPLEXES	MicroRNAs (miRNAs) control expression of thousands of genes in plants and animals. miRNAs function by guiding Argonaute proteins to complementary sites in messenger RNAs (mRNAs) targeted for repression. We determined crystal structures of human Argonaute-2 (Ago2) bound to a defined guide RNA with and without target RNAs representing miRNA recognition sites. These structures suggest a stepwise mechanism, in which Ago2 primarily exposes guide nucleotides (nt) 2 to 5 for initial target pairing. Pairing to nt 2 to 5 promotes conformational changes that expose nt 2 to 8 and 13 to 16 for further target recognition. Interactions with the guide-target minor groove allow Ago2 to interrogate target RNAs in a sequence-independent manner, whereas an adenosine binding-pocket opposite guide nt 1 further facilitates target recognition. Spurious slicing of miRNA targets is avoided through an inhibitory coordination of one catalytic magnesium ion. These results explain the conserved nucleotide-pairing patterns in animal miRNA target sites first observed over two decades ago.	[Schirle, Nicole T.; Sheu-Gruttadauria, Jessica; MacRae, Ian J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022		National Institute of General Medical Sciences [P41 GM103403]; U.S. Department of Energy [DE-AC02-06CH11357]; NIH [R01 GM104475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM104475] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to P. D. Zamore and J. R. Williamson for generous advice and scientific insights. Diffraction data were collected at beam lines 11-1 and 12-2 at the Stanford Synchrotron Radiation Lightsource and 24-ID-E at the Advanced Photon Source, supported by National Institute of General Medical Sciences grant P41 GM103403 and U.S. Department of Energy contract DE-AC02-06CH11357. N.T.S. is a predoctoral fellow of the American Heart Association and an Achievement Rewards for College Scientists (ARCS) scholar. The work was supported by NIH grant R01 GM104475 to I. J. M. Coordinates of the Ago2-guide and guide-target complexes have been deposited in the Protein Data Bank (PDB) (4W5N, 4W5O, 4W5Q, 4W5R, and 4W5T).	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hauptmann J, 2013, NAT STRUCT MOL BIOL, V20, P814, DOI 10.1038/nsmb.2577; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Nakanishi K, 2013, CELL REP, V3, P1893, DOI 10.1016/j.celrep.2013.06.010; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Poulsen C, 2013, PLANT CELL, V25, P22, DOI 10.1105/tpc.112.105643; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; ROSS PD, 1960, P NATL ACAD SCI USA, V46, P1360, DOI 10.1073/pnas.46.10.1360; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	45	339	362	3	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		608	613		10.1126/science.1258040	http://dx.doi.org/10.1126/science.1258040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359968	Green Accepted, Green Submitted			2022-12-01	WOS:000343799700042
J	Markenscoff-Papadimitriou, E; Allen, WE; Colquitt, BM; Goh, T; Murphy, KK; Monahan, K; Mosley, CP; Ahituv, N; Lomvardas, S				Markenscoff-Papadimitriou, Eirene; Allen, William E.; Colquitt, Bradley M.; Goh, Tracie; Murphy, Karl K.; Monahan, Kevin; Mosley, Colleen P.; Ahituv, Nadav; Lomvardas, Stavros			Enhancer Interaction Networks as a Means for Singular Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTOR; GENE-EXPRESSION; HIGH-RESOLUTION; HUMAN GENOME; MOUSE; PROTEIN; CHOICE; TRANSCRIPTION; PROMOTER; FEEDBACK	The transcriptional activation of one out of similar to 2800 olfactory receptor (OR) alleles is a poorly understood process. Here, we identify a plethora of putative OR enhancers and study their in vivo activity in olfactory neurons. Distinguished by an unusual epigenetic signature, candidate OR enhancers are characterized by extensive interchromosomal interactions associated with OR transcription and share a similar pattern of transcription factor footprints. In particular, we establish the role of the transcription factor Bptf as a facilitator of both enhancer interactions and OR transcription. Our observations agree with the model whereby OR transcription occurs in the context of multiple interacting enhancers. Disruption of these interchromosomal interactions results in weak and multigenic OR expression, suggesting that the rare coincidence of numerous enhancers over a stochastically chosen OR may account for the singularity and robustness in OR transcription.	[Markenscoff-Papadimitriou, Eirene; Colquitt, Bradley M.; Lomvardas, Stavros] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Allen, William E.] Stanford Univ, Grad Program Neurosci, Sch Med, Stanford, CA 94305 USA; [Goh, Tracie; Monahan, Kevin; Mosley, Colleen P.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Murphy, Karl K.; Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Murphy, Karl K.; Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lomvardas, S (corresponding author), Columbia Univ, Mortimer B Zuckerman Mind Brain & Behav Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	sl682@columbia.edu	Colquitt, Bradley/AAR-7838-2021	Colquitt, Bradley/0000-0001-5819-7924; Monahan, Kevin/0000-0001-8922-5801; Lomvardas, Stavros/0000-0002-7668-3026; Ahituv, Nadav/0000-0002-7434-8144	NIH [5R01DA030320, 5R01DA036894, 5R01DC013560, R01HD059862, 1R01NS079231, 1R01DK090382]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036894, R01DA030320] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank members of the Ahituv lab for their help and expertise with the zebrafish expression assay. We warmly thank Christos Papadimitriou for consultations about modeling and critical reading of the manuscript. We would like to thank Jessica Tollkuhn and members of the Lomvardas lab for critical reading of the manuscript. This project was supported by NIH grants 5R01DA030320, 5R01DA036894, 5R01DC013560 (for S.L.), R01HD059862, 1R01NS079231, and 1R01DK090382 (for N.A.). None of the authors of this manuscript have financial interests related to this work.	Andrey G, 2014, CELL, V156, DOI 10.1016/j.cell.2014.01.060; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Ariza-Cosano A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-713; Armelin-Correa LM, 2014, P NATL ACAD SCI USA, V111, P2782, DOI 10.1073/pnas.1317036111; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Booker BM, 2013, DEV GENES EVOL, V223, P395, DOI 10.1007/s00427-013-0453-9; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Delpretti S, 2013, CELL REP, V5, P137, DOI 10.1016/j.celrep.2013.09.002; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ferreira T, 2014, NEURON, V81, P847, DOI 10.1016/j.neuron.2014.01.001; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Johnston RJ, 2014, SCIENCE, V343, P661, DOI 10.1126/science.1243039; Jordan-Sciutto KL, 1999, J BIOL CHEM, V274, P35262, DOI 10.1074/jbc.274.49.35262; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landry JW, 2011, GENE DEV, V25, P275, DOI 10.1101/gad.2007311; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Smith RP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r72; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009; Zhou ZS, 2012, CELL REP, V2, P1143, DOI 10.1016/j.celrep.2012.09.035	56	110	113	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					543	557		10.1016/j.cell.2014.09.033	http://dx.doi.org/10.1016/j.cell.2014.09.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417106	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000344521700011
J	Moynihan, R				Moynihan, Ray			TOO MUCH MEDICINE Evening the score on sex drugs: feminist movement or marketing masquerade?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Robina, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Robina, Australia.		Moynihan, Ray/ABC-3010-2020					American Psychiatric Association, 2013, HIGHL CHANG DSM4TR D; American Sexual Health Association, FOR 990 RET ORG EX I; Clayton Anita H, 2014, BMC Res Notes, V7, P459, DOI 10.1186/1756-0500-7-459; DeBruyn J., 2014, TRIANGLE BUSINESS J; FDA, WARN LETT SLAT PHARM; Katz M, 2013, J SEX MED, V10, P1807, DOI 10.1111/jsm.12189; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moynihan R, 2005, BRIT MED J, V330, P192, DOI 10.1136/bmj.330.7484.192; Moynihan R., 2010, SEX LIES PHARM; Moynihan R, 2010, BMJ-BRIT MED J, V30, P341; Moynihan R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3339	11	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2014	349								g6246	10.1136/bmj.g6246	http://dx.doi.org/10.1136/bmj.g6246			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NY	25354348				2022-12-01	WOS:000343767700004
J	Modlin, J; Wenger, J				Modlin, John; Wenger, Jay			Achieving and Maintaining Polio Eradication - New Strategies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE; INDIA		[Modlin, John; Wenger, Jay] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Modlin, J (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.							Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; John J, 2014, LANCET; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x	5	9	9	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1476	1479		10.1056/NEJMp1407783	http://dx.doi.org/10.1056/NEJMp1407783			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7KV	25317869				2022-12-01	WOS:000342994700004
J	Lee, R; Mason, A				Lee, Ronald; Mason, Andrew		NTA Network	Is low fertility really a problem? Population aging, dependency, and consumption	SCIENCE			English	Article								Longer lives and fertility far below the replacement level of 2.1 births per woman are leading to rapid population aging in many countries. Many observers are concerned that aging will adversely affect public finances and standards of living. Analysis of newly available National Transfer Accounts data for 40 countries shows that fertility well above replacement would typically be most beneficial for government budgets. However, fertility near replacement would be most beneficial for standards of living when the analysis includes the effects of age structure on families as well as governments. And fertility below replacement would maximize per capita consumption when the cost of providing capital for a growing labor force is taken into account. Although low fertility will indeed challenge government programs and very low fertility undermines living standards, we find that moderately low fertility and population decline favor the broader material standard of living.	[Lee, Ronald] Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA; [Lee, Ronald] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [Mason, Andrew] Univ Hawaii Manoa, Dept Econ, Honolulu, HI 96821 USA; [Mason, Andrew] East West Ctr, Honolulu, HI 96848 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Hawaii System; University of Hawaii Manoa; East West Center	Lee, R (corresponding author), Univ Calif Berkeley, Dept Demog, 2232 Piedmont Ave, Berkeley, CA 94720 USA.	rlee@demog.berkeley.edu; amason@hawaii.edu	Gal, Robert/AAD-8449-2022; Rentería, Elisenda/I-2567-2015; Queiroz, Bernardo L/U-7783-2017; Zannella, Marina/AAJ-2329-2020; Bucheli, Marisa/I-5639-2019; Rice, James Mahmud/C-3581-2008	Gal, Robert/0000-0002-2326-8558; Rentería, Elisenda/0000-0002-7072-8465; Queiroz, Bernardo L/0000-0002-2890-1025; Zannella, Marina/0000-0003-2412-0819; Bucheli, Marisa/0000-0003-0159-4712; Rice, James Mahmud/0000-0001-5986-9139; Olaniyan, Olanrewaju/0000-0002-7115-7983; SECKIN, ZENNUBE AYLIN/0000-0003-4139-2728; Turra, Cassio/0000-0003-4051-3567; Tovar, Jorge/0000-0001-5525-6829; Dramani, Latif/0000-0001-6178-875X; Olivera, Javier/0000-0002-8769-7845; d'Albis, Hippolyte/0000-0002-6409-4320	NIH, National Institute on Aging [R37 AG025247]; Bill and Melinda Gates Foundation; Economic and Social Research Council [ES/L500343/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R37AG025247] Funding Source: NIH RePORTER; ESRC [ES/L500343/1] Funding Source: UKRI	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	R.L.'s research for this paper was funded by the NIH, National Institute on Aging grant R37 AG025247, and R. L. and A.M.'s research was funded by the Bill and Melinda Gates Foundation through a grant provided to Johns Hopkins Bloomberg School of Public Health. Construction of NTA for many developing countries was possible due to the support of the International Development Research Centre (Canada). The content is solely the responsibility of the authors. The views expressed in this paper are those of J.B. and do not necessarily reflect those of the United Nations. We are grateful to D. Stojanovic for able research assistance. The data are available at http://ntaccounts.org/web/nta/show/Science.	ARTHUR WB, 1978, INT ECON REV, V19, P241, DOI 10.2307/2526407; Backus D, 2008, J MONETARY ECON, V55, P48, DOI 10.1016/j.jmoneco.2007.11.008; Bloom D., 2002, DEMOGRAPHIC DIVIDEND; CALVO GA, 1988, ECONOMETRICA, V56, P411, DOI 10.2307/1911079; CUTLER DM, 1990, BROOKINGS PAPERS EC, V1990; Deardorff A. V., 1976, INT ECON REV, V17, P510; ESPENSHADE TJ, 1982, DEMOGRAPHY, V19, P125, DOI 10.2307/2061132; Feenstra RC, NEXT GENERATION PENN; Goldstein J. R., 2009, INT HDB POPULATION A, P7; Lee R, 2011, POPULATION AGING AND THE GENERATIONAL ECONOMY: A GLOBAL PERSPECTIVE, P1; Lee R, 1994, DEMOGRAPHY AGING, P8; LEE RD, 1994, J HUM RESOUR, V29, P1027, DOI 10.2307/146133; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Mason A., 2009, BUREAU EC RES SERIES, P89; Piketty T., 2014, CAPITAL 21 CENTURY, P816; Samuelson, 1975, INT ECON REV, V16, P531, DOI [10.2307/2525993, DOI 10.2307/2525993]; Samuelson P.A., 1976, INT ECON REV, V17, P516; SCHMERTMANN CP, 1992, DEMOGRAPHY, V29, P595, DOI 10.2307/2061854; United Nations Department of Economic and Social Affairs, 2013, NAT TRANSF ACC MAN M; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP POL DAT; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; Willis R. J., 1988, EC CHANGING AGE DIST, P106	22	79	80	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					229	234		10.1126/science.1250542	http://dx.doi.org/10.1126/science.1250542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301626	Green Accepted			2022-12-01	WOS:000342721500046
J	Huttenhower, C; Knight, R; Brown, CT; Caporaso, JG; Clemente, JC; Gevers, D; Franzosa, EA; Kelley, ST; Knights, D; Ley, RE; Mahurkar, A; Ravel, J; White, O				Huttenhower, Curtis; Knight, Rob; Brown, C. Titus; Caporaso, J. Gregory; Clemente, Jose C.; Gevers, Dirk; Franzosa, Eric A.; Kelley, Scott T.; Knights, Dan; Ley, Ruth E.; Mahurkar, Anup; Ravel, Jacques; White, Owen		Scientists Advancement Microbiome	Advancing the Microbiome Research Community	CELL			English	Editorial Material							METADATA	The human microbiome has become a recognized factor in promoting and maintaining health. We outline opportunities in interdisciplinary research, analytical rigor, standardization, and policy development for this relatively new and rapidly developing field. Advances in these aspects of the research community may in turn advance our understanding of human microbiome biology.	[Huttenhower, Curtis; Franzosa, Eric A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob; Gevers, Dirk] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, HHMI, Boulder, CO 80309 USA; [Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86001 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Knights, Dan] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Mahurkar, Anup; Ravel, Jacques; White, Owen] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [White, Owen] Univ Maryland, Sch Med, Ctr Hlth Related Informat & Bioimaging, Baltimore, MD 21201 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Michigan State University; Michigan State University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; California State University System; San Diego State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	White, O (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	owhite@som.umaryland.edu	raes, jeroen/D-7835-2018; Ravel, Jacques/D-2530-2009; Knight, Rob/D-1299-2010; Gevers, Dirk/C-1451-2009; Ley, Ruth E/M-8542-2014	raes, jeroen/0000-0002-1337-041X; Ley, Ruth E/0000-0002-9087-1672; Brown, C. Titus/0000-0001-6001-2677; Caporaso, Greg/0000-0002-8865-1670; Ravel, Jacques/0000-0002-0851-2233; Knight, Rob/0000-0002-0975-9019	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG005969, U54HG003067, R01HG005969, U54 HG003067, U01 HG004866] Funding Source: Medline; NIAID NIH HHS [R01 AI089878, UH2AI083264, U19AI08404, UH2 AI083264, R01AI089878] Funding Source: Medline; NIDCR NIH HHS [U54DE023798, U54 DE023798] Funding Source: Medline; NIDDK NIH HHS [U54 DK102557, P30 DK043351] Funding Source: Medline; NIGMS NIH HHS [R01GM103604, R01 GM103604] Funding Source: Medline; NINR NIH HHS [R01NR014826, R01 NR014826] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005969, U01HG004866, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008404, UH2AI083264, R01AI089878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102557, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014826] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Beauharnais CC, 2012, CLIN TRIALS, V9, P198, DOI 10.1177/1740774511434844; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Hirschman L, 2008, OMICS, V12, P129, DOI 10.1089/omi.2008.0016; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Pan HQ, 2012, HUM MUTAT, V33, P849, DOI 10.1002/humu.22074; Rhodes R, 2011, AM J BIOETHICS, V11, P1, DOI 10.1080/15265161.2011.615588; Richesson R, 2010, ADV EXP MED BIOL, V686, P87, DOI 10.1007/978-90-481-9485-8_6; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	14	48	49	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					227	230		10.1016/j.cell.2014.09.022	http://dx.doi.org/10.1016/j.cell.2014.09.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303518	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000343095600002
J	Allemani, C; Weir, HK; Carreira, H; Harewood, R; Spika, D; Wang, XS; Bannon, F; Ahn, JV; Johnson, CJ; Bonaventure, A; Marcos-Gragera, R; Stiller, C; Silva, GAE; Chen, WQ; Ogunbiyi, OJ; Rachet, B; Soeberg, MJ; You, H; Matsuda, T; Bielska-Lasota, M; Storm, H; Tucker, TC; Coleman, MP				Allemani, Claudia; Weir, Hannah K.; Carreira, Helena; Harewood, Rhea; Spika, Devon; Wang, Xiao-Si; Bannon, Finian; Ahn, Jane V.; Johnson, Christopher J.; Bonaventure, Audrey; Marcos-Gragera, Rafael; Stiller, Charles; Azevedo e Silva, Gulnar; Chen, Wan-Qing; Ogunbiyi, Olufemi J.; Rachet, Bernard; Soeberg, Matthew J.; You, Hui; Matsuda, Tomohiro; Bielska-Lasota, Magdalena; Storm, Hans; Tucker, Thomas C.; Coleman, Michel P.		CONCORD Working Grp	Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)	LANCET			English	Article							BREAST-CANCER; CHILDHOOD-CANCER; RECTAL-CANCER; NORDIC COUNTRIES; EUROPE 1999-2007; OVARIAN-CANCER; NET SURVIVAL; DATA QUALITY; CARE; STAGE	Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. Methods Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25.7 million adults (age 15-99 years) and 75 000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. Findings 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. Interpretation International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems.	[Allemani, Claudia; Carreira, Helena; Harewood, Rhea; Spika, Devon; Wang, Xiao-Si; Ahn, Jane V.; Bonaventure, Audrey; Rachet, Bernard; Coleman, Michel P.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England; [Weir, Hannah K.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA; [Bannon, Finian] Queens Univ Belfast, Ctr Publ Hlth, Northern Ireland Canc Registry, Belfast, Antrim, North Ireland; [Johnson, Christopher J.] Canc Data Registry Idaho, Boise, ID USA; [Marcos-Gragera, Rafael] Inst Invest Biomed Girona, Dept Salut, Unitat Epidemiol & Registre Canc Girona, Girona, Spain; [Stiller, Charles] Publ Hlth England, South East Knowledge & Intelligence Team, Oxford, England; [Azevedo e Silva, Gulnar] Univ Estado Rio de Janeiro, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Chen, Wan-Qing] Natl Canc Ctr, Natl Off Canc Prevent & Control, Beijing, Peoples R China; [Chen, Wan-Qing] Natl Canc Ctr, Natl Cent Canc Registry, Beijing, Peoples R China; [Ogunbiyi, Olufemi J.] Univ City Coll Hosp, Ibadan Canc Registry, Ibadan, Nigeria; [Soeberg, Matthew J.] Australian Technol Pk, New South Wales Cent Canc Registry, Sydney, NSW, Australia; [You, Hui] Canc Inst NSW, Sydney, NSW, Australia; [Matsuda, Tomohiro] Natl Canc Ctr, Populat Based Canc Registry Sect, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo 104, Japan; [Bielska-Lasota, Magdalena] Natl Inst Publ Hlth, Dept Hlth Promot & Postgrad Educ, Warsaw, Poland; [Bielska-Lasota, Magdalena] Natl Inst Hyg, PL-00791 Warsaw, Poland; [Storm, Hans] Danish Canc Soc, Canc Prevent & Documentat, Copenhagen, Denmark; [Tucker, Thomas C.] Univ Kentucky, Kentucky Canc Registry, Lexington, KY USA	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Queens University Belfast; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Public Health England; Universidade do Estado do Rio de Janeiro; University of Ibadan; University College Hospital, Ibadan; National Cancer Center - Japan; National Institute of Public Health (NIPH); National Institute of Hygiene (NIH); Danish Cancer Society; University of Kentucky	Coleman, MP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England.	concord@lshtm.ac.uk	Serraino, Diego/J-3915-2018; MOLINA PORTILLO, ELENA/ABA-3364-2021; Ochir, Chimedsuren/AAW-7743-2020; falcini, fabio/W-4345-2018; Yépez, Maria Clara/N-7710-2017; Marcos-Gragera, Rafael/A-1437-2017; Berrino, Franco/AAC-2364-2020; Belot, Aurelien/N-9287-2016; Ogunbiyi, Olufemi/ABE-4224-2020; Curado, Maria Paula/M-6200-2013; Clavel, Jacqueline/Q-2750-2016; Katalinic, Alexander/D-2512-2010; Didkowska, Joanna Aleksandra/ABG-8672-2020; Mangone, Lucia/J-4701-2016; Sant, Milena/D-2362-2017; Alexandre, Tiago/ABI-3506-2020; Matsuda, Tomohiro/H-7078-2019; Abdel-Rahman, Manar/R-4652-2016; Cornet, Edouard/M-5625-2019; BOUVIER, Anne-Marie/R-6600-2017; Tagliabue, Giovanna/D-4194-2017; Calleja, Neville/E-3895-2019; Cornet, Edouard/A-9757-2010; Coleman, Michel/AAA-9543-2020; Monnereau, Alain/L-1249-2014; SALAZAR, ANTONIO/A-5806-2013; Valkov, Mikhail Yurievich/L-4441-2018; Gatta, Gemma/B-8627-2017; BOUVIER, Véronique/L-7799-2015; Contiero, Paolo/F-6721-2016; Baili, Paolo/J-7422-2016; Pathy, Nirmala Bhoo/C-1228-2010; Sekerija, Mario/W-8550-2019; Sánchez, Maria-José/D-1087-2011; Zucchetto, Antonella/ABC-8649-2020; Alexandre, Tiago/GRJ-3364-2022; Herrmann, Christian/J-1094-2019; Gozdz, Stanislaw/D-3300-2013; De Angelis, Roberta/N-3970-2017; Bravo, Luis Eduardo/K-9882-2014; Ferretti, Stefano/K-8636-2015; JURADO, DANIEL/G-3254-2014; Bastos, Joana/M-6918-2015; Lima, Carlos Anselmo/A-4225-2013; Antunes, Luis/A-8572-2014	Serraino, Diego/0000-0003-0565-8920; MOLINA PORTILLO, ELENA/0000-0002-9955-3080; Ochir, Chimedsuren/0000-0002-7134-5255; falcini, fabio/0000-0002-0864-6266; Yépez, Maria Clara/0000-0002-3482-5786; Marcos-Gragera, Rafael/0000-0001-9824-3657; Berrino, Franco/0000-0002-4858-1866; Belot, Aurelien/0000-0003-1410-5172; Curado, Maria Paula/0000-0001-8172-2483; Clavel, Jacqueline/0000-0002-3616-7676; Katalinic, Alexander/0000-0003-0490-1554; Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Mangone, Lucia/0000-0002-5089-5178; Sant, Milena/0000-0002-4148-8597; Alexandre, Tiago/0000-0003-3791-9793; Abdel-Rahman, Manar/0000-0001-9968-9853; Cornet, Edouard/0000-0003-1667-3421; Tagliabue, Giovanna/0000-0001-8165-5524; Calleja, Neville/0000-0003-1800-2103; Cornet, Edouard/0000-0003-1667-3421; Coleman, Michel/0000-0001-8940-3807; Monnereau, Alain/0000-0002-5056-1397; SALAZAR, ANTONIO/0000-0003-2639-2340; Valkov, Mikhail Yurievich/0000-0003-3230-9638; Gatta, Gemma/0000-0003-4160-6458; BOUVIER, Véronique/0000-0002-2016-0779; Contiero, Paolo/0000-0001-6760-3605; Baili, Paolo/0000-0003-0335-2418; Pathy, Nirmala Bhoo/0000-0003-0568-8863; Sekerija, Mario/0000-0001-7508-1501; Sánchez, Maria-José/0000-0003-4817-0757; Zucchetto, Antonella/0000-0003-2812-6345; Alexandre, Tiago/0000-0003-3791-9793; Herrmann, Christian/0000-0001-9349-8917; Carreira, Helena/0000-0003-1538-2526; ZAIDI, ZOUBIDA/0000-0003-3378-4799; Eisemann, Nora/0000-0002-8521-6497; tumino, rosario/0000-0003-2666-414X; Gozdz, Stanislaw/0000-0001-6902-3807; De Angelis, Roberta/0000-0001-7787-3043; Sciacca, Salvatore/0000-0002-8613-6296; Chiolero, Arnaud/0000-0002-5544-8510; Dimitrova, Nadya/0000-0002-5958-6320; Zborovskaya, Anna/0000-0001-5684-9634; Bravo, Luis Eduardo/0000-0002-9708-0312; Sassi, Franco/0000-0001-9773-2117; Bento, Maria Jose/0000-0002-7690-9830; Woods, Ryan/0000-0002-9520-2128; Vitale, Francesco/0000-0002-6354-8060; Ferretti, Stefano/0000-0001-5241-2101; Mitter, Vera/0000-0002-1483-5020; JURADO, DANIEL/0000-0003-0628-0253; Bastos, Joana/0000-0002-9815-5603; Brewster, David/0000-0002-5346-5608; Vercelli, Marina/0000-0002-9757-2616; CHIANG, CHUN-JU/0000-0002-1330-5319; Larranaga, Nerea/0000-0002-9993-9880; Rachet, Bernard/0000-0001-5837-7773; Spika, Devon/0000-0001-9738-7755; grosclaude, pascale/0000-0002-6755-5970; Crocetti, Emanuele/0000-0002-4649-2034; Lima, Carlos Anselmo/0000-0003-4269-7320; Lillini, Roberto/0000-0001-9872-8670; Bonaventure, Audrey/0000-0001-6665-8145; Antunes, Luis/0000-0002-3098-0711; Storm, Hans/0000-0001-7223-8198; Currow, David/0000-0003-1988-1250; Tryggvadottir, Laufey/0000-0001-8067-9030; Bielska-Lasota, Magdalena/0000-0003-0960-8672; molinie, florence/0000-0002-0645-4017; Sacerdote, Carlotta/0000-0002-8008-5096; Trojanowski, Maciej/0000-0002-9124-1509	Canadian Partnership Against Cancer (Toronto, Canada); Cancer Focus Northern Ireland (Belfast, UK); Cancer Institute New South Wales (Sydney, Australia); Cancer Research UK (London, UK); Centers for Disease Control and Prevention (Atlanta, GA, USA); Swiss Re (London, UK); Swiss Cancer Research foundation (Bern, Switzerland); Swiss Cancer League (Bern, Switzerland); University of Kentucky (Lexington, KY, USA); Cancer Research UK [16148, 18525] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER	Canadian Partnership Against Cancer (Toronto, Canada); Cancer Focus Northern Ireland (Belfast, UK); Cancer Institute New South Wales (Sydney, Australia); Cancer Research UK (London, UK)(Cancer Research UK); Centers for Disease Control and Prevention (Atlanta, GA, USA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Swiss Re (London, UK); Swiss Cancer Research foundation (Bern, Switzerland); Swiss Cancer League (Bern, Switzerland); University of Kentucky (Lexington, KY, USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Canadian Partnership Against Cancer (Toronto, Canada), Cancer Focus Northern Ireland (Belfast, UK), Cancer Institute New South Wales (Sydney, Australia), Cancer Research UK (London, UK), Centers for Disease Control and Prevention (Atlanta, GA, USA), Swiss Re (London, UK), Swiss Cancer Research foundation (Bern, Switzerland), Swiss Cancer League (Bern, Switzerland), and University of Kentucky (Lexington, KY, USA).	Aareleid T, 2002, INT J CANCER, V102, P45, DOI 10.1002/ijc.10663; Allemani C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003055; Allemani C, 2013, INT J CANCER, V132, P1170, DOI 10.1002/ijc.27725; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; Andersen MR, 2013, EUR J CANC; [Anonymous], 2012, RES AD GEN ASS POL D; [Anonymous], 2013, COMP MACR CONT REG G; [Anonymous], 2013, WORLD POP PROSP 2012, V1; [Anonymous], HUM MORT DAT; Beniaiche K., 2012, DEFICIENCE NOTRE SYS; Berrino F, 1995, IARC SCI PUBL, V132, P1; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bosman FT, 2010, WHO CLASSIFICATION T, V3, P160; Bossard N, 2007, EUR J CANCER, V43, P149, DOI 10.1016/j.ejca.2006.07.021; BRASIL. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2011, PLAN AC ESTR ENFR DO; Brasso Klaus, 2006, Ugeskr Laeger, V168, P1243; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Bray Freddie, 2014, IARC TECHNICAL PUBLI, V43; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; Brenner H, 2007, INT J CANCER, V121, P2274, DOI 10.1002/ijc.22932; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Capocaccia R, 2003, ANN ONCOL, V14, pV14, DOI 10.1093/annonc/mdg751; Casali PG, 2014, ANN ONCOL, V25, P1458, DOI 10.1093/annonc/mdu218; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Chawla Neetu, 2013, Journal of the National Cancer Institute Monographs, P36, DOI 10.1093/jncimonographs/lgt009; Chen XC, 2014, LANCET ONCOL, V15, pE471, DOI 10.1016/S1470-2045(14)70441-3; Clerc-Urmes I, 2014, STATA J, V14, P87, DOI 10.1177/1536867X1401400107; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Curado MP, 2007, CANC INCIDENCE 5 CON, VIx, p[160, 961]; Curtis RE., 2006, NEW MALIGNANCIES CAN; Cutler SJ, 1964, NCI MONOGRAPH, V15; Danieli C, 2012, STAT MED, V31, P775, DOI 10.1002/sim.4464; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; De Angelis R, 2009, EUR J CANCER, V45, P909, DOI 10.1016/j.ejca.2008.11.003; Department of Health, 2011, IMPR OUTC STRAT CANC; Dickman PW, 1997, J EPIDEMIOL BIOSTAT, V2, P87; Elandt-Johnson RC., 1980, SURVIVAL MODELS DATA; Elferink MAG, 2010, EUR J CANCER, V46, P1421, DOI 10.1016/j.ejca.2010.01.025; Ellis L, 2014, INT J CANCER, V135, P1774, DOI 10.1002/ijc.28990; Ellison LF, 2010, CANCER EPIDEMIOL, V34, P550, DOI 10.1016/j.canep.2010.06.015; European Network of Cancer Registries, 2011, REC COD MULT PRIM; EWBANK DC, 1983, POP STUD-J DEMOG, V37, P105, DOI 10.1080/00324728.1983.10405927; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2005, CHECK CONVERSIONS PR; Folkesson J, 2009, INT J CANCER, V125, P2406, DOI 10.1002/ijc.24562; Fritz A, 2000, INT CLASSIFICATION D, V3rd; Gatta G, 1999, CANCER CAUSE CONTROL, V10, P575, DOI 10.1023/A:1008959211777; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; Gatta Gemma, 2013, Journal of the National Cancer Institute Monographs, P79, DOI 10.1093/jncimonographs/lgt004; Gondos A, 2005, BRIT J CANCER, V92, P1808, DOI 10.1038/sj.bjc.6602540; Gondos A, 2004, INT J CANCER, V112, P860, DOI 10.1002/ijc.20471; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Greenwood M., 1926, NATURAL DURATION CAN; Hijmans R., 2012, GADM DATABASE GLOBAL; Horton R, 2014, LANCET, V383, P1620, DOI 10.1016/S0140-6736(14)60769-8; IARC, 2010, C15 CANC INC 5 CONT; Innos K, 2012, ACTA ONCOL, V51, P521, DOI 10.3109/0284186X.2011.633928; Jansen L, 2012, EUR J EPIDEMIOL, V27, P689, DOI 10.1007/s10654-012-9723-5; Johnson CJ, 2013, CANCER EPIDEMIOL, V37, P20, DOI 10.1016/j.canep.2012.08.007; Johnson Christopher J, 2010, J Registry Manag, V37, P86; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Karanikolos Marina, 2013, Journal of the National Cancer Institute Monographs, P7, DOI 10.1093/jncimonographs/lgt003; Kelly RJ, 2014, LANCET ONCOL, V15, pE112, DOI 10.1016/S1470-2045(13)70578-3; Klint A, 2010, ACTA ONCOL, V49, P632, DOI 10.3109/02841861003691945; Knaul F., 2011, CLOSING CANC DIVIDE; Krilaviciute A, 2014, ACTA ONCOL, V53, P1238, DOI 10.3109/0284186X.2014.888495; Kurman R, 2014, WHO CLASSIF TUMOURS; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lakhani S, 2012, WHO CLASSIFICATION T; LANGMUIR AD, 1963, NEW ENGL J MED, V268, P182, DOI 10.1056/NEJM196301242680405; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li RR, 2014, CANCER EPIDEMIOL, V38, P314, DOI 10.1016/j.canep.2014.02.013; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Maringe C, 2012, GYNECOL ONCOL, V127, P75, DOI 10.1016/j.ygyno.2012.06.033; Mariotto AB, 2007, CANCER EPIDEM BIOMAR, V16, P566, DOI 10.1158/1055-9965.EPI-06-0782; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P40, DOI 10.1093/jjco/hyq167; Micheli A, 2003, ANN ONCOL, V14, pV28, DOI 10.1093/annonc/mdg752; Minicozzi P, 2014, DIGEST LIVER DIS, V46, P645, DOI 10.1016/j.dld.2014.03.009; Mitenbergs U, 2012, HLTH SYSTEMS TRANSIT, V14, P1; Mitry E, 2005, EUR J CANCER, V41, P2297, DOI 10.1016/j.ejca.2005.01.028; Mitry E, 2002, BRIT J SURG, V89, P1557, DOI 10.1046/j.1365-2168.2002.02276.x; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; National Audit Office, 2010, DEL CANC REF STRAT; National Cancer Center, 2010, CANC FACTS FIG 2010; OECD, 2013, CANC CAR ASS QUAL IM; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Perez-Cuevas R, 2013, PEDIATR BLOOD CANCER, V60, P196, DOI 10.1002/pbc.24265; Perme MP, 2009, BIOSTATISTICS, V10, P136, DOI 10.1093/biostatistics/kxn021; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rosso S, 2009, EUR J CANCER, V45, P1080, DOI 10.1016/j.ejca.2008.11.030; Rutherford MJ, 2013, BRIT J CANCER, V108, P691, DOI 10.1038/bjc.2013.12; Samiei M., 2013, CANC CARE EMERGING H, P87; Sankaranarayanan R, 1998, IARC SCI PUBLICATION, V145; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; SANKILA R, 2003, EVALUATION CLIN CARE; Sant M, 2010, TUMORI, V96, pi; Sant M, 2010, BLOOD, V116, P3724, DOI 10.1182/blood-2010-05-282632; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646; Sobin LH., 2011, TNM CLASSIFICATION M; StataCorp, 2013, STATA STAT SOFTW VER; STILLER CA, 1990, BRIT J CANCER, V62, P806, DOI 10.1038/bjc.1990.383; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Surveillance Epidemiology and End Results program, 2007, MULT PRIM HIST COD R; Swaminathan R, 2008, B WORLD HEALTH ORGAN, V86, P509, DOI 10.2471/BLT.07.046979; Tomatis L, 1997, TUMORI, V83, P505, DOI 10.1177/030089169708300113; Tretli S, 1996, J NATL CANCER I, V88, P128, DOI 10.1093/jnci/88.2.128; Umoh NJ, 2011, LIVER INT, V31, P215, DOI 10.1111/j.1478-3231.2010.02418.x; United Nations Population Division, 2005, WORLD POP PROSP 2004, P54; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; Walters S, 2013, BRIT J CANCER, V108, P1195, DOI 10.1038/bjc.2013.6; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Walters S, 2013, INT J CANCER, V132, P676, DOI 10.1002/ijc.27651; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Weir HK, 2013, CANCER CAUSE CONTROL, V24, P1231, DOI 10.1007/s10552-013-0203-3; WHO, 2012, DEC LIST RES 65 WORL; Woods LM, 2012, INT J CANCER, V131, pE1120, DOI 10.1002/ijc.27545; Wu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062930; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zeng H, 2014, INT J CANC	133	1525	1665	9	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					977	1010		10.1016/S0140-6736(14)62038-9	http://dx.doi.org/10.1016/S0140-6736(14)62038-9			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25467588	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-01	WOS:000350886900032
J	Chou, S; Daugherty, MD; Peterson, SB; Biboy, J; Yang, YY; Jutras, BL; Fritz-Laylin, LK; Ferrin, MA; Harding, BN; Jacobs-Wagner, C; Yang, XF; Vollmer, W; Malik, HS; Mougous, JD				Chou, Seemay; Daugherty, Matthew D.; Peterson, S. Brook; Biboy, Jacob; Yang, Youyun; Jutras, Brandon L.; Fritz-Laylin, Lillian K.; Ferrin, Michael A.; Harding, Brittany N.; Jacobs-Wagner, Christine; Yang, X. Frank; Vollmer, Waldemar; Malik, Harmit S.; Mougous, Joseph D.			Transferred interbacterial antagonism genes augment eukaryotic innate immune function	NATURE			English	Article							LYME-DISEASE SPIROCHETE; VI SECRETION SYSTEM; BORRELIA-BURGDORFERI; BACTERIA; PEPTIDOGLYCAN; EVOLUTION; SEQUENCE; PROTEIN; HOST; PERFORMANCE	Horizontal gene transfer allows organisms to rapidly acquire adaptive traits(1). Although documented instances of horizontal gene transfer from bacteria to eukaryotes remain rare, bacteria represent a rich source of new functions potentially available for co-option(2). One benefit that genes of bacterial origin could provide to eukaryotes is the capacity to produce antibacterials, which have evolved in prokaryotes as the result of eons of interbacterial competition. The type VI secretion amidase effector (Tae) proteins are potent bacteriocidal enzymes that degrade the cell wall when delivered into competing bacterial cells by the type VI secretion system(3). Here we show that tae genes have been transferred to eukaryotes on at least six occasions, and that the resulting domesticated amidase effector (dae) genes have been preserved for hundreds of millions of years through purifying selection. We show that the dae genes acquired eukaryotic secretion signals, are expressed within recipient organisms, and encode active antibacterial toxins that possess substrate specificity matching extant Tae proteins of the same lineage. Finally, we show that a dae gene in the deer tick Ixodes scapularis limits proliferation of Borrelia burgdorferi, the aetiologic agent of Lyme disease. Our work demonstrates that a family of horizontally acquired toxins honed to mediate interbacterial antagonism confers previously undescribed antibacterial capacity to eukaryotes. We speculate that the selective pressure imposed by competition between bacteria has produced a reservoir of genes encoding diverse antimicrobial functions that are tailored for co-option by eukaryotic innate immune systems.	[Chou, Seemay; Peterson, S. Brook; Ferrin, Michael A.; Harding, Brittany N.; Mougous, Joseph D.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Daugherty, Matthew D.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Daugherty, Matthew D.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Yang, Youyun; Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Jutras, Brandon L.; Jacobs-Wagner, Christine] Yale Univ, Microbial Sci Inst, New Haven, CT 06516 USA; [Jutras, Brandon L.; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06516 USA; [Fritz-Laylin, Lillian K.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jacobs-Wagner, Christine] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06516 USA; [Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06516 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Newcastle University - UK; Indiana University System; Indiana University Bloomington; Yale University; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Francisco; Yale University; Yale University	Mougous, JD (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu	Malik, Harmit S/I-5591-2019; Daugherty, Matthew/AAT-4418-2020	Malik, Harmit S/0000-0001-6005-0016; Biboy, jacob/0000-0002-1286-6851; Fritz-Laylin, Lillian/0000-0002-9237-9403; Jacobs-Wagner, Christine/0000-0003-0980-5334; Jutras, Brandon/0000-0002-7989-1031; Ferrin, Michael/0000-0002-9899-1169	National Institutes of Health [AI080609, AI083640]; Defense Threat Reduction Agency [HDTRA-1-13-014]; BBSRC [BB/I020012/1]; Howard Hughes Medical Institute (HHMI); American Society for Microbiology Undergraduate Research Fellowship; Irvington Institute Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083640, R01AI080609] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I020012/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Society for Microbiology Undergraduate Research Fellowship; Irvington Institute Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Holland for assistance with transcriptome analysis, D. Vollmer and C. Aldridge for PG preparation, J. Parrish for microinjection assistance, J. Young for assistance with phylogenetic analyses, H. Merrikh for sharing equipment, and T. Alber, C. Fuqua, K. Clay, E. Rynkiewicz, U. Pal, C. Grundner, G. Nester, P. Singh and members of the Malik and Mougous laboratories for helpful discussions. This work was funded by the National Institutes of Health (AI080609 to J.D.M. and AI083640 to X.F.Y.), the Defense Threat Reduction Agency (HDTRA-1-13-014 to J.D.M.) and the BBSRC (BB/I020012/1 to W.V.). S.C. was supported by a Howard Hughes Medical Institute (HHMI)-sponsored Life Sciences Research Foundation fellowship, M.A.F. by the American Society for Microbiology Undergraduate Research Fellowship, and M.D.D. by an Irvington Institute Fellowship from the Cancer Research Institute. C.J.-W. and H.S.M. are investigators of the HHMI. J.D.M. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; BECK G, 1990, BIOCHEM BIOPH RES CO, V167, P89, DOI 10.1016/0006-291X(90)91734-A; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D. H., 1993, BACTERIAL GROWTH LYS; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fulton C., 1970, Methods Cell Physiol., V4, P341; FULTON C, 1967, DEV BIOL, V15, P165, DOI 10.1016/0012-1606(67)90012-7; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Sonenshine DE., 2013, BIOL TICKS; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Warnke KM, 2011, MOL PHYLOGENET EVOL, V58, P390, DOI 10.1016/j.ympev.2010.11.024; Wybouw N, 2014, ELIFE, V3, DOI 10.7554/eLife.02365; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Zhang LL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002079	47	52	54	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					98	+		10.1038/nature13965	http://dx.doi.org/10.1038/nature13965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25470067	Green Accepted			2022-12-01	WOS:000349098000039
J	Garg, AX; Nevis, IF; McArthur, E; Sontrop, JM; Koval, JJ; Lam, NN; Hildebrand, AM; Reese, PP; Storsley, L; Gill, JS; Segev, DL; Habbous, S; Bugeja, A; Knoll, GA; Dipchand, C; Monroy-Cuadros, M; Lentine, KL				Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Reese, Peter P.; Storsley, Leroy; Gill, John S.; Segev, Dorry L.; Habbous, Steven; Bugeja, Ann; Knoll, Greg A.; Dipchand, Christine; Monroy-Cuadros, Mauricio; Lentine, Krista L.		DONOR Network	Gestational Hypertension and Preeclampsia in Living Kidney Donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL DISCHARGE DATA; MEDICAL OUTCOMES; MATCHED COHORT; CARDIOVASCULAR-DISEASE; ADMINISTRATIVE DATA; PREGNANCY OUTCOMES; RACIAL VARIATION; ORGAN DONORS; DONATION; RISK	Background Young women wishing to become living kidney donors frequently ask whether nephrectomy will affect their future pregnancies. Methods We conducted a retrospective cohort study of living kidney donors involving 85 women (131 pregnancies after cohort entry) who were matched in a 1: 6 ratio with 510 healthy nondonors from the general population (788 pregnancies after cohort entry). Kidney donations occurred between 1992 and 2009 in Ontario, Canada, with follow-up through linked health care databases until March 2013. Donors and nondonors were matched with respect to age, year of cohort entry, residency (urban or rural), income, number of pregnancies before cohort entry, and the time to the first pregnancy after cohort entry. The primary outcome was a hospital diagnosis of gestational hypertension or preeclampsia. Secondary outcomes were each component of the primary outcome examined separately and other maternal and fetal outcomes. Results Gestational hypertension or preeclampsia was more common among living kidney donors than among nondonors (occurring in 15 of 131 pregnancies [11%] vs. 38 of 788 pregnancies [5%]; odds ratio for donors, 2.4; 95% confidence interval, 1.2 to 5.0; P = 0.01). Each component of the primary outcome was also more common among donors (odds ratio, 2.5 for gestational hypertension and 2.4 for preeclampsia). There were no significant differences between donors and nondonors with respect to rates of preterm birth (8% and 7%, respectively) or low birth weight (6% and 4%, respectively). There were no reports of maternal death, stillbirth, or neonatal death among the donors. Most women had uncomplicated pregnancies after donation. Conclusions Gestational hypertension or preeclampsia was more likely to be diagnosed in kidney donors than in matched nondonors with similar indicators of baseline health. (Funded by the Canadian Institutes of Health Research and others.)	[Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Lawson Hlth Res Inst, London Kidney Clin Res Unit, Inst Clin Evaluat Sci, London, ON, Canada; [Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Schulich Sch Med & Dent, Div Nephrol, Dept Med, London, ON, Canada; [Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Schulich Sch Med & Dent, Div Nephrol, Dept Epidemiol, London, ON, Canada; [Garg, Amit X.; Nevis, Immaculate F.; McArthur, Eric; Sontrop, Jessica M.; Koval, John J.; Lam, Ngan N.; Hildebrand, Ainslie M.; Habbous, Steven] Univ Western Ontario, Schulich Sch Med & Dent, Div Nephrol, Dept Biostat, London, ON, Canada; [Storsley, Leroy] Univ Manitoba, Dept Med, Div Nephrol, Winnipeg, MB, Canada; [Gill, John S.] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada; [Bugeja, Ann; Knoll, Greg A.] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada; [Dipchand, Christine] Dalhousie Univ, Dept Med, Div Nephrol, Halifax, NS, Canada; [Monroy-Cuadros, Mauricio] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Reese, Peter P.] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Segev, Dorry L.] Johns Hopkins Univ Sch Med, Dept Surg, Baltimore, MD USA; [Lentine, Krista L.] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA; [Lentine, Krista L.] St Louis Univ, Div Nephrol, Dept Med, St Louis, MO 63103 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Manitoba; University of British Columbia; University of Ottawa; Dalhousie University; University of Calgary; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Saint Louis University; Saint Louis University	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Rm ELL-101,Westminster Tower, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Lentine, Krista/AAQ-6549-2020; Lam, Ngan/AAX-3472-2020; Garg, Amit X/G-3295-2011; Bugeja, Ann/K-7378-2019	Lentine, Krista/0000-0002-9423-4849; Lam, Ngan/0000-0002-0129-7091; Bugeja, Ann/0000-0002-4106-0451; Sontrop, Jessica M./0000-0001-7784-2028; Knoll, Greg/0000-0001-5442-9310; Boudville, Neil/0000-0002-5884-640X; Storsley, Leroy/0000-0003-1288-4854; Habbous, Steven/0000-0002-9650-9105	Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096008] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Canadian Institutes of Health Research and others.	Ahmadi AR, 2014, KIDNEY INT; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Doshi MD, 2013, AM J TRANSPLANT, V13, P111, DOI 10.1111/j.1600-6143.2012.04303.x; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Garg AX, 2012, AM J KIDNEY DIS, V59, P770, DOI 10.1053/j.ajkd.2012.01.013; Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Gibson KJ, 2006, AM J PHYSIOL-RENAL, V290, pF1153, DOI 10.1152/ajprenal.00241.2005; Hadfield RM, 2008, AUST NZ J OBSTET GYN, V48, P78, DOI 10.1111/j.1479-828X.2007.00818.x; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, AM J TRANSPLANT, V9, P825, DOI 10.1111/j.1600-6143.2009.02548.x; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Josephson MA, 2009, NAT REV NEPHROL, V5, P495, DOI 10.1038/nrneph.2009.129; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Korst LM, 2004, PAEDIATR PERINAT EP, V18, P112, DOI 10.1111/j.1365-3016.2003.00540.x; Lam N, 2012, NEPHROL DIAL TRANSPL, V27, P3291, DOI 10.1093/ndt/gfr802; Lentine KL, 2014, TRANSPLANTATION, V97, P316, DOI 10.1097/01.TP.0000436731.23554.5e; Lentine KL, 2010, NEW ENGL J MED, V363, P724, DOI 10.1056/NEJMoa1000950; Lin J, 2010, NEW ENGL J MED, V363, P797, DOI 10.1056/NEJMc1002100; Nayak-Rao S, 2011, SAUDI J KIDNEY DIS T, V22, P552; Nevis IF, 2009, AM J TRANSPLANT, V9, P661, DOI 10.1111/j.1600-6143.2009.02623.x; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; PACKHAM DK, 1992, PATHOLOGY, V24, P164, DOI 10.3109/00313029209063165; Poggio ED, 2009, CLIN J AM SOC NEPHRO, V4, P1677, DOI 10.2215/CJN.02740409; Ray JG, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000337; Reese PP, 2009, AM J TRANSPLANT, V9, P1967, DOI 10.1111/j.1600-6143.2009.02719.x; Reisaeter AV, 2009, AM J TRANSPLANT, V9, P820, DOI 10.1111/j.1600-6143.2008.02427.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sickand M, 2009, AM J TRANSPLANT, V9, P2825, DOI 10.1111/j.1600-6143.2009.02829.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Thomas SM, 2013, AM J TRANSPLANT, V13, P2935, DOI 10.1111/ajt.12446; Thomas SM, 2014, CLIN TRANSPLANT, V28, P530, DOI 10.1111/ctr.12344; Tong A, 2012, AM J KIDNEY DIS, V60, P15, DOI 10.1053/j.ajkd.2011.11.043; von Elm E, 2008, ANN INTERN MED, V148, P168, DOI DOI 10.7326/0003-4819-148-2-200801150-00020; Yang RC, 2007, AM J TRANSPLANT, V7, P1542, DOI 10.1111/j.1600-6143.2007.01793.x; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	38	168	180	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					124	133		10.1056/NEJMoa1408932	http://dx.doi.org/10.1056/NEJMoa1408932			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25397608	Green Accepted, Bronze			2022-12-01	WOS:000347443300007
J	Lutz, W; Muttarak, R; Striessnig, E				Lutz, Wolfgang; Muttarak, Raya; Striessnig, Erich			Universal education is key to enhanced climate adaptation	SCIENCE			English	Editorial Material									[Lutz, Wolfgang; Muttarak, Raya; Striessnig, Erich] WU, VID OAW, Wittgenstein Ctr Demog & Global Human Capital IIA, Vienna, Austria		Striessnig, E (corresponding author), WU, VID OAW, Wittgenstein Ctr Demog & Global Human Capital IIA, Vienna, Austria.	striess@iiasa.ac.at		Muttarak, Raya/0000-0003-0627-4451; Lutz, Wolfgang/0000-0001-7975-8145; Striessnig, Erich/0000-0001-5419-9498				Baker DP, 2012, DEV COGN NEUROS-NETH, V2, pS6, DOI 10.1016/j.dcn.2011.12.001; Center for Research on the Epidemiology of Disasters (CRED), 2010, EM DAT; Frankenberg E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05377-180216; Helgeson JF, 2013, ECOL SOC, V18, DOI 10.5751/ES-05390-180202; Keyfitz N., 1985, APPL MATH DEMOGRAPHY, Vsecond; Lutz W, 2008, SCIENCE, V319, P1047, DOI 10.1126/science.1151753; Muttarak R, 2014, ECOL SOC, V19, DOI 10.5751/ES-06476-190142; Muttarak R, 2013, ECOL SOC, V18, DOI 10.5751/ES-06101-180451; Nakhooda S., 2013, MOBILISING INT CLIMA; Nakicenovic N, 2014, CLIMATIC CHANGE, V122, P351, DOI 10.1007/s10584-013-0982-2; Niederdeppe J, 2007, CANCER EPIDEM BIOMAR, V16, P998, DOI 10.1158/1055-9965.EPI-06-0608; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Pamuk ER, 2011, POPUL DEV REV, V37, P637, DOI 10.1111/j.1728-4457.2011.00451.x; Samir KC, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI 10.1016/j.gloenvcha.2014.06.004; Walker B., 2006, RESILIENCE THINKING, DOI DOI 10.2174/	15	83	83	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1061	1062		10.1126/science.1257975	http://dx.doi.org/10.1126/science.1257975			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7EK	25430758				2022-12-01	WOS:000345763400024
J	Krause, DW; Hoffmann, S; Wible, JR; Kirk, EC; Schultz, JA; von Koenigswald, W; Groenke, JR; Rossie, JB; O'Connor, PM; Seiffert, ER; Dumont, ER; Holloway, WL; Rogers, RR; Rahantarisoa, LJ; Kemp, AD; Andriamialison, H				Krause, David W.; Hoffmann, Simone; Wible, John R.; Kirk, E. Christopher; Schultz, Julia A.; von Koenigswald, Wighart; Groenke, Joseph R.; Rossie, James B.; O'Connor, Patrick M.; Seiffert, Erik R.; Dumont, Elizabeth R.; Holloway, Waymon L.; Rogers, Raymond R.; Rahantarisoa, Lydia J.; Kemp, Addison D.; Andriamialison, Haingoson			First cranial remains of a gondwanatherian mammal reveal remarkable mosaicism	NATURE			English	Article							SOUTH-AMERICA; EYE SIZE; PREDATORY DINOSAUR; ACTIVITY PATTERN; VISUAL-ACUITY; MADAGASCAR; MULTITUBERCULATE; PRIMATES; PALEOCENE; EVOLUTION	Previously known only from isolated teeth and lower jaw fragments recovered from the Cretaceous and Palaeogene of the Southern Hemisphere, the Gondwanatheria constitute the most poorly known of all major maminaliaform radiations. Here we report the discovery of the first skull material of a gondwanatberian, a complete and well-preserved cranium from Upper Cretaceous strata in Madagascar car that we assign to a new genus and species. Phylogenetc analysis strongly supports its placement within Gondwanatheria, which are recognized a monophyletic and closely related to multituber-culates an evolutionarily success clade of Mesozoic mammals known almost exclusively from the Northern Hemisphere. The new taxon is the largest known mammaliaform from the Mesozoic of Gondwana. Its craniofacial anatomy reveals that it was herbivorous, a us in, large-eyed. of and agile, with well-developed high-frequency hearing and a keen sense of smell. The cranium exhibits primitive and derived features, the disparity of which is extreme and probably reflective of a long evolutionary history in geographic isolation.	[Krause, David W.; Hoffmann, Simone; Groenke, Joseph R.; Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA; [Kirk, E. Christopher; Kemp, Addison D.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Schultz, Julia A.; von Koenigswald, Wighart] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Rossie, James B.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [O'Connor, Patrick M.; Holloway, Waymon L.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [O'Connor, Patrick M.; Holloway, Waymon L.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Morrill Sci Ctr 221, Amherst, MA 01003 USA; [Rogers, Raymond R.] Macalester Coll, Dept Geol, St Paul, MN 55105 USA; [Rahantarisoa, Lydia J.] Univ Antananarivo, Dept Geol, Antananarivo 101, Madagascar; [Andriamialison, Haingoson] Univ Antananarivo, Dept Paleontol, Antananarivo 101, Madagascar	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Austin; University of Bonn; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University of Massachusetts System; University of Massachusetts Amherst; Macalester College; University Antananarivo; University Antananarivo	Krause, DW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	David.Krause@stonybrook.edu	D, Betsy/ABD-1855-2020; OConnor, Patrick M/I-9383-2012	OConnor, Patrick M/0000-0002-6762-3806; Groenke, Joseph/0000-0002-9527-1887; Hoffmann, Simone/0000-0001-8984-0601; Kirk, Chris/0000-0001-9439-3041	National Geographic Society [8597-09]; National Science Foundation [EAR-0446488, EAR-1123642]; Division Of Environmental Biology [0946430] Funding Source: National Science Foundation	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the Universite d'Antananarivo, the Madagascar Institut pour la Conservation des Ecosystemes Tropicaux, and the villagers of the Lac Kinkony Study Area for logistical support of fieldwork; various ministries of the Republic of Madagascar for permission to conduct field research; members of the 2010 field research team for their efforts; J. Thostenson and M. Hill of the American Museum of Natural History Microscopy & Imaging Facility, New York, New York, and J. Diehm and B. Ruether of Avonix Imaging, Plymouth, Minnesota, and various members of the Department of Radiology at Stony Brook University for providing expert assistance in computed tomography scanning; L. Betti-Nash for artwork; J. Neville for photography; D. Pulaski for reconstructing the cranium and building the finite element models; Z.-X. Luo, G. Rougier and A. Weil for their reviews of the paper; and the National Geographic Society (8597-09) and the National Science Foundation (EAR-0446488, EAR-1123642) for funding.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Berlin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079585; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; CLARK JM, 1985, NATURE, V315, P398, DOI 10.1038/315398a0; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gambaryan Petr P., 1995, Acta Palaeontologica Polonica, V40, P45; Goin FJ, 2012, NATURWISSENSCHAFTEN, V99, P449, DOI 10.1007/s00114-012-0919-z; GUROVICH Y, 2006, THESIS U BUENOS AIRE; Gurovich Y, 2008, PALAEONTOLOGY, V51, P1069, DOI 10.1111/j.1475-4983.2008.00805.x; Gurovich Y, 2009, J MAMM EVOL, V16, P25, DOI 10.1007/s10914-008-9097-3; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hurum Jorn H., 1998, Journal of Mammalian Evolution, V5, P65, DOI 10.1023/A:1020571003901; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; Kemp AD, 2014, ANAT REC, V297, P781, DOI 10.1002/ar.22892; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Koyabu D, 2012, P NATL ACAD SCI USA, V109, P14075, DOI 10.1073/pnas.1208693109; Krause DW, 2013, CAN J EARTH SCI, V50, P324, DOI 10.1139/e2012-074; Krause DW, 1992, J VERTEBR PALEONTOL, V12, P351, DOI 10.1080/02724634.1992.10011465; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1993, P NATL ACAD SCI USA, V90, P9379, DOI 10.1073/pnas.90.20.9379; Luo ZX, 2012, ZOOL J LINN SOC-LOND, V166, P433, DOI 10.1111/j.1096-3642.2012.00852.x; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Olson E. C., 1944, SPECIAL PAPERS GEOLO, DOI [10.1130/SPE55-p1, DOI 10.1130/GSAB-55-1]; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; Pascual Rosendo, 2007, Journal of Mammalian Evolution, V14, P75, DOI 10.1007/s10914-007-9039-5; Rich TH, 2009, ACTA PALAEONTOL POL, V54, P1, DOI 10.4202/app.2009.0101; Ritland S., 1982, THESIS U CHICAGO; Rogers RR, 2013, CRETACEOUS RES, V44, P12, DOI 10.1016/j.cretres.2013.03.008; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; ROUGIER G. W., 1993, THESIS U BUENOS AIRE; Rougier GW, 2011, NATURE, V479, P98, DOI 10.1038/nature10591; Ruf I, 2013, J VERTEBR PALEONTOL, V33, P382, DOI 10.1080/02724634.2013.722575; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Schultz AH, 1940, AM J PHYS ANTHROPOL, V26, P389, DOI 10.1002/ajpa.1330260138; Scillato-Yane G.J., 1985, Ameghiniana, V21, P173; SCILLATO-YANE G.J., 1984, PECULIAR PARATHERIA, P15; Vidal N, 2010, BIOL LETTERS, V6, P558, DOI 10.1098/rsbl.2010.0220; von Koenigswald W, 1999, ACTA PALAEONTOL POL, V44, P263; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007	50	80	85	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					512	+		10.1038/nature13922	http://dx.doi.org/10.1038/nature13922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25383528				2022-12-01	WOS:000346247600044
J	Stergachis, AB; Neph, S; Sandstrom, R; Haugen, E; Reynolds, AP; Zhang, MH; Byron, R; Canfield, T; Stelhing-Sun, S; Lee, K; Thurman, RE; Vong, S; Bates, D; Neri, F; Diegel, M; Giste, E; Dunn, D; Vierstra, J; Hansen, RS; Johnson, AK; Sabo, PJ; Wilken, MS; Reh, TA; Treuting, PM; Kaul, R; Groudine, M; Bender, MA; Borenstein, E; Stamatoyannopoulos, JA				Stergachis, Andrew B.; Neph, Shane; Sandstrom, Richard; Haugen, Eric; Reynolds, Alex P.; Zhang, Miaohua; Byron, Rachel; Canfield, Theresa; Stelhing-Sun, Sandra; Lee, Kristen; Thurman, Robert E.; Vong, Shinny; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Dunn, Douglas; Vierstra, Jeff; Hansen, R. Scott; Johnson, Audra K.; Sabo, Peter J.; Wilken, Matthew S.; Reh, Thomas A.; Treuting, Piper M.; Kaul, Rajinder; Groudine, Mark; Bender, M. A.; Borenstein, Elhanan; Stamatoyannopoulos, John A.			Conservation of trans-acting circuitry during mammalian regulatory evolution	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; PROTEIN-DNA INTERACTIONS; HUMAN GENOME; NETWORKS; DYNAMICS; DATABASE; MOTIFS; IDENTIFICATION; MECHANISMS; SIMILARITY	The basic body plan and major physiological axes have been highly conserved during mammalian evolution, yet only a small fraction of the human genome sequence appears to be subject to evolutionary constraint. To quantify cis-versus trans-acting contributions to mammalian regulatory evolution, we performed genomic DNase I footprinting of the mouse genome across 25 cell and tissue types, collectively defining similar to 8.6 million transcription factor (TF) occupancy sites at nucleotide resolution. Here we show that mouse TF footprints conjointly encode a regulatory lexicon that is similar to 95% similar with that derived from human TF footprints. However, only similar to 20% of mouse TF footprints have human orthologues. Despite substantial turnover of the cis-regulatory landscape, nearly half of all pairwise regulatory interactions connecting mouse TF genes have been maintained in orthologous human cell types through evolutionary innovation of TF recognition sequences. Furthermore, the higher-level organization of mouse TF-to-TF connections into cellular network architectures is nearly identical with human. Our results indicate that evolutionary selection on mammalian gene regulation is targeted chiefly at the level of trans-regulatory circuitry, enabling and potentiating cis-regulatory plasticity.	[Stergachis, Andrew B.; Neph, Shane; Sandstrom, Richard; Haugen, Eric; Reynolds, Alex P.; Canfield, Theresa; Stelhing-Sun, Sandra; Lee, Kristen; Thurman, Robert E.; Vong, Shinny; Bates, Daniel; Neri, Fidencio; Diegel, Morgan; Giste, Erika; Dunn, Douglas; Vierstra, Jeff; Hansen, R. Scott; Johnson, Audra K.; Sabo, Peter J.; Kaul, Rajinder; Borenstein, Elhanan; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zhang, Miaohua; Byron, Rachel; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hansen, R. Scott; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wilken, Matthew S.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Groudine, Mark] Univ Washington, Div Radiat Oncol, Seattle, WA 98195 USA; [Bender, M. A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98102 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Kaul, Rajinder/0000-0002-7895-9284; Sandstrom, Richard/0000-0002-3356-1547; Haugen, Eric/0000-0001-7444-8981; Vierstra, Jeff/0000-0001-6406-8563	NIH [U54HG004592, U54HG007010, U01ES01156, RC2HG005654, R37 DK44746]; NIDDK [FDK095678A]; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, RC2HG005654, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues for their insightful comments and critical readings of the manuscript. We also thank many individuals who provided mouse cell and tissue samples. This work was supported by NIH grants U54HG004592, U54HG007010 and U01ES01156 to J.A.S.; RC2HG005654 to J.A.S. and M. G.; and R37 DK44746 to M. G. and M. A. B. A. B. S. was supported by grant FDK095678A from NIDDK.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; He HH, 2014, NAT METHODS, V11, P73, DOI [10.1038/nmeth.2762, 10.1038/NEMTH.2762]; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lazarovici A., 2013, P NATL ACAD SCI US; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Raff R.A., 1996, SHAPE LIFE GENES DEV; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sullivan AM, 2014, CELL REP, V8, P2015, DOI 10.1016/j.celrep.2014.08.019; Sung M. H., 2014, MOL CELL; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Vierstra J., SCIENCE IN PRESS; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/nmeth.2713, 10.1038/NMETH.2713]; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698	40	151	152	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					365	+		10.1038/nature13972	http://dx.doi.org/10.1038/nature13972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409825	Green Accepted, hybrid, Green Published			2022-12-01	WOS:000345770600035
J	Ravn, K				Ravn, Karen			The next frontier	NATURE			English	Editorial Material							RICE ORYZA-GLABERRIMA											Keya S. O., 2008, NERICA NEW RICE AFRI; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044	3	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S64	S65		10.1038/514S64a	http://dx.doi.org/10.1038/514S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368892	Bronze			2022-12-01	WOS:000343801500008
J	Ito, Y; Hashimoto, M; Hirota, K; Ohkura, N; Morikawa, H; Nishikawa, H; Tanaka, A; Furu, M; Ito, H; Fujii, T; Nomura, T; Yamazaki, S; Morita, A; Vignali, DAA; Kappler, JW; Matsuda, S; Mimori, T; Sakaguchi, N; Sakaguchi, S				Ito, Yoshinaga; Hashimoto, Motomu; Hirota, Keiji; Ohkura, Naganari; Morikawa, Hiromasa; Nishikawa, Hiroyoshi; Tanaka, Atsushi; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Nomura, Takashi; Yamazaki, Sayuri; Morita, Akimichi; Vignali, Dario A. A.; Kappler, John W.; Matsuda, Shuichi; Mimori, Tsuneyo; Sakaguchi, Noriko; Sakaguchi, Shimon			Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease	SCIENCE			English	Article							RECEPTOR-RETROGENIC MICE; RHEUMATOID-ARTHRITIS; GENE; MECHANISMS; GENERATION; TOLERANCE; SELECTION; MUTATION; ZAP-70	Tcells that mediate autoimmune diseases such as rheumatoid arthritis (RA) are difficult to characterize because they are likely to be deleted or inactivated in the thymus if the self antigens they recognize are ubiquitously expressed. One way to obtain and analyze these autoimmune T cells is to alter T cell receptor (TCR) signaling in developing T cells to change their sensitivity to thymic negative selection, thereby allowing their thymic production. From mice thus engineered to generate Tcells mediating autoimmune arthritis, we isolated arthritogenic TCRs and characterized the self antigens they recognized. One of them was the ubiquitously expressed 60S ribosomal protein L23a (RPL23A), with which T cells and autoantibodies from RA patients reacted. This strategy may improve our understanding of the underlying drivers of autoimmunity.	[Ito, Yoshinaga; Hashimoto, Motomu; Nomura, Takashi; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; [Hashimoto, Motomu; Hirota, Keiji; Ohkura, Naganari; Morikawa, Hiromasa; Nishikawa, Hiroyoshi; Tanaka, Atsushi; Sakaguchi, Noriko; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto 6068507, Japan; [Hashimoto, Motomu; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Ohkura, Naganari; Tanaka, Atsushi] Osaka Univ, Ctr Med Innovat & Translat Res, Dept Frontier Res Tumor Immunol, Osaka 5650871, Japan; [Furu, Moritoshi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Yamazaki, Sayuri; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan; [Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Kappler, John W.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA; [Sakaguchi, Shimon] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Kyoto University; Osaka University; Kyoto University; Kyoto University; Osaka University; Kyoto University; Nagoya City University; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Jewish Health; Howard Hughes Medical Institute; National Jewish Health; Japan Science & Technology Agency (JST)	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Morikawa, Hiromasa/H-5958-2013; Nishikawa, Hiroyoshi/AAI-7044-2020; Morikawa, Hiromasa/AAU-9261-2020; Tanaka, Atsushi/U-6761-2019	Morikawa, Hiromasa/0000-0002-6793-5885; Tanaka, Atsushi/0000-0003-1660-9892; Matsuda, Shuichi/0000-0003-0802-1255; Ito, Yoshinaga/0000-0002-5567-7014; Hirota, Keiji/0000-0002-4737-0661	Japan Society for the Promotion of Science [20002007, 24790996]; Japan Science and Technology Agency; NIH [R01 DK089125]; American Lebanese Syrian Associated Charities; Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co. Ltd.; AbbVie GK.; Eisai Co. Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089125] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co. Ltd.; AbbVie GK.; Eisai Co. Ltd.(Eisai Co Ltd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. O. Adeegbe, Y. Kitagawa, and K. Chen for critical reacting of the manuscript; E. Yamamoto, M. Matsuura., R. Ishii, Y. Tada, Y. Funabiki, the technical support team (Graduate School of Medicine, Kyoto University), and K. Saito of DNA-chip Development Center for Infectious Diseases (RIMD, Osaka University) for technical assistance; I. Matsushita for histology; T. Kitamura for gifts of the packaging cell line Plat-E; the members of the Department of Rheumatology and Clinical Immunology, Kyoto University, for providing us with patients' sera; and the members of our laboratories for comments. The data presented in this paper are tabulated in the main paper and in the supplementary materials. eFOX mice and plasmids for making retrogenic mice are subject to a material transfer agreement. A patent application related to the work in this paper has been filed (PCT/JP2014/0693063: A way to diagnose autoimmune arthritis; Y.I. and S.S. as inventors). Supported by Grants-in-Aid for Specially Promoted Research 20002007 (S.S. and Y.I.),;for Young Scientists (B) 24790996 (Y.I.) from the Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (S.S.); NIH grant R01 DK089125 (D.A.A.V.); and American Lebanese Syrian Associated Charities (D.A.A.V.). M.H., T.F., M.F., H.I., and T.M. are affiliated with a department that is supported financially by five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Bristol-Myers K.K., Chugai Pharmaceutical Co. Ltd., AbbVie GK., and Eisai Co. Ltd.). The sponsors were not involved in the study design; in the collection, analysis, or interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication.	Bettini ML, 2013, NAT PROTOC, V8, P1837, DOI 10.1038/nprot.2013.111; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Fan WF, 1997, GENOMICS, V46, P234, DOI 10.1006/geno.1997.5038; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hsu LY, 2009, J EXP MED, V206, P2527, DOI 10.1084/jem.20082902; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; SUZUKI K, 1993, J BIOL CHEM, V268, P2755; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76	22	61	63	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					363	368		10.1126/science.1259077	http://dx.doi.org/10.1126/science.1259077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324392	Green Accepted			2022-12-01	WOS:000343041100048
J	Duxin, JP; Dewar, JM; Yardimci, H; Walter, JC				Duxin, Julien P.; Dewar, James M.; Yardimci, Hasan; Walter, Johannes C.			Repair of a DNA-Protein Crosslink by Replication-Coupled Proteolysis	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; XENOPUS EGG EXTRACTS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; ABASIC SITES; FORMALDEHYDE; MECHANISM; HELICASE; PATHWAY	DNA-protein crosslinks (DPCs) are caused by environmental, endogenous, and chemotherapeutic agents and pose a severe threat to genome stability. We use Xenopus egg extracts to recapitulate DPC repair in vitro and show that this process is coupled to DNA replication. A DPC on the leading strand template arrests the replisome by stalling the CMG helicase. The DPC is then degraded on DNA, yielding a peptide-DNA adduct that is bypassed by CMG. The leading strand subsequently resumes synthesis, stalls again at the adduct, and then progresses past the adduct using DNA polymerase zeta. A DPC on the lagging strand template only transiently stalls the replisome, but it too is degraded, allowing Okazaki fragment bypass. Our experiments describe a versatile, proteolysis-based mechanism of S phase DPC repair that avoids replication fork collapse.	[Duxin, Julien P.; Dewar, James M.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yardimci, Hasan] Imperial Canc Res Fund, Clare Hall Labs, London Res Inst, Canc Res UK, S Mimms EN6 3LD, Herts, England; [Walter, Johannes C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Cancer Research UK; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Yardimci, Hasan/0000-0001-5009-1391; Dewar, James/0000-0003-4153-3818; Walter, Johannes/0000-0002-4186-7570	Department of Defense Bone Marrow Research Program Postdoctoral Traineeship Award [W81XWH-13-1-0049]; NIH [GM62267]; Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267] Funding Source: NIH RePORTER; Cancer Research UK [17575] Funding Source: researchfish	Department of Defense Bone Marrow Research Program Postdoctoral Traineeship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	We thank O.D. Scharer, P.M. Burgers, R. Scully, N. Rhind, N. Tretyakova, and the members of the Walter laboratory for feedback on the manuscript. We thank K.J Marians, T. Bernhardt, B. Kay, and New England Biolabs for plasmids, Thomas Graham for Ulp1 protease and help with the purification of LacI, and Jieqiong Zhang for generation of the FANCI antibody. J.P.D was supported by the Department of Defense Bone Marrow Research Program Postdoctoral Traineeship Award W81XWH-13-1-0049. J.C.W was supported by NIH grant GM62267 and a grant from the Fanconi Anemia Research Fund. J.C.W. is an investigator of the Howard Hughes Medical Institute.	Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HUANG H, 1993, J AM CHEM SOC, V115, P9402, DOI 10.1021/ja00074a005; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-815-7_13, 10.1007/978-1-60327-817-5_13]; Orta ML, 2013, NUCLEIC ACIDS RES, V41, P5827, DOI 10.1093/nar/gkt270; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sabouri N, 2009, J BIOL CHEM, V284, P31555, DOI 10.1074/jbc.M109.043927; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yardimci H, 2012, NATURE, V492, P205, DOI 10.1038/nature11730; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Zecevic A, 2010, MUTAGENESIS, V25, P381, DOI 10.1093/mutage/geq017; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018	45	142	142	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					346	357		10.1016/j.cell.2014.09.024	http://dx.doi.org/10.1016/j.cell.2014.09.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303529	Green Accepted, Bronze			2022-12-01	WOS:000343095600016
J	Banks, AS; McAllister, FE; Camporez, JPG; Zushin, PJH; Jurczak, MJ; Laznik-Bogoslavski, D; Shulman, GI; Gygi, SP; Spiegelman, BM				Banks, Alexander S.; McAllister, Fiona E.; Camporez, Joao Paulo G.; Zushin, Peter-James H.; Jurczak, Michael J.; Laznik-Bogoslavski, Dina; Shulman, Gerald I.; Gygi, Steven P.; Spiegelman, Bruce M.			An ERK/Cdk5 axis controls the diabetogenic actions of PPAR gamma	NATURE			English	Article							CYCLIN-DEPENDENT KINASE-5; ACTIVATED PROTEIN-KINASE; INSULIN SENSITIVITY; MASS-SPECTROMETRY; MEK INHIBITION; PHOSPHORYLATION; MODULATION; GLUCOSE; OBESE; CDK5	Obesity-linked insulin resistance is a major precursor to the development of type 2 diabetes. Previous work has shown that phosphorylation of PPAR gamma (peroxisome proliferator-activated receptor gamma) at serine 273 by cydin-dependent kinase 5 (Cdk5) stimulates diabetogenic gene expression in adipose tissues(1). Inhibition of this modification is a key therapeutic mechanism for anti-diabetic drugs that bind PPAR gamma, such as the thiazolidinediones and PPAR gamma partial agonists or non-agonists(2). For a better understanding of the importance of this obesity-linked PPAR gamma phosphorylation, we created mice that ablated Cdk5 specifically in adipose tissues. These mice have both a paradoxical increase in PPAR gamma phosphorylation at serine 273 and worsened insulin resistance. Unbiased proteomic studies show that extracellular signal-regulated kinase (ERK) kinases are activated in these knockout animals. Here we show that ERK directly phosphorylates serine 273 of PPAR gamma in a robust manner and that Cdk5 suppresses ERKs through direct action on a novel site in MAP kinase/ ERK kinase (MEK). Importantly, pharmacological inhibition of MEK and ERK markedly improves insulin resistance in both obese wildtype and ob/ob mice, and also completely reverses the deleterious effects of the Cdk5 ablation. These data show that an ERK/Cdk5 axis controls PPAR gamma function and suggest that MEK/ERK inhibitors may hold promise for the treatment of type 2 diabetes.	[Banks, Alexander S.; Zushin, Peter-James H.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Banks, Alexander S.; Zushin, Peter-James H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [McAllister, Fiona E.; Gygi, Steven P.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Yale Mouse Metab Phenotyping Ctr, New Haven, CT 06510 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Laznik-Bogoslavski, Dina; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Yale University; Yale University; Yale University; Harvard University; Dana-Farber Cancer Institute	Banks, AS (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 75 Francis St, Boston, MA 02115 USA.	abanks@research.bwh.harvard.edu; bruce_spiegelman@dfci.harvard.edu	Banks, Alexander/B-4832-2012; Camporez, Joao Paulo G/B-9122-2015; Shulman, Gerald I./P-7176-2019	Banks, Alexander/0000-0003-1787-6925; Shulman, Gerald I./0000-0003-1529-5668; Camporez, Joao Paulo/0000-0003-3486-4301; Jurczak, Michael/0000-0002-6335-6915	National Institutes of Health (NIH) [DK31405, DK93638]; Harvard University Milton Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, K01DK093638, R01DK031405, R37DK031405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Milton Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Rosen for providing us with the adiponectin Cre mice before their initial publication; members of the Spiegelman laboratory (Dana-Farber Cancer Institute) and D. Cohen (Brigham and Women's Hospital) for discussions; and C. Palmer and K. LeClair for reading the manuscript. B.M.S. acknowledges National Institutes of Health (NIH) grant DK31405. A.B. acknowledges NIH grant DK93638, the Harvard University Milton Fund, and the Harvard Digestive Disease Center, Core D.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hawasli AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005808; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; McAllister FE, 2013, ANAL CHEM, V85, P4666, DOI 10.1021/ac303478g; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun KH, 2008, J NEUROCHEM, V107, P265, DOI 10.1111/j.1471-4159.2008.05616.x; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	44	196	199	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					391	U581		10.1038/nature13887	http://dx.doi.org/10.1038/nature13887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25409143	Green Accepted, Green Submitted			2022-12-01	WOS:000347810300051
J	Edmond, MB; Diekema, DJ; Perencevich, EN				Edmond, Michael B.; Diekema, Daniel J.; Perencevich, Eli N.			Ebola Virus Disease and the Need for New Personal Protective Equipment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Edmond, Michael B.; Diekema, Daniel J.; Perencevich, Eli N.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Perencevich, Eli N.] Iowa City VA Hlth Syst, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Edmond, MB (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, C512 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	michael-edmond@uiowa.edu		Edmond, Michael/0000-0002-4144-8974; Diekema, Daniel/0000-0003-1273-0724; Perencevich, Eli/0000-0002-3721-3355				[Anonymous], FIGHT EB GRAND CHALL; [Anonymous], VOM LARR VIS CONT; Centers for Disease Control and Prevention, REV HUM TO HUM TRANS; Centers for Disease Control and Prevention, GUID PERS PROT EQ US; del Rio C, 2014, ANN INTERN MED, V161, P746, DOI 10.7326/M14-1880; Kwon S, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-5; Morgan DJ, 2012, CRIT CARE MED, V40, P1045, DOI 10.1097/CCM.0b013e31823bc7c8; Morgan DJ, 2010, INFECT CONT HOSP EP, V31, P716, DOI 10.1086/653201; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004	9	25	27	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2495	2496		10.1001/jama.2014.15497	http://dx.doi.org/10.1001/jama.2014.15497			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25350321				2022-12-01	WOS:000346346900007
J	Bhatnagar, S; Gazin, C; Chamberlain, L; Ou, JH; Zhu, XC; Tushir, JS; Virbasius, CM; Lin, L; Zhu, LHJ; Wajapeyee, N; Green, MR				Bhatnagar, Sanchita; Gazin, Claude; Chamberlain, Lynn; Ou, Jianhong; Zhu, Xiaochun; Tushir, Jogender S.; Virbasius, Ching-Man; Lin, Ling; Zhu, Lihua J.; Wajapeyee, Narendra; Green, Michael R.			TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein	NATURE			English	Article							POLYCOMB GROUP PROTEINS; CHIP-CHIP DATA; GENE-EXPRESSION; TRANSCRIPTION ACTIVATION; 17Q23 AMPLICON; COMPLEX; CHROMATIN; UBIQUITYLATION; BIOCONDUCTOR; METHYLATION	The TRIM37 (also known as MUL) gene is located in the 17q23 chromosomal region, which is amplified in up to similar to 40% of breast cancers(1). TRIM37 contains a RING finger domain, a hallmark of E3 ubiquitin ligases(2), but its protein substrate(s) is unknown. Here we report that TRIM37 mono-ubiquitinates histone H2A, a chromatin modification associated with transcriptional repression(3). We find that in human breast cancer cell lines containing amplified 17q23, TRIM37 is upregulated and, reciprocally, the major H2A ubiquitin ligase RNF2 (also known as RING1B)(3,4) is downregulated. Genome-wide chromatin immunoprecipitation (ChIP) -chip experiments in 17q23-amplified breast cancer cells identified many genes, including multiple tumour suppressors, whose promoters were bound by TRIM37 and enriched for ubiquitinated H2A. However, unlike RNF2, which is a subunit of polycomb repressive complex 1 (PRC1)(3-5), we find that TRIM37 associates with polycomb repressive complex 2 (PRC2). TRIM37, PRC2 and PRC I are co-bound to specific target genes, resulting in their transcriptional silencing. RNA-interference-mediated knockdown of TRIM37 results in loss of ubiquitinated H2A, dissociation of PRCI and PRC2 from target promoters, and transcriptional reactivation of silenced genes. Knockdown of TRIM37 in human breast cancer cells containing amplified 17q23 substantially decreases tumour growth in mouse xenografts. Conversely, ectopic expression of TRIM37 renders non-transformed cells tumorigenic. Collectively, our results reveal TRIM37 as an oncogenic H2A ubiquitin ligase that is overexpressed in a subset of breast cancers and promotes transformation by facilitating silencing of tumour suppressors and other genes.	[Bhatnagar, Sanchita; Chamberlain, Lynn; Zhu, Xiaochun; Virbasius, Ching-Man; Lin, Ling; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Bhatnagar, Sanchita; Chamberlain, Lynn; Ou, Jianhong; Zhu, Xiaochun; Virbasius, Ching-Man; Lin, Ling; Zhu, Lihua J.; Green, Michael R.] Univ Massachusetts, Sch Med, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA; [Gazin, Claude] CEA DSV iRCM LEFG, Genopole G2, F-91057 Evry, France; [Gazin, Claude] Univ Paris Diderot, F-91057 Evry, France; [Tushir, Jogender S.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Zhu, Lihua J.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Wajapeyee, Narendra] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; Universite Paris Cite; Boehringer Ingelheim; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	michael.green@umassmed.edu		Bhatnagar, Sanchita/0000-0002-3588-7874; ou, jianhong/0000-0002-8652-2488; Zhu, Lihua/0000-0001-7416-0590	National Lung Cancer Partnership/Uniting Against Lung Cancer; Melanoma Research Alliance; International Association for the Study of Lung Cancer; CEA-DSV; ATIGE Genopole; Centre National de la Recherche Scientifique (CNRS); National Institutes of Health [R01GM033977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER	National Lung Cancer Partnership/Uniting Against Lung Cancer; Melanoma Research Alliance; International Association for the Study of Lung Cancer; CEA-DSV(French Atomic Energy Commission); ATIGE Genopole; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Peterson for providing Xenopus nucleosomes; R. Weinberg and M. Cristofanilli for providing cell lines; A. Virbasius and the University of Massachusetts Medical School (UMMS) RNAi Core Facility for providing shRNAs; P. Spatrick at the UMMS Genomics Core Facility; the UMMS Proteomics and Mass Spectroscopy Facility for mass spectrometry analysis; and S. Deibler for providing editorial assistance. N.W. is a Sidney Kimmel Scholar for Cancer Research and is supported by young investigator awards from the National Lung Cancer Partnership/Uniting Against Lung Cancer, Melanoma Research Alliance and International Association for the Study of Lung Cancer. This work was also supported by grants from CEA-DSV, ATIGE Genopole and Centre National de la Recherche Scientifique (CNRS) to C.G., and from the National Institutes of Health (R01GM033977) to M.R.G. M.R.G. is an investigator of the Howard Hughes Medical Institute.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Dawson PJ, 1996, AM J PATHOL, V148, P313; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deb G, 2013, EPIGENETICS-US, V8, P464, DOI 10.4161/epi.24532; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fernandez SV, 2013, BREAST CANCER RES TR, V140, P23, DOI 10.1007/s10549-013-2600-4; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Luger K, 1999, METH MOL B, V119, P1; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Orlando DA, 2012, GENOMICS, V100, P320, DOI 10.1016/j.ygeno.2012.07.006; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Salicru M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-401; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2000, GENE DEV, V14, P927; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Zacher B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-194; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	42	120	138	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					116	U313		10.1038/nature13955	http://dx.doi.org/10.1038/nature13955			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470042	Green Accepted			2022-12-01	WOS:000346310800051
J	Freund, A; Zhong, FL; Venteicher, AS; Meng, ZJ; Veenstra, TD; Frydman, J; Artandi, SE				Freund, Adam; Zhong, Franklin L.; Venteicher, Andrew S.; Meng, Zhaojing; Veenstra, Timothy D.; Frydman, Judith; Artandi, Steven E.			Proteostatic Control of Telomerase Function through TRiC-Mediated Folding of TCAB1	CELL			English	Article							TERT PROMOTER MUTATIONS; DYSKERATOSIS-CONGENITA; CYTOSOLIC CHAPERONIN; CAJAL BODIES; MOLECULAR CHAPERONES; CELLS; RNA; RECRUITMENT; HOLOENZYME; PROTEINS	Telomere maintenance by telomerase is impaired in the stem cell disease dyskeratosis congenita and during human aging. Telomerase depends upon a complex pathway for enzyme assembly, localization in Cajal bodies, and association with telomeres. Here, we identify the chaperonin CCT/TRiC as a critical regulator of telomerase trafficking using a high-content genome-wide siRNA screen in human cells for factors required for Cajal body localization. We find that TRiC is required for folding the telomerase cofactor TCAB1, which controls trafficking of telomerase and small Cajal body RNAs (scaRNAs). Depletion of TRiC causes loss of TCAB1 protein, mislocalization of telomerase and scaRNAs to nucleoli, and failure of telomere elongation. DC patient-derived mutations in TCAB1 impair folding by TRiC, disrupting telomerase function and leading to severe disease. Our findings establish a critical role for TRiC-mediated protein folding in the telomerase pathway and link proteostasis, telomere maintenance, and human disease.	[Freund, Adam; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Zhong, Franklin L.; Artandi, Steven E.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA; [Meng, Zhaojing; Veenstra, Timothy D.] Sci Applicat Int Corp Frederick, Natl Canc Inst Frederick, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; Zhong, Franklin/0000-0002-0516-6021; , judith/0000-0003-2302-6943	NIH NCRR Instrumentation grant [S10RR026338]; Stanford Cancer Biology Training Program [T32 CA09302]; Jane Coffin Childs Memorial Fund for Medical Research; Agency for Science, Technology, and Research (A*STAR), Singapore; NIH [AG033747, CA125453, CA111691, AG036695]; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA125453, R01CA111691] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG033747, R01AG033747, P01AG036695] Funding Source: NIH RePORTER	NIH NCRR Instrumentation grant; Stanford Cancer Biology Training Program; Jane Coffin Childs Memorial Fund for Medical Research; Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Artandi and Frydman labs for helpful discussions and advice. We thank David Solow-Cordero in the Stanford High-Throughput Bioscience Center, with support from NIH NCRR Instrumentation grant S10RR026338. We are grateful to Anthony Tomlinson for generously providing purified bovine TRiC and to Sharon Savage for supplying DC patient lymphoblasts. A.F. was supported by Stanford Cancer Biology Training Program (T32 CA09302) and by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. F.L.Z. was supported by a fellowship from the Agency for Science, Technology, and Research (A*STAR), Singapore. This work was supported by NIH grants AG033747, CA125453, CA111691, and AG036695 and by the Glenn Foundation for Medical Research.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Batista LFZ, 2013, CURR OPIN GENET DEV, V23, P526, DOI 10.1016/j.gde.2013.07.006; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Diolaiti ME, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt689; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kubota H, 1997, FEBS LETT, V402, P53, DOI 10.1016/S0014-5793(96)01501-3; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pfeiffer V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010405; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	49	78	80	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1389	1403		10.1016/j.cell.2014.10.059	http://dx.doi.org/10.1016/j.cell.2014.10.059			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25467444	Bronze, Green Accepted			2022-12-01	WOS:000346652900017
J	Savage, N				Savage, Neil			Stretching time	NATURE			English	Editorial Material																		Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419	2	2	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S162	S164		10.1038/515S162a	http://dx.doi.org/10.1038/515S162a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427206	Bronze			2022-12-01	WOS:000346247600008
J	Palmer, T				Palmer, Tim			Build high-resolution global climate models	NATURE			English	Editorial Material									Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 2JD, England	University of Oxford	Palmer, T (corresponding author), Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 2JD, England.	t.n.palmer@atm.ox.ac.uk		Palmer, Tim/0000-0002-7121-2196				IPCC, 2013, CONTRIBUTION WORKING, DOI DOI 10.1017/CBO9781107415324; Jakob C, 2010, B AM METEOROL SOC, V91, P869, DOI 10.1175/2009BAMS2898.1; Palmer TN, 2012, Q J ROY METEOR SOC, V138, P841, DOI 10.1002/qj.1923; Palmer T, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0118; Palmer T, 2011, PHYS WORLD, V24, P14; Rauser F., B AM METEIR IN PRESS; Rodwell MJ, 2007, Q J ROY METEOR SOC, V133, P129, DOI 10.1002/qj.23; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Shukla J, 2010, B AM METEOROL SOC, V91, P1407, DOI 10.1175/2010BAMS2900.1; Stevens B, 2013, SCIENCE, V340, P1053, DOI 10.1126/science.1237554	10	62	64	2	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					338	339		10.1038/515338a	http://dx.doi.org/10.1038/515338a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7HE	25409812	Bronze			2022-12-01	WOS:000345770600020
J	Watson, JEM; Dudley, N; Segan, DB; Hockings, M				Watson, James E. M.; Dudley, Nigel; Segan, Daniel B.; Hockings, Marc			The performance and potential of protected areas	NATURE			English	Review							ECOSYSTEM SERVICES; DEGAZETTEMENT PADDD; CONSERVATION; BIODIVERSITY; POVERTY; AFRICA; STRATEGIES; RESERVES; NETWORK; SUCCESS	Originally conceived to conserve iconic landscapes and wildlife, protected areas are now expected to achieve an increasingly diverse set of conservation, social and economic objectives. The amount of land and sea designated as formally protected has markedly increased over the past century, but there is still a major shortfall in political commitments to enhance the coverage and effectiveness of protected areas. Financial support for protected areas is dwarfed by the benefits that they provide, but these returns depend on effective management. A step change involving increased recognition, funding, planning and enforcement is urgently needed if protected areas are going to fulfil their potential.	[Watson, James E. M.; Dudley, Nigel; Hockings, Marc] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia; [Watson, James E. M.; Segan, Daniel B.] Global Conservat Program, Wildlife Conservat Soc, Bronx, NY 10460 USA; [Watson, James E. M.; Segan, Daniel B.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Dudley, Nigel] Equilibrium Res, Bristol BS1 6UQ, Avon, England; [Hockings, Marc] UNEP World Conservat Monitoring Ctr, Cambridge CD3 0DL, England	University of Queensland; Wildlife Conservation Society; University of Queensland	Watson, JEM (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia.	jwatson@wcs.org	Watson, James Edward Maxwell/D-8779-2013; Hockings, Marc/A-1283-2007	Watson, James Edward Maxwell/0000-0003-4942-1984; Hockings, Marc/0000-0003-4419-8963				Agrawal A., 2009, CONSERV SOC, V7, P1, DOI [10.4103/0972-4923.54790, DOI 10.4103/0972-4923.54790]; Ardron J, 2008, MAR POLICY, V32, P832, DOI 10.1016/j.marpol.2008.03.018; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Blom A, 2004, BIOL CONSERV, V118, P479, DOI 10.1016/j.biocon.2003.09.023; Borrini-Feyerabend G., 2013, GOVERNANCE PROTECTED; Bovarnick A., 2010, FINANCIAL SUSTAINABI; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bucaram SJ, 2013, OCEAN COAST MANAGE, V78, P88, DOI 10.1016/j.ocecoaman.2013.03.001; Burke L., 2012, REEFS RISK REVISITED; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Canadian Parks and Wilderness Society, 2012, STAT CAN PARKS 2012; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Clark NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065298; Comay L. B., 2013, NATL PARK SERVICE RE; Convention on Biodiversity, 2003, PROT AR SYNTH INF TH; Convention on Biological Diversity, 2011, COP 10 DEC X 2 STRAT; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Dudley N., 2003, RUNNING PURE IMPORTA; Dudley N., 1999, PARTNERSHIPS PROTECT, P3; Duran AP, 2013, BIOL CONSERV, V160, P272, DOI 10.1016/j.biocon.2013.02.003; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edwards DP, 2014, CONSERV LETT, V7, P302, DOI 10.1111/conl.12076; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Emslie, 1999, AFRICAN RHINO STATUS; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Frey BS, 2011, INT J CULT POLICY, V17, P555, DOI 10.1080/10286632.2010.541906; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Great Barrier Reef Marine Park Authority, 2014, GREAT BARR REEF REG; Green JMH, 2012, BIOL CONSERV, V150, P5, DOI 10.1016/j.biocon.2012.02.023; Gross-Camp ND, 2012, ORYX, V46, P24, DOI 10.1017/S0030605311001372; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; International Union for Conservation of Nature, 1980, WORLD CONS STRAT LIV; International Union for the Conservation of Nature and Natural Resources, 2008, GUIDELINES APPL PROT; Irland L. C., 2008, Journal of Sustainable Forestry, V27, P189, DOI 10.1080/10549810802219963; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Knicley JE, 2012, HARVARD ENVIRON LAW, V36, P79; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lubchenco J, 2003, ECOL APPL, V13, pS3; Maekawa M, 2013, NAT RESOUR FORUM, V37, P127, DOI 10.1111/1477-8947.12020; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Micheli F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05799-180419; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Osti M, 2011, BIODIVERS CONSERV, V20, P1863, DOI 10.1007/s10531-011-0056-6; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Phillips A., 2004, PARKS, V14, P4; Postel SL, 2005, NAT RESOUR FORUM, V29, P98, DOI 10.1111/j.1477-8947.2005.00119.x; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Prieur M., 2012, NONREGRESSION ENV LA; Rastogi A, 2012, J ENVIRON MANAGE, V113, P328, DOI 10.1016/j.jenvman.2012.10.003; Republic of Uganda, 2008, NAT OIL GAS POL UG; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ritchie EG, 2013, CONSERV BIOL, V27, P1133, DOI 10.1111/cobi.12189; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Runte A., 1977, Journal of Forest History, V21, P64, DOI 10.2307/3983461; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Sciberras M, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-4; Shahabuddin G, 2010, BIOL CONSERV, V143, P2926, DOI 10.1016/j.biocon.2010.04.040; Sheehan EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083883; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Spalding M., 2008, WORLDS PROTECTED ARE, P146; Steinberg PF, 2009, GLOBAL ENVIRON POLIT, V9, P61, DOI 10.1162/glep.2009.9.3.61; Stockholm International Peace Research Institute, 2014, MIL EXP; Stolton S, 2010, ARGUMENTS FOR PROTECTED AREAS: MULTIPLE BENEFITS FOR CONSERVATION AND USE, P1; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; Swaisgood RR, 2010, BIOSCIENCE, V60, P626, DOI 10.1525/bio.2010.60.8.8; Taylor MFJ, 2011, BIODIVERS CONSERV, V20, P767, DOI 10.1007/s10531-010-9977-8; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; UNEP-WCMC, 2014, WORLD DAT PROT AR; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Watkins H., 2014, HS2 CASE GREENER VIS; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/nclimate2007, 10.1038/NCLIMATE2007]; Watson JEM, 2009, DIVERS DISTRIB, V15, P1028, DOI 10.1111/j.1472-4642.2009.00601.x; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Willemen L, 2013, ECOSYST SERV, V4, P95, DOI 10.1016/j.ecoser.2013.02.004; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Zafir AWA, 2011, ORYX, V45, P225, DOI 10.1017/S0030605310000864; Zeiger J. B., 1992, Parks & Recreation (Arlington), V27, P74	99	1031	1075	80	868	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					67	73		10.1038/nature13947	http://dx.doi.org/10.1038/nature13947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373676				2022-12-01	WOS:000344187500030
J	Martel, A; Blooi, M; Adriaensen, C; Van Rooij, P; Beukema, W; Fisher, MC; Farrer, RA; Schmidt, BR; Tobler, U; Goka, K; Lips, KR; Muletz, C; Zamudio, KR; Bosch, J; Lotters, S; Wombwell, E; Garner, TWJ; Cunningham, AA; Spitzen-van der Sluijs, A; Salvidio, S; Ducatelle, R; Nishikawa, K; Nguyen, TT; Kolby, JE; Van Bocxlaer, I; Bossuyt, F; Pasmans, F				Martel, A.; Blooi, M.; Adriaensen, C.; Van Rooij, P.; Beukema, W.; Fisher, M. C.; Farrer, R. A.; Schmidt, B. R.; Tobler, U.; Goka, K.; Lips, K. R.; Muletz, C.; Zamudio, K. R.; Bosch, J.; Loetters, S.; Wombwell, E.; Garner, T. W. J.; Cunningham, A. A.; Spitzen-van der Sluijs, A.; Salvidio, S.; Ducatelle, R.; Nishikawa, K.; Nguyen, T. T.; Kolby, J. E.; Van Bocxlaer, I.; Bossuyt, F.; Pasmans, F.			Recent introduction of a chytrid fungus endangers Western Palearctic salamanders	SCIENCE			English	Article							BATRACHOCHYTRIUM-SALAMANDRIVORANS; DENDROBATIDIS; AMPHIBIANS; EXTINCTION	Emerging infectious diseases are reducing biodiversity on a global scale. Recently, the emergence of the chytrid fungus Batrachochytrium salamandrivorans resulted in rapid declines in populations of European fire salamanders. Here, we screened more than 5000 amphibians from across four continents and combined experimental assessment of pathogenicity with phylogenetic methods to estimate the threat that this infection poses to amphibian diversity. Results show that B. salamandrivorans is restricted to, but highly pathogenic for, salamanders and newts (Urodela). The pathogen likely originated and remained in coexistence with a clade of salamander hosts for millions of years in Asia. As a result of globalization and lack of biosecurity, it has recently been introduced into naive European amphibian populations, where it is currently causing biodiversity loss.	[Martel, A.; Blooi, M.; Adriaensen, C.; Van Rooij, P.; Ducatelle, R.; Pasmans, F.] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, B-9820 Merelbeke, Belgium; [Blooi, M.] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Beukema, W.] Univ Porto, Inst Ciencias Agr Vairao, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Fisher, M. C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Farrer, R. A.] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA 02142 USA; [Schmidt, B. R.; Tobler, U.] KARCH, CH-2000 Neuchatel, Switzerland; [Schmidt, B. R.; Tobler, U.] Univ Zurich, Inst Evolut Biol & Umweltwissensch, CH-8057 Zurich, Switzerland; [Goka, K.] Natl Inst Environm Studies, Invas Alien Species Res Team, Tsukuba, Ibaraki 3058506, Japan; [Lips, K. R.; Muletz, C.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Zamudio, K. R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Bosch, J.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Loetters, S.] Univ Trier, Biogeog Dept, D-54286 Trier, Germany; [Wombwell, E.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Wombwell, E.; Garner, T. W. J.; Cunningham, A. A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Spitzen-van der Sluijs, A.] Reptile Amphibian & Fish Conservat Netherlands RA, NL-6501 BK Nijmegen, Netherlands; [Salvidio, S.] Univ Genoa, Dept Earth Sci Environm & Life Di STAV, I-16132 Genoa, Italy; [Nishikawa, K.] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Nguyen, T. T.] Vietnam Acad Sci & Technol, Vietnam Natl Museum Nat, Hanoi, Vietnam; [Kolby, J. E.] James Cook Univ, Hlth Res Grp 1, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Van Bocxlaer, I.; Bossuyt, F.] Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, B-1050 Brussels, Belgium	Ghent University; Universidade do Porto; Imperial College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Zurich; National Institute for Environmental Studies - Japan; University System of Maryland; University of Maryland College Park; Cornell University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universitat Trier; University of Kent; Zoological Society of London; University of Genoa; Kyoto University; Vietnam Academy of Science & Technology (VAST); James Cook University; Vrije Universiteit Brussel	Martel, A (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	an.martel@ugent.be	Zamudio, Kelly/R-3533-2016; Fisher, Matthew/B-9094-2011; Cunningham, Andrew A/E-7536-2010; Bosch, Jaime/H-3042-2011; Kolby, Jonathan/GWV-5557-2022; Spitzen, Annemarieke/AAV-3970-2021; Beukema, Wouter/D-6365-2014; Garner, Trenton WJ/D-6873-2011; Pasmans, Frank/D-3667-2014; Schmidt, Benedikt R./B-8491-2008; Kolby, Jonathan/GWZ-3092-2022; Van Bocxlaer, Ines/L-4852-2015; Spitzen, Annemarieke/B-3453-2012; Muletz-Wolz, Carly/N-3816-2013	Zamudio, Kelly/0000-0001-5107-6206; Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; Beukema, Wouter/0000-0002-5839-7683; Garner, Trenton WJ/0000-0002-0336-9706; Schmidt, Benedikt R./0000-0002-4023-1001; Spitzen, Annemarieke/0000-0003-2008-9375; Farrer, Rhys/0000-0001-8456-7458; Lips, Karen/0000-0002-2719-1551; Bossuyt, Franky/0000-0001-6804-9271; Adriaensen, Connie/0000-0002-1481-1635; Muletz-Wolz, Carly/0000-0001-5047-9601	Dutch Ministry of Economic Affairs; UK Department for Environment, Food and Rural Affairs [FC1195]; Royal Zoological Society of Antwerp; Ghent University Special Research Fund [BOF13/PDO/130]; Morris Animal Foundation [D12z0-002]; UK Natural Environment Research Council (NERC); Wellcome Trust; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich European Union of Aquarium Curators; Zurcher Tierschutz; Fundacion General CSIC; Banco Santander; Economic and Social Research Council (ESRC)-NERC Interdisciplinary Ph. D. studentship; Royal Society Wolfson research merit award; Ministry of Education, Science and Culture, Japan [20770066, 23770084]; Japan Society for the Promotion of Science (JSPS); JSPS RONPAKU program; European Research Council [204509]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Division Of Environmental Biology [1120161, 1120249] Funding Source: National Science Foundation; Natural Environment Research Council [NE/K012509/1, NE/K014455/1] Funding Source: researchfish; NERC [NE/K012509/1, NE/K014455/1] Funding Source: UKRI	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Royal Zoological Society of Antwerp; Ghent University Special Research Fund(Ghent University); Morris Animal Foundation; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich European Union of Aquarium Curators; Zurcher Tierschutz; Fundacion General CSIC; Banco Santander; Economic and Social Research Council (ESRC)-NERC Interdisciplinary Ph. D. studentship; Royal Society Wolfson research merit award(Royal Society of London); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS RONPAKU program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Schenkel and J. Beukema for providing samples and the National Museum of Natural History-Naturalis, Leiden, Netherlands, for providing museum specimens. We thank the many amphibian breeders (including S. Bogaerts, M. Sparreboom, H. Janssen, F. Maillet, A. Jamin, and S. Voitel) who provided offspring to conduct the infection experiments. Financial support was partly provided by the Dutch Ministry of Economic Affairs and by the UK Department for Environment, Food and Rural Affairs, project grant FC1195. M. B. is funded by a Dehousse grant from the Royal Zoological Society of Antwerp. P. V. R. is funded by Ghent University Special Research Fund (BOF13/PDO/130). F. P. and T. W. J. G. are funded by the Morris Animal Foundation (D12z0-002). M. C. F. and T. W. J. G. are funded by the UK Natural Environment Research Council (NERC). R. A. F. is supported by the Wellcome Trust. U. T. and B. R. S. are funded by the Vontobel Stiftung, Janggen-Pohn Stiftung, Basler Stiftung fur biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zurich, Grun Stadt Zurich European Union of Aquarium Curators, and Zurcher Tierschutz. J. B. is funded by Fundacion General CSIC and Banco Santander. E. W. is funded by Economic and Social Research Council (ESRC)-NERC Interdisciplinary Ph. D. studentship. A. A. C. is supported by a Royal Society Wolfson research merit award. K. N. is funded by grants from the Ministry of Education, Science and Culture, Japan (nos. 20770066 and 23770084) and Japan Society for the Promotion of Science (JSPS) AA Core-to-Core program Type B. Asia-Africa Science Platforms. T. T. N. is funded by the JSPS RONPAKU program. F. B. is supported by European Research Council Starting Grant 204509 [project Tracing Antimicrobial Peptides and Pheromones in the Amphibian Skin (TAPAS)]. I. V. B is supported by a postdoctoral Fellowship from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO). All data described in the paper are presented in the supplementary materials.	Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Herrel A, 2014, HERPETOL J, V24, P103; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Spitzen-Van der Sluijs A, 2014, CONSERV BIOL, V28, P1302, DOI 10.1111/cobi.12281; Spitzen-van der Sluijs A, 2013, AMPHIBIA-REPTILIA, V34, P233, DOI 10.1163/15685381-00002891; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	8	319	341	6	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		630	631		10.1126/science.1258268	http://dx.doi.org/10.1126/science.1258268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359973	Green Published, Green Accepted			2022-12-01	WOS:000343799700048
J	Stone, MB				Stone, Marc B.			The FDA Warning on Antidepressants and Suicidality - Why the Controversy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEPRESSION		US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Stone, MB (corresponding author), US FDA, Silver Spring, MD 20993 USA.		Stone, Marc/H-3223-2019					Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Schumock GT, 2011, DRUG HEALTHC PATIENT, V3, P47, DOI 10.2147/DHPS.S23665; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007	5	26	28	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1668	1671		10.1056/NEJMp1411138	http://dx.doi.org/10.1056/NEJMp1411138			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354102				2022-12-01	WOS:000343768500004
J	Ubil, E; Duan, J; Pillai, ICL; Rosa-Garrido, M; Wu, Y; Bargiacchi, F; Lu, Y; Stanbouly, S; Huang, J; Rojas, M; Vondriska, TM; Stefani, E; Deb, A				Ubil, Eric; Duan, Jinzhu; Pillai, Indulekha C. L.; Rosa-Garrido, Manuel; Wu, Yong; Bargiacchi, Francesca; Lu, Yan; Stanbouly, Seta; Huang, Jie; Rojas, Mauricio; Vondriska, Thomas M.; Stefani, Enrico; Deb, Arjun			Mesenchymal-endothelial transition contributes to cardiac neovascularization	NATURE			English	Article							ISCHEMIC-MYOCARDIUM; BONE-MARROW; CELLS; FIBROBLASTS; P53; REPAIR; MICROSCOPY; FIBROSIS; HYPOXIA; TISSUE	Endothelial cells contribute to a subset of cardiac fibroblasts by undergoing endothelial-to-mesenchymal transition, but whether cardiac fibroblasts can adopt an endothelial cell fate and directly contribute to neovascularization after cardiac injury is not known. Here, using genetic fate map techniques, we demonstrate that cardiac fibroblasts rapidly adopt an endothelial-cell-like phenotype after acute ischaemic cardiac injury. Fibroblast-derived endothelial cells exhibit anatomical and functional characteristics of native endothelial cells. We show that the transcription factor p53 regulates such a switch in cardiac fibroblast fate. Loss of p53 in cardiac fibroblasts severely decreases the formation of fibroblast-derived endothelial cells, reduces post-infarct vascular density and worsens cardiac function. Conversely, stimulation of the p53 pathway in cardiac fibroblasts augments mesenchymal-to-endothelial transition, enhances vascularity and improves cardiac function. These observations demonstrate that mesenchymal-to-endothelial transition contributes to neovascularization of the injured heart and represents a potential therapeutic target for enhancing cardiac repair.	[Ubil, Eric] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Rosa-Garrido, Manuel; Lu, Yan; Stanbouly, Seta; Huang, Jie; Vondriska, Thomas M.; Deb, Arjun] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Rosa-Garrido, Manuel; Lu, Yan; Stanbouly, Seta; Huang, Jie; Vondriska, Thomas M.; Stefani, Enrico; Deb, Arjun] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Deb, Arjun] Univ Calif Los Angeles, Eli & Edythe Broad Inst Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Deb, Arjun] Univ Calif Los Angeles, Coll Letters & Sci, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Deb, Arjun] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Duan, Jinzhu; Pillai, Indulekha C. L.; Lu, Yan; Stanbouly, Seta; Huang, Jie; Vondriska, Thomas M.; Deb, Arjun] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Rosa-Garrido, Manuel; Wu, Yong; Vondriska, Thomas M.; Stefani, Enrico] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Rosa-Garrido, Manuel; Vondriska, Thomas M.; Stefani, Enrico] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Bargiacchi, Francesca] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rojas, Mauricio] Univ N Carolina, McAllister Heart Inst, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Deb, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA.	adeb@mednet.ucla.edu	Rosa-Garrido, Manuel/AAE-4188-2019; Wu, Yong/E-9761-2014; Pillai, Indulekha/P-8398-2014	Rosa-Garrido, Manuel/0000-0002-2169-3972; Pillai, Indulekha/0000-0002-5038-6031; Ubil, Eric/0000-0002-5112-464X	National Institutes of Health [NIH R01HL102190]; NIH [HL088640, HL105699]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102190, R01HL088640, R01HL105699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Michael Hooker Confocal Microscopy and the Histology Research Core facilities at UNC, Chapel Hill. We thank the confocal and advanced light microscopy facilities in the Division of Molecular Medicine and California Nanosystems Institute at UCLA, Histology facilities at Brain Research Institute & Pathology and Laboratory Medicine, UCLA, Broad Stem Cell Research Center UCLA flow cytometry laboratories and the Vector core facility at UCLA for technical assistance. We thank K. Caron, V. Bauch, J. Taylor, C. Otey at UNC, Chapel Hill and J. Lusis at UCLA for scientific suggestions and discussion. This work was supported by grants from the National Institutes of Health (NIH R01HL102190) to A. Deb. Super-resolution studies and ChIP studies were supported by NIH grant HL088640 to E. S. and NIH grant HL105699 to T. V. E. Ubil was supported in part by a pre-doctoral grant from the American Heart Association. This work was initiated when A. D. was at the University of North Carolina, Chapel Hill and completed at the University of California, Los Angeles.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Agocha AE, 1997, MOL CELL BIOCHEM, V172, P195, DOI 10.1023/A:1006848512174; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boudreau N, 1997, J CELL BIOL, V139, P257, DOI 10.1083/jcb.139.1.257; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Hasan NM, 1999, INT J CANCER, V80, P400, DOI 10.1002/(SICI)1097-0215(19990129)80:3<400::AID-IJC11>3.0.CO;2-U; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu SX, 2014, WOUND REPAIR REGEN, V22, P119, DOI 10.1111/wrr.12131; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marino S, 2000, GENE DEV, V14, P994; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Melo LG, 2004, CIRCULATION, V109, P2386, DOI 10.1161/01.CIR.0000128597.37025.00; NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shi YD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-571; Singh H, 2012, MITOCHONDRION, V12, P230, DOI 10.1016/j.mito.2011.09.004; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Webster KA, 1999, J CLIN INVEST, V104, P239; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao L, 2001, BBA-MOL CELL RES, V1538, P273, DOI 10.1016/S0167-4889(01)00078-7; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	40	227	236	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					585	+		10.1038/nature13839	http://dx.doi.org/10.1038/nature13839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25317562	Green Accepted, Green Submitted			2022-12-01	WOS:000343801500039
J	Agrawal, N; Akbani, R; Aksoy, BA; Ally, A; Arachchi, H; Asa, SL; Auman, JT; Balasundaram, M; Balu, S; Baylin, SB; Behera, M; Bernard, B; Beroukhim, R; Bishop, JA; Black, AD; Bodenheimer, T; Boice, L; Bootwalla, MS; Bowen, J; Bowlby, R; Bristow, CA; Brookens, R; Brooks, D; Bryant, R; Buda, E; Butterfield, YSN; Carling, T; Carlsen, R; Carter, SL; Carty, SE; Chan, TA; Chen, AY; Cherniack, AD; Cheung, D; Chin, L; Cho, J; Chu, A; Chuah, E; Cibulskis, K; Ciriello, G; Clarke, A; Clayman, GL; Cope, L; Copland, JA; Covington, K; Danilova, L; Davidsen, T; Demchok, JA; DiCara, D; Dhalla, N; Dhir, R; Dookran, SS; Dresdner, G; Eldridge, J; Eley, G; El-Naggar, AK; Eng, S; Fagin, JA; Fennell, T; Ferris, RL; Fisher, S; Frazer, S; Frick, J; Gabriel, SB; Ganly, I; Gao, JJ; Garraway, LA; Gastier-Foster, JM; Getz, G; Gehlenborg, N; Ghossein, R; Gibbs, RA; Giordano, TJ; Gomez-Hernandez, K; Grimsby, J; Gross, B; Guin, R; Hadjipanayis, A; Harper, HA; Hayes, DN; Heiman, DI; Herman, JG; Hoadley, KA; Hofree, M; Holt, RA; Hoyle, AP; Huang, FW; Huang, M; Hutter, CM; Ideker, T; Iype, L; Jacobsen, A; Jefferys, SR; Jones, CD; Jones, SJM; Kasaian, K; Kebebew, E; Khuri, FR; Kim, J; Kramer, R; Kreisberg, R; Kucherlapati, R; Kwiatkowski, DJ; Ladanyi, M; Lai, PH; Laird, PW; Lander, E; Lawrence, MS; Lee, D; Lee, E; Lee, S; Lee, W; Leraas, KM; Lichtenberg, TM; Lichtenstein, L; Lin, P; Ling, SY; Liu, JZ; Liu, WB; Liu, YC; LiVolsi, VA; Lu, YL; Ma, Y; Mahadeshwar, HS; Marra, MA; Mayo, M; McFadden, DG; Meng, SW; Meyerson, M; Mieczkowski, PA; Miller, M; Mills, G; Moore, RA; Mose, LE; Mungall, AJ; Murray, BA; Nikiforov, YE; Noble, MS; Ojesina, AI; Owonikoko, TK; Ozenberger, BA; Pantazi, A; Parfenov, M; Park, PJ; Parker, JS; Paull, EO; Pedamallu, CS; Perou, CM; Prins, JF; Protopopov, A; Ramalingam, SS; Ramirez, NC; Ramirez, R; Raphael, BJ; Rathmell, WK; Ren, XJ; Reynolds, SM; Rheinbay, E; Ringel, MD; Rivera, M; Roach, J; Robertson, AG; Rosenberg, MW; Rosenthal, M; Sadeghi, S; Saksena, G; Sander, C; Santoso, N; Schein, JE; Schultz, N; Schumacher, SE; Seethala, RR; Seidman, J; Senbabaoglu, Y; Seth, S; Sharpe, S; Shaw, KRM; Shen, JP; Shen, RL; Sherman, S; Sheth, M; Shi, Y; Shmulevich, I; Sica, GL; Simons, JV; Sinha, R; Sipahimalani, P; Smallridge, RC; Sofia, HJ; Soloway, MG; Song, XZ; Sougnez, C; Stewart, C; Stojanov, P; Stuart, JM; Sumer, SO; Sun, YC; Tabak, B; Tam, A; Tan, DH; Tang, JB; Tarnuzzer, R; Taylor, BS; Thiessen, N; Thorne, L; Thorsson, V; Tuttle, RM; Umbricht, CB; Van Den Berg, DJ; Vandin, F; Veluvolu, U; Verhaak, RGW; Vinco, M; Voet, D; Walter, V; Wang, ZN; Waring, S; Weinberger, PM; Weinhold, N; Weinstein, JN; Weisenberger, DJ; Wheeler, D; Wilkerson, MD; Wilson, J; Williams, M; Winer, DA; Wise, L; Wu, JY; Xi, L; Xu, AW; Yang, LM; Yang, LX; Zack, TI; Zeiger, MA; Zeng, D; Zenklusen, JC; Zhao, N; Zhang, HL; Zhang, JH; Zhang, JS; Zhang, W; Zmuda, E; Zou, LH				Agrawal, Nishant; Akbani, Rehan; Aksoy, B. Arman; Ally, Adrian; Arachchi, Harindra; Asa, Sylvia L.; Auman, J. Todd; Balasundaram, Miruna; Balu, Saianand; Baylin, Stephen B.; Behera, Madhusmita; Bernard, Brady; Beroukhim, Rameen; Bishop, Justin A.; Black, Aaron D.; Bodenheimer, Tom; Boice, Lori; Bootwalla, Moiz S.; Bowen, Jay; Bowlby, Reanne; Bristow, Christopher A.; Brookens, Robin; Brooks, Denise; Bryant, Robert; Buda, Elizabeth; Butterfield, Yaron S. N.; Carling, Tobias; Carlsen, Rebecca; Carter, Scott L.; Carty, Sally E.; Chan, Timothy A.; Chen, Amy Y.; Cherniack, Andrew D.; Cheung, Dorothy; Chin, Lynda; Cho, Juok; Chu, Andy; Chuah, Eric; Cibulskis, Kristian; Ciriello, Giovanni; Clarke, Amanda; Clayman, Gary L.; Cope, Leslie; Copland, John A.; Covington, Kyle; Danilova, Ludmila; Davidsen, Tanja; Demchok, John A.; DiCara, Daniel; Dhalla, Noreen; Dhir, Rajiv; Dookran, Sheliann S.; Dresdner, Gideon; Eldridge, Jonathan; Eley, Greg; El-Naggar, Adel K.; Eng, Stephanie; Fagin, James A.; Fennell, Timothy; Ferris, Robert L.; Fisher, Sheila; Frazer, Scott; Frick, Jessica; Gabriel, Stacey B.; Ganly, Ian; Gao, Jianjiong; Garraway, Levi A.; Gastier-Foster, Julie M.; Getz, Gad; Gehlenborg, Nils; Ghossein, Ronald; Gibbs, Richard A.; Giordano, Thomas J.; Gomez-Hernandez, Karen; Grimsby, Jonna; Gross, Benjamin; Guin, Ranabir; Hadjipanayis, Angela; Harper, Hollie A.; Hayes, D. Neil; Heiman, David I.; Herman, James G.; Hoadley, Katherine A.; Hofree, Matan; Holt, Robert A.; Hoyle, Alan P.; Huang, Franklin W.; Huang, Mei; Hutter, Carolyn M.; Ideker, Trey; Iype, Lisa; Jacobsen, Anders; Jefferys, Stuart R.; Jones, Corbin D.; Jones, Steven J. M.; Kasaian, Katayoon; Kebebew, Electron; Khuri, Fadlo R.; Kim, Jaegil; Kramer, Roger; Kreisberg, Richard; Kucherlapati, Raju; Kwiatkowski, David J.; Ladanyi, Marc; Lai, Phillip H.; Laird, Peter W.; Lander, Eric; Lawrence, Michael S.; Lee, Darlene; Lee, Eunjung; Lee, Semin; Lee, William; Leraas, Kristen M.; Lichtenberg, Tara M.; Lichtenstein, Lee; Lin, Pei; Ling, Shiyun; Liu, Jinze; Liu, Wenbin; Liu, Yingchun; LiVolsi, Virginia A.; Lu, Yiling; Ma, Yussanne; Mahadeshwar, Harshad S.; Marra, Marco A.; Mayo, Michael; McFadden, David G.; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Miller, Michael; Mills, Gordon; Moore, Richard A.; Mose, Lisle E.; Mungall, Andrew J.; Murray, Bradley A.; Nikiforov, Yuri E.; Noble, Michael S.; Ojesina, Akinyemi I.; Owonikoko, Taofeek K.; Ozenberger, Bradley A.; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Paull, Evan O.; Pedamallu, Chandra Sekhar; Perou, Charles M.; Prins, Jan F.; Protopopov, Alexei; Ramalingam, Suresh S.; Ramirez, Nilsa C.; Ramirez, Ricardo; Raphael, Benjamin J.; Rathmell, W. Kimryn; Ren, Xiaojia; Reynolds, Sheila M.; Rheinbay, Esther; Ringel, Matthew D.; Rivera, Michael; Roach, Jeffrey; Robertson, A. Gordon; Rosenberg, Mara W.; Rosenthal, Matthew; Sadeghi, Sara; Saksena, Gordon; Sander, Chris; Santoso, Netty; Schein, Jacqueline E.; Schultz, Nikolaus; Schumacher, Steven E.; Seethala, Raja R.; Seidman, Jonathan; Senbabaoglu, Yasin; Seth, Sahil; Sharpe, Samantha; Shaw, Kenna R. Mills; Shen, John P.; Shen, Ronglai; Sherman, Steven; Sheth, Margi; Shi, Yan; Shmulevich, Ilya; Sica, Gabriel L.; Simons, Janae V.; Sinha, Rileen; Sipahimalani, Payal; Smallridge, Robert C.; Sofia, Heidi J.; Soloway, Matthew G.; Song, Xingzhi; Sougnez, Carrie; Stewart, Chip; Stojanov, Petar; Stuart, Joshua M.; Sumer, S. Onur; Sun, Yichao; Tabak, Barbara; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Taylor, Barry S.; Thiessen, Nina; Thorne, Leigh; Thorsson, Vesteinn; Tuttle, R. Michael; Umbricht, Christopher B.; Van Den Berg, David J.; Vandin, Fabio; Veluvolu, Umadevi; Verhaak, Roel G. W.; Vinco, Michelle; Voet, Doug; Walter, Vonn; Wang, Zhining; Waring, Scot; Weinberger, Paul M.; Weinhold, Nils; Weinstein, John N.; Weisenberger, Daniel J.; Wheeler, David; Wilkerson, Matthew D.; Wilson, Jocelyn; Williams, Michelle; Winer, Daniel A.; Wise, Lisa; Wu, Junyuan; Xi, Liu; Xu, Andrew W.; Yang, Liming; Yang, Lixing; Zack, Travis I.; Zeiger, Martha A.; Zeng, Dong; Zenklusen, Jean Claude; Zhao, Ni; Zhang, Hailei; Zhang, Jianhua; Zhang, Jiashan (Julia); Zhang, Wei; Zmuda, Erik; Zou, Lihua		Canc Genome Atlas Res Network	Integrated Genomic Characterization of Papillary Thyroid Carcinoma	CELL			English	Article							ACTIVATED RAS ONCOGENES; TERT PROMOTER MUTATIONS; BRAF MUTATIONS; HUMAN CANCERS; PATHWAY; FUSION; GENES; CELLS; BRAF(V600E); NODULES	Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic alterations (relative to other carcinomas) and extended the set of known PTC driver alterations to include EIF1AX, PPM1D, and CHEK2 and diverse gene fusions. These discoveries reduced the fraction of PTC cases with unknown oncogenic driver from 25% to 3.5%. Combined analyses of genomic variants, gene expression, and methylation demonstrated that different driver groups lead to different pathologies with distinct signaling and differentiation characteristics. Similarly, we identified distinct molecular subgroups of BRAF-mutant tumors, and multidimensional analyses highlighted a potential involvement of onco-miRs in less-differentiated subgroups. Our results propose a reclassification of thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties, which has the potential to improve their pathological classification and better inform the management of the disease.	[Giordano, Thomas J.; Canc Genome Atlas Res Network] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA	International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Giordano, TJ (corresponding author), NCI, Canc Genome Atlas Program Off, NIH, 31 Ctr Dr,Bldg 31,Suite 3A20, Bethesda, MD 20892 USA.	gadgetz@broadinstitute.org; giordano@umich.edu	Ramalingam, Suresh/AAV-7478-2020; Lawrence, Michael/AAC-8202-2020; Skanderup, Anders Jacobsen/K-1081-2013; Cherniack, Andrew D./AAY-8132-2020; Cibulskis, Kristian/AAC-7380-2019; Weinberger, Paul/B-7007-2008; Seth, Sahil/I-5809-2019; Khuri, Fadlo R./AAU-4942-2020; Cherniack, Andrew/AAC-5310-2019; Stojanov, Petar/GQI-4462-2022; Jones, Steven J/C-3621-2009; Holt, Robert A/C-3303-2009; Marra, Marco A/B-5987-2008; liu, ying/GXF-4294-2022; Kucherlapati, Raju/ABC-8807-2021; Gao, JianJiong/B-5673-2016; Schultz, Nikolaus/ABE-6347-2020; Verhaak, Roel/ABE-7058-2020; Weisenberger, Daniel/AAA-8314-2020; Lee, Semin/S-2629-2016; Schein, Jacquie E/G-3674-2015; Ling, Shiyun/P-2242-2014; Mungall, Andrew J./U-7067-2018; LIU, YING/GZL-7252-2022; Zhao, Ni/P-9086-2014; Parker, Joel/AAG-1108-2019; Laird, Peter W/G-8683-2012; Walter, Vonn/AAI-3450-2021; Pedamallu, Chandra Sekhar/AAV-6723-2020; Pedamallu, Chandra Sekhar/AAV-6745-2020; Perou, Charles M/H-9934-2014; Ladanyi, Marc/AAG-8585-2019; Akbani, Rehan/AAG-1490-2019; Van Den Berg, David J/G-8598-2017; Chan, Timothy A/ABD-5850-2021	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Cherniack, Andrew D./0000-0003-0470-0111; Weinberger, Paul/0000-0002-5885-2631; Seth, Sahil/0000-0003-4579-3959; Khuri, Fadlo R./0000-0002-8638-7618; Stojanov, Petar/0000-0001-7815-776X; Jones, Steven J/0000-0003-3394-2208; Holt, Robert A/0000-0002-7259-1247; Marra, Marco A/0000-0001-7146-7175; Gao, JianJiong/0000-0002-5739-1781; Weisenberger, Daniel/0000-0001-8303-2603; Lee, Semin/0000-0002-9015-6046; Mungall, Andrew J./0000-0002-0905-2742; Zhao, Ni/0000-0002-7762-3949; Laird, Peter W/0000-0001-9117-3641; Walter, Vonn/0000-0001-6114-6714; Perou, Charles M/0000-0001-9827-2247; Van Den Berg, David J/0000-0002-5404-5218; Tarnuzzer, Roy/0000-0002-3725-4173; Bowen, Jay/0000-0001-6861-9043; Giordano, Thomas/0000-0003-0641-8873; Meyerson, Matthew/0000-0002-9133-8108; Hoadley, Katherine/0000-0002-1216-477X; Stuart, Joshua/0000-0002-2171-565X; Mieczkowski, Piotr/0000-0003-2418-0096; Sinha, Rileen/0000-0001-5497-5055; Park, Peter/0000-0001-9378-960X	United States National Institutes of Health [5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, P30CA16672]; NATIONAL CANCER INSTITUTE [U24CA143858, U24CA180951, U24CA143843, U24CA143883, U24CA143845, U24CA143866, K08CA160658, P30CA177558, U24CA143848, U24CA143867, P30CA016672, U24CA143882, U24CA144025, U24CA143835, U24CA143840, P30CA046592, R01CA050706, P30CA008748, U24CA143799] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007069, U54HG003067, R01HG006272, U54HG003273, U54HG003079] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to all the patients and families who contributed to this study, to Chris Gunter for editing, and Margi Sheth and Jiashan (Julia) Zhang for project management. Thomas Giordano thanks his colleagues who covered his clinical duties. Supported by the following grants from the United States National Institutes of Health: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, and U54HG003273, P30CA16672. Yuri Nikiforov is a consultant for Quest Diagnostics. Raju Kucherlapati serves on the Board of Directors of KEW Group, Inc. Daniel J. Weisenberger is a consultant for Zymo Research Corporation.	Adeniran AJ, 2006, AM J SURG PATHOL, V30, P216, DOI 10.1097/01.pas.0000176432.73455.1b; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Bischoff LA, 2013, ENDOCR PRACT, V19, P995, DOI 10.4158/EP13029.OR; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chu J., 2014, BIOINFORMATICS; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Ellis RJ, 2014, J CLIN ENDOCR METAB, V99, pE329, DOI 10.1210/jc.2013-2749; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Ghossein RA, 2013, J CLIN ENDOCR METAB, V98, pE1414, DOI 10.1210/jc.2013-1408; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; HAY ID, 1993, SURGERY, V114, P1050; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hutchinson KE, 2013, CLIN CANCER RES, V19, P6696, DOI 10.1158/1078-0432.CCR-13-1746; Imam JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052397; Jung CK, 2014, J CLIN ENDOCR METAB, V99, pE276, DOI 10.1210/jc.2013-2503; Kelly LM, 2014, P NATL ACAD SCI USA, V111, P4233, DOI 10.1073/pnas.1321937111; Kimura ET, 2003, CANCER RES, V63, P1454; Kjellman P, 2001, GENE CHROMOSOME CANC, V32, P43, DOI 10.1002/gcc.1165; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039653; LEMOINE NR, 1988, CANCER RES, V48, P4459; Mardente S, 2012, ONCOL REP, V28, P2285, DOI 10.3892/or.2012.2058; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Minamiya Y, 2012, CANCER BIOMARK, V11, P139, DOI 10.3233/CBM-2012-00272; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Nikiforov YE, 2013, CLIN CANCER RES, V19, P2283, DOI 10.1158/1078-0432.CCR-12-1253; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nucera C, 2011, CANCER RES, V71, P2417, DOI 10.1158/0008-5472.CAN-10-3844; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Park JY, 2013, ENDOCR PATHOL, V24, P69, DOI 10.1007/s12022-013-9244-0; Paull EO, 2013, BIOINFORMATICS, V29, P2757, DOI 10.1093/bioinformatics/btt471; PIEROTTI MA, 1995, J ENDOCRINOL INVEST, V18, P130, DOI 10.1007/BF03349721; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Qiu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1331, DOI 10.1159/000354531; Ricarte JC, 2013, J CLIN INVEST, V123, P4935, DOI 10.1172/JCI69766; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sabra MM, 2013, J CLIN ENDOCR METAB, V98, pE829, DOI 10.1210/jc.2012-3933; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Streit M, 2014, NAT METHODS, V11, P884, DOI 10.1038/nmeth.3088; SUAREZ HG, 1988, ONCOGENE, V2, P403; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Wreesmann VB, 2004, CANCER RES, V64, P3780, DOI 10.1158/0008-5472.CAN-03-1460; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Yip L, 2014, ANN SURG, V260, P163, DOI 10.1097/SLA.0000000000000215; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	69	1596	1622	17	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					676	690		10.1016/j.cell.2014.09.050	http://dx.doi.org/10.1016/j.cell.2014.09.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417114	Green Accepted, hybrid			2022-12-01	WOS:000344521700021
J	Castel, SE; Ren, J; Bhattacharjee, S; Chang, AY; Sanchez, M; Valbuena, A; Antequera, F; Martienssen, RA				Castel, Stephane E.; Ren, Jie; Bhattacharjee, Sonali; Chang, An-Yun; Sanchez, Mar; Valbuena, Alberto; Antequera, Francisco; Martienssen, Robert A.			Dicer Promotes Transcription Termination at Sites of Replication Stress to Maintain Genome Stability	CELL			English	Article							RNA-POLYMERASE-II; DNA-REPLICATION; FISSION YEAST; HOMOLOGOUS RECOMBINATION; HISTONE MODIFICATION; POL-II; HETEROCHROMATIN; GENE; INTERFERENCE; CHROMATIN	Nuclear RNAi is an important regulator of transcription and epigenetic modification, but the underlying mechanisms remain elusive. Using a genome-wide approach in the fission yeast S. pombe, we have found that Dcr1, but not other components of the canonical RNAi pathway, promotes the release of Pol II from the 30 end of highly transcribed genes, and, surprisingly, from antisense transcription of rRNA and tRNA genes, which are normally transcribed by Pol I and Pol III. These Dcr1-terminated loci correspond to sites of replication stress and DNA damage, likely resulting from transcription-replication collisions. At the rDNA loci, release of Pol II facilitates DNA replication and prevents homologous recombination, which would otherwise lead to loss of rDNA repeats especially during meiosis. Our results reveal a novel role for Dcr1-mediated transcription termination in genome maintenance and may account for widespread regulation of genome stability by nuclear RNAi in higher eukaryotes.	[Castel, Stephane E.; Ren, Jie; Bhattacharjee, Sonali; Chang, An-Yun; Martienssen, Robert A.] Gordon & Betty Moore Fdn, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chang, An-Yun; Martienssen, Robert A.] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Sanchez, Mar; Valbuena, Alberto; Antequera, Francisco] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Martienssen, RA (corresponding author), Gordon & Betty Moore Fdn, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	SANCHEZ, MAR/L-1898-2017; Antequera, Francisco/B-1115-2017	Antequera, Francisco/0000-0003-2623-4131; Sanchez, Maria del Mar/0000-0003-4438-0722	Natural Sciences and Engineering Research Council of Canada (PGSD); Cashin Scholarship from the Watson School of Biological Sciences; Spanish Ministerio de Economia y Competitividad [BFU2011-28804, CSD2007-00015]; NIH [GM076396]; Howard Hughes Medical Institute-Gordon and Betty Moore Foundation [GMBF3033]; Cancer Center Support Grant [5PP30CA045508]; Division Of Integrative Organismal Systems [1025830] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (PGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cashin Scholarship from the Watson School of Biological Sciences; Spanish Ministerio de Economia y Competitividad(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-Gordon and Betty Moore Foundation(Howard Hughes Medical Institute); Cancer Center Support Grant; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. O'Connell, and B. Arcangioli for strains, advice, and discussion, F. Chedin for advice on DRIP-seq, and M.T.A. Donoghue for discussion and advice relating to statistical analysis. S.E.C. was supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada (PGSD) and a Cashin Scholarship from the Watson School of Biological Sciences. This work was supported by grants BFU2011-28804 and CSD2007-00015 from the Spanish Ministerio de Economia y Competitividad to F.A. and by a grant from the NIH (GM076396) to R.A.M. R.A.M. is also supported by the Howard Hughes Medical Institute-Gordon and Betty Moore Foundation (GMBF3033) and held a Chaire Blaise Pascal (Region Ile-de-France) at Institut Biologie Ecole Normale Superieure, Paris. The authors acknowledge assistance from the Cold Spring Harbor Laboratory Shared Resources, which are funded in part by the Cancer Center Support Grant (5PP30CA045508).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cecere G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-44; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ellermeier C, 2010, P NATL ACAD SCI USA, V107, P8701, DOI 10.1073/pnas.0914160107; Ganley ARD, 2014, FEMS YEAST RES, V14, P49, DOI 10.1111/1567-1364.12133; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Goto DB, 2012, DEV GROWTH DIFFER, V54, P129, DOI 10.1111/j.1440-169X.2011.01310.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Gullerova M, 2011, GENE DEV, V25, P556, DOI 10.1101/gad.618611; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Holmes A, 2012, CELL REP, V2, P1513, DOI 10.1016/j.celrep.2012.10.011; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Marasovic M, 2013, MOL CELL, V52, P173, DOI 10.1016/j.molcel.2013.08.046; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Nakama M, 2012, GENES CELLS, V17, P218, DOI 10.1111/j.1365-2443.2012.01583.x; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; Sanchez JA, 1998, EXP CELL RES, V238, P220, DOI 10.1006/excr.1997.3835; Schlackow M, 2013, RNA, V19, P1617, DOI 10.1261/rna.040675.113; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Tanaka H, 2002, NUCLEIC ACIDS RES, V30, P4728, DOI 10.1093/nar/gkf590; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; West S, 2009, MOL CELL, V33, P354, DOI 10.1016/j.molcel.2009.01.008; White E, 2014, NAT STRUCT MOL BIOL, V21, P552, DOI 10.1038/nsmb.2827; Woolcock KJ, 2012, GENE DEV, V26, P683, DOI 10.1101/gad.186866.112; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zhang ZY, 2013, GENE DEV, V27, P145, DOI 10.1101/gad.209494.112; Zhou ZX, 2013, GENOME RES, V23, P705, DOI 10.1101/gr.146357.112	68	84	84	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					572	583		10.1016/j.cell.2014.09.031	http://dx.doi.org/10.1016/j.cell.2014.09.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417108	Green Accepted, Bronze			2022-12-01	WOS:000344521700013
J	Junker, JP; Noel, ES; Guryev, V; Peterson, KA; Shah, G; Huisken, J; McMahon, AP; Berezikov, E; Bakkers, J; van Oudenaarden, A				Junker, Jan Philipp; Noel, Emily S.; Guryev, Victor; Peterson, Kevin A.; Shah, Gopi; Huisken, Jan; McMahon, Andrew P.; Berezikov, Eugene; Bakkers, Jeroen; van Oudenaarden, Alexander			Genome-wide RNA Tomography in the Zebrafish Embryo	CELL			English	Article							IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SEQ; IDENTIFICATION; FAMILY	Advancing our understanding of embryonic development is heavily dependent on identification of novel pathways or regulators. Although genome-wide techniques such as RNA sequencing are ideally suited for discovering novel candidate genes, they are unable to yield spatially resolved information in embryos or tissues. Microscopy-based approaches, using in situ hybridization, for example, can provide spatial information about gene expression, but are limited to analyzing one or a few genes at a time. Here, we present a method where we combine traditional histological techniques with low-input RNA sequencing and mathematical image reconstruction to generate a high-resolution genome-wide 3D atlas of gene expression in the zebrafish embryo at three developmental stages. Importantly, our technique enables searching for genes that are expressed in specific spatial patterns without manual image annotation. We envision broad applicability of RNA tomography as an accurate and sensitive approach for spatially resolved transcriptomics in whole embryos and dissected organs.	[Junker, Jan Philipp; Noel, Emily S.; Bakkers, Jeroen; van Oudenaarden, Alexander] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Junker, Jan Philipp; Noel, Emily S.; Bakkers, Jeroen; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Guryev, Victor; Berezikov, Eugene] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands; [Peterson, Kevin A.; McMahon, Andrew P.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90089 USA; [Shah, Gopi; Huisken, Jan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Berezikov, Eugene; van Oudenaarden, Alexander] Skolkovo Inst Sci & Technol Skoltech, Skolkovo 143025, Moscow Region, Russia	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; University of Southern California; Max Planck Society; Skolkovo Institute of Science & Technology	van Oudenaarden, A (corresponding author), KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	Huisken, Jan/B-2472-2009; Junker, Jan Philipp/A-9754-2010; huang, dezhi/ABC-6566-2021; van Oudenaarden, Alexander/AAA-1705-2019; Berezikov, Eugene/D-3363-2013; McMahon, Andrew P/ABE-7520-2020; Bakkers, Jeroen/H-5551-2011	Huisken, Jan/0000-0001-7250-3756; Junker, Jan Philipp/0000-0002-2826-8290; Berezikov, Eugene/0000-0002-1145-2884; Bakkers, Jeroen/0000-0002-9418-0422; Noel, Emily/0000-0003-1026-634X; Guryev, Victor/0000-0002-5810-6022	European Research Council Advanced grant [ERC-AdG 294325-GeneNoiseControl]; Nederlandse Organisatie voor We tenschappelijk Onderzoek (NWO) Vidi and Vici awards; NIH [NS033642]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER	European Research Council Advanced grant(European Research Council (ERC)); Nederlandse Organisatie voor We tenschappelijk Onderzoek (NWO) Vidi and Vici awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Grun and B. Spanjaard for help with computational analysis. This work was supported by a European Research Council Advanced grant (ERC-AdG 294325-GeneNoiseControl) and by Nederlandse Organisatie voor We tenschappelijk Onderzoek (NWO) Vidi and Vici awards. Work in A. P. M.'s laboratory was supported by a grant from the NIH (NS033642).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Cutty SJ, 2012, INT J DEV BIOL, V56, P285, DOI 10.1387/ijdb.113447sc; FIENBERG SE, 1970, ANN MATH STAT, V41, P907, DOI 10.1214/aoms/1177696968; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Geffers L, 2012, MAMM GENOME, V23, P525, DOI 10.1007/s00335-012-9413-3; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/nmeth.2930, 10.1038/NMETH.2930]; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tibshirani R., 2006, J R STAT SOC B, V63; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang XH, 2008, DEV DYNAM, V237, P3640, DOI 10.1002/dvdy.21771; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yu J, 2012, DEVELOPMENT, V139, P1863, DOI 10.1242/dev.074005	41	159	163	7	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					662	675		10.1016/j.cell.2014.09.038	http://dx.doi.org/10.1016/j.cell.2014.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417113	Green Published, Bronze			2022-12-01	WOS:000344521700020
J	Tanenbaum, ME; Gilbert, LA; Qi, LS; Weissman, JS; Vale, RD				Tanenbaum, Marvin E.; Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.; Vale, Ronald D.			A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging	CELL			English	Article							TRANSCRIPTION FACTOR SP1; SYNERGISTIC ACTIVATION; STEM-CELLS; IN-VIVO; RNA; BINDING; LOCALIZATION; INTRABODIES; HUNTINGTIN; CRISPR/CAS	Signals in many biological processes can be amplified by recruiting multiple copies of regulatory proteins to a site of action. Harnessing this principle, we have developed a protein scaffold, a repeating peptide array termed SunTag, which can recruit multiple copies of an antibody-fusion protein. We show that the SunTag can recruit up to 24 copies of GFP, thereby enabling long-term imaging of single protein molecules in living cells. We also use the SunTag to create a potent synthetic transcription factor by recruiting multiple copies of a transcriptional activation domain to a nuclease-deficient CRISPR/Cas9 protein and demonstrate strong activation of endogenous gene expression and re-engineered cell behavior with this system. Thus, the SunTag provides a versatile platform for multimerizing proteins on a target protein scaffold and is likely to have many applications in imaging and controlling biological outputs.	[Tanenbaum, Marvin E.; Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Tanenbaum, Marvin E.; Gilbert, Luke A.; Weissman, Jonathan S.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Gilbert, Luke A.; Qi, Lei S.; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@ucsf.edu	Gilbert, Luke/AAC-5300-2019; Qi, Lei S/AAC-5088-2019	Gilbert, Luke/0000-0001-5854-0825; Qi, Lei S/0000-0002-3965-3223; Weissman, Jonathan/0000-0003-2445-670X	Dutch Cancer Society (KWF); UCSF Center for Systems and Synthetic Biology; NIH Office of The Director (OD); National Institute of Dental & Craniofacial Research (NIDCR); NIH P50 [GM081879, GM102706]; NIH Director's Early Independence Award [GM081879]; NIH R01 [DA036858]; NIH U01 [CA168370]; Leukemia and Lymphoma Society; Howard Hughes Medical Institute;  [GM38499]; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499, P50GM081879, P50GM102706, R01GM038499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); UCSF Center for Systems and Synthetic Biology; NIH Office of The Director (OD); National Institute of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH P50; NIH Director's Early Independence Award; NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U01; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Evan Whitehead for making the dCas9-2xNLS-10xGCN4 and scFv-GCN4- sfGFP-2xNLS-VP64 plasmids, Viki Allan for the EB3-tdTomato plasmid, Xiaokun Shu for the IFP2.0 protein, and Max Horlbeck for designing the CDKN1B sgRNAs. We also thank Nico Stuurman for help with microscopy, Kate Carbone for help with single-particle tracking, Andreas Pluckthun for helpful discussions, and the Vale lab members for helpful comments. M.E.T. was financially supported by a fellowship from the Dutch Cancer Society (KWF). L.S.Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology, NIH Office of The Director (OD), and National Institute of Dental & Craniofacial Research (NIDCR). This work was in part supported by NIH P50 (grant GM081879 to L.S.Q.), NIH Director's Early Independence Award (grant OD017887 to L.S.Q.), NIH R01 (grant DA036858 to L.S.Q. and J.S.W.), NIH P50 (grant GM102706 to J.S.W.), NIH U01 (grant CA168370 to J.S.W.), grant GM38499 to R.D.V., the Leukemia and Lymphoma Society (L.A.G.), and the Howard Hughes Medical Institute (R.D.V. and J.S.W.). A patent has been filed for the SunTag technology.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Brenner S, 2004, STEM CELLS, V22, P1128, DOI 10.1634/stemcells.2003-0196; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; CHEN XR, 1992, ONCOGENE, V7, P1805; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Coller J, 2007, METHOD ENZYMOL, V429, P299, DOI 10.1016/S0076-6879(07)29014-7; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Huang CJ, 1999, MOL MED, V5, P129, DOI 10.1007/BF03402147; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; PETTERSSON M, 1990, J MOL BIOL, V214, P373, DOI 10.1016/0022-2836(90)90187-Q; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795	38	829	878	17	293	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					635	646		10.1016/j.cell.2014.09.039	http://dx.doi.org/10.1016/j.cell.2014.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25307933	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000344521700018
J	Johnston, A; Bailey, M				Johnston, Andy; Bailey, Mark			Operation Gritrock: first UK army medics fly to Sierra Leone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Johnston, Andy] Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham B15 2TH, W Midlands, England; [Bailey, Mark] Heartlands Hosp, Birmingham, W Midlands, England	Royal Centre for Defence Medicine; University of Birmingham; Heart of England NHS Foundation Trust	Johnston, A (corresponding author), Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham B15 2TH, W Midlands, England.	andy.johnston@uhb.nhs.uk	Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589					0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2014	349								g6237	10.1136/bmj.g6237	http://dx.doi.org/10.1136/bmj.g6237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7NT	25315203	Green Published, Bronze			2022-12-01	WOS:000343767300024
J	Fakhry, C; Gillison, ML; D'Souza, G				Fakhry, Carole; Gillison, Maura L.; D'Souza, Gypsyamber			Tobacco Use and Oral HPV-16 Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HUMAN-PAPILLOMAVIRUS; UNITED-STATES; CANCER		[Fakhry, Carole] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Gillison, Maura L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	cfakhry@jhmi.edu; gdsouza2@jhu.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023175, R01DE021395, P50DE019032] Funding Source: NIH RePORTER; NIDCR NIH HHS [P50DE019032, R01DE021395, R01 DE023175, R01DE023175, R01 DE021395, P50 DE019032] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Centers for Disease Control and Prevention (U.S.), NAT HLTH NUTR EX SUR; Chaturvedi AK, 2014, J INFECT DIS, V210, P441, DOI 10.1093/infdis/jiu116; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803	6	52	52	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1465	1467		10.1001/jama.2014.13183	http://dx.doi.org/10.1001/jama.2014.13183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291584	Bronze, Green Accepted			2022-12-01	WOS:000342630200025
J	Calo, E; Flynn, RA; Martin, L; Spitale, RC; Chang, HY; Wysocka, J				Calo, Eliezer; Flynn, Ryan A.; Martin, Lance; Spitale, Robert C.; Chang, Howard Y.; Wysocka, Joanna			RNA helicase DDX21 coordinates transcription and ribosomal RNA processing	NATURE			English	Article							BOX C/D SNORNA; P-TEFB; 7SK; POLYMERASE; PROTEIN; REPLICATION; II/GU; ELONGATION; NUCLEOTIDE; DEPLETION	DEAD-box RNA helicases are vital for the regulation of variousaspects of the RNA life cycle(1), but the molecular underpinnings of their involvement, particularly in mammalian cells, remain poorly understood. Here we show that the DEAD-box RNA helicase DDX21 can sense the transcriptional status of both RNA polymerase (Pol) I and II to control multiple steps of ribosome biogenesis in human cells. We demonstrate that DDX21 widely associates with Pol I-and Pol II-transcribed genes and with diverse species of RNA, most prominently with non-coding RNAs involved in the formation of ribonucleoprotein complexes, including ribosomal RNA, small nucleolar RNAs (snoRNAs) and 7SK RNA. Although broad, these molecular interactions, both at the chromatin and RNA level, exhibit remarkable specificity for the regulation of ribosomal genes. In the nucleolus, DDX21 occupies the transcribed rDNA locus, directly contacts both rRNA and snoRNAs, and promotes rRNA transcription, processing and modification. In the nucleoplasm, DDX21 binds 7SK RNA and, as a component of the 7SK small nuclear ribonucleoprotein (snRNP) complex, is recruited to the promoters of Pol II-transcribed genes encoding ribosomal proteins and snoRNAs. Promoter-bound DDX21 facilitates the release of the positive transcription elongation factor b (P-TEFb) from the 7SK snRNP in a manner that is dependent on its helicase activity, thereby promoting transcription of its target genes. Our results uncover the multifaceted role of DDX21 in multiple steps of ribosome biogenesis, and provide evidence implicating a mammalian RNA helicase in RNA modification and Pol II elongation control.	[Calo, Eliezer; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Spitale, Robert C.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Spitale, Robert C.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; wysocka@stanford.edu		Flynn, Ryan/0000-0001-5013-0442	Stanford Medical Scientist Training Program; AP Giannini Foundation; National Institutes of Health [R01-HG004361, R01-ES023168, P50-HG007735, R01-GM095555]; W. M. Keck Foundation; Helen Hay Whitney Foundation;  [T32CA09302]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095555] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; AP Giannini Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Helen Hay Whitney Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. H. Price for the LARP7 antibody, K. Lane from M. Covert's laboratory formetabolic inhibitors, K. Cimprich and members of the Chang and Wysocka laboratories for discussions, and B. Zarnegar and P. Khavari for discussions regarding iCLIP. This work was supported by the Stanford Medical Scientist Training Program and T32CA09302 (R.A.F.), AP Giannini Foundation (R.C.S.), National Institutes of Health grants R01-HG004361, R01-ES023168, P50-HG007735 (H.Y.C.) and R01-GM095555 (J.W.), W. M. Keck Foundation (J.W.), and Helen Hay Whitney Foundation (E.C.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5330; Castelo-Branco G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r98; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Fatica A, 2000, RNA, V6, P88, DOI 10.1017/S1355838200991623; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lui LR, 2013, ESSAYS BIOCHEM, V54, P53, DOI [10.1042/BSE0540053, 10.1042/bse0540053]; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Perlaky L, 1997, EXP CELL RES, V235, P413, DOI 10.1006/excr.1997.3686; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Putnam AA, 2013, BBA-GENE REGUL MECH, V1829, P884, DOI 10.1016/j.bbagrm.2013.02.002; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Russell R, 2013, RNA BIOL, V10, P44, DOI 10.4161/rna.22210; Sharma A, 2007, J BIOL CHEM, V282, P12048, DOI 10.1074/jbc.M608104200; Valdez BC, 1997, EUR J BIOCHEM, V250, P800, DOI 10.1111/j.1432-1033.1997.00800.x; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Yang HS, 2003, J BIOL CHEM, V278, P38847, DOI 10.1074/jbc.M302258200; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yu YT, 1997, RNA, V3, P324; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326	37	171	176	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					249	U269		10.1038/nature13923	http://dx.doi.org/10.1038/nature13923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25470060	Green Accepted			2022-12-01	WOS:000349190300042
J	Tran, TH; Hsiao, YS; Jo, J; Chou, CY; Dietrich, LEP; Walz, T; Tong, L				Tran, Timothy H.; Hsiao, Yu-Shan; Jo, Jeanyoung; Chou, Chi-Yuan; Dietrich, Lars E. P.; Walz, Thomas; Tong, Liang			Structure and function of a single-chain, multi-domain long-chain acyl-CoA carboxylase	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; COMPLETE GENOME SEQUENCE; PYRUVATE-CARBOXYLASE; CRYSTAL-STRUCTURE; CARBOXYLTRANSFERASE DOMAIN; MYCOBACTERIUM-TUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; ACETYL-COENZYME; BIOTIN; SOFTWARE	Biotin-dependent carboxylases are widely distributed in nature and have important functions in the metabolism of fatty acids, amino acids, carbohydrates, cholesterol and other compounds(1-6). Defective mutations in several of these enzymes have been linked to serious metabolic diseases in humans, and acetyl-CoA carboxylase is a target for drug discovery in the treatment of diabetes, cancer and other diseases(7-9). Here we report the identification and biochemical, structural and functional characterizations of a novel single-chain (120 kDa), multi-domain biotin-dependent carboxylase in bacteria. It has preference for long-chain acyl-CoA substrates, although it is also active towards short-chain and medium-chainacyl-CoAs, and we have named it long-chain acyl-CoA carboxylase. The holoenzyme is a homo-hexamer with molecular mass of 720 kDa. The 3.0 angstrom crystal structure of the long-chain acyl-CoA carboxylase holoenzyme from Mycobacterium avium subspecies paratuberculosis revealed an architecture that is strikingly different from those of related biotin-dependent carboxylases(10,11). In addition, the domains of each monomer have no direct contact with each other. They are instead extensively swapped in the holoenzyme, such that one cycle of catalysis involves the participation of four monomers. Functional studies in Pseudomonas aeruginosa suggest that the enzyme is involved in the utilization of selected carbon and nitrogen sources.	[Tran, Timothy H.; Jo, Jeanyoung; Chou, Chi-Yuan; Dietrich, Lars E. P.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Hsiao, Yu-Shan; Walz, Thomas] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Walz, Thomas/0000-0003-2606-2835; Tong, Liang/0000-0002-0563-6468; Dietrich, Lars/0000-0003-2049-1137; Chou, Chi-Yuan/0000-0002-3400-171X	National Institutes of Health (NIH) [S10OD012018]; NIH [R01DK067238, R01AI103369, NCRR 1S10RR028832-01]; Protein Structure Initiative of the NIH [U54GM094597]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580, T32GM008798, U54GM094597] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Structure Initiative of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Huang for carrying out some initial studies in this project; A. Price-Whelan for discussions on P. aeruginosa physiology; R. Jackimowicz, N. Whalen and H. Robinson for access to the X29A beamline; Z. Li for EM support; P. Penczek for help with SPARX. The in-house instrument for X-ray diffraction was purchased with a National Institutes of Health (NIH) grant to L.T. (S10OD012018). This research is supported by grants from the NIH (R01DK067238 to L.T. and R01AI103369 to L.E.P.D.) and from the Protein Structure Initiative of the NIH (U54GM094597 to L.T.). The Orchestra High Performance Compute Cluster at Harvard Medical School is a shared facility partly supported by NIH grant NCRR 1S10RR028832-01. T.W. is an investigator with the Howard Hughes Medical Institute.	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Aguilar JA, 2008, J BACTERIOL, V190, P4888, DOI 10.1128/JB.00454-08; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2012, J BIOL CHEM, V287, P9389, DOI 10.1074/jbc.M111.319475; Forster-Fromme K, 2010, APPL MICROBIOL BIOT, V87, P859, DOI 10.1007/s00253-010-2644-x; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grande R., 2007, J BACTERIOL, V189, P5257; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang CS, 2012, NATURE, V481, P219, DOI 10.1038/nature10691; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Lai HF, 2006, APPL ENVIRON MICROB, V72, P7785, DOI 10.1128/AEM.01564-06; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shea April, 2012, Methods Mol Biol, V881, P331, DOI 10.1007/978-1-61779-827-6_12; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	45	20	22	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					120	+		10.1038/nature13912	http://dx.doi.org/10.1038/nature13912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25383525	Green Accepted, Green Submitted			2022-12-01	WOS:000349098000044
J	Faller, WJ; Jackson, TJ; Knight, JRP; Ridgway, RA; Jamieson, T; Karim, SA; Jones, C; Radulescu, S; Huels, DJ; Myant, KB; Dudek, KM; Casey, HA; Scopelliti, A; Cordero, JB; Vidal, M; Pende, M; Ryazanov, AG; Sonenberg, N; Meyuhas, O; Hall, MN; Bushell, M; Willis, AE; Sansom, OJ				Faller, William J.; Jackson, Thomas J.; Knight, John R. P.; Ridgway, Rachel A.; Jamieson, Thomas; Karim, Saadia A.; Jones, Carolyn; Radulescu, Sorina; Huels, David J.; Myant, Kevin B.; Dudek, Kate M.; Casey, Helen A.; Scopelliti, Alessandro; Cordero, Julia B.; Vidal, Marcos; Pende, Mario; Ryazanov, Alexey G.; Sonenberg, Nahum; Meyuhas, Oded; Hall, Michael N.; Bushell, Martin; Willis, Anne E.; Sansom, Owen J.			mTORC1-mediated translational elongation limits intestinal tumour initiation and growth	NATURE			English	Article							COLORECTAL-CANCER; STEM-CELLS; MAMMALIAN TARGET; BETA-CATENIN; IN-VITRO; C-MYC; KINASE; GENE; MTOR; INHIBITION	Inactivation of APC is a strongly predisposing event in the development of colorectal cancer(1,2), prompting the search for vulnerabilities specific to cells that have lost APC function. Signalling through the mTOR pathway is known to be required for epithelial cell proliferation and tumour growth(3,5), and the current paradigm suggests that a critical function of mTOR activity is to upregulate translational initiation through phosphorylation of 4EBP 1 (refs 6, 7). This model predicts that the mTOR inhibitor rapamycin, which does not efficiently inhibit 4EBP 1 (ref. 8), would be ineffective in limiting cancer progression in APC-deficient lesions. Here we show in mice that mTOR complex 1 (mTORC1) activity is absolutely required for the proliferation of Apc-deficient (but not wild-type) enterocytes, revealing an unexpected opportunity for therapeutic intervention. Although APC-deficient cells show the expected increases in protein synthesis, our study reveals that it is translation elongation, and not initiation, which is the rate-limiting component. Mechanistically, mTORC1-mediated inhibition of eEF2 kinase is required for the proliferation of APC-deficient cells. Importantly, treatment of established APC-deficient adenomas with rapamycin (which can target eEF2 through the mTORCI-56K-eEF2K axis) causes tumour cells to undergo growth arrest and differentiation. Taken together, our data suggest that inhibition of translation elongation using existing, clinically approved drugs, such as the rapalogs, would provide clear therapeutic benefit for patients at high risk of developing colorectal cancer.	[Faller, William J.; Ridgway, Rachel A.; Jamieson, Thomas; Karim, Saadia A.; Radulescu, Sorina; Huels, David J.; Myant, Kevin B.; Casey, Helen A.; Scopelliti, Alessandro; Cordero, Julia B.; Vidal, Marcos; Sansom, Owen J.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Jackson, Thomas J.; Knight, John R. P.; Jones, Carolyn; Dudek, Kate M.; Bushell, Martin; Willis, Anne E.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Pende, Mario] Inst Necker Enfants Malad, CS 61431, Paris, France; [Pende, Mario] INSERM, U1151, F-75014 Paris, France; [Pende, Mario] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Ryazanov, Alexey G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Beatson Institute; University of Leicester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center; McGill University; McGill University; Hebrew University of Jerusalem; University of Basel	Sansom, OJ (corresponding author), Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	ryazanov, alexey/J-8081-2017; Knight, John/V-2922-2019; Pende, Mario/AFR-1348-2022; Jackson, Thomas/GQI-2752-2022; Knight, John/GSE-3183-2022	Knight, John/0000-0002-8771-5484; Pende, Mario/0000-0002-7864-8937; Jackson, Thomas/0000-0003-1669-6666; Faller, William James/0000-0002-0738-2254; Willis, Anne/0000-0002-1470-8531; Sansom, Owen J./0000-0001-9540-3010; Cordero, Julia/0000-0003-1701-9480; Scopelliti, Alessandro/0000-0002-7541-8108; Hall, Michael N/0000-0002-2998-0757; Huels, David/0000-0001-6154-1183; myant, kevin/0000-0001-8017-1093	AICR; Cancer Research UK; European Research Council; European Union Seventh Framework Programme [278568]; BBSRC [BB/H024980/1, BB/F018738/2, BB/F02326X/2] Funding Source: UKRI; MRC [MC_UP_A600_1024, MC_UP_A600_1023, MC_EX_G0902052] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H024980/1, BB/F02326X/2, BB/F018738/2] Funding Source: researchfish; Cancer Research UK [11594] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1023, MC_EX_G0902052, MC_UP_A600_1024] Funding Source: researchfish; Versus Arthritis [21139, 20409] Funding Source: researchfish; National Centre for the Replacement [G1000078/1] Funding Source: researchfish	AICR; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Union Seventh Framework Programme(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); National Centre for the Replacement	W.J.F. is funded by AICR. O.J.S. is funded by Cancer Research UK, European Research Council Investigator Grant (COLONCAN) and the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 278568. M.B. is a Medical Research Council Senior Fellow. The authors acknowledge P. Cammareri, J. Morton and C. Murgia for proofreading of the manuscript.	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Baan B, 2012, GUT, V61, P1708, DOI 10.1136/gutjnl-2011-301626; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bernal NP, 2005, J PEDIATR SURG, V40, P1025, DOI 10.1016/j.jpedsurg.2005.03.021; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gorshtein A, 2009, ENDOCR-RELAT CANCER, V16, P1017, DOI 10.1677/ERC-08-0269; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Gutzkow KB, 2003, CELL SIGNAL, V15, P871, DOI 10.1016/S0898-6568(03)00038-X; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martineau Y, 2014, ONCOGENE, V33, P1367, DOI 10.1038/onc.2013.100; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	192	199	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					497	+		10.1038/nature13896	http://dx.doi.org/10.1038/nature13896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25383520	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000348196500037
J	Ortega, MA; Hao, Y; Zhang, Q; Walker, MC; van der Donk, WA; Nair, SK				Ortega, Manuel A.; Hao, Yue; Zhang, Qi; Walker, Mark C.; van der Donk, Wilfred A.; Nair, Satish K.			Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PRECURSOR LIPID II; IN-VITRO; BIOSYNTHESIS; PEPTIDE; PROTEIN; GENERATION; PRENISIN	Lantibiotics are a class of peptide antibiotics that contain one or more thioether bonds. The lantibiotic nisin is an antimicrobial peptide that is widely used as a food preservative to combat food-borne pathogens(1). Nisin contains dehydroalanine and dehydrobutyrine residues that are formed by the dehydration of Ser/Thr by the lantibiotic dehydratase NisB (ref. 2). Recent biochemical studies revealed that NisB glutamylates Ser/Thr side chains as part of the dehydration process'. However, the molecular mechanism by which NisB uses glutamate to catalyse dehydration remains unresolved. Here we show that this process involves Outamyl-tRNA(Glu) to activate Ser/Thr residues. In addition, the 2.9-angstrom crystal structure of NisB in complex with its substrate peptide NisA reveals the presence of two separate domains that catalyse the Ser/Thr glutamylation and glutamate elimination steps. The co-crystal structure also provides insights into substrate recognition by lantibiotic dehydratases. Our findings demonstrate an unexpected role for aminoacyl-tRNA in the formation of dehydroamino acids in lantibiotics, and serve as a basis for the functional characterization of the many lantibiotic-like dehydratases involved in the biosynthesis of other classes of natural products. [GRAPHICS] .	[Ortega, Manuel A.; Hao, Yue; van der Donk, Wilfred A.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Zhang, Qi; Walker, Mark C.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhang, Qi; Walker, Mark C.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 600 South Mathews Ave, Urbana, IL 61801 USA.	vddonk@illinois.edu; s-nair@life.uiuc.edu	van der Donk, Wilfred/K-2961-2015; Hao, Yue/AAA-3530-2022; Nair, Satish/AAY-2510-2021; Hao, Yue/O-6107-2019	van der Donk, Wilfred/0000-0002-5467-7071; Hao, Yue/0000-0003-0943-0499; Walker, Mark/0000-0003-3942-003X	National Institutes of Health (NIH) [R01 GM 058822, R01 GM079038]; National Institute of General Medical Sciences (NIGMS) NIH Chemistry Biology Interface Training Grant [5T32-GM070421]; Ford Foundation; Lowell P. Hager fellowship from the Department of Biochemistry; NIH [S10 RR027109 A]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058822, F32GM112284, R01GM079038, T32GM070421] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS) NIH Chemistry Biology Interface Training Grant; Ford Foundation; Lowell P. Hager fellowship from the Department of Biochemistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Brister and colleagues for facilitating data collection at LS-CAT (Argonne National Labs, Illinois). This work was supported by grants from the National Institutes of Health (NIH) (R01 GM 058822 to W.A.v.d.D., and R01 GM079038 to S.K.N.). M.A.O. was supported partly by a National Institute of General Medical Sciences (NIGMS) NIH Chemistry Biology Interface Training Grant (5T32-GM070421) and by the Ford Foundation. Y.H. was supported partly by a Lowell P. Hager fellowship from the Department of Biochemistry. The Bruker UltrafleXtreme MALDI-TOF/TOF mass spectrometer was purchased in part with a grant from the NIH (S10 RR027109 A). The content of this work is solely the responsibility of the authors and do not necessarily represent the official views of the NIH or Ford Foundation.	Bougioukou DJ, 2013, P NATL ACAD SCI USA, V110, P10952, DOI 10.1073/pnas.1303568110; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garg N, 2013, P NATL ACAD SCI USA, V110, P7258, DOI 10.1073/pnas.1222488110; Garg RP, 2008, P NATL ACAD SCI USA, V105, P6543, DOI 10.1073/pnas.0708957105; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Janssen Brian D, 2012, Methods Mol Biol, V905, P291, DOI 10.1007/978-1-61779-949-5_19; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Khusainov R, 2011, MOL MICROBIOL, V82, P706, DOI 10.1111/j.1365-2958.2011.07846.x; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Koehnke J, 2013, ANGEW CHEM INT EDIT, V52, P13991, DOI 10.1002/anie.201306302; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2009, METHOD ENZYMOL, V458, P533, DOI 10.1016/S0076-6879(09)04821-6; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044453; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2008, APPL ENVIRON MICROB, V74, P4680, DOI 10.1128/AEM.00112-08; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Marques JC, 2011, J BIOL CHEM, V286, P18331, DOI 10.1074/jbc.M111.230227; Mavaro A, 2011, J BIOL CHEM, V286, P30552, DOI 10.1074/jbc.M111.263210; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Rio D. C., 2011, RNA LAB MANUAL, P216; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sardar D., 2014, ACS SYNTH BIOL; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Sen AK, 1999, EUR J BIOCHEM, V261, P524, DOI 10.1046/j.1432-1327.1999.00303.x; Shazman S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000146; Sherlin LD, 2001, RNA, V7, P1671; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Thorn A, 2013, ACTA CRYSTALLOGR D, V69, P2251, DOI 10.1107/S0907444913027534; VANDERMEER JR, 1993, J BACTERIOL, V175, P2578, DOI 10.1128/JB.175.9.2578-2588.1993; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Zhang Q, 2014, P NATL ACAD SCI USA, V111, P12031, DOI 10.1073/pnas.1406418111; Zhang WJ, 2011, P NATL ACAD SCI USA, V108, P12249, DOI 10.1073/pnas.1109539108	49	194	198	1	148	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					509	+		10.1038/nature13888	http://dx.doi.org/10.1038/nature13888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363770	Green Accepted			2022-12-01	WOS:000348196500040
J	Kim, JM; Wu, SP; Tomasiak, TM; Mergel, C; Winter, MB; Stiller, SB; Robles-Colmanares, Y; Stroud, RM; Tampe, R; Craik, CS; Cheng, YF				Kim, JungMin; Wu, Shenping; Tomasiak, Thomas M.; Mergel, Claudia; Winter, Michael B.; Stiller, Sebastian B.; Robles-Colmanares, Yaneth; Stroud, Robert M.; Tampe, Robert; Craik, Charles S.; Cheng, Yifan			Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter	NATURE			English	Article							P-GLYCOPROTEIN; MULTIDRUG TRANSPORTER; CRYSTAL-STRUCTURE; MICROSCOPY; VISUALIZATION; CONFORMATION; FLEXIBILITY; PROTEINS; CHANNEL; REVEAL	ATP-binding cassette (ABC) transporters translocate substrates across cell membranes, using energy harnessed from ATP binding and hydrolysis at their nucleotide-binding domains(1,2). ABC exporters are present both in prokaryotes and eukaryotes, with examples implicated in multidrug resistance of pathogens and cancer cells, as well as in many human diseases(3,4). TmrAB is a heterodimeric ABC exporter from the thermophilic Gram-negative eubacterium Therm us thermophilus; it is homologous to various multidrug transporters and contains one degenerate site with a non-catalytic residue next to the Walker B motif. Here we report a subnanometre-resolution structure of detergent-solubilized TmrAB in a nucleotide-free, inward-facing conformation by single-particle electron cryomicroscopy. The reconstructions clearly resolve characteristic features of ABC transporters, including helices in the transmembrane domain and nucleotide-binding domains. A cavity in the transmembrane domain is accessible laterally from the cytoplasmic side of the membrane as well as from the cytoplasm, indicating that the transporter lies in an inward-facing open conformation. The two nucleotide-binding domains remain in contact via their carboxy-terminal helices. Furthermore, comparison between our structure and the crystal structures of other ABC transporters suggests a possible trajectory of conformational changes that involves a sliding and rotating motion between the two nucleotide-binding domains during the transition from the inward-facing to outward-facing conformations.	[Kim, JungMin; Winter, Michael B.; Stroud, Robert M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wu, Shenping; Tomasiak, Thomas M.; Robles-Colmanares, Yaneth; Stroud, Robert M.; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Mergel, Claudia; Stiller, Sebastian B.; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Goethe University Frankfurt; Goethe University Frankfurt	Stroud, RM (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	stroud@msg.ucsf.edu; tampe@em.uni-frankfurt.de; Charles.Craik@ucsf.edu; ycheng@ucsf.edu	Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01GM098672, S10RR026814, P50GM082250, 1 P41CA196276-01, P50GM073210, R37GM024485]; University of California San Francisco Program for Breakthrough Biomedical Research; German Research Foundation [SFB 807, SFB 902, TA157/7]; European Drug Initiative on Channels and Transporters (EDICT) - European Commission Seventh Framework Program; NATIONAL CANCER INSTITUTE [P41CA196276] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024485, P50GM082250, P01GM111126, P50GM073210, R01GM024485, R01GM098672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Program for Breakthrough Biomedical Research; German Research Foundation(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters (EDICT) - European Commission Seventh Framework Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01GM098672, S10RR026814 and P50GM082250 to Y.C., 1 P41CA196276-01 to C.S.C., P50GM073210 to R.M.S. and C.S.C., and R37GM024485 to R.M.S.), the University of California San Francisco Program for Breakthrough Biomedical Research (to Y.C.), and the German Research Foundation (SFB 807, SFB 902 and TA157/7 to R.T.) as well as the European Drug Initiative on Channels and Transporters (EDICT to R.T.) funded by the European Commission Seventh Framework Program.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kim J, 2011, METHODS, V55, P303, DOI 10.1016/j.ymeth.2011.09.012; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/nchembio.410, 10.1038/NCHEMBIO.410]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Zutz A, 2011, J BIOL CHEM, V286, P7104, DOI 10.1074/jbc.M110.201178	40	94	94	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					396	U598		10.1038/nature13872	http://dx.doi.org/10.1038/nature13872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363761	Green Accepted			2022-12-01	WOS:000347810300052
J	Long, JA; Mark-Kurik, E; Johanson, Z; Lee, MSY; Young, GC; Min, Z; Ahlberg, PE; Newman, M; Jones, R; den Blaauwen, J; Choo, B; Trinajstic, K				Long, John A.; Mark-Kurik, Elga; Johanson, Zerina; Lee, Michael S. Y.; Young, Gavin C.; Min, Zhu; Ahlberg, Per E.; Newman, Michael; Jones, Roger; den Blaauwen, Jan; Choo, Brian; Trinajstic, Kate			Copulation in antiarch placoderms and the origin of gnathostome internal fertilization	NATURE			English	Article							JAWED VERTEBRATES; VIVIPARITY; EVOLUTION	Reproduction in jawed vertebrates (gnathostomes) involves either external or internal fertilization(1). It is commonly argued that internal fertilization can evolve from external, but not the reverse. Male copulatory claspers are present in certain placoderms(2-4), fossil jawed vertebrates retrieved as a paraphyletic segment of the gnathostome stem group in recent studies(5-8). This suggests that internal fertilization could be primitive for gnathostomes, but such a conclusion depends on demonstrating that copulation was not just a specialized feature of certain placoderm subgroups. The reproductive biology of antiarchs, consistently identified as the least crownward placoderms(5-8) and thus of great interest in this context, has until now remained unknown. Here we show that certain antiarchs possessed dermal claspers in the males, while females bore paired dermal plates inferred to have facilitated copulation. These structures are not associated with pelvic fins. The clasper morphology resembles that of ptyctodonts, a more crownward placoderm group(7,8), suggesting that all placoderm claspers are homologous and that internal fertilization characterized all placoderms. This implies that external fertilization and spawning, which characterize most extant aquatic gnathostomes, must be derived from internal fertilization, even though this transformation has been thought implausible. Alternatively, the substantial morphological evidence for placoderm paraphyly must be rejected.	[Long, John A.; Choo, Brian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Long, John A.; Choo, Brian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 2100, Australia; [Long, John A.] Nat Hist Museum Los Angeles Cty, Los Angeles, CA USA; [Long, John A.] Museum Victoria, Melbourne, Vic 3001, Australia; [Mark-Kurik, Elga] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia; [Johanson, Zerina] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Lee, Michael S. Y.] S Australian Museum, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Young, Gavin C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Min, Zhu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Ahlberg, Per E.] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, S-75236 Uppsala, Sweden; [Newman, Michael] Vine Lodge, Haverfordwest SA62 3NZ, Pembroke, Wales; [den Blaauwen, Jan] Univ Amsterdam, NL-1098 XH Amsterdam, Netherlands; [Trinajstic, Kate] Curtin Univ, Dept Chem, Western Australian Organ & Isotope Geochem Ctr, Perth, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Earth & Planetary Sci, Perth, WA 6000, Australia	Flinders University South Australia; Flinders University South Australia; Museum Victoria; Tallinn University of Technology; Natural History Museum London; University of Adelaide; Australian National University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Uppsala University; University of Amsterdam; Curtin University; Western Australian Museum	Long, JA (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	john.long@flinders.edu.au	min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012	Zhu, Min/0000-0002-4786-0898; Long, John/0000-0001-8012-0114; Ahlberg, Per/0000-0001-9054-2900; Trinajstic, Kate/0000-0002-6519-6396; Johanson, Zerina/0000-0002-8444-6776; Choo, Brian/0000-0002-9983-0762	Australian Research Council	Australian Research Council(Australian Research Council)	For access to collections we thank E. Bernard, D. Pickering, E. Fitzgerald, L. Grande, W. Simpson and H.-D. Sues. For photography we thank P. Hurst, G. Baranov and D. Hubert. We thank M. Brazeau for reviewing an earlier version of the paper. Travel to Tallinn, London and Washington for J.A.L. to examine specimens was supported by Flinders University. G.C.Y., J.A.L. and K.T. acknowledge support from the Australian Research Council.	Ahlberg P, 2009, NATURE, V460, P888, DOI 10.1038/nature08176; Blackburn D. G., 2014, J MORPHOL; Brazeau MD, 2014, ZOOL J LINN SOC-LOND, V170, P779, DOI 10.1111/zoj.12111; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Downs JP, 2011, P ACAD NAT SCI PHILA, V161, P191, DOI 10.1635/053.161.0111; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Goodrich E.S., 1958, STUDIES STRUCTURE DE, V1, P1; Hemmings S.K., 1978, Palaeontographical Society Monographs (London), V131, P1; Johanson Z, 1997, GEOL MAG, V134, P813, DOI 10.1017/S0016756897007838; Leigh-Sharpe H., 1922, J MORPHOL, V36, P190; LONG JA, 1986, ALCHERINGA, V10, P355, DOI 10.1080/03115518608619146; Lysarkaya L. A., 1981, BALTIC DEVONIAN PLAC, P1; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; Miles R. S., 1967, ZOOLOGICAL J LINNEAN, V47, P99; PAN JA, 1984, VERTEBRAT PALASIATIC, V22, P8; Parenti LR, 2010, J MORPHOL, V271, P1399, DOI 10.1002/jmor.10886; ROUSE G, 1994, ZOOL SCR, V23, P271, DOI 10.1111/j.1463-6409.1994.tb00390.x; STENSI6 ERIK A:SON, 1948, MEDDELELSER OM GRONLAND, V139, P1; Trinajstic K. M., 2014, BIOL REV; Wang Jun-Qing, 1999, Vertebrata Palasiatica, V37, P200; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033	25	76	79	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					196	U171		10.1038/nature13825	http://dx.doi.org/10.1038/nature13825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25327249				2022-12-01	WOS:000347477600035
J	Dumanski, JP; Rasi, C; Lonn, M; Davies, H; Ingelsson, M; Giedraitis, V; Lannfelt, L; Magnusson, PKE; Lindgren, CM; Morris, AP; Cesarini, D; Johannesson, M; Janson, ET; Lind, L; Pedersen, NL; Ingelsson, E; Forsberg, LA				Dumanski, Jan P.; Rasi, Chiara; Lonn, Mikael; Davies, Hanna; Ingelsson, Martin; Giedraitis, Vilmantas; Lannfelt, Lars; Magnusson, Patrik K. E.; Lindgren, Cecilia M.; Morris, Andrew P.; Cesarini, David; Johannesson, Magnus; Janson, Eva Tiensuu; Lind, Lars; Pedersen, Nancy L.; Ingelsson, Erik; Forsberg, Lars A.			Smoking is associated with mosaic loss of chromosome Y	SCIENCE			English	Article							SWEDISH TWIN REGISTRY; SEX DISPARITIES; CANCER; MORTALITY; BLOOD	Tobacco smoking is a risk factor for numerous disorders, including cancers affecting organs outside the respiratory tract. Epidemiological data suggest that smoking is a greater risk factor for these cancers in males compared with females. This observation, together with the fact that males have a higher incidence of and mortality from most non-sex-specific cancers, remains unexplained. Loss of chromosome Y (LOY) in blood cells is associated with increased risk of nonhematological tumors. We demonstrate here that smoking is associated with LOY in blood cells in three independent cohorts [TwinGene: odds ratio (OR) = 4.3, 95% confidence interval (CI) = 2.8 to 6.7; Uppsala Longitudinal Study of Adult Men: OR = 2.4, 95% CI = 1.6 to 3.6; and Prospective Investigation of the Vasculature in Uppsala Seniors: OR = 3.5, 95% CI = 1.4 to 8.4] encompassing a total of 6014 men. The data also suggest that smoking has a transient and dose-dependent mutagenic effect on LOY status. The finding that smoking induces LOY thus links a preventable risk factor with the most common acquired human mutation.	[Dumanski, Jan P.; Rasi, Chiara; Davies, Hanna; Forsberg, Lars A.] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Dumanski, Jan P.; Rasi, Chiara; Davies, Hanna; Ingelsson, Erik; Forsberg, Lars A.] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Lonn, Mikael] Sodertorn Univ, Sch Life Sci, Huddinge, Sweden; [Ingelsson, Martin; Giedraitis, Vilmantas; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lindgren, Cecilia M.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Cesarini, David] NYU, Ctr Expt Social Sci, New York, NY 10012 USA; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Janson, Eva Tiensuu; Lind, Lars; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Sodertorn University; Uppsala University; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Liverpool; New York University; Stockholm School of Economics; Uppsala University	Dumanski, JP (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	jan.dumanski@igp.uu.se; lars.forsberg@igp.uu.se	Johannesson, Magnus/E-9680-2011; Magnusson, Patrik KE/C-4458-2017	Johannesson, Magnus/0000-0001-8759-6393; Magnusson, Patrik KE/0000-0002-7315-7899; Lindgren, Cecilia/0000-0002-4903-9374; Forsberg, Lars/0000-0002-1701-755X; Cesarini, David/0000-0002-0043-009X; Dumanski, Jan Piotr/0000-0002-1489-1452; Davies, Hanna/0000-0002-6289-3815	Swedish Cancer Society; Swedish Research Council [M-2005-1112]; Swedish Heart-Lung Foundation and Science for Life Laboratory Uppsala; Olle Enqvist Byggmastare Foundation; Wellcome Trust [WT098017, WT064890, WT090532]; Uppsala University; Uppsala University Hospital; Swedish Heart-Lung Foundation; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; NIH DK [U01-066134]; Swedish Foundation for Strategic Research (SSF); Heart and Lung foundation [20070481]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066134] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation and Science for Life Laboratory Uppsala(Swedish Heart-Lung Foundation); Olle Enqvist Byggmastare Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University; Uppsala University Hospital; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); GenomEUtwin; NIH DK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Heart and Lung foundation(Swedish Heart-Lung Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Lindblad-Toh, R. M. Myers, C.-H. Heldin, D. H. Ledbetter, G. J. B. van Ommen, and U. Landegren for critical evaluation of the manuscript. This study was sponsored by the Swedish Cancer Society, the Swedish Research Council, the Swedish Heart-Lung Foundation and Science for Life Laboratory Uppsala to J.P.D. and the Olle Enqvist Byggmastare Foundation to L.A.F. Genotyping and next-generation sequencing were performed by the SNP&SEQ Technology Platform in Uppsala, Sweden, and supported by Wellcome Trust Grants WT098017, WT064890, and WT090532, Uppsala University, Uppsala University Hospital, the Swedish Research Council, and the Swedish Heart-Lung Foundation. The SNP&SEQ Technology Platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. C.M.L. is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). A.P.M. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science. A.P.M. acknowledges funding from the Wellcome Trust under awards WT064890, WT090532, and WT098017. TwinGene was supported by the Swedish Research Council (M-2005-1112), GenomEUtwin (EU/QLRT-2001-01254 and QLG2-CT-2002-01254), NIH DK U01-066134, the Swedish Foundation for Strategic Research (SSF), and the Heart and Lung foundation no. 20070481. J.P.D. and L.A.F. are cofounders and shareholders in Cray Innovation AB, as well as co-inventors on Patent Application No. PCT/EP2014/071448, protecting the commercial applications of LOY for the assessment of cancer risk. Genetic variants detected in this study are available at the Database of Genomic Structural Variation (dbVar) under accession code nstd92 for ULSAM and PIVUS cohorts and accession code nstd104 for the TwinGene cohort.	Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bianchi NO, 2009, MUTAT RES-REV MUTAT, V682, P21, DOI 10.1016/j.mrrev.2009.02.001; Clark AG, 2014, NATURE, V508, P463, DOI 10.1038/508463a; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Edgren G, 2012, EUR J EPIDEMIOL, V27, P187, DOI 10.1007/s10654-011-9647-5; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Forsberg LA, 2013, J MED GENET, V50, P1, DOI 10.1136/jmedgenet-2012-101322; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; Veiga LCS, 2012, BRAZ J MED BIOL RES, V45, P172, DOI 10.1590/S0100-879X2012007500004; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	24	113	114	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					81	83		10.1126/science.1262092	http://dx.doi.org/10.1126/science.1262092			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25477213	Green Accepted			2022-12-01	WOS:000347102300053
J	Reich, S; Guilligay, D; Pflug, A; Malet, H; Berger, I; Crepin, T; Hart, D; Lunardi, T; Nanao, M; Ruigrok, RWH; Cusack, S				Reich, Stefan; Guilligay, Delphine; Pflug, Alexander; Malet, Helene; Berger, Imre; Crepin, Thibaut; Hart, Darren; Lunardi, Thomas; Nanao, Max; Ruigrok, Rob W. H.; Cusack, Stephen			Structural insight into cap-snatching and RNA synthesis by influenza polymerase	NATURE			English	Article							VIRUS VIRION RNA; MESSENGER-RNAS; IN-VITRO; MAXIMUM-LIKELIHOOD; ACTIVE-SITE; P-PROTEINS; TRANSCRIPTION; SUBUNIT; ENDONUCLEASE; REPLICATION	Influenza virus polymerase uses a capped primer, derived by 'cap-snatching' from host pre-messenger RNA, to transcribe its RNA genome into mRNA and a stuttering mechanism to generate the poly(A) tail. By contrast, genome replication is unprimed and generates exact full-length copies of the template. Here we use crystal structures of bat influenza A and human influenza B polymerases (FluA and FluB), bound to the viral RNA promoter, to give mechanistic insight into these distinct processes. In the FluA structure, a loop analogous to the priming loop of flavivirus polymerases suggests that influenza could initiate unprimed template replication by a similar mechanism. Comparing the FluA and FluB structures suggests that cap-snatching involves in situ rotation of the PB2 cap-binding domain to direct the capped primer first towards the endonuclease and then into the polymerase active site. The polymerase probably undergoes considerable conformational changes to convert the observed pre-initiation state into the active initiation and elongation states.	[Reich, Stefan; Guilligay, Delphine; Pflug, Alexander; Malet, Helene; Berger, Imre; Hart, Darren; Lunardi, Thomas; Nanao, Max; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Reich, Stefan; Guilligay, Delphine; Pflug, Alexander; Malet, Helene; Berger, Imre; Crepin, Thibaut; Hart, Darren; Lunardi, Thomas; Nanao, Max; Ruigrok, Rob W. H.; Cusack, Stephen] Univ Grenoble Alpes, Ctr Natl Rech Sci, EMBL Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France.	cusack@embl.fr	Nanao, Max/ABA-9292-2021; Hart, Darren/C-4858-2015	Cusack, Stephen/0000-0002-9324-0796; Reich, Stefan/0000-0001-6817-753X; Hart, Darren/0000-0002-3502-2002; Nanao, Max/0000-0002-6340-1376; MALET, Helene/0000-0002-2834-7386; Berger, Imre/0000-0001-7518-9045; Pflug, Alexander/0000-0002-4680-1298; CREPIN, Thibaut/0000-0003-2663-1794; Reich, Stefan/0000-0001-8822-2908	ERC V-RNA [322586]; EU FLU-PHARM [259751]; Roche	ERC V-RNA; EU FLU-PHARM; Roche(Roche Holding)	We thank the staff of the European Molecular Biology Laboratory (EMBL) eukaryotic expression and high-throughput crystallization facilities within the Partnership for Structural Biology (PSB) and members of the ESRF-EMBL Joint Structural Biology Group for help on European Synchrotron Radiation Facility (ESRF) beamlines. The work was supported by ERC Advanced Grant V-RNA (322586) and EU Grant FLU-PHARM (259751) to S.C. and partially by a Roche Postdoc Fellowship to S.R.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Bier K, 2011, J GEN VIROL, V92, P1627, DOI 10.1099/vir.0.029231-0; BRAAM J, 1983, CELL, V34, P609; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Datta K., 2013, NUCLEIC ACIDS RES, V441, P349; De la Pena M, 2007, EMBO J, V26, P4913, DOI 10.1038/sj.emboj.7601912; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Flick R, 1996, RNA, V2, P1046; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P17, DOI 10.1016/j.virol.2010.09.003; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P27, DOI 10.1016/j.virol.2010.09.006; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAGEN M, 1995, J GEN VIROL, V76, P603, DOI 10.1099/0022-1317-76-3-603; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kuechler E., 1982, NUCLEIC ACIDS RES, V10, P4803; Lee YS, 1998, J GEN VIROL, V79, P673, DOI 10.1099/0022-1317-79-4-673; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lim K, 2014, INT J BIOCHEM CELL B, V53, P237, DOI 10.1016/j.biocel.2014.05.022; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nie Y, 2014, METHODS MOL BIOL, V1091, P131, DOI 10.1007/978-1-62703-691-7_8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A., NATURE; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Pritlove DC, 1998, J VIROL, V72, P1280, DOI 10.1128/JVI.72.2.1280-1286.1998; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Shih SR, 1996, VIROLOGY, V226, P430, DOI 10.1006/viro.1996.0673; Siebert X, 2009, ACTA CRYSTALLOGR D, V65, P651, DOI 10.1107/S0907444909008671; Sikora D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06181; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; Wakai C, 2011, J VIROL, V85, P7504, DOI 10.1128/JVI.02375-10; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	54	288	297	4	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					361	+		10.1038/nature14009	http://dx.doi.org/10.1038/nature14009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25409151				2022-12-01	WOS:000346484800039
J	Matusek, T; Wendler, F; Poles, S; Pizette, S; D'Angelo, G; Furthauer, M; Therond, PP				Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.			The ESCRT machinery regulates the secretion and long-range activity of Hedgehog	NATURE			English	Article							CHOLESTEROL MODIFICATION; EXTRACELLULAR VESICLES; DROSOPHILA EPITHELIA; SONIC HEDGEHOG; PROTEIN; TRAFFICKING; MEMBRANE; RELEASE; VPS25; MICROVESICLES	The conserved family of Hedgehog (Hh) proteins acts as short- and long-range secreted morphogens, controlling tissue patterning and differentiation during embryonic development(1). Mature Hh carries hydrophobic palmitic acid and cholesterol modifications essential for its extracellular spreading(2). Various extracellular transportation mechanisms for Hh have been suggested, but the pathways actually used for Hh secretion and transport in vivo remain unclear. Here we show that Hh secretion in Drosophila wing imaginal discs is dependent on the endosomal sorting complex required for transport (ESCRT)(3). In vivo the reduction of ESCRT activity in cells producing Hh leads to a retention of Hh at the external cell surface. Furthermore, we show that ESCRT activity in Hh-producing cells is required for long-range signalling. We also provide evidence that pools of Hh and ESCRT proteins are secreted together into the extracellular space in vivo and can subsequently be detected together at the surface of receiving cells. These findings uncover a new function for ESCRT proteins in controlling morphogen activity and reveal a new mechanism for the transport of secreted Hh across the tissue by extracellular vesicles, which is necessary for long-range target induction.	[Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.] Univ Nice Sophia Antipolis, IBV, UMR 7277, F-06100 Nice, France; [Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.] CNRS, IBV, UMR 7277, F-06100 Nice, France; [Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.] INSERM, IBV, U1091, F-06100 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Therond, PP (corresponding author), Univ Nice Sophia Antipolis, IBV, UMR 7277, F-06100 Nice, France.	therond@unice.fr	Therond, pascal/AAE-4811-2019; FÃrthauer, Maximilian/AAY-4516-2020	FÃrthauer, Maximilian/0000-0001-6344-6585; THEROND, PASCAL/0000-0003-0434-2334; D'ANGELO, Gisela/0000-0003-3150-2241	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Fondation pour la Recherche Medicale [DEQ20110421324]; Fondation Association pour la Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer; ATIP/Avenir; ARC; Human Frontier Science Program	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Association pour la Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ATIP/Avenir; ARC(Australian Research Council); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE (program reference number ANR-11-LABX-0028-01) and by the Fondation pour la Recherche Medicale (reference number DEQ20110421324). T.M. and F.W. were supported by the Fondation Association pour la Recherche Contre le Cancer (ARC) and Ligue Nationale Contre le Cancer, respectively. M.F. was supported by ATIP/Avenir, ARC and the Human Frontier Science Program. The authors acknowledge S. Pagnotta for technical support. We thank K. Haglund for sharing the anti-AliX antibody before publication. We thank L. Staccini-Lavenant and M.-A. Derieppe for technical help.	ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Letizia A, 2007, DEVELOPMENT, V134, P1337, DOI 10.1242/dev.02823; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Palm W, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001505; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	33	96	97	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					99	U240		10.1038/nature13847	http://dx.doi.org/10.1038/nature13847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471885	Green Published			2022-12-01	WOS:000346310800047
J	Ranade, SS; Woo, SH; Dubin, AE; Moshourab, RA; Wetzel, C; Petrus, M; Mathur, J; Begay, V; Coste, B; Mainquist, J; Wilson, AJ; Francisco, AG; Reddy, K; Qiu, ZZ; Wood, JN; Lewin, GR; Patapoutian, A				Ranade, Sanjeev S.; Woo, Seung-Hyun; Dubin, Adrienne E.; Moshourab, Rabih A.; Wetzel, Christiane; Petrus, Matt; Mathur, Jayanti; Begay, Valerie; Coste, Bertrand; Mainquist, James; Wilson, A. J.; Francisco, Allain G.; Reddy, Kritika; Qiu, Zhaozhu; Wood, John N.; Lewin, Gary R.; Patapoutian, Ardem			Piezo2 is the major transducer of mechanical forces for touch sensation in mice	NATURE			English	Article							REGULATED ANION CHANNEL; MERKEL CELLS; SENSORY NEURONS; MECHANOSENSITIVE CURRENTS; ESSENTIAL COMPONENT; ION CHANNELS; MOUSE; NOCICEPTION; PROTEIN; CONTRIBUTES	The sense of touch provides critical information about our physical environment by transforming mechanical energy into electrical signals(1). It is postulated that mechanically activated cation channels initiate touch sensation, but the identity of these molecules in mammals has been elusive(2). Piezo2 is a rapidly adapting, mechanically activated ion channel expressed in a subset of sensory neurons of the dorsal root ganglion and in cutaneous mechanoreceptors known as Merkel-cell-neurite complexes(3,4). It has been demonstrated that Merkel cells have a role in vertebrate mechanosensation using Piezo2, particularly in shaping the type of current sent by the innervating sensory neuron(4-6); however, major aspects of touch sensation remain intact without Merkel cell activity(4,7). Here we show that mice lacking Piezo2 in both adult sensory neurons and Merkel cells exhibit a profound loss of touch sensation. We precisely localize Piezo2 to the peripheral endings of a broad range of low-threshold mechanoreceptors that innervate both hairy and glabrous skin. Most rapidly adapting, mechanically activated currents in dorsal root ganglion neuronal cultures are absent in Piezo2 conditional knockout mice, and ex vivo skin nerve preparation studies show that the mechanosensitivity of low-threshold mechanoreceptors strongly depends on Piezo2. This cellular phenotype correlates with an unprecedented behavioural phenotype: an almost complete deficit in light-touch sensation in multiple behavioural assays, without affecting other somatosensory functions. Our results highlight that a single ion channel that displays rapidly adapting, mechanically activated currents in vitro is responsible for the mechanosensitivity of most low-threshold mechanoreceptor subtypes involved in innocuous touch sensation. Notably, we find that touch and pain sensation are separable, suggesting that as-yet-unknown mechanically activated ion channel(s) must account for noxious (painful) mechanosensation.	[Ranade, Sanjeev S.; Woo, Seung-Hyun; Dubin, Adrienne E.; Coste, Bertrand; Francisco, Allain G.; Reddy, Kritika; Qiu, Zhaozhu; Patapoutian, Ardem] Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Moshourab, Rabih A.; Wetzel, Christiane; Begay, Valerie; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13092 Berlin, Germany; [Moshourab, Rabih A.] Univ Med Berlin, Klin Anasthesiol Schwerpunkt Operat Intens Med, Virchow Klinikum Charite, D-13353 Berlin, Germany; [Petrus, Matt; Mathur, Jayanti; Mainquist, James; Wilson, A. J.; Qiu, Zhaozhu] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Wood, John N.] UCL, Mol Nocicept Grp, Wolfson Inst Biomed Res, London WC1E 6BT, England	Howard Hughes Medical Institute; Scripps Research Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Novartis; University of London; University College London	Patapoutian, A (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ardem@scripps.edu	Lewin, Gary R/B-8028-2011	moshourab, rabih/0000-0002-9180-8472; Wetzel, Christiane/0000-0003-0587-8018; Ranade, Sanjeev/0000-0001-8601-3563; Coste, Bertrand/0000-0002-0163-2494; Lewin, Gary/0000-0002-2890-6352	California Institute of Regenerative Medicine; Max Delbruck Center (MDC); European Research Council [294678]; Deutsche Forschungsgemeinshaft [SFB958]; NIH [R01 DE022358]; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; Versus Arthritis [20200] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Max Delbruck Center (MDC); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinshaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge T. Goode for help in behavioural analysis. We also thank R. Moran and T. Johnson for assistance with histology, K. Spencer for imaging analysis and M. Braunschweig for technical assistance. S.S.R. was funded by a pre-doctoral fellowship from the California Institute of Regenerative Medicine. R.A.M. was supported by Clinical Research Fellowship from the Max Delbruck Center (MDC). G.R.L.'s laboratory was supported by senior European Research Council grant (project 294678) and a grant from the Deutsche Forschungsgemeinshaft (SFB958 project A9). A.P. is a Howard Hughes Medical Institute Investigator. This study was partly funded by NIH grant R01 DE022358 to A.P.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; Moshourab RA, 2013, J PHYSIOL-LONDON, V591, P5555, DOI 10.1113/jphysiol.2013.261180; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Rugiero F, 2010, J PHYSIOL-LONDON, V588, P301, DOI 10.1113/jphysiol.2009.182360; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251	35	429	442	15	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					121	U330		10.1038/nature13980	http://dx.doi.org/10.1038/nature13980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471886	Green Accepted			2022-12-01	WOS:000346310800052
J	Settembre, C; Ballabio, A				Settembre, Carmine; Ballabio, Andrea			CELL METABOLISM Autophagy transcribed	NATURE			English	Editorial Material							LIPID-METABOLISM; TFEB		[Settembre, Carmine; Ballabio, Andrea] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Settembre, Carmine; Ballabio, Andrea] Univ Naples Federico II, Dept Translat Med, Naples, Italy; [Settembre, Carmine; Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Baylor College of Medicine	Settembre, C (corresponding author), Telethon Inst Genet & Med, I-80078 Naples, Italy.		Settembre, Carmine/AIA-9170-2022; BALLABIO, Andrea/AAL-2672-2020	BALLABIO, Andrea/0000-0003-1381-4604; SETTEMBRE, Carmine/0000-0002-5829-8589	Fondazione Telethon Funding Source: Custom; Telethon [TGM11CB6] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976	10	22	23	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					40	41		10.1038/nature13939	http://dx.doi.org/10.1038/nature13939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383529				2022-12-01	WOS:000346310800028
J	Suppes, GJ				Suppes, Galen J.			Simulation as a tool for biopolymers design	SCIENCE			English	Editorial Material							POLYOLS		Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Suppes, GJ (corresponding author), Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.	suppesg@missouri.edu						Abraham TW, 2012, ACS SYM SER, V1105, P165; Alipour A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41332; Du X. X., 2012, 2 GENERATION HONEY B; Gower W. C., 2011, NEW VERSATILE HIGH R; Nodelman N., 2012, POLYURETHANE RIGID F; Vaughan BR, 2011, J APPL POLYM SCI, V119, P2683, DOI 10.1002/app.32865; Zhao YS, 2013, J APPL POLYM SCI, V130, P1131, DOI 10.1002/app.39287	7	3	3	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1055	1056		10.1126/science.1259181	http://dx.doi.org/10.1126/science.1259181			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430754				2022-12-01	WOS:000345763400020
J	Gligoris, TG; Scheinost, JC; Burmann, F; Petela, N; Chan, KL; Uluocak, P; Beckouet, F; Gruber, S; Nasmyth, K; Lowe, J				Gligoris, Thomas G.; Scheinost, Johanna C.; Buermann, Frank; Petela, Naomi; Chan, Kok-Lung; Uluocak, Pelin; Beckouet, Frederic; Gruber, Stephan; Nasmyth, Kim; Loewe, Jan			Closing the cohesin ring: Structure and function of its Smc3-kleisin interface	SCIENCE			English	Article							SISTER-CHROMATID COHESION; ACETYLATION; COMPLEXES; PROTEIN; CHROMOSOMES; CLEAVAGE; PROPHASE; PROMOTES; SUBUNIT; WAPL	Through their association with a kleisin subunit (Scc1), cohesin's Smc1 and Smc3 subunits are thought to form tripartite rings that mediate sister chromatid cohesion. Unlike the structure of Smc1/Smc3 and Smc1/Scc1 interfaces, that of Smc3/Scc1 is not known. Disconnection of this interface is thought to release cohesin from chromosomes in a process regulated by acetylation. We show here that the N-terminal domain of yeast Sccl contains two alpha helices, forming a four-helix bundle with the coiled coil emerging from Smc3's adenosine triphosphatase head. Mutations affecting this interaction compromise cohesin's association with chromosomes. The interface is far from Smc3 residues, whose acetylation prevents cohesin's dissociation from chromosomes. Cohesin complexes holding chromatids together in vivo do indeed have the configuration of hetero-trimeric rings, and sister DNAs are entrapped within these.	[Gligoris, Thomas G.; Scheinost, Johanna C.; Petela, Naomi; Chan, Kok-Lung; Uluocak, Pelin; Beckouet, Frederic; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Buermann, Frank; Gruber, Stephan] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Chan, Kok-Lung] Univ Sussex, MRC, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Uluocak, Pelin] Univ Oxford, Dunn Sch Pathol, Oxford OX1 3RF, England; [Loewe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Oxford; Max Planck Society; University of Sussex; University of Oxford; MRC Laboratory Molecular Biology	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk; jyl@mrc-lmb.cam.ac.uk	Beckouet, Frederic/P-5389-2016; Löwe, Jan/X-6998-2019; Gligoris, Thomas/AAO-7594-2020; Gruber, Stephan/AFC-4848-2022	Beckouet, Frederic/0000-0002-9009-1852; Gruber, Stephan/0000-0002-0150-0395; Burmann, Frank/0000-0002-9428-0933; Nasmyth, Kim/0000-0001-7030-4403; chan, kok-lung/0000-0002-8796-8385; Lowe, Jan/0000-0002-5218-6615	European Molecular Biology Organization long-term fellowship [ALTF 2008-127]; John Fell Fund [132/108]; Medical Research Council [U10518432, C573/A11625]; Wellcome Trust [095514/Z/11/Z, 091859/Z/10/Z]; Cancer Research UK [C573/A 12386]; MitoSys project [241548]; MRC [MC_U105184326] Funding Source: UKRI; Cancer Research UK [12386] Funding Source: researchfish; Medical Research Council [MC_U105184326] Funding Source: researchfish	European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); John Fell Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); MitoSys project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	T.G.G. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 2008-127) and the John Fell Fund (132/108). The work was funded by the Medical Research Council (U10518432 to J.L, C573/A11625 to J.C.S.), the Wellcome Trust (095514/Z/11/Z to J.L., 091859/Z/10/Z to K.N.), Cancer Research UK (C573/A 12386 to K.N.), and the MitoSys project (FP7/2007-2013 under grant agreement 241548 to K.N.).	Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chan KL, 2013, P NATL ACAD SCI USA, V110, P13020, DOI 10.1073/pnas.1306900110; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Roig MB, 2014, FEBS LETT, V588, P3692, DOI 10.1016/j.febslet.2014.08.015; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880	28	168	170	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					963	967		10.1126/science.1256917	http://dx.doi.org/10.1126/science.1256917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414305	Green Accepted			2022-12-01	WOS:000345696000035
J	Stine, NW; Chokshi, DA				Stine, Nicholas W.; Chokshi, Dave A.			Elimination of Lipid Levels From Quality Measures Implications and Alternatives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES		[Stine, Nicholas W.; Chokshi, Dave A.] New York City Hlth & Hosp Corp, New York, NY USA; [Stine, Nicholas W.; Chokshi, Dave A.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10013 USA	New York University	Stine, NW (corresponding author), NYU, Sch Med, New York City Hlth & Hosp Corp, Dept Populat Hlth, 125 Worth St,Ste 401, New York, NY 10013 USA.	nicholas.stine@nychhc.org		Chokshi, Dave/0000-0001-7467-4591; Stine, Nicholas/0000-0001-8811-259X				[Anonymous], STAT ASP CHOIC DEC A; Centers for Medicare & Medicaid Services (CMS), MED PROGR REV PAYM P; Department of Veterans Affairs (VA), 2014, REV PERF MEAS LIP MA; Eddy DM, 2012, HEALTH AFFAIR, V31, P2441, DOI 10.1377/hlthaff.2011.1274; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Kelly B.B., 2010, EPIDEMIOLOGY CARDIOV, V2; Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	9	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1971	1972		10.1001/jama.2014.15600	http://dx.doi.org/10.1001/jama.2014.15600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399268				2022-12-01	WOS:000345450500007
J	Afzal, S; Brondum-Jacobsen, P; Bojesen, SE; Nordestgaard, BG				Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.			Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; 25-HYDROXYVITAMIN D; HDL CHOLESTEROL; RISK; CANCER; RECEPTOR; ASSOCIATIONS; DISEASE; PROTEIN; DIFFERENTIATION	Objective To test the hypothesis that genetically low 25-hydroxyvitamin D concentrations are associated with increased mortality. Design Mendelian randomisation analysis. Setting Copenhagen City Heart Study, Copenhagen General Population Study, and Copenhagen Ischemic Heart Disease Study. Participants 95 766 white participants of Danish descent from three cohorts, with median follow-up times of 19.1, 5.8, and 7.9 years, genotyped for genetic variants in DHCR7 and CYP2R1 affecting plasma 25-hydroxyvitamin D concentrations; 35 334 also had plasma 25-hydroxyvitamin D measurements. Participants were followed from study entry through 2013, during which time 10 349 died. Main outcome measures All cause mortality and cause specific mortality, adjusted for common risk factors for all cause mortality based on the World Health Organization's global health status. Results The multivariable adjusted hazard ratios for a 20 nmol/L lower plasma 25-hydroxyvitamin D concentration were 1.19 (95% confidence interval 1.14 to 1.25) for all cause mortality, 1.18 (1.09 to 1.28) for cardiovascular mortality, 1.12 (1.03 to 1.22) for cancer mortality, and 1.27 (1.15 to 1.40) for other mortality. Each increase in DHCR7/CYP2R1 allele score was associated with a 1.9 nmol/L lower plasma 25-hydroxyvitamin D concentration and with increased all cause, cancer, and other mortality but not with cardiovascular mortality. The odds ratio for a genetically determined 20 nmol/L lower plasma 25-hydroxyvitamin D concentration was 1.30 (1.05 to 1.61) for all cause mortality, with a corresponding observational multivariable adjusted odds ratio of 1.21 (1.11 to 1.31). Corresponding genetic and observational odds ratios were 0.77 (0.55 to 1.08) and 1.13 (1.03 to 1.24) for cardiovascular mortality, 1.43 (1.02 to 1.99) and 1.10 (1.02 to 1.19) for cancer mortality, and 1.44 (1.01 to 2.04) and 1.17 (1.06 to 1.29) for other mortality. The results were robust in sensitivity analyses. Conclusions Genetically low 25-hydroxyvitamin D concentrations were associated with increased all cause mortality, cancer mortality, and other mortality but not with increased cardiovascular mortality. These findings are compatible with the notion that genetically low 25-hydroxyvitamin D concentrations may be causally associated with cancer and other mortality but also suggest that the observational association with cardiovascular mortality could be the result of confounding.	[Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Afzal, Shoaib; Brondum-Jacobsen, Peter; Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Afzal, Shoaib/B-6763-2012	Afzal, Shoaib/0000-0002-1442-4694; Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133	Danish Heart Foundation; Danish Medical Research Council; Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital	Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital	The Copenhagen General Population Study and Copenhagen City Heart Study are supported by the Danish Heart Foundation, Danish Medical Research Council, Copenhagen County Foundation, and Herlev Hospital, Copenhagen University Hospital. All researchers operate independently of the funding bodies.	Afzal S, 2014, LANCET DIABETES ENDO, V2, P298, DOI 10.1016/S2213-8587(13)70200-6; Afzal S, 2013, J INVEST DERMATOL, V133, P629, DOI 10.1038/jid.2012.395; Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, pVII; Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berry DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037465; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Didelez V, 2010, STAT SCI, V25, P22, DOI 10.1214/09-STS316; EISMAN JA, 1987, CANCER RES, V47, P21; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Ooi EM, 2014, CIRC CARDIOVASC GENE; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rode L, 2014, INT J EPIDEMIOL, V43, P1473, DOI 10.1093/ije/dyu119; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SHABAHANG M, 1993, CANCER RES, V53, P3712; SimboliCampbell M, 1996, J STEROID BIOCHEM, V58, P367, DOI 10.1016/0960-0760(96)00055-6; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Tetens I, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7153; The Human Protein Atlas, 2013, CYP2R1; The Human Protein Atlas, 2013, VDR; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Trummer O, 2013, CLIN CHEM, V59, P793, DOI 10.1373/clinchem.2012.193185; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	55	197	199	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6330	10.1136/bmj.g6330	http://dx.doi.org/10.1136/bmj.g6330			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406188	hybrid, Green Published			2022-12-01	WOS:000345445600001
J	Nogrady, B				Nogrady, Bianca			Life beyond the pain	NATURE			English	Editorial Material							SICKLE-CELL-DISEASE											Ballas SK, 2010, BLOOD, V116, P311, DOI 10.1182/blood-2010-04-276386; Brandow AM, 2013, AM J HEMATOL, V88, P37, DOI 10.1002/ajh.23341; Kohli DR, 2010, BLOOD, V116, P456, DOI 10.1182/blood-2010-01-260372; Molokie RE, 2014, EUR J PHARMACOL, V723, P419, DOI 10.1016/j.ejphar.2013.10.062; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5	5	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S8	S9		10.1038/515S8a	http://dx.doi.org/10.1038/515S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390148	Bronze			2022-12-01	WOS:000344631400006
J	Ferreira, J; Aragao, LEOC; Barlow, J; Barreto, P; Berenguer, E; Bustamante, M; Gardner, TA; Lees, AC; Lima, A; Louzada, J; Pardini, R; Parry, L; Peres, CA; Pompeu, PS; Tabarelli, M; Zuanon, J				Ferreira, J.; Aragao, L. E. O. C.; Barlow, J.; Barreto, P.; Berenguer, E.; Bustamante, M.; Gardner, T. A.; Lees, A. C.; Lima, A.; Louzada, J.; Pardini, R.; Parry, L.; Peres, C. A.; Pompeu, P. S.; Tabarelli, M.; Zuanon, J.			Brazil's environmental leadership at risk	SCIENCE			English	Editorial Material												joice.ferreira@embrapa.br	Parry, Luke/ABD-4194-2021; Bustamante, Mercedes/AAQ-7231-2020; Pardini, Renata/C-4095-2012; Bustamante, Mercedes/GQZ-8625-2022; Bustamante, Mercedes MC/H-7597-2015; Zuanon, Jansen A. S./E-5791-2013; aragao, luiz eoc/G-8387-2012; Lees, Alexander Charles/S-2443-2019; Peres, Carlos A./ABE-8361-2020; Santos Pompeu, Paulo/F-6696-2012; Tabarelli, Marcelo/F-1088-2010; Louzada, Julio/F-1265-2010; Barlow, Jos/E-7861-2014; Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019	Parry, Luke/0000-0003-0330-9516; Bustamante, Mercedes/0000-0003-1008-452X; Pardini, Renata/0000-0002-3769-8401; Bustamante, Mercedes MC/0000-0003-1008-452X; Zuanon, Jansen A. S./0000-0001-8354-2750; aragao, luiz eoc/0000-0002-4134-6708; Lees, Alexander Charles/0000-0001-7603-9081; Peres, Carlos A./0000-0002-1588-8765; Santos Pompeu, Paulo/0000-0002-7938-1517; Tabarelli, Marcelo/0000-0001-7573-7216; Louzada, Julio/0000-0002-1481-3112; Peres, Carlos A./0000-0002-1588-8765; 	ESRC [ES/K010018/1] Funding Source: UKRI; NERC [NE/K016431/1] Funding Source: UKRI; Economic and Social Research Council [ES/K010018/1] Funding Source: researchfish; Natural Environment Research Council [NE/K016431/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ANDE, 2021, ADM NAC EN PLAN MAES; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Brasil Ministerio de Minas e Energia (MME), 2010, PLAN NAC MIN 2030; Business and Biodiversity Offsets Programme (BBOP), 2012, GUID NOT STAND BIOD; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Pilgrim JD, 2013, CONSERV LETT, V6, P376, DOI 10.1111/conl.12002; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Verissimo A., 2011, PROTECTED AREAS BRAZ; Villarroya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107144; WDPA, 2012, DATABASE	14	186	192	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					706	707		10.1126/science.1260194	http://dx.doi.org/10.1126/science.1260194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT1JT	25378611				2022-12-01	WOS:000344690100025
J	Hammerschmidt, K; Rose, CJ; Kerr, B; Rainey, PB				Hammerschmidt, Katrin; Rose, Caroline J.; Kerr, Benjamin; Rainey, Paul B.			Life cycles, fitness decoupling and the evolution of multicellularity	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS; EXPERIMENTAL POPULATIONS; ADAPTIVE DIVERGENCE; COOPERATION; SELECTION; INDIVIDUALITY; CONSTRUCTION; COMPETITION; TRANSITION; CONFLICT	Cooperation is central to the emergence of multicellular life; however, the means by which the earliest collectives (groups of cells) maintained integrity in the face of destructive cheating types is unclear. One idea posits cheats as a primitive germ line in a life cycle that facilitates collective reproduction. Here we describe an experiment in which simple cooperating lineages of bacteria were propagated under a selective regime that rewarded collective-level persistence. Collectives reproduced via life cycles that either embraced, or purged, cheating types. When embraced, the life cycle alternated between phenotypic states. Selection fostered inception of a developmental switch that underpinned the emergence of collectives whose fitness, during the course of evolution, became decoupled from the fitness of constituent cells. Such development and decoupling did not occur when groups reproduced via a cheat-purging regime. Our findings capture key events in the evolution of Darwinian individuality during the transition from single cells to multicellularity.	[Hammerschmidt, Katrin; Rose, Caroline J.; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland 0745, New Zealand; [Hammerschmidt, Katrin; Rose, Caroline J.; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 0745, New Zealand; [Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kerr, Benjamin] Univ Washington, BEACON Ctr Study Evolut Act, Seattle, WA 98195 USA; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany	Massey University; Massey University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Max Planck Society	Rainey, PB (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland 0745, New Zealand.	p.b.rainey@massey.ac.nz	Hammerschmidt, Katrin/J-5180-2014; Rainey, Paul/A-3207-2008; Hammerschmidt, Katrin/CAF-4889-2022	Hammerschmidt, Katrin/0000-0003-0172-8995; Rainey, Paul/0000-0003-0879-5795; Hammerschmidt, Katrin/0000-0003-0172-8995; Rose, Caroline/0000-0001-7133-0355	French State; Ile-de-France; Marsden Fund Council; Foundational Questions in Evolutionary Biology Fund [RFP-12-20]; National Science Foundation [DBI-0939454]; NSF CAREER Award [DEB0952825]	French State; Ile-de-France; Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Foundational Questions in Evolutionary Biology Fund; National Science Foundation(National Science Foundation (NSF)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank S. Nestmann for assistance with molecular aspects of the work and for guiding construction of the mutS deletion mutant. We thank E. Libby and Y. Pichugin for discussion, and S. DeMonte and P. G. Smith for comments on drafts of the manuscript. We are indebted to PacBio and particularly J. Korlach and Y. Song for genome sequencing. P. B. R. currently holds an International Blaise Pascal Research Chair funded by the French State and the Ile-de-France, managed by the Fondation de l'Ecole Normale Superieure. The work was directly supported by the Marsden Fund Council from government funding administered by the Royal Society of New Zealand, and in part by grant RFP-12-20 from the Foundational Questions in Evolutionary Biology Fund, by the National Science Foundation under Cooperative Agreement Number DBI-0939454, and by an NSF CAREER Award Grant (DEB0952825).	Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Bonner John Tyler, 1998, Integrative Biology, V1, P27; Buss L. W., 1987, EVOLUTION INDIVIDUAL; DAMUTH J, 1988, BIOL PHILOS, V3, P407, DOI 10.1007/BF00647962; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Godfrey-Smith P., 2009, DARWINIAN POPULATION; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Griesemer J., 2000, SELECTION, V1, P67, DOI DOI 10.1556/SELECT.1.2000.1-3.7; Heilbron K, 2014, GENETICS, V197, P981, DOI 10.1534/genetics.114.163147; LEIGH EG, 1977, P NATL ACAD SCI USA, V74, P4542, DOI 10.1073/pnas.74.10.4542; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lewontin R.C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Libby E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082274; Libby E, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/035001; Maynard Smith J., 1988, EVOLUTIONARY PROGR, P219; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; McDonald MJ, 2009, GENETICS, V183, P1041, DOI 10.1534/genetics.109.107110; Michod RE, 1996, P ROY SOC B-BIOL SCI, V263, P813, DOI 10.1098/rspb.1996.0121; Michod Richard E., 1999, Lectures on Mathematics in the Life Sciences, V26, P47; Michod Richard E., 1999, DARWINIAN DYNAMICS; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; NUNNEY L, 1985, AM NAT, V126, P212, DOI 10.1086/284410; Nunney L, 1999, P ROY SOC B-BIOL SCI, V266, P493, DOI 10.1098/rspb.1999.0664; Okasha S, 2006, EVOLUTION LEVELS SEL, DOI DOI 10.1093/ACPROF:OSO/9780199267972.001.0001; Okasha S, 2012, INTERFACE FOCUS, V2, P49, DOI 10.1098/rsfs.2011.0046; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Rainey PB, 2007, NATURE, V446, P616, DOI 10.1038/446616a; Rainey PB, 2014, ANNU REV ECOL EVOL S, V45, P599, DOI 10.1146/annurev-ecolsys-120213-091740; Rainey PB, 2010, BIOESSAYS, V32, P872, DOI 10.1002/bies.201000039; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Sober E., 1998, OTHERS EVOLUTION PSY; Spiers AJ, 2002, GENETICS, V161, P33; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Tarnita CE, 2013, J THEOR BIOL, V320, P10, DOI 10.1016/j.jtbi.2012.11.022; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; WADE MJ, 1980, BEHAV ECOL SOCIOBIOL, V7, P167, DOI 10.1007/BF00299360; WOLPERT L, 1990, BIOL J LINN SOC, V39, P109, DOI 10.1111/j.1095-8312.1990.tb00506.x; Wolpert L, 2002, NATURE, V420, P745, DOI 10.1038/420745a; Zhang XX, 2007, J MICROBIOL METH, V71, P78, DOI 10.1016/j.mimet.2007.07.001	47	103	107	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					75	+		10.1038/nature13884	http://dx.doi.org/10.1038/nature13884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25373677				2022-12-01	WOS:000344187500031
J	Chaabane, H; Turki, H				Chaabane, Hend; Turki, Hamida			Cutaneous Leishmaniasis with a Paronychia-like Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chaabane, Hend; Turki, Hamida] Hedi Chaker Hosp, Sfax, Tunisia	Universite de Sfax; Hopital Hedi Chaker	Chaabane, H (corresponding author), Hedi Chaker Hosp, Sfax, Tunisia.	chaabane.hend@gmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1736	1736		10.1056/NEJMicm1314869	http://dx.doi.org/10.1056/NEJMicm1314869			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354107				2022-12-01	WOS:000343768500011
J	Liu, S; Watcha, D; Holodniy, M; Goldhaber-Fiebert, JD				Liu, Shan; Watcha, Daena; Holodniy, Mark; Goldhaber-Fiebert, Jeremy D.			Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in US Incarcerated Populations A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; TREATMENT-NAIVE; PEGYLATED INTERFERON; VIROLOGICAL RESPONSE; PROTEASE INHIBITORS; ANTIVIRAL THERAPY; TRIPLE THERAPY; ALL-CAUSE; RIBAVIRIN; HEALTH	Background: Prevalence of chronic hepatitis C virus (HCV) infection is high among incarcerated persons in the United States. New, short-duration, high-efficacy therapies may expand treatment eligibility in this population. Objective: To assess the cost-effectiveness of sofosbuvir for HCV treatment in incarcerated populations. Design: Markov model. Data Sources: Published literature and expert opinion. Target Population: Treatment-naive men with chronic, genotype 1 HCV monoinfection. Time Horizon: Lifetime. Perspective: Societal. Intervention: No treatment, 2-drug therapy (pegylated interferon and ribavirin), or 3-drug therapy with either boceprevir or sofosbuvir. For inmates with short remaining sentences (<1.5 years), only no treatment or sofosbuvir 3-drug therapy was feasible; for those with long sentences (>= 1.5 years; mean, 10 years), all strategies were considered. After release, eligible persons could receive sofosbuvir 3-drug therapy. Outcome Measures: Discounted costs (in 2013 U. S. dollars), discounted quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The strategies yielded 13.12, 13.57, 14.43, and 15.18 QALYs, respectively, for persons with long sentences. Sofosbuvir produced the largest absolute reductions in decompensated cirrhosis (16%) and hepatocellular carcinoma (9%), resulting in 2.1 additional QALYs at an added cost exceeding $54 000 compared with no treatment. For persons with short sentences, sofosbuvir cost $25 700 per QALY gained compared with no treatment; for those with long sentences, it dominated other treatments, costing $28 800 per QALY gained compared with no treatment. Results of Sensitivity Analysis: High reinfection rates in prison attenuated cost-effectiveness for persons with long sentences. Limitations: Data on sofosbuvir's long-term effectiveness and price are limited. The analysis did not consider women, Hispanic persons, or patients co-infected with HIV or hepatitis B virus. Conclusion: Sofosbuvir-based treatment is cost-effective for incarcerated persons, but affordability is an important consideration.	Univ Washington, Seattle, WA 98195 USA; UCSF Sch Med, San Francisco, CA 94143 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Goldhaber-Fiebert, JD (corresponding author), Stanford Univ, Ctr Hlth Policy, 117 Encina Commons, Stanford, CA 94305 USA.	jeremygf@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Holodniy, Mark/0000-0002-6655-7982	National Institutes of Health; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.	Arias Elizabeth, 2014, NATL VITAL STAT REPO; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Beck AJ, 2004, HEPATITIS TESTING TR; Blazquez-Perez A, 2013, PHARMACOECONOMICS, V31, P919, DOI 10.1007/s40273-013-0080-3; Camma C, 2012, HEPATOLOGY, V56, P850, DOI 10.1002/hep.25734; Carson E.A., 2014, PRISONERS 2011, P1; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Cipriano LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045176; Clarke Jennifer G., 2001, Subst Abus, V22, P209; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Di Martino V, 2011, J VIRAL HEPATITIS, V18, P493, DOI 10.1111/j.1365-2893.2011.01476.x; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Elbasha EH, 2013, APPL HEALTH ECON HEA, V11, P65, DOI 10.1007/s40258-012-0007-8; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Federal Bureau of Prisons, 2014, SENT IMP; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold M, 1996, MED CARE, V34, pDS197; Gold MR., 1996, COST EFFECTIVENESS H; Hartwell D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15170; Holtz-Eakin D, 2005, PRICES BRAND NAME DR; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Narasimhan G, 2006, J VIRAL HEPATITIS, V13, P783, DOI 10.1111/j.1365-2893.2006.00763.x; Noonan M., 2011, PRISON JAIL DEATHS C; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poret AW, 2002, DIS MANAG, V5, P95; Rice JP, 2012, HEPATOLOGY, V56, P1252, DOI 10.1002/hep.25770; Rowell TL, 2012, AM J DRUG ALCOHOL AB, V38, P593, DOI 10.3109/00952990.2012.694536; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Spaulding AC, 2012, JAMA-J AM MED ASSOC, V307, P1259, DOI 10.1001/jama.2012.374; Spaulding Anne S, 2013, Top Antivir Med, V21, P27; Sterling RK, 2005, AM J GASTROENTEROL, V100, P313, DOI 10.1111/j.1572-0241.2005.40116.x; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sutton AJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-170; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; The Pew Charitable Trusts, 2014, MAN PRIS HLTH CAR SP; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; U.S. Department of Justice, 2008, FED BUR PRIS EFF MAN; United States Bureau of Labour Statistics, 2014, CONS PRIC IND; Varan A, 2012, 5 AC HLTH POL C CORR; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Weinbaum Cindy, 2003, MMWR Recomm Rep, V52, P1; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Younossi ZM, 2014, J HEPATOL, V60, P741, DOI 10.1016/j.jhep.2013.12.006; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009	65	64	65	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					546	U43		10.7326/M14-0602	http://dx.doi.org/10.7326/M14-0602			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25329202	Green Accepted			2022-12-01	WOS:000343906800014
J	Cobb, NK; Abrams, DB				Cobb, Nathan K.; Abrams, David B.			The FDA, E-Cigarettes, and the Demise of Combusted Tobacco	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cobb, Nathan K.] Georgetown Univ, Med Ctr, Dept Med, Div Pulm & Crit Care, Washington, DC 20007 USA; [Abrams, David B.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Abrams, David B.] Georgetown Univ, Med Ctr, Canc Prevent & Control Program, Washington, DC 20007 USA; [Abrams, David B.] Schroeder Inst Tobacco Res & Policy Studies Legac, Washington, DC USA; [Cobb, Nathan K.; Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Cobb, Nathan K.] MeYou Hlth, Boston, MA USA	Georgetown University; Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cobb, NK (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Pulm & Crit Care, Washington, DC 20007 USA.		Abrams, David B/AAY-7699-2020	Abrams, David B/0000-0002-0868-4350; Cobb, Nathan/0000-0003-4210-226X				[Anonymous], 2014, FED REGISTER, V79, P23141; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Chatham-Stephens K, 2014, MMWR-MORBID MORTAL W, V63, P292; Christensen C.M., 2013, INNOVATORS DILEMMA N; Warner KE, 2013, TOB CONTROL, V22, P3, DOI 10.1136/tobaccocontrol-2013-050989	5	37	38	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1469	1471		10.1056/NEJMp1408448	http://dx.doi.org/10.1056/NEJMp1408448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317866				2022-12-01	WOS:000342994700001
J	Farh, KKH; Marson, A; Zhu, J; Kleinewietfeld, M; Housley, WJ; Beik, S; Shoresh, N; Whitton, H; Ryan, RJH; Shishkin, AA; Hatan, M; Carrasco-Alfonso, MJ; Mayer, D; Luckey, CJ; Patsopoulos, NA; De Jager, PL; Kuchroo, VK; Epstein, CB; Daly, MJ; Hafler, DA; Bernstein, BE				Farh, Kyle Kai-How; Marson, Alexander; Zhu, Jiang; Kleinewietfeld, Markus; Housley, William J.; Beik, Samantha; Shoresh, Noam; Whitton, Holly; Ryan, Russell J. H.; Shishkin, Alexander A.; Hatan, Meital; Carrasco-Alfonso, Marlene J.; Mayer, Dita; Luckey, C. John; Patsopoulos, Nikolaos A.; De Jager, Philip L.; Kuchroo, Vijay K.; Epstein, Charles B.; Daly, Mark J.; Hafler, David A.; Bernstein, Bradley E.			Genetic and epigenetic fine mapping of causal autoimmune disease variants	NATURE			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; SUSCEPTIBILITY LOCI; TRANSCRIPTION FACTORS; ENHANCER LANDSCAPE; FOXP3 OCCUPANCY; READ ALIGNMENT; CROHNS-DISEASE; RISK LOCI; B-CELLS	Genome-wide association studies have identified loci underlying human diseases, but the causal nucleotide changes and mechanisms remain largely unknown. Here we developed a fine-mapping algorithm to identify candidate causal variants for 21 autoimmune diseases from genotyping data. We integrated these predictions with transcription and cis-regulatory element annotations, derived by mapping RNA and chromatin in primary immune cells, including resting and stimulated CD4(+) T-cell subsets, regulatory T cells, CD8(+) T cells, B cells, and monocytes. We find that similar to 90% of causal variants are non-coding, with similar to 60% mapping to immune-cell enhancers, many of which gain histone acetylation and transcribe enhancer-associated RNA upon immune stimulation. Causal variants tend to occur near binding sites for master regulators of immune differentiation and stimulus-dependent gene activation, but only 10-20% directly alter recognizable transcription factor binding motifs. Rather, mostnon-coding risk variants, including those that alter gene expression, affect non-canonical sequence determinants not well-explained by current gene regulatory models.	[Farh, Kyle Kai-How; Zhu, Jiang; Kleinewietfeld, Markus; Beik, Samantha; Shoresh, Noam; Whitton, Holly; Ryan, Russell J. H.; Shishkin, Alexander A.; Hatan, Meital; Patsopoulos, Nikolaos A.; De Jager, Philip L.; Epstein, Charles B.; Daly, Mark J.; Hafler, David A.; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Farh, Kyle Kai-How; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Marson, Alexander] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA; [Zhu, Jiang; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zhu, Jiang; Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zhu, Jiang; Ryan, Russell J. H.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Zhu, Jiang; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zhu, Jiang; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Kleinewietfeld, Markus; Housley, William J.; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Kleinewietfeld, Markus; Housley, William J.; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Shishkin, Alexander A.] CALTECH, Pasadena, CA 91125 USA; [Carrasco-Alfonso, Marlene J.; Mayer, Dita; Luckey, C. John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Carrasco-Alfonso, Marlene J.; Mayer, Dita; Luckey, C. John] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02142 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02142 USA; [Patsopoulos, Nikolaos A.; De Jager, Philip L.] Harvard Univ, Div Genet, Dept Med, Brigham & Womens Hosp,Med Sch, Boston, MA 02142 USA; [Kuchroo, Vijay K.] Harvard Univ, Ctr Neurol Dis, Brigham & Womens Hosp, Sch Med, Boston, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; Yale University; California Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Marson, A (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	alexander.marson@ucsf.edu	Daly, Mark J/B-2453-2017; Kleinewietfeld, Markus/AAI-4497-2021	Daly, Mark J/0000-0002-0949-8752; Epstein, Charles B./0000-0001-8358-8345; Luckey, Chance John/0000-0002-0787-9121; Kleinewietfeld, Markus/0000-0002-2832-3149; Patsopoulos, Nikolaos/0000-0003-3757-8941; Ryan, Russell/0000-0001-8174-3962	NIH Common Fund [ES017155]; National Human Genome Research Institute [HG004570]; National Institute of Allergy and Infectious Disease [AI045757, AI046130, AI070352, AI039671]; National Institute of Neurological Disorders and Stroke [NS24247, NS067305]; National Institute of General Medical Sciences [GM093080]; National Multiple Sclerosis Society [CA1061-A-18]; UCSF Sandler Fellowship; Penates Foundation; Nancy Taylor Foundation; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, U19AI046130, U19AI070352, T32AI007019, P01AI039671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748, RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024247, R37NS024247, R01NS067305] Funding Source: NIH RePORTER; Worldwide Cancer Research [12-0089] Funding Source: researchfish	NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); UCSF Sandler Fellowship; Penates Foundation; Nancy Taylor Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Worldwide Cancer Research	We thank members of the NIH Epigenomics Consortium, M. Greenberg, H. Chang and G. Haliburton for constructive comments. We also thank IIBDGC and P. Sullivan for sharing data pre-publication, and G. Cvetanovich, S. Bhela, C. Hartnick, F. Preffer, D. Dombkowski and the Brigham and Women's Hospital PhenoGenetic Project for assistance with data collection. This research was supported by the NIH Common Fund (ES017155), the National Human Genome Research Institute (HG004570), the National Institute of Allergy and Infectious Disease (AI045757, AI046130, AI070352, AI039671), the National Institute of Neurological Disorders and Stroke (NS24247, NS067305), the National Institute of General Medical Sciences (GM093080), the National Multiple Sclerosis Society (CA1061-A-18), the UCSF Sandler Fellowship, a gift from Jake Aronov, the Penates Foundation, the Nancy Taylor Foundation, and the Howard Hughes Medical Institute.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Johnston A., 2009, CURRENT PROTOC IMMUN; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; West LC, 2013, CURR OPIN IMMUNOL, V25, P103, DOI 10.1016/j.coi.2012.11.006; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	67	1082	1102	4	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					337	343		10.1038/nature13835	http://dx.doi.org/10.1038/nature13835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25363779	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000349547400030
J	Chan, M				Chan, Margaret			Food safety must accompany food and nutrition security	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	chanm@who.int						WHO, 2014, WHO DRAFT GLOB ACT P; WHO, 2014, 5 KEYS SAF FOOD PROG; WHO, 2014, INFOSAN ACT AM; WHO, BURD FOODB DIS; WHO and FAO, 2013, 50 ANN COD AL; World Health Organization, 2014, FAO WHO 2 INT C NUTR	6	29	30	7	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1910	1911		10.1016/S0140-6736(14)62037-7	http://dx.doi.org/10.1016/S0140-6736(14)62037-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25467592				2022-12-01	WOS:000345450100010
J	Chertow, DS; Kleine, C; Edwards, JK; Scaini, R; Giuliani, R; Sprecher, A				Chertow, Daniel S.; Kleine, Christian; Edwards, Jeffrey K.; Scaini, Roberto; Giuliani, Ruggero; Sprecher, Armand			Ebola Virus Disease in West Africa - Clinical Manifestations and Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chertow, Daniel S.; Kleine, Christian; Edwards, Jeffrey K.; Scaini, Roberto; Giuliani, Ruggero; Sprecher, Armand] Liberia Mission, Med Sans Frontieres, Brussels, Belgium; [Chertow, Daniel S.] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Kleine, Christian] JW Goethe Univ Hosp, Dept Infect Dis & Trop Med, Frankfurt, Germany	Doctors Without Borders; National Institutes of Health (NIH) - USA; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Chertow, DS (corresponding author), Liberia Mission, Med Sans Frontieres, Brussels, Belgium.							Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Tattevin P, 2014, INTENS CARE MED, V40, P1738, DOI 10.1007/s00134-014-3473-7	4	240	254	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2054	2057		10.1056/NEJMp1413084	http://dx.doi.org/10.1056/NEJMp1413084			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU4KP	25372854	Bronze			2022-12-01	WOS:000345580000003
J	Brown, JCS; Nelson, J; VanderSluis, B; Deshpande, R; Butts, A; Kagan, S; Polacheck, I; Krysan, DJ; Myers, CL; Madhani, HD				Brown, Jessica C. S.; Nelson, Justin; VanderSluis, Benjamin; Deshpande, Raamesh; Butts, Arielle; Kagan, Sarah; Polacheck, Itzhack; Krysan, Damian J.; Myers, Chad L.; Madhani, Hiten D.			Unraveling the Biology of a Fungal Meningitis Pathogen Using Chemical Genetics	CELL			English	Article							BIOACTIVE COMPOUNDS; DRUG-COMBINATIONS; ANTIFUNGAL AGENTS; CAPSULE; MECHANISMS; RESISTANCE; VIRULENCE; YEAST; POLYSACCHARIDE; INHIBITOR	The fungal meningitis pathogen Cryptococcus neoformans is a central driver of mortality in HIV/AIDS. We report a genome-scale chemical genetic data map for this pathogen that quantifies the impact of 439 small-molecule challenges on 1,448 gene knockouts. We identified chemical phenotypes for 83% of mutants screened and at least one genetic response for each compound. C. neoformans chemical-genetic responses are largely distinct from orthologous published profiles of Saccharomyces cerevisiae, demonstrating the importance of pathogen-centered studies. We used the chemical-genetic matrix to predict novel pathogenicity genes, infer compound mode of action, and to develop an algorithm, O2M, that predicts antifungal synergies. These predictions were experimentally validated, thereby identifying virulence genes, a molecule that triggers G2/M arrest and inhibits the Cdc25 phosphatase, and many compounds that synergize with the antifungal drug fluconazole. Our work establishes a chemical-genetic foundation for approaching an infection responsible for greater than one-third of AIDS-related deaths.	[Brown, Jessica C. S.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Nelson, Justin; VanderSluis, Benjamin; Deshpande, Raamesh; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Butts, Arielle; Krysan, Damian J.] Univ Rochester, Med Ctr, Dept Chem, Rochester, NY 14643 USA; [Kagan, Sarah; Polacheck, Itzhack] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel; [Krysan, Damian J.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14643 USA; [Krysan, Damian J.] Univ Rochester, Sch Med & Dent, Dept Microbiol Immunol, Rochester, NY 14643 USA	University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Rochester; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Rochester; University of Rochester	Myers, CL (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	cmyers@cs.umn.edu; hitenmadhani@gmail.com		Brown, Jessica/0000-0002-3255-1486; Krysan, Damian/0000-0001-6330-3365; Madhani, Hiten/0000-0001-7400-6657	NIH [5R01AI099206, 1R01AI091422, 1R01HG005084, 1R01GM04975]; CIFAR Genetic Networks Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, R01AI099206, R01AI091422, R01AI100272, R01AI096869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIFAR Genetic Networks Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 5R01AI099206 to H.D.M., 1R01AI091422 to D.J.K., 1R01HG005084 and 1R01GM04975 to C.L.M, and a grant from the CIFAR Genetic Networks Program to C.L.M.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI [10.1038/nmeth.1534, 10.1038/NMETH.1534]; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; Butts A, 2014, MBIO, V5, DOI 10.1128/mBio.00765-13; Butts A, 2013, EUKARYOT CELL, V12, P278, DOI 10.1128/EC.00314-12; Butts A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002870; Cantas L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00096; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Chun CD, 2011, CELL HOST MICROBE, V9, P243, DOI 10.1016/j.chom.2011.02.003; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Day JN, 2013, NEW ENGL J MED, V368, P1291, DOI [10.1056/NEJMoa1110404, 10.1056/NEJMc1305981]; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Dittmar JC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-353; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Feldman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093225; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Francis LK, 2006, CLIN CANCER RES, V12, P6826, DOI 10.1158/1078-0432.CCR-06-1331; Geyer JA, 2005, BBA-PROTEINS PROTEOM, V1754, P160, DOI 10.1016/j.bbapap.2005.07.031; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HILL HD, 1968, ANAL BIOCHEM, V24, P9, DOI 10.1016/0003-2697(68)90054-7; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; HSIEH MH, 1993, DIAGN MICR INFEC DIS, V16, P343, DOI 10.1016/0732-8893(93)90087-N; Jansen G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.95; Jiang B, 2008, CHEM BIOL, V15, P363, DOI 10.1016/j.chembiol.2008.02.016; Kagan SH, 2014, GERIATR NURS, V35, P69, DOI 10.1016/j.gerinurse.2013.11.006; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; KOZEL TR, 1984, INFECT IMMUN, V43, P879, DOI 10.1128/IAI.43.3.879-886.1984; Kumar P, 2014, EUKARYOT CELL, V13, P560, DOI 10.1128/EC.00290-13; Kumar P, 2011, CURR OPIN STRUC BIOL, V21, P597, DOI 10.1016/j.sbi.2011.08.006; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Kuo D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r77; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Liu OW, 2007, EUKARYOT CELL, V6, P630, DOI 10.1128/EC.00398-06; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mandell GL, 2010, MANDELL DOUGLAS BENN; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Morgan DO., 2007, CELL CYCLE PRINCIPLE; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pu LX, 2002, J BIOL CHEM, V277, P46877, DOI 10.1074/jbc.M207902200; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; WHELAN WL, 1986, J BACTERIOL, V166, P924, DOI 10.1128/jb.166.3.924-929.1986; World Health Organization (WHO), 2011, RAP ADV DIAGN PREV M; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Xu DM, 2009, J BIOL CHEM, V284, P19754, DOI 10.1074/jbc.M109.019877; Zhai B, 2012, ANTIMICROB AGENTS CH, V56, P3758, DOI 10.1128/AAC.00212-12	63	51	52	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1168	1187		10.1016/j.cell.2014.10.044	http://dx.doi.org/10.1016/j.cell.2014.10.044			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416953	Green Accepted, Bronze			2022-12-01	WOS:000345506300026
J	Cheng, Y; Ma, ZH; Kim, BH; Wu, WS; Cayting, P; Boyle, AP; Sundaram, V; Xing, XY; Dogan, N; Li, JJ; Euskirchen, G; Lin, S; Lin, Y; Visel, A; Kawli, T; Yang, XQ; Patacsil, D; Keller, CA; Giardine, B; Kundaje, A; Wang, T; Pennacchio, LA; Weng, ZP; Hardison, RC; Snyder, MP				Cheng, Yong; Ma, Zhihai; Kim, Bong-Hyun; Wu, Weisheng; Cayting, Philip; Boyle, Alan P.; Sundaram, Vasavi; Xing, Xiaoyun; Dogan, Nergiz; Li, Jingjing; Euskirchen, Ghia; Lin, Shin; Lin, Yiing; Visel, Axel; Kawli, Trupti; Yang, Xinqiong; Patacsil, Dorrelyn; Keller, Cheryl A.; Giardine, Belinda; Kundaje, Anshul; Wang, Ting; Pennacchio, Len A.; Weng, Zhiping; Hardison, Ross C.; Snyder, Michael P.		Mouse ENCODE Consortium	Principles of regulatory information conservation between mouse and human	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMATIN; ENHANCERS; GENOME; SEQUENCES; ELEMENTS; SITES; CTCF	To broaden our understanding of the evolution of gene regulation mechanisms, we generated occupancy profiles for 34 orthologous transcription factors (TFs) in human-mouse erythroid progenitor, lymphoblast and embryonic stem-cell lines. By combining the genome-wide transcription factor occupancy repertoires, associated epigenetic signals, and co-association patterns, here we deduce several evolutionary principles of gene regulatory features operating since the mouse and human lineages diverged. The genomic distribution profiles, primary binding motifs, chromatin states, and DNA methylation preferences are well conserved for TF-occupied sequences. However, the extent to which orthologous DNA segments are bound by orthologous TFs varies both among TFs and with genomic location: binding at promoters is more highly conserved than binding at distal elements. Notably, occupancy-conserved TF-occupied sequences tend to be pleiotropic; they function in several tissues and also co-associate with many TFs. Single nucleotide variants at sites with potential regulatory functions are enriched in occupancy-conserved TF-occupied sequences.	[Cheng, Yong; Ma, Zhihai; Cayting, Philip; Boyle, Alan P.; Li, Jingjing; Euskirchen, Ghia; Lin, Shin; Lin, Yiing; Kawli, Trupti; Yang, Xinqiong; Patacsil, Dorrelyn; Kundaje, Anshul; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kim, Bong-Hyun; Weng, Zhiping] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Wu, Weisheng; Dogan, Nergiz; Keller, Cheryl A.; Giardine, Belinda; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, Huck Inst Life Sci, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Wu, Weisheng] Univ Michigan, BRCF Bioinformat Core, Ann Arbor, MI 48105 USA; [Sundaram, Vasavi; Xing, Xiaoyun; Wang, Ting] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA; [Lin, Shin] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94304 USA; [Lin, Yiing] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94701 USA; [Visel, Axel; Pennacchio, Len A.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Washington University (WUSTL); Stanford University; Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Merced	Snyder, MP (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	rch8@psu.edu; mpsnyder@stanford.edu	Dogan-Artun, Nergiz/AAG-2681-2021; cheng, yong/I-4270-2012; Hardison, Ross C/G-1142-2010; Lagarde, Julien/AAI-1686-2020; Tanzer, Andrea/L-3147-2015; Tanzer, Andrea/AAY-5431-2021; Visel, Axel/A-9398-2009; Boyle, Alan/I-1848-2014; Kundaje, Anshul/Y-2598-2019; Pervouchine, Dmitri/H-5252-2015; Ma, Zhihai/E-7130-2015; Li, Jingjing/B-5136-2016; Pervouchine, Dmitri/AAU-5399-2021; Kundaje, Anshul/Y-2739-2019; Kumar, Swathi/I-7941-2015; Herrero, Javier/H-6971-2019; Mishra, Tejaswini/D-3528-2018; Bussotti, Giovanni/C-3082-2019	Hardison, Ross C/0000-0003-4084-7516; Lagarde, Julien/0000-0002-0290-7445; Tanzer, Andrea/0000-0003-2873-4236; Tanzer, Andrea/0000-0003-2873-4236; Visel, Axel/0000-0002-4130-7784; Boyle, Alan/0000-0002-2081-1105; Kundaje, Anshul/0000-0003-3084-2287; Pervouchine, Dmitri/0000-0003-0543-9760; Li, Jingjing/0000-0001-6025-9522; Pervouchine, Dmitri/0000-0003-0543-9760; Kundaje, Anshul/0000-0003-3084-2287; Kumar, Swathi/0000-0002-2770-5145; Herrero, Javier/0000-0001-7313-717X; Mishra, Tejaswini/0000-0001-9931-1260; Zhou, Xiao-Qiao/0000-0002-0724-5153; Dogan-Artun, Nergiz/0000-0002-5922-4194; Lin, Yiing/0000-0002-0317-7608; Pennacchio, Len/0000-0002-8748-3732; Lin, Shin/0000-0003-0118-0413; Sundaram, Vasavi/0000-0001-6571-7027; Snyder, Michael/0000-0003-0784-7987; Samstein, Robert/0000-0001-6860-2401; Cheng, Yong/0000-0002-9314-0971; Pope, Benjamin/0000-0003-1847-9163; Kaul, Rajinder/0000-0002-7895-9284; Bussotti, Giovanni/0000-0002-4078-7413; josefowicz, steven/0000-0001-7453-779X; Dobin, Alexander/0000-0002-4115-9128; Edsall, Lee Elizabeth/0000-0002-0326-2829	National Human Genome Research Institute (NHGRI) [R01HG003988, U54HG006997]; American Recovery and Reinvestment Act; Department of Energy, University of California [DE-AC02-05CH11231];  [3RC2HG005602];  [5U54HG006996];  [1U54HG00699];  [R01DK065806];  [RC2HG005573]; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021482] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, R01HG007175, U54HG007004, R01HG007348, U54HG006997, U54HG006998, RC2HG005573, K99HG007356, RC2HG005602, R01HG007354, U41HG007234, R01HG003988, U54HG006996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE024427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266, R37DK044746, R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083337] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Recovery and Reinvestment Act; Department of Energy, University of California(United States Department of Energy (DOE)University of California System); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by grants 3RC2HG005602, 5U54HG006996 and 1U54HG00699 (M. P. S.), and R01DK065806 and RC2HG005573 (R. C. H.). A. V. and L. A. P. were supported by National Human Genome Research Institute (NHGRI) grant R01HG003988, U54HG006997 and supplementary funds provided by the American Recovery and Reinvestment Act. The in vivo enhancer activity assays were conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. We acknowledge R. M. Myers for providing access to ChIP-seq data in human embryonic cells. Illumina sequencing services were performed by the Stanford Center for Genomics and Personalized Medicine.	Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sundaram V., 2014, GENOME RES; Tokugawa Y, 1997, MOL IMMUNOL, V34, P1263, DOI 10.1016/S0161-5890(98)00010-8; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649	29	180	182	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					371	+		10.1038/nature13985	http://dx.doi.org/10.1038/nature13985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409826	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-01	WOS:000345770600036
J	Baidal, JAW; Taveras, EM				Baidal, Jennifer A. Woo; Taveras, Elsie M.			Protecting Progress against Childhood Obesity - The National School Lunch Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STANDARDS		[Baidal, Jennifer A. Woo] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Baidal, Jennifer A. Woo; Taveras, Elsie M.] MassGeneral Hosp Children, Dept Pediat, Boston, MA USA; [Taveras, Elsie M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Baidal, JAW (corresponding author), Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA.							Cohen JFW, 2014, AM J PREV MED, V46, P388, DOI 10.1016/j.amepre.2013.11.013; Committee on Nutrition Standards for National School Lunch and Breakfast Programs, 2010, SCH MEALS BUILD BLOC; Forestell CA, 2007, PEDIATRICS, V120, P1247, DOI 10.1542/peds.2007-0858; Government Accountability Office, 2014, SCH LUNCH IMPL NUTR; Turner L, 2014, CHILD OBES, V10, P349, DOI 10.1089/chi.2014.0038	5	23	23	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1862	1865		10.1056/NEJMp1409353	http://dx.doi.org/10.1056/NEJMp1409353			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25353967				2022-12-01	WOS:000344709800003
J	Chretien, JP				Chretien, Jean-Paul			Expectation Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DECISION		Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA		Chretien, JP (corresponding author), Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA.							Bingel U, 2014, JAMA-J AM MED ASSOC, V312, P693, DOI 10.1001/jama.2014.8342; DeWitt BS, 1970, PHYS TODAY, V23, P155; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Metrik J, 2012, PSYCHOPHARMACOLOGY, V223, P489, DOI 10.1007/s00213-012-2740-y; Prescott B, 2014, HARVARD MED SCH 0108; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192	9	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1936	1939		10.1056/NEJMms1406844	http://dx.doi.org/10.1056/NEJMms1406844			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT1RB	25390747				2022-12-01	WOS:000344709800018
J	Dayton, L				Dayton, Leigh			Blue-sky rice	NATURE			English	Editorial Material							C-4 PHOTOSYNTHESIS; NITROGEN											Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Covshoff S, 2012, CURR OPIN BIOTECH, V23, P209, DOI 10.1016/j.copbio.2011.12.011; Hatch MD, 2002, PHOTOSYNTH RES, V73, P251, DOI 10.1023/A:1020471718805; Krishnan SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098843; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044	6	14	14	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S52	S54		10.1038/514S52a	http://dx.doi.org/10.1038/514S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368887				2022-12-01	WOS:000343801500003
J	Rubin, R				Rubin, Rita			Analysis Reveals Large Increase in Hospitalizations in Recent Years Among Older Patients Prescribed Opioids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item							COMPARATIVE SAFETY; ADULTS; PAIN						Rubin, Rita/AAD-1259-2020					Colliver JD, 2006, ANN EPIDEMIOL, V16, P257, DOI 10.1016/j.annepidem.2005.08.003; Hanlon JT, 2009, PAIN MED, V10, P959, DOI 10.1111/j.1526-4637.2009.00698.x; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391	4	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2014	312	16					1621	1623		10.1001/jama.2014.13249	http://dx.doi.org/10.1001/jama.2014.13249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR0YF	25335129				2022-12-01	WOS:000343301400002
J	Brooks, HE; Carbin, GW; Marsh, PT				Brooks, Harold E.; Carbin, Gregory W.; Marsh, Patrick T.			Increased variability of tornado occurrence in the United States	SCIENCE			English	Article							SEVERE THUNDERSTORM; REANALYSIS; ENVIRONMENTS; PARAMETERS	Whether or not climate change has had an impact on the occurrence of tornadoes in the United States has become a question of high public and scientific interest, but changes in how tornadoes are reported have made it difficult to answer it convincingly. We show that, excluding the weakest tornadoes, the mean annual number of tornadoes has remained relatively constant, but their variability of occurrence has increased since the 1970s. This is due to a decrease in the number of days per year with tornadoes combined with an increase in days with many tornadoes, leading to greater variability on annual and monthly time scales and changes in the timing of the start of the tornado season.	[Brooks, Harold E.] NOAA, Natl Severe Storms Lab, Norman, OK 73072 USA; [Carbin, Gregory W.; Marsh, Patrick T.] NOAA, Natl Weather Serv Storm Predict Ctr, Norman, OK 73072 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Brooks, HE (corresponding author), NOAA, Natl Severe Storms Lab, Norman, OK 73072 USA.	harold.brooks@noaa.gov						Brooks HE, 2013, ATMOS RES, V123, P129, DOI 10.1016/j.atmosres.2012.04.002; Brooks HE, 2003, ATMOS RES, V67-8, P73, DOI 10.1016/S0169-8095(03)00045-0; Compo GP, 2006, B AM METEOROL SOC, V87, P175, DOI 10.1175/BAMS-87-2-175; Craven J. P., 2004, NATL WEA DIG, V28, P13; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Doswell CA, 2009, ATMOS RES, V93, P554, DOI 10.1016/j.atmosres.2008.11.003; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Rasmussen EN, 1998, WEATHER FORECAST, V13, P1148, DOI 10.1175/1520-0434(1998)013<1148:ABCOSD>2.0.CO;2; Shafer CM, 2012, WEATHER FORECAST, V27, P809, DOI 10.1175/WAF-D-11-00142.1; Shafer CM, 2009, MON WEATHER REV, V137, P1250, DOI 10.1175/2008MWR2597.1; Stocker T. F., 2013, CLIM CHANG 2013; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1	15	100	102	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					349	352		10.1126/science.1257460	http://dx.doi.org/10.1126/science.1257460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324388				2022-12-01	WOS:000343041100044
J	Medford, JI; Prasad, A				Medford, June I.; Prasad, Ashok			Plant synthetic biology takes root	SCIENCE			English	Editorial Material							ARABIDOPSIS; SYSTEM		[Medford, June I.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Prasad, Ashok] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Medford, JI (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	june.medford@colostate.edu	Prasad, Ashok/HDN-5956-2022					Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Antunes MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016292; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Lyons SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003533; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Morey KJ, 2011, METHOD ENZYMOL, V497, P581, DOI 10.1016/B978-0-12-385075-1.00025-1; Sainsbury F, 2014, CURR OPIN PLANT BIOL, V19, P1, DOI 10.1016/j.pbi.2014.02.003; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stewart CN, 2011, PLANT TRANSFORMATION; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	15	12	12	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					162	163		10.1126/science.1261140	http://dx.doi.org/10.1126/science.1261140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3VL	25301601				2022-12-01	WOS:000342721500018
J	Zhou, Y; Liu, X; Engstrom, EM; Nimchuk, ZL; Pruneda-Paz, JL; Tarr, PT; Yan, A; Kay, SA; Meyerowitz, EM				Zhou, Yun; Liu, Xing; Engstrom, Eric M.; Nimchuk, Zachary L.; Pruneda-Paz, Jose L.; Tarr, Paul T.; Yan, An; Kay, Steve A.; Meyerowitz, Elliot M.			Control of plant stem cell function by conserved interacting transcriptional regulators	NATURE			English	Article							ARABIDOPSIS SHOOT MERISTEMS; GENE-EXPRESSION; PROTEIN; WUSCHEL; PATTERNS; MAINTENANCE; HOMEOSTASIS; NICHES; FATE; APEX	Plant stem cells in the shoot apical meristem (SAM) and root apical meristem are necessary for postembryonic development of above-ground tissues and roots, respectively, while secondary vascular stem cells sustain vascular development(1-4). WUSCHEL (WUS), a homeodomain transcription factor expressed in the rib meristem of the Arabidopsis SAM, is a key regulatory factor controlling SAM stem cell populations(5,6), and is thought to establish the shoot stem cell niche through a feedback circuit involving the CLAVATA3 (CLV3) peptide signalling pathway(7). WUSCHEL-RELATED HOMEOBOX 5 (WOX5), which is specifically expressed in the root quiescent centre, defines quiescent centre identity and functions interchangeably with WUS in the control of shoot and root stem cell niches(8). WOX4, expressed in Arabidopsisprocambial cells, defines the vascular stem cell niche(9-11). WUS/WOX family proteins are evolutionarily and functionally conserved throughout the plant kingdom(1,2) and emerge as key actors in the specification and maintenance of stem cells within all meristems13. However, the nature of the genetic regime in stem cell niches that centre on WOX gene function has been elusive, and molecular links underlying conserved WUS/WOX function in stem cell niches remain unknown. Here we demonstrate that the Arabidopsis HAIRY MERISTEM (HAM) family of transcription regulators act as conserved interacting cofactors with WUS/WOX proteins. HAM and WUS share common targets in vivo and their physical interaction is important in driving downstream transcriptional programs and in promoting shoot stem cell proliferation. Differences in the overlapping expression patterns of WOX and HAM family members underlie the formation of diverse stem cell niche locations, and the HAM family is essential for all of these stem cell niches. These findings establish a new framework for the control of stem cell production during plant development.	[Zhou, Yun; Liu, Xing; Nimchuk, Zachary L.; Tarr, Paul T.; Yan, An; Meyerowitz, Elliot M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Engstrom, Eric M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; [Nimchuk, Zachary L.; Meyerowitz, Elliot M.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Pruneda-Paz, Jose L.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Kay, Steve A.] Univ So Calif, Dept Biol Sci, Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	California Institute of Technology; William & Mary; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Southern California	Meyerowitz, EM (corresponding author), CALTECH, Div Biol, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	meyerow@caltech.edu	Meyerowitz, Elliot M/A-7118-2009; Zhou, Yun/B-5542-2013; Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Liu, Xing/0000-0001-9677-4470; Zhou, Yun/0000-0003-4105-5174	National Institutes of Health (NIH) [R01 GM104244]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3406]; NIH [GM094212, GM056006, GM067837]; Jane Coffin Childs (JCC) Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067837, R01GM104244, RC2GM092412, R01GM056006, R37GM067837, R00GM094212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs (JCC) Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to R. Deshaies for his support with the protein purification and pull-down experiments, to D. Rees for sharing the 96-well format luminometer, to T. Laux, T. Greb and X. Deng for sharing published reagents, to K. Sugimoto and A. Roeder for help with the histology experiments and critical reading of the manuscript, to A. Sampathkumar for the suggestion of confocal imaging, and to A. Garda and L. Wang for technical support. Scanning electron microscopy was performed at the Applied Research Center of the College of William and Mary with technical assistance from B. Robertson. This work was funded by National Institutes of Health (NIH) grant R01 GM104244 and by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (through grant GBMF3406) to E.M.M., by a Caltech Gosney Postdoctoral Fellowship to Y.Z., by NIH grants GM094212,GM056006 and GM067837 to S.A.K., and was aided by a grant from The Jane Coffin Childs (JCC) Memorial Fund for Medical Research to X.L., a JCC fellow.	Barrell PJ, 2006, BIOTECHNIQUES, V41, P708, DOI 10.2144/000112306; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dinneny JR, 2008, CELL, V132, P553, DOI 10.1016/j.cell.2008.02.001; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Graf P, 2010, PLANT CELL, V22, P716, DOI 10.1105/tpc.109.068296; Harper S., 2008, CURR PROTOC PROTEIN, P661; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Huang X, 2012, PLANT CELL, V24, P4590, DOI 10.1105/tpc.112.103994; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Laux T, 1996, DEVELOPMENT, V122, P87; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Miyashima S, 2013, EMBO J, V32, P178, DOI 10.1038/emboj.2012.301; Nardmann J, 2009, MOL BIOL EVOL, V26, P1745, DOI 10.1093/molbev/msp084; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Suer S, 2011, PLANT CELL, V23, P3247, DOI 10.1105/tpc.111.087874; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511	41	147	161	14	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					377	U528		10.1038/nature13853	http://dx.doi.org/10.1038/nature13853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363783	Green Accepted, Green Published			2022-12-01	WOS:000347810300048
J	Liu, D; Xu, HP; Shih, CM; Wan, ZR; Ma, XP; Ma, WW; Luo, D; Qi, H				Liu, Dan; Xu, Heping; Shih, Changming; Wan, Zurong; Ma, Xiaopeng; Ma, Weiwei; Luo, Dan; Qi, Hai			T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction	NATURE			English	Article							FOLLICULAR HELPER-CELL; AFFINITY MATURATION; MEMORY; DIFFERENTIATION; ACTIVATION; SELECTION; EFFECTOR; SURFACE; LIGAND	The germinal centre(GC) reaction supports affinity-based B-cell competition and generates high-affinity bone-marrow plasma cells (BMPCs)(1,2). How follicular T-helper (T-FH) cells regulate GC selection is not clear(3,4). Using competitive mixed chimaera, we show here that, beyond the role in promoting T-FH development(5-7), ICOSL (inducible T-cell co-stimulator ligand, also known as ICOSLG) is important for individual B cells to competitively participate in the GC reaction and to develop into BMPCs. Using intravital imaging aided by a calcium reporter, we further show that ICOSL promotes an 'entangled' mode of T-FH-B-cell interactions, characterized by brief but extensive surface engagement, productive T-cell calcium spikes, and B-cell acquisition of CD40 signals. Reiterated entanglement promotes outer-zone co-localization of outcompeting GC B cells together with T-FH cells, affording the former increased access to T-cell help. ICOSL on GC B cells is upregulated by CD40 signals. Such an intercellular positive feedback between contact-dependent help and ICOSL-controlled entanglement promotes positive selection and BMPC development, as evidenced by observations that higher-affinity B-cell receptor variants are enriched in the ICOSLhigh fraction, that numerically disadvantaged ICOSL-deficient GC B cells or BMPCs exhibit strong affinity compensation in competitive chimaera, and that when GC competition proceeds without ICOSL, selection of high-affinity variants in otherwise normal GC reactions is impaired. By demonstrating entanglement as the basic form of GC T-FH-B-cell interactions, identifying ICOSL as a molecular linkage between T-B interactional dynamics and positive selection for high-affinity BMPC formation, our study reveals a pathway by which T-FH cells control the quality of long-lived humoral immunity.	[Liu, Dan; Xu, Heping; Shih, Changming; Wan, Zurong; Ma, Weiwei; Luo, Dan; Qi, Hai] Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Ma, Xiaopeng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Qi, H (corresponding author), Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	qihai@tsinghua.edu.cn		Qi, Hai/0000-0001-5475-3989; Xu, Heping/0000-0003-2149-7004	Ministry of Science and Technology '973' program [2014CB542501]; National Natural Science Foundation of China [81330070, 81361120397]; Tsinghua University Initiative Scientific Research Program [20131089224]; Institut Merieux; Tsinghua-Peking Center for Life Sciences	Ministry of Science and Technology '973' program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Institut Merieux; Tsinghua-Peking Center for Life Sciences	We thank L. and M. McHeyzer-Williams for providing the V<INF>H</INF> gene analysis protocol, T. Nagai for YC-Nano reporter constructs<SUP>9</SUP>, and H. Wekerle for the Twitch-1<SUP>CD</SUP> reporter construct<SUP>10</SUP>. H.Q. is indebted to Y. Hong for support. H.Q. was a Tsinghua-Bayer Investigator and a Tsinghua-Janssen Investigator. This work was funded in part by the Ministry of Science and Technology '973' program (2014CB542501), National Natural Science Foundation of China (81330070 and 81361120397), Tsinghua University Initiative Scientific Research Program (20131089224), Institut Merieux, and the Tsinghua-Peking Center for Life Sciences.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mues M, 2013, NAT MED, V19, P778, DOI 10.1038/nm.3180; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weinstein JS, 2014, J IMMUNOL, V192, P3166, DOI 10.4049/jimmunol.1302617; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	19	240	254	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					214	U241		10.1038/nature13803	http://dx.doi.org/10.1038/nature13803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25317561				2022-12-01	WOS:000347477600039
J	Brunner, JD; Lim, NK; Schenck, S; Duerst, A; Dutzler, R				Brunner, Janine D.; Lim, Novandy K.; Schenck, Stephan; Duerst, Alessia; Dutzler, Raimund			X-ray structure of a calcium-activated TMEM16 lipid scramblase	NATURE			English	Article							CA2+-ACTIVATED CL-CHANNEL; CHLORIDE CHANNEL; PROTEIN; FAMILY; IDENTIFICATION; SUBSTRUCTURE; PURIFICATION; TRANSPORTER; PRECURSORS; SOFTWARE	The TMEM16 family of proteins, also known as anoctamins, features a remarkable functional diversity. This family contains the long sought-after Ca2+-activated chloride channels as well as lipid scramblases and cation channels. Here we present the crystal structure of a TMEM16 family member from the fungus Nectria haematococca that operates as a Ca2+-activated lipid scramblase. Each subunit of the homodimeric protein contains ten transmembrane helices and a hydrophilic membrane-traversing cavity that is exposed to the lipid bilayer as a potential site of catalysis. This cavity harbours a conserved Ca2+-binding site located within the hydrophobic core of the membrane. Mutations of residues involved in Ca2+ coordination affect both lipid scrambling in N. haematococca TMEM16 and ion conduction in the Cl- channel TMEM16A. The structure reveals the general architecture of the family and its mode of Ca2+ activation. It also provides insight into potential scrambling mechanisms and serves as a framework to unravel the conduction of ions in certain TMEM16 proteins.	[Brunner, Janine D.; Lim, Novandy K.; Schenck, Stephan; Duerst, Alessia; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch	Brunner, Janine/AAJ-5628-2020; Brunner, Janine/AAL-5584-2021	Brunner, Janine/0000-0003-4237-9322	European Research Council (AnoBest) [339116]; Swiss National Science Foundation through the National Centre of Competence in Research TransCure	European Research Council (AnoBest); Swiss National Science Foundation through the National Centre of Competence in Research TransCure	This research was supported by a grant from the European Research Council (no. 339116, AnoBest) and by the Swiss National Science Foundation through the National Centre of Competence in Research TransCure. We thank the staff of the X06SA beamline for support during data collection, B. Blattman and C. Stutz-Ducommun of the Protein Crystallization Center at UZH, for their support with crystallization, B. Dreier for help with MALS experiments, A. Szydelko for providing ecClC as negative control in the scramblase assay and D. Drew for the FGY217 yeast strain. All members of the Dutzler laboratory are acknowledged for help in all stages of the project.	Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Dekkers DWC, 2002, BIOCHEM J, V362, P741, DOI 10.1042/0264-6021:3620741; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Ferrera L, 2011, COMPR PHYSIOL, V1, P2155, DOI 10.1002/cphy.c110017; Garcia-Celma J, 2013, J GEN PHYSIOL, V141, P479, DOI 10.1085/jgp.201210927; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ni YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086734; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	67	289	291	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					207	+		10.1038/nature13984	http://dx.doi.org/10.1038/nature13984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25383531				2022-12-01	WOS:000346383500036
J	Brohawn, SG; Campbell, EB; MacKinnon, R				Brohawn, Stephen G.; Campbell, Ernest B.; MacKinnon, Roderick			Physical mechanism for gating and mechano sensitivity of the human TRAAK K+ channel	NATURE			English	Article							MECHANOSENSITIVE CHANNELS; CRYSTAL-STRUCTURE; LIPID-BILAYER; TREK-1; PORE; MEMBRANE; PROTEIN; MODEL; MSCL	Activation of mechanosensitive ion channels by physical force underlies many physiological processes including the sensation of touch, hearing and pain(1-5). TRAAK (also known as KCNK4) ion channels are neuronally expressed members of the two-pore domain K+ (K2P) channel family and are mechano sensitive'. They are involved in controlling mechanical and temperature nociception in mice'. Mechanosensitivity of TRAAK is mediated directly through the lipid bilayer it is a membrane-tension-gated channel'. However, the molecular mechanism of TRAAK channel gating and mechanosensitivity is unknown. Here we present crystal structures of TRAAK in conductive and non-conductive conformations defined by the presence of permeant ions along the conduction pathway. In the non-conductive state, a lipid acyl chain accesses the channel cavity through a 5 Awide lateral opening in the membrane inner leaflet and physically blocks ion passage. In the conductive state, rotation of a transmembrane helix (TM4) about a central hinge seals the intramembrane opening, preventing lipid block of the cavity and permitting ion entry. Additional rotation of a membrane interacting TM2-TM 3 segment, unique to mechanosensitive K2Ps, against TM4 may further stabilize the conductive conformation. Comparison of the structures reveals a biophysical explanation for TRAAK mechanosensitivity an expansion in cross-sectional area up to 2.7 nm(2) in the conductive state is expected to create a membrane-tension-dependent energy difference between conformations that promotes force activation. Our results show how tension of the lipid bilayer can be harnessed to control gating and mechanosensitivity of a eukaryotic ion channel.	[Brohawn, Stephen G.; Campbell, Ernest B.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Brohawn, Stephen G.; Campbell, Ernest B.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu		Brohawn, Stephen/0000-0001-6768-3406	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bautista DM, 2011, J GEN PHYSIOL, V138, P291, DOI 10.1085/jgp.201110637; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Harinath S, 2004, NEUROPHARMACOLOGY, V46, P750, DOI 10.1016/j.neuropharm.2003.11.023; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2006, P NATL ACAD SCI USA, V103, P6859, DOI 10.1073/pnas.0600463103; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Maksaev G, 2011, CHANNELS, V5, P34, DOI 10.4161/chan.5.1.13906; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Ursell Tristan, 2008, V1, P37, DOI 10.1007/978-1-4020-6426-5_2	40	181	184	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					126	U345		10.1038/nature14013	http://dx.doi.org/10.1038/nature14013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471887	Green Accepted, Green Submitted			2022-12-01	WOS:000346310800053
J	Steuber, J; Vohl, G; Casutt, MS; Vorburger, T; Diederichs, K; Fritz, G				Steuber, Julia; Vohl, Georg; Casutt, Marco S.; Vorburger, Thomas; Diederichs, Kay; Fritz, Guenter			Structure of the V. cholerae Na+-pumping NADH:quinone oxidoreductase	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; CRYSTAL-STRUCTURE; VIBRIO-CHOLERAE; NQRC SUBUNITS; PROTEIN; CRYSTALLIZATION; MECHANISM; ELECTRON	NADH oxidation in the respiratory chain is coupled to ion translocation across the membrane to build up an electrochemical gradient. The sodium -translocattng NADH:quinone oxidoreductase (Na+-NQR), amembrane protein complex widespread among pathogenic bacteria' consists of six subunits, NqrA, B, C, D, E and F. our knowledge, no structural information on the Na+-NQR complex has been available until now. Here we present the crystal structure of the Na+-NQR complex at 3.5 angstrom resolution. The arrangement of cofactors both at the cytoplasmic and the periplastnic side of the complex, together with a hitherto unknown iron centre in the midst of the membrane-embedded part, reveals an electron transfer pathway from the NADH- oxidizing cytoplasmic NqrF subunit across the membrane to the petiplasmic NqrC, and back to the qui none reduction site on NqrA located in the cytoplasm. A soditun channel was localized in subunit Nqr13, which represents the largest membrane subunit of the Na+-NQR and is structurally related to urea and ammonia transporters. On the basis of the structure we propose a mechanism of redox-driven Na+ translocation where the change in redox state of the flavin mononucleotide cofactor in NqrB triggers the transport of Na+ through the observed channel.	[Steuber, Julia; Vorburger, Thomas] Univ Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany; [Vohl, Georg; Casutt, Marco S.; Fritz, Guenter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Vohl, Georg] Univ Freiburg, Hermann Staudinger Grad Sch, D-79104 Freiburg, Germany; [Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University Hohenheim; University of Freiburg; University of Freiburg; University of Konstanz	Fritz, G (corresponding author), Univ Freiburg, Inst Neuropathol, Breisacher Str 64, D-79106 Freiburg, Germany.	guenter.fritz@uniklinik-freiburg.de	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812	'Methoden in den Lebenswissenschaften' of the Baden-Wurttemberg Stiftung P-LS-Meth/4; Deutsche Forschungsgemeinschaft [FR 1321/3-1, FR 1488/3-2]	'Methoden in den Lebenswissenschaften' of the Baden-Wurttemberg Stiftung P-LS-Meth/4; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the staff at beamlines X06SA and X06DA at Swiss Light Source for excellent support. This work was supported by contract research 'Methoden in den Lebenswissenschaften' of the Baden-Wurttemberg Stiftung P-LS-Meth/4 (to J.S. and G.F.), and by the Deutsche Forschungsgemeinschaft grant FR 1321/3-1 (to J.S.) and grant FR 1488/3-2 (to G.F.). We thank Y. Obermaier for expression and preparation of Na<SUP>+</SUP>-NQR.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bertsova YV, 2013, J BIOL CHEM, V288, P14276, DOI 10.1074/jbc.M113.455402; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Casutt MS, 2012, BBA-BIOENERGETICS, V1817, P1817, DOI 10.1016/j.bbabio.2012.02.012; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, ACTA CRYSTALLOGR F, V66, P1677, DOI [10.1107/S1744309110043125, 10.1107/S17443091100431]; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Leung KKK, 2013, J BIOL CHEM, V288, P11242, DOI 10.1074/jbc.M113.457002; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; LLC, 2010, PYMOL MOL GRAPH SYST; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verkhovsky MI, 2012, BIOCHEMISTRY-US, V51, P5414, DOI 10.1021/bi300322n; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Vohl G, 2014, ACTA CRYSTALLOGR F, V70, P987, DOI 10.1107/S2053230X14009881; Wacker T, 2014, P NATL ACAD SCI USA, V111, P9995, DOI 10.1073/pnas.1406409111; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu WD, 2003, BIOCHEMISTRY-US, V42, P5469, DOI 10.1021/bi0272196	56	89	90	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					62	U379		10.1038/nature14003	http://dx.doi.org/10.1038/nature14003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471880	Green Submitted			2022-12-01	WOS:000346310800038
J	Wolchok, JD; Chan, TA				Wolchok, Jedd D.; Chan, Timothy A.			CANCER Antitumour immunity gets a boost	NATURE			English	Editorial Material							ADVANCED MELANOMA; SAFETY; IMMUNOGENICITY; IPILIMUMAB; ANTI-PD-1; SURVIVAL; ANTIBODY; REVEALS		[Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	wolchokj@mskcc.org	Chan, Timothy A/ABD-5850-2021		NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Coley W. B., 1910, P ROY SOC MED, V3, P1, DOI DOI 10.1177/003591571000301601; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Snyder A, 2014, N ENGL J MED; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wolchok JD, 2013, ANN ONCOL, V24, P2174, DOI 10.1093/annonc/mdt161; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	21	81	89	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					496	498		10.1038/515496a	http://dx.doi.org/10.1038/515496a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25428495	Green Accepted			2022-12-01	WOS:000346247600038
J	Yadav, M; Jhunjhunwala, S; Phung, QT; Lupardus, P; Tanguay, J; Bumbaca, S; Franci, C; Cheung, TK; Fritsche, J; Weinschenk, T; Modrusan, Z; Mellman, I; Lill, JR; Delamarre, L				Yadav, Mahesh; Jhunjhunwala, Suchit; Phung, Qui T.; Lupardus, Patrick; Tanguay, Joshua; Bumbaca, Stephanie; Franci, Christian; Cheung, Tommy K.; Fritsche, Jens; Weinschenk, Toni; Modrusan, Zora; Mellman, Ira; Lill, Jennie R.; Delamarre, Lelia			Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing	NATURE			English	Article							T-CELL EXHAUSTION; ANALYSIS REVEALS; PROSTATE-CANCER; UP-REGULATION; PEPTIDES; PD-1; ANTIGENS; PATIENT; MICROENVIRONMENT; SURVEILLANCE	Human tumours typically harbour a remarkable number of somatic mutations(1). If presented on major histocompatibility complex class I molecules (MHCI), peptides containing these mutations could potentially be immunogenic as they should be recognized as 'non-self neo-antigens by the adaptive immune system. Recent work has confirmed that mutant peptides can serve as T-cell epitopes'. However, few mutant epitopes have been described because their discovery required the laborious screening of patient tumour-infiltrating lymphocytes for their ability to recognize antigen libraries constructed following tumour exome sequencing. We sought to simplify the discovery of immunogenic mutant peptides by characterizing their general properties. We developed an approach that combines whole-exome and transcriptome sequencing analysis with mass spectrometry to identify neo-epitopes in two widely used murine tumour models. Of the >1,300 amino acid changes identified, 13% were predicted to bind MH CI, a small fraction of which were confirmed by mass spectrometry. The peptides were then structurally modelled bound to MHCI. Mutations that were solvent-exposed and therefore accessible to T-cell antigen receptors were predicted to be immunogenic. Vaccination of mice confirmed the approach, with each predicted immunogenic peptide yielding therapeutically active T-cell responses. The predictions also enabled the generation of peptide-MHCI dextramers that could be used to monitor the kinetics and distribution of the anti-tumour T-cell response before and after vaccination. These findings indicate that a suitable prediction algorithm may provide an approach for the pharmacodynamic monitoring of T-cell responses as well as for the development of personalized vaccines in cancer patients.	[Yadav, Mahesh; Jhunjhunwala, Suchit; Phung, Qui T.; Lupardus, Patrick; Tanguay, Joshua; Bumbaca, Stephanie; Franci, Christian; Cheung, Tommy K.; Modrusan, Zora; Mellman, Ira; Lill, Jennie R.; Delamarre, Lelia] Genentech Inc, San Francisco, CA 94080 USA; [Fritsche, Jens; Weinschenk, Toni] Immat Biotechnol GmbH, D-72076 Tubingen, Germany	Roche Holding; Genentech; Immatics Biotechnologies GmbH	Delamarre, L (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	lill.jennie@gene.com; delamarre.lelia@gene.com	Mellman, Ira/ABG-5896-2020; Jhunjhunwala, Suchit/GNH-2256-2022	Jhunjhunwala, Suchit/0000-0003-3484-0588; Fritsche, J./0000-0002-5557-8577				Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bertsch E, 2014, MODERN PATHOL, V27, P1144, DOI 10.1038/modpathol.2013.243; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Butler NS, 2008, J IMMUNOL, V180, P3926, DOI 10.4049/jimmunol.180.6.3926; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Granados DP, 2012, BLOOD, V119, pE181, DOI 10.1182/blood-2012-02-412593; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gujar SA, 2011, MOL THER, V19, P797, DOI 10.1038/mt.2010.297; Jin HT, 2011, CURR TOP MICROBIOL, V350, P17, DOI 10.1007/82_2010_116; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ostrov DA, 2002, J IMMUNOL, V168, P283, DOI 10.4049/jimmunol.168.1.283; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SETTE A, 1994, J IMMUNOL, V153, P5586; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang B, 2002, J IMMUNOL, V169, P3137, DOI 10.4049/jimmunol.169.6.3137; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wick DA, 2014, CLIN CANCER RES, V20, P1125, DOI 10.1158/1078-0432.CCR-13-2147; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	38	755	821	2	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					572	+		10.1038/nature14001	http://dx.doi.org/10.1038/nature14001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428506				2022-12-01	WOS:000346247600055
J	Biba, E				Biba, Erin			The sunscreen pill	NATURE			English	Editorial Material							HUMAN SKIN; EXTRACT; DAMAGE											Gonzalez S, 1997, PHOTODERMATOL PHOTO, V13, P50, DOI 10.1111/j.1600-0781.1997.tb00108.x; Middelkamp-Hup MA, 2004, J AM ACAD DERMATOL, V51, P910, DOI 10.1016/j.jaad.2004.06.027; Middelkamp-Hup MA, 2004, J AM ACAD DERMATOL, V50, P41, DOI 10.1016/S0190-9622(03)02732-4; Palombo P, 2007, SKIN PHARMACOL PHYS, V20, P199, DOI 10.1159/000101807; Zattra E, 2009, AM J PATHOL, V175, P1952, DOI 10.2353/ajpath.2009.090351	5	12	12	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S124	S125		10.1038/515S124a	http://dx.doi.org/10.1038/515S124a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407711				2022-12-01	WOS:000345770600007
J	Rolland, T; Tasan, M; Charloteaux, B; Pevzner, SJ; Zhong, Q; Sahni, N; Yi, S; Lemmens, I; Fontanillo, C; Mosca, R; Kamburov, A; Ghiassian, SD; Yang, XP; Ghamsari, L; Balcha, D; Begg, BE; Braun, P; Brehme, M; Broly, MP; Carvunis, AR; Convery-Zupan, D; Corominas, R; Coulombe-Huntington, J; Dann, E; Dreze, M; Dricot, A; Fan, CY; Franzosa, E; Gebreab, F; Gutierrez, BJ; Hardy, MF; Jin, M; Kang, SL; Kiros, R; Lin, GN; Luck, K; MacWilliams, A; Menche, JR; Murray, RR; Palagi, A; Poulin, MM; Rambout, X; Rasla, J; Reichert, P; Romero, V; Ruyssinck, E; Sahalie, JM; Scholz, A; Shah, AA; Sharma, A; Shen, Y; Spirohn, K; Tam, S; Tejeda, AO; Trigg, SA; Twizere, JC; Vega, K; Walsh, J; Cusick, ME; Xia, Y; Barabasi, AL; Iakoucheva, LM; Aloy, P; De Las Rivas, J; Tavernier, J; Calderwood, MA; Hill, DE; Hao, T; Roth, FP; Vidal, M				Rolland, Thomas; Tasan, Murat; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Lemmens, Irma; Fontanillo, Celia; Mosca, Roberto; Kamburov, Atanas; Ghiassian, Susan D.; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Corominas, Roser; Coulombe-Huntington, Jasmin; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Franzosa, Eric; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kang, Shuli; Kiros, Ruth; Lin, Guan Ning; Luck, Katja; MacWilliams, Andrew; Menche, Joerg; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Ruyssinck, Elien; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Sharma, Amitabh; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Xia, Yu; Barabasi, Albert-Laszlo; Iakoucheva, Lilia M.; Aloy, Patrick; De Las Rivas, Javier; Tavernier, Jan; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc			A Proteome-Scale Map of the Human Interactome Network	CELL			English	Article							MOLECULAR INTERACTION DATABASE; GENOME-WIDE ASSOCIATION; POSTTRANSLATIONAL MODIFICATIONS; COMPREHENSIVE RESOURCE; HUMAN-DISEASE; CANCER GENES; UPDATE; EXPRESSION; PROTEINS; DISORDERS	Just as reference genome sequences revolutionized human genetics, reference maps of interactome networks will be critical to fully understand geno-type- phenotype relationships. Here, we describe a systematic map of similar to 14,000 high-quality human binary protein-protein interactions. At equal quality, this map is similar to 30% larger than what is available from small-scale studies published in the literature in the last few decades. While currently available information is highly biased and only covers a relatively small portion of the proteome, our systematic map appears strikingly more homogeneous, revealing a "broader'' human interactome network than currently appreciated. The map also uncovers significant inter-connectivity between known and candidate cancer gene products, providing unbiased evidence for an expanded functional cancer landscape, while demonstrating how high-quality interactome models will help "connect the dots'' of the genomic revolution.	[Rolland, Thomas; Tasan, Murat; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Kamburov, Atanas; Ghiassian, Susan D.; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Coulombe-Huntington, Jasmin; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Franzosa, Eric; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kiros, Ruth; Luck, Katja; MacWilliams, Andrew; Menche, Joerg; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Sharma, Amitabh; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Xia, Yu; Barabasi, Albert-Laszlo; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA; [Rolland, Thomas; Tasan, Murat; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Kamburov, Atanas; Ghiassian, Susan D.; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Coulombe-Huntington, Jasmin; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Franzosa, Eric; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kiros, Ruth; Luck, Katja; MacWilliams, Andrew; Menche, Joerg; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Sharma, Amitabh; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Xia, Yu; Barabasi, Albert-Laszlo; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Rolland, Thomas; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Kamburov, Atanas; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kiros, Ruth; Lin, Guan Ning; Luck, Katja; MacWilliams, Andrew; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tasan, Murat; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Tasan, Murat; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Tasan, Murat; Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Tasan, Murat; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pevzner, Samuel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Zhong, Quan] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Lemmens, Irma; Ruyssinck, Elien; Tavernier, Jan] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Fontanillo, Celia; De Las Rivas, Javier] Univ Salamanca, Canc Res Ctr, E-37008 Salamanca, Spain; [Fontanillo, Celia; De Las Rivas, Javier] CSIC, Salamanca 37008, Spain; [Mosca, Roberto; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC Program Computat Biol, Barcelona 08028, Spain; [Menche, Joerg; Sharma, Amitabh; Barabasi, Albert-Laszlo] Northeastern Univ, CCNR, Boston, MA 02115 USA; [Menche, Joerg; Sharma, Amitabh; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Corominas, Roser; Kang, Shuli; Lin, Guan Ning; Iakoucheva, Lilia M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Coulombe-Huntington, Jasmin; Franzosa, Eric; Xia, Yu] McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Rambout, Xavier; Twizere, Jean-Claude] Univ Liege, GIGA R, Prot Signaling & Interact Lab, B-4000 Liege, Belgium; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Aloy, Patrick] ICREA, Barcelona 08010, Spain; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Boston University; Boston University; University System of Ohio; Wright State University Dayton; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Northeastern University; Northeastern University; University of California System; University of California San Diego; McGill University; University of Liege; Harvard University; Brigham & Women's Hospital; Harvard Medical School; ICREA; Canadian Institute for Advanced Research (CIFAR)	Roth, FP (corresponding author), Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA.	fritz.roth@utoronto.ca; marc_vidal@dfci.harvard.edu	Aloy, Patrick/AAB-3538-2019; Brehme, Marc/G-8697-2015; zhong, quan/AAE-8893-2021; Menche, Jörg/AAB-7008-2021; Twizere, Jean-Claude/AAG-3706-2019; Yi, Song/ABG-6526-2020; Yang, Xinping/HGA-6104-2022; Calderwood, Mike/B-2475-2014; Braun, Pascal/B-9669-2013; Xia, Yu/W-6150-2019; Menche, Jörg/G-3994-2015; Corominas, Roser/H-4163-2016; Dreze, Matija/AAZ-3293-2020; Barabasi, Albert-Laszlo/S-6474-2017; De Las Rivas, Javier/G-5936-2014; Tavernier, Jan/AAG-3636-2019; Roth, Frederick P/H-6308-2011	Brehme, Marc/0000-0003-0694-331X; Menche, Jörg/0000-0002-1583-6404; Yi, Song/0000-0003-0047-8103; Calderwood, Mike/0000-0001-6475-1418; Braun, Pascal/0000-0003-2012-6746; Xia, Yu/0000-0002-5596-5518; Menche, Jörg/0000-0002-1583-6404; Corominas, Roser/0000-0001-8888-5402; De Las Rivas, Javier/0000-0002-0984-9946; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Jin, Mike/0000-0001-7237-6697; Mosca, Roberto/0000-0002-3244-1885; Fontanillo, Celia/0000-0002-3631-7881; Trigg, Shelly/0000-0001-6904-4149; Yang, Xinping/0000-0003-4086-4180; Rolland, Thomas/0000-0001-6468-8391; /0000-0001-7002-8488; Rambout, Xavier/0000-0002-5147-2863; TWIZERE, Jean-Claude/0000-0002-8683-705X; Aloy, Patrick/0000-0002-3557-0236; Zhong, Quan/0000-0003-2910-5597; Roth, Frederick/0000-0002-6628-649X; Barabasi, Albert/0000-0002-4028-3522; Iakoucheva, Lilia/0000-0002-4542-5219; Sahni, Nidhi/0000-0002-9155-5882	NHGRI [R01/U01HG001715, P50HG004233]; NHLBI [U01HL098166, U01HL108630]; NCI [U54CA112962, R33CA132073]; NIH [RC4HG006066]; NICHD [R01HD065288, R21MH104766, R01MH105524]; NIMH [R01MH091350]; NSF [CCF-1219007]; NSERC [RGPIN-2014-03892]; Canada Excellence Research Chair; Krembil Foundation; Ontario Research Fund-Research Excellence Award; Avon Foundation; Junta de Castilla y Leon (Valladolid, Spain) [CSI07A09]; Ministerio de Economia y Competitividad (AES, ISCiii, Madrid, Spain) [PI12/00624]; Consejo Superior de Investigaciones Cientificas (CSIC, Madrid, Spain) [i-Link0398]; Spanish Ministerio de Ciencia e Innovacion [BIO2010-22073]; European Commission [306240]; Group-ID Multidisciplinary Research Partnerships of Ghent University; Fund for Scientific Research-Flanders [FWO-V G.0864.10]; ERC [340941]; EMBO long-term fellowship; Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative; ICREA Funding Source: Custom; Division of Computing and Communication Foundations [1219007] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065288] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA132073, U54CA112962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098166, U01HL108630] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC4HG006066, P50HG004233, R01HG001715, U01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104766, R01MH105524, R01MH091350] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Excellence Research Chair; Krembil Foundation; Ontario Research Fund-Research Excellence Award; Avon Foundation; Junta de Castilla y Leon (Valladolid, Spain)(Junta de Castilla y Leon); Ministerio de Economia y Competitividad (AES, ISCiii, Madrid, Spain); Consejo Superior de Investigaciones Cientificas (CSIC, Madrid, Spain); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Group-ID Multidisciplinary Research Partnerships of Ghent University; Fund for Scientific Research-Flanders(FWO); ERC(European Research Council (ERC)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative; ICREA(ICREA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors wish to acknowledge past and present members of the Center for Cancer Systems Biology (CCSB) and particularly H. Yu for helpful discussions. This work was supported primarily by NHGRI grant R01/U01HG001715 awarded to M.V., D.E.H., F.P.R., and J.T. and in part by the following grants and agencies: NHGRI P50HG004233 to M.V., F.P.R., and A.-L.B.; NHLBI U01HL098166 subaward to M.V.; NHLBI U01HL108630 subaward to A.-L. B.; NCI U54CA112962 subaward to M.V.; NCI R33CA132073 to M.V.; NIH RC4HG006066 to M.V., D.E.H., and T.H.; NICHD ARRA R01HD065288, R21MH104766, and R01MH105524 to L.M.I.; NIMH R01MH091350 to L.M.I. and T.H.; NSF CCF-1219007 and NSERC RGPIN-2014-03892 to Y.X.; Canada Excellence Research Chair, Krembil Foundation, Ontario Research Fund-Research Excellence Award, Avon Foundation, grant CSI07A09 from Junta de Castilla y Leon (Valladolid, Spain), grant PI12/00624 from Ministerio de Economia y Competitividad (AES 2012, ISCiii, Madrid, Spain), and grant i-Link0398 from Consejo Superior de Investigaciones Cientificas (CSIC, Madrid, Spain) to J.D.L.R.; Spanish Ministerio de Ciencia e Innovacion (BIO2010-22073) and the European Commission through the FP7 project SyStemAge grant agreement n:306240 to P.A.; Group-ID Multidisciplinary Research Partnerships of Ghent University, grant FWO-V G.0864.10 from the Fund for Scientific Research-Flanders and ERC Advanced Grant No 340941 to J.T.; EMBO long-term fellowship to A.K.; Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative to M.V. I.L. is a postdoctoral fellow with the FWO-V. M.V. is a "Chercheur Qualifie Honoraire'' from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation, Belgium). Since performing the work described, C. Fontanillo has become an employee of Celgene Research SL, part of the Celgene Corporation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Caufield JH, 2012, METHODS, V58, P317, DOI 10.1016/j.ymeth.2012.12.001; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kornblau SM, 2011, BLOOD, V118, P5604, DOI 10.1182/blood-2011-04-348052; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Loveys DA, 1996, NUCLEIC ACIDS RES, V24, P2813, DOI 10.1093/nar/24.14.2813; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Woodsmith J, 2014, CURR OPIN STRUC BIOL, V24, P34, DOI 10.1016/j.sbi.2013.11.009; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	56	831	847	7	240	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1212	1226		10.1016/j.cell.2014.10.050	http://dx.doi.org/10.1016/j.cell.2014.10.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416956	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000345506300029
J	Ritchey, MD; Loustalot, F; Bowman, BA; Hong, YL				Ritchey, Matthew D.; Loustalot, Fleetwood; Bowman, Barbara A.; Hong, Yuling			Trends in Mortality Rates by Subtypes of Heart Disease in the United States, 2000-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ritchey, Matthew D.; Loustalot, Fleetwood; Bowman, Barbara A.; Hong, Yuling] US Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Ritchey, MD (corresponding author), US Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	hha7@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Coady SA, 2001, J CLIN EPIDEMIOL, V54, P40, DOI 10.1016/S0895-4356(00)00272-9; Georgiopoulou VV, 2010, CARDIOL CLIN, V28, P675, DOI 10.1016/j.ccl.2010.07.005; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; US Centers for Disease Control and Prevention, UND CAUS DEATH 1999; World Health Organization, 2010, INT STAT CLASS DIS R, DOI 10/2010/en	6	21	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2037	2039		10.1001/jama.2014.11344	http://dx.doi.org/10.1001/jama.2014.11344			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399281	Green Accepted, Bronze			2022-12-01	WOS:000345450500020
J	Goel, SS; Aksoy, O; Gupta, S; Houghtaling, PL; Tuzcu, EM; Marwick, T; Mihaljevic, T; Svensson, L; Blackstone, EH; Griffin, BP; Stewart, WJ; Barzilai, B; Menon, V; Kapadia, SR				Goel, Sachin S.; Aksoy, Olcay; Gupta, Supriya; Houghtaling, Penny L.; Tuzcu, E. Murat; Marwick, Thomas; Mihaljevic, Tomislav; Svensson, Lars; Blackstone, Eugene H.; Griffin, Brian P.; Stewart, William J.; Barzilai, Benico; Menon, Venu; Kapadia, Samir R.			Renin-Angiotensin System Blockade Therapy After Surgical Aortic Valve Replacement for Severe Aortic Stenosis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR MASS; CONVERTING-ENZYME-INHIBITORS; HEART-FAILURE; MYOCARDIAL FIBROSIS; DYSFUNCTION; REGRESSION; HYPERTROPHY; ECHOCARDIOGRAPHY; CANDESARTAN; INFARCTION	Background: Data are lacking on the effect of renin-angiotensin system (RAS) blockade therapy with angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers after surgical aortic valve replacement (SAVR) for severe aortic stenosis (AS). Objective: To investigate the association between RAS blockade therapy and outcomes after SAVR for severe AS. Design: Retrospective study. Setting: Single tertiary referral care center. Patients: Patients who were prescribed angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers after SAVR for severe AS between 1991 and 2010 who had at least 2 refills 90 days apart and at least a 6-month follow-up constituted the RAS blockade group (n = 741). Patients who did not receive these prescriptions were in the untreated group (n = 1011). Unadjusted and propensity-matched analyses (594 matched pairs of treated and untreated patients) were performed. Measurements: The primary outcome was survival rates after SAVR. Secondary end points were changes in left ventricular mass index, left ventricular ejection fraction, and left atrial size. Results: Overall unadjusted estimated survival rates at 1, 5, and 10 years were significantly greater in the RAS blockade group than in the non-RAS blockade group (99%, 90%, and 60% vs. 99%, 81%, and 53%, respectively; P < 0.001). Among propensity-matched patients, estimated survival rates at 1, 5, and 10 years remained significantly greater in the RAS blockade group than in the non-RAS blockade group (99%, 90%, and 71% vs. 96%, 78%, and 49%, respectively; P < 0.001). For the matched cohorts, the groups did not significantly differ in the change in left ventricular mass index (P = 0.37), left ventricular ejection fraction (P = 0.67), or left atrial size (P = 0.43) after SAVR on echocardiographic analysis. Limitation: Retrospective, single-center analysis. Conclusion: Renin-angiotensin system blockade therapy is associated with increased survival rates in patients after SAVR for severe AS. A randomized trial of RAS blockade therapy after SAVR should be considered.	[Kapadia, Samir R.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Cleveland Clinic Foundation; University of Tasmania; Menzies Institute for Medical Research	Kapadia, SR (corresponding author), Cleveland Clin Fdn, J2-3,9500 Euclid Ave, Cleveland, OH 44195 USA.	kapadis@ccf.org	Marwick, Thomas/AAK-3869-2021; Menon, Venu/AAF-1871-2019; Goel, Sachin/AAD-4137-2019	Marwick, Thomas/0000-0001-9065-0899; 				Abramov D, 2010, ECHOCARDIOGR-J CARD, V27, P223, DOI 10.1111/j.1540-8175.2009.01004.x; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; BERGSTRALH EJ, 1995, 56 MAY FDN; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2002.120329; Blackstone EH, 2001, J THORAC CARDIOV SUR, V122, P430, DOI 10.1067/mtc.2001.117536; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breitenbach I, 2012, J THORAC CARDIOV SUR, V144, P640, DOI 10.1016/j.jtcvs.2011.11.017; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Cleveland Clinic, THE HAZ PACK; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Dahl JS, 2010, AM J CARDIOL, V106, P713, DOI 10.1016/j.amjcard.2010.04.028; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diggle P. J., 2002, J R STAT SOC, V2nd, DOI DOI 10.2307/2983303; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P598, DOI 10.1016/S0735-1097(98)00609-3; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Gjertsson P, 2005, J THORAC CARDIOV SUR, V129, P890, DOI 10.1016/j.jtcvs.2004.09.004; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; KRAYENBUEHL HP, 1989, CIRCULATION, V79, P744, DOI 10.1161/01.CIR.79.4.744; Lim E, 2008, ANN THORAC SURG, V85, P2026, DOI 10.1016/j.athoracsur.2008.02.023; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; Lund O, 2004, J HEART VALVE DIS, V13, P357; Mason DP, 2008, ANN THORAC SURG, V85, P1193, DOI 10.1016/j.athoracsur.2007.12.023; Mitra R, 2012, STAT METHODS MED RES; Nadir MA, 2011, J AM COLL CARDIOL, V58, P570, DOI 10.1016/j.jacc.2011.01.063; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Rajeswaran J, 2014, STAT METHODS MED RES; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P145	39	25	25	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					699	U149		10.7326/M13-1505	http://dx.doi.org/10.7326/M13-1505			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25402513				2022-12-01	WOS:000347245600027
J	Ryskina, KL; Korenstein, D; Weissman, A; Masters, P; Alguire, P; Smith, CD				Ryskina, Kira L.; Korenstein, Deborah; Weissman, Arlene; Masters, Philip; Alguire, Patrick; Smith, Cynthia D.			Development of a High-Value Care Subscore on the Internal Medicine In-Training Examination	ANNALS OF INTERNAL MEDICINE			English	Article							COST-CONSCIOUS CARE; TEACHING HIGH-VALUE; RESIDENTS; COMPETENCE; PHYSICIANS; VIGNETTES	Background: Although high-value care (HVC) that balances benefits of tests or treatments against potential harms and costs has been a recently emphasized competency for internal medicine (IM) residents, few tools to assess residents' knowledge of HVC are available. Objective: To describe the development and initial results of an HVC subscore of the Internal Medicine In-Training Examination (IM-ITE). Design: The HVC concepts were introduced to IM-ITE authors during question development. Three physicians independently reviewed each examination question for selection in the HVC subscore according to 6 HVC principles. The final subscore was determined by consensus. Data from the IM-ITE administered in October 2012 were analyzed at the program level. Setting: U.S. IM residency programs. Participants: 362 U.S. IM residency programs with IM-ITE data for at least 10 residents. Measurements: Program-level performance on the HVC subscore was compared with performance on the overall IM-ITE, the Dartmouth Atlas hospital care intensity (HCI) index of the program's primary training hospital, and residents' attitudes about HVC assessed with a voluntary survey. Results: The HVC subscore comprised 38 questions, including 21 (55%) on managing conservatively when appropriate and 14 (37%) on identifying low-value care. Of the 362 U.S. IM programs in the sample, 41% were in a different quartile when ranked based on the HVC subscore compared with overall IM-ITE performance. Rankings by HVC subscore and HCI index were modestly inversely associated, with 30% of programs ranked in the same quartile based on both measures. Limitation: Knowledge of HVC assessed from examination vignettes may not reflect practice of HVC. Conclusion: Although the HVC subscore has face validity and can contribute to evaluation of residents' HVC knowledge, additional tools are needed to accurately measure residents' proficiency in HVC.	[Ryskina, Kira L.] Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Amer Coll Physicians, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; American College of Physicians	Ryskina, KL (corresponding author), Univ Penn, Div Gen Internal Med, 13-30B4,13th Floor,Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	ryskina@mail.med.upenn.edu			National Research Service Award	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Ryskina is supported by a National Research Service Award. Drs. Korenstein, Weissman, Masters, Alguire, and Smith are employees of the ACP.	American College of Physicians Alliance for Academic Internal Medicine, 2014, ACP INT MED INTR EX; [Anonymous], 2014, DARTMOUTH ATLAS HLTH; Arora A, 2012, DARTMOUTH ATLAS HLTH; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Bernabeo EC, 2013, ADV HEALTH SCI EDUC, V18, P463, DOI 10.1007/s10459-012-9384-x; Caverzagie KJ, 2013, ANN INTERN MED, V158, P557, DOI 10.7326/0003-4819-158-7-201304020-00593; Moriates C, 2013, JAMA INTERN MED, V173, P308, DOI 10.1001/jamainternmed.2013.2286; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Post J, 2013, AM J MED, V126, P838, DOI 10.1016/j.amjmed.2013.05.015; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; Wallenstein J, 2010, ACAD EMERG MED, V17, pS67, DOI 10.1111/j.1553-2712.2010.00894.x; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007	15	11	11	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					733	U187		10.7326/M14-0444	http://dx.doi.org/10.7326/M14-0444			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25321871				2022-12-01	WOS:000347245600030
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Fat doctors are patients too	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OBESITY; POPULATION					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Amani R, 2013, ASIA PAC J CLIN NUTR, V22, P505, DOI 10.6133/apjcn.2013.22.4.11; Booth HP, 2014, FAM PRACT, V31, P643, DOI 10.1093/fampra/cmu064; Brown I, 2006, BRIT J GEN PRACT, V56, P666; Donnelly L, 2014, NHS HOSPITAL CAFES A; Flint E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4887; Furber CM, 2011, MIDWIFERY, V27, P437, DOI 10.1016/j.midw.2010.04.001; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Helm T, 2014, GUARDIAN; Henegan C, 2013, THE MEN WHO MADE US; Jackson EJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003567; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Millett D., 2014, GP 23; Puhl RM, 2013, INT J OBESITY, V37, P1415, DOI 10.1038/ijo.2013.33; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2014	349								g6464	10.1136/bmj.g6464	http://dx.doi.org/10.1136/bmj.g6464			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JP	25385743	Green Published, Bronze			2022-12-01	WOS:000345444800004
J	Durdu, S; Iskar, M; Revenu, C; Schieber, N; Kunze, A; Bork, P; Schwab, Y; Gilmour, D				Durdu, Sevi; Iskar, Murat; Revenu, Celine; Schieber, Nicole; Kunze, Andreas; Bork, Peer; Schwab, Yannick; Gilmour, Darren			Luminal signalling links cell communication to tissue architecture during organogenesis	NATURE			English	Article							LUMEN FORMATION; FGF; MIGRATION; MORPHOGENESIS; MECHANISM; DYNAMICS	Morphogenesis is the process whereby cell collectives are shaped into differentiated tissues and organs(1). The self-organizing nature of morphogenesis has been recently demonstrated by studies showing that stem cells in three-dimensional culture can generate complex organoids, such as mini-guts(2), optic-cups(3) and even mini-brains(4). To achieve this, cell collectives must regulate the activity of secreted signalling molecules that control cell differentiation, presumably through the self-assembly of microenvironments or niches. However, mechanisms that allow changes in tissue architecture to feedback directly on the activity of extracellular signals have not been described. Here we investigate how the process of tissue assembly controls signalling activity during organogenesis in vivo, using the migrating zebrafish lateral line primordium(5). We show that fibroblast growth factor (FGF) activity within the tissue controls the frequency at which it deposits rosette-like mechanosensory organs. Live imaging reveals that FGF becomes specifically concentrated in microluminal structures that assemble at the centre of these organs and spatially constrain its signalling activity. Genetic inhibition of microlumen assembly and laser micropuncture experiments demonstrate that microlumina increase signalling responses in participating cells, thus allowing FGF to coordinate the migratory behaviour of cell groups at the tissue rear. As the formation of a central lumen is a self-organizing property of many cell types, such as epithelia(6) and embryonic stem cells(7), luminal signalling provides a potentially general mechanism to locally restrict, coordinate and enhance cell communication within tissues.	[Durdu, Sevi; Iskar, Murat; Revenu, Celine; Schieber, Nicole; Kunze, Andreas; Bork, Peer; Schwab, Yannick; Gilmour, Darren] European Mol Biol Lab Heidelberg, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Gilmour, D (corresponding author), European Mol Biol Lab Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gilmour@embl.de	Bork, Peer/F-1813-2013	Bork, Peer/0000-0002-2627-833X; Schwab, Yannick/0000-0001-8027-1836; Kunze, Andreas/0000-0002-4955-1052; Schieber, Nicole L./0000-0002-3212-5057; Iskar, Murat/0000-0001-8603-4313; Durdu, Sevi/0000-0001-9746-6779; Revenu des Courtils, Celine/0000-0003-3697-3739; Iskar, Murat/0000-0001-6448-8779; Gilmour, Darren/0000-0001-7613-090X	European Molecular Biology Organization; EMBL Interdisciplinary Postdocs (EIPOD); Deutsche Forschungsgemeinschaft [SFB 488]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EMBL Interdisciplinary Postdocs (EIPOD); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to J. Ellenberg, S. de Renzis and F. Peri for suggestions and comments on the manuscript, A. Aulehla for advice about timing, and E. Karsenti and the Gilmour laboratory for discussion. We thank M. Brand for advice about FGF tagging, the EMBL Advanced Light Microscopy Facility, in particular Y. Belyaev, for imaging assistance, the European Molecular Biology Laboratory (EMBL) Monoclonal Antibody (MACF) and Protein Expression Facilities for Fgfr1a antibody, K. Miura from the EMBL Centre for Cell and Molecular Imaging for advice with data analysis, E. Dona and T. Gregor for advice with the smFISH protocol, and A. Gruia for fish care. We acknowledge funding from the European Molecular Biology Organization and EMBL Interdisciplinary Postdocs (EIPOD) (to C. R.) and the Deutsche Forschungsgemeinschaft SFB 488 (to D.G.).	Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bokel C., 2014, COLD SPRING HARB PER, V6; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eklund A., beeswarm: the bee swarm plot, an alternative to stripchart; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Ernst S, 2012, DEVELOPMENT, V139, P4571, DOI 10.1242/dev.083253; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kolotuev I, 2010, BIOL CELL, V102, P121, DOI 10.1042/BC20090096; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Kwon HJ, 2009, DEV DYNAM, V238, P1582, DOI 10.1002/dvdy.21955; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morhac M., 2012, PEAKS PEAKS R PACKAG; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Revenu C, 2014, DEVELOPMENT, V141, P1282, DOI 10.1242/dev.101675; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Wand M, 2015, KERNSMOOTH FUNCTIONS, P23; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, V3; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	42	98	99	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					120	+		10.1038/nature13852	http://dx.doi.org/10.1038/nature13852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25337877				2022-12-01	WOS:000344187500042
J	Chen, BC; Legant, WR; Wang, K; Shao, L; Milkie, DE; Davidson, MW; Janetopoulos, C; Wu, XFS; Hammer, JA; Liu, Z; English, BP; Mimori-Kiyosue, Y; Romero, DP; Ritter, AT; Lippincott-Schwartz, J; Fritz-Laylin, L; Mullins, RD; Mitchell, DM; Bembenek, JN; Reymann, AC; Bohme, R; Grill, SW; Wang, JT; Seydoux, G; Tulu, US; Kiehart, DP; Betzig, E				Chen, Bi-Chang; Legant, Wesley R.; Wang, Kai; Shao, Lin; Milkie, Daniel E.; Davidson, Michael W.; Janetopoulos, Chris; Wu, Xufeng S.; Hammer, John A., III; Liu, Zhe; English, Brian P.; Mimori-Kiyosue, Yuko; Romero, Daniel P.; Ritter, Alex T.; Lippincott-Schwartz, Jennifer; Fritz-Laylin, Lillian; Mullins, R. Dyche; Mitchell, Diana M.; Bembenek, Joshua N.; Reymann, Anne-Cecile; Boehme, Ralph; Grill, Stephan W.; Wang, Jennifer T.; Seydoux, Geraldine; Tulu, U. Serdar; Kiehart, Daniel P.; Betzig, Eric			Lattice light-sheet microscopy: Imaging molecules to embryos at high spatiotemporal resolution	SCIENCE			English	Article							FLUORESCENCE MICROSCOPY; HIGH-SPEED; DYNAMICS; CELLS; PROTEIN; ORGANIZATION; CYTOKINESIS; STRATEGIES; MIGRATION; TRACKING	Although fluorescence microscopy provides a crucial window into the physiology of living specimens, many biological processes are too fragile, are too small, or occur too rapidly to see clearly with existing tools. We crafted ultrathin light sheets from two-dimensional optical lattices that allowed us to image three-dimensional (3D) dynamics for hundreds of volumes, often at subsecond intervals, at the diffraction limit and beyond. We applied this to systems spanning four orders of magnitude in space and time, including the diffusion of single transcription factor molecules in stem cell spheroids, the dynamic instability of mitotic microtubules, the immunological synapse, neutrophil motility in a 3D matrix, and embryogenesis in Caenorhabditis elegans and Drosophila melanogaster. The results provide a visceral reminder of the beauty and the complexity of living systems.	[Chen, Bi-Chang; Legant, Wesley R.; Wang, Kai; Shao, Lin; Liu, Zhe; English, Brian P.; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Milkie, Daniel E.] Coleman Technol Inc, Newtown Sq, PA 19073 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Janetopoulos, Chris] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA; [Wu, Xufeng S.; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Mimori-Kiyosue, Yuko] RIKEN Ctr Dev Biol, Opt Image Anal Unit, Kobe, Hyogo 6500047, Japan; [Romero, Daniel P.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Ritter, Alex T.; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Ritter, Alex T.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Fritz-Laylin, Lillian; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Mitchell, Diana M.; Bembenek, Joshua N.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Reymann, Anne-Cecile; Boehme, Ralph; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Reymann, Anne-Cecile; Boehme, Ralph; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01307 Dresden, Germany; [Wang, Jennifer T.; Seydoux, Geraldine] Johns Hopkins Sch Med, Ctr Cell Dynam, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Tulu, U. Serdar; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Howard Hughes Medical Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); RIKEN; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Knoxville; Max Planck Society; Max Planck Society; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Duke University	Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	betzige@janelia.hhmi.org	SEYDOUX, Geraldine/AAA-2005-2020; Chen, Bi-Chang/F-3480-2014; Mimori-Kiyosue, Yuko/K-9158-2015; English, Brian P/O-8156-2016; Grill, Stephan/D-9427-2012	Chen, Bi-Chang/0000-0002-1876-7432; Mimori-Kiyosue, Yuko/0000-0003-3513-9072; English, Brian P/0000-0002-4037-6294; Fritz-Laylin, Lillian/0000-0002-9237-9403; Wang, Kai/0000-0001-7858-944X; Wang, Jennifer/0000-0002-8506-5182; Seydoux, Geraldine/0000-0001-8257-0493; Bembenek, Joshua/0000-0002-0966-2268; Reymann, Anne-Cecile/0000-0002-0517-5083	Howard Hughes Medical Institute (HHMI); Janelia Visitor Program; NIH [R01GM080370, RM01-GM61010, R01HD37047, GM033830]; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; Japan Society for the Promotion of Science-NEXT program [LS128]; Uehara Memorial Foundation; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; RIKEN Center for Developmental Biology; HHMI; Human Frontier Science Program [LT000926/2012]; European Research Council [281903]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047, ZIAHD008850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL000514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830, R01GM080370, R01GM061010, T32GM007445] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Janelia Visitor Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japan Society for the Promotion of Science-NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; RIKEN Center for Developmental Biology; HHMI(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Gao, now at Stony Brook University, for technical expertise; the Shared Resource teams at Janelia for their skill and dedication in specimen handling and preparation; and the Instrument Design and Fabrication team for their manufacturing expertise. B.-C.C., W.R.L., K.W., L.S., Z.L., B.P.E., and E.B. are funded by the Howard Hughes Medical Institute (HHMI). We also gratefully acknowledge the support of the Janelia Visitor Program. C.J. is supported by NIH grant R01GM080370. X.S.W. and J.A.H. are funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH. Y.M.-K. is supported by the Japan Society for the Promotion of Science-NEXT program LS128, the Uehara Memorial Foundation, the Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, and an intramural grant from the RIKEN Center for Developmental Biology. A.T.R. and J.L.S. acknowledge G. M. Griffiths of the University of Cambridge as the doctoral cosupervisor of A. T. R., who provided technical expertise with CTL experiments. These experiments are a collaboration with GMG. L.F.L. and R.D.M. were supported by NIH grant RM01-GM61010 and HHMI. A.-C. R. is supported by the Human Frontier Science Program LT000926/2012. S.W.G. acknowledges support from the European Research Council starting grant 281903. J.T.W. and G.S. are supported by NIH R01HD37047. G.S. is also an HHMI Investigator. U.S.T. and D.P.K. are supported by NIH grant GM033830. All data in the manuscript are available upon request. Researchers can apply to access the microscope as visitors through the Advanced Imaging Center at Janelia Farm (www.janelia.org/aic). Documentation for the construction of a copy of the microscope is available after execution of a research license with HHMI. Portions of the technology described herein are covered by U.S. Patent 7,894,136 issued to E.B. and assigned to Lattice Light, LLC of Ashburn, VA; U.S. Patent 8,711,211 issued to E.B. and assigned to HHMI; and U.S. Patent application 13/844,405 filed by E.B. and K.W. and assigned to HHMI.	Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bembenek JN, 2013, CURR BIOL, V23, P937, DOI 10.1016/j.cub.2013.04.028; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2005, OPT EXPRESS, V13, P3021, DOI 10.1364/OPEX.13.003021; Betzig E, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.063406; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Coelho M, 2013, INTEGR BIOL-UK, V5, P748, DOI 10.1039/c3ib40018b; Diez S, 2005, P NATL ACAD SCI USA, V102, P7601, DOI 10.1073/pnas.0408546102; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Dormann D, 2006, EMBO J, V25, P3480, DOI 10.1038/sj.emboj.7601227; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Graf R, 2005, ADV BIOCHEM ENG BIOT, V95, P57, DOI 10.1007/b102210; Grill SW, 2011, CURR OPIN GENET DEV, V21, P647, DOI 10.1016/j.gde.2011.09.005; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Khodjakov A, 2006, METHODS, V38, P2, DOI 10.1016/j.ymeth.2005.07.007; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/NMETH.2064, 10.1038/nmeth.2064]; Legant WR, 2010, NAT METHODS, V7, P969, DOI [10.1038/nmeth.1531, 10.1038/NMETH.1531]; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Murphy D. B., 2013, FUNDAMENTALS OF LIGH; PETSAS KI, 1994, PHYS REV A, V50, P5173, DOI 10.1103/PhysRevA.50.5173; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Ritter AT, 2013, IMMUNOL REV, V256, P107, DOI 10.1111/imr.12117; Ritter JG, 2008, OPT EXPRESS, V16, P7142, DOI 10.1364/OE.16.007142; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Sokolow A, 2012, BIOPHYS J, V102, P969, DOI 10.1016/j.bpj.2012.01.027; Speidel M, 2003, OPT LETT, V28, P69, DOI 10.1364/OL.28.000069; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tikhonenko I, 2009, EUKARYOT CELL, V8, P723, DOI 10.1128/EC.00018-09; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Wloga D, 2012, METHOD CELL BIOL, V109, P83, DOI 10.1016/B978-0-12-385967-9.00005-0; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/nmeth.1744, 10.1038/NMETH.1744]; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	58	1061	1098	52	720	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					439	+	1257998	10.1126/science.1257998	http://dx.doi.org/10.1126/science.1257998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6YT	25342811	Green Accepted			2022-12-01	WOS:000349773700002
J	Stewart, L				Stewart, Lorna			Will you still need me, will you still feed me?	NATURE			English	Editorial Material																		Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269	4	6	6	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					S14	S15		10.1038/514S14a	http://dx.doi.org/10.1038/514S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25317591	Bronze			2022-12-01	WOS:000342988600009
J	Nice, TJ; Baldridge, MT; McCune, BT; Norman, JM; Lazear, HM; Artyomov, M; Diamond, MS; Virgin, HW				Nice, Timothy J.; Baldridge, Megan T.; McCune, Broc T.; Norman, Jason M.; Lazear, Helen M.; Artyomov, Maxim; Diamond, Michael S.; Virgin, Herbert W.			Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity	SCIENCE			English	Article							NOSOCOMIAL TRANSMISSION; SUFFICIENT; PROTEIN; REPLICATION; PREVALENCE; REPLICON	Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-alpha (IFN-alpha) and IFN-beta prevented the systemic spread of murine norovirus (MNoV), only IFN-lambda controlled persistent enteric infection. Infection-dependent induction of IFN-lambda was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-lambda cured mice in a manner requiring nonhematopoietic cell expression of the IFN-lambda receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-lambda for curing virus infections in the gastrointestinal tract.	[Nice, Timothy J.; Baldridge, Megan T.; McCune, Broc T.; Norman, Jason M.; Artyomov, Maxim; Diamond, Michael S.; Virgin, Herbert W.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.	virgin@wustl.edu	Baldridge, Megan/T-7274-2019; Diamond, Michael/AAH-1733-2019; Nice, Timothy/X-9114-2019	Baldridge, Megan/0000-0002-7030-6131; Diamond, Michael/0000-0002-8791-3165; Nice, Timothy/0000-0002-4471-7666; Virgin, Herbert/0000-0001-8580-7628; Lazear, Helen/0000-0002-8649-4579	NIH [R01 AI084887, U19 AI109725, U19 AI083019, U19 AI106772, 5T32A100716334, 5T32CA009547, F31CA177194-01, 5T32AI007163]; Crohn's and Colitis Foundation Genetics Initiative [274415]; Broad Foundation [IBD-0357]; Cancer Research Institute and American Cancer Society; Washington University; NATIONAL CANCER INSTITUTE [F31CA177194, T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, U19AI083019, U19AI106772, R01AI084887, T32AI007163] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation Genetics Initiative; Broad Foundation; Cancer Research Institute and American Cancer Society; Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Kreamalmeyer for maintaining our mouse colony and S. Doyle and Bristol-Myers Squibb for providing Ifnlr1<SUP>-/-</SUP> mice and recombinant IFN-lambda protein. The mouse norovirus strains used in this paper are available from Washington University under a material transfer agreement (MTA). Ifnlr1<SUP>-/-</SUP> mice were made available from ZymoGenetics (Bristol-Myers Squibb) under a MTA with Washington University School of Medicine. H.W.V. is a co-inventor on a patent filed by Washington University School of Medicine related to the use of murine norovirus. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. H.W.V. was supported by NIH grants R01 AI084887 and U19 AI109725, the Crohn's and Colitis Foundation Genetics Initiative grant 274415, and Broad Foundation grant IBD-0357. M.S.D. and H.M.L. were supported by NIH grants U19 AI083019 and U19 AI106772. T.J.N. was supported by NIH training grant 5T32A100716334 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society. M.T.B. was supported by NIH training grant 5T32CA009547 and the W. M. Keck Fellowship from Washington University. B.T.M. was supported by NIH award F31CA177194-01. J.M.N. was supported by NIH training grant 5T32AI007163.	Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243; Borin BN, 2014, PROTEINS, V82, P1200, DOI 10.1002/prot.24484; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Cheon DS, 2010, FOODBORNE PATHOG DIS, V7, P1427, DOI 10.1089/fpd.2010.0547; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Liu GL, 2009, J VIROL, V83, P6963, DOI 10.1128/JVI.00284-09; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999	30	232	249	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					269	273		10.1126/science.1258100	http://dx.doi.org/10.1126/science.1258100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25431489	Green Accepted, Green Submitted			2022-12-01	WOS:000347915300035
J	Barretto, RPJ; Gillis-Smith, S; Chandrashekar, J; Yarmolinsky, DA; Schnitzer, MJ; Ryba, NJP; Zuker, CS				Barretto, Robert P. J.; Gillis-Smith, Sarah; Chandrashekar, Jayaram; Yarmolinsky, David A.; Schnitzer, Mark J.; Ryba, Nicholas J. P.; Zuker, Charles S.			The neural representation of taste quality at the periphery	NATURE			English	Article							FLUORESCENCE MICROENDOSCOPY; MAMMALIAN BRAIN; CHORDA TYMPANI; UMAMI TASTE; RECEPTORS; STIMULI; SWEET; CELLS; MICE; BUDS	The mammalian taste system is responsible for sensing and responding to the five basic taste qualities: sweet, sour, bitter, salty and umami. Previously, we showed that each taste is detected by dedicated taste receptor cells (TRCs) on the tongue and palate epithelium(1). To understand how TRCs transmit information to higher neural centres, we examined the tuning properties of large ensembles of neurons in the first neural station of the gustatory system. Here, we generated and characterized a collection of transgenic mice expressing a genetically encoded calcium indicator' in central and peripheral neurons, and used a gradient refractive index microendoscope combined with high-resolution two-photon microscopy to image taste responses from ganglion neurons buried deep at the base of the brain. Our results reveal fine selectivity in the taste preference of ganglion neurons; demonstrate a strong match between TRCs in the tongue and the principal neural afferents relaying taste information to the brain; and expose the highly specific transfer of taste information between taste cells and the central nervous system.	[Barretto, Robert P. J.; Gillis-Smith, Sarah; Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Barretto, Robert P. J.; Gillis-Smith, Sarah; Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Barretto, Robert P. J.; Gillis-Smith, Sarah; Yarmolinsky, David A.; Zuker, Charles S.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Chandrashekar, Jayaram; Zuker, Charles S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.	nick.ryba@nih.gov; cz2195@columbia.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the National Institute of Dental and Craniofacial Research (NIDCR) transgenic-core and C. Guo at Janelia Farms for help in generating the Thy1-GCaMP3 mouse lines, B. Shields for histology support, and Y. Oka and M. Butnaru for nerve recording and pharmacological advice. We also thank members of the Zuker laboratory for helpful comments. This research was supported in part by the intramural research program of NIDCR (N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farms.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FRANK M, 1969, SCIENCE, V164, P1183, DOI 10.1126/science.164.3884.1183; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; GRILL HJ, 1978, BRAIN RES, V143, P281, DOI 10.1016/0006-8993(78)90569-3; Heyer BR, 2003, CHEM SENSES, V28, P631, DOI 10.1093/chemse/bjg056; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HYMAN AM, 1980, J GEN PHYSIOL, V76, P125, DOI 10.1085/jgp.76.2.125; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Sollars SI, 2005, J PHYSIOL-LONDON, V564, P877, DOI 10.1113/jphysiol.2005.083741; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zaidi FN, 2006, J NEUROSCI, V26, P8243, DOI 10.1523/JNEUROSCI.5142-05.2006; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	30	87	88	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					373	U511		10.1038/nature13873	http://dx.doi.org/10.1038/nature13873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25383521	Green Accepted			2022-12-01	WOS:000347810300047
J	Gurdasani, D; Carstensen, T; Tekola-Ayele, F; Pagani, L; Tachmazidou, I; Hatzikotoulas, K; Karthikeyan, S; Iles, L; Pollard, MO; Choudhury, A; Ritchie, GS; Xue, YL; Asimit, J; Nsubuga, RN; Young, EH; Pomilla, C; Kivinen, K; Rockett, K; Kamali, A; Doumatey, AP; Asiki, G; Seeley, J; Sisay-Joof, F; Jallow, M; Tollman, S; Mekonnen, E; Ekong, R; Oljira, T; Bradman, N; Bojang, K; Ramsay, M; Adeyemo, A; Bekele, E; Motala, A; Norris, SA; Pirie, F; Kaleebu, P; Kwiatkowski, D; Tyler-Smith, C; Rotimi, C; Zeggini, E; Sandhu, MS				Gurdasani, Deepti; Carstensen, Tommy; Tekola-Ayele, Fasil; Pagani, Luca; Tachmazidou, Ioanna; Hatzikotoulas, Konstantinos; Karthikeyan, Savita; Iles, Louise; Pollard, Martin O.; Choudhury, Ananyo; Ritchie, GrahamR. S.; Xue, Yali; Asimit, Jennifer; Nsubuga, Rebecca N.; Young, Elizabeth H.; Pomilla, Cristina; Kivinen, Katja; Rockett, Kirk; Kamali, Anatoli; Doumatey, Ayo P.; Asiki, Gershim; Seeley, Janet; Sisay-Joof, Fatoumatta; Jallow, Muminatou; Tollman, Stephen; Mekonnen, Ephrem; Ekong, Rosemary; Oljira, Tamiru; Bradman, Neil; Bojang, Kalifa; Ramsay, Michele; Adeyemo, Adebowale; Bekele, Endashaw; Motala, Ayesha; Norris, Shane A.; Pirie, Fraser; Kaleebu, Pontiano; Kwiatkowski, Dominic; Tyler-Smith, Chris; Rotimi, Charles; Zeggini, Eleftheria; Sandhu, Manjinder S.			The African Genome Variation Project shapes medical genetics in Africa	NATURE			English	Article							POPULATION-GENETICS; MALARIA; SELECTION; WIDE; SUSCEPTIBILITY; REVEALS; ASSOCIATION; DIVERSITY; VARIANTS; ANCESTRY	Given the importance of Africa to studies of human origins and disease susceptibility, detailed characterization of African genetic diversity is needed. The African Genome Variation Project provides a resource with which to design, implement and interpret genomic studies in sub-Saharan Africa and worldwide. The African Genome Variation Project represents dense genotypes from 1,481 individuals and whole-genome sequences from 320 individuals across sub-Saharan Africa. Using this resource, we find novel evidence of complex, regionally distinct hunter-gatherer and Eurasian admixture across sub-Saharan Africa. We identify new loci under selection, including loci related to malaria susceptibility and hypertension. We show that modern imputation panels (sets of reference genotypes from which unobserved or missing genotypes in study sets can be inferred) can identify association signals at highly differentiated loci across populations in sub-Saharan Africa. Using whole-genome sequencing, we demonstrate further improvements in imputation accuracy, strengthening the case for large-scale sequencing efforts of diverse African haplotypes. Finally, we present an efficient genotype array design capturing common genetic variation in Africa.	[Gurdasani, Deepti; Carstensen, Tommy; Pagani, Luca; Tachmazidou, Ioanna; Hatzikotoulas, Konstantinos; Karthikeyan, Savita; Iles, Louise; Pollard, Martin O.; Ritchie, GrahamR. S.; Xue, Yali; Asimit, Jennifer; Young, Elizabeth H.; Pomilla, Cristina; Kivinen, Katja; Adeyemo, Adebowale; Kwiatkowski, Dominic; Tyler-Smith, Chris; Zeggini, Eleftheria; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Gurdasani, Deepti; Carstensen, Tommy; Karthikeyan, Savita; Iles, Louise; Young, Elizabeth H.; Pomilla, Cristina; Sandhu, Manjinder S.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Tekola-Ayele, Fasil; Doumatey, Ayo P.; Adeyemo, Adebowale; Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20891 USA; [Pagani, Luca] Univ Bologna, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy; [Iles, Louise] Univ York, Dept Archaeol, York YO1 7EP, N Yorkshire, England; [Choudhury, Ananyo; Ramsay, Michele] Univ Witwatersrand, SBIMB, Johannesburg, Gauteng, South Africa; [Ritchie, GrahamR. S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Nsubuga, Rebecca N.; Kamali, Anatoli; Asiki, Gershim; Seeley, Janet; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Rockett, Kirk; Kwiatkowski, Dominic] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Sisay-Joof, Fatoumatta; Jallow, Muminatou; Bojang, Kalifa] MRC Unit, Banjul, Gambia; [Tollman, Stephen] MRC, Sch Publ Hlth, Wits Rural Publ Hlth & Hlth Transit Unit, Johannesburg, Gauteng, South Africa; [Tollman, Stephen] INDEPTH Network, Accra, Ghana; [Mekonnen, Ephrem] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia; [Ekong, Rosemary] UCL, Dept Genet Evolut & Environm, London, England; [Oljira, Tamiru] Univ Haramaya, Dept Biol, Dire Dawa, Ethiopia; [Bradman, Neil] Henry Stewart Grp, London WC1A 2HN, England; [Ramsay, Michele] Natl Hlth Lab Serv, Div Human Genet, ZA-2000 Johannesburg, South Africa; [Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, ZA-2000 Johannesburg, South Africa; [Bekele, Endashaw] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Motala, Ayesha; Pirie, Fraser] Univ KwaZulu Natal, Dept Endocrinol & Diabet, ZA-4013 Durban, South Africa; [Norris, Shane A.] Univ Witwatersrand, Dept Paediat, Johannesburg, Gauteng, South Africa	Wellcome Trust Sanger Institute; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Bologna; University of York - UK; University of Witwatersrand; European Molecular Biology Laboratory (EMBL); Uganda Virus Research Institute; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; INDEPTH Network; Addis Ababa University; University of London; University College London; Haramaya University; National Health Laboratory Service; University of Witwatersrand; Addis Ababa University; University of Kwazulu Natal; University of Witwatersrand	Sandhu, MS (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Cambridge CB10 1SA, England.	dg11@sanger.ac.uk; cts@sanger.ac.uk; rotimic@mail.nih.gov; eleftheria@sanger.ac.uk; ms23@sanger.ac.uk	Pagani, Luca/G-8511-2017; Asimit, Jennifer/P-7567-2017; Pollard, Martin O./G-7205-2012; Norris, Shane/C-4664-2014; Pomilla, Cristina/AAC-4035-2020; Pomilla, Cristina/GYD-9678-2022	Pagani, Luca/0000-0002-6639-524X; Asimit, Jennifer/0000-0002-4857-2249; Pollard, Martin O./0000-0001-8738-0920; Norris, Shane/0000-0001-7124-3788; Pomilla, Cristina/0000-0002-2581-8365; Hatzikotoulas, Konstantinos/0000-0002-4699-3672; Tekola-Ayele, Fasil/0000-0003-4194-9370; Kwiatkowski, Dominic/0000-0002-5023-0176; Seeley, Janet/0000-0002-0583-5272; Motala, Ayesha/0000-0003-0517-1784; Iles, Louise Elizabeth/0000-0003-4113-5844; Mekonnen, Ephrem/0000-0003-0416-649X; Tollman, Stephen/0000-0003-0744-7588; Ramsay, Michele/0000-0002-4156-4801; Asiki, Gershim/0000-0002-9966-1153; Adeyemo, Adebowale/0000-0002-3105-3231; Ekong, Rosemary/0000-0002-5984-7893; Choudhury, Ananyo/0000-0001-8225-9531; Zeggini, Eleftheria/0000-0003-4238-659X; Gurdasani, Deepti/0000-0001-9996-6929; Bojang, Kalifa/0000-0001-7506-0938; Kivinen, Katja/0000-0002-1135-7625	Wellcome Trust [WT077383/Z/05/Z]; Wellcome Trust Sanger Institute [WT098051]; Bill and Melinda Gates Foundation; Foundation for the National Institutes of Health [566]; UK Medical Research Council [G0901213-92157, G0801566, G0600718, MR/K013491/1]; South African Sugar Association; Servier South Africa; Victor Daitz Foundation; National Institute on Minority Health and Health Disparities; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Human Genome Research Institute (NHGRI); Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH) [Z01HG200362]; MRC Centre for Genomics and Global Health; Cambridge Commonwealth Scholarship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200362, ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A900_1118, MR/K013491/1, G0901213, G1001333, G0801566, G0600718] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012] Funding Source: researchfish; MRC [G0901213, G0600718, G0801566, MR/K013491/1, G1001333, MC_UP_A900_1118] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Sanger Institute(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Sugar Association; Servier South Africa; Victor Daitz Foundation; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); MRC Centre for Genomics and Global Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Commonwealth Scholarship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded in part by the Wellcome Trust (grant number WT077383/Z/05/Z), The Wellcome Trust Sanger Institute (grant number WT098051), the Bill and Melinda Gates Foundation, the Foundation for the National Institutes of Health (grant number 566), and the UK Medical Research Council (grant numbers G0901213-92157, G0801566, G0600718 and MR/K013491/1). We also acknowledge the National Institute for Health Research Cambridge Biomedical Research Centre and the Wellcome Trust Cambridge Centre for Global Health Research. We are very grateful to J. Pickrell for sharing human origins data and MALDER code, and for useful input on interpretations of these analyses. We also thank E. Garrison for his suggestions on using Genome in a bottle sets (ftp://ftp-trace.ncbi.nih.gov/giab/ftp/data/NA12878/variant_calls/NIST/README.NIST.v2.18.txt) for validation of whole-genome sequencing data. We also thank the African Partnership for Chronic Disease Research (APCDR)for providing a network to support this study as well as a repository for deposition of curated data. Sample collections from South Africa were funded by The South African Sugar Association, Servier South Africa and The Victor Daitz Foundation. The Kenyan samples were collected by D. Ngare of Moi University, Eldoret, Kenya, as part of the Africa America Diabetes Mellitus (AADM) study and the International HapMap project (D. Ngare, who is now deceased, was a great supporter of genomics in Africa,as exemplified by his leadership in engaging the Luhya and Maasai communities for the HapMap project). The Igbo samples were collected by J. Oli of the University of Nigeria, Enugu, Nigeria. The Ga-Adangbe samples were collected by the laboratories of A. Amoah of the University of Ghana, Accra, Ghana, and J. Acheampong of the University of Science and Technology, Kumasi, Ghana. Support for the AADM study is provided by the National Institute on Minority Health and Health Disparities, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Human Genome Research Institute (NHGRI). The Gambian samples were collected by M. Jallow and colleagues at the MRC Unit, The Gambia and form part of the MalariaGEN Consortial Resource. This research was supported in part by the Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH; grant number Z01HG200362) and by the MRC Centre for Genomics and Global Health. D.G. was funded by the Cambridge Commonwealth Scholarship. We thank the 1000 Genomes Project for sharing genotype data that were analysed as part of this project. We also thank all study participants who contributed to this study.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Fumagalli M, 2010, MOL BIOL EVOL, V27, P2555, DOI 10.1093/molbev/msq141; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graffe CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-15; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86; Jacobs T, 2002, J IMMUNOL, V169, P2323, DOI 10.4049/jimmunol.169.5.2323; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Ko WY, 2013, AM J HUM GENET, V93, P54, DOI 10.1016/j.ajhg.2013.05.014; Kosoy R, 2011, GENES IMMUN, V12, P582, DOI 10.1038/gene.2011.33; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lopes MF, 1999, EUR J IMMUNOL, V29, P81, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;81::AID-IMMU81&gt;3.0.CO;2-Y; Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x; Martins GA, 2001, IMMUNOLOGY, V103, P122, DOI 10.1046/j.1365-2567.2001.01216.x; Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Panda AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049420; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Patin E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4163; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ribeiro CMS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013012; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11; Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; The Bradshaw Foundation, 2014, OR PREH ROCK ART ART; Tilman L.-E., 2007, ATLAS CULTURAL ENV C; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zhang GC, 2012, INFECT IMMUN, V80, P2316, DOI 10.1128/IAI.00261-12	50	325	325	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					327	U397		10.1038/nature13997	http://dx.doi.org/10.1038/nature13997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25470054	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000347810300037
J	Gostin, LO; Hodge, JG; Burris, S				Gostin, Lawrence O.; Hodge, James G., Jr.; Burris, Scott			Is the United States Prepared for Ebola?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Tempe, AZ USA; [Burris, Scott] Temple Univ, Publ Hlth Law Res Program, Beasley Sch Law, Philadelphia, PA 19122 USA	Georgetown University; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Altimari Daniela, 2014, HARTFORD COURANT; Association of State and Territorial Health Officials, UDGET CUTS CONTINUE; CDC/DHS, 2014, ENHANCED EBOLA SCREE; Gostin LO, LANCET; Institute of Medicine, 2009, CRISIS STANDARDS OF	5	28	29	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2497	2498		10.1001/jama.2014.15041	http://dx.doi.org/10.1001/jama.2014.15041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25325877	Bronze, Green Published			2022-12-01	WOS:000346346900008
J	in 't Veld, PJH; Herzog, F; Ladurner, R; Davidson, IF; Piric, S; Kreidl, E; Bhaskara, V; Aebersold, R; Peters, JM				in 't Veld, Pim J. Huis; Herzog, Franz; Ladurner, Rene; Davidson, Iain F.; Piric, Sabina; Kreidl, Emanuel; Bhaskara, Venugopal; Aebersold, Ruedi; Peters, Jan-Michael			Characterization of a DNA exit gate in the human cohesin ring	SCIENCE			English	Article							ATP HYDROLYSIS; CHROMOSOMES; CHROMATIN; WAPL; REPLICATION; COMPLEX; BINDING; SCC2; ACETYLATION; ASSOCIATION	Chromosome segregation depends on sister chromatid cohesion mediated by cohesin. The cohesin subunits Smc1, Smc3, and Scc1 form tripartite rings that are thought to open at distinct sites to allow entry and exit of DNA. However, direct evidence for the existence of open forms of cohesin is lacking. We found that cohesin's proposed DNA exit gate is formed by interactions between Scc1 and the coiled-coil region of Smc3. Mutation of this interface abolished cohesin's ability to stably associate with chromatin and to mediate cohesion. Electron microscopy revealed that weakening of the Smc3-Scc1 interface resulted in opening of cohesin rings, as did proteolytic cleavage of Scc1. These open forms may resemble intermediate states of cohesin normally generated by the release factor Wapl and the protease separase, respectively.	[in 't Veld, Pim J. Huis; Ladurner, Rene; Davidson, Iain F.; Piric, Sabina; Kreidl, Emanuel; Bhaskara, Venugopal; Peters, Jan-Michael] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Herzog, Franz; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Herzog, Franz] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich	Peters, JM (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	peters@imp.ac.at	Veld, Pim J. Huis in 't/AAJ-9030-2020; Herzog, Franz/G-4832-2012	Veld, Pim J. Huis in 't/0000-0003-0234-6390; Herzog, Franz/0000-0001-8270-1449; /0000-0002-8002-9967; Bhaskara, Venugopal/0000-0002-8807-3292; Ladurner, Rene/0000-0001-9261-7304; Kreidl, Emanuel/0000-0002-4037-5881	Austrian Science Fund [W1221, SFB-F34]; European Community [227764, 241548]; Boehringer Ingelheim; Austrian Research Promotion Agency (FFG Laura Bass); Vienna Science and Technology Fund [WWTF LS09-13]	Austrian Science Fund(Austrian Science Fund (FWF)); European Community(European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG Laura Bass); Vienna Science and Technology Fund	We thank O. Hudecz, K. Mechtler, G. Schmauss, K. Uzunova, M. Brandstetter, H. Kotisch, G. Resch, and A. Schleiffer for excellent technical support and I. Berger for an introduction to MultiBac. P.J.H. was supported by the Austrian Science Fund (W1221) and received funding from the European Community (FP7/2007-2013, no. 227764). Research in the laboratory of J.-M.P. is supported by Boehringer Ingelheim, the Austrian Science Fund (SFB-F34 and Wittgenstein award), the Austrian Research Promotion Agency (FFG Laura Bass), the Vienna Science and Technology Fund (WWTF LS09-13), and the European Community (FP7/2007-2013, no. 241548, MitoSys).	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Buheitel J, 2013, EMBO J, V32, P666, DOI 10.1038/emboj.2013.7; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Eichinger CS, 2013, EMBO J, V32, P656, DOI 10.1038/emboj.2012.346; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Ouyang ZQ, 2013, P NATL ACAD SCI USA, V110, P11355, DOI 10.1073/pnas.1304594110; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458	28	122	122	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					968	972		10.1126/science.1256904	http://dx.doi.org/10.1126/science.1256904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414306				2022-12-01	WOS:000345696000036
J	Root, CM; Denny, CA; Hen, R; Axel, R				Root, Cory M.; Denny, Christine A.; Hen, Rene; Axel, Richard			The participation of cortical amygdala in innate, odour-driven behaviour	NATURE			English	Article							OLFACTORY-BULB; PIRIFORM CORTEX; REPRESENTATIONS; MOUSE; DROSOPHILA; GENE; INFORMATION; CIRCUITS; NEURONS; PATHWAY	Innate behaviours are observed in naive animals without prior learning or experience, suggesting that the neural circuits that mediate these behaviours are genetically determined and stereotyped. The neural circuits that convey olfactory information from the sense organ to the cortical and subcortical olfactory centres have been anatomically defined(1-3), but the specific pathways responsible for innate responses to volatile odours have not been identified. Here we devise genetic strategies that demonstrate that a stereotyped neural circuit that transmits information from the olfactory bulb to cortical amygdala is necessary for innate aversive and appetitive behaviours. Moreover, we use the promoter of the activity-dependent gene arcto express the photosensitive ion channel, channelrhodopsin, in neurons of the cortical amygdala activated by odours that elicit innate behaviours. Optical activation of these neurons leads to appropriate behaviours that recapitulate the responses to innate odours. These data indicate that the cortical amygdala plays a critical role in generating innate odour-driven behaviours but do not preclude its participation in learned olfactory behaviours.	[Root, Cory M.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Root, Cory M.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Denny, Christine A.] New York State Psychiat Inst & Hosp, Dept Biol Sci, New York, NY 10032 USA; [Denny, Christine A.; Hen, Rene] New York State Psychiat Inst & Hosp, Dept Neurosci & Psychiat, New York, NY 10032 USA; [Denny, Christine A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, New York State Psychiat Inst, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu	Denny, Christine Ann A/I-5235-2015	Denny, Christine Ann A/0000-0002-6926-2020; Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute; Mathers Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017908] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Abbott, T. Jessell and D. Costantini for comments and reading the manuscript; B. Bader for assistance with experiments; M. Mendelsohn and N. Zabello for help with mice; P. Kisloff for assistance in preparation of the manuscript; and A. Nemes and M. Gutierrez for laboratory support. This work was supported by the Howard Hughes Medical Institute and the Mathers Foundation.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Louise E. M., 1983, PHYSIOL ENTOMOL, V8, P97; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schwabe K, 2004, NEUROSCIENCE, V126, P727, DOI 10.1016/j.neuroscience.2004.04.022; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tonegawa S, 2008, NEURON, V57, P175, DOI 10.1016/j.neuron.2008.01.005; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vo-Dinh T., 2003, BIOMEDICAL PHOTONICS, P37; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	34	171	174	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					269	U274		10.1038/nature13897	http://dx.doi.org/10.1038/nature13897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25383519	Green Accepted			2022-12-01	WOS:000344631400051
J	Gujral, TS; Chan, M; Peshkin, L; Sorger, PK; Kirschner, MW; MacBeath, G				Gujral, Taranjit S.; Chan, Marina; Peshkin, Leonid; Sorger, Peter K.; Kirschner, Marc W.; MacBeath, Gavin			A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis	CELL			English	Article							SERINE PHOSPHORYLATION; CANCER METASTASIS; GENE-EXPRESSION; CELL-MIGRATION; PROTEIN; STAT3; INHIBITORS; BINDING; BREAST; SENSITIVITY	Wnt signaling plays a critical role in embryonic development, and genetic aberrations in this network have been broadly implicated in colorectal cancer. We find that the Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b are elevated in metastatic liver, lung, colon, and breast cancer cell lines and in high-grade tumors and that their expression correlates with markers of epithelial-mesenchymal transition (EMT). Pharmacologic and genetic perturbations reveal that Fzd2 drives EMT and cell migration through a previously unrecognized, noncanonical pathway that includes Fyn and Stat3. A gene signature regulated by this pathway predicts metastasis and overall survival in patients. We have developed an antibody to Fzd2 that reduces cell migration and invasion and inhibits tumor growth and metastasis in xenografts. We propose that targeting this pathway could provide benefit for patients with tumors expressing high levels of Fzd2 and Wnt5a/ b.	[Gujral, Taranjit S.; Chan, Marina; Peshkin, Leonid; Sorger, Peter K.; Kirschner, Marc W.; MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave,Warren Alpert 524, Boston, MA 02115 USA.	marc@hms.harvard.edu; gavin_macbeath@harvard.edu		Gujral, Taran/0000-0002-4453-3031; Peshkin, Leonid/0000-0002-6420-848X; Sorger, Peter/0000-0002-3364-1838; MacBeath, Gavin/0000-0003-2585-6772	National Institutes of Health [R01 GM072872, P50 GM68762, U54 HG006097, R01 HD073104, R01 GM103785]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073104] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM103785, R01GM072872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by awards from the National Institutes of Health (R01 GM072872, P50 GM68762, U54 HG006097, R01 HD073104, and R01 GM103785). T.S.G. is a Human Frontier Science Program Fellow. We thank the staff of the Nikon Imaging Center and Systems Biology Flow Cytometry Facility at Harvard Medical School for help and support. G.M. is an employee, cofounder, and shareholder of Merrimack Pharmaceuticals and P.K.S. is a cofounder and shareholder of Merrimack Pharmaceuticals.	Balanis N, 2013, J BIOL CHEM, V288, P17954, DOI 10.1074/jbc.M113.475277; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Jordan NV, 2013, MOL CELL BIOL, V33, P3011, DOI 10.1128/MCB.01443-12; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Li CG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-11; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Paul S, 2012, NEW ENGL J MED, V367, P1959, DOI 10.1056/NEJMc1211073; PAYNE G, 1993, P NATL ACAD SCI USA, V90, P4902, DOI 10.1073/pnas.90.11.4902; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	43	220	229	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					844	856		10.1016/j.cell.2014.10.032	http://dx.doi.org/10.1016/j.cell.2014.10.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417160	Bronze, Green Accepted			2022-12-01	WOS:000344522000016
J	Starmer, AJ; Spector, ND; Srivastava, R; West, DC; Rosenbluth, G; Allen, AD; Noble, EL; Tse, LL; Dalal, AK; Keohane, CA; Lipsitz, SR; Rothschild, JM; Wien, MF; Yoon, CS; Zigmont, KR; Wilson, KM; O'Toole, JK; Solan, LG; Aylor, M; Bismilla, Z; Coffey, M; Mahant, S; Blankenburg, RL; Destino, LA; Everhart, JL; Patel, SJ; Bale, JF; Spackman, JB; Stevenson, AT; Calaman, S; Cole, FS; Balmer, DF; Hepps, JH; Lopreiato, JO; Yu, CE; Sectish, TC; Landrigan, CP				Starmer, A. J.; Spector, N. D.; Srivastava, R.; West, D. C.; Rosenbluth, G.; Allen, A. D.; Noble, E. L.; Tse, L. L.; Dalal, A. K.; Keohane, C. A.; Lipsitz, S. R.; Rothschild, J. M.; Wien, M. F.; Yoon, C. S.; Zigmont, K. R.; Wilson, K. M.; O'Toole, J. K.; Solan, L. G.; Aylor, M.; Bismilla, Z.; Coffey, M.; Mahant, S.; Blankenburg, R. L.; Destino, L. A.; Everhart, J. L.; Patel, S. J.; Bale, J. F., Jr.; Spackman, J. B.; Stevenson, A. T.; Calaman, S.; Cole, F. S.; Balmer, D. F.; Hepps, J. H.; Lopreiato, J. O.; Yu, C. E.; Sectish, T. C.; Landrigan, C. P.		I-PASS Study Grp	Changes in Medical Errors after Implementation of a Handoff Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE DRUG EVENTS; I-PASS HANDOFF; INTENSIVE-CARE; DUTY HOURS; WORK HOURS; POPULATION; EDUCATION; SAFETY; INTERVENTION; RESIDENTS	BACKGROUND Miscommunications are a leading cause of serious medical errors. Data from multicenter studies assessing programs designed to improve handoff of information about patient care are lacking. METHODS We conducted a prospective intervention study of a resident handoff-improvement program in nine hospitals, measuring rates of medical errors, preventable adverse events, and miscommunications, as well as resident workflow. The intervention included a mnemonic to standardize oral and written handoffs, handoff and communication training, a faculty development and observation program, and a sustainability campaign. Error rates were measured through active surveillance. Handoffs were assessed by means of evaluation of printed handoff documents and audio recordings. Workflow was assessed through time-motion observations. The primary outcome had two components: medical errors and preventable adverse events. RESULTS In 10,740 patient admissions, the medical-error rate decreased by 23% from the preintervention period to the postintervention period (24.5 vs. 18.8 per 100 admissions, P<0.001), and the rate of preventable adverse events decreased by 30% (4.7 vs. 3.3 events per 100 admissions, P<0.001). The rate of nonpreventable adverse events did not change significantly (3.0 and 2.8 events per 100 admissions, P = 0.79). Site-level analyses showed significant error reductions at six of nine sites. Across sites, significant increases were observed in the inclusion of all prespecified key elements in written documents and oral communication during handoff (nine written and five oral elements; P<0.001 for all 14 comparisons). There were no significant changes from the preintervention period to the postintervention period in the duration of oral handoffs (2.4 and 2.5 minutes per patient, respectively; P = 0.55) or in resident workflow, including patient-family contact and computer time. CONCLUSIONS Implementation of the handoff program was associated with reductions in medical errors and in preventable adverse events and with improvements in communication, without a negative effect on workflow.	[Starmer, A. J.; Allen, A. D.; Noble, E. L.; Tse, L. L.; Sectish, T. C.; Landrigan, C. P.] Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA; [Starmer, A. J.; Dalal, A. K.; Lipsitz, S. R.; Rothschild, J. M.; Sectish, T. C.; Landrigan, C. P.] Harvard Univ, Sch Med, Boston, MA USA; [Dalal, A. K.; Keohane, C. A.; Lipsitz, S. R.; Rothschild, J. M.; Sectish, T. C.; Landrigan, C. P.] Brigham & Womens Hosp, Ctr Patient Safety Res, Div Gen Med, Boston, MA 02115 USA; [Landrigan, C. P.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Keohane, C. A.] CRICO Risk Management Fdn, Boston, MA USA; [Starmer, A. J.; Aylor, M.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Dept Pediat, Portland, OR 97201 USA; [Spector, N. D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat,Sect Gen Pediat, Philadelphia, PA 19104 USA; [Calaman, S.] Drexel Univ, Coll Med, St Christophers Hosp Children, Sect Crit Care, Philadelphia, PA 19104 USA; [Srivastava, R.; Spackman, J. B.; Stevenson, A. T.] Univ Utah, Sch Med, Dept Pediat, Primary Childrens Hosp, Salt Lake City, UT USA; [Bale, J. F., Jr.] Univ Utah, Sch Med, Dept Neurol, Primary Childrens Hosp, Salt Lake City, UT USA; [Srivastava, R.] Intermt Healthcare, Inst Hlth Care Delivery Res, Salt Lake City, UT USA; [West, D. C.; Rosenbluth, G.] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Blankenburg, R. L.; Destino, L. A.; Everhart, J. L.; Patel, S. J.] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp Stanford, Dept Pediat,Div Gen Pediat, Palo Alto, CA 94304 USA; [Wilson, K. M.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [O'Toole, J. K.; Solan, L. G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Bismilla, Z.; Coffey, M.; Mahant, S.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Coffey, M.] Hosp Sick Children, Ctr Qual Improvement & Patient Safety, Toronto, ON M5G 1X8, Canada; [Mahant, S.] Hosp Sick Children, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; [Patel, S. J.] Kapiolani Med Ctr Women & Children, Dept Pediat, Div Gen Pediat, Honolulu, HI USA; [Patel, S. J.] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Cole, F. S.] St Louis Childrens Hosp, Edward Mallinckrodt Dept Pediat, St Louis, MO USA; [Cole, F. S.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Balmer, D. F.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Balmer, D. F.] Baylor Coll Med, Houston, TX 77030 USA; [Hepps, J. H.; Lopreiato, J. O.; Yu, C. E.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Dept Pediat, Bethesda, MD 20814 USA; [Lopreiato, J. O.] Uniformed Serv Univ Hlth Sci, Val G Hemming Simulat Ctr, Bethesda, MD 20814 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Drexel University; Drexel University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; University of California System; University of California San Francisco; Lucile Packard Children's Hospital (LPCH); Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centre for Quality Improvement & Patient Safety; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Hawaii System; St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Starmer, AJ (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	amy.starmer@childrens.harvard.edu	Balmer, Dorene/AAY-1185-2021; Hefner, Jennifer/P-5962-2014; West, Daniel/AAW-3111-2020; Satterwhite, Shannon/K-5004-2015; Ramotar, Matt W/K-2193-2019	Hefner, Jennifer/0000-0001-8083-8038; West, Daniel/0000-0002-0909-4213; Satterwhite, Shannon/0000-0002-6351-2287; Balmer, Dorene/0000-0001-6805-4062; Landrigan, Christopher/0000-0001-8386-4100; Blankenburg, Rebecca/0000-0002-1938-6113; Hobson, Wendy/0000-0002-1918-1417	Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019456] Funding Source: NIH RePORTER	Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by the Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, and others.	Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Berry JG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001158; Berry JG, 2011, JAMA-J AM MED ASSOC, V305, P682, DOI 10.1001/jama.2011.122; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Calaman S., 2013, I PASS HANDOFF CURRI; Cohen E, 2011, PEDIATRICS, V127, P529, DOI 10.1542/peds.2010-0910; DeRienzo CM, 2012, ACAD MED, V87, P403, DOI 10.1097/ACM.0b013e318248e5c2; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Feudtner C, 2000, PEDIATRICS, V106, P205; Gordon M, 2011, MED EDUC, V45, P1081, DOI 10.1111/j.1365-2923.2011.04049.x; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Kaushal R, 2002, AM J HEALTH-SYST PH, V59, P2323, DOI 10.1093/ajhp/59.23.2323; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Levine AC, 2010, SLEEP, V33, P1043, DOI 10.1093/sleep/33.8.1043; Lipsitz SR, 2000, BIOMETRICS, V56, P528, DOI 10.1111/j.0006-341X.2000.00528.x; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; O'Toole J. K., 2013, I PASS HANDOFF CURRI; O'Toole JK, 2014, ACAD PEDIATR, V14, P221, DOI 10.1016/j.acap.2014.02.013; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Riesenberg LA, 2009, ACAD MED, V84, P1775, DOI 10.1097/ACM.0b013e3181bf51a6; Rosenbluth G., MEDEDPORTAL, V9, P9397, DOI [10.15766/mep_2374-8265.9397, DOI 10.15766/MEP_2374-8265.9397]; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Sectish TC, 2010, PEDIATRICS, V126, P619, DOI 10.1542/peds.2010-1793; Sentinel Event Data, 2014, SENT EV DAT ROOT CAU; Spector N, 2013, I PASS HAND CURR COR; Starmer A. J., 2013, I PASS HANDOFF CURRI; Starmer AJ, 2014, ACAD MED, V89, P876, DOI 10.1097/ACM.0000000000000264; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Starmer AJ, 2012, PEDIATRICS, V129, P201, DOI 10.1542/peds.2011-2966; TeamSTEPPS, NAT IMPL; The Joint Commission, 2007, IMPR AM HOSP JOINT C; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	451	457	2	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1803	1812		10.1056/NEJMsa1405556	http://dx.doi.org/10.1056/NEJMsa1405556			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372088	Bronze			2022-12-01	WOS:000344170300009
J	Yeung, MSY; Zdunek, S; Bergmann, O; Bernard, S; Salehpour, M; Alkass, K; Perl, S; Tisdale, J; Possnert, G; Brundin, L; Druid, H; Frisen, J				Yeung, Maggie S. Y.; Zdunek, Sofia; Bergmann, Olaf; Bernard, Samuel; Salehpour, Mehran; Alkass, Kanar; Perl, Shira; Tisdale, John; Possnert, Goran; Brundin, Lou; Druid, Henrik; Frisen, Jonas			Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain	CELL			English	Article							WHITE-MATTER MICROSTRUCTURE; CENTRAL-NERVOUS-SYSTEM; ELECTRICAL-ACTIVITY; CELLS; NEUROGENESIS; PROTEINS; AGE; DIFFERENTIATION; PROLIFERATION; DEPENDS	The myelination of axons by oligodendrocytes has been suggested to be modulated by experience, which could mediate neural plasticity by optimizing the performance of the circuitry. We have assessed the dynamics of oligodendrocyte generation and myelination in the human brain. The number of oligodendrocytes in the corpus callosum is established in childhood and remains stable after that. Analysis of the integration of nuclear bomb test-derived C-14 revealed that myelin is exchanged at a high rate, whereas the oligodendrocyte population in white matter is remarkably stable in humans, with an annual exchange of 1/300 oligodendrocytes. We conclude that oligodendrocyte turnover contributes minimally to myelin modulation in human white matter and that this instead may be carried out by mature oligodendrocytes, which may facilitate rapid neural plasticity.	[Yeung, Maggie S. Y.; Zdunek, Sofia; Bergmann, Olaf; Alkass, Kanar; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon, CNRS, UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Forens Med, S-17177 Stockholm, Sweden; [Perl, Shira; Tisdale, John] NHLBI, NIH, Bethesda, MD 20892 USA; [Brundin, Lou] Karolinska Univ Hosp, Karolinska Inst, Dept Neurol & Neurosurg, Dept Clin Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Karolinska Institutet; Karolinska University Hospital	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bergmann, Olaf/A-5706-2009; Bernard, Samuel/A-5623-2009	Bergmann, Olaf/0000-0003-1065-4107; Bernard, Samuel/0000-0002-8442-9968; alkass, kanar/0000-0002-9154-5393; Brundin, Lou/0000-0003-4408-7817; Yeung Wong, Maggie/0000-0001-5487-780X; Druid, Henrik/0000-0002-9198-023X	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; AFA Forsakringar; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institute (StratRegen); Swedish Foundation for Strategic Research; ERC; Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; AFA Forsakringar; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institute (StratRegen); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); ERC(European Research Council (ERC)European Commission); Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation)	We thank M. Carlen for discussions, L. Slomianka for advice on stereology, C. Lebel for providing imaging data, M. Toro and S. Giatrellis for help with flow cytometry, K. Hakansson for AMS sample preparation, and the National Institute of Child, Health, and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD for providing tissue. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, AFA Forsakringar, the Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institute (StratRegen), Swedish Foundation for Strategic Research, the ERC, Torsten Soderbergs Stiftelse, and Knut och Alice Wallenbergs Stiftelse.	Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergmann O, 2013, SCIENCE, V340, P695, DOI 10.1126/science.1237976; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Bhat RV, 1996, GLIA, V17, P169; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fields R.D., 2012, NEUROGLIA; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2013, NEUROIMAGE, V73, P260, DOI 10.1016/j.neuroimage.2012.08.085; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	40	273	274	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					766	774		10.1016/j.cell.2014.10.011	http://dx.doi.org/10.1016/j.cell.2014.10.011			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417154	Green Submitted, Bronze			2022-12-01	WOS:000344522000010
J	Stuart, YE; Campbell, TS; Hohenlohe, PA; Reynolds, RG; Revell, LJ; Losos, JB				Stuart, Y. E.; Campbell, T. S.; Hohenlohe, P. A.; Reynolds, R. G.; Revell, L. J.; Losos, J. B.			Rapid evolution of a native species following invasion by a congener	SCIENCE			English	Article							CHARACTER DISPLACEMENT; ANOLIS-CAROLINENSIS; HABITAT USE; POPULATIONS; COMPETITORS; PREDATION; BEHAVIOR; SAGREI	In recent years, biologists have increasingly recognized that evolutionary change can occur rapidly when natural selection is strong; thus, real-time studies of evolution can be used to test classic evolutionary hypotheses directly. One such hypothesis is that negative interactions between closely related species can drive phenotypic divergence. Such divergence is thought to be ubiquitous, though well-documented cases are surprisingly rare. On small islands in Florida, we found that the lizard Anolis carolinensis moved to higher perches following invasion by Anolis sagrei and, in response, adaptively evolved larger toepads after only 20 generations. These results illustrate that interspecific interactions between closely related species can drive evolutionary change on observable time scales.	[Stuart, Y. E.; Reynolds, R. G.; Losos, J. B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Stuart, Y. E.; Reynolds, R. G.; Losos, J. B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Campbell, T. S.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Hohenlohe, P. A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Hohenlohe, P. A.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Reynolds, R. G.; Revell, L. J.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	Harvard University; Harvard University; University of Tampa; Idaho; University of Idaho; Idaho; University of Idaho; University of Massachusetts System; University of Massachusetts Boston	Stuart, YE (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	yestuart@utexas.edu	Hohenlohe, Paul/AAE-7744-2019; Revell, Liam J/AAF-1151-2019	Hohenlohe, Paul/0000-0002-7616-0161; Revell, Liam J/0000-0003-0767-4713; Reynolds, Robert Graham/0000-0002-0056-8304	Harvard University; Museum of Comparative Zoology; University of Massachusetts Boston; University of Tennessee Knoxville; University of Tampa; NSF [DEB-1110521]; NIH [P30GM103324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103324] Funding Source: NIH RePORTER	Harvard University; Museum of Comparative Zoology; University of Massachusetts Boston; University of Tennessee Knoxville; University of Tampa; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Kamath, C. Gilman, A. Algar, J. Allen, E. Boates, A. Echternacht, A. Harrison, H. Lyons-Galante, T. Max, J. McCrae, J. Newman, J. Rifkin, M. Stimola, P. VanMiddlesworth, K. Winchell, C. Wiench, K. Wollenberg, and three reviewers; M. Legare and J. Lyon (Merritt Island National Wildlife Refuge), J. Stiner and C. Carter (Canaveral National Seashore); and Harvard University, Museum of Comparative Zoology, University of Massachusetts Boston, University of Tennessee Knoxville, University of Tampa, NSF (DEB-1110521), and NIH (P30GM103324) for funding. Y.E.S., T.S.C., and J.B.L. designed the study; Y.E.S., T.S.C., P.A.H., L.J.R, and R.G.R. collected the data; Y.E.S., T.S.C., and P.A.H. analyzed the data; all authors contributed to the manuscript. Data are accessioned on datadryad.org: doi:10.5061/dryad.96g44.	Bono LM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0616; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Campbell T.S., 2000, THESIS U TENNESSEE K; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; Collette B. B., 1961, Bulletin of the Museum of Comparative Zoology, V125, P137; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Edwards JR, 2013, BIOL J LINN SOC, V110, P843, DOI 10.1111/bij.12180; Edwards JR, 2012, ETHOLOGY, V118, P494, DOI 10.1111/j.1439-0310.2012.02037.x; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Glossip D, 1997, HERPETOLOGICA, V53, P192; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Macrini TE, 2003, J HERPETOL, V37, P52, DOI 10.1670/0022-1511(2003)037[0052:EDITCB]2.0.CO;2; Meiri S, 2011, J ANIM ECOL, V80, P824, DOI 10.1111/j.1365-2656.2011.01827.x; Pfennig D. W., 2012, EVOLUTIONS WEDGE; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Rodriguez Schettino Lourdes, 2010, Breviora, P1; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; Shine R, 2012, EVOL APPL, V5, P107, DOI 10.1111/j.1752-4571.2011.00201.x; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; TAPER ML, 1990, SERIES ENTOM, V46, P289; TOKARZ RR, 1987, ANIM BEHAV, V35, P722, DOI 10.1016/S0003-3472(87)80108-2; Tyerman JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-34	27	188	195	11	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					463	466		10.1126/science.1257008	http://dx.doi.org/10.1126/science.1257008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342801	Green Submitted			2022-12-01	WOS:000343822900041
J	Pagliuca, FW; Millman, JR; Gurtler, M; Segel, M; Van Dervort, A; Ryu, JH; Peterson, QP; Greiner, D; Melton, DA				Pagliuca, Felicia W.; Millman, Jeffrey R.; Guertler, Mads; Segel, Michael; Van Dervort, Alana; Ryu, Jennifer Hyoje; Peterson, Quinn P.; Greiner, Dale; Melton, Douglas A.			Generation of Functional Human Pancreatic beta Cells In Vitro	CELL			English	Article							EMBRYONIC STEM-CELLS; INSULIN-SECRETION; DIFFERENTIATION; ISLETS; ENDODERM; MATURATION; MODELS; MICE; PROGENITORS; EXPRESSION	The generation of insulin-producing pancreatic beta cells from stem cells in vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes. However, insulin-producing cells previously generated from human pluripotent stem cells (hPSC) lack many functional characteristics of bona fide beta cells. Here, we report a scalable differentiation protocol that can generate hundreds of millions of glucose-responsive beta cells from hPSC in vitro. These stem-cell-derived beta cells (SC-beta) express markers found in mature beta cells, flux Ca2+ in response to glucose, package insulin into secretory granules, and secrete quantities of insulin comparable to adult beta cells in response to multiple sequential glucose challenges in vitro. Furthermore, these cells secrete human insulin into the serum of mice shortly after transplantation in a glucose-regulated manner, and transplantation of these cells ameliorates hyperglycemia in diabetic mice.	[Pagliuca, Felicia W.; Millman, Jeffrey R.; Guertler, Mads; Segel, Michael; Van Dervort, Alana; Ryu, Jennifer Hyoje; Peterson, Quinn P.; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Greiner, Dale] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA	Harvard University; University of Massachusetts System; University of Massachusetts Worcester	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Alter, Isaac/0000-0002-0253-2161; Peterson, Quinn/0000-0001-8701-0575; Segel, Michael/0000-0001-8986-7417; Millman, Jeffrey/0000-0003-0426-3492	Harvard Stem Cell Institute; Juvenile Diabetes Research Foundation; NIH; Helmsley Charitable Trust; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089572, UC4DK104218] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Chunhui Xie, Eliza Scadden, and Isaac Alter for excellent technical assistance; Maria Ericsson, Elizabeth Benecchi, and Louise Trakimas from the HMS Conventional Electron Microscopy Facility for assistance with electron microscopy; and Dena Cohen, Jeffrey Davis, Adam Roose, Barak Blum, and the Greiner and BetaLogics laboratories for helpful discussions. We also thank the members of the Harvard Stem Cell Institute Histology Core and Flow Cytometry Core facilities for invaluable assistance. The NRG-Akita mice were generously provided by Dr. Leonard Shultz. J.R.M. was supported by a fellowship from the Harvard Stem Cell Institute. Q.P.P. was supported by a fellowship from the Juvenile Diabetes Research Foundation. D.A.M. is an Investigator of the Howard Hughes Medical Institute. This work was supported by grants from the Harvard Stem Cell Institute, NIH, Helmsley Charitable Trust, the JPB Foundation and the generosity of M. and A. Barry. D.G. is a consultant for The Jackson Laboratory.	Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DECONINCK JF, 1971, DIABETOLOGIA, V7, P266, DOI 10.1007/BF01211879; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Fujita Y, 2011, ISLETS, V3, P1, DOI 10.4161/isl.3.1.14131; GAMER LW, 1995, DEV BIOL, V171, P240, DOI 10.1006/dbio.1995.1275; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Henry GL, 1998, SCIENCE, V281, P91, DOI 10.1126/science.281.5373.91; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim SK, 2000, GENE DEV, V14, P1866; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LIKE AA, 1972, DIABETES, V21, P511, DOI 10.2337/diab.21.2.S511; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Mohammed JS, 2009, LAB CHIP, V9, P97, DOI 10.1039/b809590f; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Narayanan K, 2014, TISSUE ENG PT A, V20, P424, DOI [10.1089/ten.TEA.2013.0257, 10.1089/ten.tea.2013.0257]; Ninomiya H, 1999, DEV GROWTH DIFFER, V41, P391; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rutter GA, 2013, MOL ENDOCRINOL, V27, P1984, DOI 10.1210/me.2013-1278; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Thowfeequ S, 2007, DIABETOLOGIA, V50, P1688, DOI 10.1007/s00125-007-0724-y; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	44	1212	1305	7	378	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					428	439		10.1016/j.cell.2014.09.040	http://dx.doi.org/10.1016/j.cell.2014.09.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303535	Bronze, Green Accepted			2022-12-01	WOS:000343095600022
J	Ladapo, JA; Blecker, S; Douglas, PS				Ladapo, Joseph A.; Blecker, Saul; Douglas, Pamela S.			Physician Decision Making and Trends in the Use of Cardiac Stress Testing in the United States An Analysis of Repeated Cross-sectional Data	ANNALS OF INTERNAL MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; GENDER-DIFFERENCES; TEMPORAL TRENDS; HEART-DISEASE; APPROPRIATENESS CRITERIA; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; AMERICAN SOCIETY; CORONARY; ANGIOGRAPHY	Background: Cardiac stress testing, particularly with imaging, has been the focus of debates about rising health care costs, inappropriate use, and patient safety in the context of radiation exposure. Objective: To determine whether U. S. trends in cardiac stress test use may be attributable to population shifts in demographics, risk factors, and provider characteristics and evaluate whether racial/ethnic disparities exist in physician decision making. Design: Analyses of repeated cross-sectional data. Setting: National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey (1993 to 2010). Patients: Adults without coronary heart disease. Measurements: Cardiac stress test referrals and inappropriate use. Results: Between 1993 to 1995 and 2008 to 2010, the annual number of U. S. ambulatory visits in which a cardiac stress test was ordered or performed increased from 28 per 10 000 visits to 45 per 10 000 visits. No trend was found toward more frequent testing after adjustment for patient characteristics, risk factors, and provider characteristics (P = 0.134). Cardiac stress tests with imaging comprised a growing portion of all tests, increasing from 59% in 1993 to 1995 to 87% in 2008 to 2010. At least 34.6% were probably inappropriate, with associated annual costs and harms of $501 million and 491 future cases of cancer. Authors found no evidence of a lower likelihood of black patients receiving a cardiac stress test (odds ratio, 0.91 [95% CI, 0.69 to 1.21]) than white patients, although some evidence of disparity in Hispanic patients was found (odds ratio, 0.75 [CI, 0.55 to 1.02]). Limitation: Cross-sectional design with limited clinical data. Conclusion: National growth in cardiac stress test use can largely be explained by population and provider characteristics, but use of imaging cannot. Physician decision making about cardiac stress test use does not seem to contribute to racial/ethnic disparities in cardiovascular disease.	NYU, Sch Med, New York, NY 10016 USA; Duke Univ, Sch Med, Durham, NC 27715 USA	New York University; Duke University	Ladapo, JA (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,VZ30 6th Floor,Room 614, New York, NY 10016 USA.	joseph.ladapo@nyumc.org		Douglas, Pamela/0000-0001-9876-4049; Ladapo, Joseph/0000-0002-8518-4800	National Heart, Lung, and Blood Institute; National Center for Advancing Translational Sciences; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000053] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116787] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Heart, Lung, and Blood Institute and the National Center for Advancing Translational Sciences.	American Academy of Family Physicians ABIM Foundation, 2012, CHOOS WIS EKGS EX ST; American College of Cardiology ABIM Foundation, 2013, CHOOS WIS IM TESTS H; American College of Physicians ABIM Foundation, 2012, CHOOS WIS STRESS TES; American Society of Nuclear Cardiology ABIM Foundation, 2012, CHOOS WIS STRESS TES; Andrus BW, 2012, CIRC-CARDIOVASC QUAL, V5, P31, DOI 10.1161/CIRCOUTCOMES.111.961813; [Anonymous], 2014, ACR APPR CRIT; [Anonymous], 2009, ECHOC MARK GUID US S; [Anonymous], 2007, MYOC PERF IM MARK S; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Brenner DJ, 2010, NEW ENGL J MED, V362, P943, DOI 10.1056/NEJMe1000802; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Centers for Disease Control and Prevention, 2014, HLTH PEOPL HLTH PEOP; Chang AM, 2007, ACAD EMERG MED, V14, P599, DOI 10.1197/j.aem.2007.03.1355; Cohen MC, 1999, AM HEART J, V138, P1019, DOI 10.1016/S0002-8703(99)70065-7; de Gonzalez AB, 2010, CIRCULATION, V122, P2403, DOI 10.1161/CIRCULATIONAHA.110.941625; Einstein AJ, 2010, JAMA-J AM MED ASSOC, V304, P2137, DOI 10.1001/jama.2010.1664; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Gibbons RJ, 2008, J AM COLL CARDIOL, V51, P1283, DOI 10.1016/j.jacc.2007.10.064; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; HSIAO WC, 1988, JAMA-J AM MED ASSOC, V260, P2347, DOI 10.1001/jama.260.16.2347; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Ladapo JA, 2008, AM J ROENTGENOL, V191, P455, DOI 10.2214/AJR.07.3611; Ladapo JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000505; Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012; Lauer MS, 1996, AM J CARDIOL, V78, P278, DOI 10.1016/S0002-9149(96)00277-9; Levin DC, 2011, AM J ROENTGENOL, V196, pW25, DOI 10.2214/AJR.10.4835; Lillie-Blanton M, 2004, J AM COLL CARDIOL, V44, P503, DOI 10.1016/j.jacc.2004.04.043; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Miller TD, 2001, J AM COLL CARDIOL, V38, P690, DOI 10.1016/S0735-1097(01)01413-9; National Center for Health Statistics, 2013, AMB HLTH CAR DAT REL; National Center for Health Statistics, 2009, 2009 NAMCS PUBL US D; National Center for Health Statistics, 2013, AMB HLTH CAR DAT QUE; Nelson K, 2002, ARCH INTERN MED, V162, P929, DOI 10.1001/archinte.162.8.929; Rao VM, 2012, ANN INTERN MED, V157, P574, DOI 10.7326/0003-4819-157-8-201210160-00535; Roger VL, 1998, J AM COLL CARDIOL, V32, P345, DOI 10.1016/S0735-1097(98)00229-0; Rozanski A, 2013, J AM COLL CARDIOL, V61, P1054, DOI 10.1016/j.jacc.2012.11.056; Shaw LJ, 2010, JACC-CARDIOVASC IMAG, V3, P789, DOI 10.1016/j.jcmg.2010.05.004; Shaw LJ, 2005, EUR HEART J, V26, P447, DOI 10.1093/eurheartj/ehi102; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Will JC, 2014, CIRC-CARDIOVASC QUAL, V7, P110, DOI 10.1161/CIRCOUTCOMES.113.000450; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009	45	113	114	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					482	+		10.7326/M14-0296	http://dx.doi.org/10.7326/M14-0296			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25285541	Green Accepted			2022-12-01	WOS:000343896700007
J	Guo, X; Wang, L; Li, J; Ding, ZY; Xiao, JX; Yin, XT; He, S; Shi, P; Dong, LP; Li, GH; Tian, CL; Wang, JW; Cong, Y; Xu, YH				Guo, Xue; Wang, Ling; Li, Jie; Ding, Zhanyu; Xiao, Jianxiong; Yin, Xiaotong; He, Shuang; Shi, Pan; Dong, Liping; Li, Guohong; Tian, Changlin; Wang, Jiawei; Cong, Yao; Xu, Yanhui			Structural insight into autoinhibition and histone H3-induced activation of DNMT3A	NATURE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; MAMMALIAN DEVELOPMENT; RECOMBINANT HISTONES; HIGH-RESOLUTION; METHYLTRANSFERASE; PATTERNS; EXPRESSION; SOFTWARE; GENOME	DNA methylation is an important epigenetic modification that is essential for various developmental processes through regulating gene expression, genomic imprinting, and epigenetic inheritance(1-5). Mammalian genomic DNA methylation is established during embryogenesis by de novo DNA methyltransferases, DNMT3A and DNMT3B(6-8), and the methylation patterns vary with developmental stages and cell types(9-12). DNAmethyltransferase 3-like protein (DNMT3L) is a catalytically inactive paralogue of DNMT3 enzymes, which stimulates the enzymatic activity of Dnmt3a(13). Recent studies have established a connection between DNA methylation and histone modifications, and revealed a histone-guided mechanism for the establishment of DNA methylation(14). The ATRX-DNMT3-DNMT3L (ADD) domain of Dnmt3a recognizes unmethylated histone H3 (H3K4me0)(15-17). The histone H3 tail stimulates the enzymatic activity of Dnmt3a in vitro(17,18), whereas the molecular mechanism remains elusive. Here we show that DNMT3A exists in an autoinhibitory form and that the histone H3 tail stimulates its activity in a DNMT3L-independent manner. We determine the crystal structures of DNMT3A-DNMT3L (autoinhibitory form) and DNMT3A-DNMT3L-H3 (active form) complexes at 3.82 and 2.90 angstrom resolution, respectively. Structural and biochemical analyses indicate that the ADD domain of DNMT3A interacts with and inhibits enzymatic activity of the catalyticdomain (CD) through blocking its DNA-binding affinity. HistoneH3(but not H3K4me3) disrupts ADD-CD interaction, induces a large movement of the ADD domain, and thus releases the autoinhibition of DNMT3A. The finding adds another layer of regulation of DNA methylation to ensure that the enzyme is mainly activated at proper targeting loci when unmethylated H3K4 is present, and strongly supports a negative correlation between H3K4me3 and DNA methylation across the mammalian genome(9,10,19,20). Our study provides a new insight into an unexpected autoinhibition and histone H3-induced activation of the de novo DNA methyltransferase after its initial genomic positioning.	[Guo, Xue; Wang, Ling; Li, Jie; Xiao, Jianxiong; Yin, Xiaotong; He, Shuang; Xu, Yanhui] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Guo, Xue; Wang, Ling; Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ding, Zhanyu; Cong, Yao] Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Prot Sci Shanghai, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Shi, Pan; Tian, Changlin] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Peoples R China; [Shi, Pan; Tian, Changlin] Univ Sci & Technol China, Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shi, Pan; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Dong, Liping; Li, Guohong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Dong, Liping] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Xu, YH (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.	xuyh@fudan.edu.cn	Wang, Jiawei/D-1144-2010; Wang, Ling/AAC-9797-2021; Xu, Yanhui/D-5119-2019; Xiao, Jianxiong/ABA-4938-2021; Wang, Ling/HGA-0927-2022	Wang, Jiawei/0000-0001-9893-8539; Xiao, Jianxiong/0000-0002-7263-0226; 	National Basic Research Program of China [2011CB965300, 2009CB918600, 2013CB910401]; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China [2014ZX09507-002, 2011ZX09506-001]; National Natural Science Foundation of China [31270779, 91419301, 31030019, U1432242, 31270771, 31222016, 31300685, U1332138]; Basic Research Project of Shanghai Science and Technology Commission [12JC1402700, 13JC1406300]; Fok Ying Tung Education Foundation [20090071220012]; Chinese Academy of Sciences Pilot Strategic Science and Technology Projects B [XDB08030201, XDB08030302]	National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Chinese Academy of Sciences Pilot Strategic Science and Technology Projects B	We thank staff of beamline BL17U at Shanghai Synchrotron Radiation Facility, China, for their assistance in data collection, and H. Wang for help on electron microscopy analyses. We thank staff of the Biomedical Core Facility, Fudan University, for their help on biochemical analyses, and A. D. Riggs for providing the complementary DNAs of DNMT3A and DNMT3L. This work was supported by grants from the National Basic Research Program of China (2011CB965300, 2009CB918600, 2013CB910401), the National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China (2014ZX09507-002, 2011ZX09506-001), the National Natural Science Foundation of China (31270779, 91419301, 31030019, U1432242, 31270771, 31222016,31300685, U1332138), the Basic Research Project of Shanghai Science and Technology Commission (12JC1402700, 13JC1406300), the Fok Ying Tung Education Foundation (20090071220012), and the Chinese Academy of Sciences Pilot Strategic Science and Technology Projects B (numbers XDB08030201,XDB08030302). Y.C. is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cong Y, 2010, METHOD ENZYMOL, V482, P211, DOI 10.1016/S0076-6879(10)82009-9; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guibert S, 2009, EPIGENOMICS-UK, V1, P81, DOI 10.2217/EPI.09.5; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludtke S. J., 2001, JMB; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1999, METH MOL B, V119, P1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajavelu A, 2012, NUCLEIC ACIDS RES, V40, P569, DOI 10.1093/nar/gkr753; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Shi P, 2011, PROTEIN SCI, V20, P224, DOI 10.1002/pro.545; Shi P, 2010, BIOCHEM BIOPH RES CO, V402, P461, DOI 10.1016/j.bbrc.2010.10.046; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	43	210	221	1	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					640	U281		10.1038/nature13899	http://dx.doi.org/10.1038/nature13899			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25383530				2022-12-01	WOS:000348775000049
J	Wang, XX; Ren, JS; Gao, Q; Hu, ZY; Sun, Y; Li, XM; Rowlands, DJ; Yin, WD; Wang, JZ; Stuart, DI; Rao, ZH; Fry, EE				Wang, Xiangxi; Ren, Jingshan; Gao, Qiang; Hu, Zhongyu; Sun, Yao; Li, Xuemei; Rowlands, David J.; Yin, Weidong; Wang, Junzhi; Stuart, David I.; Rao, Zihe; Fry, Elizabeth E.			Hepatitis A virus and the origins of picornaviruses	NATURE			English	Article							CAPSID PROTEIN; CRYSTAL-STRUCTURE; POLIOVIRUS; RESOLUTION; RECEPTOR; STABILITY; MODEL; SITE	Hepatitis A virus(HAV) remains enigmatic, despite 1.4 million cases worldwide annually(1). It differs radically from other picornaviruses, existing in an enveloped form(2) and being unusually stable, both genetically and physically(3), but has proved difficult to study. Here we report high-resolution X-ray structures for the mature virus and the empty particle. The structures of the two particles are indistinguishable, apart from some disorder on the inside of the empty particle. The full virus contains the small viral protein VP4, whereas the empty particle harbours only the uncleaved precursor, VP0. The smooth particle surface is devoid of depressions that might correspond to receptor-binding sites. Peptide scanning data extend the previously reported VP3 antigenic site4, while structure-based predictions(5) suggest further epitopes. HAV contains no pocket factor and can withstand remarkably high temperature and low pH, and empty particles are even more robust than full particles. The virus probably uncoats via a novel mechanism, being assembled differently to other picornaviruses. It utilizes a VP2 'domain swap' characteristic of insect picorna-like viruses(6,7), and structure-based phylogenetic analysis places HAV between typical picornaviruses and the insect viruses. The enigmatic properties of HAV may reflect its position as a link between 'modern' picornaviruses and the more 'primitive' precursor insect viruses; for instance, HAV retains the ability to move from cell-to-cell by transcytosis(8,9).	[Wang, Xiangxi; Gao, Qiang; Sun, Yao; Li, Xuemei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China; [Ren, Jingshan; Stuart, David I.; Fry, Elizabeth E.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Gao, Qiang; Yin, Weidong] Sinovac Biotech Co Ltd, Beijing 100085, Peoples R China; [Hu, Zhongyu; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Rowlands, David J.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Rowlands, David J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Stuart, David I.] Diamond Light Sources, Didcot OX11 0DE, Oxon, England; [Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Rao, Zihe] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Oxford; National Institute of Food & Drug Control - China; University of Leeds; University of Leeds; Diamond Light Source; Tsinghua University; Nankai University	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genomic Med, Oxford OX3 7BN, England.	wangjz@nicpbp.org.cn; dave@strubi.ox.ac.uk; raozh@xtal.tsinghua.edu.cn	Ren, Jingshan/AAT-7729-2021; Rao, Zihe/HCH-6944-2022	Ren, Jingshan/0000-0003-4015-1404; Stuart, David/0000-0002-3426-4210; Fry, Elizabeth/0000-0001-9754-5303	Chinese Academy of Sciences [XDB08020200]; Ministry of Science and Technology 973 Project [2014CB542800]; National Major Project of Infectious Disease [2012ZX10004701]; National Science Foundation [81330036]; Medical Research Council [G1000099, MR/N00065X/1, G1100525, G19/3] Funding Source: researchfish; MRC [G1000099, MR/N00065X/1, G19/3] Funding Source: UKRI; STFC [ST/J001465/1] Funding Source: UKRI	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology 973 Project(National Basic Research Program of China); National Major Project of Infectious Disease; National Science Foundation(National Science Foundation (NSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academyof Sciences, grant no. XDB08020200, the Ministry of Science and Technology 973 Project (grant no. 2014CB542800), the National Major Project of Infectious Disease (2012ZX10004701) and National Science Foundation grant 81330036. D. I. S. and E. E. F. are supported by the UK Medical Research Council (grant G1000099) and J. R. by the Wellcome Trust. This work is a contribution fromthe Instruct Centre, Oxford. Administrative support was provided by the Wellcome Trust (075491/Z/04). We thank J. Johnson and A. Routh for supplying CrPV, and S. Lemon and K. McKnight for discussions.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; [Anonymous], 2002, PYMOL MOL GRAPH SYST; BISHOP NE, 1993, VIROLOGY, V197, P616, DOI 10.1006/viro.1993.1636; Borley DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061122; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butan C, 2014, J VIROL, V88, P1758, DOI 10.1128/JVI.01949-13; CHAPMAN MS, 1993, VIROLOGY, V195, P745, DOI 10.1006/viro.1993.1425; De Colibus LG, 2014, NAT STRUCT MOL BIOL, V21, P282, DOI 10.1038/nsmb.2769; DEINHARDT F, 1992, VACCINE, V10, pS10, DOI 10.1016/0264-410X(92)90532-O; Dotauer A, 2005, J GEN VIROL, V86, P2747, DOI 10.1099/vir.0.81157-0; Dotzauer A, 2000, J VIROL, V74, P10950, DOI 10.1128/JVI.74.23.10950-10957.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; FILMAN DJ, 1989, EMBO J, V8, P1567, DOI 10.1002/j.1460-2075.1989.tb03541.x; Garriga D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002473; Graff J, 1999, J VIROL, V73, P6015, DOI 10.1128/JVI.73.7.6015-6023.1999; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEMON SM, 1983, INFECT IMMUN, V42, P418, DOI 10.1128/IAI.42.1.418-420.1983; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Ren JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2889; Riffel N, 2002, STRUCTURE, V10, P1627, DOI 10.1016/S0969-2126(02)00896-1; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIEGL G, 1984, INTERVIROLOGY, V22, P218, DOI 10.1159/000149554; SIEGL G, 1981, J GEN VIROL, V57, P331, DOI 10.1099/0022-1317-57-2-331; Squires G, 2013, ACTA CRYSTALLOGR D, V69, P1026, DOI 10.1107/S0907444913004617; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; TESAR M, 1993, VIROLOGY, V194, P616, DOI 10.1006/viro.1993.1301; Walter TS, 2012, J VIROL METHODS, V185, P166, DOI 10.1016/j.jviromet.2012.06.014; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; WARWICKER J, 1992, J MOL BIOL, V223, P247, DOI 10.1016/0022-2836(92)90729-4; WHO, 2013, HEP A	39	114	119	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					85	U214		10.1038/nature13806	http://dx.doi.org/10.1038/nature13806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25327248	Green Accepted			2022-12-01	WOS:000347178400040
J	Kernbauer, E; Ding, Y; Cadwell, K				Kernbauer, Elisabeth; Ding, Yi; Cadwell, Ken			An enteric virus can replace the beneficial function of commensal bacteria	NATURE			English	Article							AUTOPHAGY GENE ATG16L1; DAY-CARE-CENTER; GUT MICROBIOTA; INFECTION; DISEASE; VIROME; PATHOGENESIS; INFLAMMATION; REPLICATION; RESISTANCE	Intestinal microbial communities have profound effects on host physiology(1). Whereas the symbiotic contribution of commensal bacteria is well established, the role of eukaryotic viruses that are present in the gastrointestinal tract under homeostatic conditions is undefined(2,3). Here we demonstrate that a common enteric RNA virus can replace the beneficial function of commensal bacteria in the intestine. Mmine norovirus (MNV) infection of germ-free or antibiotictreated mice restored intestinal morphology and lymphocyte function without inducing overt inflammation and disease. The presence of MNV also suppressed an expansion of group 2 innate lymphoid cells observed in the absence of bacteria, and induced transcriptional changes in the intestine associated with immune development and type I interferon (IFN) signalling. Consistent with this observation, the IFN-a receptor was essential for the ability of MNV to compensate for bacterial depletion. Importantly, MNV infection offset the deleterious effect of treatment with antibiotics in models of intestinal injury and pathogenic bacterial infection. These data indicate that eukaryotic viruses have the capacity to support intestinal homeostasis and shape mucosal immunity, similarly to commensal bacteria.	[Kernbauer, Elisabeth; Cadwell, Ken] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Kernbauer, Elisabeth; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ding, Yi] New York Presbyterian Hosp, New York, NY 10065 USA; [Ding, Yi] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; NewYork-Presbyterian Hospital; New York University	Cadwell, K (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	ken.cadwell@med.nyu.edu		Cadwell, Ken/0000-0002-5860-0661	Cancer Center Support Grant [P30CA016087]; National Institutes of Health [R01 DK093668]; New York University Whitehead Fellowship; Vilcek Fellowship; Erwin Schrodinger Fellowship from the Austrian Science Foundation; Austrian Science Fund (FWF) [J 3435] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093668] Funding Source: NIH RePORTER	Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Whitehead Fellowship; Vilcek Fellowship; Erwin Schrodinger Fellowship from the Austrian Science Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S. Koralov and P. Loke for advice on the manuscript, E. Venturin i for assistance with deep sequencing, S. Brown and Z. Tang for data analysis, L. Ciriboga for CD3 staining, the flow cytometry and histopathology cores (Cancer Center Support Grant, P30CA016087) for assistance with sample preparation and analyses, M. Alva and D. Littman for assistance with breeding and maintaining GF mice, and H. Moura Silva for sample collection for MNV isolation. This research was supported by National Institutes of Health grant R01 DK093668 (K.C.) and a New York University Whitehead Fellowship (K.C.), Vilcek Fellowship (E.K.) and Erwin Schrodinger Fellowship from the Austrian Science Foundation (E.K.).	Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; GROHMANN G, 1991, J CLIN MICROBIOL, V29, P544, DOI 10.1128/JCM.29.3.544-550.1991; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kim M, 2010, VIRUS RES, V147, P1, DOI 10.1016/j.virusres.2009.08.013; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lipkin WI, 2013, CURR OPIN VIROL, V3, P199, DOI 10.1016/j.coviro.2013.03.010; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; MATSON DO, 1990, PEDIATR INFECT DIS J, V9, P190, DOI 10.1097/00006454-199003000-00009; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ott C, 2000, J GEN VIROL, V81, P2949, DOI 10.1099/0022-1317-81-12-2949; Popgeorgiev N, 2013, INTERVIROLOGY, V56, P395, DOI 10.1159/000354561; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Tajima M, 2013, EXP ANIM TOKYO, V62, P127, DOI 10.1538/expanim.62.127; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	38	320	336	5	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					94	U223		10.1038/nature13960	http://dx.doi.org/10.1038/nature13960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25409145	Green Accepted			2022-12-01	WOS:000346310800046
J	Morgan, B				Morgan, Branwen			FATTY LIVER DISEASE: The liver labyrinth	NATURE			English	Editorial Material													Morgan, Branwen/ABG-1328-2021	Morgan, Branwen/0000-0001-5318-1675				Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Griffett K, 2013, ACS CHEM BIOL, V8, P559, DOI 10.1021/cb300541g; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001	4	6	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S8	S9		10.1038/516S8a	http://dx.doi.org/10.1038/516S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470200	Bronze			2022-12-01	WOS:000346310800003
J	Sanchez-Garcia, F; Villagrasa, P; Matsui, J; Kotliar, D; Castro, V; Akavia, UD; Chen, BJ; Saucedo-Cuevas, L; Barrueco, RR; Llobet-Navas, D; Silva, JM; Pe'er, D				Sanchez-Garcia, Felix; Villagrasa, Patricia; Matsui, Junji; Kotliar, Dylan; Castro, Veronica; Akavia, Uri-David; Chen, Bo-Juen; Saucedo-Cuevas, Laura; Barrueco, Ruth Rodriguez; Llobet-Navas, David; Silva, Jose M.; Pe'er, Dana			Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers	CELL			English	Article							COPY-NUMBER ALTERATION; ABERRATIONS; EXPRESSION; MUTATIONS; LANDSCAPE; RSF-1; RNAI; OVEREXPRESSION; RSF-1/HBXAP; SURVIVAL	Identifying driver genes in cancer remains a crucial bottleneck in therapeutic development and basic understanding of the disease. We developed Helios, an algorithm that integrates genomic data from primary tumors with data from functional RNAi screens to pinpoint driver genes within large recurrently amplified regions of DNA. Applying Helios to breast cancer data identified a set of candidate drivers highly enriched with known drivers (p < 10(-14)). Nine of ten top-scoring Helios genes are known drivers of breast cancer, and in vitro validation of 12 candidates predicted by Helios found ten conferred enhanced anchorage-independent growth, demonstrating Helios's exquisite sensitivity and specificity. We extensively characterized RSF-1, a driver identified by Helios whose amplification correlates with poor prognosis, and found increased tumorigenesis and metastasis in mouse models. We have demonstrated a powerful approach for identifying driver genes and how it can yield important insights into cancer.	[Sanchez-Garcia, Felix; Kotliar, Dylan; Akavia, Uri-David; Chen, Bo-Juen; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Sanchez-Garcia, Felix; Kotliar, Dylan; Akavia, Uri-David; Chen, Bo-Juen; Pe'er, Dana] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Sanchez-Garcia, Felix] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Villagrasa, Patricia; Matsui, Junji; Castro, Veronica; Saucedo-Cuevas, Laura; Barrueco, Ruth Rodriguez; Llobet-Navas, David; Silva, Jose M.] Mt Sinai Hosp, Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Silva, JM (corresponding author), Mt Sinai Hosp, Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	jose.silva@mssm.edu; dpeer@biology.columbia.edu	Akavia, Uri David/P-8437-2019; Rodriguez-Barrueco, Ruth/F-6810-2010; Llobet-Navas, David/AAT-4676-2021; Llobet-Navas, David/B-5660-2009	Rodriguez-Barrueco, Ruth/0000-0003-4925-8865; Llobet-Navas, David/0000-0003-1443-7003; Villagrasa-Gonzalez, Patricia/0000-0002-8662-3641; Pe'er, Dana/0000-0002-9259-8817; Saucedo-Cuevas, Laura/0000-0001-5904-5041	NIH [R01CA164729, DP2OD002414]; National Centers for Biomedical Computing grant [1U54CA121852-01A1]; Cancer Research UK [19556] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA164729, U54CA121852] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing grant; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Sourav Bandyopadhyay, Oren Litvin, Richard Marcotte, Ben Neel, Ramon Parsons, and Sagi Shapira for valuable comments. This research was supported by the NIH (grants R01CA164729 and DP2OD002414) and a National Centers for Biomedical Computing grant (1U54CA121852-01A1). D. P. holds a Packard Fellowship for Science and Engineering.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BRUNK HD, 1955, ANN MATH STAT, V26, P607, DOI 10.1214/aoms/1177728420; CAMPBELL SM, 1988, EXP CELL RES, V177, P109, DOI 10.1016/0014-4827(88)90029-8; Chen TJ, 2011, APMIS, V119, P808, DOI 10.1111/j.1600-0463.2011.02808.x; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Danussi C., 2013, CANC RES; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Fang FM, 2011, AM J PATHOL, V178, P2407, DOI 10.1016/j.ajpath.2011.01.043; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu BS, 2012, INT J CLIN EXP PATHO, V5, P668; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li QC, 2012, BIOCHEM BIOPH RES CO, V420, P6, DOI 10.1016/j.bbrc.2012.02.095; Liu SL, 2012, TUMOR BIOL, V33, P1485, DOI 10.1007/s13277-012-0399-y; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morganella S, 2011, BIOINFORMATICS, V27, P2949, DOI 10.1093/bioinformatics/btr488; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Pires MM, 2013, CANCER BIOL THER, V14, P246, DOI 10.4161/cbt.23297; Pletscher-Frankild S., 2014, DIS TEXT MINING DATA; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sheu JJC, 2013, J PATHOL, V229, P559, DOI 10.1002/path.4147; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Widmer C., 2011, JMLR WORKSH C P, V27, P207; Wong WC, 2011, BIOINFORMATICS, V27, P2147, DOI 10.1093/bioinformatics/btr357; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yuan XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052516; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	49	63	65	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1461	1475		10.1016/j.cell.2014.10.048	http://dx.doi.org/10.1016/j.cell.2014.10.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25433701	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000346652900022
J	Savage, N				Savage, Neil			BORN IN THE BLOOD	NATURE			English	Editorial Material																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S158	S159		10.1038/515S158a	http://dx.doi.org/10.1038/515S158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427204	Bronze			2022-12-01	WOS:000346247600006
J	MacBean, N; Peylin, P				MacBean, Natasha; Peylin, Philippe			BIOGEOCHEMISTRY Agriculture and the global carbon cycle	NATURE			English	Editorial Material							ATMOSPHERIC CO2; NORTHERN ECOSYSTEMS; VEGETATION; AMPLITUDE	Evolving agricultural practices dramatically increased crop production in the twentieth century. Two studies now find that this has altered the seasonal flux of atmospheric carbon dioxide. See Letters p. 394 & p. 398	[MacBean, Natasha; Peylin, Philippe] LOrme Merisiers, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	MacBean, N (corresponding author), LOrme Merisiers, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France.	natasha.macbean@lsce.ipsl.fr	MacBean, Natasha/L-2190-2015	MacBean, Natasha/0000-0001-6797-4836; Peylin, Philippe/0000-0001-9335-6994				Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; FAO, 2013, FAO STAT YB 2013; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Gray JM, 2014, NATURE, V515, P398, DOI 10.1038/nature13957; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kohlmaier GH, 1989, TELLUS B, V41, P487, DOI 10.1111/j.1600-0889.1989.tb00137.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Zeng N, 2014, NATURE, V515, P394, DOI 10.1038/nature13893; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	12	11	15	6	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					351	352		10.1038/515351a	http://dx.doi.org/10.1038/515351a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409823				2022-12-01	WOS:000345770600032
J	Huang, PS; Oberdorfer, G; Xu, CF; Pei, XY; Nannenga, BL; Rogers, JM; DiMaio, F; Gonen, T; Luisi, B; Baker, D				Huang, Po-Ssu; Oberdorfer, Gustav; Xu, Chunfu; Pei, Xue Y.; Nannenga, Brent L.; Rogers, Joseph M.; DiMaio, Frank; Gonen, Tamir; Luisi, Ben; Baker, David			High thermodynamic stability of parametrically designed helical bundles	SCIENCE			English	Article							COILED-COIL; PROTEINS	We describe a procedure for designing proteins with backbones produced by varying the parameters in the Crick coiled coil-generating equations. Combinatorial design calculations identify low-energy sequences for alternative helix supercoil arrangements, and the helices in the lowest-energy arrangements are connected by loop building. We design an antiparallel monomeric untwisted three-helix bundle with 80-residue helices, an antiparallel monomeric right-handed four-helix bundle, and a pentameric parallel left-handed five-helix bundle. The designed proteins are extremely stable (extrapolated Delta G(fold) > 60 kilocalories per mole), and their crystal structures are close to those of the design models with nearly identical core packing between the helices. The approach enables the custom design of hyperstable proteins with fine-tuned geometries for a wide range of applications.	[Huang, Po-Ssu; Oberdorfer, Gustav; Xu, Chunfu; DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Oberdorfer, Gustav; Xu, Chunfu; DiMaio, Frank; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Oberdorfer, Gustav] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Pei, Xue Y.; Luisi, Ben] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Nannenga, Brent L.; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Rogers, Joseph M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Graz; University of Cambridge; Howard Hughes Medical Institute; University of Cambridge; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Rogers, Joseph/AGZ-9056-2022; Xu, Chunfu/B-5963-2012	Baker, David/0000-0001-7896-6217; Rogers, Joseph/0000-0002-1313-4089; Huang, Possu/0000-0002-7948-2895; Xu, Chunfu/0000-0002-8668-0566; Nannenga, Brent/0000-0001-6859-3429; Oberdorfer, Gustav/0000-0002-6144-9114	Advanced Light Source (U.S. Department of Energy) [DE-AC02-05CH11231]; Howard Hughes Medical Institute; Defense Threat Reduction Agency; Wellcome Trust; Biotechnology and Biological Sciences Research Council	Advanced Light Source (U.S. Department of Energy)(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are indebted to G. Grigoryan and W. DeGrado for their paper on coiled-coil geometry and to G. Grigoryan for the CCCP Web server that was used in initial exploratory calculations, and for helpful advice. We thank S. Gordon for protein production, Rosetta@Home volunteers for providing the computing throughput to rigorously test designs by ab initio structure prediction, and the staff at Diamond Light source and at the Advanced Light Source (U.S. Department of Energy contract no. DE-AC02-05CH11231) for access and assistance with x-ray data collection. This work was supported by Howard Hughes Medical Institute, Defense Threat Reduction Agency, and the Wellcome Trust. G.O. is a Marie Curie International Outgoing Fellowship fellow (332094 ASR-CompEnzDes FP7-People-2012-IOF). J.M.R. was supported by a studentship from the Biotechnology and Biological Sciences Research Council. Coordinates and structure factors have been deposited in the Protein Data Bank with the accession codes 4TQL (3H5L_2), 4UOS (4H3L_3), and 4UOT (5L2L_2.1). P.S.H., G.O., C.X., and D.B. designed the research. D.B. wrote the parametric backbone generation code; P.S.H. wrote the loop modeling code; and P.S.H., G.O., C.X., and D.B. carried out design calculations and biophysical analyses. J.M.R. characterized 3H5L_2 and 3H5L_2_mini. With help from G.O. and F.D., X.Y.P. and B.L. solved structures of 4H3L_3 and 5H2L_2, and B.L.N. and T.G. solved the 3H5L_2 bundle structure and did electron microscopy analysis.	Boyle AL, 2011, CHEM SOC REV, V40, P4295, DOI 10.1039/c0cs00152j; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; CHOU KC, 1990, J MOL BIOL, V213, P315, DOI 10.1016/S0022-2836(05)80193-7; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Pace C N, 1986, Methods Enzymol, V131, P266; Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/NCHEMBIO.692, 10.1038/nchembio.692]	18	179	185	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					481	485		10.1126/science.1257481	http://dx.doi.org/10.1126/science.1257481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342806	Green Accepted, Green Submitted			2022-12-01	WOS:000343822900046
J	Moreno, SP; Bailey, R; Campion, N; Herron, S; Gambus, A				Moreno, Sara Priego; Bailey, Rachael; Campion, Nicholas; Herron, Suzanne; Gambus, Agnieszka			Polyubiquitylation drives replisome disassembly at the termination of DNA replication	SCIENCE			English	Article							CHROMATIN; PROGRESSION; PROTEINS; XENOPUS; CDT1; ASSOCIATION; DESTRUCTION; PROTEOLYSIS; COMPLEXES; PREVENTS	Resolution of replication forks during termination of DNA replication is essential for accurate duplication of eukaryotic genomes. Here we present evidence consistent with the idea that polyubiquitylation of a replisome component (Mcm7) leads to its disassembly at the converging terminating forks because of the action of the p97/VCP/Cdc48 protein remodeler. Using Xenopus laevis egg extract, we have shown that blocking polyubiquitylation results in the prolonged association of the active helicase with replicating chromatin. The Mcm7 subunit is the only component of the active helicase that we find polyubiquitylated during replication termination. The observed polyubiquitylation is followed by disassembly of the active helicase dependent on p97/VCP/Cdc48. Altogether, our data provide insight into the mechanism of replisome disassembly during eukaryotic DNA replication termination.	[Moreno, Sara Priego; Bailey, Rachael; Campion, Nicholas; Herron, Suzanne; Gambus, Agnieszka] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Gambus, A (corresponding author), Univ Birmingham, Sch Canc Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	a.gambus@bham.ac.uk	Gambus, Aga/AAK-4687-2021	Gambus, Aga/0000-0002-4648-0332; Priego Moreno, Sara/0000-0001-9168-4302	U.K. Medical Research Council Career Development Award [MR/K007106/1]; Cancer Research UK Birmingham Centre award [DF/270312]; ERASMUS scholarship; Wellcome Trust strategic award [ISSFPP47]; Cancer Research UK Birmingham Centre [CAICS/05/12]; MRC [MR/K007106/1] Funding Source: UKRI; Medical Research Council [MR/K007106/1] Funding Source: researchfish	U.K. Medical Research Council Career Development Award; Cancer Research UK Birmingham Centre award; ERASMUS scholarship; Wellcome Trust strategic award(Wellcome Trust); Cancer Research UK Birmingham Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank K. Labib for sharing his data and critical discussions, J. Blow for support and help with egg extract, R. Hay for advice, O. Stemmann for vectors to express p97, and E. Petermann for help with fibers. A.G. would like to thank D. Tennant for support. This work was supported by U.K. Medical Research Council Career Development Award MR/K007106/1 to A.G. and Cancer Research UK Birmingham Centre award DF/270312 to A.G. S.P.M. was funded by ERASMUS scholarship and Wellcome Trust strategic award ISSFPP47; N.C. was funded by Cancer Research UK Birmingham Centre award CAICS/05/12.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Cuvier O, 2008, GENE DEV, V22, P860, DOI 10.1101/gad.445108; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Germe T, 2005, EMBO REP, V6, P729, DOI 10.1038/sj.embor.7400465; Heubes S, 2007, J CELL SCI, V120, P1325, DOI 10.1242/jcs.006924; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kuipers MA, 2011, J CELL BIOL, V192, P29, DOI 10.1083/jcb.201007111; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Mahaffey DT, 2003, EXP CELL RES, V288, P225, DOI 10.1016/S0014-4827(03)00088-0; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	29	121	122	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					477	481		10.1126/science.1253585	http://dx.doi.org/10.1126/science.1253585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342805				2022-12-01	WOS:000343822900045
J	Pancera, M; Zhou, TQ; Druz, A; Georgiev, IS; Soto, C; Gorman, J; Huang, JH; Acharya, P; Chuang, GY; Ofek, G; Stewart-Jones, GBE; Stuckey, J; Bailer, RT; Joyce, MG; Louder, MK; Tumba, N; Yang, YP; Zhang, BS; Cohen, MS; Haynes, BF; Mascola, JR; Morris, L; Munro, JB; Blanchard, SC; Mothes, W; Connors, M; Kwong, PD				Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr; Georgiev, Ivelin S.; Soto, Cinque; Gorman, Jason; Huang, Jinghe; Acharya, Priyamvada; Chuang, Gwo-Yu; Ofek, Gilad; Stewart-Jones, Guillaume B. E.; Stuckey, Jonathan; Bailer, Robert T.; Joyce, M. Gordon; Louder, Mark K.; Tumba, Nancy; Yang, Yongping; Zhang, Baoshan; Cohen, Myron S.; Haynes, Barton F.; Mascola, John R.; Morris, Lynn; Munro, James B.; Blanchard, Scott C.; Mothes, Walther; Connors, Mark; Kwong, Peter D.			Structure and immune recognition of trimeric pre-fusion HIV-1 Env	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN TRIMERS; B-CELL RESPONSES; NEUTRALIZING ANTIBODY; CRYSTAL-STRUCTURE; INFLUENZA-VIRUS; EBOLA-VIRUS; POTENT NEUTRALIZATION; DEPENDENT EPITOPE; CORE STRUCTURE	The human immunodeficiency virus type 1 (HIV-1) envelope (Env) spike, comprising three gp120 and three gp41 subunits, is a conformational machine that facilitates HIV-1 entry by rearranging from a mature unliganded state, through receptor-bound intermediates, to a post-fusion state. As the sole viral antigen on the HIV-1 virion surface, Env is both the target of neutralizing antibodies and a focus of vaccine efforts. Here we report the structure at 3.5 angstrom resolution for an HIV-1 Env trimer captured in a mature closed state by antibodies PGT122 and 35O22. This structure reveals the pre-fusion conformation of gp41, indicates rearrangements needed for fusion activation, and defines parameters of immune evasion and immune recognition. Pre-fusion gp41 encircles amino- and carboxy-terminal strands of gp120 with four helices that form a membrane-proximal collar, fastened by insertion of a fusion peptide-proximal methionine into a gp41-tryptophan clasp. Spike rearrangements required for entry involve opening the clasp and expelling the termini. N-linked glycosylation and sequence-variable regions cover the pre-fusion closed spike; we used chronic cohorts to map the prevalence and location of effective HIV-1-neutralizing responses, which were distinguished by their recognition of N-linked glycan and tolerance for epitope-sequence variation.	[Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr; Georgiev, Ivelin S.; Soto, Cinque; Gorman, Jason; Acharya, Priyamvada; Chuang, Gwo-Yu; Ofek, Gilad; Stewart-Jones, Guillaume B. E.; Stuckey, Jonathan; Bailer, Robert T.; Joyce, M. Gordon; Louder, Mark K.; Yang, Yongping; Zhang, Baoshan; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Huang, Jinghe; Connors, Mark] NIAID, HIV Specif Immun Sect, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA; [Tumba, Nancy; Morris, Lynn] NHLS, Ctr HIV & STIs, Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa; [Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Med, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Surg, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Pediat, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Human Vaccine Inst, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC 27710 USA; [Morris, Lynn] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Morris, Lynn] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, ZA-4041 Durban, South Africa; [Munro, James B.; Mothes, Walther] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University; Duke University; University of Witwatersrand; University of Kwazulu Natal; Yale University; Cornell University	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Gorman, Jason/AGG-9417-2022; Zhou, Tongqing/A-6880-2010; Blanchard, Scott C./A-5804-2009; Mascola, John/AAI-7193-2021; Morris, Lynn/V-3941-2018; Huang, Jinghe/O-1986-2015; Huang, Jinghe/P-8068-2019	Zhou, Tongqing/0000-0002-3935-4637; Blanchard, Scott C./0000-0003-2717-9365; Morris, Lynn/0000-0003-3961-7828; Gorman, Jason/0000-0002-3775-6560; Acharya, Priyamvada/0000-0002-0089-277X; Huang, Jinghe/0000-0002-1968-871X	Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Division of AIDS, NIAID, NIH [R21-AI100696, CHAVI-AI0678501, CHAVI-Immunogen Discovery-AI100645]; National Institutes of General Medical Sciences [P01-GM56550, R01-GM098859]; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); UK Department for International Development (DFID); United States Agency for International Development (USAID); US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005113, ZIAAI005002, ZICAI005114, P30AI050410, ZIAAI005024, ZIAAI005023, R21AI100696, ZICAI005112, ZICAI005111, UM1AI100645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098859, P01GM056550] Funding Source: NIH RePORTER	Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Division of AIDS, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); UK Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Binley for the JR-FL plasmid used in smFRET; D. Burton and W. Koff for PGT122; J. Chrzas and SER-CAT staff for assistance with data collection; B. Graham for discussions on RSV; R. Sanders for furin plasmid; R. Schwartz and the Vaccine Production Program for antibody VRC01; J. Sodroski for information on C34-Ig; I. Wilson for discussions on pre-fusion Env structure; Z. Yang for assistance with cloning; G. Nabel, G. Scott and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript; and the WCMC/AMC/TSRI HIVRAD team for their contributions to the design and validation of near-native mimicry for soluble BG505 SOSIP.664 trimers. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong,J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 envelope plasmids used in our neutralization panel. The authors acknowledge the contributions of the Center for HIV/AIDS Vaccine Discovery (CHAVI) Clinical Core Team for recruiting study participants and carrying out all aspects of the CHAVI001 and CHAVI008 protocols at Chapel Hill, North Carolina (J. Eron); Blantyre, Malawi (J. Kumwenda, T. Taha); Lilongwe, Malawi (I. Hoffman, G. Kaminga); Johannesburg, South Africa (H. Rees); Durban, South Africa (S. Abdool Karim); Moshi, Tanzania (S. Noel, S. Kapiga, J. Crump); and London, UK (S. Fidler). Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); and by grants from the Division of AIDS, NIAID, NIH (R21-AI100696, CHAVI-AI0678501, and CHAVI-Immunogen Discovery-AI100645), from the National Institutes of General Medical Sciences (P01-GM56550 and R01-GM098859), from the Irvington Fellows Program of the Cancer Research Program, and from the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium. IAVI's work is made possible by support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the UK Department for International Development (DFID): and the United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. Use of sector 22 (Southeast Region Collaborative Access Team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; [Anonymous], 2002, PYMOL MOL GRAPHICS S; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI [10.1089/aid.2010.0281, 10.1089/AID.2010.0281]; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CHEN CH, 1995, J VIROL, V69, P3771, DOI 10.1128/JVI.69.6.3771-3777.1995; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cimbro R, 2014, P NATL ACAD SCI USA, V111, P3152, DOI 10.1073/pnas.1314718111; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gorny MK, 2000, VIROLOGY, V267, P220, DOI 10.1006/viro.1999.0095; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang J, 2014, NATURE 0903; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kwong PD, 1999, J APPL CRYSTALLOGR, V32, P102, DOI 10.1107/S0021889898009686; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Leavitt M, 2003, J VIROL, V77, P560, DOI 10.1128/JVI.77.1.560-570.2003; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lin CW, 2006, J AM CHEM SOC, V128, P4542, DOI 10.1021/ja0604111; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Munro J. B., 2014, SCIENCE; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; NISHIKAWA K, 1972, J PHYS SOC JPN, V32, P1331, DOI 10.1143/JPSJ.32.1331; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; RINI JM, 1993, P NATL ACAD SCI USA, V90, P6325, DOI 10.1073/pnas.90.13.6325; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; Stanfield Robyn L., 2005, Human Antibodies, V14, P73; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; THALI M, 1992, J VIROL, V66, P5516, DOI 10.1128/JVI.66.9.5516-5524.1992; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tugarinov V, 1999, NAT STRUCT BIOL, V6, P331; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Yuan W, 2004, J VIROL, V78, P5448, DOI 10.1128/JVI.78.10.5448-5457.2004; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	127	542	568	1	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					455	+		10.1038/nature13808	http://dx.doi.org/10.1038/nature13808			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25296255	Green Submitted, Green Accepted			2022-12-01	WOS:000343775900032
J	Baird, NA; Douglas, PM; Simic, MS; Grant, AR; Moresco, JJ; Wolff, SC; Yates, JR; Manning, G; Dillin, A				Baird, Nathan A.; Douglas, Peter M.; Simic, Milos S.; Grant, Ana R.; Moresco, James J.; Wolff, Suzanne C.; Yates, John R., III; Manning, Gerard; Dillin, Andrew			HSF-1-mediated cytoskeletal integrity determines thermotolerance and life span	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; CAENORHABDITIS-ELEGANS; C.-ELEGANS; PROTEINS; TROPONIN; HSF1; ORGANIZATION; CONTRACTION; ENDOCYTOSIS; EXPRESSION	The conserved heat shock transcription factor-1 (HSF-1) is essential to cellular stress resistance and life-span determination. The canonical function of HSF-1 is to regulate a network of genes encoding molecular chaperones that protect proteins from damage caused by extrinsic environmental stress or intrinsic age-related deterioration. In Caenorhabditis elegans, we engineered a modified HSF-1 strain that increased stress resistance and longevity without enhanced chaperone induction. This health assurance acted through the regulation of the calcium-binding protein PAT-10. Loss of pat-10 caused a collapse of the actin cytoskeleton, stress resistance, and life span. Furthermore, overexpression of pat-10 increased actin filament stability, thermotolerance, and longevity, indicating that in addition to chaperone regulation, HSF-1 has a prominent role in cytoskeletal integrity, ensuring cellular function during stress and aging.	[Baird, Nathan A.; Douglas, Peter M.; Simic, Milos S.; Wolff, Suzanne C.; Dillin, Andrew] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Grant, Ana R.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA; [Manning, Gerard] Genentech Inc, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Scripps Research Institute; Roche Holding; Genentech	Dillin, A (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	dillin@berkeley.edu	Manning, Gerard/C-8308-2009	Manning, Gerard/0000-0002-5087-9151; Moresco, James/0000-0003-1178-1642; Grant, Ana/0000-0002-5439-9331; Simic, Milos/0000-0002-1167-0857; Douglas, Peter/0000-0002-0734-1049	Howard Hughes Medical Institute, National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; National Institute on Aging [R01AG027463-04]; Leona M. & Harry B. Helmsley Charitable Trust; George E. Hewitt Foundation for Medical Research; National Institute of Aging [1K99AG042495-0141]; NIH-Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG042495, R00AG042495, R01AG027463, P01AG031097] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Center for Research Resources; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Leona M. & Harry B. Helmsley Charitable Trust; George E. Hewitt Foundation for Medical Research; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Bioinformatic analysis is included in the supplementary materials. The following funding sources supported this research: Howard Hughes Medical Institute, National Center for Research Resources (5P41RR011823-17) National Institute of General Medical Sciences (8 P41 GM103533-17), and National Institute on Aging (R01AG027463-04). N.A.B. was funded by a postdoctoral fellowship to the Salk Center for Nutritional Genomics from the Leona M. & Harry B. Helmsley Charitable Trust; P.M.D. was funded by George E. Hewitt Foundation for Medical Research and National Institute of Aging (1K99AG042495-0141). We thank the laboratory of G. Lithgow for generously sharing the HSP-16 antibody and J. Durieux for helping design figure illustrations. Some of the nematode strains used in this work were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is supported by the NIH-Office of Research Infrastructure Programs (P40 OD010440).	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/88281; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Greene W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000512; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Nguyen CH, 2013, BIOCHEM J, V452, P321, DOI 10.1042/BJ20130098; Obinata T, 2010, J CELL SCI, V123, P1557, DOI 10.1242/jcs.065060; Ono K, 2004, MOL BIOL CELL, V15, P2782, DOI 10.1091/mbc.E04-03-0179; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Terami H, 1999, J CELL BIOL, V146, P193, DOI 10.1083/jcb.146.1.193; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]	22	104	106	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					360	363		10.1126/science.1253168	http://dx.doi.org/10.1126/science.1253168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324391	Green Accepted			2022-12-01	WOS:000343041100047
J	Sun, JL; Ramos, A; Chapman, B; Johnnidis, JB; Le, L; Ho, YJ; Klein, A; Hofmann, O; Camargo, FD				Sun, Jianlong; Ramos, Azucena; Chapman, Brad; Johnnidis, Jonathan B.; Le, Linda; Ho, Yu-Jui; Klein, Allon; Hofmann, Oliver; Camargo, Fernando D.			Clonal dynamics of native haematopoiesis	NATURE			English	Article							STEM-CELLS; IN-VIVO; LIFELONG HEMATOPOIESIS; SELF-RENEWAL; BONE-MARROW; MICE; INTEGRATION; DIFFERENTIATION; PROGENITORS; HOMEOSTASIS	It is currently thought that life-long blood cell production is driven by the action of a small number of multipotent haematopoietic stem cells. Evidence supporting this view has been largely acquired through the use of functional assays involving transplantation. However, whether these mechanisms also govern native non-transplant haematopoiesis is entirely unclear. Here we have established a novel experimental model in mice where cells can be uniquely and genetically labelled in situ to address this question. Using this approach, we have performed longitudinal analyses of clonal dynamics in adult mice that reveal unprecedented features of native haematopoiesis. In contrast to what occurs following transplantation, steady-state blood production is maintained by the successive recruitment of thousands of clones, each with a minimal contribution to mature progeny. Our results demonstrate that a large number of long-lived progenitors, rather than classically defined haematopoietic stem cells, are the main drivers of steady-state haematopoiesis during most of adulthood. Our results also have implications for understanding the cellular origin of haematopoietic disease.	[Sun, Jianlong; Ramos, Azucena; Le, Linda; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Sun, Jianlong; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Sun, Jianlong; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Chapman, Brad; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Johnnidis, Jonathan B.] Univ Penn, Dept Immunol, Philadelphia, PA 19104 USA; [Ho, Yu-Jui] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Klein, Allon] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Cold Spring Harbor Laboratory; Harvard University; Harvard Medical School	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	Camargo@fas.harvard.edu	; Hofmann, Oliver/F-1800-2013	camargo, fernando/0000-0002-5630-5909; Ho, Yu-jui/0000-0002-7540-024X; Hofmann, Oliver/0000-0002-7738-1513	NIH [P30 DK049216, DP2OD006472]; Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006472] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to members of the Camargo laboratory, L. Zon, S. Orkin, M. Goodell and F. Mercier for comments. We thank R. Mathew for cell sorting and Y. Fujiwara for transgenic injections (supported by NIH P30 DK049216). We thank Z. Izsvak (Max-Delbruck-Center) for HSB expression vector and M. Kay (Stanford University) for transposon plasmid. This work was supported by the NIH Director's New Innovator Award (DP2OD006472) to F.D.C. and funds from the Harvard Stem Cell Institute to B.C. and O.H.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Brugman MH, 2013, HUM GENE THER METHOD, V24, P68, DOI 10.1089/hgtb.2012.175; BUESCHER ES, 1985, J CLIN INVEST, V76, P1581, DOI 10.1172/JCI112140; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Drize NJ, 2001, EXP HEMATOL, V29, P786, DOI 10.1016/S0301-472X(01)00634-8; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Harkey MA, 2007, STEM CELLS DEV, V16, P381, DOI 10.1089/scd.2007.0015; HARRISON DE, 1987, BLOOD, V69, P773; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KAY HEM, 1965, LANCET, V2, P418; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; SHAPOSHNIKOV VL, 1979, B EXP BIOL MED+, V87, P510, DOI 10.1007/BF00806699; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zavidij O, 2012, STEM CELLS, V30, P1961, DOI 10.1002/stem.1151	33	497	506	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					322	+		10.1038/nature13824	http://dx.doi.org/10.1038/nature13824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25296256	Green Accepted			2022-12-01	WOS:000342988600042
J	Ross, AGP; Olveda, RM; Li, YS				Ross, Allen G. P.; Olveda, Remigio M.; Li, Yuesheng			An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration	LANCET			English	Editorial Material							DISEASES		[Ross, Allen G. P.] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4222, Australia; [Olveda, Remigio M.] Res Inst Trop Med, Dept Hlth, Manila, Philippines; [Li, Yuesheng] WHO Collaborating Ctr Res & Control Schistosomias, Hunan Inst Parasit Dis, Yueyang, Hunan, Peoples R China; [Li, Yuesheng] Berghofer Med Res Inst, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; QIMR Berghofer Medical Research Institute	Ross, AGP (corresponding author), Griffith Univ, Griffith Hlth Inst, Gold Coast Campus, Southport, Qld 4222, Australia.	a.ross@griffith.edu.au	LI, Yue/GRS-8071-2022	Ross, Allen/0000-0002-2329-0907				Bieri FA, 2013, NEW ENGL J MED, V368, P1603, DOI 10.1056/NEJMoa1204885; Bockarie MJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0144; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004; Fenwick A, 2006, T ROY SOC TROP MED H, V100, P200, DOI 10.1016/j.trstmh.2005.03.014; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Hotez P, 2011, VACCINE, V29, pD104, DOI 10.1016/j.vaccine.2011.06.024; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2020, FORGOTTEN PEOPLE FOR; Kabatereine NB, 2007, B WORLD HEALTH ORGAN, V85, P91, DOI 10.2471/BLT.06.030353; Liu R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-201; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Muhumuza S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063438; Olliaro PL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001165; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Rollinson D, 2013, ACTA TROP, V128, P423, DOI 10.1016/j.actatropica.2012.04.013; Ross AG, 2014, J INF DIS; Ross AGP, 2013, MICROBES INFECT, V15, P858, DOI 10.1016/j.micinf.2013.07.010; World Health Organization, 2006, PREV CHEM HUM HELM C	21	28	31	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2220	2221		10.1016/S0140-6736(14)61417-3	http://dx.doi.org/10.1016/S0140-6736(14)61417-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	25467574				2022-12-01	WOS:000355583000032
J	Bah, EI; Lamah, MC; Fletcher, T; Jacob, ST; Brett-Major, DM; Sall, AA; Shindo, N; Fischer, WA; Lamontagne, F; Saliou, SM; Bausch, DG; Moumie, B; Jagatic, T; Sprecher, A; Lawler, JV; Mayet, T; Jacquerioz, FA; Baggi, MFM; Vallenas, C; Clement, C; Mardel, S; Faye, O; Faye, O; Soropogui, B; Magassouba, N; Koivogui, L; Pinto, R; Fowler, RA				Bah, Elhadj Ibrahima; Lamah, Marie-Claire; Fletcher, Tom; Jacob, Shevin T.; Brett-Major, David M.; Sall, Amadou Alpha; Shindo, Nahoko; Fischer, William A., II; Lamontagne, Francois; Saliou, Sow Mamadou; Bausch, Daniel G.; Moumie, Barry; Jagatic, Tim; Sprecher, Armand; Lawler, James V.; Mayet, Thierry; Jacquerioz, Frederique A.; Baggi, Maria F. Mendez; Vallenas, Constanza; Clement, Christophe; Mardel, Simon; Faye, Ousmane; Faye, Oumar; Soropogui, Bare; Magassouba, Nfaly; Koivogui, Lamine; Pinto, Ruxandra; Fowler, Robert A.			Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; REGRESSION; INFECTION; OUTBREAK; UGANDA	BACKGROUND In March 2014, the World Health Organization was notified of an outbreak of Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, and to neighboring countries and has subsequently become the largest epidemic of Ebola virus disease (EVD) to date. METHODS From March 25 to April 26, 2014, we performed a study of all patients with laboratory-confirmed EVD in Conakry. Mortality was the primary outcome. Secondary outcomes included patient characteristics, complications, treatments, and comparisons between survivors and nonsurvivors. RESULTS Of 80 patients who presented with symptoms, 37 had laboratory-confirmed EVD. Among confirmed cases, the median age was 38 years (interquartile range, 28 to 46), 24 patients (65%) were men, and 14 (38%) were health care workers; among the health care workers, nosocomial transmission was implicated in 12 patients (32%). Patients with confirmed EVD presented to the hospital a median of 5 days (interquartile range, 3 to 7) after the onset of symptoms, most commonly with fever (in 84% of the patients; mean temperature, 38.6 degrees C), fatigue (in 65%), diarrhea (in 62%), and tachycardia (mean heart rate, >93 beats per minute). Of these patients, 28 (76%) were treated with intravenous fluids and 37 (100%) with antibiotics. Sixteen patients (43%) died, with a median time from symptom onset to death of 8 days (interquartile range, 7 to 11). Patients who were 40 years of age or older, as compared with those under the age of 40 years, had a relative risk of death of 3.49 (95% confidence interval, 1.42 to 8.59; P = 0.007). CONCLUSIONS Patients with EVD presented with evidence of dehydration associated with vomiting and severe diarrhea. Despite attempts at volume repletion, antimicrobial therapy, and limited laboratory services, the rate of death was 43%.	[Bah, Elhadj Ibrahima; Lamah, Marie-Claire; Saliou, Sow Mamadou; Moumie, Barry] Donka Hosp, Conakry, Guinea; [Soropogui, Bare; Magassouba, Nfaly] Univ Gamal Abdel Nasser, Projet Fievre Hemorrag Guinee, Conakry, Guinea; [Koivogui, Lamine] Inst Natl Sante Conakry, Conakry, Guinea; [Fletcher, Tom] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Mardel, Simon] Univ S Manchester Hosp, Emergency Dept, Manchester M20 8LR, Lancs, England; [Jacob, Shevin T.] Hosp Mulago, Masaka, Uganda; [Jacob, Shevin T.] Univ Washington, Dept Med, Seattle, WA USA; [Brett-Major, David M.] WHO, Preparedness & Mass Gatherings, Global Preparedness Surveillance & Response Opera, Global Capac Alert & Response,Hlth Secur Environm, Geneva, Switzerland; [Shindo, Nahoko; Vallenas, Constanza] WHO, Dept Pandem & Epidem Dis, Geneva, Switzerland; [Sall, Amadou Alpha; Faye, Ousmane; Faye, Oumar] Inst Pasteur, Dakar, Senegal; [Fischer, William A., II] Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech, CHU Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Pinto, Ruxandra] Sunnybrook Hlth Sci Ctr, Trauma Emergency & Crit Care Program, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada; [Bausch, Daniel G.] US Naval Med Res Unit 6, Virol & Emerging Infect Dept, Lima, Peru; [Bausch, Daniel G.; Jacquerioz, Frederique A.; Baggi, Maria F. Mendez] Tulane Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA; [Jagatic, Tim; Sprecher, Armand] Med Sans Frontieres, Brussels, Belgium; [Lawler, James V.] Naval Med Res Ctr Frederick, Frederick, MD USA; [Mayet, Thierry] Ctr Hosp Dax, Serv Reanimat Polyvalente, Dax, France; [Clement, Christophe] Private Hosp Polyclin Bordeaux Nord Aquitaine, Intens Care Unit, Bordeaux, France	University of Liverpool; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Mulago National Referral Hospital; University of Washington; University of Washington Seattle; World Health Organization; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sherbrooke; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Tulane University; Doctors Without Borders; Naval Medical Research Center (NMRC)	Fowler, RA (corresponding author), Univ Toronto, Dept Med & Crit Care Med, Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	rob.fowler@sunnybrook.ca	faye, Ousmane/GMW-6500-2022; Faye, Oumar/T-7168-2019; Jacob, Shevin/CAF-0449-2022	Faye, Oumar/0000-0002-3478-1322; Lawler, James/0000-0003-3736-8485; Jacob, Shevin/0000-0003-2425-9394; Lamontagne, Francois/0000-0002-0360-3427; Fletcher, Tom/0000-0002-3712-415X	NATIONAL INSTITUTE ON AGING [R03AG045088] Funding Source: NIH RePORTER; NIA NIH HHS [R03 AG045088] Funding Source: Medline; Wellcome Trust [100890] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Beeching NJ, 2010, INT J ANTIMICROB AG, V36, pS26, DOI 10.1016/j.ijantimicag.2010.06.017; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Brearley MB, 2013, PREHOSP DISASTER MED, V28, P139, DOI 10.1017/S1049023X12001847; Centers for Disease Control and Prevention, OUTBR CHRON EB VIR D; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Sterk E., 2008, MED SANS FRONTIERES; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004; World Health Organization, 2014, PRIS CHARG CLIN FIEV; World Health Organization, EB RESP ROADM UPD; World Health Organization, 2014, EB VIR DIS GUIN; World Health Organization, EB VIR DIS OUTBR W A; World Health Organization, IND LEAD KEY PARTN D; World Health Organization, GUIN STAT; World Health Organization (WHO), EB VIR DIS FACT SHEE; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	281	297	0	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					40	47		10.1056/NEJMoa1411249	http://dx.doi.org/10.1056/NEJMoa1411249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25372658	Green Published, Bronze			2022-12-01	WOS:000347100800008
J	Jin, FF; Boucharel, J; Lin, II				Jin, F. -F.; Boucharel, J.; Lin, I. -I.			Eastern Pacific tropical cyclones intensified by El Nino delivery of subsurface ocean heat	NATURE			English	Article							PART I; CLIMATE; MODEL; VARIABILITY; GENESIS; ENSO	The El Nino Southern Oscillation (ENSO) creates strong variations in sea surface temperature in the eastern equatorial Pacific, leading to major climatic and societal impacts(1,2). In particular, ENSO influences the yearly variations of tropical cyclone (TC) activities in both the Pacific and Atlantic basins through atmospheric dynamical factors such as vertical wind shear and stability(3-6). Until recently, however, the direct ocean thermal control of ENSO on TCs has not been taken into consideration because of an apparent mismatch in both timing and location: ENSO peaks in winter and its surface warming occurs mostly along the Equator, a region without TC activity. Here we show that El Nino the warm phase of an ENSO cycle effectively discharges heat into the eastern North Pacific basin two to three seasons after its wintertime peak, leading to intensified TCs. This basin is characterized by abundant TC activity and is the second most active TC region in the world(5-7). As a result of the time involved in ocean transport, El Ninio's equatorial subsurface 'heat reservoir', built up in boreal winter, appears in the eastern North Pacific several months later during peak TC season (boreal summer and autumn). By means of this delayed ocean transport mechanism, ENSO provides an additional heat supply favourable for the formation of strong hurricanes. This thermal control on intense TC variability has significant implications for seasonal predictions and long-term projections of TC activity over the eastern North Pacific.	[Jin, F. -F.; Boucharel, J.] Univ Hawaii Manoa, SOEST, Dept Atmospher Sci, Honolulu, HI 96822 USA; [Lin, I. -I.] Natl Taiwan Univ, Dept Atmospher Sci, Taipei 10617, Taiwan; [Jin, F. -F.] Chinese Meteorol Agcy, Beijing Climate Ctr, Lab Climate Studies, Beijing 100081, Peoples R China	University of Hawaii System; University of Hawaii Manoa; National Taiwan University	Jin, FF (corresponding author), Univ Hawaii Manoa, SOEST, Dept Atmospher Sci, Honolulu, HI 96822 USA.	jff@hawaii.edu; bouch@hawaii.edu	Lin, I-I/J-4695-2013	Lin, I-I/0000-0002-8364-8106; Boucharel, Julien/0000-0003-4598-3349	US National Science Foundation [ATM 1034798, ATM 1406601]; US Department of Energy [DESC005110]; US NOM [NA100AR4310200]; China Meteorological Special Project [GYHY201206033]; 973 Program of China [2010CB950404, 2013CB430203]; Taiwan's Ministry of Science and Technology [NSC 101-2111-M-002-002-MY2, NSC 101-2628-M-002-001-MY4, 102R7803]; Directorate For Geosciences [1034798, 1406601] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); US NOM; China Meteorological Special Project; 973 Program of China(National Basic Research Program of China); Taiwan's Ministry of Science and Technology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank P. Kim for providing the CMIP5 model's outputs; M. Zhao for making his Atmospheric General Circulation Model outputs available; K. Emanuel for providing the potential intensity calculation program via his website; and C. Huang for help in data processing. This study was supported by US National Science Foundation grants ATM 1034798 and ATM 1406601, US Department of Energy grant DESC005110, US NOM grant NA100AR4310200, the China Meteorological Special Project (GYHY201206033) and the 973 Program of China (2010CB950404 and 2013CB430203). I.I.L.'s work is supported by Taiwan's Ministry of Science and Technology under grants NSC 101-2111-M-002-002-MY2, NSC 101-2628-M-002-001-MY4 and 102R7803.	Balaguru K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044009; Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Bengtsson L, 2007, TELLUS A, V59, P396, DOI 10.1111/J.1600-0870.2007.00236.x; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; Camargo SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001861; Chu PS, 1997, J CLIMATE, V10, P2683, DOI 10.1175/1520-0442(1997)010<2683:TCOITV>2.0.CO;2; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Collins J. M., 2007, PAPERS APPL GEOGR C, V30, P324; Collins JM, 2000, GEOPHYS RES LETT, V27, P3881, DOI 10.1029/2000GL011614; Court A., 1980, NWS WR 159; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; Dong K., 1994, ACTA MET SIN, V8, P19; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; EMANUEL KA, 1995, J ATMOS SCI, V52, P3969, DOI 10.1175/1520-0469(1995)052<3969:SOTCTS>2.0.CO;2; Glantz M. H., 2001, CURRENT OF CHANGE IM; Goni G, 2009, OCEANOGRAPHY, V22, P190, DOI 10.5670/oceanog.2009.78; Gray W.M., 1979, METEOROLOGY TROPICAL, P155, DOI DOI 10.1175/1520-0450; Jin FF, 1996, SCIENCE, V274, P76, DOI 10.1126/science.274.5284.76; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; Larow TE, 2008, J CLIMATE, V21, P3191, DOI 10.1175/2007JCLI2036.1; Latif M. D., 2012, J GEOPHYS RES-OCEANS, V103, P14375; Leipper D. F., 1972, Journal of Physical Oceanography, V2, P218, DOI 10.1175/1520-0485(1972)002<0218:HHPOTG>2.0.CO;2; Lin II, 2008, MON WEATHER REV, V136, P3288, DOI 10.1175/2008MWR2277.1; Lin II, 2013, GEOPHYS RES LETT, V40, P1878, DOI 10.1002/grl.50091; Lorenz E. N., 1956, MASSACHUSETTS INSTIT; Maue RN, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047711; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Meinen CS, 2000, J CLIMATE, V13, P3551, DOI 10.1175/1520-0442(2000)013<3551:OOWWVC>2.0.CO;2; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Murakami H, 2013, NAT CLIM CHANGE, V3, P749, DOI [10.1038/nclimate1890, 10.1038/NCLIMATE1890]; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Price JF, 2009, OCEAN SCI, V5, P351, DOI 10.5194/os-5-351-2009; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Shay LK, 2010, MON WEATHER REV, V138, P2110, DOI 10.1175/2010MWR3189.1; Stocker T. F., 2013, CLIM CHANG 2013; Toma VE, 2010, CLIM DYNAM, V34, P587, DOI 10.1007/s00382-009-0584-x; Wang CZ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041469; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; WYRTKI K, 1985, J GEOPHYS RES-OCEANS, V90, P7129, DOI 10.1029/JC090iC04p07129; Zhao M, 2009, J CLIMATE, V22, P6653, DOI 10.1175/2009JCLI3049.1	43	88	90	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					82	U178		10.1038/nature13958	http://dx.doi.org/10.1038/nature13958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471884				2022-12-01	WOS:000346310800043
J	Snyder, A; Makarov, V; Merghoub, T; Yuan, J; Zaretsky, JM; Desrichard, A; Walsh, LA; Postow, MA; Wong, P; Ho, TS; Hollmann, TJ; Bruggeman, C; Kannan, K; Li, YY; Elipenahli, C; Liu, CL; Harbison, CT; Wang, LS; Ribas, A; Wolchok, JD; Chan, TA				Snyder, Alexandra; Makarov, Vladimir; Merghoub, Taha; Yuan, Jianda; Zaretsky, Jesse M.; Desrichard, Alexis; Walsh, Logan A.; Postow, Michael A.; Wong, Phillip; Ho, Teresa S.; Hollmann, Travis J.; Bruggeman, Cameron; Kannan, Kasthuri; Li, Yanyun; Elipenahli, Ceyhan; Liu, Cailian; Harbison, Christopher T.; Wang, Lisu; Ribas, Antoni; Wolchok, Jedd D.; Chan, Timothy A.			Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXOME ANALYSIS REVEALS; T-CELL RECOGNITION; CANCER-IMMUNOTHERAPY; TUMOR; ANTIGEN; PEPTIDE; IPILIMUMAB; PROTEIN; EPITOPE; IDENTIFICATION	BACKGROUND Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T cells and enables them to destroy tumor cells. METHODS We obtained tumor tissue from patients with melanoma who were treated with ipilimumab or tremelimumab. Whole-exome sequencing was performed on tumors and matched blood samples. Somatic mutations and candidate neoantigens generated from these mutations were characterized. Neoantigen peptides were tested for the ability to activate lymphocytes from ipilimumab-treated patients. RESULTS Malignant melanoma exomes from 64 patients treated with CTLA-4 blockade were characterized with the use of massively parallel sequencing. A discovery set consisted of 11 patients who derived a long-term clinical benefit and 14 patients who derived a minimal benefit or no benefit. Mutational load was associated with the degree of clinical benefit (P = 0.01) but alone was not sufficient to predict benefit. Using genomewide somatic neoepitope analysis and patient-specific HLA typing, we identified candidate tumor neoantigens for each patient. We elucidated a neoantigen landscape that is specifically present in tumors with a strong response to CTLA-4 blockade. We validated this signature in a second set of 39 patients with melanoma who were treated with anti-CTLA-4 antibodies. Predicted neoantigens activated T cells from the patients treated with ipilimumab. CONCLUSIONS These findings define a genetic basis for benefit from CTLA-4 blockade in melanoma and provide a rationale for examining exomes of patients for whom anti-CTLA-4 agents are being considered.	[Snyder, Alexandra; Merghoub, Taha; Postow, Michael A.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Snyder, Alexandra; Makarov, Vladimir; Desrichard, Alexis; Walsh, Logan A.; Kannan, Kasthuri; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Merghoub, Taha; Li, Yanyun; Elipenahli, Ceyhan; Liu, Cailian; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Swim Amer Ludwig Collaborat Res Lab, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Hollmann, Travis J.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Yuan, Jianda; Wong, Phillip; Ho, Teresa S.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Program Immunol, Ludwig Ctr Canc Immunotherapy, New York, NY 10065 USA; [Snyder, Alexandra; Postow, Michael A.; Wolchok, Jedd D.; Chan, Timothy A.] Weill Cornell Med Coll, New York, NY USA; [Bruggeman, Cameron] Columbia Univ, Dept Math, New York, NY 10027 USA; [Zaretsky, Jesse M.; Ribas, Antoni] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Harbison, Christopher T.; Wang, Lisu] Bristol Myers Squibb Co, Princeton, NJ USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Columbia University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Bristol-Myers Squibb	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	wolchokj@mskcc.org; chant@mskcc.org	Chan, Timothy A/ABD-5850-2021; wang, edwin/G-5372-2010; Merghoub, Taha/ABD-8362-2021	Desrichard, Alexis/0000-0002-1335-7813; Walsh, Logan/0000-0001-8771-2577; Wong, Phillip/0000-0002-6360-849X; Snyder Charen, Alexandra/0000-0002-2606-3523; Hollmann, Travis/0000-0003-1599-0433; Kannan, Kasthuri/0000-0002-8479-0657	Frederick Adler Fund; National Institutes of Health; Swim across America; Ludwig Trust; Melanoma Research Alliance; Stand Up to Cancer-Cancer Research Institute Immunotherapy Dream Team; Hazen Polsky Foundation; STARR Cancer Consortium; Ruth L. Kirschstein National Research Service Award [T32CA009512]; NATIONAL CANCER INSTITUTE [T32CA009512, P30CA008748] Funding Source: NIH RePORTER	Frederick Adler Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swim across America; Ludwig Trust; Melanoma Research Alliance; Stand Up to Cancer-Cancer Research Institute Immunotherapy Dream Team; Hazen Polsky Foundation; STARR Cancer Consortium; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Frederick Adler Fund, the National Institutes of Health, Swim across America, the Ludwig Trust, the Melanoma Research Alliance, the Stand Up to Cancer-Cancer Research Institute Immunotherapy Dream Team, the Hazen Polsky Foundation, and the STARR Cancer Consortium and by a Ruth L. Kirschstein National Research Service Award (T32CA009512, to Dr. Snyder). Bristol-Myers Squibb, the employer of two authors, did not provide funding for this study.	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; Anderson MW, 2003, J IMMUNOL, V171, P5683, DOI 10.4049/jimmunol.171.11.5683; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Li YL, 2010, J MOL BIOL, V399, P596, DOI 10.1016/j.jmb.2010.04.037; Lim JB, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-72; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Morita D, 2013, J VIROL, V87, P482, DOI 10.1128/JVI.02142-12; NOGUCHI Y, 1994, P NATL ACAD SCI USA, V91, P3171, DOI 10.1073/pnas.91.8.3171; Park YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044225; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; POISSON F, 1993, J CLIN MICROBIOL, V31, P2343, DOI 10.1128/JCM.31.9.2343-2349.1993; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Srivastava N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006094; Srivastava PK, 2013, CANCER IMMUNOL IMMUN, V62, P967, DOI 10.1007/s00262-013-1422-x; Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok Jedd D, 2010, Cancer Immun, V10, P9; Wong R, 2004, CLIN CANCER RES, V10, P5004, DOI 10.1158/1078-0432.CCR-04-0241	36	2821	2936	15	327	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2189	2199		10.1056/NEJMoa1406498	http://dx.doi.org/10.1056/NEJMoa1406498			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25409260	Green Accepted, Bronze			2022-12-01	WOS:000345976700007
J	Kutluay, SB; Zang, T; Blanco-Melo, D; Powell, C; Jannain, D; Errando, M; Bieniasz, PD				Kutluay, Sebla B.; Zang, Trinity; Blanco-Melo, Daniel; Powell, Chelsea; Jannain, David; Errando, Manel; Bieniasz, Paul D.			Global Changes in the RNA Binding Specificity of HIV-1 Gag Regulate Virion Genesis	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CIS-ACTING SEQUENCES; TYPE-1 RNA; NUCLEOCAPSID PROTEIN; MEMBRANE ASSOCIATION; SECONDARY STRUCTURE; PACKAGING SIGNAL; VIRAL PARTICLES; CELLULAR RNAS; MATRIX DOMAIN	The HIV-1 Gag protein orchestrates all steps of virion genesis, including membrane targeting and RNA recruitment into virions. Using crosslinking-immunoprecipitation (CLIP) sequencing, we uncover several dramatic changes in the RNA-binding properties of Gag that occur during virion genesis, coincident with membrane binding, multimerization, and proteolytic maturation. Prior to assembly, and after virion assembly and maturation, the nucleocapsid domain of Gag preferentially binds to psi and Rev Response elements in the viral genome, and GU-rich mRNA sequences. However, during virion genesis, this specificity transiently changes in a manner that facilitates genome packaging; nucleocapsid binds to many sites on the HIV-1 genome and to mRNA sequences with a HIV-1-like, A-rich nucleotide composition. Additionally, we find that the matrix domain of Gag binds almost exclusively to specific tRNAs in the cytosol, and this association regulates Gag binding to cellular membranes.	[Kutluay, Sebla B.; Zang, Trinity; Blanco-Melo, Daniel; Powell, Chelsea; Jannain, David; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, New York, NY 10016 USA; [Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; [Errando, Manel] Columbia Univ, Barnard Coll, Dept Phys & Astron, New York, NY 10027 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Columbia University	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, 455 First Ave, New York, NY 10016 USA.	pbienias@adarc.org	Blanco-Melo, Daniel/AAG-3682-2020	Blanco-Melo, Daniel/0000-0002-0256-5019; Errando, Manel/0000-0002-1853-863X	AmFAR Mathilde Krim Postdoctoral Fellowship; NIH grants [R01AI501111, P50GM103297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI116258, R01AI050111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103297] Funding Source: NIH RePORTER	AmFAR Mathilde Krim Postdoctoral Fellowship; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Hafner and members of the Darnell and Tuschl labs for advice and helpful discussions. We thank Michael Summers for the diagram of the Psi and RRE sequences in Figure 2. S.B.K. was supported in part by an AmFAR Mathilde Krim Postdoctoral Fellowship. This work was supported by NIH grants R01AI501111 and P50GM103297.	ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; Alfadhli A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00253; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Berglund JA, 1997, NUCLEIC ACIDS RES, V25, P1042, DOI 10.1093/nar/25.5.1042; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; BERKOWITZ RD, 1995, VIROLOGY, V212, P718, DOI 10.1006/viro.1995.1530; BERKOWITZ RD, 1993, J VIROL, V67, P7190, DOI 10.1128/JVI.67.12.7190-7200.1993; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Chamanian M, 2013, CELL HOST MICROBE, V13, P181, DOI 10.1016/j.chom.2013.01.007; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cimarelli A, 1999, J VIROL, V73, P5388, DOI 10.1128/JVI.73.7.5388-5401.1999; CLAVEL F, 1990, J VIROL, V64, P5230, DOI 10.1128/JVI.64.10.5230-5234.1990; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Das AT, 1997, J VIROL, V71, P2346, DOI 10.1128/JVI.71.3.2346-2356.1997; Dick RA, 2013, J VIROL, V87, P13598, DOI 10.1128/JVI.01659-13; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; GRANTHAM R, 1986, NATURE, V319, P727, DOI 10.1038/319727b0; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; KAYE JF, 1995, J VIROL, V69, P6588, DOI 10.1128/JVI.69.10.6588-6592.1995; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Kuzembayeva M, 2014, VIROLOGY, V454, P362, DOI 10.1016/j.virol.2014.01.019; KYPR J, 1987, NATURE, V327, P20, DOI 10.1038/327020a0; Laham-Karam N, 2007, J VIROL, V81, P10687, DOI 10.1128/JVI.00653-07; LEVER A, 1989, J VIROL, V63, P4085, DOI 10.1128/JVI.63.9.4085-4087.1989; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; LUBAN J, 1994, J VIROL, V68, P3784, DOI 10.1128/JVI.68.6.3784-3793.1994; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; McBride MS, 1997, J VIROL, V71, P2050, DOI 10.1128/JVI.71.3.2050-2058.1997; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; McBride MS, 1997, J VIROL, V71, P4544, DOI 10.1128/JVI.71.6.4544-4554.1997; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Rein A, 2011, TRENDS BIOCHEM SCI, V36, P373, DOI 10.1016/j.tibs.2011.04.001; RICHARDSON JH, 1993, J VIROL, V67, P3997, DOI 10.1128/JVI.67.7.3997-4005.1993; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Russell RS, 2003, J VIROL, V77, P84, DOI 10.1128/JVI.77.1.84-96.2003; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SHARP PM, 1986, NATURE, V324, P114, DOI 10.1038/324114a0; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664	56	142	144	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1096	1109		10.1016/j.cell.2014.09.057	http://dx.doi.org/10.1016/j.cell.2014.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416948	Green Accepted, Bronze			2022-12-01	WOS:000345506300021
J	Werner, MJ				Werner, Michael J.			Protect the USA from UVA	NATURE			English	Editorial Material									[Werner, Michael J.] Holland & Knight, Washington, DC 20006 USA; [Werner, Michael J.] Sunscreens Coalit, Publ Access, Washington, DC USA		Werner, MJ (corresponding author), Holland & Knight, Washington, DC 20006 USA.	michael.werner@hklaw.com							0	7	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S126	S126		10.1038/515S126a	http://dx.doi.org/10.1038/515S126a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407712	Bronze			2022-12-01	WOS:000345770600008
J	Horwitz, LI; Partovian, C; Lin, ZQ; Grady, JN; Herrin, J; Conover, M; Montague, J; Dillaway, C; Bartczak, K; Suter, LG; Ross, JS; Bernheim, SM; Krumholz, HM; Drye, EE				Horwitz, Leora I.; Partovian, Chohreh; Lin, Zhenqiu; Grady, Jacqueline N.; Herrin, Jeph; Conover, Mitchell; Montague, Julia; Dillaway, Chloe; Bartczak, Kathleen; Suter, Lisa G.; Ross, Joseph S.; Bernheim, Susannah M.; Krumholz, Harlan M.; Drye, Elizabeth E.			Development and Use of an Administrative Claims Measure for Profiling Hospital-wide Performance on 30-Day Unplanned Readmission	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; STATISTICAL-METHODS; RATES; RISK; ADJUSTMENT; OUTCOMES; MODEL	Background: Existing publicly reported readmission measures are condition-specific, representing less than 20% of adult hospitalizations. An all-condition measure may better measure quality and promote innovation. Objective: To develop an all-condition, hospital-wide readmission measure. Design: Measure development study. Setting: 4821 U.S. hospitals. Patients: Medicare fee-for-service beneficiaries aged 65 years or older. Measurements: Hospital-level, risk-standardized unplanned readmissions within 30 days of discharge. The measure uses Medicare fee-for-service claims and is a composite of 5 specialty-based, risk-standardized rates for medicine, surgery/gynecology, cardiorespiratory, cardiovascular, and neurology cohorts. The 2007-2008 admissions were randomly split for development and validation. Models were adjusted for age, principal diagnosis, and comorbid conditions. Calibration in Medicare and all-payer data was examined, and hospital rankings in the development and validation samples were compared. Results: The development data set contained 8 018 949 admissions associated with 1 276 165 unplanned readmissions (15.9%). The median hospital risk-standardized unplanned readmission rate was 15.8 (range, 11.6 to 21.9). The 5 specialty cohort models accurately predicted readmission risk in both Medicare and all-payer data sets for average-risk patients but slightly overestimated readmission risk at the extremes. Overall hospital risk-standardized readmission rates did not differ statistically in the split samples (P = 0.71 for difference in rank), and 76% of hospitals' validation-set rankings were within 2 deciles of the development rank (24% were more than 2 deciles). Of hospitals ranking in the top or bottom deciles, 90% remained within 2 deciles (10% were more than 2 deciles) and 82% remained within 1 decile (18% were more than 1 decile). Limitation: Risk adjustment was limited to that available in claims data. Conclusion: A claims-based, hospital-wide unplanned readmission measure for profiling hospitals produced reasonably consistent results in different data sets and was similarly calibrated in both Medicare and all-payer data.	[Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Partovian, Chohreh; Lin, Zhenqiu; Grady, Jacqueline N.; Montague, Julia; Suter, Lisa G.; Bernheim, Susannah M.; Krumholz, Harlan M.; Drye, Elizabeth E.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; Hlth Res & Educ Trust, Chicago, IL USA	Yale University; Yale University	Horwitz, LI (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,TRB Room 607, New York, NY 10016 USA.	leora.horwitz@nyumc.org	, Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020; Horwitz, Leora/A-6959-2009	Conover, Mitchell/0000-0001-5682-3688; Horwitz, Leora/0000-0003-1800-6040; Ross, Joseph/0000-0002-9218-3320	Centers for Medicare & Medicaid Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, K08AG038336, K08AG032886] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Centers for Medicare & Medicaid Services.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Anderson GM, 2014, HOSP ESCORECARD REPO; Appleby J, 2010, KAISER HLTH NEW 0707; Ash AS, 2012, STAT ISSUES ASSESSIN; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley EH, 2012, J AM COLL CARDIOL, V60, P607, DOI 10.1016/j.jacc.2012.03.067; Canadian Broadcasting Corporation, 2013, RAT MY HOSP; Centers for Medicare & Medicaid Services, 2014, HOSP WID READM VERB; CHAMBERS M, 1990, BRIT MED J, V301, P1134, DOI 10.1136/bmj.301.6761.1134; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; DESHARNAIS S, 1991, EVAL HEALTH PROF, V14, P228, DOI 10.1177/016327879101400206; DESHARNAIS S, 1991, HEALTH SERV RES, V26, P425; FLEMING PJ, 1986, COMMUN ACM, V29, P218, DOI 10.1145/5666.5673; Food and Drug Administration, 2012, FED REGISTER, V77, P2012; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Grosso LM, 2014, HOSP LEVEL 30 DAY AL; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; He YL, 2014, STAT MED, V33, P1081, DOI 10.1002/sim.6012; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP CLIN CLASS SOFT; Horwitz L., HOSP WIDE ALL CAUSE; Horwitz LI, 2013, JAMA INTERN MED, V173, P1715, DOI 10.1001/jamainternmed.2013.9318; Horwitz LI, 2013, J HOSP MED, V8, P436, DOI 10.1002/jhm.2021; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz H, 2014, HOSP 30 DAY HEART FA; Krumholz H, 2014, HOSP 30 DAY PNEUMONI; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Krumholz HM., HOSP 30 DAY AMI READ; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; National Committee for Quality Assurance, 2013, PLAN ALL CAUS READM; National Quality Forum, NAT VOL CONS STAND P; National Quality Forum, MEAS EV CRIT; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Normand SLT, 2007, HEALTH SERV OUTCOME, V7, P79, DOI 10.1007/s10742-006-0018-8; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; UnitedHealthcare, 2013, RISK ADJ 30 DAY ALL; van Walraven C, 2012, J EVAL CLIN PRACT, V18, P1211, DOI 10.1111/j.1365-2753.2011.01773.x; Wal-Mart, 2010, KAISER HLTH NEW 1012; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Wray NP, 1997, MED CARE, V35, P768, DOI 10.1097/00005650-199708000-00003; Ziaeian B, 2012, J GEN INTERN MED, V27, P1513, DOI 10.1007/s11606-012-2168-4	48	64	67	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10		S			S66	S75		10.7326/M13-3000	http://dx.doi.org/10.7326/M13-3000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RR	25402406	Green Accepted			2022-12-01	WOS:000364909900010
J	Ker, J				Ker, James			A new phenotypic marker of hypertrophic cardiomyopathy	LANCET			English	Editorial Material									Univ Pretoria, Dept Internal Med, ZA-0001 Pretoria, South Africa	University of Pretoria	Ker, J (corresponding author), Univ Pretoria, Dept Internal Med, ZA-0001 Pretoria, South Africa.	jker@wol.co.za	Ker, James/AAF-7021-2019					Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Gruner C, 2014, EUR HEART J, V35, P2706, DOI 10.1093/eurheartj/ehu154; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Jacoby DL, 2013, CAN MED ASSOC J, V185, P127, DOI 10.1503/cmaj.120138; O'Mahony C, 2013, CIRC-ARRHYTHMIA ELEC, V6, P443, DOI 10.1161/CIRCEP.111.962043; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026	6	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1731	1731		10.1016/S0140-6736(14)61888-2	http://dx.doi.org/10.1016/S0140-6736(14)61888-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25455237	Green Submitted			2022-12-01	WOS:000345116400009
J	Pleasants, S				Pleasants, Simon			A moving target	NATURE			English	Editorial Material							SICKLE HEMOGLOBIN											ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Makani J, 2013, SCI WORLD J, DOI 10.1155/2013/193252; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X	7	29	30	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S2	S2		10.1038/515S2a	http://dx.doi.org/10.1038/515S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390139				2022-12-01	WOS:000344631400002
J	Jan, CH; Williams, CC; Weissman, JS				Jan, Calvin H.; Williams, Christopher C.; Weissman, Jonathan S.			Principles of ER cotranslational translocation revealed by proximity-specific ribosome profiling	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN-TRANSPORT; SIGNAL SEQUENCES; IN-VITRO; COMPLEX; TRANSLATION; MEMBRANE; INSERTION; PEPTIDES; TOPOLOGY	Localized protein synthesis is a fundamental mechanism for creating distinct subcellular environments. Here we developed a generalizable proximity-specific ribosome profiling strategy that enables global analysis of translation in defined subcellular locations. We applied this approach to the endoplasmic reticulum (ER) in yeast and mammals. We observed the large majority of secretory proteins to be cotranslationally translocated, including substrates capable of posttranslational insertion in vitro. Distinct translocon complexes engaged nascent chains at different points during synthesis. Whereas most proteins engaged the ER immediately after or even before signal sequence (SS) emergence, a class of Sec66-dependent proteins entered with a looped SS conformation. Finally, we observed rapid ribosome exchange into the cytosol after translation termination. These data provide insights into how distinct translocation mechanisms act in concert to promote efficient cotranslational recruitment.	[Jan, Calvin H.; Williams, Christopher C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Center for RNA Systems Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Weissman and P. Walter labs, as well as A. Ting, for discussion; and E. Costa, M. Kampmann, P. Kimmig, K. Kostova, and M. Smith for critical reading of the manuscript. Technical assistance was provided by the University of California, San Francisco, Center for Advanced Technology, Nikon Imaging Center, and the Consortium for Frontotemporal Dementia Research. This research was supported by the Center for RNA Systems Biology and the Howard Hughes Medical Institute. C.H.J. is the Rebecca Ridley Kry Fellow of the Damon Runyon Cancer Research Foundation (DRG-2085-11). C. C. W. is an NSF Graduate Research Fellow. Data are deposited in Gene Expression Omnibus under accession nos. GSE61011 and GSE61012.	Ast T, 2013, CRIT REV BIOCHEM MOL, V48, P273, DOI 10.3109/10409238.2013.782999; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; BORGESE D, 1973, J MOL BIOL, V74, P415, DOI 10.1016/0022-2836(73)90037-5; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; CHRISTENSEN AK, 1987, AM J ANAT, V178, P1, DOI 10.1002/aja.1001780102; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stephens S, 2007, THEATER HEUTE, P47; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	42	218	220	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					716	+	1257521	10.1126/science.1257521	http://dx.doi.org/10.1126/science.1257521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378630	Green Accepted			2022-12-01	WOS:000344690100030
J	Chen, HY; Zheng, XB; Zheng, YX				Chen, Haiyang; Zheng, Xiaobin; Zheng, Yixian			Age-Associated Loss of Lamin-B Leads to Systemic Inflammation and Gut Hyperplasia	CELL			English	Article							NF-KAPPA-B; NUCLEAR LAMINA; IMMUNE-RESPONSE; GENE-EXPRESSION; INTESTINAL MICROBIOTA; OXIDATIVE STRESS; IMD PATHWAYS; DROSOPHILA; GENOME; MIDGUT	Aging of immune organs, termed as immunosenescence, is suspected to promote systemic inflammation and age-associated disease. The cause of immunosenescence and how it promotes disease, however, has remained unclear. We report that the Drosophila fat body, a major immune organ, undergoes immunosenescence andmounts strong systemic inflammation that leads to deregulation of immune deficiency (IMD) signaling in the midgut of old animals. Inflamed old fat bodies secrete circulating peptidoglycan recognition proteins that repress IMD activity in the midgut, thereby promoting gut hyperplasia. Further, fat body immunosenecence is caused by age-associated lamin-B reduction specifically in fat body cells, which then contributes to heterochromatin loss and derepression of genes involved in immune responses. As lamin-associated heterochromatin domains are enriched for genes involved in immune response in both Drosophila and mammalian cells, our findings may provide insights into the cause and consequence of immunosenescence during mammalian aging.	[Chen, Haiyang; Zheng, Xiaobin; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu	Zheng, Xiaobin/AAD-7564-2019		Ellison Medical Foundation [GM056312, GM106023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106023, R01GM056312] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Allan Spradling and his lab for valuable help, Allison Pinder for RNA-seq, Drs. Allan Spradling, Mitchell Dushay, Bruno Lemaitre, Lori Wallrath, Georg Krohne, and Erin Zeituni for fly strains and antibodies, Matthew Sieber, Alexis Marianes, and the Zheng lab for helpful discussions. Supported by a Senior Scholar Award to YZ from the Ellison Medical Foundation, GM056312 and GM106023 (YZ).	Ahmad Aamir, 2009, Curr Aging Sci, V2, P174; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chen HY, 2013, CELL STEM CELL, V13, P73, DOI 10.1016/j.stem.2013.05.003; Cheng J, 2013, CURR TOP MICROBIOL, V358, P323, DOI 10.1007/82_2011_189; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Day MJ, 2010, J COMP PATHOL, V141, pS60, DOI [10.1016/j.jcpa.2009.10.011, 10.1016/j.jepa.2009.10.011]; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fulop T, 2011, DISCOV MED, V11, P537, DOI 10.1016/j.coi.2004.01.009; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Guo YX, 2014, MOL BIOL CELL, V25, P1287, DOI 10.1091/mbc.E13-11-0644; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Khatami M, 2009, CELL BIOCHEM BIOPHYS, V55, P55, DOI 10.1007/s12013-009-9059-2; Kim Y, 2013, CELL RES, V23, P1420, DOI 10.1038/cr.2013.118; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Markovic MP, 2009, MOL IMMUNOL, V46, P3245, DOI 10.1016/j.molimm.2009.08.003; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Osouda S, 2005, DEV BIOL, V284, P219, DOI 10.1016/j.ydbio.2005.05.022; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Ray K, 2012, NAT REV GASTRO HEPAT, V9, P555, DOI [10.1038/nrgastro.2012.172, 10.1038/nrgastro.2012.165]; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Wang ZP, 2013, MBIO, V4, DOI 10.1128/mBio.00337-13; Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x	63	105	107	16	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					829	843		10.1016/j.cell.2014.10.028	http://dx.doi.org/10.1016/j.cell.2014.10.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417159	Green Accepted, Bronze			2022-12-01	WOS:000344522000015
J	Ko, H				Ko, Ho			Functional organization of synaptic connections in the neocortex	SCIENCE			English	Editorial Material							STIMULUS FEATURE SELECTIVITY; VISUAL CORTICAL-NEURONS; IN-VIVO; DIRECTION-SELECTIVITY; WIRING SPECIFICITY; EXCITATORY NEURONS; INHIBITORY NEURONS; RECEPTIVE-FIELDS; CORTEX; INTERNEURONS		[Ko, Ho] Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Shatin, Hong Kong, Peoples R China; [Ko, Ho] Chinese Univ Hong Kong, Fac Med, Chow Yuk Ho Technol Ctr Innovat Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ko, H (corresponding author), Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Shatin, Hong Kong, Peoples R China.		Ko, Ho/I-7513-2016; Ko, Ho/AAH-2755-2020	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274				Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Ko H, 2014, J NEUROSCI, V34, P9812, DOI 10.1523/JNEUROSCI.0875-14.2014; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee SH, 2014, NATURE, V508, pE1, DOI 10.1038/nature13128; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Poggio T., 1977, NEUROSCI RES PROGRAM, V3, P470; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	35	1	1	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209								10.1126/science.1260780	http://dx.doi.org/10.1126/science.1260780			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7VH	25359956				2022-12-01	WOS:000349836100002
J	Swoboda, KJ				Swoboda, Kathryn J.			Romancing the Spliceosome to Fight Spinal Muscular Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Swoboda, KJ (corresponding author), Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA.			Swoboda, Kathryn/0000-0002-4593-6342	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069045] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD069045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Lah GJE, 2014, NEURON, V83, P1376, DOI 10.1016/j.neuron.2014.08.002; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	5	4	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1752	1754		10.1056/NEJMcibr1409795	http://dx.doi.org/10.1056/NEJMcibr1409795			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OG	25354110	Green Accepted			2022-12-01	WOS:000343768500016
J	Bhaumik, S				Bhaumik, Soumyadeep			NON-COMMUNICABLE DISEASE The public health threat from sugary drinks in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWEETENED BEVERAGES; METABOLIC SYNDROME; WEIGHT-GAIN; CONSUMPTION; RISK					soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Bhusan R., 2012, EC TIMES        0213; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; ET Bureau, 2014, EC TIMES        0710; Euromonitor, 2014, SOFT DRINKS IND; Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HAZRA N, 2013, NAT MED J INDIA, V26, P125; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Prabhakaran D, 2010, INDIAN J MED RES, V132, P529; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; United Nations Human Rights Council General Assembly, 2014, UNH FOODS NONC DIS R; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	17	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2014	349								g6216	10.1136/bmj.g6216	http://dx.doi.org/10.1136/bmj.g6216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OD	25336402				2022-12-01	WOS:000343768200005
J	Yang, TT; Liu, Q; Kloss, B; Bruni, R; Kalathur, RC; Guo, YZ; Kloppmann, E; Rost, B; Colecraft, HM; Hendrickson, WA				Yang, Tingting; Liu, Qun; Kloss, Brian; Bruni, Renato; Kalathur, Ravi C.; Guo, Youzhong; Kloppmann, Edda; Rost, Burkhard; Colecraft, Henry M.; Hendrickson, Wayne A.			Structure and selectivity in bestrophin ion channels	SCIENCE			English	Article							VITELLIFORM MACULAR DYSTROPHY; CHLORIDE CHANNEL; BEST-DISEASE; MOUSE BESTROPHIN-2; VMD2 GENE; DEGENERATION; MEMBRANE; FAMILY; IDENTIFICATION; MUTATIONS	Human bestrophin-1 (hBest1) is a calcium-activated chloride channel from the retinal pigment epithelium, where mutations are associated with vitelliform macular degeneration, or Best disease. We describe the structure of a bacterial homolog (KpBest) of hBest1 and functional characterizations of both channels. KpBest is a pentamer that forms a five-helix transmembrane pore, closed by three rings of conserved hydrophobic residues, and has a cytoplasmic cavern with a restricted exit. From electrophysiological analysis of structure-inspired mutations in KpBest and hBest1, we find a sensitive control of ion selectivity in the bestrophins, including reversal of anion/cation selectivity, and dramatic activation by mutations at the cytoplasmic exit. A homology model of hBest1 shows the locations of disease-causing mutations and suggests possible roles in regulation.	[Yang, Tingting; Guo, Youzhong; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Liu, Qun; Hendrickson, Wayne A.] Brookhaven Natl Lab, New York Struct Biol Ctr, Upton, NY 11973 USA; [Kloss, Brian; Bruni, Renato; Kalathur, Ravi C.; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Dept Informat Bioinformat & Computat Biol, D-85748 Garching, Germany; [Colecraft, Henry M.; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory; Technical University of Munich; Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@xtl.cumc.columbia.edu	Liu, Qun/A-8757-2011; Guo, Youzhong/AAW-3010-2021; Rost, Burkhard/A-1908-2016; Kalathur, Ravi/L-7696-2016	Liu, Qun/0000-0002-1179-290X; Rost, Burkhard/0000-0003-0179-8424; Kalathur, Ravi/0000-0003-1669-9277; kalathur, ravi/0000-0002-4889-8003; Kloss, Brian/0000-0003-0130-8739; Bruni, Renato/0000-0002-2312-0254	NIH [GM095315, GM107462]; NATIONAL EYE INSTITUTE [R00EY025290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, R01GM107462, U54GM095315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Clarke for help in the diffraction analysis; A. Marks for use of planar lipid instrumentation; W. Xie for help in planar lipid experiments; Q. Fan, Y. Geng, and members of the Hendrickson laboratory for discussions; and J. Schwanof and R. Abramowitz at National Synchrotron Light Source (NSLS) beamlines X4A and X4C and F. Murphy at the Advanced Photon Source beamline 24-ID-E for their assistance in data collection. This work was supported in part by NIH grants GM095315 and GM107462 to W.A.H. X4 beamlines are supported by the New York Structural Biology Center at the NSLS of Brookhaven National Laboratory, a Department of Energy facility. The data reported in this paper are tabulated in the supplementary materials and deposited to the Protein Data Bank with access codes listed in table S2. Author contributions: T.Y. and W.A.H. designed research, analyzed data, and wrote the paper; T.Y. performed experiments; Q.L. analyzed, diffraction data; B.K., R.C.K., and R.B. performed expression tests: Y.G. advised on protein production and analyzed diffraction data; E.K. and B.R. performed bioinformatics analyses; and H.M.C. designed and analyzed electrophysiology experiments. The authors declare no conflicts of interest.	Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Kramer Franziska, 2003, Hum Mutat, V22, P418, DOI 10.1002/humu.9189; Kranjc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004672; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Maia-Lopes Susana, 2008, Hum Genet, V123, P112; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Milenkovic VM, 2007, J BIOL CHEM, V282, P1313, DOI 10.1074/jbc.M607383200; Neussert R, 2010, PFLUG ARCH EUR J PHY, V460, P163, DOI 10.1007/s00424-010-0840-2; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Yu K, 2006, INVEST OPHTH VIS SCI, V47, P4956, DOI 10.1167/iovs.06-0524	33	85	85	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					355	359		10.1126/science.1259723	http://dx.doi.org/10.1126/science.1259723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324390	Green Accepted, Green Submitted			2022-12-01	WOS:000343041100046
J	Dowen, JM; Fan, ZP; Hnisz, D; Ren, G; Abraham, BJ; Zhang, LN; Weintraub, AS; Schuijers, J; Lee, TI; Zhao, KJ; Young, RA				Dowen, Jill M.; Fan, Zi Peng; Hnisz, Denes; Ren, Gang; Abraham, Brian J.; Zhang, Lyndon N.; Weintraub, Abraham S.; Schuijers, Jurian; Lee, Tong Ihn; Zhao, Keji; Young, Richard A.			Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes	CELL			English	Article							TRANSCRIPTIONAL REGULATION; DEVELOPMENTAL REGULATORS; TOPOLOGICAL DOMAINS; GENOME ORGANIZATION; SUPER-ENHANCERS; BINDING SITES; PROTEIN CTCF; CHROMATIN; COHESIN; POLYCOMB	The pluripotent state of embryonic stem cells (ESCs) is produced by active transcription of genes that control cell identity and repression of genes encoding lineage-specifying developmental regulators. Here, we use ESC cohesin ChIA-PET data to identify the local chromosomal structures at both active and repressed genes across the genome. The results produce a map of enhancer-promoter interactions and reveal that super-enhancer-driven genes generally occur within chromosome structures that are formed by the looping of two interacting CTCF sites co-occupied by cohesin. These looped structures form insulated neighborhoods whose integrity is important for proper expression of local genes. We also find that repressed genes encoding lineage-specifying developmental regulators occur within insulated neighborhoods. These results provide insights into the relationship between transcriptional control of cell identity genes and control of local chromosome structure.	[Dowen, Jill M.; Fan, Zi Peng; Hnisz, Denes; Abraham, Brian J.; Zhang, Lyndon N.; Weintraub, Abraham S.; Schuijers, Jurian; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Ren, Gang; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Ren, Gang] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Lyndon N.; Weintraub, Abraham S.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwest A&F University - China; Massachusetts Institute of Technology (MIT)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; young@wi.mit.edu	Abraham, Brian/C-2230-2019; Young, Richard A/F-6495-2012; Hnisz, Denes/AAE-9592-2019	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647; Hnisz, Denes/0000-0002-6256-1693; REN, GANG/0000-0001-9690-5995; Schuijers, Jurian/0000-0003-2531-3516	National Institutes of Health [HG002668]; Division of Intramural Research, NHLBI; Ruth L. Kirschstein National Research Service Award [CA168263-01A1]; Austrian Science Fund (FWF) [J3490]; Rubicon Fellowship for the Life Sciences, Netherlands Organization for Scientific Research (NWO); NATIONAL CANCER INSTITUTE [F32CA168263] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3490] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Rubicon Fellowship for the Life Sciences, Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Warren Whyte for generating the H3K27me3 ChIP-seq data set, Chikdu Shivalila for help with genome editing experiments, Alla Sigova for help with experiment design, Rudolf Jaenisch for sharing CRISPR reagents, and the Whitehead Institute Genome Technology Core and NHLBI DNA Sequencing Core for Illumina sequencing. We also thank members of the Young lab for helpful discussions. This work was supported by the National Institutes of Health grant HG002668 (R.A.Y.), Division of Intramural Research, NHLBI (K.Z.), a Ruth L. Kirschstein National Research Service Award (CA168263-01A1) (J.M.D.), an Erwin Schrodinger Fellowship (J3490) from the Austrian Science Fund (FWF) (D.H.), and a Rubicon Fellowship for the Life Sciences, Netherlands Organization for Scientific Research (NWO) (J.S.). R.A.Y. is a founder of Syros Pharmaceuticals.	Baranello L, 2014, P NATL ACAD SCI USA, V111, P889, DOI 10.1073/pnas.1321957111; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Goh YF, 2012, JOVE-J VIS EXP, DOI 10.3791/3770; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaspi H, 2013, STEM CELLS, V31, P2266, DOI 10.1002/stem.1465; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003560; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	69	559	573	3	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					374	387		10.1016/j.cell.2014.09.030	http://dx.doi.org/10.1016/j.cell.2014.09.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303531	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000343095600018
J	Taylor, AI; Pinheiro, VB; Smola, MJ; Morgunov, AS; Peak-Chew, S; Cozens, C; Weeks, KM; Herdewijn, P; Holliger, P				Taylor, Alexander I.; Pinheiro, Vitor B.; Smola, Matthew J.; Morgunov, Alexey S.; Peak-Chew, Sew; Cozens, Christopher; Weeks, Kevin M.; Herdewijn, Piet; Holliger, Philipp			Catalysts from synthetic genetic polymers	NATURE			English	Article							CLEAVING DNA ENZYME; ARABINONUCLEIC ACIDS; STRUCTURAL BASIS; RNA SECONDARY; NUCLEIC-ACIDS; EVOLUTION; SHAPE; HYBRIDIZATION; SEQUENCES; RIBOZYME	The emergence of catalysis in early genetic polymers such as RNA is considered a key transition in the origin of life(1), pre-dating the appearance of protein enzymes. DNA also demonstrates the capacity to fold into three-dimensional structures and form catalysts in vitro(2). However, to what degree these natural biopolymers comprise functionally privileged chemical scaffolds(3) for folding or the evolution of catalysis is not known. The ability of synthetic genetic polymers (XNAs) with alternative backbone chemistries not found in nature to fold into defined structures and bind ligands(4) raises the possibility that these too might be capable of forming catalysts (XNAzymes). Here we report the discovery of such XNAzymes, elaborated in four different chemistries (arabino nucleic acids, ANA(5); 2'-fluoroarabino nucleic acids, FANA(6); hexitol nucleic acids, HNA; and cyclohexene nucleic acids, CeNA(7)) directly from random XNA oligomer pools, exhibiting in trans RNA endonuclease and ligase activities. We also describe an XNA-XNA ligase metalloenzyme in the FANA framework, establishing catalysis in an entirely synthetic system and enabling the synthesis of FANA oligomers and an active RNA endonuclease FANAzyme from its constituent parts. These results extend catalysis beyond biopolymers and establish technologies for the discovery of catalysts in a wide range of polymer scaffolds not found in nature(8). Evolution of catalysis independent of any natural polymer has implications for the definition of chemical boundary conditions for the emergence of life on Earth and elsewhere in the Universe(9).	[Taylor, Alexander I.; Pinheiro, Vitor B.; Morgunov, Alexey S.; Peak-Chew, Sew; Cozens, Christopher; Holliger, Philipp] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Smola, Matthew J.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Herdewijn, Piet] Katholieke Univ Leuven, Rea Inst, B-3000 Louvain, Belgium; [Herdewijn, Piet] Univ Evry, Inst Syst & Synthet Biol, F-91030 Evry, France	MRC Laboratory Molecular Biology; University of North Carolina; University of North Carolina Chapel Hill; KU Leuven; UDICE-French Research Universities; Universite Paris Saclay	Holliger, P (corresponding author), MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	Pinheiro, Vitor/O-5514-2017	Pinheiro, Vitor/0000-0003-2491-0028; Smola, Matthew/0000-0002-2123-9681; Herdewijn, Piet/0000-0003-3589-8503; Morgunov, Alexey/0000-0001-9636-3284; Cozens, Christopher/0000-0003-4067-6921; Taylor, Alexander/0000-0001-7684-1437	Medical Research Council (MRC) [U105178804]; European Science Foundation (ESF); Biotechnology and Biological Sciences Research Council (BBSRC) UK [09-EuroSYNBIO-OP-013]; European Union; European Research Council [ERC-2012 ADG_20120216/320683]; US National Science Foundation [MCB-1121024]; NSF Graduate Research Fellowship [DGE-1144081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570] Funding Source: NIH RePORTER; BBSRC [BB/M005623/1] Funding Source: UKRI; MRC [MC_U105178804, MC_U105185859] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M005623/1] Funding Source: researchfish; Medical Research Council [MC_U105185859, MC_U105178804] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Science Foundation (ESF)(European Science Foundation (ESF)); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); US National Science Foundation(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC) programme grant U105178804 (P. Holliger, A.I.T., V.B.P., A.S.M., S.P.-C., C.C.) and by grants from the European Science Foundation (ESF) and the Biotechnology and Biological Sciences Research Council (BBSRC) UK (09-EuroSYNBIO-OP-013) (P.H., A.I.T.), the European Union Framework (FP7/2007-2013 (P. Herdewijn), the European Research Council (ERC-2012 ADG_20120216/320683 (P. Herdewijn)), the US National Science Foundation (MCB-1121024 (K.M.W.)) and by an NSF Graduate Research Fellowship (DGE-1144081 (M.J.S.)).	Atkins J. F., 2012, RNA WORLDS; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Benner SA, 2004, CURR OPIN CHEM BIOL, V8, P672, DOI 10.1016/j.cbpa.2004.10.003; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bowler FR, 2013, NAT CHEM, V5, P383, DOI 10.1038/nchem.1626; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Brody JR, 2004, BIOTECHNIQUES, V36, P214, DOI 10.2144/04362BM02; CHU BCF, 1983, NUCLEIC ACIDS RES, V11, P6513, DOI 10.1093/nar/11.18.6513; CUENOUD B, 1995, NATURE, V375, P611, DOI 10.1038/375611a0; Deleavey GF, 2010, NUCLEIC ACIDS RES, V38, P4547, DOI 10.1093/nar/gkq181; Dowler T, 2006, NUCLEIC ACIDS RES, V34, P1669, DOI 10.1093/nar/gkl033; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Hendrix C, 1997, CHEM-EUR J, V3, P1513, DOI 10.1002/chem.19970030920; Herdewijn P, 2010, CHEM BIODIVERS, V7, P1, DOI 10.1002/cbdv.200900185; Homan PJ, 2014, P NATL ACAD SCI USA, V111, P13858, DOI 10.1073/pnas.1407306111; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lescrinier E, 2000, CHEM BIOL, V7, P719, DOI 10.1016/S1074-5521(00)00017-X; Lilley DMJ, 2011, PHILOS T R SOC B, V366, P2910, DOI 10.1098/rstb.2011.0132; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martin-Pintado N, 2012, NUCLEIC ACIDS RES, V40, P9329, DOI 10.1093/nar/gks672; Minasov G, 2000, BIOCHEMISTRY-US, V39, P3525, DOI 10.1021/bi992792j; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nauwelaerts K, 2007, J AM CHEM SOC, V129, P9340, DOI 10.1021/ja067047q; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Noronha AM, 2000, BIOCHEMISTRY-US, V39, P7050, DOI 10.1021/bi000280v; Paul N, 2006, CHEM BIOL, V13, P329, DOI 10.1016/j.chembiol.2006.01.007; Pinheiro VB, 2012, CURR OPIN CHEM BIOL, V16, P245, DOI 10.1016/j.cbpa.2012.05.198; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/NMETH.3029, 10.1038/nmeth.3029]; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Zlatev I., 2001, CURRENT PROTOCOLS NU; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	167	171	3	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					427	430		10.1038/nature13982	http://dx.doi.org/10.1038/nature13982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470036	Green Published, Green Submitted, Green Accepted			2022-12-01	WOS:000349547400048
J	Prince, MJ; Wu, F; Guo, YF; Robledo, LMG; O'Donnell, M; Sullivan, R; Yusuf, S				Prince, Martin J.; Wu, Fan; Guo, Yanfei; Gutierrez Robledo, Luis M.; O'Donnell, Martin; Sullivan, Richard; Yusuf, Salim			The burden of disease in older people and implications for health policy and practice	LANCET			English	Article							CORONARY-HEART-DISEASE; SUB-SAHARAN AFRICA; OBSTRUCTIVE PULMONARY-DISEASE; LOW-INCOME COUNTRIES; RISK-FACTORS; COST-EFFECTIVENESS; ELDERLY-PEOPLE; MIDDLE-INCOME; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE	23% of the total global burden of disease is attributable to disorders in people aged 60 years and older. Although the proportion of the burden arising from older people (>= 60 years) is highest in high-income regions, disability-adjusted life years (DALYs) per head are 40% higher in low-income and middle-income regions, accounted for by the increased burden per head of population arising from cardiovascular diseases, and sensory, respiratory, and infectious disorders. The leading contributors to disease burden in older people are cardiovascular diseases (30.3% of the total burden in people aged 60 years and older), malignant neoplasms (15.1%), chronic respiratory diseases (9.5%), musculoskeletal diseases (7.5%), and neurological and mental disorders (6.6%). A substantial and increased proportion of morbidity and mortality due to chronic disease occurs in older people. Primary prevention in adults aged younger than 60 years will improve health in successive cohorts of older people, but much of the potential to reduce disease burden will come from more effective primary, secondary, and tertiary prevention targeting older people. Obstacles include misplaced global health priorities, ageism, the poor preparedness of health systems to deliver age-appropriate care for chronic diseases, and the complexity of integrating care for complex multimorbidities. Although population ageing is driving the worldwide epidemic of chronic diseases, substantial untapped potential exists to modify the relation between chronological age and health. This objective is especially important for the most age-dependent disorders (ie, dementia, stroke, chronic obstructive pulmonary disease, and vision impairment), for which the burden of disease arises more from disability than from mortality, and for which long-term care costs outweigh health expenditure. The societal cost of these disorders is enormous.	[Prince, Martin J.] Inst Psychiat, London SE5 8AF, England; [Sullivan, Richard] Kings Coll London, Kings Hlth Partners Integrated Canc, Hlth Partners Canc Ctr, London, England; [Sullivan, Richard] Kings Coll London, Kings Hlth Partners Integrated Canc, Inst Canc Policy, London, England; [Sullivan, Richard] Kings Coll London, Ctr Global Hlth, London, England; [Wu, Fan] Shanghai Inst Preventat Med, Shanghai, Peoples R China; [Wu, Fan; Guo, Yanfei] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Gutierrez Robledo, Luis M.] Inst Nacl Geriatr, Mexico City, DF, Mexico; [Gutierrez Robledo, Luis M.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [O'Donnell, Martin] Natl Univ Ireland Univ Coll Galway, Galway, Ireland; [Yusuf, Salim] McMaster Univ, Hamilton, ON, Canada	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Shanghai Center for Disease Control & Prevention; Universidad Nacional Autonoma de Mexico; Ollscoil na Gaillimhe-University of Galway; McMaster University	Prince, MJ (corresponding author), Inst Psychiat, P060,De Crespigny Pk, London SE5 8AF, England.	martin.prince@kcl.ac.uk	O'Donnell, Martin/ABE-7459-2020; Prince, Martin J/A-9170-2010	O'Donnell, Martin/0000-0002-7347-7761; Prince, Martin J/0000-0003-1379-7146; Sullivan, Richard/0000-0002-6435-1825; Gutierrez Robledo, Luis M/0000-0002-9728-6644; Yusuf, Salim/0000-0003-4776-5601				Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Aguilar-Salinas CA, 2003, DIABETES CARE, V26, P2021, DOI 10.2337/diacare.26.7.2021; Ait-Khaled N, 2008, INT J TUBERC LUNG D, V12, P595; Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; Akgun KM, 2012, J GERONTOL A-BIOL, V67, P276, DOI 10.1093/gerona/glr251; Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; Alzheimer's Disease International, 2013, POL BRIEF G8 HEADS G; Alzheimer's Disease International, 2009, WORLD ALZHEIMER REPO; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Avila-Funes JA, 2009, J AM GERIATR SOC, V57, P453, DOI 10.1111/j.1532-5415.2008.02136.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brown ML, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P569; Brown ML, 2002, MED CARE, V40, P104; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Cancer Research UK, 2012, CANC INC AG UK STAT; Caughey GE, 2010, J EPIDEMIOL COMMUN H, V64, P1036, DOI 10.1136/jech.2009.088260; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Cong RH, 2008, ANN EPIDEMIOL, V18, P647, DOI 10.1016/j.annepidem.2008.04.002; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Dachs J. Norberto W., 2002, Rev Panam Salud Publica, V11, P335, DOI 10.1590/S1020-49892002000500009; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; Das S K, 2008, J Assoc Physicians India, V56, P175; De Lepeleire J, 2009, BRIT J GEN PRACT, V59, P364, DOI 10.3399/bjgp09X420653; de Vugt ME, 2005, INT PSYCHOGERIATR, V17, P577, DOI 10.1017/S101610205002292; Deepa M, 2003, J Assoc Physicians India, V51, P863; Deo R, 2012, ARCH INTERN MED, V172, P741, DOI 10.1001/archinternmed.2012.1294; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Feenstra TL, 2001, AM J RESP CRIT CARE, V164, P590, DOI 10.1164/ajrccm.164.4.2003167; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Fletcher AE, 2010, OPHTHALMIC RES, V44, P191, DOI 10.1159/000316476; Foley KM, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P981; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2003, ETHNIC DIS, V13, P85; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Frick KD, 2009, OPHTHAL EPIDEMIOL, V16, P378, DOI 10.3109/09286580903312277; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Gheorghiade Mihai, 2009, Acute Card Care, V11, P83, DOI 10.1080/17482940902883246; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hrobonova E., 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/651931; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jitapunkul S, 2009, GERIATR GERONTOL INT, V9, P47, DOI 10.1111/j.1447-0594.2008.00501.x; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Kinsella K., 2005, GLOBAL AGING CHALLEN; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; KOWAL P, 2010, GLOB HLTH ACTION, V3; Lacas A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-4; Lacey L, 2005, EUR J HEART FAIL, V7, P677, DOI 10.1016/j.ejheart.2004.10.020; Lewallen S, 2009, BRIT J OPHTHALMOL, V93, P295, DOI 10.1136/bjo.2008.140301; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lievesley N, 2009, AGEISM AGE DISCRIMIN; Lloyd-Sherlock P, 2012, LANCET, V379, P1295, DOI 10.1016/S0140-6736(12)60519-4; Luengo-Fernandez R, 2010, DEMENTIA 2010 PREVAL; Luker JA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-161; Ma Xj, 2008, Biomed Imaging Interv J, V4, pe39, DOI 10.2349/biij.4.3.e39; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Morlion B, 2013, NAT REV NEUROL, V9, P462, DOI 10.1038/nrneurol.2013.130; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Musini VM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000028.pub2; National Institutes of Health. National Heart Lung and Blood Institute, 2009, MORB MORT 2009 CHART; Ng N, 2006, SCAND J PUBLIC HEALT, V34, P199, DOI 10.1080/14034940500204506; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olaiz G, 2003, ENCUESTA NACL SALUD; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Partnership for Solution, 2004, CHRONIC CONDITIONS M; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pitner Janet K, 2005, Consult Pharm, V20, P498, DOI 10.4140/TCP.n.2005.498; Preston SD, 2008, J ROY SOC MED, V101, P409, DOI 10.1258/jrsm.2008.080035; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2011, WORLD ALZHEIMER REPO; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Prince M, 2012, INT J GERIATR PSYCH, V27, P670, DOI 10.1002/gps.2727; Prince MJ, 2012, J HYPERTENS, V30, P177, DOI 10.1097/HJH.0b013e32834d9eda; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Ramsay SE, 2005, J PUBLIC HEALTH-UK, V27, P338, DOI 10.1093/pubmed/fdi053; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Reveille JD, 2013, AM J MED SCI, V345, P431, DOI 10.1097/MAJ.0b013e318294457f; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Roy K, 2008, SOC SCI MED, V66, P1951, DOI 10.1016/j.socscimed.2008.01.015; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sanderson S, 1996, HLTH TRENDS, V28, P71; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Sousa RM, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-53; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Sposato LA, 2012, STROKE, V43, P170, DOI 10.1161/STROKEAHA.111.632158; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; Standard & Poor's, 2010, GLOB AG 2010 IRR TRU; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS9, DOI 10.1093/geronb/53B.1.S9; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Turner NJ, 1999, BRIT MED J, V319, P309, DOI 10.1136/bmj.319.7205.309; UN General Assembly, 2011, POL HIGH LEV M GEN A; United Nations, 2002, 2 WORLD ASS AG MADR; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Vashist P, 2011, OPHTHALMOLOGY, V118, pe1; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wolff JL, 2005, J AM GERIATR SOC, V53, P851, DOI 10.1111/j.1532-5415.2005.53262.x; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization, 2012, DEM PUBL HLTH PRIOR; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	142	962	997	22	300	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					549	562		10.1016/S0140-6736(14)61347-7	http://dx.doi.org/10.1016/S0140-6736(14)61347-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468153				2022-12-01	WOS:000349213600034
J	Dao, A; Yaro, AS; Diallo, M; Timbine, S; Huestis, DL; Kassogue, Y; Traore, AI; Sanogo, ZL; Samake, D; Lehmann, T				Dao, A.; Yaro, A. S.; Diallo, M.; Timbine, S.; Huestis, D. L.; Kassogue, Y.; Traore, A. I.; Sanogo, Z. L.; Samake, D.; Lehmann, T.			Signatures of aestivation and migration in Sahelian malaria mosquito populations	NATURE			English	Article							ANOPHELES-GAMBIAE COMPLEX; DRY SEASON; MOLECULAR-FORMS; SUDAN SAVANNA; WEST-AFRICA; MALI; PERSISTENCE; ARABIENSIS; DIFFERENTIATION; TRANSMISSION	During the long Sahelian dry season, mosquito vectors of malaria are expected to perish when no larval sites are available; yet, days after the first rains, mosquitoes reappear in large numbers. How these vectors persist over the 3-6-month long dry season has not been resolved, despite extensive research for over a century(1-3.) Hypotheses for vector persistence include dry-season diapause (aestivation) and long-distance migration (LDM); both are facets of vector biology that have been highly controversial owing to lack of concrete evidence. Here we show that certain species persist by a form of aestivation, while others engage in LDM. Using time-series analyses, the seasonal cycles of Anopheles coluzzii, Anopheles gambiae sensu stricto (s.s.), and Anopheles arabiensis were estimated, and their effects were found to be significant, stable and highly species-specific. Contrary to all expectations, the most complex dynamics occurred during the dry season, when the density of A. coluzzii fluctuated markedly, peaking when migration would seem highly unlikely, whereas A. gambiae s.s. was undetected. The population growth of A. coluzzii followed the first rains closely, consistent with aestivation, whereas the growth phase of both A. gambiae s.s. and A. arabiensis lagged by two months. Such a delay is incompatible with local persistence, but fits LDM. Surviving the long dry season in situ allows A. coluzzii to predominate and form the primary force of malaria transmission. Our results reveal profound ecological divergence between A. coluzzii and A. gambiae s.s., whose standing as distinct species has been challenged, and suggest that climate is one of the selective pressures that led to their speciation. Incorporating vector dormancy and LDM is key to predicting shifts in the range of malaria due to global climate change(4), and to the elimination of malaria from Africa.	[Dao, A.; Yaro, A. S.; Diallo, M.; Timbine, S.; Kassogue, Y.; Traore, A. I.; Sanogo, Z. L.; Samake, D.] Univ Sci Tech & Technol, ICER, Bamako, Mali; [Huestis, D. L.; Lehmann, T.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	University of Science & Technology of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lehmann, T (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	tlehmann@niaid.nih.gov	Kassogue, Y/AAN-9587-2020	Kassogue, Yaya/0000-0003-2476-4016; Lehmann, Tovi/0000-0002-8142-3915	Tamaki Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001196] Funding Source: NIH RePORTER	Tamaki Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the residents of Thierola for their hospitality and assistance with mosquito collections; J. Ribeiro, T. Wellems, P. McQueen, R. Faiman and G. Wasserberg for their comments on previous versions of this manuscript; and C. Traore, R. Sakai, R. Gwadz and T. Wellems for logistical support. This study was supported by the Tamaki Foundation and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Adamou A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-151; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Donnelly MJ, 2002, TRENDS PARASITOL, V18, P75, DOI 10.1016/S1471-4922(01)02198-5; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Harvey A.C., 1989, FORECASTING STRUCTUR; Holstein M. H., 1954, RES FRENCH W AFRICA; Huestis D.L., 2014, INFECT GENET EVOL; Huestis DL, 2012, J EXP BIOL, V215, P2013, DOI 10.1242/jeb.069468; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Lehmann T, 2014, J MED ENTOMOL, V51, P27, DOI 10.1603/ME13094; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; OMER SM, 1968, NATURE, V217, P879, DOI 10.1038/217879b0; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; Sogoba N, 2007, ACTA TROP, V101, P232, DOI 10.1016/j.actatropica.2007.02.005; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAYLOR CE, 1993, MED VET ENTOMOL, V7, P351, DOI 10.1111/j.1365-2915.1993.tb00704.x; TOURE YT, 1994, GENETICA, V94, P213, DOI 10.1007/BF01443435; Toure YT, 1996, MED VET ENTOMOL, V10, P197, DOI 10.1111/j.1365-2915.1996.tb00731.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yaro AS, 2012, J INSECT PHYSIOL, V58, P1050, DOI 10.1016/j.jinsphys.2012.04.002	31	83	83	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					387	+		10.1038/nature13987	http://dx.doi.org/10.1038/nature13987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25470038	Green Accepted			2022-12-01	WOS:000346484800045
J	Maddalo, D; Manchado, E; Concepcion, CP; Bonetti, C; Vidigal, JA; Han, YC; Ogrodowski, P; Crippa, A; Rekhtman, N; de Stanchina, E; Lowe, SW; Ventura, A				Maddalo, Danilo; Manchado, Eusebio; Concepcion, Carla P.; Bonetti, Ciro; Vidigal, Joana A.; Han, Yoon-Chi; Ogrodowski, Paul; Crippa, Alessandra; Rekhtman, Natasha; de Stanchina, Elisa; Lowe, Scott W.; Ventura, Andrea			In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; ACUTE-LEUKEMIA; MOUSE MODELS; FUSION GENE; CRE-LOXP; CANCER; TRANSLOCATIONS; ALK; RESISTANCE; NPM	Chromosomal rearrangements have a central role in the pathogenesis of human cancers and often result in the expression of therapeutically actionable gene fusions(1). A recently discovered example is a fusion between the genes echinoderm microtubule-associated protein like 4 (EML4) and anaplastic lymphoma kinase (ALK), generated by an inversion on the short arm of chromosome 2: inv(2) (p21p23). The EML4-ALK oncogene is detected in a subset of human non-small cell lung cancers (NSCLC)(2) and is clinically relevant because it confers sensitivity to ALK inhibitors(3). Despite their importance, modelling such genetic events in mice has proven challenging and requires complex manipulation of the germ line. Here we describe an efficient method to induce specific chromosomal rearrangements in vivo using viral-mediated delivery of the CRISPR/Cas9 system to somatic cells of adult animals. We apply it to generate a mouse model of Eml4-Alk-driven lung cancer. The resulting tumours invariably harbour the Eml4-Alk inversion, express the Eml4-Alk fusion gene, display histopathological and molecular features typical of ALK(+) human NSCLCs, and respond to treatment with ALK inhibitors. The general strategy described here substantially expands our ability to model human cancers in mice and potentially in other organisms.	[Maddalo, Danilo; Manchado, Eusebio; Concepcion, Carla P.; Bonetti, Ciro; Vidigal, Joana A.; Han, Yoon-Chi; Ogrodowski, Paul; Lowe, Scott W.; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Concepcion, Carla P.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Crippa, Alessandra] Milano Bicocca Univ, Dept Med Oncol, San Gerardo Hosp, I-20052 Monza, Italy; [Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Weill Cornell Medical College Qatar; San Gerardo Hospital; University of Milano-Bicocca; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Ventura, A (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10065 USA.	venturaa@mskcc.org		Ventura, Andrea/0000-0003-4320-9907; A. Vidigal, Joana/0000-0003-2765-6985; Maddalo, Danilo/0000-0002-3228-1703	Geoffrey Beene Cancer Research Foundation; NCI (Cancer Center Support Grant) [P30 CA008748]; HHMI; NCI; American Italian Cancer Foundation; Foundation Blanceflor Boncompagni Ludovisi, nee Bildt; Jane Coffin Childs Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA129243, P01CA013106] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Foundation; NCI (Cancer Center Support Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Italian Cancer Foundation; Foundation Blanceflor Boncompagni Ludovisi, nee Bildt; Jane Coffin Childs Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. Fazio, M. Ladanyi, G. Riely, S. Armstrong, and the members of the Ventura, Lowe and Jacks laboratories for discussion and comments. We also thank J. Hollenstein for editing the manuscript, T. Jacks for providing tumour samples from K-Ras<SUP>G12D</SUP> mice, and the Cytogenetic Core Facility of MSKCC for tissue processing and histology. This work was supported by grants from the Geoffrey Beene Cancer Research Foundation (A.V.), NCI (Cancer Center Support Grant P30 CA008748, E.d.S.), HHMI (S.W.L.), NCI Project Grant (S.W.L.); and by fellowships from the American Italian Cancer Foundation (D.M.), the Foundation Blanceflor Boncompagni Ludovisi, nee Bildt (D.M.), and the Jane Coffin Childs Foundation (E.M.). C.P.C. was supported by an NCI training grant.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Collins EC, 2000, EMBO REP, V1, P127, DOI 10.1093/embo-reports/kvd021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Pirazzoli V, 2014, CELL REP, V7, P999, DOI 10.1016/j.celrep.2014.04.014; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Taki T, 2006, CURR OPIN ONCOL, V18, P62, DOI 10.1097/01.cco.0000198972.69541.04; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	30	404	435	6	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					423	+		10.1038/nature13902	http://dx.doi.org/10.1038/nature13902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25337876	Green Accepted			2022-12-01	WOS:000346484800053
J	Sanchez-Rivera, FJ; Papagiannakopoulos, T; Romero, R; Tammela, T; Bauer, MR; Bhutkar, A; Joshi, NS; Subbaraj, L; Bronson, RT; Xue, W; Jacks, T				Sanchez-Rivera, Francisco J.; Papagiannakopoulos, Thales; Romero, Rodrigo; Tammela, Tuomas; Bauer, Matthew R.; Bhutkar, Arjun; Joshi, Nikhil S.; Subbaraj, Lakshmipriya; Bronson, Roderick T.; Xue, Wen; Jacks, Tyler			Rapid modelling of cooperating genetic events in cancer through somatic genome editing	NATURE			English	Article							LUNG ADENOCARCINOMA; SEQUENCING DATA; HUMAN-CELLS; PROGRESSION; CATENIN; REPAIR; CAS9; ENDONUCLEASE; NUCLEASES; HALLMARKS	Cancer is a multistep process that involves mutations and other alterations in oncogenes and tumour suppressor genes(1). Genome sequencing studies have identified a large collection of genetic alterations that occur in human cancers(2-4). However, the determination of which mutations are causally related to tumorigenesis remains a major challenge. Here we describe a novel CRISPR/Cas9-based approach for rapid functional investigation of candidate genes in well-established autochthonous mouse models of cancer. Using a Kras(G12D)-driven lung cancer model(5), we performed functional characterization of a panel of tumour suppressor genes with knownloss-of-function alterations in human lung cancer. Cre-dependent somatic activation of oncogenic Kras(G12D) combined with CRISPR/Cas9-mediated genome editing of tumour suppressor genes resulted in lung adenocarcinomas with distinct histopathological and molecular features. This rapid somatic genome engineering approach enables functional characterization of putative cancer genes in the lung and other tissues using autochthonous mouse models. We anticipate that this approach can be used to systematically dissect the complex catalogue of mutations identified in cancer genome sequencing studies.	[Sanchez-Rivera, Francisco J.; Papagiannakopoulos, Thales; Romero, Rodrigo; Tammela, Tuomas; Bauer, Matthew R.; Bhutkar, Arjun; Joshi, Nikhil S.; Subbaraj, Lakshmipriya; Xue, Wen; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sanchez-Rivera, Francisco J.; Romero, Rodrigo; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Bronson, Roderick T.] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu	Huang, ZhiXin/H-5123-2017; Sánchez-Rivera, Francisco J./AAV-6985-2020	Huang, ZhiXin/0000-0003-0705-1970; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; /0000-0003-3675-6961; Joshi, Nikhil/0000-0002-7045-7837; Romero, Rodrigo/0000-0002-9388-8306; Romero, Rodrigo/0000-0003-1689-0784; Subbaraj, Lakshmipriya/0000-0001-5777-3547	Howard Hughes Medical Institute; Ludwig Center for Molecular Oncology at MIT; Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE [R00CA169512, K99CA169512, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Molecular Oncology at MIT; Cancer Center Support (core) grant from the National Cancer Institute; Hope Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. McFadden and Y. Soto-Feliciano for critical reading of the manuscript, H. Yin, S. Levine and T. Mason for MiSeq sequencing support, R. Stott, J. Bartlebaugh and C. Shivalila for technical assistance and K. Cormier and C. Condon from the Hope Babette Tang (1983) Histology Facility for technical support. This work was supported by the Howard Hughes Medical Institute, the Ludwig Center for Molecular Oncology at MIT and in part by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.P. is supported by the Hope Funds for Cancer Research. T. J. is a Howard Hughes Medical Institute Investigator, the David H. Koch Professor of Biology, and a Daniel K. Ludwig Scholar.	Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Farago AF, 2012, CELL, V149, P246, DOI 10.1016/j.cell.2012.03.015; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Psarras S, 2004, J GENE MED, V6, P32, DOI 10.1002/jgm.442; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	39	267	281	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					428	+		10.1038/nature13906	http://dx.doi.org/10.1038/nature13906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25337879	Green Accepted, Green Submitted			2022-12-01	WOS:000346484800054
J	Pemberton, S				Pemberton, Stephen			The fix is in	NATURE			English	Editorial Material							GENE-THERAPY; HEMOPHILIA		New Jersey Inst Technol, Newark, NJ 07102 USA	New Jersey Institute of Technology	Pemberton, S (corresponding author), New Jersey Inst Technol, Newark, NJ 07102 USA.	stephen.pemberton@njit.edu						High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; High KA, 2011, MOL THER, V19, P1749, DOI 10.1038/mt.2011.203; Mannucci PM, 2011, HAEMOPHILIA, V17, P1, DOI 10.1111/j.1365-2516.2011.02657.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Pemberton Stephen Gregory, 2011, BLEEDING DIS HEMOPHI; Wailoo Keith, 2006, TROUBLED DREAM GENET	6	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S165	S165		10.1038/515S165a	http://dx.doi.org/10.1038/515S165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427207	Bronze			2022-12-01	WOS:000346247600009
J	Carninci, P				Carninci, Piero			GENOMICS Mice in the ENCODE spotlight	NATURE			English	Editorial Material							LANDSCAPE; ELEMENTS	Following on from affiliated projects in humans and model invertebrates, the Mouse ENCODE Project presents comprehensive data sets on genome regulation in this key mammalian model. See Articles p. 355, p. 365, p. 371 & LETTER p. 402	RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan	RIKEN	Carninci, P (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, RIKEN Yokohama Campus, Yokohama, Kanagawa 2300045, Japan.	carninci@riken.jp	Carninci, Piero/K-1568-2014	Carninci, Piero/0000-0001-7202-7243				Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	11	9	9	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					346	347		10.1038/515346a	http://dx.doi.org/10.1038/515346a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409821				2022-12-01	WOS:000345770600028
J	Romps, DM; Seeley, JT; Vollaro, D; Molinari, J				Romps, David M.; Seeley, Jacob T.; Vollaro, David; Molinari, John			Projected increase in lightning strikes in the United States due to global warming	SCIENCE			English	Article							CLIMATE-CHANGE; PRECIPITATION; PARAMETERIZATION; DISTRIBUTIONS; FREQUENCY; RADAR; FIRE	Lightning plays an important role in atmospheric chemistry and in the initiation of wildfires, but the impact of global warming on lightning rates is poorly constrained. Here we propose that the lightning flash rate is proportional to the convective available potential energy (CAPE) times the precipitation rate. Using observations, the product of CAPE and precipitation explains 77% of the variance in the time series of total cloud-toground lightning flashes over the contiguous United States (CONUS). Storms convert CAPE times precipitated water mass to discharged lightning energy with an efficiency of 1%. When this proxy is applied to 11 climate models, CONUS lightning strikes are predicted to increase 12 +/- 5% per degree Celsius of global warming and about 50% over this century.	[Romps, David M.; Seeley, Jacob T.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Romps, David M.; Seeley, Jacob T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Vollaro, David; Molinari, John] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Romps, DM (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	romps@berkeley.edu	Romps, David M/F-8285-2011	Romps, David M/0000-0001-7649-5175; Seeley, Jacob/0000-0003-0769-292X	Scientific Discovery through Advanced Computing (SciDAC) program - U.S. Department of Energy Office of Advanced Scientific Computing Research and Office of Biological and Environmental Research; U.S. Department of Energy's Earth System Modeling, an Office of Science, Office of Biological and Environmental Research program [DE-AC02-05CH11231]; National Science Foundation (NSF) Graduate Research Fellowship [DGE1106400]; NSF [AGS1132576]	Scientific Discovery through Advanced Computing (SciDAC) program - U.S. Department of Energy Office of Advanced Scientific Computing Research and Office of Biological and Environmental Research; U.S. Department of Energy's Earth System Modeling, an Office of Science, Office of Biological and Environmental Research program(United States Department of Energy (DOE)); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	D.M.R. acknowledges support from the Scientific Discovery through Advanced Computing (SciDAC) program funded by the U.S. Department of Energy Office of Advanced Scientific Computing Research and Office of Biological and Environmental Research, and by the U.S. Department of Energy's Earth System Modeling, an Office of Science, Office of Biological and Environmental Research program under contract no. DE-AC02-05CH11231. J.T.S. acknowledges support from the National Science Foundation (NSF) Graduate Research Fellowship under grant no. DGE1106400. D.V. and J.M. acknowledge support from NSF under grant no. AGS1132576. Thanks are due to the SPARC data center for archiving the high-resolution radiosonde data and making them publicly available. The authors are also grateful to J. Paul, B. Lawrence, K. Sugioka, and N. Jeevanjee for their help with the precipitation data. Thanks also to three anonymous reviewers. Data sources are described in the online supplementary materials.	Banerjee A, 2014, ATMOS CHEM PHYS, V14, P9871, DOI 10.5194/acp-14-9871-2014; BATTAN LJ, 1965, J ATMOS SCI, V22, P79, DOI 10.1175/1520-0469(1965)022<0079:SFGPAL>2.0.CO;2; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Grewe V, 2007, SCI TOTAL ENVIRON, V374, P167, DOI 10.1016/j.scitotenv.2007.01.032; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Holle RL, 2014, MON WEATHER REV, V142, P1037, DOI 10.1175/MWR-D-13-00121.1; Kitzmiller D, 2013, J HYDROL ENG, V18, P133, DOI 10.1061/(ASCE)HE.1943-5584.0000523; Krause A, 2014, J GEOPHYS RES-BIOGEO, V119, P312, DOI 10.1002/2013JG002502; Levy H, 1996, J GEOPHYS RES-ATMOS, V101, P22911, DOI 10.1029/96JD02341; Meijer EW, 2001, PHYS CHEM EARTH PT C, V26, P577, DOI 10.1016/S1464-1917(01)00050-2; Michalon N, 1999, GEOPHYS RES LETT, V26, P3097, DOI 10.1029/1999GL010837; Muller CJ, 2011, J CLIMATE, V24, P2784, DOI 10.1175/2011JCLI3876.1; Murugavel P, 2014, INT J CLIMATOL, V34, P3179, DOI 10.1002/joc.3901; Orville RE, 2001, MON WEATHER REV, V129, P1179, DOI 10.1175/1520-0493(2001)129<1179:CTGLIT>2.0.CO;2; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pawar SD, 2012, ATMOS RES, V106, P44, DOI 10.1016/j.atmosres.2011.11.007; Petersen WA, 1998, J GEOPHYS RES-ATMOS, V103, P14025, DOI 10.1029/97JD02064; PRICE C, 1992, J GEOPHYS RES-ATMOS, V97, P9919, DOI 10.1029/92JD00719; PRICE C, 1994, J GEOPHYS RES-ATMOS, V99, P10823, DOI 10.1029/94JD00019; PRICE C, 1994, MON WEATHER REV, V122, P1930, DOI 10.1175/1520-0493(1994)122<1930:MGLDIA>2.0.CO;2; Reeve N, 1999, Q J ROY METEOR SOC, V125, P893, DOI 10.1002/qj.49712555507; Romps DM, 2011, J ATMOS SCI, V68, P123, DOI 10.1175/2010JAS3542.1; Schumann U, 2007, ATMOS CHEM PHYS, V7, P3823, DOI 10.5194/acp-7-3823-2007; Singh MS, 2013, GEOPHYS RES LETT, V40, P4398, DOI 10.1002/grl.50796; Sobel AH, 2011, J CLIMATE, V24, P473, DOI 10.1175/2010JCLI3748.1; SPARC, 2013, US HIGH VERT RES RAD; Tapia A, 1998, J APPL METEOROL, V37, P1497, DOI 10.1175/1520-0450(1998)037<1497:EOCRFL>2.0.CO;2; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Wacker RS, 1999, J GEOPHYS RES-ATMOS, V104, P2151, DOI 10.1029/1998JD200060; Williams E, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000380; WILLIAMS ER, 1992, SCIENCE, V256, P1184, DOI 10.1126/science.256.5060.1184; WILLIAMS ER, 1992, J ATMOS SCI, V49, P1386, DOI 10.1175/1520-0469(1992)049<1386:ARAESO>2.0.CO;2; WILLIAMS ER, 1994, MON WEATHER REV, V122, P1917, DOI 10.1175/1520-0493(1994)122<1917:GCRTSV>2.0.CO;2; Ye B, 1998, J CLIMATE, V11, P1997, DOI 10.1175/1520-0442-11.8.1997	38	297	307	15	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					851	854		10.1126/science.1259100	http://dx.doi.org/10.1126/science.1259100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395536	Green Submitted			2022-12-01	WOS:000344659900045
J	Marx, V				Marx, Vivien			A DEEP LOOK AT SYNAPTIC DYNAMICS	NATURE			English	Editorial Material							PROTEINS											Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Watanabe S, 2014, NATURE; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884	8	5	5	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					293	297		10.1038/515293a	http://dx.doi.org/10.1038/515293a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391965				2022-12-01	WOS:000344631400056
J	Jones, MK; Watanabe, M; Zhu, S; Graves, CL; Keyes, LR; Grau, KR; Gonzalez-Hernandez, MB; Iovine, NM; Wobus, CE; Vinje, J; Tibbetts, SA; Wallet, SM; Karst, SM				Jones, Melissa K.; Watanabe, Makiko; Zhu, Shu; Graves, Christina L.; Keyes, Lisa R.; Grau, Katrina R.; Gonzalez-Hernandez, Mariam B.; Iovine, Nicole M.; Wobus, Christiane E.; Vinje, Jan; Tibbetts, Scott A.; Wallet, Shannon M.; Karst, Stephanie M.			Enteric bacteria promote human and mouse norovirus infection of B cells	SCIENCE			English	Article							BLOOD-GROUP ANTIGEN; INTESTINAL EPITHELIAL-CELLS; MURINE NOROVIRUSES; NORWALK VIRUS; GASTROENTERITIS; MICROBIOTA; REPLICATION; LEWIS	The cell tropism of human noroviruses and the development of an in vitro infection model remain elusive. Although susceptibility to individual human norovirus strains correlates with an individual's histo-blood group antigen (HBGA) profile, the biological basis of this restriction is unknown. We demonstrate that human and mouse noroviruses infected B cells in vitro and likely in vivo. Human norovirus infection of B cells required the presence of HBGA-expressing enteric bacteria. Furthermore, mouse norovirus replication was reduced in vivo when the intestinal microbiota was depleted by means of oral antibiotic administration. Thus, we have identified B cells as a cellular target of noroviruses and enteric bacteria as a stimulatory factor for norovirus infection, leading to the development of an in vitro infection model for human noroviruses.	[Jones, Melissa K.; Watanabe, Makiko; Zhu, Shu; Keyes, Lisa R.; Grau, Katrina R.; Tibbetts, Scott A.; Karst, Stephanie M.] Univ Florida, Coll Med, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Graves, Christina L.; Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Graves, Christina L.; Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Gonzalez-Hernandez, Mariam B.; Wobus, Christiane E.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Iovine, Nicole M.] Univ Florida, Dept Med, Div Infect Dis, Gainesville, FL USA; [Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; Centers for Disease Control & Prevention - USA	Karst, SM (corresponding author), Univ Florida, Coll Med, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.	skarst@ufl.edu	Vinje, Jan/ABE-6336-2020	Graves, Christina/0000-0002-7387-2462; Vinje, Jan/0000-0002-1530-3675; Wobus, Christiane/0000-0001-5286-0924	NIH [R01 AI080611, R21 AI103961]; National Institute of Food and Agriculture [2011-68003-30395]; NIH/National Institute of Dental and Craniofacial Research [T90 DE021990-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103961, T32AI007110, R01AI080611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIH/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank R. Condit, G. McFadden, and H. Virgin for critical discussions and reading of the manuscript. We thank R. Renne and F. Zhu for providing cell lines and J. Pfeiffer for mouse antibiotic depletion protocols. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This work was funded by NIH R01 AI080611 and R21 AI103961 for C. E. W; and National Institute of Food and Agriculture 2011-68003-30395 for J.V. C. L. G. was supported in part by NIH/National Institute of Dental and Craniofacial Research T90 DE021990-02 (Burne). A patent application pertinent to this work has been filed (U.S. patent application no. 61/992,040: Methods and Compositions for Caliciviridae, M.J. and S. K. as inventors).	Arias A, 2012, J GEN VIROL, V93, P1432, DOI 10.1099/vir.0.042176-0; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Herbst-Kralovetz MM, 2013, EMERG INFECT DIS, V19, P431, DOI 10.3201/eid1903.121029; Hsu CC, 2006, COMPARATIVE MED, V56, P247; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Kahan SM, 2011, VIROLOGY, V421, P202, DOI 10.1016/j.virol.2011.09.030; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Koo HL, 2010, DISCOV MED, V10, P61; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; May J, 2013, VIROLOGY, V444, P218, DOI 10.1016/j.virol.2013.06.013; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Rasko DA, 2000, EUR J BIOCHEM, V267, P6059, DOI 10.1046/j.1432-1327.2000.01683.x; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Takanashi S, 2014, ARCH VIROL, V159, P257, DOI 10.1007/s00705-013-1806-4; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; van Beek J., 2013, EUROSURVEILLANCE; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	32	543	570	14	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					755	759		10.1126/science.1257147	http://dx.doi.org/10.1126/science.1257147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378626	Green Accepted			2022-12-01	WOS:000344690100043
J	Ahn, HS; Kim, HJ; Welch, HG				Ahn, Hyeong Sik; Kim, Hyun Jung; Welch, H. Gilbert			Korea's Thyroid-Cancer "Epidemic" - Screening and Overdiagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ahn, Hyeong Sik; Kim, Hyun Jung] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Welch, H. Gilbert] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Korea University; Korea University Medicine (KU Medicine); Dartmouth College	Ahn, HS (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.							HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; Is thyroid cancer overdiagnosed?, 2014, KOREA TIMES     0323; 이승훈, 2008, Endocrinology and Metabolism, V23, P35; National Evidence-based Healthcare Collaborating Agency, 2013, RES EV THYR SCREEN S; VANDERLAAN WP, 1947, NEW ENGL J MED, V237, P221, DOI [10.1056/NEJM194708142370703, 10.1056/NEJM194702132360702]	5	701	743	5	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2014	371	19					1765	1767		10.1056/NEJMp1409841	http://dx.doi.org/10.1056/NEJMp1409841			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS3IH	25372084				2022-12-01	WOS:000344170300004
J	Gao, P; Postiglione, MP; Krieger, TG; Hernandez, L; Wang, C; Han, Z; Streicher, C; Papusheva, E; Insolera, R; Chugh, K; Kodish, O; Huang, K; Simons, BD; Luo, LQ; Hippenmeyer, S; Shi, SH				Gao, Peng; Postiglione, Maria Pia; Krieger, Teresa G.; Hernandez, Luisirene; Wang, Chao; Han, Zhi; Streicher, Carmen; Papusheva, Ekaterina; Insolera, Ryan; Chugh, Kritika; Kodish, Oren; Huang, Kun; Simons, Benjamin D.; Luo, Liqun; Hippenmeyer, Simon; Shi, Song-Hai			Deterministic Progenitor Behavior and Unitary Production of Neurons in the Neocortex	CELL			English	Article							OUTER SUBVENTRICULAR ZONE; NEURAL PROGENITORS; CEREBRAL-CORTEX; RADIAL GLIA; STEM; CELLS; NEUROGENESIS; DISPERSION; MIGRATION; REGIONS	Radial glial progenitors (RGPs) are responsible for producing nearly all neocortical neurons. To gain insight into the patterns of RGP division and neuron production, we quantitatively analyzed excitatory neuron genesis in the mouse neocortex using Mosaic Analysis with Double Markers, which provides single-cell resolution of progenitor division patterns and potential in vivo. We found that RGPs progress through a coherent program in which their proliferative potential diminishes in a predictable manner. Upon entry into the neurogenic phase, individual RGPs produce similar to 8-9 neurons distributed in both deep and superficial layers, indicating a unitary output in neuronal production. Removal of OTX1, a transcription factor transiently expressed in RGPs, results in both deep-and superficial-layer neuron loss and a reduction in neuronal unit size. Moreover, similar to 1/6 of neurogenic RGPs proceed to produce glia. These results suggest that progenitor behavior and histogenesis in the mammalian neocortex conform to a remarkably orderly and deterministic program.	[Gao, Peng; Hernandez, Luisirene; Insolera, Ryan; Chugh, Kritika; Kodish, Oren; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Gao, Peng; Hernandez, Luisirene; Insolera, Ryan; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Postiglione, Maria Pia; Streicher, Carmen; Papusheva, Ekaterina; Hippenmeyer, Simon] IST Austria, A-3400 Klosterneuburg, Austria; [Krieger, Teresa G.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Krieger, Teresa G.; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Wang, Chao; Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Wang, Chao; Huang, Kun] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA; [Han, Zhi] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Institute of Science & Technology - Austria; University of Cambridge; University of Cambridge; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nankai University; University of Cambridge; Howard Hughes Medical Institute; Stanford University; Stanford University	Hippenmeyer, S (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	simon.hippenmeyer@ist.ac.at; shis@mskcc.org	Huang, Kun/E-3272-2011; Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Insolera, Ryan/0000-0001-8282-9370; Hippenmeyer, Simon/0000-0003-2279-1061; Luo, Liqun/0000-0001-5467-9264; Han, Zhi/0000-0002-5603-8433	European Union [FP7-CIG618444]; Simons Foundation [274336]; NIH [R01DA024681, R01MH101382, R01NS050835, T32HD060600]; Wellcome Trust [098357/Z/12/Z]; Human Frontier Science Program [RGP0053]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [1208869] Funding Source: researchfish	European Union(European Commission); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Dr. Nicoletta Tekki-Kessaris, Dr. Ryoichiro Kageyama, and Dr. Antonio Simeone for kindly providing Emx1-CreER<SUP>T2</SUP>, Nestin-CreER<SUP>T2</SUP>, and Otx1<SUP>+/-</SUP> mouse lines, respectively; Dr. Rick Livesey for helpful discussions, Zhizhong Li and Susanne Laukoter for technical support; and Shi and Hippenmeyer lab members for insightful discussions and input. This work was supported by the European Union (FP7-CIG618444 to S.H.), the Simons Foundation (274336 to S.-H.S.), NIH grants (R01DA024681 and R01MH101382 to S.-H.S., R01NS050835 to L.L., and T32HD060600 to L.H.), the Wellcome Trust (098357/Z/12/Z to B.D.S.), and the Human Frontier Science Program (RGP0053 to S.-H.S., S.H., B.D.S., and K.H.). L.L. is an investigator of the Howard Hughes Medical Institute.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bayraktar OA, 2013, NATURE, V498, P449, DOI 10.1038/nature12266; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Desai AR, 2000, DEVELOPMENT, V127, P2863; Diggle P., 2003, STAT ANAL SPATIAL PO; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Guo C, 2013, NEURON, V80, P1167, DOI 10.1016/j.neuron.2013.09.037; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; He J, 2012, NEURON, V75, P786, DOI 10.1016/j.neuron.2012.06.033; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Marin O, 2012, NATURE, V490, P185, DOI 10.1038/490185a; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	53	234	236	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					775	788		10.1016/j.cell.2014.10.027	http://dx.doi.org/10.1016/j.cell.2014.10.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417155	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000344522000011
J	Planavsky, NJ; Reinhard, CT; Wang, XL; Thomson, D; McGoldrick, P; Rainbird, RH; Johnson, T; Fischer, WW; Lyons, TW				Planavsky, Noah J.; Reinhard, Christopher T.; Wang, Xiangli; Thomson, Danielle; McGoldrick, Peter; Rainbird, Robert H.; Johnson, Thomas; Fischer, Woodward W.; Lyons, Timothy W.			Low Mid-Proterozoic atmospheric oxygen levels and the delayed rise of animals	SCIENCE			English	Article							CHROMIUM ISOTOPES; EARLY HISTORY; ENVIRONMENT; DIAGENESIS; PALEOSOLS; REDUCTION; OXIDATION; REDOX; SOILS; OCEAN	The oxygenation of Earth's surface fundamentally altered global biogeochemical cycles and ultimately paved the way for the rise of metazoans at the end of the Proterozoic. However, current estimates for atmospheric oxygen (O-2) levels during the billion years leading up to this time vary widely. On the basis of chromium (Cr) isotope data from a suite of Proterozoic sediments from China, Australia, and North America, interpreted in the context of data from similar depositional environments from Phanerozoic time, we find evidence for inhibited oxidation of Cr at Earth's surface in the mid-Proterozoic (1.8 to 0.8 billion years ago). These data suggest that atmospheric O-2 levels were at most 0.1% of present atmospheric levels. Direct evidence for such low O-2 concentrations in the Proterozoic helps explain the late emergence and diversification of metazoans.	[Planavsky, Noah J.; Wang, Xiangli] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Reinhard, Christopher T.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Wang, Xiangli; Johnson, Thomas] Univ Illinois, Dept Geol, Champaign, IL 61820 USA; [Thomson, Danielle] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [McGoldrick, Peter] Univ Tasmania, Ctr Ore Deposit & Explorat Sci, Hobart, Tas 7001, Australia; [Rainbird, Robert H.] Geol Survey Canada, Ottawa, ON, Canada; [Fischer, Woodward W.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	Yale University; University System of Georgia; Georgia Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Carleton University; University of Tasmania; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; California Institute of Technology; University of California System; University of California Riverside	Planavsky, NJ (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	noah.planavsky@yale.edu; chris.reinhard@eas.gatech.edu	wang, Xiangli/AAT-7987-2020	Rainbird, Robert/0000-0003-4538-4637; Wang, Xiangli/0000-0002-0420-3070	NASA Exobiology Program; NSF-ELT program; California Institute of Technology; National Science and Engineering Research Council of Canada Discovery Grant; Natural Resources Canada's GEM Program; Australian Research Council's Centres of Excellence Program; Division Of Earth Sciences [1338299] Funding Source: National Science Foundation	NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NSF-ELT program; California Institute of Technology; National Science and Engineering Research Council of Canada Discovery Grant; Natural Resources Canada's GEM Program; Australian Research Council's Centres of Excellence Program(Australian Research Council); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	N.J.P., C. T. R., X. W., T.J, and T. W. L. acknowledge funding from NASA Exobiology Program. N.J.P., C. T. R., and T. W. L. acknowledge funding from the NSF-ELT program. C. T. R. acknowledges an O.K. Earl fellowship from the California Institute of Technology. R. H. R. and D. T. acknowledge funding from a National Science and Engineering Research Council of Canada Discovery Grant and by Natural Resources Canada's GEM Program. P. McG. acknowledges funding through the Australian Research Council's Centres of Excellence Program and thanks S. Gilbert for expert help with the LA-ICPMS work. We are indebted to A. Bekker, B. Maynard, A. Hofmann, K. Konhauser, J. Owens, C. Li, and G. Love for discussion and samples. Full data tables are in the supplementary materials.	ALLER RC, 1986, CONT SHELF RES, V6, P263, DOI 10.1016/0278-4343(86)90064-6; BARTLETT R, 1979, J ENVIRON QUAL, V8, P31, DOI 10.2134/jeq1979.00472425000800010008x; Brown AC, 2005, ECON GEOL, V100, P765, DOI 10.2113/100.4.765; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Crowe SA, 2013, NATURE, V501, P535, DOI 10.1038/nature12426; Ellis AS, 2004, ENVIRON SCI TECHNOL, V38, P3604, DOI 10.1021/es0352294; Ellis AS, 2002, SCIENCE, V295, P2060, DOI 10.1126/science.1068368; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Johnson TM, 2004, REV MINERAL GEOCHEM, V55, P289, DOI 10.2138/gsrmg.55.1.289; Knoll AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016121; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Leach D.L., 2005, EC GEOLOGY 100 ANNIV, P561, DOI [10.5382/AV100.18, DOI 10.5382/AV100.18]; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Mills DB, 2014, P NATL ACAD SCI USA, V111, P4168, DOI 10.1073/pnas.1400547111; Payne JL, 2011, PHOTOSYNTH RES, V107, P37, DOI 10.1007/s11120-010-9593-1; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schauble E, 2004, CHEM GEOL, V205, P99, DOI 10.1016/j.chemgeo.2003.12.015; Schoenberg R, 2008, CHEM GEOL, V249, P294, DOI 10.1016/j.chemgeo.2008.01.009; Sheldon ND, 2006, PRECAMBRIAN RES, V147, P148, DOI 10.1016/j.precamres.2006.02.004; Sperling EA, 2013, EARTH PLANET SC LETT, V371, P143, DOI 10.1016/j.epsl.2013.04.003; van Acken D, 2013, PRECAMBRIAN RES, V236, P124, DOI 10.1016/j.precamres.2013.07.012; ZBINDEN EA, 1988, PRECAMBRIAN RES, V42, P141, DOI 10.1016/0301-9268(88)90014-9; Zink S, 2010, GEOCHIM COSMOCHIM AC, V74, P5729, DOI 10.1016/j.gca.2010.07.015	31	465	503	14	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		635	638		10.1126/science.1258410	http://dx.doi.org/10.1126/science.1258410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359975				2022-12-01	WOS:000343799700050
J	Adams, PJ; Ben-Johny, M; Dick, IE; Inoue, T; Yue, DT				Adams, Paul J.; Ben-Johny, Manu; Dick, Ivy E.; Inoue, Takanari; Yue, David T.			Apocalmodulin Itself Promotes Ion Channel Opening and Ca2+ Regulation	CELL			English	Article							PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; DOPAMINE NEURONS; SODIUM-CHANNELS; CALMODULIN; INACTIVATION; MODULATION; ACTIVATION; EXPRESSION; INDUCTION	The Ca2+-free form of calmodulin (apoCaM) often appears inert, modulating target molecules only upon conversion to its Ca2+-bound form. This schema has appeared to govern voltage-gated Ca2+ channels, where apoCaM has been considered a dormant Ca2+ sensor, associated with channels but awaiting the binding of Ca2+ ions before inhibiting channel opening to provide vital feedback inhibition. Using single-molecule measurements of channels and chemical dimerization to elevate apoCaM, we find that apoCaM binding on its own markedly upregulates opening, rivaling the strongest forms of modulation. Upon Ca2+ binding to this CaM, inhibition may simply reverse the initial upregulation. As RNA-edited and - spliced channel variants show different affinities for apoCaM, the apoCaM-dependent control mechanisms may underlie the functional diversity of these variants and explain an elongation of neuronal action potentials by apoCaM. More broadly, voltage-gated Na channels adopt this same modulatory principle. ApoCaM thus imparts potent and pervasive ion-channel regulation.	[Adams, Paul J.; Ben-Johny, Manu; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Ctr Cell Dynam, Sch Med, Calcium Signals Lab,Dept Biomed Engn, Baltimore, MD 21205 USA; [Adams, Paul J.; Ben-Johny, Manu; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Ctr Cell Dynam, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Inoue, Takanari] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Inoue, Takanari] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Inoue, Takanari] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Japan Science & Technology Agency (JST)	Yue, DT (corresponding author), Johns Hopkins Univ, Ctr Cell Dynam, Sch Med, Calcium Signals Lab,Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu		Ben-Johny, Manu/0000-0002-5645-0815; Dick, Ivy/0000-0002-7253-6846	NINDS; NHLBI; NIMH; Parkinson Society Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073874, R01NS085074] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Parkinson Society Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Hojjat Bazzazi and Philemon Yang for providing some Ca<INF>V</INF>1.3 variants, Ca<SUP>2+</SUP> Signals Lab members for valuable comments, and Wanjun Yang for technical support. This work was supported by grants from the NINDS (to D.T.Y.), NHLBI (D.T.Y.), NIMH (M.B.-J.), and Parkinson Society Canada (P.J.A.).	Alberts B., 1994, MOL BIOL CELL 2, V3rd ed.; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; Bean BP, 2007, NATURE, V447, P1059, DOI 10.1038/4471059a; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bossuyt J, 2013, J MOL MED, V91, P907, DOI 10.1007/s00109-013-1060-y; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Christel CJ, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2012.239954; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRACE AA, 1984, J NEUROSCI, V4, P2866; Hahn KM, 2010, NAT METHODS, V7, P595, DOI 10.1038/nmeth0810-595; Herzog RI, 2003, J NEUROSCI, V23, P8261; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hille B, 1984, IONIC CHANNELS EXCIT; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI [10.1038/nmeth.1524, 10.1038/NMETH.1524]; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Miriyala J, 2008, CIRC RES, V102, pE54, DOI 10.1161/CIRCRESAHA.108.171736; Nedergaard S, 1999, J NEUROPHYSIOL, V82, P2903, DOI 10.1152/jn.1999.82.6.2903; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Phua SC, 2012, ACS CHEM BIOL, V7, P1950, DOI 10.1021/cb300280k; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tay LH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1777; Tsien R.W., 1975, ELECT CURRENT FLOW E; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; Ueno T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002033; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008; Yang TT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3540; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569	59	52	54	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					608	622		10.1016/j.cell.2014.09.047	http://dx.doi.org/10.1016/j.cell.2014.09.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417111	Bronze, Green Accepted			2022-12-01	WOS:000344521700016
J	Gusarova, V; Alexa, CA; Na, EQ; Stevis, PE; Xin, YR; Bonner-Weir, S; Cohen, JC; Hobbs, HH; Murphy, AJ; Yancopoulos, GD; Gromada, J				Gusarova, Viktoria; Alexa, Corey A.; Na, Erqian; Stevis, Panayiotis E.; Xin, Yurong; Bonner-Weir, Susan; Cohen, Jonathan C.; Hobbs, Helen H.; Murphy, Andrew J.; Yancopoulos, George D.; Gromada, Jesper			ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion	CELL			English	Article							GLUCOSE-INFUSION; INSULIN-RESISTANCE; BETATROPHIN; MICE; REGENERATION; INDIVIDUALS; REPLICATION; HYPERPLASIA; METABOLISM; DISEASE	Recently, it was reported that angiopoietin-like protein 8 (ANGPTL8) was the long-sought "betatrophin" that could control pancreatic beta cell proliferation. However, studies of Angptl8(-/-) mice revealed profound reduction of triglyceride levels, but no abnormalities in glucose homeostasis. We now report that Angptl8(-/-) mice undergo entirely normal beta cell expansion in response to insulin resistance resulting from either a high-fat diet or from the administration of the insulin receptor antagonist S961. Furthermore, overexpression of ANGPTL8 in livers of mice doubles plasma triglyceride levels, but does not alter beta cell expansion nor glucose metabolism. These data indicate that ANGPTL8 does not play a role in controlling beta cell growth, nor can it be given to induce such expansion. The findings that plasma triglyceride levels are reduced by Angptl8 deletion and increased following ANGPTL8 overexpression support the possibility that inhibition of ANGPTL8 represents a therapeutic strategy for hypertriglyceridemia.	[Gusarova, Viktoria; Alexa, Corey A.; Na, Erqian; Stevis, Panayiotis E.; Xin, Yurong; Murphy, Andrew J.; Yancopoulos, George D.; Gromada, Jesper] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Regeneron; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gusarova, V (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	viktoria.gusarova@regeneron.com		Bonner-Weir, Susan/0000-0003-4682-0656; Murphy, Andrew/0000-0003-4152-4081	NIH [PO1 HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to thank Lisa Shihanian, Kristen Tramaglini, and Lawrence Miloscio for excellent technical assistance. We would also like to acknowledge support from the NIH (PO1 HL20948). Viktoria Gusarova, Corey A. Alexa, Erqian Na, Panayiotis E. Stevis, Yurong Xin, Andrew J. Murphy, George D. Yancopoulos, and Jesper Gromada are employees and shareholders of Regeneron Pharmaceuticals.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Espes D, 2014, DIABETOLOGIA, V57, P50, DOI 10.1007/s00125-013-3071-1; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; TURNER RC, 1995, DIABETES, V44, P1249; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	22	171	188	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					691	696		10.1016/j.cell.2014.09.027	http://dx.doi.org/10.1016/j.cell.2014.09.027			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417115	Green Accepted, Bronze			2022-12-01	WOS:000344521700022
J	Tabata, R; Sumida, K; Yoshii, T; Ohyama, K; Shinohara, H; Matsubayashi, Y				Tabata, Ryo; Sumida, Kumiko; Yoshii, Tomoaki; Ohyama, Kentaro; Shinohara, Hidefumi; Matsubayashi, Yoshikatsu			Perception of root-derived peptides by shoot LRR-RKs mediates systemic N-demand signaling	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; RESPONSES; PLANTS; IDENTIFICATION; NODULATION; NITRATE; KINASE	Nitrogen (N) is a critical nutrient for plants but is often distributed unevenly in the soil. Plants therefore have evolved a systemic mechanism by which N starvation on one side of the root system leads to a compensatory and increased nitrate uptake on the other side. Here, we study the molecular systems that support perception of N and the long-distance signaling needed to alter root development. Rootlets starved of N secrete small peptides that are translocated to the shoot and received by two leucine-rich repeat receptor kinases (LRR-RKs). Arabidopsis plants deficient in this pathway show growth retardation accompanied with N-deficiency symptoms. Thus, signaling from the root to the shoot helps the plant adapt to fluctuations in local N availability.	[Tabata, Ryo; Sumida, Kumiko; Shinohara, Hidefumi; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yoshii, Tomoaki; Ohyama, Kentaro] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	matsu@bio.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019; Tabata, Ryo/R-5798-2016; Tabata, Ryo/ABI-7295-2020	Tabata, Ryo/0000-0002-9071-9945; Matsubayashi, Yoshikatsu/0000-0002-2669-2119	Ministry of Education, Culture, Sports, Science, and Technology [25221105]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science, and Technology (no. 25221105). The supplementary materials contain additional data.	Bryan AC, 2012, PLANTA, V235, P111, DOI 10.1007/s00425-011-1489-6; De Coninck B, 2013, J EXP BOT, V64, P5297, DOI 10.1093/jxb/ert295; Delay C, 2013, J EXP BOT, V64, P5383, DOI 10.1093/jxb/ert332; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Gansel X, 2001, PLANT J, V26, P143, DOI 10.1046/j.1365-313x.2001.01016.x; Imin N, 2013, J EXP BOT, V64, P5395, DOI 10.1093/jxb/ert369; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Ohyama K, 2008, PLANT J, V55, P152, DOI 10.1111/j.1365-313X.2008.03464.x; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; Reid DE, 2011, ANN BOT-LONDON, V108, P789, DOI 10.1093/aob/mcr205; Roberts I, 2013, J EXP BOT, V64, P5371, DOI 10.1093/jxb/ert331; Ruffel S, 2008, PLANT PHYSIOL, V146, P2020, DOI 10.1104/pp.107.115667; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003	14	312	344	10	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					343	346		10.1126/science.1257800	http://dx.doi.org/10.1126/science.1257800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324386				2022-12-01	WOS:000343041100042
J	Webster, BM; Colombi, P; Jager, J; Lusk, P				Webster, Brant M.; Colombi, Paolo; Jaeger, Jens; Lusk, Patrick			Surveillance of Nuclear Pore Complex Assembly by ESCRT-III/Vps4	CELL			English	Article							MEDIATED ABSCISSION CHECKPOINT; ESCRT-III; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; RNA TRANSPORT; PROTEIN; YEAST; ENVELOPE; PATHWAY; DEGRADATION	The maintenance of nuclear compartmentalization by the nuclear envelope and nuclear pore complexes (NPCs) is essential for cell function; loss of compartmentalization is associated with cancers, laminopathies, and aging. We uncovered a pathway that surveils NPC assembly intermediates to promote the formation of functional NPCs. Surveillance is mediated by Heh2, a member of the LEM (Lap2-emerin-MAN1) family of integral inner nuclear membrane proteins, which binds to an early NPC assembly intermediate, but not to mature NPCs. Heh2 recruits the endosomal sorting complex required for transport (ESCRT)-III subunit Snf7 and the AAA-ATPase Vps4 to destabilize and clear defective NPC assembly intermediates. When surveillance or clearance is compromised, malformed NPCs accumulate in a storage of improperly assembled nuclear pore complexes compartment, or SINC. The SINC is retained in old mothers to prevent loss of daughter lifespan, highlighting a continuum of mechanisms to ensure nuclear compartmentalization.	[Webster, Brant M.; Colombi, Paolo; Jaeger, Jens; Lusk, Patrick] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Lusk, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	patrick.lusk@yale.edu		Lusk, C. Patrick/0000-0003-4703-0533	NIH [R01 GM105672, R21HG006742, 5T32GM007223]; Mather's Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM105672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mather's Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the Mather's Foundation for their support and to A. Frost for sharing unpublished data. Thank you to C. Burd and D. Katzmann for advice and reagents, and to M. King, T. Carroll, C. Schlieker, and M. Hochstrasser for comments on the manuscript. We appreciate reagents from E. Hurt, M. Rout, and T. Walther and the EM expertise of M. Graham and X. Liu. We are indebted to R. Christiano, Z. Hakhverdyan, and M. Rout for help during revisions. All authors are supported by NIH R01 GM105672 with additional funds to C.P.L. and P.C. from NIH R21HG006742. B.M.W. was also supported by NIH 5T32GM007223.	Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chadrin A, 2010, J CELL BIOL, V189, P795, DOI 10.1083/jcb.200910043; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Colombi P, 2013, J CELL BIOL, V203, P215, DOI 10.1083/jcb.201305115; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Fernandez-Martinez J, 2009, CURR OPIN CELL BIOL, V21, P603, DOI 10.1016/j.ceb.2009.05.001; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Funakoshi T, 2011, MOL BIOL CELL, V22, P1058, DOI 10.1091/mbc.E10-07-0641; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayakawa A, 2012, J CELL BIOL, V196, P19, DOI 10.1083/jcb.201108124; Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Lee CP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002904; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lusk CP, 2014, NUCLEUS-PHILA, V5, P97, DOI 10.4161/nucl.28314; Mackay DR, 2010, J CELL BIOL, V191, P923, DOI 10.1083/jcb.201007124; Makio T, 2013, J CELL BIOL, V203, P187, DOI 10.1083/jcb.201304047; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Stauffer DR, 2001, J CELL SCI, V114, P2383; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Verzijlbergen KF, 2010, P NATL ACAD SCI USA, V107, P64, DOI 10.1073/pnas.0911164107; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Yewdell WT, 2011, MOL BIOL CELL, V22, P1375, DOI 10.1091/mbc.E10-06-0554	70	146	151	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					388	401		10.1016/j.cell.2014.09.012	http://dx.doi.org/10.1016/j.cell.2014.09.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303532	Bronze, Green Accepted			2022-12-01	WOS:000343095600019
J	Skourti-Stathaki, K; Kamieniarz-Gdula, K; Proudfoot, NJ				Skourti-Stathaki, Konstantina; Kamieniarz-Gdula, Kinga; Proudfoot, Nicholas J.			R-loops induce repressive chromatin marks over mammalian gene terminators	NATURE			English	Article							RNA; METHYLATION; HP1-GAMMA; G9A	The formation of R-loops is a natural consequence of the transcription process, caused by invasion of the DNA duplex by nascent transcripts. These structures have been considered rare transcriptional by-products with potentially harmful effects on genome integrity owing to the fragility of the displaced DNA coding strand(1). However, R-loops may also possess beneficial effects, as their widespread formation has been detected over CpG island promoters in human genes(2,3). Furthermore, we have previously shown that R-loops are particularly enriched over G-rich terminator elements. These facilitate RNA polymerase II (Pol II) pausing before efficient termination(4). Here we reveal an unanticipated link between R-loops and RNA-interference-dependent H3K9me2 formation over pause-site termination regions in mammalian protein-coding genes. We show that R-loops induce antisense transcription over these pause elements, which in turn leads to the generation of double-stranded RNA and the recruitment of DICER, AGO1, AGO2 and the G9a histone lysine methyltransferase. Consequently, an H3K9me2 repressive mark is formed and heterochromatin protein 1 gamma (HP1 gamma) is recruited, which reinforces Pol II pausing before efficient transcriptional termination. We predict that R-loops promote a chromatin architecture that defines the termination region for a substantial subset of mammalian genes.	[Skourti-Stathaki, Konstantina; Kamieniarz-Gdula, Kinga; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222; Kamieniarz-Gdula, Kinga/0000-0003-3789-5381	Wellcome Trust [091805/Z/10/Z]; European Research Council [339270-polyloop]; Marie Curie Actions grant from EU FP7 (REA grant) [327985]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Marie Curie Actions grant from EU FP7 (REA grant)	This work was supported by a Wellcome Trust Programme grant (091805/Z/10/Z) and a European Research Council Advanced grant (339270-polyloop) to N.J.P., and a Marie Curie Actions grant from EU FP7 (REA grant agreement, 327985) to K.K.-G. We are grateful to R. Nunes Bastos for valuable help with immunofluorescence/imaging analysis and figure formatting. We also thank Q. Sun for helpful discussions and advice. We thank R. J. Crouch for the gift of the GFP-RNase H1 expression plasmid, G. Hannon for the Ago2-knockout mouse cell line and Y. Shinkai for the G9a/Glp double-knockout mouse embryonic stem cells.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Nakama M, 2012, GENES CELLS, V17, P218, DOI 10.1111/j.1365-2443.2012.01583.x; Nojima T, 2013, CELL REP, V3, P1080, DOI 10.1016/j.celrep.2013.03.012; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	23	225	228	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					436	+		10.1038/nature13787	http://dx.doi.org/10.1038/nature13787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25296254	Green Accepted			2022-12-01	WOS:000346484800056
J	Gorna, R				Gorna, Robin			AIDS: transforming global health	LANCET			English	Editorial Material							HIV		AIDS Strategy Advocacy & Policy ASAP, Brighton BN1 2PG, E Sussex, England		Gorna, R (corresponding author), AIDS Strategy Advocacy & Policy ASAP, Brighton BN1 2PG, E Sussex, England.	robin@asapltd.com						Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Gorna R, 1988, AIDS TREATMENT UPDAT; Gorna R, 2013, HUFFINGTON POST; Gorna R, 1994, POSITIVE PRACTICE GU; Gorna R, 1996, VIRGINS VICTIMS CAN; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Loutfy MR, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18509; Monforte AD, 2010, AIDS, V24, P1091, DOI 10.1097/QAD.0b013e3283390db3; Remme M, 2012, LANCET, V379, P2150, DOI 10.1016/S0140-6736(12)60944-1	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					E58	E59		10.1016/S0140-6736(14)62260-1	http://dx.doi.org/10.1016/S0140-6736(14)62260-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU2LP	25435454				2022-12-01	WOS:000345450100001
J	Rowland, AA; Chitwood, PJ; Phillips, MJ; Voeltz, GK				Rowland, Ashley A.; Chitwood, Patrick J.; Phillips, Melissa J.; Voeltz, Gia K.			ER Contact Sites Define the Position and Timing of Endosome Fission	CELL			English	Article							ENDOPLASMIC-RETICULUM; WASH COMPLEX; RETROMER; PROTEINS; CA2+; CHOLESTEROL; REGULATORS; INHIBITOR; DYNASORE; DOMAINS	Endocytic cargo and Rab GTPases are segregated to distinct domains of an endosome. These domains maintain their identity until they undergo fission to traffic cargo. It is not fully understood how segregation of cargo or Rab proteins is maintained along the continuous endosomal membrane or what machinery is required for fission. Endosomes form contact sites with the endoplasmic reticulum (ER) that are maintained during trafficking. Here, we show that stable contacts form between the ER and endosome at constricted sorting domains, and free diffusion of cargo is limited at these positions. We demonstrate that the site of constriction and fission for early and late endosomes is spatially and temporally linked to contact sites with the ER. Lastly, we show that altering ER structure and dynamics reduces the efficiency of endosome fission. Together, these data reveal a surprising role for ER contact in defining the timing and position of endosome fission.	[Rowland, Ashley A.; Chitwood, Patrick J.; Phillips, Melissa J.; Voeltz, Gia K.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Voeltz, GK (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	gia.voeltz@colorado.edu		Hoyer, Melissa/0000-0003-0858-4998; CHITWOOD, PATRICK/0000-0003-4350-8720	NIH [GM07135, T32 GM08759, GM083977]; NSF Graduate Research Fellowship [DGE 1144083]; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM083977, T32GM007135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nunnari, J. Friedman, and L. Greene for helpful discussions. We also thank C. Merrifield, L. Greene, and G. Hajnoczky for generating plasmids used here and D. Billadeau for the FAM21 containing plasmid and the WASH1 antibody. A. A. R. is a Gordon Stone Fellow and was supported by a pre-doctoral training grant from the NIH (GM07135). M. J. P. is supported by an NSF Graduate Research Fellowship DGE 1144083 and was supported by a pre-doctoral training grant from the NIH (T32 GM08759). This work is also supported by a Research Scholar grant from the American Cancer Society and by a grant from the NIH (GM083977) to G. K. V.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gautreau A., 2014, COLD SPRING HARB PER, V6, P1; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Hunt SD, 2013, J CELL SCI, V126, P2493, DOI 10.1242/jcs.122317; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lopez-Sanjurjo CI, 2013, J CELL SCI, V126, P289, DOI 10.1242/jcs.116103; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Trischler M, 1999, J CELL SCI, V112, P4773; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	45	250	252	6	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1027	1041		10.1016/j.cell.2014.10.023	http://dx.doi.org/10.1016/j.cell.2014.10.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416943	Green Accepted, Bronze			2022-12-01	WOS:000345506300016
J	Zeng, N; Zhao, F; Collatz, GJ; Kalnay, E; Salawitch, RJ; West, TO; Guanter, L				Zeng, Ning; Zhao, Fang; Collatz, George J.; Kalnay, Eugenia; Salawitch, Ross J.; West, Tristram O.; Guanter, Luis			Agricultural Green Revolution as a driver of increasing atmospheric CO2 seasonal amplitude	NATURE			English	Article							MAUNA-LOA; CARBON-DIOXIDE; CHLOROPHYLL FLUORESCENCE; HUMAN APPROPRIATION; CYCLE; VEGETATION; 20TH-CENTURY; VARIABILITY; BIOSPHERE; ECOSYSTEM	The atmospheric carbon dioxide (CO2) record displays a prominent seasonal cycle that arises mainly from changes in vegetation growth and the corresponding CO2 uptake during the boreal spring and summer growing seasons and CO2 release during the autumn and winter seasons(1). The CO2 seasonal amplitude has increased over the past five decades, suggesting an increase in Northern Hemisphere biospheric activity(2,5,6). It has been proposed that vegetation growth may have been stimulated by higher concentrations of CO2 as well as by warming in recent decades, but such mechanisms have been unable to explain the full range and magnitude of the observed increase in CO2 seasonal amplitude(2,6-13). Here we suggest that the intensification of agriculture (the Green Revolution, in which much greater crop yield per unit area was achieved by hybridization, irrigation and fertilization) during the past five decades is a driver of changes in the seasonal characteristics of the global carbon cycle. Our analysis of CO2 data and atmospheric inversions shows a robust 15 per cent long-term increase in CO2 seasonal amplitude from 1961 to 2010, punctuated by large decadal and interannual variations. Using a terrestrial carbon cycle model that takes into account high-yield cultivars, fertilizer use and irrigation, we find that the long-term increase in CO2 seasonal amplitude arises from two major regions: the midlatitude cropland between 25 degrees N and 60 degrees N and the high-latitude natural vegetation between 50 degrees N and 70 degrees N. The long-term trend of seasonal amplitude increase is 0.311 +/- 0.027 per cent per year, of which sensitivity experiments attribute 45,29 and 26 per cent to land-use change, climate variability and change, and increased productivity due to CO2 fertilization, respectively. Vegetation growth was earlier by one to two weeks, as measured by the mid-point of vegetation carbon uptake, and took up 0.5 petagrams more carbon in July, the height of the growing season, during 2001-2010 than in 1961-1970, suggesting that human land use and management contribute to seasonal changes in the CO2 exchange between the biosphere and the atmosphere.	[Zeng, Ning; Zhao, Fang; Kalnay, Eugenia; Salawitch, Ross J.] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Zeng, Ning; Zhao, Fang; Kalnay, Eugenia; Salawitch, Ross J.] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Collatz, George J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [West, Tristram O.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Guanter, Luis] Free Univ Berlin, Inst Space Sci, D-12165 Berlin, Germany	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Free University of Berlin	Zeng, N (corresponding author), Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.	zeng@atmos.umd.edu	Zeng, Ning/A-3130-2008; collatz, george j/D-5381-2012; Salawitch, Ross/B-4605-2009; Guanter, Luis/I-1588-2015	Zeng, Ning/0000-0002-7489-7629; Salawitch, Ross/0000-0001-8597-5832; Kalnay, Eugenia/0000-0002-9984-9906; Guanter, Luis/0000-0002-8389-5764	NOM [NA100AR4310248, NAO9NE54400006]; NSF [AGS-1129088]; NASA [NNH12AU351]	NOM; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We thank all data providers, especially the NOAA CO<INF>2</INF> and Carbon Tracker team, and the Jena inversion team. M. Heimann suggested the flux data site comparison. This research was supported by NOM (NA100AR4310248 and NAO9NE54400006), the NSF (AGS-1129088), and NASA (NNH12AU351).	BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Buermann W, 2007, P NATL ACAD SCI USA, V104, P4249, DOI 10.1073/pnas.0611224104; Cadule P, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003556; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HEIMANN M, 1986, P16; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Jain HK, 2010, GREEN REVOLUTION: HISTORY, IMPACT AND FUTURE, P1; JOINER J, 2013, ATMOS MEAS TECH, V6, P2803, DOI [DOI 10.5194/AMT-6-2803-2013, DOI 10.5194/amt-6-2803-2013]; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kohlmaier GH, 1989, TELLUS B, V41, P487, DOI 10.1111/j.1600-0889.1989.tb00137.x; Kucharik CJ, 2003, J ENVIRON QUAL, V32, P247, DOI 10.2134/jeq2003.0247; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parazoo NC, 2013, GEOPHYS RES LETT, V40, P2829, DOI 10.1002/grl.50452; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Tans P., 2013, TRENDS IN ATMOSPHERI; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; TUCKER CJ, 1986, NATURE, V319, P195, DOI 10.1038/319195a0; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Zeng N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005gl024607; Zeng N, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002273; Zeng N, 2003, ADV ATMOS SCI, V20, P677, DOI 10.1007/BF02915395	33	120	130	10	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					394	+		10.1038/nature13893	http://dx.doi.org/10.1038/nature13893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409829				2022-12-01	WOS:000345770600041
J	Leening, MJG; Ferket, BS; Steyerberg, EW; Kavousi, M; Deckers, JW; Nieboer, D; Heeringa, J; Portegies, MLP; Hofman, A; Ikram, MA; Hunink, MGM; Franco, OH; Stricker, BH; Witteman, JCM; Roos-Hesselink, JW				Leening, Maarten J. G.; Ferket, Bart S.; Steyerberg, Ewout W.; Kavousi, Maryam; Deckers, Jaap W.; Nieboer, Daan; Heeringa, Jan; Portegies, Marileen L. P.; Hofman, Albert; Ikram, M. Arfan; Hunink, M. G. Myriam; Franco, Oscar H.; Stricker, Bruno H.; Witteman, Jacqueline C. M.; Roos-Hesselink, Jolien W.			Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; STROKE INCIDENCE; COMPETING RISKS; PREDICTION; FRAMINGHAM; HEALTH; ASSOCIATION; PREVENTION; ROTTERDAM; US	Objective To evaluate differences in first manifestations of cardiovascular disease between men and women in a competing risks framework. Design Prospective population based cohort study. Setting People living in the community in Rotterdam, the Netherlands. Participants 8419 participants (60.9% women) aged >= 55 and free from cardiovascular disease at baseline. Main outcome measures First diagnosis of coronary heart disease (myocardial infarction, revascularisation, and coronary death), cerebrovascular disease (stroke, transient ischaemic attack, and carotid revascularisation), heart failure, or other cardiovascular death; or death from non-cardiovascular causes. Data were used to calculate lifetime risks of cardiovascular disease and its first incident manifestations adjusted for competing non-cardiovascular death. Results During follow-up of up to 20.1 years, 2888 participants developed cardiovascular disease (826 coronary heart disease, 1198 cerebrovascular disease, 762 heart failure, and 102 other cardiovascular death). At age 55, overall lifetime risks of cardiovascular disease were 67.1% (95% confidence interval 64.7% to 69.5%) for men and 66.4% (64.2% to 68.7%) for women. Lifetime risks of first incident manifestations of cardiovascular disease in men were 27.2% (24.1% to 30.3%) for coronary heart disease, 22.8% (20.4% to 25.1%) for cerebrovascular disease, 14.9% (13.3% to 16.6%) for heart failure, and 2.3% (1.6% to 2.9%) for other deaths from cardiovascular disease. For women the figures were 16.9% (13.5% to 20.4%), 29.8% (27.7% to 31.9%), 17.5% (15.9% to 19.2%), and 2.1% (1.6% to 2.7%), respectively. Differences in the number of events that developed over the lifespan in women compared with men (per 1000) were -7 for any cardiovascular disease, -102 for coronary heart disease, 70 for cerebrovascular disease, 26 for heart failure, and -1 for other cardiovascular death; all outcomes manifested at a higher age in women. Patterns were similar when analyses were restricted to hard atherosclerotic cardiovascular disease outcomes, but absolute risk differences between men and women were attenuated for both coronary heart disease and stroke. Conclusions At age 55, though men and women have similar lifetime risks of cardiovascular disease, there are considerable differences in the first manifestation. Men are more likely to develop coronary heart disease as a first event, while women are more likely to have cerebrovascular disease or heart failure as their first event, although these manifestations appear most often at older ages.	[Leening, Maarten J. G.; Ferket, Bart S.; Kavousi, Maryam; Heeringa, Jan; Portegies, Marileen L. P.; Hofman, Albert; Ikram, M. Arfan; Hunink, M. G. Myriam; Franco, Oscar H.; Stricker, Bruno H.; Witteman, Jacqueline C. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Leening, Maarten J. G.; Deckers, Jaap W.; Roos-Hesselink, Jolien W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Cardiol, NL-3000 CA Rotterdam, Netherlands; [Leening, Maarten J. G.; Hofman, Albert] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ferket, Bart S.; Ikram, M. Arfan; Hunink, M. G. Myriam] Univ Med Ctr Rotterdam, Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands; [Ferket, Bart S.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Inst Healthcare Delivery Sci, New York, NY 10029 USA; [Steyerberg, Ewout W.; Nieboer, Daan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Portegies, Marileen L. P.; Ikram, M. Arfan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Stricker, Bruno H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Stricker, Bruno H.] Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Icahn School of Medicine at Mount Sinai; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC	Stricker, BH (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol NA 2818, POB 2040, NL-3000 CA Rotterdam, Netherlands.	b.stricker@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Kavousi, Maryam/F-1174-2018; Ikram, M. Arfan/AAM-5225-2021	Franco, Óscar H/0000-0002-4606-4929; Kavousi, Maryam/0000-0001-5976-6519; Ferket, Bart/0000-0003-2754-545X	Erasmus MC Thorax Foundation [A1]; Physico Foundation; De Drie Lichten Foundation [04/14]; Netherlands Organisation for Health Research and Development (ZonMw); Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA) [80-82500-98-10208]; Netherlands Organisation for Scientific Research (NWO) (Vici) [918-76-619]; Prins Bernhard Cultuurfonds Fellowship award [30140588]; AXA Research Fund; Netherlands Heart Foundation (NHF) [2012T008]; Erasmus University Trustfonds; Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; Ministry of Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam	Erasmus MC Thorax Foundation; Physico Foundation; De Drie Lichten Foundation; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA); Netherlands Organisation for Scientific Research (NWO) (Vici)(Netherlands Organization for Scientific Research (NWO)); Prins Bernhard Cultuurfonds Fellowship award; AXA Research Fund; Netherlands Heart Foundation (NHF)(Netherlands Heart Foundation); Erasmus University Trustfonds; Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam	This work was supported by grants from the Erasmus MC Thorax Foundation (project grant A1 to JWR-H); the Physico Foundation; the De Drie Lichten Foundation (project grant 04/14 to MJGL); the Netherlands Organisation for Health Research and Development (ZonMw) and the Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA grant 80-82500-98-10208 to BHS; and Vici grant 918-76-619 to JCMW). MJGL is supported by a Prins Bernhard Cultuurfonds Fellowship award (grant 30140588 to MJGL); MK is supported by the AXA Research Fund; MAI is supported by the Netherlands Heart Foundation (NHF grant 2012T008 to MAI); additional funding was obtained from the Erasmus University Trustfonds. The Rotterdam Study is supported by the Erasmus MC and Erasmus University Rotterdam; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Bos MJ, 2007, JAMA-J AM MED ASSOC, V298, P2877, DOI 10.1001/jama.298.24.2877; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Butler J, 2011, HEART, V97, P1304, DOI 10.1136/hrt.2011.225482; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Ferket BS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001361; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 1995, Ned Tijdschr Geneeskd, V139, P1975; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Huffman MD, 2013, J AM COLL CARDIOL, V61, P1510, DOI 10.1016/j.jacc.2013.01.022; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Lee SJ, 2013, JAMA-J AM MED ASSOC, V310, P2609, DOI 10.1001/jama.2013.282612; Leening MJG, 2014, EPIDEMIOLOGY, V25, P470, DOI 10.1097/EDE.0000000000000091; Leening MJG, 2012, EUR J EPIDEMIOL, V27, P173, DOI 10.1007/s10654-012-9668-8; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Lloyd-Jones DM, 2007, AM J CARDIOL, V99, P535, DOI 10.1016/j.amjcard.2006.09.099; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Marma AK, 2009, CIRCULATION, V120, P384, DOI 10.1161/CIRCULATIONAHA.108.835470; Meister R, 2008, REPROD TOXICOL, V26, P31, DOI 10.1016/j.reprotox.2008.06.006; Michos ED, 2012, CIRCULATION, V125, P1723, DOI 10.1161/CIRCULATIONAHA.112.099929; Nichols M., 2012, EUROPEAN CARDIOVASCU; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312	42	171	175	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2014	349								g5992	10.1136/bmj.g5992	http://dx.doi.org/10.1136/bmj.g5992			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JX	25403476	Green Published, hybrid			2022-12-01	WOS:000345445500001
J	Anderson, KA; Green, MF; Huynh, FK; Wagner, GR; Hirschey, MD				Anderson, Kristin A.; Green, Michelle F.; Huynh, Frank K.; Wagner, Gregory R.; Hirschey, Matthew D.			SnapShot: Mammalian Sirtuins	CELL			English	Editorial Material							PROTEIN; SIRT6		[Anderson, Kristin A.; Green, Michelle F.; Huynh, Frank K.; Wagner, Gregory R.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Anderson, Kristin A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Anderson, KA (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.		Huynh, Frank/AAK-9575-2020	Huynh, Frank/0000-0002-4764-9558; Hirschey, Matthew/0000-0003-4541-5376; Green, Michelle/0000-0002-6055-4342	NCI NIH HHS [T32 CA059365] Funding Source: Medline; NIAAA NIH HHS [R01 AA022146, R01AA022146] Funding Source: Medline; NIA NIH HHS [P30AG028716-01, P30 AG028716, R01AG04535, R01 AG045351] Funding Source: Medline; NIDDK NIH HHS [T32 DK007012] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716, R01AG045351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022146] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gertler AA, 2013, BIOGERONTOLOGY, V14, P629, DOI 10.1007/s10522-013-9478-8; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Ryu D., 2014, CELL METAB; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15	10	56	56	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4								10.1016/j.cell.2014.10.045	http://dx.doi.org/10.1016/j.cell.2014.10.045			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417168	Bronze, Green Accepted			2022-12-01	WOS:000344522000025
J	Cumming, GS; Buerkert, A; Hoffmann, EM; Schlecht, E; von Cramon-Taubadel, S; Tscharntke, T				Cumming, Graeme S.; Buerkert, Andreas; Hoffmann, Ellen M.; Schlecht, Eva; von Cramon-Taubadel, Stephan; Tscharntke, Teja			Implications of agricultural transitions and urbanization for ecosystem services	NATURE			English	Review							SOCIAL-ECOLOGICAL SYSTEMS; TROPICAL FORESTS; CLIMATE-CHANGE; GLOBAL CHANGE; WEST-AFRICA; BIODIVERSITY; CONSERVATION; SUSTAINABILITY; LANDSCAPE; COLLAPSE	Historically, farmers and hunter-gatherers relied directly on ecosystem services, which they both exploited and enjoyed. Urban populations still rely on ecosystems, but prioritize non-ecosystem services (socioeconomic). Population growth and densification increase the scale and change the nature of both ecosystem-and non-ecosystem-service supply and demand, weakening direct feedbacks between ecosystems and societies and potentially pushing social-ecological systems into traps that can lead to collapse. The interacting and mutually reinforcing processes of technological change, population growth and urbanization contribute to over-exploitation of ecosystems through complex feedbacks that have important implications for sustainable resource use.	[Cumming, Graeme S.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7701 Cape Town, South Africa; [Buerkert, Andreas; Hoffmann, Ellen M.; Schlecht, Eva] Univ Kassel, D-37213 Witzenhausen, Germany; [Schlecht, Eva] Univ Gottingen, D-37213 Witzenhausen, Germany; [von Cramon-Taubadel, Stephan] Univ Gottingen, Dept Agr Econ & Rural Dev, D-37073 Gottingen, Germany; [Tscharntke, Teja] Univ Gottingen, D-37077 Gottingen, Germany	National Research Foundation - South Africa; University of Cape Town; Universitat Kassel; University of Gottingen; University of Gottingen; University of Gottingen	Cumming, GS (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7701 Cape Town, South Africa.	gscumming@gmail.com	Cumming, Graeme S./B-6551-2008; Hoffmann, Ellen/AAP-4442-2020; Tscharntke, Teja/N-5123-2014	Cumming, Graeme S./0000-0002-3678-1326; Hoffmann, Ellen/0000-0003-1953-9383; 	Universitat Kassel; Georg-August-Universitat Gottingen; James S. McDonnell Foundation [BU1308/5-3, SCHL587/4-3]; UrbanFood project - Volkswagen Foundation [I/82 189, RTG 1644]	Universitat Kassel; Georg-August-Universitat Gottingen; James S. McDonnell Foundation; UrbanFood project - Volkswagen Foundation	G.S.C. thanks the Universitat Kassel (http://www.icdd.unikassel.de) and Georg-August-Universitat Gottingen for travel funding. This research was partially supported by a James S. McDonnell Foundation grant to G. S. C. and benefitted from discussions between A. B. and E. S. in BU1308/5-3, SCHL587/4-3 and the UrbanFood project, funded by the Volkswagen Foundation (No. I/82 189); between S. v. C-T. and T. T. within the RTG 1644 (Scaling Problems in Statistics); and the discussions of T. T. within the CRC 990 (EFForTS).	Angelstam P, 2011, SILVA FENN, V45, P1111, DOI 10.14214/sf.90; Bationo A, 1998, AGR ECOSYST ENVIRON, V71, P19, DOI 10.1016/S0167-8809(98)00129-7; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Berkes Fikret., 2012, SACRED ECOLOGY; Bjorklund J, 1999, ECOL ECON, V29, P269, DOI 10.1016/S0921-8009(99)00014-2; Boserup E., 1981, POPULATION AND TECHN; Brinkmann K, 2012, LANDSCAPE URBAN PLAN, V105, P94, DOI 10.1016/j.landurbplan.2011.12.003; Buerkert Andreas, 2013, Secheresse (Montrouge), V24, P322, DOI 10.1684/sec.2013.0402; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chapin FS, 2006, AM NAT, V168, pS36, DOI 10.1086/509047; Child MF, 2009, BIOL CONSERV, V142, P2593, DOI 10.1016/j.biocon.2009.06.007; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Costanza R, 2007, AMBIO, V36, P522, DOI 10.1579/0044-7447(2007)36[522:SOCWCW]2.0.CO;2; Cramer W, 2004, PHILOS T R SOC B, V359, P331, DOI 10.1098/rstb.2003.1428; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Cumming GS, 2006, ECOL SOC, V11; Daily GC, 1996, ECOL APPL, V6, P991, DOI 10.2307/2269582; Dasgupta S, 2002, J ECON PERSPECT, V16, P147, DOI 10.1257/0895330027157; DeFries R, 2010, LAND USE POLICY, V27, P130, DOI 10.1016/j.landusepol.2009.07.003; Deutscher Bauernverband (German Farmers' Union), 2013, SITUATIONSBERICHT 20; Einhorn ES, 1989, MODERN WELFARE STATE; FAOSTAT, 2013, CROPS PRIMARY PRODUC; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Genske D., 2006, PROC 10TH IAEG INT C, P82; Getter KL, 2006, HORTSCIENCE, V41, P1276, DOI 10.21273/HORTSCI.41.5.1276; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Hofsten Erland, 1976, SWEDISH POPULATION H, P152; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Huang J, 2012, J CLEAN PROD, V21, P45, DOI 10.1016/j.jclepro.2011.09.014; ISEAL, 2012, STD CONTR HUM WELL B; Ishii HT, 2010, LANDSC ECOL ENG, V6, P307, DOI 10.1007/s11355-010-0104-5; Jansson A, 1999, ECOSYSTEMS, V2, P351, DOI 10.1007/s100219900085; Johnson Todd M., 1997, CLEAR WATER BLUE SKI; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuznets S, 1955, AM ECON REV, V45, P1; Leamer EE, 1999, J DEV ECON, V59, P3, DOI 10.1016/S0304-3878(99)00004-8; Lebel L, 2002, AMBIO, V31, P311, DOI 10.1639/0044-7447(2002)031[0311:ITASAI]2.0.CO;2; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Livi-Bacci M., 2012, CONCISE HIST WORLD P; Lobell H, 2008, SCAND ECON HIST REV, V56, P142, DOI 10.1080/03585520802191282; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Luck MA, 2001, ECOSYSTEMS, V4, P782, DOI 10.1007/s10021-001-0046-8; MATSUYAMA K, 1992, J ECON THEORY, V58, P317, DOI 10.1016/0022-0531(92)90057-O; McGinnis MD, 2011, POLICY STUD J, V39, P169, DOI 10.1111/j.1541-0072.2010.00401.x; MCINTOSH RJ, 1981, J AFR HIST, V22, P1, DOI 10.1017/S0021853700018983; Millennium Assessment, 2005, ECOSYSTEMS AND HUMAN; Mooney HA, 2013, P NATL ACAD SCI USA, V110, P3665, DOI 10.1073/pnas.1107484110; Mortimore M, 2005, J ARID ENVIRON, V63, P567, DOI 10.1016/j.jaridenv.2005.03.005; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nevens F, 2013, J CLEAN PROD, V50, P111, DOI 10.1016/j.jclepro.2012.12.001; Norberg J., 2008, COMPLEXITY THEORY FO; O'Brien KL, 2000, GLOBAL ENVIRON CHANG, V10, P221, DOI 10.1016/S0959-3780(00)00021-2; Ocampo J., 2009, J LBERIAN LATIN AM E, V28, P11; Ostrom E, 2003, J THEOR POLIT, V15, P239, DOI 10.1177/0951692803015003002; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Popp A, 2014, CLIMATIC CHANGE, V123, P495, DOI 10.1007/s10584-013-0926-x; Rabotyagov SS, 2014, REV ENV ECON POLICY, V8, P58, DOI 10.1093/reep/ret024; Rasmussen LV, 2012, ECOL SOC, V17, DOI 10.5751/ES-04614-170114; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Revilla E, 2014, J BUS RES, V67, P1123, DOI 10.1016/j.jbusres.2013.05.021; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodriguez J. P., 2005, MILLENNIUM ECOSYSTEM, V2; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Scheffer M, 2007, ECOL SOC, V12; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schon L., 1997, SCANDINAVIAN EC HIST, V45, P209, DOI DOI 10.1080/03585522.1997.10414668; Shen JL, 2009, ENVIRON POLLUT, V157, P3106, DOI 10.1016/j.envpol.2009.05.016; Smith A., 1845, AN INQUIRY INTO THE; Smith EA, 2000, ANNU REV ANTHROPOL, V29, P493, DOI 10.1146/annurev.anthro.29.1.493; Soma T, 2012, INT J INTANG HERIT, V7, P103; State Environmental Protection Administration of China, 2004, SEPA REPORT; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Tainter J. A., 1988, THE COLLAPSE OF COMP; Tappan G, 2007, AGR SYST, V94, P38, DOI 10.1016/j.agsy.2005.07.011; Tengo M., 2004, THESIS; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POPULATION PRO, VI; van Beers C, 2001, ECOL ECON, V36, P475, DOI 10.1016/S0921-8009(00)00245-7; Wu JG, 2014, LANDSCAPE URBAN PLAN, V125, P209, DOI 10.1016/j.landurbplan.2014.01.018; Xiuqin Y., 2010, BEIJING STATISTICAL; Young H, 2013, DEV CHANGE, V44, P125, DOI 10.1111/dech.12003; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zhang S., 2007, STUDY ON WATER TARIF; Zhuang GS, 2001, CHINESE SCI BULL, V46, P895, DOI 10.1007/BF02900460; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	99	271	291	48	606	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					50	57		10.1038/nature13945	http://dx.doi.org/10.1038/nature13945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25373674				2022-12-01	WOS:000344187500028
J	Geng, J; Kim, K; Zhang, JF; Escalada, A; Tunuguntla, R; Comolli, LR; Allen, FI; Shnyrova, AV; Cho, KR; Munoz, D; Wang, YM; Grigoropoulos, CP; Ajo-Franklin, CM; Frolov, VA; Noy, A				Geng, Jia; Kim, Kyunghoon; Zhang, Jianfei; Escalada, Artur; Tunuguntla, Ramya; Comolli, Luis R.; Allen, Frances I.; Shnyrova, Anna V.; Cho, Kang Rae; Munoz, Dayannara; Wang, Y. Morris; Grigoropoulos, Costas P.; Ajo-Franklin, Caroline M.; Frolov, Vadim A.; Noy, Aleksandr			Stochastic transport through carbon nanotubes in lipid bilayers and live cell membranes	NATURE			English	Article							ALPHA-HEMOLYSIN; WATER; CHANNEL; DNA; INSERTION	There is much interest in developing synthetic analogues of biological membrane channels(1) with high efficiency and exquisite selectivity for transporting ions and molecules. Bottom-up(2) and top-down(3) methods can produce nanopores of a size comparable to that of endogenous protein channels, but replicating their affinity and transport properties remains challenging. In principle, carbon nanotubes (CNTs) should be an ideal membrane channel platform: they exhibit excellent transport properties(4-8) and their narrow hydrophobic inner pores mimic structural motifs typical of biological channels(1). Moreover, simulations predict that CNTs with a length comparable to the thickness of a lipid bilayer membrane can self-insert into the membrane(9,10). Functionalized CNTs have indeed been found to penetrate lipid membranes and cell walls(11,12), and short tubes have been forced into membranes to create sensors(13), yet membrane transport applications of short CNTs remain underexplored. Here we show that short CNTs spontaneously insert into lipid bilayers and live cell membranes to form channels that exhibit a unitary conductance of 70-100 picosiemens under physiological conditions. Despite their structural simplicity, these 'CNT porins' transport water, protons, small ions and DNA, stochastically switch between metastable conductance substates, and display characteristic macromolecule-induced ionic current blockades. We also show that local channel and membrane charges can control the conductance and ion selectivity of the CNT porins, thereby establishing these nanopores as a promising biomimetic platform for developing cell interfaces, studying transport in biological channels, and creating stochastic sensors.	[Geng, Jia; Kim, Kyunghoon; Tunuguntla, Ramya; Cho, Kang Rae; Munoz, Dayannara; Noy, Aleksandr] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA; [Geng, Jia; Zhang, Jianfei; Noy, Aleksandr] Univ Calif, Sch Nat Sci, Merced, CA 95340 USA; [Geng, Jia; Kim, Kyunghoon; Tunuguntla, Ramya; Noy, Aleksandr] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Kim, Kyunghoon; Grigoropoulos, Costas P.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Escalada, Artur; Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, CSIC, Biophys Unit, Leioa 48940, Spain; [Escalada, Artur; Shnyrova, Anna V.; Frolov, Vadim A.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Comolli, Luis R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Allen, Frances I.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Allen, Frances I.; Ajo-Franklin, Caroline M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Allen, Frances I.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Wang, Y. Morris] Lawrence Livermore Natl Lab, Div Mat Sci, Livermore, CA 94550 USA; [Ajo-Franklin, Caroline M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Frolov, Vadim A.] Basque Fdn Sci, Ikerbasque, Bilbao 48011, Spain	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC-UPV - Unidad de Biofisica (UBF); University of Basque Country; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Basque Foundation for Science	Noy, A (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA.	noy1@llnl.gov	Ajo-Franklin, Caroline M/F-3405-2016; Geng, Jia/G-4332-2010; Frolov, Vadim/ABH-3889-2020; Geng, Jia/AAR-2192-2021; Wang, Yinmin (Morris)/F-2249-2010; Comolli, Luis Raul/C-5907-2017	Geng, Jia/0000-0003-4753-1039; Frolov, Vadim/0000-0002-0653-5669; Cho, Kang Rae/0000-0003-1605-1032; Kim, Kyunghoon/0000-0001-8034-947X; Wang, Yinmin (Morris)/0000-0002-7161-2034; Shnyrova, Anna/0000-0002-5329-348X; Allen, Frances/0000-0002-0311-8624; Noy, Aleksandr/0000-0003-4924-2652; Grigoropoulos, Costas/0000-0002-8505-4037; Wang, Yinmin (MORRIS)/0000-0003-0393-5154; Comolli, Luis Raul/0000-0002-9313-6550	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering; LDRD programme at LLNL [12-ERD-073]; LSP programme at LLNL; ROTC summer fellowship; Spanish Ministry of Economy and Competitiveness [BFU2012-34885]; European FEDER funds; Basque Government [IE12-332]; US Department of Energy [DE-AC52-07NA27344]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); LDRD programme at LLNL; LSP programme at LLNL; ROTC summer fellowship; Spanish Ministry of Economy and Competitiveness(Spanish Government); European FEDER funds(European Commission); Basque Government(Basque Government); US Department of Energy(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	Parts of this work were supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (characterization and transport studies), and the LDRD programme at LLNL, 12-ERD-073(synthesis). R. T. acknowledges support from the LSP programme at LLNL. D. M. acknowledges support from an ROTC summer fellowship. V. A. F. acknowledges partial support by the Spanish Ministry of Economy and Competitiveness, grant BFU2012-34885, co-financed with European FEDER funds, and the Basque Government, grant IE12-332. Work at LLNL was performed under the auspices of the US Department of Energy under contract DE-AC52-07NA27344. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract DE-AC02-05CH11231.	Buyukdagli S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158103; Dutt M, 2011, CURR NANOSCI, V7, P699, DOI 10.2174/157341311797483772; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Gu LQ, 2000, BIOPHYS J, V79, P1967, DOI 10.1016/S0006-3495(00)76445-9; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI 10.1038/NNANO.2010.237; Haque F, 2013, NAT PROTOC, V8, P373, DOI 10.1038/nprot.2013.001; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Lacerda L, 2013, NANOSCALE, V5, P10242, DOI 10.1039/c3nr03184e; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Le Duc Y, 2011, ANGEW CHEM INT EDIT, V50, P11366, DOI 10.1002/anie.201103312; Lee CY, 2010, SCIENCE, V329, P1320, DOI 10.1126/science.1193383; LEV AA, 1993, P ROY SOC B-BIOL SCI, V252, P187, DOI 10.1098/rspb.1993.0064; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liu HT, 2010, SCIENCE, V327, P64, DOI 10.1126/science.1181799; Liu L., 2013, NATURE COMMUN, V4; Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101; Majumder M, 2005, J AM CHEM SOC, V127, P9062, DOI 10.1021/ja043013b; NEHER E, 1978, J MEMBRANE BIOL, V40, P97, DOI 10.1007/BF01871143; Nestorovich EM, 2003, BIOPHYS J, V85, P3718, DOI 10.1016/S0006-3495(03)74788-2; Powell MR, 2008, NAT NANOTECHNOL, V3, P51, DOI 10.1038/nnano.2007.420; Powell MR, 2011, NAT NANOTECHNOL, V6, P798, DOI [10.1038/nnano.2011.189, 10.1038/NNANO.2011.189]; Shimizu S, 2013, J PHYS CHEM C, V117, P9641, DOI 10.1021/jp312659m; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Sun XM, 2008, J AM CHEM SOC, V130, P6551, DOI 10.1021/ja8006929; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Walther JH, 2013, NANO LETT, V13, P1910, DOI 10.1021/nl304000k; Zimmerli U, 2008, BIOPHYS J, V94, P2546, DOI 10.1529/biophysj.106.102467	33	286	290	23	534	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					612	+		10.1038/nature13817	http://dx.doi.org/10.1038/nature13817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355362				2022-12-01	WOS:000343801500045
J	Vincent, ACJ; Harris, JM				Vincent, Amanda C. J.; Harris, Jean M.			Boundless no more	SCIENCE			English	Editorial Material									[Vincent, Amanda C. J.] Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V6T 1Z4, Canada; [Harris, Jean M.] Ezemvelo KwaZulu Natal Wildlife, Sci Serv, ZA-3202 Pietermaritzburg, South Africa	University of British Columbia	Vincent, ACJ (corresponding author), Univ British Columbia, Fisheries Ctr, Project Seahorse, Vancouver, BC V6T 1Z4, Canada.	a.vincent@fisheries.ubc.ca						Anderson SC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014735, 10.1371/journal.pone.0024368]; Davies TD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00561; Dupont DP, 2014, MAR POLICY, V44, P60, DOI 10.1016/j.marpol.2013.08.003; FAO, 2014, STAT WORLD FISH AQ; Giles BG, 2006, BIODIVERS CONSERV, V15, P2497, DOI 10.1007/s10531-005-2432-6; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hansen GJA, 2011, BIOL CONSERV, V144, P1866, DOI 10.1016/j.biocon.2011.04.002; Harris JM., 2007, FISHERIES MANAGEMENT, P112; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Kleiber D, 2015, FISH FISH, V16, P547, DOI 10.1111/faf.12075; Kolding J, 2014, GOVERNANCE OF MARINE FISHERIES AND BIODIVERSITY CONSERVATION: INTERACTION AND COEVOLUTION, P317; Miller AMM, 2014, MAR POLICY, V45, P138, DOI 10.1016/j.marpol.2013.12.009; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Vincent ACJ, 2014, FISH FISH, V15, P563, DOI 10.1111/faf.12035	15	14	14	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					420	421		10.1126/science.1255923	http://dx.doi.org/10.1126/science.1255923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342785				2022-12-01	WOS:000343822900019
J	Liu, ZJ; Merkurjev, D; Yang, F; Li, WB; Oh, S; Friedman, MJ; Song, XY; Zhang, F; Ma, Q; Ohgi, KA; Krones, A; Rosenfeld, MG				Liu, Zhijie; Merkurjev, Daria; Yang, Feng; Li, Wenbo; Oh, Soohwan; Friedman, Meyer J.; Song, Xiaoyuan; Zhang, Feng; Ma, Qi; Ohgi, Kenneth A.; Krones, Anna; Rosenfeld, Michael G.			Enhancer Activation Requires trans-Recruitment of a Mega Transcription Factor Complex	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENOME-WIDE ANALYSIS; SUPER-ENHANCERS; DNA-BINDING; GENE-EXPRESSION; RETINOIC ACID; CELL IDENTITY; BREAST-CANCER; PHOSPHORYLATION; REGULATORS	Enhancers provide critical information directing cell-type-specific transcriptional programs, regulated by binding of signal-dependent transcription factors and their associated cofactors. Here, we report that the most strongly activated estrogen (E-2)-responsive enhancers are characterized by trans-recruitment and in situ assembly of a large 1-2 MDa complex of diverse DNA-binding transcription factors by ER alpha at ERE-containing enhancers. We refer to enhancers recruiting these factors as mega transcription factor-bound in trans (MegaTrans) enhancers. The MegaTrans complex is a signature of the most potent functional enhancers and is required for activation of enhancer RNA transcription and recruitment of co-activators, including p300 and Med1. The MegaTrans complex functions, in part, by recruiting specific enzymatic machinery, exemplified by DNA-dependent protein kinase. Thus, MegaTrans-containing enhancers represent a cohort of functional enhancers that mediate a broad and important transcriptional program and provide a molecular explanation for transcription factor clustering and hotspots noted in the genome.	[Liu, Zhijie; Merkurjev, Daria; Yang, Feng; Li, Wenbo; Oh, Soohwan; Friedman, Meyer J.; Song, Xiaoyuan; Zhang, Feng; Ma, Qi; Ohgi, Kenneth A.; Krones, Anna; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Merkurjev, Daria; Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Oh, Soohwan] Univ Calif San Diego, Grad Program Biol Sci, La Jolla, CA 92093 USA; [Song, Xiaoyuan] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230027, Peoples R China; [Song, Xiaoyuan] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liu, ZJ (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	z9liu@ucsd.edu; mrosenfeld@ucsd.edu	Ma, Qi/C-9716-2015; , songxy/P-1094-2014; Yang, Feng/A-4770-2017; li, wenbo/GZM-8930-2022	, songxy/0000-0002-9011-5033; Ma, Qi/0000-0002-8705-4460	NIH [DK018477, HL065445, NS034934, DK039949, CA173903]; NATIONAL CANCER INSTITUTE [R01CA173903, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, T32DK007541, R37DK039949, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to Janet Hightower for assistance with figure preparation, to Rachel Pardee for proofreading, and to Dr. Majid Ghassemian (University of California, San Diego [UCSD]) for assistance in mass spectrometry. We thank Dr. Dimple Notani (UCSD) for critically reading the manuscript, and Drs. Namit Singh and Kevin Corbett (UCSD) for their experimental contributions on gel filtration studies. We thank Drs. Dorota Skowronska-Krawczyk and Bogdan Tanasa (UCSD) for critical comments and discussions on this paper. M.G.R. is an investigator with the Howard Hughes Medical Institute. This work was supported by NIH grants (DK018477, HL065445, NS034934, DK039949, and CA173903).	Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Foulds CE, 2013, MOL CELL, V51, P185, DOI 10.1016/j.molcel.2013.06.007; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	36	131	135	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					358	373		10.1016/j.cell.2014.08.027	http://dx.doi.org/10.1016/j.cell.2014.08.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303530	Green Accepted, Bronze			2022-12-01	WOS:000343095600017
J	Juric, D; Castel, P; Griffith, M; Griffith, OL; Won, HH; Ellis, H; Ebbesen, SH; Ainscough, BJ; Ramu, A; Iyer, G; Shah, RH; Huynh, T; Mino-Kenudson, M; Sgroi, D; Isakoff, S; Thabet, A; Elamine, L; Solit, DB; Lowe, S; Quadt, C; Peters, M; Derti, A; Schegel, R; Huang, A; Mardis, ER; Berger, MF; Baselga, J; Scaltriti, M				Juric, Dejan; Castel, Pau; Griffith, Malachi; Griffith, Obi L.; Won, Helen H.; Ellis, Haley; Ebbesen, Saya H.; Ainscough, Benjamin J.; Ramu, Avinash; Iyer, Gopa; Shah, Ronak H.; Huynh, Tiffany; Mino-Kenudson, Mari; Sgroi, Dennis; Isakoff, Steven; Thabet, Ashraf; Elamine, Leila; Solit, David B.; Lowe, ScottW.; Quadt, Cornelia; Peters, Malte; Derti, Adnan; Schegel, Robert; Huang, Alan; Mardis, Elaine R.; Berger, Michael F.; Baselga, Jose; Scaltriti, Maurizio			Convergent loss of PTEN leads to clinical resistance to a PI(3)K alpha inhibitor	NATURE			English	Article							INTRATUMOR HETEROGENEITY; DOMAIN MUTATIONS; EVOLUTION; CANCERS; GROWTH	Broad and deep tumour genome sequencing has shed new light on tumour heterogeneity and provided important insights into the evolution of metastases arising from different clones(1,2). There is an additional layer of complexity, in that tumour evolution may be influenced by selective pressure provided by therapy, in a similar fashion to that occurring in infectious diseases. Here we studied tumour genomic evolution in a patient (index patient) with metastatic breast cancer bearing an activating PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha, PI(3)K alpha) mutation. The patient was treated with the PI(3)K alpha inhibitor BYL719, which achieved a lasting clinical response, but the patient eventually became resistant to this drug (emergence of lung metastases) and died shortly thereafter. A rapid autopsy was performed and material from a total of 14 metastatic sites was collected and sequenced. All metastatic lesions, when compared to the pre-treatment tumour, had a copy loss of PTEN (phosphatase and tensin homolog) and those lesions that became refractory to BYL719 had additional and different PTEN genetic alterations, resulting in the loss of PTEN expression. To put these results in context, we examined six other patients also treated with BYL719. Acquired bi-allelic loss of PTEN was found in one of these patients, whereas in two others PIK3CA mutations present in the primary tumour were no longer detected at the time of progression. To characterize our findings functionally, we examined the effects of PTEN knockdown in several preclinical models (both in cell lines intrinsically sensitive to BYL719 and in PTEN-null xenografts derived from our index patient), which we found resulted in resistance to BYL719, whereas simultaneous PI(3) K p110 beta blockade reverted this resistance phenotype. We conclude that parallel genetic evolution of separate metastatic sites with different PTEN genomic alterations leads to a convergent PTEN-null phenotype resistant to PI(3)K alpha inhibition.	[Juric, Dejan; Huynh, Tiffany; Mino-Kenudson, Mari; Sgroi, Dennis; Isakoff, Steven; Thabet, Ashraf; Elamine, Leila] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Castel, Pau; Won, Helen H.; Ellis, Haley; Iyer, Gopa; Shah, Ronak H.; Solit, David B.; Berger, Michael F.; Baselga, Jose; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program HOPP, New York, NY 10065 USA; [Griffith, Malachi; Mardis, Elaine R.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Griffith, Malachi; Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Griffith, Malachi; Griffith, Obi L.; Ainscough, Benjamin J.; Ramu, Avinash; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Won, Helen H.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ebbesen, Saya H.; Lowe, ScottW.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Iyer, Gopa; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Genitourinary Oncol, New York, NY 10065 USA; [Lowe, ScottW.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Canc Biol & Genet Program, New York, NY 10065 USA; [Quadt, Cornelia; Peters, Malte] Novartis Pharma AG, CH-4056 Basel, Switzerland; [Derti, Adnan; Schegel, Robert; Huang, Alan] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Med Serv, New York, NY 10065 USA	Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Novartis; Novartis; Memorial Sloan Kettering Cancer Center	Scaltriti, M (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program HOPP, 1275 York Ave,Box 20, New York, NY 10065 USA.	bergerm1@mskcc.org; baselgaj@mskcc.org; scaltrim@mskcc.org	Mardis, Elaine/W-2202-2019; Isakoff, Steven/ABE-3566-2020; Castel, Pau/AAL-5791-2020; Shah, Ronak H/H-9726-2017; Sgroi, Dennis/AAV-2487-2021; Griffith, Malachi/P-1285-2014; Solit, David B./AAC-5309-2019; Griffith, Obi/P-1286-2014	Castel, Pau/0000-0002-4972-4347; Shah, Ronak H/0000-0001-9042-6213; Griffith, Malachi/0000-0002-6388-446X; Solit, David/0000-0002-6614-802X; Griffith, Obi/0000-0002-0843-4271; Ainscough, Benjamin/0000-0001-8340-514X; Ramu, Avinash/0000-0003-3799-809X	"Stand Up to Cancer" Dream Team Translational Research Grant; Entertainment Industry Foundation [SU2C-AACR-DT0209]; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; MMHCC [CA105388]; National Institutes of Health [T32 CA-71345-15]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA190642, U01CA105388, T32CA113275, U01CA168409, T32CA071345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065094] Funding Source: NIH RePORTER	"Stand Up to Cancer" Dream Team Translational Research Grant; Entertainment Industry Foundation; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; MMHCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the MSKCC Diagnostic Molecular Pathology Laboratory and the MSK Maria-Josee and Henry Kravis Center for Molecular Oncology for assistance with sequencing. We thank M. Asher and U. Bhanot from the MSKCC Pathology Core for assistance with tissue staining. This work was funded by a "Stand Up to Cancer" Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0209), the Breast Cancer Research Foundation, the Geoffrey Beene Cancer Research Center, the Starr Cancer Consortium and an MMHCC grant (CA105388). D.J. is also funded by a National Institutes of Health Training Grant (T32 CA-71345-15) and by philanthropic support from Stephen and Kathleen Chubb.	Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Juric D, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P8-10-07; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Lemey P, 2005, J VIROL, V79, P11981, DOI 10.1128/JVI.79.18.11981-11989.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	27	363	378	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					240	U230		10.1038/nature13948	http://dx.doi.org/10.1038/nature13948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25409150	Green Accepted			2022-12-01	WOS:000349190300040
J	Becattini, S; Latorre, D; Mele, F; Foglierini, M; De Gregorio, C; Cassotta, A; Fernandez, B; Kelderman, S; Schumacher, TN; Corti, D; Lanzavecchia, A; Sallusto, F				Becattini, Simone; Latorre, Daniela; Mele, Federico; Foglierini, Mathilde; De Gregorio, Corinne; Cassotta, Antonino; Fernandez, Blanca; Kelderman, Sander; Schumacher, Ton N.; Corti, Davide; Lanzavecchia, Antonio; Sallusto, Federica			Functional heterogeneity of human memory CD4(+) T cell clones primed by pathogens or vaccines	SCIENCE			English	Article							HYPER-IGE SYNDROME; ENVIRONMENTAL CUES; DENDRITIC CELLS; IMMUNE-RESPONSE; TH17 CELLS; NAIVE; DIFFERENTIATION; EFFECTOR; RECOGNITION; FATE	Distinct types of CD4(+) T cells protect the host against different classes of pathogens. However, it is unclear whether a given pathogen induces a single type of polarized T cell. By combining antigenic stimulation and T cell receptor deep sequencing, we found that human pathogen-and vaccine-specific T helper 1 (T(H)1), T(H)2, and T(H)17 memory cells have different frequencies but comparable diversity and comprise not only clones polarized toward a single fate, but also clones whose progeny have acquired multiple fates. Single naive T cells primed by a pathogen in vitro could also give rise to multiple fates. Our results unravel an unexpected degree of interclonal and intraclonal functional heterogeneity of the human T cell response and suggest that polarized responses result from preferential expansion rather than priming.	[Becattini, Simone; Latorre, Daniela; Mele, Federico; Foglierini, Mathilde; De Gregorio, Corinne; Cassotta, Antonino; Fernandez, Blanca; Corti, Davide; Lanzavecchia, Antonio; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Lugano, Switzerland; [Becattini, Simone; Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Kelderman, Sander; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Netherlands Cancer Institute	Sallusto, F (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Lugano, Switzerland.	federica.sallusto@irb.usi.ch	Cassotta, Antonino/AAW-2529-2021; Schumacher, Ton/Y-2432-2019	Cassotta, Antonino/0000-0001-8674-4294; Schumacher, Ton/0000-0003-0517-8804; Latorre, Daniela/0000-0003-1031-1534; Foglierini, Mathilde/0000-0001-7538-4262; Becattini, Simone/0000-0001-5985-0403	European Research Council [323183]; Swiss National Science Foundation [149475, 147662]; European Commission [FP7-HEALTH-2011-280873, FP7-HEALTH-2013-601958]; Helmut Horten Foundation	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmut Horten Foundation	We thank D. Jarrossay for cell sorting; O. Petrini, C. Fragoso, and A. Sette for providing valuable reagents; the Adaptive Biotechnologies team for technical support; and S. Monticelli for critical reading of the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. All TCR sequences are available in the supplementary materials as. txt files. FASTA format files are available at downloads. adaptivebiotech.com (username: SallustoSciDec2014data; password: di2PhaiT). The sequences have been deposited in the Gene Expression Omnibus (accession numbers xxxxxx). Supported by European Research Council grant 323183 PREDICT (F.S.), Swiss National Science Foundation grants 149475 (F.S.) and 147662 (A.L.), and European Commission grants FP7-HEALTH-2011-280873, ADITEC (A.L. and F.S.) and FP7-HEALTH-2013-601958, SUPERSIST (T.N.S.). The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	31	220	224	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					400	406		10.1126/science.1260668	http://dx.doi.org/10.1126/science.1260668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25477212				2022-12-01	WOS:000348225800038
J	Strait, RT; Posgai, MT; Mahler, A; Barasa, N; Jacob, CO; Kohl, J; Ehlers, M; Stringer, K; Shanmukhappa, SK; Witte, D; Hossain, MM; Khodoun, M; Herr, AB; Finkelman, FD				Strait, Richard T.; Posgai, Monica T.; Mahler, Ashley; Barasa, Nathaniel; Jacob, Chaim O.; Koehl, Joerg; Ehlers, Marc; Stringer, Keith; Shanmukhappa, Shiva Kumar; Witte, David; Hossain, Md Monir; Khodoun, Marat; Herr, Andrew B.; Finkelman, Fred D.			IgG1 protects against renal disease in a mouse model of cryoglobulinaemia	NATURE			English	Article							FC-GAMMA-RIIB; CLASS SWITCH RECOMBINATION; ANTIINFLAMMATORY ACTIVITY; MONOCLONAL-ANTIBODIES; SEGMENTAL FLEXIBILITY; IMMUNE-RESPONSES; IN-VIVO; COMPLEMENT; INFLAMMATION; RECEPTORS	Immunoglobulins protect against disease to a considerable extent by activating complement and stimulatory immunoglobulin crystallizable fragment receptors (Ig FcRs), and aggregating microbial pathogens(1,2). Yet IgGI, the predominant murine serum Ig isotype, cannot activate complement by the classical pathway, binds more avidly to an inhibitory than to stimulatory FcRs, and has limited ability to aggregate pathogens(1-3). In these regards, it resembles human IgG4 (ref. 4). We hypothesized that limited ability to activate effector mechanisms might protect against immune complex immunopathology. Here we show that IgG 1 -deficient (gamma 1(-)) mice(5), immunized with a potent antigen, develop lethal renal disease soon after they begin to produce antigen-specific antibody, whereas similarly immunized wildtype mice remain healthy. Surprisingly, renal disease in this model is complement and FcR independent and results from immune complex precipitation in glomerular capillaries, as in some cryoglobulinaemic humans(6). IgG3, which self-associates to form large immune complexes(7,8), accounts for more than 97% of the mouse Ig in this cryoglobulin; furthermore, glomerular disease develops when mice are injected with IgG3 anti-trinitrophenyl (TNP) monoclonal antibody followed by a TNP-labelled protein. Renal disease is prevented in both active and passive immunization models by antigen-specific IgGI; other isotypes are less potent at preventing disease. These observations demonstrate the adaptive significance of Ig isotypes that poorly activate effector mechanisms, reveal an immune-complex-dependent, complement- and FcR-independent nephrotoxic mechanism, and suggest that isotypes that poorly activate effector mechanisms may be useful for inhibiting immune complex immunopathology.	[Strait, Richard T.; Mahler, Ashley; Barasa, Nathaniel] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Strait, Richard T.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Posgai, Monica T.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Jacob, Chaim O.] Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Koehl, Joerg; Herr, Andrew B.; Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Joerg; Ehlers, Marc] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Stringer, Keith; Shanmukhappa, Shiva Kumar; Witte, David] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Hossain, Md Monir] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Khodoun, Marat; Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Med Serv, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Southern California; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Lubeck; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Finkelman, FD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.	finkelfd@UCMAIL.UC.EDU	Herr, Andrew/R-3049-2019; Koehl, Joerg/C-8531-2011; Ehlers, Marc/C-9441-2011; Hossain, Md/N-5360-2015	Herr, Andrew/0000-0002-3598-3399; Koehl, Joerg/0000-0003-1121-3178; Ehlers, Marc/0000-0002-5383-8603; 	US Department of Veterans Affairs Merit Award; National Institutes of Health [R01 AI072040]; Cincinnati Children's Hospital; University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072040] Funding Source: NIH RePORTER	US Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital; University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Wills-Karp for C3-deficient mice, D. Metzger for J-chain-deficient mice, M. Muramatsu for AID-deficient mice, S. Izui for a hybridoma that secretes mouse IgG1 anti-TNP monoclonal antibody, M. Robson and L. Aarden for switch variant hybridomas that secrete mouse IgG1, IgG2a and IgG2b anti-TNP monoclonal antibodies, B. DiPasquale for histological staining, and J. Lambris for C5aR antagonist. Research was supported by a US Department of Veterans Affairs Merit Award, National Institutes of Health R01 AI072040, and the University of Cincinnati and Cincinnati Children's Hospital, all to F.D.F.	ABDELMOULA M, 1989, J IMMUNOL, V143, P526; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; BOOT JHA, 1988, J IMMUNOL METHODS, V106, P195, DOI 10.1016/0022-1759(88)90197-4; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; Erlandsson L, 1998, EUR J IMMUNOL, V28, P2355, DOI 10.1002/(SICI)1521-4141(199808)28:08&lt;2355::AID-IMMU2355&gt;3.0.CO;2-L; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; FINKELMAN FD, 1982, J IMMUNOL, V129, P638; FULPIUS T, 1994, KIDNEY INT, V45, P962, DOI 10.1038/ki.1994.130; Giorgini A, 2008, J IMMUNOL, V181, P8745, DOI 10.4049/jimmunol.181.12.8745; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; NISHIMURA Y, 1984, J BIOCHEM-TOKYO, V95, P255, DOI 10.1093/oxfordjournals.jbchem.a134592; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roccatello D, 2007, AM J KIDNEY DIS, V49, P69, DOI 10.1053/j.ajkd.2006.09.015; SCHNEIDER WP, 1988, P NATL ACAD SCI USA, V85, P2509, DOI 10.1073/pnas.85.8.2509; Sheerin NS, 2001, EUR J IMMUNOL, V31, P1255, DOI 10.1002/1521-4141(200104)31:4<1255::AID-IMMU1255>3.0.CO;2-W; Snapper C., 1999, FUNDAMENTAL IMMUNOLO, P837; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575	26	44	46	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					501	+		10.1038/nature13868	http://dx.doi.org/10.1038/nature13868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25363774	Bronze, Green Accepted			2022-12-01	WOS:000348196500038
J	Bogoch, II; Creatore, MI; Cetron, MS; Brownstein, JS; Pesik, N; Miniota, J; Tam, T; Hu, W; Nicolucci, A; Ahmed, S; Yoon, JW; Berry, I; Hay, SI; Anema, A; Tatem, AJ; MacFadden, D; German, M; Khan, K				Bogoch, Isaac I.; Creatore, Maria I.; Cetron, Martin S.; Brownstein, John S.; Pesik, Nicki; Miniota, Jennifer; Tam, Theresa; Hu, Wei; Nicolucci, Adriano; Ahmed, Saad; Yoon, James W.; Berry, Isha; Hay, Simon I.; Anema, Aranka; Tatem, Andrew J.; MacFadden, Derek; German, Matthew; Khan, Kamran			Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak	LANCET			English	Article							HEALTH REGULATIONS	Background The WHO declared the 2014 west African Ebola epidemic a public health emergency of international concern in view of its potential for further international spread. Decision makers worldwide are in need of empirical data to inform and implement emergency response measures. Our aim was to assess the potential for Ebola virus to spread across international borders via commercial air travel and assess the relative efficiency of exit versus entry screening of travellers at commercial airports. Methods We analysed International Air Transport Association data for worldwide flight schedules between Sept 1, 2014, and Dec 31, 2014, and historic traveller flight itinerary data from 2013 to describe expected global population movements via commercial air travel out of Guinea, Liberia, and Sierra Leone. Coupled with Ebola virus surveillance data, we modelled the expected number of internationally exported Ebola virus infections, the potential effect of air travel restrictions, and the efficiency of airport-based traveller screening at international ports of entry and exit. We deemed individuals initiating travel from any domestic or international airport within these three countries to have possible exposure to Ebola virus. We deemed all other travellers to have no significant risk of exposure to Ebola virus. Findings Based on epidemic conditions and international flight restrictions to and from Guinea, Liberia, and Sierra Leone as of Sept 1, 2014 (reductions in passenger seats by 51% for Liberia, 66% for Guinea, and 85% for Sierra Leone), our model projects 2.8 travellers infected with Ebola virus departing the above three countries via commercial flights, on average, every month. 91 547 (64%) of all air travellers departing Guinea, Liberia, and Sierra Leone had expected destinations in low-income and lower-middle-income countries. Screening international travellers departing three airports would enable health assessments of all travellers at highest risk of exposure to Ebola virus infection.	[Bogoch, Isaac I.; MacFadden, Derek; Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Bogoch, Isaac I.] Univ Hlth Network, Div Internal Med, Toronto, ON, Canada; [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada; [Creatore, Maria I.; Miniota, Jennifer; Hu, Wei; Nicolucci, Adriano; Yoon, James W.; Berry, Isha; German, Matthew; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Cetron, Martin S.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Brownstein, John S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Brownstein, John S.; Anema, Aranka] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Pesik, Nicki] Ctr Dis Control & Prevent, Quarantine & Border Hlth Serv Branch, Div Global Migrat & Quarantine, Atlanta, GA USA; [Tam, Theresa] Publ Hlth Agcy Canada, Hlth Secur Infrastruct Branch, Ottawa, ON, Canada; [Ahmed, Saad] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Hay, Simon I.; Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Anema, Aranka] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England; [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Centers for Disease Control & Prevention - USA; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Centers for Disease Control & Prevention - USA; Public Health Agency of Canada; Western University (University of Western Ontario); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; University of British Columbia; University of Southampton	Khan, K (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	khank@smh.ca	Hay, Simon I/F-8967-2015; Bogoch, Isaac/AAS-9631-2020	Hay, Simon I/0000-0002-0611-7272; Tatem, Andrew/0000-0002-7270-941X; Ahmed, Syed/0000-0001-7633-6617	Canadian Institutes of Health Research; NATIONAL LIBRARY OF MEDICINE [R01LM010812] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Canadian Institutes of Health Research.	Anema A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-1; [Anonymous], 2014, LANCET INFECT DIS, V14, P779, DOI 10.1016/S1473-3099(14)70785-6; [Anonymous], 2014, LANCET, V384, P637, DOI 10.1016/S0140-6736(14)61377-5; [Anonymous], 2014, ECONOMIST; [Anonymous], 2014, EB CRIS LIB POL FIR; [Anonymous], 2014, EB TRAV S AFR BANS I; [Anonymous], INT GUID MON MOV PER; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859; Chretien JP, 2010, BIOSECUR BIOTERROR, V8, P277, DOI 10.1089/bsp.2009.0058; Davies M, 2014, REEBOLA HEMORRHAGIC; Khan K, 2013, B WORLD HEALTH ORGAN, V91, P368, DOI 10.2471/BLT.12.114777; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Mai-Duc C, 2014, LOS ANGELES TIMES, P1; WHO, 2014, 1 WHO; World Bank, 2013, WORLD DEV IND POP DY; York Geoffrey, 2014, GLOBE MAIL	18	134	137	0	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					29	35		10.1016/S0140-6736(14)61828-6	http://dx.doi.org/10.1016/S0140-6736(14)61828-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25458732	Green Published			2022-12-01	WOS:000347154200025
J	Wang, DS; Cai, CG; Dong, XB; Yu, QC; Zhang, XO; Yang, L; Zeng, YA				Wang, Daisong; Cai, Cheguo; Dong, Xiaobing; Yu, Qing Cissy; Zhang, Xiao-Ou; Yang, Li; Zeng, Yi Arial			Identification of multipotent mammary stemcells by protein C receptor expression	NATURE			English	Article							STEM-CELLS; WNT PROTEINS; GLAND; LINEAGES; MOUSE; BASAL; GENE	The mammary gland is composed of multiple types of epithelial cells, which are generated by mammary stem cells (MaSCs) residing at the top of the hierarchy(1,2). However, the existence of these multi-potent MaSCs remains controversial and the nature of such cells is unknown(3,4). Here we demonstrate that protein C receptor (Procr), a novel Wnt target in the mammary gland, marks a unique population of multipotent mouse MaSCs. Procr-positive cells localize to the basal layer, exhibit epithelial-to-mesenchymal transition characteristics, and express low levels of basal keratins. Procr-expressing cells have a high regenerative capacity in transplantation assays and differentiate into all lineages of the mammary epithelium by lineage tracing. These results define a novel multipotent mammary stem cell population that could be important in the initiation of breast cancer.	[Wang, Daisong; Cai, Cheguo; Dong, Xiaobing; Yu, Qing Cissy; Zeng, Yi Arial] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhang, Xiao-Ou; Yang, Li] Chinese Acad Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Zeng, YA (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	yzeng@sibcb.ac.cn	Kessenbrock, Kai/B-6936-2011; Cai, Cheguo/K-3747-2019; Zhang, Xiao-Ou/J-6229-2014	cai, cheguo/0000-0002-3712-1696; yang, li/0000-0001-8833-7473; Zhang, Xiao-Ou/0000-0002-2027-1313				Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beaulieu LM, 2007, EXP CELL RES, V313, P677, DOI 10.1016/j.yexcr.2006.11.019; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Gu JM, 2002, J BIOL CHEM, V277, P43335, DOI 10.1074/jbc.M207538200; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Schaffner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061071; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Spek CA, 2012, THROMB RES, V129, pS80, DOI 10.1016/S0049-3848(12)70022-1; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	27	225	236	6	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					81	U201		10.1038/nature13851	http://dx.doi.org/10.1038/nature13851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25327250				2022-12-01	WOS:000347178400039
J	Al Jord, A; Lemaitre, AI; Delgehyr, N; Faucourt, M; Spassky, N; Meunier, A				Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice			Centriole amplification by mother and daughter centrioles differs in multiciliated cells	NATURE			English	Article							PRIMARY CILIUM; CENTROSOME; CILIOGENESIS; BIOGENESIS; TUBULIN; MORPHOGENESIS; EPITHELIUM; INTERACTS; CYCLE; CPAP	The semi-conservative centrosome duplication in cycling cells gives rise to a centrosome composed of a mother and a newly formed daughter centriole(1). Both centrioles are regarded as equivalent in their ability to form new centrioles and their symmetric duplication is crucial for cell division homeostasis(2,4). Multiciliated cells do not use the archetypal duplication program and instead form more than a hundred centrioles that are required for the growth of motile cilia and the efficient propelling of physiological fluids(5). The majority of these new centrioles are thought to appear de novo, that is, independently from the centrosome, around electron-dense structures called deuterosomes(5,9). Their origin remains unknown. Using live imaging combined with correlative super-resolution light and electron microscopy, we show that all new centrioles derive from the pre-existing progenitor cell centrosome through multiple rounds of procentriole seeding. Moreover, we establish that only the daughter centrosomal centriole contributes to deuterosome formation, and thus to over ninety per cent of the final centriole population. This unexpected centriolar asymmetry grants new perspectives when studying cilia-related diseases and pathological centriole amplification observed in cycling cells and associated with microcephaly and cancer(2-4,10).	[Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice] Ecole Normale Super, ENS, IBENS, Inst Biol, F-75005 Paris, France; [Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice] INSERM, U1024, F-75005 Paris, France; [Al Jord, Adel; Lemaitre, Anne-Iris; Delgehyr, Nathalie; Faucourt, Marion; Spassky, Nathalie; Meunier, Alice] CNRS, UMR 8197, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Spassky, N (corresponding author), Ecole Normale Super, ENS, IBENS, Inst Biol, F-75005 Paris, France.	nathalie.spassky@ens.fr; alice.meunier@ens.fr	Spassky, Nathalie/E-3932-2016	spassky, nathalie/0000-0003-4722-6464; Al Jord, Adel/0000-0002-5075-3014; Meunier, Alice/0000-0001-6131-7747; Delgehyr, Nathalie/0000-0001-9870-0475	Federation pour la Recherche sur le Cerveau; Region Ile de France DIM NeRF; France-BioImaging; CNRS; ENS; INSERM; FPGG; ANR [ANR-12-BSV4-0006 CILIASTEM, ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02 PSL]; ARC [PJA-20131200184]; La ligue contre le cancer-comite de Paris [RS14/75-88]; 'Investissements d'Avenir' program of the French Government; City of Paris; FRM; French Ministry of Higher Education and Research	Federation pour la Recherche sur le Cerveau; Region Ile de France DIM NeRF(Region Ile-de-France); France-BioImaging(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FPGG; ANR(French National Research Agency (ANR)); ARC(Australian Research Council); La ligue contre le cancer-comite de Paris; 'Investissements d'Avenir' program of the French Government(French National Research Agency (ANR)); City of Paris(Region Ile-de-France); FRM(Fondation pour la Recherche Medicale); French Ministry of Higher Education and Research	We thank P. Rostaing of the IBENS Electron microscopy facility for making the correlative 3D-SIM and electron microscopy experiments possible. We also thank the Imaging Facility of IBENS, which is supported by grants from Federation pour la Recherche sur le Cerveau, Region Ile de France DIM NeRF 2009 and 2011 and France-BioImaging. We wish to thank L. Sengmanivong from the Nikon Imaging Centre at Institut Curie-CNRS. We are grateful to L. Goldstein for providing us with the Kif3a mutant mice. We thank C. Janke for the GT335 antibody, E. A. Nigg for the Cep164 and Plk4 antibodies, T. K. Tang for Cep120 and Cpap antibodies, X. Yan and X. Zhu for Deup1 and Cep152 antibodies, J.Azimzadeh for the Poc5 antibody and X. Morin for his gift of the pCAAGS-Cen2-GFP-mCherry plasmid. We also thank M. Bornens, B. Guirao, J. B. Boule, C. Janke and J.-F. Brunet for their comments on the manuscript and all the members of the Spassky laboratory for discussions. This study was supported by the CNRS, the ENS, INSERM, an FPGG grant, ANR award ANR-12-BSV4-0006 CILIASTEM, ARC award PJA-20131200184, La ligue contre le cancer-comite de Paris RS14/75-88, the 'Investissements d'Avenir' program of the French Government and implemented by the ANR (referenced ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University), a start-up grant from the City of Paris and a start-up grant from the FRM. A.A.J. and A-I.L. received fellowships from the French Ministry of Higher Education and Research.	Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; DIRKSEN ER, 1971, J CELL BIOL, V51, P286, DOI 10.1083/jcb.51.1.286; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Grau MB, 2013, J CELL BIOL, V202, P441, DOI 10.1083/jcb.201305041; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; LOOTS GP, 1989, CELL TISSUE RES, V255, P589; Ma LN, 2014, GENE DEV, V28, P1461, DOI 10.1101/gad.243832.114; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Tan FE, 2013, DEVELOPMENT, V140, P4277, DOI 10.1242/dev.094102; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Zhao HJ, 2013, NAT CELL BIOL, V15, P1434, DOI 10.1038/ncb2880	38	83	84	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					104	U259		10.1038/nature13770	http://dx.doi.org/10.1038/nature13770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25307055				2022-12-01	WOS:000346310800048
J	Lee, JM; Wagner, M; Xiao, R; Kim, KH; Feng, D; Lazar, MA; Moore, DD				Lee, Jae Man; Wagner, Martin; Xiao, Rui; Kim, Kang Ho; Feng, Dan; Lazar, Mitchell A.; Moore, David D.			Nutrient-sensing nuclear receptors coordinate autophagy	NATURE			English	Article							FARNESOID-X-RECEPTOR; NEGATIVE FEEDBACK-REGULATION; ACTIVATED RECEPTOR; BILE-ACID; TARGETED DISRUPTION; FATTY-ACIDS; IDENTIFICATION; MTOR; AMPK; METABOLISM	Autophagy is an evolutionarily conserved catabolic process that recycles nutrients upon starvation and maintains cellular energy homeostasis(1-3). Its acute regulation by nutrient-sensing signalling pathways is well described, but its longer-term transcriptional regulation is not. The nuclear receptors peroxisome proliferator-activated receptor-alpha (PPAR alpha) and farnesoid X receptor (FXR) are activated in the fasted and fed liver, respectively(4,5). Here we show that both PPARa and FXR regulate hepatic autophagy in mice. Pharmacological activation of PPARa reverses the normal suppression of autophagy in the fed state, inducing autophagic lipid degradation, or lipophagy. This response is lost in PPARa knockout (Ppara(-/-), also known as Nr1c1(-/-) mice, which are partially defective in the induction of autophagy by fasting. Pharmacological activation of the bile acid receptor FXR strongly suppresses the induction of autophagy in the fasting state, and this response is absent in FXR knockout (Fxr(-/-), also known as Nr1h4(-/-)) mice, which show a partial defect in suppression of hepatic autophagy in the fed state. PPARa and FXR compete for binding to shared sites in autophagic gene promoters, with opposite transcriptional outputs. These results reveal complementary, interlocking mechanisms for regulation of autophagy by nutrient status.	[Lee, Jae Man; Wagner, Martin; Xiao, Rui; Kim, Kang Ho; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Feng, Dan; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19014 USA; [Feng, Dan; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19014 USA	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	moore@bcm.edu	Lazar, Mitchell A/AAF-3738-2019	Feng, Dan/0000-0001-5926-8894	Alkek Foundation; Robert R.P. Doherty Jr-Welch Chair in Science [R01 DK49780, DK43806];  [U54 HD-07495-39];  [P30 DX56338-05A2];  [P39 CA125123-04];  [S10RR027783-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049780, R37DK043806, R01DK043806, P30DK056338, P30DK019525] Funding Source: NIH RePORTER	Alkek Foundation; Robert R.P. Doherty Jr-Welch Chair in Science; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Mizushima for the GFP-LC3<SUP>Tg/+</SUP> mice; T. Yoshimori for the mRFP-GFP-LC3 plasmid; M. Komatsu for the Atg7<SUP>F/F</SUP> mice; D. Townley and M. Mancini for transmission electron microscopy and confocal microscopy; the members of the Moore laboratory for comments and additional support. Core facilities supported by grants U54 HD-07495-39, P30 DX56338-05A2, P39 CA125123-04 and S10RR027783-01A1. Next-generation sequencing was performed by the Functional Genomics Core of the Penn Diabetes Research Center (DK19525). This work was supported by funding from the Alkek Foundation and the Robert R.P. Doherty Jr-Welch Chair in Science to D.D.M., and R01 DK49780 and DK43806 to M.A.L.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Chennamsetty I, 2011, J CLIN INVEST, V121, P3724, DOI 10.1172/JCI45277; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Glauert A. M., 1975, PRACTICAL METHODS EL, P143; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Settembre C, 2014, TRENDS CELL BIOL; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	332	348	5	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					112	U291		10.1038/nature13961	http://dx.doi.org/10.1038/nature13961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383539	Green Submitted, Green Accepted			2022-12-01	WOS:000346310800050
J	Bagcchi, S				Bagcchi, Sanjeet			BLOOD DONATION More blood for India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drsanjitbagchi@gmail.com						Aggarwal S, 2012, ANN TROP MED PUBLIC, V5, P50; [Anonymous], 2014, DNA; Bhaumik S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5623; Indian Red Cross Society, 2013, NAT VOL BLOOD DON DA; Sharman G., 2012, WEEK            0901; World Health Organization, BLOOD SAF AV	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2014	349								g7166	10.1136/bmj.g7166	http://dx.doi.org/10.1136/bmj.g7166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KH	25432665				2022-12-01	WOS:000346115900002
J	Schieffelin, JS; Shaffer, JG; Goba, A; Gbakie, M; Gire, SK; Colubri, A; Sealfon, RSG; Kanneh, L; Moigboi, A; Momoh, M; Fullah, M; Moses, LM; Brown, BL; Andersen, KG; Winnicki, S; Schaffner, SF; Park, DJ; Yozwiak, NL; Jiang, PP; Kargbo, D; Jalloh, S; Fonnie, M; Sinnah, V; French, I; Kovoma, A; Kamara, FK; Tucker, V; Konuwa, E; Sellu, J; Mustapha, I; Foday, M; Yillah, M; Kanneh, F; Saffa, S; Massally, JLB; Boisen, ML; Branco, LM; Vandi, MA; Grant, DS; Happi, C; Gevao, SM; Fletcher, TE; Fowler, RA; Bausch, DG; Sabeti, PC; Khan, SH; Garry, RF				Schieffelin, J. S.; Shaffer, J. G.; Goba, A.; Gbakie, M.; Gire, S. K.; Colubri, A.; Sealfon, R. S. G.; Kanneh, L.; Moigboi, A.; Momoh, M.; Fullah, M.; Moses, L. M.; Brown, B. L.; Andersen, K. G.; Winnicki, S.; Schaffner, S. F.; Park, D. J.; Yozwiak, N. L.; Jiang, P. -P.; Kargbo, D.; Jalloh, S.; Fonnie, M.; Sinnah, V.; French, I.; Kovoma, A.; Kamara, F. K.; Tucker, V.; Konuwa, E.; Sellu, J.; Mustapha, I.; Foday, M.; Yillah, M.; Kanneh, F.; Saffa, S.; Massally, J. L. B.; Boisen, M. L.; Branco, L. M.; Vandi, M. A.; Grant, D. S.; Happi, C.; Gevao, S. M.; Fletcher, T. E.; Fowler, R. A.; Bausch, D. G.; Sabeti, P. C.; Khan, S. H.; Garry, R. F.		Viral Hemorrhagic Fever Consortium; WHO Clinical Response Team	Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMORRHAGIC-FEVER; VIRUS; TRANSMISSION; FEATURES; MONKEYS; CONGO	BACKGROUND Limited clinical and laboratory data are available on patients with Ebola virus disease (EVD). The Kenema Government Hospital in Sierra Leone, which had an existing infrastructure for research regarding viral hemorrhagic fever, has received and cared for patients with EVD since the beginning of the outbreak in Sierra Leone in May 2014. METHODS We reviewed available epidemiologic, clinical, and laboratory records of patients in whom EVD was diagnosed between May 25 and June 18, 2014. We used quantitative reverse-transcriptase-polymerase-chain-reaction assays to assess the load of Ebola virus (EBOV, Zaire species) in a subgroup of patients. RESULTS Of 106 patients in whom EVD was diagnosed, 87 had a known outcome, and 44 had detailed clinical information available. The incubation period was estimated to be 6 to 12 days, and the case fatality rate was 74%. Common findings at presentation included fever (in 89% of the patients), headache (in 80%), weakness (in 66%), dizziness (in 60%), diarrhea (in 51%), abdominal pain (in 40%), and vomiting (in 34%). Clinical and laboratory factors at presentation that were associated with a fatal outcome included fever, weakness, dizziness, diarrhea, and elevated levels of blood urea nitrogen, aspartate aminotransferase, and creatinine. Exploratory analyses indicated that patients under the age of 21 years had a lower case fatality rate than those over the age of 45 years (57% vs. 94%, P = 0.03), and patients presenting with fewer than 100,000 EBOV copies per milliliter had a lower case fatality rate than those with 10 million EBOV copies per milliliter or more (33% vs. 94%, P = 0.003). Bleeding occurred in only 1 patient. CONCLUSIONS The incubation period and case fatality rate among patients with EVD in Sierra Leone are similar to those observed elsewhere in the 2014 outbreak and in previous outbreaks. Although bleeding was an infrequent finding, diarrhea and other gastrointestinal manifestations were common.	[Schieffelin, J. S.; Moses, L. M.; Garry, R. F.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Shaffer, J. G.; Bausch, D. G.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Goba, A.; Gbakie, M.; Kanneh, L.; Moigboi, A.; Momoh, M.; Fullah, M.; Kargbo, D.; Jalloh, S.; Fonnie, M.; Sinnah, V.; French, I.; Kovoma, A.; Kamara, F. K.; Tucker, V.; Konuwa, E.; Sellu, J.; Mustapha, I.; Foday, M.; Yillah, M.; Kanneh, F.; Saffa, S.; Massally, J. L. B.; Grant, D. S.; Khan, S. H.] Kenema Govt Hosp, Kenema, Sierra Leone; [Momoh, M.; Fullah, M.] Eastern Polytech Coll, Kenema, Sierra Leone; [Vandi, M. A.] Minist Hlth & Sanitat, Kenema Dist Hlth Management Team, Kenema, Sierra Leone; [Gevao, S. M.] Univ Sierra Leone, Freetown, Sierra Leone; [Gire, S. K.; Colubri, A.; Andersen, K. G.; Winnicki, S.; Schaffner, S. F.; Yozwiak, N. L.; Jiang, P. -P.; Sabeti, P. C.] Harvard Univ, Ctr Syst Biol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Gire, S. K.; Sealfon, R. S. G.; Andersen, K. G.; Winnicki, S.; Schaffner, S. F.; Park, D. J.; Yozwiak, N. L.; Jiang, P. -P.; Sabeti, P. C.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Sealfon, R. S. G.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Brown, B. L.; Boisen, M. L.] Corgenix Med, Broomfield, CO USA; [Branco, L. M.] Zalgen Labs, Germantown, MD USA; [Happi, C.] Redeemers Univ, Redemption City, Nigeria; [Fletcher, T. E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Fowler, R. A.] Univ Toronto, Toronto, ON, Canada; [Bausch, D. G.] US Naval Med Res Unit 6, Lima, Peru	Tulane University; Tulane University; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Redeemers University; Liverpool School of Tropical Medicine; University of Liverpool; University of Toronto; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Schieffelin, JS (corresponding author), Tulane Univ, Sch Med, Dept Med, 1430 Tulane Ave,TB 8, New Orleans, LA 70112 USA.	jschieff@tulane.edu; pardis@broadinstitute.org	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022	Garry, Robert/0000-0002-5683-3250; Melnik, Lilia/0000-0002-3247-3158; Boisen, Matthew/0000-0001-6043-8459; Moses, Lina/0000-0003-4292-647X; Schaffner, Stephen/0000-0001-6699-3568; Branco, Luis/0000-0001-8161-0182; Fletcher, Tom/0000-0002-3712-415X; Happi, Christian/0000-0002-3056-6705	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099699, U19AI109762, R44AI088843, U19AI115589, R01AI104621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501, T32GM080177] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the National Institutes of Health and others.	Adesunkanmi ARK, 2003, ANZ J SURG, V73, P275, DOI 10.1046/j.1445-2197.2003.t01-1-02608.x; Adesunkanmi ARK, 2005, INDIAN J SURG, V67, P29; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; FISHERHOCH SP, 1983, LANCET, V2, P1055; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Kasolo F, 2010, TECHNICAL GUIDELINES, P270; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Kuhn JH, 2011, BIOSECUR BIOTERROR, V9, P361, DOI 10.1089/bsp.2011.0051; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5980; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Sadek RF, 1999, J INFECT DIS, V179, pS24, DOI 10.1086/514311; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; World Health Organization, 2014, EB RESP ROADM SIT RE; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	24	378	404	1	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2092	2100		10.1056/NEJMoa1411680	http://dx.doi.org/10.1056/NEJMoa1411680			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25353969	Green Accepted, Green Published			2022-12-01	WOS:000345580000008
J	Gray, JM; Frolking, S; Kort, EA; Ray, DK; Kucharik, CJ; Ramankutty, N; Friedl, MA				Gray, Josh M.; Frolking, Steve; Kort, Eric A.; Ray, Deepak K.; Kucharik, Christopher J.; Ramankutty, Navin; Friedl, Mark A.			Direct human influence on atmospheric CO2 seasonality from increased cropland productivity	NATURE			English	Article							NET PRIMARY PRODUCTION; CARBON SEQUESTRATION; HARVEST INDEX; NORTHERN ECOSYSTEMS; USE EFFICIENCY; GRAIN-YIELD; MAUNA-LOA; AGRICULTURE; CLIMATE; TRENDS	Ground- and aircraft-based measurements show that the seasonal amplitude of Northern Hemisphere atmospheric carbon dioxide (CO2) concentrations has increased by as much as 50 per cent over the past 50 years(1-3). This increase has been linked to changes in temperate, boreal and arctic ecosystem properties and processes such as enhanced photosynthesis, increased heterotrophic respiration, and expansion of woody vegetation(4-6). However, the precise causal mechanisms behind the observed changes in atmospheric CO2 seasonality remain unclear(2-4). Here we use production statistics and a carbon accounting model to show that increases in agricultural productivity, which have been largely overlooked in previous investigations, explain as much as a quarter of the observed changes in atmospheric CO2 seasonality. Specifically, Northern Hemisphere extratropical maize, wheat, rice, and soybean production grew by 240 per cent between 1961 and 2008, thereby increasing the amount of net carbon uptake by croplands during the Northern Hemisphere growing season by 0.33 petagrams. Maize alone accounts for two-thirds of this change, owing mostly to agricultural intensification within concentrated production zones in the midwestern United States and northern China. Maize, wheat, rice, and soybeans account for about 68 per cent of extratropical dry biomass production, so it is likely that the total impact of increased agricultural production exceeds the amount quantified here.	[Gray, Josh M.; Friedl, Mark A.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Frolking, Steve] Univ New Hampshire, Earth Syst Res Ctr, Durham, NH 03824 USA; [Kort, Eric A.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Ray, Deepak K.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Kucharik, Christopher J.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Kucharik, Christopher J.] Univ Wisconsin, Nelson Inst Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; [Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 0B9, Canada	Boston University; University System Of New Hampshire; University of New Hampshire; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; McGill University	Gray, JM (corresponding author), Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA.	joshgray@bu.edu	Ray, Deepak K/F-7720-2012; Friedl, Mark A/A-3570-2012; Ramankutty, Navin/AAM-6074-2020; Kort, Eric A/F-9942-2012; Frolking, Steve/ABF-9046-2021	Ramankutty, Navin/0000-0002-3737-5717; Kort, Eric A/0000-0003-4940-7541; Frolking, Steve/0000-0001-6414-5004; Gray, Josh/0000-0003-4341-4353; Ray, Deepak/0000-0002-2856-9608; Kucharik, Christopher/0000-0002-0400-758X	CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; CarboEuropelP; FAO-GTOS-TCO; iLEAPS; Max Planck Institute for Biogeochemistry; National Science Foundation; University of Tuscia; Universite Laval; US Department of Energy; NASA [NNX11AE75G]; NSF [EF-1064614, EAR-1038818]; Gordon and Betty Moore Foundation; Institute on Environment at the University of Minnesota; Emerging Frontiers [1065029] Funding Source: National Science Foundation	CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); CarboEuropelP; FAO-GTOS-TCO; iLEAPS; Max Planck Institute for Biogeochemistry; National Science Foundation(National Science Foundation (NSF)); University of Tuscia; Universite Laval; US Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on Environment at the University of Minnesota; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: AmeriFlux (US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (DE-FG02-04ER63917 and DE-FG02-04ER63911)), AfriFlux, AsiaFlux, CarboAfrica, CarboEuropelP, Carboltaly, CarboMont, ChinaFlux, Fluxnet-Canada (supported by CFCAS, NSERC, BIOCAP, Environment Canada, and NRCan), GreenGrass, KoFlux, LBA, NECC, OzFlux, TCOS-Siberia, USCCC. We acknowledge the financial support to the eddy covariance data harmonization provided by CarboEuropelP, FAO-GTOS-TCO, iLEAPS, Max Planck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and US Department of Energy and the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California - Berkeley, University of Virginia. This work was supported by NASA grant number NNX11AE75G and NSF grant numbers EF-1064614 and NSF EAR-1038818. Research support to D.K.R. was primarily provided by the Gordon and Betty Moore Foundation and the Institute on Environment at the University of Minnesota. We also acknowledge input and data provided by H. Graven and P. Patra.	Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Arai-Sanoh Y, 2010, PLANT PROD SCI, V13, P235, DOI 10.1626/pps.13.235; Aubinet M, 2009, AGR FOREST METEOROL, V149, P407, DOI 10.1016/j.agrformet.2008.09.003; BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Barichivich J, 2013, GLOBAL CHANGE BIOL, V19, P3167, DOI 10.1111/gcb.12283; Bonifas KD, 2005, WEED SCI, V53, P670, DOI 10.1614/WS-05-002R.1; Buermann W, 2007, P NATL ACAD SCI USA, V104, P4249, DOI 10.1073/pnas.0611224104; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Dawe D, 2004, FIELD CROP RES, V87, P89, DOI 10.1016/j.fcr.2003.08.008; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; FAO, 2013, FAOST DAT; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Frolking S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001425; Gehring C, 2013, EUR J AGRON, V46, P25, DOI 10.1016/j.eja.2012.11.006; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HAY RKM, 1995, ANN APPL BIOL, V126, P197, DOI 10.1111/j.1744-7348.1995.tb05015.x; Insalud N, 2006, ANN BOT-LONDON, V98, P995, DOI 10.1093/aob/mcl194; Johnson JMF, 2006, AGRON J, V98, P622, DOI 10.2134/agronj2005.0179; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keppel-Aleks G, 2013, J CLIMATE, V26, P4447, DOI 10.1175/JCLI-D-12-00589.1; Kucharik CJ, 2008, AGRON J, V100, P328, DOI 10.2134/agronj2007.0145; Kumudini S, 2001, CROP SCI, V41, P391, DOI 10.2135/cropsci2001.412391x; Le Quere C, 2012, EARTH SYST SCI DATA, V5, P1107, DOI [10.5194/ESSDD-5-1107-2012, DOI 10.5194/ESSDD-5-1107-2012]; Lobell DB, 2002, GLOBAL CHANGE BIOL, V8, P722, DOI 10.1046/j.1365-2486.2002.00503.x; Lorenz AJ, 2010, CROP SCI, V50, P1, DOI 10.2135/cropsci2009.02.0086; Ma SC, 2010, FIELD CROP RES, V115, P158, DOI 10.1016/j.fcr.2009.10.017; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; Qiu J., 2003, GEOCARTO INT, V18, P3, DOI [10.1080/10106040308542268, DOI 10.1080/10106040308542268]; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Shearman VJ, 2005, CROP SCI, V45, P175; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; West TO, 2011, BIOGEOSCIENCES, V8, P2037, DOI 10.5194/bg-8-2037-2011; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; West TO, 2003, BIOGEOCHEMISTRY, V63, P73, DOI 10.1023/A:1023394024790; Williams JD, 2013, J SOIL WATER CONSERV, V68, P349, DOI 10.2489/jswc.68.5.349; Wirsenius S, 2003, AGR SYST, V77, P219, DOI 10.1016/S0308-521X(02)00188-9; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112	57	94	97	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					398	+		10.1038/nature13957	http://dx.doi.org/10.1038/nature13957			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25409830				2022-12-01	WOS:000345770600042
J	Rybak-Wolf, A; Jens, M; Murakawa, Y; Herzog, M; Landthaler, M; Rajewsky, N				Rybak-Wolf, Agnieszka; Jens, Marvin; Murakawa, Yasuhiro; Herzog, Margareta; Landthaler, Markus; Rajewsky, Nikolaus			A Variety of Dicer Substrates in Human and C-elegans	CELL			English	Article							RNA-BINDING PROTEIN; TRANSCRIPTOME-WIDE IDENTIFICATION; MESSENGER-RNA; GERM-CELLS; P-GRANULES; PRE-MIRNA; DROSHA; RECOGNITION; CLEAVAGE; EXPRESSION	The endoribonuclease Dicer is known for its central role in the biogenesis of eukaryotic small RNAs/microRNAs. Despite its importance, Dicer target transcripts have not been directly mapped. Here, we apply biochemical methods to human cells and C. elegans and identify thousands of Dicer-binding sites. We find known and hundreds of additional miRNAs with high sensitivity and specificity. We also report structural RNAs, promoter RNAs, and mitochondrial transcripts as Dicer targets. Interestingly, most Dicer-binding sites reside on mRNAs/lncRNAs and are not significantly processed into small RNAs. These passive sites typically harbor small, Dicer-bound hairpins within intact transcripts and generally stabilize target expression. We show that passive sites can sequester Dicer and reduce microRNA expression. mRNAs with passive sites were in human and worm significantly associated with processing-body/granule function. Together, we provide the first transcriptome-wide map of Dicer targets and suggest conserved binding modes and functions outside of the miRNA pathway.	[Rybak-Wolf, Agnieszka; Jens, Marvin; Herzog, Margareta; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany; [Murakawa, Yasuhiro; Landthaler, Markus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab RNA Biol & Posttranscript Regulat, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Landthaler, M (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, Robert Rossle Str 10, D-13125 Berlin, Germany.	markus.landthaler@mdc-berlin.de; rajewsky@mdc-berlin.de	Landthaler, Markus/A-1427-2010	Landthaler, Markus/0000-0002-1075-8734; Jens, Marvin/0000-0002-6660-8743; Rajewsky, Nikolaus/0000-0002-4785-4332; Rybak-Wolf, Agnieszka/0000-0002-1192-5290	DFG [GRK1772]; BMBF; Senate of Berlin; DAAD fellowship	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Senate of Berlin; DAAD fellowship(Deutscher Akademischer Austausch Dienst (DAAD))	The authors would like to thank all members of the Rajewsky lab for discussion and support. We thank T. Duchaine and W. Filipowicz for discussion and advice on the manuscript. We would like to thank H. Tabara for the anti DCR-1 antibodies. M. J. received a fellowship of the DFG-funded GRK1772. The group of M. L. was supported by the BMBF and Senate of Berlin. Y. M. was funded by DAAD fellowship.	Ando Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023385; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Beshore EL, 2011, DEV BIOL, V350, P370, DOI 10.1016/j.ydbio.2010.12.005; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Doyle M, 2013, RNA, V19, P1238, DOI 10.1261/rna.039255.113; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Feng Y, 2012, RNA, V18, P2083, DOI 10.1261/rna.033688.112; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fukunaga R, 2014, EMBO J, V33, P371, DOI 10.1002/embj.201387176; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sarkies P, 2013, BIOCHEM SOC T, V41, P876, DOI 10.1042/BST20130021; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Shi Z, 2013, GENOME RES, V23, P497, DOI 10.1101/gr.149112.112; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Tian Y, 2014, MOL CELL, V53, P606, DOI 10.1016/j.molcel.2014.01.003; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	52	73	77	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1153	1167		10.1016/j.cell.2014.10.040	http://dx.doi.org/10.1016/j.cell.2014.10.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416952	Bronze			2022-12-01	WOS:000345506300025
J	Carter, M				Carter, Meg			MEDICINE AND THE MEDIA How Twitter may have helped Nigeria contain Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meg@megcarter.com						[Anonymous], 2014, SOCIAL MEDIA WEEK; [Anonymous], 2014, ECONOMIST; [Anonymous], SIERRA LEONE TELECOM; BBC, 2014, BBC; Gleit N, 2014, COMING TOGETHER TO F; Neporent L., 2014, ABC NEWS; OCarroll Lisa, 2014, GUARDIAN SEP, V24; Wall M, 2014, BBC NEWS; Wallis W., 2014, FINANCIAL TIMES; World Health Organization (WHO), 2014, EBOLA RESPONSE ROADM	10	26	26	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2014	349								g6946	10.1136/bmj.g6946	http://dx.doi.org/10.1136/bmj.g6946			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JZ	25410185	Bronze, Green Published			2022-12-01	WOS:000345445700005
J	Elert, E				Elert, Emily			A GOOD GRAIN	NATURE			English	Editorial Material																			0	98	109	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S50	S51		10.1038/514S50a	http://dx.doi.org/10.1038/514S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25368886	Bronze			2022-12-01	WOS:000343801500002
J	McJeon, H; Edmonds, J; Bauer, N; Clarke, L; Fisher, B; Flannery, BP; Hilaire, J; Krey, V; Marangoni, G; Mi, R; Riahi, K; Rogner, H; Tavoni, M				McJeon, Haewon; Edmonds, Jae; Bauer, Nico; Clarke, Leon; Fisher, Brian; Flannery, Brian P.; Hilaire, Jerome; Krey, Volker; Marangoni, Giacomo; Mi, Raymond; Riahi, Keywan; Rogner, Holger; Tavoni, Massimo			Limited impact on decadal-scale climate change from increased use of natural gas	NATURE			English	Article							SHALE GAS; CHANGE MITIGATION; EMISSIONS; MODEL; TECHNOLOGIES; SCENARIOS; ECONOMICS; METHANE; STABILIZATION; UNCERTAINTY	The most important energy development of the past decade has been the wide deployment of hydraulic fracturing technologies that enable the production of previously uneconomic shale gas resources in North America(1). If these advanced gas production technologies were to be deployed globally, the energy market could see a large influx of economically competitive unconventional gas resources(2). The climate implications of such abundant natural gas have been hotly debated. Some researchers have observed that abundant natural gas substituting for coal could reduce carbon dioxide (CO2) emissions(3-6). Others have reported that the non-CO2 greenhouse gas emissions associated with shale gas production make its lifecycle emissions higher than those of coal(7,8). Assessment of the full impact of abundant gas on climate change requires an integrated approach to the global energyeconomyclimate systems, but the literature has been limited in either its geographic scope(9,10) or its coverage of greenhouse gases(2). Here we show that market-driven increases in global supplies of unconventional natural gas do not discernibly reduce the trajectory of greenhouse gas emissions or climate forcing. Our results, based on simulations from five state-of-the-art integrated assessment models(11) of energyeconomyclimate systems independently forced by an abundant gas scenario, project large additional natural gas consumption of up to +170 per cent by 2050. The impact on CO2 emissions, however, is found to be much smaller (from -2 per cent to +11 per cent), and a majority of the models reported a small increase in climate forcing (from -0.3 per cent to +7 per cent) associated with the increased use of abundant gas. Our results show that although market penetration of globally abundant gas may substantially change the future energy system, it is not necessarily an effective substitute for climate change mitigation policy(9,10).	[McJeon, Haewon; Edmonds, Jae; Clarke, Leon] Pacific NW Natl Lab, JGCRI, College Pk, MD 20740 USA; [Bauer, Nico; Hilaire, Jerome] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Fisher, Brian; Mi, Raymond] BAEconomics, Kingston, ACT 2604, Australia; [Flannery, Brian P.] Resources Future Inc, Washington, DC 20036 USA; [Krey, Volker; Riahi, Keywan; Rogner, Holger] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Marangoni, Giacomo; Tavoni, Massimo] Ctr Euromediterraneo Cambiamenti Climat, I-20156 Milan, Italy; [Marangoni, Giacomo; Tavoni, Massimo] Politecn Milan, I-20156 Milan, Italy	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Potsdam Institut fur Klimafolgenforschung; Resources for the Future; International Institute for Applied Systems Analysis (IIASA); Polytechnic University of Milan	McJeon, H (corresponding author), Pacific NW Natl Lab, JGCRI, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	haewon.mcjeon@pnnl.gov	Krey, Volker/ABD-5070-2021; Riahi, Keywan/B-6426-2011; Marangoni, Giacomo/AAV-1668-2021	Riahi, Keywan/0000-0001-7193-3498; Marangoni, Giacomo/0000-0003-3994-380X; Flannery, Brian/0000-0002-3318-8068; Krey, Volker/0000-0003-0307-3515; McJeon, Haewon/0000-0003-0348-5704; tavoni, massimo/0000-0001-5069-4707; Hilaire, Jerome/0000-0002-9879-6339	BAEconomics; Global Technology Strategy Project; International Institute for Applied Systems Analysis; German Federal Ministry of Education and Research; Italian Ministry of Education, University and Research; Italian Ministry of Environment, Land and Sea under the GEMINA project	BAEconomics; Global Technology Strategy Project; International Institute for Applied Systems Analysis; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Environment, Land and Sea under the GEMINA project(Ministry of Environment (ME), Republic of Korea)	B.F. and R.M. and their development of BAEGEM were supported by BAEconomics with assistance for special applications to the resource sector from Rio Tinto (Australia). H.M., L.C.,J.E. and B.P.F. were supported by the Global Technology Strategy Project. V.K., K.R. and H.R. were supported by the International Institute for Applied Systems Analysis cross-cutting project on unconventional natural gas. N.B. and J.H. were supported by funding from the German Federal Ministry of Education and Research in the project 'Economics of Climate Change'. G.M. and M.T. were supported by the Italian Ministry of Education, University and Research and the Italian Ministry of Environment, Land and Sea under the GEMINA project. We thank M. Jeong and E. Golman for research assistance. The views and opinions expressed in this paper are those of the authors alone.	Aguiar A., 2012, GLOBAL TRADE ASSISTA; [Anonymous], 2008, MAGICC SCENGEN 5 3 U; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; Bauer N., CLIM CHANGE IN PRESS; Bauer N., TECHNOL FORECAST SOC; Bauer N, 2012, P NATL ACAD SCI USA, V109, P16805, DOI 10.1073/pnas.1201264109; Bauer N, 2008, COMPUT MANAG SCI, V5, P95, DOI 10.1007/s10287-007-0042-3; Boden T. A., 2009, GLOBAL REGIONAL NATL; Bosetti V, 2008, ENERG ECON, V30, P2912, DOI 10.1016/j.eneco.2008.04.008; Bosetti V, 2006, ENERG J, P13; Bosetti V, 2011, ENERG ECON, V33, P1313, DOI 10.1016/j.eneco.2011.02.010; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Brown S., 2009, NATURAL GAS BRIDGE L; Burnham A, 2012, ENVIRON SCI TECHNOL, V46, P619, DOI 10.1021/es201942m; Calvin K., 2011, GCAM WIKI DOCUMENTAT; Calvin K, 2012, ENERG ECON, V34, pS251, DOI 10.1016/j.eneco.2012.09.003; CLARKE JF, 1993, ENERG ECON, V15, P123, DOI 10.1016/0140-9883(93)90031-L; Edenhofer O, 2010, ENERG J, V31, P11; EDMONDS J, 1983, ENERG ECON, V5, P74, DOI 10.1016/0140-9883(83)90014-2; EDMONDS J, 1983, ENERGY, V8, P419, DOI 10.1016/0360-5442(83)90064-6; Edmonds J., 1983, ENERGY J, V4, DOI [10.5547/ISSN0195-6574-EJ-Vol4-No3-3, DOI 10.5547/ISSN0195-6574-EJ-VOL4-NO3-3]; Edmonds J. A., 2012, CLIMATE CHANGE MODEL, P169; Energy Modeling Forum, 2013, 26 EMF; Environmental Protection Agency, 2012, GLOB ANTHR NONCO2 GR; Environmental Protection Agency, 2011, EPA PUBL, V430-R-11-005; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Global Energy Assessment, 2012, GEA SCEN DAT; HANOCH G, 1971, ECONOMETRICA, V39, P695, DOI 10.2307/1909573; Harrison J., 2012, GEMPACK MANUAL; Hertel TW, 1999, GLOBAL TRADE ANAL MO; Howarth RW, 2011, NATURE, V477, P271, DOI 10.1038/477271a; Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5; Hultman N, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044008; Integrated Assessment Modeling Consortium, 2014, IPCC AR5 SCEN DAT; Intergovernmental Panel on Climate Change, 2000, GUID UNC MAN NAT GRE; Intergovernmental Panel on Climate Change, 2006, IPPC GUID NAT GREENH; International Energy Agency, 2012, CO2 EM FUEL COMB 197; International Energy Agency, 2012, EM CO2 CH4 N2O HFCS; International Energy Agency, 2008, WORLD EN OUTL 2008; International Energy Agency, 2011, AR WE ENT GOLD AG GA; International Energy Agency, 2013, EN BAL NONOECD COUNT; International Energy Agency, 2012, CO2 EM FUEL COMB 201; International Energy Agency, 2013, EN BAL OECD COUNTR; International Institute for Applied Systems Analysis, 2014, GLOB BIOSPH MAN MOD; Joos F, 2001, GLOBAL BIOGEOCHEM CY, V15, P891, DOI 10.1029/2000GB001375; Klein D, 2014, CLIMATIC CHANGE, V123, P705, DOI 10.1007/s10584-013-0940-z; Kriegler E, 2014, CLIMATIC CHANGE, V123, P353, DOI 10.1007/s10584-013-0953-7; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Laurenzi IJ, 2013, ENVIRON SCI TECHNOL, V47, P4896, DOI 10.1021/es305162w; Leimbach M, 2010, ENERG J, V31, P109; Levi M, 2013, CLIMATIC CHANGE, V118, P609, DOI 10.1007/s10584-012-0658-3; Liu GJ, 2011, ENRGY PROCED, V4, P1989, DOI 10.1016/j.egypro.2011.02.080; Liu GJ, 2011, ENERG FUEL, V25, P415, DOI 10.1021/ef101184e; Luderer G., 2011, DESCRIPTION REMIND R; Luderer G, 2012, CLIMATIC CHANGE, V114, P9, DOI 10.1007/s10584-011-0105-x; MANNE A, 1995, ENERG POLICY, V23, P17, DOI 10.1016/0301-4215(95)90763-W; McCollum D, 2014, CLIMATIC CHANGE, V123, P413, DOI 10.1007/s10584-013-0939-5; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Messner S, 2000, ENERGY, V25, P267, DOI 10.1016/S0360-5442(99)00063-8; Messner S., 1995, USERS GUIDE MESSAGE; Mi R., 2014, BAEGEM MODEL DOCUMEN; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Moniz E., 2011, FUTURE NATURAL GAS I; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Newell RG, 2014, ENVIRON SCI TECHNOL, V48, P8360, DOI 10.1021/es4046154; Nordhaus WD, 1996, AM ECON REV, V86, P741; Nordhaus WD, 1999, ENERG J, P93; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P1011, DOI 10.1073/pnas.0903797106; Patwardhan A. P., 2012, GLOBAL ENERGY ASSESS; Ramage M., 2009, LIQUID TRANSPORTATIO; Rao S, 2006, ENERG J, P177; Reilly J., 1987, ENERGY J, V8, P1; Riahi K, 2004, ENERGY, V29, P1309, DOI 10.1016/j.energy.2004.03.089; Riahi K., 2012, ENERGY PATHWAYS SUST; Riahi K., TECHNOL FOR IN PRESS; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rogner H., 2012, GLOBAL ENERGY ASSESS, P425, DOI [10.1017/CBO9780511793677.013, DOI 10.1017/CBO9780511793677.013]; Rogner HH, 1997, ANNU REV ENERG ENV, V22, P217, DOI 10.1146/annurev.energy.22.1.217; Schwanitz VJ, 2014, ENERG POLICY, V67, P882, DOI 10.1016/j.enpol.2013.12.015; Scott MJ, 1999, ENERG POLICY, V27, P855, DOI 10.1016/S0301-4215(99)00057-9; Skone T. J., 2010, LIFE CYCLE ANAL NATU; Sovacool BK, 2014, RENEW SUST ENERG REV, V37, P249, DOI 10.1016/j.rser.2014.04.068; Strefler J., 2008, CLIM CHANGE IN PRESS; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; United Nations Framework Convention on Climate Change, 2012, 2012 ANN 1 PART GHG; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P1, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0148-z]; vanOldenborgh, 2013, CLIMATE CHANGE 2013, DOI [DOI 10.1017/CBO9781107415324.004, 10.1017/CBO9781107415324, DOI 10.1017/CBO9781107415324]; Venkatesh A, 2011, ENVIRON SCI TECHNOL, V45, P8182, DOI 10.1021/es200930h; Weber CL, 2012, ENVIRON SCI TECHNOL, V46, P5688, DOI 10.1021/es300375n; Weyant JR, 2006, ENERG J, P1; WIGLEY TML, 1987, NATURE, V330, P127, DOI 10.1038/330127a0; Wigley TML, 2002, J CLIMATE, V15, P2690, DOI 10.1175/1520-0442(2002)015<2690:RFDTRG>2.0.CO;2; WIGLEY TML, 1992, NATURE, V357, P293, DOI 10.1038/357293a0; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475	96	143	144	6	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					482	+		10.1038/nature13837	http://dx.doi.org/10.1038/nature13837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25317557	Green Published			2022-12-01	WOS:000343775900038
J	Calegari, F; Ayuso, D; Trabattoni, A; Belshaw, L; De Camillis, S; Anumula, S; Frassetto, F; Poletto, L; Palacios, A; Decleva, P; Greenwood, JB; Martin, F; Nisoli, M				Calegari, F.; Ayuso, D.; Trabattoni, A.; Belshaw, L.; De Camillis, S.; Anumula, S.; Frassetto, F.; Poletto, L.; Palacios, A.; Decleva, P.; Greenwood, J. B.; Martin, F.; Nisoli, M.			Ultrafast electron dynamics in phenylalanine initiated by attosecond pulses	SCIENCE			English	Article							REAL-TIME OBSERVATION; CHARGE MIGRATION; PEPTIDE CATIONS	In the past decade, attosecond technology has opened up the investigation of ultrafast electronic processes in atoms, simple molecules, and solids. Here, we report the application of isolated attosecond pulses to prompt ionization of the amino acid phenylalanine and the subsequent detection of ultrafast dynamics on a sub-4.5-femtosecond temporal scale, which is shorter than the vibrational response of the molecule. The ability to initiate and observe such electronic dynamics in polyatomic molecules represents a crucial step forward in attosecond science, which is progressively moving toward the investigation of more and more complex systems.	[Calegari, F.; Nisoli, M.] CNR, Inst Photon & Nanotechnol IFN, I-20133 Milan, Italy; [Ayuso, D.; Palacios, A.; Martin, F.] Univ Autonoma Madrid, Dept Quim, E-28049 Madrid, Spain; [Trabattoni, A.; Anumula, S.; Nisoli, M.] Politecn Milan, Dept Phys, I-20133 Milan, Italy; [Belshaw, L.; De Camillis, S.; Greenwood, J. B.] Queens Univ Belfast, Sch Maths & Phys, Ctr Plasma Phys, Belfast BT7 1NN, Antrim, North Ireland; [Frassetto, F.; Poletto, L.] CNR, IFN, I-35131 Padua, Italy; [Decleva, P.] Univ Trieste, Dipartimento Sci Chim & Farmaceut, I-34127 Trieste, Italy; [Decleva, P.] CNR, Ist Officina Mat, I-34127 Trieste, Italy; [Martin, F.] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Autonomous University of Madrid; Polytechnic University of Milan; Queens University Belfast; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR)	Martin, F (corresponding author), Univ Autonoma Madrid, Dept Quim, Modulo 13, E-28049 Madrid, Spain.	fernando.martin@uam.es; mauro.nisoli@polimi.it	Nisoli, Mauro/K-8563-2017; Ayuso, David/M-7330-2016; Frassetto, Fabio/AAY-3281-2020; Palacios, Alicia/V-4525-2019; Calegari, Francesca/H-8881-2012; Greenwood, Jason B/L-4799-2014; Martin, Fernando/C-3972-2014	Nisoli, Mauro/0000-0003-2309-732X; Ayuso, David/0000-0002-5394-5361; Palacios, Alicia/0000-0001-6531-9926; Calegari, Francesca/0000-0003-3234-7298; Greenwood, Jason B/0000-0001-9470-7223; Martin, Fernando/0000-0002-7529-925X; De Camillis, Simone/0000-0002-9392-5197; Poletto, Luca/0000-0002-0914-0531; De Camillis, Simone/0000-0002-8823-9643; Trabattoni, Andrea/0000-0002-0187-9075	European Research Council under ERC [227355 ELYCHE, 290853 XCHEM]; LASERLAB-EUROPE (European Commission) [284464]; European COST Action [CM1204 XLIC]; Ministerio de Ciencia e Innovacion [FIS2010-15127]; ERA-Chemistry project [PIM2010EEC-00751]; European grant MC-ITN CORINF [268284]; European grant MC-RG ATTOTREND [268284]; UK's Science and Technology Facilities Council; Engineering and Physical Sciences Research Council [EP/J007048/1]; Leverhulme Trust [RPG-2012-735]; Northern Ireland Department of Employment and Learning; Engineering and Physical Sciences Research Council [EP/G03088X/1] Funding Source: researchfish; EPSRC [EP/J007048/1, EP/G03088X/1] Funding Source: UKRI	European Research Council under ERC(European Research Council (ERC)); LASERLAB-EUROPE (European Commission)(European Commission); European COST Action; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ERA-Chemistry project; European grant MC-ITN CORINF; European grant MC-RG ATTOTREND; UK's Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Northern Ireland Department of Employment and Learning; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge support from the European Research Council under ERC grant nos. 227355 ELYCHE and 290853 XCHEM, LASERLAB-EUROPE (grant agreement no. 284464, European Commission's Seventh Framework Programme), European COST Action CM1204 XLIC, the Ministerio de Ciencia e Innovacion project FIS2010-15127, the ERA-Chemistry project PIM2010EEC-00751, European grants MC-ITN CORINF and MC-RG ATTOTREND 268284, UK's Science and Technology Facilities Council Laser Loan Scheme, the Engineering and Physical Sciences Research Council (grant EP/J007048/1), the Leverhulme Trust (grant RPG-2012-735), and the Northern Ireland Department of Employment and Learning.	Belshaw L, 2012, J PHYS CHEM LETT, V3, P3751, DOI 10.1021/jz3016028; Breidbach J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033901; Breidbach J, 2003, J CHEM PHYS, V118, P3983, DOI 10.1063/1.1540618; Calvert CR, 2012, PHYS CHEM CHEM PHYS, V14, P6289, DOI 10.1039/c2cp23840c; Canton SE, 2011, P NATL ACAD SCI USA, V108, P7302, DOI 10.1073/pnas.1018534108; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Cederbaum LS, 1999, CHEM PHYS LETT, V307, P205, DOI 10.1016/S0009-2614(99)00508-4; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Hennig H, 2005, J PHYS CHEM A, V109, P409, DOI 10.1021/jp046232s; Huang ZJ, 2006, J MOL STRUC-THEOCHEM, V758, P195, DOI 10.1016/j.theochem.2005.10.043; Kelkensberg F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.043002; Klunder K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143002; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kuleff AI, 2007, CHEM PHYS, V338, P320, DOI 10.1016/j.chemphys.2007.04.012; Lepine F, 2014, NAT PHOTONICS, V8, P195, DOI 10.1038/nphoton.2014.25; Lunnemann S, 2008, CHEM PHYS LETT, V450, P232, DOI 10.1016/j.cplett.2007.11.031; Mendive-Tapia D, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4815914; Plesiat E, 2012, PHYS CHEM CHEM PHYS, V14, P10853, DOI 10.1039/c2cp40693d; Ranitovic P, 2014, P NATL ACAD SCI USA, V111, P912, DOI 10.1073/pnas.1321999111; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Siu W, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063412; Toffoli D, 2002, CHEM PHYS, V276, P25, DOI 10.1016/S0301-0104(01)00549-3; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; WALS J, 1994, PHYS REV LETT, V72, P3783, DOI 10.1103/PhysRevLett.72.3783; Weinkauf R, 1996, J PHYS CHEM-US, V100, P18567, DOI 10.1021/jp960926m; WEINKAUF R, 1995, J PHYS CHEM-US, V99, P11255, DOI 10.1021/j100028a029	30	495	502	5	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					336	339		10.1126/science.1254061	http://dx.doi.org/10.1126/science.1254061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324385	Green Submitted, Green Accepted			2022-12-01	WOS:000343041100040
J	Rosenbaum, L				Rosenbaum, Lisa			Invisible Risks, Emotional Choices - Mammography and Medical Decision Making	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCREENING MAMMOGRAPHY; CANCER; BENEFITS											Allen JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1169; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Kahneman D., 2011, INTERPRETATION; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Ransohoff DF, 2002, AM J MED, V113, P663, DOI 10.1016/S0002-9343(02)01235-4; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 2002, HEURISTICS BIASES PS, P297; Sunstein C.R., 2005, LAWS FEAR PRECAUTION; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	14	31	32	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1549	1552		10.1056/NEJMms1409003	http://dx.doi.org/10.1056/NEJMms1409003			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317876				2022-12-01	WOS:000342994700015
J	de Bruin, EC; McGranahan, N; Mitter, R; Salm, M; Wedge, DC; Yates, L; Jamal-Hanjani, M; Shafi, S; Murugaesu, N; Rowan, AJ; Gronroos, E; Muhammad, MA; Horswell, S; Gerlinger, M; Varela, I; Jones, D; Marshall, J; Voet, T; Van Loo, P; Rassl, DM; Rintoul, RC; Janes, SM; Lee, SM; Forster, M; Ahmad, T; Lawrence, D; Falzon, M; Capitanio, A; Harkins, TT; Lee, CC; Tom, W; Teefe, E; Chen, SC; Begum, S; Rabinowitz, A; Phillimore, B; Spencer-Dene, B; Stamp, G; Szallasi, Z; Matthews, N; Stewart, A; Campbell, P; Swanton, C				de Bruin, Elza C.; McGranahan, Nicholas; Mitter, Richard; Salm, Max; Wedge, David C.; Yates, Lucy; Jamal-Hanjani, Mariam; Shafi, Seema; Murugaesu, Nirupa; Rowan, Andrew J.; Groenroos, Eva; Muhammad, Madiha A.; Horswell, Stuart; Gerlinger, Marco; Varela, Ignacio; Jones, David; Marshall, John; Voet, Thierry; Van Loo, Peter; Rassl, Doris M.; Rintoul, Robert C.; Janes, Sam M.; Lee, Siow-Ming; Forster, Martin; Ahmad, Tanya; Lawrence, David; Falzon, Mary; Capitanio, Arrigo; Harkins, Timothy T.; Lee, Clarence C.; Tom, Warren; Teefe, Enock; Chen, Shann-Ching; Begum, Sharmin; Rabinowitz, Adam; Phillimore, Benjamin; Spencer-Dene, Bradley; Stamp, Gordon; Szallasi, Zoltan; Matthews, Nik; Stewart, Aengus; Campbell, Peter; Swanton, Charles			Spatial and temporal diversity in genomic instability processes defines lung cancer evolution	SCIENCE			English	Article							CHROMOSOMAL INSTABILITY; MUTATIONS; ADENOCARCINOMA; REARRANGEMENTS; HETEROGENEITY; MUTAGENESIS; RESISTANCE; SIGNATURES; PATTERNS	Spatial and temporal dissection of the genomic changes occurring during the evolution of human non-small cell lung cancer (NSCLC) may help elucidate the basis for its dismal prognosis. We sequenced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification. There was pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity. Despite maintained carcinogen exposure, tumors from smokers showed a relative decrease in smoking-related mutations over time, accompanied by an increase in APOBEC-associated mutations. In tumors from former smokers, genome-doubling occurred within a smoking-signature context before subclonal diversification, which suggested that a long period of tumor latency had preceded clinical detection. The regionally separated driver mutations, coupled with the relentless and heterogeneous nature of the genome instability processes, are likely to confound treatment success in NSCLC.	[de Bruin, Elza C.; Jamal-Hanjani, Mariam; Shafi, Seema; Murugaesu, Nirupa; Muhammad, Madiha A.; Lee, Siow-Ming; Forster, Martin; Swanton, Charles] UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, London WC1E 6BT, England; [McGranahan, Nicholas; Mitter, Richard; Salm, Max; Rowan, Andrew J.; Groenroos, Eva; Horswell, Stuart; Gerlinger, Marco; Begum, Sharmin; Rabinowitz, Adam; Phillimore, Benjamin; Spencer-Dene, Bradley; Stamp, Gordon; Matthews, Nik; Stewart, Aengus; Swanton, Charles] Canc Res UK London Res Inst, London WC2A 3LY, England; [McGranahan, Nicholas] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Wedge, David C.; Yates, Lucy; Jones, David; Marshall, John; Voet, Thierry; Van Loo, Peter; Campbell, Peter] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Yates, Lucy] Univ Cambridge, Cambridge CB2 1TN, England; [Varela, Ignacio] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria, CSIC UC Sodercan, E-39005 Santander, Spain; [Voet, Thierry; Van Loo, Peter] Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Rassl, Doris M.; Rintoul, Robert C.] Papworth Hosp NHS Fdn Trust, Cambridge CB23 3RE, England; [Janes, Sam M.] UCL, Lungs Living Res Ctr, London WC1E 6BT, England; [Lee, Siow-Ming; Forster, Martin; Ahmad, Tanya; Lawrence, David; Falzon, Mary; Capitanio, Arrigo] Univ Coll London Hosp, London NW1 2BU, England; [Harkins, Timothy T.; Lee, Clarence C.; Tom, Warren; Teefe, Enock; Chen, Shann-Ching] Thermo Fisher Sci, Carlsbad, CA 92008 USA; [Szallasi, Zoltan] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Szallasi, Zoltan] Harvard Univ, Sch Med, Childrens Hosp Informat Program, Boston, MA 02115 USA	Cancer Research UK; University of London; University College London; Cancer Research UK; University of London; University College London; Wellcome Trust Sanger Institute; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); KU Leuven; Papworth Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Thermo Fisher Scientific; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard Medical School	Swanton, C (corresponding author), UCL, Inst Canc, Canc Res UK Lung Canc Ctr Excellence, Mortimer St, London WC1E 6BT, England.	charles.swanton@cancer.org.uk	wang, edwin/G-5372-2010; Gronroos, Eva/P-6951-2015; Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; McGranahan, Nicholas/ABD-6561-2021; Wedge, David/AAC-4977-2021; Rintoul, Robert Campbell/Q-1727-2015; Voet, Thierry/E-8877-2017	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; McGranahan, Nicholas/0000-0001-9537-4045; Rintoul, Robert Campbell/0000-0003-3875-3780; Voet, Thierry/0000-0003-1204-9963; Horswell, Stuart/0000-0003-2787-1933; Mitter, Richard/0000-0002-1279-3760; Janes, Sam/0000-0002-6634-5939; Salm, Max/0000-0002-5742-3376; Gerlinger, Marco/0000-0003-2719-299X; Van Loo, Peter/0000-0003-0292-1949; Yates, Lucy/0000-0003-4519-7794; Gronroos, Eva/0000-0001-8303-5409; Lee, Siow Ming/0000-0002-1741-6235; Szallasi, Zoltan/0000-0001-5395-7509; Swanton, Charles/0000-0002-4299-3018; Wedge, David/0000-0002-7572-3196; Teefe, Enock/0000-0001-9063-7707	Cancer Research UK; Rosetrees Trust; UK Medical Research Council; Spanish Ministerio de Economia y Competitividad; Cambridge Biomedical Research Centre; Cancer Research UK Cancer Centre; European Union [259303]; Prostate Cancer Foundation; European Research Council; Breast Cancer Research Foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Servicio Santander Supercomputacion; 14M Genomics Ltd; Academy of Medical Sciences (AMS) [AMS-SGCL7-Murugaesu] Funding Source: researchfish; Cancer Research UK [18377, 17786] Funding Source: researchfish; Medical Research Council [G0902275] Funding Source: researchfish; National Institute for Health Research [CL-2011-18-001] Funding Source: researchfish; Rosetrees Trust [M35-F1-CD1] Funding Source: researchfish; MRC [G0902275] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Cambridge Biomedical Research Centre(General Electric); Cancer Research UK Cancer Centre(Cancer Research UK); European Union(European Commission); Prostate Cancer Foundation; European Research Council(European Research Council (ERC)European Commission); Breast Cancer Research Foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Servicio Santander Supercomputacion; 14M Genomics Ltd; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	E.B. is a Rosetrees Trust fellow; M.J.H. has a Cancer Research UK fellowship; N. Mu. received funding from the Rosetrees Trust; M. G. is funded by the UK Medical Research Council; I. V. is funded by Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal; R. C. R. and D. M. R. are partly funded by the Cambridge Biomedical Research Centre and Cancer Research UK Cancer Centre; P. V. L. is a postdoctoral researcher of the Research Foundation-Flanders (FWO); S.M.J. is a Wellcome Senior Fellow in Clinical Science; and C. S. is a senior Cancer Research UK clinical research fellow and is funded by Cancer Research UK, the Rosetrees Trust, European Union Framework Programme 7 (projects PREDICT and RESPONSIFY, ID: 259303), the Prostate Cancer Foundation, the European Research Council and the Breast Cancer Research Foundation. This research is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. We would like to thank Servicio Santander Supercomputacion for their support. P. C. is a paid consultant for and holds equity in 14M Genomics Ltd. The results published here are in part based upon data generated by the Cancer Genome Atlas pilot project established by the National Cancer Institute and National Human Genome Research Institute, NIH. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/. The data were retrieved through dbGaP authorization (accession no. phs000178.v5.p5). Sequence data have been deposited at the European Genome-Phenome Archive (EGA, www.ebi.ac.uk/ega/), which is hosted by the European Bionformatics Institute (EBI), under accession numbers EGAS00001000809, EGAS00001000888 and EGAS00001000889.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pfeifer GP, 2003, MUTAT RES-FUND MOL M, V526, P39, DOI 10.1016/S0027-5107(03)00013-7; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soria JC, 2013, EUR J CANCER, V49, pS798; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	35	727	752	4	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					251	256		10.1126/science.1253462	http://dx.doi.org/10.1126/science.1253462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301630	Green Accepted, Green Submitted			2022-12-01	WOS:000342721500052
J	Nakajima, M; Gorlich, A; Heintz, N				Nakajima, Miho; Goerlich, Andreas; Heintz, Nathaniel			Oxytocin Modulates Female Sociosexual Behavior through a Specific Class of Prefrontal Cortical Interneurons	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; GABAERGIC NEURONS; ESTROUS-CYCLE; GENE-EXPRESSION; DRIVER LINES; CELL-TYPES; VASOPRESSIN; INHIBITION; SYSTEM; NUCLEUS	Human imaging studies have revealed that intranasal administration of the "prosocial" hormone oxytocin (OT) activates the frontal cortex, and this action of OT correlates with enhanced brain function in autism. Here, we report the discovery of a population of somatostatin (Sst)-positive, regular spiking interneurons that express the oxytocin receptor (OxtrINs). Silencing of OxtrINs in the medial prefrontal cortex (mPFC) of female mice resulted in loss of social interest in male mice specifically during the sexually receptive phase of the estrous cycle. This sociosexual deficit was also present in mice in which the Oxtr gene was conditionally deleted from the mPFC and in control mice infused with an Oxtr antagonist. Our data demonstrate a gender-, cell type-, and state-specific role for OT/Oxtr signaling in the mPFC and identify a latent cortical circuit element that may modulate other complex social behaviors in response to OT.	[Nakajima, Miho; Goerlich, Andreas; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@rockefeller.edu	Nakajima, Miho/AAU-3731-2020; Core, Vector/CAF-4832-2022		Howard Hughes Medical Institute; NIH PHS [MH090963 P2]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute and NIH PHS MH090963 P2 (N.H. is an HHMI Investigator). We wish to thank Guojun Ma and Clint Earnheart for their contributions to the initial characterization of bacTRAP lines targeting cortical interneuron populations and the GENSAT Project for the Htr3a Cre mice used in this study. We would also like to thank Jie Xing, Paola Emhardt, and Beatriz Lopez for their skilled assistance, Soohyun Lee, Robin Tremblay, Eric Schmidt, Joseph Doughterty, Jodi Gresack, Hirofumi Nakayama, Awni Mousa and all other Heintz lab members for their excellent advice, and Wenxiang Zhang from the Rockefeller University Genomics Resource Center for help with the TRAP data production.	Anacker AMJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00185; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Biochemistry D., 2013, PRINCIPLES NEURAL SC; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; CROWLEY WR, 1978, LIFE SCI, V23, P2579, DOI 10.1016/0024-3205(78)90373-9; deLecea L, 1997, J NEUROSCI, V17, P5868; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dumais KM, 2013, HORM BEHAV, V64, P693, DOI 10.1016/j.yhbeh.2013.08.012; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gordon I, 2013, P NATL ACAD SCI USA, V110, P20953, DOI 10.1073/pnas.1312857110; Gorski JA, 2002, J NEUROSCI, V22, P6309; GREER ER, 1986, LIFE SCI, V38, P2311, DOI 10.1016/0024-3205(86)90638-7; Guastella AJ, 2012, HORM BEHAV, V61, P773, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Knobloch HS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00031; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; Leng G, 2008, CURR OPIN PHARMACOL, V8, P731, DOI 10.1016/j.coph.2008.07.001; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; MacDonald E, 2011, PSYCHONEUROENDOCRINO, V36, P1114, DOI 10.1016/j.psyneuen.2011.02.015; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McCarthy MM, 1997, MOL MED TODAY, V3, P269, DOI 10.1016/S1357-4310(97)01058-7; Moscovice LR, 2012, HORM BEHAV, V62, P592, DOI 10.1016/j.yhbeh.2012.08.011; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Oblak AL, 2011, BRAIN RES, V1380, P218, DOI 10.1016/j.brainres.2010.09.021; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; PERLOW MJ, 1982, SCIENCE, V216, P1416, DOI 10.1126/science.7201163; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; RICHARD S, 1990, J BIOL CHEM, V265, P6098; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Scheele D, 2012, J NEUROSCI, V32, P16074, DOI 10.1523/JNEUROSCI.2755-12.2012; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Takahashi S, 2013, SCHIZOPHR RES, V146, P238, DOI 10.1016/j.schres.2013.02.033; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; VANTOL HHM, 1988, ENDOCRINOLOGY, V122, P945, DOI 10.1210/endo-122-3-945; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Watanabe T, 2014, JAMA PSYCHIAT, V71, P166, DOI 10.1001/jamapsychiatry.2013.3181; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	69	161	163	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					295	305		10.1016/j.cell.2014.09.020	http://dx.doi.org/10.1016/j.cell.2014.09.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303526	Green Accepted, Bronze			2022-12-01	WOS:000343095600012
J	Powell, J; O'Hara, J; Wilson, JA				Powell, Jason; O'Hara, James; Wilson, Janet A.			Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXTRA-ESOPHAGEAL REFLUX; GASTROESOPHAGEAL-REFLUX; LARYNGOPHARYNGEAL REFLUX; CHRONIC LARYNGITIS; DISEASE; METAANALYSIS; THERAPY; MANAGEMENT; EFFICACY; PEPSIN		[Powell, Jason] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [O'Hara, James] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Wilson, Janet A.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK	Powell, J (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jason.powell@doctors.org.uk		wilson, janet/0000-0002-6416-5870; O'Hara, James/0000-0002-4096-3296	National Institute for Health Research [12/01/04] Funding Source: researchfish; Department of Health [12/01/04] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Ah-See K, 2012, CLIN OTOLARYNGOL, V37, P9, DOI 10.1111/j.1749-4486.2012.02443.x; Bredenoord AJ, 2013, LANCET, V381, P1933, DOI 10.1016/S0140-6736(12)62171-0; Bulmer DM, 2010, LARYNGOSCOPE, V120, P777, DOI 10.1002/lary.20665; Chang AB, 2011, COCHRANE DB SYST REV, V1; Cremonini F, 2010, ALIMENT PHARM THER, V32, P29, DOI 10.1111/j.1365-2036.2010.04315.x; Ford CN, 2005, JAMA-J AM MED ASSOC, V294, P1534, DOI 10.1001/jama.294.12.1534; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Gatta L, 2007, ALIMENT PHARM THER, V25, P385, DOI 10.1111/j.1365-2036.2006.03213.x; Gibson PG, 2014, CURR OPIN ALLERGY CL, V14, P55, DOI 10.1097/ACI.0000000000000027; Gupta R, 2009, CURR OPIN OTOLARYNGO, V17, P143, DOI 10.1097/MOO.0b013e32832b2581; HANSON DG, 1995, ANN OTO RHINOL LARYN, V104, P550, DOI 10.1177/000348949510400709; Hopkins C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005054.pub2; Karkos PD, 2007, EUR ARCH OTO-RHINO-L, V264, P513, DOI 10.1007/s00405-006-0222-8; Karkos PD, 2006, LARYNGOSCOPE, V116, P144, DOI 10.1097/01.mlg.0000191463.67692.36; Khalil H S, 2003, Rev Laryngol Otol Rhinol (Bord), V124, P187; KIBBLEWHITE DJ, 1990, J OTOLARYNGOL, V19, P103; Koufman JA, 2011, ANN OTO RHINOL LARYN, V120, P281, DOI 10.1177/000348941112000501; Lowden M, 2009, LOGOP PHONIATR VOCO, V34, P32, DOI 10.1080/14015430902735847; MacKenzie K, 2001, BRIT MED J, V323, P658, DOI 10.1136/bmj.323.7314.658; Mazzini Gda S, 2012, INT J OTOLARYNGOL, V2012; McGlashan JA, 2009, EUR ARCH OTO-RHINO-L, V266, P243, DOI 10.1007/s00405-008-0708-7; Moore JM, 2010, CURR OPIN GASTROEN, V26, P389, DOI 10.1097/MOG.0b013e32833adc8d; National Institute for Health and Care Excellence, 2011, REF GUID SUSP CANC; Ndukwe N, 2012, INT J HEALTH CARE Q, V25, P75, DOI 10.1108/09526861211192421; Pearson JP, 2011, ALIMENT PHARM THER, V33, P2, DOI 10.1111/j.1365-2036.2011.04581.x; Powell J, 2013, LARYNGOSCOPE, V123, P985, DOI 10.1002/lary.23693; Qadeer MA, 2006, AM J GASTROENTEROL, V101, P2646, DOI 10.1111/j.1572-0241.2006.00844.x; Toohill RJ, 2005, ANN OTO RHINOL LARYN, V114, P177, DOI 10.1177/000348940511400302; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wilhelm SM, 2013, EXPERT REV CLIN PHAR, V6, P443, DOI 10.1586/17512433.2013.811206; Wood JM, 2011, J LARYNGOL OTOL, V125, P1218, DOI 10.1017/S0022215111002234; Yamamichi N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-45; Yuksel ES, 2012, LARYNGOSCOPE, V122, P1312, DOI 10.1002/lary.23252	33	7	8	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2014	349								g5813	10.1136/bmj.g5813	http://dx.doi.org/10.1136/bmj.g5813			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LK	25300569				2022-12-01	WOS:000342998200010
J	Ruan, HB; Dietrich, MO; Liu, ZW; Zimmer, MR; Li, MD; Singh, JP; Zhang, KS; Yin, RN; Wu, J; Horvath, TL; Yang, XY				Ruan, Hai-Bin; Dietrich, Marcelo O.; Liu, Zhong-Wu; Zimmer, Marcelo R.; Li, Min-Dian; Singh, Jay Prakash; Zhang, Kaisi; Yin, Ruonan; Wu, Jing; Horvath, Tamas L.; Yang, Xiaoyong			O-GlcNAc Transferase Enables AgRP Neurons to Suppress Browning of White Fat	CELL			English	Article							AGOUTI-RELATED PROTEIN; NPY/AGRP NEURONS; MELANOCORTIN SYSTEM; N-ACETYLGLUCOSAMINE; ENERGY HOMEOSTASIS; GENETIC-CONTROL; NEUROPEPTIDE-Y; MESSENGER-RNA; ADIPOSE ORGAN; GLUCOSE	Induction of beige cells causes the browning of white fat and improves energy metabolism. However, the central mechanism that controls adipose tissue browning and its physiological relevance are largely unknown. Here, we demonstrate that fasting and chemical-genetic activation of orexigenic AgRP neurons in the hypothalamus suppress the browning of white fat. O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of cytoplasmic and nuclear proteins regulates fundamental cellular processes. The levels of O-GlcNAc transferase (OGT) and O-GlcNAc modification are enriched in AgRP neurons and are elevated by fasting. Genetic ablation of OGT in AgRP neurons inhibits neuronal excitability through the voltage-dependent potassium channel, promotes white adipose tissue browning, and protects mice against diet-induced obesity and insulin resistance. These data reveal adipose tissue browning as a highly dynamic physiological process under central control, in which O-GlcNAc signaling in AgRP neurons is essential for suppressing thermogenesis to conserve energy in response to fasting.	[Ruan, Hai-Bin; Dietrich, Marcelo O.; Liu, Zhong-Wu; Zimmer, Marcelo R.; Li, Min-Dian; Singh, Jay Prakash; Zhang, Kaisi; Yin, Ruonan; Wu, Jing; Horvath, Tamas L.; Yang, Xiaoyong] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Ruan, Hai-Bin; Dietrich, Marcelo O.; Liu, Zhong-Wu; Zimmer, Marcelo R.; Li, Min-Dian; Singh, Jay Prakash; Zhang, Kaisi; Yin, Ruonan; Wu, Jing; Horvath, Tamas L.; Yang, Xiaoyong] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Li, Min-Dian; Zhang, Kaisi; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Zimmer, Marcelo R.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-93042 Porto Alegre, RS, Brazil	Yale University; Yale University; Yale University; Yale University; Yale University; Universidade Federal do Rio Grande do Sul	Horvath, TL (corresponding author), Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu; xiaoyong.yang@yale.edu	Dietrich, Marcelo/A-9928-2009; Li, Min-Dian/F-1721-2015; Zimmer, Marcelo Rigon/ABB-7993-2020; Ruan, Hai-Bin/AAN-7777-2021; Ruan, Hai-Bin/G-9907-2012	Dietrich, Marcelo/0000-0001-9781-2221; Li, Min-Dian/0000-0002-3650-1507; Zimmer, Marcelo Rigon/0000-0001-9628-8915; Ruan, Hai-Bin/0000-0002-3858-1272; Ruan, Hai-Bin/0000-0002-3858-1272	NIH [R01 DK089098, DP1 DK098058]; American Diabetes Association; Ellison Medical Foundation; American Heart Association Scientist Development Grant; ADA Mentor-Based Fellowship; CNPq/Brazil	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association Scientist Development Grant(American Heart Association); ADA Mentor-Based Fellowship; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank Dr. Steven Jones from University of Louisville for providing Ogt-flox mice and Dr. Alison Xu from University of California at San Francisco for donating AgRP-Cre mice. This work was supported by NIH R01 DK089098, American Diabetes Association, and Ellison Medical Foundation to X.Y., American Heart Association Scientist Development Grant to H.-B.R., NIH DP1 DK098058 and ADA Mentor-Based Fellowship to T.L.H., and CNPq/Brazil to M.O.D. and M.R.Z.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; APFELBAUM M, 1971, AM J CLIN NUTR, V24, P1405; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Kajimura S., 2013, ANN REV PHYSL; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Nogueiras R, 2008, REGUL PEPTIDES, V149, P26, DOI 10.1016/j.regpep.2007.09.034; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Ruan HB, 2013, MOL CELL PROTEOMICS, V12, P3489, DOI 10.1074/mcp.R113.029751; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; SHIBATA H, 1987, J APPL PHYSIOL, V63, P465, DOI 10.1152/jappl.1987.63.2.465; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/nmeth.1806, 10.1038/NMETH.1806]; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; WELLE S, 1983, J CLIN INVEST, V71, P916, DOI 10.1172/JCI110846; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Wiedmer P, 2011, PHYSIOL BEHAV, V105, P43, DOI 10.1016/j.physbeh.2011.03.027; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WU J, 2013, CELL, V27, P234; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yasuda T, 2004, EXP BIOL MED, V229, P235, DOI 10.1177/153537020422900303	66	178	178	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					306	317		10.1016/j.cell.2014.09.010	http://dx.doi.org/10.1016/j.cell.2014.09.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303527	Green Accepted, Bronze			2022-12-01	WOS:000343095600013
J	Rodriguez-Manas, L; Fried, LP				Rodriguez-Manas, Leocadio; Fried, Linda P.			Frailty in the clinical scenario	LANCET			English	Editorial Material							WOMENS HEALTH; OLDER-ADULTS; DISABILITY		[Rodriguez-Manas, Leocadio] Univ Europea Madrid, Hosp Univ Getafe, Dept Geriatr, Getafe 28905, Spain; [Rodriguez-Manas, Leocadio] Univ Europea Madrid, Sch Hlth Sci, Getafe 28905, Spain; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Fried, Linda P.] Columbia Univ, Med Ctr, New York, NY USA	European University of Madrid; Hospital Universitario de Getafe; European University of Madrid; Columbia University; Columbia University	Rodriguez-Manas, L (corresponding author), Univ Europea Madrid, Hosp Univ Getafe, Dept Geriatr, Getafe 28905, Spain.	leocadio.rodriguez@salud.madrid.org		Rodriguez-Manas, Leocadio/0000-0002-6551-1333				Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; European Commission, 2012, EUR EC, V2; Ferrucci L, 1996, J CLIN EPIDEMIOL, V49, P1089, DOI 10.1016/0895-4356(96)00231-4; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FRAILOMIC project, EU FP7 HLTH 2012 INN; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2009, HAZZARDS GEIATRIC ME; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Garcia-Garcia FJ, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.01.004; Laosa O, 2014, CURR PHARM DESIGN, V20, P3068, DOI 10.2174/13816128113196660705; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rodriguez-Artalejo F, 2014, J EPIDEMIOL COMMUN H, V68, P703, DOI 10.1136/jech-2014-203863; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Sourial N, 2013, J GERONTOL A-BIOL, V68, P1505, DOI 10.1093/gerona/glt053; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; Xue QL, 2011, ARCH INTERN MED, V171, P1119, DOI 10.1001/archinternmed.2011.252	18	158	163	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					E7	E9		10.1016/S0140-6736(14)61595-6	http://dx.doi.org/10.1016/S0140-6736(14)61595-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25468154				2022-12-01	WOS:000349214000001
J	Pappas, L; Foglierini, M; Piccoli, L; Kallewaard, NL; Turrini, F; Silacci, C; Fernandez-Rodriguez, B; Agatic, G; Giacchetto-Sasselli, I; Pellicciotta, G; Sallusto, F; Zhu, Q; Vicenzi, E; Corti, D; Lanzavecchia, A				Pappas, Leontios; Foglierini, Mathilde; Piccoli, Luca; Kallewaard, Nicole L.; Turrini, Filippo; Silacci, Chiara; Fernandez-Rodriguez, Blanca; Agatic, Gloria; Giacchetto-Sasselli, Isabella; Pellicciotta, Gabriele; Sallusto, Federica; Zhu, Qing; Vicenzi, Elisa; Corti, Davide; Lanzavecchia, Antonio			Rapid development of broadly influenza neutralizing antibodies through redundant mutations	NATURE			English	Article							MEMORY B-CELLS; MONOCLONAL-ANTIBODIES; AFFINITY MATURATION; SEQUENCE-ANALYSIS; GERMINAL-CENTERS; IMMUNE-RESPONSE; VIRUS; GENERATION; HEMAGGLUTININ; EXPRESSION	The neutralizing antibody response to influenza virus is dominated by antibodies that bind to the globular head of haemagglutinin, which undergoes a continuous antigenic drift, necessitating the re-formulation of influenza vaccines on an annual basis. Recently, several laboratories have described a new class of rare influenza-neutralizing antibodies that target a conserved site in the haemagglutinin stem(1-6). Most of these antibodies use the heavy-chain variable region VH1-69 gene, and structural data demonstrate that they bind to the haemagglutinin stem through conserved heavy-chain complementarity determining region(HCDR) residues. However, the VH1-69 antibodies are highly mutated and are produced by some but not all individuals(6,7), suggesting that several somatic mutations may be required for their development(8,9). To address this, here we characterize 197 anti-stem antibodies from a single donor, reconstruct the developmental pathways of several VH1-69 clones and identify two key elements that are required for the initial development of most VH1-69 antibodies: a polymorphic germline-encoded phenylalanine at position 54 and a conserved tyrosine at position 98 in HCDR3. Strikingly, in most cases a single proline to alanine mutation at position 52a in HCDR2 is sufficient to confer high affinity binding to the selecting H1 antigen, consistent with rapid affinity maturation. Surprisingly, additional favourable mutations continue to accumulate, increasing the breadth of reactivity and making both the initial mutations and phenylalanine at position 54 functionally redundant. These results define VH1-69 allele polymorphism, rearrangement of the VDJ gene segments and single somatic mutations as the three requirements for generating broadly neutralizing VH1-69 antibodies and reveal an unexpected redundancy in the affinity maturation process.	[Pappas, Leontios; Foglierini, Mathilde; Piccoli, Luca; Silacci, Chiara; Fernandez-Rodriguez, Blanca; Giacchetto-Sasselli, Isabella; Sallusto, Federica; Corti, Davide; Lanzavecchia, Antonio] Univ Svizzera Italiana, Insitute Res Biomed, CH-6500 Bellinzona, Switzerland; [Kallewaard, Nicole L.; Zhu, Qing] Dis & Vaccines MedImmune LLC, Dept Infect, Gaithersburg, MD 20878 USA; [Vicenzi, Elisa] Ist Sci San Raffaele, Viral Pathogens & Biosafety Unit, I-20132 Milan, Italy; [Agatic, Gloria; Corti, Davide] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Pellicciotta, Gabriele] Ist Sci San Raffaele, Unit Prevent Med, I-20132 Milan, Italy; [Lanzavecchia, Antonio] ETH, Insitute Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; AstraZeneca; Medimmune; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Insitute Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.usi.ch	Turrini, Filippo/I-3677-2018; Vicenzi, Elisa/AAL-3980-2020	Turrini, Filippo/0000-0002-9121-9117; Piccoli, Luca/0000-0002-1085-6502; Vicenzi, Elisa/0000-0003-0051-3968; Foglierini, Mathilde/0000-0001-7538-4262	European Research Council IMMUNExplore [250348]; Swiss National Science Foundation [141254]; Fondazione Cariplo Vaccine Program [2009-3594]; Human Frontiers Science Program [RGP0009/2007-C]; European Commission ADITEC [FP7-HEALTH-2011-280873]; National Institutes of Health [AI-057266]; Helmut Horten Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER	European Research Council IMMUNExplore; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Cariplo Vaccine Program; Human Frontiers Science Program(Human Frontier Science Program); European Commission ADITEC(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmut Horten Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the European Research Council (grant number 250348) IMMUNExplore, the Swiss National Science Foundation (grant number 141254), Fondazione Cariplo Vaccine Program (grant number 2009-3594), the Human Frontiers Science Program (grant number RGP0009/2007-C), the European Commission (grant number FP7-HEALTH-2011-280873) ADITEC and the National Institutes of Health (U19 grant number AI-057266). A.L. is supported by the Helmut Horten Foundation.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Avnir Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004103; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Ghezzi S, 2013, AIDS, V27, P2335, DOI 10.1097/01.aids.0000432474.76873.5f; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hassantoufighi A, 2010, VACCINE, V28, P790, DOI 10.1016/j.vaccine.2009.10.066; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kaji T, 2013, INT IMMUNOL, V25, P683, DOI 10.1093/intimm/dxt030; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Sangster MY, 2013, CLIN VACCINE IMMUNOL, V20, P867, DOI 10.1128/CVI.00735-12; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vencovsky J, 2002, RHEUMATOLOGY, V41, P401, DOI 10.1093/rheumatology/41.4.401; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	39	204	209	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					418	+		10.1038/nature13764	http://dx.doi.org/10.1038/nature13764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25296253				2022-12-01	WOS:000346484800052
J	Wu, F				Wu, Felicia			PERSPECTIVE: Time to face the fungal threat	NATURE			English	Editorial Material							AFLATOXIN; EXPOSURE; INTERVENTIONS; EFFICACY; RISK		Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Wu, F (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.							Chen JG, 2013, CANCER PREV RES, V6, P1038, DOI 10.1158/1940-6207.CAPR-13-0168; Cleveland TE, 2003, PEST MANAG SCI, V59, P629, DOI 10.1002/ps.724; Egner PA, 2003, MUTAT RES-FUND MOL M, V523, P209, DOI 10.1016/S0027-5107(02)00337-8; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; Khlangwiset P, 2010, FOOD ADDIT CONTAM A, V27, P998, DOI 10.1080/19440041003677475; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Mitchell NJ, 2014, AM J TROP MED HYG, V91, P777, DOI 10.4269/ajtmh.14-0093; Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5; Wu F, 2014, TOXICOL SCI, V141, P329, DOI 10.1093/toxsci/kfu137	10	31	34	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S7	S7		10.1038/516S7a	http://dx.doi.org/10.1038/516S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470199	Bronze			2022-12-01	WOS:000346310800002
J	Steinberg, BE; Tracey, KJ; Slutsky, AS				Steinberg, Benjamin E.; Tracey, Kevin J.; Slutsky, Arthur S.			Bacteria and the Neural Code	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SENSORY NEURONS		[Steinberg, Benjamin E.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Slutsky, Arthur S.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Northwell Health	Steinberg, BE (corresponding author), Univ Toronto, Dept Anesthesia, Toronto, ON, Canada.		Slutsky, Arthur/M-3325-2019	Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM057226] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R	5	9	11	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2131	2133		10.1056/NEJMcibr1412003	http://dx.doi.org/10.1056/NEJMcibr1412003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427116				2022-12-01	WOS:000345580000017
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			STATISTICS NOTES Uncertainty beyond sampling error	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANCER; BIAS		[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	doug.altman@csm.ox.ac.uk			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Altman DG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7064; Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JP, 2011, LANCET, V343, pd5928; Kaplan RM, 2014, CTS-CLIN TRANSL SCI, V7, P342, DOI 10.1111/cts.12178; Lange T, 2014, INT J EPIDEMIOL, V43, P971, DOI 10.1093/ije/dyu100; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177	7	5	5	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2014	349								g7065	10.1136/bmj.g7065	http://dx.doi.org/10.1136/bmj.g7065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KE	25424583	Green Published, Bronze			2022-12-01	WOS:000346115600011
J	Tuitama, LT; Young-soo, S; Clark, H; Tukuitonga, C; Beaglehole, R				Tuitama, Leao Talalelei; Young-soo, Shin; Clark, Helen; Tukuitonga, Colin; Beaglehole, Robert			Acting on the Pacific crisis in non-communicable diseases	LANCET			English	Editorial Material									[Tuitama, Leao Talalelei] Govt Samoa, Minist Hlth, Apia, Samoa; [Young-soo, Shin] WHO Reg Off Western Pacific, Manila, Philippines; [Clark, Helen] United Nations Dev Programme, New York, NY USA; [Tukuitonga, Colin] Secretariat Pacific Community, Noumea, New Caledonia; [Beaglehole, Robert] Univ Auckland, Auckland 1010, New Zealand	WHO Western Pacific Regional Office; World Health Organization; University of Auckland	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1010, New Zealand.	r.beaglehole@auckland.ac.nz			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Anderson I., 2013, EC COSTS NONCOMMUNIC; MANA Pacific, 2014, PAC HLTH MIN M HON J; Pacific Islands Forum Secretariat, 2014, HLTH MIN WANT TOB FR; Secretariat of the Pacifi c Community, 2011, PAC NCD CRIS; Taylor R, 2013, AUST NZ J PUBL HEAL, V37, P509, DOI 10.1111/1753-6405.12116; UNDP, 2013, TRAD TRAD AGR NONC D; World Bank, 2014, NONC DIS NCD ROADM R; World Health Organization, 2010, GLOBAL STATUS REPORT	8	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1823	+		10.1016/S0140-6736(14)61824-9	http://dx.doi.org/10.1016/S0140-6736(14)61824-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25457906				2022-12-01	WOS:000345116800004
J	Pandey, A; Atkins, KE; Medlock, J; Wenzel, N; Townsend, JP; Childs, JE; Nyenswah, TG; Ndeffo-Mbah, ML; Galvani, AP				Pandey, Abhishek; Atkins, Katherine E.; Medlock, Jan; Wenzel, Natasha; Townsend, Jeffrey P.; Childs, James E.; Nyenswah, Tolbert G.; Ndeffo-Mbah, Martial L.; Galvani, Alison P.			Strategies for containing Ebola in West Africa	SCIENCE			English	Article							REPRODUCTIVE NUMBER; HEMORRHAGIC-FEVER; VIRUS; CONGO; DYNAMICS; KIKWIT	The ongoing Ebola outbreak poses an alarming risk to the countries of West Africa and beyond. To assess the effectiveness of containment strategies, we developed a stochastic model of Ebola transmission between and within the general community, hospitals, and funerals, calibrated to incidence data from Liberia. We find that a combined approach of case isolation, contact-tracing with quarantine, and sanitary funeral practices must be implemented with utmost urgency in order to reverse the growth of the outbreak. As of 19 September, under status quo, our model predicts that the epidemic will continue to spread, generating a predicted 224 (134 to 358) daily cases by 1 December, 280 (184 to 441) by 15 December, and 348 (249 to 545) by 30 December.	[Pandey, Abhishek; Atkins, Katherine E.; Wenzel, Natasha; Ndeffo-Mbah, Martial L.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA; [Atkins, Katherine E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Medlock, Jan] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Townsend, Jeffrey P.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Childs, James E.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Nyenswah, Tolbert G.] Minist Hlth & Social Welf, Monrovia, Liberia	Yale University; University of London; London School of Hygiene & Tropical Medicine; Oregon State University; Yale University; Yale University	Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.	alison.galvani@yale.edu	Townsend, Jeffrey/H-2747-2019; Pandey, Abhishek/K-2865-2019	Townsend, Jeffrey/0000-0002-9890-3907; Pandey, Abhishek/0000-0003-4578-7487; Ndeffo Mbah, Martial/0000-0003-4158-7613	National Institutes of Health [NIH 2 U01 GM087719, 5 U01 GM105627]; Notsew Orm Sands Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notsew Orm Sands Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by the National Institutes of Health (NIH 2 U01 GM087719 and 5 U01 GM105627) and the Notsew Orm Sands Foundation. The data reported in this paper are tabulated in the supplementary materials. We thank S. G. Gaffney, A. Hofmann, and M. Traina for helpful feedback on the manuscript. All model code and data are available via https://github.com/abhiganit/EbolaCodes/tree/master/Science_Code.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; ANDERSON R M, 1991; [Anonymous], 2014, MIN FOR AFF REP LIB; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Fisman D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114548, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]; Galvani AP, 2014, ANN INTERN MED, V161, P749, DOI 10.7326/M14-1904; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Heymann D., 2008, CONTR COMM DIS MAN, P204; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Liberia Institute of Statistics and Geo-Information Services, 2008, 2008 NAT POP HOUS CE; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Ministry of Health & Social Welfare, 2014, 149 MIN HLTH SOC WEL; Ministry of Health & Social Welfare, 2014, 135 MIN HLTH SOC WEL; Ministry of Health & Social Welfare, 2014, 136 MIN HLTH SOC WEL; Ministry of Health & Social Welfare, 2014, 10130 MIN HLTH SOC W; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286; The Bureau of Public Affairs, 2014, MIN FOR AFF REP LIB; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2014, WHY EB OUTBR HAS BEE; World Health Organization, 2014, WHO STAT M INT HLTH	30	183	186	1	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					991	995		10.1126/science.1260612	http://dx.doi.org/10.1126/science.1260612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414312	Green Accepted			2022-12-01	WOS:000345696000043
J	Wall, HK; Hannan, JA; Wright, JS				Wall, Hilary K.; Hannan, Judy A.; Wright, Janet S.			Patients With Undiagnosed Hypertension Hiding in Plain Sight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wall, Hilary K.; Hannan, Judy A.; Wright, Janet S.] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Wall, HK (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy NE,MS F72, Atlanta, GA 30341 USA.	hwall@cdc.gov		Wall, Hilary/0000-0001-6088-0706; Mihailidis, Alex/0000-0003-2233-0919	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Banerjee D, 2012, AM J HYPERTENS, V25, P97, DOI 10.1038/ajh.2011.179; Baus Adam, 2012, Perspect Health Inf Manag, V9, p1e; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Nwankwo T, 2011, HYPERTENSION ADULTS; Rakotz MK, 2014, ANN FAM MED, V12, P352, DOI 10.1370/afm.1665; Shah NR, 2009, AHRQ COMP EFF RES ME; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981	10	56	56	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					1973	1974		10.1001/jama.2014.15388	http://dx.doi.org/10.1001/jama.2014.15388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399269	Green Accepted			2022-12-01	WOS:000345450500008
J	Honigsbaum, M				Honigsbaum, Mark			The art of medicine Ebola: epidemic echoes and the chronicle of a tragedy foretold	LANCET			English	Editorial Material									Queen Mary Univ London, London, England	University of London; Queen Mary University London	Honigsbaum, M (corresponding author), Queen Mary Univ London, London, England.	mark.honigsbaum@qmul.ac.uk		honigsbaum, mark/0000-0002-1891-8763	Wellcome Trust [103159] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1740	1741		10.1016/S0140-6736(14)62063-8	http://dx.doi.org/10.1016/S0140-6736(14)62063-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25473684	Bronze, Green Published			2022-12-01	WOS:000345116400014
J	Barbier, EB				Barbier, Edward B.			Account for depreciation of natural capital	NATURE			English	Editorial Material									Univ Wyoming, Laramie, WY 82071 USA	University of Wyoming	Barbier, EB (corresponding author), Univ Wyoming, Laramie, WY 82071 USA.	ebarbier@uwyo.edu						[Anonymous], 2013, CAPITAL 21 CENTURY; Barbier EB, 2013, RESOURCES-BASEL, V2, P213, DOI 10.3390/resources2030213; Barbier EB, 2013, ENVIRON DEV ECON, V18, P133, DOI 10.1017/S1355770X12000551; UNU-IHDP and UNEP, 2012, INCL WEALTH REP 2012	4	30	31	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					32	33		10.1038/515032a	http://dx.doi.org/10.1038/515032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS3OE	25373661	Bronze			2022-12-01	WOS:000344187500015
J	Kennedy, BK; Berger, SL; Brunet, A; Campisi, J; Cuervo, AM; Epel, ES; Franceschi, C; Lithgow, GJ; Morimoto, RI; Pessin, JE; Rando, TA; Richardson, A; Schadt, EE; Wyss-Coray, T; Sierra, F				Kennedy, Brian K.; Berger, Shelley L.; Brunet, Anne; Campisi, Judith; Cuervo, Ana Maria; Epel, Elissa S.; Franceschi, Claudio; Lithgow, Gordon J.; Morimoto, Richard I.; Pessin, Jeffrey E.; Rando, Thomas A.; Richardson, Arlan; Schadt, Eric E.; Wyss-Coray, Tony; Sierra, Felipe			Geroscience: Linking Aging to Chronic Disease	CELL			English	Editorial Material							LIFE-SPAN; LONGEVITY; CELLS	Mammalian aging can be delayed with genetic, dietary, and pharmacologic approaches. Given that the elderly population is dramatically increasing and that aging is the greatest risk factor for a majority of chronic diseases driving both morbidity and mortality, it is critical to expand geroscience research directed at extending human healthspan.	[Kennedy, Brian K.; Campisi, Judith; Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Program, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Biol, Philadelphia, PA 19104 USA; [Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Brunet, Anne; Rando, Thomas A.] Stanford Univ, Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Epel, Elissa S.] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Franceschi, Claudio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy; [Franceschi, Claudio] Univ Bologna, CIG, Interdept Ctr L Galvani Integrated Studies Bioinf, Bologna 3, Italy; [Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, DIMES, Bologna 3, Italy; [Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA; [Rando, Thomas A.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.; Wyss-Coray, Tony] Vet Adm Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA; [Richardson, Arlan] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA; [Schadt, Eric E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schadt, Eric E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Sierra, Felipe] NIA, Div Aging Biol, Bethesda, MD 20892 USA	Buck Institute for Research on Aging; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; Northwestern University; Yeshiva University; Albert Einstein College of Medicine; Stanford University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kennedy, BK (corresponding author), Buck Inst Res Aging, Novato, CA USA.	bkennedy@buckinstitute.org	Franceschi, Claudio/L-4484-2017; Wyss-Coray, Tony/AAF-3380-2019	Franceschi, Claudio/0000-0001-9841-6386; Wyss-Coray, Tony/0000-0001-5893-0831; Berger, Shelley/0000-0001-5398-4400; Cuervo, Ana Maria/0000-0002-0771-700X; Rando, Thomas/0000-0001-5843-8564; Kennedy, Brian/0000-0002-5754-1874	NATIONAL INSTITUTE ON AGING [P01AG036695, R01AG033373, R01AG043080, R01AG024287, P01AG031782] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Deelen J, 2013, BIOESSAYS, V35, P386, DOI 10.1002/bies.201200148; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Pawelec G, 2012, CURR OPIN IMMUNOL, V24, P507, DOI 10.1016/j.coi.2012.04.002; Rando TA, 2014, J GERONTOL A-BIOL, V69, pS39, DOI 10.1093/gerona/glu043; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675	14	1027	1044	5	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					708	712		10.1016/j.cell.2014.10.039	http://dx.doi.org/10.1016/j.cell.2014.10.039			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417146	Green Accepted, Bronze			2022-12-01	WOS:000344522000002
J	Wong, M; Munro, S				Wong, Mie; Munro, Sean			The specificity of vesicle traffic to the Golgi is encoded in the golgin coiled-coil proteins	SCIENCE			English	Article							MATRIX PROTEIN; MEMBRANE-PROTEIN; COMPLEXES; SIGNALS; LACKING; SNARES; GCC185; DOMAIN; GM130; ER	The Golgi apparatus is a multicompartment central sorting station at the intersection of secretory and endocytic vesicular traffic. The mechanisms that permit cargo-loaded transport vesicles from different origins to selectively access different Golgi compartments are incompletely understood. We developed a rerouting and capture assay to investigate systematically the vesicle-tethering activities of 10 widely conserved golgin coiled-coil proteins. We find that subsets of golgins with distinct localizations on the Golgi surface have capture activities toward vesicles of different origins. These findings demonstrate that golgins act as tethers in vivo, and hence the specificity we find to be encoded in this tethering is likely to make a major contribution to the organization of membrane traffic at the Golgi apparatus.	[Wong, Mie; Munro, Sean] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Munro, S (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	sean@mrc-lmb.cam.ac.uk		Wong, Mie/0000-0001-8664-6651; Munro, Sean/0000-0001-6160-5773	UK Medical Research Council (MRC) [U105178783]; MRC [MC_U105178783] Funding Source: UKRI; Medical Research Council [MC_U105178783] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Akhmanova, F. Barr, H. Clausen, P. Gleeson, A. Linstedt, M. Lowe, U. Mandel, M. Robinson, and M. Seaman for generous provision of reagents; G. Howard for help with electron microscopy; and A. Gillingham, R. Hegde, B. Nichols, and K. Roper for comments on the manuscript. Supported by the UK Medical Research Council (MRC file reference no. U105178783). The data are presented in the main manuscript and the supplementary materials.	Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Elkis Y, 2013, MOL CELL ENDOCRINOL, V365, P52, DOI 10.1016/j.mce.2012.09.003; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; MITOMA J, 1992, J BIOCHEM-TOKYO, V111, P20, DOI 10.1093/oxfordjournals.jbchem.a123712; Munro S., 2011, COLD SPRING HARB PER, V3, DOI [10.1101/cshperspect.a005256, DOI 10.1101/CSHPERSPECT.A005256]; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; PONNAMBALAM S, 1994, J CELL BIOL, V125, P253, DOI 10.1083/jcb.125.2.253; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Whyte JRC, 2002, J CELL SCI, V115, P2627; Willett R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2535; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	41	172	173	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		601	+	1256898	10.1126/science.1256898	http://dx.doi.org/10.1126/science.1256898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359980	Green Accepted			2022-12-01	WOS:000343799700040
J	Orenstein, W; Seib, K				Orenstein, Walter; Seib, Katherine			Mounting a Good Offense against Measles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								More measles cases have been reported in the United States so far in 2014 - 592 cases from January 1 to August 29 - than during any year in the past two decades (see graph) (www.cdc.gov/measles/	[Orenstein, Walter; Seib, Katherine] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University	Orenstein, W (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.							[Anonymous], 2014, Public Health Rep, V129 Suppl 3, P12; [Anonymous], 2012, VACCINES; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Orenstein WA, 2006, PEDIATR INFECT DIS J, V25, P1093, DOI 10.1097/01.inf.0000246840.13477.28; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P103	5	31	31	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1661	1663		10.1056/NEJMp1408696	http://dx.doi.org/10.1056/NEJMp1408696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354100	Bronze			2022-12-01	WOS:000343768500001
J	Sohn, E				Sohn, Emily			The toxic side of rice	NATURE			English	Editorial Material																		Castrillo G, 2013, PLANT CELL, V25, P2944, DOI 10.1105/tpc.113.114009; Lorenz A.J., 2009, CROP SCI; Meharg AA, 2009, ENVIRON SCI TECHNOL, V43, P1612, DOI 10.1021/es802612a; Meng XY, 2011, NEW PHYTOL, V191, P49, DOI 10.1111/j.1469-8137.2011.03743.x; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Zhu YG, 2014, ANNU REV EARTH PL SC, V42, P443, DOI 10.1146/annurev-earth-060313-054942	6	65	68	7	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S62	S63		10.1038/514S62a	http://dx.doi.org/10.1038/514S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368891	Bronze			2022-12-01	WOS:000343801500007
J	Tanaka, J; Yano, K; Aya, K; Hirano, K; Takehara, S; Koketsu, E; Ordonio, RL; Park, SH; Nakajima, M; Ueguchi-Tanaka, M; Matsuoka, M				Tanaka, Junmu; Yano, Kenji; Aya, Koichiro; Hirano, Ko; Takehara, Sayaka; Koketsu, Eriko; Ordonio, Reynante Lacsamana; Park, Seung-Hyun; Nakajima, Masatoshi; Ueguchi-Tanaka, Miyako; Matsuoka, Makoto			Antheridiogen determines sex in ferns via a spatiotemporally split gibberellin synthesis pathway	SCIENCE			English	Article							LYGODIUM-JAPONICUM; IDENTIFICATION; RECEPTORS; SYSTEM	Some ferns possess the ability to control their sex ratio to maintain genetic variation in their colony with the aid of antheridiogen pheromones, antheridium (male organ)-inducing compounds that are related to gibberellin. We determined that ferns have evolved an antheridiogen-mediated communication system to produce males by modifying the gibberellin biosynthetic pathway, which is split between two individuals of different developmental stages in the colony. Antheridiogen acts as a bridge between them because it is more readily taken up by prothalli than bioactive gibberellin. The pathway initiates in early-maturing prothalli (gametophytes) within a colony, which produce antheridiogens and secrete them into the environment. After the secreted antheridiogen is absorbed by neighboring late-maturing prothalli, it is modified in to bioactive gibberellin to trigger male organ formation.	[Tanaka, Junmu; Yano, Kenji; Aya, Koichiro; Hirano, Ko; Takehara, Sayaka; Koketsu, Eriko; Ordonio, Reynante Lacsamana; Ueguchi-Tanaka, Miyako; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Park, Seung-Hyun; Nakajima, Masatoshi] Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan	Nagoya University; University of Tokyo	Ueguchi-Tanaka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	mueguchi@nuagr1.agr.nagoya-u.ac.jp; makoto@nuagr1.agr.nagoya-u.ac.jp		Yano, Kenji/0000-0002-2428-9748	JSPS through the Funding Program for Next Generation World-Leading Researchers;  [23113005]	JSPS through the Funding Program for Next Generation World-Leading Researchers; 	We thank M. Kawamura and W. Takase (Nagoya University) for technical assistance and H. Yamane (Teikyo University), M. Hasebe (National Institute for Basic Biology), S. Ooe (Osaka Prefectural Education Center), and T. Yoshimura (Kumiai Chemical Industry Co., Ltd.) for helpful discussions. Supported by Grant-in-Aid for Scientific Research on Innovative Areas no. 23113005 (M.M. and M.N.) and by JSPS through the Funding Program for Next Generation World-Leading Researchers (M.U.-T.). Additional data are in the supplement. DNA Data Bank of Japan (DDBJ) accession numbers: Lj_CPS/KS, AB915786; Lj_KO, AB915787; Lj_KAO, AB915788; Lj_GA20ox, AB915789; Lj_GA3ox1, AB915790; Lj_GA3ox2, AB915791; Lj_GID1-1, AB915792; Lj_GID1-2, AB915793; Lj_GID1-3, AB915794; Lj_DELLA1, AB915795; Lj_DELLA2, AB915796; Lj_GID2, AB915797.	Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Hanson L, 2002, BOT J LINN SOC, V140, P169, DOI 10.1046/j.1095-8339.2002.00083.x; Hedden P, 2008, NATURE, V456, P455, DOI 10.1038/456455a; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; IZUMI K, 1985, PLANT CELL PHYSIOL, V26, P821; Manton I., 1965, NEW PHYTOL, V64, P286; Naf U, 1979, EXPT BIOL FERNS, P436; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; NAKAYAMA I, 1990, PLANT CELL PHYSIOL, V31, P1183; Schneller JJ, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P134, DOI 10.1017/CBO9780511541827.006; TAKENO K, 1980, BOT MAG TOKYO, V93, P67, DOI 10.1007/BF02489487; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Voeller B. R., 1969, CURRENT TOPICS PLANT, P77; Williams J, 1998, PLANT PHYSIOL, V117, P559, DOI 10.1104/pp.117.2.559; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamamoto Y, 2010, PLANT CELL, V22, P3589, DOI 10.1105/tpc.110.074542; Yamane H, 1998, INT REV CYTOL, V184, P1, DOI 10.1016/S0074-7696(08)62177-4; YAMANE H, 1979, PLANTA, V147, P251, DOI 10.1007/BF00388747; Yoon JM, 2013, BIOORG MED CHEM LETT, V23, P1096, DOI 10.1016/j.bmcl.2012.12.007	20	47	53	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2014	346	6208					469	473		10.1126/science.1259923	http://dx.doi.org/10.1126/science.1259923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8KB	25342803				2022-12-01	WOS:000343822900043
J	Acton, SE; Farrugia, AJ; Astarita, JL; Mourao-Sa, D; Jenkins, RP; Nye, E; Hooper, S; van Blijswijk, J; Rogers, NC; Snelgrove, KJ; Rosewell, I; Moita, LF; Stamp, G; Turley, SJ; Sahai, E; Sousa, CRE				Acton, Sophie E.; Farrugia, Aaron J.; Astarita, Jillian L.; Mourao-Sa, Diego; Jenkins, Robert P.; Nye, Emma; Hooper, Steven; van Blijswijk, Janneke; Rogers, Neil C.; Snelgrove, Kathryn J.; Rosewell, Ian; Moita, Luis F.; Stamp, Gordon; Turley, Shannon J.; Sahai, Erik; Reis e Sousa, Caetano			Dendritic cells control fibroblastic reticular network tension and lymph node expansion	NATURE			English	Article							T-CELLS; IN-VIVO; B-CELLS; ACTIVATION; INVASION; RHO; MIGRATION; PROTEINS; MOTILITY; CLEC-2	After immunogenic challenge, infiltrating and dividing lymphocytes markedly increase lymph node cellularity, leading to organ expansion(1,2). Here we report that the physical elasticity of lymph nodes is maintained in part by podoplanin (PDPN) signalling in stromal fibroblastic reticular cells (FRCs) and its modulation by CLEC-2 expressed on dendritic cells. We show in mouse cells that PDPN induces actomyosin contractility in FRCs via activation of RhoA/C and downstream Rho-associated protein kinase (ROCK). Engagement by CLEC-2 causes PDPN clustering and rapidly uncouples PDPN from RhoA/C activation, relaxing the actomyosin cytoskeleton and permitting FRC stretching. Notably, administration of CLEC-2 protein to immunized mice augments lymph node expansion. In contrast, lymph node expansion is significantly constrained in mice selectively lacking CLEC-2 expression in dendritic cells. Thus, the same dendritic cells that initiate immunity by presenting antigens to T lymphocytes(3) also initiate remodelling of lymph nodes by delivering CLEC-2 to FRCs. CLEC-2 modulation of PDPN signalling permits FRC network stretching and allows for the rapid lymph node expansion-driven by lymphocyte influx and proliferation-that is the critical hallmark of adaptive immunity.	[Acton, Sophie E.; Farrugia, Aaron J.; Mourao-Sa, Diego; van Blijswijk, Janneke; Rogers, Neil C.; Snelgrove, Kathryn J.; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Immunobiol Lab, London WC2A 3LY, England; [Acton, Sophie E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Farrugia, Aaron J.; Jenkins, Robert P.; Hooper, Steven; Sahai, Erik] Canc Res UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3LY, England; [Astarita, Jillian L.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Nye, Emma; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, Transgen Lab, Potters Bar EN6 3LD, Herts, England; [Moita, Luis F.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Moita, Luis F.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal; [Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Cancer Research UK; University of London; University College London; Cancer Research UK; Harvard University; Dana-Farber Cancer Institute; Cancer Research UK; Cancer Research UK; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Roche Holding; Genentech	Acton, SE (corresponding author), Canc Res UK London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	sophie.acton@cancer.org.uk; caetano@cancer.org.uk	Reis e Sousa, Caetano/O-1657-2014; Acton, Sophie/G-9784-2012; Reis e Sousa, Caetano/ABD-7322-2021; Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013	Reis e Sousa, Caetano/0000-0001-7392-2119; Acton, Sophie/0000-0003-2704-716X; Reis e Sousa, Caetano/0000-0001-7392-2119; Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Rogers, Neil/0000-0001-8977-7585; Farrugia, Aaron J/0000-0003-0448-5896; Sahai, Erik/0000-0002-3932-5086; Mourao, Diego/0000-0001-6618-6969	Henry Wellcome Postdoctoral fellowship; Cancer Research UK; Cancer Research UK [15154, 15689] Funding Source: researchfish	Henry Wellcome Postdoctoral fellowship; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank B. Reizis for CD11c-Cre mice, the LRI Biological Resources staff for animal care and assistance with experiments and R. Horton-Harpin for production of CLEC-2-Fc. We are grateful to M. Y. Gerner and R. N. Germain for critical reading of the manuscript and to all the members of the Immunobiology Laboratory and Tumour Cell Biology Laboratory for helpful discussions and comments. This work was supported by a Henry Wellcome Postdoctoral fellowship (S.E.A.) and core funding from Cancer Research UK (I.R., G.S., E.S. and C.R.S.).	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Fernandez Munoz B., 2011, INT J BIOCHEM CELL B, V43, P886; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	28	177	187	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					498	+		10.1038/nature13814	http://dx.doi.org/10.1038/nature13814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25341788	Green Submitted, Green Accepted			2022-12-01	WOS:000343775900042
J	Okabe, K; Kobayashi, S; Yamada, T; Kurihara, T; Tai-Nagara, I; Miyamoto, T; Mukouyama, YS; Sato, TN; Suda, T; Ema, M; Kubota, Y				Okabe, Keisuke; Kobayashi, Sakiko; Yamada, Toru; Kurihara, Toshihide; Tai-Nagara, Ikue; Miyamoto, Takeshi; Mukouyama, Yoh-suke; Sato, Thomas N.; Suda, Toshio; Ema, Masatsugu; Kubota, Yoshiaki			Neurons Limit Angiogenesis by Titrating VEGF in Retina	CELL			English	Article							BAC TG MICE; PROGENITOR CELLS; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; GROWTH; MOUSE; MORPHOGENESIS; RECEPTOR; EXPRESSION; SURVIVAL	Vascular and nervous systems, two major networks in mammalian bodies, show a high degree of anatomical parallelism and functional crosstalk. During development, neurons guide and attract blood vessels, and consequently this parallelism is established. Here, we identified a noncanonical neurovascular interaction in eye development and disease. VEGFR2, a critical endothelial receptor for VEGF, was more abundantly expressed in retinal neurons than in endothelial cells, including endothelial tip cells. Genetic deletion of VEGFR2 in neurons caused misdirected angiogenesis toward neurons, resulting in abnormally increased vascular density around neurons. Further genetic experiments revealed that this misdirected angiogenesis was attributable to an excessive amount of VEGF protein around neurons caused by insufficient engulfment of VEGF by VEGFR2-deficient neurons. Moreover, absence of neuronal VEGFR2 caused misdirected regenerative angiogenesis in ischemic retinopathy. Thus, this study revealed neurovascular crosstalk and unprecedented cellular regulation of VEGF: retinal neurons titrate VEGF to limit neuronal vascularization.	[Okabe, Keisuke; Kobayashi, Sakiko; Yamada, Toru; Tai-Nagara, Ikue; Kubota, Yoshiaki] Keio Univ, Sch Med, Lab Vasc Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Okabe, Keisuke] Keio Univ, Sch Med, Dept Plast Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Yamada, Toru] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kurihara, Toshihide] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan; [Kurihara, Toshihide] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab,Shinjuku Ku, Tokyo 1608582, Japan; [Mukouyama, Yoh-suke] NHLBI, Lab Stem Cell & Neurovasc Biol, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Sato, Thomas N.] Japan Sci & Technol Agcy, ERATO Sato Live Bioforecasting Project, Kyoto 6190288, Japan; [Sato, Thomas N.] Adv Telecommun Res Inst Int, Kyoto 6190288, Japan; [Sato, Thomas N.] Dept Biomed Engn, Ithaca, NY 14850 USA; [Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Sato, Thomas N.] Centenary Inst, Sydney, NSW 2050, Australia; [Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 5202192, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Keio University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Japan Science & Technology Agency (JST); Advanced Telecommunications Research Institute International; Nara Institute of Science & Technology; University of Sydney; Centenary Institute; Shiga University of Medical Science	Kubota, Y (corresponding author), Keio Univ, Sch Med, Lab Vasc Biol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ykubo33@a3.keio.jp	Suda, Toshio/H-6761-2013; Kurihara, Toshihide/ABA-7058-2020	Suda, Toshio/0000-0001-7540-1771; Kurihara, Toshihide/0000-0002-5457-2720; Mukouyama, Yoh-suke/0000-0002-9084-4922; Ema, Masatsugu/0000-0003-0645-6183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Kanae Foundation; Mochida Memorial Foundation; SENSHIN Medical Research Foundation; Daiichi Sankyo Foundation of Life Science; Naito Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006115] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26221309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation; Mochida Memorial Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Daiichi Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Toshihiro Nagai and Naoko Numata (Keio University) for their technical supports, and Institute of Immunology (Utsunomiya, Japan) for helping us generate some of the mutant mice. This work was supported by Grants-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a research grant from Takeda Science Foundation, The Kanae Foundation, The Mochida Memorial Foundation, SENSHIN Medical Research Foundation, Daiichi Sankyo Foundation of Life Science, and The Naito Foundation.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Erskine L, 2011, NEURON, V70, P951, DOI 10.1016/j.neuron.2011.02.052; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Ishitobi H, 2011, DEVELOPMENT, V138, P5357, DOI 10.1242/dev.065565; Ishitobi H, 2010, EXP ANIM TOKYO, V59, P615, DOI 10.1538/expanim.59.615; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubota Y, 2011, J EXP MED, V208, P949, DOI 10.1084/jem.20102187; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Matsumoto K, 2012, GENESIS, V50, P561, DOI 10.1002/dvg.22031; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Ryan HE, 2000, CANCER RES, V60, P4010; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Yang XJ, 1996, J NEUROSCI, V16, P6089; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	50	172	174	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					584	596		10.1016/j.cell.2014.09.025	http://dx.doi.org/10.1016/j.cell.2014.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417109	Bronze			2022-12-01	WOS:000344521700014
J	McCarthy, M				McCarthy, Michael			US revamps domestic Ebola response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mxmc@mac.com						McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6418; US Centers for Disease Control and Prevention, EBOLA EBOLA VIRUS DI	2	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2014	349								g6417	10.1136/bmj.g6417	http://dx.doi.org/10.1136/bmj.g6417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OE	25338759	Green Published, Bronze			2022-12-01	WOS:000343768300007
J	Nguyen, PA; Groen, AC; Loose, M; Ishihara, K; Wuhr, M; Field, CM; Mitchison, TJ				Nguyen, Phuong A.; Groen, Aaron C.; Loose, Martin; Ishihara, Keisuke; Wuehr, Martin; Field, Christine M.; Mitchison, Timothy J.			Spatial organization of cytokinesis signaling reconstituted in a cell-free system	SCIENCE			English	Article							SPINDLE; SPECIFICATION; MICROTUBULES; EMBRYOS; ACTIN	During animal cell division, the cleavage furrow is positioned by microtubules that signal to the actin cortex at the cell midplane. We developed a cell-free system to recapitulate cytokinesis signaling using cytoplasmic extract from Xenopus eggs. Microtubules grew out as asters from artificial centrosomes and met to organize antiparallel overlap zones. These zones blocked the interpenetration of neighboring asters and recruited cytokinesis midzone proteins, including the chromosomal passenger complex (CPC) and centralspindlin. The CPC was transported to overlap zones, which required two motor proteins, Kif4A and a Kif20A paralog. Using supported lipid bilayers to mimic the plasma membrane, we observed the recruitment of cleavage furrow markers, including an active RhoA reporter, at microtubule overlaps. This system opens further approaches to understanding the biophysics of cytokinesis signaling.	[Nguyen, Phuong A.; Groen, Aaron C.; Loose, Martin; Ishihara, Keisuke; Wuehr, Martin; Field, Christine M.; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Nguyen, Phuong A.; Groen, Aaron C.; Ishihara, Keisuke; Field, Christine M.; Mitchison, Timothy J.] Marine Biol Lab, Woods Hole, MA 02543 USA	Harvard University; Harvard Medical School; Marine Biological Laboratory - Woods Hole	Field, CM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Christine_Field@hms.harvard.edu	Wühr, Martin/A-2447-2009; Ishihara, Keisuke/I-5656-2019	Wühr, Martin/0000-0002-0244-8947; Ishihara, Keisuke/0000-0002-8481-8680; Loose, Martin/0000-0001-7309-9724	NIH [GM39565, GM103785]; Evans Foundation; MBL Associates; Colwin Fund; HFSP fellowship [LT000466/2012-L]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039565, R01GM103785, R37GM039565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evans Foundation; MBL Associates; Colwin Fund; HFSP fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Ohi, D. Burgess, D. Miyamoto, and E. Tan for reagents; H. Basu for preliminary work; the Nikon Imaging Center at Harvard Medical School and Nikon at the Woods Hole Marine Biological Laboratory (MBL) for microscopy support; and the National Xenopus Resource at MBL for Xenopus animals and care. This work was supported by NIH grant GM39565 (T.J.M.); MBL fellowships from the Evans Foundation, MBL Associates, and the Colwin Fund (T.J.M. and C. M. F.); HFSP fellowship LT000466/2012-L (M. L.); and NIH grant GM103785 (M.W.).	Argiros H, 2012, CYTOSKELETON, V69, P840, DOI 10.1002/cm.21061; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Danilchik MV, 2006, DEVELOPMENT, V133, P4517, DOI 10.1242/dev.02642; Field CM, 2014, METHOD ENZYMOL, V540, P399, DOI 10.1016/B978-0-12-397924-7.00022-4; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mitchison TJ, 2013, MOL BIOL CELL, V24, P1559, DOI 10.1091/mbc.E12-12-0850; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	20	83	83	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2014	346	6206					244	247		10.1126/science.1256773	http://dx.doi.org/10.1126/science.1256773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3VL	25301629	Green Accepted			2022-12-01	WOS:000342721500050
J	Meisel, JD; Panda, O; Mahanti, P; Schroeder, FC; Kim, DH				Meisel, Joshua D.; Panda, Oishika; Mahanti, Parag; Schroeder, Frank C.; Kim, Dennis H.			Chemosensation of Bacterial Secondary Metabolites Modulates Neuroendocrine Signaling and Behavior of C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; TGF-BETA; LARVAL DEVELOPMENT; G-PROTEINS; GENE; EXPRESSION; RECEPTOR; NEURONS; PATHWAY; AVOIDANCE	Discrimination between pathogenic and beneficial microbes is essential for host organism immunity and homeostasis. Here, we show that chemosensory detection of two secondary metabolites produced by Pseudomonas aeruginosa modulates a neuroendocrine signaling pathway that promotes avoidance behavior in the simple animal host Caenorhabditis elegans. Secondary metabolites phenazine-1-carboxamide and pyochelin activate a G-protein-signaling pathway in the ASJ chemosensory neuron pair that induces expression of the neuromodulator DAF-7/TGF-beta. DAF-7, in turn, activates a canonical TGF-beta signaling pathway in adjacent interneurons to modulate aerotaxis behavior and promote avoidance of pathogenic P. aeruginosa. Our data provide a chemical, genetic, and neuronal basis for how the behavior and physiology of a simple animal host can be modified by the microbial environment and suggest that secondary metabolites produced by microbes may provide environmental cues that contribute to pathogen recognition and host survival.	[Meisel, Joshua D.; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Panda, Oishika; Mahanti, Parag; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; [Panda, Oishika; Mahanti, Parag; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Massachusetts Institute of Technology (MIT); Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Kim, DH (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dhkim@mit.edu	Mahanti, Parag/AAK-8974-2021	Schroeder, Frank/0000-0002-4420-0237; Panda, Oishika/0000-0002-1217-8231	NIH [GM084477, GM088290]; National Science Foundation; Ellison New Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084477, R01GM088290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ellison New Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Alcedo, K. Ashrafi, F. Ausubel, H.R. Horvitz, the C. elegans Knockout Consortium, and the Caenorhabditis Genetics Center (which is supported by the NIH, Office of the Director) for providing strains and reagents. We thank N. Bhatla, C. Engert, C. Pender, and S. Sando for technical assistance. J.D.M. was supported by a Graduate Research Fellowship from the National Science Foundation. This study was supported by the NIH (GM084477 to D.H.K. and GM088290 to F.C.S.) and an Ellison New Scholar Award (to D.H.K.).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Bargmann Cornelia I, 2006, WormBook, P1; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chang HC, 2011, NATURE, V480, P525, DOI 10.1038/nature10643; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fierro-Gonzalez JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016561; Gallagher T, 2013, J NEUROSCI, V33, P9716, DOI 10.1523/JNEUROSCI.4493-12.2013; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Gunther CV, 2000, DEVELOPMENT, V127, P3337; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kim K, 2010, DEVELOPMENT, V137, P963, DOI 10.1242/dev.044719; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Korsager S, 2013, J AM CHEM SOC, V135, P2891, DOI 10.1021/ja3114032; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Mehnaz S, 2013, J NAT PROD, V76, P135, DOI 10.1021/np3005166; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nakata K, 2013, ORG LETT, V15, P1170, DOI 10.1021/ol303453j; Niu DF, 2008, TETRAHEDRON, V64, P10517, DOI 10.1016/j.tet.2008.08.093; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reddy KC, 2011, P NATL ACAD SCI USA, V108, P12887, DOI 10.1073/pnas.1108265108; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Taggi AE, 2004, J AM CHEM SOC, V126, P10364, DOI 10.1021/ja047416n; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang XD, 2012, P NATL ACAD SCI USA, V109, P17081, DOI 10.1073/pnas.1205982109; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700; Zwaal RR, 1997, GENETICS, V145, P715	65	138	151	0	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					267	280		10.1016/j.cell.2014.09.011	http://dx.doi.org/10.1016/j.cell.2014.09.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303524	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000343095600010
J	Ofri, D				Ofri, Danielle			The Little Things	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10012 USA; [Ofri, Danielle] Bellevue Hosp, New York, NY USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10012 USA.			Ofri, Danielle/0000-0001-9865-7104					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1378	1379		10.1056/NEJMp1408761	http://dx.doi.org/10.1056/NEJMp1408761			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	25295499				2022-12-01	WOS:000342674800006
J	Cooke, CR; Iwashyna, TJ				Cooke, Colin R.; Iwashyna, Theodore J.			Sepsis Mandates Improving Inpatient Care While Advancing Quality Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cooke, Colin R.; Iwashyna, Theodore J.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Cooke, Colin R.; Iwashyna, Theodore J.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Cooke, Colin R.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Cooke, Colin R.; Iwashyna, Theodore J.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] VA Ann Arbor Hlth Syst, Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Cooke, CR (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Room 127W, Ann Arbor, MI 48109 USA.	cookecr@umich.edu		Iwashyna, Theodore/0000-0002-4226-9310; Cooke, Colin/0000-0001-9713-5371	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044752] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berenson R, 2014, ACHIEVING POTENTIAL; Centers for Medicare and Medicaid Services (CMS) HHS, 2014, Fed Regist, V79, P49853; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Miller RR, 2013, AM J RESP CRIT CARE, V188, P77, DOI 10.1164/rccm.201212-2199OC; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	9	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1397	1398		10.1001/jama.2014.11350	http://dx.doi.org/10.1001/jama.2014.11350			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291572	Green Accepted			2022-12-01	WOS:000342630200011
J	Eirew, P; Steif, A; Khattra, J; Ha, G; Yap, D; Farahani, H; Gelmon, K; Chia, S; Mar, C; Wan, A; Laks, E; Biele, J; Shumansky, K; Rosner, J; McPherson, A; Nielsen, C; Roth, AJL; Lefebvre, C; Bashashati, A; de Souza, C; Siu, C; Aniba, R; Brimhall, J; Oloumi, A; Osako, T; Bruna, A; Sandoval, JL; Algara, T; Greenwood, W; Leung, K; Cheng, HW; Xue, H; Wang, YZ; Lin, D; Mungall, AJ; Moore, R; Zhao, YJ; Lorette, J; Nguyen, L; Huntsman, D; Eaves, CJ; Hansen, C; Marra, MA; Caldas, C; Shah, SP; Aparicio, S				Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Gelmon, Karen; Chia, Stephen; Mar, Colin; Wan, Adrian; Laks, Emma; Biele, Justina; Shumansky, Karey; Rosner, Jamie; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; de Souza, Camila; Siu, Celia; Aniba, Radhouane; Brimhall, Jazmine; Oloumi, Arusha; Osako, Tomo; Bruna, Alejandra; Sandoval, Jose L.; Algara, Teresa; Greenwood, Wendy; Leung, Kaston; Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong; Mungall, Andrew J.; Moore, Richard; Zhao, Yongjun; Lorette, Julie; Long Nguyen; Huntsman, David; Eaves, Connie J.; Hansen, Carl; Marra, Marco A.; Caldas, Carlos; Shah, Sohrab P.; Aparicio, Samuel			Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution	NATURE			English	Article							EVOLUTION; METASTASIS; INFERENCE; REVEALS; TUMORS; MODEL	Human cancers, including breast cancers, comprise clones differing in mutation content. Clones evolve dynamically in space and time following principles of Darwinian evolution(1,2), underpinning important emergent features such as drug resistance and metastasis(3-7). Human breast cancer xenoengraftment is used as a means of capturing and studying tumour biology, and breast tumour xenografts are generally assumed to be reasonable models of the originating tumours(8-10). However, the consequences and reproducibility of engraftment and propagation on the genomic clonal architecture of tumours have not been systematically examined at single-cell resolution. Here we show, using deep-genome and single-cell sequencing methods, the clonal dynamics of initial engraftment and subsequent serial propagation of primary and metastatic human breast cancers in immunodeficient mice. In all 15 cases examined, clonal selection on engraftment was observed in both primary and metastatic breast tumours, varying in degree from extreme selective engraftment of minor (<5% of starting population) clones to moderate, polyclonal engraftment. Furthermore, ongoing clonal dynamics during serial passaging is a feature of tumours experiencing modest initial selection. Through single-cell sequencing, we show that major mutation clusters estimated from tumour population sequencing relate predictably to the most abundant clonal genotypes, even in clonally complex and rapidly evolving cases. Finally, we show that similar clonal expansion patterns can emerge in independent grafts of the same starting tumour population, indicating that genomic aberrations can be reproducible determinants of evolutionary trajectories. Our results show that measurement of genomically defined clonal population dynamics will be highly informative for functional studies using patient-derived breast cancer xenoengraftment.	[Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Wan, Adrian; Laks, Emma; Biele, Justina; Shumansky, Karey; Rosner, Jamie; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; de Souza, Camila; Siu, Celia; Aniba, Radhouane; Brimhall, Jazmine; Oloumi, Arusha; Osako, Tomo; Algara, Teresa; Shah, Sohrab P.; Aparicio, Samuel] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Laks, Emma; Biele, Justina; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; Aniba, Radhouane; Oloumi, Arusha; Osako, Tomo; Algara, Teresa; Huntsman, David; Shah, Sohrab P.; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Gelmon, Karen; Chia, Stephen; Mar, Colin] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Bruna, Alejandra; Sandoval, Jose L.; Greenwood, Wendy; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 2XZ, England; [Bruna, Alejandra; Sandoval, Jose L.; Greenwood, Wendy; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Leung, Kaston; Hansen, Carl] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Leung, Kaston; Hansen, Carl] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 1L3, Canada; [Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Mungall, Andrew J.; Moore, Richard; Zhao, Yongjun; Marra, Marco A.; Shah, Sohrab P.; Aparicio, Samuel] Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Lorette, Julie; Huntsman, David; Aparicio, Samuel] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Long Nguyen; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Long Nguyen; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency	Aparicio, S (corresponding author), British Columbia Canc Agcy, Dept Mol Oncol, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sshah@bccrc.ca; saparicio@bccrc.ca	Huntsman, David/ABE-6082-2020; Steif, Adi/CAA-0180-2022; Sandoval, José Luis/ABE-5022-2020; McPherson, Andrew W/J-6552-2015; Mungall, Andrew J./U-7067-2018; Caldas, Carlos/U-7250-2019; Marra, Marco A/B-5987-2008; Ha, Gavin/N-1984-2019	Sandoval, José Luis/0000-0002-6256-7083; McPherson, Andrew W/0000-0002-5654-5101; Mungall, Andrew J./0000-0002-0905-2742; Caldas, Carlos/0000-0003-3547-1489; Marra, Marco A/0000-0001-7146-7175; Ha, Gavin/0000-0001-7578-7272; Aparicio, Samuel/0000-0002-0487-9599; Nguyen, Long/0000-0002-3347-438X; Farahani, Hossein/0000-0002-9503-1875; Bruna, Alejandra/0000-0003-1214-9665; Wang, Yuzhuo/0000-0002-9749-8591; Greenwood, Wendy F/0000-0002-2509-8695; Rosner, Jamie/0000-0001-8901-7228; Yap, Damian/0000-0002-5370-4592; Eaves, Connie/0000-0002-3452-1926	Canada Research Chairs; Michael Smith Foundation for Health Research (MSFHR) Fellowship; NSERC CREATE scholarship through the graduate program in Genome Science and Technology at UBC; BC Cancer Foundation; Canadian Breast Cancer Foundation; Canadian Cancer Society Research Institute; Terry Fox Research Institute; Genome Canada; Canadian Institutes for Health Research (CIHR); Cancer Research UK [16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research (MSFHR) Fellowship; NSERC CREATE scholarship through the graduate program in Genome Science and Technology at UBC; BC Cancer Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Genome Canada(Genome Canada); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to the staff of the CTAG Molecular Pathology facility, members of the Library Technical Development, Library Construction, Sequencing and Bioinformatics teams at the Michael Smith Genome Sciences Centre for technical assistance with data generation, and S. Kalloger for assistance with sample collection. S.A. and S.P.S. are supported by Canada Research Chairs. P.E. is supported by a Michael Smith Foundation for Health Research (MSFHR) Fellowship. A.S. is supported by an NSERC CREATE scholarship through the graduate program in Genome Science and Technology at UBC. S.P.S. is a MSFHR scholar. We acknowledge long-term funding support provided by the BC Cancer Foundation. The S.A., S.P.S. and C.H. groups receive operating funds from the Canadian Breast Cancer Foundation, Canadian Cancer Society Research Institute, Terry Fox Research Institute, Genome Canada and Canadian Institutes for Health Research (CIHR). We thank S. Mullaly for critical reading of the manuscript.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nolan-Stevaux O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067316; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	24	443	454	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					422	426		10.1038/nature13952	http://dx.doi.org/10.1038/nature13952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470049	Green Accepted			2022-12-01	WOS:000349547400047
J	Hantel, A; Olopade, CO				Hantel, Andrew; Olopade, Christopher Olusola			Drug and Vaccine Access in the Ebola Epidemic: Advising Caution in Compassionate Usec	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFORMED-CONSENT		[Hantel, Andrew; Olopade, Christopher Olusola] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Hantel, A (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 7082, Chicago, IL 60637 USA.		Hantel, Andrew/AAV-5385-2021	Hantel, Andrew/0000-0001-9612-3643				Adebamowo C., 2014, STATEMENT USE INNOVA; Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474; Craighill P. M., 2014, WASHINGTON POST; Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674; Gallagher J, 2014, BBC NEWS; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; U.S. Department of Health and Human Services, 2013, GUID IND EXP ACC INV; WHO, 2014, ETH CONS US UNR INT; WHO, 2014, EB SIT LIB NONC INT	9	11	11	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					141	+		10.7326/M14-2002	http://dx.doi.org/10.7326/M14-2002			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25322080				2022-12-01	WOS:000350106600020
J	Plata, G; Henry, CS; Vitkup, D				Plata, German; Henry, Christopher S.; Vitkup, Dennis			Long-term phenotypic evolution of bacteria	NATURE			English	Article							GENETIC INTERACTION NETWORKS; GENERATION; CONSERVATION; STRAINS	For many decades comparative analyses of protein sequences and structures have been used to investigate fundamental principles of molecular evolution(1,2). In contrast, relatively little is known about the long-term evolution of species' phenotypic and genetic properties. This represents an important gap in our understanding of evolution, as exactly these proprieties play key roles in natural selection and adaptation to diverse environments. Here we perform a comparative analysis of bacterial growth and gene deletion phenotypes using hundreds of genome-scale metabolic models. Overall, bacterial phenotypic evolution can be described by a two-stage process with a rapid initial phenotypic diversification followed by a slow long-term exponential divergence. The observed average divergence trend, with approximately similar fractions of phenotypic properties changing per unit time, continues for billions of years. We experimentally confirm the predicted divergence trend using the phenotypic profiles of 40 diverse bacterial species across more than 60 growth conditions. Our analysis suggests that, at long evolutionary distances, gene essentiality is significantly more conserved than the ability to utilize different nutrients, while synthetic lethality is significantly less conserved. We also find that although a rapid phenotypic evolution is sometimes observed within the same species, a transition from high to low phenotypic similarity occurs primarily at the genus level.	[Plata, German; Vitkup, Dennis] Columbia Univ, Dept Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Plata, German] Columbia Univ, Integrated Program Cellular Mol Struct & Genet St, New York, NY 10032 USA; [Henry, Christopher S.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Columbia University; United States Department of Energy (DOE); Argonne National Laboratory; Columbia University	Vitkup, D (corresponding author), Columbia Univ, Dept Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA.	dv2121@columbia.edu		Plata, German/0000-0002-6470-7748	National Institute of General Medical Sciences [GM079759, U54CA121852]; Department of Energy, as part of the SB Knowledgebase [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079759] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, as part of the SB Knowledgebase(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Bochner and Biolog for providing the experimental phenotypic growth data. We also thank members of the Vitkup laboratory for discussions. This work was supported in part by the National Institute of General Medical Sciences GM079759 grant to D.V. and the U54CA121852 grant to Columbia University. The work by C.S.H. was supported by the Department of Energy contract DE-AC02-06CH11357, as part of the SB Knowledgebase.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Darwin C, 2009, ON THE ORIGIN OF SPECIES, P1, DOI 10.1017/CBO9780511694295.004; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Monk JM, 2013, P NATL ACAD SCI USA, V110, P20338, DOI 10.1073/pnas.1307797110; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Plata G, 2012, NAT CHEM BIOL, V8, P848, DOI 10.1038/NCHEMBIO.1063; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sabarly V, 2011, J EVOLUTION BIOL, V24, P1559, DOI 10.1111/j.1420-9101.2011.02287.x; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; ZUCKERKANDL EMILE, 1965, P97	30	49	50	2	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					369	U498		10.1038/nature13827	http://dx.doi.org/10.1038/nature13827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25363780				2022-12-01	WOS:000347810300046
J	Pflug, A; Guilligay, D; Reich, S; Cusack, S				Pflug, Alexander; Guilligay, Delphine; Reich, Stefan; Cusack, Stephen			Structure of influenza A polymerase bound to the viral RNA promoter	NATURE			English	Article							VIRUS PB1 PROTEIN; HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; MESSENGER-RNA; VIRION RNA; MUTATIONAL ANALYSIS; ENDONUCLEASE ACTIVITY; TERMINAL DOMAIN; ACTIVE-SITE; CAPPED RNAS	The influenza virus polymerase transcribes or replicates the segmented RNA genome (viral RNA) into viral messenger RNA or full-length copies. To initiate RNA synthesis, the polymerase binds to the conserved 39 and 59 extremities of the viral RNA. Here we present the crystal structure of the heterotrimeric bat influenza A polymerase, comprising subunits PA, PB1 and PB2, bound to its viral RNA promoter. PB1 contains a canonical RNA polymerase fold that is stabilized by large interfaces with PA and PB2. The PA endonuclease and the PB2 cap-binding domain, involved in transcription by cap-snatching, form protrusions facing each other across a solvent channel. The 59 extremity of the promoter folds into a compact hook that is bound in a pocket formed by PB1 and PA close to the polymerase active site. This structure lays the basis for an atomic-level mechanistic understanding of the many functions of influenza polymerase, and opens new opportunities for anti-influenza drug design.	[Pflug, Alexander; Guilligay, Delphine; Reich, Stefan; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Pflug, Alexander; Guilligay, Delphine; Reich, Stefan; Cusack, Stephen] Univ Grenoble Alpes, Ctr Natl Rech Sci, EMBL Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France.	cusack@embl.fr		Reich, Stefan/0000-0001-6817-753X; Reich, Stefan/0000-0001-8822-2908; Cusack, Stephen/0000-0002-9324-0796; Pflug, Alexander/0000-0002-4680-1298	ERC [322586]	ERC(European Research Council (ERC)European Commission)	We thank members of the ESRF-EMBL Joint Structural Biology Group for access to European Synchrotron Radiation Facility (ESRF) beamlines, staff of the European Molecular Biology Laboratory (EMBL) eukaryotic expression and high-throughput crystallization facilities within the Partnership for Structural Biology (PSB), D. Hart for help with construct design, and H. Malet for electron microscopy. This work was supported by ERC Advanced Grant V-RNA (322586) to S.C.	BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Briese T, 2014, J VIROL, V88, P5298, DOI 10.1128/JVI.03391-13; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark MP, 2014, J MED CHEM, V57, P6668, DOI 10.1021/jm5007275; De la Pena M, 2007, EMBO J, V26, P4913, DOI 10.1038/sj.emboj.7601912; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Flick R, 1996, RNA, V2, P1046; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gonzalez S, 1999, J VIROL, V73, P631; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Hutchinson EC, 2011, J GEN VIROL, V92, P1859, DOI 10.1099/vir.0.032813-0; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kerry PS, 2008, VIROLOGY, V373, P202, DOI 10.1016/j.virol.2007.11.030; Kim HJ, 1997, J GEN VIROL, V78, P353, DOI 10.1099/0022-1317-78-2-353; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Leahy MB, 2001, J VIROL, V75, P134, DOI 10.1128/JVI.75.1.134-142.2001; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li ML, 1998, EMBO J, V17, P5844, DOI 10.1093/emboj/17.19.5844; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Nie Y, 2014, METHODS MOL BIOL, V1091, P131, DOI 10.1007/978-1-62703-691-7_8; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Pautus S, 2013, J MED CHEM, V56, P8915, DOI 10.1021/jm401369y; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Poole DS, 2014, J VIROL, V88, P12572, DOI 10.1128/JVI.01857-14; Poole EL, 2007, FEBS LETT, V581, P5300, DOI 10.1016/j.febslet.2007.10.025; Poon LLM, 1998, J VIROL, V72, P8214, DOI 10.1128/JVI.72.10.8214-8219.1998; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Reich S., NATURE; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tefsen B, 2014, J VIROL, V88, P1935, DOI 10.1128/JVI.03270-13; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	57	316	323	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					355	+		10.1038/nature14008	http://dx.doi.org/10.1038/nature14008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25409142				2022-12-01	WOS:000346484800038
J	Tschopp, P; Sherratt, E; Sanger, TJ; Groner, AC; Aspiras, AC; Hu, JK; Pourquie, O; Gros, J; Tabin, CJ				Tschopp, Patrick; Sherratt, Emma; Sanger, Thomas J.; Groner, Anna C.; Aspiras, Ariel C.; Hu, Jimmy K.; Pourquie, Olivier; Gros, Jerome; Tabin, Clifford J.			A relative shift in cloacal location repositions external genitalia in amniote evolution	NATURE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSITION; VERTEBRATE EMBRYOS; HOMOLOGY; PACKAGE; LIMB; ONTOLOGY; PROGRAM; BIOLOGY; TISSUES	The move of vertebrates to a terrestrial lifestyle required major adaptations in their locomotory apparatus and reproductive organs. While the fin-to-limb transition has received considerable attention(1,2), little is known about the developmental and evolutionary origins of external genitalia. Similarities in gene expression have been interpreted as a potential evolutionary link between the limb and genitals(3-6); however, no underlying developmental mechanism has been identified. We re-examined this question using micro-computed tomography, lineage tracing in three amniote clades, and RNA-sequencing-based transcriptional profiling. Here we show that the developmental origin of external genitalia has shifted through evolution, and in some taxa limbs and genitals share a common primordium. In squamates, the genitalia develop directly from the budding hindlimbs, or the remnants thereof, whereas in mice the genital tubercle originates from the ventral and tail bud mesenchyme. The recruitment of different cell populations for genital outgrowth follows a change in the relative position of the cloaca, the genitalia organizing centre. Ectopic grafting of the cloaca demonstrates the conserved ability of different mesenchymal cells to respond to these genitalia-inducing signals. Our results support a limb-like developmental origin of external genitalia as the ancestral condition. Moreover, they suggest that a change in the relative position of the cloacal signalling centre during evolution has led to an altered developmental route for external genitalia in mammals, while preserving parts of the ancestral limb molecular circuitry owing to a common evolutionary origin.	[Tschopp, Patrick; Aspiras, Ariel C.; Hu, Jimmy K.; Pourquie, Olivier; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sherratt, Emma; Sanger, Thomas J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Groner, Anna C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pourquie, Olivier] IGBMC, F-67400 Illkirch Graffenstaden, France; [Pourquie, Olivier] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gros, Jerome] Inst Pasteur, Dev & Stem Cell Biol Dept, F-75724 Paris 15, France	Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Brigham & Women's Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	jgros@pasteur.fr; tabin@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022; Sherratt, Emma/A-9931-2011	Pourquié, Olivier/0000-0001-5189-1227; Sherratt, Emma/0000-0003-2164-7877; Gros, Jerome/0000-0002-2264-2851; Hu, Jimmy/0000-0003-1035-0779	National Science Foundation [ECS-0335765]; Swiss National Science Foundation; EMBO; Human Frontiers Science Program; National Institutes of Health [R37-HD032443]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank D. Duboule, H. Kaessmann, A. Necsulea, B. Okaty, G. Rey and G. P. Wagner for discussions, M. A. de Bakker for the snake Tbx5 probe and A. M. Herrera and M. J. Cohn for discussing and sharing unpublished results. mu CT scans were performed at the Center for Nanoscale Systems, Harvard University (supported by National Science Foundation award ECS-0335765) and at the Museum of Comparative Zoology. Next-generation sequencing was performed at the HMS Biopolymers Facility and computational analyses were run on the Orchestra Cluster, HMS Research Computing. P.T. was supported by post-doctoral fellowships from the Swiss National Science Foundation, EMBO and the Human Frontiers Science Program. A.C.G. was supported by a post-doctoral fellowship from the Swiss National Science Foundation. This work was supported by National Institutes of Health grant R37-HD032443 to C.J.T.	Arendt D, 2005, THEOR BIOSCI, V124, P185, DOI 10.1016/j.thbio.2005.08.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barde I., 2001, PRODUCTION TITRATION; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cohn MJ, 2011, DEV DYNAM, V240, P1108, DOI 10.1002/dvdy.22631; COPE ED, 1896, P ACAD NAT SCI PHILA, V48, P461; De Barros MA, 2013, MICROSC RES TECHNIQ, V76, P388, DOI 10.1002/jemt.22178; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; GREER AE, 1991, J HERPETOL, V25, P166, DOI 10.2307/1564644; Griffiths M, 1978, BIOL MONOTREMES; Gros J, 2014, SCIENCE, V343, P1253, DOI 10.1126/science.1248228; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Herrera AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06896; Jurberg AD, 2013, DEV CELL, V25, P451, DOI 10.1016/j.devcel.2013.05.009; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Larkins C. E., 2014, SEX DEV; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Matsumaru D, 2014, EUR J HUM GENET, V22, P350, DOI 10.1038/ejhg.2013.160; McGlinn E, 2011, METHODS MOL BIOL, V770, P259, DOI 10.1007/978-1-61779-210-6_10; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Raynaud A., 1985, Biology of Reptilia, V15, P149; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Suzuki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043453; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	48	52	52	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					391	+		10.1038/nature13819	http://dx.doi.org/10.1038/nature13819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25383527	Green Accepted, Green Submitted			2022-12-01	WOS:000346484800046
J	Kanapathipillai, R; Restrepo, AMH; Fast, P; Wood, D; Dye, C; Kieny, MP; Moorthy, V				Kanapathipillai, Rupa; Restrepo, Ana Maria Henao; Fast, Patricia; Wood, David; Dye, Christopher; Kieny, Marie-Paule; Moorthy, Vasee			Ebola Vaccine - An Urgent International Priority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Restrepo, Ana Maria Henao; Fast, Patricia; Wood, David; Dye, Christopher; Kieny, Marie-Paule; Moorthy, Vasee] WHO, Geneva, Switzerland	World Health Organization			Dye, Christopher/AIC-4659-2022; Kieny, Marie-Paule/Q-1238-2019; Kieny, Marie-Paule/N-3914-2017	Kieny, Marie-Paule/0000-0002-5943-6488; Dye, Christopher/0000-0002-2957-1793; Moorthy, Vasee/0000-0002-6535-2854	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2014, EXPT EB VACC WHO CON; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Stanley D.A., 2014, NAT MED	3	71	76	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2249	2251		10.1056/NEJMp1412166	http://dx.doi.org/10.1056/NEJMp1412166			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25289888				2022-12-01	WOS:000346048800004
J	Giosan, L; Syvitski, J; Constantinescu, S; Day, J				Giosan, Liviu; Syvitski, James; Constantinescu, Stefan; Day, John			Protect the world's deltas	NATURE			English	Editorial Material							MISSISSIPPI DELTA; RESTORATION; MANAGEMENT		[Giosan, Liviu] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Syvitski, James] Univ Colorado, Boulder, CO 80309 USA; [Syvitski, James] Int Geosphere Biosphere Programme, Bucharest, Romania; [Constantinescu, Stefan] Univ Bucharest, Bucharest, Romania; [Day, John] Louisiana State Univ, Baton Rouge, LA 70803 USA	Woods Hole Oceanographic Institution; University of Colorado System; University of Colorado Boulder; University of Bucharest; Louisiana State University System; Louisiana State University	Giosan, L (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	lgiosan@whoi.edu	Giosan, Liviu/F-1809-2010; Constantinescu, Stefan/N-1069-2019; Constantinescu, Stefan/D-9405-2011	Giosan, Liviu/0000-0001-6769-5204; Constantinescu, Stefan/0000-0002-0137-9054; Constantinescu, Stefan/0000-0002-0137-9054; Syvitski, Jaia/0000-0003-3116-6997; Constantinescu, Stefan/0000-0002-1699-1131				Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Day J., 2014, PERSPECTIVES RESTORA; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Giosan L, 2013, ANTHROPOCENE, V1, P35, DOI 10.1016/j.ancene.2013.09.001; Ibanez C, 2014, ECOL ENG, V65, P122, DOI 10.1016/j.ecoleng.2013.08.002; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kondolf GM, 2014, EARTHS FUTURE, V2, P256, DOI 10.1002/2013EF000184; Paola C, 2011, ANNU REV MAR SCI, V3, P67, DOI 10.1146/annurev-marine-120709-142856; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629	10	338	346	7	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					31	33		10.1038/516031a	http://dx.doi.org/10.1038/516031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW5JD	25471866	Bronze			2022-12-01	WOS:000346310800019
J	Eccles, S; Pincus, C; Higgins, B; Woodhead, M				Eccles, Sinan; Pincus, Celia; Higgins, Bernard; Woodhead, Mark		Guideline Dev Grp	GUIDELINES Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; ETIOLOGY; SOCIETY; UK		[Eccles, Sinan] Royal Gwent Hosp, Newport NP20 2UB, Gwent, Wales; [Pincus, Celia; Higgins, Bernard] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Higgins, Bernard] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Woodhead, Mark] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Resp Med, Manchester, Lancs, England; [Woodhead, Mark] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Royal Gwent Hospital; Royal College of Physicians; Newcastle Freeman Hospital; Newcastle University - UK; University of Manchester; University of Manchester	Pincus, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	celia.pincus@rcplondon.ac.uk						Guest JF, 1997, EUR RESPIR J, V10, P1530, DOI 10.1183/09031936.97.10071530; LEU HS, 1989, AM J EPIDEMIOL, V129, P1258, DOI 10.1093/oxfordjournals.aje.a115245; Lim WS, 2011, THORAX, V66, P548, DOI 10.1136/thoraxjnl-2011-200081; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; McCabe C, 2009, ARCH INTERN MED, V169, P1525, DOI 10.1001/archinternmed.2009.259; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; National Institute for Health and Care Excellence, 2014, PNEUM INCL COMM ACQ; WOODHEAD MA, 1987, LANCET, V1, P671; [No title captured]	11	68	74	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2014	349								g6722	10.1136/bmj.g6722	http://dx.doi.org/10.1136/bmj.g6722			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KN	25471702				2022-12-01	WOS:000346116600001
J	Marchingo, JM; Kan, A; Sutherland, RM; Duffy, KR; Wellard, CJ; Belz, GT; Lew, AM; Dowling, MR; Heinzel, S; Hodgkin, PD				Marchingo, Julia M.; Kan, Andrey; Sutherland, Robyn M.; Duffy, Ken R.; Wellard, Cameron J.; Belz, Gabrielle T.; Lew, Andrew M.; Dowling, Mark R.; Heinzel, Susanne; Hodgkin, Philip D.			Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion	SCIENCE			English	Article							NAIVE; ACTIVATION; MODEL; DIFFERENTIATION; STIMULATION; INDUCTION; RESPONSES; DIVISION; SIGNAL	T cell responses are initiated by antigen and promoted by a range of costimulatory signals. Understanding how T cells integrate alternative signal combinations and make decisions affecting immune response strength or tolerance poses a considerable theoretical challenge. Here, we report that T cell receptor (TCR) and costimulatory signals imprint an early, cell-intrinsic, division fate, whereby cells effectively count through generations before returning automatically to a quiescent state. This autonomous program can be extended by cytokines. Signals from the TCR, costimulatory receptors, and cytokines add together using a linear division calculus, allowing the strength of a T cell response to be predicted from the sum of the underlying signal components. These data resolve a long-standing costimulation paradox and provide a quantitative paradigm for therapeutically manipulating immune response strength.	[Marchingo, Julia M.; Kan, Andrey; Sutherland, Robyn M.; Wellard, Cameron J.; Belz, Gabrielle T.; Lew, Andrew M.; Dowling, Mark R.; Heinzel, Susanne; Hodgkin, Philip D.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Marchingo, Julia M.; Kan, Andrey; Sutherland, Robyn M.; Wellard, Cameron J.; Belz, Gabrielle T.; Lew, Andrew M.; Dowling, Mark R.; Heinzel, Susanne; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Duffy, Ken R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Dowling, Mark R.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne; Maynooth University; Royal Melbourne Hospital	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia.	hodgkin@wehi.edu.au	Belz, Gabrielle T/C-9350-2013; Duffy, Ken/D-7955-2011; Marchingo, Julia/AAQ-6970-2021; Lew, Andrew/C-7248-2013	Belz, Gabrielle T/0000-0002-9660-9587; Duffy, Ken/0000-0001-5587-9356; Lew, Andrew/0000-0002-2198-8164; Marchingo, Julia/0000-0001-8823-9718; Dowling, Mark/0000-0002-8056-5348; Hodgkin, Philip/0000-0002-8604-1940; Wellard, Cameron/0000-0002-6115-5394; Heinzel, Susanne/0000-0001-9524-2835	National Health and Medical Research Council (NHMRC) [1010654, 1043414, 1054925, 1037321]; Human Frontier Science Program [RGP0060/2012]; Australian Research Council Future Fellowship; Science Foundation Ireland [12IP1263]; Australian Postgraduate Award; Walter and Eliza Hall Institute Edith Moffat Scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program(Human Frontier Science Program); Australian Research Council Future Fellowship(Australian Research Council); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Australian Postgraduate Award(Australian Government); Walter and Eliza Hall Institute Edith Moffat Scholarship	We thank S. Turner for providing the recombinant influenza virus and discussion and comments on the manuscript; L. Corcoran and V. Bryant for discussion and comments on the manuscript; A. Giang for discussion of experiments; M. Camilleri, L. Mackiewicz, M. Dayton, and D. Pavlyshyn for technical assistance; and P. Bouillet for Bcl2l11<SUP>-/-</SUP> mice. Fucci Red and Fucci Green mice were provided by the Riken BioResource Centre through the National BioResource Project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We also thank K. Lafferty and his two-signal theory for inspiring this work. The data are tabulated in the main paper and in the supplementary materials. Experimental data and the code for fitting the Cyton model will be made available upon request. This work was supported by the National Health and Medical Research Council (NHMRC) through project grants 1010654 and 1043414, program grants 1054925 and 1037321, and fellowships to M. R. D., A. M. L., and P. D. H., K. R. D. and P. D. H. were supported by Human Frontier Science Program grant RGP0060/2012, G. T. B. was supported by an Australian Research Council Future Fellowship, and K. R. D. was supported by Science Foundation Ireland grant 12IP1263. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme. J.M.M. was the recipient of an Australian Postgraduate Award and a Walter and Eliza Hall Institute Edith Moffat Scholarship.	Baxter AG, 2002, NAT REV IMMUNOL, V2, P439, DOI 10.1038/nri823; Bertram EM, 2004, SEMIN IMMUNOL, V16, P185, DOI 10.1016/j.smim.2004.02.006; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dowling MR, 2014, P NATL ACAD SCI USA, V111, P6377, DOI 10.1073/pnas.1322420111; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3406; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Oxenius A, 1999, J IMMUNOL, V162, P965; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	27	132	134	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1123	1127		10.1126/science.1260044	http://dx.doi.org/10.1126/science.1260044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430770	Green Published			2022-12-01	WOS:000345763400045
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			STATISTICS NOTES Uncertainty and sampling error	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England.	doug.altman@csm.ox.ac.uk			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Altman DG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7065; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226	5	11	8	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2014	349								g7064	10.1136/bmj.g7064	http://dx.doi.org/10.1136/bmj.g7064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KE	25424395	Bronze, Green Published			2022-12-01	WOS:000346115600010
J	Corbyn, Z				Corbyn, Zoe			Lessons from a sunburnt country	NATURE			English	Editorial Material							SKIN-CANCER PREVENTION; TRENDS											Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Fell GL, 2014, CELL, V157, P1527, DOI 10.1016/j.cell.2014.04.032; George PM, 1996, J AM ACAD DERMATOL, V34, P424, DOI 10.1016/S0190-9622(96)90433-8; Goulart JM, 2010, PHOTOCH PHOTOBIO SCI, V9, P432, DOI 10.1039/b9pp00122k; Hillhouse J, 2008, CANCER-AM CANCER SOC, V113, P3257, DOI 10.1002/cncr.23922; Iannacone MR, 2014, MELANOMA MANAG, V1, P75, DOI [10.2217/mmt.14.6, 10.2217/MMT.14.6]; Iannacone MR, 2014, INT J CANC; Lazovich D, 2012, CANCER EPIDEM BIOMAR, V21, P1893, DOI 10.1158/1055-9965.EPI-12-0327; Linos E, 2011, CANCER CAUSE CONTROL, V22, P1067, DOI 10.1007/s10552-011-9780-1; Shih STF, 2009, PREV MED, V49, P449, DOI 10.1016/j.ypmed.2009.09.008; Sinclair C, 2009, BRIT J DERMATOL, V161, P116, DOI 10.1111/j.1365-2133.2009.09459.x; Volkov A, 2013, AUST NZ J PUBL HEAL, V37, P63, DOI 10.1111/1753-6405.12012; Wallingford SC, 2013, BRIT J DERMATOL, V169, P880, DOI 10.1111/bjd.12460	13	15	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					S114	S116		10.1038/515S114a	http://dx.doi.org/10.1038/515S114a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25407707	Bronze			2022-12-01	WOS:000345770600003
J	Howard, LM; Piot, P; Stein, A				Howard, Louise M.; Piot, Peter; Stein, Alan			No health without perinatal mental health	LANCET			English	Editorial Material									[Howard, Louise M.] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Piot, Peter] London Sch Hyg & Trop Med, Off Director, London WC1, England; [Stein, Alan] Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England; [Stein, Alan] Univ Witwatersrand, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Witwatersrand	Stein, A (corresponding author), Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England.	alan.stein@psych.ox.ac.uk	Howard, Louise/E-3495-2010	Howard, Louise/0000-0001-9942-744X; Stein, Alan/0000-0001-8207-2822				Bauer A, 2014, COSTS PERINATAL MENT; Carneiro P., 2003, 9495 NBER; Farrelly S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-157; Fuhr DC, 2014, LANCET PSYCHIAT, V1, P213, DOI 10.1016/S2215-0366(14)70282-2; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Latin American and Caribbean Demographic Centre CELADE, 2012, WORLD POP LAT AM CAR; National Institute for Health and Care Excellence, 2014, ANT POSTN MENT HLTH; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Pearson R, 2013, NY TIMES BK REV, P18; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Thornicroft G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5189; WHO, 2014, SOCIAL DETERMINANTS	15	86	88	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1723	1724		10.1016/S0140-6736(14)62040-7	http://dx.doi.org/10.1016/S0140-6736(14)62040-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25455235				2022-12-01	WOS:000345116400005
J	De Rubeis, S; He, X; Goldberg, AP; Poultney, CS; Samocha, K; Cicek, AE; Kou, Y; Liu, L; Fromer, M; Walker, S; Singh, T; Klei, L; Kosmicki, J; Fu, SC; Aleksic, B; Biscaldi, M; Bolton, PF; Brownfeld, JM; Cai, JL; Campbell, NG; Carracedo, A; Chahrour, MH; Chiocchetti, AG; Coon, H; Crawford, EL; Crooks, L; Curran, SR; Dawson, G; Duketis, E; Fernandez, BA; Gallagher, L; Geller, E; Guter, SJ; Hill, RS; Ionita-Laza, I; Gonzalez, PJ; Kilpinen, H; Klauck, SM; Kolevzon, A; Lee, I; Lei, J; Lehtimaki, T; Lin, CF; Ma'ayan, A; Marshall, CR; McInnes, AL; Neale, B; Owen, MJ; Ozaki, N; Parellada, M; Parr, JR; Purcell, S; Puura, K; Rajagopalan, D; Rehnstrom, K; Reichenberg, A; Sabo, A; Sachse, M; Sanders, SJ; Schafer, C; Schulte-Ruther, M; Skuse, D; Stevens, C; Szatmari, P; Tammimies, K; Valladares, O; Voran, A; Wang, LS; Weiss, LA; Willsey, AJ; Yu, TW; Yuen, RKC; Cook, EH; Freitag, CM; Gill, M; Hultman, CM; Lehner, T; Palotie, A; Schellenberg, GD; Skiar, P; State, MW; Sutcliffe, JS; Walsh, CA; Scherer, SW; Zwick, ME; Barrett, JC; Cutler, DJ; Roeder, K; Devlin, B; Daly, MJ; Buxbaum, JD				De Rubeis, Silvia; He, Xin; Goldberg, Arthur P.; Poultney, Christopher S.; Samocha, Kaitlin; Cicek, A. Ercument; Kou, Yan; Liu, Li; Fromer, Menachem; Walker, Susan; Singh, Tarjinder; Klei, Lambertus; Kosmicki, Jack; Fu, Shih-Chen; Aleksic, Branko; Biscaldi, Monica; Bolton, Patrick F.; Brownfeld, Jessica M.; Cai, Jinlu; Campbell, Nicholas G.; Carracedo, Angel; Chahrour, Maria H.; Chiocchetti, Andreas G.; Coon, Hilary; Crawford, Emily L.; Crooks, Lucy; Curran, Sarah R.; Dawson, Geraldine; Duketis, Eftichia; Fernandez, Bridget A.; Gallagher, Louise; Geller, Evan; Guter, Stephen J.; Hill, R. Sean; Ionita-Laza, Iuliana; Gonzalez, Patricia Jimenez; Kilpinen, Helena; Klauck, Sabine M.; Kolevzon, Alexander; Lee, Irene; Lei, Jing; Lehtimaeki, Terho; Lin, Chiao-Feng; Ma'ayan, Avi; Marshall, Christian R.; McInnes, Alison L.; Neale, Benjamin; Owen, Michael J.; Ozaki, Norio; Parellada, Mara; Parr, Jeremy R.; Purcell, Shaun; Puura, Kaija; Rajagopalan, Deepthi; Rehnstrom, Karola; Reichenberg, Abraham; Sabo, Aniko; Sachse, Michael; Sanders, Stephan J.; Schafer, Chad; Schulte-Ruether, Martin; Skuse, David; Stevens, Christine; Szatmari, Peter; Tammimies, Kristiina; Valladares, Otto; Voran, Annette; Wang, Li-San; Weiss, Lauren A.; Willsey, A. Jeremy; Yu, Timothy W.; Yuen, Ryan K. C.; Cook, Edwin H.; Freitag, Christine M.; Gill, Michael; Hultman, Christina M.; Lehner, Thomas; Palotie, Aarno; Schellenberg, Gerard D.; Skiar, Pamela; State, Matthew W.; Sutcliffe, James S.; Walsh, Christopher A.; Scherer, Stephen W.; Zwick, Michael E.; Barrett, Jeffrey C.; Cutler, David J.; Roeder, Kathryn; Devlin, Bernie; Daly, Mark J.; Buxbaum, Joseph D.		DDD Study; Homozygosity Mapping Collaborative; UK10K Consortium; Autism Sequencing Consortium	Synaptic, transcriptional and chromatin genes disrupted in autism	NATURE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; SPECTRUM DISORDERS; NEURODEVELOPMENTAL DISORDERS; FRAMEWORK; NETWORK; RISK; SCHIZOPHRENIA; EXPRESSION; DISCOVERY	The genetic architecture of autism spectrum disorder involves the interplay of common and rare variants and their impact on hundreds of genes. Using exome sequencing, here we show that analysis of rare coding variation in 3,871 autism cases and 9,937 ancestry-matched or parental controls implicates 22 autosomal genes at a false discovery rate (FDR) < 0.05, plus a set of 107 autosomal genes strongly enriched for those likely to affect risk (FDR < 0.30). These 107 genes, which show unusual evolutionary constraint against mutations, incur de novo loss-of-function mutations in over 5% of autistic subjects. Many of the genes implicated encode proteins for synaptic formation, transcriptional regulation and chromatin-remodelling pathways. These include voltage-gated ion channels regulating the propagation of action potentials, pacemaking and excitability-transcription coupling, as well as histone-modifying enzymes and chromatin remodellers-most prominently those that mediate post-translational lysine methylation/demethylation modifications of histones.	[De Rubeis, Silvia; Goldberg, Arthur P.; Poultney, Christopher S.; Kou, Yan; Fu, Shih-Chen; Brownfeld, Jessica M.; Cai, Jinlu; Kolevzon, Alexander; Reichenberg, Abraham; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [De Rubeis, Silvia; Goldberg, Arthur P.; Poultney, Christopher S.; Kou, Yan; Fromer, Menachem; Fu, Shih-Chen; Brownfeld, Jessica M.; Cai, Jinlu; Kolevzon, Alexander; Purcell, Shaun; Reichenberg, Abraham; Skiar, Pamela; Buxbaum, Joseph D.] Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; [He, Xin; Cicek, A. Ercument; Roeder, Kathryn] Carnegie Mellon Univ, Ray & Stephanie Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Goldberg, Arthur P.; Fromer, Menachem; Skiar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Samocha, Kaitlin; Fromer, Menachem; Kosmicki, Jack; Palotie, Aarno] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Liu, Li; Lei, Jing; Schafer, Chad; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Walker, Susan; Marshall, Christian R.; Rajagopalan, Deepthi; Tammimies, Kristiina; Yuen, Ryan K. C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Singh, Tarjinder; Crooks, Lucy; Rehnstrom, Karola; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Aleksic, Branko; Ozaki, Norio; UK10K Consortium] Nagoya Univ, Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan; [Biscaldi, Monica] Univ Med Ctr Freiburg, Dept Child & Adolescent Psychiat Psychotherapy &, D-79106 Freiburg, Germany; [Biscaldi, Monica] Ctr Mental Disorders, D-79106 Freiburg, Germany; [Bolton, Patrick F.; Curran, Sarah R.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child Psychiat, London SE5 8AF, England; [Bolton, Patrick F.; Curran, Sarah R.] Kings Coll London, Inst Psychiat Psychol & Neurosci, SGDP Ctr, London SE5 8AF, England; [Campbell, Nicholas G.; Crawford, Emily L.; Sutcliffe, James S.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [Campbell, Nicholas G.; Crawford, Emily L.; Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Genom Med Grp, Santiago De Compostela 15706, Spain; [Carracedo, Angel] Galician Fdn Genom Med SERGAS, Santiago De Compostela 15706, Spain; [Carracedo, Angel] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Chahrour, Maria H.; Hill, R. Sean; Yu, Timothy W.; Walsh, Christopher A.; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chahrour, Maria H.; Hill, R. Sean; Yu, Timothy W.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Chiocchetti, Andreas G.; Duketis, Eftichia; Sachse, Michael; Freitag, Christine M.] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60528 Frankfurt, Germany; [Coon, Hilary] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT 84108 USA; [Dawson, Geraldine] Duke Univ, Duke Inst Brain Sci, Durham, NC 27708 USA; [Fernandez, Bridget A.] Mem Univ Newfoundland, Disciplines Genet & Med, St John, NF A1B 3V6, Canada; [Gallagher, Louise; Gill, Michael] Trin Coll Dublin, Sch Med, Dept Psychiat, Dublin 8, Ireland; [Geller, Evan; Lin, Chiao-Feng; Valladares, Otto; Wang, Li-San; Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Guter, Stephen J.; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60608 USA; [Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Gonzalez, Patricia Jimenez] Hosp Nacl de Ninos Dr Saenz Herrera, CCSS, Child Dev & Behav Unit, San Jose, Costa Rica; [Kilpinen, Helena] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Klauck, Sabine M.] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Lee, Irene; Skuse, David] UCL, Inst Child Hlth, London WC1N 1EH, England; [Lehtimaeki, Terho] Fimlab Labs, Dept Clin Chem, SF-33100 Tampere, Finland; [Ma'ayan, Avi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [McInnes, Alison L.] Kaiser Permanente, Dept Psychiat, San Francisco, CA 94118 USA; [Neale, Benjamin; Stevens, Christine; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Owen, Michael J.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, S Glam, Wales; [Owen, Michael J.] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF24 4HQ, S Glam, Wales; [Parellada, Mara] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Child & Adolescent Psychiat Dept, IiSGM,CIBERSAM, E-28040 Madrid, Spain; [Parr, Jeremy R.] Newcastle Univ, Sch Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Puura, Kaija] Tampere Univ, Dept Child Psychiat, Tampere 33521, Finland; [Puura, Kaija] Tampere Univ Hosp, Tampere 33521, Finland; [Reichenberg, Abraham] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Sabo, Aniko] Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; [Sanders, Stephan J.; Weiss, Lauren A.; Willsey, A. Jeremy; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Schulte-Ruether, Martin] Univ Hosp RWTH Aachen, JARA Brain Translat Med, Translat Brain Med Psychiat & Neurol, Dept Child & Adolescent Psychiat Psychosomat Psyc, D-52056 Aachen, Germany; [Skuse, David] Great Ormond St Hosp Sick Children, Natl Hlth Serv Fdn Trust, Dept Child & Adolescent Mental Hlth, London WC1N 3JH, England; [Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Offord Ctr Child Studies, Hamilton, ON L8S 4K1, Canada; [Voran, Annette] Saarland Univ Hosp, Dept Child & Adolescent Psychiat, D-66424 Homburg, Germany; [Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Lehner, Thomas] NIMH, NIH, Bethesda, MD 20892 USA; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland, FI-00014 Helsinki, Finland; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Skiar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Zwick, Michael E.; Cutler, David J.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Carnegie Mellon University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wellcome Trust Sanger Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya University; University of Freiburg; University of London; King's College London; University of London; King's College London; Vanderbilt University; Vanderbilt University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; King Abdulaziz University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Goethe University Frankfurt; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Duke University; Memorial University Newfoundland; Trinity College Dublin; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Icahn School of Medicine at Mount Sinai; University of London; University College London; Icahn School of Medicine at Mount Sinai; Kaiser Permanente; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cardiff University; Cardiff University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complutense University of Madrid; General University Gregorio Maranon Hospital; Newcastle University - UK; Tampere University; Tampere University; Tampere University Hospital; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; University of California System; University of California San Francisco; RWTH Aachen University; RWTH Aachen University Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; McMaster University; Universitatsklinikum des Saarlandes; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Toronto; Emory University; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Buxbaum, JD (corresponding author), Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA.	mjdaly@broadinstitute.org; joseph.buxbaum@mssm.edu	Breen, Gerome D/A-5540-2010; De Rubeis, Silvia/E-9852-2013; Ma'ayan, Avi/AAG-3131-2019; Daly, Mark J/B-2453-2017; Scherer, Stephen/B-3785-2013; Reichenberg, Abraham/GQB-1227-2022; Sutcliffe, James S/C-1348-2012; Parellada, Mara/GQH-7619-2022; Yuen, Ryan K. C./J-4876-2012; Collier, David A/D-1649-2011; Sifrim, Alejandro/AAY-2019-2021; State, Matthew/W-2256-2019; Parellada, Mara/AAQ-1272-2021; Lehtimäki, Terho/AAD-1094-2022; Aleksic, Branko/L-7851-2019; Breen, Gerome/Y-2706-2019; Yu, Timothy W./AAF-5738-2019; Puura, Kaija/ADG-7880-2022; Ozaki, Norio/M-8908-2014; Sala, Carlo/A-2493-2009; , Martin/F-4784-2013; Sanders, Stephan/S-8645-2019; Aleksic, Branko/G-1540-2011; Carracedo, Angel/D-4257-2012; Liu, Li/G-1897-2015; Buxbaum, Joseph D/G-6001-2010; Morrow, Eric/J-2767-2013; Eapen, Valsamma/N-9608-2017	Breen, Gerome D/0000-0003-2053-1792; De Rubeis, Silvia/0000-0001-9383-6883; Ma'ayan, Avi/0000-0002-6904-1017; Daly, Mark J/0000-0002-0949-8752; Scherer, Stephen/0000-0002-8326-1999; Sutcliffe, James S/0000-0001-5200-6007; Yuen, Ryan K. C./0000-0001-7273-4968; Collier, David A/0000-0003-4087-1559; Sifrim, Alejandro/0000-0001-8247-4020; Parellada, Mara/0000-0001-7977-3601; Lehtimäki, Terho/0000-0002-2555-4427; Aleksic, Branko/0000-0001-8982-4580; Breen, Gerome/0000-0003-2053-1792; Yu, Timothy W./0000-0003-2988-7701; Ozaki, Norio/0000-0002-7360-4898; Sala, Carlo/0000-0003-0662-9523; , Martin/0000-0002-7198-9923; Aleksic, Branko/0000-0001-8982-4580; Carracedo, Angel/0000-0003-1085-8986; Lin, Chiao-Feng/0000-0002-6177-8807; Kelly, Kirsten/0000-0003-4234-543X; Chiocchetti, Andreas G/0000-0002-7329-9985; Guter, Stephen/0000-0002-4476-2045; Tammimies, Kristiina/0000-0002-8324-4697; Palotie, Aarno/0000-0002-2527-5874; Lei, Jing/0000-0003-3104-9387; Singh, Tarjinder/0000-0003-0601-6815; Chahrour, Maria/0000-0002-3174-1480; Anney, Richard/0000-0002-6083-407X; Lee, Irene O./0000-0003-0004-6802; Gallagher, Louise/0000-0001-9462-2836; Cicek, A. Ercument/0000-0001-8613-6619; Buxbaum, Joseph/0000-0001-8898-8313; Morrow, Eric/0000-0003-3430-3520; Freitag, Christine Margarete/0000-0001-9676-4782; Eapen, Valsamma/0000-0001-6296-8306; Roeder, Kathryn/0000-0002-8869-6254; Stevens, Christine/0000-0002-2621-2234; Dawson, Geraldine/0000-0003-1410-2764; Geller, Evan/0000-0002-8035-8736; Sanders, Stephan/0000-0001-9112-5148; State, Matthew/0000-0003-1624-8302; Green, Jonathan/0000-0002-0143-181X; Lim, Teng Ting/0000-0003-3651-0654; Samocha, Kaitlin/0000-0002-1704-3352; Kilpinen, Helena/0000-0001-6692-6154; Gill, Michael/0000-0003-0206-5337	National Institutes of Health (NIH) [U01MH100233, U01MH100209, U01MH100229, U01MH100239]; NIH grants [R01MH089208, U54 HG003067]; NIH [R01 MH089482, R37 MH057881, R01 MH061009, UL1TR000445, P50 HD055751, MH089482, NIH RO1 MH083565, RC2MH089952, NIMH MH095034, MH077139, 5UL1 RR024975, P30 HD15052]; Charles and Ann Schlaifer Memorial Fund; UK National Institute for Health Research (NIHR) Senior Investigator award; NIHR Biomedical Research Centre in Mental Health at the South London&Maudsley Hospital; Maria Jose Jove Foundation; Strategic Action from Health Carlos III Institute (FEDER) [FIS PI13/01136];  [HICF-1009-003];  [WT098051];  [WT091310]; MRC [G0500870] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH100209, R01MH083565, R01MH095797, R01MH061009, R01MH089482, R01MH077139, R01MH094400, R01MH095034, U01MH100239, RC2MH089952, R01MH089208, U01MH100233, U01MH100229, R37MH057881, R01MH097849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073601] Funding Source: NIH RePORTER; Medical Research Council [MR/L010305/1, G9817803B, G0500870] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Ann Schlaifer Memorial Fund; UK National Institute for Health Research (NIHR) Senior Investigator award; NIHR Biomedical Research Centre in Mental Health at the South London&Maudsley Hospital; Maria Jose Jove Foundation; Strategic Action from Health Carlos III Institute (FEDER); ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by National Institutes of Health (NIH) grants U01MH100233, U01MH100209, U01MH100229 and U01MH100239 to the Autism Sequencing Consortium. Sequencing at Broad Institute was supported by NIH grants R01MH089208 (M.J.D.) and new sequencing by U54 HG003067 (S. Gabriel, E. Lander). Other funding includes NIH R01 MH089482, R37 MH057881 (B. D. and K. R.), R01 MH061009 (J.S.S.), UL1TR000445 (NCAT to VUMC); P50 HD055751 (E. H. C.); MH089482 (J.S.S.), NIH RO1 MH083565 and RC2MH089952 (C. A. W.), NIMH MH095034 (P. S), MH077139 (P.F. Sullivan); 5UL1 RR024975 and P30 HD15052. The DDD Study is funded by HICF-1009-003 and WT098051. UK10K is funded by WT091310. We also acknowledge The National Children's Research Foundation, Our Lady's Children's Hospital, Crumlin; The Meath Foundation; AMNCH, Tallaght; The Health Research Board, Ireland and Autism Speaks, U. S. A. C. A. W. is an Investigator of the Howard Hughes Medical Institute. S.D.R., A.P.G., C.S.P., Y.K. and S.-C.F. are Seaver fellows, supported by the Seaver foundation. A. P. G. is also supported by the Charles and Ann Schlaifer Memorial Fund. P. F. B. is supported by a UK National Institute for Health Research (NIHR) Senior Investigator award and the NIHR Biomedical Research Centre in Mental Health at the South London&Maudsley Hospital. A. C. is supported by Maria Jose Jove Foundation and the grant FIS PI13/01136 of the Strategic Action from Health Carlos III Institute (FEDER). This work was supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. We acknowledge the assistance of D. Hall and his team at National Database for Autism Research. We thank Jian Feng for providing a list of targets of both RBFOX1 and H3K4me3. We thank M. Potter for data coordination; K. Moore and J. Reichert for technical assistance; and, S. Lindsay for helping with molecular validation. We acknowledge the clinicians and organizations that contributed to samples used in this study. Finally, we are grateful to the many families whose participation made this study possible.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Khare SP, 2012, NUCLEIC ACIDS RES, V40, pD337, DOI 10.1093/nar/gkr1125; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Liu L, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-22; Long H, 2013, CEREB CORTEX, V23, P71, DOI 10.1093/cercor/bhr378; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Tan CM, 2013, BIOINFORMATICS, V29, P1872, DOI 10.1093/bioinformatics/btt319; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	47	1525	1538	8	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					209	U119		10.1038/nature13772	http://dx.doi.org/10.1038/nature13772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363760	Green Accepted, Green Submitted			2022-12-01	WOS:000344631400038
J	van Hasselt, PM; Ferdinandusse, S; Monroe, GR; Ruiter, JPN; Turkenburg, M; Geerlings, MJ; Duran, K; Harakalova, M; van der Zwaag, B; Monavari, AA; Okur, I; Sharrard, MJ; Cleary, M; O'Connell, N; Walker, V; Rubio-Gozalbo, ME; de Vries, MC; Visser, G; Houwen, RHJ; van der Smagt, JJ; Verhoeven-Duif, NM; Wanders, RJA; van Haaften, G				van Hasselt, Peter M.; Ferdinandusse, Sacha; Monroe, Glen R.; Ruiter, Jos P. N.; Turkenburg, Marjolein; Geerlings, Maartje J.; Duran, Karen; Harakalova, Magdalena; van der Zwaag, Bert; Monavari, Ardeshir A.; Okur, Ilyas; Sharrard, Mark J.; Cleary, Maureen; O'Connell, Nuala; Walker, Valerie; Rubio-Gozalbo, M. Estela; de Vries, Maaike C.; Visser, Gepke; Houwen, Roderick H. J.; van der Smagt, Jasper J.; Verhoeven-Duif, Nanda M.; Wanders, Ronald J. A.; van Haaften, Gijs			Monocarboxylate Transporter 1 Deficiency and Ketone Utilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOMIC ENRICHMENT; ANCILLARY PROTEIN; EXPRESSION; HYPOGLYCEMIA; BASIGIN; DISEASE; FAMILY; CD147; MCT1	Ketoacidosis is a potentially lethal condition caused by the imbalance between hepatic production and extrahepatic utilization of ketone bodies. We performed exome sequencing in a patient with recurrent, severe ketoacidosis and identified a homozygous frameshift mutation in the gene encoding monocarboxylate transporter 1 (SLC16A1, also called MCT1). Genetic analysis in 96 patients suspected of having ketolytic defects yielded seven additional inactivating mutations in MCT1, both homozygous and heterozygous. Mutational status was found to be correlated with ketoacidosis severity, MCT1 protein levels, and transport capacity. Thus, MCT1 deficiency is a novel cause of profound ketoacidosis; the present work suggests that MCT1-mediated ketone-body transport is needed to maintain acid-base balance.	[van Hasselt, Peter M.; Visser, Gepke] Wilhelmina Childrens Hosp, Div Pediat, Dept Metab Dis, Utrecht, Netherlands; [Houwen, Roderick H. J.] Wilhelmina Childrens Hosp, Div Pediat, Dept Pediat Gastroenterol, Utrecht, Netherlands; [Monroe, Glen R.; Geerlings, Maartje J.; Duran, Karen; Harakalova, Magdalena; van der Zwaag, Bert; van der Smagt, Jasper J.; Verhoeven-Duif, Nanda M.; van Haaften, Gijs] Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, Utrecht, Netherlands; [Ferdinandusse, Sacha; Ruiter, Jos P. N.; Turkenburg, Marjolein; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [Ferdinandusse, Sacha; Ruiter, Jos P. N.; Turkenburg, Marjolein; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Div Pediat, Dept Metab Dis, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Lab Genet Metab Dis, Maastricht, Netherlands; [de Vries, Maaike C.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands; [Monavari, Ardeshir A.] Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin, Ireland; [Okur, Ilyas] Gazi Univ, Sch Med, Dept Pediat Metab & Nutr, Ankara, Turkey; [Sharrard, Mark J.] Sheffield Childrens Hosp, Dept Paediat Metab Med, Sheffield, S Yorkshire, England; [Cleary, Maureen] Great Ormond St Hosp NHS Fdn Trust, Dept Metab Med, London, England; [O'Connell, Nuala] Dept Lab, Salisbury, Wilts, England; [Walker, Valerie] Southampton Gen Hosp, Dept Clin Biochem, Southampton SO9 4XY, Hants, England	Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; Radboud University Nijmegen; Childrens University Hospital - Temple Street; Gazi University; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Southampton	van Hasselt, PM (corresponding author), UMC Utrecht, Dept Metab Dis, Wilhelmina Childrens Hosp, KE 04-133-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	p.vanhasselt@umcutrecht.nl; g.vanhaaften@umcutrecht.nl	de Vries, M.C./L-4735-2015; Geerlings, Maartje/P-3338-2019; Okur, Ilyas/AAM-2081-2021; Rubio-Gozalbo, M Estela/H-1833-2011; Geerlings, Maartje/P-8309-2015; van Haaften, Gijs/G-7832-2012	Geerlings, Maartje/0000-0003-1164-3573; Okur, Ilyas/0000-0002-8772-0689; Geerlings, Maartje/0000-0003-1164-3573; van Haaften, Gijs/0000-0003-3033-0329; Ferdinandusse, Sacha/0000-0002-7738-5709; Monroe, Glen/0000-0002-8653-2643	Child Health program of the University Medical Center Utrecht	Child Health program of the University Medical Center Utrecht	Supported by the Child Health program of the University Medical Center Utrecht.	FISHBEIN WN, 1986, SCIENCE, V234, P1254, DOI 10.1126/science.3775384; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Marquard J, 2013, DIABETOLOGIA, V56, P31, DOI 10.1007/s00125-012-2750-7; Merezhinskaya N, 2000, MUSCLE NERVE, V23, P90, DOI 10.1002/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Sass JO, 2012, J INHERIT METAB DIS, V35, P23, DOI 10.1007/s10545-011-9324-6; van Veen MR, 2011, PEDIATRICS, V127, pE1021, DOI 10.1542/peds.2010-1706; Westerberg DP, 2013, AM FAM PHYSICIAN, V87, P337; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200	19	56	59	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 13	2014	371	20					1900	1907		10.1056/NEJMoa1407778	http://dx.doi.org/10.1056/NEJMoa1407778			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT1RB	25390740	Green Published			2022-12-01	WOS:000344709800007
J	Baker, KS; Mather, AE; McGregor, H; Coupland, P; Langridge, GC; Day, M; Deheer-Graham, A; Parkhill, J; Russell, JE; Thomson, NR				Baker, Kate S.; Mather, Alison E.; McGregor, Hannah; Coupland, Paul; Langridge, Gemma C.; Day, Martin; Deheer-Graham, Ana; Parkhill, Julian; Russell, Julie E.; Thomson, Nicholas R.			The extant World War 1 dysentery bacillus NCTC1: a genomic analysis	LANCET			English	Article							GLOBAL ENTERIC MULTICENTER; SHIGELLA-SONNEI; DIARRHEAL DISEASE; ESCHERICHIA-COLI; RESISTANCE; SUSCEPTIBILITY; PATHOGENICITY; EVOLUTION; PLASMIDS; SEQUENCE	Background Shigellosis (previously bacillary dysentery) was the primary diarrhoeal disease of World War 1, but outbreaks still occur in military operations, and shigellosis causes hundreds of thousands of deaths per year in developing nations. We aimed to generate a high-quality reference genome of the historical Shigella flexneri isolate NCTC1 and to examine the isolate for resistance to antimicrobials. Methods In this genomic analysis, we sequenced the oldest extant Shigella flexneri serotype 2a isolate using single-molecule real-time (SMRT) sequencing technology. Isolated from a soldier with dysentery from the British forces fighting on the Western Front in World War 1, this bacterium, NCTC1, was the first isolate accessioned into the National Collection of Type Cultures. We created a reference sequence for NCTC1, investigated the isolate for antimicrobial resistance, and undertook comparative genetics with S flexneri reference strains isolated during the 100 years since World War 1. Findings We discovered that NCTC1 belonged to a 2a lineage of S flexneri, with which it shares common characteristics and a large core genome. NCTC1 was resistant to penicillin and erythromycin, and contained a complement of chromosomal antimicrobial resistance genes similar to that of more recent isolates. Genomic islands gained in the S flexneri 2a lineage over time were predominately associated with additional antimicrobial resistances, virulence, and serotype conversion. Interpretation This S flexneri 2a lineage is a well adapted pathogen that has continued to respond to selective pressures. We have created a valuable historical benchmark for shigellae in the form of a high-quality reference sequence for a publicly available isolate. Copyright (C) Baker et al.	[Baker, Kate S.; Mather, Alison E.; Coupland, Paul; Langridge, Gemma C.; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [McGregor, Hannah; Deheer-Graham, Ana; Russell, Julie E.] Publ Hlth England, Natl Collect Type Cultures, Salisbury, Wilts, England; [Day, Martin] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Wellcome Trust Sanger Institute; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Thomson, NR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	nrt@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Baker, Kate/P-2087-2016; Thomson, Nicholas R/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Baker, Kate/0000-0001-5850-1949; Thomson, Nicholas R/0000-0002-4432-8505; Coupland, Paul/0000-0002-2871-3374; Langridge, Gemma/0000-0001-8037-2741	Wellcome Trust; Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Claire Jenkins from the Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale, for antimicrobial resistance testing and other staff at the Wellcome Trust Sanger Institute (WTSI), including David Harris, members of the sequencing teams, and other support staff. Authors from the WTSI (KSB, AEM, PC, GCL, JP, and NRT) were supported by the Wellcome Trust (grant number 098051).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWES F. W., 1919, Special Reports Series; Ashton PM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-7; Barlow M, 2002, J MOL EVOL, V55, P314, DOI 10.1007/s00239-002-2328-y; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; DATTA N, 1983, NATURE, V306, P616, DOI 10.1038/306616a0; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Flexner S., 1900, PHILA MED J, V6, P414; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; HYAMS KC, 1991, NEW ENGL J MED, V325, P1423, DOI 10.1056/NEJM199111143252006; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kothary MH, 2001, J FOOD SAFETY, V21, P49, DOI 10.1111/j.1745-4565.2001.tb00307.x; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LINDBERG F, 1986, REV INFECT DIS, V8, pS292; Linton DS, 2010, B HIST MED, V84, P607, DOI 10.1353/bhm.2010.0036; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Mather AE, 2014, LANCET, V384, P1720, DOI 10.1016/S0140-6736(14)61790-6; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; OLSSON O, 1983, P NATL ACAD SCI-BIOL, V80, P7556, DOI 10.1073/pnas.80.24.7556; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Rahman M, 2007, J HEALTH POPUL NUTR, V25, P158; Rajakumar K, 1997, INFECT IMMUN, V65, P4606, DOI 10.1128/IAI.65.11.4606-4614.1997; SANSONETTI P, 1980, CR ACAD SCI D NAT, V290, P879; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Scheibye-Alsing K, 2009, COMPUT BIOL CHEM, V33, P121, DOI 10.1016/j.compbiolchem.2008.11.003; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shiga K, 1898, ZENTRALBL BAKTERIOL, V23, P599; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Vrints M, 2009, J CLIN MICROBIOL, V47, P1379, DOI 10.1128/JCM.02460-08; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welcome Trust Sangar Institute, SMALT; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang N, 2014, J CLIN MICROBIOL, V52, P1119, DOI 10.1128/JCM.02669-13	45	22	22	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1691	1697		10.1016/S0140-6736(14)61789-X	http://dx.doi.org/10.1016/S0140-6736(14)61789-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25441199	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000345116200031
J	Binzel, RP				Binzel, Richard P.			Find asteroids to get to Mars	NATURE			English	Editorial Material																			0	8	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					559	560		10.1038/514559a	http://dx.doi.org/10.1038/514559a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25355345	Bronze			2022-12-01	WOS:000343801500023
J	Boelens, MC; Wu, TJ; Nabet, BY; Xu, B; Qiu, Y; Yoon, T; Azzam, DJ; Victor, CTS; Wiemann, BZ; Ishwaran, H; ter Brugge, PJ; Jonkers, J; Slingerland, J; Minn, AJ				Boelens, Mirjam C.; Wu, Tony J.; Nabet, Barzin Y.; Xu, Bihui; Qiu, Yu; Yoon, Taewon; Azzam, Diana J.; Victor, Christina Twyman-Saint; Wiemann, Brianne Z.; Ishwaran, Hemant; ter Brugge, Petra J.; Jonkers, Jos; Slingerland, Joyce; Minn, Andy J.			Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways	CELL			English	Article							GENE-EXPRESSION; STEM-CELLS; TUMORS; MICROVESICLES; NOTCH; RNAS; RECEPTORS; MICRORNAS; SIGNATURE; MECHANISM	Stromal communication with cancer cells can influence treatment response. We show that stromal and breast cancer (BrCa) cells utilize paracrine and juxtacrine signaling to drive chemotherapy and radiation resistance. Upon heterotypic interaction, exosomes are transferred from stromal to BrCa cells. RNA within exosomes, which are largely noncoding transcripts and transposable elements, stimulates the pattern recognition receptor RIG-I to activate STAT1-dependent antiviral signaling. In parallel, stromal cells also activate NOTCH3 on BrCa cells. The paracrine antiviral and juxtacrine NOTCH3 pathways converge as STAT1 facilitates transcriptional responses to NOTCH3 and expands therapy-resistant tumor-initiating cells. Primary human and/or mouse BrCa analysis support the role of antiviral/NOTCH3 pathways in NOTCH signaling and stroma-mediated resistance, which is abrogated by combination therapy with gamma secretase inhibitors. Thus, stromal cells orchestrate an intricate crosstalk with BrCa cells by utilizing exosomes to instigate antiviral signaling. This expands BrCa subpopulations adept at resisting therapy and reinitiating tumor growth.	[Boelens, Mirjam C.; Wu, Tony J.; Nabet, Barzin Y.; Xu, Bihui; Qiu, Yu; Yoon, Taewon; Wiemann, Brianne Z.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Victor, Christina Twyman-Saint] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Boelens, Mirjam C.; Wu, Tony J.; Nabet, Barzin Y.; Xu, Bihui; Qiu, Yu; Yoon, Taewon; Victor, Christina Twyman-Saint; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Ishwaran, Hemant] Univ Miami, Miller Sch Med, Div Biostat, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Azzam, Diana J.; Slingerland, Joyce] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Braman Family Breast Canc Inst Sylvester,Sylveste, Miami, FL 33136 USA; [Slingerland, Joyce] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Miami; University of Miami; University of Miami; Netherlands Cancer Institute	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	andyminn@exchange.upenn.edu	Jonkers, Jos/AAG-3246-2019; Azzam, Diana/ABB-8342-2021	Jonkers, Jos/0000-0002-9264-9792; Azzam, Diana/0000-0002-2605-8855; Minn, Andy/0000-0003-1418-0906; Nabet, Barzin/0000-0002-4824-3533; Ishwaran, Hemant/0000-0003-2758-9647; Twyman-Saint Victor, Christina/0000-0001-7253-6179; Wu, Tony James/0000-0002-5049-6986	Dutch Cancer Society; Basser Center for BRCA Research; Department of Defense [W81XWH-12-1-0180, W81XWH-09-1-0339]; NIH/NCI [5R01CA172651]; NIH [5R01CA163739, DK007066, TR000139]; NATIONAL CANCER INSTITUTE [R01CA163739, R01CA172651, F31CA189707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Basser Center for BRCA Research; Department of Defense(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.C.B. was supported by a fellowship from the Dutch Cancer Society. A.J.M. is a Department of Defense Era of Hope Scholar (W81XWH-09-1-0339). Support for this work and for B.X. was also provided by the Basser Center for BRCA Research. B.Y.N. and T.J.W. were supported by grants from the Department of Defense (W81XWH-12-1-0180 and W81XWH-09-1-0339). A.J.M., T.Y., and Y.Q. were supported by a grant from the NIH/NCI (5R01CA172651). Additional support was provided to H.I. and A.J.M. from the NIH (5R01CA163739) and to C.T. from an NIH training grant and career development award (DK007066 and TR000139). We would like to thank Danielle Loughlin for insightful discussions.	Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Goodier JL, 2010, HUM MOL GENET, V19, P1712, DOI 10.1093/hmg/ddq048; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kux K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00049; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105	35	555	596	9	193	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					499	513		10.1016/j.cell.2014.09.051	http://dx.doi.org/10.1016/j.cell.2014.09.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417103	Bronze, Green Accepted			2022-12-01	WOS:000344521700008
J	McKenzie, IA; Ohayon, D; Li, HL; de Faria, JP; Emery, B; Tohyama, K; Richardson, WD				McKenzie, Ian A.; Ohayon, David; Li, Huiliang; de Faria, Joana Paes; Emery, Ben; Tohyama, Koujiro; Richardson, William D.			Motor skill learning requires active central myelination	SCIENCE			English	Article							GENE REGULATORY FACTOR; CELLS; PROGENITORS; PROLIFERATION; NEURONS	Myelin-forming oligodendrocytes (OLs) are formed continuously in the healthy adult brain. In this work, we study the function of these late-forming cells and the myelin they produce. Learning a new motor skill (such as juggling) alters the structure of the brain's white matter, which contains many OLs, suggesting that late-born OLs might contribute to motor learning. Consistent with this idea, we show that production of newly formed OLs is briefly accelerated in mice that learn a new skill (running on a "complex wheel" with irregularly spaced rungs). By genetically manipulating the transcription factor myelin regulatory factor in OL precursors, we blocked production of new OLs during adulthood without affecting preexisting OLs or myelin. This prevented the mice from mastering the complex wheel. Thus, generation of new OLs and myelin is important for learning motor skills.	[McKenzie, Ian A.; Ohayon, David; Li, Huiliang; de Faria, Joana Paes; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Emery, Ben] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Emery, Ben] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Tohyama, Koujiro] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Morioka, Iwate 0208505, Japan	University of London; University College London; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Iwate Medical University	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk	de Faria, Joana Paes/M-8815-2014; Richardson FMedSci FRS, William D/C-1762-2008	de Faria, Joana Paes/0000-0001-7046-6197; OHAYON, David/0000-0003-3545-3774; Richardson FMedSci FRS, William D/0000-0001-7261-2485	European Research Council [293544]; UK Medical Research Council; Wellcome Trust; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for Promotion of Science; Royal Society USA/Canada Exchange Fellowship; Portuguese Fundacao para a Ciencia e a Tecnologia; Australian National Health and Medical Research Council; BBSRC [BB/L003236/1] Funding Source: UKRI; MRC [G0800575] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L003236/1] Funding Source: researchfish; Medical Research Council [G0800575] Funding Source: researchfish; Wellcome Trust [100269/Z/12/Z] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Society USA/Canada Exchange Fellowship; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the staff of the Center for Electron, Microscopy and Bio-Imaging Research, Iwate Medical University, and U. Dennehy and M. Grist (University College London) for technical help and our colleagues in the Wolfson Institute for Biomedical Research for encouragement and suggestions. W.D.R. thanks T. Richardson for stimulating discussions. The study was supported by the European Research Council (grant agreement 293544), the UK Medical Research Council, the Wellcome Trust, and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. W.D.R. and K.T. acknowledge an Invitation Fellowship from the Japan Society for Promotion of Science. I.M. was supported by a Royal Society USA/Canada Exchange Fellowship, J.P.d.F. by a fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia, and B.E. by a Career Development Fellowship from the Australian National Health and Medical Research Council. Pdgfra-CreER<SUP>T2</SUP> and Sox10-CreER<SUP>T2</SUP> mice can be obtained by request through www.e-lucid.com/ with a material transfer agreement. Myrf(flox) mice can be obtained from Jackson Laboratories, strain 010607. The supplementary materials include additional data.	Bakiri Y, 2009, NEUROSCIENCE, V158, P266, DOI 10.1016/j.neuroscience.2008.01.015; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fields RD, 2011, SEMIN CELL DEV BIOL, V22, P214, DOI 10.1016/j.semcdb.2011.02.009; Gallo V, 2008, J PHYSIOL-LONDON, V586, P3767, DOI 10.1113/jphysiol.2008.158436; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hibbits N, 2009, ASN NEURO, V1, DOI 10.1042/AN20090032; HILDEBRAND M, 1989, BIOSCIENCE, V39, P766, DOI 10.2307/1311182; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Liebetanz D, 2007, EXP NEUROL, V205, P207, DOI 10.1016/j.expneurol.2007.01.030; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Maldonado PP, 2011, J ANAT, V219, P8, DOI 10.1111/j.1469-7580.2011.01350.x; Mangin JM, 2012, NAT NEUROSCI, V15, P1192, DOI 10.1038/nn.3190; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schalomon PM, 2002, BRAIN RES BULL, V57, P27, DOI 10.1016/S0361-9230(01)00633-5; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	34	629	637	7	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					318	322		10.1126/science.1254960	http://dx.doi.org/10.1126/science.1254960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324381	Green Accepted			2022-12-01	WOS:000343041100035
J	Epstein, L; Hunter, JC; Arwady, MA; Tsai, V; Stein, L; Gribogiannis, M; Frias, M; Guh, AY; Laufer, AS; Black, S; Pacilli, M; Moulton-Meissner, H; Rasheed, JK; Avillan, JJ; Kitchel, B; Limbago, BM; MacCannell, D; Lonsway, D; Noble-Wang, J; Conway, J; Conover, C; Vernon, M; Kallen, AJ				Epstein, Lauren; Hunter, Jennifer C.; Arwady, M. Allison; Tsai, Victoria; Stein, Linda; Gribogiannis, Marguerite; Frias, Mabel; Guh, Alice Y.; Laufer, Alison S.; Black, Stephanie; Pacilli, Massimo; Moulton-Meissner, Heather; Rasheed, J. Kamile; Avillan, Johannetsy J.; Kitchel, Brandon; Limbago, Brandi M.; MacCannell, Duncan; Lonsway, David; Noble-Wang, Judith; Conway, Judith; Conover, Craig; Vernon, Michael; Kallen, Alexander J.			New Delhi Metallo-beta-Lactamase-Producing Carbapenem-Resistant Escherichia coli Associated With Exposure to Duodenoscopes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FIELD GEL-ELECTROPHORESIS; PSEUDOMONAS-AERUGINOSA; ENTEROBACTERIACEAE; OUTBREAK; EPIDEMIOLOGY; ACQUISITION; PREVENTION; GUIDELINE	IMPORTANCE Carbapenem-resistant Enterobacteriaceae (CRE) producing the New Delhi metallo-beta-lactamase (NDM) are rare in the United States, but have the potential to add to the increasing CRE burden. Previous NDM-producing CRE clusters have been attributed to person-to-person transmission in health care facilities. OBJECTIVE To identify a source for, and interrupt transmission of, NDM-producing CRE in a northeastern Illinois hospital. DESIGN, SETTING, AND PARTICIPANTS Outbreak investigation among 39 case patients at a tertiary care hospital in northeastern Illinois, including a case-control study, infection control assessment, and collection of environmental and device cultures; patient and environmental isolate relatedness was evaluated with pulsed-field gel electrophoresis (PFGE). Following identification of a likely source, targeted patient notification and CRE screening cultures were performed. MAIN OUTCOMES AND MEASURES Association between exposure and acquisition of NDM-producing CRE; results of environmental cultures and organism typing. RESULTS In total, 39 case patients were identified from January 2013 through December 2013, 35 with duodenoscope exposure in 1 hospital. No lapses in duodenoscope reprocessing were identified; however, NDM-producing Escherichia coli was recovered from a reprocessed duodenoscope and shared more than 92% similarity to all case patient isolates by PFGE. Based on the case-control study, case patients had significantly higher odds of being exposed to a duodenoscope (odds ratio [OR], 78 [95% CI, 6.0-1008], P < .001). After the hospital changed its reprocessing procedure from automated high-level disinfection with ortho-phthalaldehyde to gas sterilization with ethylene oxide, no additional case patients were identified. CONCLUSIONS AND RELEVANCE In this investigation, exposure to duodenoscopes with bacterial contamination was associated with apparent transmission of NDM-producing E coli among patients at 1 hospital. Bacterial contamination of duodenoscopes appeared to persist despite the absence of recognized reprocessing lapses. Facilities should be aware of the potential for transmission of bacteria including antimicrobial-resistant organisms via this route and should conduct regular reviews of their duodenoscope reprocessing procedures to ensure optimal manual cleaning and disinfection.	[Epstein, Lauren; Hunter, Jennifer C.; Guh, Alice Y.; Laufer, Alison S.; Moulton-Meissner, Heather; Rasheed, J. Kamile; Avillan, Johannetsy J.; Kitchel, Brandon; Limbago, Brandi M.; MacCannell, Duncan; Lonsway, David; Noble-Wang, Judith; Kallen, Alexander J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Epstein, Lauren; Hunter, Jennifer C.; Arwady, M. Allison] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA; [Arwady, M. Allison; Tsai, Victoria; Conway, Judith; Conover, Craig] Illinois Dept Publ Hlth, Chicago, IL USA; [Stein, Linda; Gribogiannis, Marguerite] Advocate Lutheran Gen Hosp, Park Ridge, IL USA; [Frias, Mabel; Vernon, Michael] Cook Cty Dept Publ Hlth, Oak Forest, IL USA; [Black, Stephanie; Pacilli, Massimo] Chicago Dept Publ Hlth, Chicago, IL USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health	Epstein, L (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,Mailstop A-24, Atlanta, GA 30333 USA.	xdd0@cdc.gov		Moulton-Meissner, Heather/0000-0002-0728-2552; Epstein, Lauren/0000-0002-1175-1112				Alfa MJ, 2013, AM J INFECT CONTROL, V41, pS56, DOI 10.1016/j.ajic.2012.12.006; Alfa MJ, 2013, AM J INFECT CONTROL, V41, P249, DOI 10.1016/j.ajic.2012.03.015; Aumeran C, 2011, ENDOSKOPIE HEUTE, V24, P124, DOI 10.1055/s-0030-1255647; Beilenhoff U, 2007, ENDOSCOPY, V39, P175, DOI 10.1055/s-2006-945181; Bommarito M, 2013, AM J INFECT CONTROL, V41, pS24; Bond WW, 2004, CLINICAL MICROBIOLOG; Carbonne A, 2009, CONTROL OF A MULTI H; Centers for Disease Control and Prevention, STANDARD OPERATING P; Centers for Disease Control and Prevention, 2012 CRE TOOLKIT GUI; Centers for Disease Control and Prevention, MULTIPLEX REAL TIME; DOHERTY DE, 1982, DIGEST DIS SCI, V27, P169, DOI 10.1007/BF01311712; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Fraser TG, 2004, INFECT CONT HOSP EP, V25, P856, DOI 10.1086/502309; Frias M, 2014, MMWR-MORBID MORTAL W, V62, P1051; Gasink LB, 2009, INFECT CONT HOSP EP, V30, P1180, DOI 10.1086/648451; Gastmeier P, 2014, INFECTION, V42, P15, DOI 10.1007/s15010-013-0544-6; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hennekinne JA, 2003, J APPL MICROBIOL, V94, P321, DOI 10.1046/j.1365-2672.2003.01837.x; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kovaleva J, 2009, ENDOSCOPY, V41, P913, DOI 10.1055/s-0029-1215086; Lin MY, 2013, CLIN INFECT DIS, V57, P1246, DOI 10.1093/cid/cit500; LOW DE, 1980, ARCH INTERN MED, V140, P1076, DOI 10.1001/archinte.140.8.1076; Miner N, 2007, GASTROENTEROL NURS, V30, P285, DOI 10.1097/01.SGA.0000287201.98483.43; Muscarella LF, 2010, ENDOSCOPY, V42, P957, DOI 10.1055/s-0030-1255871; Nelson DB, 2003, J LAB CLIN MED, V141, P159, DOI 10.1067/mlc.2003.24; Ofstead CL, 2010, GASTROENTEROL NURS, V33, P304, DOI 10.1097/SGA.0b013e3181e9431a; Petersen BT, 2011, GASTROINTEST ENDOSC, V73, P1075, DOI 10.1016/j.gie.2011.03.1183; RUTALA WA, 2008, GUIDELINE FOR DISINF; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; STRUELENS MJ, 1993, AM J MED, V95, P489, DOI 10.1016/0002-9343(93)90331-I; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Taylor A, INFECTION CONTROL IN; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thornhill G, 2012, AM J INFECT CONTROL, V40, pe184; US Food and Drug Administration, 2009, FDA CLEARED STERILAN; Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482	36	266	280	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2014	312	14					1447	1455		10.1001/jama.2014.12720	http://dx.doi.org/10.1001/jama.2014.12720			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PQ	25291580	Bronze			2022-12-01	WOS:000342630200021
J	Aplin, LM; Farine, DR; Morand-Ferron, J; Cockburn, A; Thornton, A; Sheldon, BC				Aplin, Lucy M.; Farine, Damien R.; Morand-Ferron, Julie; Cockburn, Andrew; Thornton, Alex; Sheldon, Ben C.			Experimentally induced innovations lead to persistent culture via conformity in wild birds	NATURE			English	Article							TRANSMISSION; CHIMPANZEES; DYNAMICS	In human societies, cultural norms arise when behaviours are transmitted through social networks via high-fidelity social learning'. However, a paucity of experimental studies has meant that there is no comparable understanding of the process by which socially transmitted behaviours might spread and persist in animal populations'''. Here we show experimental evidence of the establishment of foraging traditions in a wild bird population. We introduced alternative novel foraging techniques into replicated wild sub-populations of great tits (Parus major) and used automated tracking to map the diffusion, establishment and long-term persistence of the seeded innovations. Furthermore, we used social network analysis to examine the social factors that influenced diffusion dynamics. From only two trained birds in each sub-population, the information spread rapidly through social network ties, to reach an average of 75% of individuals, with a total of 414 knowledgeable individuals performing 57,909 solutions over all replicates. The sub-populations were heavily biased towards using the technique that was originally introduced, resulting in established local traditions that were stable over two generations, despite a high population turnover. Finally, we demonstrate a strong effect of social conformity, with individuals disproportionately adopting the most frequent local variant when first acquiring an innovation, and continuing to favour social information over personal information. Cultural conformity is thought to be a key factor in the evolution of complex culture in humans''. In providing the first experimental demonstration of conformity in a wild non-primate, and of cultural norms in foraging techniques in any wild animal, our results suggest a much broader taxonomic occurrence of such an apparently complex cultural behaviour.	[Aplin, Lucy M.; Farine, Damien R.; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Aplin, Lucy M.; Cockburn, Andrew] Australian Natl Univ, Res Sch Biol, Dept Evolut Ecol & Genet, Canberra, ACT 2600, Australia; [Farine, Damien R.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Farine, Damien R.] Smithsonian Trop Res Inst, Ancon 9100, Panama; [Morand-Ferron, Julie] Univ Ottawa, Dept Biol, Ottawa, ON K1N 9B2, Canada; [Thornton, Alex] Univ Exeter, Ctr Ecol & Conservat, Dept Biosci, Penryn TR10 9EZ, England; [Sheldon, Ben C.] Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden	University of Oxford; Australian National University; University of California System; University of California Davis; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Ottawa; University of Exeter; Uppsala University	Aplin, LM (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England.	lucy.aplin@zoo.ox.ac.uk	Morand-Ferron, Julie/AAW-7022-2021; Farine, Damien R./Y-2454-2019; Sheldon, Ben C/A-8056-2010; Cockburn, Andrew/A-4864-2008	Morand-Ferron, Julie/0000-0001-5186-7710; Farine, Damien R./0000-0003-2208-7613; Sheldon, Ben C/0000-0002-5240-7828; Thornton, Alex/0000-0002-1607-2047	BBSRC [BB/L006081/1, BB/H021817/1]; ERC [AdG 250164]; Australian Postgraduate Award; BBSRC [BB/H021817/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021817/2, BB/L006081/1, BB/H021817/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Australian Postgraduate Award(Australian Government); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by grants from the BBSRC (BB/L006081/1) and the ERC (AdG 250164) to B.C.S., who was also supported by a visiting professorship at Uppsala University. L.M.A. was also supported by an Australian Postgraduate Award; and AT., by a BBSRC David Phillips Fellowship (BB/H021817/1). The EGI social networks group, S. Lang and K. McMahon provided assistance in the field, and M. Whitaker produced electronic components for the puzzle boxes.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2013, ANIM BEHAV, V85, P1225, DOI 10.1016/j.anbehav.2013.03.009; Bouwhuis S, 2012, AM NAT, V179, pE15, DOI 10.1086/663194; Cantor M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0340; Claidiere N, 2013, CURR BIOL, V23, P1251, DOI 10.1016/j.cub.2013.05.036; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; de Waal FBM, 2013, SCIENCE, V340, P437, DOI 10.1126/science.1237521; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; FISHER J., 1949, BRITISH BIRDS, V42, P347; Galef B. G., 2012, OXFORD HDB COMP COGN, P803; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2004, LEARN BEHAV, V32, P4; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Morgan TJH, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00087; Psorakis I, 2012, J R SOC INTERFACE, V9, P3055, DOI 10.1098/rsif.2012.0223; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Rogers E., 1995, DIFFUSION INNOVATION, VFourth; SHERRY DF, 1984, ANIM BEHAV, V32, P937, DOI 10.1016/S0003-3472(84)80185-2; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Thornton A, 2009, P ROY SOC B-BIOL SCI, V276, P1269, DOI 10.1098/rspb.2008.1794; van de Waal E, 2013, SCIENCE, V340, P483, DOI 10.1126/science.1232769; van Leeuwen EJC, 2013, EVOL HUM BEHAV, V34, P1, DOI 10.1016/j.evolhumbehav.2012.07.005; van Schaik CP, 2012, CURR BIOL, V22, pR402, DOI 10.1016/j.cub.2012.04.001; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372	30	393	400	5	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					538	541		10.1038/nature13998	http://dx.doi.org/10.1038/nature13998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25470065	Green Accepted, Green Submitted			2022-12-01	WOS:000350097300047
J	Mansour, MR; Abraham, BJ; Anders, L; Berezovskaya, A; Gutierrez, A; Durbin, AD; Etchin, J; Lawton, L; Sallan, SE; Silverman, LB; Loh, ML; Hunger, SP; Sanda, T; Young, RA; Look, AT				Mansour, Marc R.; Abraham, Brian J.; Anders, Lars; Berezovskaya, Alla; Gutierrez, Alejandro; Durbin, Adam D.; Etchin, Julia; Lawton, Lee; Sallan, Stephen E.; Silverman, Lewis B.; Loh, Mignon L.; Hunger, Stephen P.; Sanda, Takaomi; Young, Richard A.; Look, A. Thomas			An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MONOALLELIC EXPRESSION; TRANSCRIPTION FACTORS; SELECTIVE-INHIBITION; CELL IDENTITY; TAL1 COMPLEX; GENES; DISRUPTION; DISEASE; LINEAGE	In certain human cancers, the expression of critical oncogenes is driven from large regulatory elements, called super-enhancers, that recruit much of the cell's transcriptional apparatus and are defined by extensive acetylation of histone H3 lysine 27 (H3K27ac). In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene. MYB binds to this new site and recruits its H3K27 acetylase-binding partner CBP, as well as core components of a major leukemogenic transcriptional complex that contains RUNX1, GATA-3, and TAL1 itself. Additionally, most endogenous super-enhancers found in T-ALL cells are occupied by MYB and CBP, which suggests a general role for MYB in super-enhancer initiation. Thus, this study identifies a genetic mechanism responsible for the generation of oncogenic super-enhancers in malignant cells.	[Mansour, Marc R.; Berezovskaya, Alla; Gutierrez, Alejandro; Durbin, Adam D.; Etchin, Julia; Sallan, Stephen E.; Silverman, Lewis B.; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Mansour, Marc R.] UCL, UCL Canc Inst, Dept Haematol, London WC1E 6BT, England; [Abraham, Brian J.; Anders, Lars; Lawton, Lee; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gutierrez, Alejandro; Sallan, Stephen E.; Silverman, Lewis B.; Look, A. Thomas] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Loh, Mignon L.] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Hunger, Stephen P.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Hunger, Stephen P.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Sanda, Takaomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Sanda, Takaomi] Yong Loo Lin Sch Med, Dept Med, Singapore 117599, Singapore; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of London; University College London; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT)	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.	young@wi.mit.edu; thomas_look@dfci.harvard.edu	Abraham, Brian/C-2230-2019; Young, Richard A/F-6495-2012	Abraham, Brian/0000-0001-8085-3027; Young, Richard A/0000-0001-8855-8647; Durbin, Adam/0000-0002-5472-9847; Loh, Mignon/0000-0003-4099-4700; Mansour, Marc/0000-0001-6835-3791	Claudia Adams Barr Innovative Basic Science Research Program; Kay Kendall Leukaemia Trust; Leukaemia and Lymphoma Research, UK; National Cancer Institute, NIH [CA167124]; Department of Defense [CA120215]; William Lawrence and Blanche Hughes Foundation; National Research Foundation (NRF), Prime Minister's Office, Singapore under its NRF Fellowship Program [NRF-NRFF2013-02]; NIH [1R01CA176746-01, 5P01CA109901-08, 5P01CA68484, CA98543, CA114766, CA98413, CA30969, CA29139]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA176746, U10CA098413, R21CA167124, U24CA114766, P01CA109901, U10CA029139, P01CA068484, R01CA120215, U10CA030969, U10CA098543] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	Claudia Adams Barr Innovative Basic Science Research Program; Kay Kendall Leukaemia Trust; Leukaemia and Lymphoma Research, UK; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); William Lawrence and Blanche Hughes Foundation; National Research Foundation (NRF), Prime Minister's Office, Singapore under its NRF Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Gilbert for helpful editorial comments on the manuscript, J. Reddy for sharing data, and F. Alt and F. Meng for helpful advice on the design of the CRISPR experiments. We would like to dedicate this paper to the memory of Michael Fayngersh. We gratefully acknowledge the children with T-ALL and their families for the samples analyzed in these studies. M.R.M. was supported by the Claudia Adams Barr Innovative Basic Science Research Program, the Kay Kendall Leukaemia Trust, and a Bennett Fellowship from Leukaemia and Lymphoma Research, UK. A.G. is a Research Fellow of the Gabrielle's Angel Foundation for Cancer Research, a Clinical Investigator of the Damon Runyon Cancer Research Foundation, and is supported by grants National Cancer Institute, NIH, CA167124, Department of Defense, CA120215 and an award from the William Lawrence and Blanche Hughes Foundation. T.S. is supported by a grant from the National Research Foundation (NRF), Prime Minister's Office, Singapore under its NRF Fellowship Program (award no. NRF-NRFF2013-02). This work was funded by NIH grants 1R01CA176746-01 and 5P01CA109901-08 (A.T.L.), and 5P01CA68484 (S.E.S. and A.T.L.). Children's Oncology Group cell banking and sample distribution were supported by grants CA98543, CA114766, CA98413, CA30969, and CA29139 from the NIH. S.P.H. is the Ergen Family Chair in Pediatric Cancer. R.A.Y. is a founder and member of the Board of Directors of Syros Pharmaceuticals, a company developing therapies that target gene regulatory elements including super-enhancers.	APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; BREIT TM, 1993, J EXP MED, V177, P965, DOI 10.1084/jem.177.4.965; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Ferrando AA, 2004, BLOOD, V103, P1909, DOI 10.1182/blood-2003-07-2577; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jirtle RL, 1999, EXP CELL RES, V248, P18, DOI 10.1006/excr.1999.4453; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; LEROYVIARD K, 1994, BLOOD, V84, P3819, DOI 10.1182/blood.V84.11.3819.bloodjournal84113819; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2013, J EXP MED, V210, P1545, DOI 10.1084/jem.20122516; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Tie F, 2014, DEVELOPMENT, V141, P1129, DOI 10.1242/dev.102392; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhou Y, 2013, BLOOD, V122, P4199, DOI 10.1182/blood-2013-02-483875	24	471	492	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1373	1377		10.1126/science.1259037	http://dx.doi.org/10.1126/science.1259037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25394790	Green Accepted, Green Submitted			2022-12-01	WOS:000346189600053
J	Freeman, KH				Freeman, Katherine H.			EARTH SCIENCE Controls on isotopic gradients in rain	NATURE			English	Editorial Material							HYDROGEN ISOTOPES; OXYGEN; WATER; PRECIPITATION; TEMPERATURE; HIMALAYA		Penn State Univ, Dept Geosci, University Pk, PA 16803 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Freeman, KH (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16803 USA.	khf4@psu.edu	Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				DANSGAARD W, 1964, TELLUS, V16, P436; ERIKSSON E, 1965, TELLUS, V18, P498; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; Garzione CN, 2000, EARTH PLANET SC LETT, V183, P215, DOI 10.1016/S0012-821X(00)00252-1; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; GAT JR, 1991, J GEOPHYS RES-ATMOS, V96, P13179, DOI 10.1029/91JD00054; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; INGRAHAM NL, 1991, WATER RESOUR RES, V27, P77, DOI 10.1029/90WR01708; Polissar PJ, 2009, EARTH PLANET SC LETT, V287, P64, DOI 10.1016/j.epsl.2009.07.037; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Rozanski K, 1993, GEOPHYS MONOGR SER, V78, P1, DOI DOI 10.1029/GM078P0001; Winnick MJ, 2014, EARTH PLANET SC LETT, V406, P123, DOI 10.1016/j.epsl.2014.09.005	12	0	0	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					41	42		10.1038/516041a	http://dx.doi.org/10.1038/516041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471876				2022-12-01	WOS:000346310800029
J	Schwartz, M				Schwartz, Myron			PERSPECTIVE: Incision revision	NATURE			English	Editorial Material									Mt Sinai Med Ctr, Miller Transplantat Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Schwartz, M (corresponding author), Mt Sinai Med Ctr, Miller Transplantat Inst, New York, NY 10029 USA.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S17	S17		10.1038/516S17a	http://dx.doi.org/10.1038/516S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470196	hybrid			2022-12-01	WOS:000346310800006
J	Rawlings, AM; Sharrett, AR; Schneider, ALC; Coresh, J; Albert, M; Couper, D; Griswold, M; Gottesman, RF; Wagenknecht, LE; Windham, BG; Selvin, E				Rawlings, Andreea M.; Sharrett, A. Richey; Schneider, Andrea L. C.; Coresh, Josef; Albert, Marilyn; Couper, David; Griswold, Michael; Gottesman, Rebecca F.; Wagenknecht, Lynne E.; Windham, B. Gwen; Selvin, Elizabeth			Diabetes in Midlife and Cognitive Change Over 20 Years A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							VASCULAR RISK-FACTORS; BLOOD-PRESSURE; APOE GENOTYPE; UNITED-STATES; DEMENTIA; DECLINE; GLUCOSE; ATTRITION; MELLITUS; DISEASE	Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A(1c) (HbA(1c)) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5% or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19% greater cognitive decline over 20 years ( adjusted global Z-score difference, -0.15 [95% CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among those with an HbA1c level less than 5.7%. Participants with poorly controlled diabetes (HbA1c level >= 7.0%) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend < 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA(1c) measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ N Carolina, Chapel Hill, NC USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Wake Forest Univ, Winston Salem, NC 27109 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Mississippi; University of Mississippi Medical Center; Wake Forest University	Selvin, E (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu	Gottesman, Rebecca/ABA-8468-2020	Christman Schneider, Andrea Lauren/0000-0003-0026-5052; Rawlings, Andreea/0000-0002-4903-7360; Couper, David/0000-0002-4313-9235	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [U01HL096812, HL096814, HL096899, HL096902, HL096917, R01HL70825, T32HL007024]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK089174]; National Institute on Aging [R01AG040282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096814, U01HL096899, U01HL096917, R01HL070825, U01HL096812, T32HL007024, U01HL096902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040282] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ARIC is a collaborative study supported by contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C from the National Heart, Lung, and Blood Institute (NHLBI). Neurocognitive (ARIC-NCS) data are collected with support from NHLBI grants U01HL096812, HL096814, HL096899, HL096902, and HL096917, and previous magnetic resonance imaging examinations of the brain were funded by NHLBI grant R01HL70825. Ms. Rawlings and Dr. Schneider were supported by training grant T32HL007024 from NHLBI. Dr. Selvin was supported by grant R01DK089174 from the National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Gottesman was supported by grant R01AG040282 from the National Institute on Aging.	Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bangen KJ, 2013, J STROKE CEREBROVASC, V22, P1361, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.013; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Benton AL, 1989, MULTILINGUAL APHASIA; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Gerstein HC, 2013, NEW ENGL J MED, V369, P189, DOI 10.1056/NEJMe1306987; Gottesman RF, 2014, AM J EPIDEMIOL, V179, P956, DOI 10.1093/aje/kwu020; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Herzog RI, 2012, NAT REV NEUROL, V8, P124, DOI 10.1038/nrneurol.2012.10; Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120; Kaffashian S, 2013, NEUROLOGY, V80, P1300, DOI 10.1212/WNL.0b013e31828ab370; Knopman DS, 2009, ALZHEIMERS DEMENT, V5, P207, DOI 10.1016/j.jalz.2009.01.027; KNOPMAN DS, 1989, ARCH NEUROL-CHICAGO, V46, P141, DOI 10.1001/archneur.1989.00520380041011; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; Power MC, 2013, EPIDEMIOLOGY, V24, P886, DOI 10.1097/EDE.0b013e3182a7121c; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Sanz CM, 2013, DIABETES CARE, V36, P1512, DOI 10.2337/dc12-1017; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Schneider AL, 2014, ALZHEIMER DIS ASS DI; Selnes OA, 2006, NAT CLIN PRACT NEURO, V2, P538, DOI 10.1038/ncpneuro0294; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Spauwen PJJ, 2013, DIABETES CARE, V36, P1554, DOI 10.2337/dc12-0746; Tuligenga RH, 2014, LANCET DIABETES ENDO, V2, P228, DOI 10.1016/S2213-8587(13)70192-X; Wechsler, 1981, WECHSLER ADULT INTEL; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson RS, 2012, NEUROLOGY, V78, P1116, DOI 10.1212/WNL.0b013e31824f7ff2; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117	39	226	234	5	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					785	U68		10.7326/M14-0737	http://dx.doi.org/10.7326/M14-0737			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25437406	Green Accepted			2022-12-01	WOS:000347247200007
J	Ortqvist, AK; Lundholm, C; Kieler, H; Ludvigsson, JF; Fall, T; Ye, WM; Almqvist, C				Ortqvist, Anne K.; Lundholm, Cecilia; Kieler, Helle; Ludvigsson, Jonas F.; Fall, Tove; Ye, Weimin; Almqvist, Catarina			Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH COHORT; ALLERGIC DISEASE; INCREASED RISK; INFECTIONS; EXPOSURE; CHILDREN; ECZEMA; ASSOCIATION; CONSUMPTION; PREGNANCY	Objective To investigate the association between exposure to antibiotics in fetal and early life and asthma in childhood, with adjustment for confounding factors. Design Nationwide prospective population based cohort study, including sibling control design. Setting Swedish population identified from national demographic and health registers. Participants 493 785 children born 2006-10; 180 894 of these were eligible for sibling analyses. Main outcome measure Asthma defined as having both an asthma diagnosis and dispensed asthma drugs. The association between antibiotic exposure and asthma was investigated in the whole cohort with Cox proportional hazard regression. A stratified proportional hazards model conditional on sibling group was used to adjust for shared factors within families. Confounding by respiratory infections was assessed by investigating whether specific groups of antibiotics were associated with asthma. Results Antibiotic exposure in fetal life was associated with an increased risk of asthma in cohort analyses (hazard ratio 1.28, 95% confidence interval 1.25 to 1.32), but not in sibling analyses (0.99, 0.92 to 1.07). In cohort analyses, antibiotics used to treat respiratory infections in childhood were associated with a more pronounced increased risk of asthma (4.12, 3.78 to 4.50) than antibiotics used for urinary tract and skin infections (1.54, 1.24 to 1.92). In sibling analyses, the excess risks after exposure to antibiotics for respiratory infections decreased (2.36, 1.78 to 3.13) and disappeared for antibiotics for urinary tract and skin (0.85, 0.47 to 1.55). Conclusions Previous positive associations between exposure to antibiotics in fetal and early life and subsequent childhood asthma could have been caused by confounding by shared familial factors, in addition to confounding by respiratory infections.	[Ortqvist, Anne K.; Lundholm, Cecilia; Ludvigsson, Jonas F.; Ye, Weimin; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Kieler, Helle] Karolinska Univ Hosp, Dept Med, Ctr Pharmacoepidemiol T2, S-17176 Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Paediat, S-70185 Orebro, Sweden; [Fall, Tove] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Orebro University; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Ortqvist, AK (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, S-17177 Stockholm, Sweden.	Anne.ortqvist@ki.se	Fall, Tove/O-7226-2014; Örtqvist, Anne Kristina/P-6618-2019; Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Lundholm, Cecilia/0000-0002-6546-3650; Kieler, Helle/0000-0001-9338-7133	Swedish Research Council through Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM) [2011-3060, 80748301, 340-2013-5867]; Stockholm County Council (ALF project); Karolinska Institutet; Swedish Heart Lung Foundation	Swedish Research Council through Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM); Stockholm County Council (ALF project)(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation)	This study was funded by the Swedish Research Council (grant No 2011-3060) through the Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM) framework grants No 80748301 and 340-2013-5867, grants provided by the Stockholm County Council (ALF project), the strategic research programme in epidemiology at Karolinska Institutet, and the Swedish Heart Lung Foundation. The funding sources had no role in the study design; the collection, analysis and interpretation of data; and the writing of the article and the decision to submit it for publication.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P104, DOI 10.1111/j.1365-2222.2011.03850.x; Almqvist C, ACTA PAEDIA IN PRESS; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Celedon JC, 2004, CLIN EXP ALLERGY, V34, P1011, DOI 10.1111/j.1365-2222.2004.01994.x; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; Dom S, 2010, CLIN EXP ALLERGY, V40, P1378, DOI 10.1111/j.1365-2222.2010.03538.x; Goksor E, 2013, PEDIAT ALLERG IMM-UK, V24, P339, DOI 10.1111/pai.12078; Heintze K, 2013, EUR J CLIN PHARMACOL, V69, P1197, DOI 10.1007/s00228-012-1463-7; Hellman J, 2012, SWEDRES SWARM 2012 U; Ic-Jusufagic AS, 2014, LANCET RESP MED, V2, P621, DOI 10.1016/S2213-2600(14)70096-7; Kardas P, 2002, J ANTIMICROB CHEMOTH, V49, P897, DOI 10.1093/jac/dkf046; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Marra F, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-32; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; McKeever TM, 2002, J ALLERGY CLIN IMMUN, V109, P43, DOI 10.1067/mai.2002.121016; McKeever TM, 2002, AM J RESP CRIT CARE, V166, P827, DOI 10.1164/rccm.200202-158OC; Metsala J, 2015, CLIN EXP ALLERGY, V45, P137, DOI 10.1111/cea.12356; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Ong MS, 2014, ANN ALLERG ASTHMA IM, V112, P441, DOI 10.1016/j.anai.2014.01.022; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; Rusconi F, 2007, AM J RESP CRIT CARE, V175, P16, DOI 10.1164/rccm.200512-1978OC; Rusconi F, 2011, INT J EPIDEMIOL, V40, P662, DOI 10.1093/ije/dyq263; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Su Y, 2010, CLIN EXP ALLERGY, V40, P1222, DOI 10.1111/j.1365-2222.2010.03539.x; Wang JY, 2013, INT J EPIDEMIOL, V42, P1087, DOI 10.1093/ije/dyt121; Wickens K, 2008, CLIN EXP ALLERGY, V38, P1318, DOI 10.1111/j.1365-2222.2008.03024.x	33	84	88	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2014	349								g6979	10.1136/bmj.g6979	http://dx.doi.org/10.1136/bmj.g6979			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KH	25432937	Green Published, hybrid			2022-12-01	WOS:000346115900001
J	Fowlie, M; Goulder, L; Kotchen, M; Borenstein, S; Bushnell, J; Davis, L; Greenstone, M; Kolstad, C; Knittel, C; Stavins, R; Wara, M; Wolak, F; Wolfram, C				Fowlie, Meredith; Goulder, Lawrence; Kotchen, Matthew; Borenstein, Severin; Bushnell, James; Davis, Lucas; Greenstone, Michael; Kolstad, Charles; Knittel, Christopher; Stavins, Robert; Wara, Michael; Wolak, Frank; Wolfram, Catherine			An economic perspective on the EPA's Clean Power Plan	SCIENCE			English	Editorial Material									[Fowlie, Meredith; Borenstein, Severin; Davis, Lucas; Wolfram, Catherine] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Goulder, Lawrence; Kolstad, Charles; Wara, Michael; Wolak, Frank] Stanford Univ, Palo Alto, CA 94305 USA; [Kotchen, Matthew] Yale Univ, New Haven, CT 06511 USA; [Bushnell, James] Univ Calif Davis, Davis, CA 95616 USA; [Greenstone, Michael] Univ Chicago, Chicago, IL 60637 USA; [Knittel, Christopher] MIT, Cambridge, MA 02412 USA; [Stavins, Robert] Harvard Univ, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Stanford University; Yale University; University of California System; University of California Davis; University of Chicago; Massachusetts Institute of Technology (MIT); Harvard University	Fowlie, M (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	fowlie@berkeley.edu						Allcott H, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.1.3; Holland SP, 2009, AM ECON J-ECON POLIC, V1, P106, DOI 10.1257/pol.1.1.106; Schmalensee R, 2013, J ECON PERSPECT, V27, P103, DOI 10.1257/jep.27.1.103; U.S. EPA, 2014, REGULATORY IMPACT AN	4	21	21	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					815	816		10.1126/science.1261349	http://dx.doi.org/10.1126/science.1261349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT0YL	25395524				2022-12-01	WOS:000344659900023
J	Zhang, BY; Chassaing, B; Shi, ZD; Uchiyama, R; Zhang, Z; Denning, TL; Crawford, SE; Pruijssers, AJ; Iskarpatyoti, JA; Estes, MK; Dermody, TS; Ouyang, WJ; Williams, IR; Vijay-Kumar, M; Gewirtz, AT				Zhang, Benyue; Chassaing, Benoit; Shi, Zhenda; Uchiyama, Robin; Zhang, Zhan; Denning, Timothy L.; Crawford, Sue E.; Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Estes, Mary K.; Dermody, Terence S.; Ouyang, Wenjun; Williams, Ifor R.; Vijay-Kumar, Matam; Gewirtz, Andrew T.			Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18	SCIENCE			English	Article							DENDRITIC CELLS; BACTERIAL FLAGELLIN; T-CELLS; NLRC4; PROTECTS; MUCOSAL; TLR5; MICE	Activators of innate immunity may have the potential to combat a broad range of infectious agents. We report that treatment with bacterial flagellin prevented rotavirus (RV) infection in mice and cured chronically RV-infected mice. Protection was independent of adaptive immunity and interferon (IFN, type I and II) and required flagellin receptors Toll-like receptor 5 (TLR5) and NOD-like receptor C4 (NLRC4). Flagellin-induced activation of TLR5 on dendritic cells elicited production of the cytokine interleukin-22 (IL-22), which induced a protective gene expression program in intestinal epithelial cells. Flagellin also induced NLRC4-dependent production of IL-18 and immediate elimination of RV-infected cells. Administration of IL-22 and IL-18 to mice fully recapitulated the capacity of flagellin to prevent or eliminate RV infection and thus holds promise as a broad-spectrum antiviral agent.	[Zhang, Benyue; Chassaing, Benoit; Shi, Zhenda; Uchiyama, Robin; Zhang, Zhan; Denning, Timothy L.; Gewirtz, Andrew T.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Uchiyama, Robin; Denning, Timothy L.; Williams, Ifor R.; Gewirtz, Andrew T.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Crawford, Sue E.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Vijay-Kumar, Matam] Penn State Univ, Dept Nutr Sci & Med, University Pk, PA 16802 USA	University System of Georgia; Georgia State University; Emory University; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Roche Holding; Genentech; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gewirtz, AT (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	agewirtz@gsu.edu	Williams, Ifor R/D-3648-2011; Ouyang, Wenjun/ABA-8763-2020; Pruijssers, Andrea J/S-5725-2018; Vijay-Kumar, Matam/Q-8988-2019; Chassaing, Benoit/R-3819-2017	Williams, Ifor R/0000-0002-8810-2911; Pruijssers, Andrea J/0000-0001-7910-626X; Chassaing, Benoit/0000-0002-4285-769X; Ouyang, Wenjun/0000-0002-1811-5864; Denning, Timothy/0000-0002-1072-7444	NIH [DK061417]; American Reinvestment and Recovery Act [AI107943, DK064730, DK56338, AI038296, AI080656]; Crohn's and Colitis Foundation of America; Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038296, R21AI107943, R56AI080656, R01AI080656, R01AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064730, P30DK056338, R01DK061417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Reinvestment and Recovery Act; Crohn's and Colitis Foundation of America; Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Virgin, T. Nice, A.-U. Rasheed, R. Ahmed, G. Silvestri, B. Rouse, B. Pulendran, A. Lukacher, S-M. Kang, and D. Kalman for helpful discussions. We thank D. Moore and K. Yu for technical support. This work was supported by NIH grants DK061417-and an accompanying award from the American Reinvestment and Recovery Act-AI107943, DK064730, DK56338, AI038296, and AI080656. B.C. is supported by a fellowship from the Crohn's and Colitis Foundation of America. T.S.D. is supported by Elizabeth B. Lamb Center for Pediatric Research. Recombinant IL-22, antibodies to IL-17 and IL-22, and Il22<SUP>-/-</SUP> mice were provided under a materials transfer agreement by Genentech (South San Francisco, CA). Patents for use of flagellin and IL-22/IL-18 to treat or prevent viral infection have been applied for under application nos. PCT/US2011/052301 (Emory University) and 61/888/439 (Georgia State University, provisional). RNA-sequencing data are deposited in Gene Expression Omnibus with accession no. GSE62479.	Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Chassaing B., 2014, GASTROENTEROLOGY; Feng NG, 1997, ADV EXP MED BIOL, V412, P233; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Jiang JQ, 2008, J VIROL, V82, P6812, DOI 10.1128/JVI.00450-08; Jones RM, 2011, GUT, V60, P648, DOI 10.1136/gut.2010.223891; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; UHNOO I, 1990, J VIROL, V64, P361, DOI 10.1128/JVI.64.1.361-368.1990; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vijay-Kumar M, 2005, J IMMUNOL, V174, P6322, DOI 10.4049/jimmunol.174.10.6322; Vijay-Kumar M, 2009, MUCOSAL IMMUNOL, V2, P197, DOI 10.1038/mi.2009.9; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	25	155	170	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2014	346	6211					861	865		10.1126/science.1256999	http://dx.doi.org/10.1126/science.1256999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0YL	25395539	Green Accepted			2022-12-01	WOS:000344659900048
J	Iossifov, I; O'Roak, BJ; Sanders, SJ; Ronemus, M; Krumm, N; Levy, D; Stessman, HA; Witherspoon, KT; Vives, L; Patterson, KE; Smith, JD; Paeper, B; Nickerson, DA; Dea, J; Dong, S; Gonzalez, LE; Mandell, JD; Mane, SM; Murtha, MT; Sullivan, CA; Walker, MF; Waqar, Z; Wei, LP; Willsey, AJ; Yamrom, B; Lee, YH; Grabowska, E; Dalkic, E; Wang, ZH; Marks, S; Andrews, P; Leotta, A; Kendall, J; Hakker, I; Rosenbaum, J; Ma, BC; Rodgers, L; Troge, J; Narzisi, G; Yoon, S; Schatz, MC; Ye, K; McCombie, WR; Shendure, J; Eichler, EE; State, MW; Wigler, M				Iossifov, Ivan; O'Roak, Brian J.; Sanders, Stephan J.; Ronemus, Michael; Krumm, Niklas; Levy, Dan; Stessman, Holly A.; Witherspoon, Kali T.; Vives, Laura; Patterson, Karynne E.; Smith, Joshua D.; Paeper, Bryan; Nickerson, Deborah A.; Dea, Jeanselle; Dong, Shan; Gonzalez, Luis E.; Mandell, Jeffrey D.; Mane, Shrikant M.; Murtha, Michael T.; Sullivan, Catherine A.; Walker, Michael F.; Waqar, Zainulabedin; Wei, Liping; Willsey, A. Jeremy; Yamrom, Boris; Lee, Yoon-ha; Grabowska, Ewa; Dalkic, Ertugrul; Wang, Zihua; Marks, Steven; Andrews, Peter; Leotta, Anthony; Kendall, Jude; Hakker, Inessa; Rosenbaum, Julie; Ma, Beicong; Rodgers, Linda; Troge, Jennifer; Narzisi, Giuseppe; Yoon, Seungtai; Schatz, Michael C.; Ye, Kenny; McCombie, W. Richard; Shendure, Jay; Eichler, Evan E.; State, Matthew W.; Wigler, Michael			The contribution of de novo coding mutations to autism spectrum disorder	NATURE			English	Article							COPY-NUMBER VARIATION; INTELLECTUAL DISABILITY; STRUCTURAL VARIATION; INHERITED DISEASE; PATERNAL AGE; SCHIZOPHRENIA; NETWORK; RISK; EVOLUTION; RESOURCE	Whole exome sequencing has proven to be a powerful tool for understanding the genetic architecture of human disease. Here we apply it to more than 2,500 simplex families, each having a child with an autistic spectrum disorder. By comparing affected to unaffected siblings, we show that 13% of de novo missense mutations and 43% of de novo likely gene-disrupting (LGD) mutations contribute to 12% and 9% of diagnoses, respectively. Including copy number variants, coding de novo mutations contribute to about 30% of all simplex and 45% of female diagnoses. Almost all LGD mutations occur opposite wild-type alleles. LGD targets in affected females significantly overlap the targets in males of lower intelligence quotient (IQ), but neither overlaps significantly with targets in males of higher IQ. We estimate that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation. LGD targets in the joint class overlap with published targets for intellectual disability and schizophrenia, and are enriched for chromatin modifiers, FMRP-associated genes and embryonically expressed genes. Most of the significance for the latter comes from affected females.	[Iossifov, Ivan; Ronemus, Michael; Levy, Dan; Yamrom, Boris; Lee, Yoon-ha; Grabowska, Ewa; Dalkic, Ertugrul; Wang, Zihua; Marks, Steven; Andrews, Peter; Leotta, Anthony; Kendall, Jude; Hakker, Inessa; Rosenbaum, Julie; Ma, Beicong; Rodgers, Linda; Troge, Jennifer; Narzisi, Giuseppe; Yoon, Seungtai; Schatz, Michael C.; McCombie, W. Richard; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [O'Roak, Brian J.; Krumm, Niklas; Stessman, Holly A.; Witherspoon, Kali T.; Vives, Laura; Patterson, Karynne E.; Smith, Joshua D.; Paeper, Bryan; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [O'Roak, Brian J.] Oregon Hlth & Sci Univ, Portland, OR 97208 USA; [Sanders, Stephan J.; Dea, Jeanselle; Mandell, Jeffrey D.; Walker, Michael F.; Willsey, A. Jeremy; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Sanders, Stephan J.; Dong, Shan; Willsey, A. Jeremy; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Dong, Shan; Wei, Liping] Peking Univ, Sch Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Gonzalez, Luis E.; Murtha, Michael T.; Sullivan, Catherine A.; Waqar, Zainulabedin; State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, New Haven, CT 06520 USA; [Mane, Shrikant M.] Yale Univ, Ctr Child Study, Yale Ctr Genom Anal, New Haven, CT 06520 USA; [Wei, Liping] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Grabowska, Ewa; Narzisi, Giuseppe] New York Genome Ctr, New York, NY 10013 USA; [Dalkic, Ertugrul] Bulent Ecevit Univ, Sch Med, Dept Med Biol, TR-67600 Zonguldak, Turkey; [Ye, Kenny] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [State, Matthew W.] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT 06520 USA	Cold Spring Harbor Laboratory; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of California System; University of California San Francisco; Yale University; Peking University; Yale University; Yale University; National Institute of Biological Sciences, Beijing; Bulent Ecevit University; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yale University	Shendure, J (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; eee@gs.washington.edu; matthew.state@ucsf.edu; wigler@cshl.edu	Ye, Kenny/U-2341-2019; Ye, Kenny/GSM-7731-2022; Schatz, Michael/L-2690-2019; Shendure, Jay/AAU-3684-2021; State, Matthew/W-2256-2019; DONG, Shan/GVS-5706-2022; Sanders, Stephan/S-8645-2019	Ye, Kenny/0000-0002-1466-855X; Schatz, Michael/0000-0002-4118-4446; Mandell, Jeffrey/0000-0002-3839-2543; Stessman, Holly/0000-0002-0764-3493; Dong, Shan/0000-0001-9130-0225; Shendure, Jay/0000-0002-1516-1865; O'Roak, Brian/0000-0002-4141-0095; Sanders, Stephan/0000-0001-9112-5148; State, Matthew/0000-0003-1624-8302	Simons Foundation Autism Research Initiative grants [SF191889, M144095 R11154, SF235988]; Howard Hughes Medical Institute (International Student Research Fellowship); Canadian Institutes of Health Research (Doctoral Foreign Study Award); NHLBI [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]	Simons Foundation Autism Research Initiative grants; Howard Hughes Medical Institute (International Student Research Fellowship)(Howard Hughes Medical Institute); Canadian Institutes of Health Research (Doctoral Foreign Study Award); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Simons Foundation Autism Research Initiative grants to E.E.E. (SF191889), M.W.S. (M144095 R11154) and M.W. (SF235988) supported this work. Additional support was provided by the Howard Hughes Medical Institute (International Student Research Fellowship to S.J.S.) and the Canadian Institutes of Health Research (Doctoral Foreign Study Award to A.J.W.). E.E.E. is an Investigator of the Howard Hughes Medical Institute. We thank all the families at the participating SSC sites, as well as the principal investigators (A. L. Beaudet, R. Bernier, J. Constantino, E. H. Cook Jr, E. Fombonne, D. Geschwind, D. E. Grice, A. Klin, D. H. Ledbetter, C. Lord, C. L. Martin, D. M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. W. State, W. Stone, J. S. Sutcliffe, C. A. Walsh and E. Wijsman) and the coordinators and staff at the SSC sites for the recruitment and comprehensive assessment of simplex families; the SFARI staff for facilitating access to the SSC; and the Rutgers University Cell and DNA Repository (RUCDR) for accessing biomaterials. We would also like to thank the CSHL Woodbury Sequencing Center, the Genome Institute at the Washington University School of Medicine, and Yale Center for Genomic Analysis (in particular J. Overton) for generating sequencing data; E. Antoniou and E. Ghiban for their assistance in data production at CSHL; and T. Brooks-Boone, N. Wright-Davis and M. Wojciechowski for their help in administering the project at Yale. The NHLBI GO Exome Sequencing Project and its ongoing studies produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Eckersiey-Maslin MA, 2014, TRENDS GENET, V30, P237, DOI 10.1016/j.tig.2014.03.003; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jeffries AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085093; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Veitia RA, 2013, TRENDS GENET, V29, P385, DOI 10.1016/j.tig.2013.04.004; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	49	1425	1456	4	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					216	U136		10.1038/nature13908	http://dx.doi.org/10.1038/nature13908			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25363768	Green Accepted			2022-12-01	WOS:000344631400039
J	Soh, YQS; Alfoldi, J; Pyntikova, T; Brown, LG; Graves, T; Minx, PJ; Fulton, RS; Kremitzki, C; Koutseva, N; Mueller, JL; Rozen, S; Hughes, JF; Owens, E; Womack, JE; Murphy, WJ; Cao, Q; de Jong, P; Warren, WC; Wilson, RK; Skaletsky, H; Page, DC				Soh, Y. Q. Shirleen; Alfoeldi, Jessica; Pyntikova, Tatyana; Brown, Laura G.; Graves, Tina; Minx, Patrick J.; Fulton, Robert S.; Kremitzki, Colin; Koutseva, Natalia; Mueller, Jacob L.; Rozen, Steve; Hughes, Jennifer F.; Owens, Elaine; Womack, James E.; Murphy, William J.; Cao, Qing; de Jong, Pieter; Warren, Wesley C.; Wilson, Richard K.; Skaletsky, Helen; Page, David C.			Sequencing the Mouse Y Chromosome Reveals Convergent Gene Acquisition and Amplification on Both Sex Chromosomes	CELL			English	Article							HYBRID MALE-STERILITY; HUMAN X-CHROMOSOME; LONG ARM; HUMAN GENOME; SEGREGATION DISTORTION; SPERMIOGENESIS GENE; REPETITIVE SEQUENCE; SPERM DEVELOPMENT; MEIOTIC DRIVE; HOUSE MICE	We sequenced the MSY (male-specific region of the Y chromosome) of the C57BL/6J strain of the laboratory mouse Mus musculus. In contrast to theories that Y chromosomes are heterochromatic and gene poor, the mouse MSY is 99.9% euchromatic and contains about 700 protein-coding genes. Only 2% of the MSY derives from the ancestral autosomes that gave rise to the mammalian sex chromosomes. Instead, all but 45 of the MSY's genes belong to three acquired, massively amplified gene families that have no homologs on primate MSYs but do have acquired, amplified homologs on the mouse X chromosome. The complete mouse MSY sequence brings to light dramatic forces in sex chromosome evolution: line-age-specific convergent acquisition and amplification of X-Y gene families, possibly fueled by antagonism between acquired X-Y homologs. The mouse MSY sequence presents opportunities for experimental studies of a sex-specific chromosome in its entirety, in a genetically tractable model organism.	[Soh, Y. Q. Shirleen; Alfoeldi, Jessica; Pyntikova, Tatyana; Brown, Laura G.; Koutseva, Natalia; Mueller, Jacob L.; Rozen, Steve; Hughes, Jennifer F.; Skaletsky, Helen; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Soh, Y. Q. Shirleen; Alfoeldi, Jessica; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Brown, Laura G.; Skaletsky, Helen; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Graves, Tina; Minx, Patrick J.; Fulton, Robert S.; Kremitzki, Colin; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Owens, Elaine; Womack, James E.; Murphy, William J.] 4458 Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Cao, Qing; de Jong, Pieter] Childrens Hosp Oakland, BACPAC Resources, Oakland, CA 94609 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Page, DC (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Soh, Shirleen/0000-0002-7422-7414; Rozen, Steven G./0000-0002-4288-0056; Kremitzki, Colin/0000-0001-9175-3136; Mueller, Jacob L./0000-0003-1232-0303	NIH; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD064753] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Goodheart for assistance with mice; D.W. Bellott, B.J. Lesch, K. Romer, and L. Teitz for comments on the manuscript and T. DiCesare for graphical assistance. This work is supported by NIH and Howard Hughes Medical Institute.	Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Bergstrom DE, 1998, GENOMICS, V48, P304, DOI 10.1006/geno.1997.5176; BISHOP CE, 1987, NUCLEIC ACIDS RES, V15, P2959, DOI 10.1093/nar/15.7.2959; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Burgoyne PS, 1998, SEMIN CELL DEV BIOL, V9, P423, DOI 10.1006/scdb.1998.0228; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; Campbell P, 2012, GENETICS, V191, P1271, DOI 10.1534/genetics.112.141804; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cocquet J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002900; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; CONWAY SJ, 1994, MAMM GENOME, V5, P203, DOI 10.1007/BF00360546; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EICHER EM, 1989, GENETICS, V122, P181; Elliott RW, 2004, MAMM GENOME, V15, P704, DOI 10.1007/s00335-004-2388-y; Elliott RW, 2001, MAMM GENOME, V12, P45, DOI 10.1007/s003350010234; Ellis PJI, 2011, HUM MOL GENET, V20, P3010, DOI 10.1093/hmg/ddr204; Ellis PJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-171; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson L, 2009, MAMM GENOME, V20, P193, DOI 10.1007/s00335-009-9175-8; FORD C. E., 1966, TRANSPLANTATION, V4, P333, DOI 10.1097/00007890-196605000-00012; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; HURST LD, 1991, GENETICS, V128, P841; HURST LD, 1992, GENETICS, V130, P229; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MCLAREN A, 1988, P NATL ACAD SCI USA, V85, P6442, DOI 10.1073/pnas.85.17.6442; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; MOENS PB, 1995, CHROMOSOMA, V104, P175, DOI 10.1007/BF00352182; Moriwaki K., 1988, MOUSE NEWS LETT, V82, P138; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; NISHIOKA Y, 1986, GENETICS, V113, P417; Oh B, 1997, DEVELOPMENT, V124, P493; OHNO S, 1967, MONOGRAPHS ENDOCRINO, V1; PALUMBO G, 1994, GENETICS, V138, P1181; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; Partridge L, 1998, SCIENCE, V281, P2003, DOI 10.1126/science.281.5385.2003; Pertile MD, 2009, GENOME RES, V19, P2202, DOI 10.1101/gr.092080.109; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; PHILLIPS SJ, 1982, NATURE, V297, P241, DOI 10.1038/297241a0; PRADO VF, 1992, CYTOGENET CELL GENET, V61, P87, DOI 10.1159/000133375; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; RICE WR, 1987, GENETICS, V116, P161; ROBERTS C, 1988, P NATL ACAD SCI USA, V85, P6446, DOI 10.1073/pnas.85.17.6446; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Silver L.M., 1995, MOUSE GENETICS CONCE; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Smit A., 1996, REPEATMASKER OPEN 3; STYRNA J, 1991, J REPROD FERTIL, V92, P187, DOI 10.1530/jrf.0.0920187; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Toure A, 2004, GENOMICS, V83, P140, DOI 10.1016/S0888-7543(03)00216-7; Vernet N, 2012, REPRODUCTION, V144, P433, DOI 10.1530/REP-12-0158; Vernet N, 2011, CURR BIOL, V21, P787, DOI 10.1016/j.cub.2011.03.057; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Yamauchi Y, 2014, SCIENCE, V343, P69, DOI 10.1126/science.1242544	88	193	196	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					800	813		10.1016/j.cell.2014.09.052	http://dx.doi.org/10.1016/j.cell.2014.09.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417157	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000344522000013
J	Inglis, T				Inglis, Tim			Developed nations must not fear sending Ebola help	NATURE			English	Editorial Material									Univ Western Australia, Nedlands, WA 6009, Australia	University of Western Australia	Inglis, T (corresponding author), Univ Western Australia, Nedlands, WA 6009, Australia.	tim.inglis@uwa.edu.au							0	4	4	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					537	537		10.1038/514537a	http://dx.doi.org/10.1038/514537a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25355324	Bronze			2022-12-01	WOS:000343801500013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Dementiagate-how politicised pay diverts GPs from working for patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				British Medical Association, GENERAL PRACTICE CON; Kmietowicz Z, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6424; NHS England, 2014, ENHANCED SERVICE SPE; UK National Screening Committee, THE UK NSC POLICY ON	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g6446	10.1136/bmj.g6446	http://dx.doi.org/10.1136/bmj.g6446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OI	25344300	Green Published, Bronze			2022-12-01	WOS:000343768700010
J	Thaiss, CA; Zeevi, D; Levy, M; Zilberman-Schapira, G; Suez, J; Tengeler, AC; Abramson, L; Katz, MN; Korem, T; Zmora, N; Kuperman, Y; Biton, I; Gilad, S; Harmelin, A; Shapiro, H; Halpern, Z; Segal, E; Elinav, E				Thaiss, Christoph A.; Zeevi, David; Levy, Maayan; Zilberman-Schapira, Gili; Suez, Jotham; Tengeler, Anouk C.; Abramson, Lior; Katz, Meirav N.; Korem, Tal; Zmora, Niv; Kuperman, Yael; Biton, Inbal; Gilad, Shlomit; Harmelin, Alon; Shapiro, Hagit; Halpern, Zamir; Segal, Eran; Elinav, Eran			Transkingdom Control of Microbiota Diurnal Oscillations Promotes Metabolic Homeostasis	CELL			English	Article							CIRCADIAN CLOCK; GUT MICROBIOTA; PHOSPHORYLATION; ENTRAINMENT; RECEPTORS; SLEEP; TIME	All domains of life feature diverse molecular clock machineries that synchronize physiological processes to diurnal environmental fluctuations. However, no mechanisms are known to cross-regulate prokaryotic and eukaryotic circadian rhythms in multikingdom ecosystems. Here, we show that the intestinal microbiota, in both mice and humans, exhibits diurnal oscillations that are influenced by feeding rhythms, leading to time-specific compositional and functional profiles over the course of a day. Ablation of host molecular clock components or induction of jet lag leads to aberrant microbiota diurnal fluctuations and dysbiosis, driven by impaired feeding rhythmicity. Consequently, jet-lag-induced dysbiosis in both mice and humans promotes glucose intolerance and obesity that are transferrable to germ-free mice upon fecal transplantation. Together, these findings provide evidence of coordinated metaorganism diurnal rhythmicity and offer a microbiome-dependent mechanism for common metabolic disturbances in humans with aberrant circadian rhythms, such as those documented in shift workers and frequent flyers.	[Thaiss, Christoph A.; Levy, Maayan; Zilberman-Schapira, Gili; Suez, Jotham; Tengeler, Anouk C.; Abramson, Lior; Katz, Meirav N.; Shapiro, Hagit; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Zeevi, David; Korem, Tal; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Katz, Meirav N.; Zmora, Niv; Halpern, Zamir] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Dept Internal Med, IL-64239 Tel Aviv, Israel; [Zmora, Niv; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Digest Ctr, IL-64239 Tel Aviv, Israel; [Kuperman, Yael; Biton, Inbal; Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Gilad, Shlomit] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Weizmann Institute of Science	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il	Elinav, Eran/ABE-8881-2020; Shapiro, Hagit/F-8648-2015; Korem, Tal/D-4155-2018; Tengeler, Anouk/H-3214-2015; Suez, Jotham/AAZ-5433-2020; Segal, Eran/AAF-4855-2019	Elinav, Eran/0000-0002-5775-2110; Korem, Tal/0000-0002-0609-0858; Tengeler, Anouk/0000-0001-8346-8132; Suez, Jotham/0000-0003-3836-972X; Zeevi, David/0000-0002-6492-6078; Segal, Eran/0000-0002-6859-1164	Weizmann Institute management; Nancy and Stephen Grand Israel Center for Personalized Medicine; Boehringer Ingelheim Fonds PhD Fellowship; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; European Research Council; Kenneth Rainin Foundation; German-Israel Binational foundation; Israel Science Foundation; Minerva Foundation; Rising Tide foundation; Alon Foundation scholar award	Weizmann Institute management; Nancy and Stephen Grand Israel Center for Personalized Medicine; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); estate of Samuel and Alwyn J. Weber; European Research Council(European Research Council (ERC)European Commission); Kenneth Rainin Foundation; German-Israel Binational foundation; Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Rising Tide foundation; Alon Foundation scholar award	We thank the members of the Elinav lab for fruitful discussions. We thank Gad Asher and Liat Rousso-Noori (Department of Biological Chemistry, Weizmann Institute of Science) for helpful advice, meaningful insights, and for providing Per1/2<SUP>-/-</SUP> mice. ASC<SUP>-/-</SUP> mice were kindly provided by Richard Flavell (Yale University). We acknowledge Carmit Bar-Nathan for dedicated germ-free mouse care taking. We thank the Weizmann Institute management and The Nancy and Stephen Grand Israel Center for Personalized Medicine for providing financial and infrastructure support. C.A.T. is the recipient of a Boehringer Ingelheim Fonds PhD Fellowship and thanks Shalev Itzkovitz and Yair Reisner for helpful discussions. E.E. is supported by Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council; the Kenneth Rainin Foundation; the German-Israel Binational foundation; the Israel Science Foundation; the Minerva Foundation; the Rising Tide foundation; and the Alon Foundation scholar award. E.E. is the incumbent of the Rina Gudinski Career Development Chair.	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lenz P, 2011, NAT REV MICROBIOL, V9, P565, DOI 10.1038/nrmicro2612; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	45	663	700	13	188	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					514	529		10.1016/j.cell.2014.09.048	http://dx.doi.org/10.1016/j.cell.2014.09.048			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417104	Bronze			2022-12-01	WOS:000344521700009
J	Turner, W				Turner, Woody			Sensing biodiversity	SCIENCE			English	Editorial Material									NASA Headquarters, Div Earth Sci, Washington, DC 20546 USA	National Aeronautics & Space Administration (NASA)	Turner, W (corresponding author), NASA Headquarters, Div Earth Sci, Washington, DC 20546 USA.	woody.turner@nasa.gov						Asner GP, 2014, P NATL ACAD SCI USA, V111, P5604, DOI 10.1073/pnas.1401181111; Cord AF, 2013, J BIOGEOGR, V40, P2226, DOI 10.1111/jbi.12199; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Organelli E, 2013, APPL OPTICS, V52, P2257, DOI 10.1364/AO.52.002257; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Spector S., 2010, REMOTE SENSING ECOLO, DOI 10.1093/oso/9780199219940.001.0001; Stoeger AS, 2014, BIOACOUSTICS, V23, P231, DOI 10.1080/09524622.2014.888375; Swatantran A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028922; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025	14	133	143	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					301	302		10.1126/science.1256014	http://dx.doi.org/10.1126/science.1256014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324372				2022-12-01	WOS:000343041100018
J	Sedgwick, P				Sedgwick, Philip			Poisson regression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019; Day, Rosie/N-5733-2015	Sedgwick, Philip/0000-0001-8859-2175; Day, Rosie/0000-0003-1766-4068				Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Sedgwick P., 2010, BMJ-BRIT MED J, V341, pc4804, DOI DOI 10.1136/BMJ.C4804; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4488; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4373; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2340; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960	6	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2014	349								g6150	10.1136/bmj.g6150	http://dx.doi.org/10.1136/bmj.g6150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7LQ	25304320				2022-12-01	WOS:000342999100003
J	Chen, JC; Alvarez, MJ; Talos, F; Dhruv, H; Rieckhof, GE; Iyer, A; Diefes, KL; Aldape, K; Berens, M; Shen, MM; Califano, A				Chen, James C.; Alvarez, Mariano J.; Talos, Flaminia; Dhruv, Harshil; Rieckhof, Gabrielle E.; Iyer, Archana; Diefes, Kristin L.; Aldape, Kenneth; Berens, Michael; Shen, Michael M.; Califano, Andrea			Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks	CELL			English	Article							B-CELL LYMPHOMA; UBIQUITIN LIGASE; MESENCHYMAL TRANSFORMATION; TUMOR-SUPPRESSOR; KAPPA-B; GLIOBLASTOMA; CANCER; PROGRESSION; PATHWAYS; GLIOMA	Identification of driver mutations in human diseases is often limited by cohort size and availability of appropriate statistical models. We propose a framework for the systematic discovery of genetic alterations that are causal determinants of disease, by prioritizing genes upstream of functional disease drivers, within regulatory networks inferred de novo from experimental data. We tested this framework by identifying the genetic determinants of the mesenchymal subtype of glioblastoma. Our analysis uncovered KLHL9 deletions as upstream activators of two previously established master regulators of the subtype, C/EBP beta and C/EBP delta. Rescue of KLHL9 expression induced proteasomal degradation of C/EBP proteins, abrogated the mesenchymal signature, and reduced tumor viability in vitro and in vivo. Deletions of KLHL9 were confirmed in > 50% of mesenchymal cases in an independent cohort, thus representing the most frequent genetic determinant of the subtype. The method generalized to study other human diseases, including breast cancer and Alzheimer's disease.	[Chen, James C.; Alvarez, Mariano J.; Rieckhof, Gabrielle E.; Iyer, Archana; Shen, Michael M.; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Chen, James C.; Alvarez, Mariano J.; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Chen, James C.; Talos, Flaminia; Shen, Michael M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Dhruv, Harshil; Berens, Michael] TGen, Canc & Cell Biol Div, Phoenix, AZ 85004 USA; [Diefes, Kristin L.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Toronto, Ontario Canc Inst, Adult Brain Tumor Ctr, Toronto, ON M5G 2M9, Canada; [Shen, Michael M.] Columbia Univ, Dept Urol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Shen, Michael M.; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Translational Genomics Research Institute; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, 1130 St Nicholas Ave, New York, NY 10032 USA.	califano@c2b2.columbia.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657; Califano, Andrea/0000-0003-4742-3679; Alfaro, Kristin/0000-0002-9870-8415; Chen, James/0000-0002-2629-1139; Shen, Mouquan/0000-0001-6448-4866	NCI CTD2 network [1RC2CA148308-01]; National Centers for Biomedical Computing NIH Roadmap Initiative [U54CA121852, R01 NS061776-05, P01CA154293]; Kirschstein NRSA training grant [T32GM082797]; CTDD grant [5U01CA16842603, W81XWH1210022]; Urology Care Foundation; NIH/NCI [P50CA127001]; Ben & Catherine IVY Foundation; NATIONAL CANCER INSTITUTE [U01CA168397, U54CA121852, P50CA127001, P01CA154293, U01CA168426, RC2CA148308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797, T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	NCI CTD2 network; National Centers for Biomedical Computing NIH Roadmap Initiative; Kirschstein NRSA training grant; CTDD grant; Urology Care Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ben & Catherine IVY Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NCI CTD2 network 1RC2CA148308-01 (A.C.), National Centers for Biomedical Computing NIH Roadmap Initiative U54CA121852 (A.C., M.J.A.), R01 NS061776-05 (A.C.), P01CA154293 (M.M.S.), Kirschstein NRSA training grant T32GM082797 (J.C.C.), CTDD grant 5U01CA16842603 (G.E.R.), W81XWH1210022 (A.I.), a fellowship from the Urology Care Foundation (F.T.), and NIH/NCI P50CA127001 (K.A., K.L.D.). H.D. and M.B. were supported by the Ben & Catherine IVY Foundation.	Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Danussi C, 2013, CANCER RES, V73, P5140, DOI 10.1158/0008-5472.CAN-13-1168-T; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tamborero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055489; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	36	124	127	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					402	414		10.1016/j.cell.2014.09.021	http://dx.doi.org/10.1016/j.cell.2014.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303533	Bronze, Green Accepted			2022-12-01	WOS:000343095600020
J	Cheng, CJ; Bahal, R; Babar, IA; Pincus, Z; Barrera, F; Liu, C; Svoronos, A; Braddock, DT; Glazer, PM; Engelman, DM; Saltzman, WM; Slack, FJ				Cheng, Christopher J.; Bahal, Raman; Babar, Imran A.; Pincus, Zachary; Barrera, Francisco; Liu, Connie; Svoronos, Alexander; Braddock, Demetrios T.; Glazer, Peter M.; Engelman, Donald M.; Saltzman, W. Mark; Slack, Frank J.			MicroRNA silencing for cancer therapy targeted to the tumour microenvironment	NATURE			English	Article							PEPTIDE-NUCLEIC-ACIDS; IN-VIVO; CELL PROLIFERATION; ONCOMIR ADDICTION; TRANSLOCATION; TRANSCRIPTOME; MOLECULES; BARRIERS; DELIVERY; MODEL	MicroRNAs are short non-codingRNAs expressed in different tissue and cell types that suppress the expression of target genes. As such, microRNAs are critical cogs innumerous biological processes(1,2), and dysregulated microRNA expression is correlated with many human diseases. Certain microRNAs, called oncomiRs, play a causal role in the onset and maintenance of cancer when overexpressed. Tumours that depend on these microRNAs are said to display oncomiR addiction(3-5). Some of the most effective anticancer therapies target oncogenes such as EGFR and HER2; similarly, inhibition of oncomiRs using antisense oligomers (that is, antimiRs) is an evolving therapeutic strategy(6,7). However, the in vivo efficacy of current antimiR technologies is hindered by physiological and cellular barriers to delivery into targeted cells(8). Here we introduce a novel antimiR delivery platform that targets the acidic tumour microenvironment, evades systemic clearance by the liver, and facilitates cell entry via a non-endocytic pathway. We find that the attachment of peptide nucleic acid antimiRs to a peptide with a low pH-induced transmembrane structure (pHLIP) produces a novel construct that could target the tumour microenvironment, transport antimiRs across plasma membranes under acidic conditions such as those found in solid tumours (pH approximately 6), and effectively inhibit the miR-155 oncomiR in a mouse model of lymphoma. This study introduces a new model for using antimiRs as anti-cancer drugs, which can have broad impacts on the field of targeted drug delivery.	[Cheng, Christopher J.; Babar, Imran A.; Pincus, Zachary; Liu, Connie; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Cheng, Christopher J.; Saltzman, W. Mark] Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; [Cheng, Christopher J.; Barrera, Francisco; Svoronos, Alexander; Engelman, Donald M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Bahal, Raman; Glazer, Peter M.] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06511 USA; [Braddock, Demetrios T.] Yale Univ, Dept Pathol, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Slack, FJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	fslack@bidmc.harvard.edu	Glazer, Peter/S-7651-2019	Barrera, Francisco N./0000-0002-5200-7891; Pincus, Zachary/0000-0001-9785-5977; Glazer, Peter/0000-0003-4525-5560; Slack, Frank/0000-0001-8263-0409; Bahal, Raman/0000-0002-4514-8004	Ruth L. Kirschstein Postdoctoral Fellowship from the National Cancer Institute/National Institutes of Health (NCI/NIH) [F32CA174247]; NCI/NIH [R01CA131301, R01CA148996]; National Heart, Lung, and Blood Institute (NHLBI)/NIH [R01HL085416]; National Institute of General Medical Sciences (NIGMS)/NIH [R01GM073857]; National Institute of Environmental Health Sciences (NIEHS)/NIH [R01ES005775]; National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH [R01EB000487]; NHLBI/NIH [2T32HL007974]; Yale Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA131301, R01CA148996, R01CA149128, F32CA174247] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085416, T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073857, T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG042487] Funding Source: NIH RePORTER	Ruth L. Kirschstein Postdoctoral Fellowship from the National Cancer Institute/National Institutes of Health (NCI/NIH); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences (NIGMS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences (NIEHS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Yale Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Bosenberg, Y. Dang, A. Karabadzhak, and J. Zhou for discussions and suggestions; R. Ardito, M. Bonk, K. Card, D. Caruso, D. Jenci, D. Laliberte, W. Nazzaro, N. Santiago, and S. Wilson for rodent services; A. Brooks for tissue pathology services; Antech Diagnostics for complete blood count analysis; E. Aronesty, B. Cooper, and E. Norris at Expression Analysis for RNA-seq services; and J. Deacon, A. Kasinski, J. Sawyer, and C. Stahlhut for reading the manuscript. C. J. C. is the recipient of a Ruth L. Kirschstein Postdoctoral Fellowship from the National Cancer Institute/National Institutes of Health (NCI/NIH) (F32CA174247). Our work has been supported by grants from the NCI/NIH (R01CA131301), the National Heart, Lung, and Blood Institute (NHLBI)/NIH (R01HL085416), the National Institute of General Medical Sciences (NIGMS)/NIH (R01GM073857), the National Institute of Environmental Health Sciences (NIEHS)/NIH (R01ES005775), the NCI/NIH (R01CA148996), the National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH (R01EB000487), the NHLBI/NIH (2T32HL007974), and pilot grants from the Yale Comprehensive Cancer Center.	Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Brognara E, 2014, J NEURO-ONCOL, V118, P19, DOI 10.1007/s11060-014-1405-6; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng CJ, 2013, CURR MED CHEM, V20, P3582; Cheng CJ, 2012, CANCER J, V18, P232, DOI 10.1097/PPO.0b013e318258b75b; Christensen L, 1995, J Pept Sci, V1, P175; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eifel PJ., 2011, DEVITA HELLMAN ROSEN; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160; Fabbri E, 2011, EPIGENOMICS-UK, V3, P733, DOI [10.2217/EPI.11.90, 10.2217/epi.11.90]; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; HE L, 2004, NAT REV GENET, V5, P522; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li SC, 2012, MOL MED REP, V5, P949, DOI 10.3892/mmr.2012.779; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; NIELSEN PE, 1994, BIOCONJUGATE CHEM, V5, P3, DOI 10.1021/bc00025a001; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; Reshetnyak YK, 2011, MOL IMAGING BIOL, V13, P1146, DOI 10.1007/s11307-010-0457-z; Reshetnyak YK, 2006, P NATL ACAD SCI USA, V103, P6460, DOI 10.1073/pnas.0601463103; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sandhu Sukhinder K, 2011, Adv Hematol, V2011, P347137, DOI 10.1155/2011/347137; Shiraishi Takehiko, 2011, Artif DNA PNA XNA, V2, P90; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Thevenin D, 2009, CHEM BIOL, V16, P754, DOI 10.1016/j.chembiol.2009.06.006; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang YZ, 2014, CLIN EXP IMMUNOL, V176, P207, DOI 10.1111/cei.12265; White PJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001021; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	37	574	601	12	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					107	+		10.1038/nature13905	http://dx.doi.org/10.1038/nature13905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25409146	Green Accepted			2022-12-01	WOS:000349098000041
J	Rosenbaum, L				Rosenbaum, Lisa			Communicating Uncertainty - Ebola, Public Health, and the Scientific Process	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2014, CBS NEWS; [Anonymous], 2014, CDCS SURG RESP W AFR; Meals R.A., 2012, SIGNAL NOISE WHY SO, V38, P2072; Slovic P., 2014, WASH POST; Sunstein C., 2001, 138 U CHIC LAW SCH O	5	32	32	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					7	9		10.1056/NEJMp1413816	http://dx.doi.org/10.1056/NEJMp1413816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX7MU	25394322	Bronze			2022-12-01	WOS:000347100800004
J	Whorton, M				Whorton, Matt			STRUCTURAL BIOLOGY Calcium-activated proteins visualized	NATURE			English	Editorial Material							TMEM16A		Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Whorton, M (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	whorton@ohsu.edu						Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	12	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					176	178		10.1038/nature13944	http://dx.doi.org/10.1038/nature13944			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25383534				2022-12-01	WOS:000346383500030
J	Chae, E; Bomblies, K; Kim, ST; Karelina, D; Zaidem, M; Ossowski, S; Martin-Pizarro, C; Laitinen, RAE; Rowan, BA; Tenenboim, H; Lechner, S; Demar, M; Habring-Muller, A; Lanz, C; Ratsch, G; Weigel, D				Chae, Eunyoung; Bomblies, Kirsten; Kim, Sang-Tae; Karelina, Darya; Zaidem, Maricris; Ossowski, Stephan; Martin-Pizarro, Carmen; Laitinen, Roosa A. E.; Rowan, Beth A.; Tenenboim, Hezi; Lechner, Sarah; Demar, Monika; Habring-Mueller, Anette; Lanz, Christa; Raetsch, Gunnar; Weigel, Detlef			Species-wide Genetic Incompatibility Analysis Identifies Immune Genes as Hot Spots of Deleterious Epistasis	CELL			English	Article							ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; MILDEW RESISTANCE; NATURAL VARIATION; INNATE IMMUNITY; MAJOR CLUSTER; EVOLUTION; HYBRID; RECEPTOR; ASSOCIATION	Intraspecific genetic incompatibilities prevent the assembly of specific alleles into single genotypes and influence genome-and species-wide patterns of sequence variation. A common incompatibility in plants is hybrid necrosis, characterized by autoimmune responses due to epistatic interactions between natural genetic variants. By systematically testing thousands of F-1 hybrids of Arabidopsis thaliana strains, we identified a small number of incompatibility hot spots in the genome, often in regions densely populated by nucleotide-binding domain and leucine-rich repeat (NLR) immune receptor genes. In several cases, these immune receptor loci interact with each other, suggestive of conflict within the immune system. A particularly dangerous locus is a highly variable cluster of NLR genes, DM2, which causes multiple independent incompatibilities with genes that encode a range of biochemical functions, including NLRs. Our findings suggest that deleterious interactions of immune receptors limit the combinations of favorable disease resistance alleles accessible to plant genomes.	[Chae, Eunyoung; Bomblies, Kirsten; Kim, Sang-Tae; Karelina, Darya; Zaidem, Maricris; Ossowski, Stephan; Martin-Pizarro, Carmen; Laitinen, Roosa A. E.; Rowan, Beth A.; Tenenboim, Hezi; Lechner, Sarah; Demar, Monika; Habring-Mueller, Anette; Lanz, Christa; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Karelina, Darya; Raetsch, Gunnar] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Bomblies, Kirsten] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kim, Sang-Tae] Inst for Basic Sci Korea, Ctr Genome Engn, Daejeon 305811, South Korea; [Ossowski, Stephan] Ctr Genom Regulat, Genom & Epigenom Variat Dis Grp, Barcelona 08003, Spain; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona 08003, Spain; [Laitinen, Roosa A. E.; Tenenboim, Hezi] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Lechner, Sarah] CeGAT GmbH, D-72076 Tubingen, Germany; [Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA	Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Harvard University; Institute for Basic Science - Korea (IBS); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Max Planck Society; CeGaT; Memorial Sloan Kettering Cancer Center	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Ossowski, Stephan/E-2139-2011; Kim, Sang-Tae/U-9457-2018; Kim, Sang-Tae/X-8917-2019; Chae, Eunyoung/AAA-6997-2021; Pizarro, Carmen Martín/AAR-3369-2021; Rätsch, Gunnar/O-5914-2017; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Ossowski, Stephan/0000-0002-7416-9568; Kim, Sang-Tae/0000-0003-1645-6021; Kim, Sang-Tae/0000-0003-1645-6021; Chae, Eunyoung/0000-0002-0889-9837; Pizarro, Carmen Martín/0000-0001-9305-3096; Rätsch, Gunnar/0000-0001-5486-8532; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Bomblies, Kirsten/0000-0002-2434-3863; Zaidem, Maricris/0000-0002-1913-6771; Rowan, Beth/0000-0001-7240-4889; Tenenboim, Hezi/0000-0002-3783-9446	NIH Ruth Kirschstein National Research Service Award; Human Frontier Science Program Long-Term Fellowship; Alexander von Humboldt Foundation Fellowship; Human Frontier Science Program Organization Grant [RGP 57/2007]; Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075741] Funding Source: NIH RePORTER	NIH Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Alexander von Humboldt Foundation Fellowship(Alexander von Humboldt Foundation); Human Frontier Science Program Organization Grant(Human Frontier Science Program); Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ruben Alcazar, Jane Parker, and Maarten Koornneef for information regarding RPP1, Jesse Poland for GBS advice, Frank Wellmer for AP3 amiRNA, Eui-Hwan Chung and Jeffery Dangl for pointers on cell-death assays, William Ho, Paula Sancha-Vilchez, and Josip Perkovic for technical support, and Jeffery Dangl, Ya-Long Guo, Daniel Koenig, George Wang, and Jun Cao for discussions. We especially thank the anonymous reviewers, who greatly helped us with the evolutionary framing of our work. This work was supported by an NIH Ruth Kirschstein National Research Service Award (K. B.), Human Frontier Science Program Long-Term Fellowship (R. A. E. L.), Alexander von Humboldt Foundation Fellowship (B. A. R.), Human Frontier Science Program Organization Grant (RGP 57/2007), and a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and the Max Planck Society (D. W.).	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4357; Chin DB, 2001, GENETICS, V157, P831; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Crespi B, 2013, TRENDS ECOL EVOL, V28, P48, DOI 10.1016/j.tree.2012.08.015; Cutter AD, 2012, TRENDS ECOL EVOL, V27, P209, DOI 10.1016/j.tree.2011.11.004; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Holub EB, 1997, ADV BOT RES, V24, P227; Hou J, 2014, CURR BIOL, V24, P1153, DOI 10.1016/j.cub.2014.03.063; Jacob F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00297; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Lachance J, 2010, EVOLUTION, V64, P3035, DOI 10.1111/j.1558-5646.2010.01028.x; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Muller H., 1942, BIOL S, V6, P71; Nemri A, 2010, P NATL ACAD SCI USA, V107, P10302, DOI 10.1073/pnas.0913160107; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V150, P449; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2013, NAT REV IMMUNOL, V13, P280, DOI 10.1038/nri3421; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Steinbrenner A D, 2012, Cold Spring Harb Symp Quant Biol, V77, P249, DOI 10.1101/sqb.2012.77.014860; Tahir J, 2013, PLANT J, V73, P118, DOI 10.1111/tpj.12021; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Todesco M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004459; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wuest SE, 2012, P NATL ACAD SCI USA, V109, P13452, DOI 10.1073/pnas.1207075109; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110	61	167	168	3	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1341	1351		10.1016/j.cell.2014.10.049	http://dx.doi.org/10.1016/j.cell.2014.10.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25467443	Bronze, Green Accepted			2022-12-01	WOS:000346652900013
J	Dias, C; Feng, J; Sun, HS; Shao, NY; Mazei-Robison, MS; Damez-Werno, D; Scobie, K; Bagot, R; LaBonte, B; Ribeiro, E; Liu, XC; Kennedy, P; Vialou, V; Ferguson, D; Pena, C; Calipari, ES; Koo, JW; Mouzon, E; Ghose, S; Tamminga, C; Neve, R; Shen, L; Nestler, EJ				Dias, Caroline; Feng, Jian; Sun, Haosheng; Shao, Ning yi; Mazei-Robison, Michelle S.; Damez-Werno, Diane; Scobie, Kimberly; Bagot, Rosemary; LaBonte, Benoit; Ribeiro, Efrain; Liu, XiaoChuan; Kennedy, Pamela; Vialou, Vincent; Ferguson, Deveroux; Pena, Catherine; Calipari, Erin S.; Koo, Ja Wook; Mouzon, Ezekiell; Ghose, Subroto; Tamminga, Carol; Neve, Rachael; Shen, Li; Nestler, Eric J.			beta-catenin mediates stress resilience through Dicer1/microRNA regulation	NATURE			English	Article							NUCLEUS-ACCUMBENS; DISTINCT ROLES; SOCIAL DEFEAT; SYNTHASE KINASE-3; STRIATAL NEURONS; TRANSCRIPTION; PATHWAY; REWARD; BDNF; IDENTIFICATION	beta-catenin is a multi-functional protein that has an important role in the mature central nervous system; its dysfunction has been implicated in several neuropsychiatric disorders, including depression. Here we show that in mice beta-catenin mediates pro-resilient and anxiolytic effects in the nucleus accumbens, a key brain reward region, an effect mediated by D2-type medium spiny neurons. Using genome-wide beta-catenin enrichment mapping, we identify Dicer1-important in small RNA (for example, microRNA) biogenesis-as a beta-catenin target gene that mediates resilience. Small RNA profiling after excising beta-catenin fromnucleus accumbens in the context of chronic stress reveals beta-catenin-dependent microRNA regulation associated with resilience. Together, these findings establish beta-catenin as a critical regulator in the development of behavioural resilience, activating a network that includes Dicer1 and downstream microRNAs. Wethus present a foundation for the development of novel therapeutic targets to promote stress resilience.	[Dias, Caroline; Feng, Jian; Sun, Haosheng; Shao, Ning yi; Mazei-Robison, Michelle S.; Damez-Werno, Diane; Scobie, Kimberly; Bagot, Rosemary; LaBonte, Benoit; Ribeiro, Efrain; Liu, XiaoChuan; Kennedy, Pamela; Vialou, Vincent; Ferguson, Deveroux; Pena, Catherine; Calipari, Erin S.; Koo, Ja Wook; Mouzon, Ezekiell; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Dias, Caroline; Feng, Jian; Sun, Haosheng; Shao, Ning yi; Mazei-Robison, Michelle S.; Damez-Werno, Diane; Scobie, Kimberly; Bagot, Rosemary; LaBonte, Benoit; Ribeiro, Efrain; Liu, XiaoChuan; Kennedy, Pamela; Vialou, Vincent; Ferguson, Deveroux; Pena, Catherine; Calipari, Erin S.; Koo, Ja Wook; Mouzon, Ezekiell; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Ghose, Subroto; Tamminga, Carol] Univ Texas Southwestern, Dept Psychiat, Dallas, TX 75390 USA; [Neve, Rachael] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT)	Shen, L (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	li.shen@mssm.edu; eric.nestler@mssm.edu	vialou, vincent/F-2968-2013; Pena, Catherine Jensen/AAU-3014-2021; SHAO, Ning-Yi/N-4947-2015; Bagot, Rosemary/V-4325-2019; Mazei-Robison, Michelle/I-4304-2017; Ghose, Subroto/J-6732-2016; Labonte, Benoit/GPF-5629-2022	vialou, vincent/0000-0002-8212-751X; Pena, Catherine Jensen/0000-0002-2884-5035; SHAO, Ning-Yi/0000-0003-4231-828X; Mazei-Robison, Michelle/0000-0002-2372-1420; Labonte, Benoit/0000-0002-1251-5605; Calipari, Erin/0000-0003-4723-0623	National Institute of Mental Health; Hope for Depression Research Foundation (HDRF); NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R00MH094405] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation (HDRF); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank O. Jabado and M. Mahajan for support and S. Borkan for providing beta-catenin constructs. This work was supported by grants from the National Institute of Mental Health and the Hope for Depression Research Foundation (HDRF).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Darvas M, 2011, BIOL PSYCHIAT, V69, P704, DOI 10.1016/j.biopsych.2010.09.033; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.ne.15.030192.001441; Goodstadt L, 2010, BIOINFORMATICS, V26, P2778, DOI 10.1093/bioinformatics/btq524; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hodar C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-348; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Rada P, 2003, NEUROSCIENCE, V119, P557, DOI 10.1016/S0306-4522(03)00162-3; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robison AJ, 2014, NEUROPSYCHOPHARMACOL, V39, P1178, DOI 10.1038/npp.2013.319; Sadot E, 2002, J CELL SCI, V115, P2771; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veronese A, 2011, P NATL ACAD SCI USA, V108, P4840, DOI 10.1073/pnas.1101734108; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Yawata S, 2012, P NATL ACAD SCI USA, V109, P12764, DOI 10.1073/pnas.1210797109	51	157	160	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					51	U86		10.1038/nature13976	http://dx.doi.org/10.1038/nature13976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25383518	Green Accepted			2022-12-01	WOS:000346310800036
J	Edwards, ST; Landon, BE				Edwards, Samuel T.; Landon, Bruce E.			Medicare's Chronic Care Management Payment - Payment Reform for Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY		[Edwards, Samuel T.] Vet Affairs Boston Healthcare Syst, Sect Gen Internal Med, Boston, MA 02130 USA; [Edwards, Samuel T.] Harvard Univ, Sch Med, Boston, MA USA; [Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Edwards, ST (corresponding author), Vet Affairs Boston Healthcare Syst, Sect Gen Internal Med, Boston, MA 02130 USA.							Centers for Medicaid and Medicare Services, MED PROGR REV PAYM B; Edwards ST, 2014, J GEN INTERN MED, V29, P947, DOI 10.1007/s11606-014-2808-y; Edwards ST, 2014, HLTH AFF MILLWOOD, V33, P1823; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Press MJ, 2014, NEW ENGL J MED, V371, P489, DOI 10.1056/NEJMp1406033	5	40	40	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2049	2051		10.1056/NEJMp1410790	http://dx.doi.org/10.1056/NEJMp1410790			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU4KP	25427110				2022-12-01	WOS:000345580000001
J	Liu, YJ; Xu, H; Kong, WJ; Shang, M; Dai, HX; Yu, JQ				Liu, Yue-Jin; Xu, Hui; Kong, Wei-Jun; Shang, Ming; Dai, Hui-Xiong; Yu, Jin-Quan			Overcoming the limitations of directed C-H functionalizations of heterocycles	NATURE			English	Article							CARBON-HYDROGEN BONDS; ORTHO-METALATION; ACTIVATION; ARYLATION; ISOCYANIDES; BORYLATION; CHEMISTRY; AROMATICS; PYRIDINE	In directed C-H activation reactions, any nitrogen or sulphur atoms present in heterocyclic substrates will coordinate strongly with metal catalysts. This coordination, which can lead to catalyst poisoning or C-H functionalization at an undesired position, limits the application of C-H activation reactions in heterocycle-based drug discovery(1-5), in which regard they have attracted much interest from pharmaceutical companies(3-5). Here we report a robust and synthetically useful method that overcomes the complications associated with performing C-H functionalization reactions on heterocycles. Our approach employs a simple N-methoxy amide group, which serves as both a directing group and an anionic ligand that promotes the in situ generation of the reactive PdX2 (X = ArCONOMe) species from a Pd(0) source using air as the sole oxidant. In this way, the PdX2 species is localized near the target C-H bond, avoiding interference from any nitrogen or sulphur atoms present in the heterocyclic substrates. This reaction overrides the conventional positional selectivity patterns observed with substrates containing strongly coordinating heteroatoms, including nitrogen, sulphur and phosphorus. Thus, this operationally simple aerobic reaction demonstrates that it is possible to bypass a fundamental limitation that has long plagued applications of directed C-H activation in medicinal chemistry.	[Liu, Yue-Jin; Xu, Hui; Kong, Wei-Jun; Shang, Ming; Dai, Hui-Xiong; Yu, Jin-Quan] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, Shanghai 200032, Peoples R China; [Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Scripps Research Institute	Dai, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	hxdai@sioc.ac.cn; yu200@scripps.edu	Kong, Wei-Jun/F-9551-2018	Kong, Wei-Jun/0000-0001-6996-3444	Shanghai Institute of Organic Chemistry; Chinese Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams; National Natural Science Foundation of China [NSFC-21121062]; Recruitment Program of Global Experts; Scripps Research Institute; NIH (NIGMS) [1R01 GM102265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Shanghai Institute of Organic Chemistry; Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Recruitment Program of Global Experts; Scripps Research Institute; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for financial support: the Shanghai Institute of Organic Chemistry, the Chinese Academy of Sciences, the CAS/SAFEA International Partnership Program for Creative Research Teams, the National Natural Science Foundation of China (grant NSFC-21121062), the Recruitment Program of Global Experts, the Scripps Research Institute and the NIH (NIGMS,1R01 GM102265).	Ackermann L, 2011, ORG LETT, V13, P3332, DOI 10.1021/ol2010648; Bryan MC, 2013, J MED CHEM, V56, P6007, DOI 10.1021/jm400250p; Campbell AN, 2012, ACCOUNTS CHEM RES, V45, P851, DOI 10.1021/ar2002045; Cho JY, 2000, J AM CHEM SOC, V122, P12868, DOI 10.1021/ja0013069; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Davies IW, 2009, SCIENCE, V325, P701, DOI 10.1126/science.1174501; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Fu HY, 2012, J ORG CHEM, V77, P4473, DOI 10.1021/jo300528b; Hurst TE, 2010, CHEM-EUR J, V16, P8155, DOI 10.1002/chem.201000401; ITO Y, 1991, J AM CHEM SOC, V113, P8899, DOI 10.1021/ja00023a043; Jun CH, 1999, SYNLETT, P1; KAKIUCHI F, 1995, B CHEM SOC JPN, V68, P62, DOI 10.1246/bcsj.68.62; Kuznetsov A, 2013, ORG LETT, V15, P2498, DOI 10.1021/ol400977r; Kwak J, 2011, J AM CHEM SOC, V133, P3780, DOI 10.1021/ja111670s; Lang S, 2013, CHEM SOC REV, V42, P4867, DOI 10.1039/c3cs60022j; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Malik HA, 2014, CHEM SCI, V5, P2352, DOI 10.1039/c3sc53414f; Meanwell NA, 2011, CHEM RES TOXICOL, V24, P1420, DOI 10.1021/tx200211v; Nakao Y, 2010, J AM CHEM SOC, V132, P13666, DOI 10.1021/ja106514b; Ritchie TJ, 2011, DRUG DISCOV TODAY, V16, P164, DOI 10.1016/j.drudis.2010.11.014; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Takagi J, 2002, TETRAHEDRON LETT, V43, P5649, DOI 10.1016/S0040-4039(02)01135-8; Tsai CC, 2010, J AM CHEM SOC, V132, P11887, DOI 10.1021/ja1061246; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Wasa M, 2010, ANGEW CHEM INT EDIT, V49, P1275, DOI 10.1002/anie.200906104; Wencel-Delord J, 2012, ANGEW CHEM INT EDIT, V51, P13001, DOI 10.1002/anie.201205734; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d	30	241	245	9	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					389	393		10.1038/nature13885	http://dx.doi.org/10.1038/nature13885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25383516	Green Accepted			2022-12-01	WOS:000345770600040
J	Meitinger, F; Khmelinskii, A; Morlot, S; Kurtulmus, B; Palani, S; Andres-Pons, A; Hub, B; Knop, M; Charvin, G; Pereira, G				Meitinger, Franz; Khmelinskii, Anton; Morlot, Sandrine; Kurtulmus, Bahtiyar; Palani, Saravanan; Andres-Pons, Amparo; Hub, Birgit; Knop, Michael; Charvin, Gilles; Pereira, Gislene			A Memory System of Negative Polarity Cues Prevents Replicative Aging	CELL			English	Article							BUD-SITE SELECTION; CELL POLARITY; CAENORHABDITIS-ELEGANS; SYMMETRY-BREAKING; SMALL GTPASES; YEAST GENES; RHO FAMILY; PROTEIN; CDC42; PHOSPHORYLATION	Cdc42 is a highly conserved master regulator of cell polarity. Here, we investigated the mechanism by which yeast cells never re-establish polarity at cortical sites (cytokinesis remnants [CRMs]) that have previously supported Cdc42-mediated growth as a paradigm to mechanistically understand how Cdc42-inhibitory polarity cues are established. We revealed a two-step mechanism of loading the Cdc42 antagonist Nba1 into CRMs to mark these compartments as refractory for a second round of Cdc42 activation. Our data indicate that Nba1 together with a cortically tethered adaptor protein confers memory of previous polarization events to translate this spatial legacy into a biochemical signal that ensures the local singularity of Cdc42 activation. "Memory loss'' mutants that repeatedly use the same polarity site over multiple generations display nuclear segregation defects and a shorter lifespan. Our work thus established CRMs as negative polarity cues that prevent Cdc42 reactivation to sustain the fitness of replicating cells.	[Meitinger, Franz; Kurtulmus, Bahtiyar; Palani, Saravanan; Andres-Pons, Amparo; Pereira, Gislene] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Khmelinskii, Anton; Knop, Michael] Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Morlot, Sandrine; Charvin, Gilles] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Hub, Birgit] German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; German Cancer Research Center (DKFZ)	Pereira, G (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	g.pereira@dkfz.de	Palani, Sarvanan/AAA-1260-2020; Pereira, Gislene/D-4024-2014; Khmelinskii, Anton/B-2830-2008	Meitinger, Franz/0000-0002-8635-9078; charvin, gilles/0000-0002-6852-6952; Palani, Saravanan/0000-0002-1893-6777; Kurtulmus, Bahtiyar/0000-0001-5796-0887; Morlot, Sandrine/0000-0002-0326-6694; Andres-Pons, Amparo/0000-0001-5801-4024; Khmelinskii, Anton/0000-0002-0256-5190	Atip Avenir program; IDEX program from the University of Strasbourg; French Ligue Nationale contre le Cancer; DFG [Sonderforschungsbereich 1036 (SFB1036), TP10]; Marie Curie Grant [MEXT-CT-042544]; graduate school LGFG "Regulation of Cell Division''; DKFZ	Atip Avenir program; IDEX program from the University of Strasbourg; French Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); DFG(German Research Foundation (DFG)); Marie Curie Grant(European Commission); graduate school LGFG "Regulation of Cell Division''; DKFZ(Helmholtz Association)	We thank Daniel Lew for reagents; Karsten Richter and DKFZ electron microscopy facility for support with electron microscopy; Daniela T. Bertazzi Lazzarini for working with Nba1 and Nis1 at the initial phase of this project; Elmar Schiebel, Iain Hagan, and members of G. P.'s lab for comments on the manuscript. G. C. was supported by the Atip Avenir program and the IDEX program from the University of Strasbourg. S. M. acknowledges a fellowship from the French Ligue Nationale contre le Cancer. M. K. and A. K. were supported by the Sonderforschungsbereich 1036 (SFB1036, TP10) from the DFG. The work of F. M., S. P., and A. A.-P. was supported by the Marie Curie Grant MEXT-CT-042544 granted to G. P. S. P. acknowledges funding from the graduate school LGFG "Regulation of Cell Division''. S. P. and B. K. are members of the international graduate school HBIGS. This project was funded by the Marie Curie Grant MEXT-CT-042544 and DKFZ core funding.	Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bloch D, 2013, CURR OPIN PLANT BIOL, V16, P734, DOI 10.1016/j.pbi.2013.10.009; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Cabib E, 1993, Arch Med Res, V24, P301; Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen CT, 2013, TRENDS CELL BIOL, V23, P118, DOI 10.1016/j.tcb.2012.10.012; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Dworkin J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003368; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fehrmann S, 2013, CELL REP, V5, P1589, DOI 10.1016/j.celrep.2013.11.013; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Iwase M, 2001, GENES GENET SYST, V76, P335, DOI 10.1266/ggs.76.335; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Keating HH, 1998, J CELL SCI, V111, P3027; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Li R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003475; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Meitinger F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001495; Meitinger F, 2011, GENE DEV, V25, P875, DOI 10.1101/gad.622411; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Noatynska A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130083; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Pollarolo G, 2011, NAT NEUROSCI, V14, P1525, DOI 10.1038/nn.2976; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Smith ST, 2013, P I CIVIL ENG-STR B, V166, P1, DOI 10.1680/stbu.2012.166.1.1; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; WADDLE JA, 1994, DEVELOPMENT, V120, P2317; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wloka C, 2012, CYTOSKELETON, V69, P710, DOI 10.1002/cm.21046	48	27	27	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1056	1069		10.1016/j.cell.2014.10.014	http://dx.doi.org/10.1016/j.cell.2014.10.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416945	Bronze			2022-12-01	WOS:000345506300018
J	Pomeranz, JL; Brownell, KD				Pomeranz, Jennifer L.; Brownell, Kelly D.			Can Government Regulate Portion Sizes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pomeranz, Jennifer L.] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Pomeranz, Jennifer L.] Temple Univ, Ctr Obes Res & Educ, Philadelphia, PA 19122 USA; [Brownell, Kelly D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Duke University	Pomeranz, JL (corresponding author), Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA.							Cohen DA, 2014, AM J PUBLIC HEALTH, V104, P586, DOI 10.2105/AJPH.2013.301692	1	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 20	2014	371	21					1956	1958		10.1056/NEJMp1410076	http://dx.doi.org/10.1056/NEJMp1410076			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT5ST	25409367				2022-12-01	WOS:000345002900002
J	McBride, CS; Baier, F; Omondi, AB; Spitzer, SA; Lutomiah, J; Sang, R; Ignell, R; Vosshall, LB				McBride, Carolyn S.; Baier, Felix; Omondi, Aman B.; Spitzer, Sarabeth A.; Lutomiah, Joel; Sang, Rosemary; Ignell, Rickard; Vosshall, Leslie B.			Evolution of mosquito preference for humans linked to an odorant receptor	NATURE			English	Article							AEGYPTI L DIPTERA; AEDES-AEGYPTI; VOLATILE COMPOUNDS; GENOME ANNOTATION; MALARIA MOSQUITO; HOST LOCATION; ALTERS ODOR; IDENTIFICATION; ALIGNMENT; BEHAVIOR	Female mosquitoes are major vectors of human disease and the most dangerous are those that preferentially bite humans. A 'domestic' form of the mosquito Aedes aegypti has evolved to specialize in biting humans and is the main worldwide vector of dengue, yellow fever, and chikungunya viruses. The domestic form coexists with an ancestral, 'forest' form that prefers to bite non-human animals and is found along the coast of Kenya. We collected the two forms, established laboratory colonies, and document striking divergence in preference for human versus non-human animal odour. We further show that the evolution of preference for human odour in domestic mosquitoes is tightly linked to increases in the expression and ligand-sensitivity of the odorant receptor AaegOr4, which we found recognizes a compound present at high levels inhuman odour. Our results provide a rare example of a gene contributing to behavioural evolution and provide insight into how disease-vectoring mosquitoes came to specialize on humans.	[McBride, Carolyn S.; Baier, Felix; Spitzer, Sarabeth A.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [McBride, Carolyn S.; Vosshall, Leslie B.] Howard Hughes Med Inst, New York, NY 10065 USA; [Omondi, Aman B.; Ignell, Rickard] Swedish Univ Agr Sci, Dept Plant Protect Biol, Unit Chem Ecol, S-23053 Alnarp, Sweden; [Lutomiah, Joel; Sang, Rosemary] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya	Rockefeller University; Howard Hughes Medical Institute; Swedish University of Agricultural Sciences; Kenya Medical Research Institute	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	Leslie.Vosshall@rockefeller.edu		Baier, Felix/0000-0003-4056-1729; Vosshall, Leslie/0000-0002-6060-8099	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health grants: K99 award from NIDCD [DC012069]; NIAID Vectorbase DBP [HHSN272200900039C]; CTSA award from NCATS [5UL1TR000043]; Swedish Research Council and SLU: Insect Chemical Ecology and Evolution (IC-E3); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012069, R00DC012069] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health grants: K99 award from NIDCD; NIAID Vectorbase DBP; CTSA award from NCATS; Swedish Research Council and SLU: Insect Chemical Ecology and Evolution (IC-E3); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. K. N. Lawniczak, K. J. Lee, M. N. Nitabach, and the Vosshall laboratory for discussion and comments on the manuscript; J. E. Brown and J. R. Powell for discussion and coordination of field collections; W. Takken for advice regarding many aspects of this work; J.-P. Mutebi, B. Miller, and A. Ponlawat for live specimens from Uganda and Thailand; D. Beck, K. Nygaard, K. Prakash, and L. Seeholzer for expert technical assistance. We also thank X. Chen for pre-publication access to a draft Ae. albopictus genome assembly, and J. Liesch for access to Orlando strain RNA-seq data. We received valuable advice on collecting and working with forest and domestic forms of Ae. aegypti from M. Trpis, J. L. Peterson, and P. Lounibos, and on the design and use of two-port olfactometers from U. Bernier and V. Sherman. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. This work was supported in part by the following National Institutes of Health grants: K99 award from NIDCD to C.S.M. (DC012069), an NIAID Vectorbase DBP subcontract to L. B. V. (HHSN272200900039C), and a CTSA award from NCATS (5UL1TR000043). R. I. received support from the Swedish Research Council and SLU: Insect Chemical Ecology and Evolution (IC-E3). L.B.V. is an investigator of the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Birkett MA, 2004, MED VET ENTOMOL, V18, P313, DOI 10.1111/j.0269-283X.2004.00528.x; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Christophers S. R., 1960, AEDES AEGYPTI YELLOW; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Coyne J. A., 2004, SPECIATION; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johns S. J., TOPO2 TRANSM PROT DI; Jumean Z, 2005, J CHEM ECOL, V31, P911, DOI 10.1007/s10886-005-3552-x; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; LABOWS J, 1979, J CHROMATOGR, V163, P294, DOI 10.1016/S0378-4347(00)81417-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd ed.; Linz J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0626; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Martin A, 2013, EVOLUTION, V67, P1235, DOI 10.1111/evo.12081; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392; MCCLELLAND G. A. H., 1960, ANN TROP MED AND PARASITOL, V54, P305; MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x; McKenna R. J., 1973, THESIS U CALIFORNIA; Menger D. J., 2014, MED VET ENTOMOL; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MUKWAYA L G, 1974, Acta Tropica, V31, P165; MUKWAYA LG, 1977, PHYSIOL ENTOMOL, V2, P133, DOI 10.1111/j.1365-3032.1977.tb00091.x; Nielsen BL, 2013, PHYSIOL BEHAV, V120, P150, DOI 10.1016/j.physbeh.2013.07.012; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Petersen, 1977, THESIS U NOTRE DAME; RINES HW, 1974, J AGR FOOD CHEM, V22, P96, DOI 10.1021/jf60191a004; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SAUL SH, 1980, AM MIDL NAT, V104, P118, DOI 10.2307/2424965; Socaci SA, 2014, PHYTOCHEM ANALYSIS, V25, P161, DOI 10.1002/pca.2483; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stoeffler M, 2007, J CHEM ECOL, V33, P1382, DOI 10.1007/s10886-007-9315-0; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; TRPIS M, 1978, B ENTOMOL RES, V68, P521, DOI 10.1017/S0007485300009494; TRPIS M, 1975, B ENTOMOL RES, V65, P199, DOI 10.1017/S0007485300005903; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Wada-Katsumata A, 2013, SCIENCE, V340, P972, DOI 10.1126/science.1234854; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	69	250	256	5	239	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					222	U151		10.1038/nature13964	http://dx.doi.org/10.1038/nature13964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25391959	Green Accepted			2022-12-01	WOS:000344631400040
J	Misof, B; Liu, SL; Meusemann, K; Peters, RS; Donath, A; Mayer, C; Frandsen, PB; Ware, J; Flouri, T; Beutel, RG; Niehuis, O; Petersen, M; Izquierdo-Carrasco, F; Wappler, T; Rust, J; Aberer, AJ; Aspock, U; Aspock, H; Bartel, D; Blanke, A; Berger, S; Bohm, A; Buckley, TR; Calcott, B; Chen, JQ; Friedrich, F; Fukui, M; Fujita, M; Greve, C; Grobe, P; Gu, SC; Huang, Y; Jermiin, LS; Kawahara, AY; Krogmann, L; Kubiak, M; Lanfear, R; Letsch, H; Li, YY; Li, ZY; Li, JG; Lu, HR; Machida, R; Mashimo, Y; Kapli, P; McKenna, DD; Meng, GL; Nakagaki, Y; Navarrete-Heredia, JL; Ott, M; Ou, YX; Pass, G; Podsiadlowski, L; Pohl, H; von Reumont, BM; Schutte, K; Sekiya, K; Shimizu, S; Slipinski, A; Stamatakis, A; Song, WH; Su, X; Szucsich, NU; Tan, MH; Tan, XM; Tang, M; Tang, JB; Timelthaler, G; Tomizuka, S; Trautwein, M; Tong, XL; Uchifune, T; Walzl, MG; Wiegmann, BM; Wilbrandt, J; Wipfler, B; Wong, TKF; Wu, Q; Wu, GX; Xie, YL; Yang, SZ; Yang, Q; Yeates, DK; Yoshizawa, K; Zhang, Q; Zhang, R; Zhang, WW; Zhang, YH; Zhao, J; Zhou, CR; Zhou, LL; Ziesmann, T; Zou, SJ; Li, YR; Xu, X; Zhang, Y; Yang, HM; Wang, J; Wang, J; Kjer, KM; Zhou, X				Misof, Bernhard; Liu, Shanlin; Meusemann, Karen; Peters, Ralph S.; Donath, Alexander; Mayer, Christoph; Frandsen, Paul B.; Ware, Jessica; Flouri, Tomas; Beutel, Rolf G.; Niehuis, Oliver; Petersen, Malte; Izquierdo-Carrasco, Fernando; Wappler, Torsten; Rust, Jes; Aberer, Andre J.; Aspoeck, Ulrike; Aspoeck, Horst; Bartel, Daniela; Blanke, Alexander; Berger, Simon; Boehm, Alexander; Buckley, Thomas R.; Calcott, Brett; Chen, Junqing; Friedrich, Frank; Fukui, Makiko; Fujita, Mari; Greve, Carola; Grobe, Peter; Gu, Shengchang; Huang, Ying; Jermiin, Lars S.; Kawahara, Akito Y.; Krogmann, Lars; Kubiak, Martin; Lanfear, Robert; Letsch, Harald; Li, Yiyuan; Li, Zhenyu; Li, Jiguang; Lu, Haorong; Machida, Ryuichiro; Mashimo, Yuta; Kapli, Pashalia; McKenna, Duane D.; Meng, Guanliang; Nakagaki, Yasutaka; Luis Navarrete-Heredia, Jose; Ott, Michael; Ou, Yanxiang; Pass, Guenther; Podsiadlowski, Lars; Pohl, Hans; von Reumont, Bjoern M.; Schuette, Kai; Sekiya, Kaoru; Shimizu, Shota; Slipinski, Adam; Stamatakis, Alexandros; Song, Wenhui; Su, Xu; Szucsich, Nikolaus U.; Tan, Meihua; Tan, Xuemei; Tang, Min; Tang, Jingbo; Timelthaler, Gerald; Tomizuka, Shigekazu; Trautwein, Michelle; Tong, Xiaoli; Uchifune, Toshiki; Walzl, Manfred G.; Wiegmann, Brian M.; Wilbrandt, Jeanne; Wipfler, Benjamin; Wong, Thomas K. F.; Wu, Qiong; Wu, Gengxiong; Xie, Yinlong; Yang, Shenzhou; Yang, Qing; Yeates, David K.; Yoshizawa, Kazunori; Zhang, Qing; Zhang, Rui; Zhang, Wenwei; Zhang, Yunhui; Zhao, Jing; Zhou, Chengran; Zhou, Lili; Ziesmann, Tanja; Zou, Shijie; Li, Yingrui; Xu, Xun; Zhang, Yong; Yang, Huanming; Wang, Jian; Wang, Jun; Kjer, Karl M.; Zhou, Xin			Phylogenomics resolves the timing and pattern of insect evolution	SCIENCE			English	Article							HOLOMETABOLOUS INSECTS; EVIDENCE CONVERGE; LIGHT	Insects are the most speciose group of animals, but the phylogenetic relationships of many major lineages remain unresolved. We inferred the phylogeny of insects from 1478 protein-coding genes. Phylogenomic analyses of nucleotide and amino acid sequences, with site-specific nucleotide or domain-specific amino acid substitution models, produced statistically robust and congruent results resolving previously controversial phylogenetic relationships. We dated the origin of insects to the Early Ordovician [similar to 479 million years ago (Ma)], of insect flight to the Early Devonian (similar to 406 Ma), of major extant lineages to the Mississippian (similar to 345 Ma), and the major diversification of holometabolous insects to the Early Cretaceous. Our phylogenomic study provides a comprehensive reliable scaffold for future comparative analyses of evolutionary innovations among insects.	[Misof, Bernhard; Meusemann, Karen; Donath, Alexander; Mayer, Christoph; Niehuis, Oliver; Petersen, Malte; Blanke, Alexander; Greve, Carola; Grobe, Peter; Wilbrandt, Jeanne; Ziesmann, Tanja] ZMB, Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany; [Liu, Shanlin; Huang, Ying; Li, Yiyuan; Meng, Guanliang; Song, Wenhui; Su, Xu; Tan, Meihua; Tang, Min; Wu, Qiong; Yang, Shenzhou; Yang, Qing; Zhang, Qing; Zhang, Rui; Zhao, Jing; Zhou, Chengran; Zhou, Lili; Zhang, Yong; Zhou, Xin] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Liu, Shanlin; Chen, Junqing; Gu, Shengchang; Huang, Ying; Li, Yiyuan; Li, Zhenyu; Li, Jiguang; Lu, Haorong; Meng, Guanliang; Ou, Yanxiang; Song, Wenhui; Su, Xu; Tan, Meihua; Tan, Xuemei; Tang, Min; Tang, Jingbo; Wu, Qiong; Wu, Gengxiong; Xie, Yinlong; Yang, Shenzhou; Yang, Qing; Zhang, Qing; Zhang, Rui; Zhang, Wenwei; Zhang, Yunhui; Zhao, Jing; Zhou, Chengran; Zhou, Lili; Zou, Shijie; Li, Yingrui; Xu, Xun; Zhang, Yong; Yang, Huanming; Wang, Jian; Wang, Jun; Zhou, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Meusemann, Karen; Slipinski, Adam; Yeates, David K.] Commonwealth Sci & Ind Res Org Australia CSIRO, Australian Natl Insect Collect, Natl Res Collect Australia, Canberra, ACT, Australia; [Peters, Ralph S.] Zool Forsch Museum Alexander Koenig ZFMK, Abt Arthropoda, Bonn, Germany; [Frandsen, Paul B.] Rutgers State Univ, Dept Entomol, Piscataway, NJ 08854 USA; [Ware, Jessica] Rutgers State Univ, Dept Biol Sci, Piscataway, NJ 08854 USA; [Flouri, Tomas; Izquierdo-Carrasco, Fernando; Aberer, Andre J.; Berger, Simon; Kapli, Pashalia; Stamatakis, Alexandros] HITS, Heidelberg, Germany; [Beutel, Rolf G.; Pohl, Hans; Wipfler, Benjamin] FSU Jena, Inst Spezielle Zool & Evolut Biol, Phyletischem Museum Jena, Jena, Germany; [Wappler, Torsten; Rust, Jes] Univ Bonn, Steinmann Inst, Bereich Palaontol, Bonn, Germany; [Aspoeck, Ulrike] Nat Hist Museum Wien, Zool Abt Insekten 2, Vienna, Austria; [Aspoeck, Ulrike; Bartel, Daniela; Boehm, Alexander; Pass, Guenther; Szucsich, Nikolaus U.; Timelthaler, Gerald; Walzl, Manfred G.] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Aspoeck, Horst] MUW, Inst Spezif Prophylaxe & Tropenmed, Vienna, Austria; [Buckley, Thomas R.] Manaaki Whenua Landcare Res, Auckland, New Zealand; [Calcott, Brett] Johns Hopkins Univ, Dept Emergency Med, Ctr Adv Modeling, Baltimore, MD 21209 USA; [Friedrich, Frank; Kubiak, Martin] Univ Hamburg, Biozentrum Grindel, Hamburg, Germany; [Friedrich, Frank; Kubiak, Martin] Univ Hamburg, Zool Museum, Hamburg, Germany; [Fukui, Makiko] Ehime Univ, Grad Sch Sci & Engn, Evolutionary Morphol Lab, Matsuyama, Ehime 790, Japan; [Blanke, Alexander; Fujita, Mari; Machida, Ryuichiro; Mashimo, Yuta; Nakagaki, Yasutaka; Sekiya, Kaoru; Shimizu, Shota; Tomizuka, Shigekazu; Uchifune, Toshiki] Univ Tsukuba, Sugadaira Montane Res Ctr, Hexapod Comparat Embryol Lab, Tsukuba, Ibaraki 305, Japan; [Jermiin, Lars S.; Wong, Thomas K. F.] CSIRO, Land & Water Flagship, Canberra, ACT, Australia; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Krogmann, Lars] SMNS, Stuttgart, Germany; [Lanfear, Robert] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Lanfear, Robert] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [Lanfear, Robert] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Letsch, Harald] Univ Vienna, Dept Bot & Biodiversitatsforsch, Vienna, Austria; [Kapli, Pashalia] Univ Crete, Nat Hist Museum Crete, GR-71409 Iraklion, Greece; [Kapli, Pashalia] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [McKenna, Duane D.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [McKenna, Duane D.] Univ Memphis, Feinstone Ctr Genom Res, Memphis, TN 38152 USA; [Luis Navarrete-Heredia, Jose] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Ctr Estudios Zool, Zapopan, Jalisco, Mexico; [Ott, Michael] Bavarian Acad Sci & Humanities, Leibniz Supercomp Ctr, Garching, Germany; [Podsiadlowski, Lars] Univ Bonn, Inst Evolutionary Biol & Ecol Zool & Evolutionary, Bonn, Germany; [von Reumont, Bjoern M.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Schuette, Kai] Univ Hamburg, Abt Entomol, Biozentrum Grindel, Hamburg, Germany; [Schuette, Kai] Univ Hamburg, Zool Museum, Hamburg, Germany; [Stamatakis, Alexandros] Karlsruher Inst Technol, Fak Informat, Karlsruhe, Germany; [Trautwein, Michelle] Calif Acad Sci, San Francisco, CA 94118 USA; [Tong, Xiaoli] South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Uchifune, Toshiki] Yokosuka City Museum, Yokosuka, Kanagawa, Japan; [Wiegmann, Brian M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Yoshizawa, Kazunori] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kjer, Karl M.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Piscataway, NJ 08854 USA	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Rutgers State University New Brunswick; Rutgers State University New Brunswick; Friedrich Schiller University of Jena; University of Bonn; University of Vienna; Landcare Research - New Zealand; Johns Hopkins University; University of Hamburg; University of Hamburg; Ehime University; University of Tsukuba; Commonwealth Scientific & Industrial Research Organisation (CSIRO); State University System of Florida; University of Florida; Australian National University; The National Evolutionary Synthesis Center; Macquarie University; University of Vienna; University of Crete; University of Crete; University of Memphis; University of Memphis; Universidad de Guadalajara; University of Bonn; Natural History Museum London; University of Hamburg; University of Hamburg; Helmholtz Association; Karlsruhe Institute of Technology; California Academy of Sciences; South China Agricultural University; University of North Carolina; North Carolina State University; Hokkaido University; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; Rutgers State University New Brunswick	Misof, B (corresponding author), ZMB, Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany.	b.misof.zfmk@uni-bonn.de; wangj@genomics.cn; kjer@aesop.rutgers.edu; xinzhou@genomics.cn	Pohl, Hans/M-6873-2019; Jermiin, Lars Sommer/C-2458-2009; Donath, Alexander/F-2636-2015; Buckley, Thomas/H-1284-2012; Wong, Thomas/J-7623-2013; Lanfear, Robert/A-2022-2010; Li, Yiyuan/I-8414-2019; Mayer, Christoph/AAD-6696-2019; Yoshizawa, Kazunori/Q-9390-2019; Zhou, Xin/D-4025-2009; Podsiadlowski, Lars/B-2796-2008; Liu, Shanlin/GNH-3256-2022; Friedrich, Frank/A-8309-2015; Stamatakis, Alexandros/B-8740-2009; Slipinski, Adam/AAZ-2485-2020; Kapli, Paschalia/AAL-3890-2021; Yeates, David K/A-9917-2008; von Reumont, Bjoern M/Q-7065-2018; Blanke, Alexander/H-9858-2013; Aspöck, Horst/O-1990-2017; Wipfler, Benjamin/M-2926-2015; Slipinski, Stanislaw Adam/B-4293-2009; Ho, Igor Osorio/AAG-8616-2020; Li, Yingrui/K-1064-2015; Navarrete-Heredia, José/T-8250-2019; Wappler, Torsten/D-4287-2011; Liu, Shanlin/HGA-2841-2022; Wappler, Torsten/P-6831-2019; Xu, Xun/AAI-6763-2020; Jermiin, Lars Sommer/AAQ-7033-2020; Navarrete-Heredia, José L/R-3624-2019; Meusemann, Karen/J-4027-2013; Szucsich, Nikolaus/O-1776-2017; Zhou, Xin/AAI-9326-2021; Yoshizawa, Kazunori/A-4268-2012; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jermiin, Lars Sommer/0000-0002-9619-3809; Donath, Alexander/0000-0001-5618-0547; Buckley, Thomas/0000-0002-3076-4234; Wong, Thomas/0000-0002-0580-6324; Lanfear, Robert/0000-0002-1140-2596; Li, Yiyuan/0000-0003-1426-0033; Mayer, Christoph/0000-0001-5104-6621; Yoshizawa, Kazunori/0000-0001-6170-4296; Zhou, Xin/0000-0002-1407-7952; Podsiadlowski, Lars/0000-0001-7786-8930; Liu, Shanlin/0000-0001-8118-8313; Stamatakis, Alexandros/0000-0003-0353-0691; Slipinski, Adam/0000-0002-1216-8068; Yeates, David K/0000-0001-7729-6143; von Reumont, Bjoern M/0000-0002-7462-8226; Aspöck, Horst/0000-0001-9407-3566; Wappler, Torsten/0000-0003-1592-0988; Liu, Shanlin/0000-0001-8118-8313; Wappler, Torsten/0000-0003-1592-0988; Xu, Xun/0000-0002-5338-5173; Jermiin, Lars Sommer/0000-0002-9619-3809; Szucsich, Nikolaus/0000-0002-8945-5153; Zhou, Xin/0000-0002-1407-7952; Mashimo, Yuta/0000-0001-6866-1778; Trautwein, Michelle/0000-0003-4469-5839; Blanke, Alexander/0000-0003-4385-6039; Ware, Jessica/0000-0002-4066-7681; Letsch, Harald/0000-0001-9854-4855; Petersen, Malte/0000-0001-7601-9873; FUKUI, Makiko/0000-0002-0525-1621; Tang, Min/0000-0002-6021-7282; Timelthaler, Gerald/0000-0002-0260-089X; Wang, Jun/0000-0002-8540-8931; Pohl, Hans/0000-0002-7090-6612; MENG, GUANLIANG/0000-0002-6488-1527; Wang, Jun/0000-0002-2113-5874; Frandsen, Paul/0000-0002-4801-7579	Umbrella BioProject [PRJNA183205]; China National GeneBank; BGI-Shenzhen, China; German Research Foundation [NI 1387/1-1, MI 649/6, MI 649/10, RE 345/1-2, BE1789/8-1, BE 1789/10-1, STA 860/4, WA 1496/8-1]; Austria Science Fund FWF; NSF [DEB 0816865]; Ministry of Education, Culture, Sports, Science and Technology of Japan [B 22770090]; Japan Society for the Promotion of Science [P14071]; Deutsches Elektronen-Synchrotron [I-20120065]; Paul Scherrer Institute [20110069]; Schlinger Endowment to CSIRO Ecosystem Sciences; Heidelberg Institute for Theoretical Studies; University of Memphis-FedEx Institute of Technology; Rutgers University; Division Of Environmental Biology [1257960] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [P 23251] Funding Source: researchfish	Umbrella BioProject; China National GeneBank; BGI-Shenzhen, China; German Research Foundation(German Research Foundation (DFG)); Austria Science Fund FWF(Austrian Science Fund (FWF)); NSF(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsches Elektronen-Synchrotron; Paul Scherrer Institute; Schlinger Endowment to CSIRO Ecosystem Sciences; Heidelberg Institute for Theoretical Studies; University of Memphis-FedEx Institute of Technology; Rutgers University; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The data reported in this paper are tabulated in the supplementary materials and archived at National Center for Biotechnology Information, NIH, under the Umbrella BioProject ID PRJNA183205 ("The 1KITE project: evolution of insects"). Supplementary files are archived at the Dryad Digital Repository http://dx.doi.org/10.5061/dryad.3c0f1. Funding support: China National GeneBank and BGI-Shenzhen, China; German Research Foundation (NI 1387/1-1; MI 649/6, MI 649/10, RE 345/1-2, BE1789/8-1, BE 1789/10-1, STA 860/4, Heisenberg grant WA 1496/8-1); Austria Science Fund FWF; NSF (DEB 0816865); Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid for Young Scientists (B 22770090); Japan Society for the Promotion of Science (P14071); Deutsches Elektronen-Synchrotron (I-20120065); Paul Scherrer Institute (20110069); Schlinger Endowment to CSIRO Ecosystem Sciences; Heidelberg Institute for Theoretical Studies; University of Memphis-FedEx Institute of Technology; and Rutgers University. The authors declare no conflicts of interest.	Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Blanke A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-16; Dell'Ampio E, 2014, MOL BIOL EVOL, V31, P239, DOI 10.1093/molbev/mst196; Doyle JA, 2012, ANNU REV EARTH PL SC, V40, P301, DOI 10.1146/annurev-earth-042711-105313; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Hennig W., 1969, STAMMESGESCHICHTE IN; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Labandeira Conrad, 2006, Arthropod Systematics & Phylogeny, V64, P53; Labandeira CC, 2014, NEW PHYTOL, V202, P247, DOI 10.1111/nph.12643; Letsch H, 2013, SYST ENTOMOL, V38, P783, DOI 10.1111/syen.12028; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Nel A, 2013, NATURE, V503, P257, DOI 10.1038/nature12629; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; Prokop J, 2005, GEOBIOS-LYON, V38, P383, DOI 10.1016/j.geobios.2003.11.006; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Smith VS, 2011, BIOL LETTERS, V7, P782, DOI 10.1098/rsbl.2011.0105; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x	21	1521	1576	49	1074	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					763	767		10.1126/science.1257570	http://dx.doi.org/10.1126/science.1257570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378627				2022-12-01	WOS:000344690100045
J	Adams, WM				Adams, W. M.			The value of valuing nature	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY; CONSERVATION; CHALLENGE; BENEFITS; FOREST		Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England	University of Cambridge	Adams, WM (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	wa12@cam.ac.uk		Adams, William/0000-0002-1559-0379				Abson DJ, 2011, CONSERV BIOL, V25, P250, DOI 10.1111/j.1523-1739.2010.01623.x; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Birch JC, 2014, ECOSYST SERV, V8, P118, DOI 10.1016/j.ecoser.2014.03.005; Cimon-Morin J, 2013, BIOL CONSERV, V166, P144, DOI 10.1016/j.biocon.2013.06.023; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Kallis G, 2013, ECOL ECON, V94, P97, DOI 10.1016/j.ecolecon.2013.07.002; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Lopez-Hoffman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087912; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Moller I, 2011, ESTUAR COAST SHELF S, V92, P424, DOI 10.1016/j.ecss.2011.01.016; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Muradian R, 2012, ECOSYST SERV, V1, P93, DOI 10.1016/j.ecoser.2012.07.009; Palmer MA, 2014, ECOL ENG, V65, P62, DOI 10.1016/j.ecoleng.2013.07.059; Redford KH, 2014, ORYX, V48, P330, DOI 10.1017/S0030605314000040; Redford KH, 2009, CONSERV BIOL, V23, P785, DOI 10.1111/j.1523-1739.2009.01271.x; Simonit S, 2013, P NATL ACAD SCI USA, V110, P9326, DOI 10.1073/pnas.1112242110	16	71	74	2	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		549	551		10.1126/science.1255997	http://dx.doi.org/10.1126/science.1255997			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BE	25359952				2022-12-01	WOS:000343799700023
J	Cheung, F				Cheung, Felix			The search for the rice of the future	NATURE			English	Editorial Material							GENE											[Anonymous], 2014, GIGASCIENCE, V3, P7; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; LI JW, 2014, CHINA RICE, V20, P7; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yuan LP, 2014, RICE SCI, V21, P1, DOI 10.1016/S1672-6308(13)60167-5	8	10	12	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S60	S61		10.1038/514S60a	http://dx.doi.org/10.1038/514S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368890				2022-12-01	WOS:000343801500006
J	Eisenstein, M				Eisenstein, Michael			Against the grain	NATURE			English	Editorial Material							GOLDEN-RICE; BETA-CAROTENE; VITAMIN-A											Johnson AAT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024476; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Tang GW, 2012, AM J CLIN NUTR, V96, P658, DOI 10.3945/ajcn.111.030775; Wang M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00156; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303	6	15	16	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S55	S57		10.1038/514S55a	http://dx.doi.org/10.1038/514S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25368888	Bronze			2022-12-01	WOS:000343801500004
J	Friedman, RA				Friedman, Richard A.			Antidepressants' Black-Box Warning-10 Years Later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FDA WARNINGS; DEPRESSION		[Friedman, Richard A.] Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA; [Friedman, Richard A.] Cornell Univ, Psychopharmacol Clin, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Friedman, RA (corresponding author), Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA.							[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P321; Hamad T, RELATIONSHIP PSYCHOT; Libby AM, 2009, ARCH GEN PSYCHIAT, V66, P633, DOI 10.1001/archgenpsychiatry.2009.46; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Valuck RJ, 2007, AM J PSYCHIAT, V164, P1198, DOI 10.1176/appi.ajp.2007.07010007	5	69	72	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 30	2014	371	18					1666	1668		10.1056/NEJMp1408480	http://dx.doi.org/10.1056/NEJMp1408480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR7OG	25354101				2022-12-01	WOS:000343768500003
J	Zeigler, R				Zeigler, Robert			Time to unleash rice	NATURE			English	Editorial Material									Int Rice Res Inst, Los Banos, Philippines	CGIAR; International Rice Research Institute (IRRI)	Zeigler, R (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	r.zeigler@irri.org							0	4	5	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					S66	S66		10.1038/514S66a	http://dx.doi.org/10.1038/514S66a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR8BW	25368893	Bronze			2022-12-01	WOS:000343801500009
J	Ferrannini, E				Ferrannini, Ele			The Target of Metformin in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Pisa, Dept Clin & Expt Med, Pisa, Italy	University of Pisa	Ferrannini, E (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.							Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Brown JB, 2010, DIABETES CARE, V33, P501, DOI 10.2337/dc09-1749; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Natali A, 2004, DIABETES CARE, V27, P1349, DOI 10.2337/diacare.27.6.1349	5	76	83	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2014	371	16					1547	1548		10.1056/NEJMcibr1409796	http://dx.doi.org/10.1056/NEJMcibr1409796			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7KV	25317875				2022-12-01	WOS:000342994700014
J	Ma, H; Groth, RD; Cohen, SM; Emery, JF; Li, BX; Hoedt, E; Zhang, GA; Neubert, TA; Tsien, RW				Ma, Huan; Groth, Rachel D.; Cohen, Samuel M.; Emery, John F.; Li, Boxing; Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.; Tsien, Richard W.			gamma CaMKII Shuttles Ca2+/CaM to the Nucleus to Trigger CREB Phosphorylation and Gene Expression	CELL			English	Article							PROTEIN-KINASE-II; CALMODULIN COMPLEX; TRANSCRIPTION; MEMORY; SIGNAL; DEPOLARIZATION; TRANSLOCATION; CALCINEURIN; ACTIVATION; SYNAPSE	Activity-dependent CREB phosphorylation and gene expression are critical for long-term neuronal plasticity. Local signaling at Ca(V)1 channels triggers these events, but how information is relayed onward to the nucleus remains unclear. Here, we report a mechanism that mediates long-distance communication within cells: a shuttle that transports Ca2+/calmodulin from the surface membrane to the nucleus. We show that the shuttle protein is gamma CaMKII, its phosphorylation at Thr287 by beta CaMKII protects the Ca2+/CaM signal, and CaN triggers its nuclear translocation. Both beta CaMKII and CaN act in close proximity to Ca(V)1 channels, supporting their dominance, whereas gamma CaMKII operates as a carrier, not as a kinase. Upon arrival within the nucleus, Ca2+/CaM activates CaMKK and its substrate CaMKIV, the CREB kinase. This mechanism resolves long-standing puzzles about CaM/CaMK-dependent signaling to the nucleus. The significance of the mechanism is emphasized by dysregulation of Ca(V)1, gamma CaMKII, beta CaMKII, and CaN in multiple neuropsychiatric disorders.	[Ma, Huan; Cohen, Samuel M.; Emery, John F.; Li, Boxing; Tsien, Richard W.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, Inst Neurosci, New York, NY 10016 USA; [Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.] NYU, Langone Med Ctr, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Hoedt, Esthelle; Zhang, Guoan; Neubert, Thomas A.] NYU, Langone Med Ctr, Skirball Inst, New York, NY 10016 USA; [Groth, Rachel D.] Pfizer, Ctr Therapeut Innovat, San Francisco, CA 94158 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Pfizer	Ma, H (corresponding author), NYU, Langone Med Ctr, Dept Neurosci & Physiol, Inst Neurosci, New York, NY 10016 USA.	mahuan@gmail.com; richard.tsien@nyumc.org	Ma, Huan/A-1379-2012	neubert, Thomas/0000-0001-7049-2088	National Institute of General Medical Sciences [GM058234]; National Institute of Neurological Disorders and Stroke [NS24067]; National Institute of Mental Health [MH071739]; Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Medical Scientist Training Program Fellowship; NIH [NP30 NS050276, S10 RR027990]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071739, R37MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, R01NS024067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA040484] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Family Foundation; Mathers Family Foundation; Burnett Family Foundation; Medical Scientist Training Program Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Gord Fishell, Andy Hudmon, Paul De Koninck, Niels Ringstad, and Michael Tadross for insightful comments on an earlier manuscript and Steven Burden for valuable suggestions. We thank Kathleen Morgan and Cynthia Gallant for their support at initial stages. We also thank Tsien laboratory members for discussions throughout the execution of this project. This work was supported by research grants to R.W.T. from the National Institute of General Medical Sciences (GM058234), the National Institute of Neurological Disorders and Stroke (NS24067), the National Institute of Mental Health (MH071739), and the Simons, Mathers, and Burnett Family Foundations. S.C. is supported by a Medical Scientist Training Program Fellowship. The Neubert laboratory is supported by the NIH (NP30 NS050276 and S10 RR027990 to T.A.N.).	BACHS O, 1994, CELL CALCIUM, V16, P289, DOI 10.1016/0143-4160(94)90092-2; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Gangopadhyay SS, 2003, BIOCHEM J, V372, P347, DOI 10.1042/BJ20030015; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Hahm SH, 2003, MOL PHARMACOL, V64, P1503, DOI 10.1124/mol.64.6.1503; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma H, 2013, BIOSCIENCE REP, V33, P97, DOI 10.1042/BSR20120099; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mermelstein PG, 2001, P NATL ACAD SCI USA, V98, P15342, DOI 10.1073/pnas.211563998; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Saha RN, 2008, EXP BIOL MED, V233, P385, DOI 10.3181/0709-MR-241; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Stratton M, 2014, ELIFE, V3, DOI 10.7554/eLife.02490; Takeuchi M, 1998, GENE, V221, P107, DOI 10.1016/S0378-1119(98)00422-3; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Thorogate R, 2004, J CELL SCI, V117, P5923, DOI 10.1242/jcs.01510; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	62	151	152	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					281	294		10.1016/j.cell.2014.09.019	http://dx.doi.org/10.1016/j.cell.2014.09.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303525	Green Accepted, Bronze			2022-12-01	WOS:000343095600011
J	Dunn, AG; Arachi, D; Hudgins, J; Tsafnat, G; Coiera, E; Bourgeois, FT				Dunn, Adam G.; Arachi, Diana; Hudgins, Joel; Tsafnat, Guy; Coiera, Enrico; Bourgeois, Florence T.			Financial Conflicts of Interest and Conclusions About Neuraminidase Inhibitors for Influenza An Analysis of Systematic Reviews	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-STUDY REPORTS; DRUG TRIALS; INDUSTRY SPONSORSHIP; METAANALYSIS; OSELTAMIVIR; OUTCOMES; ADULTS; BIAS; ASSOCIATION; PUBLICATION	Background: Industry funding and financial conflicts of interest may contribute to bias in the synthesis and interpretation of scientific evidence. Objective: To examine the association between financial conflicts of interest and characteristics of systematic reviews of neuraminidase inhibitors. Design: Retrospective analysis. Setting: Reviews that examined the use of neuraminidase inhibitors in the prophylaxis or treatment of influenza, were published between January 2005 and May 2014, and used a systematic search protocol. Measurements: Two investigators blinded to all information regarding the review authors independently assessed the presentation of evidence on the use of neuraminidase inhibitors as favorable or not favorable. Financial conflicts of interest were identified using the index reviews, other publications, and Web-based searches. Associations between financial conflicts of interest, favorability assessments, and presence of critical appraisals of evidence quality were analyzed. Results: Twenty-six systematic reviews were identified, of which 13 examined prophylaxis and 24 examined treatment, accounting for 37 distinct assessments. Among assessments associated with a financial conflict of interest, 7 of 8 (88%) were classified as favorable, compared with 5 of 29 (17%) among those without a financial conflict of interest. Reviewers without financial conflicts of interest were more likely to include statements about the quality of the primary studies than those with financial conflicts of interest. Limitations: The heterogeneity in populations and outcomes examined in the reviews precluded analysis of the contribution of selective inclusion of evidence on the discordance of the assessments made in the reviews. Many of the systematic reviews had overlapping authorship. Conclusion: Reviewers with financial conflicts of interest may be more likely to present evidence about neuraminidase inhibitors in a favorable manner and recommend the use of these drugs than reviewers without financial conflicts of interest.	[Dunn, Adam G.] Univ New S Wales, Ctr Hlth Informat, Sydney, NSW 2052, Australia; Boston Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	University of New South Wales Sydney; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Dunn, AG (corresponding author), Univ New S Wales, Ctr Hlth Informat, Sydney, NSW 2052, Australia.	a.dunn@unsw.edu.au	Dunn, Adam/H-4425-2019; Arachi, Diana/AAY-8129-2020; Bourgeois, Florence/H-6710-2016	Dunn, Adam/0000-0002-1720-8209; Arachi, Diana/0000-0003-2446-7011; Bourgeois, Florence/0000-0001-7798-4560; Coiera, Enrico/0000-0002-6444-6584	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Primary Funding Source: Australian National Health and Medical Research Council.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Aoki FY, 2013, J INFECT DIS, V207, P547, DOI 10.1093/infdis/jis727; Beck CR, 2013, INFLUENZA OTHER RESP, V7, P14, DOI 10.1111/irv.12048; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Cohen D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2591; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Ebell MH, 2013, FAM PRACT, V30, P125, DOI 10.1093/fampra/cms059; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Groves T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4687; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2263; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Jones M, 2006, EXPERT OPIN DRUG SAF, V5, P603, DOI 10.1517/14740338.5.5.603; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Krumholz HM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2548; Krumholz HM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f547; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub2, 10.1002/14651858.MR000033.pub3]; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Payne D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7303; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Rattinger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005826; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Roundtree AK, 2009, J CLIN EPIDEMIOL, V62, P128, DOI 10.1016/j.jclinepi.2008.08.003; Schmidt AF, 2014, J CLIN EPIDEMIOL, V67, P635, DOI 10.1016/j.jclinepi.2013.12.005; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Smith JR, 2010, CRIT CARE MED, V38, pE43, DOI 10.1097/CCM.0b013e3181c85229; Smith R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g171; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	46	50	51	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					513	+		10.7326/M14-0933	http://dx.doi.org/10.7326/M14-0933			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25285542				2022-12-01	WOS:000343896700010
J	Oehlers, SH; Cronan, MR; Scott, NR; Thomas, MI; Okuda, KS; Walton, EM; Beerman, RW; Crosier, PS; Tobin, DM				Oehlers, Stefan H.; Cronan, Mark R.; Scott, Ninecia R.; Thomas, Monica I.; Okuda, Kazuhide S.; Walton, Eric M.; Beerman, Rebecca W.; Crosier, Philip S.; Tobin, David M.			Interception of host angiogenic signalling limits mycobacterial growth	NATURE			English	Article							ZEBRAFISH; GRANULOMA; METRONIDAZOLE; TUBERCULOSIS; INFECTION; TUMOR; VEGF; MACROPHAGE; INHIBITOR; TISSUE	Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis(1,2). Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis(2). Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations(3). Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.	[Oehlers, Stefan H.; Cronan, Mark R.; Scott, Ninecia R.; Thomas, Monica I.; Walton, Eric M.; Beerman, Rebecca W.; Tobin, David M.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC 27710 USA; [Okuda, Kazuhide S.; Crosier, Philip S.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1023, New Zealand	Duke University; University of Auckland	Tobin, DM (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC 27710 USA.	david.tobin@duke.edu	Okuda, Kazuhide Shaun/N-2576-2017; Oehlers, Stefan/L-5341-2019	Okuda, Kazuhide Shaun/0000-0002-8060-0377; Oehlers, Stefan/0000-0003-0260-672X; Beerman, Rebecca/0000-0002-2057-4170; Scott, Ninecia/0000-0002-7847-0673; Cronan, Mark/0000-0002-3760-1649; Tobin, David/0000-0003-3465-5518	Australian National Health and Medical Research Council CJ Martin Early Career Fellowship; American Cancer Society Postdoctoral Fellowship [PF-13-223-01-MPC]; Duke Summer Research Opportunities Program; Malaysian Ministry of Science and Technology and Innovation scholarship; New Zealand Ministry of Science and Innovation [UOAX0813]; Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH) [5P30 AI064518]; Mallinckrodt Scholar Award; Searle Scholar Award; Vallee Foundation Young Investigator Award; NIH Director's New Innovator Award [1DP2-OD008614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council CJ Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Duke Summer Research Opportunities Program; Malaysian Ministry of Science and Technology and Innovation scholarship; New Zealand Ministry of Science and Innovation; Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt Scholar Award; Searle Scholar Award; Vallee Foundation Young Investigator Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Sisk and J. Saelens for technical assistance, L. Ramakrishnan, P. Edelstein and C. Kontos for helpful discussions, L. Ramakrishnan, W. Britton and J. Coers for critical review of the manuscript, and J. Fuller, C. Gallione, E. Linney, H. Mao, S. Lee, D. Marchuk, H. Matsunami, A. Nixon, J. Perfect, J. Rawls, D. Silver, K. Smith, K. Takaki, J. Tenor and B. Uy for reagents and equipment This work was funded by an Australian National Health and Medical Research Council CJ Martin Early Career Fellowship (S.H.O.); an American Cancer Society Postdoctoral Fellowship PF-13-223-01-MPC (M.R.C.); the Duke Summer Research Opportunities Program (N.R.S.); a Malaysian Ministry of Science and Technology and Innovation scholarship (K.S.O.); a New Zealand Ministry of Science and Innovation grant UOAX0813 (P.S.C.); the Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH)-funded program (5P30 AI064518), and by a Mallinckrodt Scholar Award, a Searle Scholar Award, a Vallee Foundation Young Investigator Award and an NIH Director's New Innovator Award 1DP2-OD008614 (D.M.T.).	Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Carroll MW, 2013, ANTIMICROB AGENTS CH, V57, P3903, DOI 10.1128/AAC.00753-13; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Elks PM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003789; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fong TAT, 1999, CANCER RES, V59, P99; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Liang D, 1998, BBA-GENE STRUCT EXPR, V1397, P14, DOI 10.1016/S0167-4781(97)00233-9; Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Podar K, 2006, P NATL ACAD SCI USA, V103, P19478, DOI 10.1073/pnas.0609329103; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rittershaus ESC, 2013, CELL HOST MICROBE, V13, P643, DOI 10.1016/j.chom.2013.05.012; Saita N, 2000, INFECT IMMUN, V68, P5991, DOI 10.1128/IAI.68.10.5991-5997.2000; Santhakumar K, 2012, CANCER RES, V72, P4017, DOI 10.1158/0008-5472.CAN-11-3148; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367	38	157	163	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					612	U178		10.1038/nature13967	http://dx.doi.org/10.1038/nature13967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25470057	Green Accepted, Green Submitted			2022-12-01	WOS:000348775000043
J	Gostin, LO; Waxman, HA; Foege, W				Gostin, Lawrence O.; Waxman, Henry A.; Foege, William			The President's National Security Agenda Curtailing Ebola, Safeguarding the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Waxman, Henry A.] US House Representat, Washington, DC USA; [Foege, William] Emory Univ, Sch Publ Hlth, Atlanta, GA USA	Georgetown University; Emory University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu						[Anonymous], BUDGET CUTS CONTINUE; Barry M, 2014, LOS ANGELES TIMES; Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186	4	14	14	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					27	28		10.1001/jama.2014.16572	http://dx.doi.org/10.1001/jama.2014.16572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25412348				2022-12-01	WOS:000347478000008
J	Willyard, C				Willyard, Cassandra			Balancing act	NATURE			English	Editorial Material																		NORDFANG O, 1991, THROMB HAEMOSTASIS, V66, P464	1	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S168	S169		10.1038/515S168a	http://dx.doi.org/10.1038/515S168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427209				2022-12-01	WOS:000346247600011
J	Fowler, BJ; Gelfand, BD; Kim, Y; Kerur, N; Tarallo, V; Hirano, Y; Amarnath, S; Fowler, DH; Radwan, M; Young, MT; Pittman, K; Kubes, P; Agarwal, HK; Parang, K; Hinton, DR; Bastos-Carvalho, A; Li, SJ; Yasuma, T; Mizutani, T; Yasuma, R; Wright, C; Ambati, J				Fowler, Benjamin J.; Gelfand, Bradley D.; Kim, Younghee; Kerur, Nagaraj; Tarallo, Valeria; Hirano, Yoshio; Amarnath, Shoba; Fowler, Daniel H.; Radwan, Marta; Young, Mark T.; Pittman, Keir; Kubes, Paul; Agarwal, Hitesh K.; Parang, Keykavous; Hinton, David R.; Bastos-Carvalho, Ana; Li, Shengjian; Yasuma, Tetsuhiro; Mizutani, Takeshi; Yasuma, Reo; Wright, Charles; Ambati, Jayakrishna			Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity	SCIENCE			English	Article							VERSUS-HOST-DISEASE; P2X(7) RECEPTOR; MACULAR DEGENERATION; INFLAMMASOME ACTIVATION; CASPASE-1 ACTIVATION; NLRP3 INFLAMMASOME; P2X7 RECEPTOR; ATP RELEASE; INTERLEUKIN-18; PATHOGENESIS	Nucleoside reverse transcriptase inhibitors (NRTIs) are mainstay therapeutics for HIV that block retrovirus replication. Alu (an endogenous retroelement that also requires reverse transcriptase for its life cycle)-derived RNAs activate P2X7 and the NLRP3 inflammasome to cause cell death of the retinal pigment epithelium in geographic atrophy, a type of age-related macular degeneration. We found that NRTIs inhibit P2X7-mediated NLRP3 inflammasome activation independent of reverse transcriptase inhibition. Multiple approved and clinically relevant NRTIs prevented caspase-1 activation, the effector of the NLRP3 inflammasome, induced by Alu RNA. NRTIs were efficacious in mouse models of geographic atrophy, choroidal neovascularization, graft-versus-host disease, and sterile liver inflammation. Our findings suggest that NRTIs are ripe for drug repurposing in P2X7-driven diseases.	[Fowler, Benjamin J.; Gelfand, Bradley D.; Kim, Younghee; Kerur, Nagaraj; Tarallo, Valeria; Hirano, Yoshio; Bastos-Carvalho, Ana; Li, Shengjian; Yasuma, Tetsuhiro; Mizutani, Takeshi; Yasuma, Reo; Wright, Charles; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Fowler, Benjamin J.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Gelfand, Bradley D.] Univ Kentucky, Dept Microbiol Immunol & Human Genet, Lexington, KY 40536 USA; [Gelfand, Bradley D.] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40536 USA; [Tarallo, Valeria] CNR, Inst Genet & Biophys, Angiogenesis Lab, I-80125 Naples, Italy; [Amarnath, Shoba; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Radwan, Marta; Young, Mark T.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Pittman, Keir; Kubes, Paul] Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Agarwal, Hitesh K.; Parang, Keykavous] Chapman Univ, Sch Pharm, Irvine, CA 92618 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cardiff University; University of Calgary; Chapman University System; Chapman University; University of Southern California; University of Southern California	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA.	jamba2@email.uky.edu	amarnath, shoba/AAP-4391-2020; Young, Mark T/E-8928-2010; Gelfand, Brad/L-3926-2019; Parang, Keykavous/ABC-1584-2021	Young, Mark T/0000-0002-9615-9002; Parang, Keykavous/0000-0001-8600-0893; Tarallo, Valeria/0000-0002-6920-4402; Hirano, Yoshio/0000-0002-9173-0839	NIH [DP1GM114862, R01EY018350, R01EY018836, R01EY020672, R01EY022238, R01EY024068, T32HL091812, UL1RR033173, K99EY024336]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Ellison Medical Foundation Senior Scholar in Aging Award; Foundation Fighting Blindness Individual Investigator Research Award; Harrington Discovery Institute Scholar-Innovator Award; Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness departmental unrestricted grant; Programme for Advanced Medical Education - Fundacao Calouste Gulbenkian; Programme for Advanced Medical Education - Fundacao Champalimaud; Programme for Advanced Medical Education - Ministerio da Saude; Programme for Advanced Medical Education - Fundacao para a Ciencia e Tecnologia, Portugal; Bayer Global Ophthalmology Research Award; Alcon Japan Research award; Beckman Initiative for Macular Research; American Heart Association; International Retinal Research Foundation (IRRF); Fight for Sight postdoctoral award; Loris and David Rich Postdoctoral Scholar Award (IRRF); Center for Cancer Research, National Cancer Institute; Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/J017345/1]; NIH grants [P30EY003040, R01EY001545]; Arnold and Mabel Beckman Foundation; Alberta Innovates Health Solutions Graduate Studentship; BBSRC; BBSRC [BB/J017345/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017345/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, TL1TR000115] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173, TL1RR033172] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020672, R01EY018350, R01EY001545, P30EY003040, K99EY024336, R01EY018836, R01EY022238, R01EY024068] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM114862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Ellison Medical Foundation Senior Scholar in Aging Award(Lawrence Ellison Foundation); Foundation Fighting Blindness Individual Investigator Research Award; Harrington Discovery Institute Scholar-Innovator Award; Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness departmental unrestricted grant(Research to Prevent Blindness (RPB)); Programme for Advanced Medical Education - Fundacao Calouste Gulbenkian; Programme for Advanced Medical Education - Fundacao Champalimaud; Programme for Advanced Medical Education - Ministerio da Saude; Programme for Advanced Medical Education - Fundacao para a Ciencia e Tecnologia, Portugal; Bayer Global Ophthalmology Research Award; Alcon Japan Research award; Beckman Initiative for Macular Research; American Heart Association(American Heart Association); International Retinal Research Foundation (IRRF); Fight for Sight postdoctoral award; Loris and David Rich Postdoctoral Scholar Award (IRRF); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council (BBSRC) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Alberta Innovates Health Solutions Graduate Studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. K. Ambati, K. Ambati, A. M. Adams, A. M. Rao, and G. S. Rao for discussions; L. Toll, G. R. Pattison R. King, L. Xu, M. McConnell, C. Payne, D. Robertson, G. Botzet, and J. May for technical assistance; G. Dubyak for discussions and providing the HEK293-P2X7 cell line; and the University of Kentucky Viral Core (COBRE) for providing lentivirus-GFP. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. J.A. and B.J.F. are listed as inventors on a patent application for the therapeutic use of NRTIs and chemical derivatives filed by their employer, the University of Kentucky. J.A. is a cofounder of iVeena, Inc., which has licensed the technology described in this work. J.A. was supported by NIH grants (DP1GM114862, R01EY018350, R01EY018836, R01EY020672, R01EY022238, and R01EY024068), Doris Duke Distinguished Clinical Scientist Award, Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Ellison Medical Foundation Senior Scholar in Aging Award, Foundation Fighting Blindness Individual Investigator Research Award, Harrington Discovery Institute Scholar-Innovator Award, Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, and Research to Prevent Blindness departmental unrestricted grant; B. J. F. by NIH T32HL091812 and UL1RR033173; A. B. C. by the Programme for Advanced Medical Education (sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal) and Bayer Global Ophthalmology Research Award; Y.H. by Alcon Japan Research award; N.K. by Beckman Initiative for Macular Research and NIH K99EY024336; B. D. G. by American Heart Association and International Retinal Research Foundation (IRRF); T.Y. by Fight for Sight postdoctoral award; and C. W. by The Loris and David Rich Postdoctoral Scholar Award (IRRF). D. H. F and S. A. are supported by the Center for Cancer Research, National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. M. T.Y. and M. R. are supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/J017345/1. D. R. H. is supported by NIH grants P30EY003040 and R01EY001545 and by the Arnold and Mabel Beckman Foundation. K.P. is supported by an Alberta Innovates Health Solutions Graduate Studentship, and M.R. by the BBSRC. me-d4T is available from the University of Kentucky via a Materials Transfer Agreement.	Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Agarwal HK, 2011, BIOORG MED CHEM LETT, V21, P1917, DOI 10.1016/j.bmcl.2011.02.070; Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; [Anonymous], 2014, GUID US ANT AG HIV 1; BALZARINI J, 1989, J BIOL CHEM, V264, P6127; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2002, EST SAF START DOS CL; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Gourine AV, 2005, BRIT J PHARMACOL, V146, P139, DOI 10.1038/sj.bjp.0706287; Hu HZ, 1999, IMMUNOLOGY, V98, P379, DOI 10.1046/j.1365-2567.1999.00881.x; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Salas E, 2013, J PHARMACOL EXP THER, V347, P802, DOI 10.1124/jpet.113.209452; Schmaltz C, 2003, BLOOD, V101, P2440, DOI 10.1182/blood-2002-07-2109; Solini A, 1999, J CELL SCI, V112, P297; Stylianou E, 2003, CLIN EXP IMMUNOL, V132, P462, DOI 10.1046/j.1365-2249.2003.02179.x; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	40	145	154	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					1000	1003		10.1126/science.1261754	http://dx.doi.org/10.1126/science.1261754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25414314	Green Accepted, Green Submitted			2022-12-01	WOS:000345696000045
J	Conte, G; de Asmundis, C; Ciconte, G; Julia, J; Sieira, J; Chierchia, GB; Brugada, P				Conte, Giulio; de Asmundis, Carlo; Ciconte, Giuseppe; Julia, Justo; Sieira, Juan; Chierchia, Gian-Battista; Brugada, Pedro			Follow-up From Childhood to Adulthood of Individuals With Family History of Brugada Syndrome and Normal Electrocardiograms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; CHILDREN		[Conte, Giulio; de Asmundis, Carlo; Ciconte, Giuseppe; Julia, Justo; Sieira, Juan; Chierchia, Gian-Battista; Brugada, Pedro] UZ Brussel VUB, Heart Rhythm Management Ctr, B-1090 Brussels, Belgium	Vrije Universiteit Brussel	Conte, G (corresponding author), UZ Brussel VUB, Heart Rhythm Management Ctr, Laarbeeklaan 101, B-1090 Brussels, Belgium.	giulioconte.cardio@gmail.com	Ciconte, Giuseppe/J-9938-2016; Santinelli, Vincenzo/J-9927-2016	Ciconte, Giuseppe/0000-0001-7886-5467; Conte, Giulio/0000-0003-2248-3456; de Asmundis, Carlo/0000-0001-9351-0760; Santinelli, Vincenzo/0000-0003-4169-3619				Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Conte G, 2014, J AM COLL CARDIOL, V63, P2272, DOI 10.1016/j.jacc.2014.02.574; Makita N, 2007, HEART RHYTHM, V4, P516, DOI 10.1016/j.hrthm.2006.10.028; Matsuo K, 2003, PACE, V26, P1551, DOI 10.1046/j.1460-9592.2003.t01-1-00227.x; Yamakawa Y, 2004, CIRC J, V68, P275, DOI 10.1253/circj.68.275	6	42	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 19	2014	312	19					2039	2041		10.1001/jama.2014.13752	http://dx.doi.org/10.1001/jama.2014.13752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LT	25399282	Bronze			2022-12-01	WOS:000345450500021
J	Hartog, CS; Natanson, C; Sun, JF; Klein, HG; Reinhart, K				Hartog, Christiane S.; Natanson, Charles; Sun, Junfeng; Klein, Harvey G.; Reinhart, Konrad			Concerns over use of hydroxyethyl starch solutions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RENAL-FUNCTION; VOLUME RESUSCITATION; FLUID RESUSCITATION; METAANALYSIS; MORTALITY; SURGERY; THERAPY; SAFETY		[Hartog, Christiane S.; Reinhart, Konrad] Jena Univ Hosp, Ctr Sepsis Care & Control, Dept Anaesthesiol & Intens Care Med, D-07747 Jena, Germany; [Natanson, Charles; Sun, Junfeng] NIH, Crit Care Med Dept, Bethesda, MD 20892 USA; [Klein, Harvey G.] NIH, Dept Transfus Med, Bethesda, MD 20892 USA	Friedrich Schiller University of Jena; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Reinhart, K (corresponding author), Jena Univ Hosp, Ctr Sepsis Care & Control, Dept Anaesthesiol & Intens Care Med, D-07747 Jena, Germany.	konrad.reinhart@med.uni-jena.de		Hartog, Christiane/0000-0003-1098-9775				ALEXANDER B, 1975, FED PROC, V34, P1429; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Bellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000; Bion JF, 2013, BR J ANAESTH; Brun-Buisson C, 2014, JAMA-J AM MED ASSOC, V311, P1068, DOI 10.1001/jama.2014.836; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; EMA, 2013, ASS REP SOL INF CONT; FDA, 2013, SAF COMM BOX WARN IN; Hartog CS, 2012, INTENS CARE MED, V38, P1258, DOI 10.1007/s00134-012-2614-0; Hartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; James MF, 2012, BRIT J ANAESTH, V108, P60; Jonville-Bera A, 2001, NEW ENGL J MED, V345, P622, DOI 10.1056/NEJM200108233450818; Kozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac; LEGENDRE C, 1993, LANCET, V342, P248, DOI 10.1016/0140-6736(93)92345-T; MRHA, 2013, CLASS 2 DRUG AL ACT; Mutter TC, 2013, COCHRANE DATABASE SY, V7, DOI DOI 10.1002/14651858.CD007594.PUB3; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Navickis RJ, 2012, J THORAC CARDIOV SUR, V144, P223, DOI 10.1016/j.jtcvs.2012.04.009; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Schortgen F, 2001, LANCET, V357, P911, DOI 10.1016/S0140-6736(00)04211-2; Takala J, 2013, ANESTH ANALG, V117, P527, DOI 10.1213/ANE.0b013e318296913f; US Department of Health and Human Services Public Health Service Food and Drug Administration (FDA), 2007, NDA REV MEM MID CYCL; Wiedermann CJ, 2014, WIEN KLIN WOCHENSCHR, V126, P189, DOI 10.1007/s00508-014-0503-y; Wilkes MM, 2014, NETH J CRIT CARE, V18, P4; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1738; Wittstock M, 2013, B ARZNEIMITTELSICHER, P13; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	30	43	43	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2014	349								g5981	10.1136/bmj.g5981	http://dx.doi.org/10.1136/bmj.g5981			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JP	25385352	Green Published			2022-12-01	WOS:000345444800003
J	Woyke, T; Rubin, EM				Woyke, Tanja; Rubin, Edward M.			Searching for new branches on the tree of life	SCIENCE			English	Editorial Material							LINEAGES; HYDROGEN		[Woyke, Tanja] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Woyke, T (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov						Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Claverie Jean-Michel, 2013, Commun Integr Biol, V6, pe25685, DOI 10.4161/cib.25685; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ivanova NN, 2014, SCIENCE, V344, P909, DOI 10.1126/science.1250691; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Martin WF, 2012, FEBS LETT, V586, P485, DOI 10.1016/j.febslet.2011.09.031; Nasir A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00194; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schneider GF, 2012, NAT BIOTECHNOL, V30, P326, DOI 10.1038/nbt.2181; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011	15	13	15	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2014	346	6210					698	699		10.1126/science.1258871	http://dx.doi.org/10.1126/science.1258871			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT1JT	25378606				2022-12-01	WOS:000344690100020
J	Akagi, T; Henry, IM; Tao, R; Comai, L				Akagi, Takashi; Henry, Isabelle M.; Tao, Ryutaro; Comai, Luca			A Y-chromosome-encoded small RNA acts as a sex determinant in persimmons	SCIENCE			English	Article							SILENE-LATIFOLIA; FLOWERING PLANTS; EVOLUTION; PAPAYA; EBENACEAE; MODEL; DIVERGENCE; EXPANSION; MARKERS; SYSTEM	In plants, multiple lineages have evolved sex chromosomes independently, providing a powerful comparative framework, but few specific determinants controlling the expression of a specific sex have been identified. We investigated sex determinants in the Caucasian persimmon, Diospyros lotus, a dioecious plant with heterogametic males (XY). Male-specific short nucleotide sequences were used to define a male-determining region. A combination of transcriptomics and evolutionary approaches detected a Y-specific sex-determinant candidate, OGI, that displays male-specific conservation among Diospyros species. OGI encodes a small RNA targeting the autosomal MeGI gene, a homeodomain transcription factor regulating anther fertility in a dosage-dependent fashion. This identification of a feminizing gene suppressed by a Y-chromosome-encoded small RNA contributes to our understanding of the evolution of sex chromosome systems in higher plants.	[Akagi, Takashi; Henry, Isabelle M.; Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Akagi, Takashi; Henry, Isabelle M.; Comai, Luca] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Akagi, Takashi; Tao, Ryutaro] Kyoto Univ, Lab Pomol, Grad Sch Agr, Kyoto, Japan	University of California System; University of California Davis; University of California System; University of California Davis; Kyoto University	Tao, R (corresponding author), Kyoto Univ, Lab Pomol, Grad Sch Agr, Kyoto, Japan.	rtao@kais.kyoto-u.ac.jp; lcomai@ucdavis.edu	Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619; Henry, Isabelle/0000-0002-6796-1119	Japan Society for the Promotion of Science (JSPS); JSPS [26712005, 26660025]; University of California Davis Genome Center seed grant; Office of Science (Biology and Environmental Research) of the U.S. Department of Energy [DE-SC0007183]; BioProject [PRJNA261435]; Transcriptome Shotgun Assembly (TSA) project [GBSJ00000000]; Division Of Integrative Organismal Systems [1457230] Funding Source: National Science Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of California Davis Genome Center seed grant; Office of Science (Biology and Environmental Research) of the U.S. Department of Energy; BioProject; Transcriptome Shotgun Assembly (TSA) project; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Lieberman and K. Ngo for bioinformatics support, the University of California Davis Genome Center DNA Technologies Core for sequencing support, and the U.S. Department of Agriculture's Agricultural Research Service for providing plant samples from various Diospyros species. Supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) fellows (to T. A.); a Grant-in-Aid for Young Scientists (A) (no. 26712005 to T. A.) and for Challenging Exploratory Research (no. 26660025 to R. T.) from JSPS; a University of California Davis Genome Center seed grant (to I. M. H.); and the Office of Science (Biology and Environmental Research) of the U.S. Department of Energy (grant DE-SC0007183 to L. C.). All sequence data generated in the context of this manuscript have been deposited in the appropriate NCBI database: Illumina and PacBio reads in the Short Read Archives (SRA) database (SRA ID SRP045872), RNA-Seq reads and associated statistics in the Gene Expression Omnibus (GEO: GSE61386) database (BioProject ID PRJNA261435), and the OGI and MeGI genomic sequences obtained from various Diospyros species were submitted to GenBank (IDs KM408638 to KM408642). The Whole Genome Shotgun (WGS) project has been deposited at DDBJ/EMBL/GenBank under the accession no. JRBH00000000. The version described in this paper is version JRBH01000000. The Transcriptome Shotgun Assembly (TSA) project has been deposited at DDBJ/EMBL/GenBank under the accession no. GBSJ00000000. The version described in this paper is the first version, GBSJ01000000. The authors declare no competing financial interests. T. A., I. M. H., and L. C. designed the experiments. T. A. performed the experiments. T. A. and I. M. H. analyzed the data. R. T. initiated the study and maintained the KK persimmon sib-family. T. A. drafted the manuscript. All authors participated in data interpretation, edited the manuscript, and approved the final manuscript. Correspondence and requests for materials should be addressed to R. T. (rtao@kais.kyoto-u.ac.jp) and L.C. (lcomai@udavis.edu).	Ainsworth C, 2000, ANN BOT-LONDON, V86, P211, DOI 10.1006/anbo.2000.1201; Akagi T, 2014, J JPN SOC HORTIC SCI, V83, P214, DOI 10.2503/jjshs1.CH-109; Aryal R, 2014, PLANT SCI, V217, P56, DOI 10.1016/j.plantsci.2013.10.018; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bergero R, 2013, GENETICS, V194, P673, DOI 10.1534/genetics.113.150755; Blavet N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-226; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Cherif E, 2013, NEW PHYTOL, V197, P409, DOI 10.1111/nph.12069; CHRISTOPHEL DC, 1982, NATURE, V296, P439, DOI 10.1038/296439a0; Duangjai S, 2006, AM J BOT, V93, P1808, DOI 10.3732/ajb.93.12.1808; Gschwend AR, 2012, P NATL ACAD SCI USA, V109, P13716, DOI 10.1073/pnas.1121096109; Kejnovsky E, 2010, CYTOGENET GENOME RES, V129, P250, DOI 10.1159/000314285; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Ming R, 2007, AM J BOT, V94, P141, DOI 10.3732/ajb.94.2.141; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Quinn AE, 2011, BIOL LETTERS, V7, P443, DOI 10.1098/rsbl.2010.1126; Sakuma S, 2013, NEW PHYTOL, V197, P939, DOI 10.1111/nph.12068; Turner B, 2013, MOL PHYLOGENET EVOL, V69, P740, DOI 10.1016/j.ympev.2013.07.002; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1	25	232	256	12	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2014	346	6209			SI		646	650		10.1126/science.1257225	http://dx.doi.org/10.1126/science.1257225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BE	25359977				2022-12-01	WOS:000343799700053
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: What use is mass flu vaccination?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD005187.PUB4; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000364.pub4; Demicheli V, 2014, COCHRANE DB SYST REV, V3; Department of Health, 2014, NAT FLU IMM PROGR; Department of Health Social Services and Public Safety (Northern Ireland), 2013, SEAS INFL PROGR 2013; Jefferson T, 2012, COCHRANE DB SYST REV, V2; JEFFERSON T, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004876.PUB3; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Poole PJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002733.PUB2; Scottish Government, 2013, SEAS INFL VACC PROGR; Welsh Government, 2014, SEAS FLU VCC PROGR 2	11	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2014	349								g6182	10.1136/bmj.g6182	http://dx.doi.org/10.1136/bmj.g6182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OC	25331457	Green Published, hybrid			2022-12-01	WOS:000343768100003
J	Ford, AT; Goheen, JR; Otieno, TO; Bidner, L; Isbell, LA; Palmer, TM; Ward, D; Woodroffe, R; Pringle, RM				Ford, Adam T.; Goheen, Jacob R.; Otieno, Tobias O.; Bidner, Laura; Isbell, Lynne A.; Palmer, Todd M.; Ward, David; Woodroffe, Rosie; Pringle, Robert M.			Large carnivores make savanna tree communities less thorny	SCIENCE			English	Article							POPULATION-CONTROL; COMPETITION; PREY	Understanding how predation risk and plant defenses interactively shape plant distributions is a core challenge in ecology. By combining global positioning system telemetry of an abundant antelope (impala) and its main predators (leopards and wild dogs) with a series of manipulative field experiments, we showed that herbivores' risk-avoidance behavior and plants' antiherbivore defenses interact to determine tree distributions in an African savanna. Well-defended thorny Acacia trees (A. etbaica) were abundant in low-risk areas where impala aggregated but rare in high-risk areas that impala avoided. In contrast, poorly defended trees (A. brevispica) were more abundant in high-than in low-risk areas. Our results suggest that plants can persist in landscapes characterized by intense herbivory, either by defending themselves or by thriving in risky areas where carnivores hunt.	[Ford, Adam T.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Ford, Adam T.; Goheen, Jacob R.; Otieno, Tobias O.; Bidner, Laura; Isbell, Lynne A.; Palmer, Todd M.; Woodroffe, Rosie; Pringle, Robert M.] Mpala Res Ctr, Nanyuki, Kenya; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Bidner, Laura; Isbell, Lynne A.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL USA; [Ward, David] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa; [Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of British Columbia; University of Wyoming; University of California System; University of California Davis; State University System of Florida; University of Florida; University of Kwazulu Natal; Zoological Society of London; Princeton University	Ford, AT (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	atford@zoology.ubc.ca	Palmer, Todd/GRS-0639-2022	Palmer, Todd/0000-0001-5710-9750	Canada's Natural Sciences and Engineering Research Council; University of British Columbia; University of Wyoming; American Society of Mammalogists; Keren Keyemet I'Israel; U.S. National Science Foundation; Wenner-Gren Foundation; Direct For Social, Behav & Economic Scie [1266389] Funding Source: National Science Foundation	Canada's Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia; University of Wyoming; American Society of Mammalogists; Keren Keyemet I'Israel; U.S. National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by grants from Canada's Natural Sciences and Engineering Research Council (A.T.F., J.R.G.), the University of British Columbia (A.T.F.) the University of Wyoming (J.R.G.), the American Society of Mammalogists (A.T.F.), Keren Keyemet I'Israel (D.W.) the U.S. National Science Foundation (L.A.I.), and the Wenner-Gren Foundation (L.B.). We thank S. Lima, M. Kinnaird, M. Littlewood, B. Agwanda, C. Forbes, J. Estes, M. Kauffman, R. Ostfeld, S. Buskirk, C. Martinez del Rio, C. Riginos, and the Kenya Wildlife Service. Comments from three anonymous reviewers greatly improved the manuscript.	Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Augustine DJ, 2004, J WILDLIFE MANAGE, V68, P916, DOI 10.2193/0022-541X(2004)068[0916:IOCMOH]2.0.CO;2; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Goheen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055192; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; MURDOCH WW, 1966, AM NAT, V100, P219, DOI 10.1086/282415; Orrock JL, 2010, ECOL LETT, V13, P11, DOI 10.1111/j.1461-0248.2009.01412.x; Pimm S.L., 1991, BALANCE NATURE ECOLO; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schmitz O. J., 2010, MONOGR POPUL BIOL, V47; SCHMITZ OJ, 1994, P NATL ACAD SCI USA, V91, P5364, DOI 10.1073/pnas.91.12.5364; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; Veblen KE, 2012, J ARID ENVIRON, V78, P119, DOI 10.1016/j.jaridenv.2011.10.016; YOUNG TP, 1995, ECOL APPL, V5, P97, DOI 10.2307/1942055	18	140	141	8	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2014	346	6207					346	349		10.1126/science.1252753	http://dx.doi.org/10.1126/science.1252753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7ZY	25324387				2022-12-01	WOS:000343041100043
J	Eisenstein, M				Eisenstein, Michael			Remove, reuse, recycle	NATURE			English	Editorial Material							AUTOPHAGY; BECLIN-1											Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2012, EMBO REP, V13, P173, DOI 10.1038/embor.2012.5; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362	7	12	15	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					S2	S4		10.1038/514S2a	http://dx.doi.org/10.1038/514S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25317592	Bronze			2022-12-01	WOS:000342988600002
J	Laland, K; Uller, T; Feldman, M; Sterelny, K; Muller, GB; Moczek, A; Jablonka, E; Odling-Smee, J				Laland, Kevin; Uller, Tobias; Feldman, Marc; Sterelny, Kim; Mueller, Gerd B.; Moczek, Armin; Jablonka, Eva; Odling-Smee, John			Does evolutionary theory need a rethink? - POINT Yes, urgently	NATURE			English	Editorial Material									[Laland, Kevin] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Laland, K (corresponding author), Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland.	knl1@st-andrews.ac.uk	Krammel, Vera/N-4826-2014; Hoekstra, Hopi/I-6690-2012	Krammel, Vera/0000-0002-8273-8396; Sterelny, Kim/0000-0003-3159-6698; Schluter, Dolph/0000-0003-1683-7836; Laland, Kevin/0000-0002-2457-0900; Lenski, Richard/0000-0002-1064-8375; Strassmann, Joan/0000-0003-0638-8440; Hoekstra, Hopi/0000-0003-1431-1769				[Anonymous], 2013, NICHE CONSTRUCTION N; Arthur W, 2004, BIASED EMBRYOS EVOLU; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Erwin D. H., 2013, CAMBRIAN EXPLOSION C; Hoppitt W., 2013, SOCIAL LEARNING INTR; Jablonka E, 2014, LIFE MIND-PHILOS ISS, P1; Noble D, 2014, J PHYSIOL-LONDON, V592, P2237, DOI 10.1113/jphysiol.2014.273151; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M., 2010, EVOLUTION EXTENDED S; West-Eberhard Mary Jane, 2003, pi	10	416	441	7	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					161	164		10.1038/514161a	http://dx.doi.org/10.1038/514161a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3BG	25297418	Bronze, Green Submitted			2022-12-01	WOS:000342663100014
J	Yore, MM; Syed, I; Moraes-Vieira, PM; Zhang, TJ; Herman, MA; Homan, EA; Patel, RT; Lee, J; Chen, SL; Peroni, OD; Dhaneshwar, AS; Hammarstedt, A; Smith, U; McGraw, TE; Saghatelian, A; Kahn, BB				Yore, Mark M.; Syed, Ismail; Moraes-Vieira, Pedro M.; Zhang, Tejia; Herman, Mark A.; Homan, Edwin A.; Patel, Rajesh T.; Lee, Jennifer; Chen, Shili; Peroni, Odile D.; Dhaneshwar, Abha S.; Hammarstedt, Ann; Smith, Ulf; McGraw, Timothy E.; Saghatelian, Alan; Kahn, Barbara B.			Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects	CELL			English	Article							FREE FATTY-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OBESITY; GPR120; OVEREXPRESSION; MACROPHAGES; LIPOGENESIS; ADIPOCYTES	Increased adipose tissue lipogenesis is associated with enhanced insulin sensitivity. Mice overexpressing the Glut4 glucose transporter in adipocytes have elevated lipogenesis and increased glucose tolerance despite being obese with elevated circulating fatty acids. Lipidomic analysis of adipose tissue revealed the existence of branched fatty acid esters of hydroxy fatty acids (FAHFAs) that were elevated 16- to 18-fold in these mice. FAHFA isomers differ by the branched ester position on the hydroxy fatty acid (e.g., palmitic-acid-9-hydroxy-stearic-acid, 9-PAHSA). PAHSAs are synthesized in vivo and regulated by fasting and high-fat feeding. PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. PAHSA administration in mice lowers ambient glycemia and improves glucose tolerance while stimulating GLP-1 and insulin secretion. PAHSAs also reduce adipose tissue inflammation. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes.	[Yore, Mark M.; Syed, Ismail; Moraes-Vieira, Pedro M.; Herman, Mark A.; Lee, Jennifer; Peroni, Odile D.; Dhaneshwar, Abha S.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Yore, Mark M.; Syed, Ismail; Moraes-Vieira, Pedro M.; Herman, Mark A.; Lee, Jennifer; Peroni, Odile D.; Dhaneshwar, Abha S.; Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Patel, Rajesh T.; McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Zhang, Tejia; Homan, Edwin A.; Chen, Shili; Saghatelian, Alan] Harvard Univ, Dept Mol & Clin Med, Cambridge, MA 02138 USA; [Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University; Harvard University; University of Gothenburg	Saghatelian, A (corresponding author), Salk Inst Biol Studies, Torrey Pines Rd, La Jolla, CA 92037 USA.	asaghatelian@salk.edu; bkahn@bidmc.harvard.edu	Mo, Xiulei/A-1616-2017; Moraes-Vieira, Pedro/C-8701-2014	Moraes-Vieira, Pedro/0000-0002-8263-786X; SYED, ISMAIL/0000-0002-1941-5957; Herman, Mark/0000-0001-6979-103X	NIH [R37DK43051, P30 DK57521, R01 DK098002]; JPB foundation; Searle Scholars Award; Burroughs Welcome Fund CABS; Sloan Foundation Fellowship; Harvard Training Program in Nutrition and Metabolism [2T32HD052961, 5T32DK007516, K08 DK076726, P30 DK046200]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK098002, T32DK007516, K08DK076726, P30DK057521, R37DK043051] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0009795] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Searle Scholars Award; Burroughs Welcome Fund CABS(Burroughs Wellcome Fund); Sloan Foundation Fellowship(Alfred P. Sloan Foundation); Harvard Training Program in Nutrition and Metabolism; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Dr. Thue Schwartz for stimulating discussions; Drs. Anna Greka and Dequan Tian for performing functional assays; Pratik Aryal, Marlee Jackson, Kerry Wellenstein, and Peter Dwyer for technical assistance; and Dr. Douglas Hanahan for the STC1 cells. Supported by grants from the NIH R37DK43051 and P30 DK57521 (B.B.K.); R01 DK098002 (B.B.K. and T.E.M.); a grant from the JPB foundation (B.B.K.). Searle Scholars Award, Burroughs Welcome Fund CABS, and Sloan Foundation Fellowship (A.S.); Harvard Training Program in Nutrition and Metabolism, 2T32HD052961 (M.M.Y.); 5T32DK007516 (B.B.K., M.M.Y., and J.L.); K08 DK076726 (M.A.H.); P30 DK046200 (M.A.H.). B.B.K., M.A.H., A.S., and E.A.H. are inventors on a patent related to the fatty acid hydroxy-fatty acids.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Mo XL, 2013, PROG MOL BIOL TRANSL, V114, P251, DOI 10.1016/B978-0-12-386933-3.00007-8; Moe MK, 2004, RAPID COMMUN MASS SP, V18, P1731, DOI 10.1002/rcm.1545; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Virtanen JK, 2014, DIABETES CARE, V37, P189, DOI 10.2337/dc13-1504	30	464	477	8	146	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					318	332		10.1016/j.cell.2014.09.035	http://dx.doi.org/10.1016/j.cell.2014.09.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25303528	Green Accepted, Bronze			2022-12-01	WOS:000343095600014
J	Ribeiro, ED; Pinotsis, N; Ghisleni, A; Salmazo, A; Konarev, PV; Kostan, J; Sjoblom, B; Schreiner, C; Polyansky, AA; Gkougkoulia, EA; Holt, MR; Aachmann, FL; Zagrovic, B; Bordignon, E; Pirker, KF; Svergun, DI; Gautel, M; Djinovic-Carugo, K				Ribeiro, Euripedes de Almeida, Jr.; Pinotsis, Nikos; Ghisleni, Andrea; Salmazo, Anita; Konarev, Petr V.; Kostan, Julius; Sjoeblom, Bjoern; Schreiner, Claudia; Polyansky, Anton A.; Gkougkoulia, Eirini A.; Holt, Mark R.; Aachmann, Finn L.; Zagrovic, Bojan; Bordignon, Enrica; Pirker, Katharina F.; Svergun, Dmitri I.; Gautel, Mathias; Djinovic-Carugo, Kristina			The Structure and Regulation of Human Muscle alpha-Actinin	CELL			English	Article							SARCOMERIC Z-DISK; Z-BAND; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HYPERTROPHIC CARDIOMYOPATHY; TARGET RECOGNITION; CRYSTAL-STRUCTURE; LIM PROTEIN; F-ACTIN; Z-LINE; BINDING	The spectrin superfamily of proteins plays key roles in assembling the actin cytoskeleton in various cell types, crosslinks actin filaments, and acts as scaffolds for the assembly of large protein complexes involved in structural integrity and mechanosensation, as well as cell signaling. alpha-actinins in particular are the major actin crosslinkers in muscle Z-disks, focal adhesions, and actin stress fibers. We report a complete high-resolution structure of the 200 kDa alpha-actinin-2 dimer from striated muscle and explore its functional implications on the biochemical and cellular level. The structure provides insight into the phosphoinositide-based mechanism controlling its interaction with sarcomeric proteins such as titin, lays a foundation for studying the impact of pathogenic mutations at molecular resolution, and is likely to be broadly relevant for the regulation of spectrin-like proteins.	[Ribeiro, Euripedes de Almeida, Jr.; Pinotsis, Nikos; Salmazo, Anita; Kostan, Julius; Sjoeblom, Bjoern; Schreiner, Claudia; Polyansky, Anton A.; Gkougkoulia, Eirini A.; Zagrovic, Bojan; Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Ghisleni, Andrea; Holt, Mark R.; Gautel, Mathias] Kings Coll London, Randall Div Cell & Mol Biophys, British Heart Fdn Ctr Res Excellence, London SE1 1UL, England; [Konarev, Petr V.; Svergun, Dmitri I.] European Mol Biol Lab, Deutsch Elektronen Synchrotron, D-22603 Hamburg, Germany; [Aachmann, Finn L.] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Pirker, Katharina F.] Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, A-1190 Vienna, Austria; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana 1000, Slovenia; [Polyansky, Anton A.] Russian Acad Sci, MM Shemyakin & Yu Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Bordignon, Enrica] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of London; King's College London; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Norwegian University of Science & Technology (NTNU); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Natural Resources & Life Sciences, Vienna; University of Ljubljana; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Free University of Berlin	Gautel, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, British Heart Fdn Ctr Res Excellence, London SE1 1UL, England.	mathias.gautel@kcl.ac.uk; kristina.djinovic@univie.ac.at	Djinovic-Carugo, Kristina/AAW-1167-2021; Konarev, Petr V/W-1380-2017; Polyansky, Anton A/J-2145-2018; Pinotsis, Nikos/AAD-4013-2019; Aachmann, Finn/G-4136-2015; Gkougkoulia, Eirini/AAY-9789-2020; Gautel, Mathias/AAB-9860-2019	Djinovic-Carugo, Kristina/0000-0003-0252-2972; Polyansky, Anton A/0000-0002-1011-2706; Pinotsis, Nikos/0000-0002-5096-257X; Aachmann, Finn/0000-0003-1613-4663; Gkougkoulia, Eirini/0000-0003-0112-5449; Ghisleni, Andrea/0000-0001-8456-5903; Holt, Mark/0000-0001-7775-8539; Svergun, Dmitri/0000-0003-0830-5696; Kostan, Julius/0000-0002-8347-111X; Konarev, Petr/0000-0002-5606-1596; Gautel, Mathias/0000-0003-4027-9803; Bordignon, Enrica/0000-0003-2450-5161; Zagrovic, Bojan/0000-0003-3814-3675	Austrian Science Fund (FWF) [I525, I1593, P22276, P19060]; Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise'' the Center of Optimized Structural Studies [253275]; Marie Curie Initial Training Network: MUZIC [238423]; University of Vienna; European Community [283570]; BioTek2021 Project [217708/O10]; Research Council of Norway; European Research Council [279408]; Russian Scientific Foundation [14-24-00118]; Leducq Foundation Transatlantic Network of Excellence: Proteotoxicity [11 CVD 04]; Medical Research Council of Great Britain [MR/J010456/1]; Human Frontier Science Program [RGP0017/2012]; Austrian Science Fund (FWF) [I 1593, I 525] Funding Source: researchfish; Medical Research Council [MR/K015664/1, G0200496, MR/J010456/1, G0600251] Funding Source: researchfish; MRC [MR/J010456/1, G0600251, MR/K015664/1] Funding Source: UKRI; Russian Science Foundation [14-24-00118] Funding Source: Russian Science Foundation	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise'' the Center of Optimized Structural Studies; Marie Curie Initial Training Network: MUZIC; University of Vienna; European Community(European Commission); BioTek2021 Project; Research Council of Norway(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission); Russian Scientific Foundation(Russian Science Foundation (RSF)); Leducq Foundation Transatlantic Network of Excellence: Proteotoxicity(Leducq Foundation); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Science Foundation(Russian Science Foundation (RSF))	We are greatly indebted to Ay Lin Kho for NRC preparations. Thanks also to Dusan Turk (Institute Jozef Stefan, Ljubljana) for initial help with refinement and Oliviero Carugo (University of Vienna and University of Pavia) and Bettina Hartlieb (Baxter Innovations GmbH) for critical reading of the manuscript. We thank the staff of the MX beamlines at the ESRF in Grenoble, SAXS beamline X33 (Deutsches Elektronen-Synchrotron, Hamburg), and SWING beamline (Soleil, Saint-Aubin) for their excellent support. We thank the staff of Campus Science Support Facilities GmbH (Campus Vienna Biocenter) for technical assistance. The K. D.-C. group was supported by Austrian Science Fund (FWF) Projects I525, I1593, P22276, and P19060, by the Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise'' funding the Center of Optimized Structural Studies (253275), by the Marie Curie Initial Training Network: MUZIC (238423), and by the University of Vienna. This research was also funded by the European Community Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (283570). F. L. A. thanks BioTek2021 Project 217708/O10 and the Research Council of Norway for financial support. B.Z. and A. A. P. were supported by the European Research Council (279408). A. A. P. was supported by the Russian Scientific Foundation (14-24-00118). M. G. and A. G. were supported by the Leducq Foundation Transatlantic Network of Excellence: Proteotoxicity (11 CVD 04) and the Medical Research Council of Great Britain (MR/J010456/1). A. G. and E.d.A.R. were also supported by the Marie Curie Initial Training Network: MUZIC (238423). M. G. holds the British Heart Foundation Chair of Molecular Cardiology (CH/08/001). D. I. S. acknowledges support from the Human Frontier Science Program (RGP0017/2012).	Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Beck MR, 2011, J MOL BIOL, V413, P712, DOI 10.1016/j.jmb.2011.08.059; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Carugo O., 2014, WOLUMES ALGORITHM CO; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Foley KS, 2014, BIOCHEM J, V459, P1, DOI 10.1042/BJ20131511; Fraley TS, 2003, J BIOL CHEM, V278, P24039, DOI 10.1074/jbc.M213288200; Franzot G, 2005, J MOL BIOL, V348, P151, DOI 10.1016/j.jmb.2005.01.002; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; Full SJ, 2007, PROTEIN SCI, V16, P2597, DOI 10.1110/ps.073146807; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P614, DOI 10.1038/nsmb.1789; Gautel M, 1996, J CELL SCI, V109, P2747; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; GOLDSTEIN MA, 1988, J GEN PHYSIOL, V92, P113, DOI 10.1085/jgp.92.1.113; GOLDSTEIN MA, 1979, J CELL BIOL, V83, P187, DOI 10.1083/jcb.83.1.187; Gueguen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074728; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Korsgren C, 2010, BLOOD, V116, P2600, DOI 10.1182/blood-2009-12-260612; Korsgren C, 2010, J BIOL CHEM, V285, P4757, DOI 10.1074/jbc.M109.056200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Li JL, 2013, AM J PHYSIOL-HEART C, V305, pH1614, DOI 10.1152/ajpheart.00477.2013; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; MASAKI T, 1967, J BIOCHEM-TOKYO, V62, P630, DOI 10.1093/oxfordjournals.jbchem.a128717; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Papa I, 1999, J MUSCLE RES CELL M, V20, P187, DOI 10.1023/A:1005489319058; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; SCHACHT J, 1976, J NEUROCHEM, V27, P1119, DOI 10.1111/j.1471-4159.1976.tb00318.x; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Swindells MB, 1996, NAT STRUCT BIOL, V3, P501, DOI 10.1038/nsb0696-501; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tang JH, 2001, J MOL BIOL, V310, P845, DOI 10.1006/jmbi.2001.4789; TAYLOR KA, 1993, J MOL BIOL, V230, P196, DOI 10.1006/jmbi.1993.1136; Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Winkler J, 1997, EUR J BIOCHEM, V248, P193, DOI 10.1111/j.1432-1033.1997.00193.x; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	52	109	109	2	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1447	1460		10.1016/j.cell.2014.10.056	http://dx.doi.org/10.1016/j.cell.2014.10.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25433700	Green Published, hybrid			2022-12-01	WOS:000346652900021
J	Harbauer, AB; Opalinska, M; Gerbeth, C; Herman, JS; Rao, S; Schonfisch, B; Guiard, B; Schmidt, O; Pfanner, N; Meisinger, C				Harbauer, Angelika B.; Opalinska, Magdalena; Gerbeth, Carolin; Herman, Josip S.; Rao, Sanjana; Schoenfisch, Birgit; Guiard, Bernard; Schmidt, Oliver; Pfanner, Nikolaus; Meisinger, Chris			Cell cycle-dependent regulation of mitochondrial preprotein translocase	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; OUTER-MEMBRANE; MORPHOLOGY; DYNAMICS; KINASES; FUSION; SPECIFICITY; PHOSPHATASE; PROGRESSION	Mitochondria play central roles in cellular energy conversion, metabolism, and apoptosis. Mitochondria import more than 1000 different proteins from the cytosol. It is unknown if the mitochondrial protein import machinery is connected to the cell division cycle. We found that the cyclin-dependent kinase Cdk1 stimulated assembly of the main mitochondrial entry gate, the translocase of the outer membrane (TOM), in mitosis. The molecular mechanism involved phosphorylation of the cytosolic precursor of Tom6 by cyclin Clb3-activated Cdk1, leading to enhanced import of Tom6 into mitochondria. Tom6 phosphorylation promoted assembly of the protein import channel Tom40 and import of fusion proteins, thus stimulating the respiratory activity of mitochondria in mitosis. Tom6 phosphorylation provides a direct means for regulating mitochondrial biogenesis and activity in a cell cycle-specific manner.	[Harbauer, Angelika B.; Opalinska, Magdalena; Gerbeth, Carolin; Herman, Josip S.; Rao, Sanjana; Schoenfisch, Birgit; Schmidt, Oliver; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Harbauer, Angelika B.; Gerbeth, Carolin] Univ Freiburg, Trinat Graduiertenkolleg 1478, D-79104 Freiburg, Germany; [Harbauer, Angelika B.; Gerbeth, Carolin; Rao, Sanjana] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Harbauer, Angelika B.; Schmidt, Oliver; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Rao, Sanjana] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; chris.meisinger@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Schmidt, Oliver/0000-0002-7921-4663; Opalinska, Magdalena/0000-0003-1449-4243; Harbauer, Angelika/0000-0002-4568-9003	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School); Bundesministerium fur Bildung und Forschung (Dynamo) [Sonderforschungsbereich 746]; Trinationales Graduiertenkolleg GRK [1478]	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School); Bundesministerium fur Bildung und Forschung (Dynamo)(Federal Ministry of Education & Research (BMBF)); Trinationales Graduiertenkolleg GRK	We thank M. Bohnert, N. Wiedemann, M. van der Laan, T. Becker, L. Ellenrieder, D. Mikropoulou, and W. Stroukov for discussion, materials, and basic characterization of yeast mutants. This work was supported by the Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School), Bundesministerium fur Bildung und Forschung (Dynamo), Sonderforschungsbereich 746, and Trinationales Graduiertenkolleg GRK 1478. Work included in this study has also been performed in partial fulfillment of the requirements for the doctoral theses of A. B. H. and O.S. at the University of Freiburg. The data presented in this paper are tabulated in the main paper and the supplementary materials.	Amon A, 2002, METHOD ENZYMOL, V351, P457; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Fajas L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00004; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gerbeth C, 2013, CELL METAB, V18, P578, DOI 10.1016/j.cmet.2013.09.006; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Radulovic M, 2010, MOL CELL PROTEOMICS, V9, P145, DOI 10.1074/mcp.M900078-MCP200; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Vevea JD, 2014, TRENDS CELL BIOL, V24, P53, DOI 10.1016/j.tcb.2013.07.003; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753	35	85	88	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1109	1113		10.1126/science.1261253	http://dx.doi.org/10.1126/science.1261253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25378463				2022-12-01	WOS:000345763400042
J	Dolgin, E				Dolgin, Elie			Oral solutions	NATURE			English	Editorial Material							HEMOPHILIA-A MICE; GENE-THERAPY; INHIBITOR FORMATION; IMMUNE TOLERANCE; FACTOR-VIII; FACTOR-IX; B-CELLS; INDUCTION; DELIVERY; FVIII											Bowman K, 2008, J CONTROL RELEASE, V132, P252, DOI 10.1016/j.jconrel.2008.06.019; Dhadwar SS, 2010, J THROMB HAEMOST, V8, P2743, DOI 10.1111/j.1538-7836.2010.04116.x; High KA, 2012, BLOOD, V120, P4482, DOI 10.1182/blood-2012-05-423210; Lei TC, 2005, BLOOD, V105, P4865, DOI 10.1182/blood-2004-11-4274; Quade-Lyssy P, 2014, J THROMB HAEMOST, V12, P932, DOI 10.1111/jth.12572; Rawle FE, 2006, J THROMB HAEMOST, V4, P2172, DOI 10.1111/j.1538-7836.2006.02118.x; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Sherman A, 2014, BLOOD, V124, P1659, DOI 10.1182/blood-2013-10-528737; Verma D, 2010, P NATL ACAD SCI USA, V107, P7101, DOI 10.1073/pnas.0912181107; Wang XM, 2014, MOL THER, V22, P1139, DOI 10.1038/mt.2014.43; Zhang AHA, 2013, BLOOD, V122	11	5	6	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S166	S167		10.1038/515S166a	http://dx.doi.org/10.1038/515S166a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427208	Bronze			2022-12-01	WOS:000346247600010
J	Reynolds, AJ; Richardson, BA; Hayakawa, M; Lease, EM; Warner-Richter, M; Englund, MM; Ou, SR; Sullivan, M				Reynolds, Arthur J.; Richardson, Brandt A.; Hayakawa, Momoko; Lease, Erin M.; Warner-Richter, Mallory; Englund, Michelle M.; Ou, Suh-Ruu; Sullivan, Molly			Association of a Full-Day vs Part-Day Preschool Intervention With School Readiness, Attendance, and Parent Involvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EARLY-CHILDHOOD INTERVENTION; LOW-BIRTH-WEIGHT; EDUCATIONAL-ATTAINMENT; FOLLOW-UP; HEALTH; INCOME; PARTICIPATION; PREDICTORS; CHILDREN	IMPORTANCE Early childhood interventions have demonstrated positive effects on well-being. Whether full-day vs part-day attendance improves outcomes is unknown. OBJECTIVE To evaluate the association between a full-vs part-day early childhood program and school readiness, attendance, and parent involvement. DESIGN, SETTING, AND PARTICIPANTS End-of-preschool follow-up of a nonrandomized, matched-group cohort of predominantly low-income, ethnic minority children enrolled in the Child-Parent Centers (CPC) for the full day (7 hours; n = 409) or part day (3 hours on average; n = 573) in the 2012-2013 school year in 11 schools in Chicago, Illinois. INTERVENTION The Midwest CPC Education Program provides comprehensive instruction, family-support, and health services from preschool to third grade. MAIN OUTCOMES AND MEASURES School readiness skills at the end of preschool, attendance and chronic absences, and parental involvement. The readiness domains in the Teaching Strategies GOLD Assessment System include a total of 49 items with a score range of 105-418. The specific domains are socioemotional with 9 items (score range, 20-81), language with 6 items (score range, 15-54), literacy with 12 items (score range, 9-104), math with 7 items (score, 8-60), physical health with 5 items (score range, 14-45), and cognitive development with 10 items (score range, 18-90). RESULTS Full-day preschool participants had higher scores than part-day peers on socioemotional development (58.6 vs 54.5; difference, 4.1; 95% CI, 0.5-7.6; P = .03), language (39.9 vs 37.3; difference, 2.6; 95% CI, 0.6-4.6; P = .01), math (40.0 vs 36.4; difference, 3.6; 95% CI, 0.5-6.7; P = .02), physical health (35.5 vs 33.6; difference, 1.9; 95% CI, 0.5-3.2; P = .006), and the total score (298.1 vs 278.2; difference, 19.9; 95% CI, 1.2-38.4; P = .04). Literacy (64.5 vs 58.6; difference, 5.9; 95% CI, -0.07 to 12.4; P = .08) and cognitive development (59.7 vs 57.7; difference, 2.0; 95% CI, -2.4 to 6.3; P = .38) were not significant. Full-day preschool graduates also had higher rates of attendance (85.9% vs 80.4%; difference, 5.5; 95% CI, 2.6-8.4; P = .001) and lower rates of chronic absences (>= 10% days missed; 53.0% vs 71.6%; difference, -18.6; 95% CI, -28.5 to -8.7; P = .001; >= 20% days missed; 21.2% vs 38.8%; difference -17.6%; 95% CI, -25.6 to -9.7; P <.001) but no differences in parental involvement. CONCLUSIONS AND RELEVANCE In an expansion of the CPCs in Chicago, a full-day preschool intervention was associated with increased school readiness skills in 4 of 6 domains, attendance, and reduced chronic absences compared with a part-day program. These findings should be replicated in other programs and contexts.	[Reynolds, Arthur J.; Hayakawa, Momoko; Lease, Erin M.; Warner-Richter, Mallory; Englund, Michelle M.; Ou, Suh-Ruu] Univ Minnesota, Inst Child Dev, Minneapolis, MN 55455 USA; [Reynolds, Arthur J.; Richardson, Brandt A.; Hayakawa, Momoko; Lease, Erin M.; Warner-Richter, Mallory; Englund, Michelle M.; Ou, Suh-Ruu; Sullivan, Molly] Univ Minnesota, Human Capital Res Collaborat, Minneapolis, MN 55455 USA; [Richardson, Brandt A.] Univ Minnesota, Dept Appl Econ, Minneapolis, MN 55455 USA; [Reynolds, Arthur J.; Hayakawa, Momoko; Sullivan, Molly] Univ Minnesota, Humphrey Sch Publ Affairs, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Reynolds, AJ (corresponding author), Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA.	ajr@umn.edu		Ou, Suh-Ruu/0000-0003-4735-3113; Englund, Michelle/0000-0002-3800-3157	US Department of Education's Investing in Innovation Fund [U411B110098]; J. B. and M. K. Pritzker Family Foundation; McCormick Foundation; Boeing Corp; Evanston Community Foundation; Finnegan Family Foundation; Lewis-Sebring Family Foundation; Foundation65; Northwestern University; Elizabeth Beidler Tisdahl Foundation; Target Corp; W. K. Kellogg Foundation; Doris Duke Charitable Trust; Foundation for Child Development; McKnight Foundation; Greater Twin Cities United Way; St Paul Foundation; Minneapolis Foundation; Joyce Foundation; National Institute of Child Health and Human Development [R01HD034294]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034294] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034294] Funding Source: NIH RePORTER	US Department of Education's Investing in Innovation Fund; J. B. and M. K. Pritzker Family Foundation; McCormick Foundation; Boeing Corp; Evanston Community Foundation; Finnegan Family Foundation; Lewis-Sebring Family Foundation; Foundation65; Northwestern University; Elizabeth Beidler Tisdahl Foundation; Target Corp; W. K. Kellogg Foundation; Doris Duke Charitable Trust(Doris Duke Charitable Foundation (DDCF)); Foundation for Child Development; McKnight Foundation; Greater Twin Cities United Way; St Paul Foundation; Minneapolis Foundation; Joyce Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Preparation of this report was supported by grant U411B110098 from the US Department of Education's Investing in Innovation Fund and the following contributors: J. B. and M. K. Pritzker Family Foundation, McCormick Foundation, Boeing Corp, Evanston Community Foundation, Finnegan Family Foundation, Lewis-Sebring Family Foundation, Foundation65, Northwestern University, Elizabeth Beidler Tisdahl Foundation, Target Corp, W. K. Kellogg Foundation, Doris Duke Charitable Trust, Foundation for Child Development, McKnight Foundation, Greater Twin Cities United Way, St Paul Foundation, Minneapolis Foundation, and the Joyce Foundation. Support also was provided by grant R01HD034294 from the National Institute of Child Health and Human Development.	Arteaga I, 2014, ECON EDUC REV, V40, P221, DOI 10.1016/j.econedurev.2013.07.009; Balfanz R., 2012, CHRONIC ABSENTEEISM; Barnett W. S., 2012, THE STATE OF PRESCHO; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; CAMPBELL FA, 2002, APPL DEVELOPMENTAL S, V0006; Diggle P. J., 2002, ANALYSIS OF LONGITUD; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hill JL, 2003, DEV PSYCHOL, V39, P730, DOI 10.1037/0012-1649.39.4.730; Hoffman JP, 2003, GENERALIZED LINEAR M; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Human Capital Research Collaborative, 2014, IMPLEMENTATION FIDEL; Human Capital Research Collaborative, 2012, PROGRAM REQUIREMENT; Karoly LA., 2005, EARLY CHILDHOOD INTE; Koh HK, 2014, JAMA-J AM MED ASSOC, V311, P2475, DOI 10.1001/jama.2014.6446; Lambert R, 2013, EVIDENCE FOR THE ASS; Lambert R, 2013, TECHNICAL MANUAL FOR; Lambert RG, 2014, J PSYCHOEDUC ASSESS, V32, P27, DOI 10.1177/0734282913485214; Lipsey M.W., 2001, PRACTICAL META ANAL, V49; Little R. J. A., 1987, STATISTICAL ANALYSIS; Loeb S, 2007, ECON EDUC REV, V26, P52, DOI 10.1016/j.econedurev.2005.11.005; Manning M, 2010, CHILD YOUTH SERV REV, V32, P506, DOI 10.1016/j.childyouth.2009.11.003; Ou SR, 2008, SCHOOL PSYCHOL QUART, V23, P199, DOI 10.1037/1045-3830.23.2.199; Ou SR, 2007, SOC SERV REV, V81, P85, DOI 10.1086/510783; RAMEY CT, 1992, PEDIATRICS, V89, P454; Reynolds AJ, 2001, JAMA-J AM MED ASSOC, V285, P2339, DOI 10.1001/jama.285.18.2339; REYNOLDS AJ, 1995, EARLY CHILD RES Q, V10, P1, DOI 10.1016/0885-2006(95)90024-1; Reynolds AJ, 2011, ASSESSING THE VALIDI; Reynolds AJ, 2000, SUCCESS IN EARLY INT; Reynolds AJ, 2007, ARCH PEDIAT ADOL MED, V161, P730, DOI 10.1001/archpedi.161.8.730; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Reynolds AJ, 2011, CHILD DEV, V82, P555, DOI 10.1111/j.1467-8624.2010.01562.x; Reynolds AJ, 2011, CHILD DEV, V82, P379, DOI 10.1111/j.1467-8624.2010.01563.x; Robin KB, 2006, IS MORE BETTER THE E; Schweinhart Lawrence J., 2005, LIFETIME EFFECTS THE; Soderberg JS, 2014, INTER RATER RELIABIL; SPSSInc, 2013, ADVANCED STATISTICS; Teaching Strategies Inc, 2011, TEACHING STRATEGIES; US Department of Education National Center for Education Statistics, 2013, CONDITIONS OF EDUCAT; Valenti JE, 2009, EDUC URBAN SOC, V41, P695, DOI 10.1177/0013124509336060; Yves H, 2007, EARLY CHILD RES PRAC, V9, P1	40	38	38	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2126	2134		10.1001/jama.2014.15376	http://dx.doi.org/10.1001/jama.2014.15376			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU5DG	25423219	Green Accepted, Bronze			2022-12-01	WOS:000345626800016
J	Rasmussen, AL; Okumura, A; Ferris, MT; Green, R; Feldmann, F; Kelly, SM; Scott, DP; Safronetz, D; Haddock, E; LaCasse, R; Thomas, MJ; Sova, P; Carter, VS; Weiss, JM; Miller, DR; Shaw, GD; Korth, MJ; Heise, MT; Baric, RS; de Villena, FPM; Fedlmann, H; Katze, MG				Rasmussen, Angela L.; Okumura, Atsushi; Ferris, Martin T.; Green, Richard; Feldmann, Friederike; Kelly, Sara M.; Scott, Dana P.; Safronetz, David; Haddock, Elaine; LaCasse, Rachel; Thomas, Matthew J.; Sova, Pavel; Carter, Victoria S.; Weiss, Jeffrey M.; Miller, Darla R.; Shaw, Ginger D.; Korth, Marcus J.; Heise, Mark T.; Baric, Ralph S.; de Villena, Fernando Pardo-Manuel; Fedlmann, Heinz; Katze, Michael G.			Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance	SCIENCE			English	Article							VIRUS INFECTION; GUINEA-PIGS; COAGULATION; OUTBREAK; MAP	Existing mouse models of lethal Ebola virus infection do not reproduce hallmark symptoms of Ebola hemorrhagic fever, neither delayed blood coagulation and disseminated intravascular coagulation nor death fromshock, thus restricting pathogenesis studies to nonhuman primates. Here we show that mice from the Collaborative Cross panel of recombinant inbred mice exhibit distinct disease phenotypes after mouse-adapted Ebola virus infection. Phenotypes range from complete resistance to lethal disease to severe hemorrhagic fever characterized by prolonged coagulation times and 100% mortality. Inflammatory signaling was associated with vascular permeability and endothelial activation, and resistance to lethal infection arose by induction of lymphocyte differentiation and cellular adhesion, probably mediated by the susceptibility allele Tek. These data indicate that genetic background determines susceptibility to Ebola hemorrhagic fever.	[Rasmussen, Angela L.; Okumura, Atsushi; Green, Richard; Kelly, Sara M.; Thomas, Matthew J.; Sova, Pavel; Carter, Victoria S.; Weiss, Jeffrey M.; Korth, Marcus J.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ferris, Martin T.; Miller, Darla R.; Shaw, Ginger D.; Heise, Mark T.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Feldmann, Friederike; Scott, Dana P.; LaCasse, Rachel] NIAID, Rocky Mt Vet Branch, NIH, Rocky Mt Labs, Hamilton, MT USA; [Okumura, Atsushi; Safronetz, David; Haddock, Elaine; Fedlmann, Heinz] NIAID, Virol Lab, NIH, Rocky Mt Labs, Hamilton, MT USA; [Heise, Mark T.; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill	Katze, MG (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	honey@uw.edu	Okumura, Atsushi/E-8012-2015	Okumura, Atsushi/0000-0002-7779-3059; Rasmussen, Angela/0000-0001-9462-3169; Green, Richard/0000-0001-8851-7204	National Institute of Allergy and Infectious Diseases, National Institutes of Health [U54 AI081680, U19 AI109761, U19 AI100625]; Office of the Director, National Institutes of Health [P51 OD010425]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, U19AI109761, U19AI100625, U54AI081680] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by awards U54 AI081680, U19 AI109761, and U19 AI100625 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; P51 OD010425 from the Office of the Director, National Institutes of Health; and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Microarray data have been deposited with the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) (accession number GSE57214), and raw data can be obtained at https://www.ccebola.org/project/Supplemental/begin.view. Mice were developed by the Collaborative Cross Consortium, an international consortium of researchers who designed, planned, and implemented the Collaborative Cross project. Initial animals were provided by the Jackson Laboratory, and CC lines were developed independently at the Oak Ridge National Laboratories in Tennessee, USA; Tel Aviv University, Israel; and Geniad, Ltd., Australia. CC lines are currently produced and distributed at the University of North Carolina, Chapel Hill. A.L.R. designed the study, performed functional analysis of microarray data, and wrote the manuscript; A.O. performed infections, veterinary examinations, and necropsies and assessed phenotype, collected and processed samples, and titrated virus from organs by focus-forming assay; M.T.F., M.T.H., F.P.-M.V., and R.S.B. established systems for designing and breeding CC-RIX mouse populations and utilizing them for virus pathogenesis studies and contributed to strain selection and data analysis; R.G. performed microarray data normalization, batch correction, and differential expression analysis; S.M.K. and J.M.W. performed target preparation and hybridization of microarrays; R.L. coordinated veterinary care for experimental animals; D.P.S. performed histopathological staining and analyzed the histopathology data; F.F., D.S., and E.H. assisted with mouse procedures in high biocontainment; M.J.T. and R.G. performed sequencing and subsequent analysis of viral RNA; A.F. performed functional analysis of microarray data; P.S. quantified viral RNA by quantitative polymerase chain reaction; M.J.K. edited the manuscript; and H.F. and M.G.K. contributed significantly to study design, provided space and infrastructure for the experiments and analysis, assisted in data analysis, and edited the manuscript.	Antoniak S, 2014, J CARDIOVASC TRANSL, V7, P203, DOI 10.1007/s12265-013-9515-7; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Brouillard P, 2000, GENOMICS, V67, P96, DOI 10.1006/geno.2000.6232; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Ebihara H, 2011, J INFECT DIS, V204, pS991, DOI 10.1093/infdis/jir336; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Flanagan JM, 2011, BLOOD, V117, P6681, DOI 10.1182/blood-2011-01-332205; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Johnson JC, 2014, ANTIVIR RES, V107, P102, DOI 10.1016/j.antiviral.2014.04.014; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Ryabchikova E, 1996, ARCH VIROL, V141, P909, DOI 10.1007/BF01718165; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Strong JE, 2008, P NATL ACAD SCI USA, V105, P17982, DOI 10.1073/pnas.0809698105; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yen JY, 2011, J INFECT DIS, V204, pS1043, DOI 10.1093/infdis/jir345; Zheng QP, 2013, GENE, V523, P195, DOI 10.1016/j.gene.2013.02.053	27	175	181	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2014	346	6212					987	991		10.1126/science.1259595	http://dx.doi.org/10.1126/science.1259595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU6EL	25359852	Green Submitted, Green Accepted			2022-12-01	WOS:000345696000042
J	Chellamuthu, VR; Ermilova, E; Lapina, T; Luddecke, J; Minaeva, E; Herrmann, C; Hartmann, MD; Forchhammer, K				Chellamuthu, Vasuki-Ranjani; Ermilova, Elena; Lapina, Tatjana; Lueddecke, Jan; Minaeva, Ekaterina; Herrmann, Christina; Hartmann, Marcus D.; Forchhammer, Karl			A Widespread Glutamine-Sensing Mechanism in the Plant Kingdom	CELL			English	Article							SIGNAL-TRANSDUCTION PROTEINS; N-ACETYLGLUTAMATE-KINASE; PII-LIKE PROTEIN; P-II PROTEIN; CHLAMYDOMONAS-REINHARDTII; METABOLITE CONCENTRATIONS; SUBCELLULAR VOLUMES; REGULATORY PROTEIN; CRYSTAL-STRUCTURE; COMPLEX-FORMATION	Glutamine is the primary metabolite of nitrogen assimilation from inorganic nitrogen sources in microorganisms and plants. The ability to monitor cellular nitrogen status is pivotal for maintaining metabolic homeostasis and sustaining growth. The present study identifies a glutamine-sensing mechanism common in the entire plant kingdom except Brassicaceae. The plastid-localized PII signaling protein controls, in a glutamine-dependent manner, the key enzyme of the ornithine synthesis pathway, N-acetyl-L-glutamate kinase (NAGK), that leads to arginine and polyamine formation. Crystal structures reveal that the plant-specific C-terminal extension of PII, which we term the Q loop, forms a low-affinity glutamine-binding site. Glutamine binding alters PII conformation, promoting interaction and activation of NAGK. The binding motif is highly conserved in plants except Brassicaceae. A functional Q loop restores glutamine sensing in a recombinant Arabidopsis thaliana PII protein, demonstrating the modular concept of the glutamine-sensing mechanism adopted by PII proteins during the evolution of plant chloroplasts.	[Chellamuthu, Vasuki-Ranjani; Lueddecke, Jan; Herrmann, Christina; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Ermilova, Elena; Lapina, Tatjana; Minaeva, Ekaterina] St Petersburg State Univ, Lab Adaptat Microorganisms, Fac Biol, St Petersburg 199034, Russia; [Chellamuthu, Vasuki-Ranjani; Hartmann, Marcus D.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Saint Petersburg State University; Max Planck Society	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de	Minaeva, Ekaterina/O-4647-2014; Hartmann, Marcus D./L-8759-2019; Lapina, Tatyana V/J-4802-2013; /H-1738-2013	Minaeva, Ekaterina/0000-0002-3174-6134; Hartmann, Marcus D./0000-0001-6937-5677; Lapina, Tatyana V/0000-0002-5663-1990; /0000-0003-0800-5933	Deutsche Forschungsgemeinschaft [Fo195/9-1, Fo195/10/11]; Russian Foundation for Basic Research [N 13-04-00087]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was funded by the Deutsche Forschungsgemeinschaft (grants Fo195/9-1 and Fo195/10/11 to K.F.) and by a grant of the Russian Foundation for Basic Research (N 13-04-00087 to E.E.). V.-R.C. and M.D.H. are grateful to Andrei Lupas for continuous support. We thank Karen Brune for careful linguistic editing of the paper and Oleksandra Fokina for helpful experimental advice, acknowledge the skillful assistance of Reinhard Albrecht and Kerstin Bar in crystallographic sample preparation, and are grateful for the excellent support by the staff of Swiss Light Source beamline X10SA.	ADLER SP, 1975, J BIOL CHEM, V250, P6264; Beez S, 2009, J MOL BIOL, V389, P748, DOI 10.1016/j.jmb.2009.04.053; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Chellamuthu VR, 2013, PLANTA, V237, P451, DOI 10.1007/s00425-012-1801-0; Ermilova E, 2013, PROTIST, V164, P49, DOI 10.1016/j.protis.2012.04.002; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Ferrario-Mery S, 2005, PLANTA, V223, P28, DOI 10.1007/s00425-005-0063-5; Ferrario-Mery S, 2008, FEBS LETT, V582, P1061, DOI 10.1016/j.febslet.2008.02.056; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Forchhammer K, 2007, FRONT BIOSCI-LANDMRK, V12, P358, DOI 10.2741/2069; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Fritz C, 2006, PLANT CELL ENVIRON, V29, P2055, DOI 10.1111/j.1365-3040.2006.01580.x; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Heinrich A, 2006, J BIOL CHEM, V281, P34909, DOI 10.1074/jbc.M607582200; Hesketh A, 2002, MOL MICROBIOL, V46, P319, DOI 10.1046/j.1365-2958.2002.03149.x; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Jiang P, 1997, J BACTERIOL, V179, P4342, DOI 10.1128/jb.179.13.4342-4353.1997; Jiang P, 2011, BIOCHEMISTRY-US, V50, P10929, DOI 10.1021/bi201410x; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11522, DOI 10.1021/bi9011594; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Keys AJ, 2006, PHOTOSYNTH RES, V87, P165, DOI 10.1007/s11120-005-9024-x; Lea P.J., 2010, ANN PLANT REV, V42, P1, DOI [10.1002/9781444328608.ch1, DOI 10.1002/9781444328608.CH1]; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Radchenko M, 2011, BIOCHEM SOC T, V39, P189, DOI 10.1042/BST0390189; Radchenko MV, 2013, P NATL ACAD SCI USA, V110, P12948, DOI 10.1073/pnas.1304386110; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Smith CS, 2004, BBA-PROTEINS PROTEOM, V1699, P145, DOI 10.1016/j.bbapap.2004.02.009; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Sugiyama K, 2004, PLANT CELL PHYSIOL, V45, P1768, DOI 10.1093/pcp/pch199; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; WINTER H, 1993, PLANTA, V191, P180, DOI 10.1007/BF00199748; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Zeth K, 2014, J BIOL CHEM, V289, P8960, DOI 10.1074/jbc.M113.536557; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540	49	86	87	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1188	1199		10.1016/j.cell.2014.10.015	http://dx.doi.org/10.1016/j.cell.2014.10.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416954	Green Published, Bronze			2022-12-01	WOS:000345506300027
J	Varvarigou, V; Farioli, A; Korre, M; Sato, S; Dahabreh, IJ; Kales, SN				Varvarigou, Vasileia; Farioli, Andrea; Korre, Maria; Sato, Sho; Dahabreh, Issa J.; Kales, Stefanos N.			Law enforcement duties and sudden cardiac death among police officers in United States: case distribution study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; FIREFIGHTERS; EVENTS; STRESS; EXERTION; ANGER; RISK	Objective To assess the association between risk of sudden cardiac death and stressful law enforcement duties compared with routine/non-emergency duties. Design Case distribution study (case series with survey information on referent exposures). Setting United States law enforcement. Participants Summaries of deaths of over 4500 US police officers provided by the National Law Enforcement Officers Memorial Fund and the Officer Down Memorial Page from 1984 to 2010. Main outcome measures Observed and expected sudden cardiac death counts and relative risks for sudden cardiac death events during specific strenuous duties versus routine/non-emergency activities. Independent estimates of the proportion of time that police officers spend across various law enforcement duties obtained from surveys of police chiefs and front line officers. Impact of varying exposure assessments, covariates, and missing cases in sensitivity and stability analyses. Results 441 sudden cardiac deaths were observed during the study period. Sudden cardiac death was associated with restraints/altercations (25%, n=108), physical training (20%, n=88), pursuits of suspects (12%, n=53), medical/rescue operations (8%, n=34), routine duties (23%, n=101), and other activities (11%, n=57). Compared with routine/non-emergency activities, the risk of sudden cardiac death was 34-69 times higher during restraints/altercations, 32-51 times higher during pursuits, 20-23 times higher during physical training, and 6-9 times higher during medical/rescue operations. Results were robust to all sensitivity and stability analyses. Conclusions Stressful law enforcement duties are associated with a risk of sudden cardiac death that is markedly higher than the risk during routine/non-emergency duties. Restraints/altercations and pursuits are associated with the greatest risk. Our findings have public health implications and suggest that primary and secondary cardiovascular prevention efforts are needed among law enforcement officers.	[Varvarigou, Vasileia; Farioli, Andrea; Korre, Maria; Kales, Stefanos N.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Varvarigou, Vasileia] Tufts Med Sch, St Elizabeths Med Ctr, Dept Internal Med, Brighton, MA USA; [Farioli, Andrea; Korre, Maria; Sato, Sho; Kales, Stefanos N.] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Farioli, Andrea] Univ Bologna, DIMEC, Dept Med & Surg Sci, Bologna, Italy; [Dahabreh, Issa J.] Brown Univ, Sch Publ Hlth, Ctr Evidence Based Med, Providence, RI 02912 USA; [Dahabreh, Issa J.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA	Harvard University; Harvard T.H. Chan School of Public Health; St. Elizabeth's Medical Center; Tufts University; Harvard University; Cambridge Health Alliance; University of Bologna; Brown University; Brown University	Kales, SN (corresponding author), Cambridge Hosp, Dept Environm Hlth, Macht Bldg 427,1493 Cambridge St, Cambridge, MA 02139 USA.	skales@hsph.harvard.edu	Farioli, Andrea/K-9256-2016	Farioli, Andrea/0000-0003-2001-2140	Harvard-NIOSH Education and Research Center [2 T42 OH008416-08]; Monica Odening '06 Internship and Research Fund in Mathematics (Hamilton College); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008416] Funding Source: NIH RePORTER	Harvard-NIOSH Education and Research Center(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Monica Odening '06 Internship and Research Fund in Mathematics (Hamilton College); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Research support was provided by a pilot project grant awarded by the Harvard-NIOSH Education and Research Center Grant No 2 T42 OH008416-08 and the Monica Odening '06 Internship and Research Fund in Mathematics (Hamilton College).	Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Anderson GS, 2002, POLICING, V25, P399, DOI 10.1108/13639510210429437; [Anonymous], 2012, PROT HUM SUBJ; [Anonymous], 2012, OCC EMPL STAT; [Anonymous], CURR POP SURV; Braunwald E., 2012, BRAUNWALDS HEART DIS; Collins PA, 2003, OCCUP MED-OXFORD, V53, P256, DOI 10.1093/occmed/kqg061; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336; Farioli A, 2014, OCCUP MED LOND; Geibe JR, 2008, AM J CARDIOL, V101, P585, DOI 10.1016/j.amjcard.2007.10.017; Greenland S, 1999, STAT MED, V18, P1, DOI 10.1002/(SICI)1097-0258(19990115)18:1<1::AID-SIM961>3.0.CO;2-L; Hickman MJ, 2011, POLICE Q, V14, P227, DOI 10.1177/1098611111413991; Holder JD, 2006, J OCCUP ENVIRON MED, V48, P1047, DOI 10.1097/01.jom.0000235909.31632.46; Johnson Kevin, 2013, US TODAY; Kales SN, 2007, NEW ENGL J MED, V356, P1207, DOI 10.1056/NEJMoa060357; Kales Stefanos N, 2003, Environ Health, V2, P14, DOI 10.1186/1476-069X-2-14; Kales SN, 2009, AM J HYPERTENS, V22, P11, DOI 10.1038/ajh.2008.296; Korre M, 2014, POLIC-J POLICY PRACT, V8, P109, DOI 10.1093/police/pau001; Lash T.L., 2014, INT J EPIDEMIOL; Lipovetzky N, 2007, ISR MED ASSOC J, V9, P310; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; National Occuparional Research Agenda. CDC, 2014, CDC; Ramey SL, 2008, AAOHN J, V56, P54; Smith DL, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-6; Soteriades ES, 2011, CARDIOL REV, V19, P202, DOI 10.1097/CRD.0b013e318215c105; Tiesman HM, 2013, AM J IND MED, V56, P693, DOI 10.1002/ajim.22182; U.S Department of Labor BLS, 2012, ED DESK RISK POL WOR; VIOLANTI JM, 1994, PSYCHOL REP, V75, P824, DOI 10.2466/pr0.1994.75.2.824; Yang J, 2013, AM J CARDIOL, V112, P1962, DOI 10.1016/j.amjcard.2013.08.029; Zimmerman FH, 2012, CARDIOL REV, V20, P159, DOI 10.1097/CRD.0b013e318248d631	31	34	35	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2014	349								g6534	10.1136/bmj.g6534	http://dx.doi.org/10.1136/bmj.g6534			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2JY	25406189	Green Published, hybrid			2022-12-01	WOS:000345445600002
J	Gammon, K				Gammon, Katharine			Editorial control	NATURE			English	Editorial Material							DISEASE											Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016	3	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					S11	S13		10.1038/515S11a	http://dx.doi.org/10.1038/515S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25390136				2022-12-01	WOS:000344631400008
J	Lee, YN; Barsbold, R; Currie, PJ; Kobayashi, Y; Lee, HJ; Godefroit, P; Escuillie, F; Chinzorig, T				Lee, Yuong-Nam; Barsbold, Rinchen; Currie, Philip J.; Kobayashi, Yoshitsugu; Lee, Hang-Jae; Godefroit, Pascal; Escuillie, Francois; Chinzorig, Tsogtbaatar			Resolving the long-standing enigmas of a giant ornithomimosaur Deinocheirus mirificus	NATURE			English	Article							NORTH-AMERICA; DINOSAURS; THEROPODA; ECOMORPHOLOGY; PYGOSTYLE; DESERT	The holotype of Deinocheirus mirificus was collected by the 1965 Polish-Mongolian Palaeontological Expedition at Altan Uul III in the southern Gobi of Mongolia(1). Because the holotype consists mostly of giant forelimbs (2.4 min length) with scapulocoracoids(2), for almost 50 years Deinocheirus has remained one of the most mysterious dinosaurs. The mosaic of ornithomimosaur and nonornithomimosaur characters in the holotype has made it difficult to resolve the phylogenetic status of Deinocheirus(3,4). Here we describe two new specimens of Deinocheirus that were discovered in the Nemegt Formation of Altan Uul IV in 2006 and Bugiin Tsav in 2009. The Bugiin Tsav specimen (MPC-D100/127) includes a left forelimb clearly identifiable as Deinocheirus and is 6% longer than the holotype. The Altan Uul IV specimen(MPC-D100/128) is approximately 74% the size of MPC-D 100/127. Cladistic analysis indicates that Deinocheirus is the largest member of the Ornithomimosauria; however, it has many unique skeletal features unknown in other ornithomimosaurs, indicating that Deinocheirus was a heavily built, non-cursorial animal with an elongate snout, a deep jaw, tall neural spines, a pygostyle, a U-shaped furcula, an expanded pelvis for strong muscle attachments, a relatively short hind limb and broad-tipped pedal unguals. Ecomorphological features in the skull, more than a thousand gastroliths, and stomach contents (fish remains) suggest that Deinocheirus was a megaomnivore that lived in mesic environments.	[Lee, Yuong-Nam; Lee, Hang-Jae] Korea Inst Geosci & Mineral Resources, Geol Museum, Taejon 305350, South Korea; [Barsbold, Rinchen; Chinzorig, Tsogtbaatar] Mongolian Acad Sci, Paleontol Ctr, Ulaanbaatar 210351, Mongolia; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan; [Godefroit, Pascal] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium; [Escuillie, Francois] Eldonia, F-3800 Gannat, France	Korea Institute of Geoscience & Mineral Resources (KIGAM); Mongolian Academy of Sciences; University of Alberta; Hokkaido University; Royal Belgian Institute of Natural Sciences	Lee, YN (corresponding author), Korea Inst Geosci & Mineral Resources, Geol Museum, Taejon 305350, South Korea.	ylee@kigam.re.kr	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Tsogtbaatar, Chinzorig/0000-0001-5231-0113	Hwaseong City, Gyeonggi Province, South Korea; Korea Institute of Geosciences and Mineral Resources, Korea; Paleontological Center of Mongolian Academy of Sciences, Mongolia	Hwaseong City, Gyeonggi Province, South Korea; Korea Institute of Geosciences and Mineral Resources, Korea; Paleontological Center of Mongolian Academy of Sciences, Mongolia	Information gained from Zofia Kielan-Jaworowska and Wojtec Skarzynski (who respectively found and excavated the holotype) allowed us to refind the original quarry at Altan Uul III. Thanks go to all members of Korea-Mongolia International Dinosaur Expedition (KID) in 2006 and 2009. The KID expedition was supported by a grant to Y.-N.L. from Hwaseong City, Gyeonggi Province, South Korea. Research support was from Korea Institute of Geosciences and Mineral Resources, Korea and Paleontological Center of Mongolian Academy of Sciences, Mongolia.	Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; Barsbold R, 2000, NATURE, V403, P155, DOI 10.1038/35003103; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Choiniere JN, 2012, J AFR EARTH SCI, V71-72, P1, DOI 10.1016/j.jafrearsci.2012.05.005; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; KIELANJA.Z, 1966, B ACAD POL SCI BIOL, V14, P249; Kobayashi Y, 2005, CAN J EARTH SCI, V42, P1501, DOI 10.1139/E05-044; Kobayashi Yoshitsugu, 2006, Journal of the Paleontological Society of Korea, V22, P195; Lautenschlager S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0497; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Mallon JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067182; Norell MA, 2001, NATURE, V412, P873, DOI 10.1038/35091139; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Osmolska H, 1970, PALAEONTOLOGIA POLON, V21, P5; Persons WS, 2014, ACTA PALAEONTOL POL, V59, P553, DOI 10.4202/app.2012.0093; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schwarz-Wings D, 2010, P ROY SOC B-BIOL SCI, V277, P11, DOI 10.1098/rspb.2009.1275; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zelenitsky DK, 2012, SCIENCE, V338, P510, DOI 10.1126/science.1225376	28	69	70	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					257	U231		10.1038/nature13874	http://dx.doi.org/10.1038/nature13874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25337880				2022-12-01	WOS:000344631400048
J	Matoba, S; Liu, YT; Lu, FL; Iwabuchi, KA; Shen, L; Inoue, A; Zhang, Y				Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi			Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylation	CELL			English	Article							PLURIPOTENT STEM-CELLS; CLONED BOVINE EMBRYOS; PREIMPLANTATION EMBRYOS; SIGNIFICANT IMPROVEMENT; DEACETYLASE INHIBITOR; LYSINE 9; HETEROCHROMATIN; GENOME; OOCYTES; CLONING	Mammalian oocytes can reprogram somatic cells into a totipotent state enabling animal cloning through somatic cell nuclear transfer (SCNT). However, the majority of SCNT embryos fail to develop to term due to undefined reprogramming defects. Here, we identify histone H3 lysine 9 trimethylation (H3K9me3) of donor cell genome as a major barrier for efficient reprogramming by SCNT. Comparative transcriptome analysis identified reprogramming resistant regions (RRRs) that are expressed normally at 2-cell mouse embryos generated by in vitro fertilization (IVF) but not SCNT. RRRs are enriched for H3K9me3 in donor somatic cells and its removal by ectopically expressed H3K9me3 demethylase Kdm4d not only reactivates the majority of RRRs, but also greatly improves SCNT efficiency. Furthermore, use of donor somatic nuclei depleted of H3K9 methyltransferases markedly improves SCNT efficiency. Our study thus identifies H3K9me3 as a critical epigenetic barrier in SCNT-mediated reprogramming and provides a promising approach for improving mammalian cloning efficiency.	[Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, Y (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, WAB 149G,200 Longwood Ave, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	Lu, Falong/Q-3013-2016; MATOBA, Shogo/D-9995-2016	MATOBA, Shogo/0000-0003-0474-232X; Lu, Falong/0000-0002-8321-4818	NIH [U01DK089565]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs.Shinpei Yamaguchi, Luis M.Tuesta, and Hao Wu for critical reading of the manuscript.This project is supported by NIH U01DK089565 (to Y.Z.).S.M.and K.A.I.are supported by postdoctoral fellowship from the Japan Society for the Promotion of Science (JSPS).Y.Z.is an investigator of the Howard Hughes Medical Institute.	Akagi S, 2011, J REPROD DEVELOP, V57, P120, DOI 10.1262/jrd.10-058A; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Canzio D, 2013, NATURE, V496, P377, DOI 10.1038/nature12032; Chang G, 2014, CELL RES, V24, P293, DOI 10.1038/cr.2013.173; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li SG, 2006, REPRODUCTION, V131, P1085, DOI 10.1530/rep.1.01065; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pichugin A, 2010, REPRODUCTION, V139, P129, DOI 10.1530/REP-08-0435; Poleshko A, 2014, NUCLEUS-PHILA, V5, P32, DOI 10.4161/nucl.28167; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Suzuki T, 2006, CLONING STEM CELLS, V8, P295, DOI 10.1089/clo.2006.8.295; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Terndrup M, 2014, MOL CELL BIOL, V34, P1031, DOI 10.1128/MCB.00864-13; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Yang CX, 2013, REPRODUCTION, V145, P149, DOI 10.1530/REP-11-0421; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	43	279	314	2	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					884	895		10.1016/j.cell.2014.09.055	http://dx.doi.org/10.1016/j.cell.2014.09.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417163	Bronze, Green Accepted			2022-12-01	WOS:000344522000019
J	Pardee, K; Green, AA; Ferrante, T; Cameron, DE; DaleyKeyser, A; Yin, P; Collins, JJ				Pardee, Keith; Green, Alexander A.; Ferrante, Tom; Cameron, D. Ewen; DaleyKeyser, Ajay; Yin, Peng; Collins, James J.			Paper-Based Synthetic Gene Networks	CELL			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATORS; ENVIRONMENTAL SIGNAL; DNA; RNA; RIBOREGULATORS; TRANSLATION; EXPRESSION; PATHWAY; CELLS	Synthetic gene networks have wide-ranging uses in reprogramming and rewiring organisms. To date, there has not been a way to harness the vast potential of these networks beyond the constraints of a laboratory or in vivo environment. Here, we present an in vitro paper-based platform that provides an alternate, versatile venue for synthetic biologists to operate and a much-needed medium for the safe deployment of engineered gene circuits beyond the lab. Commercially available cell-free systems are freeze dried onto paper, enabling the inexpensive, sterile, and abiotic distribution of synthetic-biology-based technologies for the clinic, global health, industry, research, and education. For field use, we create circuits with colorimetric outputs for detection by eye and fabricate a low-cost, electronic optical interface. We demonstrate this technology with small-molecule and RNA actuation of genetic switches, rapid proto-typing of complex gene circuits, and programmable in vitro diagnostics, including glucose sensors and strain-specific Ebola virus sensors.	[Pardee, Keith; Green, Alexander A.; Ferrante, Tom; DaleyKeyser, Ajay; Yin, Peng; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Pardee, Keith; Green, Alexander A.; Cameron, D. Ewen; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pardee, Keith; Green, Alexander A.; Cameron, D. Ewen; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Cameron, D. Ewen; Collins, James J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston University; Boston University; Howard Hughes Medical Institute	Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	jcollins@bu.edu	Green, Alexander A./X-7025-2019	Green, Alexander A./0000-0003-2058-1204	Canadian Institutes of Health Research; Wyss Institute; NIH Director's New Innovator Award [1DP2OD007292]; ONR Young Investigator Program Award [N000141110914]; NSF Expedition in Computing Award [CCF1317291]; Howard Hughes Medical Institute; Office of Naval Research MURI program; Defense Threat Reduction Agency [HDTRA1-14-1-0006]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wyss Institute; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR Young Investigator Program Award; NSF Expedition in Computing Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Naval Research MURI program(MURI); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K.P. is a Canadian Institutes of Health Research-funded postdoctoral fellow at the Wyss Institute at Harvard University. This work was supported by the Wyss Institute; and NIH Director's New Innovator Award (1DP2OD007292), an ONR Young Investigator Program Award (N000141110914), and an NSF Expedition in Computing Award (CCF1317291) through P.Y. and the Howard Hughes Medical Institute, the Office of Naval Research MURI program, and the Defense Threat Reduction Agency grant HDTRA1-14-1-0006 through J.J.C.	Anbarasi MS., 2011, INT J COMPUT SCI INF, V2, P512; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; BUDD J, 1989, COLLOID SURFACE, V36, P273, DOI 10.1016/0166-6622(89)80243-4; Byrd KB, 2014, REMOTE SENS ENVIRON, V149, P166, DOI 10.1016/j.rse.2014.04.003; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Cooper RM, 2014, LAB CHIP, V14, P182, DOI 10.1039/c3lc50935d; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Hughes TR, 2011, SUBCELL BIOCHEM, V52, P11, DOI 10.1007/978-90-481-9069-0; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kang JH, 2014, NAT MED, V20, P1211, DOI 10.1038/nm.3640; Karzbrun E, 2014, SCIENCE, V345, P829, DOI 10.1126/science.1255550; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kobori S, 2013, MOL BIOSYST, V9, P1282, DOI 10.1039/c3mb70032a; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Schmidt JA., 2010, LIGNIN LIGNANS ADV C, P49, DOI 10.1201/EBK1574444865-c3; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimizu Y, 2010, METHODS MOL BIOL, V607, P11, DOI 10.1007/978-1-60327-331-2_2; Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a; Takahashi MK, 2014, ACS SYNTH BIOL; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	39	395	411	18	246	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					940	954		10.1016/j.cell.2014.10.004	http://dx.doi.org/10.1016/j.cell.2014.10.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417167	Green Accepted, Bronze			2022-12-01	WOS:000344522000023
